Psyllid ID: psy6508

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------
Protein Sequence
NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDHHARVSISSDHHTRVSISSDHRARVSISSDHHVRVSISSDHHARYIMAY
Secondary Structure (PSIPRED)
cccccEEEEEEEEcccccHHHHHHHHHHHHHHHHcccccccEEEEEEEEccEEEEEEEEEccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccEEEEEEccccccccccccccccccEEEEEEEEEEEccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEEEEEEEEccccHHHHHHHHHHHHHHHcccccccEEEEEEEEEEccEEEEcccHHHHHHHcccccccccccccEEEEEccccccEEEEEEEccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccHHHHHHHHccccEEEcEEEEccccccccccccEEEEcccccHHHHHHccccccccccEEEEccHHHHHHccccccccEEEccccccEEEEEcccccEEEEEcccccEEEEEccccEEEEEEcccccccccccc
Secondary Structure Prediction (SSPRO)
cccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHccccEEEEEEEEcccccEEEEEEEccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccEEEccccHHHHccccccEEEEccccccccccccccccccccccccccccccHHHHccccccccccccccccccccEEEHHHHHHHHHHHHcccccccccHHHHHHHccccccccHHHHHHHHHHccccHcccccHHHHHHccHHHcccccccccccEEEEEccccccccccHHHHHHHHHHHHHHHHHHHHHHcHHHHHHHHHHHHHHHcccccHHHHHHHHHHcccccHccccHHcHHHHcccccccccccccccccccccEEEccccccccccccHHHEEEcccccccccccccccccccccccccccccccccccccccEEEEEcccccEEEEEEcccccEEEEEccccEEEEEEccccEEEEEccccccEEEEEc
Coil and Loop (DISEMBL)
NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEycdggdlcsfiRSHEKLSEFQCQQFVRQLVLALKFLrennvchfdlkpqniliknnTLKLAGLKQGVSEKAKGSAYIEQGNTKvicsvfepreipssktsleYQRSKGELYvefkfapfasqirtgwlrdsEEKELGNHLKralepavcrhefsnFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPmydlvtsstlalrggltfidpVEEEVAYCQslsssedddsgvITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVsdhvtlpergryvlnsglwsdckfyvgndvhckefkaHKLILsmsspvfatmfhgelcekgdtkilditpeafstmldsdhharvnissdhharvsissdhhtrvsissdhrarvsissdhhvrvsissdhHARYIMAY
Flexible Loop (DISEMBL)
neqhtevaikcidktkvsenRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHfdlkpqnilikNNTLKLAGLKQGVSEKAkgsayieqgntkvicsvfepreipssktsleYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLvsdhvtlpergryvlnsglWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDhharvsissdhhtrvsissdhrarvsissdhhvrvsissdhharYIMAY
Low Complexity Region (SEG)
NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDHHARVSISSDHHTRVSISSDHRARVSISSDHHVRVSISSDHHARYIMAY
Disordered region (IsUnstruct)
******VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE****************KGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSL*******SGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTML**************************************************************
Disordered Region (DISOPRED)
***HTEVAIKCIDKTKVS**R*DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE***************SKGELYVEFKFA**********************LKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDH*****************DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDHHARVSISSDHHTRVSI*S*HRA*VSISSDHHVRVSISSDHHARYIMAY
Disordered Region (DISEMBL)
NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYC*********DSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDHHARVSISSDHHTRVSISSDHRARVSISSDHHVRVSISSDHHARYIMAY
Disordered Region (DISPRO)
***HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDHHARVSISSDHHTRVSISSDHRARVSISSDHHVRVSISSDHHARYIMAY
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDHHARVSISSDHHTRVSISSDHRARVSISSDHHVRVSISSDHHARYIMAY
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	477	2.2.26 [Sep-21-2011]
Q6P0I8	271	Exosome complex component	yes	N/A	0.421	0.741	0.378	5e-36
Q4V7Q6	468	Serine/threonine-protein	N/A	N/A	0.251	0.256	0.472	2e-25
Q5ZJH6	468	Serine/threonine-protein	yes	N/A	0.251	0.256	0.448	5e-24
Q6PHR2	472	Serine/threonine-protein	yes	N/A	0.251	0.254	0.44	3e-22
D3ZHP7	472	Serine/threonine-protein	yes	N/A	0.251	0.254	0.44	3e-22
Q3U3Q1	472	Serine/threonine-protein	yes	N/A	0.251	0.254	0.44	3e-22
Q28F19	270	Exosome complex component	no	N/A	0.356	0.629	0.345	1e-21
Q8U0L9	250	Probable exosome complex	yes	N/A	0.473	0.904	0.291	2e-19
A9A5C9	244	Probable exosome complex	yes	N/A	0.415	0.811	0.297	4e-19
O75385	1050	Serine/threonine-protein	no	N/A	0.245	0.111	0.394	1e-18

>sp|Q6P0I8|EXOS6_DANRE Exosome complex component MTR3 OS=Danio rerio GN=exosc6 PE=2 SV=2

 Score =  152 bits (384), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 78/206 (37%), Positives = 118/206 (57%), Gaps = 5/206 (2%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           G+  +AKGSAYIE GNTK+ICSV+ P+E   ++   E     G L  +F+ APF+   R 
Sbjct: 50  GLVSQAKGSAYIEAGNTKIICSVYGPKE---TERRDETDMKTGRLVCDFRLAPFSCVKRG 106

Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
            W++ SEE++L   L  +L P VC H +   Q+D+ V+VL+NDGS L+ A+ CA++AL D
Sbjct: 107 AWIQGSEERDLSATLMESLRPGVCLHRYPRSQIDVNVMVLENDGSVLAHAVTCASMALAD 166

Query: 244 AAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQ 303
           A I MYD+V   TL   G    +DP   E   C S      D+ G +TL+ +  + QV+ 
Sbjct: 167 AGIEMYDIVLGCTLRQSGNACLVDPSYAE--ECGSWQEGYGDNQGCVTLALLPNLNQVSG 224

Query: 304 VTLVGTIQQERLADHIEQLIGCCESL 329
           +   G ++++ L + +   +  C  L
Sbjct: 225 LNADGEMREDTLTEAMRTCMDGCHKL 250

Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events.
Danio rerio (taxid: 7955)

>sp|Q4V7Q6|ULK3_XENLA Serine/threonine-protein kinase ULK3 OS=Xenopus laevis GN=ulk3 PE=2 SV=1

 Score =  117 bits (293), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 59/125 (47%), Positives = 81/125 (64%), Gaps = 5/125 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIKC+ K  +++   ++++ EI+ LK +HH HI+ + DF WD+ Y+++I EYC GGDL 
Sbjct: 40  VAIKCVSKKSLNKAAVENLLTEIEILKTVHHPHILELKDFQWDQDYIFLITEYCAGGDLS 99

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLA--GL 121
            FIR+   L E   Q F++QL  ALKFL E N+ H DLKPQNIL+       LKLA  G 
Sbjct: 100 RFIRTRRILPERIVQVFLQQLASALKFLHEKNISHLDLKPQNILLSRLDRPHLKLADFGF 159

Query: 122 KQGVS 126
            Q +S
Sbjct: 160 AQHMS 164

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1

 Score =  112 bits (281), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 56/125 (44%), Positives = 81/125 (64%), Gaps = 5/125 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+KC+ K  ++    ++++ EI+ LK + H HIV + DF WD  ++Y+I+E+C GGDL 
Sbjct: 41  VAVKCVSKRSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLS 100

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLA--GL 121
            FIR    L E   + F++QL  ALKFL ++N+ H DLKPQNIL+   +N  LKLA  G 
Sbjct: 101 RFIRMRRILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLSTPENPQLKLADFGF 160

Query: 122 KQGVS 126
            Q +S
Sbjct: 161 AQYMS 165

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6PHR2|ULK3_HUMAN Serine/threonine-protein kinase ULK3 OS=Homo sapiens GN=ULK3 PE=1 SV=2

 Score =  107 bits (266), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 55/125 (44%), Positives = 79/125 (63%), Gaps = 5/125 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIKC+ K  +++   ++++ EI+ LK + H HIV + DF WD   +Y+I+E+C GGDL 
Sbjct: 41  VAIKCVAKKSLNKASVENLLTEIEILKGIRHPHIVQLKDFQWDSDNIYLIMEFCAGGDLS 100

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL---IKNNTLKLA--GL 121
            FI +   L E   + F++QL  AL+FL E N+ H DLKPQNIL   ++   LKLA  G 
Sbjct: 101 RFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKPHLKLADFGF 160

Query: 122 KQGVS 126
            Q +S
Sbjct: 161 AQHMS 165

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1

 Score =  107 bits (266), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 55/125 (44%), Positives = 79/125 (63%), Gaps = 5/125 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIKC+ K  +++   ++++ EI+ LK + H HIV + DF WD   +Y+I+E+C GGDL 
Sbjct: 41  VAIKCVAKKSLNKASVENLLTEIEILKGIRHPHIVQLKDFQWDNDNIYLIMEFCAGGDLS 100

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL---IKNNTLKLA--GL 121
            FI +   L E   + F++QL  AL+FL E N+ H DLKPQNIL   ++   LKLA  G 
Sbjct: 101 RFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKPHLKLADFGF 160

Query: 122 KQGVS 126
            Q +S
Sbjct: 161 AQHMS 165

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus GN=Ulk3 PE=2 SV=1

 Score =  106 bits (265), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 55/125 (44%), Positives = 79/125 (63%), Gaps = 5/125 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIKC+ K  +++   ++++ EI+ LK + H HIV + DF WD   +Y+I+E+C GGDL 
Sbjct: 41  VAIKCVAKKSLNKASVENLLTEIEILKGIRHPHIVQLKDFQWDNDNIYLIMEFCAGGDLS 100

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL---IKNNTLKLA--GL 121
            FI +   L E   + F++QL  AL+FL E N+ H DLKPQNIL   ++   LKLA  G 
Sbjct: 101 RFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKPHLKLADFGF 160

Query: 122 KQGVS 126
            Q +S
Sbjct: 161 AQHMS 165

Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q28F19|EXOS6_XENTR Exosome complex component MTR3 OS=Xenopus tropicalis GN=exosc6 PE=2 SV=1

 Score =  104 bits (260), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 103/191 (53%), Gaps = 21/191 (10%)

Query: 121 LKQGVSEKAKGSAYIE--QGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFA 178
           ++ G+  +AKGSAY+E   G TKV+C+V  PRE        E   ++G L  + ++APF+
Sbjct: 45  VRAGLLSQAKGSAYLEAGSGGTKVLCAVHGPRE---RGMGGERAETRGRLLCDLRWAPFS 101

Query: 179 SQIRTGW----LRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAI 234
              R  W          ++ G  L+ +LEPAV    +   +V ++VLVL++ GSAL AA+
Sbjct: 102 R--RGPWSGSCPAGPSPRQAGLQLQESLEPAVRLDRYPRAEVIVWVLVLEDRGSALPAAV 159

Query: 235 NCANLALVDAAIPMYDLVTSSTLAL-RGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLS 293
           +CA+LAL DA I M+DL     L+   GG   +DP ++E          E    G ++LS
Sbjct: 160 SCASLALADAGIEMFDLALGCGLSRGPGGELLLDPDDDE---------EEAGSGGTMSLS 210

Query: 294 YMSVIQQVTQV 304
            +  + QV+ +
Sbjct: 211 LLPTLNQVSGL 221

Non-catalytic component of the RNA exosome complex which has 3'->5' exoribonuclease activity and participates in a multitude of cellular RNA processing and degradation events.

Xenopus tropicalis (taxid: 8364)

>sp|Q8U0L9|ECX1_PYRFU Probable exosome complex exonuclease 1 OS=Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) GN=PF1568 PE=3 SV=1

 Score = 97.8 bits (242), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/254 (29%), Positives = 120/254 (47%), Gaps = 28/254 (11%)

Query: 104 LKPQNI-LIKNNTLKLAG----------LKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
           LKP+ + LI  N  +L G          +K GV + A GSAYIE G  K+I +V+ PREI
Sbjct: 3   LKPEGLKLIDENGRRLDGRKKYELRPIKMKVGVLKNANGSAYIEWGKNKIIAAVYGPREI 62

Query: 153 -PSSKTSLEYQRS-KGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHE 210
            P        QR  +  L V +  APF+ + R     D    E+   ++ ALEPA+    
Sbjct: 63  HPK-----HLQRPDRAILRVRYNMAPFSVEERKKPGPDRRSIEISKVIRGALEPALILEM 117

Query: 211 FSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVE 270
           F    +D+F+ VLQ D     A I  A+LAL DA IPM DLV + +     G   +D  +
Sbjct: 118 FPRTAIDVFIEVLQADAGTRVAGITAASLALADAGIPMRDLVAACSAGKIEGEIVLDLNK 177

Query: 271 EEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLC 330
           EE  Y ++           + ++ M +   +T + + G + +E   + ++  I   +++ 
Sbjct: 178 EEDNYGEA----------DVPVAIMPIKNDITLLQMDGYLTKEEFIEAVKLAIKGAKAVY 227

Query: 331 TDRVQKLVSDHVTL 344
             + + L   ++ +
Sbjct: 228 QKQREALKEKYLKI 241

Probably involved in the 3'->5' degradation of a variety of RNA species.

Pyrococcus furiosus (strain ATCC 43587 / DSM 3638 / JCM 8422 / Vc1) (taxid: 186497)

EC: 3

EC: .

EC: 1

EC: .

EC: 1

EC: 3

EC: .

EC: -

>sp|A9A5C9|ECX1_NITMS Probable exosome complex exonuclease 1 OS=Nitrosopumilus maritimus (strain SCM1) GN=Nmar_0432 PE=3 SV=1

 Score = 96.7 bits (239), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 104/225 (46%), Gaps = 27/225 (12%)

Query: 105 KPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRS 164
           +P+ I+IK   LK           A GS+YIE G+ K++  VF PR++     S      
Sbjct: 25  EPRRIMIKAGGLK----------NADGSSYIEFGDNKILVGVFGPRDVHPKHMS---DTD 71

Query: 165 KGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQ 224
            G L V +   PF+   R        E E+   +K ALEPAV   +F    VD+F+ VLQ
Sbjct: 72  TGILRVRYHMEPFSVGERKNPAPSRREIEISKVIKEALEPAVMLEKFPRTAVDVFIEVLQ 131

Query: 225 NDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSED 284
            DG    AA+  A++AL DA IPM D+V +           +D             ++E+
Sbjct: 132 ADGGTRCAALTAASVALADAGIPMRDMVAAIAAGKVADTVILD------------VNNEE 179

Query: 285 DDSGV--ITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCE 327
           D +G   + + YM  ++++T + L G +  E     I+  +  C+
Sbjct: 180 DQAGQADMPIGYMPNLEKITLLQLDGVLTPEEYKKCIQVGVDGCK 224

Probably involved in the 3'->5' degradation of a variety of RNA species.

Nitrosopumilus maritimus (strain SCM1) (taxid: 436308)

EC: 3

EC: .

EC: 1

EC: .

EC: 1

EC: 3

EC: .

EC: -

>sp|O75385|ULK1_HUMAN Serine/threonine-protein kinase ULK1 OS=Homo sapiens GN=ULK1 PE=1 SV=2

 Score = 95.1 bits (235), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 47/119 (39%), Positives = 75/119 (63%), Gaps = 2/119 (1%)

Query: 2   EQH-TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E+H  EVA+KCI+K  +++++   +  EIK LK L H++IV + DF      VY+++EYC
Sbjct: 37  EKHDLEVAVKCINKKNLAKSQ-TLLGKEIKILKELKHENIVALYDFQEMANSVYLVMEYC 95

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
           +GGDL  ++ +   LSE   + F++Q+  A++ L    + H DLKPQNIL+ N   + A
Sbjct: 96  NGGDLADYLHAMRTLSEDTIRLFLQQIAGAMRLLHSKGIIHRDLKPQNILLSNPAGRRA 154

Serine/threonine-protein kinase involved in autophagy in response to starvation. Acts upstream of phosphatidylinositol 3-kinase PIK3C3 to regulate the formation of autophagophores, the precursors of autophagosomes. Part of regulatory feedback loops in autophagy: acts both as a downstream effector and negative regulator of mammalian target of rapamycin complex 1 (mTORC1) via interaction with RPTOR. Activated via phosphorylation by AMPK and also acts as a regulator of AMPK by mediating phosphorylation of AMPK subunits PRKAA1, PRKAB2 and PRKAG1, leading to negatively regulate AMPK activity. May phosphorylate ATG13/KIAA0652 and RPTOR; however such data need additional evidences. Plays a role early in neuronal differentiation and is required for granule cell axon formation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	477
242025392	278	conserved hypothetical protein [Pediculu	0.454	0.780	0.504	2e-49
340727523	273	PREDICTED: exosome complex component MTR	0.488	0.853	0.436	1e-42
380027897	273	PREDICTED: exosome complex component MTR	0.465	0.813	0.440	2e-42
156537299	284	PREDICTED: exosome complex component MTR	0.442	0.742	0.462	2e-41
350423078	273	PREDICTED: exosome complex component MTR	0.465	0.813	0.449	3e-41
170067614	246	exosome component 6 [Culex quinquefascia	0.410	0.796	0.450	4e-41
270009587	300	hypothetical protein TcasGA2_TC008865 [T	0.496	0.79	0.453	4e-41
91087143	282	PREDICTED: similar to exosomal 3-5 exori	0.454	0.769	0.479	5e-41
357622504	548	mRNA transport regulator 3 [Danaus plexi	0.383	0.333	0.468	2e-40
357625820	306	mRNA transport regulator 3 [Danaus plexi	0.383	0.598	0.468	3e-40

>gi|242025392|ref|XP_002433108.1| conserved hypothetical protein [Pediculus humanus corporis] gi|212518649|gb|EEB20370.1| conserved hypothetical protein [Pediculus humanus corporis]

 Score =  203 bits (516), Expect = 2e-49,   Method: Compositional matrix adjust.
 Identities = 112/222 (50%), Positives = 148/222 (66%), Gaps = 5/222 (2%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           +K GV  +AKGSAY+E  NTKV+ SVFEPREIP     L      GE+Y EFKFAPF   
Sbjct: 56  MKTGVVTQAKGSAYLELNNTKVLVSVFEPREIPR----LSEFTPNGEIYCEFKFAPFYGL 111

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R G + D EEK+L   LKR+LEPAVCRHEF NFQVD++ L+L NDGS LSAAI  A LA
Sbjct: 112 ERKGHIMDLEEKDLSIILKRSLEPAVCRHEFPNFQVDVYALLLDNDGSCLSAAITAAGLA 171

Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQ 300
           L DA IPMYD++TS TL +   + FIDP  EE  +C+S   ++  + G+I+LSYM  + Q
Sbjct: 172 LADAGIPMYDILTSVTLGIHNDMIFIDPNFEEEKFCKSFFKNKTSEIGIISLSYMPEMAQ 231

Query: 301 VTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHV 342
           VT++T  GT+    +   ++ LI  C+++ +D  +K + D+V
Sbjct: 232 VTEITQSGTVSINTILKSMDLLISKCKTI-SDLTKKCLMDNV 272

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340727523|ref|XP_003402091.1| PREDICTED: exosome complex component MTR3-like [Bombus terrestris]

 Score =  180 bits (457), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 104/238 (43%), Positives = 153/238 (64%), Gaps = 5/238 (2%)

Query: 102 FDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEY 161
           +DL  ++    NN ++   LK G+  +AKGSAYIE GNTKV+CSVF+PRE+ S+K S   
Sbjct: 32  YDLSERSDKRTNNEMRKIFLKAGIVSQAKGSAYIELGNTKVVCSVFDPREV-SNKNSY-- 88

Query: 162 QRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVL 221
             ++GE+Y EFKFAPF+ Q R    +++EEK+    L+RALEPAVC HEF NFQVD++V+
Sbjct: 89  -YAQGEIYCEFKFAPFSCQKRKVHQQNAEEKQYSLILQRALEPAVCLHEFPNFQVDVYVM 147

Query: 222 VLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSS 281
           VL N GS+L+AAI  A+ AL +A +PM+ LVT+ST+ +      +DP + E A C +   
Sbjct: 148 VLDNAGSSLAAAIMAASTALANAGVPMFGLVTASTIGIYDNHYLMDPTDIEEAICNTQPD 207

Query: 282 SEDD-DSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLV 338
           ++ D + G+ITL+ +    Q+++V L+G+I    +    E L    + +C    Q LV
Sbjct: 208 NQGDFNHGIITLASLPQHNQISEVFLIGSINTNSVVQATEILTAANKDICPVLQQCLV 265

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|380027897|ref|XP_003697651.1| PREDICTED: exosome complex component MTR3-like [Apis florea]

 Score =  180 bits (456), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 100/227 (44%), Positives = 147/227 (64%), Gaps = 5/227 (2%)

Query: 113 NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEF 172
           N+ ++   LK G+  +AKGSAYIE GNTKV+CSVF+PRE+ +         ++GE+Y EF
Sbjct: 43  NSEMRKIFLKTGIVSQAKGSAYIELGNTKVVCSVFDPRELSNRNGYC----TQGEIYCEF 98

Query: 173 KFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSA 232
           KFAPF+ Q R    +D+EEK+    L+RALEPAVC HEF NFQVD++ +VL N GS+L+A
Sbjct: 99  KFAPFSCQKRKIHQQDAEEKQYSLILQRALEPAVCLHEFPNFQVDVYAMVLDNAGSSLAA 158

Query: 233 AINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDD-DSGVIT 291
           AI  A+ AL +A +PM+ LVT+ST+ +      +DP + E   C +   ++DD + G+IT
Sbjct: 159 AIMAASTALANAGVPMFGLVTASTIGIYDNYYLMDPTDTEEVICNTQPDNQDDFNHGIIT 218

Query: 292 LSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLV 338
           L+ ++   QV++V L+G+I  + +    E LI   + +C    Q LV
Sbjct: 219 LASLAQHNQVSEVFLIGSIDTKSIIQATEILITVNKDICPVLQQCLV 265

Source: Apis florea

Species: Apis florea

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|156537299|ref|XP_001606070.1| PREDICTED: exosome complex component MTR3-like [Nasonia vitripennis]

 Score =  177 bits (448), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 100/216 (46%), Positives = 142/216 (65%), Gaps = 5/216 (2%)

Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVE 171
           K+  L+   +K GV  +AKGSAYIE G TKVICS F+PREIP+ KTS   Q   GE++ E
Sbjct: 44  KHKELRKMFIKLGVVSQAKGSAYIEMGQTKVICSAFDPREIPN-KTSYSTQ---GEIFCE 99

Query: 172 FKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALS 231
           FKFA FA+  R G  +D+EEKE    ++RALEPAVCRHEF NFQVD++ LVL N GSAL 
Sbjct: 100 FKFASFATCKRKGHQQDTEEKEYSLIMQRALEPAVCRHEFPNFQVDVYALVLDNGGSALG 159

Query: 232 AAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSED-DDSGVI 290
           AAI  A+LAL +A++PM+ +VT+ T  +   L  +DP ++E A C S++  +   + G+I
Sbjct: 160 AAIMGASLALANASVPMFGIVTAVTAGIYDDLLLLDPTDKEEALCLSVAKQKKLTNHGII 219

Query: 291 TLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCC 326
             + +    Q+++  LVG++  + + + +E L   C
Sbjct: 220 MQAMLLQHDQISEFFLVGSMDVDCVNNSMELLSKTC 255

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|350423078|ref|XP_003493378.1| PREDICTED: exosome complex component MTR3-like [Bombus impatiens]

 Score =  176 bits (445), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/227 (44%), Positives = 145/227 (63%), Gaps = 5/227 (2%)

Query: 113 NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEF 172
           NN ++   LK G+  +AKGSAYIE GNTKV+CSVF+PRE+ S+K     Q   GE+Y EF
Sbjct: 43  NNEMRKIFLKTGIVSQAKGSAYIELGNTKVVCSVFDPREV-SNKNGYCAQ---GEIYCEF 98

Query: 173 KFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSA 232
           KFAPF+ Q R    +++EEK+    L+RALEPAVC HEF NFQVD++V+VL N GS+L+A
Sbjct: 99  KFAPFSCQKRKIHQQNAEEKQYSLILQRALEPAVCLHEFPNFQVDVYVMVLDNAGSSLAA 158

Query: 233 AINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDD-DSGVIT 291
           AI  A+ AL +A +PM+ LVT+ST+ +      +DP + E A C +   ++ D + G IT
Sbjct: 159 AIMAASTALANAGVPMFGLVTASTIGIYDNHYLMDPTDIEEAICNTQPDNQGDFNHGTIT 218

Query: 292 LSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLV 338
           L+ +    Q+++V L+G+I    +    E L    + +C    Q LV
Sbjct: 219 LASLPQHNQISEVFLIGSINTNSVVQATEILTTANKDICPVLQQCLV 265

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|170067614|ref|XP_001868552.1| exosome component 6 [Culex quinquefasciatus] gi|167863716|gb|EDS27099.1| exosome component 6 [Culex quinquefasciatus]

 Score =  175 bits (444), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 91/202 (45%), Positives = 125/202 (61%), Gaps = 6/202 (2%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           +K GV   AKGSAY+E GNTKVI SVF+PREIP   T     R  GELY + KF+PFA  
Sbjct: 1   MKLGVVSTAKGSAYLELGNTKVIVSVFDPREIPKQNTF----RELGELYCDLKFSPFACV 56

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R     D+EE+ L   + +AL+P VCRH F NFQ+D+F  VL++DGS L A I  A LA
Sbjct: 57  HRKNPQTDAEERSLAAAMTKALQPVVCRHLFPNFQIDIFANVLEDDGSVLGAVITAAGLA 116

Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQ 300
           L DA I M+D+VT++T+A+ G   ++DP   E   C  L  S   + GVITL+ +  + Q
Sbjct: 117 LSDATISMFDIVTATTVAVYGDRIYLDPTLAEERLC--LEGSRSGNHGVITLAKLHTLDQ 174

Query: 301 VTQVTLVGTIQQERLADHIEQL 322
            +++ L G +  + L +  ++L
Sbjct: 175 TSEIRLAGNVSLDLLKNACQRL 196

Source: Culex quinquefasciatus

Species: Culex quinquefasciatus

Genus: Culex

Family: Culicidae

Order: Diptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|270009587|gb|EFA06035.1| hypothetical protein TcasGA2_TC008865 [Tribolium castaneum]

 Score =  175 bits (444), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 111/245 (45%), Positives = 150/245 (61%), Gaps = 8/245 (3%)

Query: 99  VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTS 158
           +C+  L P   L  +       LK GV  +AKGSAYIE   TKVI SVF+PREIP+ KT 
Sbjct: 54  ICNLSLGPCVFL--DLIFNFLVLKTGVVSQAKGSAYIELDQTKVIVSVFDPREIPN-KTD 110

Query: 159 LEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDL 218
                SKGE+Y EFKFAPF+   R    +D+EE++    +K+ALE AV RHEF NFQVD+
Sbjct: 111 YS---SKGEIYCEFKFAPFSCHKRRLHQQDAEEQQFSAIMKQALESAVFRHEFPNFQVDI 167

Query: 219 FVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQ- 277
           + +VL NDG+ALSAAI  A +AL  A IPMYDL+TS TLA++G    +DP  EE   CQ 
Sbjct: 168 YAMVLHNDGAALSAAITAAGVALAHAGIPMYDLITSVTLAVQGNHLLVDPTLEEERLCQV 227

Query: 278 SLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKL 337
            L   E+++ G++ LS ++  +Q++Q    G +    L+  IE L    + + T  V+K 
Sbjct: 228 PLFKEEENNHGIVVLSVLATHEQISQFYQSGYLSYACLSSGIEMLTNAAKDIVT-LVKKC 286

Query: 338 VSDHV 342
           +  HV
Sbjct: 287 LVKHV 291

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|91087143|ref|XP_975288.1| PREDICTED: similar to exosomal 3-5 exoribonuclease complex subunit Rrp41-like protein [Tribolium castaneum]

 Score =  175 bits (443), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 107/223 (47%), Positives = 143/223 (64%), Gaps = 6/223 (2%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           LK GV  +AKGSAYIE   TKVI SVF+PREIP+ KT      SKGE+Y EFKFAPF+  
Sbjct: 56  LKTGVVSQAKGSAYIELDQTKVIVSVFDPREIPN-KTDYS---SKGEIYCEFKFAPFSCH 111

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R    +D+EE++    +K+ALE AV RHEF NFQVD++ +VL NDG+ALSAAI  A +A
Sbjct: 112 KRRLHQQDAEEQQFSAIMKQALESAVFRHEFPNFQVDIYAMVLHNDGAALSAAITAAGVA 171

Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQ-SLSSSEDDDSGVITLSYMSVIQ 299
           L  A IPMYDL+TS TLA++G    +DP  EE   CQ  L   E+++ G++ LS ++  +
Sbjct: 172 LAHAGIPMYDLITSVTLAVQGNHLLVDPTLEEERLCQVPLFKEEENNHGIVVLSVLATHE 231

Query: 300 QVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHV 342
           Q++Q    G +    L+  IE L    + + T  V+K +  HV
Sbjct: 232 QISQFYQSGYLSYACLSSGIEMLTNAAKDIVT-LVKKCLVKHV 273

Source: Tribolium castaneum

Species: Tribolium castaneum

Genus: Tribolium

Family: Tenebrionidae

Order: Coleoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357622504|gb|EHJ73955.1| mRNA transport regulator 3 [Danaus plexippus]

 Score =  173 bits (438), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 89/190 (46%), Positives = 129/190 (67%), Gaps = 7/190 (3%)

Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQI 181
           + G+  +AKGS+YIE   TKV CSVF+PREI       EY  + G+LY E K+APF+ + 
Sbjct: 57  RTGMISQAKGSSYIELKRTKVACSVFDPREIVHQN---EYS-TLGQLYCEVKYAPFSCRG 112

Query: 182 -RTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R   + DS+E+ L   LK+ALEPAVCRH F N+Q+D+F+ +L+NDG+ L AAIN A LA
Sbjct: 113 ERKALVPDSDERALSVALKKALEPAVCRHLFPNYQIDIFIYILENDGACLPAAINAAGLA 172

Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQ 300
           L DAA+PMYD++T+S+LA+ G   F+DP ++E     ++   E  + GVIT+S +  +QQ
Sbjct: 173 LSDAAVPMYDIITASSLAISGDKVFVDPTDDEEQL--AIRDHEGVNHGVITMSMLPELQQ 230

Query: 301 VTQVTLVGTI 310
           V+    +G++
Sbjct: 231 VSDYRQIGSM 240

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|357625820|gb|EHJ76127.1| mRNA transport regulator 3 [Danaus plexippus]

 Score =  172 bits (436), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 89/190 (46%), Positives = 129/190 (67%), Gaps = 7/190 (3%)

Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQI 181
           + G+  +AKGS+YIE   TKV CSVF+PREI       EY  + G+LY E K+APF+ + 
Sbjct: 57  RTGMISQAKGSSYIELKRTKVACSVFDPREIVHQN---EYS-TLGQLYCEVKYAPFSCRG 112

Query: 182 -RTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R   + DS+E+ L   LK+ALEPAVCRH F N+Q+D+F+ +L+NDG+ L AAIN A LA
Sbjct: 113 ERKALVPDSDERALSVALKKALEPAVCRHLFPNYQIDIFIYILENDGACLPAAINAAGLA 172

Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQ 300
           L DAA+PMYD++T+S+LA+ G   F+DP ++E     ++   E  + GVIT+S +  +QQ
Sbjct: 173 LSDAAVPMYDIITASSLAISGDKVFVDPTDDEEQL--AIRDHEGVNHGVITMSMLPELQQ 230

Query: 301 VTQVTLVGTI 310
           V+    +G++
Sbjct: 231 VSDYRQIGSM 240

Source: Danaus plexippus

Species: Danaus plexippus

Genus: Danaus

Family: Nymphalidae

Order: Lepidoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	477
ZFIN|ZDB-GENE-050522-362	271	exosc6 "exosome component 6" [	0.421	0.741	0.378	1.1e-34
FB|FBgn0036916	326	Mtr3 "Mtr3" [Drosophila melano	0.423	0.619	0.340	7.7e-24
FB|FBgn0037679	520	CG8866 [Drosophila melanogaste	0.274	0.251	0.422	1.1e-23
TAIR|locus:2124024	256	RRP41L "AT4G27490" [Arabidopsi	0.358	0.667	0.404	2.8e-23
UNIPROTKB|Q4V7Q6	468	ulk3 "Serine/threonine-protein	0.255	0.260	0.464	3.4e-23
ZFIN|ZDB-GENE-070410-33	468	ulk3 "unc-51-like kinase 3 (C.	0.251	0.256	0.442	1.4e-22
UNIPROTKB|Q5ZJH6	468	ULK3 "Serine/threonine-protein	0.251	0.256	0.448	5.3e-22
POMBASE|SPBC211.08c	257	SPBC211.08c "exosomal 3'-5' ex	0.440	0.817	0.313	1.3e-21
RGD|1309832	272	Exosc6 "exosome component 6" [	0.406	0.713	0.350	2.8e-21
UNIPROTKB|F1N332	472	ULK3 "Uncharacterized protein"	0.438	0.442	0.340	2.4e-20

ZFIN|ZDB-GENE-050522-362 exosc6 "exosome component 6" [Danio rerio (taxid:7955)]

 Score = 376 (137.4 bits), Expect = 1.1e-34, P = 1.1e-34
 Identities = 78/206 (37%), Positives = 118/206 (57%)

Query:   124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
             G+  +AKGSAYIE GNTK+ICSV+ P+E   ++   E     G L  +F+ APF+   R 
Sbjct:    50 GLVSQAKGSAYIEAGNTKIICSVYGPKE---TERRDETDMKTGRLVCDFRLAPFSCVKRG 106

Query:   184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
              W++ SEE++L   L  +L P VC H +   Q+D+ V+VL+NDGS L+ A+ CA++AL D
Sbjct:   107 AWIQGSEERDLSATLMESLRPGVCLHRYPRSQIDVNVMVLENDGSVLAHAVTCASMALAD 166

Query:   244 AAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQ 303
             A I MYD+V   TL   G    +DP   E   C S      D+ G +TL+ +  + QV+ 
Sbjct:   167 AGIEMYDIVLGCTLRQSGNACLVDPSYAEE--CGSWQEGYGDNQGCVTLALLPNLNQVSG 224

Query:   304 VTLVGTIQQERLADHIEQLIGCCESL 329
             +   G ++++ L + +   +  C  L
Sbjct:   225 LNADGEMREDTLTEAMRTCMDGCHKL 250

GO:0000178 "exosome (RNase complex)" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0003723 "RNA binding" evidence=IEA

GO:0006364 "rRNA processing" evidence=IEA

GO:0005730 "nucleolus" evidence=IEA

FB|FBgn0036916 Mtr3 "Mtr3" [Drosophila melanogaster (taxid:7227)]

 Score = 278 (102.9 bits), Expect = 7.7e-24, P = 7.7e-24
 Identities = 75/220 (34%), Positives = 114/220 (51%)

Query:   121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
             ++ GV    +GSAY+E GNTKV+  V  P+E+  +      + + G L     FA F+  
Sbjct:    52 IRAGVLTTVRGSAYMEYGNTKVLAIVAPPKELIRASAR---RMNMGVLNCYVNFAAFS-- 106

Query:   181 IRTGWLRDSEEKE--LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCAN 238
               TG L    E+E  L + L +A+EP VCR EF NFQ+D+ VL+L +DG  LS AINC  
Sbjct:   107 --TGDLDSVPERERHLSSMLTKAMEPVVCRTEFLNFQLDIRVLILDDDGCLLSTAINCCG 164

Query:   239 LALVDAAIPMYDLVTSSTLALRGGLTFIDPVE--EEVAYCQSLSSSEDDDS-------GV 289
             +ALV+  I  YDL+T+ST  +     F++P    EE+ +    SS++   S       G+
Sbjct:   165 VALVECGISTYDLITASTACIYRDHVFLNPSAKVEELLWKHRNSSTDSTTSPSSAQEHGL 224

Query:   290 ITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESL 329
             I  + M   +Q+ Q    G +        ++  +   +SL
Sbjct:   225 IITASMDTFEQIAQCQQCGYLSPATYVKLLDYTLAINKSL 264

GO:0000175 "3'-5'-exoribonuclease activity" evidence=ISS

GO:0000176 "nuclear exosome (RNase complex)" evidence=ISS;IDA

GO:0000177 "cytoplasmic exosome (RNase complex)" evidence=ISS

GO:0005737 "cytoplasm" evidence=IDA

GO:0010468 "regulation of gene expression" evidence=IMP

FB|FBgn0037679 CG8866 [Drosophila melanogaster (taxid:7227)]

 Score = 295 (108.9 bits), Expect = 1.1e-23, P = 1.1e-23
 Identities = 60/142 (42%), Positives = 99/142 (69%)

Query:     2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
             +Q T  AIK ++ + +S+   ++++ EI+ L+ L H++IVT+ DF WD++ +YI+LEYC+
Sbjct:    30 KQRTYHAIKYVEMSTLSQTSRENLITEIRLLRELKHKYIVTLQDFFWDDKNIYIVLEYCN 89

Query:    62 GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NN-TLK 117
              G+L +FIR+ + L E  C+ F+RQL  A++++R N+V HFDLKPQN+L+    NN +LK
Sbjct:    90 AGNLSAFIRTKKALPESTCRYFLRQLAAAVQYMRANDVSHFDLKPQNLLLTRGANNVSLK 149

Query:   118 LAG------LKQG-VSEKAKGS 132
             +A       LK G ++++ KGS
Sbjct:   150 VADFGFAQHLKLGEINQQLKGS 171

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004672 "protein kinase activity" evidence=NAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0005524 "ATP binding" evidence=IEA

TAIR|locus:2124024 RRP41L "AT4G27490" [Arabidopsis thaliana (taxid:3702)]

 Score = 273 (101.2 bits), Expect = 2.8e-23, P = 2.8e-23
 Identities = 76/188 (40%), Positives = 102/188 (54%)

Query:   121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
             L+ G    A GSAY E GNTKVI SVF PRE   SK ++ Y    G L     +  FAS 
Sbjct:    48 LQTGAVSSASGSAYAEFGNTKVIVSVFGPRE---SKKAMVYS-DVGRLNCNVSYTNFASP 103

Query:   181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
                G  + ++ KE  + L +ALE  +    F    VD+F LVL++ GS LS  I+CA+LA
Sbjct:   104 T-LG--QGTDHKEYSSMLHKALEGVIMMETFPKTTVDVFALVLESGGSDLSVLISCASLA 160

Query:   241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQ 300
             L DA I MYDL+T+ +++  G    IDPV EE   C      ED   G   ++ M    +
Sbjct:   161 LADAGIMMYDLITAVSVSCIGKSLMIDPVTEEEG-C------ED---GSFMMTCMPSRYE 210

Query:   301 VTQVTLVG 308
             +TQ+T+ G
Sbjct:   211 ITQLTITG 218

GO:0000175 "3'-5'-exoribonuclease activity" evidence=ISS

GO:0003723 "RNA binding" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISM;IDA

GO:0006396 "RNA processing" evidence=ISS

GO:0009909 "regulation of flower development" evidence=RCA

GO:0016570 "histone modification" evidence=RCA

GO:0034968 "histone lysine methylation" evidence=RCA

GO:0048449 "floral organ formation" evidence=RCA

GO:0005634 "nucleus" evidence=IDA

GO:0008408 "3'-5' exonuclease activity" evidence=IMP

GO:0009845 "seed germination" evidence=IMP

GO:0090351 "seedling development" evidence=IMP

UNIPROTKB|Q4V7Q6 ulk3 "Serine/threonine-protein kinase ULK3" [Xenopus laevis (taxid:8355)]

 Score = 289 (106.8 bits), Expect = 3.4e-23, P = 3.4e-23
 Identities = 59/127 (46%), Positives = 82/127 (64%)

Query:     7 VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
             VAIKC+ K  +++   ++++ EI+ LK +HH HI+ + DF WD+ Y+++I EYC GGDL 
Sbjct:    40 VAIKCVSKKSLNKAAVENLLTEIEILKTVHHPHILELKDFQWDQDYIFLITEYCAGGDLS 99

Query:    67 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT---LKLA--GL 121
              FIR+   L E   Q F++QL  ALKFL E N+ H DLKPQNIL+       LKLA  G 
Sbjct:   100 RFIRTRRILPERIVQVFLQQLASALKFLHEKNISHLDLKPQNILLSRLDRPHLKLADFGF 159

Query:   122 KQGVSEK 128
              Q +S +
Sbjct:   160 AQHMSSE 166

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005737 "cytoplasm" evidence=ISS

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=ISS

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

ZFIN|ZDB-GENE-070410-33 ulk3 "unc-51-like kinase 3 (C. elegans)" [Danio rerio (taxid:7955)]

 Score = 282 (104.3 bits), Expect = 1.4e-22, Sum P(2) = 1.4e-22
 Identities = 54/122 (44%), Positives = 80/122 (65%)

Query:     7 VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
             VA+K + K  ++++  ++++ EI+ LK + H HIV + DF WD   +Y+ILE+C GGDL 
Sbjct:    41 VAVKVVSKKSLNKSSMENLLTEIEILKTVRHPHIVQLKDFQWDSENIYLILEWCSGGDLS 100

Query:    67 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA--GLKQG 124
              FIRS   L E   ++ ++Q+  AL+FL E N+ H DLKPQNIL+  N LKL+  G  Q 
Sbjct:   101 RFIRSRRILPERVARRCLQQIACALQFLHERNISHLDLKPQNILLSGNMLKLSDFGFAQY 160

Query:   125 VS 126
             +S
Sbjct:   161 MS 162

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)]

 Score = 279 (103.3 bits), Expect = 5.3e-22, P = 5.3e-22
 Identities = 56/125 (44%), Positives = 81/125 (64%)

Query:     7 VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
             VA+KC+ K  ++    ++++ EI+ LK + H HIV + DF WD  ++Y+I+E+C GGDL 
Sbjct:    41 VAVKCVSKRSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLS 100

Query:    67 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLA--GL 121
              FIR    L E   + F++QL  ALKFL ++N+ H DLKPQNIL+   +N  LKLA  G 
Sbjct:   101 RFIRMRRILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLSTPENPQLKLADFGF 160

Query:   122 KQGVS 126
              Q +S
Sbjct:   161 AQYMS 165

GO:0005524 "ATP binding" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=ISS

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=ISS

POMBASE|SPBC211.08c SPBC211.08c "exosomal 3'-5' exoribonuclease, PH-like (predicted)" [Schizosaccharomyces pombe (taxid:4896)]

 Score = 258 (95.9 bits), Expect = 1.3e-21, P = 1.3e-21
 Identities = 73/233 (31%), Positives = 119/233 (51%)

Query:   121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
             LK G + KA GS+Y E    K+ C+V  PR  PS   +    RS  +L  EF+ +PF++ 
Sbjct:    40 LKLGWATKAVGSSYFESEKIKIACTVSGPR--PSKTFAF---RSSAKLNCEFRLSPFSTS 94

Query:   181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGS--ALSAAINCAN 238
             +R G ++  EEK     ++ A+ P++  H +    +D+++ V+++DG+   L+AAI+CA+
Sbjct:    95 VRQGHVQTVEEKSYSQMIEAAISPSILLHLYPKSSIDVYIQVIESDGALATLAAAISCAS 154

Query:   239 LALVDAAIPMYDLVTSSTLALRGGLT--FIDPVEEEVAYCQSLSSSEDDDSGVITLSYMS 296
              A+ DA I   DLVT S++         +IDP      Y    + +     G + + YM+
Sbjct:   155 SAIADANIDCIDLVTGSSVLFNPNTDEYWIDP-----DYVDERARAA---KGSVVMGYMA 206

Query:   297 VIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERGR 349
              +  VTQV   GT    RL+   E+    C     D   +LV +H  L E+ +
Sbjct:   207 SLGHVTQVWERGTCSPSRLSFLTEK----CIKNAKDT--RLVINHALLLEKSK 253

GO:0000175 "3'-5'-exoribonuclease activity" evidence=ISM

GO:0000176 "nuclear exosome (RNase complex)" evidence=ISO

GO:0000177 "cytoplasmic exosome (RNase complex)" evidence=ISO

GO:0000467 "exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)" evidence=ISO

GO:0003723 "RNA binding" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0034661 "ncRNA catabolic process" evidence=ISO

GO:0070478 "nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay" evidence=ISO

GO:0070481 "nuclear-transcribed mRNA catabolic process, non-stop decay" evidence=ISO

GO:0070651 "nonfunctional rRNA decay" evidence=ISO

GO:0071035 "nuclear polyadenylation-dependent rRNA catabolic process" evidence=ISO

GO:0071038 "nuclear polyadenylation-dependent tRNA catabolic process" evidence=ISO

GO:0071042 "nuclear polyadenylation-dependent mRNA catabolic process" evidence=ISO

RGD|1309832 Exosc6 "exosome component 6" [Rattus norvegicus (taxid:10116)]

 Score = 255 (94.8 bits), Expect = 2.8e-21, P = 2.8e-21
 Identities = 76/217 (35%), Positives = 113/217 (52%)

Query:   122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREI--------PSSKTSLEYQRSKGELYVEFK 173
             + G+  +AKGSAY+E G TKV+C+V  PR+         P+          +G L  +F+
Sbjct:    42 RAGLLSQAKGSAYLEAGGTKVLCAVSGPRQAEGGERGGGPAGAGGEAPAALRGRLLCDFR 101

Query:   174 FAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAA 233
              APF+ + R      SE++ELG  L+ ALEPAV    +   Q+++  L+L++ GSAL+AA
Sbjct:   102 RAPFSGRRRRAPQGSSEDRELGLALQEALEPAVRLGRYPRAQLEVSALLLEDGGSALAAA 161

Query:   234 INCANLALVDAAIPMYDLVTSSTLALRGGLT---FIDPVEEEVAYCQSLSSSEDDDSGVI 290
             +  A LAL DA + MYDLV    L+L  G +    +DP   E          E  ++G +
Sbjct:   162 LTAAALALADAGVEMYDLVVGCGLSLTPGPSPTWLLDPTRLE---------EEHSEAG-L 211

Query:   291 TLSYMSVIQQVTQVTLVGTI-QQERLADHIEQ-LIGC 325
             T++ M V+ QV  +   G   Q E   D +   L GC
Sbjct:   212 TVALMPVLNQVAGLLGSGEGGQTESWTDAVRLGLEGC 248

GO:0000178 "exosome (RNase complex)" evidence=IEA;ISO

GO:0045006 "DNA deamination" evidence=IEA;ISO

GO:0045190 "isotype switching" evidence=ISO

GO:0045830 "positive regulation of isotype switching" evidence=ISO

GO:0004532 "exoribonuclease activity" evidence=ISO

UNIPROTKB|F1N332 ULK3 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 265 (98.3 bits), Expect = 2.4e-20, P = 2.4e-20
 Identities = 78/229 (34%), Positives = 121/229 (52%)

Query:     7 VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
             VAIKC+ K  +++   ++++ EI+ LK + H HIV + DF WD   +Y+I+E+C GGDL 
Sbjct:    41 VAIKCVAKKSLNKASVENLLTEIEILKGIRHPHIVQLKDFQWDSDNIYLIMEFCAGGDLS 100

Query:    67 SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT---LKLA--GL 121
              FI +   L E   + F++QL  AL+FL E N+ H DLKPQNIL+ +     LKLA  G 
Sbjct:   101 RFIHTRRILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKPHLKLADFGF 160

Query:   122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFA--PFAS 179
              Q +S + +   ++ +G+   +      +    ++  L    S G +  E  F   PFAS
Sbjct:   161 AQHMSPRDE--KHVLRGSPLYMAPEMVCQRQYDARVDLW---SVGVILYEALFGQPPFAS 215

Query:   180 QIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGS 228
             +       + EEK   N   R +E  + R + S+   DL   +L+ D S
Sbjct:   216 RS----FSELEEKIRSN---RVIELPL-RPQLSHDCRDLLQRLLERDPS 256

GO:0046777 "protein autophosphorylation" evidence=IEA

GO:0045880 "positive regulation of smoothened signaling pathway" evidence=IEA

GO:0045879 "negative regulation of smoothened signaling pathway" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	477
cd11371	210	cd11371, RNase_PH_MTR3, MTR3 subunit of eukaryotic	9e-78
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	9e-38
cd11370	226	cd11370, RNase_PH_RRP41, RRP41 subunit of eukaryot	4e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-34
pfam01138	129	pfam01138, RNase_PH, 3' exoribonuclease family, do	2e-33
COG0689	230	COG0689, Rph, RNase PH [Translation, ribosomal str	7e-33
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-32
cd11366	214	cd11366, RNase_PH_archRRP41, RRP41 subunit of arch	7e-32
PRK03983	244	PRK03983, PRK03983, exosome complex exonuclease Rr	1e-30
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	3e-30
TIGR02065	230	TIGR02065, ECX1, archaeal exosome-like complex exo	6e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-26
cd11372	199	cd11372, RNase_PH_RRP46, RRP46 subunit of eukaryot	1e-25
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-24
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	6e-23
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	4e-22
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	6e-21
cd11358	218	cd11358, RNase_PH, RNase PH-like 3'-5' exoribonucl	1e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-19
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	7e-19
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-18
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-18
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	5e-18
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	7e-18
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-18
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-17
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-17
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-17
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-16
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-16
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	3e-16
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	9e-16
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-15
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-15
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-15
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	3e-15
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-15
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-14
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-14
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	3e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-13
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	2e-13
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-13
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-13
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-13
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-13
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-12
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	6e-12
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-12
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	8e-12
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-11
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-11
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-11
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-11
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	3e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-11
pfam00651	101	pfam00651, BTB, BTB/POZ domain	4e-11
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	7e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-10
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-10
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-10
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-10
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-10
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-10
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-09
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-09
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-09
smart00225	97	smart00225, BTB, Broad-Complex, Tramtrack and Bric	3e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-09
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-09
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	7e-09
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	9e-09
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-08
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-08
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-08
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-08
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-08
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	2e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-08
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-08
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-08
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-07
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-07
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-07
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-07
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-07
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-07
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-07
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-07
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	3e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	4e-07
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	5e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	5e-07
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-07
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	5e-07
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	6e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-07
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	8e-07
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	9e-07
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-07
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-06
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-06
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-06
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-06
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-06
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-06
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-06
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-06
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-06
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-06
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	3e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	3e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-06
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-06
cd11362	227	cd11362, RNase_PH_bact, Ribonuclease PH	5e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	6e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-06
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	7e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-06
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-06
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-05
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-05
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-05
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-05
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-05
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-05
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-05
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-05
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-05
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-05
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-05
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-05
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-05
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	4e-05
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-05
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-05
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	5e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-05
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-05
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	7e-05
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-05
TIGR01966	236	TIGR01966, RNasePH, ribonuclease PH	8e-05
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	8e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	9e-05
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-04
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-04
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-04
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-04
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-04
COG2123	272	COG2123, COG2123, RNase PH-related exoribonuclease	2e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-04
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-04
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-04
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-04
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-04
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-04
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-04
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-04
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	5e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-04
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	6e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	6e-04
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	6e-04
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	8e-04
cd11365	256	cd11365, RNase_PH_archRRP42, RRP42 subunit of arch	9e-04
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	0.001
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	0.001
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	0.001
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	0.001
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.001
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	0.001
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	0.001
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	0.001
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	0.001
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	0.001
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	0.001
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	0.001
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	0.002
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	0.002
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	0.002
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	0.002
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.002
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	0.002
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	0.003
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	0.003
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	0.004
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	0.004
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	0.004
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	0.004

>gnl|CDD|206776 cd11371, RNase_PH_MTR3, MTR3 subunit of eukaryotic exosome

 Score =  241 bits (617), Expect = 9e-78
 Identities = 96/219 (43%), Positives = 129/219 (58%), Gaps = 14/219 (6%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           LK GV  +AKGSAY+E GNTKVICSV+ PR IP           +G L  E KFAPFA+ 
Sbjct: 6   LKTGVVSQAKGSAYVELGNTKVICSVYGPRPIPGRTEF----SDRGRLNCEVKFAPFATP 61

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R    +DSEE+EL + L +ALEPAV   ++   Q+D+FV VL++DGS L+AAI  A+LA
Sbjct: 62  GRRRHGQDSEERELSSLLHQALEPAVRLEKYPKSQIDVFVTVLESDGSVLAAAITAASLA 121

Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQ 300
           L DA I MYDLVT+ + AL G    +DP  EE          E+  SG + L+YM  + Q
Sbjct: 122 LADAGIEMYDLVTACSAALIGDELLLDPTREE----------EEASSGGVMLAYMPSLNQ 171

Query: 301 VTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVS 339
           VTQ+   G +  ++L + ++  I  C  +     Q L+ 
Sbjct: 172 VTQLWQSGEMDVDQLEEALDLCIDGCNRIHPVVRQALLE 210

The MTR3 subunit of eukaryotic exosome is a member of the RNase_PH family, named after the bacterial Ribonuclease PH, a 3'-5' exoribonuclease. Structurally all members of this family form hexameric rings (trimers of Rrp41-Rrp45, Rrp46-Rrp43, and Mtr3-Rrp42 dimers). The eukaryotic exosome core is composed of six individually encoded RNase PH-like subunits and three additional proteins (Rrp4, Csl4 and Rrp40) that form a stable cap and contain RNA-binding domains. The RNase PH-like subunits are no longer phosphorolytic enzymes, the exosome directly associates with Rrp44 and Rrp6, hydrolytic exoribonucleases related to bacterial RNase II/R and RNase D. The exosome plays an important role in RNA turnover. It plays a crucial role in the maturation of stable RNA species such as rRNA, snRNA and snoRNA, quality control of mRNA, and the degradation of RNA processing by-products and non-coding transcripts. Length = 210

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  138 bits (350), Expect = 9e-38
 Identities = 48/117 (41%), Positives = 77/117 (65%), Gaps = 2/117 (1%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
              VAIK I K K+ ++R + I+ EIK LK L H +IV + D   DE  +Y+++EYC+GG
Sbjct: 24  GKLVAIKVIKKKKIKKDR-ERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           DL   ++   +LSE + + ++RQ++ AL++L    + H DLKP+NIL+ ++  +KLA
Sbjct: 83  DLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLA 139

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|206775 cd11370, RNase_PH_RRP41, RRP41 subunit of eukaryotic exosome

 Score =  133 bits (336), Expect = 4e-36
 Identities = 61/212 (28%), Positives = 100/212 (47%), Gaps = 31/212 (14%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFAS---Q 180
           GV   A GSAY+EQGNTKV+ +V+ P E  +   +L     +  +  E+  A F++   +
Sbjct: 20  GVFSSADGSAYLEQGNTKVLAAVYGPHEPRNRSQALH---DRAVVNCEYSMATFSTGERK 76

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R     D    EL   +++  E  +  H +   Q+D++V VLQ DG  L+A IN A LA
Sbjct: 77  RRGK--GDRRSTELSLAIRQTFEAVILTHLYPRSQIDIYVQVLQADGGLLAACINAATLA 134

Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSG-VITLSYMSVIQ 299
           L+DA IPM D V + +         +D           L+  E+      +T++ +    
Sbjct: 135 LIDAGIPMKDYVCACSAGYLDSTPLLD-----------LNYLEESGDLPDLTVAVLPKSD 183

Query: 300 QVTQVTLVGTIQQERL-ADHIEQLI-----GC 325
           +V  + +     + RL  D +E+++     GC
Sbjct: 184 KVVLLQM-----ESRLHLDRLEKVLELAIEGC 210

The RRP41 subunit of eukaryotic exosome is a member of the RNase_PH family, named after the bacterial Ribonuclease PH, a 3'-5' exoribonuclease. Structurally all members of this family form hexameric rings (trimers of Rrp41-Rrp45, Rrp46-Rrp43, and Mtr3-Rrp42 dimers). The eukaryotic exosome core is composed of six individually encoded RNase PH-like subunits and three additional proteins (Rrp4, Csl4 and Rrp40) that form a stable cap and contain RNA-binding domains. The RNase PH-like subunits are no longer phosphorolytic enzymes, the exosome directly associates with Rrp44 and Rrp6, hydrolytic exoribonucleases related to bacterial RNase II/R and RNase D. The exosome plays an important role in RNA turnover. It plays a crucial role in the maturation of stable RNA species such as rRNA, snRNA and snoRNA, quality control of mRNA, and the degradation of RNA processing by-products and non-coding transcripts. Length = 226

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  128 bits (325), Expect = 3e-34
 Identities = 39/115 (33%), Positives = 69/115 (60%), Gaps = 1/115 (0%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            VA+K + K      +  +   EI+ L+ L H +IV ++D   D+ ++Y+++EYC+GGDL
Sbjct: 26  IVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDL 85

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
             ++     LSE + ++   Q++  L++L  N + H DLKP+NIL+  N  +K+A
Sbjct: 86  FDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIA 140

Length = 260

>gnl|CDD|216323 pfam01138, RNase_PH, 3' exoribonuclease family, domain 1

 Score =  122 bits (309), Expect = 2e-33
 Identities = 51/127 (40%), Positives = 72/127 (56%), Gaps = 4/127 (3%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           ++ GV  +A GSA +E G+TKV+ +V  P E P  +         GEL VE++ +PFAS 
Sbjct: 7   IETGVLSQADGSALVELGDTKVLATVTGPIEPPQKERD----FFPGELTVEYEESPFASG 62

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R        E EL   + RAL P++    +  +++ + V VL +DGS L AAIN A+LA
Sbjct: 63  ERPEGRPSEREIELSRLIDRALRPSIPLEGYPRWEIRIDVTVLSDDGSLLDAAINAASLA 122

Query: 241 LVDAAIP 247
           L DA IP
Sbjct: 123 LADAGIP 129

This family includes 3'-5' exoribonucleases. Ribonuclease PH contains a single copy of this domain, and removes nucleotide residues following the -CCA terminus of tRNA. Polyribonucleotide nucleotidyltransferase (PNPase) contains two tandem copies of the domain. PNPase is involved in mRNA degradation in a 3'-5' direction. The exosome is a 3'-5' exoribonuclease complex that is required for 3' processing of the 5.8S rRNA. Three of its five protein components contain a copy of this domain. A hypothetical protein from S. pombe appears to belong to an uncharacterized subfamily. This subfamily is found in both eukaryotes and archaebacteria. Length = 129

>gnl|CDD|223761 COG0689, Rph, RNase PH [Translation, ribosomal structure and biogenesis]

 Score =  124 bits (313), Expect = 7e-33
 Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 20/217 (9%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV + A+GS+ IE GNTKVIC+V  PRE             KG L  E+   P ++  R 
Sbjct: 26  GVLKHAEGSSLIEFGNTKVICTVSGPREPVPRFLRGT---GKGWLTAEYGMLPRSTDERK 82

Query: 184 GWLRD-SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALV 242
               D    KE+   + RAL   +         +D+   VLQ DG   +A+I  A+LAL 
Sbjct: 83  KREADRGRTKEISRLIGRALRAVIDLELLPESTIDIDCDVLQADGGTRTASITGASLALA 142

Query: 243 DAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSV--IQQ 300
           DA IP+ DLV + ++ +  G+  +D   EE +  ++           + +       + +
Sbjct: 143 DAGIPLRDLVAAISVGIVDGVIVLDLDYEEDSAAEA----------DMNVVMTGNGGLVE 192

Query: 301 VTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKL 337
           +  +   G   ++ L     +L+      C +  +  
Sbjct: 193 IQGLAEDGPFTEDEL----LELLDLAIKGCNELRELQ 225

Length = 230

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  121 bits (305), Expect = 7e-32
 Identities = 45/122 (36%), Positives = 76/122 (62%), Gaps = 4/122 (3%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            +   +VAIK I K + S +  + ++ EI+ LK L+H +IV +     DE ++Y+++EYC
Sbjct: 15  KKTGKKVAIKIIKK-EDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYC 73

Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLK 117
           +GG L   ++ +E KLSE +  + + Q++  L++L  N + H DLKP+NIL+   N  +K
Sbjct: 74  EGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVK 133

Query: 118 LA 119
           LA
Sbjct: 134 LA 135

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|206771 cd11366, RNase_PH_archRRP41, RRP41 subunit of archaeal exosome

 Score =  120 bits (304), Expect = 7e-32
 Identities = 67/197 (34%), Positives = 96/197 (48%), Gaps = 13/197 (6%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV + A GSAY+E GN K+I +V+ PRE+      L     +  + V +  APF+   R 
Sbjct: 10  GVLKNADGSAYVEWGNNKIIAAVYGPREVHPRHLQL---PDRAVIRVRYNMAPFSVDERK 66

Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
               D  E E+   +K ALEPA+   EF    +D+FV VLQ D     A +N A+LAL D
Sbjct: 67  RPGPDRREIEISKVIKEALEPAIILEEFPRTAIDVFVEVLQADAGTRVAGLNAASLALAD 126

Query: 244 AAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQ 303
           A IPM DLV +       G   +D  +EE  Y       E D    + ++ M  + ++T 
Sbjct: 127 AGIPMRDLVAACAAGKVDGKIVLDLNKEEDNY------GEAD----MPIAMMPNLGEITL 176

Query: 304 VTLVGTIQQERLADHIE 320
           + L G +  +     IE
Sbjct: 177 LQLDGDLTPDEFKQAIE 193

The RRP41 subunit of the archaeal exosome is a member of the RNase_PH family, named after the bacterial Ribonuclease PH, a 3'-5' exoribonuclease. Structurally all members of this family form hexameric rings (trimers of dimers). In archaea, the ring is formed by three Rrp41:Rrp42 dimers. The central chamber within the ring contains three phosphorolytic active sites located in an Rrp41 pocket at the interface between Rrp42 and Rrp41. The ring is capped by three copies of Rrp4 and/or Csl4 which contain putative RNA interaction domains. The archaeal exosome degrades single-stranded RNA (ssRNA) in the 3'-5' direction, but also can catalyze the reverse reaction of adding nucleoside diphosphates to the 3'-end of RNA which has been shown to lead to the formation of poly-A-rich tails on RNA. Length = 214

>gnl|CDD|235187 PRK03983, PRK03983, exosome complex exonuclease Rrp41; Provisional

 Score =  118 bits (297), Expect = 1e-30
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 23/229 (10%)

Query: 109 ILIKNNTLKLAG----------LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTS 158
            LI  + L+L G          ++ GV + A GSAY+E GN K+I +V+ PRE+      
Sbjct: 7   KLILEDGLRLDGRKPDELRPIKIEVGVLKNADGSAYLEWGNNKIIAAVYGPREMHPRHLQ 66

Query: 159 LEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDL 218
           L     +  L V +  APF+   R     D    E+   ++ ALEPA+    F    +D+
Sbjct: 67  LP---DRAVLRVRYNMAPFSVDERKRPGPDRRSIEISKVIREALEPAIMLELFPRTVIDV 123

Query: 219 FVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQS 278
           F+ VLQ D     A I  A+LAL DA IPM DLV    +    G+  +D  +EE      
Sbjct: 124 FIEVLQADAGTRVAGITAASLALADAGIPMRDLVAGCAVGKVDGVIVLDLNKEE------ 177

Query: 279 LSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCE 327
               ++     + ++ M  + ++T + L G + +E   + +E      +
Sbjct: 178 ----DNYGEADMPVAIMPRLGEITLLQLDGNLTREEFLEALELAKKGIK 222

Length = 244

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  117 bits (296), Expect = 3e-30
 Identities = 40/139 (28%), Positives = 69/139 (49%), Gaps = 5/139 (3%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDG 62
             +A+K ++ +  SE   +++  EI+ L  L H +IV       DE    + I LEY  G
Sbjct: 26  ELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG 85

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGL 121
           G L S ++   KL E   +++ RQ++  L +L  N + H D+K  NIL+ ++  +KLA  
Sbjct: 86  GSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADF 145

Query: 122 KQGVSEKAKGSAYIEQGNT 140
             G +++       E   +
Sbjct: 146 --GCAKRLGDIETGEGTGS 162

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|131120 TIGR02065, ECX1, archaeal exosome-like complex exonuclease 1

 Score =  107 bits (270), Expect = 6e-27
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 13/190 (6%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV + A GSAY+E G TK++ +V+ PRE       L     +  L V +  APF++  R 
Sbjct: 26  GVLKNADGSAYLEFGGTKILAAVYGPREAHPRHLQLP---DRAVLRVRYHMAPFSTDERK 82

Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
                  E E+   ++ ALEPA+   +F    +D+F+ VLQ DG    A +  A+LAL D
Sbjct: 83  RPGPSRREIEISKVIREALEPAILLEQFPRTVIDVFIEVLQADGGTRCAGLTAASLALAD 142

Query: 244 AAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQ 303
           A IPM DLV    +    G+  +D  EEE  Y       E D    + ++ M    ++T 
Sbjct: 143 AGIPMRDLVVGVAVGKVDGVVVLDLSEEEDMY------GEAD----MPVAIMPKTGEITL 192

Query: 304 VTLVGTIQQE 313
           + L G +  +
Sbjct: 193 LQLDGDLTPD 202

This family contains the archaeal protein orthologous to the eukaryotic exosome protein Rrp41. It is somewhat more distantly related to the bacterial protein ribonuclease PH. An exosome-like complex has been demonstrated experimentally for the Archaea in Sulfolobus solfataricus, so members of this family are designated exosome complex exonuclease 1, after usage in SwissProt [Transcription, Degradation of RNA]. Length = 230

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 3e-26
 Identities = 43/114 (37%), Positives = 58/114 (50%), Gaps = 1/114 (0%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK I   K+ E    SI+ EI  LK L H +IV  +  +     +YIILEY + G L 
Sbjct: 28  VAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLR 87

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I+      E     +V Q++  L +L E  V H D+K  NIL  K+  +KLA
Sbjct: 88  QIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLA 141

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|206777 cd11372, RNase_PH_RRP46, RRP46 subunit of eukaryotic exosome

 Score =  103 bits (259), Expect = 1e-25
 Identities = 51/160 (31%), Positives = 79/160 (49%), Gaps = 13/160 (8%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
            + G+  +A GSA   QG+T V+ +V+ P E+   K   +         +E    P    
Sbjct: 6   CELGLLSRADGSARFSQGDTSVLAAVYGPIEVKLRKELPD------RATLEVIVRP---- 55

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            ++G L   +EK L   L+  LEP +  H      + + + VLQ+DGS L+ AIN A LA
Sbjct: 56  -KSG-LPGVKEKLLELLLRSTLEPIILLHLHPRTLISVVLQVLQDDGSLLACAINAACLA 113

Query: 241 LVDAAIPMYDLVTSSTLALR-GGLTFIDPVEEEVAYCQSL 279
           L+DA +PM  L  + T A+   G   +DP  EE    +++
Sbjct: 114 LLDAGVPMKGLFAAVTCAITEDGEIILDPTAEEEKEAKAV 153

The RRP46 subunit of eukaryotic exosome is a member of the RNase_PH family, named after the bacterial Ribonuclease PH, a 3'-5' exoribonuclease. Structurally all members of this family form hexameric rings (trimers of Rrp41-Rrp45, Rrp46-Rrp43, and Mtr3-Rrp42 dimers). The eukaryotic exosome core is composed of six individually encoded RNase PH-like subunits and three additional proteins (Rrp4, Csl4 and Rrp40) that form a stable cap and contain RNA-binding domains. The RNase PH-like subunits are no longer phosphorolytic enzymes, the exosome directly associates with Rrp44 and Rrp6, hydrolytic exoribonucleases related to bacterial RNase II/R and RNase D. The exosome plays an important role in RNA turnover. It plays a crucial role in the maturation of stable RNA species such as rRNA, snRNA and snoRNA, quality control of mRNA, and the degradation of RNA processing by-products and non-coding transcripts. Length = 199

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  102 bits (256), Expect = 1e-24
 Identities = 41/117 (35%), Positives = 64/117 (54%), Gaps = 5/117 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
             +K ID + +SE   +  +NE+K LK L+H +I+   +   ++  + I++EY DGGDL 
Sbjct: 28  YVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLS 87

Query: 67  SFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             I+      +   E Q   +  QL LALK+L    + H D+KPQNI +  N  +KL
Sbjct: 88  QKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKL 144

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 97.3 bits (243), Expect = 6e-23
 Identities = 44/143 (30%), Positives = 75/143 (52%), Gaps = 5/143 (3%)

Query: 7   VAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            AIK I K  +  +N+ D ++ E   L      ++V +      ++ +Y+++EY  GGDL
Sbjct: 21  YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL- 121
            S + +   L E   + ++ ++VLAL++L  N + H DLKP NILI  N  LKL   GL 
Sbjct: 81  ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLS 140

Query: 122 KQGVSEKAKGSAYIEQGNTKVIC 144
           K G+  +       E+ + +++ 
Sbjct: 141 KVGLVRRQINLNDDEKEDKRIVG 163

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 10/159 (6%)

Query: 5   TEVAIKCIDKTKV-SENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
            E AIK +DK ++  E +   +  E + L +L  H  I+ +     DE  +Y +LEY   
Sbjct: 27  KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPN 86

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA-- 119
           G+L  +IR +  L E   + +  +++LAL++L    + H DLKP+NIL+ K+  +K+   
Sbjct: 87  GELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDF 146

Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTS 158
           G     + K        + N     ++    E    + +
Sbjct: 147 G-----TAKVLDPNSSPESNKGDATNIDSQIEKNRRRFA 180

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 94.1 bits (235), Expect = 1e-21
 Identities = 37/140 (26%), Positives = 74/140 (52%), Gaps = 11/140 (7%)

Query: 7   VAIKCIDKTKVSENR-FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            A+K + K K+ + +  + ++NE + L+ + H  +V +     D+  +Y+++EY  GG+L
Sbjct: 29  YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
            S +R   +  E   + +  Q+VLAL++L   ++ + DLKP+N+L+  +  +K+      
Sbjct: 89  FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDF--- 145

Query: 125 VSEKAKGSAYIEQGNTKVIC 144
                 G A   +G T  +C
Sbjct: 146 ------GFAKRVKGRTYTLC 159

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.2 bits (230), Expect = 6e-21
 Identities = 40/98 (40%), Positives = 56/98 (57%), Gaps = 5/98 (5%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQ 86
           EI  LK L H +IV +LD +  ER +Y++ EYCD  DL  ++      LS    +  + Q
Sbjct: 48  EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106

Query: 87  LVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
           L+  L +   + + H DLKPQNILI ++  LKLA  GL
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGL 144

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|206766 cd11358, RNase_PH, RNase PH-like 3'-5' exoribonucleases

 Score = 89.7 bits (223), Expect = 1e-20
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 34/217 (15%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV  +A GSA ++ GNTKVIC+V  P   P           KG LYV  + +P A   R 
Sbjct: 9   GVLNQADGSALVKLGNTKVICAVTGPIVEPDKLER----PDKGTLYVNVEISPGAVGERR 64

Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFS---NFQVDLFVLVLQNDGSALSAAINCANLA 240
                 EE E+   L+R +E +V   + +   ++ + + + VL  DG  L A  N A  A
Sbjct: 65  QGPPGDEEMEISRLLERTIEASVILDKSTRKPSWVLYVDIQVLSRDGGLLDACWNAAIAA 124

Query: 241 LVDAAIP-------------MYDLVTSSTLAL-RGGLTFIDPVEEEVAYCQSLSSSEDDD 286
           L DA IP             M DL+ + ++     G+  +DP  EE     S        
Sbjct: 125 LKDAGIPRVFVDERSPPLLLMKDLIVAVSVGGISDGVLLLDPTGEEEELADS-------- 176

Query: 287 SGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLI 323
              +T++      ++  ++ VG        + I++ +
Sbjct: 177 --TLTVAVDKS-GKLCLLSKVGGG--SLDTEEIKECL 208

RNase PH-like 3'-5' exoribonucleases are enzymes that catalyze the 3' to 5' processing and decay of RNA substrates. Evolutionarily related members can be fond in prokaryotes, archaea, and eukaryotes. Bacterial ribonuclease PH contains a single copy of this domain, and removes nucleotide residues following the -CCA terminus of tRNA. Polyribonucleotide nucleotidyltransferase (PNPase) contains two tandem copies of the domain and is involved in mRNA degradation in a 3'-5' direction. Archaeal exosomes contain two individually encoded RNase PH-like 3'-5' exoribonucleases and are required for 3' processing of the 5.8S rRNA. The eukaryotic exosome core is composed of six individually encoded RNase PH-like subunits, but it is not a phosphorolytic enzyme per se; it directly associates with Rrp44 and Rrp6, which are hydrolytic exoribonucleases related to bacterial RNase II/R and RNase D. All members of the RNase PH-like family form ring structures by oligomerization of six domains or subunits, except for a total of 3 subunits with tandem repeats in the case of PNPase, with a central channel through which the RNA substrate must pass to gain access to the phosphorolytic active sites. Length = 218

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 35/113 (30%), Positives = 65/113 (57%), Gaps = 2/113 (1%)

Query: 8   AIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+KC+ K  + E      I +E + L+  +H  IV +     D++Y+Y+++EYC GG+L 
Sbjct: 22  ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
           + +R      E+  + ++  +VLA ++L    + + DLKP+N+L+  N  +KL
Sbjct: 82  TILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKL 134

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 87.2 bits (217), Expect = 7e-19
 Identities = 46/120 (38%), Positives = 68/120 (56%), Gaps = 11/120 (9%)

Query: 7   VAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLWDERY-----VYIILEY 59
           VAIK I  + V ++  D+  I+ EIK L+ L H++I+ +LD L          VYI+ E 
Sbjct: 28  VAIKKI--SNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL 85

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
            +  DL   I+S + L++   Q F+ Q++  LK+L   NV H DLKP NIL+  N  LK+
Sbjct: 86  MET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKI 144

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 84.5 bits (210), Expect = 2e-18
 Identities = 37/146 (25%), Positives = 68/146 (46%), Gaps = 10/146 (6%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
            +  EVA+K + +    +   +  + E + ++ L H +IV +L    +E  + I++EY  
Sbjct: 26  GKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMP 84

Query: 62  GGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
           GGDL  ++R +    LS      F  Q+   +++L   N  H DL  +N L+ +N  +K+
Sbjct: 85  GGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKI 144

Query: 119 A--GLKQGVSEKAKGSAYIEQGNTKV 142
           +  GL    S       Y +    K+
Sbjct: 145 SDFGL----SRDLYDDDYYKVKGGKL 166

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 84.1 bits (209), Expect = 3e-18
 Identities = 39/141 (27%), Positives = 71/141 (50%), Gaps = 9/141 (6%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA+K + +    +   +  + E + ++ L H ++V +L    +E  +YI++EY +GGDL
Sbjct: 30  EVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDL 88

Query: 66  CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
            S++R +  KLS      F  Q+   +++L   N  H DL  +N L+ +N  +K++  GL
Sbjct: 89  LSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGL 148

Query: 122 KQGVSEKAKGSAYIEQGNTKV 142
               S       Y  +   K+
Sbjct: 149 ----SRDLYDDDYYRKRGGKL 165

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 83.0 bits (206), Expect = 5e-18
 Identities = 36/112 (32%), Positives = 62/112 (55%), Gaps = 3/112 (2%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
             EVAIK I     S+ + + I+NEI+ LK   H +IV        +  ++I++E+C GG
Sbjct: 25  GKEVAIKVIKL--ESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82

Query: 64  DLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            L   ++S  + L+E Q     ++L+  L++L  N + H D+K  NIL+ ++
Sbjct: 83  SLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSD 134

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 39/116 (33%), Positives = 65/116 (56%), Gaps = 5/116 (4%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAIK   K ++ +   + I+NEI  +K   H +IV   D       +++++EY DGG L
Sbjct: 46  EVAIK---KMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSL 102

Query: 66  CSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
              I  +  +++E Q     R+++  L++L   NV H D+K  NIL+ K+ ++KLA
Sbjct: 103 TDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLA 158

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 82.7 bits (205), Expect = 8e-18
 Identities = 43/124 (34%), Positives = 64/124 (51%), Gaps = 12/124 (9%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGD 64
           +  K ID   ++E     +V+E+  L+ L H +IV   D + D   + +YI++EYC+GGD
Sbjct: 28  LVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGD 87

Query: 65  LCSFI----RSHEKLSEFQCQQFVRQLVLALK-----FLRENNVCHFDLKPQNI-LIKNN 114
           L   I    +  + + E    + + QL+LAL          N V H DLKP NI L  NN
Sbjct: 88  LAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN 147

Query: 115 TLKL 118
            +KL
Sbjct: 148 NVKL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 84.0 bits (206), Expect = 1e-17
 Identities = 46/172 (26%), Positives = 80/172 (46%), Gaps = 9/172 (5%)

Query: 2   EQHTEVAIKCIDKTKVSENRFD-SIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEY 59
                VA+K + K   S+++     + EI+ L  L H  +IV + DF  DE  +Y+++EY
Sbjct: 20  RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79

Query: 60  CDGGDLCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KNN 114
            DGG L   ++       LSE +    + Q++ AL++L    + H D+KP+NIL+     
Sbjct: 80  VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGR 139

Query: 115 TLKLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRS 164
            +KL   GL + + +    S+     +T V    +   E+    +      S
Sbjct: 140 VVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSS 191

Length = 384

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 39/120 (32%), Positives = 61/120 (50%), Gaps = 13/120 (10%)

Query: 7   VAIKCIDKTKVSENRFDSIVN-----EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           VAIK     K+        +      EIK LK L+H +I+ +LD    +  +Y++ E+ D
Sbjct: 27  VAIK-----KIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD 81

Query: 62  GGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
             DL   I+  ++ L E   + ++ QL+  L F   + + H DLKP+N+LI     LKLA
Sbjct: 82  T-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLA 140

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 81.4 bits (202), Expect = 2e-17
 Identities = 39/128 (30%), Positives = 70/128 (54%), Gaps = 5/128 (3%)

Query: 8   AIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K + K K+ +    +  + E   L  ++H  IV +      E  +Y++LEY  GG+L 
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLA--GL-K 122
           S +    + SE + + +  ++VLAL++L    + + DLKP+NIL+  +  +KL   GL K
Sbjct: 82  SHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAK 141

Query: 123 QGVSEKAK 130
           +  SE ++
Sbjct: 142 ELSSEGSR 149

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 81.0 bits (201), Expect = 3e-17
 Identities = 40/124 (32%), Positives = 63/124 (50%), Gaps = 5/124 (4%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
              T+VA+K + +    E R +  + E   +K L H +IV +L        +YI+ EY  
Sbjct: 26  GTETKVAVKTLKEGASEEER-EEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMP 84

Query: 62  GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           GGDL  F+R H EKL+     Q   Q+   +++L   N  H DL  +N L+ +N  +K++
Sbjct: 85  GGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKIS 144

Query: 120 --GL 121
             GL
Sbjct: 145 DFGL 148

Length = 258

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 80.0 bits (198), Expect = 1e-16
 Identities = 35/116 (30%), Positives = 61/116 (52%), Gaps = 3/116 (2%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            VA+K +   ++     +  + EIKAL+   H ++V +LD         +++EY    DL
Sbjct: 27  TVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDL 85

Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
              +R  E+ L E Q + ++R L+  + ++  N + H DLKP N+LI  +  LK+A
Sbjct: 86  SEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIA 141

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 79.1 bits (196), Expect = 2e-16
 Identities = 38/100 (38%), Positives = 59/100 (59%), Gaps = 7/100 (7%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERY--VYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFV 84
           EIK L+ L H +IV + + +  +    +Y++ EY D  DL   + S E K +E Q + ++
Sbjct: 48  EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106

Query: 85  RQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GL 121
           +QL+  L++L  N + H D+K  NILI N+  LKLA  GL
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 45/142 (31%), Positives = 79/142 (55%), Gaps = 18/142 (12%)

Query: 5   TEVAIKCIDKTKVSENRFDSI--VN---EIKALKLL-HHQHIVTMLDFLWDERY--VYII 56
              AIKC+      +  F S+  VN   EI+AL+ L  H +I+ +++ L+D +   + ++
Sbjct: 25  KYYAIKCM------KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78

Query: 57  LEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
            E  D  +L   I+  ++ L E + + ++ QL+ +L  +  N + H D+KP+NILIK++ 
Sbjct: 79  FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDI 137

Query: 116 LKLA--GLKQGVSEKAKGSAYI 135
           LKLA  G  +G+  K   + YI
Sbjct: 138 LKLADFGSCRGIYSKPPYTEYI 159

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 77.8 bits (192), Expect = 9e-16
 Identities = 53/139 (38%), Positives = 78/139 (56%), Gaps = 13/139 (9%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFL---WDERY--V 53
           +E + +VAIK I      +NR D+   + EIK L+ L H++++ + D +     E +  V
Sbjct: 27  SETNEKVAIKKI--ANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84

Query: 54  YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK- 112
           YI+ E  D  DL   IRS + LS+  CQ F+ QL+  LK++   NV H DLKP N+L+  
Sbjct: 85  YIVYELMDT-DLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNA 143

Query: 113 NNTLKLA--GLKQGVSEKA 129
           N  LK+   GL +  SEK 
Sbjct: 144 NCDLKICDFGLARTTSEKG 162

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 46/120 (38%), Positives = 65/120 (54%), Gaps = 3/120 (2%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E H  VA+K +      E    S + EI  LK L H++IV + D L  ++ + ++ EYCD
Sbjct: 23  ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD 82

Query: 62  GGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             DL  +  S +  +     + F+ QL+  L F   +NV H DLKPQN+LI KN  LKLA
Sbjct: 83  Q-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLA 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 75.7 bits (186), Expect = 2e-15
 Identities = 40/138 (28%), Positives = 70/138 (50%), Gaps = 6/138 (4%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
              V IK I   +++++   +  NE + LKLL H +I+   +   +++ + I++EY  GG
Sbjct: 25  QKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG 84

Query: 64  DLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KNNTLKLA 119
            L  +I  R +  L E     F  Q++LAL  +    + H DLK QNIL+      +K+ 
Sbjct: 85  TLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIG 144

Query: 120 --GLKQGVSEKAKGSAYI 135
             G+ + +S K+K    +
Sbjct: 145 DFGISKILSSKSKAYTVV 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 75.1 bits (185), Expect = 3e-15
 Identities = 38/141 (26%), Positives = 60/141 (42%), Gaps = 1/141 (0%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            +    +A+K I            I +E+K L+LL H ++V           VYI +EYC
Sbjct: 22  LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYC 81

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG L   +     L E   + +  QL+  L +L  + + H D+KP NI +  N  +KL 
Sbjct: 82  SGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLG 141

Query: 120 GLKQGVSEKAKGSAYIEQGNT 140
                V  K   +   E+  +
Sbjct: 142 DFGCAVKLKNNTTTMGEEVQS 162

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 34/105 (32%), Positives = 62/105 (59%), Gaps = 1/105 (0%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K ++K K V +    +++NE + L+ L+H  +V +     DE  +Y++++   GGDL 
Sbjct: 29  AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             +    K SE Q + ++ ++VLAL++L    + H D+KP NIL+
Sbjct: 89  YHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL 133

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 73.7 bits (182), Expect = 8e-15
 Identities = 38/153 (24%), Positives = 73/153 (47%), Gaps = 14/153 (9%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           + + TEVA+K + +    E R D  + E + +K L H ++V +L    +E  +Y++LEY 
Sbjct: 20  DGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78

Query: 61  DGGDLCSFIRSH------EKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILI 111
           +GGDL  ++R         + S    +    F  Q+   +++L      H DL  +N L+
Sbjct: 79  EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV 138

Query: 112 -KNNTLKLAGLKQGVSEK-AKGSAYIEQGNTKV 142
            ++  +K++    G+S        Y ++   K+
Sbjct: 139 GEDLVVKISDF--GLSRDVYDDDYYRKKTGGKL 169

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 73.4 bits (181), Expect = 1e-14
 Identities = 34/125 (27%), Positives = 58/125 (46%), Gaps = 5/125 (4%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
               A+K I      E     ++ E+K L+     ++V      + E  + I+LEY DGG
Sbjct: 26  GKIYALKKI-HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGG 84

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILI-KNNTLKLAGL 121
            L   ++   K+ E       RQ++  L +L  + ++ H D+KP N+LI     +K+A  
Sbjct: 85  SLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADF 144

Query: 122 KQGVS 126
             G+S
Sbjct: 145 --GIS 147

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 47/125 (37%), Positives = 68/125 (54%), Gaps = 6/125 (4%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A K I   +  E   D +V EI  L    H +IV + +  + E  ++I++E+CDGG L S
Sbjct: 34  AAKIIQ-IESEEELEDFMV-EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDS 91

Query: 68  FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQGV 125
            +   E+ L+E Q +   RQ++ AL FL  + V H DLK  NIL+  +  +KLA    GV
Sbjct: 92  IMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADF--GV 149

Query: 126 SEKAK 130
           S K K
Sbjct: 150 SAKNK 154

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 34/114 (29%), Positives = 61/114 (53%), Gaps = 3/114 (2%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGDL 65
           VAIK   +++  E+   + + E+K L+ L H++IV + + F    R  Y++ EY +   L
Sbjct: 29  VAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRL-YLVFEYVERTLL 87

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKL 118
                S   L     + ++ QL+ A+ +   +N+ H D+KP+NIL+  +  LKL
Sbjct: 88  ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 40/115 (34%), Positives = 59/115 (51%), Gaps = 8/115 (6%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 87
           EI  L  L H +IV  L    +E  +YI LE   GG L   ++ +    E   + + RQ+
Sbjct: 52  EIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI 111

Query: 88  VLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GLKQGVSEKA-----KGSAY 134
           +L L++L + N  H D+K  NIL+  N  +KLA  G+ + V E +     KGS Y
Sbjct: 112 LLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPY 166

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.1 bits (175), Expect = 1e-13
 Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 7/123 (5%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTML-DFLWDERYVYIILEYCDGGD 64
            VAIK ID  + +E+  + I  EI+ L      +I      FL   + ++II+EYC GG 
Sbjct: 28  VVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSK-LWIIMEYCGGGS 85

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQ 123
               ++   KL E      +R+++L L++L E    H D+K  NIL+     +KLA    
Sbjct: 86  CLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADF-- 142

Query: 124 GVS 126
           GVS
Sbjct: 143 GVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 70.6 bits (174), Expect = 2e-13
 Identities = 37/140 (26%), Positives = 69/140 (49%), Gaps = 18/140 (12%)

Query: 7   VAIKCIDKTKVSENRFDSI-----VNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYC 60
           VAIK   K K    +F S      + E+K+L KL  H +IV + +   +   +Y + EY 
Sbjct: 27  VAIK---KMK---KKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80

Query: 61  DGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLK 117
           +G +L   ++  +    SE   +  + Q++  L  + ++   H DLKP+N+L+     +K
Sbjct: 81  EG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVK 139

Query: 118 LA--GLKQGVSEKAKGSAYI 135
           +A  GL + +  +   + Y+
Sbjct: 140 IADFGLAREIRSRPPYTDYV 159

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 36/121 (29%), Positives = 61/121 (50%), Gaps = 5/121 (4%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E  + V  K ++ T++SE      +NEI  L LL H +I+   +   D+  + I +EY +
Sbjct: 23  EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYAN 82

Query: 62  GGDLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNI-LIKNNTLK 117
           GG L   I   +K   F+ +  +    Q+V A+ ++ +  + H D+K  NI L K   +K
Sbjct: 83  GGTLYDKI-VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIK 141

Query: 118 L 118
           L
Sbjct: 142 L 142

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 40/131 (30%), Positives = 67/131 (51%), Gaps = 7/131 (5%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+K +D   +S+   +  VNEI+ L  ++H +I++  +   D   + I++EY   GDL  
Sbjct: 29  ALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSK 88

Query: 68  FIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLK 122
            I   +K    + E +  +   QL+  L+ L E  + H DLK  NIL+  N L K+  L 
Sbjct: 89  AISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDL- 147

Query: 123 QGVSEKAKGSA 133
            G+S+  K + 
Sbjct: 148 -GISKVLKKNM 157

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 4/95 (4%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS--HEKLSEFQCQQFVR 85
           EI  LK L+H +IV +LD +  E  +Y++ E+ D  DL  ++ S     L     + ++ 
Sbjct: 48  EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL-DLKKYMDSSPLTGLDPPLIKSYLY 106

Query: 86  QLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           QL+  + +   + V H DLKPQN+LI +   LKLA
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLA 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 69.9 bits (172), Expect = 3e-13
 Identities = 40/127 (31%), Positives = 63/127 (49%), Gaps = 14/127 (11%)

Query: 5   TEVAIKCIDKTKVSE--NRFDSI----VNEIKALKLLHHQHIVTMLDFLWDERYVYIILE 58
             VAIK   K K+ E     D I    + EIK L+ L H +I+ +LD    +  + ++ E
Sbjct: 26  RIVAIK---KIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82

Query: 59  YCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTL 116
           + +  DL   I+     L+    + ++   +  L++L  N + H DLKP N+LI  +  L
Sbjct: 83  FMET-DLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVL 141

Query: 117 KLA--GL 121
           KLA  GL
Sbjct: 142 KLADFGL 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 68.7 bits (168), Expect = 9e-13
 Identities = 34/108 (31%), Positives = 58/108 (53%), Gaps = 1/108 (0%)

Query: 7   VAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            AIKC+ K ++ +  +   +  E   L  L H  IV M+    DE  VY +LE+  GG+L
Sbjct: 46  YAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGEL 105

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            + +R   +      + +  +LVLA ++L   ++ + DLKP+N+L+ N
Sbjct: 106 FTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDN 153

Length = 329

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 41/137 (29%), Positives = 67/137 (48%), Gaps = 21/137 (15%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFD---SIVNEIKALKLL---HHQHIVTMLD---FLWDER 51
           N     VA+K +   +V  +      S + EI  LK L    H +IV +LD       +R
Sbjct: 22  NTGRF-VALKKV---RVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDR 77

Query: 52  Y--VYIILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
              + ++ E+ D  DL +++    K  L     +  +RQL+  + FL  + + H DLKPQ
Sbjct: 78  ELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQ 136

Query: 108 NILIKNN-TLKLA--GL 121
           NIL+ ++  +K+A  GL
Sbjct: 137 NILVTSDGQVKIADFGL 153

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 37/120 (30%), Positives = 70/120 (58%), Gaps = 2/120 (1%)

Query: 1   NEQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           NE    VAIK  +K+K+  + + D + +E K L  ++H   V +     DE Y+Y++LE+
Sbjct: 53  NEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEF 112

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             GG+  +F+R +++        +  Q+VL  ++L+  N+ + DLKP+N+L+ K+  +K+
Sbjct: 113 VIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKM 172

Length = 340

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 42/117 (35%), Positives = 60/117 (51%), Gaps = 6/117 (5%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I      E    + + EI  +K L H++IV + D +  E  + ++ EY D  DL 
Sbjct: 28  VALKEI-HLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLK 85

Query: 67  SFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            ++ +H     L     + F  QL+  + F  EN V H DLKPQN+LI K   LKLA
Sbjct: 86  KYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLA 142

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 66.8 bits (163), Expect = 2e-12
 Identities = 36/119 (30%), Positives = 63/119 (52%), Gaps = 3/119 (2%)

Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D++  EI  LK L H++IV  L    D  ++ I LEY  GG + + + ++    E   + 
Sbjct: 51  DALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN 110

Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNT 140
           FVRQ++  L +L    + H D+K  NIL+ N   +K++    G+S+K + ++   + N 
Sbjct: 111 FVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDF--GISKKLEANSLSTKTNG 167

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 66.3 bits (162), Expect = 6e-12
 Identities = 43/137 (31%), Positives = 69/137 (50%), Gaps = 21/137 (15%)

Query: 5   TEVAIKCIDKTKVSENRFDSIV---NEIKALKLLH----HQHIVTM--LDFLWDERY--V 53
             VAIK I       N F   +     ++ LKLL     H++I  +  +D ++   +  +
Sbjct: 28  ETVAIKKI------TNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNEL 81

Query: 54  YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           Y+  E  +  DL   IRS + L++   Q F+ Q++  LK++   NV H DLKP N+L+  
Sbjct: 82  YLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNA 140

Query: 114 N-TLKLA--GLKQGVSE 127
           +  LK+   GL +G SE
Sbjct: 141 DCELKICDFGLARGFSE 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 66.2 bits (162), Expect = 7e-12
 Identities = 32/92 (34%), Positives = 51/92 (55%), Gaps = 7/92 (7%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           EIK L+   H++I+ +LD +    +     VYI+ E  +  DL   I++ + LS    Q 
Sbjct: 53  EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKT-QHLSNDHIQY 110

Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           F+ Q++  LK++   NV H DLKP N+L+  N
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTN 142

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 36/118 (30%), Positives = 63/118 (53%), Gaps = 11/118 (9%)

Query: 7   VAIKCIDKTKVSENRFDSIVN-----EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           VAIK     K  E+  D ++      EI+ LK L H ++V +++    +R ++++ EYCD
Sbjct: 29  VAIK-----KFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCD 83

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
              L    ++   + E   ++ + Q + A+ F  ++N  H D+KP+NILI K   +KL
Sbjct: 84  HTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.0 bits (158), Expect = 8e-12
 Identities = 38/108 (35%), Positives = 56/108 (51%), Gaps = 2/108 (1%)

Query: 9   IKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSF 68
           IK ID TK+     ++   E+  L  + H +IVT      +   ++I++EYCDGGDL   
Sbjct: 30  IKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKR 89

Query: 69  I-RSHEKL-SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           I R    L SE Q   +  Q+ L LK + +  + H D+K QNI +  N
Sbjct: 90  INRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 46/123 (37%), Positives = 68/123 (55%), Gaps = 6/123 (4%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A K ID TK SE   +  + EI  L    H +IV +LD  + E  ++I++E+C GG + +
Sbjct: 34  AAKVID-TK-SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 91

Query: 68  FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQGV 125
            +   E+ L+E Q +   +Q + AL +L EN + H DLK  NIL   +  +KLA    GV
Sbjct: 92  VMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADF--GV 149

Query: 126 SEK 128
           S K
Sbjct: 150 SAK 152

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 31/110 (28%), Positives = 63/110 (57%), Gaps = 3/110 (2%)

Query: 8   AIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K +DK ++ + N+   ++ E + L  L H  + T+      E Y+ ++++YC GG+L 
Sbjct: 30  ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89

Query: 67  SFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
             +  +  + LSE   + +  +++LAL++L    + + DLKP+NIL+  +
Sbjct: 90  RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHES 139

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 65.2 bits (159), Expect = 1e-11
 Identities = 31/94 (32%), Positives = 56/94 (59%), Gaps = 1/94 (1%)

Query: 27  NEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQ 86
           NE + LK + H  I+ +     D+R++Y+++EY  GG+L S++R+  + S      +  +
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109

Query: 87  LVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           +V AL++L    + + DLKP+NIL+ K   +KL 
Sbjct: 110 IVCALEYLHSKEIVYRDLKPENILLDKEGHIKLT 143

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 4/126 (3%)

Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
            ++ +EI+ LK L H +IV  L F   E Y+ I LEY  GG + S +R++ +  E   + 
Sbjct: 53  KALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRF 112

Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQGVSEKAKGSAYIEQGNTK 141
           F  Q++  L +L    + H DLK  N+L+  +   K++    G+S+K+    Y    N  
Sbjct: 113 FTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDF--GISKKSD-DIYDNDQNMS 169

Query: 142 VICSVF 147
           +  SVF
Sbjct: 170 MQGSVF 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 39/141 (27%), Positives = 69/141 (48%), Gaps = 5/141 (3%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           TEVA+K    T   + +    + E + LK   H +IV ++     ++ +YI++E   GG 
Sbjct: 20  TEVAVKTCRSTLPPDLK-RKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78

Query: 65  LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLK 122
           L +F+R  + +L+  +  Q        +++L   N  H DL  +N L+ +NN LK++   
Sbjct: 79  LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDF- 137

Query: 123 QGVSEKAKGSAYIEQGNTKVI 143
            G+S + +G  Y      K I
Sbjct: 138 -GMSREEEGGIYTVSDGLKQI 157

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 37/113 (32%), Positives = 61/113 (53%), Gaps = 3/113 (2%)

Query: 9   IKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSF 68
           IK I+ +K+S    +    E+  L  + H +IV   +   +   +YI+++YC+GGDL   
Sbjct: 30  IKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKK 89

Query: 69  IRSHEKL--SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI-LIKNNTLKL 118
           I +   +   E Q   +  Q+ LALK + +  + H D+K QNI L K+ T+KL
Sbjct: 90  INAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKL 142

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 36/126 (28%), Positives = 57/126 (45%), Gaps = 8/126 (6%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             VAIK +      E     I+ EI  LK     +IV      +    ++I++EYC  G 
Sbjct: 29  QVVAIKVVP----VEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGS 84

Query: 65  LCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLK 122
           +   ++   K L+E +    + Q +  L++L  N   H D+K  NIL+ +    KLA   
Sbjct: 85  VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADF- 143

Query: 123 QGVSEK 128
            GVS +
Sbjct: 144 -GVSGQ 148

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 43/122 (35%), Positives = 68/122 (55%), Gaps = 12/122 (9%)

Query: 2   EQHT--EVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLW-----DERY 52
           + HT  +VAIK I    V E+  D+  I+ EIK L+LL H  IV +   +      + + 
Sbjct: 21  DTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKD 78

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
           +Y++ E  +  DL   I++++ L+    Q F+ QL+ ALK++   NV H DLKP+NIL  
Sbjct: 79  IYVVFELMES-DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILAN 137

Query: 113 NN 114
            +
Sbjct: 138 AD 139

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.7 bits (155), Expect = 3e-11
 Identities = 36/117 (30%), Positives = 62/117 (52%), Gaps = 5/117 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           +A+K I   +  E    + + EI  LK + H +IV + D +  E+ +Y++ EY D  DL 
Sbjct: 30  IALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLK 88

Query: 67  SFIRSHEKLSEFQ--CQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KNNTLKLA 119
             + S    ++     + ++ Q++  + +   + V H DLKPQN+LI  + N LKLA
Sbjct: 89  KHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLA 145

Length = 294

>gnl|CDD|216043 pfam00651, BTB, BTB/POZ domain

 Score = 59.2 bits (144), Expect = 4e-11
 Identities = 22/77 (28%), Positives = 38/77 (49%), Gaps = 6/77 (7%)

Query: 352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAF 411
             +G   D    VG+    KEF AHK +L+  SP F  +F G    +    + D++PE F
Sbjct: 5   RENGELCDVTLVVGD----KEFHAHKAVLAACSPYFKALFTGNKEVE--ITLEDVSPEDF 58

Query: 412 STMLDSDHHARVNISSD 428
             +L+  +  ++ I+ +
Sbjct: 59  EALLEFIYTGKLEITEE 75

The BTB (for BR-C, ttk and bab) or POZ (for Pox virus and Zinc finger) domain is present near the N-terminus of a fraction of zinc finger (pfam00096) proteins and in proteins that contain the pfam01344 motif such as Kelch and a family of pox virus proteins. The BTB/POZ domain mediates homomeric dimerisation and in some instances heteromeric dimerisation. The structure of the dimerised PLZF BTB/POZ domain has been solved and consists of a tightly intertwined homodimer. The central scaffolding of the protein is made up of a cluster of alpha-helices flanked by short beta-sheets at both the top and bottom of the molecule. POZ domains from several zinc finger proteins have been shown to mediate transcriptional repression and to interact with components of histone deacetylase co-repressor complexes including N-CoR and SMRT. The POZ or BTB domain is also known as BR-C/Ttk or ZiN. Length = 101

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 62.1 bits (151), Expect = 7e-11
 Identities = 30/108 (27%), Positives = 60/108 (55%), Gaps = 3/108 (2%)

Query: 6   EVAIKCID---KTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           E+A+K +     +  ++   +++  EI+ LK L H+ IV     L D+  + I +EY  G
Sbjct: 29  ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPG 88

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
           G +   ++++  L+E   +++ RQ++  +++L  N + H D+K  NIL
Sbjct: 89  GSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL 136

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 61.7 bits (150), Expect = 9e-11
 Identities = 37/128 (28%), Positives = 70/128 (54%), Gaps = 5/128 (3%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEYCDGGDL 65
           AIK + K+  +++N+  ++  E   + +      V  L + +  + Y+Y+++EY +GGD 
Sbjct: 25  AIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDC 84

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLA--GLK 122
            S I++   L E   +Q++ ++VL ++ L +  + H D+KP+N+LI     LKL   GL 
Sbjct: 85  ASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLS 144

Query: 123 QGVSEKAK 130
           +   E  K
Sbjct: 145 RNGLENKK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 36/116 (31%), Positives = 55/116 (47%), Gaps = 3/116 (2%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY--CDGGD 64
           VA+K I      E    + + EI  LK L H +IV + D L  E  +Y+I E+   D   
Sbjct: 28  VAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMDLKK 87

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
               +   + +     + ++ Q++  + F     V H DLKPQN+LI N   +KLA
Sbjct: 88  YLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLA 143

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 45/124 (36%), Positives = 72/124 (58%), Gaps = 8/124 (6%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGDLC 66
           A K I+ TK  E   D +V EI+ L   +H +IV +L  F WD + ++I++E+C GG + 
Sbjct: 41  AAKVIE-TKSEEELEDYMV-EIEILATCNHPYIVKLLGAFYWDGK-LWIMIEFCPGGAVD 97

Query: 67  SFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQG 124
           + +   ++ L+E Q Q   RQ++ AL++L    + H DLK  N+L+  +  +KLA    G
Sbjct: 98  AIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADF--G 155

Query: 125 VSEK 128
           VS K
Sbjct: 156 VSAK 159

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 33/125 (26%), Positives = 63/125 (50%), Gaps = 7/125 (5%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK ID  K   +  D +  E++A+   +H ++V           +++++ Y  GG L
Sbjct: 28  KVAIKRIDLEKCQTS-VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSL 86

Query: 66  CSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
              ++S      L E      +++++  L++L  N   H D+K  NIL+ ++ ++K+A  
Sbjct: 87  LDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADF 146

Query: 122 KQGVS 126
             GVS
Sbjct: 147 --GVS 149

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 62.3 bits (152), Expect = 1e-10
 Identities = 41/135 (30%), Positives = 69/135 (51%), Gaps = 20/135 (14%)

Query: 7   VAIKCIDKTKVSENRFDSIVN------EIKALKLLHHQHIVTMLDFLW----DERYVYII 56
           VAIK     K+  + FD          E+K L+   H +I+ + D L     D + VY++
Sbjct: 33  VAIK-----KIP-HAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVV 86

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNT 115
           ++     DL   I S + L+E   + F+ QL+  LK++   NV H DLKP N+L+ ++  
Sbjct: 87  MDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCE 145

Query: 116 LKLA--GLKQGVSEK 128
           L++   G+ +G+S  
Sbjct: 146 LRIGDFGMARGLSSS 160

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 61.0 bits (148), Expect = 2e-10
 Identities = 28/106 (26%), Positives = 53/106 (50%), Gaps = 2/106 (1%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+K ID +K++    +  ++E + L  L   +I+   +   D+  + I++EY + GDL  
Sbjct: 29  AMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHK 88

Query: 68  FIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            ++      L E Q  +F  Q++L L  L    + H D+K  N+ +
Sbjct: 89  LLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL 134

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 61.3 bits (149), Expect = 3e-10
 Identities = 40/129 (31%), Positives = 57/129 (44%), Gaps = 24/129 (18%)

Query: 7   VAIKCI---DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------------- 50
           VA+K I   D   V        + EIK ++ L H +IV + + L                
Sbjct: 33  VAVKKIVLTDPQSVK-----HALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTE 87

Query: 51  -RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
              VYI+ EY +  DL + +     LSE   + F+ QL+  LK++   NV H DLKP N+
Sbjct: 88  LNSVYIVQEYMET-DLANVL-EQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANV 145

Query: 110 LIKNNTLKL 118
            I    L L
Sbjct: 146 FINTEDLVL 154

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 28/107 (26%), Positives = 50/107 (46%), Gaps = 5/107 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+KC+   K       + + E   +  L H ++V +L  +     +YI+ EY   G L 
Sbjct: 32  VAVKCL---KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV 88

Query: 67  SFIRSHEK-LSEFQCQ-QFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            ++RS  + +     Q  F   +   +++L E N  H DL  +N+L+
Sbjct: 89  DYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV 135

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 60.2 bits (146), Expect = 5e-10
 Identities = 38/116 (32%), Positives = 58/116 (50%), Gaps = 4/116 (3%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 28  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 86

Query: 67  SF--IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            F        +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 87  KFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 142

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 33/118 (27%), Positives = 66/118 (55%), Gaps = 11/118 (9%)

Query: 7   VAIKCIDKTKVSENRFDSIVN-----EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           VAIK     K  E+  D +V      EI+ LK L H+++V +++    ++ +Y++ E+ D
Sbjct: 29  VAIK-----KFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVD 83

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
              L    +    L E + ++++ Q++  ++F   +N+ H D+KP+NIL+ ++  +KL
Sbjct: 84  HTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKL 141

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 34/120 (28%), Positives = 54/120 (45%), Gaps = 14/120 (11%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
              VAIK +        +      E++ALK L H+H++++         VYII E  + G
Sbjct: 30  RVRVAIKILKSD--DLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG 87

Query: 64  DLCSFIRSHE-------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
            L +F+RS E        L +  C     Q+   + +L E N  H DL  +NIL+  + +
Sbjct: 88  SLLAFLRSPEGQVLPVASLIDMAC-----QVAEGMAYLEEQNSIHRDLAARNILVGEDLV 142

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 33/110 (30%), Positives = 52/110 (47%), Gaps = 7/110 (6%)

Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK----LSEFQCQ 81
           + EI  LK L H +++  L    +   + I+LE  D GDL   I+  +K    + E    
Sbjct: 50  LKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW 109

Query: 82  QFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA--GLKQGVSEK 128
           ++  QL  AL+ +    + H D+KP N+ I     +KL   GL +  S K
Sbjct: 110 KYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 159

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 58.0 bits (140), Expect = 2e-09
 Identities = 29/102 (28%), Positives = 52/102 (50%), Gaps = 1/102 (0%)

Query: 18  SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE 77
           +E  ++ +  E+  LK L H +IV  L    D+  + I +E+  GG + S +     L E
Sbjct: 42  AEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE 101

Query: 78  FQCQQFVRQLVLALKFLRENNVCHFDLKPQNI-LIKNNTLKL 118
               ++ +Q++  + +L  N V H D+K  N+ L+ N  +KL
Sbjct: 102 PVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKL 143

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.5 bits (144), Expect = 2e-09
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 1/107 (0%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K + K   +++N    +  E  AL L     IV +   L     VY+++EY  GGD+ 
Sbjct: 33  AVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVK 92

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           S +  +    E    +++ ++ LAL +L  + + H DLKP N+LI N
Sbjct: 93  SLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISN 139

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 57.9 bits (141), Expect = 2e-09
 Identities = 22/75 (29%), Positives = 43/75 (57%)

Query: 36  HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR 95
            + + + +   +   +   +I++Y   GDL   ++   KLSE + ++ +RQLV AL  L 
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 96  ENNVCHFDLKPQNIL 110
           ++N+ H D+K +N+L
Sbjct: 127 KHNIIHNDIKLENVL 141

Length = 267

>gnl|CDD|197585 smart00225, BTB, Broad-Complex, Tramtrack and Bric a brac

 Score = 53.8 bits (130), Expect = 3e-09
 Identities = 20/73 (27%), Positives = 38/73 (52%), Gaps = 6/73 (8%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL--DITPEAFSTMLD 416
           D    VG     K+F AHK +L+  SP F  +F  +  E   ++I   D++PE F  +L+
Sbjct: 1   DVTLVVGG----KKFHAHKAVLAAHSPYFKALFSSDFKESDKSEIYLDDVSPEDFRALLN 56

Query: 417 SDHHARVNISSDH 429
             +  ++++  ++
Sbjct: 57  FLYTGKLDLPEEN 69

Domain in Broad-Complex, Tramtrack and Bric a brac. Also known as POZ (poxvirus and zinc finger) domain. Known to be a protein-protein interaction motif found at the N-termini of several C2H2-type transcription factors as well as Shaw-type potassium channels. Known structure reveals a tightly intertwined dimer formed via interactions between N-terminal strand and helix structures. However in a subset of BTB/POZ domains, these two secondary structures appear to be missing. Be aware SMART predicts BTB/POZ domains without the beta1- and alpha1-secondary structures. Length = 97

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 57.5 bits (139), Expect = 3e-09
 Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 13/106 (12%)

Query: 26  VNEIKALKLLHHQHIVTM----------LDFLWDERYVYIILEYCDGGDLCSFIRSH-EK 74
           + EIK L+ L+H++IV +          LDF  D+   Y++ EY D  DL   + S    
Sbjct: 54  IREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVH 112

Query: 75  LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
            SE   + F++QL+  L +  + N  H D+K  NIL+ N   +KLA
Sbjct: 113 FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLA 158

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 57.8 bits (140), Expect = 4e-09
 Identities = 25/122 (20%), Positives = 54/122 (44%), Gaps = 13/122 (10%)

Query: 4   HTEVAIKCIDKTKVSENRFDS------------IVNEIKALKLLHHQHIVTMLDFLWDER 51
              VAIK +   ++S +                 + E+K +  + H++I+ ++D   +  
Sbjct: 34  GKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD 93

Query: 52  YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           ++ ++++     DL   +    +L+E Q +  + Q++  L  L +    H DL P NI I
Sbjct: 94  FINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152

Query: 112 KN 113
            +
Sbjct: 153 NS 154

Length = 335

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 3/106 (2%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAIK I+  K  + + + I+NEI  +K L + +IV  LD       +++++EY  GG L
Sbjct: 46  EVAIKQINLQK--QPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              + +   + E Q     R+ + AL+FL  N V H D+K  N+L+
Sbjct: 104 TDVV-TETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 37/128 (28%), Positives = 62/128 (48%), Gaps = 4/128 (3%)

Query: 7   VAIKCIDK-TKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K      N    ++ E   L     + +V +L    D+ Y+Y+ +EY  GGD 
Sbjct: 29  VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GLK 122
            + + +   LSE   + ++ ++  A+  L E    H DLKP+N LI  +  +KL   GL 
Sbjct: 89  RTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Query: 123 QGVSEKAK 130
           +G+   A 
Sbjct: 149 KGIVTYAN 156

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 40/138 (28%), Positives = 68/138 (49%), Gaps = 9/138 (6%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VA+K   +    E +    ++E + LK   H +IV ++      + +YI++E   GGD
Sbjct: 20  TPVAVKTCKEDLPQELKI-KFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLA---LKFLRENNVCHFDLKPQNILI-KNNTLKLAG 120
             SF+R  +K  E + +Q V+  + A   + +L   N  H DL  +N L+ +NN LK++ 
Sbjct: 79  FLSFLR--KKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISD 136

Query: 121 LKQGVSEKAKGSAYIEQG 138
              G+S +     Y   G
Sbjct: 137 F--GMSRQEDDGIYSSSG 152

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 9e-09
 Identities = 44/126 (34%), Positives = 63/126 (50%), Gaps = 14/126 (11%)

Query: 7   VAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTML-DFLWDERYVYIILEYCDGG- 63
           VAIK I   K+   + F+ I  EI  LK   H +IV     +L  +  ++I++EYC GG 
Sbjct: 31  VAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRD-KLWIVMEYCGGGS 86

Query: 64  --DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAG 120
             D+    R    LSE Q     R+ +  L +L E    H D+K  NIL+ ++  +KLA 
Sbjct: 87  LQDIYQVTRGP--LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLAD 144

Query: 121 LKQGVS 126
              GVS
Sbjct: 145 F--GVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 39/125 (31%), Positives = 60/125 (48%), Gaps = 13/125 (10%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDE--------RYVYIILEYCDGGDLCSFIRSHE-KLSEF 78
           EIK LK L H ++V ++D   +           VY++  Y D  DL   + +   KL+E 
Sbjct: 57  EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPSVKLTES 115

Query: 79  QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GLKQGVSEKAKGSAYI 135
           Q + ++ QL+  + +L EN++ H D+K  NILI N   LK+A  GL +            
Sbjct: 116 QIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGG 175

Query: 136 EQGNT 140
             G T
Sbjct: 176 GGGGT 180

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 38/125 (30%), Positives = 55/125 (44%), Gaps = 26/125 (20%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVT------------MLDFLWDERYV 53
           VAIK +D  +  E   + I  E   L K  +H +I T              D LW     
Sbjct: 34  VAIKIMDIIEDEE---EEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLW----- 85

Query: 54  YIILEYCDGG---DLC-SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
            +++E C GG   DL     +  ++L E      +R+ +  L +L EN V H D+K QNI
Sbjct: 86  -LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNI 144

Query: 110 LIKNN 114
           L+  N
Sbjct: 145 LLTKN 149

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 20/79 (25%), Positives = 43/79 (54%)

Query: 36  HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR 95
            +  +V +     DE Y+Y+I+EY  GGD+ + +   +  +E + + ++ + +LA+  + 
Sbjct: 59  DNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIH 118

Query: 96  ENNVCHFDLKPQNILIKNN 114
           +    H D+KP N+L+   
Sbjct: 119 KLGYIHRDIKPDNLLLDAK 137

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 31/102 (30%), Positives = 58/102 (56%), Gaps = 11/102 (10%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDE-----RY---VYIILEYCDGGDLCSFIRS-HEKLSEF 78
           EIK L+LL H+++V +++    +     RY    Y++ E+C+  DL   + + + K +  
Sbjct: 61  EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLS 119

Query: 79  QCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           + ++ ++ L+  L ++  N + H D+K  NILI K+  LKLA
Sbjct: 120 EIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLA 161

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 3/106 (2%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAIK ++  +  + + + I+NEI  ++   H +IV  LD       +++++EY  GG L
Sbjct: 46  EVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              + +   + E Q     R+ + AL+FL  N V H D+K  NIL+
Sbjct: 104 TDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 148

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 36/119 (30%), Positives = 57/119 (47%), Gaps = 6/119 (5%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
            T+VA+K +    +S   F   + E + +K L H  +V +     +E  +YI+ EY   G
Sbjct: 30  TTKVAVKTLKPGTMSPEAF---LQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKG 86

Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            L  F++S E  KL   Q      Q+   + +L   N  H DL  +NIL+ +N   K+A
Sbjct: 87  SLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIA 145

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 37/109 (33%), Positives = 54/109 (49%), Gaps = 6/109 (5%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIR----SHEKLSEFQCQQF 83
           E + L  L H  IV       +     II EYC+G DL   +     + + LSE Q  ++
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 84  VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGS 132
             QL+L + ++ +  + H DLK +NI +KNN LK+     GVS    GS
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIGDF--GVSRLLMGS 158

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 34/96 (35%), Positives = 51/96 (53%), Gaps = 3/96 (3%)

Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQFV 84
           + E   LK L H +IVT+ D +  ++ + ++ EY D  DL  ++      LS    + F+
Sbjct: 51  IREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFL 109

Query: 85  RQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            QL+  L +  +  V H DLKPQN+LI     LKLA
Sbjct: 110 FQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLA 145

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 28/111 (25%), Positives = 54/111 (48%), Gaps = 4/111 (3%)

Query: 5   TEVAIK----CIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           T +A+K      + +   E   +++  EI+ +  L+H HI+ ML    ++ +  + +E+ 
Sbjct: 26  TLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWM 85

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            GG +   +  +    E     +  QL+  L +L EN + H D+K  N+LI
Sbjct: 86  AGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI 136

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 54.8 bits (132), Expect = 3e-08
 Identities = 32/116 (27%), Positives = 65/116 (56%), Gaps = 6/116 (5%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGD 64
           +VA+K +D  K  + R + + NE+  ++   H +IV M   +L  +  +++++E+ +GG 
Sbjct: 46  QVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDE-LWVVMEFLEGGA 102

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
           L   + +H +++E Q       ++ AL FL    V H D+K  +IL+ ++  +KL+
Sbjct: 103 LTDIV-THTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLS 157

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 54.4 bits (131), Expect = 4e-08
 Identities = 29/110 (26%), Positives = 56/110 (50%), Gaps = 5/110 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHH---QHIVTMLDFLWDERYVYIILEYCDGG 63
           VA+K I+     ++  D I  E+  L  L      +I            ++II+EY +GG
Sbjct: 29  VALKIINLDTPDDDVSD-IQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGG 87

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            + + +++   ++E      +R++++ALK++ +  V H D+K  NIL+ N
Sbjct: 88  SVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTN 136

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 32/112 (28%), Positives = 55/112 (49%), Gaps = 8/112 (7%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R +YI+ EY   G L
Sbjct: 30  DVAIKMIKEGSMSEDEF---IEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86

Query: 66  CSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++R H K   FQ  Q +   + +   + +L      H DL  +N L+ + 
Sbjct: 87  LNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQ 136

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 32/99 (32%), Positives = 57/99 (57%), Gaps = 6/99 (6%)

Query: 28  EIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQF 83
           E + L  L H +IV   +  W+  +  +YI++ +C+GGDL   ++    + L E Q  ++
Sbjct: 49  EAQLLSQLKHPNIVAYRES-WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEW 107

Query: 84  VRQLVLALKFLRENNVCHFDLKPQNI-LIKNNTLKLAGL 121
             Q+ +AL++L E ++ H DLK QN+ L + N +K+  L
Sbjct: 108 FVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDL 146

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 39/109 (35%), Positives = 58/109 (53%), Gaps = 5/109 (4%)

Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKL-SEFQCQQFV 84
           + E+  LK L H +IVT+ D +  ER + ++ EY D  DL  ++ +   L S    + F+
Sbjct: 51  IREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFM 109

Query: 85  RQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GLKQGVSEKAK 130
            QL+  L +  +  + H DLKPQN+LI     LKLA  GL +  S   K
Sbjct: 110 FQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 53.9 bits (130), Expect = 4e-08
 Identities = 34/111 (30%), Positives = 53/111 (47%), Gaps = 6/111 (5%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + K   S+ +    + E   +    H +I+ +   +   R V II EY + G L 
Sbjct: 35  VAIKTL-KAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLD 93

Query: 67  SFIRSHEKLSEFQCQQFVRQL---VLALKFLRENNVCHFDLKPQNILIKNN 114
            F+R ++   +F   Q V  L      +K+L E N  H DL  +NIL+ +N
Sbjct: 94  KFLREND--GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 23/89 (25%), Positives = 42/89 (47%), Gaps = 2/89 (2%)

Query: 25  IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQF 83
           I+ E+  L   +  +IV      ++   + I +EY DGG L   ++  +  + E    + 
Sbjct: 46  ILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKI 105

Query: 84  VRQLVLALKFLREN-NVCHFDLKPQNILI 111
              ++  L +L E   + H D+KP NIL+
Sbjct: 106 AVAVLKGLTYLHEKHKIIHRDVKPSNILV 134

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 41/115 (35%), Positives = 57/115 (49%), Gaps = 9/115 (7%)

Query: 4   HTEVAIKCIDK---TKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEY 59
              VAIK I K   T V   R      E+K LK L H++I+++ D F+     +Y + E 
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKR---TYRELKLLKHLRHENIISLSDIFISPLEDIYFVTEL 91

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
             G DL   + S     +F  Q F+ Q++  LK++    V H DLKP NILI  N
Sbjct: 92  L-GTDLHRLLTSRPLEKQF-IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINEN 144

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 38/114 (33%), Positives = 57/114 (50%), Gaps = 4/114 (3%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+K I   K S    DS   E   L  + H +IV   +    + ++YI++EYCDGGDL  
Sbjct: 29  AMKEIRLPKSSSAVEDS-RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQ 87

Query: 68  FIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI-LIKNNTLKL 118
            I+        E    Q+  Q+ L ++ + E  V H D+K +NI L +N  +KL
Sbjct: 88  KIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKL 141

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 25/72 (34%), Positives = 46/72 (63%), Gaps = 2/72 (2%)

Query: 49  DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           D++Y+Y+++EY  GGDL + + +++ + E   + +  ++VLAL  +      H D+KP N
Sbjct: 114 DDKYLYMVMEYMPGGDLVNLMSNYD-IPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 172

Query: 109 ILI-KNNTLKLA 119
           +L+ K+  LKLA
Sbjct: 173 MLLDKSGHLKLA 184

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 32/113 (28%), Positives = 56/113 (49%), Gaps = 7/113 (6%)

Query: 6   EVAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLD-FLWD-ERYVYIILEYC-- 60
           E AIK     K        S   EI  L+ L H+++V++++ FL   ++ VY++ +Y   
Sbjct: 29  EYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH 88

Query: 61  DGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           D   +  F R  ++  +     +  + Q++  + +L  N V H DLKP NIL+
Sbjct: 89  DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 30/120 (25%), Positives = 60/120 (50%), Gaps = 9/120 (7%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
             +VAIK I +  +SE+ F   + E K +  L H ++V +      +R ++I+ EY   G
Sbjct: 28  KIDVAIKMIREGAMSEDDF---IEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANG 84

Query: 64  DLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            L +++R  +       +  +     +  A+++L  N   H DL  +N L+ ++N +K++
Sbjct: 85  CLLNYLRERKGK--LGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVS 142

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 31/124 (25%), Positives = 59/124 (47%), Gaps = 9/124 (7%)

Query: 16  KVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS--- 71
           +  +     IV+E+  +K  L H +IV       +   +YI+++  +G  L     S   
Sbjct: 46  RERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKE 105

Query: 72  -HEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILIKNN---TLKLAGLKQGVS 126
             ++ +E +      Q+VLAL++L +E  + H DL P NI++  +   T+   GL +   
Sbjct: 106 KKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ 165

Query: 127 EKAK 130
            ++K
Sbjct: 166 PESK 169

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 31/115 (26%), Positives = 65/115 (56%), Gaps = 5/115 (4%)

Query: 2   EQHT--EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           E+HT  +VA+K +D  K  + R + + NE+  ++  HH+++V M +       +++++E+
Sbjct: 43  EKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +GG L   + +H +++E Q       ++ AL +L    V H D+K  +IL+ ++
Sbjct: 101 LEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 154

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 29/95 (30%), Positives = 52/95 (54%), Gaps = 3/95 (3%)

Query: 49  DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           DE ++Y+++EY  GGDL + +   +   E   + ++ +LVLAL  + +    H D+KP N
Sbjct: 72  DEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDN 131

Query: 109 ILI-KNNTLKLA--GLKQGVSEKAKGSAYIEQGNT 140
           ILI  +  +KLA  GL + +++      Y+   + 
Sbjct: 132 ILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHN 166

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 32/100 (32%), Positives = 56/100 (56%), Gaps = 5/100 (5%)

Query: 24  SIVNEIKALKLLHHQHIVTMLDFLWDERY--VYIILEYCDGGDLCSFIRSHEK-LSEFQC 80
           S + EI  L  L H +IV + + +  +    +++++EYC+  DL S + +     SE Q 
Sbjct: 52  SSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQV 110

Query: 81  QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
           +  + QL+  L++L EN + H DLK  N+L+ +   LK+A
Sbjct: 111 KCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIA 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 2/85 (2%)

Query: 28  EIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVR 85
           EI+ LK L H+ IV     L D  ER + I +E+  GG +   ++S+  L+E   +++ R
Sbjct: 54  EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113

Query: 86  QLVLALKFLRENNVCHFDLKPQNIL 110
           Q++  + +L  N + H D+K  NIL
Sbjct: 114 QILEGVSYLHSNMIVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 33/133 (24%), Positives = 69/133 (51%), Gaps = 6/133 (4%)

Query: 8   AIKCIDKTKVSENR-FDSIVNEIKALKL-LHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           AIK + K  V E+   +  + E + L L   H  +  +      + +++ ++EY +GGDL
Sbjct: 24  AIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDL 83

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL--- 121
              I+S  +  E + + +  +++  L+FL +  + + DLK  N+L+ K+  +K+A     
Sbjct: 84  MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMC 143

Query: 122 KQGVSEKAKGSAY 134
           K+ ++ + K S +
Sbjct: 144 KENMNGEGKASTF 156

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 19/159 (11%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILE 58
           +    +VA+K ++ +   ++R D    EI+ L+ L H++IV           R + +I+E
Sbjct: 30  DNTGEQVAVKSLNHSGEEQHRSD-FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME 88

Query: 59  YCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL- 116
           Y   G L  +++ H ++++  +   F  Q+   + +L      H DL  +NIL+++  L 
Sbjct: 89  YLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLV 148

Query: 117 KLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP 153
           K++  GL + + E  K   Y           V EP E P
Sbjct: 149 KISDFGLAKVLPED-KDYYY-----------VKEPGESP 175

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 28/85 (32%), Positives = 48/85 (56%), Gaps = 2/85 (2%)

Query: 28  EIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVR 85
           EI+ LK L H+ IV     L D  E+ + I +EY  GG +   ++++  L+E   +++ R
Sbjct: 54  EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113

Query: 86  QLVLALKFLRENNVCHFDLKPQNIL 110
           Q++  + +L  N + H D+K  NIL
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 28/85 (32%), Positives = 47/85 (55%), Gaps = 2/85 (2%)

Query: 28  EIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVR 85
           EI+ LK L H  IV     L D  E+ + I +EY  GG +   ++++  L+E   +++ R
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTR 113

Query: 86  QLVLALKFLRENNVCHFDLKPQNIL 110
           Q++  + +L  N + H D+K  NIL
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANIL 138

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 37/136 (27%), Positives = 69/136 (50%), Gaps = 17/136 (12%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E    VAIK    ++ +E   ++ + E+K L+ L  ++IV + +       +Y++ EY +
Sbjct: 24  ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVE 83

Query: 62  GGDLCSFIRSHEKLSEF-------QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N 113
              L       E L E        + + ++ QL+ A+ +  +N++ H D+KP+N+LI  N
Sbjct: 84  KNML-------ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHN 136

Query: 114 NTLKLA--GLKQGVSE 127
           + LKL   G  + +SE
Sbjct: 137 DVLKLCDFGFARNLSE 152

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 38/115 (33%), Positives = 59/115 (51%), Gaps = 4/115 (3%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I   +     F +I  E   LK L H +IV + D +  +  + ++ EY    DLC
Sbjct: 33  VALKVIRLQEEEGTPFTAI-REASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-DLC 90

Query: 67  SFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
            ++  H   L     + F+ QL+  L ++ +  + H DLKPQN+LI +   LKLA
Sbjct: 91  QYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLA 145

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 51.6 bits (123), Expect = 4e-07
 Identities = 23/72 (31%), Positives = 42/72 (58%)

Query: 40  IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNV 99
           +V M     D+R +Y+I+E+  GGD+ + +   + LSE   Q ++ + VLA+  + +   
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 100 CHFDLKPQNILI 111
            H D+KP N+L+
Sbjct: 123 IHRDIKPDNLLL 134

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 51.4 bits (124), Expect = 5e-07
 Identities = 39/106 (36%), Positives = 62/106 (58%), Gaps = 8/106 (7%)

Query: 28  EIKALK-LLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFV 84
           EI  L+ L  H +IV +L+ +  E  + +Y++ EY +  DL + IR    L +   +  +
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIR-ANILEDVHKRYIM 113

Query: 85  RQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GLKQGVSE 127
            QL+ ALK++   NV H DLKP NIL+ ++  +KLA  GL + +SE
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSE 159

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 9/144 (6%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           +T VA+K   +T   + +    + E + LK   H +IV ++     ++ +YI++E   GG
Sbjct: 20  NTPVAVKSCRETLPPDLK-AKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78

Query: 64  DLCSFIRS---HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           D  +F+R+     K+ E    Q V      +++L   +  H DL  +N L+ + N LK++
Sbjct: 79  DFLTFLRTEGPRLKVKEL--IQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKIS 136

Query: 120 GLKQGVSEKAKGSAYIEQGNTKVI 143
               G+S + +   Y   G  K I
Sbjct: 137 DF--GMSREEEDGVYASTGGMKQI 158

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.2 bits (122), Expect = 5e-07
 Identities = 33/96 (34%), Positives = 49/96 (51%), Gaps = 3/96 (3%)

Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ-CQQFV 84
           + E+  LK L H +IVT+ D +  E+ + ++ EY D  DL  ++            + F+
Sbjct: 52  IREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFL 110

Query: 85  RQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
            QL+  L +     V H DLKPQN+LI     LKLA
Sbjct: 111 FQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLA 146

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 50.7 bits (121), Expect = 5e-07
 Identities = 30/109 (27%), Positives = 55/109 (50%), Gaps = 2/109 (1%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + K   +E +    ++E   +    H +I+ +   +   +   II EY + G L 
Sbjct: 36  VAIKTL-KPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALD 94

Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            ++R H+ + S +Q    +R +   +K+L + N  H DL  +NIL+ +N
Sbjct: 95  KYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSN 143

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 50.9 bits (122), Expect = 5e-07
 Identities = 42/153 (27%), Positives = 75/153 (49%), Gaps = 10/153 (6%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +  T  S  R +++++E+K +  L +H++IV +L        + +I EYC  GD
Sbjct: 67  KVAVKMLKPTAHSSER-EALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125

Query: 65  LCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLA-- 119
           L +F+R      L+      F  Q+   + FL   N  H DL  +N+L+ +  + K+   
Sbjct: 126 LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDF 185

Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
           GL + +      S Y+ +GN ++      P  I
Sbjct: 186 GLARDIMND---SNYVVKGNARLPVKWMAPESI 215

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 14/107 (13%)

Query: 28  EIKALKLLHH-QHIVTMLDFLWDER-----YVYIILEYCDGGDLCSFIRSH-----EKLS 76
           EI  L++L    +IV +LD    E       +Y++ EY D  DL  F+ S+       L 
Sbjct: 50  EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108

Query: 77  EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGL 121
               + F+ QL+  +    ++ V H DLKPQN+L+      LK+A L
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADL 155

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 26/73 (35%), Positives = 45/73 (61%), Gaps = 2/73 (2%)

Query: 49  DERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           D+  +Y+++EY  GGDL S +  +E +  E   Q ++ +LVLA+  + +    H D+KP+
Sbjct: 72  DKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPE 131

Query: 108 NILI-KNNTLKLA 119
           N+LI +   +KLA
Sbjct: 132 NVLIDRTGHIKLA 144

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 5/104 (4%)

Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK----LSEFQCQ 81
           V EI  LK L+H +++  LD   ++  + I+LE  D GDL   I+  +K    + E    
Sbjct: 50  VKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVW 109

Query: 82  QFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQG 124
           ++  QL  A++ +    V H D+KP N+ I     +KL  L  G
Sbjct: 110 KYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLG 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 30/130 (23%), Positives = 60/130 (46%), Gaps = 12/130 (9%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +++E  
Sbjct: 33  GEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELM 91

Query: 61  DGGDLCSFIRSHEKLSEFQC-------QQFVR---QLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS    +E          Q+F++   ++   + +L      H DL  +N +
Sbjct: 92  AKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCM 151

Query: 111 IKNN-TLKLA 119
           +  + T+K+ 
Sbjct: 152 VAEDLTVKIG 161

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 50.5 bits (121), Expect = 7e-07
 Identities = 26/123 (21%), Positives = 49/123 (39%), Gaps = 17/123 (13%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK + +    + +      E + +  L H +IV +L     E+   ++ EY   GD
Sbjct: 36  TSVAIKTLKENAEPKVQ-QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGD 94

Query: 65  LCSFIRSHEKLSEFQCQ----------------QFVRQLVLALKFLRENNVCHFDLKPQN 108
           L  F+  +   S+   +                    Q+   +++L  ++  H DL  +N
Sbjct: 95  LHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARN 154

Query: 109 ILI 111
            L+
Sbjct: 155 CLV 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.6 bits (121), Expect = 7e-07
 Identities = 30/111 (27%), Positives = 56/111 (50%), Gaps = 1/111 (0%)

Query: 2   EQHTEVAIKCIDK-TKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K I+K   +  N+   +  E   L    +  +V+M      +R++ +++EY 
Sbjct: 24  ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYV 83

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           +GGD  + +++   L     + +  + VLAL++L    + H DLKP N+LI
Sbjct: 84  EGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI 134

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 26/105 (24%), Positives = 55/105 (52%), Gaps = 1/105 (0%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +          D ++ E   ++ L + +IV M+     E ++ +++E  + G L 
Sbjct: 25  VAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLN 83

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            F++ ++ ++E    + V Q+ + +K+L E N  H DL  +N+L+
Sbjct: 84  KFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL 128

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 50.0 bits (119), Expect = 7e-07
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 31  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 86

Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 87  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 138

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 51.7 bits (123), Expect = 8e-07
 Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 13/115 (11%)

Query: 10  KCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCS 67
           K I    + E     +V E+  ++ L H++IV  +D   ++  + +YI++E+CD GDL  
Sbjct: 44  KAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSR 103

Query: 68  FIRS----HEKLSEFQCQQFVRQLVLALKFLRE-------NNVCHFDLKPQNILI 111
            I+       K+ E       RQL+ AL +            V H DLKPQNI +
Sbjct: 104 NIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFL 158

Length = 1021

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 41/137 (29%), Positives = 63/137 (45%), Gaps = 21/137 (15%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           AIK + K   SEN       E++ L KL HH +I+ +L    +  Y+YI +EY   G+L 
Sbjct: 33  AIKML-KEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLL 91

Query: 67  SFIR----------------SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
            F+R                +   L+  Q  QF   +   +++L E    H DL  +N+L
Sbjct: 92  DFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVL 151

Query: 111 IKNNTL-KLA--GLKQG 124
           +  N   K+A  GL +G
Sbjct: 152 VGENLASKIADFGLSRG 168

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 34/138 (24%), Positives = 63/138 (45%), Gaps = 8/138 (5%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +   K      +  + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 34  VAVKTL---KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 90

Query: 67  SFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQ 123
            ++R    ++++         Q+  A+++L + N  H DL  +N L+ +N+ +K+A    
Sbjct: 91  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 148

Query: 124 GVSEKAKGSAYIEQGNTK 141
           G+S    G  Y      K
Sbjct: 149 GLSRLMTGDTYTAHAGAK 166

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.1 bits (119), Expect = 8e-07
 Identities = 38/137 (27%), Positives = 60/137 (43%), Gaps = 21/137 (15%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           AIK + K   S++       E++ L KL HH +I+ +L       Y+Y+ +EY   G+L 
Sbjct: 26  AIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL 84

Query: 67  SFIR----------------SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
            F+R                +   LS  Q   F   +   + +L +    H DL  +NIL
Sbjct: 85  DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 144

Query: 111 IKNN-TLKLA--GLKQG 124
           +  N   K+A  GL +G
Sbjct: 145 VGENYVAKIADFGLSRG 161

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 27/84 (32%), Positives = 50/84 (59%), Gaps = 2/84 (2%)

Query: 38  QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRE 96
           Q I T+     DE Y+Y++++Y  GGDL + +   E +L E   + ++ ++VLA+  + +
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 97  NNVCHFDLKPQNILIK-NNTLKLA 119
            +  H D+KP N+L+  N  ++LA
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLA 144

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 50.3 bits (120), Expect = 9e-07
 Identities = 39/131 (29%), Positives = 68/131 (51%), Gaps = 9/131 (6%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERY-----VYIILE 58
            +VAIK + +   SE        E++ LK + H++++ +LD F  D         Y+++ 
Sbjct: 41  AKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP 100

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
           +  G DL   ++ HEKLSE + Q  V Q++  LK++    + H DLKP N+ + N   +L
Sbjct: 101 FM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV-NEDCEL 157

Query: 119 AGLKQGVSEKA 129
             L  G++ + 
Sbjct: 158 KILDFGLARQT 168

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 8/137 (5%)

Query: 4   HTEVAIKCIDKTKV--SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
              VA+K +    +  ++ R D I  EI  LK L+H +++       ++  + I+LE  D
Sbjct: 27  GVPVALKKVQIFDLMDAKARADCI-KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 85

Query: 62  GGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTL 116
            GDL   I+  +K    + E    ++  QL  AL+ +    V H D+KP N+ I     +
Sbjct: 86  AGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVV 145

Query: 117 KLAGLKQGVSEKAKGSA 133
           KL  L  G    +K +A
Sbjct: 146 KLGDLGLGRFFSSKTTA 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 32/133 (24%), Positives = 66/133 (49%), Gaps = 6/133 (4%)

Query: 8   AIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           A+K + K  +  ++  +  + E + L L   H  +  +      +  ++ ++EY +GGDL
Sbjct: 24  AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL- 121
              I+   +  E + + +  ++VL L+FL E  + + DLK  N+L+     +K+A  G+ 
Sbjct: 84  MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC 143

Query: 122 KQGVSEKAKGSAY 134
           K+G+      S +
Sbjct: 144 KEGILGGVTTSTF 156

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 28/84 (33%), Positives = 51/84 (60%), Gaps = 8/84 (9%)

Query: 40  IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRE 96
           +V +     D++Y+Y+++EY  GGDL + + ++   EK ++F    +  ++VLAL  +  
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKF----YTAEVVLALDAIHS 160

Query: 97  NNVCHFDLKPQNILI-KNNTLKLA 119
             + H D+KP N+L+ K+  LKLA
Sbjct: 161 MGLIHRDVKPDNMLLDKHGHLKLA 184

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.9 bits (119), Expect = 1e-06
 Identities = 20/62 (32%), Positives = 40/62 (64%)

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
           +Y++ +Y  GG+L   ++   + SE + + ++ +LVLAL+ L + ++ + DLKP+NIL+ 
Sbjct: 71  LYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLD 130

Query: 113 NN 114
             
Sbjct: 131 AT 132

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 29/84 (34%), Positives = 49/84 (58%), Gaps = 8/84 (9%)

Query: 40  IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---EKLSEFQCQQFVRQLVLALKFLRE 96
           +V +     D+RY+Y+++EY  GGDL + + ++   EK + F    +  ++VLAL  +  
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARF----YTAEVVLALDAIHS 160

Query: 97  NNVCHFDLKPQNILI-KNNTLKLA 119
               H D+KP N+L+ K+  LKLA
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLA 184

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 22/166 (13%)

Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEYCD 61
           +  +VA+KCI     ++    + + E   +  L H ++V +L  + +E+  +YI+ EY  
Sbjct: 28  RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83

Query: 62  GGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
            G L  ++RS  +  L      +F   +  A+++L  NN  H DL  +N+L+  + +   
Sbjct: 84  KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNV--- 140

Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSK 165
                    AK S +   G TK   S  +  ++P   T+ E  R K
Sbjct: 141 ---------AKVSDF---GLTKEASSTQDTGKLPVKWTAPEALREK 174

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 5/114 (4%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T+VA+K +    +S   F   + E   +K L H  +V +   +  E  +YII EY   G 
Sbjct: 31  TKVAVKTLKPGTMSVQAF---LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87

Query: 65  LCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           L  F++S E  K+   +   F  Q+   + ++   N  H DL+  N+L+  + +
Sbjct: 88  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM 141

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 39/125 (31%), Positives = 64/125 (51%), Gaps = 8/125 (6%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           +A+K I + ++ E++F+ I+ E+  L      +IV      + E  VY+ +EY D G L 
Sbjct: 29  MAMKEI-RLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLD 87

Query: 67  SFI---RSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNN-TLKLAGL 121
                  + E + E   ++    +V  LKFL+E  N+ H D+KP N+L+  N  +KL   
Sbjct: 88  KLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDF 147

Query: 122 KQGVS 126
             GVS
Sbjct: 148 --GVS 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 31/101 (30%), Positives = 59/101 (58%), Gaps = 16/101 (15%)

Query: 28  EIKALKLLHHQHIVTMLDF------LWDERYVYIILEYCDGGDLCSFIR---SHEKLSEF 78
           E+  +KL++H++I+ +L+       L + + VY+++E  D  +LC  I+    HE++S  
Sbjct: 65  ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMS-- 121

Query: 79  QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
                + Q++  +K L    + H DLKP NI++K++ TLK+
Sbjct: 122 ---YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 159

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 34/110 (30%), Positives = 55/110 (50%), Gaps = 6/110 (5%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VAIK + +  +S   F   + E   +K L H  +V +   +  E  +YII EY + G
Sbjct: 30  HTKVAIKSLKQGSMSPEAF---LAEANLMKQLQHPRLVRLYAVVTQEP-IYIITEYMENG 85

Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            L  F+++ E  KL+  +      Q+   + F+   N  H DL+  NIL+
Sbjct: 86  SLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 39/134 (29%), Positives = 68/134 (50%), Gaps = 7/134 (5%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAIK ++  +  + + + I+NEI  ++   + +IV  LD       +++++EY  GG L
Sbjct: 46  EVAIKQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL--- 121
              + +   + E Q     R+ + AL FL  N V H D+K  NIL+  + ++KL      
Sbjct: 104 TDVV-TETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC 162

Query: 122 KQGVSEKAKGSAYI 135
            Q   E++K S  +
Sbjct: 163 AQITPEQSKRSTMV 176

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 20/73 (27%), Positives = 40/73 (54%)

Query: 39  HIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN 98
           ++V +  ++  E  V+++L++ +GG L S I     + E   +++  ++V+AL  L    
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREG 105

Query: 99  VCHFDLKPQNILI 111
           +   DL P NIL+
Sbjct: 106 IVCRDLNPNNILL 118

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 32/104 (30%), Positives = 52/104 (50%), Gaps = 21/104 (20%)

Query: 28  EIKALKLLHHQHIVTM--------LDFLWDERYVYIILEYCDGGDLCSFIRSHEK---LS 76
           EI  L  L H +IVT+        LD       +Y+++EY +  DL S + + ++    S
Sbjct: 54  EINILLKLQHPNIVTVKEVVVGSNLDK------IYMVMEYVEH-DLKSLMETMKQPFLQS 106

Query: 77  EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
           E +C   + QL+  +  L +N + H DLK  N+L+ N   LK+ 
Sbjct: 107 EVKC--LMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKIC 148

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 37/115 (32%), Positives = 57/115 (49%), Gaps = 4/115 (3%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I   K  E    + + E   LK L H +IV + D +  +  +  + EY    DL 
Sbjct: 33  VALKVI-SMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLA 90

Query: 67  SFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            ++  H   L  +  + F+ QL+  L ++   ++ H DLKPQN+LI     LKLA
Sbjct: 91  QYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLA 145

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 36/109 (33%), Positives = 57/109 (52%), Gaps = 5/109 (4%)

Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQQFV 84
           + E+  LK L H +IVT+ D +  ++ + ++ EY D  DL  ++      +S    + F+
Sbjct: 52  IREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFL 110

Query: 85  RQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GLKQGVSEKAK 130
            Q++  L +     V H DLKPQN+LI +   LKLA  GL +  S   K
Sbjct: 111 YQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 49.0 bits (116), Expect = 2e-06
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAI+ ++  +  + + + I+NEI  ++   + +IV  LD       +++++EY  GG L
Sbjct: 47  EVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              + +   + E Q     R+ + AL+FL  N V H D+K  NIL+
Sbjct: 105 TDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.8 bits (117), Expect = 3e-06
 Identities = 33/111 (29%), Positives = 57/111 (51%), Gaps = 8/111 (7%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF------LWDERYVYIILE 58
            +VAIK + +   S         E++ LK + H++++ +LD       L D + VY++  
Sbjct: 41  RKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH 100

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
              G DL + ++  +KLS+   Q  V Q++  LK++    + H DLKP NI
Sbjct: 101 LM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI 149

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 6/111 (5%)

Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           +HT+VA+K +    +S   F   + E   +K L H  +V +   +  E  +YII E+   
Sbjct: 29  KHTKVAVKTMKPGSMSVEAF---LAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAK 84

Query: 63  GDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           G L  F++S E  K    +   F  Q+   + F+ + N  H DL+  NIL+
Sbjct: 85  GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 135

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.0 bits (112), Expect = 3e-06
 Identities = 27/113 (23%), Positives = 51/113 (45%), Gaps = 14/113 (12%)

Query: 14  KTKVSENRFDSIVNEIKALKLLHHQHIVT--MLDFLWDERYVYIILEYCDGGDLCSFIRS 71
           K   S  +      E+  L+LL  + +    +L     + + Y+++E+ +G  L      
Sbjct: 27  KINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL------ 80

Query: 72  HEKLSEFQCQQFVRQLVLALKFLRE---NNVCHFDLKPQNILIKNNTLKLAGL 121
            +++SE + +    QL   L  L +     +CH DL P NIL+ +   K+ G+
Sbjct: 81  -DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDG--KILGI 130

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 39/122 (31%), Positives = 56/122 (45%), Gaps = 5/122 (4%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           AIK I K +  E+ F  +  EI  +K   H +IV           ++I +E+C GG L  
Sbjct: 38  AIKVI-KLEPGED-FAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQD 95

Query: 68  FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLAGLKQGVS 126
                  LSE Q     R+ +  L +L      H D+K  NIL+ +N  +KLA    GVS
Sbjct: 96  IYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADF--GVS 153

Query: 127 EK 128
            +
Sbjct: 154 AQ 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 33/122 (27%), Positives = 66/122 (54%), Gaps = 16/122 (13%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 104

Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 105 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158

Query: 117 KL 118
           K+
Sbjct: 159 KI 160

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 31/92 (33%), Positives = 54/92 (58%), Gaps = 4/92 (4%)

Query: 49  DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           D +Y+Y+I+E+  GGDL + +  ++  SE   + ++ + VLA++ + +    H D+KP N
Sbjct: 72  DAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDN 131

Query: 109 ILI-KNNTLKLA--GLKQGVSEKAKGSAYIEQ 137
           ILI +   +KL+  GL  G   K   SAY ++
Sbjct: 132 ILIDRGGHIKLSDFGLSTGF-HKQHDSAYYQK 162

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.5 bits (116), Expect = 4e-06
 Identities = 34/129 (26%), Positives = 58/129 (44%), Gaps = 17/129 (13%)

Query: 7   VAIKCI--DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           VA+K +  D +  +   F     E+K L  L   +I  +L     +  + +I+EY + GD
Sbjct: 49  VAVKVLRPDASDNAREDFLK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGD 105

Query: 65  LCSFIRSHE----------KLSEFQCQQFV-RQLVLALKFLRENNVCHFDLKPQNILI-K 112
           L  F++ H           K   F    ++  Q+   +++L   N  H DL  +N L+ K
Sbjct: 106 LNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGK 165

Query: 113 NNTLKLAGL 121
           N T+K+A  
Sbjct: 166 NYTIKIADF 174

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 29/110 (26%), Positives = 61/110 (55%), Gaps = 7/110 (6%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILEYCDGGD 64
           VA+K +D  K  + R + + NE+  ++   H+++V M +   + DE  +++++E+ +GG 
Sbjct: 48  VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGA 103

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L   + +H +++E Q       ++ AL  L    V H D+K  +IL+ ++
Sbjct: 104 LTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHD 152

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 31/112 (27%), Positives = 59/112 (52%), Gaps = 5/112 (4%)

Query: 2   EQHT--EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           E+H+  +VA+K +D  K  + R + + NE+  ++   HQ++V M         +++++E+
Sbjct: 42  EKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF 99

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             GG L   + S  +L+E Q       ++ AL +L    V H D+K  +IL+
Sbjct: 100 LQGGALTDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL 150

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 48.1 bits (115), Expect = 4e-06
 Identities = 30/108 (27%), Positives = 54/108 (50%), Gaps = 5/108 (4%)

Query: 8   AIKCIDKTKVSEN-RFDSIVNEIKALKLLH---HQHIVTMLDFLWDERYVYIILEYCDGG 63
           AIK + K  +      +S++ E +  +  +   H  +V +      E +V  ++EY  GG
Sbjct: 28  AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   I + +  SE +   +   +VL L++L EN + + DLK  N+L+
Sbjct: 88  DLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL 134

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 35/108 (32%), Positives = 48/108 (44%), Gaps = 3/108 (2%)

Query: 22  FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ 81
           F  I  EI  +K   H +IV           ++I +EYC GG L         LSE Q  
Sbjct: 50  FSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIA 109

Query: 82  QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEK 128
              R+ +  L +L      H D+K  NIL+ +N  +KLA    GV+ K
Sbjct: 110 YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADF--GVAAK 155

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|206767 cd11362, RNase_PH_bact, Ribonuclease PH

 Score = 47.2 bits (113), Expect = 5e-06
 Identities = 37/130 (28%), Positives = 62/130 (47%), Gaps = 17/130 (13%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYV--EFKFAPFASQI 181
           G ++ A+GS  IE G+TKV+C+     ++P       + R KG+ +V  E+   P ++  
Sbjct: 10  GFNKHAEGSVLIEFGDTKVLCTASVEEKVPP------FLRGKGKGWVTAEYSMLPRSTHE 63

Query: 182 RTGWLRDSEEKELGNH-------LKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAI 234
           RT   R++ + +           + R+L  AV         + +   VLQ DG   +A+I
Sbjct: 64  RT--QREASKGKQSGRTQEIQRLIGRSLRAAVDLEALGERTITIDCDVLQADGGTRTASI 121

Query: 235 NCANLALVDA 244
             A +AL DA
Sbjct: 122 TGAYVALADA 131

Ribonuclease PH (RNase PH)-like 3'-5' exoribonucleases are enzymes that catalyze the 3' to 5' processing and decay of RNA substrates. Structurally all members of this family form hexameric rings (trimers of dimers). Bacterial RNase PH forms a homohexameric ring, and removes nucleotide residues following the -CCA terminus of tRNA. Length = 227

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 32/132 (24%), Positives = 71/132 (53%), Gaps = 5/132 (3%)

Query: 40  IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNV 99
           +V M     D+  +Y+I+E+  GGD+ + +   + L+E + Q ++ + VLA+  + +   
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 100 CHFDLKPQNILIKNNT-LKLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK 156
            H D+KP N+L+ +   +KL+  GL  G+ +  +   Y    ++  + S F  + + S +
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHS--LPSDFTFQNMNSKR 180

Query: 157 TSLEYQRSKGEL 168
            +  ++R++ +L
Sbjct: 181 KAETWKRNRRQL 192

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 48.1 bits (114), Expect = 6e-06
 Identities = 38/140 (27%), Positives = 72/140 (51%), Gaps = 18/140 (12%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111

Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165

Query: 117 KLAGLKQGVSEKAKGSAYIE 136
           K+  L  G++  A  S  + 
Sbjct: 166 KI--LDFGLARTAGTSFMMT 183

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 47.6 bits (113), Expect = 7e-06
 Identities = 28/105 (26%), Positives = 53/105 (50%), Gaps = 1/105 (0%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K I K   VS +     + E   L  ++   IV +         +Y++L + +GG+L 
Sbjct: 22  ALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELF 81

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++   +    + + +  +L+ AL+ L + NV + DLKP+NIL+
Sbjct: 82  HHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL 126

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.1 bits (112), Expect = 7e-06
 Identities = 32/112 (28%), Positives = 54/112 (48%), Gaps = 7/112 (6%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           +AIK I +      +   +  EI     L H++IV  L    +  +  I +E   GG L 
Sbjct: 36  IAIKEIPERDSRYVQ--PLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLS 93

Query: 67  SFIRSH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           + +RS     K +E     + +Q++  LK+L +N + H D+K  N+L+  NT
Sbjct: 94  ALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV--NT 143

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 32/108 (29%), Positives = 53/108 (49%), Gaps = 16/108 (14%)

Query: 20  NRFDSIVN------EIKALKLLHHQHIVTMLDFL-------WDERYVYIILEYCDGGDLC 66
           N F ++V+      E+K L    H ++++ LD L       ++E YV   L   D   L 
Sbjct: 35  NVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQSD---LH 91

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
             I S + LS    + F+ Q++  LK+L    + H D+KP N+L+ +N
Sbjct: 92  KIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSN 139

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 47.4 bits (113), Expect = 7e-06
 Identities = 34/144 (23%), Positives = 72/144 (50%), Gaps = 21/144 (14%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYC 60
            + + VA+K + K   +E     +V+E++ +K++  H++I+ +L     E  +Y+++EY 
Sbjct: 40  NETSTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYA 98

Query: 61  DGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 104
             G+L  F+R+                 E L++     F  Q+   ++FL      H DL
Sbjct: 99  AHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDL 158

Query: 105 KPQNILI-KNNTLKLA--GLKQGV 125
             +N+L+ +++ +K+A  GL + +
Sbjct: 159 AARNVLVTEDHVMKIADFGLARDI 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 8e-06
 Identities = 25/82 (30%), Positives = 51/82 (62%), Gaps = 3/82 (3%)

Query: 41  VTMLDFLW-DERYVYIILEYCDGGDLCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENN 98
           +T L + + DE  +Y++++Y  GGDL + + +  ++L E   + ++ ++VLA+  + +  
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 99  VCHFDLKPQNILI-KNNTLKLA 119
             H D+KP N+L+ KN  ++LA
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLA 144

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 29/112 (25%), Positives = 50/112 (44%), Gaps = 6/112 (5%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T+VA+K +    +S   F   + E + +K L H  +V +   +  E  +YI+ EY   G 
Sbjct: 31  TKVAVKTLKPGTMSPESF---LEEAQIMKKLRHDKLVQLYAVV-SEEPIYIVTEYMSKGS 86

Query: 65  LCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++  E   L          Q+   + ++   N  H DL+  NIL+ + 
Sbjct: 87  LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDG 138

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 40/153 (26%), Positives = 71/153 (46%), Gaps = 21/153 (13%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--------YVYIIL 57
           +VAIK + +    +NR      E+  +K L+H +I+ + D+ + E         ++ +++
Sbjct: 93  KVAIKKVLQDPQYKNR------ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVM 146

Query: 58  EYCDG---GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           E+        +  + R++  L  F  + +  QL  AL ++    +CH DLKPQN+LI  N
Sbjct: 147 EFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPN 206

Query: 115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF 147
           T  L     G ++         Q +   ICS F
Sbjct: 207 THTLKLCDFGSAKNLLAG----QRSVSYICSRF 235

Length = 440

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 46.9 bits (111), Expect = 1e-05
 Identities = 22/75 (29%), Positives = 46/75 (61%)

Query: 40  IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNV 99
           +VT+      +  +++IL+Y +GG+L + +   E+  E + Q +  ++VLAL+ L +  +
Sbjct: 67  LVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126

Query: 100 CHFDLKPQNILIKNN 114
            + D+K +NIL+ +N
Sbjct: 127 IYRDIKLENILLDSN 141

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 2/109 (1%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + K+  +E +    ++E   +    H +I+ +   +   R V II E+ + G L 
Sbjct: 35  VAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALD 93

Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           SF+R ++ + +  Q    +R +   +K+L E N  H DL  +NIL+ +N
Sbjct: 94  SFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 34/121 (28%), Positives = 55/121 (45%), Gaps = 22/121 (18%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVT------------MLDFLWDERYVYI 55
           AIK +D T   E      +N +K  K  HH++I T            M D LW      +
Sbjct: 35  AIKVMDVTGDEEEEIKQEINMLK--KYSHHRNIATYYGAFIKKNPPGMDDQLW------L 86

Query: 56  ILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           ++E+C  G +   I++ +   L E       R+++  L  L ++ V H D+K QN+L+  
Sbjct: 87  VMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTE 146

Query: 114 N 114
           N
Sbjct: 147 N 147

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 28/125 (22%), Positives = 56/125 (44%), Gaps = 3/125 (2%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VA+K I+    S+     +  EI   + L H +I+  +     +  +Y++      G 
Sbjct: 26  TLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85

Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGL 121
               +++H  E L E      ++ ++ AL ++      H  +K  +IL+  +  + L+GL
Sbjct: 86  CEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGL 145

Query: 122 KQGVS 126
           +  VS
Sbjct: 146 RYSVS 150

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 8/129 (6%)

Query: 6   EVAIK-CIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
            VA+K C  K   S +  +  + E   ++   H HIV ++  + +   V+I++E    G+
Sbjct: 36  AVAVKTC--KNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENP-VWIVMELAPLGE 92

Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--G 120
           L S+++ +   L       +  QL  AL +L      H D+  +N+L+   + +KL   G
Sbjct: 93  LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFG 152

Query: 121 LKQGVSEKA 129
           L + + +++
Sbjct: 153 LSRYLEDES 161

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 4/107 (3%)

Query: 8   AIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTML--DFLWDERYVYIILEYCDGGD 64
           AIK + K  +  ++  D  + E + L L      +T L   F   +R ++ ++EY +GGD
Sbjct: 24  AIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDR-LFFVMEYVNGGD 82

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L   I+   K  E + + +  ++ LAL FL  + V + DLK  NIL+
Sbjct: 83  LMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL 129

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 9/109 (8%)

Query: 25  IVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCSFIRSHEKL----SEF 78
           I+ E++  K     +IV       DE    + I +EYC+GG L S  +  +K      E 
Sbjct: 46  ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK 105

Query: 79  QCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQGVS 126
              +    ++  L +L    + H D+KP NIL+ +   +KL     GVS
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDF--GVS 152

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 27/113 (23%), Positives = 52/113 (46%), Gaps = 4/113 (3%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
            +VAIK I +  +SE  F   + E + +  L H  +V +     +   + ++ E+ + G 
Sbjct: 29  RKVAIKTIREGAMSEEDF---IEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGC 85

Query: 65  LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           L  ++R+   K S+         +   + +L  +NV H DL  +N L+  N +
Sbjct: 86  LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQV 138

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 29/109 (26%), Positives = 56/109 (51%), Gaps = 4/109 (3%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
             +VAIK I++  +SE  F   + E K +  L H  +V +      ++ +YI+ E+ + G
Sbjct: 28  QIKVAIKAINEGAMSEEDF---IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENG 84

Query: 64  DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            L +++R  + KLS+       + +   +++L  N+  H DL  +N L+
Sbjct: 85  CLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 45.7 bits (108), Expect = 2e-05
 Identities = 31/111 (27%), Positives = 55/111 (49%), Gaps = 6/111 (5%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + K   +E +    ++E   +    H +I+ +   +   + V I+ EY + G L 
Sbjct: 35  VAIKTL-KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLD 93

Query: 67  SFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           +F+R H+   +F   Q V   R +   +K+L +    H DL  +NIL+ +N
Sbjct: 94  AFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSN 142

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 32/120 (26%), Positives = 54/120 (45%), Gaps = 3/120 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           N     VAIK ID  + +E+  + I  EI  L      ++            ++II+EY 
Sbjct: 26  NRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG     +R+     EFQ    +++++  L +L      H D+K  N+L+ +   +KLA
Sbjct: 85  GGGSALDLLRAG-PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLA 143

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 37/147 (25%), Positives = 72/147 (48%), Gaps = 27/147 (18%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYC 60
           +Q   VA+K + K   ++     +++E++ +KL+  H++I+ +L     E  +Y+I+EY 
Sbjct: 42  DQTVTVAVKML-KDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100

Query: 61  DGGDLCSFIR---------------SHEKLSEFQ----CQQFVRQLVLALKFLRENNVCH 101
             G+L  F+R                 E+   F+    C     Q+   +++L      H
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC---AYQVARGMEYLESRRCIH 157

Query: 102 FDLKPQNILI-KNNTLKLA--GLKQGV 125
            DL  +N+L+ ++N +K+A  GL +GV
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGV 184

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 8/119 (6%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VA+K +    +    F   + E + +K L H  ++ +      E  +YI+ E    G 
Sbjct: 31  TPVAVKTLKPGTMDPKDF---LAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS 87

Query: 65  LCSFIRSHEKLSEFQCQQFVR---QLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           L  +++        +  Q +    Q+   + +L   N  H DL  +N+L+ +NN  K+A
Sbjct: 88  LLEYLQ-GGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVA 145

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 45.5 bits (108), Expect = 3e-05
 Identities = 35/116 (30%), Positives = 52/116 (44%), Gaps = 10/116 (8%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T V +K + KTK  EN       E+   + L H+++V +L    +    Y+ILEY D GD
Sbjct: 36  TLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGD 94

Query: 65  LCSFIRSHEK---------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L  F+R+ +          LS  Q      Q+ L +  L      H DL  +N L+
Sbjct: 95  LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV 150

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 31/112 (27%), Positives = 55/112 (49%), Gaps = 4/112 (3%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K + K +  +        EI  LK L+H++IV       +   + + +I+EY   G 
Sbjct: 36  VAVKTL-KRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           L  ++  H KL+  Q   F +Q+   + +L   +  H DL  +N+L+ N+ L
Sbjct: 95  LRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRL 145

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 58/237 (24%), Positives = 96/237 (40%), Gaps = 35/237 (14%)

Query: 8   AIKCIDKTKVSENRFDSI-VNEIKALKLLHHQH---IVTMLDFLWDERYVYIILEYCDGG 63
           A+KC+DK ++   + +++ +NE   L L+       IV M         +  IL+  +GG
Sbjct: 23  AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 82

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---TLKLAG 120
           DL   +  H   SE + + +  +++L L+ +    V + DLKP NIL+  +    +   G
Sbjct: 83  DLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 121 LKQGVSEK-----------------AKGSAYIEQGN-TKVICSVFE------PREIPSSK 156
           L    S+K                  KG AY    +   + C +F+      P     +K
Sbjct: 143 LACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 202

Query: 157 TSLEYQRSKGELYVEF--KFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEF 211
              E  R    + VE    F+P    +  G L+    + LG   + A E  V  H F
Sbjct: 203 DKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQE--VKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 32/119 (26%), Positives = 64/119 (53%), Gaps = 10/119 (8%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   ++        E+  LK ++H++I+++L+    ++       VY+++E  
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           D  +LC  I  H +L   +    + Q++  +K L    + H DLKP NI++K++ TLK+
Sbjct: 109 DA-NLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 37/128 (28%), Positives = 60/128 (46%), Gaps = 18/128 (14%)

Query: 7   VAIKCI--DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           VA+K +  D TK + N F   + EIK +  L + +I+ +L     +  + +I EY + GD
Sbjct: 47  VAVKMLRADVTKTARNDF---LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103

Query: 65  LCSFIRSHEKLSEFQCQQFV------------RQLVLALKFLRENNVCHFDLKPQNILIK 112
           L  F+   E  S F     +             Q+   +K+L   N  H DL  +N L+ 
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163

Query: 113 NN-TLKLA 119
           N+ T+K+A
Sbjct: 164 NHYTIKIA 171

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 22/76 (28%), Positives = 41/76 (53%)

Query: 36  HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR 95
           +H  +V +      E  ++ ++EY +GGDL   ++   KL E   + +  ++ LAL +L 
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 113

Query: 96  ENNVCHFDLKPQNILI 111
           E  + + DLK  N+L+
Sbjct: 114 ERGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 37/142 (26%), Positives = 68/142 (47%), Gaps = 5/142 (3%)

Query: 2   EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           + H   A+K + K  V + N+   +  E   L    ++ +V +     D+  +Y +++Y 
Sbjct: 24  DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYI 83

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 119
            GGD+ S +   E   E   + ++ +L LA++ + +    H D+KP NILI  +  +KL 
Sbjct: 84  PGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLT 143

Query: 120 --GLKQGVSEKAKGSAYIEQGN 139
             GL  G       S Y ++G+
Sbjct: 144 DFGLCTGF-RWTHNSKYYQKGS 164

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 45.1 bits (107), Expect = 5e-05
 Identities = 27/96 (28%), Positives = 49/96 (51%), Gaps = 5/96 (5%)

Query: 24  SIVNEI-KALKLLHH---QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ 79
           +I N+I + LK+LH     +IV      + +  + I +E+ DGG L   ++   ++ E  
Sbjct: 41  AIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENI 100

Query: 80  CQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNN 114
             +    ++  L +LRE   + H D+KP NIL+ + 
Sbjct: 101 LGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR 136

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 19/62 (30%), Positives = 36/62 (58%)

Query: 50  ERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
              +++++EY +GGDL   ++   KL E   + +  ++ +AL FL E  + + DLK  N+
Sbjct: 68  TSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNV 127

Query: 110 LI 111
           L+
Sbjct: 128 LL 129

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 30/114 (26%), Positives = 52/114 (45%), Gaps = 10/114 (8%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T+VAIK +    +    F   + E + +K L H  +V +   +  E  +YI+ E+   G 
Sbjct: 31  TKVAIKTLKPGTMMPEAF---LQEAQIMKKLRHDKLVPLYAVV-SEEPIYIVTEFMGKGS 86

Query: 65  LCSFIRS----HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++     + KL   Q      Q+   + ++   N  H DL+  NIL+ +N
Sbjct: 87  LLDFLKEGDGKYLKLP--QLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDN 138

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 44.9 bits (106), Expect = 5e-05
 Identities = 37/127 (29%), Positives = 57/127 (44%), Gaps = 17/127 (13%)

Query: 7   VAIKCI--DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           VA+K +  D  K + N F   + EIK +  L   +I+ +L        + +I EY + GD
Sbjct: 49  VAVKMLREDANKNARNDF---LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGD 105

Query: 65  LCSFIRSHE-----------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-K 112
           L  F+  HE            +S         Q+   +K+L   N  H DL  +N L+ K
Sbjct: 106 LNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGK 165

Query: 113 NNTLKLA 119
           N T+K+A
Sbjct: 166 NYTIKIA 172

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 29/108 (26%), Positives = 48/108 (44%), Gaps = 2/108 (1%)

Query: 6   EVAIKCI-DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF-LWDERYVYIILEYCDGG 63
           EVAIK +       E++      E      L+H +IV +LD        ++ + EY  G 
Sbjct: 5   EVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGR 64

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            L   + +   L   +  + + Q++ AL       + H DLKPQNI++
Sbjct: 65  TLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMV 112

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 44.2 bits (104), Expect = 6e-05
 Identities = 31/108 (28%), Positives = 57/108 (52%), Gaps = 7/108 (6%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VA+K I K  V+   F   + E   +  LHH+++V +L  +     +YI++E    G+L
Sbjct: 31  KVAVKNI-KCDVTAQAF---LEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELMSKGNL 85

Query: 66  CSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +F+R+  +  +S  Q  QF   +   +++L    + H DL  +NIL+
Sbjct: 86  VNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV 133

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 27/113 (23%), Positives = 56/113 (49%), Gaps = 4/113 (3%)

Query: 2   EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILE 58
           E     A+K + K  +  ++  +  + E + L L  +   +T L   F   +R ++ ++E
Sbjct: 18  ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDR-LFFVME 76

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           + +GGDL   I+   +  E + + +  ++  AL FL +  + + DLK  N+L+
Sbjct: 77  FVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 31/133 (23%), Positives = 68/133 (51%), Gaps = 19/133 (14%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 51  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 109

Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++R+                 E+LS         Q+   +++L      H DL  +
Sbjct: 110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169

Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 170 NVLVTEDNVMKIA 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 44.0 bits (104), Expect = 8e-05
 Identities = 30/124 (24%), Positives = 53/124 (42%), Gaps = 15/124 (12%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +T  ++ R D    E + L    H++IV       +     ++ EY + GDL 
Sbjct: 38  VAVKTLKETASNDARKD-FEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLN 96

Query: 67  SFIRSH--------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
            F+RSH               +L+  Q  Q   Q+   + +L   +  H DL  +N L+ 
Sbjct: 97  KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG 156

Query: 113 NNTL 116
            + +
Sbjct: 157 YDLV 160

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|131021 TIGR01966, RNasePH, ribonuclease PH

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 17/146 (11%)

Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYV- 170
           K + L+   + +   + A+GS  IE GNTKV+C+     ++P       + R  GE ++ 
Sbjct: 6   KPDQLRPVSITRDFLKHAEGSVLIEFGNTKVLCTASVEEKVPP------FLRGSGEGWIT 59

Query: 171 -EFKFAPFASQIRTGWLRDSEE-------KELGNHLKRALEPAVCRHEFSNFQVDLFVLV 222
            E+   P A+Q R    R+S +       +E+   + RAL   V         + +   V
Sbjct: 60  AEYGMLPRATQTRN--RRESAKGKQSGRTQEIQRLIGRALRAVVDLEALGERTIWIDCDV 117

Query: 223 LQNDGSALSAAINCANLALVDAAIPM 248
           +Q DG   +A+I  A +AL DA   +
Sbjct: 118 IQADGGTRTASITGAFVALADAISKL 143

This bacterial enzyme, ribonuclease PH, performs the final 3'-trimming and modification of tRNA precursors. This model is restricted absolutely to bacteria. Related families outside the model include proteins described as probable exosome complex exonucleases (rRNA processing) and polyribonucleotide nucleotidyltransferases (mRNA degradation). The most divergent member within the family is RNase PH from Deinococcus radiodurans [Transcription, RNA processing]. Length = 236

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 44.4 bits (105), Expect = 8e-05
 Identities = 29/104 (27%), Positives = 50/104 (48%), Gaps = 7/104 (6%)

Query: 24  SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQF 83
            I  EI+ L+ ++H ++V   D       + ++LE+ DGG L           E      
Sbjct: 118 QICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSL----EGTHIADEQFLADV 173

Query: 84  VRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVS 126
            RQ++  + +L   ++ H D+KP N+LI +   +K+A    GVS
Sbjct: 174 ARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADF--GVS 215

Length = 353

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 33/140 (23%), Positives = 69/140 (49%), Gaps = 21/140 (15%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 50  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 108

Query: 66  CSFIR----------------SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R                  E+++         Q+   +++L      H DL  +N+
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNV 168

Query: 110 LI-KNNTLKLA--GLKQGVS 126
           L+ +NN +K+A  GL + V+
Sbjct: 169 LVTENNVMKIADFGLARDVN 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 3/107 (2%)

Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VAIK +  + K S  ++  I+ E++ L+ L H + +        E   ++++EYC  G  
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 101

Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              +  H+K L E +        +  L +L  +N+ H D+K  NIL+
Sbjct: 102 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL 148

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 31/108 (28%), Positives = 55/108 (50%), Gaps = 4/108 (3%)

Query: 8   AIKCIDKTKVSENRFDSI-VNEIKALKLLHH---QHIVTMLDFLWDERYVYIILEYCDGG 63
           A+KC+DK ++   + +++ +NE   L L+       IV M         +  IL+  +GG
Sbjct: 23  AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGG 82

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   +  H   SE + + +  +++L L+ +    V + DLKP NIL+
Sbjct: 83  DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 16/158 (10%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +     S+N       E + L  L H+HIV       +   + ++ EY   GDL 
Sbjct: 38  VAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 95

Query: 67  SFIRSH-------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            F+R+H              +L++ Q     +Q+   + +L   +  H DL  +N L+  
Sbjct: 96  KFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 155

Query: 114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE 151
           N L   G   G+S     + Y   G   ++   + P E
Sbjct: 156 NLLVKIG-DFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 192

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 32/116 (27%), Positives = 55/116 (47%), Gaps = 4/116 (3%)

Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VAIK +  + K S  ++  I+ E++ L+ L H + +        E   ++++EYC  G  
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSA 101

Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
              +  H+K L E +        +  L +L  +   H D+K  NIL+    T+KLA
Sbjct: 102 SDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLA 157

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 34/122 (27%), Positives = 56/122 (45%), Gaps = 24/122 (19%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTML------------DFLWDERYVY 54
           AIK +D   V+E+  + I  EI  LK   HH++I T              D LW      
Sbjct: 45  AIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLW------ 95

Query: 55  IILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
           +++E+C  G +   +++ +   L E       R+++  L  L  + V H D+K QN+L+ 
Sbjct: 96  LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155

Query: 113 NN 114
            N
Sbjct: 156 EN 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 32/126 (25%), Positives = 52/126 (41%), Gaps = 17/126 (13%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            +    VA+K +   + SE+       E + L +L HQHIV       + R + ++ EY 
Sbjct: 32  EQDKMLVAVKAL--KEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM 89

Query: 61  DGGDLCSFIRSH---------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 105
             GDL  F+RSH                +L+  Q      Q+   + +L   +  H DL 
Sbjct: 90  RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLA 149

Query: 106 PQNILI 111
            +N L+
Sbjct: 150 TRNCLV 155

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 25/109 (22%), Positives = 58/109 (53%), Gaps = 3/109 (2%)

Query: 8   AIKCIDKTKVSENRFDSI-VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A K +DK ++ + + + + +NE K L+ +  + IV++      +  + +++   +GGDL 
Sbjct: 22  ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81

Query: 67  SFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
             I +  +    E +   +  Q++  L+ L +  + + DLKP+N+L+ +
Sbjct: 82  YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDD 130

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|225034 COG2123, COG2123, RNase PH-related exoribonuclease [Translation, ribosomal structure and biogenesis]

 Score = 42.7 bits (101), Expect = 2e-04
 Identities = 55/246 (22%), Positives = 86/246 (34%), Gaps = 48/246 (19%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRS--KGELYVEFKFAPFASQI 181
           GV  KA GSA ++ GNT+V+  V        ++    +  +  +G L V  + +P AS  
Sbjct: 41  GVIPKANGSALVKLGNTQVVVGV-------KAEIGEPFPDTPNEGVLVVNVELSPLASPS 93

Query: 182 RTGWLRDSEEKELGNHLKRA--------LEPAVCRHEFSNFQVDLFVLVLQNDGSALSAA 233
                 D    EL   + R         LE          + V + V VL  DG+ + AA
Sbjct: 94  FEPGPPDELAIELSRVVDRGLRESKAIDLEKLCIEEGKKVWVVFVDVHVLDYDGNLIDAA 153

Query: 234 INCANLALVDAAIPMY----------------------DLVTSSTLALRGGLTFIDPVEE 271
              A  AL++  +P                        +   S T A  G +  +DP  E
Sbjct: 154 SLAAVAALLNTRVPKAVEVGDGEIVIEVEEEPVPLPVSNPPISVTFAKIGNVLVVDPSLE 213

Query: 272 EVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCT 331
           E            D    IT++    I  + Q    G+I +  L   ++  +   E L  
Sbjct: 214 EELVA--------DGRLTITVNEDGEIVAI-QKVGGGSITESDLEKALKTALSKAEKLRE 264

Query: 332 DRVQKL 337
              + L
Sbjct: 265 ALKEAL 270

Length = 272

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 29/107 (27%), Positives = 53/107 (49%), Gaps = 4/107 (3%)

Query: 32  LKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLAL 91
           LK L H  +V +         +Y +L+Y +GG+L   ++      E + + +  ++  A+
Sbjct: 50  LKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAI 109

Query: 92  KFLRENNVCHFDLKPQNILIKNN---TLKLAGL-KQGVSEKAKGSAY 134
            +L   N+ + DLKP+NIL+ +     L   GL K+GV  +   S +
Sbjct: 110 GYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTF 156

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 42.8 bits (100), Expect = 2e-04
 Identities = 32/120 (26%), Positives = 54/120 (45%), Gaps = 3/120 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           N     VAIK ID  + +E+  + I  EI  L      ++         +  ++II+EY 
Sbjct: 26  NRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG     +     L E Q    +R+++  L +L      H D+K  N+L+ ++  +KLA
Sbjct: 85  GGGSALDLLEPG-PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 143

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 19/59 (32%), Positives = 34/59 (57%)

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           ++ ++E+  GGDL   ++   KL E   + +  ++ LAL FL E  + + DLK  N+L+
Sbjct: 71  LFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL 129

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 25/82 (30%), Positives = 48/82 (58%), Gaps = 2/82 (2%)

Query: 40  IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENN 98
           I T+     DE  +Y++++Y  GGDL + +   E +L E   + ++ ++V+A+  + + +
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 99  VCHFDLKPQNILIK-NNTLKLA 119
             H D+KP NIL+  N  ++LA
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLA 144

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.5 bits (100), Expect = 3e-04
 Identities = 18/62 (29%), Positives = 40/62 (64%)

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
           +++IL+Y +GG+L + +   E  +E + + ++ ++VLAL  L +  + + D+K +NIL+ 
Sbjct: 80  LHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD 139

Query: 113 NN 114
           + 
Sbjct: 140 SE 141

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 34/107 (31%), Positives = 52/107 (48%), Gaps = 12/107 (11%)

Query: 24  SIVNEIKALKLLH---HQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFIRSHEK- 74
           S V E+  LK L    H +IV ++D     R      V ++ E+ D  DL +++      
Sbjct: 45  STVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPP 103

Query: 75  -LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            L     +  +RQ +  L FL  N + H DLKP+NIL+ +   +KLA
Sbjct: 104 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLA 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 18/59 (30%), Positives = 32/59 (54%)

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           +Y ++EY +GGDL   I+   K  E Q   +  ++ + L FL    + + DLK  N+++
Sbjct: 76  LYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 35/131 (26%), Positives = 58/131 (44%), Gaps = 20/131 (15%)

Query: 14  KTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIR-- 70
           K   S++       E++ L KL HH +I+ +L       Y+Y+ +EY   G+L  F+R  
Sbjct: 43  KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 102

Query: 71  -----------SHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
                      ++   S    QQ   F   +   + +L +    H DL  +NIL+  N +
Sbjct: 103 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162

Query: 117 -KLA--GLKQG 124
            K+A  GL +G
Sbjct: 163 AKIADFGLSRG 173

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.0 bits (98), Expect = 4e-04
 Identities = 30/108 (27%), Positives = 58/108 (53%), Gaps = 9/108 (8%)

Query: 28  EIKALKLLHHQHIVTMLDF------LWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ 81
           E++ LK + H++++ +LD       + +   VY++     G DL + ++  +KLS+   Q
Sbjct: 64  ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-QKLSDEHVQ 121

Query: 82  QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKA 129
             + QL+  LK++    + H DLKP N+ + N   +L  L  G++ +A
Sbjct: 122 FLIYQLLRGLKYIHSAGIIHRDLKPSNVAV-NEDCELRILDFGLARQA 168

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 41.8 bits (98), Expect = 4e-04
 Identities = 31/124 (25%), Positives = 55/124 (44%), Gaps = 3/124 (2%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAI  + +   S+ +    + E   L    H +IV +   +     + I+ EY   G L 
Sbjct: 36  VAIHTL-RAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALD 94

Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQG 124
           SF+R HE +L   Q    +  L   +K+L E    H  L    +L+ ++   K++G ++ 
Sbjct: 95  SFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL 154

Query: 125 VSEK 128
             +K
Sbjct: 155 QEDK 158

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 41.9 bits (98), Expect = 4e-04
 Identities = 34/141 (24%), Positives = 71/141 (50%), Gaps = 21/141 (14%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
             VA+K + K   ++     +V+E++ +K++  H++I+ +L     +  +Y+++EY   G
Sbjct: 45  VTVAVKML-KDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKG 103

Query: 64  DLCSFIRSHE-----------KLSEFQ--CQQFVR---QLVLALKFLRENNVCHFDLKPQ 107
           +L  ++R+             KL E Q   +  V    Q+   +++L      H DL  +
Sbjct: 104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163

Query: 108 NILI-KNNTLKLA--GLKQGV 125
           N+L+ ++N +K+A  GL + V
Sbjct: 164 NVLVTEDNVMKIADFGLARDV 184

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 14/140 (10%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 33  DEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 91

Query: 61  DGGDLCSFIRSHEKLSEF----------QCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS     E           +  Q   ++   + +L  N   H DL  +N +
Sbjct: 92  TRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 151

Query: 111 IKNN-TLKLA--GLKQGVSE 127
           +  + T+K+   G+ + + E
Sbjct: 152 VAEDFTVKIGDFGMTRDIYE 171

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 41.7 bits (98), Expect = 5e-04
 Identities = 26/85 (30%), Positives = 44/85 (51%)

Query: 27  NEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQ 86
            E   L  ++H  IV +      E  +Y+IL++  GGDL + +      +E   + ++ +
Sbjct: 47  MERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAE 106

Query: 87  LVLALKFLRENNVCHFDLKPQNILI 111
           L LAL  L    + + DLKP+NIL+
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILL 131

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 41.6 bits (97), Expect = 5e-04
 Identities = 36/126 (28%), Positives = 56/126 (44%), Gaps = 17/126 (13%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           EQ   VAIK + K K      +   +E      L H +IV +L  +  E+ + +I  YC 
Sbjct: 33  EQTQAVAIKTL-KDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCS 91

Query: 62  GGDLCSFI--RS-HEKL----------SEFQCQQF---VRQLVLALKFLRENNVCHFDLK 105
             DL  F+  RS H  +          S  +   F   V Q+   ++FL  ++V H DL 
Sbjct: 92  HSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLA 151

Query: 106 PQNILI 111
            +N+L+
Sbjct: 152 TRNVLV 157

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 27/105 (25%), Positives = 56/105 (53%), Gaps = 14/105 (13%)

Query: 22  FDSIVN------EIKALKLLHHQHIVTMLDFLWDERY------VYIILEYCDGGDLCSFI 69
           F SI++      E++ LK + H++++ +LD     R       VY++  +  G DL + +
Sbjct: 54  FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THLMGADLNNIV 112

Query: 70  RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           +  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 113 KC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 156

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 41.6 bits (97), Expect = 6e-04
 Identities = 29/107 (27%), Positives = 52/107 (48%), Gaps = 3/107 (2%)

Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VAIK +  + K S  ++  I+ E+K L+ + H + +        E   ++++EYC  G  
Sbjct: 53  VAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSA 111

Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              +  H+K L E +        +  L +L  +N+ H D+K  NIL+
Sbjct: 112 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 158

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 41.7 bits (98), Expect = 6e-04
 Identities = 18/63 (28%), Positives = 34/63 (53%)

Query: 49  DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           D+  +Y +++Y  GGD+ S +       E   + ++ +L  A++ + +    H D+KP N
Sbjct: 72  DKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDN 131

Query: 109 ILI 111
           ILI
Sbjct: 132 ILI 134

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 41.5 bits (97), Expect = 6e-04
 Identities = 29/125 (23%), Positives = 64/125 (51%), Gaps = 7/125 (5%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGD 64
           VA+K + K +   N    +  EI+ L+ L+H++IV       ++    + +I+E+   G 
Sbjct: 36  VAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGS 94

Query: 65  LCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  ++ R+  K++  Q  ++  Q+   + +L      H DL  +N+L+++ + +K+   G
Sbjct: 95  LKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 154

Query: 121 LKQGV 125
           L + +
Sbjct: 155 LTKAI 159

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 41.3 bits (97), Expect = 6e-04
 Identities = 30/106 (28%), Positives = 53/106 (50%), Gaps = 2/106 (1%)

Query: 8   AIKCIDKTKVSENRFDSIVN--EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           A+K + K  +  N+ D+     E   L+ + H  IV ++        +Y+ILEY  GG+L
Sbjct: 28  AMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 87

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              +       E     ++ ++ LAL+ L +  + + DLKP+NIL+
Sbjct: 88  FMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL 133

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 27/113 (23%), Positives = 59/113 (52%), Gaps = 3/113 (2%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           ++  +VAIK + K +  ++  D ++ E + +  L + +IV M+     E  + +++E   
Sbjct: 20  KKQIDVAIKVL-KNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMAS 77

Query: 62  GGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           GG L  F+    ++++     + + Q+ + +K+L   N  H DL  +N+L+ N
Sbjct: 78  GGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVN 130

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|206770 cd11365, RNase_PH_archRRP42, RRP42 subunit of archaeal exosome

 Score = 40.7 bits (96), Expect = 9e-04
 Identities = 53/197 (26%), Positives = 80/197 (40%), Gaps = 38/197 (19%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKFAPFAS 179
           ++ GV  KA+GSA ++ GNT+V+  V  E    P   T      ++G L V  +  P AS
Sbjct: 31  IETGVIPKAEGSALVKLGNTQVLAGVKLEV-GEPFPDTP-----NEGVLIVNAELLPLAS 84

Query: 180 -QIRTGWLRDSEEKELGNHLKRA--------LEPAVCRHEFSNFQVDLFVLVLQNDGSAL 230
                G   D    EL   + R         LE  V       + V + + VL  DG+  
Sbjct: 85  PTFEPG-PPDENAIELARVVDRGIRESKAIDLEKLVIEPGKKVWVVFIDIYVLDYDGNLF 143

Query: 231 SAAINCANLALVDAAIPMY--------------------DLVTSSTLALRGGLTFIDP-V 269
            A+   A  AL++  +P Y                     L  S T+A  GG   +DP +
Sbjct: 144 DASALAAVAALLNTKVPEYEVDENEVIEVLGEELPLPVNTLPVSVTVAKIGGYIVVDPTL 203

Query: 270 EEEVAYCQSLSSSEDDD 286
           EEE+     ++ + D+D
Sbjct: 204 EEELVMDARITITIDED 220

The RRP42 subunit of the archaeal exosome is a member of the RNase_PH family, named after the bacterial Ribonuclease PH, a 3'-5' exoribonuclease. Structurally all members of this family form hexameric rings (trimers of dimers). In archaea, the ring is formed by three Rrp41:Rrp42 dimers. The central chamber within the ring contains three phosphorolytic active sites located in an Rrp41 pocket at the interface between Rrp42 and Rrp41. The ring is capped by three copies of Rrp4 and/or Csl4 which contain putative RNA interaction domains. The archaeal exosome degrades single-stranded RNA (ssRNA) in the 3'-5' direction, but also can catalyze the reverse reaction of adding nucleoside diphosphates to the 3'-end of RNA which has been shown to lead to the formation of poly-A-rich tails on RNA. It is required for 3' processing of the 5.8S rRNA. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 21/113 (18%), Positives = 52/113 (46%), Gaps = 2/113 (1%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           + +  EVA+K + +  ++  +    + E   +  L H  IV ++     E  + +++E  
Sbjct: 20  SGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRLIGVCKGEPLM-LVMELA 77

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
             G L  +++   ++     ++   Q+ + + +L   +  H DL  +N+L+ N
Sbjct: 78  PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVN 130

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 27/116 (23%), Positives = 49/116 (42%), Gaps = 8/116 (6%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + K    +      + E   +   +H +IV +L         YII+E  +GGDL 
Sbjct: 29  VAVKTLRKGATDQ-EKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLL 87

Query: 67  SFIRSHEKLSEFQCQQFVRQLV-LALK------FLRENNVCHFDLKPQNILIKNNT 115
           S++R             +++L+ + L       +L + +  H DL  +N L+    
Sbjct: 88  SYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKG 143

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 23/92 (25%), Positives = 48/92 (52%), Gaps = 1/92 (1%)

Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + I+ E++ L   +  +IV      + +  + I +E+ DGG L   ++  +++ E    +
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 107

Query: 83  FVRQLVLALKFLRE-NNVCHFDLKPQNILIKN 113
               ++  L +LRE + + H D+KP NIL+ +
Sbjct: 108 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNS 139

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 40.4 bits (95), Expect = 0.001
 Identities = 30/148 (20%), Positives = 64/148 (43%), Gaps = 11/148 (7%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
             +   VA+KC+   K+S+   D  + E   +  L H++++ +   +     + ++ E  
Sbjct: 20  GGKVIPVAVKCLKSDKLSDI-MDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELA 77

Query: 61  DGGDLCSFIRSHEKLSEFQCQ---QFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTL 116
             G L   +R    L  F       +  Q+   +++L      H DL  +NIL+  ++ +
Sbjct: 78  PLGSLLDRLRKD-ALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKV 136

Query: 117 KLA--GLKQGVSEKAKGSAYIEQGNTKV 142
           K+   GL + + +      Y+ + + KV
Sbjct: 137 KIGDFGLMRALPQ--NEDHYVMEEHLKV 162

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 38/135 (28%), Positives = 59/135 (43%), Gaps = 25/135 (18%)

Query: 7   VAIKCI--DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           VA+K +  D  K + N F   + E+K L  L   +I+ +L    DE  + +I EY + GD
Sbjct: 49  VAVKILRPDANKNARNDF---LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGD 105

Query: 65  LCSFIRSHE-------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 105
           L  F+ SH                     +S         Q+   +K+L   N  H DL 
Sbjct: 106 LNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLA 165

Query: 106 PQNILI-KNNTLKLA 119
            +N L+ +N T+K+A
Sbjct: 166 TRNCLVGENLTIKIA 180

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 23/92 (25%), Positives = 47/92 (51%), Gaps = 1/92 (1%)

Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + I+ E++ L   +  +IV      + +  + I +E+ DGG L   ++   ++ E    +
Sbjct: 48  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 107

Query: 83  FVRQLVLALKFLRE-NNVCHFDLKPQNILIKN 113
               ++  L +LRE + + H D+KP NIL+ +
Sbjct: 108 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 139

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 20/68 (29%), Positives = 38/68 (55%), Gaps = 1/68 (1%)

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 111
           ++ ++EY +GGDL   I+S  K    +   +  +++  L+FL    + + DLK  NIL+ 
Sbjct: 71  LFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLD 130

Query: 112 KNNTLKLA 119
            +  +K+A
Sbjct: 131 TDGHIKIA 138

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 29/107 (27%), Positives = 55/107 (51%), Gaps = 4/107 (3%)

Query: 8   AIKCIDKTKVSENRFDS--IVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           A+K + K K+  NR +   I+ E   L K + H  +V +         +Y +L++ +GG+
Sbjct: 24  AVKVLQK-KIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGE 82

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L   ++      E + + +  ++  AL +L   N+ + DLKP+NIL+
Sbjct: 83  LFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL 129

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 40.1 bits (94), Expect = 0.001
 Identities = 26/108 (24%), Positives = 51/108 (47%), Gaps = 3/108 (2%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            VAIK + + + S      I++E   +  + H H+V +L      + V +I +    G L
Sbjct: 38  PVAIKVL-REETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCL 95

Query: 66  CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
             ++R+H + +       +  Q+   + +L E  + H DL  +N+L+K
Sbjct: 96  LDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVK 143

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 26/116 (22%), Positives = 54/116 (46%), Gaps = 11/116 (9%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYV-----YIILEY 59
           ++ A+K +D     +   ++  N +KAL    H ++V      + +        +++LE 
Sbjct: 44  SKAAVKILDPIHDIDEEIEAEYNILKALS--DHPNVVKFYGMYYKKDVKNGDQLWLVLEL 101

Query: 60  CDGGDLCS----FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           C+GG +      F++  E++ E      + + ++ L+ L  N   H D+K  NIL+
Sbjct: 102 CNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL 157

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 18/59 (30%), Positives = 35/59 (59%)

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           +Y +L+Y +GG+L   ++      E + + +  ++  AL +L   N+ + DLKP+NIL+
Sbjct: 71  LYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL 129

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 40.3 bits (94), Expect = 0.001
 Identities = 39/130 (30%), Positives = 63/130 (48%), Gaps = 10/130 (7%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFL-----WDERY-VYIILEY 59
           +VAIK + +   SE        E+  LK + H++++ +LD        DE    Y+++ Y
Sbjct: 42  KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPY 101

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
               DL   I  H  LSE + Q  V Q++  LK++    + H DLKP N+ + N   +L 
Sbjct: 102 MQT-DL-QKIMGHP-LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV-NEDCELK 157

Query: 120 GLKQGVSEKA 129
            L  G++  A
Sbjct: 158 ILDFGLARHA 167

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 33/119 (27%), Positives = 53/119 (44%), Gaps = 7/119 (5%)

Query: 27  NEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLSEFQCQQ 82
           +E+  L    H  IV   D    +  + +I+EY  GGDL   I+     H    E++   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGL 173

Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNI-LIKNNTLKLAGLKQGVSEKAKGSAYIEQGNT 140
              Q+VLAL  +    + H DLK  NI L+    +KL     G S++   S  ++  ++
Sbjct: 174 LFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDF--GFSKQYSDSVSLDVASS 230

Length = 478

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 40.1 bits (93), Expect = 0.002
 Identities = 32/117 (27%), Positives = 55/117 (47%), Gaps = 16/117 (13%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGG 63
           E A+K I+ T +S     S   EI  L+ L H +++ +        +R V+++ +Y +  
Sbjct: 30  EYALKQIEGTGISM----SACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH- 84

Query: 64  DLCSFIRSHE---------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   I+ H          +L     +  + Q++  + +L  N V H DLKP NIL+
Sbjct: 85  DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 5/121 (4%)

Query: 2   EQHTE--VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +  T+  VAIK ID  + +E+  + I  EI  L      +I            ++II+EY
Sbjct: 25  DNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEY 83

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             GG     ++    L E      +R+++  L +L      H D+K  N+L+ +   +KL
Sbjct: 84  LGGGSALDLLKPG-PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKL 142

Query: 119 A 119
           A
Sbjct: 143 A 143

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 3/107 (2%)

Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K +  + K +  ++  I+ E+K L+ L H + +        E   ++++EYC  G  
Sbjct: 49  VAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSA 107

Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              +  H+K L E +        +  L +L  +N+ H D+K  NIL+
Sbjct: 108 SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL 154

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 22/80 (27%), Positives = 42/80 (52%)

Query: 32  LKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLAL 91
           LK + H  +V +         +Y +L+Y +GG+L   ++      E + + +  ++  AL
Sbjct: 50  LKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASAL 109

Query: 92  KFLRENNVCHFDLKPQNILI 111
            +L   N+ + DLKP+NIL+
Sbjct: 110 GYLHSLNIVYRDLKPENILL 129

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 22/68 (32%), Positives = 39/68 (57%), Gaps = 2/68 (2%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
             VA+K +  +  ++ R +++++E+K L  L  H++IV +L        V +I EYC  G
Sbjct: 69  LRVAVKMLKASAHTDER-EALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYG 127

Query: 64  DLCSFIRS 71
           DL +F+R 
Sbjct: 128 DLLNFLRK 135

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 37/161 (22%), Positives = 61/161 (37%), Gaps = 19/161 (11%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +    ++  +      E + L  L H+HIV       D   + ++ EY   GDL 
Sbjct: 38  VAVKALKDPTLAARK--DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95

Query: 67  SFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
            F+R+H                 +L   Q      Q+   + +L   +  H DL  +N L
Sbjct: 96  KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155

Query: 111 IKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE 151
           +  N L   G   G+S     + Y   G   ++   + P E
Sbjct: 156 VGANLLVKIG-DFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 195

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 39.0 bits (91), Expect = 0.003
 Identities = 29/114 (25%), Positives = 54/114 (47%), Gaps = 7/114 (6%)

Query: 7   VAIKCIDKTKVSENR-FDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGG 63
           VA+K +  +     R F+    EI+ LK L H +IV      +    R + +++EY   G
Sbjct: 36  VAVKKLQHSTAEHLRDFE---REIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 64  DLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
            L  +++ H E+L   +   +  Q+   +++L      H DL  +NIL+++   
Sbjct: 93  SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENR 146

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 39.2 bits (91), Expect = 0.003
 Identities = 36/166 (21%), Positives = 74/166 (44%), Gaps = 31/166 (18%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           +T VA+K + K   S +    +++E   LK ++H H++ +      +  + +I+EY   G
Sbjct: 30  YTTVAVKML-KENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYG 88

Query: 64  DLCSFIRSHEK------------------------LSEFQCQQFVRQLVLALKFLRENNV 99
            L SF+R   K                        L+      F  Q+   +++L E  +
Sbjct: 89  SLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKL 148

Query: 100 CHFDLKPQNILI-KNNTLKLA--GLKQGVSEKAKGSAYIEQGNTKV 142
            H DL  +N+L+ +   +K++  GL + V E+    +Y+++   ++
Sbjct: 149 VHRDLAARNVLVAEGRKMKISDFGLSRDVYEE---DSYVKRSKGRI 191

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 16/117 (13%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGG 63
           + A+K I+ T +S     S   EI  L+ L H +++++        +R V+++ +Y +  
Sbjct: 30  DYALKQIEGTGISM----SACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 84

Query: 64  DLCSFIRSHE---------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   I+ H          +L     +  + Q++  + +L  N V H DLKP NIL+
Sbjct: 85  DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILV 141

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 30/112 (26%), Positives = 57/112 (50%), Gaps = 8/112 (7%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + ++   ++  D  + E   +   +HQ+IV ++   ++    +I+LE   GGDL 
Sbjct: 39  VAVKTLPESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLK 97

Query: 67  SFIRSH----EKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILI 111
           SF+R +    E+ S    +  +   R +    K+L EN+  H D+  +N L+
Sbjct: 98  SFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLL 149

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 30/132 (22%), Positives = 66/132 (50%), Gaps = 5/132 (3%)

Query: 8   AIKCIDK-TKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K + K   ++++     + E + L+   H  +  +         +  ++EY +GG+L 
Sbjct: 24  AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL-K 122
             +      SE + + +  ++V AL +L   +V + DLK +N+++ K+  +K+   GL K
Sbjct: 84  FHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Query: 123 QGVSEKAKGSAY 134
           +G+S+ A    +
Sbjct: 144 EGISDGATMKTF 155

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 39.4 bits (92), Expect = 0.004
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 7/96 (7%)

Query: 20  NRFDSI-VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF 78
           N  +SI  +EI  +  L H +IV ++     E+  Y+I EY +G +L   +R+   LS  
Sbjct: 724 NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWE 780

Query: 79  QCQQFVRQLVLALKFLREN---NVCHFDLKPQNILI 111
           + ++    +  AL+FL       V   +L P+ I+I
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816

Length = 968

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	477
KOG1068|consensus	245		100.0
KOG0615|consensus	475		100.0
KOG0595|consensus	429		100.0
TIGR02065	230	ECX1 archaeal exosome-like complex exonuclease 1.	100.0
KOG0575|consensus	592		100.0
KOG0581|consensus	364		100.0
COG0689	230	Rph RNase PH [Translation, ribosomal structure and	100.0
PRK03983	244	exosome complex exonuclease Rrp41; Provisional	100.0
KOG0598|consensus	357		100.0
KOG0616|consensus	355		99.97
KOG0592|consensus	604		99.97
KOG0600|consensus	560		99.97
KOG1069|consensus	217		99.97
KOG0591|consensus	375		99.97
KOG0583|consensus	370		99.97
KOG0198|consensus	313		99.97
KOG0659|consensus	318		99.97
KOG0611|consensus	668		99.96
KOG0661|consensus	538		99.96
KOG0597|consensus	808		99.96
KOG0192|consensus	362		99.96
KOG0593|consensus	396		99.96
KOG0588|consensus	786		99.96
KOG0578|consensus	550		99.96
KOG0582|consensus	516		99.96
KOG0605|consensus	550		99.96
KOG0610|consensus	459		99.96
KOG0594|consensus	323		99.96
KOG0660|consensus	359		99.96
PRK00173	238	rph ribonuclease PH; Reviewed	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
KOG0585|consensus	576		99.95
KOG0658|consensus	364		99.95
KOG0663|consensus	419		99.95
TIGR01966	236	RNasePH ribonuclease PH. This bacterial enzyme, ri	99.95
KOG0589|consensus	426		99.95
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.95
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.95
KOG0667|consensus	586		99.95
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.95
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.95
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.95
KOG0033|consensus	355		99.95
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.95
KOG0586|consensus	596		99.95
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.95
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.94
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
TIGR02696	719	pppGpp_PNP guanosine pentaphosphate synthetase I/p	99.94
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.94
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.94
KOG0694|consensus	694		99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
KOG0032|consensus	382		99.94
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.94
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.94
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.94
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.94
KOG0607|consensus	463		99.94
KOG0580|consensus	281		99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.94
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.94
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.94
KOG4717|consensus	864		99.94
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.94
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.94
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.94
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.94
KOG4236|consensus	888		99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
KOG0197|consensus	468		99.94
KOG0599|consensus	411		99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
KOG0194|consensus	474		99.94
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.94
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.94
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.93
KOG4250|consensus	732		99.93
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.93
PHA02988	283	hypothetical protein; Provisional	99.93
KOG0201|consensus	467		99.93
PTZ00267	478	NIMA-related protein kinase; Provisional	99.93
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.93
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.93
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.93
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.93
KOG0604|consensus	400		99.93
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.93
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.93
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.93
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.93
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.93
KOG4645|consensus	1509		99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.93
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.93
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.93
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.93
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.93
KOG4721|consensus	904		99.93
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.93
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.93
KOG1187|consensus	361		99.93
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.93
KOG4279|consensus	1226		99.93
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.93
KOG0596|consensus	677		99.92
TIGR03591	684	polynuc_phos polyribonucleotide nucleotidyltransfe	99.92
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.92
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.92
KOG0662|consensus	292		99.92
KOG1026|consensus	774		99.92
PTZ00283	496	serine/threonine protein kinase; Provisional	99.92
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.92
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.92
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.92
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.92
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.92
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.92
PRK11824	693	polynucleotide phosphorylase/polyadenylase; Provis	99.92
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.92
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.92
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.92
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.92
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.92
KOG0193|consensus	678		99.92
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.92
KOG0577|consensus	948		99.92
PHA03212	391	serine/threonine kinase US3; Provisional	99.92
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.92
KOG0574|consensus	502		99.92
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.92
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.91
PTZ00036	440	glycogen synthase kinase; Provisional	99.91
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.91
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.91
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.91
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.91
KOG0584|consensus	632		99.91
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.91
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.91
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.91
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.91
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.91
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.91
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.91
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.91
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.91
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.91
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.91
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.91
PHA03207	392	serine/threonine kinase US3; Provisional	99.91
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.91
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.91
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.91
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.91
KOG0690|consensus	516		99.91
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.91
KOG1989|consensus	738		99.91
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.91
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.91
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.91
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.91
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.91
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.91
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.91
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.91
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.91
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.91
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.91
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.91
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.91
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.91
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.91
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.91
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.91
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.9
KOG2345|consensus	302		99.9
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.9
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.9
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.9
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.9
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.9
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.9
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.9
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.9
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.9
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.9
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.9
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.9
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.9
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.9
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.9
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.9
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.9
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.9
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.9
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.9
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.9
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.9
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.9
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.9
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.9
KOG0984|consensus	282		99.9
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.9
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.9
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.9
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.9
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.9
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.9
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.9
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.9
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.9
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.9
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.9
KOG0986|consensus	591		99.9
PHA03211	461	serine/threonine kinase US3; Provisional	99.9
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.9
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.9
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.9
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.9
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.9
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.9
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.9
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.9
PLN00009	294	cyclin-dependent kinase A; Provisional	99.9
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.9
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.9
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.9
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.9
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.9
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.9
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.9
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.9
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.9
KOG1152|consensus	772		99.9
KOG0666|consensus	438		99.9
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.9
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.9
KOG1095|consensus	1025		99.9
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.9
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.9
KOG0579|consensus	1187		99.9
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.9
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.9
KOG0614|consensus	732		99.9
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.9
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.9
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.89
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.89
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.89
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.89
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.89
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.89
PLN00207	891	polyribonucleotide nucleotidyltransferase; Provisi	99.89
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.89
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.89
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.89
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.89
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.89
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.89
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.89
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.89
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.89
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.89
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.89
KOG0612|consensus	1317		99.89
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.89
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.89
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.89
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.89
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.89
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.89
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.89
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.89
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.89
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.89
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.89
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.89
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.89
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.89
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.89
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.89
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.89
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.89
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.89
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.89
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.89
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.89
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.89
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.89
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.89
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.89
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.89
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.89
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.89
KOG0983|consensus	391		99.89
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.89
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.89
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.89
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.89
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.89
KOG0608|consensus	1034		99.89
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.89
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.89
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.89
PHA03209	357	serine/threonine kinase US3; Provisional	99.89
KOG1035|consensus	1351		99.89
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.88
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.88
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.88
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.88
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.88
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.88
PRK04282	271	exosome complex RNA-binding protein Rrp42; Provisi	99.88
KOG1151|consensus	775		99.88
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.88
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.88
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.88
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.88
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.88
PTZ00284	467	protein kinase; Provisional	99.88
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.88
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.88
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.88
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.88
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.88
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.88
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.88
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.88
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.88
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.88
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.88
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.88
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.88
KOG1094|consensus	807		99.88
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.88
KOG0695|consensus	593		99.88
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.88
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.88
KOG1006|consensus	361		99.88
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.87
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.87
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.87
KOG4257|consensus	974		99.87
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.87
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.87
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.87
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.87
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.87
KOG0665|consensus	369		99.87
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.87
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.87
PHA03210	501	serine/threonine kinase US3; Provisional	99.87
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.87
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.87
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.87
KOG0196|consensus	996		99.87
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.87
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.87
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.87
KOG1027|consensus	903		99.87
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.87
KOG0587|consensus	953		99.87
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.86
KOG0603|consensus	612		99.86
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.86
KOG2052|consensus	513		99.86
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.86
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.86
KOG0664|consensus	449		99.86
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.86
KOG3653|consensus	534		99.86
KOG0696|consensus	683		99.86
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.86
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.86
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.86
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.85
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.85
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.85
KOG0669|consensus	376		99.85
KOG0671|consensus	415		99.85
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.85
TIGR03591	684	polynuc_phos polyribonucleotide nucleotidyltransfe	99.85
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.85
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.84
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.84
KOG4278|consensus	1157		99.84
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.84
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.84
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.83
PRK11824	693	polynucleotide phosphorylase/polyadenylase; Provis	99.83
KOG0670|consensus	752		99.83
KOG0199|consensus	1039		99.82
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.82
KOG0668|consensus	338		99.82
PHA02882	294	putative serine/threonine kinase; Provisional	99.82
KOG1345|consensus	378		99.81
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.81
KOG0200|consensus	609		99.81
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.8
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.8
KOG1025|consensus	1177		99.78
KOG1167|consensus	418		99.76
PLN00207	891	polyribonucleotide nucleotidyltransferase; Provisi	99.76
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.76
PHA02713	557	hypothetical protein; Provisional	99.75
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.74
KOG4441|consensus	571		99.74
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.73
PHA02790	480	Kelch-like protein; Provisional	99.73
PLN00181	793	protein SPA1-RELATED; Provisional	99.72
PRK09188	365	serine/threonine protein kinase; Provisional	99.71
KOG0576|consensus	829		99.71
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.68
KOG1290|consensus	590		99.67
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.65
PF00651	111	BTB: BTB/POZ domain; InterPro: IPR013069 The BTB (	99.64
PRK10345	210	hypothetical protein; Provisional	99.64
PHA03098	534	kelch-like protein; Provisional	99.64
COG2123	272	RNase PH-related exoribonuclease [Translation, rib	99.64
PF01138	132	RNase_PH: 3' exoribonuclease family, domain 1 This	99.63
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.62
KOG1163|consensus	341		99.59
KOG4158|consensus	598		99.59
KOG1164|consensus	322		99.55
KOG4350|consensus	620		99.55
KOG0590|consensus	601		99.54
KOG1024|consensus	563		99.53
PRK14879	211	serine/threonine protein kinase; Provisional	99.51
smart00090	237	RIO RIO-like kinase.	99.51
KOG1165|consensus	449		99.51
KOG2075|consensus	521		99.49
PRK12274	218	serine/threonine protein kinase; Provisional	99.49
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.49
smart00225	90	BTB Broad-Complex, Tramtrack and Bric a brac. Doma	99.48
KOG0195|consensus	448		99.48
KOG0603|consensus	612		99.47
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.47
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.41
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.41
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.34
KOG1240|consensus	1431		99.33
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.28
KOG1614|consensus	291		99.25
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.25
KOG1166|consensus	974		99.17
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.15
KOG1023|consensus	484		99.11
KOG1067|consensus	760		99.11
COG1185	692	Pnp Polyribonucleotide nucleotidyltransferase (pol	99.06
KOG0590|consensus	601		99.05
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.04
KOG1033|consensus	516		99.04
KOG1243|consensus	690		99.01
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.94
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.94
KOG0606|consensus	1205		98.92
PF03725	68	RNase_PH_C: 3' exoribonuclease family, domain 2 Th	98.91
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.89
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.86
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.86
TIGR02696	719	pppGpp_PNP guanosine pentaphosphate synthetase I/p	98.85
KOG1613|consensus	298		98.74
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.73
KOG1612|consensus	288		98.71
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.71
KOG3087|consensus	229		98.68
KOG4591|consensus	280		98.68
KOG0601|consensus	524		98.58
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.55
COG1185	692	Pnp Polyribonucleotide nucleotidyltransferase (pol	98.46
KOG0601|consensus	524		98.39
KOG0783|consensus	1267		98.36
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.34
KOG1266|consensus	458		98.33
KOG3741|consensus	655		98.29
KOG0783|consensus	1267		98.29
PRK09902	216	hypothetical protein; Provisional	98.18
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.97
KOG4682|consensus	488		97.95
KOG1067|consensus	760		97.89
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.75
KOG0606|consensus	1205		97.74
KOG2838|consensus	401		97.74
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.72
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.68
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.66
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.49
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	97.41
PLN02876	822	acyl-CoA dehydrogenase	97.24
PF01636	239	APH: Phosphotransferase enzyme family This family	97.2

>KOG1068|consensus

Probab=100.00  E-value=1.7e-37  Score=280.60  Aligned_cols=217  Identities=35%  Similarity=0.519  Sum_probs=202.2

Q ss_pred             cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC-CCCCcch
Q psy6508         113 NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-WLRDSEE  191 (477)
Q Consensus       113 ~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-~~~~~~~  191 (477)
                      ++++|.+....|+...++||+|+++|+|++.|.+|||.|.......  . -+.+.+.+++...+|++..++. +.+++++
T Consensus        20 ~~elR~i~~~~g~~~~a~GSay~E~GnTKVl~aV~GPre~~~~~~~--~-~~~a~lnc~~~~a~Fst~~r~~~~~~~rr~   96 (245)
T KOG1068|consen   20 PNELRRIYARIGVLTQADGSAYMEQGNTKVLCAVYGPREIRGKSAR--R-PDKAVLNCEVSSAQFSTGDRKKRPKGDRRE   96 (245)
T ss_pred             hhHhhhhhhhcCccccCCccchhhcCCeEEEEEEeCCccccccccc--c-cccceEEEEEeeeccccchhccCCCccHHH
Confidence            4688999999999999999999999999999999999998765521  2 4668999999999999988884 6889999


Q ss_pred             HHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCChH
Q psy6508         192 KELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEE  271 (477)
Q Consensus       192 ~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~~  271 (477)
                      .+++..++++++|+|+++.|||++|||+++|||+||+.+++++||+++||+||||||+|++++||+++.++.+++||+..
T Consensus        97 ~e~s~~L~~afe~~I~~~lyPrsqIDI~v~VleddG~~laa~inaatlAL~daGI~m~D~i~~~t~~l~~~~~l~Dl~~~  176 (245)
T KOG1068|consen   97 KELSLMLQQAFEPVILLELYPRSQIDIYVQVLEDDGSNLAAAINAATLALADAGIPMYDLITACTAGLADGTPLLDLTSL  176 (245)
T ss_pred             HHHHHHHHHHHHHHHHhhhCccccceEEEEEEECCCccHHHHHHHHHHHHHHcCCChhhhhhhceeeecCCccccccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhccc
Q psy6508         272 EVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       272 E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ||..          ..+.+|+++++..++|+.+|++++++.+.|+.+|+.++++|+.+++. ++..++++..
T Consensus       177 eesa----------~~~~ltVa~l~~~~~i~~l~~~~~~~~d~l~~vl~~a~~~c~~v~~~-l~~~l~~~l~  237 (245)
T KOG1068|consen  177 EESA----------RAPGLTVAALPNREEIALLQLDERLHCDHLETVLELAIAGCKRVYER-LRLVLREHLK  237 (245)
T ss_pred             hhhc----------cCCceEEEEecCcceEEEEEecCCCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHH
Confidence            9995          36689999999999999999999999999999999999999999999 9998887754

>KOG0615|consensus

Probab=100.00  E-value=8.9e-36  Score=286.12  Aligned_cols=176  Identities=28%  Similarity=0.418  Sum_probs=153.6

Q ss_pred             CCCcEEEEEEcccCCCChh-----HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSEN-----RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~-----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      ++|+.||||+++++.....     ......+|+++|++|+|||||+++++|+.....||||||++||.|.+.+-.++.+.
T Consensus       195 ~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~  274 (475)
T KOG0615|consen  195 KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLR  274 (475)
T ss_pred             ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccc
Confidence            6899999999998865431     22346799999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      +...+.+++|++.|++|||++||+||||||+|||+..  ..+-+.+.|||+++.....   ..-.|..||+.|.|||++.
T Consensus       275 ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~---sfm~TlCGTpsYvAPEVl~  351 (475)
T KOG0615|consen  275 EDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG---SFMKTLCGTPSYVAPEVLA  351 (475)
T ss_pred             cchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhccccc---eehhhhcCCccccChhhee
Confidence            9999999999999999999999999999999999965  3566777899998654321   2336889999999999998


Q ss_pred             CC------CcccccCcceEEEEEE--eeecccccc
Q psy6508         155 SK------TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       155 ~~------~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      ..      .++|+ ||+||++|-+  |++||++..
T Consensus       352 ~kg~~~~~~kVDi-WSlGcvLfvcLsG~pPFS~~~  385 (475)
T KOG0615|consen  352 SKGVEYYPSKVDI-WSLGCVLFVCLSGYPPFSEEY  385 (475)
T ss_pred             cCCeecccchhee-eeccceEEEEeccCCCccccc
Confidence            76      47899 9999999988  999999643

>KOG0595|consensus

Probab=100.00  E-value=1.1e-35  Score=285.72  Aligned_cols=174  Identities=36%  Similarity=0.596  Sum_probs=157.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      +++..||||.+.+...+.+..+.+..|+.+|+.++|||||+++++++..+.+|+|||||+||+|.+|+++++.+++..++
T Consensus        33 ~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r  112 (429)
T KOG0595|consen   33 KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATAR  112 (429)
T ss_pred             cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHH
Confidence            57899999999999888888889999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC---c--ceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---T--LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~---~--~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      .++.||+.||++||+++|+||||||+||||+.+   .  ..+.+.|||+++......+   -.|-.|++.|||||+....
T Consensus       113 ~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~---a~tlcGSplYMAPEV~~~~  189 (429)
T KOG0595|consen  113 HFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSM---AETLCGSPLYMAPEVIMSQ  189 (429)
T ss_pred             HHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhH---HHHhhCCccccCHHHHHhc
Confidence            999999999999999999999999999999642   2  6777889999987775443   3467889999999998544


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||.|+++|++  +.+||..
T Consensus       190 ~YdAKADL-WSiG~Ilyq~l~g~~Pf~a  216 (429)
T KOG0595|consen  190 QYDAKADL-WSIGTILYQCLTGKPPFDA  216 (429)
T ss_pred             cccchhhH-HHHHHHHHHHHhCCCCccc
Confidence               78999 9999999999  7788873

>TIGR02065 ECX1 archaeal exosome-like complex exonuclease 1

Probab=100.00  E-value=6.1e-33  Score=261.32  Aligned_cols=223  Identities=27%  Similarity=0.463  Sum_probs=199.6

Q ss_pred             CCCceeec---cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecccccc
Q psy6508         105 KPQNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQI  181 (477)
Q Consensus       105 kp~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~  181 (477)
                      -++++-.|   .+++|.+.+.+|....++||++++.|+|++.+.+++|.|.....  .+. -..|.+.+++.+.||++..
T Consensus         4 ~~~~~R~DGR~~~e~R~~~~~~g~~~~a~GSa~~~~G~T~Vl~~V~gp~e~~~~~--~~~-~~~~~l~v~~~~~~~a~~~   80 (230)
T TIGR02065         4 LEDGVRLDGRKPDELRPIKIEAGVLKNADGSAYVEFGGTKIIAAVYGPREMHPRH--LQL-PDRAVLRVRYHMAPFSTDE   80 (230)
T ss_pred             cCCCcCCCCCCcccccCeEEEECCCCCCCeEEEEEECCcEEEEEEeCCCcccccc--ccC-CCceEEEEEEEeCCcccCC
Confidence            34555554   36899999999999999999999999999999999998865442  011 3468888999999999866


Q ss_pred             ccCCCCCcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeC
Q psy6508         182 RTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRG  261 (477)
Q Consensus       182 r~~~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~  261 (477)
                      +....++..+.++++.+++++++.++++.||+..+++++++|++||+.+++++||+++||.||||||+++++|+++++.+
T Consensus        81 ~~~~~~~~~~~~~s~~l~~~l~~~i~~~~~p~~~i~i~v~vl~~DG~~~~aai~aa~lAL~dagIp~~~~v~avtv~~~~  160 (230)
T TIGR02065        81 RKRPGPSRREIEISKVIREALEPAILLEQFPRTAIDVFIEVLQADAGTRCAGLTAASLALADAGIPMRDLVVGVAVGKVD  160 (230)
T ss_pred             ccCCCCCccHHHHHHHHHHHHHHHhChhhcCCeEEEEEEEEEEcCCCHHHHHHHHHHHHHHHcCCccccceeeEEEEEEC
Confidence            65555677888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhc
Q psy6508         262 GLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDH  341 (477)
Q Consensus       262 ~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~  341 (477)
                      +.+++||+.+|+..          +.+.++++++++.++|+.+++.|.++.+++.++++.|.++|+.+++. |++.++++
T Consensus       161 ~~~v~Dpt~~Ee~~----------~~~~l~va~~~~~~~i~~i~~~g~~~~e~~~~~l~~a~~~~~~l~~~-~~~~l~~~  229 (230)
T TIGR02065       161 GVVVLDLNEEEDMY----------GEADMPVAMMPKLGEITLLQLDGDMTPDEFRQALDLAVKGIKIIYQI-QREALKNK  229 (230)
T ss_pred             CeEEECCCHHHhhc----------CCCceEEEEeCCCCCEEEEEEecCcCHHHHHHHHHHHHHHHHHHHHH-HHHHHHhh
Confidence            99999999999984          47889999999899999999999999999999999999999999999 99998875

This family contains the archaeal protein orthologous to the eukaryotic exosome protein Rrp41. It is somewhat more distantly related to the bacterial protein ribonuclease PH. An exosome-like complex has been demonstrated experimentally for the Archaea in Sulfolobus solfataricus, so members of this family are designated exosome complex exonuclease 1, after usage in SwissProt.

>KOG0575|consensus

Probab=100.00  E-value=2.6e-34  Score=288.91  Aligned_cols=174  Identities=26%  Similarity=0.444  Sum_probs=156.9

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++.+..+ .+...+++.+|+++.++|+|||||+++++|++.+++|||+|+|+.++|..++++.+.+++.++
T Consensus        41 ~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEa  120 (592)
T KOG0575|consen   41 DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEA  120 (592)
T ss_pred             CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHH
Confidence            5899999999988655 456678899999999999999999999999999999999999999999999998889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.+++||+.||.|||+++|+|||||..|+|++++ ++|+.  |||++.......  +...|..||+.|.|||++...   
T Consensus       121 ry~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIg--DFGLAt~le~~~--Erk~TlCGTPNYIAPEVl~k~gHs  196 (592)
T KOG0575|consen  121 RYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIG--DFGLATQLEYDG--ERKKTLCGTPNYIAPEVLNKSGHS  196 (592)
T ss_pred             HHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEec--ccceeeeecCcc--cccceecCCCcccChhHhccCCCC
Confidence            9999999999999999999999999999999887 66655  999998766432  445688999999999999876   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ..+|+ ||+||++|.+  |.+||.+.
T Consensus       197 fEvDi-WSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  197 FEVDI-WSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             Cchhh-hhhhhHHHhhhhCCCCcccc
Confidence            88999 9999999999  77999853

>KOG0581|consensus

Probab=100.00  E-value=1.5e-34  Score=275.70  Aligned_cols=170  Identities=24%  Similarity=0.336  Sum_probs=153.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-eEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      ++++.+|+|++. ....+..++++.+|+++++..+|||||++|++|..++ .++|+||||+||+|..+++..+++++...
T Consensus       102 ~t~~i~AlK~I~-~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L  180 (364)
T KOG0581|consen  102 PTGKIYALKVIL-LNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVL  180 (364)
T ss_pred             CCCeEEEEEeec-ccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHH
Confidence            589999999994 3445667788999999999999999999999999998 59999999999999999998889999999


Q ss_pred             HHHHHHHHHHHHHHHh-CCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          81 QQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      -+++.++++||.|||+ ++|+||||||+|||++. +++|+.  |||++.....|    .-+|.+||..||+||.+.+.  
T Consensus       181 ~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKic--DFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Y  254 (364)
T KOG0581|consen  181 GKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKIC--DFGVSGILVNS----IANTFVGTSAYMSPERISGESY  254 (364)
T ss_pred             HHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEec--cccccHHhhhh----hcccccccccccChhhhcCCcC
Confidence            9999999999999996 89999999999999986 566665  99999887766    45799999999999999987  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|| ||+|..++|+  |..||..
T Consensus       255 s~~sDI-WSLGLsllE~a~GrfP~~~  279 (364)
T KOG0581|consen  255 SVKSDI-WSLGLSLLELAIGRFPYPP  279 (364)
T ss_pred             Ccccce-ecccHHHHHHhhCCCCCCC
Confidence             77899 9999999999  6667775

>COG0689 Rph RNase PH [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1e-32  Score=251.47  Aligned_cols=212  Identities=28%  Similarity=0.371  Sum_probs=194.5

Q ss_pred             cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCc-ch
Q psy6508         113 NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDS-EE  191 (477)
Q Consensus       113 ~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~-~~  191 (477)
                      .+++|.+.+..|...+++||++++.|+|++.|.+++|.|......  .- -..|.+.+|.++.||++..|.....+. +.
T Consensus        15 ~delR~i~~~~~~~~~a~GS~~~~~G~tkVic~vsGp~e~~p~~l--~~-~~~g~~t~ey~m~p~sT~~R~~~~~~~gR~   91 (230)
T COG0689          15 PDELRPIKITRGVLKHAEGSSLIEFGNTKVICTVSGPREPVPRFL--RG-TGKGWLTAEYGMLPRSTDERKKREADRGRT   91 (230)
T ss_pred             cccccceEEEeccccCCCccEEEEeCCeEEEEEEecCCCCCChhh--cC-CCceEEEEEEecccccccccccccccccch
Confidence            468999999999999999999999999999999999998766541  11 346999999999999986666554444 78


Q ss_pred             HHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCChH
Q psy6508         192 KELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEE  271 (477)
Q Consensus       192 ~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~~  271 (477)
                      .++++++.+++++++.++.||+..|+|+++|+|+||+++.++||||++||+|||+||+++|+|+|+++.++.+++||+..
T Consensus        92 ~eisrli~~al~~~i~L~~~p~~~I~i~~dVlqaDggTrta~It~A~lAL~DAgipl~~~vaaiSvgi~~~~~~lDl~~~  171 (230)
T COG0689          92 KEISRLIGRALRAVIDLELLPESTIDIDCDVLQADGGTRTASITGASLALADAGIPLRDLVAAISVGIVDGVIVLDLDYE  171 (230)
T ss_pred             hHHHHHHHHHHHHHhhhhhcCccEEEEEEEEEECCCCeeeehhhHHHHHHHHcCCchhhheeEeEEEEECCceEecCcch
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhhccCCCCCCCCCceEEEEEccCCC--cEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHh
Q psy6508         272 EVAYCQSLSSSEDDDSGVITLSYMSVIQ--QVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLV  338 (477)
Q Consensus       272 E~~~~~~~~~~~~~~~~~~~~a~~~~~~--~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l  338 (477)
                      |+..          +.+.++++++++.+  +|.+++.+|.|+.++|..+|++|+++|+.++.. ++++|
T Consensus       172 Eds~----------~~~d~~v~~~~~~~~~ei~~~~~~~~~~~del~~lL~la~~g~~~~~~~-~~~al  229 (230)
T COG0689         172 EDSA----------AEADMNVVMTGNGGLVEIQGLAEDGPFTEDELLELLDLAIKGCNELREL-QREAL  229 (230)
T ss_pred             hhcc----------cccCceEEEEecCCeEEEEEEeccCCcCHHHHHHHHHHHHHHHHHHHHH-HHHHh
Confidence            9984          58899999999999  999999999999999999999999999999999 88776

>PRK03983 exosome complex exonuclease Rrp41; Provisional

Probab=100.00  E-value=8.8e-32  Score=255.74  Aligned_cols=216  Identities=29%  Similarity=0.459  Sum_probs=196.1

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|....++||++++.|+|++.+.+++|.|.....  ... ..-|.+.+++.+.||++..+....++..+.+
T Consensus        22 ~~~R~i~i~~G~l~~a~GSa~v~~G~T~Vl~~V~gp~e~~~~~--~~~-~~~~~l~v~~~~~p~~~~~~~~~~~~~~~~~   98 (244)
T PRK03983         22 DELRPIKIEVGVLKNADGSAYLEWGNNKIIAAVYGPREMHPRH--LQL-PDRAVLRVRYNMAPFSVDERKRPGPDRRSIE   98 (244)
T ss_pred             CcccceEEEeCCCCCCCeEEEEEECCeEEEEEEecCCcccccc--ccC-CCcEEEEEEEEcCCCccccccCCCCChhHHH
Confidence            5899999999999999999999999999999999988865432  011 4568888889999999866555556777889


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCChHHH
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEV  273 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~~E~  273 (477)
                      +++.+++++++.++++.||++.|++++++|++||+.+++++||+++||+||||||+++++++++++.++.+++||+..|+
T Consensus        99 ~s~~l~~~l~~~i~~~~~p~~~I~I~i~VL~~DG~~~~aai~Aa~lAL~dagIp~~~~v~avtv~~~~~~~i~DPt~~Ee  178 (244)
T PRK03983         99 ISKVIREALEPAIMLELFPRTVIDVFIEVLQADAGTRVAGITAASLALADAGIPMRDLVAGCAVGKVDGVIVLDLNKEED  178 (244)
T ss_pred             HHHHHHHHHHHhccHHhCCCeEEEEEEEEEECCCCHHHHHHHHHHHHHHhcCCccccceeEEEEEEECCEEEECCCHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhccc
Q psy6508         274 AYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ..          ..+.+++|++++.++|+.+++.|.++.+++.++++.|.++|+.+.+. |++.+.++..
T Consensus       179 ~~----------~~~~l~va~~~~~~~I~~l~~~G~~~~~~~~~~i~~A~~~~~~i~~~-i~~~l~~~~~  237 (244)
T PRK03983        179 NY----------GEADMPVAIMPRLGEITLLQLDGNLTREEFLEALELAKKGIKRIYQL-QREALKSKYG  237 (244)
T ss_pred             cc----------CCceEEEEEECCCCCEEEEEEecCcCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHH
Confidence            84          47899999999899999999999999999999999999999999999 9999987654

>KOG0598|consensus

Probab=100.00  E-value=2e-33  Score=267.86  Aligned_cols=177  Identities=24%  Similarity=0.377  Sum_probs=154.9

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      ++++.||+|++++..+.. ...+...+|..+|.+++||+||+++-.|++.+.+|+|+||+.||.|...|++++.+++..+
T Consensus        48 dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~a  127 (357)
T KOG0598|consen   48 DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRA  127 (357)
T ss_pred             ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHH
Confidence            689999999999987754 3567789999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.+|+.||.|||++||+||||||+|||++.++ .+.+.|||++...-...  ....|..||+.|+|||++.+.   .
T Consensus       128 rfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~G-Hi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPEil~~~gy~~  204 (357)
T KOG0598|consen  128 RFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQG-HIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPEILLGKGYDK  204 (357)
T ss_pred             HHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCC-cEEEeccccchhcccCC--CccccccCCccccChHHHhcCCCCc
Confidence            99999999999999999999999999999998754 33445999987422211  123568999999999999887   7


Q ss_pred             cccccCcceEEEEEE--eeeccccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQIR  182 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~~r  182 (477)
                      ++|+ ||+|+++|||  +.+||.+..+
T Consensus       205 ~vDW-WsLGillYeML~G~pPF~~~~~  230 (357)
T KOG0598|consen  205 AVDW-WSLGILLYEMLTGKPPFYAEDV  230 (357)
T ss_pred             ccch-HhHHHHHHHHhhCCCCCcCccH
Confidence            8999 9999999999  7799987553

>KOG0616|consensus

Probab=99.97  E-value=1.8e-32  Score=253.37  Aligned_cols=171  Identities=28%  Similarity=0.513  Sum_probs=154.7

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|..||+|++++...- .++.+...+|..+|+.+.||+++++++.+.+.+.+||||||.+||.|..++++.+++++..+
T Consensus        67 ~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~a  146 (355)
T KOG0616|consen   67 HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHA  146 (355)
T ss_pred             cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhH
Confidence            57899999999887653 35567788999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.++.||+.||+|||+++|++|||||+|||+|.+ -++++  |||.+....|..+     |-.||+-|.|||....+   
T Consensus       147 rFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKit--DFGFAK~v~~rT~-----TlCGTPeYLAPEii~sk~yn  219 (355)
T KOG0616|consen  147 RFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKIT--DFGFAKRVSGRTW-----TLCGTPEYLAPEIIQSKGYN  219 (355)
T ss_pred             HHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEE--eccceEEecCcEE-----EecCCccccChHHhhcCCCC
Confidence            9999999999999999999999999999999875 55555  9999998887643     67788999999999877   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ |++|+++|||  |++||...
T Consensus       220 kavDW-WalGVLIYEMlaG~pPF~~~  244 (355)
T KOG0616|consen  220 KAVDW-WALGVLIYEMLAGYPPFYDD  244 (355)
T ss_pred             cchhH-HHHHHHHHHHHcCCCCCcCC
Confidence            78999 9999999999  89999853

>KOG0592|consensus

Probab=99.97  E-value=2.2e-32  Score=270.89  Aligned_cols=178  Identities=25%  Similarity=0.363  Sum_probs=155.2

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      ++++.||||++.++.+.. ...+-+.+|-.+|.+| .||.|+++|..|+++..+|+|+||+++|+|.++|++.+.+++..
T Consensus        96 ~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~c  175 (604)
T KOG0592|consen   96 ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETC  175 (604)
T ss_pred             CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHH
Confidence            589999999998886643 3345678999999999 89999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc---------ccC--CeEEEecccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI---------EQG--NTKVICSVFE  148 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~---------~~g--~t~v~~~~y~  148 (477)
                      .+.++.||+.||+|||++|||||||||+|||++.|. ++.+.|||.+....++...         ...  .+.|||..|.
T Consensus       176 aR~YAAeIldAleylH~~GIIHRDlKPENILLd~dm-hikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYV  254 (604)
T KOG0592|consen  176 ARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDG-HIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYV  254 (604)
T ss_pred             HHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCC-cEEEeeccccccCChhhccccCccCcccccCcccceeeeeccc
Confidence            999999999999999999999999999999998764 5666799988755443221         112  4689999999


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE--eeecccccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      +||++...   ..+|+ |++||++|+|  |.+||.+..
T Consensus       255 SPElL~~~~~~~~sDi-WAlGCilyQmlaG~PPFra~N  291 (604)
T KOG0592|consen  255 SPELLNDSPAGPSSDL-WALGCILYQMLAGQPPFRAAN  291 (604)
T ss_pred             CHHHhcCCCCCcccch-HHHHHHHHHHhcCCCCCcccc
Confidence            99999887   78899 9999999999  889998654

>KOG0600|consensus

Probab=99.97  E-value=3.3e-31  Score=260.58  Aligned_cols=193  Identities=26%  Similarity=0.348  Sum_probs=161.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCC-CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHE-KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~-~l~~~   78 (477)
                      ++|+.||+|++......+....-..+|+.||++|+||||+++.++..+.  ..+|||+|||+ .+|.-++...+ .|++.
T Consensus       140 ~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~vkft~~  218 (560)
T KOG0600|consen  140 ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPGVKFTEP  218 (560)
T ss_pred             ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcCCCcccChH
Confidence            5899999999998876665556678999999999999999999988766  68999999998 79999988754 79999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      +++.+++||+.||.|+|++||+|||||.+|||||++ .+++  .|||+++..+++.... -+..|.|.||.|||.+.|. 
T Consensus       219 qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKi--aDFGLAr~y~~~~~~~-~T~rVvTLWYRpPELLLG~t  295 (560)
T KOG0600|consen  219 QIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKI--ADFGLARFYTPSGSAP-YTSRVVTLWYRPPELLLGAT  295 (560)
T ss_pred             HHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEe--ccccceeeccCCCCcc-cccceEEeeccChHHhcCCc
Confidence            999999999999999999999999999999999875 4554  5999998655554322 3568999999999999987 


Q ss_pred             ---CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHHHHhhhh
Q psy6508         157 ---TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPA  205 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~l~~~  205 (477)
                         .++|+ ||.|||+.||.      .+++-+++..+..++..+.+-+-.|.
T Consensus       296 ~Yg~aVDl-WS~GCIl~El~------~gkPI~~G~tEveQl~kIfklcGSP~  340 (560)
T KOG0600|consen  296 SYGTAVDL-WSVGCILAELF------LGKPILQGRTEVEQLHKIFKLCGSPT  340 (560)
T ss_pred             ccccceee-hhhhHHHHHHH------cCCCCcCCccHHHHHHHHHHHhCCCC
Confidence               78999 99999999993      22333356778888888888655444

>KOG1069|consensus

Probab=99.97  E-value=4.8e-30  Score=223.12  Aligned_cols=207  Identities=25%  Similarity=0.378  Sum_probs=181.4

Q ss_pred             cceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHHH
Q psy6508         115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKEL  194 (477)
Q Consensus       115 ~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l  194 (477)
                      .+|.+-+..|+..+.+||+.+.+|+|++.|.+|||-++..++      -..-...+|+.+.|-.+      .+...++.+
T Consensus         4 ~lr~~~cei~iLsr~dGSs~fsqgdT~V~c~V~GP~dvk~r~------E~~~katleVi~rp~~G------~~~~~eK~~   71 (217)
T KOG1069|consen    4 RLRGIACEISILSRPDGSSEFSQGDTKVICSVYGPIDVKARQ------EDPEKATLEVIWRPKSG------VNGTVEKVL   71 (217)
T ss_pred             hhhhhhhhhceecCCCCccceecCCcEEEEEeeCCcchhhcc------cCchhceEEEEEecccC------cchHHHHHH
Confidence            345556788999999999999999999999999999998877      33445667888888776      456677999


Q ss_pred             HHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEee-CCeEEeCCChHHH
Q psy6508         195 GNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALR-GGLTFIDPVEEEV  273 (477)
Q Consensus       195 ~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~-~~~~~~Dp~~~E~  273 (477)
                      +++|+.++++.+.++.|||..|.|.+|++++||+.+++||||||+||+||||||+.+++|+.+++. ++.+++||+..++
T Consensus        72 e~iI~~tl~~~I~l~l~Prt~iqVsiqvv~ddgs~LacaINaAclALvDaGIpl~~mfcai~~~~~~d~~lv~Dpt~~qe  151 (217)
T KOG1069|consen   72 ERIIRKTLSKAIILELYPRTTIQVSIQVVEDDGSTLACAINAACLALVDAGIPLRSMFCAISCALHEDGVLVLDPTAKQE  151 (217)
T ss_pred             HHHHHHHHHHhheeeecCCceEEEEEEEEecCCcchHHHHHHHHHHHHhcCCchHHhhhhceEEEecCccEEECCcHHhh
Confidence            999999999999999999999999999999999999999999999999999999999999999998 5689999999999


Q ss_pred             hhhccCCCCCCCCCceEEEEE---ccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhcccc
Q psy6508         274 AYCQSLSSSEDDDSGVITLSY---MSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTL  344 (477)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~a~---~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~l  344 (477)
                      ...          .+..++++   .....+|..+.+.|.++.++|+.+++.+..++..+++. +++.++++++.
T Consensus       152 k~~----------~~~~~lsf~~~~~~~~~vi~s~t~G~~~~d~lf~~le~a~~~~~~~f~f-~r~~~q~~~s~  214 (217)
T KOG1069|consen  152 KIS----------TARATLSFEGGSLGEPKVIISETNGEKSEDQLFYVLELAQAAAQSLFPF-YREVLQRKYSK  214 (217)
T ss_pred             hhh----------hceEEEEEecCCCCCcceEEEeccCCCCHHHHHHHHHhhHHHHHHHHHH-HHHHHHhhcCc
Confidence            853          44455544   22355799999999999999999999999999999999 99999887764

>KOG0591|consensus

Probab=99.97  E-value=3.7e-32  Score=249.48  Aligned_cols=174  Identities=26%  Similarity=0.318  Sum_probs=150.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEE-EEEeCCe-EEEEEecCCCCCHHHHHHh----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERY-VYIILEYCDGGDLCSFIRS----HEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~-~~~~~~~-~~lv~e~~~g~sL~~~l~~----~~~l   75 (477)
                      .+|+.||.|.++-..++...++...+|+.+|++|+|||||++|+ .|.+++. ++||||+|.+|+|.++++.    ++.+
T Consensus        42 ~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~i  121 (375)
T KOG0591|consen   42 LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLI  121 (375)
T ss_pred             cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccC
Confidence            47899999999988888888899999999999999999999999 5655555 8999999999999999964    3469


Q ss_pred             CHHHHHHHHHHHHHHHHHHHh--CC--cEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          76 SEFQCQQFVRQLVLALKFLRE--NN--VCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~--~g--ivHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                      ++..+++++.|++.||..+|+  ..  |.||||||.||+++.+ .+++  .|||+.+....+..  ...+.||||.||+|
T Consensus       122 pE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKL--GDfGL~r~l~s~~t--fA~S~VGTPyYMSP  197 (375)
T KOG0591|consen  122 PEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKL--GDFGLGRFLSSKTT--FAHSLVGTPYYMSP  197 (375)
T ss_pred             chHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceee--ccchhHhHhcchhH--HHHhhcCCCcccCH
Confidence            999999999999999999999  44  9999999999999875 4444  59999876554332  33578999999999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      |.+.++   +++|+ ||+||++|||  ..+||.+.
T Consensus       198 E~i~~~~Y~~kSDi-WslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  198 ERIHESGYNFKSDI-WSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             HHHhcCCCCcchhH-HHHHHHHHHHHhcCCCcccc
Confidence            999877   88999 9999999999  67999864

>KOG0583|consensus

Probab=99.97  E-value=5.4e-31  Score=264.33  Aligned_cols=176  Identities=31%  Similarity=0.458  Sum_probs=151.7

Q ss_pred             CCCcEEEEEEcccCCCC---hhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVS---ENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|..||+|+++++...   ....+.+.+|+.++++++ ||||+++++++.....+|+|||||.||+|.+++.+.+++.+
T Consensus        40 ~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E  119 (370)
T KOG0583|consen   40 LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKE  119 (370)
T ss_pred             cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCCh
Confidence            36789999988776332   123456778999999998 99999999999999999999999999999999999889999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+++.+++|++.|++|+|++||+||||||+|||++.++..+.++|||++...++  ....-.|..|++.|+|||++.+. 
T Consensus       120 ~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~--~~~~l~t~cGsp~Y~aPEvl~~~~  197 (370)
T KOG0583|consen  120 DEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG--EDGLLKTFCGSPAYAAPEVLSGKG  197 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC--CCCcccCCCCCcccCCHHHhCCCC
Confidence            999999999999999999999999999999999988644555569999876631  12344688999999999999875 


Q ss_pred             ----CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                          .++|+ ||+|+++|.|  |+.||...
T Consensus       198 ~Y~g~~aDv-WS~GViLy~ml~G~~PF~d~  226 (370)
T KOG0583|consen  198 TYSGKAADV-WSLGVILYVLLCGRLPFDDS  226 (370)
T ss_pred             CcCCchhhh-hhhHHHHHHHHhCCCCCCCc
Confidence                67899 9999999999  88999864

>KOG0198|consensus

Probab=99.97  E-value=1e-29  Score=245.96  Aligned_cols=174  Identities=22%  Similarity=0.328  Sum_probs=144.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC--eEEEEEecCCCCCHHHHHHhCC-CCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCSFIRSHE-KLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~lv~e~~~g~sL~~~l~~~~-~l~~~~   79 (477)
                      +|...|||.+.......  .+.+.+|+.+|++++|||||++++......  .+++.|||++||+|.+++.+.+ .+++..
T Consensus        41 ~g~~~AvK~v~~~~~~~--~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~  118 (313)
T KOG0198|consen   41 TGELMAVKSVELEDSPT--SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPL  118 (313)
T ss_pred             CCcceeeeeeecccchh--HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHH
Confidence            47899999987763222  567899999999999999999999744333  6999999999999999999877 799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc-ccccCCeEEEeccccccccCC-CC-
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPS-SK-  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~-~~-  156 (477)
                      ++.+.+||++||.|||++||+||||||+|||++..+..+.+.|||.+....+.. .........+|+.||+||+.. +. 
T Consensus       119 v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~  198 (313)
T KOG0198|consen  119 VRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEV  198 (313)
T ss_pred             HHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCc
Confidence            999999999999999999999999999999998832233445999988766521 222334678999999999998 43 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+||+++||  +..||..
T Consensus       199 ~~~~sDi-WSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  199 ARRESDI-WSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             CCccchh-hhcCCEEEeccCCCCcchh
Confidence              48999 9999999999  5577775

>KOG0659|consensus

Probab=99.97  E-value=1.4e-30  Score=237.43  Aligned_cols=191  Identities=24%  Similarity=0.359  Sum_probs=161.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      ++|+.||||+++..+..+.......+|++.|+.++||||+.++++|...+.+-||+||++ .+|...++... .++...+
T Consensus        25 ~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~i  103 (318)
T KOG0659|consen   25 ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADI  103 (318)
T ss_pred             CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHH
Confidence            689999999999887666555678899999999999999999999999999999999998 89999998754 6899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.|+.++++||+|||++.|+||||||.|+|++++ .+|+  .|||+++. .|+.. +.....|.|.||.|||.+.|.   
T Consensus       104 K~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKi--ADFGLAr~-f~~p~-~~~~~~V~TRWYRAPELLfGsr~Y  179 (318)
T KOG0659|consen  104 KSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKI--ADFGLARF-FGSPN-RIQTHQVVTRWYRAPELLFGSRQY  179 (318)
T ss_pred             HHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEe--ecccchhc-cCCCC-cccccceeeeeccChHHhccchhc
Confidence            9999999999999999999999999999999865 4455  59999853 33332 222335999999999999887   


Q ss_pred             -CcccccCcceEEEEEE-eeeccccccccCCCCCcchHHHHHHHHHHhhhh
Q psy6508         157 -TSLEYQRSKGELYVEF-KFAPFASQIRTGWLRDSEEKELGNHLKRALEPA  205 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~-~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~l~~~  205 (477)
                       ..+|+ ||.||++.|+ ...||-       +++.+.+++..+++-.-.|.
T Consensus       180 g~~VDm-WavGCI~AELllr~P~f-------pG~sDidQL~~If~~LGTP~  222 (318)
T KOG0659|consen  180 GTGVDM-WAVGCIFAELLLRVPFF-------PGDSDIDQLSKIFRALGTPT  222 (318)
T ss_pred             CCcchh-hhHHHHHHHHHccCCCC-------CCCchHHHHHHHHHHcCCCC
Confidence             77899 9999999999 545555       67888889988887554443

>KOG0611|consensus

Probab=99.96  E-value=6.3e-31  Score=251.61  Aligned_cols=175  Identities=30%  Similarity=0.468  Sum_probs=154.1

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      ..|+.||||.+++..+. +...-.+++|++||..|+||||+.+|.+|+..+.+.|||||..+|.|.+|+...+.+++.++
T Consensus        76 ~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEa  155 (668)
T KOG0611|consen   76 KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREA  155 (668)
T ss_pred             cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHH
Confidence            47899999999998774 34566789999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.+++||++|+.|+|.++++|||||.+|||+|.| ++++.  |||++.......   .-.|..|.+.|.+||+..+.   
T Consensus       156 RhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIA--DFGLSNly~~~k---fLqTFCGSPLYASPEIvNG~PY~  230 (668)
T KOG0611|consen  156 RHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIA--DFGLSNLYADKK---FLQTFCGSPLYASPEIVNGTPYK  230 (668)
T ss_pred             HHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeee--ccchhhhhcccc---HHHHhcCCcccCCccccCCCCCC
Confidence            9999999999999999999999999999999875 56655  999875322211   23578889999999999988   


Q ss_pred             -CcccccCcceEEEEEE--eeeccccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQIR  182 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~~r  182 (477)
                       +.+|- |++|+++|.+  |..||.+.+.
T Consensus       231 GPEVDs-WsLGvLLYtLVyGtMPFDG~Dh  258 (668)
T KOG0611|consen  231 GPEVDS-WSLGVLLYTLVYGTMPFDGRDH  258 (668)
T ss_pred             CCccch-hhHHHHHHHHhhcccccCCchH
Confidence             77898 9999999998  7899987543

>KOG0661|consensus

Probab=99.96  E-value=4.1e-31  Score=258.15  Aligned_cols=184  Identities=22%  Similarity=0.354  Sum_probs=150.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCC-eEEEEEecCCCCCHHHHHHhCC-CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDER-YVYIILEYCDGGDLCSFIRSHE-KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~-~l~~~   78 (477)
                      ++|+.||||.++++..+-+..- =.||++.|++|+ ||||+++.+++.+.. .+|+|||||+ .+|.++++.++ .+++.
T Consensus        33 ~~~~~VAIK~MK~Kf~s~ee~~-nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R~r~fse~  110 (538)
T KOG0661|consen   33 ETGELVAIKKMKKKFYSWEECM-NLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDRNRLFSES  110 (538)
T ss_pred             CCCceeeHHHHHhhhccHHHHH-HHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhcCCcCCHH
Confidence            5788999999998876643322 357999999998 999999999998877 9999999998 89999998754 69999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .++.|++||++||+|+|.+|+.|||+||+|||+.. +-+|+  .|||+++.......+   +..|-|.||+|||++.+. 
T Consensus       111 ~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKi--aDFGLARev~SkpPY---TeYVSTRWYRAPEvLLrs~  185 (538)
T KOG0661|consen  111 DIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKI--ADFGLAREVRSKPPY---TEYVSTRWYRAPEVLLRSG  185 (538)
T ss_pred             HHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEe--cccccccccccCCCc---chhhhcccccchHHhhhcc
Confidence            99999999999999999999999999999999984 45555  599999877655421   346888999999998876 


Q ss_pred             ---CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHH
Q psy6508         157 ---TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLK  199 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~  199 (477)
                         .++|+ |++||+++|+.      .-|+.|++..+.+++.++..
T Consensus       186 ~Ys~pvD~-wA~GcI~aEl~------sLrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  186 YYSSPVDM-WAVGCIMAELY------SLRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             ccCCchHH-HHHHHHHHHHH------HhcccCCCCcHHHHHHHHHH
Confidence               77999 99999999992      12223345555555555544

>KOG0597|consensus

Probab=99.96  E-value=1.4e-30  Score=258.48  Aligned_cols=196  Identities=26%  Similarity=0.346  Sum_probs=162.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+.+.||||.+.+...+++..+.+.+|+++++.++||||+.++++|+...++|+|+|||. |+|..++...+.++++.++
T Consensus        25 ~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~-g~L~~il~~d~~lpEe~v~  103 (808)
T KOG0597|consen   25 YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV-GDLFTILEQDGKLPEEQVR  103 (808)
T ss_pred             cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh-hhHHHHHHhccCCCHHHHH
Confidence            467899999999998888888999999999999999999999999999999999999998 5999999999999999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||+++|+|||+||+|||++.+. .+..+|||+++...-..  ..-....||+.||+||...+.   ..
T Consensus       104 ~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m~~~t--~vltsikGtPlYmAPElv~e~pyd~~  180 (808)
T KOG0597|consen  104 AIAYDLVSALYYLHSNRILHRDMKPQNILLEKGG-TLKLCDFGLARAMSTNT--SVLTSIKGTPLYMAPELVEEQPYDHT  180 (808)
T ss_pred             HHHHHHHHHHHHHHhcCcccccCCcceeeecCCC-ceeechhhhhhhcccCc--eeeeeccCcccccCHHHHcCCCccch
Confidence            9999999999999999999999999999998753 33446999986433211  111234678899999999887   77


Q ss_pred             ccccCcceEEEEEE--eeeccccccc----------cCCCCCcchHHHHHHHHHHh
Q psy6508         159 LEYQRSKGELYVEF--KFAPFASQIR----------TGWLRDSEEKELGNHLKRAL  202 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~~~r----------~~~~~~~~~~~l~~~i~~~l  202 (477)
                      +|. ||+||++||+  |.+||....-          +..++..-...+..+++..+
T Consensus       181 sDl-WslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL  235 (808)
T KOG0597|consen  181 SDL-WSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL  235 (808)
T ss_pred             hhH-HHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence            899 9999999999  8899975431          11133444555666666544

>KOG0192|consensus

Probab=99.96  E-value=2e-30  Score=258.03  Aligned_cols=174  Identities=21%  Similarity=0.248  Sum_probs=149.6

Q ss_pred             CcE-EEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-eEEEEEecCCCCCHHHHHHh--CCCCCHHH
Q psy6508           4 HTE-VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEYCDGGDLCSFIRS--HEKLSEFQ   79 (477)
Q Consensus         4 g~~-vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~lv~e~~~g~sL~~~l~~--~~~l~~~~   79 (477)
                      |.. ||+|++.....+....+.|.+|+.+|++++|||||+++|++.+.. ..+|||||+++|+|.+++.+  +..++...
T Consensus        64 g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~  143 (362)
T KOG0192|consen   64 GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKV  143 (362)
T ss_pred             CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHH
Confidence            556 999999887766655789999999999999999999999999887 79999999999999999988  56899999


Q ss_pred             HHHHHHHHHHHHHHHHhCC-cEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC--C
Q psy6508          80 CQQFVRQLVLALKFLRENN-VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS--K  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~--~  156 (477)
                      +..|+.||+.|+.|||+++ ||||||||+|||++.+...+.++|||+++....+.  .......||..|||||++.+  .
T Consensus       144 ~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~  221 (362)
T KOG0192|consen  144 RLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKS  221 (362)
T ss_pred             HHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCccccChhhhcCCCC
Confidence            9999999999999999999 99999999999999875566667999997554332  12223578899999999993  3


Q ss_pred             ---CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                         .++|+ ||+|+++||+  +-.||.+.
T Consensus       222 ~~~~K~Dv-ySFgIvlWEl~t~~~Pf~~~  249 (362)
T KOG0192|consen  222 PYTEKSDV-YSFGIVLWELLTGEIPFEDL  249 (362)
T ss_pred             cCCccchh-hhHHHHHHHHHHCCCCCCCC
Confidence               88999 9999999999  45688753

>KOG0593|consensus

Probab=99.96  E-value=1.7e-30  Score=240.75  Aligned_cols=187  Identities=21%  Similarity=0.319  Sum_probs=154.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      ++|+.||||++.-+..++...+-.++|+++|++|+|||+|.++.+|.....+++|+|||+ .++.+-|+... .++...+
T Consensus        25 ~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~d-hTvL~eLe~~p~G~~~~~v  103 (396)
T KOG0593|consen   25 DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCD-HTVLHELERYPNGVPSELV  103 (396)
T ss_pred             CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecc-hHHHHHHHhccCCCCHHHH
Confidence            689999999987666555555668899999999999999999999999999999999998 56666676654 6999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +++++|++.|+.|+|+++++||||||+|||++.+++ +.+||||.++...+..  +..+..|.|.||.+||.+.+.    
T Consensus       104 k~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gv-vKLCDFGFAR~L~~pg--d~YTDYVATRWYRaPELLvGDtqYG  180 (396)
T KOG0593|consen  104 KKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGV-VKLCDFGFARTLSAPG--DNYTDYVATRWYRAPELLVGDTQYG  180 (396)
T ss_pred             HHHHHHHHHHhhhhhhcCeecccCChhheEEecCCc-EEeccchhhHhhcCCc--chhhhhhhhhhccChhhhcccCcCC
Confidence            999999999999999999999999999999987542 3346999987654311  223457889999999999885    


Q ss_pred             CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHH
Q psy6508         157 TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLK  199 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~  199 (477)
                      .++|+ |+.||++.||.      .+.+.|++..+.+++-.+.+
T Consensus       181 ~pVDi-WAiGCv~aEl~------~G~pL~PG~SDiDQLy~I~k  216 (396)
T KOG0593|consen  181 KPVDI-WAIGCVFAELL------TGEPLWPGRSDIDQLYLIRK  216 (396)
T ss_pred             Ccccc-hhhhHHHHHHh------cCCcCCCCcchHHHHHHHHH
Confidence            78999 99999999995      44556677777777766654

>KOG0588|consensus

Probab=99.96  E-value=5.3e-30  Score=258.92  Aligned_cols=175  Identities=25%  Similarity=0.418  Sum_probs=155.5

Q ss_pred             CCCcEEEEEEcccC-CCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      +||+.+|||++.+. ..++.....+.+|+-+|+-+.|||++++|++|+...++|+|.||++||.|++++-+++++++.++
T Consensus        35 ~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~ea  114 (786)
T KOG0588|consen   35 ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREA  114 (786)
T ss_pred             cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHH
Confidence            68999999999887 55566667889999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      .++++||+.|+.|+|..+|+||||||+|+|++..+- +.+.|||.+....+....   .|..|.+.|.+||+..|.    
T Consensus       115 a~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~n-IKIADFGMAsLe~~gklL---eTSCGSPHYA~PEIV~G~pYdG  190 (786)
T KOG0588|consen  115 AHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNN-IKIADFGMASLEVPGKLL---ETSCGSPHYAAPEIVSGRPYDG  190 (786)
T ss_pred             HHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccC-EeeeccceeecccCCccc---cccCCCcccCCchhhcCCCCCC
Confidence            999999999999999999999999999999986432 445599998765444332   477899999999999988    


Q ss_pred             CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      .++|+ ||.|+|+|-+  |..||.+.+
T Consensus       191 ~~sDV-WSCGVILfALLtG~LPFdDdN  216 (786)
T KOG0588|consen  191 RPSDV-WSCGVILFALLTGKLPFDDDN  216 (786)
T ss_pred             Ccccc-chhHHHHHHHHhCCCCCCCcc
Confidence            78999 9999999998  789998754

>KOG0578|consensus

Probab=99.96  E-value=6e-30  Score=255.53  Aligned_cols=208  Identities=25%  Similarity=0.375  Sum_probs=170.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||||++.......  .+-+.+|+.+|+..+|+|||++++.|...+.+|+||||++||+|.+.+... .+++.++.
T Consensus       296 ~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA  372 (550)
T KOG0578|consen  296 STKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIA  372 (550)
T ss_pred             cCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHH
Confidence            367889999998886544  356899999999999999999999998889999999999999999988764 69999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .+++++++||+|||.+||+|||||.+|||++. +.+++.  |||++.......  ..-.|.+||+.|||||+..+.   +
T Consensus       373 ~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKlt--DFGFcaqi~~~~--~KR~TmVGTPYWMAPEVvtrk~YG~  448 (550)
T KOG0578|consen  373 AICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLT--DFGFCAQISEEQ--SKRSTMVGTPYWMAPEVVTRKPYGP  448 (550)
T ss_pred             HHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEe--eeeeeecccccc--CccccccCCCCccchhhhhhcccCc
Confidence            99999999999999999999999999999975 455555  999987655432  244689999999999999885   8


Q ss_pred             cccccCcceEEEEEE--eeecccccccc---------CCCCCcchHHHHHHHHHHhhhhhhcccCCCCccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQIRT---------GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVD  217 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~~r~---------~~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~  217 (477)
                      ++|| ||+|++.+||  |-+||.....-         +.+.-.....++..++..|..+++.+...|....
T Consensus       449 KVDI-WSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~  518 (550)
T KOG0578|consen  449 KVDI-WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAK  518 (550)
T ss_pred             cccc-hhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHH
Confidence            9999 9999999999  88999853211         2233344556677777777777776666666543

>KOG0582|consensus

Probab=99.96  E-value=1.9e-29  Score=244.79  Aligned_cols=175  Identities=28%  Similarity=0.399  Sum_probs=151.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      +.+..||||+++.+..+.+ .+.+++|++.|+.++||||++++..|..+..+|+||.||.+|++.++++..  ..+++..
T Consensus        49 p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~  127 (516)
T KOG0582|consen   49 PTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEAS  127 (516)
T ss_pred             ccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHH
Confidence            4678999999999887765 788999999999999999999999999999999999999999999999874  3599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceeccc--CCc-ccccCCeEEEeccccccccCCC
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAK--GSA-YIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~--gs~-~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..|++++++||.|||.+|.+|||||+.||||+++ .+++.  |||++....  |.. ..+. +|.++++.|++||++..
T Consensus       128 Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLa--dFgvsa~l~~~G~R~~~rf-~tfvgtp~wmAPEvl~q  204 (516)
T KOG0582|consen  128 IATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLA--DFGVSASLFDSGDRQVTRF-NTFVGTPCWMAPEVLMQ  204 (516)
T ss_pred             HHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEc--CceeeeeecccCceeeEee-ccccCcccccChHHhhh
Confidence            99999999999999999999999999999999764 55555  888775432  221 1222 78899999999999654


Q ss_pred             C-----CcccccCcceEEEEEE--eeecccccc
Q psy6508         156 K-----TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       156 ~-----~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      .     .++|| ||+|++.+|+  |.+||....
T Consensus       205 ~~~GYdfKaDI-wSfGITA~ELA~G~aPf~k~p  236 (516)
T KOG0582|consen  205 QLHGYDFKADI-WSFGITACELAHGHAPFSKYP  236 (516)
T ss_pred             cccCccchhhh-hhhhHHHHHHhcCCCCcccCC
Confidence            4     88999 9999999999  889998644

>KOG0605|consensus

Probab=99.96  E-value=1.4e-29  Score=251.11  Aligned_cols=176  Identities=23%  Similarity=0.403  Sum_probs=152.1

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .||+.+|+|++++..+- ..+.+.++.|-.+|....+|+||++|-.|++..++||||||++||++..+|.+.+.+++..+
T Consensus       164 ~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~a  243 (550)
T KOG0605|consen  164 DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWA  243 (550)
T ss_pred             cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHH
Confidence            68999999999988763 35567789999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCc---------------------ccc--
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSA---------------------YIE--  136 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~---------------------~~~--  136 (477)
                      +.++.+++.|+..||+.|++||||||+|+|||. +.+|+.  |||++.....+.                     ...  
T Consensus       244 rfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLS--DFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (550)
T KOG0605|consen  244 RFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLS--DFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKF  321 (550)
T ss_pred             HHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeec--cccccchhhhhhhhhhhcchhhhhhhhccCCCcccccc
Confidence            999999999999999999999999999999986 566666  999874321100                     000  


Q ss_pred             -----c-----------------CCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         137 -----Q-----------------GNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       137 -----~-----------------g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                           .                 -...+|||-|+|||++.+.   ...|+ ||+|||+|||  ||+||.+.
T Consensus       322 ~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw-WSLG~ImyEmLvGyPPF~s~  391 (550)
T KOG0605|consen  322 NTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW-WSLGCIMYEMLVGYPPFCSE  391 (550)
T ss_pred             ccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH-HHHHHHHHHHHhCCCCCCCC
Confidence                 0                 0146899999999999887   77899 9999999999  99999963

>KOG0610|consensus

Probab=99.96  E-value=2.7e-29  Score=241.88  Aligned_cols=179  Identities=23%  Similarity=0.427  Sum_probs=147.6

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~   78 (477)
                      .++..+|+|++.+.... .+...+...|..||+.++||+++.+|..|+.+...|++||||+||+|..+++++  +.+++.
T Consensus       100 ~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~  179 (459)
T KOG0610|consen  100 GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSES  179 (459)
T ss_pred             CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchh
Confidence            45689999999988764 455678899999999999999999999999999999999999999999999875  379999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCC------------------------c
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGS------------------------A  133 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs------------------------~  133 (477)
                      .++.++.+++.||+|||..|||+|||||+||||.++ .+-+.  ||.++.++..+                        +
T Consensus       180 ~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLs--DFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~  257 (459)
T KOG0610|consen  180 AARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLS--DFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSC  257 (459)
T ss_pred             hHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEee--eccccccCCCCCeeeccCCCCCCCCCcccccccccc
Confidence            999999999999999999999999999999999764 44444  44443222110                        0


Q ss_pred             c------------------------------cccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeeccc
Q psy6508         134 Y------------------------------IEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       134 ~------------------------------~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      .                              -...+..|||-.|.|||++.|.   .++|+ |.+|+++|||  |..||.
T Consensus       258 f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDW-WtfGIflYEmLyG~TPFK  336 (459)
T KOG0610|consen  258 FSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDW-WTFGIFLYEMLYGTTPFK  336 (459)
T ss_pred             cccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhH-HHHHHHHHHHHhCCCCcC
Confidence            0                              0112356888889999999987   88999 9999999999  668998


Q ss_pred             ccccc
Q psy6508         179 SQIRT  183 (477)
Q Consensus       179 ~~~r~  183 (477)
                      +.++.
T Consensus       337 G~~~~  341 (459)
T KOG0610|consen  337 GSNNK  341 (459)
T ss_pred             CCCch
Confidence            75543

>KOG0594|consensus

Probab=99.96  E-value=5.2e-29  Score=237.48  Aligned_cols=191  Identities=28%  Similarity=0.358  Sum_probs=157.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCC-ccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhCC-
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQH-IVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSHE-   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~-   73 (477)
                      .+|+.||+|++..+...+.......+|+.+|+.|+|+| |+++++++..++      .+++|+||++ .+|..++.... 
T Consensus        34 ~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~~  112 (323)
T KOG0594|consen   34 RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLPK  112 (323)
T ss_pred             cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhccc
Confidence            47899999999887654444456789999999999999 999999998777      8999999998 89999998755 


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccc
Q psy6508          74 ---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEP  149 (477)
Q Consensus        74 ---~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~p  149 (477)
                         .++...++.+++||+.||.|||++||+||||||+|||+++. .++  ++|||+++... -. ...-.+.+.|.||.|
T Consensus       113 ~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lK--laDFGlAra~~-ip-~~~yt~evvTlWYRa  188 (323)
T KOG0594|consen  113 KPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLK--LADFGLARAFS-IP-MRTYTPEVVTLWYRA  188 (323)
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEe--eeccchHHHhc-CC-cccccccEEEeeccC
Confidence               47888999999999999999999999999999999999874 454  45999986322 11 123457899999999


Q ss_pred             cccCCCC----CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHHHHhhh
Q psy6508         150 REIPSSK----TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEP  204 (477)
Q Consensus       150 pE~~~~~----~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~l~~  204 (477)
                      ||++.+.    ..+|+ ||+||++.||.      .+++.++++.+..++.++.+-.-.|
T Consensus       189 PEvLlGs~~Ys~~vDi-Ws~GcIfaEm~------~~~~LFpG~se~~ql~~If~~lGtP  240 (323)
T KOG0594|consen  189 PEVLLGSTSYSTSVDI-WSLGCIFAEMF------TRRPLFPGDSEIDQLFRIFRLLGTP  240 (323)
T ss_pred             HHHhcCCCcCCCCcch-HhHHHHHHHHH------hCCCCCCCCcHHHHHHHHHHHcCCC
Confidence            9999887    77899 99999999995      2455667788888888887754433

>KOG0660|consensus

Probab=99.96  E-value=2.3e-29  Score=239.27  Aligned_cols=175  Identities=25%  Similarity=0.332  Sum_probs=147.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-----CCeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-----ERYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||++.....+.-..++..+|+++|+.++|+||+.+++++..     -+.+|+|+|+|+ .+|.+.++.+..++
T Consensus        45 ~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-tDL~~iik~~~~L~  123 (359)
T KOG0660|consen   45 RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-TDLHQIIKSQQDLT  123 (359)
T ss_pred             CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-hHHHHHHHcCcccc
Confidence            578999999998777677777889999999999999999999999865     246999999996 89999999987799


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..+..+++|++.||+|+|+.|++||||||.|++++.+. .+.++|||+++..+.......-+..+.|.||.+||.....
T Consensus       124 d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~  202 (359)
T KOG0660|consen  124 DDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADC-DLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNS  202 (359)
T ss_pred             HHHHHHHHHHHHHhcchhhcccccccccchhheeeccCC-CEEeccccceeeccccCcccchhcceeeeeecCHHHHhcc
Confidence            999999999999999999999999999999999998762 4466799999887643111111347889999999998655


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ ||.|||+.||  +.+-|.|
T Consensus       203 ~~Yt~aiDi-WSvGCI~AEmL~gkplFpG  230 (359)
T KOG0660|consen  203 SEYTKAIDI-WSVGCILAEMLTGKPLFPG  230 (359)
T ss_pred             ccccchhhh-hhhhHHHHHHHcCCCCCCC
Confidence                77899 9999999999  3344443

>PRK00173 rph ribonuclease PH; Reviewed

Probab=99.95  E-value=2.7e-27  Score=223.83  Aligned_cols=210  Identities=20%  Similarity=0.265  Sum_probs=185.7

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecccccccc-----CCCCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT-----GWLRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~-----~~~~~  188 (477)
                      +++|.+.+.+|....++||++++.|+|++.+.++++.+.....   +- -..|.+.+++.+.||++..+.     ...++
T Consensus         9 ~e~R~i~~~~g~~~~a~GSa~v~~G~T~Vla~V~~~~~~p~~~---~~-~~~g~l~v~~~~~p~a~~~~~~~~~~~g~~~   84 (238)
T PRK00173          9 DQLRPVTITRNFTKHAEGSVLVEFGDTKVLCTASVEEGVPRFL---KG-QGQGWVTAEYGMLPRATHTRNDREAAKGKQG   84 (238)
T ss_pred             ccccCeEEEeCCCCCCCeeEEEEecCcEEEEEEEcCCCCCCcc---CC-CCcEEEEEEEecCCCCCcccccccccCCCCC
Confidence            5789999999999999999999999999999999876654322   11 346899999999999987663     22455


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhC-----------CCCCCceEEEEEE
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDA-----------AIPMYDLVTSSTL  257 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~da-----------gi~m~~~v~a~s~  257 (477)
                      ....++++.+++.+++.+.++.+|+..++|.+++|++||+.+.+++||+++||+||           |+||.++++++|+
T Consensus        85 ~~~~~~sr~i~r~lr~~i~l~~l~~~~i~v~v~VL~~DG~~~~aai~Aa~~AL~da~~~~~~~~~~~~ip~~~~~~~vt~  164 (238)
T PRK00173         85 GRTQEIQRLIGRSLRAVVDLKALGERTITIDCDVIQADGGTRTASITGAYVALADALNKLVARGKLKKNPLKDQVAAVSV  164 (238)
T ss_pred             ccHHHHHHHHHHHHHHhcCHHHcCCeEEEEEEEEEeCCCCHHHHHHHHHHHHHHHhhhhhhccCcccCCcccCceeEEEE
Confidence            67899999999999999999999999999999999999999999999999999999           9999999999999


Q ss_pred             EeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe---eecHHHHHHHHHHHHhcccchhhHHH
Q psy6508         258 ALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG---TIQQERLADHIEQLIGCCESLCTDRV  334 (477)
Q Consensus       258 ~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g---~~~~~~~~~~l~~~~~~~~~i~~~~i  334 (477)
                      ++.++.+++|||.+||..          +.+.+++++ ++.++|+.+++.|   .++.+++.++++.|.++|+++.+. +
T Consensus       165 ~~~~~~~lvDpt~~Ee~~----------~~~~l~v~~-~~~~~i~~v~~~g~g~~~~~e~l~~~i~~A~~~~~~l~~~-~  232 (238)
T PRK00173        165 GIVDGEPVLDLDYEEDSA----------AETDMNVVM-TGSGGFVEVQGTAEGAPFSREELDALLDLAEKGIAELVAL-Q  232 (238)
T ss_pred             EEECCEEEECCCHHHHhc----------CCceEEEEE-CCCCCEEEEEccCCCCCcCHHHHHHHHHHHHHHHHHHHHH-H
Confidence            999999999999999984          478899986 5577899999854   699999999999999999999999 8


Q ss_pred             HhHhh
Q psy6508         335 QKLVS  339 (477)
Q Consensus       335 ~~~l~  339 (477)
                      ++.|.
T Consensus       233 ~~~l~  237 (238)
T PRK00173        233 KAALA  237 (238)
T ss_pred             HHHhc
Confidence            88775

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=5.4e-28  Score=240.62  Aligned_cols=174  Identities=17%  Similarity=0.275  Sum_probs=145.5

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++... .......+.+|+.++++++||||+++++++...+.+|+||||++|++|.+++..++.+++..+
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~   97 (323)
T cd05571          18 ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA   97 (323)
T ss_pred             CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHH
Confidence            5789999999976543 233456788999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.||+.||+|||++||+||||||+||+++.+. .+.++|||++.......  ....+..+++.|+|||...+.   .
T Consensus        98 ~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  174 (323)
T cd05571          98 RFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGR  174 (323)
T ss_pred             HHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC--CcccceecCccccChhhhcCCCCCc
Confidence            99999999999999999999999999999997653 34445999875422111  122346788999999998765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||  +..||.+
T Consensus       175 ~~Di-wSlG~il~elltg~~Pf~~  197 (323)
T cd05571         175 AVDW-WGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             cccC-cccchhhhhhhcCCCCCCC
Confidence            7899 9999999999  6678764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0585|consensus

Probab=99.95  E-value=8.4e-29  Score=241.78  Aligned_cols=174  Identities=28%  Similarity=0.425  Sum_probs=140.0

Q ss_pred             CCCcEEEEEEcccCCCChh------------HHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSEN------------RFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCS   67 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~   67 (477)
                      .+++.||||++.+......            ..++..+|+.+|++++|||||+++.+..+  .+.+|||+|||..|.+..
T Consensus       120 ~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w  199 (576)
T KOG0585|consen  120 VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW  199 (576)
T ss_pred             CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCcccc
Confidence            3689999999988654321            23578999999999999999999999864  457999999999888754


Q ss_pred             HHHhCCC-CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecc-----cCCcccccCCeE
Q psy6508          68 FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKA-----KGSAYIEQGNTK  141 (477)
Q Consensus        68 ~l~~~~~-l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~-----~gs~~~~~g~t~  141 (477)
                      .=. .+. +++.++++++++++.||+|||.+||+||||||+|+|+++++ ++.+.|||++..+     .|+-.  +-...
T Consensus       200 ~p~-d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g-~VKIsDFGVs~~~~~~~~~~~d~--~L~~t  275 (576)
T KOG0585|consen  200 CPP-DKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG-TVKISDFGVSNEFPQGSDEGSDD--QLSRT  275 (576)
T ss_pred             CCC-CcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC-cEEeeccceeeecccCCccccHH--HHhhc
Confidence            322 234 89999999999999999999999999999999999997753 3344599998754     12211  11237


Q ss_pred             EEeccccccccCCCC-------CcccccCcceEEEEEE--eeeccccc
Q psy6508         142 VICSVFEPREIPSSK-------TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       142 v~~~~y~ppE~~~~~-------~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      +||+.|+|||...+.       .+.|+ |++|+++|-+  |..||.+.
T Consensus       276 vGTPAF~APE~c~~~~~~~~~g~a~Di-WalGVTLYCllfG~~PF~~~  322 (576)
T KOG0585|consen  276 VGTPAFFAPELCSGGNSFSYSGFALDI-WALGVTLYCLLFGQLPFFDD  322 (576)
T ss_pred             CCCccccchHhhcCCCCccccchhhhh-hhhhhhHHHhhhccCCcccc
Confidence            999999999998773       77899 9999999998  77899864

>KOG0658|consensus

Probab=99.95  E-value=1.7e-29  Score=240.58  Aligned_cols=228  Identities=25%  Similarity=0.338  Sum_probs=169.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-----eEEEEEecCCCCCHHHHHHh----C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-----YVYIILEYCDGGDLCSFIRS----H   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~----~   72 (477)
                      ++++.||||++-.+..-.      .+|+++|+.+.|||||++.-+|....     ...+||||++ .+|.++++.    +
T Consensus        47 e~~~~vAIKKv~~d~r~k------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP-~tL~~~~r~~~~~~  119 (364)
T KOG0658|consen   47 ETEEEVAIKKVLQDKRYK------NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP-ETLYRVIRHYTRAN  119 (364)
T ss_pred             CCCceeEEEEecCCCCcC------cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch-HHHHHHHHHHhhcC
Confidence            467899999876553211      27999999999999999988876432     4569999998 899999984    4


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      .+++...++-+.+||..||.|||+.||+||||||+|+|+|.+...+.++|||.++.....   +...+.+.+..|.|||.
T Consensus       120 ~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~---epniSYicSRyYRaPEL  196 (364)
T KOG0658|consen  120 QRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG---EPNISYICSRYYRAPEL  196 (364)
T ss_pred             CCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC---CCceeEEEeccccCHHH
Confidence            679999999999999999999999999999999999999998888888999998764422   12346677778999999


Q ss_pred             CCCC----CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHHHHhhh----------hhhcccC-------
Q psy6508         153 PSSK----TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEP----------AVCRHEF-------  211 (477)
Q Consensus       153 ~~~~----~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~l~~----------~i~~~~~-------  211 (477)
                      +.+.    .++|+ ||.||++.||.      .+++-++++....++..+++-.-.|          .-...++       
T Consensus       197 ifga~~Yt~~IDi-WSaGCV~aELl------~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~  269 (364)
T KOG0658|consen  197 IFGATEYTTSIDI-WSAGCVMAELL------KGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHP  269 (364)
T ss_pred             HcCccccCceeEE-hhhhHHHHHHh------cCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCccccccc
Confidence            9987    78999 99999999993      2223334555556666666522111          1111222       


Q ss_pred             ---------CCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCC
Q psy6508         212 ---------SNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI  246 (477)
Q Consensus       212 ---------Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi  246 (477)
                               |...++....+|+-++..+.++..|.+..+.|.-.
T Consensus       270 ~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr  313 (364)
T KOG0658|consen  270 WHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELR  313 (364)
T ss_pred             ceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhh
Confidence                     22334445556667777888888888877776643

>KOG0663|consensus

Probab=99.95  E-value=1.8e-28  Score=230.17  Aligned_cols=188  Identities=24%  Similarity=0.330  Sum_probs=155.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCC-CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHE-KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~-~l~~~   78 (477)
                      .+++.||+|+++.+.-.....-.-.+|+.+|.+.+|||||.+-.+....  +.+|||||||+ .+|..++...+ ++...
T Consensus        99 ~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~  177 (419)
T KOG0663|consen   99 KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPG  177 (419)
T ss_pred             CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccCCCchH
Confidence            5788999999988764333233467999999999999999999987644  47999999998 89999998865 89999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      +++.++.|++.|++|||.+.|+||||||+|+|++. +.+|+.  |||+++ ..|+.. ..-+..|.|.||.|||.+.+. 
T Consensus       178 evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKia--DFGLAR-~ygsp~-k~~T~lVVTLWYRaPELLLG~~  253 (419)
T KOG0663|consen  178 EVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIA--DFGLAR-EYGSPL-KPYTPLVVTLWYRAPELLLGAK  253 (419)
T ss_pred             HHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEec--ccchhh-hhcCCc-ccCcceEEEeeecCHHHhcCCc
Confidence            99999999999999999999999999999999965 566665  999985 455552 223467999999999999887 


Q ss_pred             ---CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHHHH
Q psy6508         157 ---TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRA  201 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~  201 (477)
                         .++|+ ||.|||+-|+.      ..++.+++..+..++.++++-.
T Consensus       254 tyst~iDM-WSvGCI~aE~l------~~kPlf~G~sE~dQl~~If~ll  294 (419)
T KOG0663|consen  254 TYSTAVDM-WSVGCIFAELL------TQKPLFPGKSEIDQLDKIFKLL  294 (419)
T ss_pred             ccCcchhh-hhHHHHHHHHH------hcCCCCCCCchHHHHHHHHHHh
Confidence               78999 99999999994      2334446778888888887743

>TIGR01966 RNasePH ribonuclease PH

Probab=99.95  E-value=9.3e-27  Score=220.05  Aligned_cols=209  Identities=22%  Similarity=0.279  Sum_probs=180.8

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC-----CCCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-----WLRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-----~~~~  188 (477)
                      +++|.+.+.+|++..++||++++.|+|++.+.++.+.+.....   +- -.-|.+.+++.+.||++..+..     ....
T Consensus         8 ~e~R~i~i~~G~~~~A~GSa~v~~G~T~Vla~V~~~~~~p~~~---~~-~~~g~l~v~~~~~p~a~~~~~~r~~~~g~~~   83 (236)
T TIGR01966         8 DQLRPVSITRDFLKHAEGSVLIEFGNTKVLCTASVEEKVPPFL---RG-SGEGWITAEYGMLPRATQTRNRRESAKGKQS   83 (236)
T ss_pred             CCccCeEEEeCCcCCCCceEEEEecCCEEEEEEEccCccCCcc---cC-CCcEEEEEEEecCCCCCCCCccccccCCCCC
Confidence            5788999999999999999999999999999999544432211   11 2468999999999999865421     1233


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhC-----------CCCCCceEEEEEE
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDA-----------AIPMYDLVTSSTL  257 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~da-----------gi~m~~~v~a~s~  257 (477)
                      ....++++.+++.+++.+.++.||+..|+|.+++|++||+.+++|+||+++||+||           |+||+++++++|+
T Consensus        84 ~~~~e~~~~i~r~lr~~i~l~~l~~~~i~I~v~VL~~DG~~~~aai~Aa~aAL~da~~~~~~~~~~~~ip~~~~~~~vt~  163 (236)
T TIGR01966        84 GRTQEIQRLIGRALRAVVDLEALGERTIWIDCDVIQADGGTRTASITGAFVALADAISKLHKRGILKESPIRDFVAAVSV  163 (236)
T ss_pred             ccHHHHHHHHHHHHHHhcCHhhcCCeEEEEEEEEEeCCCCHHHHHHHHHHHHHHHHHHhhhhcCcccCCCccCceeEEEE
Confidence            35778999999999999999999999999999999999999999999999999999           9999999999999


Q ss_pred             EeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE---eeecHHHHHHHHHHHHhcccchhhHHH
Q psy6508         258 ALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV---GTIQQERLADHIEQLIGCCESLCTDRV  334 (477)
Q Consensus       258 ~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~---g~~~~~~~~~~l~~~~~~~~~i~~~~i  334 (477)
                      ++.++.+++|||..||..          ..+.+++++.+ .++|+.++..   +.++.+++.++++.|.++|+.+++. +
T Consensus       164 ~~~~~~~v~Dpt~~Ee~~----------~~~~l~l~~~~-~~~i~~i~~~g~~~~~~~~~l~~~i~~a~~~~~~l~~~-~  231 (236)
T TIGR01966       164 GIVDGEPVLDLDYEEDSA----------ADVDMNVVMTG-SGGFVEVQGTAEEGPFSRDELNKLLDLAKKGIRELIEL-Q  231 (236)
T ss_pred             EEECCEEEECCChhHHhc----------cCceEEEEEcC-CCCEEEEEecCCCCCcCHHHHHHHHHHHHHHHHHHHHH-H
Confidence            999999999999999984          46889998754 6899999985   4799999999999999999999999 8


Q ss_pred             HhHh
Q psy6508         335 QKLV  338 (477)
Q Consensus       335 ~~~l  338 (477)
                      ++.|
T Consensus       232 ~~~l  235 (236)
T TIGR01966       232 KQAL  235 (236)
T ss_pred             HHHh
Confidence            8765

This bacterial enzyme, ribonuclease PH, performs the final 3'-trimming and modification of tRNA precursors. This model is restricted absolutely to bacteria. Related families outside the model include proteins described as probable exosome complex exonucleases (rRNA processing) and polyribonucleotide nucleotidyltransferases (mRNA degradation). The most divergent member within the family is RNase PH from Deinococcus radiodurans.

>KOG0589|consensus

Probab=99.95  E-value=2e-28  Score=243.10  Aligned_cols=175  Identities=27%  Similarity=0.369  Sum_probs=152.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCe-EEEEEecCCCCCHHHHHHhCC--CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY-VYIILEYCDGGDLCSFIRSHE--KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-~~lv~e~~~g~sL~~~l~~~~--~l~~~   78 (477)
                      .+++.|++|.+.....++..++...+|+.++++++|||||.+++.|+.++. .+|+|+||+||+|.+.+.+.+  .++++
T Consensus        27 ~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~  106 (426)
T KOG0589|consen   27 SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEE  106 (426)
T ss_pred             cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHH
Confidence            356789999999999888777889999999999999999999999998887 999999999999999997754  59999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..|+.|++.|+.|||+++|+|||||+.|||++.+ .+++  .|||+++......  ..-.|.+||+.|++||.+.+. 
T Consensus       107 ~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkL--gDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~p  182 (426)
T KOG0589|consen  107 RILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKL--GDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIP  182 (426)
T ss_pred             HHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceee--cchhhhhhcCCch--hhhheecCCCcccCHHHhCCCC
Confidence            999999999999999999999999999999999765 4544  5999987544322  234588999999999999887 


Q ss_pred             --CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                        .++|+ |++||++|||  ..++|...+
T Consensus       183 Yn~KSDi-WsLGC~~yEm~~lk~aF~a~~  210 (426)
T KOG0589|consen  183 YNEKSDI-WSLGCCLYEMCTLKPAFKASN  210 (426)
T ss_pred             CCccCcc-hhhcchHHHHHhcccccCccc
Confidence              88999 9999999999  446666543

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.95  E-value=3.6e-27  Score=234.88  Aligned_cols=174  Identities=17%  Similarity=0.279  Sum_probs=144.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++++... .......+.+|+.+++.++||||+++++++...+..|+||||++|++|..++...+.+++..+
T Consensus        18 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~   97 (325)
T cd05594          18 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA   97 (325)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence            4789999999976543 233456778999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.++.|++.||.|||+ +||+||||||+|||++.+. .+.++|||++.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (325)
T cd05594          98 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYG  174 (325)
T ss_pred             HHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC--cccccccCCcccCCHHHHccCCCC
Confidence            9999999999999997 7999999999999997653 34445999875432211  111244678899999998665   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       175 ~~~Di-wslG~il~el~tG~~Pf~~  198 (325)
T cd05594         175 RAVDW-WGLGVVMYEMMCGRLPFYN  198 (325)
T ss_pred             Ccccc-ccccceeeeeccCCCCCCC
Confidence            77899 9999999999  6678864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=2.7e-27  Score=235.01  Aligned_cols=174  Identities=22%  Similarity=0.310  Sum_probs=144.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|++++..........+.+|+.++++++||||+++++++..++.+|+||||++|++|.+++.+...+++..+.
T Consensus        22 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~  101 (318)
T cd05582          22 DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK  101 (318)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHH
Confidence            46889999999865544444566789999999999999999999999999999999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++||+||||||+||+++.+. .+.++|||++.......  ....+..++..|+|||...+.   .+
T Consensus       102 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~  178 (318)
T cd05582         102 FYLAELALALDHLHSLGIIYRDLKPENILLDEEG-HIKLTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQS  178 (318)
T ss_pred             HHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCC-cEEEeeccCCcccCCCC--CceecccCChhhcCHHHHcCCCCCCc
Confidence            9999999999999999999999999999997643 34445999875433211  111234567889999988665   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|+++|++  +..||..
T Consensus       179 ~Di-wslG~il~el~tg~~p~~~  200 (318)
T cd05582         179 ADW-WSFGVLMFEMLTGSLPFQG  200 (318)
T ss_pred             cce-eccceEeeeeccCCCCCCC
Confidence            899 9999999999  5677764

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0667|consensus

Probab=99.95  E-value=9.6e-28  Score=244.05  Aligned_cols=183  Identities=27%  Similarity=0.388  Sum_probs=153.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-C-----CCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-H-----QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-H-----pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--   73 (477)
                      ++++.||||++++..   ....+...|+.+|..|+ |     -|+|+++++|...+++|||+|.++ .+|.++++.++  
T Consensus       209 ~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~  284 (586)
T KOG0667|consen  209 KTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFR  284 (586)
T ss_pred             CCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCC
Confidence            589999999997653   44566788999999996 4     389999999999999999999997 89999999864  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      .++...++.++.||+.||.+||+.||||+||||+||||.+ +..++..+|||.+.......+     |.+.+..|.|||+
T Consensus       285 Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tYiQSRfYRAPEV  359 (586)
T KOG0667|consen  285 GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TYIQSRFYRAPEV  359 (586)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCCcce-----eeeeccccccchh
Confidence            6899999999999999999999999999999999999953 444666669998865553332     7788889999999


Q ss_pred             CCCC---CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHHH
Q psy6508         153 PSSK---TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKR  200 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~~  200 (477)
                      +.|.   .+.|+ ||+|||+.||-      .+.+.++++.+-.++..+++-
T Consensus       360 ILGlpY~~~IDm-WSLGCIlAEL~------tG~PLfpG~ne~DQl~~I~e~  403 (586)
T KOG0667|consen  360 ILGLPYDTAIDM-WSLGCILAELF------TGEPLFPGDNEYDQLARIIEV  403 (586)
T ss_pred             hccCCCCCccce-eehhhhHHhHh------cCccccCCCCHHHHHHHHHHH
Confidence            9988   88999 99999999993      223344578888888888763

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.95  E-value=1.3e-27  Score=239.43  Aligned_cols=170  Identities=24%  Similarity=0.418  Sum_probs=143.9

Q ss_pred             CcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~   82 (477)
                      +..||+|++.+... .....+.+.+|+.+++.++||||+++++++..++.+|+||||++||+|.+++...+.+++..+..
T Consensus        56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~  135 (340)
T PTZ00426         56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCF  135 (340)
T ss_pred             CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHH
Confidence            46899999876533 23345678899999999999999999999999999999999999999999999888899999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSL  159 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~  159 (477)
                      ++.|++.||.|||++||+||||||+|||++.++ .+.++|||++...+..     ..+..+++.|+|||+..+.   .++
T Consensus       136 ~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~  209 (340)
T PTZ00426        136 YAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDG-FIKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAA  209 (340)
T ss_pred             HHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccc
Confidence            999999999999999999999999999997643 3444599988654322     2355678899999998655   678


Q ss_pred             cccCcceEEEEEE--eeeccccc
Q psy6508         160 EYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       160 Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      |+ ||+|+++|||  |..||.+.
T Consensus       210 Di-wSlGvil~ell~G~~Pf~~~  231 (340)
T PTZ00426        210 DW-WTLGIFIYEILVGCPPFYAN  231 (340)
T ss_pred             cc-cchhhHHHHHhcCCCCCCCC
Confidence            99 9999999999  67888753

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.95  E-value=7.8e-28  Score=240.11  Aligned_cols=171  Identities=27%  Similarity=0.448  Sum_probs=145.4

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++++... .....+.+.+|+.++++++||||+++++.+..++..|++|||++|++|.+++.+.+.+++..+
T Consensus        41 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  120 (329)
T PTZ00263         41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVA  120 (329)
T ss_pred             CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHH
Confidence            4688999999876533 223456789999999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......     .+..+++.|+|||...+.   .
T Consensus       121 ~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~  194 (329)
T PTZ00263        121 KFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKG-HVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPEVIQSKGHGK  194 (329)
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCC-CEEEeeccCceEcCCCc-----ceecCChhhcCHHHHcCCCCCC
Confidence            99999999999999999999999999999997653 34445999886544322     245678889999998766   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||.+
T Consensus       195 ~~Di-wslG~il~elltg~~pf~~  217 (329)
T PTZ00263        195 AVDW-WTMGVLLYEFIAGYPPFFD  217 (329)
T ss_pred             ccee-echHHHHHHHHcCCCCCCC
Confidence            7899 9999999999  6788864

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.95  E-value=2.2e-27  Score=236.77  Aligned_cols=174  Identities=17%  Similarity=0.284  Sum_probs=144.8

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++.+... .......+.+|+.+++.++||||+++++.+...+.+|+||||+++++|..++...+.+++..+
T Consensus        18 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~   97 (328)
T cd05593          18 ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRT   97 (328)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHH
Confidence            4789999999976543 234456788999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..+++.|+|||...+.   .
T Consensus        98 ~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  174 (328)
T cd05593          98 RFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA--ATMKTFCGTPEYLAPEVLEDNDYGR  174 (328)
T ss_pred             HHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc--cccccccCCcCccChhhhcCCCCCc
Confidence            99999999999999999999999999999997642 34445999875432211  111234578899999998765   7


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||..
T Consensus       175 ~~Di-wslGvil~elltG~~Pf~~  197 (328)
T cd05593         175 AVDW-WGLGVVMYEMMCGRLPFYN  197 (328)
T ss_pred             cCCc-cccchHHHHHhhCCCCCCC
Confidence            7899 9999999999  6788864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0033|consensus

Probab=99.95  E-value=3.8e-29  Score=225.47  Aligned_cols=174  Identities=22%  Similarity=0.354  Sum_probs=153.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++|+.+|+|+++....+....+++.+|+.|.+.|+||||+++.+...+....|||+|++.|++|..-+-....+++..+-
T Consensus        34 ~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aS  113 (355)
T KOG0033|consen   34 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS  113 (355)
T ss_pred             cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHH
Confidence            58899999999988888778899999999999999999999999999999999999999999999887666678999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeec--cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~--~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .+++||+++|.|+|.+||||||+||+|+++.  ++...+.+++||++....+..   .-...+|+|.|++||+....   
T Consensus       114 H~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~---~~~G~~GtP~fmaPEvvrkdpy~  190 (355)
T KOG0033|consen  114 HCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGE---AWHGFAGTPGYLSPEVLKKDPYS  190 (355)
T ss_pred             HHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCcc---ccccccCCCcccCHHHhhcCCCC
Confidence            9999999999999999999999999999994  345566677999987654221   22457899999999998876   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |+.|+++|-+  |++||.+
T Consensus       191 kpvDi-W~cGViLfiLL~G~~PF~~  214 (355)
T KOG0033|consen  191 KPVDI-WACGVILYILLVGYPPFWD  214 (355)
T ss_pred             Ccchh-hhhhHHHHHHHhCCCCCCC
Confidence            67899 9999999877  9999997

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-27  Score=243.52  Aligned_cols=176  Identities=22%  Similarity=0.337  Sum_probs=143.6

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++.+... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~  103 (377)
T cd05629          24 DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVT  103 (377)
T ss_pred             CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence            4788999999876533 233456788999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCC-------------ccc------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGS-------------AYI------------  135 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs-------------~~~------------  135 (477)
                      +.++.|++.||+|||++||+||||||+|||++.++ .+.++|||++......             ...            
T Consensus       104 ~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~-~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (377)
T cd05629         104 RFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG-HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD  182 (377)
T ss_pred             HHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEEeecccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999997643 3444599987421100             000            


Q ss_pred             --------------------ccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         136 --------------------EQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       136 --------------------~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                                          ....+.++++.|+|||+..+.   .++|+ ||+|+++||+  |..||.+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvil~elltG~~Pf~~  250 (377)
T cd05629         183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW-WSLGAIMFECLIGWPPFCS  250 (377)
T ss_pred             cccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee-EecchhhhhhhcCCCCCCC
Confidence                                000124678899999998765   67899 9999999999  7788864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0586|consensus

Probab=99.95  E-value=1.3e-27  Score=240.83  Aligned_cols=174  Identities=29%  Similarity=0.436  Sum_probs=157.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .++..||||.+.+...+....+.+.+|+++|+.|+||||++++.+.+.+..+|+||||+.+|.+++|+.+++++.+..++
T Consensus        79 ~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar  158 (596)
T KOG0586|consen   79 LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEAR  158 (596)
T ss_pred             CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhh
Confidence            57899999999999888877778999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc-ceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      .++.|++.|++|+|+++|+|||||++||||+.+. +++.  |||.+...+-.   ..-.|..+++.|.|||++.+.    
T Consensus       159 ~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIa--DfgfS~~~~~~---~~lqt~cgsppyAaPEl~~g~~y~g  233 (596)
T KOG0586|consen  159 AKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIA--DFGFSTFFDYG---LMLQTFCGSPPYAAPELFNGKKYDG  233 (596)
T ss_pred             hhhHHHHHHHHHHhhcceeccccchhhcccccccceeee--ccccceeeccc---ccccccCCCCCccChHhhcCcccCC
Confidence            9999999999999999999999999999999874 5554  88887665532   234578899999999999987    


Q ss_pred             CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      +.+|+ |++|+++|.+  +..||.+..
T Consensus       234 pe~D~-Wslgvvly~LV~GsLPFDG~~  259 (596)
T KOG0586|consen  234 PEVDI-WSLGVVLYALVEGSLPFDGQN  259 (596)
T ss_pred             cceeh-hhhhhhheeeeecccccCCcc
Confidence            78999 9999999999  889999764

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-27  Score=236.67  Aligned_cols=174  Identities=21%  Similarity=0.327  Sum_probs=145.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++++... .......+.+|+.++++++||||+++++++..++..|+||||++|++|.+++...+++++..+
T Consensus        16 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~   95 (312)
T cd05585          16 DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRA   95 (312)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHH
Confidence            4688999999876432 234456788999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+. .+.++|||++.......  ....+..+++.|+|||...+.   .
T Consensus        96 ~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  172 (312)
T cd05585          96 RFYTAELLCALENLHKFNVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTK  172 (312)
T ss_pred             HHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCC-cEEEEECcccccCccCC--CccccccCCcccCCHHHHcCCCCCC
Confidence            99999999999999999999999999999997643 34445999876422111  112345678899999998765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||.+
T Consensus       173 ~~Dv-wslGvil~el~tg~~pf~~  195 (312)
T cd05585         173 AVDW-WTLGVLLYEMLTGLPPFYD  195 (312)
T ss_pred             ccce-echhHHHHHHHhCCCCcCC
Confidence            7899 9999999999  7788864

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.94  E-value=3e-27  Score=240.24  Aligned_cols=177  Identities=20%  Similarity=0.304  Sum_probs=143.6

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++.+... .....+.+.+|+.+|++++||||+++++.+.+++.+|+||||++||+|.+++.+.+.+++..+
T Consensus        24 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~  103 (376)
T cd05598          24 DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLA  103 (376)
T ss_pred             CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence            4689999999865432 223346688999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCC---ccc----------------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGS---AYI----------------------  135 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs---~~~----------------------  135 (477)
                      +.++.||+.||.|||++||+||||||+|||++.+. .+.++|||++......   .+.                      
T Consensus       104 ~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (376)
T cd05598         104 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR  182 (376)
T ss_pred             HHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC-CEEEEeCCCCcccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999997643 3444699986421100   000                      


Q ss_pred             ----------------ccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         136 ----------------EQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       136 ----------------~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                                      ....+.++++.|+|||+..+.   .++|+ ||+|+++|||  |..||.+.
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvilyell~G~~Pf~~~  247 (376)
T cd05598         183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW-WSVGVILYEMLVGQPPFLAD  247 (376)
T ss_pred             ccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee-eeccceeeehhhCCCCCCCC
Confidence                            001124678899999998765   67899 9999999999  77888753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.3e-27  Score=241.66  Aligned_cols=176  Identities=20%  Similarity=0.351  Sum_probs=144.6

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++.+... .......+.+|+.+++.++||||+++++++..++.+|+||||++||+|.+++...+.+++..+
T Consensus        24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~  103 (364)
T cd05599          24 DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET  103 (364)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHH
Confidence            4688999999976533 233446688999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc----c---------------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY----I---------------------  135 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~----~---------------------  135 (477)
                      +.++.|++.||+|||++||+||||||+|||++.+. .+.++|||++........    .                     
T Consensus       104 ~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (364)
T cd05599         104 RFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG-HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK  182 (364)
T ss_pred             HHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEeecccceecccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999997653 334459998754221100    0                     


Q ss_pred             -----------ccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         136 -----------EQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       136 -----------~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                                 ....+.++|+.|+|||+..+.   .++|+ ||+|+++|||  |..||.+
T Consensus       183 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~el~~G~~Pf~~  241 (364)
T cd05599         183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW-WSLGVIMYEMLVGYPPFCS  241 (364)
T ss_pred             ccccchhhcccccccccccCccccCHHHHcCCCCCCeeee-ecchhHHHHhhcCCCCCCC
Confidence                       011134688999999988665   67899 9999999999  7788865

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=2.2e-27  Score=236.22  Aligned_cols=174  Identities=16%  Similarity=0.283  Sum_probs=144.1

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|+++.... .......+.+|+.+++.++||||+++++++...+.+|+||||++|++|..++...+.+++..+
T Consensus        18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~   97 (323)
T cd05595          18 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA   97 (323)
T ss_pred             CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHH
Confidence            4789999999876533 233456778999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..++..|+|||...+.   .
T Consensus        98 ~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  174 (323)
T cd05595          98 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGR  174 (323)
T ss_pred             HHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC--CccccccCCcCcCCcccccCCCCCc
Confidence            99999999999999999999999999999997643 34446999875422111  111234577889999998765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+  +..||.+
T Consensus       175 ~~Di-wSlGvil~ell~g~~Pf~~  197 (323)
T cd05595         175 AVDW-WGLGVVMYEMMCGRLPFYN  197 (323)
T ss_pred             hhch-hhhHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6678864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=3.1e-27  Score=235.13  Aligned_cols=174  Identities=21%  Similarity=0.325  Sum_probs=143.9

Q ss_pred             CCCcEEEEEEcccCCC--ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV--SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      ++++.||+|++++...  .......+.+|+.+|+.++||||+++++.+..++.+|+||||++|++|.+++.+.+.+++..
T Consensus        22 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  101 (323)
T cd05584          22 DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDT  101 (323)
T ss_pred             CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHH
Confidence            4688999999876432  22334567899999999999999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. ++.++|||++........  ...+..+++.|+|||...+.   
T Consensus       102 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~  178 (323)
T cd05584         102 ACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQG-HVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEILMRSGHG  178 (323)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEeeCcCCeecccCCC--cccccCCCccccChhhccCCCCC
Confidence            999999999999999999999999999999997643 344459998764322111  12234578899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++||+  +..||..
T Consensus       179 ~~~Di-wslG~il~ell~G~~pf~~  202 (323)
T cd05584         179 KAVDW-WSLGALMYDMLTGAPPFTA  202 (323)
T ss_pred             Cccee-cccHHHHHHHhcCCCCCCC
Confidence            67899 9999999999  6788865

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>TIGR02696 pppGpp_PNP guanosine pentaphosphate synthetase I/polynucleotide phosphorylase

Probab=99.94  E-value=2.1e-26  Score=241.03  Aligned_cols=274  Identities=16%  Similarity=0.195  Sum_probs=212.4

Q ss_pred             CCCCceeec---cCcceeecccccceecccCCcccccCCeEEEeccc-cccccCCCCCcccccCcceEEEEEEeeecccc
Q psy6508         104 LKPQNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF-EPREIPSSKTSLEYQRSKGELYVEFKFAPFAS  179 (477)
Q Consensus       104 lkp~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y-~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~  179 (477)
                      +-.+++.+|   .+++|.+.+.+|+...++||++++.|+|++.+++. +|++.........- -..+.+++++.++||+.
T Consensus       330 il~~g~R~DGR~~~eiR~i~~~~g~l~~a~GSa~~~~G~Tqvl~~~tlG~~~~~q~~~~l~~-~~~~~~~~~YnfpPFSt  408 (719)
T TIGR02696       330 VLTEGVRIDGRGVTDIRPLDAEVQVIPRVHGSALFERGETQILGVTTLNMLKMEQQIDSLSP-ETSKRYMHHYNFPPYST  408 (719)
T ss_pred             HhcCCCCCCCCCccccccceeecCCCCCCCceEEEEecCcEEEEEEeCCCchhhhhcccccc-cccceEEEEEeCCCCcc
Confidence            334444454   36899999999999999999999999999999854 44332221100011 23578889999999998


Q ss_pred             ccccCC-CCCcchHHHHHHHHHHhhhhhh-cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEE
Q psy6508         180 QIRTGW-LRDSEEKELGNHLKRALEPAVC-RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTL  257 (477)
Q Consensus       180 ~~r~~~-~~~~~~~~l~~~i~~~l~~~i~-~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~  257 (477)
                      ..++.. .+++++.+...++++++++.+. ++.||++ |.+..++|++|||..+|++||++|||+||||||+++|+|||+
T Consensus       409 ~er~~~~~~~RReighg~La~rALe~vI~~~e~fP~T-IrvvseVLeSdGSss~AsIcaasLALmDAGVPmkd~VAgis~  487 (719)
T TIGR02696       409 GETGRVGSPKRREIGHGALAERALVPVLPSREEFPYA-IRQVSEALGSNGSTSMGSVCASTLSLLNAGVPLKAPVAGIAM  487 (719)
T ss_pred             cCCCCCCCCCccHHHHHHHHHHHHHHhhCcHhhCCCE-EEEEEEeeccCCcHHHHHHHHHHHHHHHcCcchhheeeEEEE
Confidence            776654 4577899999999999999996 6999998 788889999999999999999999999999999999999999


Q ss_pred             EeeC----Ce----EEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeee---cHHHHHHHHHHHHhcc
Q psy6508         258 ALRG----GL----TFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTI---QQERLADHIEQLIGCC  326 (477)
Q Consensus       258 ~~~~----~~----~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~---~~~~~~~~l~~~~~~~  326 (477)
                      ++.+    +.    +++||+..|+..            +.+.+.+.+..++|+.++++|++   +.+.+.++|+.|++||
T Consensus       488 Gli~e~~~~~~~~~iL~Di~g~ED~~------------Gdmdfkvagt~~gIt~lQmd~ki~gi~~e~l~~aL~~A~~g~  555 (719)
T TIGR02696       488 GLISDEVDGETRYVALTDILGAEDAF------------GDMDFKVAGTSEFVTALQLDTKLDGIPASVLASALKQARDAR  555 (719)
T ss_pred             EEeccccCCCcceeEEeCCCchhhhc------------CCceEEEEecCCCEEEEEEEeeECCCCHHHHHHHHHHHHHHH
Confidence            9983    33    899999999883            56777777888999999999997   8899999999999999


Q ss_pred             cchhhHHHHhHhhhccc-cch-------------hhHH--------hhhcCcceeEEEEecCccceeeEeeeehhhhccc
Q psy6508         327 ESLCTDRVQKLVSDHVT-LPE-------------RGRY--------VLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSS  384 (477)
Q Consensus       327 ~~i~~~~i~~~l~~~~~-l~~-------------r~~~--------~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S  384 (477)
                      ..+... |++++... . +..             +-..        .+.=-.-|.+.|-+++++.+..+-..+.-+...-
T Consensus       556 ~~Il~~-m~~al~~p-~~~s~~aP~~~~~~I~~~ki~~vIG~gGk~I~~i~~~tg~~Idi~d~G~V~I~a~d~~~~~~A~  633 (719)
T TIGR02696       556 LAILDV-MAEAIDTP-DEMSPYAPRIITVKIPVDKIGEVIGPKGKMINQIQDETGAEISIEDDGTVYIGAADGPSAEAAR  633 (719)
T ss_pred             HHHHHH-HHHHHhCc-cccccCCCeeEEEEeChHHhhheeCCCcHhHHHHHHHHCCEEEEecCcEEEEEeCCHHHHHHHH
Confidence            999999 99999887 4 111             1111        1111245577777776555544555555555555


Q ss_pred             HHHHHhcCC
Q psy6508         385 PVFATMFHG  393 (477)
Q Consensus       385 ~~f~~~f~~  393 (477)
                      .+-..+...
T Consensus       634 ~~I~~i~~~  642 (719)
T TIGR02696       634 AMINAIANP  642 (719)
T ss_pred             HHHHHhhCc
Confidence            666666553

Sohlberg, et al. present characterization of two proteins from Streptomyces coelicolor. The protein in this family was shown to have poly(A) polymerase activity and may be responsible for polyadenylating RNA in this species. Reference 2 showed that a nearly identical plasmid-encoded protein from Streptomyces antibioticus is a bifunctional enzyme that acts also as a guanosine pentaphosphate synthetase.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.94  E-value=4.2e-27  Score=237.80  Aligned_cols=176  Identities=22%  Similarity=0.339  Sum_probs=144.5

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      ++++.||+|+++.... .....+.+.+|+.++..++||||+++++.+...+.+|+||||++||+|.+++.+.+.+++..+
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~  103 (360)
T cd05627          24 DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEAT  103 (360)
T ss_pred             CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHH
Confidence            4788999999975432 233456788999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc--------------------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY--------------------------  134 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~--------------------------  134 (477)
                      +.++.|++.||.|||++||+||||||+|||++.++ .+.++|||++........                          
T Consensus       104 ~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~-~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (360)
T cd05627         104 QFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG-HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA  182 (360)
T ss_pred             HHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC-CEEEeeccCCcccccccccccccccccCCccccccccccccccc
Confidence            99999999999999999999999999999997643 344569998754321100                          


Q ss_pred             -------cccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         135 -------IEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       135 -------~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                             .....+.++++.|+|||+..+.   .++|+ ||+|+++|||  |..||.+
T Consensus       183 ~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~Di-wSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW-WSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             ccccccccccccccCCCccccCHHHHcCCCCCCccee-ccccceeeecccCCCCCCC
Confidence                   0001134688899999998765   67899 9999999999  6678864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.94  E-value=9.4e-28  Score=242.81  Aligned_cols=176  Identities=21%  Similarity=0.328  Sum_probs=145.2

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||||++++... .......+.+|+.++++++||||+++++.+.+...+|+||||++||+|.+++.+.+.+++..+
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~  103 (363)
T cd05628          24 DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEET  103 (363)
T ss_pred             CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHH
Confidence            4688999999976533 233446788999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc--------------------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY--------------------------  134 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~--------------------------  134 (477)
                      +.++.|++.||+|||++||+||||||+|||++.+. .+.++|||++........                          
T Consensus       104 ~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (363)
T cd05628         104 QFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG-HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA  182 (363)
T ss_pred             HHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-CEEEeeccCccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999997643 344569998754321100                          


Q ss_pred             -------cccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         135 -------IEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       135 -------~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                             .....+.++++.|+|||++.+.   .++|+ ||+|+++|||  |..||.+
T Consensus       183 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Dv-wSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDW-WSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             chhhhccccccccccCCccccCHHHHcCCCCCCchhh-hhhHHHHHHHHhCCCCCCC
Confidence                   0001235788899999998665   67899 9999999999  7788864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0694|consensus

Probab=99.94  E-value=3.3e-28  Score=247.70  Aligned_cols=172  Identities=24%  Similarity=0.438  Sum_probs=149.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||||++++..+ ..+..+..+.|.+|+... +||+++.++..|+.++++|+||||+.||++..+.+ .+.+++..
T Consensus       391 ~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~-~~~F~e~r  469 (694)
T KOG0694|consen  391 GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIH-TDVFSEPR  469 (694)
T ss_pred             CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEe-cccccHHH
Confidence            5788999999999876 456678899999999888 59999999999999999999999999999655443 36899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      ++.++..++.||+|||++||+|||||.+|||+|.+ .+|+  .|||+++..-+.  -....|..||+-|++||++.+.  
T Consensus       470 arfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~ki--ADFGlcKe~m~~--g~~TsTfCGTpey~aPEil~e~~Y  545 (694)
T KOG0694|consen  470 ARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKI--ADFGLCKEGMGQ--GDRTSTFCGTPEFLAPEVLTEQSY  545 (694)
T ss_pred             HHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEe--cccccccccCCC--CCccccccCChhhcChhhhccCcc
Confidence            99999999999999999999999999999999875 4555  599999754322  2244688999999999999988  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ |++|+++|||  |..||.+
T Consensus       546 t~aVDW-W~lGVLlyeML~Gq~PF~g  570 (694)
T KOG0694|consen  546 TRAVDW-WGLGVLLYEMLVGESPFPG  570 (694)
T ss_pred             cchhhH-HHHHHHHHHHHcCCCCCCC
Confidence             88999 9999999999  7788884

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=7.5e-28  Score=235.99  Aligned_cols=171  Identities=25%  Similarity=0.411  Sum_probs=144.4

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++.+++.+|+||||+++++|.+++...+.+++..+
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  103 (291)
T cd05612          24 ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTG  103 (291)
T ss_pred             CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHH
Confidence            46899999998765332 23456788999999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||+|||++|++||||||+|||++.++ ++.++|||.+......     ..+..+++.|+|||...+.   .
T Consensus       104 ~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~  177 (291)
T cd05612         104 LFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG-HIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNK  177 (291)
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCc
Confidence            99999999999999999999999999999997643 3445599987654332     1245678889999988765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||.+
T Consensus       178 ~~Di-wSlG~il~~l~~g~~pf~~  200 (291)
T cd05612         178 AVDW-WALGILIYEMLVGYPPFFD  200 (291)
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6677764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0032|consensus

Probab=99.94  E-value=1.6e-27  Score=239.32  Aligned_cols=175  Identities=27%  Similarity=0.420  Sum_probs=153.0

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|++++..... ...+.+.+|+.+|+++. ||||+.+++.|++...+++|||+|.||.|.+.+... .+++..
T Consensus        58 ~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~d  136 (382)
T KOG0032|consen   58 STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERD  136 (382)
T ss_pred             CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHH
Confidence            469999999998887643 34578999999999997 999999999999999999999999999999999876 499999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC---cceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~---~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..++.|++.+++|||+.|++||||||+|+|+...   ..++..+|||++....+.   ....+.+|++.|.|||+....
T Consensus       137 a~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~---~~~~~~~Gtp~y~APEvl~~~  213 (382)
T KOG0032|consen  137 AAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG---ERLHTIVGTPEYVAPEVLGGR  213 (382)
T ss_pred             HHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC---ceEeeecCCccccCchhhcCC
Confidence            99999999999999999999999999999999542   346777799999876652   234578999999999999854


Q ss_pred             ---CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                         ..+|+ ||+|+++|.|  |++||.+..
T Consensus       214 ~y~~~~Di-WS~Gvi~yiLL~G~~PF~~~~  242 (382)
T KOG0032|consen  214 PYGDEVDV-WSIGVILYILLSGVPPFWGET  242 (382)
T ss_pred             CCCcccch-hHHHHHHHHHhhCCCCCcCCC
Confidence               78899 9999999999  888998643

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.1e-27  Score=236.16  Aligned_cols=171  Identities=26%  Similarity=0.406  Sum_probs=145.3

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||||++++.... ....+.+.+|+.+++.++||||+++++++...+..|+||||++|++|.+++...+.+++..+
T Consensus        24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~  103 (333)
T cd05600          24 DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA  103 (333)
T ss_pred             CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHH
Confidence            46889999999765432 23446788999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.....     ...+..+++.|+|||...+.   .
T Consensus       104 ~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~  177 (333)
T cd05600         104 RFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG-HIKLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDF  177 (333)
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCC
Confidence            99999999999999999999999999999997643 344459998765433     22455678899999998765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||  +..||..
T Consensus       178 ~~Dv-wslG~il~ell~g~~pf~~  200 (333)
T cd05600         178 TVDY-WSLGCMLYEFLCGFPPFSG  200 (333)
T ss_pred             ccce-ecchHHHhhhhhCCCCCCC
Confidence            7899 9999999999  6678764

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.94  E-value=2.7e-27  Score=240.99  Aligned_cols=176  Identities=23%  Similarity=0.354  Sum_probs=145.1

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      ++++.||||++++... .....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++||+|.+++.+.+.+++..+
T Consensus        24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~  103 (381)
T cd05626          24 DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLA  103 (381)
T ss_pred             CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHH
Confidence            5788999999976543 334456789999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccC---Cccc----------------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKG---SAYI----------------------  135 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~g---s~~~----------------------  135 (477)
                      +.++.|++.||.|||++||+||||||+|||++.++ ++.+.|||++.....   +.+.                      
T Consensus       104 ~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~-~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (381)
T cd05626         104 RFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDG-HIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN  182 (381)
T ss_pred             HHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCC-CEEEeeCcCCcccccccccccccccccccccccCcccccccccc
Confidence            99999999999999999999999999999997643 344569998642210   0000                      


Q ss_pred             --------------------ccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         136 --------------------EQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       136 --------------------~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                                          ....+.+++..|+|||.+.+.   .++|+ ||+|+++|||  +..||..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di-wSlG~il~elltG~~Pf~~  250 (381)
T cd05626         183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW-WSVGVILFEMLVGQPPFLA  250 (381)
T ss_pred             cccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce-eehhhHHHHHHhCCCCCcC
Confidence                                001234688899999998655   67899 9999999999  7788864

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=6e-27  Score=235.46  Aligned_cols=175  Identities=26%  Similarity=0.399  Sum_probs=146.6

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++..... .....+.+|+.+++.++||||+++++++.+++..|+||||++|++|.+++.+.+.+++..+
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~  103 (350)
T cd05573          24 DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETA  103 (350)
T ss_pred             CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHH
Confidence            468999999997654322 4456788999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCc--------------------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSA--------------------------  133 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~--------------------------  133 (477)
                      +.++.|++.||.|||++||+||||||+|||++.+ .+++  +|||.+.......                          
T Consensus       104 ~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL--~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (350)
T cd05573         104 RFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKL--ADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHK  181 (350)
T ss_pred             HHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEe--ecCCCCccCcccCcccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999764 4444  5999876443221                          


Q ss_pred             -ccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         134 -YIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       134 -~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       ......+..+++.|+|||...+.   .++|+ ||+|+++||+  +..||..
T Consensus       182 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~ell~g~~Pf~~  232 (350)
T cd05573         182 QRRVRANSTVGTPDYIAPEVLRGTPYGLECDW-WSLGVILYEMLYGFPPFYS  232 (350)
T ss_pred             cccccccccccCccccCHHHHcCCCCCCceee-EecchhhhhhccCCCCCCC
Confidence             01122346788899999998766   67899 9999999999  6678864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.94  E-value=1.9e-26  Score=229.49  Aligned_cols=174  Identities=20%  Similarity=0.342  Sum_probs=140.3

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHH-HHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIK-ALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||||++.+.... ......+.+|.. +++.++||||+++++.+...+..|+||||++|++|..++...+.+++..
T Consensus        18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~   97 (323)
T cd05575          18 ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPR   97 (323)
T ss_pred             CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHH
Confidence            47899999998765332 222344555655 5678999999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.......  .......++..|+|||...+.   
T Consensus        98 ~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (323)
T cd05575          98 ARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEHS--KTTSTFCGTPEYLAPEVLRKQPYD  174 (323)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeccCCCcccccCC--CccccccCChhhcChhhhcCCCCC
Confidence            999999999999999999999999999999997653 34445999875422111  112234678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       175 ~~~Dv-wslG~il~ell~g~~pf~~  198 (323)
T cd05575         175 RTVDW-WCLGAVLYEMLYGLPPFYS  198 (323)
T ss_pred             ccccc-cccchhhhhhhcCCCCCCC
Confidence            67899 9999999999  6688865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0607|consensus

Probab=99.94  E-value=3.5e-28  Score=226.70  Aligned_cols=176  Identities=25%  Similarity=0.426  Sum_probs=146.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|.+||||++.+.  ....+.++.+|++++.+. .|+||++++++|+++..+|||||-+.||+|.+.++++..+++.++
T Consensus       101 ~t~~EYAVKiidKq--~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EA  178 (463)
T KOG0607|consen  101 QTGKEYAVKIIDKQ--PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREA  178 (463)
T ss_pred             ccchhhhhhhhhcC--CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHH
Confidence            47899999999876  344567899999999999 599999999999999999999999999999999999889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-C---cceeecccccceecccCCcc---cccCCeEEEeccccccccC
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-N---TLKLAGLKQGVSEKAKGSAY---IEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~---~~rl~~~dfG~~~~~~gs~~---~~~g~t~v~~~~y~ppE~~  153 (477)
                      .++..+|+.||.|||.+||.||||||+|||-.+ |   .+++.++|+|.-.+..+...   ...-.|.+|...||+||+.
T Consensus       179 s~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVV  258 (463)
T KOG0607|consen  179 SRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVV  258 (463)
T ss_pred             HHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHH
Confidence            999999999999999999999999999999954 3   45666666665433333221   1122366777789999975


Q ss_pred             CC---C-----CcccccCcceEEEEEE--eeeccccc
Q psy6508         154 SS---K-----TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       154 ~~---~-----~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .-   .     ...|. ||+|+++|-|  ||+||.+.
T Consensus       259 d~fv~qA~~YDKrCDl-wSLGvIlYImLsGYpPFvG~  294 (463)
T KOG0607|consen  259 DVFVDQATFYDKRCDL-WSLGVILYIMLSGYPPFVGH  294 (463)
T ss_pred             hhhccccccccccccH-HHHHHHHHHHHhCCCCccCc
Confidence            42   2     56799 9999999998  99999874

>KOG0580|consensus

Probab=99.94  E-value=3.9e-28  Score=218.55  Aligned_cols=172  Identities=27%  Similarity=0.435  Sum_probs=150.5

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHH--hCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIR--SHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~--~~~~l~~~   78 (477)
                      +++..||+|++.++.+.. ...+++.+|++|-..|+||||+++|++|.++..+|+++||..+|+|...|+  ...++++.
T Consensus        45 ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~  124 (281)
T KOG0580|consen   45 KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQ  124 (281)
T ss_pred             cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccccccccc
Confidence            578889999998876543 334679999999999999999999999999999999999999999999999  55679999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ....+++|++.||.|+|.++++||||||+|+|++. +++++.  |||.+.....+    .-.|-.+|.-|.|||+..+. 
T Consensus       125 ~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiA--dfGwsV~~p~~----kR~tlcgt~dyl~pEmv~~~~  198 (281)
T KOG0580|consen  125 RAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIA--DFGWSVHAPSN----KRKTLCGTLDYLPPEMVEGRG  198 (281)
T ss_pred             chhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeecc--CCCceeecCCC----CceeeecccccCCHhhcCCCC
Confidence            99999999999999999999999999999999975 566655  99998776532    22567778889999999887 


Q ss_pred             --CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                        ..+|+ |++|++.||+  +.+||.+.
T Consensus       199 hd~~Vd~-w~lgvl~yeflvg~ppFes~  225 (281)
T KOG0580|consen  199 HDKFVDL-WSLGVLCYEFLVGLPPFESQ  225 (281)
T ss_pred             ccchhhH-HHHHHHHHHHHhcCCchhhh
Confidence              77999 9999999998  88999864

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=3.2e-26  Score=228.52  Aligned_cols=174  Identities=22%  Similarity=0.359  Sum_probs=140.7

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc---CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL---HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l---~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||+|++.+.... ......+.+|..++...   +||||+++++.+...+.+|+||||++|++|..++.+.+.+++
T Consensus        16 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~   95 (330)
T cd05586          16 DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSE   95 (330)
T ss_pred             CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCH
Confidence            46899999998754332 22334566677777765   699999999999999999999999999999999988888999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..++.++.||+.||.|||++||+||||||+|||++.+. ++.++|||++.......  ....+..++..|+|||.+.+. 
T Consensus        96 ~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~  172 (330)
T cd05586          96 DRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATG-HIALCDFGLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEK  172 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCCC--CCccCccCCccccCHHHHcCCC
Confidence            99999999999999999999999999999999997653 34456999875422111  122345678899999987543 


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|+|  +..||.+
T Consensus       173 ~~~~~~Dv-wslGvil~elltG~~Pf~~  199 (330)
T cd05586         173 GYTKHVDF-WSLGVLVFEMCCGWSPFYA  199 (330)
T ss_pred             CCCCccce-eccccEEEEeccCCCCCCC
Confidence               67899 9999999999  6788865

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.94  E-value=4e-27  Score=239.90  Aligned_cols=176  Identities=20%  Similarity=0.306  Sum_probs=143.8

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++.+... .....+.+.+|+.++++++||||+++++.+.+++.+|+||||++||+|.+++.+.+.+++..+
T Consensus        24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~  103 (382)
T cd05625          24 DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLA  103 (382)
T ss_pred             CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence            4688999999876533 233456788999999999999999999999999999999999999999999988778999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccC---Cccc----------------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKG---SAYI----------------------  135 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~g---s~~~----------------------  135 (477)
                      +.++.|++.||+|||++||+||||||+|||++.++ .+.++|||++.....   +.+.                      
T Consensus       104 ~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (382)
T cd05625         104 RFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN  182 (382)
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEeECCCCcccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999997643 344459998642110   0000                      


Q ss_pred             --------------------ccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         136 --------------------EQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       136 --------------------~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                                          ....+.++++.|+|||+..+.   .++|+ ||+|+++|||  +..||.+
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di-wSlGvil~elltG~~Pf~~  250 (382)
T cd05625         183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW-WSVGVILYEMLVGQPPFLA  250 (382)
T ss_pred             ccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE-EechHHHHHHHhCCCCCCC
Confidence                                001234678899999998765   77899 9999999999  7788875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.94  E-value=2e-26  Score=229.10  Aligned_cols=174  Identities=21%  Similarity=0.344  Sum_probs=140.1

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHH-HHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIK-ALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|++.+.... ......+.+|.. +++.++||||+++++.+...+..|+||||++|++|..++.....+++..
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   97 (321)
T cd05603          18 SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPR   97 (321)
T ss_pred             CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHH
Confidence            46889999998765432 223345556654 5788999999999999999999999999999999999998877899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.||+.||.|||++||+||||||+||+++.++ ++.++|||++.......  .......+++.|+|||...+.   
T Consensus        98 ~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (321)
T cd05603          98 ARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEPE--ETTSTFCGTPEYLAPEVLRKEPYD  174 (321)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC-CEEEccCCCCccCCCCC--CccccccCCcccCCHHHhcCCCCC
Confidence            999999999999999999999999999999997643 34456999875321111  112334678889999998665   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  +..||.+
T Consensus       175 ~~~Di-wslG~il~el~~g~~pf~~  198 (321)
T cd05603         175 RTVDW-WCLGAVLYEMLYGLPPFYS  198 (321)
T ss_pred             CcCcc-cccchhhhhhhcCCCCCCC
Confidence            67899 9999999999  6788865

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.94  E-value=2.6e-26  Score=228.67  Aligned_cols=174  Identities=20%  Similarity=0.340  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHH-HHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIK-ALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|++.+... .......+.+|.. +++.++||||+++++.+..++..|+||||++|++|..++.+.+.+++..
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   97 (325)
T cd05604          18 LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPR   97 (325)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHH
Confidence            4688999999876533 2233345666665 4677899999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (325)
T cd05604          98 ARFYAAEIASALGYLHSINIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAPEVIRKQPYD  174 (325)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEEeecCCcccCCCCC--CCcccccCChhhCCHHHHcCCCCC
Confidence            999999999999999999999999999999997653 34456999875432111  122345678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|+|  +..||.+
T Consensus       175 ~~~Dv-wslG~il~el~~G~~pf~~  198 (325)
T cd05604         175 NTVDW-WCLGAVLYEMLYGLPPFYC  198 (325)
T ss_pred             CcCcc-ccccceehhhhcCCCCCCC
Confidence            67899 9999999999  6788864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG4717|consensus

Probab=99.94  E-value=5.1e-27  Score=230.69  Aligned_cols=173  Identities=29%  Similarity=0.453  Sum_probs=151.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~   81 (477)
                      +|..||||++.+.+...-....+..|++.|+-++|||||++|.+......+|||+|+-+||+|++|+-++. .+.+..++
T Consensus        42 TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~  121 (864)
T KOG4717|consen   42 TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAK  121 (864)
T ss_pred             ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHH
Confidence            68999999999998877666778999999999999999999999999999999999999999999997764 69999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +++.||+.|+.|+|+..+|||||||+|+.+-.  +-+++.  |||++......   +.-+|..|...|.+||++.+.   
T Consensus       122 kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLT--DFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYD  196 (864)
T KOG4717|consen  122 KYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLT--DFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYD  196 (864)
T ss_pred             HHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEee--eccccccCCCc---chhhcccchhhccCchhhhcCccC
Confidence            99999999999999999999999999998854  455555  99987544322   223577888899999999987   


Q ss_pred             -CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                       +++|| ||+|+|+|-+  |.+||...+
T Consensus       197 APAVDi-WSLGVILyMLVCGq~PFqeAN  223 (864)
T KOG4717|consen  197 APAVDI-WSLGVILYMLVCGQPPFQEAN  223 (864)
T ss_pred             Ccchhh-hHHHHHHHHHHhCCCcccccc
Confidence             88999 9999999887  889997643

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.94  E-value=9e-27  Score=231.15  Aligned_cols=174  Identities=21%  Similarity=0.362  Sum_probs=141.8

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++++.... ....+.+..|..++..+ +||||+++++++..++.+|+||||++|++|.+++...+.+++..
T Consensus        18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~   97 (316)
T cd05592          18 GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEAR   97 (316)
T ss_pred             CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHH
Confidence            46889999999765432 23345566777777755 89999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (316)
T cd05592          98 ARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYN  174 (316)
T ss_pred             HHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCCC--CccccccCCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999997643 34455999876432211  122345678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       175 ~~~Dv-wslG~il~ell~G~~Pf~~  198 (316)
T cd05592         175 ESVDW-WSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             Ccccc-hhHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6778864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.94  E-value=1e-26  Score=232.15  Aligned_cols=174  Identities=22%  Similarity=0.359  Sum_probs=144.5

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++++..... ...+.+.+|..+++.+ +||||+++++++...+.+|+||||++|++|.+++.+.+++++..
T Consensus        18 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~   97 (329)
T cd05588          18 KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEH   97 (329)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHH
Confidence            468899999998764432 3446688999999999 79999999999999999999999999999999998878899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++|++||||||+||+++.+. .+.++|||++.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (329)
T cd05588          98 ARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAPEILRGEDYG  174 (329)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEECcCccccccccCC--CccccccCCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999997643 33445999875322111  112245678889999998766   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||..
T Consensus       175 ~~~Di-wslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         175 FSVDW-WALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             Cccce-echHHHHHHHHHCCCCccc
Confidence            67899 9999999999  7788864

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.94  E-value=3.7e-26  Score=228.00  Aligned_cols=175  Identities=21%  Similarity=0.333  Sum_probs=143.3

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~   79 (477)
                      .+|+.||+|++++... .....+.+.+|+.+++.++||||+++++++...+..|+||||++|++|.+++.+. +.+++..
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~  103 (330)
T cd05601          24 ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDM  103 (330)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHH
Confidence            4788999999986543 2334567889999999999999999999999999999999999999999999876 5799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      +..++.|++.||.|||++||+||||||+||+++.++ .+.++|||.+......... ......++..|+|||....    
T Consensus       104 ~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~  181 (330)
T cd05601         104 AQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTG-HIKLADFGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGD  181 (330)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCC-CEEeccCCCCeECCCCCce-eeecccCCccccCHHHhcccccc
Confidence            999999999999999999999999999999997643 3444599988654322111 1123457788999998752    


Q ss_pred             --C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 --K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 --~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .   .++|+ ||+|+++|++  +..||..
T Consensus       182 ~~~~~~~~~Di-wslG~il~el~~g~~Pf~~  211 (330)
T cd05601         182 GKGTYGVECDW-WSLGVIAYEMIYGRSPFHE  211 (330)
T ss_pred             ccCCCCCccee-ecccceeeeeccCCCCCCC
Confidence              1   67899 9999999999  6678764

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.94  E-value=3.1e-26  Score=228.77  Aligned_cols=175  Identities=21%  Similarity=0.312  Sum_probs=143.0

Q ss_pred             CCCcEEEEEEcccCCCC--hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVS--ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      ++++.||+|++.+....  ....+.+.+|+.+++.+ +||||+++++++..++.+|+||||++||+|.+++..++.+++.
T Consensus        26 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~  105 (332)
T cd05614          26 DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSED  105 (332)
T ss_pred             CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHH
Confidence            46889999998764322  23345688999999999 5999999999999999999999999999999999887889999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++.++.|++.||.|||++||+||||||+|||++.++ ++.++|||++....... .....+..++..|+|||...+.  
T Consensus       106 ~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~-~~kl~DfG~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~  183 (332)
T cd05614         106 EVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEG-HVVLTDFGLSKEFLSEE-KERTYSFCGTIEYMAPEIIRGKGG  183 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCC-CEEEeeCcCCccccccC-CCccccccCCccccCHHHhcCCCC
Confidence            9999999999999999999999999999999997653 34456999875432111 1112235678899999987653  


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+|+++||+  +..||..
T Consensus       184 ~~~~~Di-wslG~il~elltg~~pf~~  209 (332)
T cd05614         184 HGKAVDW-WSLGILIFELLTGASPFTL  209 (332)
T ss_pred             CCCcccc-ccchhhhhhhhcCCCCCCC
Confidence              57899 9999999999  6788864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4236|consensus

Probab=99.94  E-value=2.2e-26  Score=226.77  Aligned_cols=174  Identities=26%  Similarity=0.371  Sum_probs=149.6

Q ss_pred             CCCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHH-Hh-CCCCCHH
Q psy6508           1 NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFI-RS-HEKLSEF   78 (477)
Q Consensus         1 ~~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l-~~-~~~l~~~   78 (477)
                      +++|+.||||++.+.....+....+++|+.||++++||.||.+-..|+..+.+++|||-+. |+..+++ .. .+++++.
T Consensus       586 RktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er  664 (888)
T KOG4236|consen  586 RKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSSEKGRLPER  664 (888)
T ss_pred             cccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHhhcccchHH
Confidence            4689999999999988877777889999999999999999999999999999999999998 4555554 33 4689999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      ..+.++.||+.||.|||.+||+|+||||+|||+.+  +.....+||||.++.....+   ...+.+||+.|.|||++..+
T Consensus       665 ~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks---FRrsVVGTPAYLaPEVLrnk  741 (888)
T KOG4236|consen  665 ITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS---FRRSVVGTPAYLAPEVLRNK  741 (888)
T ss_pred             HHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh---hhhhhcCCccccCHHHHhhc
Confidence            99999999999999999999999999999999964  45566677999997655443   23578999999999999877


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .+.|+ ||.|+++|--  |..||..
T Consensus       742 GyNrSLDM-WSVGVIiYVsLSGTFPFNE  768 (888)
T KOG4236|consen  742 GYNRSLDM-WSVGVIIYVSLSGTFPFNE  768 (888)
T ss_pred             cccccccc-eeeeEEEEEEecccccCCC
Confidence               77899 9999999876  7777763

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=2e-26  Score=229.14  Aligned_cols=174  Identities=23%  Similarity=0.331  Sum_probs=142.9

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++++... .....+.+..|..+++.+ +||||+++++++..++.+|+||||++|++|..++...+.+++..
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~   97 (321)
T cd05591          18 GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPR   97 (321)
T ss_pred             CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence            4678999999876533 233445678899999876 79999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+||+++.++ .+.++|||.+.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (321)
T cd05591          98 SRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYG  174 (321)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeecccceecccCC--ccccccccCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999997643 33445999876432211  112345678899999988765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||..
T Consensus       175 ~~~Dv-wslG~il~el~tg~~Pf~~  198 (321)
T cd05591         175 PSVDW-WALGVLMYEMMAGQPPFEA  198 (321)
T ss_pred             Cccce-echhHHHHHHhcCCCCCCC
Confidence            67899 9999999999  6678764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0197|consensus

Probab=99.94  E-value=1.7e-26  Score=230.26  Aligned_cols=169  Identities=23%  Similarity=0.345  Sum_probs=139.2

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS--HEKLSEFQCQQ   82 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~--~~~l~~~~~~~   82 (477)
                      ..||+|.++....+.   +.|.+|+++|++|+|+|||++++++..+..+||||||++.|+|.++|+.  ...+.......
T Consensus       231 ~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~  307 (468)
T KOG0197|consen  231 TKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLD  307 (468)
T ss_pred             CcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHH
Confidence            479999987765443   4678999999999999999999999998899999999999999999987  34799999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSL  159 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~  159 (477)
                      ++.||++|++||.++++|||||...|||++++. ...+.|||+++......|......+ .--.|.|||.+...   .++
T Consensus       308 ~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~~Y~~~~~~k-fPIkWtAPEa~~~~~FS~kS  385 (468)
T KOG0197|consen  308 FAAQIAEGMAYLESKNYIHRDLAARNILVDEDL-VVKISDFGLARLIGDDEYTASEGGK-FPIKWTAPEALNYGKFSSKS  385 (468)
T ss_pred             HHHHHHHHHHHHHhCCccchhhhhhheeeccCc-eEEEcccccccccCCCceeecCCCC-CCceecCHHHHhhCCccccc
Confidence            999999999999999999999999999998764 3444699999854444443222222 22238889988765   789


Q ss_pred             cccCcceEEEEEE---eeecccc
Q psy6508         160 EYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       160 Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |+ ||+|++++|+   |..||.+
T Consensus       386 DV-WSFGVlL~E~fT~G~~py~~  407 (468)
T KOG0197|consen  386 DV-WSFGVLLWELFTYGRVPYPG  407 (468)
T ss_pred             ce-eehhhhHHHHhccCCCCCCC
Confidence            99 9999999999   4566554

>KOG0599|consensus

Probab=99.94  E-value=1.3e-27  Score=218.59  Aligned_cols=171  Identities=24%  Similarity=0.382  Sum_probs=144.3

Q ss_pred             CCCcEEEEEEcccCCC---Ch---hHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC
Q psy6508           2 EQHTEVAIKCIDKTKV---SE---NRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~---~~---~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~   74 (477)
                      ++|+.+|+|++....-   ++   ...+.-.+|+.||+++ .||||+++.+.++++..+++|+|.|+.|.|.++|...-.
T Consensus        40 ~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt  119 (411)
T KOG0599|consen   40 ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT  119 (411)
T ss_pred             ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee
Confidence            6889999999865422   11   2345677899999999 799999999999999999999999999999999998778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      ++++..++|++|+..|+.|||.++||||||||+|||+++| ++++  .|||.+.+......   -..-.||+.|.+||.+
T Consensus       120 lSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~i--sDFGFa~~l~~Gek---LrelCGTPgYLAPEti  194 (411)
T KOG0599|consen  120 LSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKI--SDFGFACQLEPGEK---LRELCGTPGYLAPETI  194 (411)
T ss_pred             ecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEE--eccceeeccCCchh---HHHhcCCCcccChhhe
Confidence            9999999999999999999999999999999999999876 4444  59999876543221   1235788999999988


Q ss_pred             CCC---------CcccccCcceEEEEEE--eeeccc
Q psy6508         154 SSK---------TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       154 ~~~---------~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ..+         ..+|. |+.|+++|.+  |.+||.
T Consensus       195 kC~m~e~~pGYs~EVD~-Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  195 KCSMYENHPGYSKEVDE-WACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             eeecccCCCCccchhhH-HHHHHHHHHHHcCCCchh
Confidence            655         56899 9999999998  788886

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=1.3e-26  Score=230.38  Aligned_cols=174  Identities=20%  Similarity=0.345  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++++... .....+.+.+|..+++.+ +||||+++++++...+.+|+||||++|++|.+++.+.+.+++..
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~   97 (320)
T cd05590          18 ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR   97 (320)
T ss_pred             CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHH
Confidence            4688999999876532 233456678899999877 79999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||||+|||++.+. .+.++|||++.......  ....+..+++.|+|||...+.   
T Consensus        98 ~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (320)
T cd05590          98 ARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYG  174 (320)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcCC--CcccccccCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999997653 34445999875432111  112235678899999988765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       175 ~~~Di-wslG~il~el~~g~~Pf~~  198 (320)
T cd05590         175 PSVDW-WAMGVLLYEMLCGHAPFEA  198 (320)
T ss_pred             Cccch-hhhHHHHHHHhhCCCCCCC
Confidence            67899 9999999999  6788864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0194|consensus

Probab=99.94  E-value=7e-26  Score=229.00  Aligned_cols=169  Identities=20%  Similarity=0.363  Sum_probs=143.1

Q ss_pred             EEEEEcccC-CCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHH
Q psy6508           7 VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFV   84 (477)
Q Consensus         7 vAiK~i~~~-~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~   84 (477)
                      ||+|..+.+ ........+|.+|.++|++++||||+++||+...+.++++|||+|+||+|.++|++++ .++..+...++
T Consensus       189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~  268 (474)
T KOG0194|consen  189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFC  268 (474)
T ss_pred             eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHH
Confidence            899998763 3567788899999999999999999999999999999999999999999999999977 49999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCcc-eeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLE  160 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~~-rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~D  160 (477)
                      .+.+.||+|||+++++||||-.+|+|+..+++ ++  .|||++....  .+.......-....|.|||.+...   .++|
T Consensus       269 ~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKI--SDFGLs~~~~--~~~~~~~~~klPirWLAPEtl~~~~~s~kTD  344 (474)
T KOG0194|consen  269 YDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKI--SDFGLSRAGS--QYVMKKFLKKLPIRWLAPETLNTGIFSFKTD  344 (474)
T ss_pred             HHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEe--CccccccCCc--ceeeccccccCcceecChhhhccCccccccc
Confidence            99999999999999999999999999988665 55  4999975433  333222233233459999998876   7899


Q ss_pred             ccCcceEEEEEE---eeeccccc
Q psy6508         161 YQRSKGELYVEF---KFAPFASQ  180 (477)
Q Consensus       161 i~~s~G~il~e~---~~~Pf~~~  180 (477)
                      + |++|+++||+   +..||.+.
T Consensus       345 V-~sfGV~~~Eif~~g~~Py~g~  366 (474)
T KOG0194|consen  345 V-WSFGVLLWEIFENGAEPYPGM  366 (474)
T ss_pred             h-hheeeeEEeeeccCCCCCCCC
Confidence            9 9999999999   45677653

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.94  E-value=4e-26  Score=227.34  Aligned_cols=174  Identities=20%  Similarity=0.329  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHH-HHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIK-ALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++.+.... ......+.+|.. +++.++||||+++++++...+..|+||||++|++|.+++...+.+++..
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   97 (325)
T cd05602          18 AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR   97 (325)
T ss_pred             CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            46788999998764322 122234455544 5678899999999999999999999999999999999998878899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..+++.|+|||+..+.   
T Consensus        98 ~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (325)
T cd05602          98 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHN--GTTSTFCGTPEYLAPEVLHKQPYD  174 (325)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEEccCCCCcccccCC--CCcccccCCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999997643 34456999875432111  112345678899999988765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|+|  +..||.+
T Consensus       175 ~~~Di-wslG~il~el~~g~~pf~~  198 (325)
T cd05602         175 RTVDW-WCLGAVLYEMLYGLPPFYS  198 (325)
T ss_pred             Ccccc-ccccHHHHHHhcCCCCCCC
Confidence            67899 9999999999  6678864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.94  E-value=2.8e-26  Score=228.87  Aligned_cols=174  Identities=22%  Similarity=0.364  Sum_probs=144.1

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++++.... ......+.+|..++.++ +||||+++++++..++..|+||||+++++|..++...+.+++..
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~   97 (329)
T cd05618          18 KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH   97 (329)
T ss_pred             CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHH
Confidence            46889999999876433 33445688899998887 89999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++||+||||||+||+++.+. .+.++|||++.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (329)
T cd05618          98 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYG  174 (329)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-CEEEeeCCccccccCCC--CccccccCCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999997653 34445999875432211  112245678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||..
T Consensus       175 ~~~Di-wslG~il~el~~g~~Pf~~  198 (329)
T cd05618         175 FSVDW-WALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             Cccce-ecccHHHHHHhhCCCCCcc
Confidence            67899 9999999999  7788853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.93  E-value=1.6e-26  Score=234.29  Aligned_cols=174  Identities=21%  Similarity=0.352  Sum_probs=142.8

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++.+... .....+.+.+|+.+++.++||||+++++.+..++.+|+||||++||+|.+++... .+++..+
T Consensus        66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~  144 (370)
T cd05621          66 SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWA  144 (370)
T ss_pred             CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHH
Confidence            4688999999875432 2233456889999999999999999999999999999999999999999999764 6899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.||+.||.|||++||+||||||+|||++.+. .+.++|||.+........ ....+..+++.|+|||++.+.    
T Consensus       145 ~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~-~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~  222 (370)
T cd05621         145 KFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHG-HLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDG  222 (370)
T ss_pred             HHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCC
Confidence            99999999999999999999999999999997642 334459998865432221 122356788999999987542    


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|+|  +..||.+
T Consensus       223 ~~~~~~Di-wSlG~ilyell~G~~Pf~~  249 (370)
T cd05621         223 YYGRECDW-WSVGVFLFEMLVGDTPFYA  249 (370)
T ss_pred             CCCcccCE-EeehHHHHHHHhCCCCCCC
Confidence               57899 9999999999  7788864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG4250|consensus

Probab=99.93  E-value=3.2e-27  Score=241.14  Aligned_cols=173  Identities=28%  Similarity=0.364  Sum_probs=146.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhCC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSHE--   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~--   73 (477)
                      ++|+.||||.+++.. +....+.+.+|+++|++|+|||||+++++-++..      ...++||||.||+|+..+.+..  
T Consensus        36 etG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~  114 (732)
T KOG4250|consen   36 ETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA  114 (732)
T ss_pred             ccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccc
Confidence            689999999998764 4455678999999999999999999999855433      5789999999999999998743  


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc---CcceeecccccceecccCCcccccCCeEEEeccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEP  149 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~---~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~p  149 (477)
                       .+++.+++.++.++..||.|||++||+||||||+||++-.   +..-..++|||.++..+...   .-.+.+||..|.+
T Consensus       115 ~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~~S~vGT~~YLh  191 (732)
T KOG4250|consen  115 YGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LFTSLVGTEEYLH  191 (732)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---eeeeecCchhhcC
Confidence             5999999999999999999999999999999999999943   44455567999998765443   2357899999999


Q ss_pred             cccCCC-C---CcccccCcceEEEEEE--eeecccc
Q psy6508         150 REIPSS-K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       150 pE~~~~-~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ||...+ +   ..+|. ||+|+++|+.  |..||-.
T Consensus       192 Pel~E~q~~y~~tVDL-WS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  192 PELYERQKKYTATVDL-WSFGVTLYECATGELPFIP  226 (732)
T ss_pred             hHHHhhccCcCceeeh-hhhhhHHHHHhccCCCCCc
Confidence            999885 3   66899 9999999999  7777763

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.93  E-value=1.1e-26  Score=232.40  Aligned_cols=174  Identities=21%  Similarity=0.305  Sum_probs=135.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeC-CeEEEEEecCCCCCHHHHHHhC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDE-RYVYIILEYCDGGDLCSFIRSH--------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~-~~~~lv~e~~~g~sL~~~l~~~--------   72 (477)
                      +++.||+|+++... .....+.+.+|+.+++.+ +||||+++++++... +.++++|||++||+|.+++...        
T Consensus        36 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~  114 (338)
T cd05102          36 SCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYR  114 (338)
T ss_pred             cchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhccccc
Confidence            45689999987543 334456789999999999 899999999988754 4689999999999999999752        


Q ss_pred             ------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy6508          73 ------------------------------------------------------EKLSEFQCQQFVRQLVLALKFLRENN   98 (477)
Q Consensus        73 ------------------------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~g   98 (477)
                                                                            ..+++..+..++.|++.||.|||++|
T Consensus       115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~  194 (338)
T cd05102         115 EKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRK  194 (338)
T ss_pred             ccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                                                                  23677888999999999999999999


Q ss_pred             cEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE---
Q psy6508          99 VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF---  172 (477)
Q Consensus        99 ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---  172 (477)
                      |+||||||+|||++.+. ++.++|||++.............+..++..|+|||...+.   .++|+ ||+|+++||+   
T Consensus       195 ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi-wslG~il~el~~~  272 (338)
T cd05102         195 CIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDV-WSFGVLLWEIFSL  272 (338)
T ss_pred             EECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCH-HHHHHHHHHHHhC
Confidence            99999999999997643 3445699988653322111111233345679999987655   67899 9999999997   


Q ss_pred             eeecccc
Q psy6508         173 KFAPFAS  179 (477)
Q Consensus       173 ~~~Pf~~  179 (477)
                      +..||.+
T Consensus       273 g~~pf~~  279 (338)
T cd05102         273 GASPYPG  279 (338)
T ss_pred             CCCCCCC
Confidence            5677764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA02988 hypothetical protein; Provisional

Probab=99.93  E-value=3.3e-27  Score=230.54  Aligned_cols=170  Identities=22%  Similarity=0.253  Sum_probs=140.9

Q ss_pred             CCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           3 QHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      +|+.||||.++...... ...+.+.+|+.+|++++||||+++++++.+    ...++++|||++||+|.+++.+.+.+++
T Consensus        42 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~  121 (283)
T PHA02988         42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSF  121 (283)
T ss_pred             CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCCh
Confidence            57899999997765433 234678899999999999999999999876    3578999999999999999998888999


Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS-  155 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~-  155 (477)
                      .....++.|++.||.|||+. +++||||||+||+++.+. .+.++|||++.......     .+.+++..|+|||...+ 
T Consensus       122 ~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~  195 (283)
T PHA02988        122 KTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSPP-----FKNVNFMVYFSYKMLNDI  195 (283)
T ss_pred             hHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhcccc-----ccccCcccccCHHHhhhc
Confidence            99999999999999999984 999999999999998653 33445999876443322     23456778999999865 


Q ss_pred             -C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 -K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 -~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .   .++|+ ||+|+++||+  +..||.+
T Consensus       196 ~~~~~~k~Di-~SlGvil~el~~g~~Pf~~  224 (283)
T PHA02988        196 FSEYTIKDDI-YSLGVVLWEIFTGKIPFEN  224 (283)
T ss_pred             cccccchhhh-hHHHHHHHHHHHCCCCCCC
Confidence             2   68899 9999999999  7788874

>KOG0201|consensus

Probab=99.93  E-value=1.1e-27  Score=232.54  Aligned_cols=175  Identities=26%  Similarity=0.391  Sum_probs=154.8

Q ss_pred             CCCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           1 NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         1 ~~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      |++++.||||+++.+... ...++++.|+.+|.++++|||.++|+.+..+..+|++||||.||++.+.++..+.+++..+
T Consensus        35 ~~t~k~vAiKii~Le~~~-deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i  113 (467)
T KOG0201|consen   35 NKTKKVVAIKIIDLEEAE-DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEI  113 (467)
T ss_pred             ccccceEEEEEechhhcc-hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCcccee
Confidence            468999999999887643 4567889999999999999999999999999999999999999999999998777799999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++++++.||.|||.++.+|||||+.|||+..+ .+++.  |||++..........  +|.+||+.|||||+..+.   
T Consensus       114 ~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~--DfgVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~  189 (467)
T KOG0201|consen  114 AVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLA--DFGVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYD  189 (467)
T ss_pred             eeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEE--ecceeeeeechhhcc--ccccccccccchhhhcccccc
Confidence            9999999999999999999999999999999764 55555  999987766544333  799999999999999875   


Q ss_pred             CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      .++|| ||+|++.+||  |.+|++...
T Consensus       190 ~KADI-WSLGITaiEla~GePP~s~~h  215 (467)
T KOG0201|consen  190 TKADI-WSLGITAIELAKGEPPHSKLH  215 (467)
T ss_pred             chhhh-hhhhHHHHHHhcCCCCCcccC
Confidence            88999 9999999999  789998643

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=3.6e-26  Score=239.34  Aligned_cols=172  Identities=23%  Similarity=0.301  Sum_probs=142.0

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCCHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLSEFQ   79 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~~~~   79 (477)
                      ++.||+|.+...  .......+.+|+.+|+.++||||+++++.+..++..|+||||++||+|.+++..    ...+++..
T Consensus        93 ~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~  170 (478)
T PTZ00267         93 KEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYE  170 (478)
T ss_pred             CeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHH
Confidence            677899976543  234445688999999999999999999999999999999999999999988754    34689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.............+..+++.|+|||...+.   
T Consensus       171 ~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  249 (478)
T PTZ00267        171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTG-IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS  249 (478)
T ss_pred             HHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCC-cEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence            999999999999999999999999999999998643 3444599998765544332334456688899999988765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       250 ~~~Dv-~slG~~l~el~tg~~Pf~~  273 (478)
T PTZ00267        250 KKADM-WSLGVILYELLTLHRPFKG  273 (478)
T ss_pred             cHHhH-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6688864

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=4.6e-26  Score=227.56  Aligned_cols=175  Identities=21%  Similarity=0.307  Sum_probs=141.9

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+++.||+|++.+... .....+.+.+|..+++.++||||+++++++..++.+|+||||++|++|.+++.+ ...+++..
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~  103 (331)
T cd05597          24 NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM  103 (331)
T ss_pred             CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHH
Confidence            4688999999875332 223445688999999999999999999999999999999999999999999976 45799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      ++.++.|++.||+|||++||+||||||+|||++.+. .+.++|||.+........ .......+++.|+|||++.+    
T Consensus       104 ~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~  181 (331)
T cd05597         104 ARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNG-HIRLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDG  181 (331)
T ss_pred             HHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCC-CEEEEECCceeecCCCCC-ccccceeccccccCHHHHhhcccc
Confidence            999999999999999999999999999999997543 334459998754332211 11123467889999998752    


Q ss_pred             ----CCcccccCcceEEEEEE--eeecccc
Q psy6508         156 ----KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ----~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          ..++|+ ||+|+++|++  +..||.+
T Consensus       182 ~~~~~~~~Di-wslG~~l~el~~g~~Pf~~  210 (331)
T cd05597         182 KGRYGPECDW-WSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             ccCCCCccee-ehhhhHHHHHhhCCCCCCC
Confidence                157899 9999999999  7788865

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.93  E-value=3.5e-26  Score=223.44  Aligned_cols=173  Identities=19%  Similarity=0.256  Sum_probs=141.8

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~   78 (477)
                      .+|+.||+|.+.+..... .....+.+|+.+++.++||||+++++.+...+..+++|||+++|+|.+++...  ..+++.
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~  102 (285)
T cd05631          23 ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQ  102 (285)
T ss_pred             cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHH
Confidence            478999999987654332 23356789999999999999999999999999999999999999999888643  368999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......   ......++..|+|||...+.  
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~  178 (285)
T cd05631         103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRG-HIRISDLGLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeCCCcEEcCCCC---eecCCCCCCCccCHhhhcCCCC
Confidence            9999999999999999999999999999999997643 34445999886543221   11234678899999998765  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ ||+|+++|++  +..||..
T Consensus       179 ~~~~Dv-wslGvil~el~~g~~pf~~  203 (285)
T cd05631         179 TFSPDW-WGLGCLIYEMIQGQSPFRK  203 (285)
T ss_pred             CcccCc-hhHHHHHHHHHhCCCCCCC
Confidence             67899 9999999999  6788874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.93  E-value=3.9e-26  Score=227.65  Aligned_cols=174  Identities=21%  Similarity=0.368  Sum_probs=144.5

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      ++++.||+|++++.... ....+.+.+|..++.++ +||||+++++++...+.+|+||||++|++|..++...+.+++..
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~   97 (327)
T cd05617          18 KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEH   97 (327)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence            46889999999876433 33456788999999998 69999999999999999999999999999999998878899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..+++.|+|||...+.   
T Consensus        98 ~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (327)
T cd05617          98 ARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEYG  174 (327)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCC-CEEEeccccceeccCCC--CceecccCCcccCCHHHHCCCCCC
Confidence            999999999999999999999999999999997643 24445999876432211  112345678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||..
T Consensus       175 ~~~Di-wslGvil~ell~g~~pf~~  198 (327)
T cd05617         175 FSVDW-WALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             chhee-ehhHHHHHHHHhCCCCCCc
Confidence            67899 9999999999  7788863

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.93  E-value=2.7e-26  Score=232.71  Aligned_cols=174  Identities=22%  Similarity=0.347  Sum_probs=143.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++.+... .....+.+.+|..+++.++||||+++++.+..++..|+||||++||+|.+++... .+++..+
T Consensus        66 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~-~~~~~~~  144 (371)
T cd05622          66 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWA  144 (371)
T ss_pred             CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHH
Confidence            4788999999875432 2233456889999999999999999999999999999999999999999998764 6899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+........ ....+..+++.|+|||.+.+.    
T Consensus       145 ~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~-~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~  222 (371)
T cd05622         145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG  222 (371)
T ss_pred             HHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCC-CEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCc
Confidence            99999999999999999999999999999997643 344459999865433221 122356788999999987542    


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|||  +..||.+
T Consensus       223 ~~~~~~Di-wSlGvilyell~G~~Pf~~  249 (371)
T cd05622         223 YYGRECDW-WSVGVFLYEMLVGDTPFYA  249 (371)
T ss_pred             cCCCccce-eehhHHHHHHHhCCCCCCC
Confidence               57899 9999999999  7788874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0604|consensus

Probab=99.93  E-value=7.7e-27  Score=216.20  Aligned_cols=205  Identities=20%  Similarity=0.323  Sum_probs=161.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCCC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHEK--   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~--   74 (477)
                      .+|+.+|+|++.-.       .+.++|+++.-.. .|||||.++++++.    ...+.+|||.++||.|.+.++.++.  
T Consensus        85 ~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~a  157 (400)
T KOG0604|consen   85 RTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQA  157 (400)
T ss_pred             cchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccccc
Confidence            35666677765322       3467899886655 69999999998764    3578999999999999999998764  


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++.++..|++||..|+.|||+.+|.||||||+|+|...  .+..+.+.|||.++......   .-.|...|+.|.|||+
T Consensus       158 fTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~---~L~TPc~TPyYvaPev  234 (400)
T KOG0604|consen  158 FTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPG---DLMTPCFTPYYVAPEV  234 (400)
T ss_pred             chHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCCc---cccCCcccccccCHHH
Confidence            999999999999999999999999999999999999954  35566677999997665322   1246778899999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeeccccccccC--------------CCCCcchHHHHHHHHHHhhhhhhcccCCC
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFASQIRTG--------------WLRDSEEKELGNHLKRALEPAVCRHEFSN  213 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~~r~~--------------~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr  213 (477)
                      +...   .+.|+ ||+|+++|-+  ||+||.+.....              .++..+-..++...+..++..+..++-.|
T Consensus       235 lg~eKydkscdm-wSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteR  313 (400)
T KOG0604|consen  235 LGPEKYDKSCDM-WSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTER  313 (400)
T ss_pred             hCchhcCCCCCc-cchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhh
Confidence            8766   66799 9999999988  999998753221              14556667777777777777776666666


Q ss_pred             Cccc
Q psy6508         214 FQVD  217 (477)
Q Consensus       214 ~~i~  217 (477)
                      .+|.
T Consensus       314 lTI~  317 (400)
T KOG0604|consen  314 LTIE  317 (400)
T ss_pred             eeHH
Confidence            6654

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.93  E-value=3.7e-26  Score=226.74  Aligned_cols=174  Identities=18%  Similarity=0.317  Sum_probs=141.8

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|++++.... ....+.+..|..++... +||||+++++++...+.+|+||||++|++|..++...+.+++..
T Consensus        18 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~   97 (316)
T cd05620          18 GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYR   97 (316)
T ss_pred             CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHH
Confidence            46889999999765321 23345567788888765 89999999999999999999999999999999998878899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||+|||++||+||||||+||+++.++ .+.++|||.+.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (316)
T cd05620          98 ATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFGD--NRASTFCGTPDYIAPEILQGLKYT  174 (316)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCC-CEEeCccCCCeecccCC--CceeccCCCcCccCHHHHcCCCCC
Confidence            999999999999999999999999999999997653 34456999875322111  112345678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++||+  +..||.+
T Consensus       175 ~~~Di-wslGvil~el~~g~~Pf~~  198 (316)
T cd05620         175 FSVDW-WSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             cccch-hhhHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6678764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.93  E-value=3.8e-26  Score=227.38  Aligned_cols=173  Identities=23%  Similarity=0.374  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHH---HhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKAL---KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il---~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||||++++... .....+.+.+|..++   +.++||||+++++++...+..|+||||++|++|..++.. +.+++
T Consensus        22 ~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~  100 (324)
T cd05589          22 KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSE  100 (324)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCH
Confidence            4789999999976532 223345677777665   456799999999999999999999999999999998865 47999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..+..++.|++.||.|||++|++||||||+||+++.++ .+.++|||++....+..  ....+..+++.|+|||...+. 
T Consensus       101 ~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~  177 (324)
T cd05589         101 PRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG-FVKIADFGLCKEGMGFG--DRTSTFCGTPEFLAPEVLTETS  177 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC-cEEeCcccCCccCCCCC--CcccccccCccccCHhHhcCCC
Confidence            99999999999999999999999999999999997653 34445999875433221  122345678899999998765 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+|+++|++  +..||.+
T Consensus       178 ~~~~~Di-wslG~il~el~~G~~pf~~  203 (324)
T cd05589         178 YTRAVDW-WGLGVLIYEMLVGESPFPG  203 (324)
T ss_pred             CCcccch-hhHHHHHHHHHhCCCCCCC
Confidence              67899 9999999999  6677764

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.93  E-value=2.5e-26  Score=233.02  Aligned_cols=174  Identities=22%  Similarity=0.335  Sum_probs=142.1

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++++.... ....+.+.+|+.+++.++||||+++++++.+++.+|+||||++||+|.+++.. ..+++..+
T Consensus        66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~  144 (370)
T cd05596          66 SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWA  144 (370)
T ss_pred             CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHH
Confidence            46889999999764332 23345678999999999999999999999999999999999999999999876 46899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+........ ....+..+++.|+|||.+.+.    
T Consensus       145 ~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~-~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  222 (370)
T cd05596         145 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDG  222 (370)
T ss_pred             HHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCC-CEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCC
Confidence            99999999999999999999999999999997643 344459998865433221 112345688899999987532    


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++||+  +..||.+
T Consensus       223 ~~~~~~Di-wSlGvilyelltG~~Pf~~  249 (370)
T cd05596         223 YYGRECDW-WSVGVFLYEMLVGDTPFYA  249 (370)
T ss_pred             CCCCceee-eehhHHHHHHHhCCCCcCC
Confidence               57899 9999999999  7788875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.93  E-value=8.8e-27  Score=227.08  Aligned_cols=174  Identities=20%  Similarity=0.305  Sum_probs=141.5

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~   76 (477)
                      .+|+.||+|.+.+..... ...+.+..|+.+++.++||||+++++++..++..|+||||++|++|..++..    +..++
T Consensus        16 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~   95 (280)
T cd05608          16 ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP   95 (280)
T ss_pred             cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCC
Confidence            468899999987654332 3346778999999999999999999999999999999999999999988743    34689


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..++.++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.......  ....+..++..|+|||...+.
T Consensus        96 ~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~  172 (280)
T cd05608          96 EPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQ--SKTKGYAGTPGFMAPELLQGE  172 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCccceecCCCC--ccccccCCCcCccCHHHhcCC
Confidence            999999999999999999999999999999999997643 34445999875433211  112234577889999998765


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|++  +..||..
T Consensus       173 ~~~~~~Dv-wslG~il~el~~g~~pf~~  199 (280)
T cd05608         173 EYDFSVDY-FALGVTLYEMIAARGPFRA  199 (280)
T ss_pred             CCCccccH-HHHHHHHHHHHhCCCCCCC
Confidence               67899 9999999999  6778864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.93  E-value=7.9e-26  Score=225.15  Aligned_cols=174  Identities=20%  Similarity=0.301  Sum_probs=141.6

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCC-CCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHH-QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++.+... .....+.+..|..+++.++| ++|+++++++...+.+|+||||++|++|.+++...+.+++..
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~  102 (324)
T cd05587          23 GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPH  102 (324)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHH
Confidence            4678999999976533 23345678899999999965 568899999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..++..|+|||...+.   
T Consensus       103 ~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  179 (324)
T cd05587         103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEG-HIKIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYG  179 (324)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCC-CEEEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCC
Confidence            999999999999999999999999999999997643 33445999875322111  111234578899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       180 ~~~Di-wslGvil~elltG~~pf~~  203 (324)
T cd05587         180 KSVDW-WAFGVLLYEMLAGQPPFDG  203 (324)
T ss_pred             cccch-hhhHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6788864

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG4645|consensus

Probab=99.93  E-value=9.9e-27  Score=249.96  Aligned_cols=177  Identities=26%  Similarity=0.402  Sum_probs=152.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++|...|+|-++...........+.+|..+|..++|||+|++||+-...+..+|.||||+||+|.+.++..+..++...+
T Consensus      1258 ~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~ 1337 (1509)
T KOG4645|consen 1258 DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTR 1337 (1509)
T ss_pred             CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHH
Confidence            68889999988766555555677889999999999999999999999999999999999999999999987778888889


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccC--CeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQG--NTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g--~t~v~~~~y~ppE~~~~~---  156 (477)
                      .+..|++.|+.|||++|||||||||.||+++.++ -+...|||.+....+......|  +..+||+.|||||++.+.   
T Consensus      1338 vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~k 1416 (1509)
T KOG4645|consen 1338 VYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNG-LIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGK 1416 (1509)
T ss_pred             HHHHHHHHHHHHHHhcCceecCCCccceeeecCC-cEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccC
Confidence            9999999999999999999999999999998876 4555699999877766421111  357899999999999876   


Q ss_pred             ---CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                         .+.|| ||+||+.+||  |..||+.-
T Consensus      1417 G~~~A~Di-WslGCVVlEM~tGkrPW~~~ 1444 (1509)
T KOG4645|consen 1417 GHGGAADI-WSLGCVVLEMATGKRPWAEL 1444 (1509)
T ss_pred             CCCcchhh-hcccceEEEeecCCCchhhc
Confidence               67899 9999999999  77888753

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=5.6e-26  Score=225.64  Aligned_cols=174  Identities=21%  Similarity=0.361  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||||++++... .......+.+|..+++.+ +||||+++++++...+.+|+||||++|++|..++.+.+.+++..
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~   97 (318)
T cd05570          18 GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPR   97 (318)
T ss_pred             CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHH
Confidence            4688999999986543 233456678899999888 79999999999999999999999999999999998887899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~  174 (318)
T cd05570          98 ARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYG  174 (318)
T ss_pred             HHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCC-cEEecccCCCeecCcCC--CcccceecCccccCHHHhcCCCCC
Confidence            999999999999999999999999999999997653 34445999875422111  111234678889999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       175 ~~~Di-wslGvil~~l~~G~~pf~~  198 (318)
T cd05570         175 PAVDW-WALGVLLYEMLAGQSPFEG  198 (318)
T ss_pred             cchhh-hhHHHHHHHHhhCCCCCCC
Confidence            67899 9999999999  6678864

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.93  E-value=3.4e-26  Score=225.50  Aligned_cols=166  Identities=24%  Similarity=0.297  Sum_probs=134.0

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC----------
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE----------   73 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------   73 (477)
                      +..||+|++.... .......+.+|+.++++++||||+++++++...+..+++|||+++++|.+++....          
T Consensus        46 ~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  124 (304)
T cd05096          46 PLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND  124 (304)
T ss_pred             ceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhcccccccccccc
Confidence            4579999987543 34456779999999999999999999999999999999999999999999986531          


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEe
Q psy6508          74 ---------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVIC  144 (477)
Q Consensus        74 ---------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~  144 (477)
                               .+++..+..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.............+..++
T Consensus       125 ~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~  203 (304)
T cd05096         125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLP  203 (304)
T ss_pred             ccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCC
Confidence                     357788899999999999999999999999999999998653 3445699988654332222222333445


Q ss_pred             ccccccccCCCC---CcccccCcceEEEEEE
Q psy6508         145 SVFEPREIPSSK---TSLEYQRSKGELYVEF  172 (477)
Q Consensus       145 ~~y~ppE~~~~~---~~~Di~~s~G~il~e~  172 (477)
                      ..|+|||...+.   .++|+ ||+|+++||+
T Consensus       204 ~~y~aPE~~~~~~~~~~~Dv-~slG~~l~el  233 (304)
T cd05096         204 IRWMAWECILMGKFTTASDV-WAFGVTLWEI  233 (304)
T ss_pred             ccccCHHHHhcCCCCchhhh-HHHHHHHHHH
Confidence            679999987654   67899 9999999997

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.93  E-value=8.7e-26  Score=224.73  Aligned_cols=174  Identities=20%  Similarity=0.298  Sum_probs=142.3

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++++.... ....+.+..|..++..+ +||+|+++++++...+.+|+||||++||+|.+++...+.+++..
T Consensus        23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~  102 (323)
T cd05616          23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPH  102 (323)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHH
Confidence            46789999999765432 23345677888888887 68999999999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..+++.|+|||...+.   
T Consensus       103 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  179 (323)
T cd05616         103 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYG  179 (323)
T ss_pred             HHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCC-cEEEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCC
Confidence            999999999999999999999999999999997653 34446999876432111  111234577889999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++||+  +..||.+
T Consensus       180 ~~~Di-wSlGvil~elltg~~Pf~~  203 (323)
T cd05616         180 KSVDW-WAFGVLLYEMLAGQAPFEG  203 (323)
T ss_pred             Cccch-hchhHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6788864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.93  E-value=1.7e-26  Score=227.58  Aligned_cols=172  Identities=25%  Similarity=0.403  Sum_probs=138.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+++.||+|+++..... .....+.+|+.+++.++||||+++++++..+...|+||||++ ++|.+++..+ +.+++..+
T Consensus        28 ~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  105 (303)
T cd07869          28 VNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENV  105 (303)
T ss_pred             CCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHH
Confidence            36889999998765422 223457789999999999999999999999999999999997 7888888664 46899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||+|||++||+||||||+|||++.++ ++.++|||.+.......  ....+..++..|+|||+..+.    
T Consensus       106 ~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  182 (303)
T cd07869         106 KLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTG-ELKLADFGLARAKSVPS--HTYSNEVVTLWYRPPDVLLGSTEYS  182 (303)
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECCCCcceeccCCC--ccCCCCcccCCCCChHHHcCCCCCC
Confidence            99999999999999999999999999999997643 34456999875432211  122345678899999987543    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  |..||.+
T Consensus       183 ~~~Di-wslG~il~~l~~g~~pf~~  206 (303)
T cd07869         183 TCLDM-WGVGCIFVEMIQGVAAFPG  206 (303)
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            56899 9999999999  7788874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.93  E-value=1.6e-26  Score=234.63  Aligned_cols=174  Identities=22%  Similarity=0.286  Sum_probs=138.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------   72 (477)
                      +++.||+|+++.... ....+.+.+|+.+++.+ +||||+++++++...+..|+||||+++|+|.+++...         
T Consensus        67 ~~~~vavK~~~~~~~-~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~  145 (374)
T cd05106          67 NVLRVAVKMLKASAH-TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVM  145 (374)
T ss_pred             ccceeEEEeccCCCC-HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccc
Confidence            446899999976543 33456789999999999 8999999999999999999999999999999998542         


Q ss_pred             -------------------------------------------------------------CCCCHHHHHHHHHHHHHHH
Q psy6508          73 -------------------------------------------------------------EKLSEFQCQQFVRQLVLAL   91 (477)
Q Consensus        73 -------------------------------------------------------------~~l~~~~~~~i~~qi~~aL   91 (477)
                                                                                   .++++..+++++.|++.||
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL  225 (374)
T cd05106         146 ALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGM  225 (374)
T ss_pred             cccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHH
Confidence                                                                         1367888999999999999


Q ss_pred             HHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEE
Q psy6508          92 KFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGEL  168 (477)
Q Consensus        92 ~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~i  168 (477)
                      .|||++||+||||||+|||++++. .+.+.|||++.............+..++..|+|||...+.   .++|+ ||+|++
T Consensus       226 ~yLH~~giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-wSlGvi  303 (374)
T cd05106         226 DFLASKNCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDV-WSYGIL  303 (374)
T ss_pred             HHHHHCCEEeccCchheEEEeCCC-eEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccH-HHHHHH
Confidence            999999999999999999998653 3445699988654322211122222334569999987654   78899 999999


Q ss_pred             EEEE---eeecccc
Q psy6508         169 YVEF---KFAPFAS  179 (477)
Q Consensus       169 l~e~---~~~Pf~~  179 (477)
                      +|++   +..||..
T Consensus       304 l~ellt~G~~Pf~~  317 (374)
T cd05106         304 LWEIFSLGKSPYPG  317 (374)
T ss_pred             HHHHHhCCCCCCcc
Confidence            9997   5577764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.93  E-value=1.2e-25  Score=224.61  Aligned_cols=175  Identities=23%  Similarity=0.336  Sum_probs=141.8

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+++.||+|++.+... .....+.+.+|..++..++||||+++++++..++..|+||||++||+|.+++.+ ...+++..
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~  103 (331)
T cd05624          24 HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDM  103 (331)
T ss_pred             CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHH
Confidence            4678999999876432 223345688999999999999999999999999999999999999999999987 45799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      ++.++.|++.||+|||++||+||||||+|||++.+. .+.++|||++........ .......++..|+|||...+    
T Consensus       104 ~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~  181 (331)
T cd05624         104 ARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNG-HIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDG  181 (331)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCC-CEEEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccC
Confidence            999999999999999999999999999999997643 334459998765432211 11123457889999998753    


Q ss_pred             --C--CcccccCcceEEEEEE--eeecccc
Q psy6508         156 --K--TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 --~--~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .  .++|+ ||+|+++|+|  +..||..
T Consensus       182 ~~~~~~~~Di-wSlGvil~ell~g~~Pf~~  210 (331)
T cd05624         182 MGKYGPECDW-WSLGVCMYEMLYGETPFYA  210 (331)
T ss_pred             CCCCCCcccE-EeeehhhhhhhhCCCCccC
Confidence              1  57899 9999999999  6788864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.93  E-value=8.1e-26  Score=224.32  Aligned_cols=174  Identities=22%  Similarity=0.332  Sum_probs=141.3

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      ++++.||||+++.... .....+.+..|..+++.+ +||||+++++++...+.+|+||||++||+|.+++.....+++..
T Consensus        18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~   97 (316)
T cd05619          18 GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPR   97 (316)
T ss_pred             CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence            4688999999876532 123345567788888765 89999999999999999999999999999999998877899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.......  ....+..++..|+|||...+.   
T Consensus        98 ~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  174 (316)
T cd05619          98 ATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLGD--AKTCTFCGTPDYIAPEILLGQKYN  174 (316)
T ss_pred             HHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCC-CEEEccCCcceECCCCC--CceeeecCCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999997653 34446999875422111  111345678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       175 ~~~Dv-wslG~il~el~~G~~pf~~  198 (316)
T cd05619         175 TSVDW-WSFGVLLYEMLIGQSPFHG  198 (316)
T ss_pred             chhhh-hhHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6678764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.93  E-value=3e-26  Score=223.73  Aligned_cols=175  Identities=21%  Similarity=0.319  Sum_probs=142.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|++..........+.+.+|+.+++.++||||+++++++..++..|+||||++++.+..+......+++..++
T Consensus        24 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  103 (287)
T cd07848          24 ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVR  103 (287)
T ss_pred             CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHH
Confidence            46889999999876555555667889999999999999999999999999999999999987776655555579999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+........ .......++..|+|||...+.   .+
T Consensus       104 ~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~  181 (287)
T cd07848         104 SYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND-VLKLCDFGFARNLSEGSN-ANYTEYVATRWYRSPELLLGAPYGKA  181 (287)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEEeeccCccccccccc-ccccccccccccCCcHHHcCCCCCCc
Confidence            9999999999999999999999999999997643 344459998865432111 112234678889999988665   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ ||+|+++||+  +..||.+
T Consensus       182 ~Di-wslGvil~el~~g~~pf~~  203 (287)
T cd07848         182 VDM-WSVGCILGELSDGQPLFPG  203 (287)
T ss_pred             hhH-HhHHHHHHHHHhCCCCCCC
Confidence            899 9999999999  6677764

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG4721|consensus

Probab=99.93  E-value=1.2e-26  Score=230.43  Aligned_cols=186  Identities=19%  Similarity=0.279  Sum_probs=151.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ   82 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~   82 (477)
                      .++.||||+++.-+         ..+++-|++|+||||+.+.|+|.....+|||||||..|-|...|+..+.++......
T Consensus       146 ~netVAVKKV~elk---------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~  216 (904)
T KOG4721|consen  146 HNETVAVKKVRELK---------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVD  216 (904)
T ss_pred             cCceehhHHHhhhh---------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHH
Confidence            36789999875321         246888999999999999999999999999999999999999999988999999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCc-ceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      |..+|+.|+.|||.+.|||||||..||||..++ +|+  .|||.++....-   ...-...||..||+||++...   .+
T Consensus       217 Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKI--sDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEK  291 (904)
T KOG4721|consen  217 WSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKI--SDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEK  291 (904)
T ss_pred             HHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEe--ccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccc
Confidence            999999999999999999999999999997654 444  599988644322   122346778889999999887   88


Q ss_pred             ccccCcceEEEEEE--eeecccccccc------------CCCCCcchHHHHHHHHHHhh
Q psy6508         159 LEYQRSKGELYVEF--KFAPFASQIRT------------GWLRDSEEKELGNHLKRALE  203 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~~~r~------------~~~~~~~~~~l~~~i~~~l~  203 (477)
                      +|| ||+|+++|||  +-.||......            ...+..-++.+..++++++.
T Consensus       292 VDI-wSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~  349 (904)
T KOG4721|consen  292 VDI-WSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWN  349 (904)
T ss_pred             cce-ehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHh
Confidence            999 9999999999  55777654322            22344556777777777654

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.93  E-value=3.2e-26  Score=228.86  Aligned_cols=175  Identities=28%  Similarity=0.381  Sum_probs=139.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||+++..........++.+|+.+++.++||||+++++++...     ..+|+||||+. ++|.+++.....++
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~  101 (338)
T cd07859          23 HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDDLT  101 (338)
T ss_pred             CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhcccCC
Confidence            4789999999875543344456788999999999999999999987643     35899999996 79999998878899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..+..++.|++.||.|||++||+||||||+|||++.+. ++.++|||.+........ .......++++.|+|||+..+
T Consensus       102 ~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~  180 (338)
T cd07859         102 PEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS  180 (338)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEccCccccccccccCccccccCCCCCCCcCCHHHHhc
Confidence            999999999999999999999999999999999997653 344459998864322111 111233567889999998754


Q ss_pred             --C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 --K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 --~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .   .++|+ ||+|+++|++  +..||.+
T Consensus       181 ~~~~~~~~~Dv-wSlGvvl~el~tg~~pf~~  210 (338)
T cd07859         181 FFSKYTPAIDI-WSIGCIFAEVLTGKPLFPG  210 (338)
T ss_pred             cccccCchhHH-HHHHHHHHHHHcCCCCCCC
Confidence              1   67899 9999999999  6677764

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.93  E-value=3.4e-26  Score=228.45  Aligned_cols=171  Identities=22%  Similarity=0.266  Sum_probs=143.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|..||+|.+.... .....+.+.+|+.++++++||||+++++++..++..++||||++|++|.+++.....+++..+.
T Consensus        28 ~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  106 (331)
T cd06649          28 PSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG  106 (331)
T ss_pred             CCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHH
Confidence            468889999987643 3445577999999999999999999999999999999999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++ +|+||||||+||+++.+. .+.++|||++......    ......++..|+|||...+.   .
T Consensus       107 ~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~  181 (331)
T cd06649         107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSV  181 (331)
T ss_pred             HHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCc
Confidence            9999999999999986 699999999999997653 3444599987544322    12334677899999998765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+  +..||..
T Consensus       182 ~~Di-wslG~il~el~tg~~p~~~  204 (331)
T cd06649         182 QSDI-WSMGLSLVELAIGRYPIPP  204 (331)
T ss_pred             hHhH-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6788853

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=8.7e-26  Score=224.78  Aligned_cols=174  Identities=21%  Similarity=0.306  Sum_probs=142.2

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|++++... .....+.+..|..+++.+. ||+|+++++++...+.+|+||||++|++|.+++...+.+++..
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~  102 (323)
T cd05615          23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQ  102 (323)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHH
Confidence            4788999999876533 2334456788999998885 6788899999999999999999999999999998888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++........  ...+..++..|+|||...+.   
T Consensus       103 ~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~-~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~  179 (323)
T cd05615         103 AVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEG-HIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQPYG  179 (323)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEeccccccccCCCCc--cccCccCCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999998653 344569998754322111  11234577899999988765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       180 ~~~Di-wslGvil~elltG~~pf~~  203 (323)
T cd05615         180 KSVDW-WAYGVLLYEMLAGQPPFDG  203 (323)
T ss_pred             Cccch-hhhHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6788864

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.93  E-value=8.9e-26  Score=220.88  Aligned_cols=172  Identities=25%  Similarity=0.371  Sum_probs=139.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+++.||+|+++.... ......+.+|+.++++++||||+++++++..++..++||||++ ++|.+++...+ .+++..+
T Consensus        28 ~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~  105 (288)
T cd07871          28 LTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNV  105 (288)
T ss_pred             CCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHH
Confidence            4688999999875532 2233567899999999999999999999999999999999998 59999987654 5789999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||+|||++||+||||||+|||++.+. .+.++|||.+.......  .......++..|+|||...+.    
T Consensus       106 ~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  182 (288)
T cd07871         106 KIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKG-ELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYS  182 (288)
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEECcCcceeeccCCC--ccccCceecccccChHHhcCCcccC
Confidence            99999999999999999999999999999997643 34445999876433211  122345678899999987653    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       183 ~~~Di-wslG~~l~~l~~g~~pf~~  206 (288)
T cd07871         183 TPIDM-WGVGCILYEMATGRPMFPG  206 (288)
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6677763

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG1187|consensus

Probab=99.93  E-value=7.8e-26  Score=226.50  Aligned_cols=164  Identities=20%  Similarity=0.248  Sum_probs=135.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-eEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      +|+.||||++.......  ..+|.+|+.++.+++|||+++++|+|.+.+ ..+||+||+++|+|.++|....  .++|..
T Consensus        98 ~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~  175 (361)
T KOG1187|consen   98 DGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWET  175 (361)
T ss_pred             CCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHH
Confidence            46899999887654332  455999999999999999999999999888 5999999999999999998765  789999


Q ss_pred             HHHHHHHHHHHHHHHHhC---CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeE-EEeccccccccCCC
Q psy6508          80 CQQFVRQLVLALKFLREN---NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTK-VICSVFEPREIPSS  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~-v~~~~y~ppE~~~~  155 (477)
                      +.+|+.+++.||+|||+.   .|+||||||+|||+|.+ ......|||++......  .....+. .+|..|.+||....
T Consensus       176 R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~-~~aKlsDFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~  252 (361)
T KOG1187|consen  176 RLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDED-FNAKLSDFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYAST  252 (361)
T ss_pred             HHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCC-CCEEccCccCcccCCcc--ccceeeecCCCCccCChhhhcc
Confidence            999999999999999985   39999999999999965 23344699998443320  1111222 68889999999865


Q ss_pred             C---CcccccCcceEEEEEE
Q psy6508         156 K---TSLEYQRSKGELYVEF  172 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~  172 (477)
                      .   .++|+ ||+|+++.|+
T Consensus       253 g~lt~KsDV-ySFGVvllEl  271 (361)
T KOG1187|consen  253 GKLTEKSDV-YSFGVVLLEL  271 (361)
T ss_pred             CCcCccccc-ccchHHHHHH
Confidence            4   78999 9999999998

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.93  E-value=4.6e-26  Score=227.75  Aligned_cols=171  Identities=22%  Similarity=0.267  Sum_probs=142.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.+.... .....+.+.+|++++++++||||+++++++...+..|+||||++|++|.+++...+.+++..+.
T Consensus        28 ~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  106 (333)
T cd06650          28 PSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG  106 (333)
T ss_pred             CCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHH
Confidence            467889999887653 3445567999999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++ +++||||||+|||++.+. .+.++|||++......    ......++..|+|||...+.   .
T Consensus       107 ~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~  181 (333)
T cd06650         107 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSV  181 (333)
T ss_pred             HHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCc
Confidence            9999999999999985 799999999999997643 2444599987543322    11234567789999998765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||..
T Consensus       182 ~~Dv-wslG~il~~l~~g~~p~~~  204 (333)
T cd06650         182 QSDI-WSMGLSLVEMAIGRYPIPP  204 (333)
T ss_pred             HHHH-HHHHHHHHHHHHCCCCCCC
Confidence            7899 9999999999  6677763

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>KOG4279|consensus

Probab=99.93  E-value=1.5e-25  Score=226.88  Aligned_cols=200  Identities=26%  Similarity=0.367  Sum_probs=162.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCC--CHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKL--SEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l--~~~   78 (477)
                      .+....|||-++.+.  .+..+.+..|+.+.++|+|.|||+++|.+..++++-|.||-++||+|.++|+.. +++  ++.
T Consensus       598 ~tqvrIaIKEIpekd--sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEs  675 (1226)
T KOG4279|consen  598 DTQVRIAIKEIPEKD--SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNES  675 (1226)
T ss_pred             cceeEEEeeeccccc--chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchh
Confidence            356678999886553  334467889999999999999999999999999999999999999999999763 566  788


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      .+..+.+||++||+|||++.|||||||-+|+|++-  +-+|+  .|||.+++.-|-..  ...|..||.-||+||++..+
T Consensus       676 tm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKI--SDFGTsKRLAginP--~TETFTGTLQYMAPEvIDqG  751 (1226)
T KOG4279|consen  676 TMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKI--SDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDQG  751 (1226)
T ss_pred             HHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEe--cccccchhhccCCc--cccccccchhhhChHhhccC
Confidence            99999999999999999999999999999999974  55555  49999988777543  34578899999999998765


Q ss_pred             -----CcccccCcceEEEEEE--eeecccccccc-------------CCCCCcchHHHHHHHHHHhhhhhhc
Q psy6508         157 -----TSLEYQRSKGELYVEF--KFAPFASQIRT-------------GWLRDSEEKELGNHLKRALEPAVCR  208 (477)
Q Consensus       157 -----~~~Di~~s~G~il~e~--~~~Pf~~~~r~-------------~~~~~~~~~~l~~~i~~~l~~~i~~  208 (477)
                           .++|| ||+||+++||  |.+||..-+.+             +..+..-..+-..+|.++++|..+.
T Consensus       752 ~RGYG~aADI-WS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~  822 (1226)
T KOG4279|consen  752 PRGYGKAADI-WSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCD  822 (1226)
T ss_pred             CcCCCchhhh-hhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCccc
Confidence                 77999 9999999999  78999754432             1233344556677788888777653

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.93  E-value=3e-26  Score=232.82  Aligned_cols=174  Identities=22%  Similarity=0.280  Sum_probs=137.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------   73 (477)
                      ++..||+|+++.... ....+.+.+|+.+++.+ +||||+++++++...+..++||||++||+|.+++....        
T Consensus        64 ~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~  142 (375)
T cd05104          64 AAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKH  142 (375)
T ss_pred             cceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccc
Confidence            466899999875432 33456789999999999 89999999999999999999999999999999986421        


Q ss_pred             -------------------------------------------------------------------CCCHHHHHHHHHH
Q psy6508          74 -------------------------------------------------------------------KLSEFQCQQFVRQ   86 (477)
Q Consensus        74 -------------------------------------------------------------------~l~~~~~~~i~~q   86 (477)
                                                                                         .+++..+..++.|
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q  222 (375)
T cd05104         143 EDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQ  222 (375)
T ss_pred             cchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHH
Confidence                                                                               3678889999999


Q ss_pred             HHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccC
Q psy6508          87 LVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQR  163 (477)
Q Consensus        87 i~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~  163 (477)
                      ++.||.|||++||+||||||+|||++.+. .+.++|||++.............+..++..|+|||...+.   .++|+ |
T Consensus       223 i~~~l~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi-~  300 (375)
T cd05104         223 VAKGMSFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV-W  300 (375)
T ss_pred             HHHHHHHHHHCCeeccCCchhhEEEECCC-cEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCH-H
Confidence            99999999999999999999999998653 3334599988654332211111222334569999998765   77899 9


Q ss_pred             cceEEEEEE---eeecccc
Q psy6508         164 SKGELYVEF---KFAPFAS  179 (477)
Q Consensus       164 s~G~il~e~---~~~Pf~~  179 (477)
                      |+|++++|+   +..||..
T Consensus       301 slG~~l~ellt~g~~p~~~  319 (375)
T cd05104         301 SYGILLWEIFSLGSSPYPG  319 (375)
T ss_pred             HHHHHHHHHHhcCCCCCCC
Confidence            999999997   4566653

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0596|consensus

Probab=99.92  E-value=4.7e-26  Score=226.16  Aligned_cols=173  Identities=22%  Similarity=0.356  Sum_probs=147.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK-LSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~-l~~~~~   80 (477)
                      +.+.||+|++...........-|.+|+..|.+| .|.+|+++|++-..++.+|||||+-+ .+|..+|++... ++...+
T Consensus       384 ~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd-~DL~kiL~k~~~~~~~~~l  462 (677)
T KOG0596|consen  384 DKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGD-IDLNKILKKKKSIDPDWFL  462 (677)
T ss_pred             CCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeeccc-ccHHHHHHhccCCCchHHH
Confidence            456688888776666777778899999999999 59999999999999999999999876 899999988654 444689


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.+++++|.+||||.||||.|+|+-.+.++++  |||++........-....+.+||..||+||.+...    
T Consensus       463 k~ywkqML~aV~~IH~~gIVHSDLKPANFLlVkG~LKLI--DFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~  540 (677)
T KOG0596|consen  463 KFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVKGRLKLI--DFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSR  540 (677)
T ss_pred             HHHHHHHHHHHHHHHHhceeecCCCcccEEEEeeeEEee--eechhcccCccccceeeccccCcccccCHHHHhhccccc
Confidence            999999999999999999999999999999999877777  99999765544444455689999999999987533    


Q ss_pred             ----------CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                                +++|+ ||+|||+|+|  +..||..
T Consensus       541 ~~~~~k~Ki~r~SDv-WSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  541 ENGKSKIKISRKSDV-WSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             cCCCcceeecCccch-hhhhhHHHHHHhcCCchHH
Confidence                      67899 9999999999  6688875

>TIGR03591 polynuc_phos polyribonucleotide nucleotidyltransferase

Probab=99.92  E-value=2.5e-24  Score=230.47  Aligned_cols=274  Identities=17%  Similarity=0.200  Sum_probs=215.3

Q ss_pred             CCCCceeec---cCcceeecccccceecccCCcccccCCeEEEecc-ccccccCCCCCcccccCcceEEEEEEeeecccc
Q psy6508         104 LKPQNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKFAPFAS  179 (477)
Q Consensus       104 lkp~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~-y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~  179 (477)
                      +-.+++-+|   .+++|.+.+.+|+...++||++++.|+|++.|.+ ++||+.......... -..|.+++++.++||++
T Consensus       305 il~~g~R~DGR~~~e~Rpi~~~~g~l~~a~GSa~~~~G~Tqvl~~vt~g~~~~~~~~~~~~~-~~~~~~~~~y~~~pfs~  383 (684)
T TIGR03591       305 ILKEGKRIDGRDLDTIRPISIEVGVLPRTHGSALFTRGETQALVVTTLGTERDEQIIDDLEG-EYRKRFMLHYNFPPYSV  383 (684)
T ss_pred             HhcCCCCCCCCCCCCcCceEEEeCCCCCCCceEEEEeCCeEEEEEEecCCcccccCCcccCC-CccEEEEEEEEcCCCCC
Confidence            334555554   3689999999999999999999999999999999 799875322211111 23589999999999998


Q ss_pred             ccccC-CCCCcchHHHHHHHHHHhhhhhhc-ccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEE
Q psy6508         180 QIRTG-WLRDSEEKELGNHLKRALEPAVCR-HEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTL  257 (477)
Q Consensus       180 ~~r~~-~~~~~~~~~l~~~i~~~l~~~i~~-~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~  257 (477)
                      ..++. ..+++++.+..+++++++++.+.. +.||++ |++.++||++||+...|+++|+++||+||||||+++|+|+|+
T Consensus       384 ~e~~~~g~~~rrei~~~~l~~ral~~~i~~~~~~p~t-I~v~~~VLesdGs~~~Aai~aaslAL~dAgvP~~~~Vagvs~  462 (684)
T TIGR03591       384 GEVGRVGGPGRREIGHGALAERALKAVLPSEEEFPYT-IRVVSEILESNGSSSMASVCGGSLALMDAGVPIKAPVAGIAM  462 (684)
T ss_pred             CCcCCCCCCChHHHHHHHHHHHHHHHhcCccccCCeE-EEEEEEEEeCCCChHHHHHHHHHHHHHhcCCCCcCCEEEEEE
Confidence            76653 356778888999999999998874 889964 999999999999999999999999999999999999999999


Q ss_pred             EeeC-C----eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee---ecHHHHHHHHHHHHhcccch
Q psy6508         258 ALRG-G----LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT---IQQERLADHIEQLIGCCESL  329 (477)
Q Consensus       258 ~~~~-~----~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~---~~~~~~~~~l~~~~~~~~~i  329 (477)
                      ++.+ +    .+++||+..|+..          ++..++++  +..+.|+.++++++   ++.+.+.++++.|+++|..+
T Consensus       463 gli~~~~~~~~il~D~~~~Ed~~----------~d~d~~va--~t~~gI~~lq~d~k~~~i~~~~l~~al~~a~~~~~~I  530 (684)
T TIGR03591       463 GLIKEGDERFAVLSDILGDEDHL----------GDMDFKVA--GTRDGITALQMDIKIDGITREIMEQALEQAKEGRLHI  530 (684)
T ss_pred             EEEcCCCcceEEEeCCChHHHhc----------CCceEEEE--EcCCceEEEEEEcCcCCcCHHHHHHHHHHHHHHHHHH
Confidence            9984 2    5999999999884          24555554  45566999999876   59999999999999999999


Q ss_pred             hhHHHHhHhhhccccch--------------hhHHh--------hhcCcceeEEEEecCccceeeEeeeehhhhcccHHH
Q psy6508         330 CTDRVQKLVSDHVTLPE--------------RGRYV--------LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVF  387 (477)
Q Consensus       330 ~~~~i~~~l~~~~~l~~--------------r~~~~--------~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f  387 (477)
                      .+. |++++.++..-+.              +-..+        +.=-.-|.++|.+++++....+...+..+-..-..+
T Consensus       531 ~~~-m~~~l~~~~~~~~~~~p~~~~~~I~~~kI~~vIG~gGk~Ik~I~~~tg~~I~i~ddG~V~i~~~~~~~~~~a~~~I  609 (684)
T TIGR03591       531 LGE-MNKVISEPRAELSPYAPRIETIKINPDKIRDVIGPGGKVIREITEETGAKIDIEDDGTVKIAASDGEAAEAAIKMI  609 (684)
T ss_pred             HHH-HHHHHhhhhccccccCCeEEEEecCHHHHHhhcCCCcHHHHHHHHHHCCEEEEecCeEEEEEECcHHHHHHHHHHH
Confidence            999 9999987754211              11111        221245677787877666666766777777777777


Q ss_pred             HHhcC
Q psy6508         388 ATMFH  392 (477)
Q Consensus       388 ~~~f~  392 (477)
                      ..+..
T Consensus       610 ~~~~~  614 (684)
T TIGR03591       610 EGITA  614 (684)
T ss_pred             Hhhhc
Confidence            77654

Members of this protein family are polyribonucleotide nucleotidyltransferase, also called polynucleotide phosphorylase. Some members have been shown also to have additional functions as guanosine pentaphosphate synthetase and as poly(A) polymerase (see model TIGR02696 for an exception clade, within this family).

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.92  E-value=3e-25  Score=216.06  Aligned_cols=174  Identities=21%  Similarity=0.288  Sum_probs=140.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      +.+.||+|.++... .....+.+.+|+.++++++||||+++++++......|++|||+++++|.+++...          
T Consensus        34 ~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~  112 (283)
T cd05048          34 SATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAES  112 (283)
T ss_pred             ceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCccccccc
Confidence            34679999986543 3445567999999999999999999999999989999999999999999999764          


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecc
Q psy6508          73 ------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV  146 (477)
Q Consensus        73 ------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~  146 (477)
                            ..+++..+..++.|++.||.|||++|++||||||+||+++++. .+.+.|||.+................++..
T Consensus       113 ~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~  191 (283)
T cd05048         113 GDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVR  191 (283)
T ss_pred             ccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC-cEEECCCcceeeccccccccccCCCccccc
Confidence                  3478889999999999999999999999999999999997653 344459998865433322233344556778


Q ss_pred             ccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         147 FEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |+|||...+.   .++|+ ||+|+++||+   +..||.+
T Consensus       192 y~aPE~~~~~~~~~~sDv-~slG~il~el~~~g~~p~~~  229 (283)
T cd05048         192 WMPPEAILYGKFTTESDI-WSFGVVLWEIFSYGLQPYYG  229 (283)
T ss_pred             ccCHHHhccCcCchhhhH-HHHHHHHHHHHcCCCCCCCC
Confidence            9999987654   67899 9999999998   4567654

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.92  E-value=5.3e-26  Score=217.72  Aligned_cols=174  Identities=22%  Similarity=0.328  Sum_probs=145.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      .+++.|++|.+..........+.+.+|+.+++.++||||+++++.+...+..|++|||++|++|.+++...  ..+++..
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  102 (256)
T cd08529          23 ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQ  102 (256)
T ss_pred             CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHH
Confidence            46889999999877666666778999999999999999999999999999999999999999999999774  4689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++|+||||+||+++.+. .+.+.|||..........  ...+..++..|.|||...+.   
T Consensus       103 ~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~-~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~  179 (256)
T cd08529         103 VWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYN  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCC-CEEEcccccceeccCccc--hhhccccCccccCHHHhcCCCCC
Confidence            999999999999999999999999999999998642 334458887764432211  12334567789999988766   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|++++++  +..||..
T Consensus       180 ~~~Di-~slG~il~~l~~g~~p~~~  203 (256)
T cd08529         180 EKSDV-WALGVVLYECCTGKHPFDA  203 (256)
T ss_pred             Cccch-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6677764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.92  E-value=5.9e-26  Score=220.86  Aligned_cols=173  Identities=17%  Similarity=0.220  Sum_probs=138.8

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~   78 (477)
                      .+|+.||+|.+....... .....+..|+.++++++||||+++++.+..+...|+||||++|++|.+++...+  .+++.
T Consensus        16 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~   95 (277)
T cd05607          16 NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEME   95 (277)
T ss_pred             cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHH
Confidence            468999999987644322 223445679999999999999999999999999999999999999998886543  58899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||+|||++|++||||||+||+++.+. .+.++|||.+.......   ......++..|+|||...+.  
T Consensus        96 ~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~  171 (277)
T cd05607          96 RVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGK---TITQRAGTNGYMAPEILKEEPY  171 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCc---eeeccCCCCCccCHHHHccCCC
Confidence            9999999999999999999999999999999997643 23345999876543211   11223466789999988665  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ ||+|+++|++  +..||..
T Consensus       172 ~~~~Dv-wslGv~l~el~~g~~p~~~  196 (277)
T cd05607         172 SYPVDW-FAMGCSIYEMVAGRTPFKD  196 (277)
T ss_pred             CCchhH-HHHHHHHHHHHhCCCCCCC
Confidence             67899 9999999999  6678764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG0662|consensus

Probab=99.92  E-value=1.3e-25  Score=193.94  Aligned_cols=190  Identities=29%  Similarity=0.419  Sum_probs=159.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      ++++.||+|.++.....+.......+|+-+|+.++|.||++++++.-.++.+-+|+|||. .+|..+... ++.++...+
T Consensus        25 ~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-qdlkkyfdslng~~d~~~~  103 (292)
T KOG0662|consen   25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSLNGDLDPEIV  103 (292)
T ss_pred             CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-HHHHHHHHhcCCcCCHHHH
Confidence            578899999998877666666678899999999999999999999999999999999997 799988876 567999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.++.|++.||.|+|++++.|||+||+|++|+. +++++.  |||+++ +.|-.. .--...+.|.||.||.++.+.   
T Consensus       104 rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkla--dfglar-afgipv-rcysaevvtlwyrppdvlfgakly  179 (292)
T KOG0662|consen  104 RSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLA--DFGLAR-AFGIPV-RCYSAEVVTLWYRPPDVLFGAKLY  179 (292)
T ss_pred             HHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEec--ccchhh-hcCCce-EeeeceeeeeeccCcceeeeeehh
Confidence            999999999999999999999999999999976 466665  999884 444332 223467899999999999887   


Q ss_pred             -CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHHHHh
Q psy6508         157 -TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRAL  202 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~l  202 (477)
                       .+.|+ ||.||++.|+.     ..+|+.+++..-..++.++.+..-
T Consensus       180 ~tsidm-wsagcifaela-----nagrplfpg~dvddqlkrif~~lg  220 (292)
T KOG0662|consen  180 STSIDM-WSAGCIFAELA-----NAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_pred             ccchHh-hhcchHHHHHh-----hcCCCCCCCCcHHHHHHHHHHHhC
Confidence             77899 99999999883     245566667777788888877543

>KOG1026|consensus

Probab=99.92  E-value=3.1e-25  Score=231.53  Aligned_cols=174  Identities=24%  Similarity=0.329  Sum_probs=150.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      +...||||.++... +.+.+++|++|+.++..|+|||||+++|+|..++++|+|+|||..|+|.++|..+.         
T Consensus       515 ~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g  593 (774)
T KOG1026|consen  515 DEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASG  593 (774)
T ss_pred             cceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCC
Confidence            45679999986553 45577899999999999999999999999999999999999999999999996532         


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          74 -----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        74 -----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                           +++..+...|+.||+.|+.||-++.+|||||-.+|+||.++ +.+++.|||+++...++-|+..+......-.||
T Consensus       594 ~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~-l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWM  672 (774)
T KOG1026|consen  594 QDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN-LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWM  672 (774)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc-eEEEecccccchhhhhhhhhcccCCceeeeecC
Confidence                 27889999999999999999999999999999999999876 334446999999999999988775555666799


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |||.+.-+   ..+|+ ||+|+++||+   |.-|+.+
T Consensus       673 ppEsIly~kFTteSDV-Ws~GVvLWEIFsyG~QPy~g  708 (774)
T KOG1026|consen  673 PPESILYGKFTTESDV-WSFGVVLWEIFSYGKQPYYG  708 (774)
T ss_pred             CHHHhhcCcccchhhh-hhhhhhhhhhhccccCcccc
Confidence            99988755   78999 9999999999   5567665

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=4.1e-26  Score=239.44  Aligned_cols=176  Identities=23%  Similarity=0.260  Sum_probs=144.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC--------eEEEEEecCCCCCHHHHHHhC-
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--------YVYIILEYCDGGDLCSFIRSH-   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--------~~~lv~e~~~g~sL~~~l~~~-   72 (477)
                      .+|+.||||++.....+......+.+|+.++..++|+||++++..+....        .+++||||+++|+|.+++... 
T Consensus        55 ~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~  134 (496)
T PTZ00283         55 SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRA  134 (496)
T ss_pred             CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhh
Confidence            47899999999887766666778999999999999999999988765332        378999999999999998653 


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccc
Q psy6508          73 ---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEP  149 (477)
Q Consensus        73 ---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~p  149 (477)
                         ..+++..+..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++...........+.+..+++.|+|
T Consensus       135 ~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~-~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~a  213 (496)
T PTZ00283        135 KTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVA  213 (496)
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCC-CEEEEecccCeeccccccccccccccCCcceeC
Confidence               3689999999999999999999999999999999999997643 344459999865443222233445678889999


Q ss_pred             cccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         150 REIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       150 pE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ||...+.   .++|+ ||+|+++||+  +..||.+
T Consensus       214 PE~~~~~~~s~k~DV-wSlGvilyeLltG~~Pf~~  247 (496)
T PTZ00283        214 PEIWRRKPYSKKADM-FSLGVLLYELLTLKRPFDG  247 (496)
T ss_pred             HHHhCCCCCCcHHHH-HHHHHHHHHHHHCCCCCCC
Confidence            9998765   67899 9999999999  6678764

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=3.6e-25  Score=216.30  Aligned_cols=173  Identities=18%  Similarity=0.242  Sum_probs=140.6

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~   78 (477)
                      .+++.||+|++....... .....+.+|+.+++.++||||+++++.+..++..|++|||++|++|.+++...  ..+++.
T Consensus        23 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  102 (285)
T cd05605          23 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEE  102 (285)
T ss_pred             CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHH
Confidence            468899999987654332 23355788999999999999999999999999999999999999999888653  368999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++|++||||||+||+++++. .+.++|||.+.......   ......++..|+|||...+.  
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~  178 (285)
T cd05605         103 RAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYG-HIRISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCC-CEEEeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCC
Confidence            9999999999999999999999999999999997643 33445999875432111   11234677889999998655  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ ||+|+++|++  +..||.+
T Consensus       179 ~~~~Di-ws~G~~l~el~~g~~pf~~  203 (285)
T cd05605         179 TFSPDW-WGLGCLIYEMIEGKSPFRQ  203 (285)
T ss_pred             Cccccc-hhHHHHHHHHHHCCCCCCC
Confidence             66899 9999999999  6788864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.92  E-value=4.5e-25  Score=211.16  Aligned_cols=174  Identities=24%  Similarity=0.361  Sum_probs=138.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+++.||+|.+.... ..+....+.+|+.++++++||||+++++++..+...|+||||+++++|.+++...+ .+++..+
T Consensus        18 ~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   96 (252)
T cd05084          18 ADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL   96 (252)
T ss_pred             cCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHH
Confidence            468899999876443 34455679999999999999999999999999999999999999999999997643 6899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+...........+........|+|||...+.   .
T Consensus        97 ~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  175 (252)
T cd05084          97 IQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS  175 (252)
T ss_pred             HHHHHHHHHHHHHHHhCCccccccchheEEEcCCC-cEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCCh
Confidence            99999999999999999999999999999997653 3445699987654332221112222223469999987655   6


Q ss_pred             cccccCcceEEEEEE---eeeccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      ++|+ |++|+++|++   +..||.
T Consensus       176 ~~Dv-~slG~il~e~~~~~~~p~~  198 (252)
T cd05084         176 ESDV-WSFGILLWEAFSLGAVPYA  198 (252)
T ss_pred             HHHH-HHHHHHHHHHHhCCCCCcc
Confidence            7899 9999999997   445564

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.92  E-value=3.5e-25  Score=215.14  Aligned_cols=174  Identities=23%  Similarity=0.303  Sum_probs=141.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      +++.||+|.++... ..+..+.+.+|+.+++.++||||+++++++......|++|||++|++|.+++...+         
T Consensus        34 ~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~  112 (280)
T cd05049          34 DKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSP  112 (280)
T ss_pred             CcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhccc
Confidence            46789999986543 23345789999999999999999999999999999999999999999999997642         


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          74 -----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        74 -----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                           .+++..+..++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+.......+........++..|+
T Consensus       113 ~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~  191 (280)
T cd05049         113 DSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWM  191 (280)
T ss_pred             ccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC-eEEECCcccceecccCcceecCCCCcccceec
Confidence                 378889999999999999999999999999999999997652 34445999876543333323333445567899


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |||...+.   .++|+ ||+|+++||+   +..||.+
T Consensus       192 aPE~~~~~~~~~~~Di-~slG~il~e~~~~g~~p~~~  227 (280)
T cd05049         192 PPESIMYRKFTTESDV-WSFGVVLWEIFTYGKQPWYG  227 (280)
T ss_pred             ChhhhccCCcchhhhH-HHHHHHHHHHHhcCCCCCCC
Confidence            99988765   67899 9999999998   4567653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=6.2e-25  Score=211.28  Aligned_cols=176  Identities=24%  Similarity=0.335  Sum_probs=143.5

Q ss_pred             CCCcEEEEEEcccCCCCh---hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE---NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      ++++.||+|.+.......   ...+.+.+|+.++++++||||+++++++..+...++++||++|++|.+++...+.+++.
T Consensus        25 ~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~  104 (263)
T cd06625          25 DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTET  104 (263)
T ss_pred             CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHH
Confidence            468899999987654322   23457889999999999999999999999999999999999999999999887789999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccC-CeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQG-NTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g-~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||.|||+.|++||||+|+||+++.+. ++.++|||.+...........+ ....++..|.|||...+. 
T Consensus       105 ~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  183 (263)
T cd06625         105 VTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG  183 (263)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceeccccccccccccCCCcCccccCcceeccCC
Confidence            9999999999999999999999999999999998642 3445599987644322111111 223456789999998766 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+|+++|++  +..||..
T Consensus       184 ~~~~~Di-~slG~il~el~~g~~p~~~  209 (263)
T cd06625         184 YGRKADV-WSVGCTVVEMLTEKPPWAE  209 (263)
T ss_pred             CCchhhh-HHHHHHHHHHHhCCCCccc
Confidence              67899 9999999999  6677754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.92  E-value=4.6e-25  Score=219.85  Aligned_cols=176  Identities=16%  Similarity=0.222  Sum_probs=139.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      ++|+.||+|.++.........+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++..+  +.+++..
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~  102 (327)
T cd08227          23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELA  102 (327)
T ss_pred             ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHH
Confidence            57899999999876655555567889999999999999999999999999999999999999999999753  3589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceeccc--CCccc---ccCCeEEEeccccccccCC
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAK--GSAYI---EQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~--gs~~~---~~g~t~v~~~~y~ppE~~~  154 (477)
                      ++.++.|++.||.|||++||+||||||+||+++.+. ++...||+......  +....   .......++..|+|||...
T Consensus       103 ~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  181 (327)
T cd08227         103 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQ  181 (327)
T ss_pred             HHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCC-cEEEcccchhhccccccccccccccccccccceecccChHHhh
Confidence            999999999999999999999999999999997643 23334666433211  11100   0112234556799999876


Q ss_pred             CC-----CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.     .++|+ ||+|++++|+  +..||..
T Consensus       182 ~~~~~~~~~~Di-wslG~il~el~~g~~pf~~  212 (327)
T cd08227         182 QNLQGYDAKSDI-YSVGITACELANGHVPFKD  212 (327)
T ss_pred             cccCCCCchhhH-HHHHHHHHHHHHCCCCCCC
Confidence            42     67899 9999999999  7788863

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.92  E-value=3.3e-25  Score=214.22  Aligned_cols=173  Identities=20%  Similarity=0.211  Sum_probs=138.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      .+..||+|.++... +....+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++... ..+++..++
T Consensus        32 ~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~  110 (266)
T cd05064          32 RELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLM  110 (266)
T ss_pred             ceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHH
Confidence            46689999987653 3344567899999999999999999999999999999999999999999999774 478999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .....|||.......... ........+..|+|||...+.   .+
T Consensus       111 ~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~  188 (266)
T cd05064         111 GMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDL-VCKISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSA  188 (266)
T ss_pred             HHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCC-cEEECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccch
Confidence            9999999999999999999999999999997653 344468987654322211 111122234579999987654   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|+++||+   +..||..
T Consensus       189 ~Di-~slG~~l~ell~~g~~p~~~  211 (266)
T cd05064         189 SDV-WSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             hHH-HHHHHHHHHHhcCCCCCcCc
Confidence            899 9999999994   5677753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PRK11824 polynucleotide phosphorylase/polyadenylase; Provisional

Probab=99.92  E-value=6.1e-24  Score=228.13  Aligned_cols=230  Identities=20%  Similarity=0.277  Sum_probs=188.0

Q ss_pred             cEEccCCCCceeecc---CcceeecccccceecccCCcccccCCeEEEecc-ccccccCCCCCcccccCcceEEEEEEee
Q psy6508          99 VCHFDLKPQNILIKN---NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKF  174 (477)
Q Consensus        99 ivHrDlkp~NIll~~---~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~-y~ppE~~~~~~~~Di~~s~G~il~e~~~  174 (477)
                      ++-.-|-.+++-+|.   +++|.+.+.+|+...++||++++.|+|++.|.+ ++||........... -..|.+++++.+
T Consensus       304 ~~r~~il~~g~R~DGR~~~e~Rpi~~~~g~l~~a~GSal~~~G~T~Vl~~vt~g~~~~~~~~~~~~~-~~~~~~~~~y~~  382 (693)
T PRK11824        304 IVRRRILEEGIRIDGRKLDEIRPISIEVGVLPRTHGSALFTRGETQALVVATLGTLRDEQIIDGLEG-EYKKRFMLHYNF  382 (693)
T ss_pred             HHHHHHhcCCCCCCCCCcCcccceEEEeCCCCCCCceEEEEECCeEEEEEEecCCCcccccccccCC-CCcEEEEEEEEc
Confidence            333344455666653   689999999999999999999999999999999 788653222100011 246899999999


Q ss_pred             ecccccccc-CCCCCcchHHHHHHHHHHhhhhhhc-ccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceE
Q psy6508         175 APFASQIRT-GWLRDSEEKELGNHLKRALEPAVCR-HEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLV  252 (477)
Q Consensus       175 ~Pf~~~~r~-~~~~~~~~~~l~~~i~~~l~~~i~~-~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v  252 (477)
                      +||++..+. ...+++++.+..+.+++++++.+.. +.||. .|++.++||++||+...|+++|+++||+||||||+++|
T Consensus       383 ~pfs~~e~~~~~~~~rre~~~~~li~ral~~vi~~~~~~p~-~I~v~~~VLe~dGs~~~Aai~aaslAL~dAgvP~~~~V  461 (693)
T PRK11824        383 PPYSVGETGRVGSPGRREIGHGALAERALEPVLPSEEEFPY-TIRVVSEILESNGSSSMASVCGSSLALMDAGVPIKAPV  461 (693)
T ss_pred             CCCCCCCcCCCCCCChhHHHHHHHHHHHHHHhcCcccCCCE-EEEEEEEEEecCCCHHHHHHHHHHHHHHhcCCCccCce
Confidence            999976653 3346777888999999999999986 78996 79999999999999999999999999999999999999


Q ss_pred             EEEEEEeeC-C---eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee---ecHHHHHHHHHHHHhc
Q psy6508         253 TSSTLALRG-G---LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT---IQQERLADHIEQLIGC  325 (477)
Q Consensus       253 ~a~s~~~~~-~---~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~---~~~~~~~~~l~~~~~~  325 (477)
                      +|+|+++.+ +   .+++||+..|+..          ++..++++  ...+.|+.++++|+   ++.+.+.++++.|.++
T Consensus       462 a~vs~gli~~~~~~~il~D~~~~Ed~~----------~d~d~~va--~t~~gi~~lq~d~k~~~i~~~~l~~al~~a~~g  529 (693)
T PRK11824        462 AGIAMGLIKEGDKYAVLTDILGDEDHL----------GDMDFKVA--GTRDGITALQMDIKIDGITREILEEALEQAKEG  529 (693)
T ss_pred             eEEEEEEEcCCCceEEEcCCChhhHhh----------CCceEEEE--ecCCceEEEEEecccCCcCHHHHHHHHHHHHHH
Confidence            999999984 3   3899999999884          35556665  44556999998876   5999999999999999


Q ss_pred             ccchhhHHHHhHhhhccc
Q psy6508         326 CESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       326 ~~~i~~~~i~~~l~~~~~  343 (477)
                      |..+.+. |.+.+.....
T Consensus       530 ~~~I~~~-M~~aI~~~r~  546 (693)
T PRK11824        530 RLHILGK-MNEAISEPRA  546 (693)
T ss_pred             HHHHHHH-HHHHhcCChh
Confidence            9999999 9998865543

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.92  E-value=8.8e-25  Score=209.93  Aligned_cols=175  Identities=19%  Similarity=0.253  Sum_probs=139.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++++.||+|+++.........+.+.+|+.+++.++||||+++++++. ....+++|||+++++|.+++...+.+++..+.
T Consensus        20 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~   98 (257)
T cd05116          20 KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNIT   98 (257)
T ss_pred             CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCCcHHHHHHhcCCCCHHHHH
Confidence            46788999998766555556678999999999999999999999875 45679999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-ccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-EQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||+|||++|++||||||.||+++.+. .+.+.|||.+......... .......++..|+|||.....   .
T Consensus        99 ~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  177 (257)
T cd05116          99 ELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSS  177 (257)
T ss_pred             HHHHHHHHHHHHHHHCCEeecccchhhEEEcCCC-eEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCc
Confidence            9999999999999999999999999999998753 3445699987643322111 111112224579999987654   5


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||..
T Consensus       178 ~~Di-~slG~~l~el~t~g~~p~~~  201 (257)
T cd05116         178 KSDV-WSFGVLMWEAFSYGQKPYKG  201 (257)
T ss_pred             hhHH-HHHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999997   4567764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.92  E-value=8.2e-25  Score=213.94  Aligned_cols=173  Identities=24%  Similarity=0.348  Sum_probs=139.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      ++..||+|.+...  .....+.+.+|+.++++++||||+++++++...+.+|++|||+++++|.+++...+         
T Consensus        34 ~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~  111 (288)
T cd05093          34 DKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEG  111 (288)
T ss_pred             cceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCcccccccc
Confidence            4566899988644  34455679999999999999999999999999999999999999999999997543         


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccc
Q psy6508          74 ----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEP  149 (477)
Q Consensus        74 ----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~p  149 (477)
                          .+++..+..++.|++.||.|||++|++||||||+||+++++. .+...|||.+...........+....++..|+|
T Consensus       112 ~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  190 (288)
T cd05093         112 NRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP  190 (288)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cEEeccCCccccccCCceeecCCCCCccccccC
Confidence                389999999999999999999999999999999999997653 344459998765443332223333344567999


Q ss_pred             cccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         150 REIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       150 pE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ||...+.   .++|+ ||+|+++++|   +..||.+
T Consensus       191 PE~~~~~~~~~~sDi-wslG~il~~l~t~g~~p~~~  225 (288)
T cd05093         191 PESIMYRKFTTESDV-WSLGVVLWEIFTYGKQPWYQ  225 (288)
T ss_pred             HHHhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            9988755   67999 9999999998   3466653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.92  E-value=3.5e-25  Score=221.28  Aligned_cols=175  Identities=22%  Similarity=0.309  Sum_probs=140.5

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+++.||+|++.+... .....+.+.+|+.++..++||||+++++.+.+.+.+|+||||++||+|.+++.+ ...+++..
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~  103 (332)
T cd05623          24 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDM  103 (332)
T ss_pred             CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHH
Confidence            4678899999865432 222344588999999999999999999999999999999999999999999977 35789999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.+. ++.++|||.+........ .......+++.|+|||+..+    
T Consensus       104 ~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~  181 (332)
T cd05623         104 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEDG  181 (332)
T ss_pred             HHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCC-CEEEeecchheecccCCc-ceecccccCccccCHHHHhccccC
Confidence            999999999999999999999999999999997542 344459998754321111 11123467889999998752    


Q ss_pred             ----CCcccccCcceEEEEEE--eeecccc
Q psy6508         156 ----KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ----~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          ..++|+ ||+|+++||+  +..||..
T Consensus       182 ~~~~~~~~Dv-wSlGvil~ell~g~~Pf~~  210 (332)
T cd05623         182 KGKYGPECDW-WSLGVCMYEMLYGETPFYA  210 (332)
T ss_pred             CCCCCCcCCE-EeeHHHHHHHhcCCCCCCC
Confidence                167899 9999999999  6688864

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.92  E-value=1.8e-25  Score=242.46  Aligned_cols=175  Identities=22%  Similarity=0.209  Sum_probs=140.9

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--------
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--------   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--------   72 (477)
                      .+|+.||+|+++..... +...+++.+|+.++++++||||+++++++.+++..|++|||++|++|.+++...        
T Consensus        25 ~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e  104 (932)
T PRK13184         25 VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK  104 (932)
T ss_pred             CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccch
Confidence            46889999999765432 334567999999999999999999999999999999999999999999998642        


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCc--------------c
Q psy6508          73 ---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSA--------------Y  134 (477)
Q Consensus        73 ---~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~--------------~  134 (477)
                         ..++...+..++.|++.||+|||++||+||||||+||+++.+ .++  .+|||.+.......              .
T Consensus       105 ~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vK--LiDFGLAk~i~~~~~~~~~l~~~~~~s~~  182 (932)
T PRK13184        105 ELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVV--ILDWGAAIFKKLEEEDLLDIDVDERNICY  182 (932)
T ss_pred             hhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEE--EEecCcceecccccccccccccccccccc
Confidence               135567788999999999999999999999999999999764 444  45999886541110              0


Q ss_pred             --cccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         135 --IEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       135 --~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .......++++.|+|||...+.   .++|+ ||+|++++||  +..||..
T Consensus       183 s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI-WSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDI-YALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             cccccCCCCCCCCCCCCHHHhcCCCCCcHhHH-HHHHHHHHHHHHCCCCCCC
Confidence              0111234688899999988765   67899 9999999999  6788864

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.92  E-value=2.3e-25  Score=213.55  Aligned_cols=174  Identities=22%  Similarity=0.302  Sum_probs=145.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      ++++.|++|.+.....+.....++.+|+.++++++||||+++++++.+++..+++|||+++++|.+++.+.  ..+++..
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~  102 (256)
T cd08221          23 EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEM  102 (256)
T ss_pred             CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHH
Confidence            46889999998877666666778999999999999999999999999999999999999999999999775  3689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||+.|++||||+|+||+++.+. .+...|||.+.......  ....+..++..|.|||...+.   
T Consensus       103 ~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~~~~~--~~~~~~~~~~~y~ape~~~~~~~~  179 (256)
T cd08221         103 VLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAG-LIKLGDFGISKILGSEY--SMAETVVGTPYYMSPELCQGVKYN  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCC-CEEECcCcceEEccccc--ccccccCCCccccCHhhcCCCCCC
Confidence            999999999999999999999999999999997643 34445999876543322  123455678889999987655   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|++++++  +..||..
T Consensus       180 ~~~Dv-~slG~i~~~l~~g~~~~~~  203 (256)
T cd08221         180 FKSDI-WALGCVLYELLTLKRTFDA  203 (256)
T ss_pred             Ccchh-HHHHHHHHHHHHCCCCCCC
Confidence            56899 9999999999  5566653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>KOG0193|consensus

Probab=99.92  E-value=1.4e-25  Score=225.29  Aligned_cols=172  Identities=20%  Similarity=0.331  Sum_probs=146.4

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i   83 (477)
                      ..||||+++....+++..+.|++|+.++++-+|.||+-+.|++...+. .||+.||+|.+|+.+++-. .+|.....+.|
T Consensus       415 GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idI  493 (678)
T KOG0193|consen  415 GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDI  493 (678)
T ss_pred             cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHH
Confidence            479999999999999999999999999999999999999999988776 9999999999999999764 36999999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecc---cCCcccccCCeEEEeccccccccCCCC----
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKA---KGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~---~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.|+++|+.|||.++|+|||||..|||+.++ .++++.|||++...   .|..-   -.+..+...|+|||+.+..    
T Consensus       494 AqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~-~kVkIgDFGLatvk~~w~g~~q---~~qp~gsilwmAPEvIRmqd~nP  569 (678)
T KOG0193|consen  494 AQQIAQGMDYLHAKNIIHRDLKSNNIFLHED-LKVKIGDFGLATVKTRWSGEQQ---LEQPHGSLLWMAPEVIRMQDDNP  569 (678)
T ss_pred             HHHHHHhhhhhhhhhhhhhhccccceEEccC-CcEEEecccceeeeeeeccccc---cCCCccchhhhcHHHHhhcccCC
Confidence            9999999999999999999999999999875 46666799998532   22211   1223344569999998765    


Q ss_pred             --CcccccCcceEEEEEE--eeeccccccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFASQIR  182 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~~~r  182 (477)
                        +.+|+ |++|+++||+  +-.||+...+
T Consensus       570 fS~qSDV-YaFGiV~YELltg~lPysi~~~  598 (678)
T KOG0193|consen  570 FSFQSDV-YAFGIVWYELLTGELPYSIQNR  598 (678)
T ss_pred             CCcccch-hhhhHHHHHHHhCcCCcCCCCh
Confidence              77999 9999999999  7789985544

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.92  E-value=6.5e-25  Score=221.22  Aligned_cols=168  Identities=23%  Similarity=0.311  Sum_probs=136.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++.... .....+.+.+|+.+++.++||||+++++++...+.+|+||||+++++|.+.    ...++..+.
T Consensus        97 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~  171 (353)
T PLN00034         97 PTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLA  171 (353)
T ss_pred             CCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHH
Confidence            468999999986543 334456789999999999999999999999999999999999999998653    346778889


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-----
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-----  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-----  156 (477)
                      .++.||+.||.|||++||+||||||+|||++.+. ++.++|||++.......  ....+.+++..|+|||.+...     
T Consensus       172 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~  248 (353)
T PLN00034        172 DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAK-NVKIADFGVSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGA  248 (353)
T ss_pred             HHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEcccccceeccccc--ccccccccCccccCccccccccccCc
Confidence            9999999999999999999999999999997653 34445999876543221  112345788899999987432     


Q ss_pred             ---CcccccCcceEEEEEE--eeeccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                         .++|+ |++|+++||+  +..||.
T Consensus       249 ~~~~~~Dv-wslGvil~el~~g~~pf~  274 (353)
T PLN00034        249 YDGYAGDI-WSLGVSILEFYLGRFPFG  274 (353)
T ss_pred             CCCcchhH-HHHHHHHHHHHhCCCCCC
Confidence               46899 9999999998  667776

>KOG0577|consensus

Probab=99.92  E-value=2.2e-25  Score=222.32  Aligned_cols=168  Identities=22%  Similarity=0.363  Sum_probs=144.5

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~   79 (477)
                      .+...||||++..... +.+.++++.+|+..|++++|||++.+-++|..+...|||||||- |+-.+++.-+ +++.+.+
T Consensus        49 ~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVhkKplqEvE  127 (948)
T KOG0577|consen   49 RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE  127 (948)
T ss_pred             CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHHhccchHHH
Confidence            5778999999987754 45778999999999999999999999999999999999999997 7888888654 4799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      +..|..+.+.||.|||+.+.+|||||..|||+++. -+++  .|||.++...      ..++.+|||.||+||++...  
T Consensus       128 IAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKL--aDFGSAsi~~------PAnsFvGTPywMAPEVILAMDE  199 (948)
T KOG0577|consen  128 IAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKL--ADFGSASIMA------PANSFVGTPYWMAPEVILAMDE  199 (948)
T ss_pred             HHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeee--ccccchhhcC------chhcccCCccccchhHheeccc
Confidence            99999999999999999999999999999999764 4444  5999875443      34689999999999998643  


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          -++|+ ||+|++.+|+  ..+|+..
T Consensus       200 GqYdgkvDv-WSLGITCIELAERkPPlFn  227 (948)
T KOG0577|consen  200 GQYDGKVDV-WSLGITCIELAERKPPLFN  227 (948)
T ss_pred             cccCCccce-eeccchhhhhhhcCCCccC
Confidence                67999 9999999999  4455543

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.92  E-value=6e-25  Score=224.22  Aligned_cols=164  Identities=16%  Similarity=0.230  Sum_probs=135.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|....        ..+.+|+.++++++||||+++++++..+...++++|++. ++|..++.....+++..++
T Consensus       115 ~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~l~~~~~~  185 (391)
T PHA03212        115 KTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRNIAICDIL  185 (391)
T ss_pred             CCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCCCCHHHHH
Confidence            4788999997432        346789999999999999999999999999999999996 7999999887789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++||+||||||+|||++.+ .++  ++|||++....... .....+..+++.|+|||+..+.   .
T Consensus       186 ~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vk--L~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~  262 (391)
T PHA03212        186 AIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC--LGDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGP  262 (391)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEE--EEeCCccccccccc-ccccccccCccCCCChhhhcCCCCCc
Confidence            999999999999999999999999999999764 444  45999875322111 0112245688999999998765   6


Q ss_pred             cccccCcceEEEEEE--eeeccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++|+ ||+|+++||+  +..||.
T Consensus       263 ~~Di-wSlGvil~elltg~~p~~  284 (391)
T PHA03212        263 AVDI-WSAGIVLFEMATCHDSLF  284 (391)
T ss_pred             HHHH-HHHHHHHHHHHHCCCCcC
Confidence            7899 9999999999  555655

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.92  E-value=7.7e-25  Score=212.75  Aligned_cols=174  Identities=21%  Similarity=0.288  Sum_probs=138.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      +++.||+|++.... ......++.+|+.+++.++||||+++++++..++..++||||+++++|.+++.+..         
T Consensus        35 ~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  113 (277)
T cd05062          35 PETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQ  113 (277)
T ss_pred             ceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccc
Confidence            45679999986443 23345678999999999999999999999999999999999999999999997532         


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                       .+++..+..++.|++.||.|||++|++||||||+||+++++. ++..+|||.+...........+....++..|+|||.
T Consensus       114 ~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05062         114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  192 (277)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCC-CEEECCCCCccccCCcceeecCCCCccCHhhcChhH
Confidence             256778899999999999999999999999999999998643 445569998765433333223333344567999998


Q ss_pred             CCCC---CcccccCcceEEEEEEe---eecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEFK---FAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~~---~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++||+.   ..||.+
T Consensus       193 ~~~~~~~~~~Di-~slG~~l~el~~~~~~p~~~  224 (277)
T cd05062         193 LKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQG  224 (277)
T ss_pred             hhcCCcCchhHH-HHHHHHHHHHHcCCCCCCCC
Confidence            7655   67899 99999999983   456653

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0574|consensus

Probab=99.92  E-value=1.9e-25  Score=206.85  Aligned_cols=171  Identities=22%  Similarity=0.376  Sum_probs=148.7

Q ss_pred             CCCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           1 NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         1 ~~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      +++|..||||.++.+    ...+++.+|+.+++++..|++|++|+.+.....+|||||||..|+..+.++- ++++++.+
T Consensus        55 ~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~E  130 (502)
T KOG0574|consen   55 RESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQE  130 (502)
T ss_pred             hccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHH
Confidence            368999999998765    3567899999999999999999999999888899999999999999999875 45799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      +..+++..+.||+|||...-+|||||..|||++.+ -.++  .|||++......-  ...+|.++|+.||+||++..-  
T Consensus       131 Is~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKL--ADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVI~EIGY  206 (502)
T KOG0574|consen  131 ISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKL--ADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIEEIGY  206 (502)
T ss_pred             HHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhh--hhccccchhhhhH--HhhCccccCcccccHHHHHHhcc
Confidence            99999999999999999999999999999999764 4444  5999987655432  345789999999999998654  


Q ss_pred             -CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                       ..+|| ||+|++..||  |.+||+.-
T Consensus       207 ~~~ADI-WSLGITaIEMAEG~PPYsDI  232 (502)
T KOG0574|consen  207 DTKADI-WSLGITAIEMAEGRPPYSDI  232 (502)
T ss_pred             chhhhH-hhhcchhhhhhcCCCCcccc
Confidence             77899 9999999999  88888864

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.92  E-value=9.5e-25  Score=213.69  Aligned_cols=171  Identities=26%  Similarity=0.451  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      ++++.||+|+++..... ....+.+.+|+.++++++||||+++++.+..++..|++|||+++++|.+++...+.+++..+
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~  103 (290)
T cd05580          24 GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVA  103 (290)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHH
Confidence            46889999998765432 34456789999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||+|.||+++.+. ++.+.|||.+......     .....++..|+|||...+.   .
T Consensus       104 ~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  177 (290)
T cd05580         104 RFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG-YIKITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGK  177 (290)
T ss_pred             HHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCc
Confidence            99999999999999999999999999999997653 2344599987654433     1233456789999987655   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|++++++  +..||..
T Consensus       178 ~~Di-~slG~il~~l~~g~~p~~~  200 (290)
T cd05580         178 AVDW-WALGILIYEMLAGYPPFFD  200 (290)
T ss_pred             cccH-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6677764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.91  E-value=1.5e-25  Score=216.11  Aligned_cols=177  Identities=21%  Similarity=0.330  Sum_probs=144.6

Q ss_pred             CCCcEEEEEEcccCCCC----hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVS----ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+++.||+|+++.....    ....+.+.+|+.++++++||||+++++++...+..++++||++|++|.+++.+.+.+++
T Consensus        23 ~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~  102 (268)
T cd06630          23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKE  102 (268)
T ss_pred             CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCH
Confidence            57889999998755422    12356789999999999999999999999999999999999999999999988788999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc--ccCCeEEEeccccccccCCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--EQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ..+..++.|++.||.|||++|++|+||+|+||+++.++..+.++|||.+.........  .......++..|.|||...+
T Consensus       103 ~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~  182 (268)
T cd06630         103 AVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG  182 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc
Confidence            9999999999999999999999999999999999876545556699987544322110  01123456678999998765


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ |++|++++++  +..||..
T Consensus       183 ~~~~~~~Dv-~slG~~l~~l~~g~~p~~~  210 (268)
T cd06630         183 EQYGRSCDV-WSVGCVIIEMATAKPPWNA  210 (268)
T ss_pred             CCCCcccch-HHHHHHHHHHHhCCCCCCC
Confidence            5   67899 9999999999  6677753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.91  E-value=1.9e-25  Score=231.35  Aligned_cols=167  Identities=23%  Similarity=0.401  Sum_probs=132.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--------CeEEEEEecCCCCCHHHHHHh--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--------RYVYIILEYCDGGDLCSFIRS--   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~lv~e~~~g~sL~~~l~~--   71 (477)
                      .+++.||||++....      ....+|+.+|+.++||||+++++++...        ..+++||||++ ++|.+++..  
T Consensus        89 ~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~  161 (440)
T PTZ00036         89 DTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYA  161 (440)
T ss_pred             CCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHh
Confidence            468899999885432      1234799999999999999999876432        25789999998 688777653  


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccc
Q psy6508          72 --HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEP  149 (477)
Q Consensus        72 --~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~p  149 (477)
                        ...+++..++.++.|++.||.|||++||+||||||+|||++.+...+.++|||++.......   ...+.++++.|+|
T Consensus       162 ~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~a  238 (440)
T PTZ00036        162 RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRA  238 (440)
T ss_pred             hcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC---CcccCCCCcCccC
Confidence              35799999999999999999999999999999999999998655445556999986543221   1123466788999


Q ss_pred             cccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         150 REIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       150 pE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ||...+.    .++|+ ||+|+++|||  |.+||.+
T Consensus       239 PE~~~~~~~~~~~~Di-wSlGvil~elltG~~pf~~  273 (440)
T PTZ00036        239 PELMLGATNYTTHIDL-WSLGCIIAEMILGYPIFSG  273 (440)
T ss_pred             HHHhcCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            9987553    67899 9999999999  7788874

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.91  E-value=1.6e-25  Score=228.81  Aligned_cols=173  Identities=23%  Similarity=0.331  Sum_probs=136.6

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      +..||||+++... .....+.+.+|+.+|+++. ||||+++++++...+..|+|||||++|+|.+++...          
T Consensus        67 ~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~  145 (400)
T cd05105          67 VMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPE  145 (400)
T ss_pred             ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccc
Confidence            4579999986543 3344567999999999995 999999999999999999999999999999998642          


Q ss_pred             --------------------------------------------------------------------------------
Q psy6508          73 --------------------------------------------------------------------------------   72 (477)
Q Consensus        73 --------------------------------------------------------------------------------   72 (477)
                                                                                                      
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  225 (400)
T cd05105         146 KPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNL  225 (400)
T ss_pred             cccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHH
Confidence                                                                                            


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecc
Q psy6508          73 ------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV  146 (477)
Q Consensus        73 ------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~  146 (477)
                            ..+++..+..++.|++.||.|||++|++||||||+||+++.+. .+.++|||++.............+..++..
T Consensus       226 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~  304 (400)
T cd05105         226 LSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVK  304 (400)
T ss_pred             HHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCC-EEEEEeCCcceeccccccccccCCcCCCcc
Confidence                  1367788899999999999999999999999999999998753 344569998765432211111223345567


Q ss_pred             ccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         147 FEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |+|||...+.   .++|+ ||+|+++||+   +..||..
T Consensus       305 y~aPE~~~~~~~~~~~Di-wSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         305 WMAPESIFDNLYTTLSDV-WSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             eEChhhhcCCCCCchhhH-HHHHHHHHHHHHCCCCCCcc
Confidence            9999987655   67899 9999999997   4566653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.91  E-value=1.3e-24  Score=209.15  Aligned_cols=173  Identities=27%  Similarity=0.494  Sum_probs=143.9

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++.+.... ....+.+.+|+.++++++||||+++++.+.+++..|+++||+++++|.+++.+...+++..+
T Consensus        16 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~   95 (262)
T cd05572          16 SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTA   95 (262)
T ss_pred             CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHH
Confidence            46889999999765543 34456799999999999999999999999999999999999999999999988778999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++|+||+|+||+++.+. .+.++|||.+.......   ......++..|+|||...+.   .
T Consensus        96 ~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~  171 (262)
T cd05572          96 RFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDF  171 (262)
T ss_pred             HHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccc---ccccccCCcCccChhHhcCCCCCC
Confidence            99999999999999999999999999999997643 34445999876543321   11234566789999987654   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|+++|++  +..||..
T Consensus       172 ~~Di-~slG~il~~l~~g~~p~~~  194 (262)
T cd05572         172 SVDY-WSLGILLYELLTGRPPFGE  194 (262)
T ss_pred             hhhh-hhhHHHHHHHHhCCCCcCC
Confidence            6899 9999999999  6677764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.91  E-value=6.6e-25  Score=213.31  Aligned_cols=175  Identities=23%  Similarity=0.335  Sum_probs=140.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-------CC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-------KL   75 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------~l   75 (477)
                      ++..||+|.++... .......+.+|+.+++.++||||+++++++.+....+++|||++|++|.+++...+       .+
T Consensus        35 ~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~  113 (277)
T cd05036          35 VELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSL  113 (277)
T ss_pred             CceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCC
Confidence            56789999886443 23344678999999999999999999999998889999999999999999997653       48


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      ++..++.++.||+.||.|||++|++||||||+||+++.+  ...+.+.|||.+....+..+...+........|+|||..
T Consensus       114 ~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  193 (277)
T cd05036         114 TMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAF  193 (277)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHH
Confidence            899999999999999999999999999999999999754  234455699988765544433222233334579999987


Q ss_pred             CCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         154 SSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       154 ~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .+.   .++|+ ||+|+++||+   +..||.+
T Consensus       194 ~~~~~~~~~Di-wslG~il~el~~~g~~pf~~  224 (277)
T cd05036         194 LDGIFTSKTDV-WSFGVLLWEIFSLGYMPYPG  224 (277)
T ss_pred             hcCCcCchhHH-HHHHHHHHHHHcCCCCCCCC
Confidence            654   77899 9999999996   5677764

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.91  E-value=3.1e-25  Score=214.13  Aligned_cols=171  Identities=22%  Similarity=0.301  Sum_probs=140.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++++.||+|.++...  ......+.+|+.+++.++||||+++++.+...+..|++|||+++++|.+++...+.+++..+.
T Consensus        32 ~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  109 (267)
T cd06645          32 NTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIA  109 (267)
T ss_pred             CCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHH
Confidence            468899999987553  233456889999999999999999999999999999999999999999999888889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC---CC--
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS---SK--  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~---~~--  156 (477)
                      .++.|++.||.|||++|++|+||||+||+++.+. ++.+.|||.+.......  .......++..|+|||...   ..  
T Consensus       110 ~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  186 (267)
T cd06645         110 YVSRETLQGLYYLHSKGKMHRDIKGANILLTDNG-HVKLADFGVSAQITATI--AKRKSFIGTPYWMAPEVAAVERKGGY  186 (267)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECcceeeeEccCcc--cccccccCcccccChhhhccccCCCC
Confidence            9999999999999999999999999999997643 34445999875443211  1123346778899999863   11  


Q ss_pred             -CcccccCcceEEEEEE--eeeccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                       .++|+ ||+|+++|++  +..||.
T Consensus       187 ~~~~Dv-wSlG~il~~l~~~~~p~~  210 (267)
T cd06645         187 NQLCDI-WAVGITAIELAELQPPMF  210 (267)
T ss_pred             Cchhhh-HHHHHHHHHHhcCCCCcc
Confidence             67899 9999999999  556765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0584|consensus

Probab=99.91  E-value=7.7e-26  Score=228.40  Aligned_cols=197  Identities=20%  Similarity=0.294  Sum_probs=156.6

Q ss_pred             CCcEEEEEEcccCCC--ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC--eEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           3 QHTEVAIKCIDKTKV--SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      +|..||.-.++....  +++..++|..|+.+|+.|+||||+++|++|.+..  .+-+|+|.+..|+|+.|+++.++++.+
T Consensus        64 ~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~k  143 (632)
T KOG0584|consen   64 EGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIK  143 (632)
T ss_pred             cchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHH
Confidence            344555333333322  3455689999999999999999999999998765  489999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHHhC--CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          79 QCQQFVRQLVLALKFLREN--NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      .++.|++||+.||.|||++  .|+|||||-+||||+.+.-.+.+.|+|++.....+..    ...+|||-|||||++...
T Consensus       144 aik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~a----ksvIGTPEFMAPEmYEE~  219 (632)
T KOG0584|consen  144 AIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHA----KSVIGTPEFMAPEMYEEN  219 (632)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcccc----ceeccCccccChHHHhhh
Confidence            9999999999999999998  6999999999999988655555569999876554432    347999999999999876


Q ss_pred             --CcccccCcceEEEEEE--eeecccccccc-------------CCCCCcchHHHHHHHHHHhhh
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFASQIRT-------------GWLRDSEEKELGNHLKRALEP  204 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~~~r~-------------~~~~~~~~~~l~~~i~~~l~~  204 (477)
                        ..+|+ |+||+.++||  +-.||+.-..+             .........++..+|.++|.+
T Consensus       220 YnE~VDV-YaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~  283 (632)
T KOG0584|consen  220 YNELVDV-YAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT  283 (632)
T ss_pred             cchhhhh-hhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC
Confidence              88999 9999999999  44677543221             113344567777777777765

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.91  E-value=9.7e-24  Score=202.26  Aligned_cols=173  Identities=26%  Similarity=0.351  Sum_probs=141.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      .+++.||+|.++... .....+.+.+|+.+++.++||||+++++.+..++.+|++|||+++++|.+++...  ..+++..
T Consensus        23 ~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  101 (255)
T cd08219          23 NSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDT  101 (255)
T ss_pred             CCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHH
Confidence            368899999986543 2344567889999999999999999999999999999999999999999998653  3589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++|+||||+||+++++. ++...|||.+........  ......++..|+|||...+.   
T Consensus       102 ~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  178 (255)
T cd08219         102 ILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLTSPGA--YACTYVGTPYYVPPEIWENMPYN  178 (255)
T ss_pred             HHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCC-cEEEcccCcceeeccccc--ccccccCCccccCHHHHccCCcC
Confidence            999999999999999999999999999999997643 344459998754432211  12234567789999988665   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|+++|++  +..||..
T Consensus       179 ~~~Dv-~slG~i~~~l~~g~~p~~~  202 (255)
T cd08219         179 NKSDI-WSLGCILYELCTLKHPFQA  202 (255)
T ss_pred             chhhh-hhhchhheehhhccCCCCC
Confidence            67899 9999999999  6778864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.91  E-value=6.8e-25  Score=222.68  Aligned_cols=174  Identities=22%  Similarity=0.365  Sum_probs=142.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-----eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-----YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||++..........+++.+|+.+++.++||||+++++++...+     ..|+||||+. ++|.+++...+.++
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~  101 (372)
T cd07853          23 RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLS  101 (372)
T ss_pred             CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCC
Confidence            47899999998765444445567899999999999999999999998776     7899999997 78999988777899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..++.++.|++.||.|||++|++||||||+|||++.+. .+.++|||.+........ ......+++..|+|||...+.
T Consensus       102 ~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~  179 (372)
T cd07853         102 SDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNC-VLKICDFGLARVEEPDES-KHMTQEVVTQYYRAPEILMGS  179 (372)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCC-CEEeccccceeecccCcc-ccCCCCCcCCCcCCHHHHcCC
Confidence            999999999999999999999999999999999998653 444569998865332211 112234567889999987653


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ ||+|++++|+  +..||.+
T Consensus       180 ~~~~~~~Di-wslG~il~el~~g~~pf~~  207 (372)
T cd07853         180 RHYTSAVDI-WSVGCIFAELLGRRILFQA  207 (372)
T ss_pred             CCCCcHHHH-HhHHHHHHHHHcCCCCCCC
Confidence                56899 9999999999  6677764

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.91  E-value=2e-24  Score=211.46  Aligned_cols=172  Identities=23%  Similarity=0.311  Sum_probs=137.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      ++..+++|.+....  ....+.+.+|+.++++++||||+++++++......++||||+++++|.+++..++         
T Consensus        34 ~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~  111 (291)
T cd05094          34 DKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDG  111 (291)
T ss_pred             cceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCccccccccc
Confidence            45568889875442  3444678999999999999999999999999999999999999999999997542         


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecc
Q psy6508          74 -------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV  146 (477)
Q Consensus        74 -------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~  146 (477)
                             .+++..++.++.|++.||.|||++|++||||||+||+++.+. .+...|||.+...........+....++..
T Consensus       112 ~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~  190 (291)
T cd05094         112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIR  190 (291)
T ss_pred             ccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC-cEEECCCCcccccCCCceeecCCCCCccee
Confidence                   378899999999999999999999999999999999998653 344459998764433222223334455677


Q ss_pred             ccccccCCCC---CcccccCcceEEEEEE---eeeccc
Q psy6508         147 FEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       147 y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      |+|||...+.   .++|+ ||+|+++||+   +..||.
T Consensus       191 y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~  227 (291)
T cd05094         191 WMPPESIMYRKFTTESDV-WSFGVILWEIFTYGKQPWF  227 (291)
T ss_pred             ecChHHhccCCCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            9999987665   56899 9999999997   456664

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.3e-24  Score=210.18  Aligned_cols=175  Identities=19%  Similarity=0.336  Sum_probs=139.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCe------EEEEEecCCCCCHHHHHHhC----
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYCDGGDLCSFIRSH----   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~------~~lv~e~~~g~sL~~~l~~~----   72 (477)
                      ++..||+|.++.........+.+.+|+..++.++||||+++++++.....      .++++||+++++|..++...    
T Consensus        26 ~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~  105 (273)
T cd05035          26 SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGG  105 (273)
T ss_pred             CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccC
Confidence            35789999998766556666789999999999999999999998765443      89999999999999998542    


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          73 --EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        73 --~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                        ..+++..+..++.|++.||.|||++|++||||||+||+++++. ++.++|||.+...........+.....+..|+||
T Consensus       106 ~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05035         106 LPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI  184 (273)
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCC-eEEECCccceeeccccccccccccccCCccccCH
Confidence              2589999999999999999999999999999999999997652 3445699988755433332222223344579999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |...+.   .++|+ ||+|+++||+   +..||.+
T Consensus       185 e~~~~~~~~~~~Dv-~SlG~il~el~~~g~~p~~~  218 (273)
T cd05035         185 ESLADRVYTSKSDV-WAFGVTMWEIATRGQTPYPG  218 (273)
T ss_pred             hhcccCCCCcccch-HHHHHHHHHHHhCCCCCCCC
Confidence            987655   77999 9999999998   5566653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.91  E-value=7.6e-25  Score=210.29  Aligned_cols=174  Identities=23%  Similarity=0.376  Sum_probs=144.8

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|.+.+..... ...+.+.+|+.++++++||||+++++.+..+...|+++||++|++|.+++.....+++..+
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~  102 (258)
T cd05578          23 DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQV  102 (258)
T ss_pred             cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHH
Confidence            468999999997664433 4567899999999999999999999999999999999999999999999988778999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|+++||.|||++|++|+||+|+||+++++. .+..+|||.........   ......++..|.|||...+.   .
T Consensus       103 ~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~  178 (258)
T cd05578         103 KFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQG-HVHITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSV  178 (258)
T ss_pred             HHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCC-CEEEeecccccccCCCc---cccccCCChhhcCHHHHcccCCCC
Confidence            99999999999999999999999999999997642 34455999875433221   11234566789999987665   6


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ |++|+++|++  +..||...
T Consensus       179 ~~Di-~slG~~l~~l~~g~~p~~~~  202 (258)
T cd05578         179 AVDW-WSLGVTAYECLRGKRPYRGH  202 (258)
T ss_pred             cccc-hhhHHHHHHHHhCCCCCCCC
Confidence            7899 9999999999  67787743

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.91  E-value=4.6e-25  Score=211.22  Aligned_cols=174  Identities=25%  Similarity=0.357  Sum_probs=144.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      .+++.||+|.+.....+....+.+.+|+.++++++|||++++++.+..++..++||||++|++|.+++...  ..+++..
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  102 (256)
T cd08220          23 ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDT  102 (256)
T ss_pred             CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHH
Confidence            46889999999877666666778999999999999999999999999999999999999999999999764  3589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++|+||+|+||++++++..+...|||.+.......   ......++..|+|||...+.   
T Consensus       103 ~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  179 (256)
T cd08220         103 ILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYN  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc---cccccccCCcccCchhccCCCCC
Confidence            999999999999999999999999999999998654444456999876443211   11234566789999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|++++++  +..||..
T Consensus       180 ~~~Dv-~slG~~l~~l~~~~~~~~~  203 (256)
T cd08220         180 QKSDI-WALGCVLYELASLKRAFEA  203 (256)
T ss_pred             cccch-HHHHHHHHHHHhCCCCccc
Confidence            67899 9999999999  5566653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.91  E-value=1.4e-24  Score=212.23  Aligned_cols=171  Identities=23%  Similarity=0.307  Sum_probs=134.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc---CCCCccceEEEEE-----eCCeEEEEEecCCCCCHHHHHHhC--
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL---HHQHIVTMLDFLW-----DERYVYIILEYCDGGDLCSFIRSH--   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~~~~~~~-----~~~~~~lv~e~~~g~sL~~~l~~~--   72 (477)
                      +|+.||+|.++...........+.+|+.+++.+   +||||+++++++.     ....++++|||++ ++|.+++...  
T Consensus        26 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~  104 (290)
T cd07862          26 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE  104 (290)
T ss_pred             CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCC
Confidence            467899999876654443445567788887766   6999999999875     2456899999997 7999999763  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ..+++..+..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+......   ....+..++..|+|||.
T Consensus       105 ~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~  180 (290)
T cd07862         105 PGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEV  180 (290)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCC-CEEEccccceEeccCC---cccccccccccccChHH
Confidence            3589999999999999999999999999999999999997643 3444599988654322   22334567889999998


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++||+  +..||.+
T Consensus       181 ~~~~~~~~~~Di-wslG~il~el~~g~~~f~~  211 (290)
T cd07862         181 LLQSSYATPVDL-WSVGCIFAEMFRRKPLFRG  211 (290)
T ss_pred             HhCCCCCCccch-HHHHHHHHHHHcCCCCcCC
Confidence            7654   67899 9999999998  5566653

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.91  E-value=1.5e-24  Score=211.21  Aligned_cols=173  Identities=25%  Similarity=0.331  Sum_probs=139.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      ++..+|+|.++..  .....+.+.+|+.+++.++||||+++++++......+++|||+++++|.+++...+         
T Consensus        34 ~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~  111 (280)
T cd05092          34 DKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGG  111 (280)
T ss_pred             CceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccc
Confidence            4668899987644  34456789999999999999999999999999999999999999999999997643         


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccc
Q psy6508          74 ------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF  147 (477)
Q Consensus        74 ------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y  147 (477)
                            .+++..+..++.|++.||.|||++|++||||||+||+++++. .+.+.|||.+................++..|
T Consensus       112 ~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y  190 (280)
T cd05092         112 EDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW  190 (280)
T ss_pred             ccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC-CEEECCCCceeEcCCCceeecCCCccccccc
Confidence                  478899999999999999999999999999999999997642 3445599987644332222223334455679


Q ss_pred             cccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         148 EPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       148 ~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|||...+.   .++|+ ||+|+++||+   +..||..
T Consensus       191 ~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~  227 (280)
T cd05092         191 MPPESILYRKFTTESDI-WSFGVVLWEIFTYGKQPWYQ  227 (280)
T ss_pred             cCHHHhccCCcCchhhH-HHHHHHHHHHHcCCCCCCcc
Confidence            999987665   67899 9999999998   4577743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.91  E-value=3.7e-25  Score=241.12  Aligned_cols=174  Identities=25%  Similarity=0.356  Sum_probs=141.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhC----CCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSH----EKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~----~~l   75 (477)
                      .+++.||+|.+............+..|+.++++|+||||++++++|..  ...+||||||+++++|.++|...    +.+
T Consensus        36 ~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L  115 (1021)
T PTZ00266         36 RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI  115 (1021)
T ss_pred             CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCC
Confidence            357789999998776666667789999999999999999999998864  35799999999999999999752    469


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhC-------CcEEccCCCCceeeccC----------------cceeecccccceecccCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLREN-------NVCHFDLKPQNILIKNN----------------TLKLAGLKQGVSEKAKGS  132 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~-------givHrDlkp~NIll~~~----------------~~rl~~~dfG~~~~~~gs  132 (477)
                      ++..++.|+.||+.||.|||+.       +|+||||||+||||+.+                ...+.++|||++......
T Consensus       116 ~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~  195 (1021)
T PTZ00266        116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE  195 (1021)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc
Confidence            9999999999999999999984       49999999999999642                122455699988654322


Q ss_pred             cccccCCeEEEeccccccccCCCC-----CcccccCcceEEEEEE--eeecccc
Q psy6508         133 AYIEQGNTKVICSVFEPREIPSSK-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       133 ~~~~~g~t~v~~~~y~ppE~~~~~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   ...+.++++.|+|||++.+.     .++|+ ||+|+++|+|  +..||..
T Consensus       196 s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDV-WSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        196 S---MAHSCVGTPYYWSPELLLHETKSYDDKSDM-WALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             c---cccccCCCccccCHHHHhccCCCCCchhHH-HHHHHHHHHHHHCCCCCCc
Confidence            1   12345678899999987532     57899 9999999999  6688864

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.91  E-value=1.2e-24  Score=208.52  Aligned_cols=174  Identities=24%  Similarity=0.366  Sum_probs=144.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---------C
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---------E   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------~   73 (477)
                      ++..|++|.++...... ..+.+.+|+..++.++||||+++++++.....++++|||+++++|.+++...         .
T Consensus        22 ~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  100 (262)
T cd00192          22 KTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKS  100 (262)
T ss_pred             CCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccc
Confidence            37889999987665433 4678999999999999999999999999999999999999999999999875         6


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      .+++..+..++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+................++..|+|||..
T Consensus       101 ~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  179 (262)
T cd00192         101 TLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDL-VVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL  179 (262)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCC-cEEEcccccccccccccccccccCCCcCccccCHHHh
Confidence            799999999999999999999999999999999999998752 3444599988655433222223344556789999987


Q ss_pred             CCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         154 SSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       154 ~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ...   .++|+ |++|+++|++   +..||..
T Consensus       180 ~~~~~~~~~Di-~slG~il~~l~~~g~~p~~~  210 (262)
T cd00192         180 KDGIFTSKSDV-WSFGVLLWEIFTLGATPYPG  210 (262)
T ss_pred             ccCCcchhhcc-HHHHHHHHHHHhcCCCCCCC
Confidence            654   67899 9999999998   4677764

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.91  E-value=3.9e-25  Score=218.10  Aligned_cols=176  Identities=22%  Similarity=0.350  Sum_probs=140.9

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.|++|.++..... ....+.+.+|+.+++.++||||+++++.+..++.++++|||++|++|.+++...+.+++..+
T Consensus        24 ~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~  103 (305)
T cd05609          24 ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMA  103 (305)
T ss_pred             CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHH
Confidence            46789999998765432 23456788999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-------------ccCCeEEEeccc
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-------------EQGNTKVICSVF  147 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-------------~~g~t~v~~~~y  147 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+...|||.+.....+...             ....+..++..|
T Consensus       104 ~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  182 (305)
T cd05609         104 RMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG-HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY  182 (305)
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC-CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccc
Confidence            99999999999999999999999999999997642 3344599976532111000             001123456679


Q ss_pred             cccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         148 EPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       148 ~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|||.....   .++|+ |++|+++||+  +..||.+
T Consensus       183 ~aPE~~~~~~~~~~~Di-~slG~vl~el~~g~~pf~~  218 (305)
T cd05609         183 IAPEVILRQGYGKPVDW-WAMGIILYEFLVGCVPFFG  218 (305)
T ss_pred             cCchhccCCCCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            999987654   67899 9999999999  6677763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.91  E-value=4.5e-25  Score=212.87  Aligned_cols=174  Identities=23%  Similarity=0.310  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCC
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~   76 (477)
                      .+++.||||.++.... .......+.+|+.+++.++||||+++++++...+..++++||+++++|.+++..    ...++
T Consensus        25 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~  104 (267)
T cd08228          25 LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP  104 (267)
T ss_pred             CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCC
Confidence            3688999998865433 344456789999999999999999999999999999999999999999998853    23589


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..+..++.|++.||.|||++|++|+||||+||+++.+. .+.+.|||.+.......  ....+..++..|+|||...+.
T Consensus       105 ~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  181 (267)
T cd08228         105 ERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCC-CEEECccccceeccchh--HHHhcCCCCccccChhhhccC
Confidence            999999999999999999999999999999999997643 23445898765433211  111233466789999987655


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|++++++  +..||..
T Consensus       182 ~~~~~~Di-~slG~~l~el~~g~~p~~~  208 (267)
T cd08228         182 GYNFKSDI-WSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCCchhhH-HHHHHHHHHHhcCCCCCcc
Confidence               67899 9999999999  6677753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=6.8e-25  Score=224.20  Aligned_cols=168  Identities=20%  Similarity=0.221  Sum_probs=138.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.+....       ...+|+.+|++++||||+++++.+...+..|++||++. ++|.+++...+.+++..++
T Consensus       117 ~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~  188 (392)
T PHA03207        117 EQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAI  188 (392)
T ss_pred             ccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHH
Confidence            356789999876432       24589999999999999999999999999999999996 7999999777789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++||+||||||+|||++.+. ++.++|||++................++..|+|||.+.+.   .+
T Consensus       189 ~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  267 (392)
T PHA03207        189 TIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAK  267 (392)
T ss_pred             HHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCch
Confidence            9999999999999999999999999999997643 3445699988654433222222245678899999998765   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|+++||+  +..||.+
T Consensus       268 ~Dv-wslGvil~el~~g~~pf~~  289 (392)
T PHA03207        268 TDI-WSAGLVLFEMSVKNVTLFG  289 (392)
T ss_pred             hhH-HHHHHHHHHHHHCCCCCCC
Confidence            899 9999999999  6677764

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.91  E-value=1.8e-24  Score=210.76  Aligned_cols=174  Identities=22%  Similarity=0.325  Sum_probs=138.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      +++.||+|.+.... .......+.+|+.++++++||||+++++++......|++|||+++++|.+++...          
T Consensus        33 ~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  111 (283)
T cd05090          33 HAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS  111 (283)
T ss_pred             CcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccccc
Confidence            56789999987543 3445567899999999999999999999999999999999999999999998532          


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEec
Q psy6508          73 -------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICS  145 (477)
Q Consensus        73 -------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~  145 (477)
                             ..+++..+..++.|++.||.|||++|++||||||+||+++++. .+.+.|||.+.............+..++.
T Consensus       112 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  190 (283)
T cd05090         112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL-HVKISDLGLSREIYSADYYRVQPKSLLPI  190 (283)
T ss_pred             ccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC-cEEeccccccccccCCcceecccCCCccc
Confidence                   2378888999999999999999999999999999999998653 23445999886543322222223334456


Q ss_pred             cccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         146 VFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       146 ~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .|+|||...+.   .++|+ ||+|++++|+   +..||.+
T Consensus       191 ~y~aPE~~~~~~~~~~~Dv-~slG~il~el~~~g~~p~~~  229 (283)
T cd05090         191 RWMPPEAIMYGKFSSDSDI-WSFGVVLWEIFSFGLQPYYG  229 (283)
T ss_pred             eecChHHhccCCCCchhhh-HHHHHHHHHHHcCCCCCCCC
Confidence            79999987654   67899 9999999997   4467653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.91  E-value=1.3e-24  Score=219.49  Aligned_cols=170  Identities=22%  Similarity=0.358  Sum_probs=138.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||+|++............+.+|+.+++.++||||+++++++...+      .+|+||||++ ++|.+.+..  .+
T Consensus        44 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~  120 (359)
T cd07876          44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM--EL  120 (359)
T ss_pred             CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHhc--cC
Confidence            46889999999776555555677889999999999999999999986443      5799999997 677777653  58


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.......   ......++..|+|||...+
T Consensus       121 ~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~  196 (359)
T cd07876         121 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNF---MMTPYVVTRYYRAPEVILG  196 (359)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEecCCCccccccCc---cCCCCcccCCCCCchhccC
Confidence            8999999999999999999999999999999999997643 34445999876433221   1234567888999999876


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ ||+|+++|+|  +..||.+
T Consensus       197 ~~~~~~~Di-wSlG~il~el~tg~~pf~~  224 (359)
T cd07876         197 MGYKENVDI-WSVGCIMGELVKGSVIFQG  224 (359)
T ss_pred             CCCCcchhh-HHHHHHHHHHHhCCCCCCC
Confidence            5   67899 9999999999  6788874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.91  E-value=8e-25  Score=214.51  Aligned_cols=167  Identities=23%  Similarity=0.277  Sum_probs=137.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      .+..||+|.+.... .....+.+.+|+.++++++||||+++++++..+...+++||++++++|.+++.+..         
T Consensus        45 ~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  123 (296)
T cd05051          45 APVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN  123 (296)
T ss_pred             CceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhccccccccccc
Confidence            34679999987553 33456789999999999999999999999999999999999999999999998765         


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccc
Q psy6508          74 --KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        74 --~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE  151 (477)
                        .+++..+..++.|++.||.|||++|++||||||+||+++.+ .++.++|||.+.............+..++..|+|||
T Consensus       124 ~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  202 (296)
T cd05051         124 SKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN-YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWE  202 (296)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceeecCC-CceEEccccceeecccCcceeecCcCCCCceecCHH
Confidence              68999999999999999999999999999999999999775 244456999886544332222223344556799999


Q ss_pred             cCCCC---CcccccCcceEEEEEE
Q psy6508         152 IPSSK---TSLEYQRSKGELYVEF  172 (477)
Q Consensus       152 ~~~~~---~~~Di~~s~G~il~e~  172 (477)
                      ...+.   .++|+ ||+|+++||+
T Consensus       203 ~~~~~~~~~~~Dv-~slG~~l~el  225 (296)
T cd05051         203 SVLLGKFTTKSDV-WAFGVTLWEI  225 (296)
T ss_pred             HhhcCCCCccchh-hhhHHHHHHH
Confidence            87654   77899 9999999987

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.91  E-value=3e-24  Score=207.14  Aligned_cols=176  Identities=26%  Similarity=0.379  Sum_probs=142.3

Q ss_pred             CCCcEEEEEEcccCCCCh-------hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSE-------NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~   74 (477)
                      .+++.||+|.+.......       ...+.+.+|+.++++++||||+++++++..++..+++|||+++++|.+++...+.
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  102 (267)
T cd06628          23 SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA  102 (267)
T ss_pred             CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccC
Confidence            367899999887654321       1235688999999999999999999999999999999999999999999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc----ccCCeEEEecccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI----EQGNTKVICSVFEPR  150 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~----~~g~t~v~~~~y~pp  150 (477)
                      +++..+..++.|++.||.|||++|++||||+|+||+++++. .+.+.|||.+.........    .......++..|.||
T Consensus       103 l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~p  181 (267)
T cd06628         103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKG-GIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP  181 (267)
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCC-CEEecccCCCcccccccccCCccccccccCCCcCccCh
Confidence            99999999999999999999999999999999999997653 3444599987655421110    011123456789999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.   .++|+ |++|++++++  +..||..
T Consensus       182 e~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~  214 (267)
T cd06628         182 EVVKQTSYTRKADI-WSLGCLVVEMLTGKHPFPD  214 (267)
T ss_pred             hHhccCCCCchhhh-HHHHHHHHHHhhCCCCCCC
Confidence            987665   56899 9999999999  6678864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0690|consensus

Probab=99.91  E-value=2.5e-25  Score=208.07  Aligned_cols=174  Identities=19%  Similarity=0.316  Sum_probs=150.3

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||+++++-+- .+....-..|-++|+..+||++..+--.|+...++|+||||+.||.|.-.|.+.+.+++...
T Consensus       191 at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~Rt  270 (516)
T KOG0690|consen  191 ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRT  270 (516)
T ss_pred             ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhh
Confidence            47899999999988653 33445567899999999999999998889999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.+...|+.||.|||+++||+||||.+|+|++.+ .+++  .|||+++.  +-.+-....|..||+.|.+||++...   
T Consensus       271 RFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKi--tDFGLCKE--~I~~g~t~kTFCGTPEYLAPEVleDnDYg  346 (516)
T KOG0690|consen  271 RFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKI--TDFGLCKE--EIKYGDTTKTFCGTPEYLAPEVLEDNDYG  346 (516)
T ss_pred             hhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEe--eecccchh--cccccceeccccCChhhcCchhhcccccc
Confidence            9999999999999999999999999999999875 4555  49999853  32333344678899999999999877   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ |.+|+++|||  |..||...
T Consensus       347 raVDW-WG~GVVMYEMmCGRLPFyn~  371 (516)
T KOG0690|consen  347 RAVDW-WGVGVVMYEMMCGRLPFYNK  371 (516)
T ss_pred             ceeeh-hhhhHHHHHHHhccCccccc
Confidence            88999 9999999999  88898853

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.91  E-value=3.1e-25  Score=216.13  Aligned_cols=172  Identities=22%  Similarity=0.313  Sum_probs=136.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      +++.||+|+++... .....+.+.+|+.+++.++||||+++++++......++++||+++++|.+++...          
T Consensus        34 ~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~  112 (283)
T cd05091          34 QTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTD  112 (283)
T ss_pred             ceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccc
Confidence            46789999987553 2334567889999999999999999999999999999999999999999998532          


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEec
Q psy6508          73 ------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICS  145 (477)
Q Consensus        73 ------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~  145 (477)
                            ..+++..+..++.|++.||.|||++|++||||||+||+++++ .++  ..|||++.............+...+.
T Consensus       113 ~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k--l~Dfg~~~~~~~~~~~~~~~~~~~~~  190 (283)
T cd05091         113 DDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK--ISDLGLFREVYAADYYKLMGNSLLPI  190 (283)
T ss_pred             cccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE--ecccccccccccchheeeccCccCCc
Confidence                  247888899999999999999999999999999999999764 444  45999876543322211122334456


Q ss_pred             cccccccCCCC---CcccccCcceEEEEEE---eeeccc
Q psy6508         146 VFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       146 ~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      .|+|||...+.   .++|+ ||+|+++||+   +..||.
T Consensus       191 ~y~aPE~~~~~~~~~~~Dv-~slG~~l~el~~~g~~p~~  228 (283)
T cd05091         191 RWMSPEAIMYGKFSIDSDI-WSYGVVLWEVFSYGLQPYC  228 (283)
T ss_pred             cccCHHHHhcCCCCcchhH-HHHHHHHHHHHcCCCCCCC
Confidence            79999987644   67899 9999999997   335554

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG1989|consensus

Probab=99.91  E-value=5e-25  Score=230.90  Aligned_cols=196  Identities=20%  Similarity=0.331  Sum_probs=151.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEE-E---eC---CeEEEEEecCCCCCHHHHHHhC--
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFL-W---DE---RYVYIILEYCDGGDLCSFIRSH--   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~-~---~~---~~~~lv~e~~~g~sL~~~l~~~--   72 (477)
                      .|+.||+|++-..  ++...+...+|+.+|++|. |||||.+++.. .   ..   -.++|.||||+||.|-+++..+  
T Consensus        61 ~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq  138 (738)
T KOG1989|consen   61 GGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQ  138 (738)
T ss_pred             CCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHh
Confidence            3489999997554  5666788999999999995 99999999942 2   11   2578999999999999999753  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccCcceeecccccceeccc-------CCcccccCCeEEE
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAK-------GSAYIEQGNTKVI  143 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~-------gs~~~~~g~t~v~  143 (477)
                      .+|++.++++|++|+++|+.+||..+  |+|||||-+||||..++ ..++||||-+...-       +-.+++..-.+.-
T Consensus       139 ~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g-~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~T  217 (738)
T KOG1989|consen  139 TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADG-NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYT  217 (738)
T ss_pred             ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCC-CEEeCcccccccccCCCccHHHHHHHHHHHHhhC
Confidence            46999999999999999999999987  99999999999997754 44456999875432       2234444446777


Q ss_pred             eccccccccCC---CC---CcccccCcceEEEEEEe--eecccccccc-------CCCC-CcchHHHHHHHHHHh
Q psy6508         144 CSVFEPREIPS---SK---TSLEYQRSKGELYVEFK--FAPFASQIRT-------GWLR-DSEEKELGNHLKRAL  202 (477)
Q Consensus       144 ~~~y~ppE~~~---~~---~~~Di~~s~G~il~e~~--~~Pf~~~~r~-------~~~~-~~~~~~l~~~i~~~l  202 (477)
                      |+-|++||++.   +.   +++|| |++||++|-+.  ..||...+.-       .+++ ......+..+|+.+|
T Consensus       218 Tp~YRsPEMIDlysg~pI~eKsDI-WALGclLYkLCy~t~PFe~sg~laIlng~Y~~P~~p~ys~~l~~LI~~mL  291 (738)
T KOG1989|consen  218 TPQYRSPEMIDLYSGLPIGEKSDI-WALGCLLYKLCYFTTPFEESGKLAILNGNYSFPPFPNYSDRLKDLIRTML  291 (738)
T ss_pred             CccccChHHHhhhcCCCCcchhHH-HHHHHHHHHHHHhCCCcCcCcceeEEeccccCCCCccHHHHHHHHHHHHh
Confidence            88999999864   22   88999 99999999994  4999876432       2222 355566666666544

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.91  E-value=6.7e-25  Score=214.37  Aligned_cols=173  Identities=21%  Similarity=0.263  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~   78 (477)
                      .+++.||+|.+....... .....+.+|+.+++.++|+||+++++.+..++..|++|||+++++|.+++...  ..+++.
T Consensus        23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  102 (285)
T cd05632          23 ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEE  102 (285)
T ss_pred             CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHH
Confidence            468899999987654432 23456788999999999999999999999999999999999999999888653  369999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++||+||||||+||+++++. .+.++|||.+.......   ...+..++..|+|||...+.  
T Consensus       103 ~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~  178 (285)
T cd05632         103 RALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYG-HIRISDLGLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCC-CEEEecCCcceecCCCC---cccCCCCCcCccChHHhcCCCC
Confidence            9999999999999999999999999999999997653 34456999875432211   11234577889999998655  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ ||+|+++|++  +..||..
T Consensus       179 ~~~~Di-~slG~~l~~l~~g~~P~~~  203 (285)
T cd05632         179 TLSPDY-WGLGCLIYEMIEGQSPFRG  203 (285)
T ss_pred             Ccccch-HHHHHHHHHHHhCCCCCCC
Confidence             67899 9999999999  6778764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.3e-24  Score=210.79  Aligned_cols=173  Identities=20%  Similarity=0.289  Sum_probs=137.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      +++.||+|.+.... .......+.+|+.+++.++||||+++++++......|++|||+++++|.+++....         
T Consensus        35 ~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~  113 (277)
T cd05032          35 PETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGL  113 (277)
T ss_pred             cceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCC
Confidence            45789999986543 33345678899999999999999999999999999999999999999999996532         


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                       .+++..+..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.....+.......+..++..|.|||.
T Consensus       114 ~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  192 (277)
T cd05032         114 GPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDL-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (277)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCC-CEEECCcccchhhccCcccccCCCCCccccccCHHH
Confidence             367888999999999999999999999999999999998653 344569998765433322222233445567999998


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeeccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      ..+.   .++|+ |++|+++||+   +..||.
T Consensus       193 ~~~~~~~~~~Di-~slG~il~el~t~g~~p~~  223 (277)
T cd05032         193 LKDGVFTTKSDV-WSFGVVLWEMATLAEQPYQ  223 (277)
T ss_pred             HhcCCCCcccch-HHHHHHHHHhhccCCCCCc
Confidence            7654   67899 9999999998   346664

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.91  E-value=1.1e-24  Score=210.10  Aligned_cols=171  Identities=20%  Similarity=0.318  Sum_probs=136.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      ++++.||+|.+....   ...+.+.+|+.++++++||||+++++++..++.++++|||+++++|.+++....  .+++..
T Consensus        29 ~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~  105 (263)
T cd05052          29 KYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVV  105 (263)
T ss_pred             cCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHH
Confidence            457889999986542   234678899999999999999999999999999999999999999999997643  589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++|++||||||+||+++++. .+.+.|||.+.......... ......+..|++||...+.   
T Consensus       106 ~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  183 (263)
T cd05052         106 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFS  183 (263)
T ss_pred             HHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-cEEeCCCccccccccceeec-cCCCCCccccCCHHHhccCCCC
Confidence            999999999999999999999999999999997643 34456999876544322211 1112234569999987655   


Q ss_pred             CcccccCcceEEEEEEe---eeccc
Q psy6508         157 TSLEYQRSKGELYVEFK---FAPFA  178 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~~---~~Pf~  178 (477)
                      .++|+ |++|+++||+.   ..||.
T Consensus       184 ~~~Dv-~slG~il~el~t~g~~p~~  207 (263)
T cd05052         184 IKSDV-WAFGVLLWEIATYGMSPYP  207 (263)
T ss_pred             chhHH-HHHHHHHHHHHcCCCCCCC
Confidence            56899 99999999993   35654

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.91  E-value=7.5e-24  Score=207.39  Aligned_cols=174  Identities=21%  Similarity=0.393  Sum_probs=137.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------   72 (477)
                      ....||+|.+.... ......++.+|+.+++++ +||||+++++++..++.+|++|||+++++|.+++...         
T Consensus        41 ~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~  119 (293)
T cd05053          41 ETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASP  119 (293)
T ss_pred             CceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccc
Confidence            34679999987543 334456789999999999 7999999999999999999999999999999999642         


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEec
Q psy6508          73 -------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICS  145 (477)
Q Consensus        73 -------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~  145 (477)
                             +.+++..++.++.|++.||.|||++||+||||||+||+++++. .+.+.|||.+.................+.
T Consensus       120 ~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  198 (293)
T cd05053         120 DDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPV  198 (293)
T ss_pred             ccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCC-eEEeCccccccccccccceeccCCCCCCc
Confidence                   3588999999999999999999999999999999999997643 34456999886544332211111222345


Q ss_pred             cccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         146 VFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       146 ~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .|+|||...+.   .++|+ ||+|+++||+   +..||.+
T Consensus       199 ~y~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~  237 (293)
T cd05053         199 KWMAPEALFDRVYTHQSDV-WSFGVLLWEIFTLGGSPYPG  237 (293)
T ss_pred             cccCHHHhccCCcCcccce-eehhhHHHHHhcCCCCCCCC
Confidence            69999987654   67899 9999999996   4566653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.91  E-value=3.3e-24  Score=206.93  Aligned_cols=171  Identities=23%  Similarity=0.314  Sum_probs=140.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|++.....  .....+.+|+.++++++||||+++++.+..++..|+||||+++++|.+++...+.+++..+.
T Consensus        32 ~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~  109 (267)
T cd06646          32 HTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIA  109 (267)
T ss_pred             CCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHH
Confidence            4678999999865432  23456789999999999999999999999999999999999999999999877789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-----
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-----  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-----  156 (477)
                      .++.|++.||.|||++||+||||||+||+++.+. .+...|||.+.......  .......++..|+|||.....     
T Consensus       110 ~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~  186 (267)
T cd06646         110 YVCRETLQGLAYLHSKGKMHRDIKGANILLTDNG-DVKLADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGY  186 (267)
T ss_pred             HHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-CEEECcCccceeecccc--cccCccccCccccCHhHcccccCCCC
Confidence            9999999999999999999999999999997643 34456999886543211  112334566789999987421     


Q ss_pred             -CcccccCcceEEEEEE--eeeccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                       .++|+ ||+|++++|+  +..||.
T Consensus       187 ~~~~Dv-ws~G~il~el~~g~~p~~  210 (267)
T cd06646         187 NQLCDI-WAVGITAIELAELQPPMF  210 (267)
T ss_pred             cchhhH-HHHHHHHHHHHhCCCCcc
Confidence             56899 9999999999  667775

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=1.2e-24  Score=209.33  Aligned_cols=172  Identities=20%  Similarity=0.263  Sum_probs=137.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      ++++.||+|.++....   ..+.+.+|+.++++++||||+++++++...+..|++|||+++++|.+++....  .+++..
T Consensus        28 ~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  104 (261)
T cd05068          28 NNTTPVAVKTLKPGTM---DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQ  104 (261)
T ss_pred             cCCeEEEEEeeCCCcc---cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHH
Confidence            3567899999876543   24568899999999999999999999999999999999999999999997644  689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+........... ........|+|||...+.   
T Consensus       105 ~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~  182 (261)
T cd05068         105 LIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENN-ICKVADFGLARVIKEDIYEAR-EGAKFPIKWTAPEAALYNRFS  182 (261)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCC-CEEECCcceEEEccCCccccc-CCCcCceeccCccccccCCCC
Confidence            999999999999999999999999999999997653 344459998865442211111 111123469999987665   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|++++++   +..||.+
T Consensus       183 ~~~Di-~slG~~l~el~t~g~~p~~~  207 (261)
T cd05068         183 IKSDV-WSFGILLTEIVTYGRMPYPG  207 (261)
T ss_pred             chhhH-HHHHHHHHHHHhcCCCCCCC
Confidence            67899 9999999997   5566654

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=6.9e-25  Score=213.32  Aligned_cols=172  Identities=28%  Similarity=0.384  Sum_probs=139.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+++.||+|.+...  .....+.+.+|+.++++++||||+++++.+..+...|+||||+++++|.+++.+. ..+++..+
T Consensus        28 ~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~  105 (280)
T cd06611          28 ETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQI  105 (280)
T ss_pred             CCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHH
Confidence            46889999998654  3445567899999999999999999999999999999999999999999998764 46999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++|++|+||||+||+++.+. ++.+.|||.+.......  .......++..|+|||.....    
T Consensus       106 ~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  182 (280)
T cd06611         106 RYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKD  182 (280)
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCC-CEEEccCccchhhcccc--cccceeecchhhcCHHHHhhcccCC
Confidence            99999999999999999999999999999997642 33445998765432211  122345677889999986421    


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ |++|+++|++  +..||..
T Consensus       183 ~~~~~~sDi-~slG~il~~l~~g~~p~~~  210 (280)
T cd06611         183 NPYDYKADI-WSLGITLIELAQMEPPHHE  210 (280)
T ss_pred             CCCCccccH-HHHHHHHHHHHhCCCCccc
Confidence                46899 9999999998  6677764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.91  E-value=8.9e-25  Score=209.81  Aligned_cols=173  Identities=16%  Similarity=0.240  Sum_probs=136.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ   82 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~   82 (477)
                      ++..||+|.+...... ...+.+.+|+.+++.+.||||+++++++. .+..+++|||+++++|.+++.+...+++..+..
T Consensus        22 ~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~   99 (257)
T cd05060          22 KEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE   99 (257)
T ss_pred             CcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHH
Confidence            3478999998766543 44567899999999999999999999876 456899999999999999998877899999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC---Cc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      ++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+........ ........++..|.|||...+.   .+
T Consensus       100 ~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  178 (257)
T cd05060         100 LAHQVAMGMAYLESKHFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSK  178 (257)
T ss_pred             HHHHHHHHHHHHhhcCeeccCcccceEEEcCCC-cEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCcc
Confidence            999999999999999999999999999997653 344459998764422211 1111111223469999987655   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|+++|++   +..||..
T Consensus       179 ~Di-~slG~~l~~~~~~g~~p~~~  201 (257)
T cd05060         179 SDV-WSYGVTLWEAFSYGAKPYGE  201 (257)
T ss_pred             chH-HHHHHHHHHHHcCCCCCccc
Confidence            899 9999999998   4577753

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.91  E-value=7.8e-25  Score=211.20  Aligned_cols=174  Identities=22%  Similarity=0.291  Sum_probs=140.9

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCC
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~   76 (477)
                      .+++.||||.+..... .....+++.+|+.+++.++||||+++++.+..++..+++|||++|++|.+++..    ...++
T Consensus        25 ~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~  104 (267)
T cd08229          25 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP  104 (267)
T ss_pred             CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCC
Confidence            4788999998876443 334456889999999999999999999999999999999999999999999864    34689


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..++.++.|++.||.|||++|++|+||||+||+++.++ .+...|||.........  .......++..|+|||...+.
T Consensus       105 ~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~  181 (267)
T cd08229         105 EKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEECcchhhhccccCC--cccccccCCcCccCHHHhcCC
Confidence            999999999999999999999999999999999997643 34456998765432111  111234566789999988655


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|++++++  +..||.+
T Consensus       182 ~~~~~~Dv-~slG~il~~l~~g~~p~~~  208 (267)
T cd08229         182 GYNFKSDI-WSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CccchhhH-HHHHHHHHHHHhCCCCccc
Confidence               56899 9999999999  6678764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.91  E-value=3.6e-24  Score=212.24  Aligned_cols=173  Identities=21%  Similarity=0.363  Sum_probs=135.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhC-------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSH-------   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~-------   72 (477)
                      ++++.||+|.+......    ..+.+|+.++++++||||+++++++..  +..+|++|||+. ++|.+++...       
T Consensus        26 ~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~  100 (317)
T cd07868          26 KDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANK  100 (317)
T ss_pred             CCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccC
Confidence            35788999998755432    346789999999999999999998864  457899999996 7998887532       


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc---CcceeecccccceecccCCcc-cccCCeEEEecc
Q psy6508          73 --EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSV  146 (477)
Q Consensus        73 --~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~---~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~  146 (477)
                        ..+++..++.++.|++.||.|||++||+||||||+|||+..   ....+.++|||.+........ .....+..+++.
T Consensus       101 ~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~  180 (317)
T cd07868         101 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  180 (317)
T ss_pred             CcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccc
Confidence              24899999999999999999999999999999999999942   233455569999865432211 111234567889


Q ss_pred             ccccccCCCC----CcccccCcceEEEEEE--eeeccccc
Q psy6508         147 FEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       147 y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      |+|||...+.    .++|+ ||+|++++++  +..||.+.
T Consensus       181 y~aPE~~~~~~~~~~~~Di-wslG~il~el~~g~~~f~~~  219 (317)
T cd07868         181 YRAPELLLGARHYTKAIDI-WAIGCIFAELLTSEPIFHCR  219 (317)
T ss_pred             ccCCHHHcCCCCcCchhhH-HHHHHHHHHHHhCCCCccCC
Confidence            9999987653    57899 9999999999  67888643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.91  E-value=3.9e-24  Score=208.98  Aligned_cols=173  Identities=18%  Similarity=0.247  Sum_probs=141.0

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~   78 (477)
                      .+++.||+|.+....... .....+.+|+.++++++||||+++++.+..++..|++|||++|++|.+++...+  .+++.
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~  102 (285)
T cd05630          23 ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEG  102 (285)
T ss_pred             CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHH
Confidence            468899999987654332 233557789999999999999999999999999999999999999999986533  58999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++||+||||||+||+++.+. ++.+.|||.+........   -....++..|+|||...+.  
T Consensus       103 ~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~  178 (285)
T cd05630         103 RAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCC-CEEEeeccceeecCCCcc---ccCCCCCccccChHHHcCCCC
Confidence            9999999999999999999999999999999998643 344569998754322111   1224577889999998765  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ ||+|+++|++  +..||..
T Consensus       179 ~~~~Di-wslG~~l~~l~~g~~Pf~~  203 (285)
T cd05630         179 TFSPDW-WALGCLLYEMIAGQSPFQQ  203 (285)
T ss_pred             CCcccc-HHHHHHHHHHHhCCCCCCC
Confidence             67899 9999999999  7788874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.91  E-value=2.9e-24  Score=208.74  Aligned_cols=173  Identities=20%  Similarity=0.285  Sum_probs=140.8

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~   78 (477)
                      .+|+.||+|.+....... ...+.+.+|+.++++++||||+++++.+...+..|+||||++|++|.+++.+.+  .+++.
T Consensus        16 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~   95 (277)
T cd05577          16 ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA   95 (277)
T ss_pred             CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHH
Confidence            468899999987654322 234567889999999999999999999999999999999999999999997755  69999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++|++||||+|+||+++++. .+.+.|||.+.......   ......+...|.|||...+.  
T Consensus        96 ~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~  171 (277)
T cd05577          96 RAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGK---KIKGRAGTPGYMAPEVLQGEVY  171 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC-CEEEccCcchhhhccCC---ccccccCCCCcCCHHHhcCCCC
Confidence            9999999999999999999999999999999997653 33445999775433211   11233456689999987655  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ |++|++++++  +..||..
T Consensus       172 ~~~~Di-~slG~il~~l~~g~~p~~~  196 (277)
T cd05577         172 DFSVDW-FALGCTLYEMIAGRSPFRQ  196 (277)
T ss_pred             Cchhhh-HHHHHHHHHHhhCCCCCCC
Confidence             57899 9999999999  6788864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.91  E-value=9.1e-25  Score=210.48  Aligned_cols=174  Identities=22%  Similarity=0.285  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----EKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~l~   76 (477)
                      .+|+.||+|.++..... ....+.+.+|+.++++++|||++++++.+...+..+++|||+++++|.+++...    ..++
T Consensus        25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  104 (267)
T cd08224          25 LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP  104 (267)
T ss_pred             CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcC
Confidence            37899999998754433 344678999999999999999999999999999999999999999999998642    3589


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..+..++.|++.||.|||+.|++||||+|+||+++.+. ++...|||.+.......  .......++..|.|||...+.
T Consensus       105 ~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~-~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~  181 (267)
T cd08224         105 ERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCC-cEEEeccceeeeccCCC--cccceecCCccccCHHHhccC
Confidence            999999999999999999999999999999999997643 34455998875432211  112234567789999987655


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|++++++  +..||..
T Consensus       182 ~~~~~~Di-~slG~il~~l~~g~~p~~~  208 (267)
T cd08224         182 GYNFKSDI-WSLGCLLYEMAALQSPFYG  208 (267)
T ss_pred             CCCchhcH-HHHHHHHHHHHHCCCCccc
Confidence               57899 9999999999  6677754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.91  E-value=1.5e-24  Score=211.43  Aligned_cols=174  Identities=20%  Similarity=0.228  Sum_probs=136.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|.++... .....+.+.+|+.+++.++||||+++++++...  ...+++|||+++++|.+++... .+++..
T Consensus        31 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~  108 (283)
T cd05080          31 GTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQ  108 (283)
T ss_pred             CCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHH
Confidence            367889999987553 233456788999999999999999999987653  4689999999999999999774 699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      ++.++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+........ .........+..|+|||...+.  
T Consensus       109 ~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~  187 (283)
T cd05080         109 LLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF  187 (283)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCC-cEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCC
Confidence            999999999999999999999999999999997653 344459998764432111 1111112234458999987654  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ ||+|++++++  +..||..
T Consensus       188 ~~~~Di-~slG~~l~el~tg~~p~~~  212 (283)
T cd05080         188 SYASDV-WSFGVTLYELLTHCDSKQS  212 (283)
T ss_pred             Cccccc-HHHHHHHHHHHhCCCCCCC
Confidence             67899 9999999999  5566653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=1.2e-24  Score=218.17  Aligned_cols=168  Identities=24%  Similarity=0.394  Sum_probs=137.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+++.||||++..........+.+.+|+.++++++||||+++++++...      ...|++++++ +++|.++++. ..+
T Consensus        38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~-~~l  115 (343)
T cd07878          38 RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKC-QKL  115 (343)
T ss_pred             CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhc-CCC
Confidence            4688999999876544444456788999999999999999999987543      3579999998 6899988764 579


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ++..+..++.|++.||.|||++||+||||||+||+++.+ .+++  +|||++......     ..+.+++..|+|||...
T Consensus       116 ~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl--~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~  188 (343)
T cd07878         116 SDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI--LDFGLARQADDE-----MTGYVATRWYRAPEIML  188 (343)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEE--cCCccceecCCC-----cCCccccccccCchHhc
Confidence            999999999999999999999999999999999999764 4444  599998765432     23456788999999876


Q ss_pred             CC----CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.    .++|+ ||+|+++|+|  +..||.+
T Consensus       189 ~~~~~~~~~Di-wslG~il~el~~g~~pf~~  218 (343)
T cd07878         189 NWMHYNQTVDI-WSVGCIMAELLKGKALFPG  218 (343)
T ss_pred             CCccCCchhhh-HhHHHHHHHHHHCCCCCCC
Confidence            53    67899 9999999999  6677764

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.91  E-value=2.1e-24  Score=210.21  Aligned_cols=172  Identities=27%  Similarity=0.384  Sum_probs=139.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .++..+++|.+...  .....+.+.+|+.+++.++||||+++++.+...+..|+++||+++++|..++.+ ...+++..+
T Consensus        28 ~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~  105 (282)
T cd06643          28 ETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQI  105 (282)
T ss_pred             CCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHH
Confidence            46788999988644  344567789999999999999999999999999999999999999999998765 457899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||+.|++||||||+||+++.++ ++..+|||.+.......  .......++..|+|||.....    
T Consensus       106 ~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  182 (282)
T cd06643         106 RVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKD  182 (282)
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC-CEEEccccccccccccc--cccccccccccccCHhhccccCCCC
Confidence            99999999999999999999999999999997643 34456999875432211  112334567789999987421    


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ ||+|++++++  +..||..
T Consensus       183 ~~~~~~~Dv-~slGvil~el~~g~~p~~~  210 (282)
T cd06643         183 RPYDYKADV-WSLGITLIEMAQIEPPHHE  210 (282)
T ss_pred             CCCCccchh-hhHHHHHHHHccCCCCccc
Confidence                46899 9999999999  5577754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.91  E-value=1.9e-25  Score=215.26  Aligned_cols=175  Identities=27%  Similarity=0.446  Sum_probs=139.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      ..+..|+||.++.. ...+..+.+.+|++.+++++||||+++++++...+..++||||+++|+|.+++...  ..+++..
T Consensus        26 ~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~  104 (259)
T PF07714_consen   26 DKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQ  104 (259)
T ss_dssp             SSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHH
T ss_pred             CCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            45788999999543 34455788999999999999999999999999888899999999999999999986  5799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..|+.|++.||.|||+++++|++|+|+||+++.+. .+.+.|||......................|.|||.....   
T Consensus       105 ~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  183 (259)
T PF07714_consen  105 RLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNG-QVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYT  183 (259)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTT-EEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEES
T ss_pred             cccccccccccccccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999999999999999999999998653 4444699988766333333334445566789999987655   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|++++|+   +..||..
T Consensus       184 ~ksDV-ysfG~~l~ei~~~~~~p~~~  208 (259)
T PF07714_consen  184 KKSDV-YSFGMLLYEILTLGKFPFSD  208 (259)
T ss_dssp             HHHHH-HHHHHHHHHHHTTSSGTTTT
T ss_pred             ccccc-cccccccccccccccccccc
Confidence            67899 9999999999   3456553

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.90  E-value=2.4e-24  Score=208.31  Aligned_cols=174  Identities=18%  Similarity=0.242  Sum_probs=135.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-----CCCH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-----KLSE   77 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----~l~~   77 (477)
                      ++..+|+|.++.... ......+.+|+.++++++||||+++++.+.+....++||||+++++|.+++....     ..++
T Consensus        21 ~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~   99 (269)
T cd05087          21 TPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDP   99 (269)
T ss_pred             CceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccH
Confidence            456799998866542 2334578899999999999999999999998889999999999999999997532     3567


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC--
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS--  155 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~--  155 (477)
                      ..+..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+................++..|+|||...+  
T Consensus       100 ~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (269)
T cd05087         100 TTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH  178 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEECCccccccccCcceeecCCCcCCcccccCHhHhcccc
Confidence            78889999999999999999999999999999997642 344569998754332222122223345567999998753  


Q ss_pred             --------CCcccccCcceEEEEEE---eeecccc
Q psy6508         156 --------KTSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       156 --------~~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                              ..++|+ ||+|++++|+   +..||..
T Consensus       179 ~~~~~~~~~~~~Di-wslG~~l~el~~~g~~p~~~  212 (269)
T cd05087         179 GNLLVVDQTKESNV-WSLGVTIWELFELGSQPYRH  212 (269)
T ss_pred             ccccccCCCccchh-HHHHHHHHHHHhCCCCCCCC
Confidence                    257899 9999999986   5667753

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG2345|consensus

Probab=99.90  E-value=3.6e-25  Score=200.40  Aligned_cols=211  Identities=18%  Similarity=0.213  Sum_probs=156.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-----CCeEEEEEecCCCCCHHHHHHhC----C
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-----ERYVYIILEYCDGGDLCSFIRSH----E   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~~----~   73 (477)
                      +++.||+|++....  .+..+..++|+...++++|||+++++++...     ....||+++|+..|+|.+.++..    .
T Consensus        45 ~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~  122 (302)
T KOG2345|consen   45 TGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGN  122 (302)
T ss_pred             cccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCC
Confidence            67889999987654  5667889999999999999999999887543     34599999999999999998753    2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccCcceeecccccceeccc----CCcccc--c-CCeEEEe
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAK----GSAYIE--Q-GNTKVIC  144 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~----gs~~~~--~-g~t~v~~  144 (477)
                      .+++.++..|+.++++||++||+..  +.||||||.||++.+.. .++.+|||.+..+.    |+....  + ......+
T Consensus       123 ~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct  201 (302)
T KOG2345|consen  123 FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSG-LPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCT  201 (302)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCC-ceEEEeccCccccceEeechHHHHHHHHHHHHhCC
Confidence            6999999999999999999999998  99999999999997732 33446999876543    221110  0 1124556


Q ss_pred             ccccccccCCCC------CcccccCcceEEEEEE--eeeccccccccC----------CCCCcchHHHHHHHHHHhhhhh
Q psy6508         145 SVFEPREIPSSK------TSLEYQRSKGELYVEF--KFAPFASQIRTG----------WLRDSEEKELGNHLKRALEPAV  206 (477)
Q Consensus       145 ~~y~ppE~~~~~------~~~Di~~s~G~il~e~--~~~Pf~~~~r~~----------~~~~~~~~~l~~~i~~~l~~~i  206 (477)
                      ..|.|||.+.-+      .++|| ||+||++|+|  +..||.-...++          ..........+..+.+.+..++
T Consensus       202 ~pyRAPELf~vk~~~ti~ertDI-WSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~ml  280 (302)
T KOG2345|consen  202 IPYRAPELFNVKSHCTITERTDI-WSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSML  280 (302)
T ss_pred             CcccCchheecccCcccccccch-hhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHh
Confidence            689999998765      78999 9999999999  668886422110          0111111225556666666666


Q ss_pred             hcccCCCCccc
Q psy6508         207 CRHEFSNFQVD  217 (477)
Q Consensus       207 ~~~~~Pr~~i~  217 (477)
                      ..++..|+.+.
T Consensus       281 qvdP~qRP~i~  291 (302)
T KOG2345|consen  281 QVDPNQRPTIP  291 (302)
T ss_pred             cCCcccCCCHH
Confidence            66666666653

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.90  E-value=4.5e-24  Score=207.38  Aligned_cols=166  Identities=18%  Similarity=0.190  Sum_probs=133.4

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~i   83 (477)
                      ..|++|++....  ......+.+|+.+++.++||||+++++++..+...|+||||+++++|..++.+ .+.+++..+..+
T Consensus        45 ~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i  122 (274)
T cd05076          45 LRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITV  122 (274)
T ss_pred             eeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHH
Confidence            468999886542  23345788999999999999999999999999999999999999999999875 457899999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCc------ceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNT------LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~------~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      +.|++.||+|||++||+||||||+||+++..+      ..+...|||.......      .....++..|+|||...+. 
T Consensus       123 ~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~  196 (274)
T cd05076         123 AQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGN  196 (274)
T ss_pred             HHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCC
Confidence            99999999999999999999999999996432      2345568887643221      1123455679999977542 


Q ss_pred             ---CcccccCcceEEEEEE---eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                         .++|+ |++|+++||+   +..||..
T Consensus       197 ~~~~~~Dv-~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         197 SLSTAADK-WSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             CCCcHHHH-HHHHHHHHHHHhCCCCCccc
Confidence               67899 9999999997   5567653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.90  E-value=5.4e-24  Score=210.62  Aligned_cols=175  Identities=18%  Similarity=0.247  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      .+++.||+|+++.........+.+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++...  ..+++..
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~  102 (314)
T cd08216          23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELA  102 (314)
T ss_pred             CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHH
Confidence            36899999999876555666778999999999999999999999999999999999999999999999763  3589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcc-----cccCCeEEEeccccccccC
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAY-----IEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~-----~~~g~t~v~~~~y~ppE~~  153 (477)
                      +..++.|++.||+|||++||+||||||+||+++. +.+++  .|||.+........     .....+..++..|+|||..
T Consensus       103 ~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl--~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (314)
T cd08216         103 IAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVL--SGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL  180 (314)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEE--ecCccceeeccccccccccccccccccccccccCHHHh
Confidence            9999999999999999999999999999999976 44454  48887653322111     1122334556679999987


Q ss_pred             CCC-----CcccccCcceEEEEEE--eeecccc
Q psy6508         154 SSK-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~~~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+.     .++|+ ||+|++++|+  +..||..
T Consensus       181 ~~~~~~~~~~~Di-ws~G~il~el~~g~~pf~~  212 (314)
T cd08216         181 QQNLQGYNEKSDI-YSVGITACELANGHVPFKD  212 (314)
T ss_pred             cCCCCCCCcchhH-HHHHHHHHHHHhCCCCCCC
Confidence            542     67899 9999999999  6778864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.90  E-value=3.5e-24  Score=207.22  Aligned_cols=172  Identities=19%  Similarity=0.319  Sum_probs=136.1

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhC------C
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSH------E   73 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~------~   73 (477)
                      .||+|.++.........+.+.+|+.+++.++||||+++++.+...      ...+++|||+++++|.+++...      .
T Consensus        28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~  107 (272)
T cd05075          28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ  107 (272)
T ss_pred             eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence            699999887665666678899999999999999999999976432      2578999999999999987421      2


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      .+++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+...........+.....+..|++||..
T Consensus       108 ~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  186 (272)
T cd05075         108 YLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENM-NVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESL  186 (272)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCC-CEEECCCCcccccCcccceecCCcccCCcccCCHHHc
Confidence            488999999999999999999999999999999999997643 3445699988654332222233334455679999988


Q ss_pred             CCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         154 SSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       154 ~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .+.   .++|+ ||+|+++||+   +..||.+
T Consensus       187 ~~~~~~~~~Di-~slG~il~el~~~g~~p~~~  217 (272)
T cd05075         187 ADRVYTTKSDV-WSFGVTMWEIATRGQTPYPG  217 (272)
T ss_pred             cCCCcChHHHH-HHHHHHHHHHHcCCCCCCCC
Confidence            765   67899 9999999998   4567653

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.90  E-value=1.3e-24  Score=217.65  Aligned_cols=174  Identities=22%  Similarity=0.330  Sum_probs=136.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHHhC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD-ERYVYIILEYCDGGDLCSFIRSH--------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~--------   72 (477)
                      +++.||+|+++... .....+.+.+|+.+++++ +||||+++++++.. +..++++|||+++++|.+++...        
T Consensus        36 ~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~  114 (337)
T cd05054          36 SCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYR  114 (337)
T ss_pred             ccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccc
Confidence            46789999987543 334456788999999999 89999999998764 45789999999999999998642        


Q ss_pred             -----------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q psy6508          73 -----------------------------------------------------EKLSEFQCQQFVRQLVLALKFLRENNV   99 (477)
Q Consensus        73 -----------------------------------------------------~~l~~~~~~~i~~qi~~aL~~LH~~gi   99 (477)
                                                                           ..+++..+..++.|++.||.|||++||
T Consensus       115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i  194 (337)
T cd05054         115 NKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKC  194 (337)
T ss_pred             cccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence                                                                 257889999999999999999999999


Q ss_pred             EEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE---e
Q psy6508         100 CHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF---K  173 (477)
Q Consensus       100 vHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~  173 (477)
                      +||||||+||+++.+. .+.++|||.+...........+.+..++..|+|||...+.   .++|+ ||+|++++|+   +
T Consensus       195 vHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~SlGv~l~el~t~g  272 (337)
T cd05054         195 IHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDV-WSFGVLLWEIFSLG  272 (337)
T ss_pred             ecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccH-HHHHHHHHHHHHcC
Confidence            9999999999998643 3444699988654322111122233445679999987665   67899 9999999997   5


Q ss_pred             eecccc
Q psy6508         174 FAPFAS  179 (477)
Q Consensus       174 ~~Pf~~  179 (477)
                      ..||.+
T Consensus       273 ~~p~~~  278 (337)
T cd05054         273 ASPYPG  278 (337)
T ss_pred             CCCCCC
Confidence            577764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.90  E-value=1.5e-24  Score=208.04  Aligned_cols=170  Identities=17%  Similarity=0.253  Sum_probs=137.4

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQCQQ   82 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~~~   82 (477)
                      ..||||.+...... ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++++|.+++.+..  .+++..+..
T Consensus        24 ~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~  101 (257)
T cd05040          24 IPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCD  101 (257)
T ss_pred             eEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHH
Confidence            36999999876544 556789999999999999999999999888 89999999999999999998754  689999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCC-cccccCCeEEEeccccccccCCCC---Cc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGS-AYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs-~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      ++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+...... ..........++..|.|||...+.   .+
T Consensus       102 ~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~  180 (257)
T cd05040         102 YAVQIANGMRYLESKRFIHRDLAARNILLASDD-KVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHA  180 (257)
T ss_pred             HHHHHHHHHHHHHhCCccccccCcccEEEecCC-EEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCch
Confidence            999999999999999999999999999998653 3444599987654321 111112223445679999987654   66


Q ss_pred             ccccCcceEEEEEE---eeeccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      +|+ ||+|+++++|   +..||.
T Consensus       181 ~Di-~slG~~l~el~t~g~~p~~  202 (257)
T cd05040         181 SDV-WMFGVTLWEMFTYGEEPWA  202 (257)
T ss_pred             hhh-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999998   556664

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.90  E-value=9.3e-25  Score=210.53  Aligned_cols=176  Identities=21%  Similarity=0.309  Sum_probs=142.6

Q ss_pred             CCCcEEEEEEcccCCCC----hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVS----ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.+|+|.++.....    ....+.+.+|+.++++++||||+++++++.+.+..++++||++|++|.+++.+.+.+++
T Consensus        22 ~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  101 (265)
T cd06631          22 NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPE  101 (265)
T ss_pred             cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCH
Confidence            46788999998765322    23346789999999999999999999999999999999999999999999988778999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc----ccccCCeEEEeccccccccC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA----YIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~----~~~~g~t~v~~~~y~ppE~~  153 (477)
                      ..+..++.|++.||.|||+.|++|+||+|+||+++++. .+.+.|||.+.......    .........++..|.|||..
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~  180 (265)
T cd06631         102 PVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG-IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI  180 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCC-eEEeccchhhHhhhhccccccccccccccCCCccccChhhh
Confidence            99999999999999999999999999999999997542 34445998875432111    11111234567789999998


Q ss_pred             CCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         154 SSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+.   .++|+ |++|++++++  +..||..
T Consensus       181 ~~~~~~~~~Dv-~slG~~~~~l~~g~~p~~~  210 (265)
T cd06631         181 NESGYGRKSDI-WSIGCTVFEMATGKPPLAS  210 (265)
T ss_pred             cCCCCcchhhH-HHHHHHHHHHHhCCCcccc
Confidence            765   67899 9999999999  6678764

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.90  E-value=1.5e-24  Score=213.69  Aligned_cols=174  Identities=22%  Similarity=0.280  Sum_probs=138.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      ++..||+|.++... .....+.+.+|+.+++++ +||||+++++.+...+..|++|||+++++|.+++....  .+++..
T Consensus        64 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~  142 (302)
T cd05055          64 AVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLED  142 (302)
T ss_pred             ceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHH
Confidence            45579999987553 234456789999999999 79999999999999999999999999999999997643  389999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++|+||||+||+++.+. .+..+|||.+.............+..++..|+|||...+.   
T Consensus       143 ~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  221 (302)
T cd05055         143 LLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGK-IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT  221 (302)
T ss_pred             HHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCC-eEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCC
Confidence            999999999999999999999999999999997653 4445699987543221111111122345679999987655   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++   +..||.+
T Consensus       222 ~~~Di-wslGvil~el~t~g~~p~~~  246 (302)
T cd05055         222 FESDV-WSYGILLWEIFSLGSNPYPG  246 (302)
T ss_pred             cHhHH-HHHHHHHHHHHhCCCCCcCC
Confidence            67899 9999999997   5677754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.90  E-value=7.3e-24  Score=202.52  Aligned_cols=173  Identities=25%  Similarity=0.345  Sum_probs=139.4

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      ++.||+|.+...... ...+.+.+|+.++++++||||+++++++...+..|++|||++|++|.+++.+. ..+++..+..
T Consensus        19 ~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~   97 (251)
T cd05041          19 NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQ   97 (251)
T ss_pred             CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHH
Confidence            789999998765433 45568999999999999999999999999999999999999999999999663 4688999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSL  159 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~  159 (477)
                      ++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.......+...+.....+..|.|||...+.   .++
T Consensus        98 ~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  176 (251)
T cd05041          98 MSLDAAAGMEYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES  176 (251)
T ss_pred             HHHHHHHHHHHHHhCCEehhhcCcceEEEcCCC-cEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcch
Confidence            999999999999999999999999999997643 3344599987654422222222233345569999987655   678


Q ss_pred             cccCcceEEEEEE---eeecccc
Q psy6508         160 EYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       160 Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |+ |++|+++|++   +..||.+
T Consensus       177 Di-~slG~i~~~l~t~~~~p~~~  198 (251)
T cd05041         177 DV-WSYGILLWETFSLGDTPYPG  198 (251)
T ss_pred             hH-HHHHHHHHHHHhccCCCCcc
Confidence            99 9999999997   4566654

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.90  E-value=5.5e-24  Score=209.75  Aligned_cols=172  Identities=20%  Similarity=0.364  Sum_probs=136.3

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      +..||+|.+.... .....+++.+|+.+++.+ +||||+++++.+......|++|||+++++|.+++.+.          
T Consensus        47 ~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  125 (304)
T cd05101          47 AVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD  125 (304)
T ss_pred             ceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence            4579999986542 344557789999999999 8999999999999999999999999999999999763          


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecc
Q psy6508          73 ------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV  146 (477)
Q Consensus        73 ------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~  146 (477)
                            ..++...+..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+................++..
T Consensus       126 ~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~  204 (304)
T cd05101         126 IARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVK  204 (304)
T ss_pred             cccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCC-cEEECCCccceecccccccccccCCCCCce
Confidence                  2467888999999999999999999999999999999997643 344469998865433222122222334567


Q ss_pred             ccccccCCCC---CcccccCcceEEEEEE---eeeccc
Q psy6508         147 FEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       147 y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      |+|||...+.   .++|+ ||+|+++|++   +..||.
T Consensus       205 y~aPE~~~~~~~~~~~Di-~slG~~l~el~~~g~~p~~  241 (304)
T cd05101         205 WMAPEALFDRVYTHQSDV-WSFGVLMWEIFTLGGSPYP  241 (304)
T ss_pred             eeCchhhccCCCCchhhH-HHHHHHHHHHHcCCCCCcc
Confidence            9999987655   67899 9999999998   345554

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.90  E-value=6.4e-25  Score=212.02  Aligned_cols=174  Identities=21%  Similarity=0.273  Sum_probs=139.4

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-------CCCC
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-------EKLS   76 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-------~~l~   76 (477)
                      ++.||||.+.... .......+.+|+.+++.++||||+++++++......+++|||+++++|.+++...       ..++
T Consensus        26 ~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~  104 (269)
T cd05044          26 PIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT  104 (269)
T ss_pred             ceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCcccc
Confidence            3678999886542 2344567899999999999999999999999999999999999999999999752       2378


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc----ceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT----LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~----~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +..+..++.|++.||.|||++|++|+||||+||+++.+.    ..+...|||.+.............+...+..|+|||.
T Consensus       105 ~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (269)
T cd05044         105 LKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPES  184 (269)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHH
Confidence            899999999999999999999999999999999997643    3455669998865443332222223445567999998


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..+.   .++|+ |++|+++|++   +..||..
T Consensus       185 ~~~~~~~~~~Dv-~slG~il~ellt~g~~p~~~  216 (269)
T cd05044         185 LLDGKFTTQSDV-WSFGVLMWEILTLGQQPYPA  216 (269)
T ss_pred             HccCCcccchhH-HHHHHHHHHHHHcCCCCCcc
Confidence            7655   77899 9999999997   5567753

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.90  E-value=4.9e-24  Score=207.66  Aligned_cols=173  Identities=25%  Similarity=0.348  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---~~l~~~   78 (477)
                      .+++.||+|.++.........+.+.+|+.++++++||||+++++++..++..|+||||++ ++|.+++...   ..+++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~  101 (285)
T cd07861          23 KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAE  101 (285)
T ss_pred             CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHH
Confidence            468899999987654444445678899999999999999999999999999999999998 6899888653   468999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++.++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+.......  .......++..|+|||...+.  
T Consensus       102 ~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~  178 (285)
T cd07861         102 LVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKG-VIKLADFGLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPR  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCC-cEEECcccceeecCCCc--ccccCCcccccccChHHhcCCCC
Confidence            9999999999999999999999999999999997643 23445999875432211  112234567789999987543  


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|++++++  +..||.+
T Consensus       179 ~~~~~Dv-~slG~il~~l~tg~~~~~~  204 (285)
T cd07861         179 YSTPVDI-WSIGTIFAEMATKKPLFHG  204 (285)
T ss_pred             cCcHHHH-HHHHHHHHHHHHCCCCCCC
Confidence              56899 9999999999  6677763

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.90  E-value=1.6e-23  Score=203.67  Aligned_cols=175  Identities=19%  Similarity=0.258  Sum_probs=139.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhCC-CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHE-KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~   78 (477)
                      ++++.||+|+++..... ...+.+.+|+.+++.++||||+++++++..  ....+++|||+++++|.+++.... .+++.
T Consensus        31 ~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~  109 (284)
T cd05038          31 NTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLK  109 (284)
T ss_pred             CCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHH
Confidence            35789999998766443 356789999999999999999999999877  567999999999999999997754 58999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCC-cccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGS-AYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs-~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||+|||++|++||||||+||+++.+. .+.+.|||.+...... ..............|.|||...+. 
T Consensus       110 ~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~  188 (284)
T cd05038         110 RLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESED-LVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSK  188 (284)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCC
Confidence            9999999999999999999999999999999997652 4455699988655422 111111122333458999987654 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|++++|+  +..||..
T Consensus       189 ~~~~~Di-~slG~~l~el~tg~~p~~~  214 (284)
T cd05038         189 FSSASDV-WSFGVTLYELFTYGDPSQS  214 (284)
T ss_pred             CCcccch-HHHhhhhheeeccCCCccc
Confidence              67899 9999999999  4566543

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.90  E-value=5.7e-24  Score=212.10  Aligned_cols=175  Identities=18%  Similarity=0.240  Sum_probs=139.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      .+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..|+++||+.+++|.+++...  ..+++..
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~  102 (328)
T cd08226          23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEAL  102 (328)
T ss_pred             CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHH
Confidence            47899999999876656666678999999999999999999999999999999999999999999999864  3589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceeccc--CCc---ccccCCeEEEeccccccccC
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAK--GSA---YIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~--gs~---~~~~g~t~v~~~~y~ppE~~  153 (477)
                      +..++.|++.||.|||++|++||||||+||+++.+ .+++  .+||......  +..   .........++..|+|||..
T Consensus       103 ~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (328)
T cd08226         103 IGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSL--SGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELL  180 (328)
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEE--echHHHhhhhccCccccccccccccccCccCccChhhh
Confidence            99999999999999999999999999999999764 3444  4666432211  111   00111112234569999998


Q ss_pred             CCC-----CcccccCcceEEEEEE--eeecccc
Q psy6508         154 SSK-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~~~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+.     .++|+ |++|++++++  +..||..
T Consensus       181 ~~~~~~~~~~~Di-wslG~~l~el~~g~~p~~~  212 (328)
T cd08226         181 RQDLYGYNVKSDI-YSVGITACELATGRVPFQD  212 (328)
T ss_pred             cCCCCCCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            653     56899 9999999999  6788864

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.90  E-value=1.3e-24  Score=211.64  Aligned_cols=167  Identities=22%  Similarity=0.284  Sum_probs=138.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.+.... .....+.+.+|+.++++++||||+++++.+...+..+++|||+++++|..+    ..+++..+.
T Consensus        24 ~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~   98 (279)
T cd06619          24 LTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLG   98 (279)
T ss_pred             CCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHH
Confidence            468899999986553 344456799999999999999999999999999999999999999999754    357899999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++|+||||+||+++.+. .+.+.|||.+.......    ..+..++..|+|||...+.   .+
T Consensus        99 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~  173 (279)
T cd06619          99 RIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPERISGEQYGIH  173 (279)
T ss_pred             HHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC-CEEEeeCCcceeccccc----ccCCCCChhhcCceeecCCCCCCc
Confidence            9999999999999999999999999999997653 34445999876543221    1234677889999988765   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|+++|++  +..||..
T Consensus       174 ~Dv-wslG~~l~~l~~g~~pf~~  195 (279)
T cd06619         174 SDV-WSLGISFMELALGRFPYPQ  195 (279)
T ss_pred             chH-HHHHHHHHHHHhCCCCchh
Confidence            899 9999999999  6788864

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.90  E-value=1.5e-24  Score=207.95  Aligned_cols=173  Identities=22%  Similarity=0.345  Sum_probs=139.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHHhC--CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-ERYVYIILEYCDGGDLCSFIRSH--EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~   78 (477)
                      .+++.||+|.+..........+.+.+|+.++++++|||++++++.+.. +..+|++|||+++++|.+++...  ..+++.
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~  102 (257)
T cd08223          23 TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPEN  102 (257)
T ss_pred             CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHH
Confidence            357889999997766555566778999999999999999999998764 45689999999999999999763  358999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      ++..++.|++.|+.+||++|++||||||+||+++.+. .+.+.|||.+.......  ....+..+++.|+|||...+.  
T Consensus       103 ~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~-~~~l~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~  179 (257)
T cd08223         103 QVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN-IIKVGDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPY  179 (257)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCC-cEEEecccceEEecccC--CccccccCCcCccChhHhcCCCC
Confidence            9999999999999999999999999999999997643 34445999875442211  112234567789999998766  


Q ss_pred             -CcccccCcceEEEEEE--eeeccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                       .++|+ |++|++++++  +..||.
T Consensus       180 ~~~~Dv-~slG~il~~l~~g~~~~~  203 (257)
T cd08223         180 NYKSDV-WALGCCVYEMATLKHAFN  203 (257)
T ss_pred             Cchhhh-HHHHHHHHHHHcCCCCCC
Confidence             67899 9999999999  556665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.90  E-value=2.8e-24  Score=210.89  Aligned_cols=165  Identities=22%  Similarity=0.274  Sum_probs=132.7

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-----------
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-----------   73 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------   73 (477)
                      ..||+|.++... .....+.+.+|++++++++|||++++++++...+..++||||+++++|.+++....           
T Consensus        45 ~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  123 (295)
T cd05097          45 VLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI  123 (295)
T ss_pred             eEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccC
Confidence            358999987543 34455679999999999999999999999999999999999999999999986532           


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                       .+++..+..++.|++.||.|||++|++||||||+||+++++. .+.++|||.+................++..|+|||.
T Consensus       124 ~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  202 (295)
T cd05097         124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWES  202 (295)
T ss_pred             CcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhh
Confidence             367888999999999999999999999999999999997653 344559998764332222222222334567999998


Q ss_pred             CCCC---CcccccCcceEEEEEE
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF  172 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~  172 (477)
                      ..+.   .++|+ ||+|++++++
T Consensus       203 ~~~~~~~~~~Dv-wSlG~~l~el  224 (295)
T cd05097         203 ILLGKFTTASDV-WAFGVTLWEM  224 (295)
T ss_pred             hccCCcCchhhH-HHHHHHHHHH
Confidence            7654   77899 9999999998

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.90  E-value=4.6e-24  Score=210.89  Aligned_cols=170  Identities=23%  Similarity=0.269  Sum_probs=141.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.++... .....+++.+|+.++++++||||+++++++..++.+|++|||++|++|.+++++.+.+++..+.
T Consensus        24 ~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~  102 (308)
T cd06615          24 PSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILG  102 (308)
T ss_pred             CCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHH
Confidence            467889999986543 3444567889999999999999999999999999999999999999999999888889999999


Q ss_pred             HHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||+ .|++||||||+||+++++. .+.+.|||.+......    ...+..++..|.|||...+.   .
T Consensus       103 ~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  177 (308)
T cd06615         103 KISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTV  177 (308)
T ss_pred             HHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccccc----ccccCCCCcCccChhHhcCCCCCc
Confidence            999999999999998 5999999999999997653 2444599987543221    12344567789999987655   6


Q ss_pred             cccccCcceEEEEEE--eeeccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++|+ |++|++++++  +..||.
T Consensus       178 ~~Di-wslG~~l~~l~~g~~p~~  199 (308)
T cd06615         178 QSDI-WSLGLSLVEMAIGRYPIP  199 (308)
T ss_pred             cchH-HHHHHHHHHHHhCCCCCC
Confidence            7899 9999999999  556765

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.90  E-value=8.2e-24  Score=204.04  Aligned_cols=176  Identities=24%  Similarity=0.299  Sum_probs=140.6

Q ss_pred             CCCcEEEEEEcccCCCC---hhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVS---ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      ++|+.||||.+......   ....+.+.+|+.++++++||||+++++++.+.  ..++++|||++|++|.+++.+.+.++
T Consensus        25 ~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~  104 (265)
T cd06652          25 DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALT  104 (265)
T ss_pred             CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCC
Confidence            46889999988654322   23456788999999999999999999988763  57899999999999999998877889


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-ccCCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-EQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..+..++.|++.||.|||++|++|+||||+||+++++. .+.+.|||.+......... .......++..|+|||...+
T Consensus       105 ~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (265)
T cd06652         105 ENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVG-NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG  183 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCC-CEEECcCccccccccccccccccccCCCCccccChhhhcC
Confidence            999999999999999999999999999999999998643 3445699987654322111 11123446678999998765


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ |++|+++|++  +..||..
T Consensus       184 ~~~~~~~Dv-~slG~il~el~~g~~p~~~  211 (265)
T cd06652         184 EGYGRKADI-WSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             CCCCcchhH-HHHHHHHHHHhhCCCCCCc
Confidence            5   67899 9999999999  6677753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.90  E-value=9.4e-25  Score=214.55  Aligned_cols=171  Identities=24%  Similarity=0.348  Sum_probs=140.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.+......  ..+.+.+|+.+++.++||||+++++.+..+...|+||||++|++|.+++.+ ..+++..+.
T Consensus        43 ~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~  119 (296)
T cd06654          43 ATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIA  119 (296)
T ss_pred             CCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHH
Confidence            46889999998765433  346688999999999999999999999999999999999999999999875 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+.......  .......++..|+|||...+.   .+
T Consensus       120 ~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  196 (296)
T cd06654         120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPK  196 (296)
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEECccccchhccccc--cccCcccCCccccCHHHHcCCCCCcc
Confidence            9999999999999999999999999999997653 34445999875432211  111234567789999987665   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|+++|++  +..||..
T Consensus       197 ~Dv-~s~Gvil~~l~~g~~pf~~  218 (296)
T cd06654         197 VDI-WSLGIMAIEMIEGEPPYLN  218 (296)
T ss_pred             chH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999999  7788864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.90  E-value=1.7e-24  Score=208.23  Aligned_cols=172  Identities=21%  Similarity=0.319  Sum_probs=137.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      ++++.||+|.+.....   ..+.+.+|+.+++.++||||+++++.+...+..+++|||+++++|.+++.+.  ..+++..
T Consensus        28 ~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  104 (261)
T cd05072          28 NNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPK  104 (261)
T ss_pred             cCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHH
Confidence            3567799998765432   3467899999999999999999999999999999999999999999999753  4688899


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||||+||+++++. .+.+.|||.+......... ......++..|+|||...+.   
T Consensus       105 ~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  182 (261)
T cd05072         105 LIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESL-MCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFT  182 (261)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCC-cEEECCCccceecCCCcee-ccCCCccceecCCHHHhccCCCC
Confidence            999999999999999999999999999999998753 3445699988654432211 11122344569999987655   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++   +..||..
T Consensus       183 ~~~Di-~slG~~l~~l~t~g~~p~~~  207 (261)
T cd05072         183 IKSDV-WSFGILLYEIVTYGKIPYPG  207 (261)
T ss_pred             hhhhh-hhhHHHHHHHHccCCCCCCC
Confidence            57899 9999999998   4467653

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.90  E-value=3.1e-24  Score=216.40  Aligned_cols=170  Identities=23%  Similarity=0.369  Sum_probs=138.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+++.||||++..........+.+.+|+.+++.++||||+++++++...      ...|++|||++ ++|.+.+..  .+
T Consensus        40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~l  116 (355)
T cd07874          40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--EL  116 (355)
T ss_pred             CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh--cC
Confidence            3688999999977655555567788999999999999999999988643      35799999997 678887764  58


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||++.....+.   ...+..++..|+|||...+
T Consensus       117 ~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~  192 (355)
T cd07874         117 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG  192 (355)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCC-CEEEeeCcccccCCCcc---ccCCccccCCccCHHHHcC
Confidence            8999999999999999999999999999999999997643 34445999986543322   1234567889999999876


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ ||+|+++|+|  +..||.+
T Consensus       193 ~~~~~~~Di-wslG~il~el~~g~~pf~~  220 (355)
T cd07874         193 MGYKENVDI-WSVGCIMGEMVRHKILFPG  220 (355)
T ss_pred             CCCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            5   67899 9999999999  6677764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.90  E-value=6.1e-24  Score=205.04  Aligned_cols=173  Identities=24%  Similarity=0.296  Sum_probs=137.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +...||+|.++... .......+.+|+.++++++||||+++++.+...+..+++|||+++++|.+++... +.+++..+.
T Consensus        31 ~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~  109 (266)
T cd05033          31 KEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV  109 (266)
T ss_pred             CcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHH
Confidence            34679999986543 3444567899999999999999999999999999999999999999999999764 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++||+||||||+||+++++. .+.+.|||.+....+............+..|+|||...+.   .+
T Consensus       110 ~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~  188 (266)
T cd05033         110 GMLRGIASGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSA  188 (266)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-CEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccc
Confidence            9999999999999999999999999999998653 2344599988765421110001111223569999988765   67


Q ss_pred             ccccCcceEEEEEE---eeeccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      +|+ |++|+++|++   +..||.
T Consensus       189 ~Dv-~slG~~l~~l~~~g~~p~~  210 (266)
T cd05033         189 SDV-WSFGIVMWEVMSYGERPYW  210 (266)
T ss_pred             cch-HHHHHHHHHHHccCCCCCC
Confidence            899 9999999996   556664

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.90  E-value=1.5e-24  Score=210.18  Aligned_cols=171  Identities=28%  Similarity=0.365  Sum_probs=137.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      +.+.|++|.+.... .....+.+.+|+.++++++||||+++++++......|++|||+++++|.+++....         
T Consensus        34 ~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~  112 (275)
T cd05046          34 GETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP  112 (275)
T ss_pred             CcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhccccccccccc
Confidence            45679999876543 23345779999999999999999999999999899999999999999999998755         


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      .+++..+..++.|++.||+|||++|++||||||+||+++.+ .+++  .+||.+.......+. ......++..|+|||.
T Consensus       113 ~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l--~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~  189 (275)
T cd05046         113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKV--SLLSLSKDVYNSEYY-KLRNALIPLRWLAPEA  189 (275)
T ss_pred             CCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEE--cccccccccCccccc-ccCCceeEEeecChhh
Confidence            68999999999999999999999999999999999999764 4444  477776543332221 2233456667999998


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeeccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      ..+.   .++|+ ||+|+++|++   +..||.
T Consensus       190 ~~~~~~~~~~Di-~slG~~l~~l~~~~~~p~~  220 (275)
T cd05046         190 VQEDDFSTKSDV-WSFGVLMWEVFTQGELPFY  220 (275)
T ss_pred             hccCCCCchhhH-HHHHHHHHHHHhCCCCCcc
Confidence            7654   67899 9999999987   345664

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.90  E-value=4.6e-24  Score=210.83  Aligned_cols=172  Identities=23%  Similarity=0.358  Sum_probs=137.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+++.||+|.++..... .....+.+|+.++++++||||+++++++..++..|+||||++ ++|.+++...+ .+++..+
T Consensus        29 ~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  106 (309)
T cd07872          29 LTENLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNV  106 (309)
T ss_pred             CCCCeEEEEEeeccccC-CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHH
Confidence            36788999998765422 223457789999999999999999999999999999999998 68988887643 5889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.......  .......++..|+|||...+.    
T Consensus       107 ~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  183 (309)
T cd07872         107 KIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYS  183 (309)
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEECccccceecCCCc--cccccccccccccCCHHHhCCCCCC
Confidence            99999999999999999999999999999997642 33445999875432211  112234667889999987543    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|++++++  +..||.+
T Consensus       184 ~~~Di-wslG~il~el~tg~~pf~~  207 (309)
T cd07872         184 TQIDM-WGVGCIFFEMASGRPLFPG  207 (309)
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6677764

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.90  E-value=9.6e-24  Score=209.11  Aligned_cols=173  Identities=21%  Similarity=0.367  Sum_probs=136.8

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      +..||+|.++... .......+.+|+.+++++ +||||+++++++..++..|++|||+++++|.+++...          
T Consensus        44 ~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~  122 (314)
T cd05099          44 TVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD  122 (314)
T ss_pred             ceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCccccccc
Confidence            4579999987543 344456789999999999 6999999999999999999999999999999999753          


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecc
Q psy6508          73 ------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV  146 (477)
Q Consensus        73 ------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~  146 (477)
                            ..+++..+..++.|++.||.|||++|++||||||+||+++.+. ++.+.|||.+................++..
T Consensus       123 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~  201 (314)
T cd05099         123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVK  201 (314)
T ss_pred             ccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCC-cEEEccccccccccccccccccccCCCCcc
Confidence                  2478899999999999999999999999999999999997643 344459998875543322221112223356


Q ss_pred             ccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         147 FEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |+|||...+.   .++|+ |++|+++|++   +..||..
T Consensus       202 y~aPE~~~~~~~~~~~Di-wslG~~l~el~~~g~~p~~~  239 (314)
T cd05099         202 WMAPEALFDRVYTHQSDV-WSFGILMWEIFTLGGSPYPG  239 (314)
T ss_pred             ccCHHHHccCCcCccchh-hHHHHHHHHHHhCCCCCCCC
Confidence            9999987655   67899 9999999997   4566653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0984|consensus

Probab=99.90  E-value=4.2e-24  Score=188.53  Aligned_cols=170  Identities=24%  Similarity=0.290  Sum_probs=140.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHH----hCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIR----SHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~----~~~~l~   76 (477)
                      .+|...|+|.+...- +.+..++..+|+.+..+- .+|++|.+||....+..+||.||.+. .||..+.+    +.+.+|
T Consensus        69 ~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ip  146 (282)
T KOG0984|consen   69 QSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIP  146 (282)
T ss_pred             cCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCc
Confidence            478899999997664 445567788899886655 79999999999999999999999997 88887654    456899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCe-EEEeccccccccCC
Q psy6508          77 EFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNT-KVICSVFEPREIPS  154 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t-~v~~~~y~ppE~~~  154 (477)
                      +..+-+|+..++.||.|||++ .++|||+||+|||++.++ ++..||||++.....|--    .| ..||..|+|||...
T Consensus       147 E~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIsG~L~dSiA----kt~daGCkpYmaPEri~  221 (282)
T KOG0984|consen  147 EDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGISGYLVDSIA----KTMDAGCKPYMAPERIN  221 (282)
T ss_pred             hHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccceeehhhhH----HHHhcCCCccCChhhcC
Confidence            999999999999999999987 899999999999998754 444569999876555432    23 57899999999887


Q ss_pred             CC-------CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK-------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~-------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..       .++|+ ||+|+.++|+  +..||..
T Consensus       222 ~e~n~~gY~vksDv-WSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  222 PELNQKGYSVKSDV-WSLGITMIEMAILRFPYES  254 (282)
T ss_pred             cccCcccceeehhh-hhhhhhhhhhhhccccccc
Confidence            65       57899 9999999999  5677764

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.90  E-value=9.3e-24  Score=203.06  Aligned_cols=173  Identities=19%  Similarity=0.298  Sum_probs=133.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~   81 (477)
                      .+..||+|++.... .....+.+.+|+.++++++||||+++++++. ....++||||+++++|.+++.. ...+++..+.
T Consensus        21 ~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~   98 (257)
T cd05115          21 KQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVV   98 (257)
T ss_pred             CceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHH
Confidence            35579999986553 3444567999999999999999999999875 4578999999999999999975 3468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCC-cccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGS-AYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs-~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+...... ...........+..|+|||.....   .
T Consensus        99 ~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  177 (257)
T cd05115          99 ELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSS  177 (257)
T ss_pred             HHHHHHHHHHHHHHhcCeeecccchheEEEcCCC-cEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCc
Confidence            9999999999999999999999999999997653 3334599987533211 111111111223579999987654   5


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++   +..||..
T Consensus       178 ~~Di-~slG~~l~el~~~g~~p~~~  201 (257)
T cd05115         178 RSDV-WSYGITMWEAFSYGQKPYKK  201 (257)
T ss_pred             hhhH-HHHHHHHHHHhcCCCCCcCc
Confidence            7899 9999999996   4567753

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=4.7e-24  Score=211.35  Aligned_cols=176  Identities=23%  Similarity=0.399  Sum_probs=142.8

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~   78 (477)
                      .+++.||+|.+....... ...+.+.+|+.+++.++||||+++++.+......|++|||+.|++|.+++...  ..+++.
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~  103 (316)
T cd05574          24 GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEE  103 (316)
T ss_pred             CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHH
Confidence            368899999998765443 35567899999999999999999999999999999999999999999999764  468999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-----------------------
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-----------------------  135 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-----------------------  135 (477)
                      .++.++.|++.||.|||+.|++||||||+||+++.++ ++.+.|||.+.........                       
T Consensus       104 ~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (316)
T cd05574         104 VARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESG-HIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFS  182 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCC-CEEEeecchhhcccccccccccccccccccccccccchhhhc
Confidence            9999999999999999999999999999999998653 3444588876543211100                       


Q ss_pred             ----ccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         136 ----EQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       136 ----~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          ...+..+++..|+|||...+.   .++|+ ||+|+++|++  +..||.+
T Consensus       183 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di-~slG~ll~~l~~g~~pf~~  234 (316)
T cd05574         183 EEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDW-WTLGILLYEMLYGTTPFKG  234 (316)
T ss_pred             ccccCCCCCCcCccCCcCHHHHcCCCCCchHHH-HHHHHHHHHHhhCCCCCCC
Confidence                011234567789999988765   67899 9999999999  6778764

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.90  E-value=1.9e-24  Score=211.07  Aligned_cols=171  Identities=25%  Similarity=0.335  Sum_probs=132.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc---CCCCccceEEEEEe-----CCeEEEEEecCCCCCHHHHHHhCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL---HHQHIVTMLDFLWD-----ERYVYIILEYCDGGDLCSFIRSHE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~~~   73 (477)
                      ++|+.||+|.++...........+.+|+.+++.+   +||||+++++++..     ...++++|||++ ++|.+++....
T Consensus        23 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~  101 (288)
T cd07863          23 HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVP  101 (288)
T ss_pred             CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcC
Confidence            4788999999876543333334466788777766   69999999998764     346899999998 69999987643


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccc
Q psy6508          74 --KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        74 --~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE  151 (477)
                        .+++..++.++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.......   ......++..|+|||
T Consensus       102 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~-~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE  177 (288)
T cd07863         102 PPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-QVKLADFGLARIYSCQM---ALTPVVVTLWYRAPE  177 (288)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccCccccccCcc---cCCCccccccccCch
Confidence              489999999999999999999999999999999999997643 23445999875433211   112345678899999


Q ss_pred             cCCCC---CcccccCcceEEEEEE--eeeccc
Q psy6508         152 IPSSK---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       152 ~~~~~---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ...+.   .++|+ ||+|+++|++  +.+||.
T Consensus       178 ~~~~~~~~~~~Di-wslG~~l~~l~~g~~~f~  208 (288)
T cd07863         178 VLLQSTYATPVDM-WSVGCIFAEMFRRKPLFC  208 (288)
T ss_pred             HhhCCCCCCcchh-hhHHHHHHHHHhCCcCcC
Confidence            88655   77899 9999999998  556664

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.90  E-value=3.7e-24  Score=216.64  Aligned_cols=170  Identities=24%  Similarity=0.359  Sum_probs=138.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+++.||||++............+.+|+.+++.++||||+++++++...      ..+|+||||++ ++|.+++..  .+
T Consensus        47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~  123 (364)
T cd07875          47 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--EL  123 (364)
T ss_pred             CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh--cC
Confidence            4678899999987655555567788999999999999999999987543      35799999997 688888764  58


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.....+.   ...+..++..|+|||...+
T Consensus       124 ~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~  199 (364)
T cd07875         124 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG  199 (364)
T ss_pred             CHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCC-cEEEEeCCCccccCCCC---cccCCcccCCcCCHHHHhC
Confidence            8999999999999999999999999999999999997653 34445999986543322   1234567889999999876


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ ||+|+++|+|  +..||.+
T Consensus       200 ~~~~~~~Di-wSlG~il~ell~g~~pf~~  227 (364)
T cd07875         200 MGYKENVDI-WSVGCIMGEMIKGGVLFPG  227 (364)
T ss_pred             CCCCchhhH-HhHHHHHHHHHhCCCCCCC
Confidence            5   67899 9999999999  6677764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.3e-23  Score=202.72  Aligned_cols=176  Identities=23%  Similarity=0.321  Sum_probs=141.1

Q ss_pred             CCCcEEEEEEcccCCC---ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKV---SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+++.||+|.+.....   .......+.+|+.++++++||||+++++++.+.  +.+++++||+++++|.+++...+.++
T Consensus        25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~  104 (264)
T cd06653          25 DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALT  104 (264)
T ss_pred             CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCC
Confidence            4688999998764321   234456789999999999999999999998754  56899999999999999998877899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccC-CeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQG-NTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g-~t~v~~~~y~ppE~~~~  155 (477)
                      +..+..++.|++.||.|||++|++|+||||+||+++.+. .+...|||.+...........+ ....++..|.|||...+
T Consensus       105 ~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (264)
T cd06653         105 ENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG  183 (264)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECccccccccccccccCccccccCCcccccCHhhhcC
Confidence            999999999999999999999999999999999997653 3445699988754432111111 12346678999998876


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ |++|++++++  +..||..
T Consensus       184 ~~~~~~~Di-~slG~il~~l~~g~~p~~~  211 (264)
T cd06653         184 EGYGRKADV-WSVACTVVEMLTEKPPWAE  211 (264)
T ss_pred             CCCCccccH-HHHHHHHHHHHhCCCCCCc
Confidence            5   67899 9999999999  6688864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.90  E-value=3.3e-23  Score=202.05  Aligned_cols=169  Identities=18%  Similarity=0.264  Sum_probs=134.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCC-CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHE-KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~-~l~~~   78 (477)
                      .+++.||+|.++... .....+.+.+|+.+++.++||||+++++++...  ...+++|||++|++|.+++.+.. .+++.
T Consensus        31 ~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~  109 (284)
T cd05079          31 NTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLK  109 (284)
T ss_pred             CccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHH
Confidence            367889999986543 344456799999999999999999999998765  57899999999999999997643 58999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc-ccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||+|||++|++||||||+||+++.+. .+.+.|||.+....... ......+..++..|+|||...+. 
T Consensus       110 ~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~  188 (284)
T cd05079         110 QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSK  188 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCC-CEEECCCccccccccCccceeecCCCCCCccccCHHHhccCC
Confidence            9999999999999999999999999999999997653 34556999876443211 11111223344569999987654 


Q ss_pred             --CcccccCcceEEEEEEe
Q psy6508         157 --TSLEYQRSKGELYVEFK  173 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~~  173 (477)
                        .++|+ ||+|+++|++.
T Consensus       189 ~~~~~Di-~slG~il~ell  206 (284)
T cd05079         189 FYIASDV-WSFGVTLYELL  206 (284)
T ss_pred             CCccccc-hhhhhhhhhhh
Confidence              67899 99999999994

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.90  E-value=2.4e-24  Score=207.01  Aligned_cols=169  Identities=22%  Similarity=0.349  Sum_probs=135.3

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      +..||+|.+......   .+.+.+|+.++++++||||+++++++......|++|||+++++|.+++... ..+++..+..
T Consensus        28 ~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~  104 (256)
T cd05113          28 QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLE  104 (256)
T ss_pred             CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHH
Confidence            456999998755432   356889999999999999999999999888999999999999999999764 3689999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSL  159 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~  159 (477)
                      ++.|++.||.|||++|++|+||||+||+++.+. ++.++|||............ .....++..|+|||...+.   .++
T Consensus       105 ~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~  182 (256)
T cd05113         105 MCKDVCEGMAYLESKQFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDEYTS-SVGSKFPVRWSPPEVLLYSKFSSKS  182 (256)
T ss_pred             HHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-CEEECCCccceecCCCceee-cCCCccChhhCCHHHHhcCcccchh
Confidence            999999999999999999999999999997643 44556999876443222211 1112234569999988654   678


Q ss_pred             cccCcceEEEEEE---eeeccc
Q psy6508         160 EYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       160 Di~~s~G~il~e~---~~~Pf~  178 (477)
                      |+ ||+|+++|++   +..||.
T Consensus       183 Di-~slG~~l~~l~~~g~~p~~  203 (256)
T cd05113         183 DV-WAFGVLMWEVYSLGKMPYE  203 (256)
T ss_pred             HH-HHHHHHHHHHhcCCCCCcC
Confidence            99 9999999998   446665

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.90  E-value=2.9e-24  Score=206.46  Aligned_cols=173  Identities=24%  Similarity=0.329  Sum_probs=145.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.|++|++...... ...+.+.+|+..+++++||||+++++++...+..+++|||+++++|.+++.....+++..+.
T Consensus        24 ~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~  102 (264)
T cd06623          24 PTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLA  102 (264)
T ss_pred             CCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHH
Confidence            36899999998766432 45678999999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHh-CCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.|+.|||+ +|++||||+|+||+++.+ .+++  .|||.+........  ...+..++..|.|||.....   
T Consensus       103 ~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l--~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~  178 (264)
T cd06623         103 YIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKI--ADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYS  178 (264)
T ss_pred             HHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEE--ccCccceecccCCC--cccceeecccccCHhhhCCCCCC
Confidence            999999999999999 999999999999999764 4444  58988765432211  11345677889999987766   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ |++|+++|++  +..||...
T Consensus       179 ~~~Dv-~slG~il~~l~tg~~p~~~~  203 (264)
T cd06623         179 YAADI-WSLGLTLLECALGKFPFLPP  203 (264)
T ss_pred             chhhH-HHHHHHHHHHHhCCCCCccc
Confidence            57899 9999999999  66787654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.90  E-value=2.9e-24  Score=206.11  Aligned_cols=171  Identities=22%  Similarity=0.336  Sum_probs=136.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      ++..+|+|.+......   .+.+.+|+.++++++||||+++++++...+..+++|||++|++|.+++... +.+++..+.
T Consensus        27 ~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~  103 (256)
T cd05114          27 AQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL  103 (256)
T ss_pred             cCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHH
Confidence            4567999988654333   356889999999999999999999999999999999999999999999753 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+...|||.+.......... .....++..|+|||...+.   .+
T Consensus       104 ~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~  181 (256)
T cd05114         104 SMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLDDEYTS-SSGAKFPVKWSPPEVFNFSKYSSK  181 (256)
T ss_pred             HHHHHHHHHHHHHHHCCccccccCcceEEEcCCC-eEEECCCCCccccCCCceec-cCCCCCchhhCChhhcccCccchh
Confidence            9999999999999999999999999999997653 34556999876433221111 1111233469999988654   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|+++|++   +..||..
T Consensus       182 ~Di-~s~G~~l~el~~~g~~p~~~  204 (256)
T cd05114         182 SDV-WSFGVLMWEVFTEGKMPFEK  204 (256)
T ss_pred             hhh-HHHHHHHHHHHcCCCCCCCC
Confidence            899 9999999998   4467653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.90  E-value=4e-24  Score=208.25  Aligned_cols=174  Identities=21%  Similarity=0.326  Sum_probs=141.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|++..........+.+.+|+.++++++|||++++++++......+++|||+++++|..++.....+++..+.
T Consensus        24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~  103 (286)
T cd07847          24 ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK  103 (286)
T ss_pred             CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHH
Confidence            36889999998765433334456889999999999999999999999999999999999998888887776679999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||.|||++|++||||||+||+++.++ .+.+.|||.+....+...  ......++..|+|||...+.    .
T Consensus       104 ~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  180 (286)
T cd07847         104 KIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG-QIKLCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGP  180 (286)
T ss_pred             HHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC-cEEECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCc
Confidence            9999999999999999999999999999998653 344569998865443221  11233456789999987543    5


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|++++++  +..||.+
T Consensus       181 ~~Di-~slG~i~~~l~~g~~p~~~  203 (286)
T cd07847         181 PVDV-WAIGCVFAELLTGQPLWPG  203 (286)
T ss_pred             hhhh-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6677763

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.90  E-value=8.9e-24  Score=206.61  Aligned_cols=174  Identities=20%  Similarity=0.282  Sum_probs=137.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      .+..||+|.++... .......+.+|+.+++.++||||+++++++...+..|++|||+++|+|.+++.+.+         
T Consensus        35 ~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  113 (288)
T cd05061          35 AETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR  113 (288)
T ss_pred             cceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCC
Confidence            35589999986543 23334568899999999999999999999998899999999999999999997532         


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                       ..+...+..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+...........+....++..|+|||.
T Consensus       114 ~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~-~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~  192 (288)
T cd05061         114 PPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (288)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCC-cEEECcCCccccccccccccccCCCcccccccCHHH
Confidence             345678899999999999999999999999999999998643 445569998765433332233333444567999998


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++||+   +..||.+
T Consensus       193 ~~~~~~~~~~Dv-wslG~~l~el~~~~~~p~~~  224 (288)
T cd05061         193 LKDGVFTTSSDM-WSFGVVLWEITSLAEQPYQG  224 (288)
T ss_pred             hccCCCChHhHH-HHHHHHHHHHHhCCCCCCCC
Confidence            7654   67899 9999999998   3456653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG0986|consensus

Probab=99.90  E-value=4.2e-25  Score=214.70  Aligned_cols=172  Identities=22%  Similarity=0.328  Sum_probs=148.6

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~   78 (477)
                      .||+.||+|.+.++.+.. .......+|..+|++++.|+||.+--+|++.+.+|+|+..|+||+|.-.|.+.+  .+++.
T Consensus       208 aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~  287 (591)
T KOG0986|consen  208 ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQ  287 (591)
T ss_pred             cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchH
Confidence            578999999988776532 234457899999999999999999889999999999999999999999887765  79999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .++.++.+|+.||++||+.+||+||+||+|||+|+ +.+|+.  |+|++....+....   ...+||..|||||++... 
T Consensus       288 ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRIS--DLGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~  362 (591)
T KOG0986|consen  288 RARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRIS--DLGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEV  362 (591)
T ss_pred             HHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEee--ccceEEecCCCCcc---ccccCcccccCHHHHcCCc
Confidence            99999999999999999999999999999999986 677877  99998754432221   234899999999999877 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .+.|+ |++||++|||  |..||..
T Consensus       363 Y~~s~Dw-f~lGCllYemi~G~sPFr~  388 (591)
T KOG0986|consen  363 YDFSPDW-FSLGCLLYEMIAGHSPFRQ  388 (591)
T ss_pred             ccCCccH-HHHHhHHHHHHcccCchhh
Confidence              78899 9999999999  8899975

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=6.9e-24  Score=219.74  Aligned_cols=160  Identities=21%  Similarity=0.239  Sum_probs=131.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++++.||||....        ..+.+|+.+|++++||||+++++++..++..+++||++. ++|.+++... ..+++..+
T Consensus       192 ~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~l~~~~~  262 (461)
T PHA03211        192 DYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLRPLGLAQV  262 (461)
T ss_pred             CCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCCCCCHHHH
Confidence            3577899996321        235689999999999999999999999999999999996 7999988764 46999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.|+.|++.||.|||++||+||||||+|||++.+. .+.++|||++....+...........++..|++||+..+.   .
T Consensus       263 ~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~  341 (461)
T PHA03211        263 TAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTP  341 (461)
T ss_pred             HHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCC-CEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCc
Confidence            99999999999999999999999999999997642 3344599998765443222222234578899999998766   6


Q ss_pred             cccccCcceEEEEEE
Q psy6508         158 SLEYQRSKGELYVEF  172 (477)
Q Consensus       158 ~~Di~~s~G~il~e~  172 (477)
                      ++|+ ||+|+++||+
T Consensus       342 ~sDv-wSlGviL~El  355 (461)
T PHA03211        342 SVDI-WSAGLVIFEA  355 (461)
T ss_pred             hHHH-HHHHHHHHHH
Confidence            7899 9999999998

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.90  E-value=2.7e-24  Score=211.17  Aligned_cols=173  Identities=24%  Similarity=0.303  Sum_probs=135.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      ++..||+|++.... .....+.+.+|+.+++.++||||+++++++...+..|++|||+++++|.+++....         
T Consensus        45 ~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  123 (296)
T cd05095          45 QPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKAD  123 (296)
T ss_pred             ceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccc
Confidence            34579999986543 34445679999999999999999999999999999999999999999999997642         


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccc
Q psy6508          74 --KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        74 --~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE  151 (477)
                        .+++..+..++.|++.||.|||++|++||||||+||+++.+. ++.+.|||.+.............+...+..|++||
T Consensus       124 ~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         124 VVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence              366778999999999999999999999999999999997643 44556999876543322222222233345689999


Q ss_pred             cCCCC---CcccccCcceEEEEEE----eeeccc
Q psy6508         152 IPSSK---TSLEYQRSKGELYVEF----KFAPFA  178 (477)
Q Consensus       152 ~~~~~---~~~Di~~s~G~il~e~----~~~Pf~  178 (477)
                      ...+.   .++|+ ||+|+++||+    +..||.
T Consensus       203 ~~~~~~~~~~~Di-wSlG~~l~el~~~~~~~p~~  235 (296)
T cd05095         203 SILLGKFTTASDV-WAFGVTLWEILTLCKEQPYS  235 (296)
T ss_pred             HHhcCCccchhhh-hHHHHHHHHHHHhCCCCCcc
Confidence            75544   67899 9999999998    335664

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.90  E-value=9.2e-25  Score=214.22  Aligned_cols=171  Identities=21%  Similarity=0.371  Sum_probs=141.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||||.+....  ....+.+.+|+.+++.++||||+++++.+...+..|++|||+++++|.+++.. +.+++..+.
T Consensus        45 ~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~  121 (292)
T cd06658          45 HTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIA  121 (292)
T ss_pred             CCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhc-CCCCHHHHH
Confidence            468899999986542  33456789999999999999999999999999999999999999999998865 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. ++.+.|||.+......  .....+..++..|+|||...+.   .+
T Consensus       122 ~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  198 (292)
T cd06658         122 TVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKE--VPKRKSLVGTPYWMAPEVISRLPYGTE  198 (292)
T ss_pred             HHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC-CEEEccCcchhhcccc--cccCceeecCccccCHHHHccCCCCch
Confidence            9999999999999999999999999999997642 3445599987543321  1223456678889999987654   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ ||+|+++||+  +..||..
T Consensus       199 ~Dv-~slGvil~el~~g~~p~~~  220 (292)
T cd06658         199 VDI-WSLGIMVIEMIDGEPPYFN  220 (292)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999999  6677764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.90  E-value=1.9e-24  Score=211.45  Aligned_cols=173  Identities=23%  Similarity=0.307  Sum_probs=135.5

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-----------
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-----------   72 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-----------   72 (477)
                      .+.+++|.+.... .....+++.+|+.+++.++||||+++++.+..++..++++||+.+++|.+++...           
T Consensus        30 ~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  108 (290)
T cd05045          30 YTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSD  108 (290)
T ss_pred             ceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccc
Confidence            3568899886543 3344567999999999999999999999999999999999999999999998642           


Q ss_pred             -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCC
Q psy6508          73 -------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGN  139 (477)
Q Consensus        73 -------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~  139 (477)
                                   ..+++..+..++.|++.||.|||++|++||||||+||+++++. .+.++|||.+.............
T Consensus       109 ~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~  187 (290)
T cd05045         109 GNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRS  187 (290)
T ss_pred             cccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCC-cEEeccccccccccCccchhccc
Confidence                         2477889999999999999999999999999999999997653 34446999876433222111122


Q ss_pred             eEEEeccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         140 TKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       140 t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ...++..|+|||...+.   .++|+ ||+|++++++   +..||.+
T Consensus       188 ~~~~~~~y~apE~~~~~~~~~~~Di-~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         188 KGRIPVKWMAIESLFDHIYTTQSDV-WSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             CCCCCccccCHHHHccCCcchHhHH-HHHHHHHHHHHhcCCCCCCC
Confidence            22334579999986554   67899 9999999997   4456653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.90  E-value=1.8e-24  Score=212.60  Aligned_cols=171  Identities=26%  Similarity=0.376  Sum_probs=140.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.|++|.+.....  ...+.+.+|+.+++.++||||+++++.+...+.+|+|+||+++++|..++.. ..+++..+.
T Consensus        42 ~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~  118 (296)
T cd06655          42 ATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIA  118 (296)
T ss_pred             CCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHH
Confidence            4688999999875532  2346788999999999999999999999999999999999999999999876 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. ++.+.|||.+........  ......++..|+|||...+.   .+
T Consensus       119 ~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  195 (296)
T cd06655         119 AVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK  195 (296)
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccchhcccccc--cCCCcCCCccccCcchhcCCCCCch
Confidence            9999999999999999999999999999997643 344459998754332111  11234566789999987665   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|+++|++  +..||..
T Consensus       196 ~Dv-~slGvil~~lltg~~pf~~  217 (296)
T cd06655         196 VDI-WSLGIMAIEMVEGEPPYLN  217 (296)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999999  6677764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=2e-24  Score=209.31  Aligned_cols=171  Identities=27%  Similarity=0.406  Sum_probs=142.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.+.... .......+.+|+.+++.++||||+++++.+..+...|+++||+++++|.+++... ++++..+.
T Consensus        24 ~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~  101 (274)
T cd06609          24 RTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIA  101 (274)
T ss_pred             CCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHH
Confidence            468899999987654 2344567889999999999999999999999999999999999999999999875 79999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++|++||||+|+||+++++ .+++  .|||.+.......  .......++..|+|||...+.   .
T Consensus       102 ~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l--~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  177 (274)
T cd06609         102 FILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKL--ADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDE  177 (274)
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEE--cccccceeecccc--cccccccCCccccChhhhccCCCCc
Confidence            999999999999999999999999999999864 4444  5999876544321  112234566789999988765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|+++|++  +..||..
T Consensus       178 ~sDv-~slG~il~~l~tg~~p~~~  200 (274)
T cd06609         178 KADI-WSLGITAIELAKGEPPLSD  200 (274)
T ss_pred             hhhH-HHHHHHHHHHHhCCCCccc
Confidence            7899 9999999999  6677764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=1.8e-23  Score=200.83  Aligned_cols=172  Identities=24%  Similarity=0.348  Sum_probs=141.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+++.+++|.+.....  ...+.+.+|+.++++++||||+++++.+..++.+|++|||+++++|.+++... ..+++..+
T Consensus        26 ~~~~~~~ik~~~~~~~--~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~  103 (262)
T cd06613          26 ATGELVAIKVIKLEPG--DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQI  103 (262)
T ss_pred             CCCCEEEEEEEEcCch--hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHH
Confidence            3578899999876542  24578899999999999999999999999999999999999999999999876 68999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||++|++|+||+|+||+++.+. .+.++|||.+.......  .......++..|+|||...+.    
T Consensus       104 ~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~  180 (262)
T cd06613         104 AYVCRETLKGLAYLHETGKIHRDIKGANILLTEDG-DVKLADFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGG  180 (262)
T ss_pred             HHHHHHHHHHHHHHHhCCceecCCChhhEEECCCC-CEEECccccchhhhhhh--hccccccCCccccCchhhcccccCC
Confidence            99999999999999999999999999999998643 34456999876433211  111234566789999987532    


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|+++++|  +..||..
T Consensus       181 ~~~~~Di-~slG~~l~~~~tg~~p~~~  206 (262)
T cd06613         181 YDGKCDI-WALGITAIELAELQPPMFD  206 (262)
T ss_pred             cCchhhh-HHHHHHHHHHHhCCCCCCC
Confidence              56899 9999999999  7778764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.90  E-value=3.1e-24  Score=207.46  Aligned_cols=171  Identities=17%  Similarity=0.262  Sum_probs=132.5

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-----CCCHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-----KLSEF   78 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----~l~~~   78 (477)
                      ...+++|.+.... .......+.+|+.+++.++||||+++++.+......|+||||+++|+|.+++....     ..++.
T Consensus        22 ~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  100 (269)
T cd05042          22 KARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKD  100 (269)
T ss_pred             CeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHH
Confidence            4568888875432 33445678899999999999999999999999999999999999999999997643     24677


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS--  155 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~--  155 (477)
                      .+..++.|++.||+|||++||+||||||+||+++.+ .+++  .|||.+.......+........++..|+|||....  
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl--~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (269)
T cd05042         101 VLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKI--GDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG  178 (269)
T ss_pred             HHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEE--eccccccccccchheeccCCCCCcccccCHHHHhhcc
Confidence            889999999999999999999999999999999764 4444  59998754322222111222334556999997532  


Q ss_pred             --------CCcccccCcceEEEEEE---eeeccc
Q psy6508         156 --------KTSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       156 --------~~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                              ..++|+ ||+|+++||+   +..||.
T Consensus       179 ~~~~~~~~~~~~Di-wslG~~l~el~~~~~~p~~  211 (269)
T cd05042         179 QDLLPKDQTKKSNI-WSLGVTMWELFTAADQPYP  211 (269)
T ss_pred             ccccccccchhhHH-HHHHHHHHHHHhCCCCCCC
Confidence                    157899 9999999998   345554

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.90  E-value=3.4e-24  Score=209.87  Aligned_cols=172  Identities=24%  Similarity=0.357  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+++.|++|.+...  .....+.+.+|+.+++.++||||+++++.+..++.+|+||||++|++|..++.+ ...+++..+
T Consensus        35 ~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~  112 (292)
T cd06644          35 ETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI  112 (292)
T ss_pred             CCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHH
Confidence            46889999998654  345567789999999999999999999999999999999999999999988765 346899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||++|++||||||+||+++.++ .+.++|||.+.......  .......++..|+|||...+.    
T Consensus       113 ~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  189 (292)
T cd06644         113 QVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNVKTL--QRRDSFIGTPYWMAPEVVMCETMKD  189 (292)
T ss_pred             HHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCC-CEEEccCccceeccccc--cccceecCCccccCceeeccccccC
Confidence            99999999999999999999999999999997542 34445999875432221  112344566789999987421    


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ |++|+++|++  +..||..
T Consensus       190 ~~~~~~~Dv-~slG~il~el~~g~~p~~~  217 (292)
T cd06644         190 TPYDYKADI-WSLGITLIEMAQIEPPHHE  217 (292)
T ss_pred             CCCCchhhh-HhHHHHHHHHhcCCCCCcc
Confidence                46899 9999999998  6677754

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.90  E-value=4e-24  Score=209.50  Aligned_cols=174  Identities=24%  Similarity=0.342  Sum_probs=139.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      .+|+.||+|.+..........+.+.+|+.++++++||||+++++++...+..|+||||++ ++|.+++....  .+++..
T Consensus        25 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  103 (294)
T PLN00009         25 VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRL  103 (294)
T ss_pred             CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHH
Confidence            468899999987665444445678899999999999999999999999999999999997 68888886543  357888


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.||+.||+|||++|++||||+|+||+++.++.++..+|||.+......  ........++..|+|||...+.   
T Consensus       104 ~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~  181 (294)
T PLN00009        104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHY  181 (294)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--ccccccCceeecccCHHHHhCCCCC
Confidence            99999999999999999999999999999999865445556699987543221  1112334567889999987543   


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ |++|+++|++  +..||..
T Consensus       182 ~~~~Dv-~slG~i~~~l~tg~~pf~~  206 (294)
T PLN00009        182 STPVDI-WSVGCIFAEMVNQKPLFPG  206 (294)
T ss_pred             CcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence             57899 9999999999  6677753

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.90  E-value=1e-23  Score=201.42  Aligned_cols=174  Identities=24%  Similarity=0.352  Sum_probs=139.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++++.||+|.++... .......+.+|+.+++.++||||+++++++...+..+++|||+++++|.+++... ..+++..+
T Consensus        17 ~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   95 (250)
T cd05085          17 KDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQL   95 (250)
T ss_pred             cCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHH
Confidence            357789999986553 3344457889999999999999999999999999999999999999999998754 36889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|+|++|++||||||+||+++.+. .+...|||.+........ .......++..|+|||...+.   .
T Consensus        96 ~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  173 (250)
T cd05085          96 VKFALDAAAGMAYLESKNCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIY-SSSGLKQIPIKWTAPEALNYGRYSS  173 (250)
T ss_pred             HHHHHHHHHHHHHHHhCCeeecccChheEEEcCCC-eEEECCCccceecccccc-ccCCCCCCcccccCHHHhccCCCCc
Confidence            99999999999999999999999999999997653 344569998765433222 111122334569999987655   5


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++   +..||.+
T Consensus       174 ~~Di-~slG~ll~~~~~~g~~p~~~  197 (250)
T cd05085         174 ESDV-WSYGILLWETFSLGVCPYPG  197 (250)
T ss_pred             hhHH-HHHHHHHHHHhcCCCCCCCC
Confidence            7899 9999999987   5567754

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.90  E-value=5.5e-24  Score=210.09  Aligned_cols=173  Identities=20%  Similarity=0.356  Sum_probs=136.6

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      +..||+|.++... ......++.+|+.+++.+ +||||+++++++...+..|++|||+++++|.+++...+         
T Consensus        50 ~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~  128 (307)
T cd05098          50 VTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYN  128 (307)
T ss_pred             cceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccc
Confidence            3579999987543 334456788999999999 79999999999999999999999999999999997642         


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecc
Q psy6508          74 -------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV  146 (477)
Q Consensus        74 -------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~  146 (477)
                             .+++..++.++.|++.||+|||++|++||||||+||+++.+. .+.++|||.+................++..
T Consensus       129 ~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~  207 (307)
T cd05098         129 PTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVK  207 (307)
T ss_pred             cccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCC-cEEECCCcccccccccchhhccccCCCccc
Confidence                   478899999999999999999999999999999999997653 344569998764432221111112223457


Q ss_pred             ccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         147 FEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |+|||...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       208 y~aPE~~~~~~~~~~~Dv-wslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         208 WMAPEALFDRIYTHQSDV-WSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             eeChHHhccCCCCcHHHH-HHHHHHHHHHHcCCCCCCCc
Confidence            9999987655   67899 9999999998   4466653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.90  E-value=1.1e-23  Score=203.16  Aligned_cols=166  Identities=17%  Similarity=0.211  Sum_probs=132.6

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i   83 (477)
                      ..|++|.+....  ......+.+|+.+++.++||||+++++++..+...+++|||+++++|..++... ..+++..+..+
T Consensus        33 ~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i  110 (262)
T cd05077          33 IKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKV  110 (262)
T ss_pred             eeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHH
Confidence            468899876542  334457889999999999999999999999988999999999999999998753 46899999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcc------eeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTL------KLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~------rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      +.|++.||.|||++||+||||||+|||++.+..      .+...|||......      ......++..|+|||..... 
T Consensus       111 ~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~------~~~~~~~~~~y~aPE~~~~~~  184 (262)
T cd05077         111 AKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL------SRQECVERIPWIAPECVEDSK  184 (262)
T ss_pred             HHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCcccc------CcccccccccccChhhhcCCC
Confidence            999999999999999999999999999965331      24456888764321      11234456679999987532 


Q ss_pred             ---CcccccCcceEEEEEE---eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                         .++|+ ||+|+++||+   +..||..
T Consensus       185 ~~~~~~Di-wslG~~l~el~~~~~~p~~~  212 (262)
T cd05077         185 NLSIAADK-WSFGTTLWEICYNGEIPLKD  212 (262)
T ss_pred             CCCchhHH-HHHHHHHHHHHhCCCCCCCC
Confidence               57899 9999999997   4456653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.90  E-value=8.5e-24  Score=207.86  Aligned_cols=172  Identities=24%  Similarity=0.345  Sum_probs=141.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++++.||+|.+......  ..+.+.+|+.+++.++||||+++++.+..++..|+||||++|++|.+++.+ ..+++..+.
T Consensus        42 ~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~  118 (297)
T cd06656          42 ATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIA  118 (297)
T ss_pred             CCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHH
Confidence            47899999998755432  345688999999999999999999999999999999999999999999876 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||+.|++||||||+||+++.+. .+...|||.+........  ......+++.|.|||...+.   .+
T Consensus       119 ~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  195 (297)
T cd06656         119 AVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK  195 (297)
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEECcCccceEccCCcc--CcCcccCCccccCHHHHcCCCCCcH
Confidence            9999999999999999999999999999997643 344459998764332211  11234567789999988665   67


Q ss_pred             ccccCcceEEEEEE--eeeccccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      +|+ |++|+++|++  +..||.+.
T Consensus       196 ~Di-~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         196 VDI-WSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             HHH-HHHHHHHHHHHhCCCCCCCC
Confidence            899 9999999999  77888653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.90  E-value=1.3e-24  Score=208.30  Aligned_cols=174  Identities=32%  Similarity=0.505  Sum_probs=143.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|++..............+|+.++++++||||+++++++......+++||++++++|.+++...+.+++..+.
T Consensus        22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~  101 (260)
T PF00069_consen   22 KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEIL  101 (260)
T ss_dssp             TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHH
T ss_pred             CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            46778999999887655444445567999999999999999999999999999999999988999999976789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC-CC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS-SK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~-~~---~  157 (477)
                      .++.|++.||.+||++|++|+||||+||+++.+ ..+.++|||.+......  ........++..|.|||... +.   .
T Consensus       102 ~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~-~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~  178 (260)
T PF00069_consen  102 KIAYQILEALAYLHSKGIVHRDIKPENILLDEN-GEVKLIDFGSSVKLSEN--NENFNPFVGTPEYMAPEVLQQGKKYTR  178 (260)
T ss_dssp             HHHHHHHHHHHHHHHTTEEESSBSGGGEEESTT-SEEEESSGTTTEESTST--TSEBSSSSSSGGGSCHHHHTTTSSBST
T ss_pred             ccccccccccccccccccccccccccccccccc-ccccccccccccccccc--ccccccccccccccccccccccccccc
Confidence            999999999999999999999999999999843 23345599987642111  11223445677899999987 33   7


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|+++++|  +..||..
T Consensus       179 ~~Di-~slG~il~~l~~~~~p~~~  201 (260)
T PF00069_consen  179 KSDI-WSLGIILYELLTGKLPFEE  201 (260)
T ss_dssp             HHHH-HHHHHHHHHHHHSSSSSTT
T ss_pred             cccc-ccccccccccccccccccc
Confidence            8999 9999999999  5567764

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.90  E-value=1.6e-23  Score=200.07  Aligned_cols=177  Identities=24%  Similarity=0.350  Sum_probs=147.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      ++++.|++|++..........+.+.+|+.++++++||||+++++.+...  ...++++||+++++|.+++.....+++..
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  102 (260)
T cd06606          23 DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV  102 (260)
T ss_pred             CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHH
Confidence            4688999999987765555677899999999999999999999999988  89999999999999999998877899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++|+||+|+||+++.+. ++.++|||.+................++..|.|||...+.   
T Consensus       103 ~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~  181 (260)
T cd06606         103 IRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDG-VVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG  181 (260)
T ss_pred             HHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCC-CEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCC
Confidence            999999999999999999999999999999998742 4445699987665543321112234566789999987655   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ |++|++++++  +..||...
T Consensus       182 ~~~Dv-~slG~il~~l~~g~~p~~~~  206 (260)
T cd06606         182 RAADI-WSLGCTVIEMATGKPPWSEL  206 (260)
T ss_pred             chhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            67899 9999999998  67787653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.90  E-value=1.4e-23  Score=202.97  Aligned_cols=172  Identities=23%  Similarity=0.282  Sum_probs=135.5

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i   83 (477)
                      ..||||.+.... .....+.|.+|+.+++.++||||+++++++..+...+++|||+++++|.+++... +.+++..++.+
T Consensus        33 ~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i  111 (269)
T cd05065          33 IFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM  111 (269)
T ss_pred             eeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHH
Confidence            469999986543 4455678999999999999999999999999999999999999999999999764 46899999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-ccCCeE--EEeccccccccCCCC---C
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-EQGNTK--VICSVFEPREIPSSK---T  157 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-~~g~t~--v~~~~y~ppE~~~~~---~  157 (477)
                      +.|++.||.|||++|++||||||+||+++.+. ++...|||........... ......  .....|+|||...+.   .
T Consensus       112 ~~~l~~al~~lH~~g~~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  190 (269)
T cd05065         112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS  190 (269)
T ss_pred             HHHHHHHHHHHHHCCEeecccChheEEEcCCC-cEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccc
Confidence            99999999999999999999999999997653 4445599987543322110 000000  112369999988655   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ |++|+++||+   +..||..
T Consensus       191 ~~Dv-wslG~~l~e~l~~g~~p~~~  214 (269)
T cd05065         191 ASDV-WSYGIVMWEVMSYGERPYWD  214 (269)
T ss_pred             hhhh-hhhHHHHHHHhcCCCCCCCC
Confidence            7899 9999999995   5566653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.90  E-value=1.7e-23  Score=202.14  Aligned_cols=173  Identities=24%  Similarity=0.316  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCC--CHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKL--SEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l--~~~   78 (477)
                      +++..||+|.+....  ....+.+.+|+.+++.++||||+++++++..++..++++||+++++|.+++... ..+  ++.
T Consensus        31 ~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  108 (268)
T cd06624          31 STQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQ  108 (268)
T ss_pred             CCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHH
Confidence            467789999886543  334567899999999999999999999999999999999999999999999764 345  888


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++||+||||||+||+++.+.-++.++|||.+....+...  ......++..|.|||...+.  
T Consensus       109 ~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  186 (268)
T cd06624         109 TIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPR  186 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccccChhhhccccc
Confidence            89999999999999999999999999999999976433455569998754432211  11123456789999987542  


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|++++++  +..||..
T Consensus       187 ~~~~~~Dv-~slGvvl~~l~~g~~p~~~  213 (268)
T cd06624         187 GYGAPADI-WSLGCTIVEMATGKPPFIE  213 (268)
T ss_pred             cCCchhhh-HHHHHHHHHHHhCCCCCcc
Confidence               57899 9999999999  6778764

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.90  E-value=9.8e-24  Score=205.17  Aligned_cols=170  Identities=16%  Similarity=0.208  Sum_probs=133.7

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~   84 (477)
                      .||+|+++... .....+.+.+|+.+++.++||||+++++++.. ...++++||+++|+|.+++..+ +.+++..+..++
T Consensus        38 ~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~  115 (279)
T cd05109          38 PVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWC  115 (279)
T ss_pred             EEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHH
Confidence            58999986543 34455678999999999999999999999875 4578999999999999999764 468999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEY  161 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di  161 (477)
                      .|++.||.|||++|++||||||+||+++++. ++.++|||.+.................+..|+|||...+.   .++|+
T Consensus       116 ~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~-~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di  194 (279)
T cd05109         116 VQIAKGMSYLEEVRLVHRDLAARNVLVKSPN-HVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDV  194 (279)
T ss_pred             HHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHH
Confidence            9999999999999999999999999997643 3455699988654422211111122334569999988655   67899


Q ss_pred             cCcceEEEEEE---eeecccc
Q psy6508         162 QRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       162 ~~s~G~il~e~---~~~Pf~~  179 (477)
                       ||+|+++||+   +..||..
T Consensus       195 -~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         195 -WSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             -HHHHHHHHHHHcCCCCCCCC
Confidence             9999999996   4566653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>KOG1152|consensus

Probab=99.90  E-value=9.4e-24  Score=210.54  Aligned_cols=170  Identities=26%  Similarity=0.455  Sum_probs=143.8

Q ss_pred             CCCcEEEEEEcccCCCChhHH------HHHHHHHHHHHhcC---CCCccceEEEEEeCCeEEEEEec-CCCCCHHHHHHh
Q psy6508           2 EQHTEVAIKCIDKTKVSENRF------DSIVNEIKALKLLH---HQHIVTMLDFLWDERYVYIILEY-CDGGDLCSFIRS   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~------~~~~~E~~il~~l~---HpnIv~~~~~~~~~~~~~lv~e~-~~g~sL~~~l~~   71 (477)
                      ++...|+||.+.++.+-.+.+      -.+-.|++||..|+   |+||+|++++|++++++||+||. -+|-+|.+++..
T Consensus       584 ~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~  663 (772)
T KOG1152|consen  584 ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEF  663 (772)
T ss_pred             ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhc
Confidence            567889999998876533222      23668999999997   99999999999999999999995 467899999999


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          72 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        72 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                      ++++++.++..|++|++.|+++||++||+|||||-+|+.++.+ ..|++  |||.+...+...+    .+.+||-.|.||
T Consensus       664 kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~kli--dfgsaa~~ksgpf----d~f~gtv~~aap  737 (772)
T KOG1152|consen  664 KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLI--DFGSAAYTKSGPF----DVFVGTVDYAAP  737 (772)
T ss_pred             cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEe--eccchhhhcCCCc----ceeeeeccccch
Confidence            9999999999999999999999999999999999999999875 45555  9997754443222    478999999999


Q ss_pred             ccCCCC----CcccccCcceEEEEEEee--eccc
Q psy6508         151 EIPSSK----TSLEYQRSKGELYVEFKF--APFA  178 (477)
Q Consensus       151 E~~~~~----~~~Di~~s~G~il~e~~~--~Pf~  178 (477)
                      |++.|.    ...|| |++|+++|.+.|  .||.
T Consensus       738 evl~g~~y~gk~qdi-walgillytivykenpyy  770 (772)
T KOG1152|consen  738 EVLGGEKYLGKPQDI-WALGILLYTIVYKENPYY  770 (772)
T ss_pred             hhhCCCccCCCcchh-hhhhheeeEEEeccCCCc
Confidence            999887    56799 999999999954  5554

>KOG0666|consensus

Probab=99.90  E-value=8.7e-25  Score=203.51  Aligned_cols=166  Identities=21%  Similarity=0.355  Sum_probs=139.0

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHHhC-----CCCCHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-ERYVYIILEYCDGGDLCSFIRSH-----EKLSEF   78 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~-----~~l~~~   78 (477)
                      +.+|||.++.+...........+|+.+++.++|||++.+..+|.. +..+|+++||.+ .+|.+.++-+     +.+|..
T Consensus        54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~  132 (438)
T KOG0666|consen   54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRS  132 (438)
T ss_pred             hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHH
Confidence            479999998774433334556799999999999999999998876 789999999998 8999999643     359999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC---cceeecccccceecccCCc-ccccCCeEEEeccccccccCC
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---TLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~---~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      .++.|+.||+.|+.|||++-|+||||||.|||+..+   .-++.+.|+|+++.....- .+-.++..|.|.||.+||.+.
T Consensus       133 mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLL  212 (438)
T KOG0666|consen  133 MVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLL  212 (438)
T ss_pred             HHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhc
Confidence            999999999999999999999999999999999543   3466667999987544332 223456789999999999998


Q ss_pred             CC----CcccccCcceEEEEEE
Q psy6508         155 SK----TSLEYQRSKGELYVEF  172 (477)
Q Consensus       155 ~~----~~~Di~~s~G~il~e~  172 (477)
                      |.    .++|+ |+.|||+.|+
T Consensus       213 Ga~hYT~AiDv-WAiGCIfaEl  233 (438)
T KOG0666|consen  213 GARHYTKAIDV-WAIGCIFAEL  233 (438)
T ss_pred             ccccccchhhh-HHHHHHHHHH
Confidence            87    78899 9999999999

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.90  E-value=1.1e-23  Score=208.98  Aligned_cols=171  Identities=18%  Similarity=0.233  Sum_probs=133.2

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i   83 (477)
                      ..||+|.++... .....+++.+|+.+++.++||||+++++++... ..++++||+++|+|.+++..+. .+++..+..+
T Consensus        37 ~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~  114 (316)
T cd05108          37 IPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW  114 (316)
T ss_pred             eeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHH
Confidence            348999986442 344556799999999999999999999998764 5789999999999999998743 6889999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cccc
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLE  160 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~D  160 (477)
                      +.|++.||+|||++||+||||||+||+++.+. .+.++|||.+.................+..|++||...+.   .++|
T Consensus       115 ~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~D  193 (316)
T cd05108         115 CVQIAKGMNYLEERRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSD  193 (316)
T ss_pred             HHHHHHHHHHHHhcCeeccccchhheEecCCC-cEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhh
Confidence            99999999999999999999999999997643 3444599988654321111111112234569999987665   6789


Q ss_pred             ccCcceEEEEEE---eeecccc
Q psy6508         161 YQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       161 i~~s~G~il~e~---~~~Pf~~  179 (477)
                      + ||+|+++||+   +..||.+
T Consensus       194 i-~slGv~l~el~t~g~~p~~~  214 (316)
T cd05108         194 V-WSYGVTVWELMTFGSKPYDG  214 (316)
T ss_pred             h-HHHHHHHHHHHcCCCCCCCC
Confidence            9 9999999996   4566653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.90  E-value=1e-23  Score=205.68  Aligned_cols=171  Identities=27%  Similarity=0.368  Sum_probs=140.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---~~l~~~   78 (477)
                      .+|+.||+|.++... .......+.+|+.++++++||||+++++.+...+..|+||||++|++|.+++...   ..+++.
T Consensus        24 ~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  102 (286)
T cd06622          24 PTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPED  102 (286)
T ss_pred             CCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHH
Confidence            478999999986543 3445578999999999999999999999999999999999999999999998763   368999


Q ss_pred             HHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||.|||+ .|++||||||+||+++.+. ++.++|||.+......    ...+..++..|.|||...+. 
T Consensus       103 ~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~  177 (286)
T cd06622         103 VLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGG  177 (286)
T ss_pred             HHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCcccccCC----ccccCCCccCccCcchhcCCC
Confidence            999999999999999997 5999999999999998742 4455699987543221    12334566789999987542 


Q ss_pred             --------CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                              .++|+ |++|++++++  +..||..
T Consensus       178 ~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~  209 (286)
T cd06622         178 PNQNPTYTVQSDV-WSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             CCccCCCCcccch-HhHHHHHHHHHhCCCCCCC
Confidence                    46899 9999999999  6677753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG1095|consensus

Probab=99.90  E-value=1.6e-24  Score=233.90  Aligned_cols=172  Identities=23%  Similarity=0.368  Sum_probs=145.6

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-------CCCH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-------KLSE   77 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------~l~~   77 (477)
                      ..||||.+++.. +.....+|.+|..+|+.++||||++++|++.+....+|++|||+||+|..+|++.+       .+..
T Consensus       723 ~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~  801 (1025)
T KOG1095|consen  723 IQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSM  801 (1025)
T ss_pred             eEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCH
Confidence            359999986543 45667889999999999999999999999999999999999999999999998752       4889


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+...++.||++|++||+++++|||||..+|+|++.. ..+++.|||+++......|+..+.....-..|||||.+... 
T Consensus       802 ~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~-r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i  880 (1025)
T KOG1095|consen  802 RDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDER-RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI  880 (1025)
T ss_pred             HHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeeccc-CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcc
Confidence            9999999999999999999999999999999999876 34445699999865555555544432333459999999865 


Q ss_pred             --CcccccCcceEEEEEE---eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                        .++|+ ||+|+++||+   |..||.+
T Consensus       881 FtskSDv-WsFGVllWEifslG~~PY~~  907 (1025)
T KOG1095|consen  881 FTSKSDV-WSFGVLLWEIFSLGATPYPS  907 (1025)
T ss_pred             cccccch-hhhHHHHHHHHhCCCCCCCC
Confidence              78999 9999999998   7788874

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.90  E-value=2.3e-23  Score=208.31  Aligned_cols=172  Identities=18%  Similarity=0.356  Sum_probs=135.8

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC----------
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE----------   73 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------   73 (477)
                      ..||+|.++... .....+.+.+|+.+++++ +||||+++++++..++..++++||+++++|.+++.+..          
T Consensus        45 ~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  123 (334)
T cd05100          45 VTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDT  123 (334)
T ss_pred             eeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence            468999886442 344567899999999999 89999999999999999999999999999999997532          


Q ss_pred             ------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccc
Q psy6508          74 ------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF  147 (477)
Q Consensus        74 ------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y  147 (477)
                            .++...+..++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+................++..|
T Consensus       124 ~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y  202 (334)
T cd05100         124 CKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKW  202 (334)
T ss_pred             ccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCC-cEEECCcccceecccccccccccCCCcCceE
Confidence                  377888999999999999999999999999999999997643 3444599987654432221112222334569


Q ss_pred             cccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         148 EPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       148 ~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|||...+.   .++|+ |++|+++||+   +..||.+
T Consensus       203 ~aPE~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         203 MAPEALFDRVYTHQSDV-WSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             cCHHHhccCCcCchhhh-HHHHHHHHHHHhcCCCCCCC
Confidence            999988665   67899 9999999997   4466653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.90  E-value=1.1e-23  Score=203.85  Aligned_cols=176  Identities=24%  Similarity=0.343  Sum_probs=139.7

Q ss_pred             CCCcEEEEEEcccCCCC--------hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC
Q psy6508           2 EQHTEVAIKCIDKTKVS--------ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~--------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~   73 (477)
                      .+|+.||+|.++.....        ....+.+.+|+.+++.++|||++++++++...+..++||||++|++|.+++.+.+
T Consensus        24 ~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  103 (272)
T cd06629          24 TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG  103 (272)
T ss_pred             CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc
Confidence            46889999988643211        1123568899999999999999999999999999999999999999999998878


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      .+++..+..++.|++.||.|||++|++||||+|+||+++.+. .+...|||.+.............+..++..|.|||..
T Consensus       104 ~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  182 (272)
T cd06629         104 RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADG-ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVI  182 (272)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCC-eEEEeeccccccccccccccccccccCCccccCHHHh
Confidence            899999999999999999999999999999999999997643 3444599987643321111112234456789999976


Q ss_pred             CCC-----CcccccCcceEEEEEE--eeecccc
Q psy6508         154 SSK-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~~~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ...     .++|+ |++|++++++  +..||..
T Consensus       183 ~~~~~~~~~~~Dv-~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         183 HSYSQGYSAKVDI-WSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             ccccCCCCccchh-HHHHHHHHHHHhCCCCCcC
Confidence            543     56899 9999999999  6677753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>KOG0579|consensus

Probab=99.90  E-value=4e-25  Score=221.79  Aligned_cols=195  Identities=26%  Similarity=0.330  Sum_probs=154.3

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~~~   82 (477)
                      +-.-|-|++...  +.+..+++.-|+.||..+.||+|+++++.|..++.+||..|||.||-....+-. ...+.+.++..
T Consensus        57 ~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqv  134 (1187)
T KOG0579|consen   57 KLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQV  134 (1187)
T ss_pred             hhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHH
Confidence            334456766443  456778999999999999999999999999999999999999999999988754 44799999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-----
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-----  156 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-----  156 (477)
                      +++|++.||.|||+++|+|||||..|||++- +.+|+.  |||++....  .......+.+||+.||+||+....     
T Consensus       135 vc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLA--DFGVSAKn~--~t~qkRDsFIGTPYWMAPEVvmCET~KD~  210 (1187)
T KOG0579|consen  135 VCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLA--DFGVSAKNK--STRQKRDSFIGTPYWMAPEVVMCETFKDQ  210 (1187)
T ss_pred             HHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeee--cccccccch--hHHhhhccccCCcccccchheeeccccCC
Confidence            9999999999999999999999999999974 677777  999975433  333455789999999999987655     


Q ss_pred             ---CcccccCcceEEEEEE--eeecccccccc-------------CCCCCcchHHHHHHHHHHhhhh
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQIRT-------------GWLRDSEEKELGNHLKRALEPA  205 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~~r~-------------~~~~~~~~~~l~~~i~~~l~~~  205 (477)
                         .++|| ||+|++++||  +-+|...-...             ...+..-...++.++++++...
T Consensus       211 PYDykaDi-WSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Kn  276 (1187)
T KOG0579|consen  211 PYDYKADI-WSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKN  276 (1187)
T ss_pred             CchhhhhH-HhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcC
Confidence               56899 9999999999  44555432211             1133444566677777665443

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.90  E-value=1.1e-23  Score=202.32  Aligned_cols=170  Identities=22%  Similarity=0.329  Sum_probs=134.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +++.+|+|.+......   ..++.+|+.+++.++||||+++++++...+..|++|||++|++|.+++..+ ..+++..+.
T Consensus        27 ~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  103 (256)
T cd05059          27 GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL  103 (256)
T ss_pred             CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHH
Confidence            4567999998654433   245788999999999999999999999999999999999999999999764 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.++ .+.+.|||.+.......... .........|+|||...+.   .+
T Consensus       104 ~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~  181 (256)
T cd05059         104 DMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLDDQYTS-SQGTKFPVKWAPPEVFDYSRFSSK  181 (256)
T ss_pred             HHHHHHHHHHHHHHHCCcccccccHhhEEECCCC-cEEECCcccceecccccccc-cCCCCCCccccCHHHhccCCCCch
Confidence            9999999999999999999999999999997653 34445999875432211111 1111223469999987655   67


Q ss_pred             ccccCcceEEEEEE---eeeccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      +|+ |++|+++|++   +..||.
T Consensus       182 ~Di-~slG~il~~l~~~g~~p~~  203 (256)
T cd05059         182 SDV-WSFGVLMWEVFSEGKMPYE  203 (256)
T ss_pred             hhH-HHHHHHHHHHhccCCCCCC
Confidence            899 9999999997   456665

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.90  E-value=1.4e-24  Score=207.90  Aligned_cols=175  Identities=27%  Similarity=0.384  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      .+|+.||+|.+.....+....+.+.+|+.+++.++||||+++++.+...+..|+++||+++++|.+++....  .+++..
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  102 (257)
T cd08225          23 SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQ  102 (257)
T ss_pred             CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHH
Confidence            467889999987765444455678899999999999999999999999999999999999999999997643  478999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++|+||||+||++++++..+...|||.+.......  .......++..|+|||...+.   
T Consensus       103 ~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~  180 (257)
T cd08225         103 ILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYN  180 (257)
T ss_pred             HHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc--ccccccCCCccccCHHHHcCCCCC
Confidence            999999999999999999999999999999998765444556999775443221  111233466789999987654   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|++++++  +..||..
T Consensus       181 ~~~Dv-~slG~il~~l~~g~~p~~~  204 (257)
T cd08225         181 NKTDI-WSLGCVLYELCTLKHPFEG  204 (257)
T ss_pred             chhhH-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  5667653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0614|consensus

Probab=99.90  E-value=1.2e-25  Score=220.78  Aligned_cols=170  Identities=24%  Similarity=0.431  Sum_probs=149.2

Q ss_pred             EEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~   84 (477)
                      .+|+|++++..+- .++.+.+..|-.+|...+.|+||++|..|.++.++|+.||.|-||.|...+.+.+.+++...+.++
T Consensus       447 ~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~  526 (732)
T KOG0614|consen  447 TFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYV  526 (732)
T ss_pred             HHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhH
Confidence            4889999887764 355667899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLE  160 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~D  160 (477)
                      .-+++|++|||++||++|||||+|++++.+ -++++  |||.++.....   ....|..||+.|.+||+...+   .++|
T Consensus       527 acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLV--DFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avD  601 (732)
T KOG0614|consen  527 ACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLV--DFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVD  601 (732)
T ss_pred             HHHHHHHHHHHhcCceeccCChhheeeccCCceEEe--ehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhH
Confidence            999999999999999999999999999864 55665  99998764432   223578889999999998766   8899


Q ss_pred             ccCcceEEEEEE--eeecccccc
Q psy6508         161 YQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       161 i~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      + |++|+++||+  |.+||++.+
T Consensus       602 y-WaLGIli~ELL~G~pPFs~~d  623 (732)
T KOG0614|consen  602 Y-WALGILIYELLTGSPPFSGVD  623 (732)
T ss_pred             H-HHHHHHHHHHHcCCCCCCCCc
Confidence            9 9999999999  789998643

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.90  E-value=2.1e-23  Score=201.74  Aligned_cols=171  Identities=17%  Similarity=0.293  Sum_probs=132.8

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----CCCCHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----EKLSEFQC   80 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~l~~~~~   80 (477)
                      ..+++|.++... .....+.+.+|+.+++.++||||+++++.+......|++|||+++++|.+++.+.    ...+...+
T Consensus        23 ~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  101 (268)
T cd05086          23 ARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL  101 (268)
T ss_pred             ceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHH
Confidence            346677765443 2344568999999999999999999999999999999999999999999999764    24667788


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC-----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS-----  155 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~-----  155 (477)
                      ..++.|++.||+|||++|++||||||+|||++.+. .+...|||.+.......+........++..|+|||....     
T Consensus       102 ~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  180 (268)
T cd05086         102 QRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGL  180 (268)
T ss_pred             HHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc-cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCcc
Confidence            89999999999999999999999999999997643 344459998654332222222334456678999998642     


Q ss_pred             -----CCcccccCcceEEEEEE---eeeccc
Q psy6508         156 -----KTSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       156 -----~~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                           ..++|+ ||+|+++||+   +..||.
T Consensus       181 ~~~~~~~~~Di-wslG~~l~el~~~~~~p~~  210 (268)
T cd05086         181 ITAEQTKPSNV-WALGVTLWELFENAAQPYS  210 (268)
T ss_pred             ccCCCCCcchh-HHHHHHHHHHHhCCCCCCC
Confidence                 156899 9999999998   344654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.90  E-value=1.7e-23  Score=203.87  Aligned_cols=173  Identities=23%  Similarity=0.345  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+|+.||+|++......+...+.+.+|+.++++++||||+++++++..+...|+|+||+ +++|.+++... ..+++..+
T Consensus        23 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~  101 (286)
T cd07832          23 ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQV  101 (286)
T ss_pred             CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHH
Confidence            46889999999877655555678999999999999999999999999999999999999 89999998653 46899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++|++|+||||+||+++++. .+.+.|||.+........ .......++..|+|||...+.    
T Consensus       102 ~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  179 (286)
T cd07832         102 KSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG-VLKIADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYD  179 (286)
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC-cEEEeeeeecccccCCCC-CccccccCcccccCceeeeccccCC
Confidence            99999999999999999999999999999998643 234459998765432211 112235677889999987543    


Q ss_pred             CcccccCcceEEEEEE--eeeccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      .++|+ |++|++++++  +.+||.
T Consensus       180 ~~~Di-~slG~~l~~l~tg~~~~~  202 (286)
T cd07832         180 PGVDL-WAVGCIFAELLNGSPLFP  202 (286)
T ss_pred             chhHH-HHHHHHHHHHHcCCcCcC
Confidence            67899 9999999999  444444

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.89  E-value=1.6e-23  Score=204.71  Aligned_cols=173  Identities=22%  Similarity=0.294  Sum_probs=136.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      +++.||+|.+.... .......+.+|+.++++++||||+++++++......|++|||+++++|.+++....         
T Consensus        34 ~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  112 (288)
T cd05050          34 PFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSH  112 (288)
T ss_pred             cceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccc
Confidence            56789999987543 33445678999999999999999999999999899999999999999999997431         


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCe
Q psy6508          74 -------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNT  140 (477)
Q Consensus        74 -------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t  140 (477)
                                   .+++..+..++.|++.||.|||++|++||||||+||+++.+. .+...|||.+.............+
T Consensus       113 ~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~  191 (288)
T cd05050         113 STSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKASEN  191 (288)
T ss_pred             cccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCC-ceEECccccceecccCccccccCC
Confidence                         367888999999999999999999999999999999997643 344469998765433222222222


Q ss_pred             EEEeccccccccCCCC---CcccccCcceEEEEEE---eeeccc
Q psy6508         141 KVICSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       141 ~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      ......|+|||...+.   .++|+ ||+|+++|++   +..||.
T Consensus       192 ~~~~~~y~aPE~~~~~~~~~~~Dv-~slG~il~el~~~~~~p~~  234 (288)
T cd05050         192 DAIPIRWMPPESIFYNRYTTESDV-WAYGVVLWEIFSYGMQPYY  234 (288)
T ss_pred             CccChhhcCHHHHhcCCCCchhHH-HHHHHHHHHHHhCCCCCCC
Confidence            2334569999987654   67899 9999999998   335664

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.89  E-value=1.6e-23  Score=206.59  Aligned_cols=168  Identities=24%  Similarity=0.337  Sum_probs=132.1

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-----------
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-----------   73 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------   73 (477)
                      .+|+|.++.. ......+.+.+|+.++.++ +||||+++++++..++.+|++|||+++++|.+++...+           
T Consensus        36 ~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  114 (303)
T cd05088          36 DAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA  114 (303)
T ss_pred             eEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhccccccccccccc
Confidence            4577776532 2344456788999999999 89999999999999999999999999999999997542           


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          74 -----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        74 -----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                           .+++..++.++.|++.||+|||++|++||||||+||+++.+. ++.++|||.+......   ........+..|+
T Consensus       115 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~  190 (303)
T cd05088         115 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVY---VKKTMGRLPVRWM  190 (303)
T ss_pred             ccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCC-cEEeCccccCcccchh---hhcccCCCccccc
Confidence                 478999999999999999999999999999999999997643 3445699987532211   1111122345699


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |||...+.   .++|+ ||+|++++|+   +..||..
T Consensus       191 aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~  226 (303)
T cd05088         191 AIESLNYSVYTTNSDV-WSYGVLLWEIVSLGGTPYCG  226 (303)
T ss_pred             CHHHHhccCCcccccc-hhhhhHHHHHHhcCCCCccc
Confidence            99987654   67899 9999999998   5577753

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.89  E-value=1.8e-24  Score=207.98  Aligned_cols=159  Identities=20%  Similarity=0.235  Sum_probs=129.7

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i   83 (477)
                      ..||+|.+....  ....+.+.+|..+++.++||||+++++++..+...++||||+++|+|.+++..++ .+++..++.+
T Consensus        28 ~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  105 (258)
T cd05078          28 TEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEV  105 (258)
T ss_pred             chhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHH
Confidence            458888875432  3344678899999999999999999999999899999999999999999997654 5899999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcc-------eeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-------KLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~-------rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +.|++.||.|||++||+||||||+||+++.++.       .+...|||.......      ..+..++..|+|||...+.
T Consensus       106 ~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~  179 (258)
T cd05078         106 AKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP------KEILLERIPWVPPECIENP  179 (258)
T ss_pred             HHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCC------chhccccCCccCchhccCC
Confidence            999999999999999999999999999976432       144568887643221      1234456679999988653


Q ss_pred             ----CcccccCcceEEEEEE
Q psy6508         157 ----TSLEYQRSKGELYVEF  172 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~  172 (477)
                          .++|+ ||+|+++|++
T Consensus       180 ~~~~~~~Di-wslG~~l~~l  198 (258)
T cd05078         180 QNLSLAADK-WSFGTTLWEI  198 (258)
T ss_pred             CCCCchhhH-HHHHHHHHHH
Confidence                56899 9999999998

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.89  E-value=2.6e-23  Score=202.34  Aligned_cols=172  Identities=22%  Similarity=0.305  Sum_probs=136.2

Q ss_pred             CCCcEEEEEEcccCCCChh-HHHHHHHHHH---HHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSEN-RFDSIVNEIK---ALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~-~~~~~~~E~~---il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+++.||+|.+.+...... ....+..|..   .++...||||+++++.+...+..|+||||++|++|.+++...+.+++
T Consensus        17 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~   96 (278)
T cd05606          17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE   96 (278)
T ss_pred             cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCH
Confidence            4688999999877644321 1222344443   34445799999999999999999999999999999999988778999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..++.++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+......    ...+..++..|+|||...+. 
T Consensus        97 ~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~  171 (278)
T cd05606          97 AEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGV  171 (278)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCC-CEEEccCcCccccCcc----CCcCcCCCcCCcCcHHhcCCC
Confidence            99999999999999999999999999999999997653 3445699987543321    12344677889999997633 


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|++++++  +..||..
T Consensus       172 ~~~~~~Di-~s~G~~l~~l~~g~~p~~~  198 (278)
T cd05606         172 AYDSSADW-FSLGCMLFKLLRGHSPFRQ  198 (278)
T ss_pred             CCCcccch-HhHHHHHHHHHhCCCCCCC
Confidence               66899 9999999999  6778864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=3.8e-24  Score=205.66  Aligned_cols=170  Identities=23%  Similarity=0.365  Sum_probs=136.5

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHH-hcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|.+++.... ......+..|..++. ..+|||++++++.+..++.+|+++||++|++|.+++...+.+++..
T Consensus        19 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~   98 (260)
T cd05611          19 STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDW   98 (260)
T ss_pred             CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHH
Confidence            46889999998765432 222334556655544 4589999999999999999999999999999999998877899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||+.|++||||+|+||+++.+. .+.+.|||.+.....      .....++..|++||...+.   
T Consensus        99 ~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~  171 (260)
T cd05611          99 AKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE------NKKFVGTPDYLAPETILGVGDD  171 (260)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-cEEEeecccceeccc------cccCCCCcCccChhhhcCCCCc
Confidence            999999999999999999999999999999997642 344459997754322      2234466789999988765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|+++|++  +..||..
T Consensus       172 ~~~Dv-~slG~il~~l~~g~~p~~~  195 (260)
T cd05611         172 KMSDW-WSLGCVIFEFLFGYPPFHA  195 (260)
T ss_pred             chhhh-HHHHHHHHHHHHCCCCCCC
Confidence            57899 9999999999  6778763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.89  E-value=2.9e-23  Score=200.86  Aligned_cols=175  Identities=20%  Similarity=0.318  Sum_probs=137.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhC----
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSH----   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~----   72 (477)
                      +++.||||++..........+++.+|+.++++++||||+++++++....      ..+++++|+++++|.+++...    
T Consensus        26 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  105 (273)
T cd05074          26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE  105 (273)
T ss_pred             CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC
Confidence            5789999999776656666778999999999999999999999876432      357899999999999887532    


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          73 --EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        73 --~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                        ..++...+..++.|++.||+|||++||+||||||+||+++++. .+...|||.+...........+.....+..|++|
T Consensus       106 ~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~p  184 (273)
T cd05074         106 EPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGDYYRQGCASKLPVKWLAL  184 (273)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCC-CEEECcccccccccCCcceecCCCccCchhhcCH
Confidence              1478899999999999999999999999999999999997542 3345699987654333222233334455679999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |.....   .++|+ ||+|+++|++   +..||.+
T Consensus       185 e~~~~~~~~~~sDi-~slG~il~el~~~g~~p~~~  218 (273)
T cd05074         185 ESLADNVYTTHSDV-WAFGVTMWEIMTRGQTPYAG  218 (273)
T ss_pred             hHHhcCccchhhhh-HHHHHHHHHHhhCCCCCCCC
Confidence            987655   67899 9999999998   4566653

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN00207 polyribonucleotide nucleotidyltransferase; Provisional

Probab=99.89  E-value=3e-22  Score=214.30  Aligned_cols=225  Identities=16%  Similarity=0.205  Sum_probs=183.7

Q ss_pred             CCCCceeec---cCcceeecccccceecccCCcccccCCeEEEeccc-cccccCCCC-CcccccCcceEEEEEEeeeccc
Q psy6508         104 LKPQNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF-EPREIPSSK-TSLEYQRSKGELYVEFKFAPFA  178 (477)
Q Consensus       104 lkp~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y-~ppE~~~~~-~~~Di~~s~G~il~e~~~~Pf~  178 (477)
                      |-.+++-+|   .+++|.+.+..|....++||++++.|+|++.+.++ +|.+..... ...+. -..+.+++++.++||+
T Consensus       433 i~~~g~R~DGR~~~eiRpI~~e~G~Lp~A~GSAlf~~G~TqVLatVtlGp~~~~q~~d~l~~~-~~~~~f~~~y~fPPfs  511 (891)
T PLN00207        433 IVEGGKRSDGRTPDEIRPINSSCGLLPRAHGSALFTRGETQALAVVTLGDKQMAQRIDNLVDA-DEVKRFYLQYSFPPSC  511 (891)
T ss_pred             HhcCCCCCCCCCcCccceEEEEeCCcCCCCceEEEEECCeEEEEEEEecCccccccccccccc-cceeeEEEEEEcCCCC
Confidence            444555554   36899999999999999999999999999999984 776543222 11122 2357788899999999


Q ss_pred             cccc-cCCCCCcchHHHHHHHHHHhhhhhhcc-cCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEE
Q psy6508         179 SQIR-TGWLRDSEEKELGNHLKRALEPAVCRH-EFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSST  256 (477)
Q Consensus       179 ~~~r-~~~~~~~~~~~l~~~i~~~l~~~i~~~-~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s  256 (477)
                      ...+ +...+.+++....++++++++|.+..+ .||. .|+|.++||++||+...+++||+++||+||||||+++|+|++
T Consensus       512 ~ge~~r~g~psrREi~hg~L~eRALrpvip~~~~fP~-tIrV~~~VLesDGSssmAaV~aaSLALmDAGIPmk~~VAGvs  590 (891)
T PLN00207        512 VGEVGRIGAPSRREIGHGMLAERALEPILPSEDDFPY-TIRVESTITESNGSSSMASVCGGCLALQDAGVPVKCPIAGIA  590 (891)
T ss_pred             CccccCCCCCCHHHHHHHHHHHHHHHHhCCcccCCCE-EEEEEEEEEeCCCChHHHHHHHHHHHHHhcCCCccCceeEEE
Confidence            6444 333456677888999999999999875 8995 899999999999999999999999999999999999999999


Q ss_pred             EEee-C-------Ce--EEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeee---cHHHHHHHHHHHH
Q psy6508         257 LALR-G-------GL--TFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTI---QQERLADHIEQLI  323 (477)
Q Consensus       257 ~~~~-~-------~~--~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~---~~~~~~~~l~~~~  323 (477)
                      +++. +       +.  +++||+..|+.            .+.+.+.+.+..+.|+.+++++++   +.+.+.++|+.|.
T Consensus       591 vGli~d~~~~~~~g~~~IL~Dp~g~Ed~------------~gdmDfkVAgT~~gIt~iqmd~k~~gis~e~l~eAL~~A~  658 (891)
T PLN00207        591 MGMVLDTEEFGGDGSPLILSDITGSEDA------------SGDMDFKVAGNEDGITAFQMDIKVGGITLPIMERALLQAK  658 (891)
T ss_pred             EEEEecccccCCCCcEEEEeCCCHHHHh------------cCCceEEEEecccceEEEEEecccCCCCHHHHHHHHHHHH
Confidence            9998 3       23  56799999988            345555555777899999998765   8999999999999


Q ss_pred             hcccchhhHHHHhHhhhccc
Q psy6508         324 GCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       324 ~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ++|..+... |++++...-.
T Consensus       659 ~g~~~Il~~-M~~~i~~pr~  677 (891)
T PLN00207        659 DGRKHILAE-MSKCSPPPSK  677 (891)
T ss_pred             HHHHHHHHH-HHHHHhhhhh
Confidence            999999999 9999866543

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.89  E-value=1.9e-23  Score=203.47  Aligned_cols=172  Identities=23%  Similarity=0.327  Sum_probs=135.7

Q ss_pred             CCCcEEEEEEcccCCCChhH-HHHHHHHHHHHHh---cCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENR-FDSIVNEIKALKL---LHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~---l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+++.||+|.+.+....... ...+.+|..+++.   .+||||+++++.+..++..++||||++|++|.+++..++.+++
T Consensus        17 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~   96 (279)
T cd05633          17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE   96 (279)
T ss_pred             CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCH
Confidence            46889999998766543222 2234455544443   4799999999999999999999999999999999988888999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC-C
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS-K  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~-~  156 (477)
                      ..+..++.|++.||.|||++|++||||||+||+++.++ .+...|||.+.......    .....++..|+|||.... .
T Consensus        97 ~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~  171 (279)
T cd05633          97 KEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGT  171 (279)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCC-CEEEccCCcceeccccC----ccCcCCCcCccCHHHhcCCC
Confidence            99999999999999999999999999999999997653 34456999875433211    123457788999998753 2


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|++  +..||..
T Consensus       172 ~~~~~~Di-~slG~~l~~l~~g~~pf~~  198 (279)
T cd05633         172 AYDSSADW-FSLGCMLFKLLRGHSPFRQ  198 (279)
T ss_pred             CCCchhhh-HHHHHHHHHHHhCCCCcCC
Confidence               67899 9999999999  6778864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.89  E-value=2.2e-23  Score=201.34  Aligned_cols=173  Identities=21%  Similarity=0.285  Sum_probs=136.8

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      +..||+|.++... .....+.+.+|+.++++++||||+++++++..++..|++|||+++++|.+++... +.+++..+..
T Consensus        32 ~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  110 (267)
T cd05066          32 EIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVG  110 (267)
T ss_pred             ceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHH
Confidence            3479999986543 3445578999999999999999999999999999999999999999999999765 4689999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC---Cc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      ++.|++.||.|||++|++||||||+||+++.+. .+...|||.+........ .........+..|+|||...+.   .+
T Consensus       111 i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~  189 (267)
T cd05066         111 MLRGIASGMKYLSDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSA  189 (267)
T ss_pred             HHHHHHHHHHHHHHCCEeehhhchhcEEECCCC-eEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCch
Confidence            999999999999999999999999999997653 455569998765432111 0001111223469999988754   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ |++|+++|++   +..||..
T Consensus       190 ~Dv-~slG~~l~ell~~g~~p~~~  212 (267)
T cd05066         190 SDV-WSYGIVMWEVMSYGERPYWE  212 (267)
T ss_pred             hhh-HHHHHHHHHHhcCCCCCccc
Confidence            899 9999999985   5567653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.89  E-value=3e-23  Score=201.62  Aligned_cols=172  Identities=22%  Similarity=0.340  Sum_probs=141.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.++... .....+.+.+|+.++++++||||+++++.+.+++..|+||||++|++|.+++.. +++++..+.
T Consensus        27 ~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~  104 (277)
T cd06640          27 RTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIA  104 (277)
T ss_pred             cCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHH
Confidence            367899999987553 234457899999999999999999999999999999999999999999999875 578999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++|+||+|+||+++.+. ++...|||.+.......  .......++..|.|||...+.   .+
T Consensus       105 ~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~  181 (277)
T cd06640         105 TMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSK  181 (277)
T ss_pred             HHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC-CEEEcccccceeccCCc--cccccccCcccccCHhHhccCCCccH
Confidence            9999999999999999999999999999997643 34456999876543221  112234566789999987665   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|+++|++  +..||..
T Consensus       182 ~Dv-~slG~il~el~tg~~p~~~  203 (277)
T cd06640         182 ADI-WSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             HHH-HHHHHHHHHHHHCCCCCCC
Confidence            899 9999999999  6677764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.89  E-value=1.5e-23  Score=200.97  Aligned_cols=173  Identities=23%  Similarity=0.357  Sum_probs=141.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      .+|+.||+|.+..........+.+.+|+.++++++||||+++++.+...+..|+|+||+++++|.+++....  .+++..
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  102 (256)
T cd08218          23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQ  102 (256)
T ss_pred             CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHH
Confidence            468899999987665555556788999999999999999999999999999999999999999999987643  588999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++|+||+|+||+++.+. .+...|||..........  ......++..|.|||...+.   
T Consensus       103 ~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~  179 (256)
T cd08218         103 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRPYN  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEEeeccceeecCcchh--hhhhccCCccccCHHHhCCCCCC
Confidence            999999999999999999999999999999997643 234459998765432211  11233466789999997665   


Q ss_pred             CcccccCcceEEEEEE--eeeccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      .++|+ |++|++++++  +..||.
T Consensus       180 ~~~Dv-~slG~i~~~l~~g~~~~~  202 (256)
T cd08218         180 NKSDI-WALGCVLYEMCTLKHAFE  202 (256)
T ss_pred             Cccch-hHHHHHHHHHHcCCCCcc
Confidence            67899 9999999999  556665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.89  E-value=5e-24  Score=206.25  Aligned_cols=164  Identities=21%  Similarity=0.262  Sum_probs=132.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.+|+|.+.......       .|......+ +||||+++++.+...+..|+||||++|++|.+++.....+++..+
T Consensus        39 ~~~~~~~~k~~~~~~~~~-------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~  111 (267)
T PHA03390         39 PTQKLFVQKIIKAKNFNA-------IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEV  111 (267)
T ss_pred             CCCcEEEEEEEehhhcch-------hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHH
Confidence            467889999987653322       122222223 799999999999999999999999999999999988778999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|+++||.|||+.|++||||||+||+++.+.-++...|||.+......      .+..++..|+|||...+.   .
T Consensus       112 ~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~  185 (267)
T PHA03390        112 KKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDV  185 (267)
T ss_pred             HHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCc
Confidence            9999999999999999999999999999999876534455699987654332      123456789999998665   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|++++++  +..||..
T Consensus       186 ~~Dv-wslG~il~~l~~g~~p~~~  208 (267)
T PHA03390        186 SFDW-WAVGVLTYELLTGKHPFKE  208 (267)
T ss_pred             hhhH-HHHHHHHHHHHHCCCCCCC
Confidence            6899 9999999999  6788864

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.89  E-value=1e-23  Score=207.47  Aligned_cols=172  Identities=24%  Similarity=0.366  Sum_probs=137.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+++.||+|.++..... .....+.+|+.++++++||||+++++++..++..++||||++ ++|.+++... ..+++..+
T Consensus        29 ~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~  106 (301)
T cd07873          29 LTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNV  106 (301)
T ss_pred             CCCcEEEEEEEeccccc-CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHH
Confidence            46789999998755422 223457789999999999999999999999999999999997 6999988764 46899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.......  .......++..|+|||...+.    
T Consensus       107 ~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  183 (301)
T cd07873         107 KLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYS  183 (301)
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCC-cEEECcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCc
Confidence            99999999999999999999999999999997653 33445999875432111  111234567889999987553    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|+|  +..||..
T Consensus       184 ~~~Dv-~slG~~l~el~tg~~~f~~  207 (301)
T cd07873         184 TQIDM-WGVGCIFYEMSTGRPLFPG  207 (301)
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            56899 9999999999  6677763

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.89  E-value=2.9e-23  Score=200.42  Aligned_cols=176  Identities=24%  Similarity=0.316  Sum_probs=140.0

Q ss_pred             CCCcEEEEEEcccCCCC---hhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVS---ENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+++.||+|.+......   .+..+.+.+|+.++++++||||+++++++..  ...+++++||+++++|.+++...+.++
T Consensus        25 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~  104 (266)
T cd06651          25 DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALT  104 (266)
T ss_pred             CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCC
Confidence            46889999998765432   2344678899999999999999999998875  367899999999999999998877899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc-CCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ-GNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~-g~t~v~~~~y~ppE~~~~  155 (477)
                      +.....++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+........... .....++..|.|||...+
T Consensus       105 ~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (266)
T cd06651         105 ESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAG-NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG  183 (266)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCCCccccccccccCCccccCCccccccCHHHhCC
Confidence            999999999999999999999999999999999997653 344559998754332111111 112335667999998876


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ |++|++++++  +..||..
T Consensus       184 ~~~~~~~Dv-~slG~i~~el~~g~~pf~~  211 (266)
T cd06651         184 EGYGRKADV-WSLGCTVVEMLTEKPPWAE  211 (266)
T ss_pred             CCCCchhhh-HHHHHHHHHHHHCCCCccc
Confidence            5   57899 9999999999  6678764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=2.1e-23  Score=203.50  Aligned_cols=171  Identities=21%  Similarity=0.244  Sum_probs=142.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++|+.||+|++.... .....+.+.+|+.+++.++||||+++++.+...+..|+||||+++++|.+++.+.+.+++..+.
T Consensus        28 ~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  106 (284)
T cd06620          28 PTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILG  106 (284)
T ss_pred             CCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHH
Confidence            368899999886543 2344567899999999999999999999999999999999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||+ .|++||||||+||+++++. ++.+.|||++.....+    ......++..|+|||...+.   .
T Consensus       107 ~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~  181 (284)
T cd06620         107 KIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTV  181 (284)
T ss_pred             HHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccchhhh----ccCccccCcccCCHHHHccCCCCc
Confidence            999999999999997 6999999999999997643 3445699986533221    11234677889999987654   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|++++++  +..||..
T Consensus       182 ~~Di-~slG~~l~~l~tg~~p~~~  204 (284)
T cd06620         182 KSDV-WSLGISIIELALGKFPFAF  204 (284)
T ss_pred             cchH-HHHHHHHHHHHhCCCCCcc
Confidence            7899 9999999999  6788874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.89  E-value=4e-23  Score=198.69  Aligned_cols=176  Identities=23%  Similarity=0.361  Sum_probs=145.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.|++|.++.........+.+.+|+.+++.++||||+++++.+...+..++++||+++++|.+++.....+++..+.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  102 (264)
T cd06626          23 DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR  102 (264)
T ss_pred             CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHH
Confidence            46889999999877655556788999999999999999999999999999999999999999999999887778999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc--CCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ--GNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~--g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.||.|||++|++|+||+|+||+++++. .+.+.|||.+...........  .....++..|.|||...+.   
T Consensus       103 ~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~  181 (264)
T cd06626         103 VYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNG-VIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGK  181 (264)
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCC
Confidence            9999999999999999999999999999998743 344459998765443222111  1123456689999987643   


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|++++++  +..||..
T Consensus       182 ~~~~~~Dv-~s~G~il~~l~~g~~pf~~  208 (264)
T cd06626         182 GHGRAADI-WSLGCVVLEMATGKRPWSE  208 (264)
T ss_pred             CCCcccch-HHHHHHHHHHHhCCCCccC
Confidence               56899 9999999999  7788864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.89  E-value=1.6e-23  Score=205.57  Aligned_cols=172  Identities=22%  Similarity=0.329  Sum_probs=139.2

Q ss_pred             CCCcEEEEEEcccCCCC---hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCH
Q psy6508           2 EQHTEVAIKCIDKTKVS---ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~   77 (477)
                      .+|+.||||.++.....   ......+.+|+.++++++||||+++++++..++..++||||+ +++|.+++.... .+++
T Consensus        23 ~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~  101 (298)
T cd07841          23 ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTP  101 (298)
T ss_pred             CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCH
Confidence            46889999999776543   233456788999999999999999999999999999999999 799999998765 7999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..+..++.|+++||.|||++|++|+||||+||+++.++ .+.+.|||.+.......  ........+..|.|||...+. 
T Consensus       102 ~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~  178 (298)
T cd07841         102 ADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDG-VLKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGAR  178 (298)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCC-CEEEccceeeeeccCCC--ccccccccceeeeCHHHHhCCC
Confidence            99999999999999999999999999999999998653 34445999886543221  111233456789999987542 


Q ss_pred             ---CcccccCcceEEEEEE--eeeccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                         .++|+ |++|++++++  +.+||.
T Consensus       179 ~~~~~~Dv-~slG~il~e~~~g~~~~~  204 (298)
T cd07841         179 HYGVGVDM-WSVGCIFAELLLRVPFLP  204 (298)
T ss_pred             CCCcHHHH-HHHHHHHHHHHcCCcccc
Confidence               66899 9999999998  544554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.89  E-value=1.1e-23  Score=202.38  Aligned_cols=171  Identities=26%  Similarity=0.354  Sum_probs=137.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~   80 (477)
                      +++.+|+|.+....  ......+.+|+.+++.++||||+++++++......+++|||+++++|.+++.+.  ..+++..+
T Consensus        29 ~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  106 (261)
T cd05148          29 NRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASL  106 (261)
T ss_pred             CCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHH
Confidence            47889999987653  223456889999999999999999999999999999999999999999999763  36899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++++. .+.+.|||.+..........  .+..++..|+|||...+.   .
T Consensus       107 ~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~  183 (261)
T cd05148         107 IDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLS--SDKKIPYKWTAPEAASHGTFST  183 (261)
T ss_pred             HHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCc-eEEEccccchhhcCCccccc--cCCCCceEecCHHHHccCCCCc
Confidence            99999999999999999999999999999997653 34446999876543322211  122344569999987654   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ |++|+++|++   +..||..
T Consensus       184 ~~Di-wslG~~l~~l~~~g~~p~~~  207 (261)
T cd05148         184 KSDV-WSFGILLYEMFTYGQVPYPG  207 (261)
T ss_pred             hhhH-HHHHHHHHHHHcCCCCCCCc
Confidence            7899 9999999998   3566653

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0612|consensus

Probab=99.89  E-value=5.4e-25  Score=233.94  Aligned_cols=173  Identities=25%  Similarity=0.404  Sum_probs=149.6

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++++..+- .....-|+.|-.+|..-+.+-|+.++-+|+++.++|+||||++||+|-.++.+.+++|+..+
T Consensus        98 ~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~A  177 (1317)
T KOG0612|consen   98 STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWA  177 (1317)
T ss_pred             ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHH
Confidence            47889999999886543 22335588999999999999999999999999999999999999999999999889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-Ccceeecccccceecc--cCCcccccCCeEEEeccccccccCCCC-
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKA--KGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~--~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      +.++..|+.||.-||+.|+|||||||+||||+. |.+|+.  |||.+...  +|..   ...+.||||-|.+||++... 
T Consensus       178 rFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLA--DFGsClkm~~dG~V---~s~~aVGTPDYISPEvLqs~~  252 (1317)
T KOG0612|consen  178 RFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLA--DFGSCLKMDADGTV---RSSVAVGTPDYISPEVLQSQG  252 (1317)
T ss_pred             HHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeec--cchhHHhcCCCCcE---EeccccCCCCccCHHHHHhhc
Confidence            999999999999999999999999999999986 566665  99988654  4543   34578999999999987532 


Q ss_pred             -------CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 -------TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 -------~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                             +..|+ ||+|+++|||  |..||...
T Consensus       253 ~~~g~yG~ecDw-WSlGV~~YEMlyG~TPFYad  284 (1317)
T KOG0612|consen  253 DGKGEYGRECDW-WSLGVFMYEMLYGETPFYAD  284 (1317)
T ss_pred             CCccccCCccch-hhhHHHHHHHHcCCCcchHH
Confidence                   67899 9999999999  77999754

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.89  E-value=5.6e-24  Score=207.66  Aligned_cols=169  Identities=27%  Similarity=0.404  Sum_probs=140.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~   81 (477)
                      +++.|++|++.....   ..+.+.+|+.+++.++|||++++++.+..++..|+++||++|++|.+++.... .+++..+.
T Consensus        43 ~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~  119 (286)
T cd06614          43 TGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA  119 (286)
T ss_pred             CCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHH
Confidence            578899999876543   45678899999999999999999999999999999999999999999998876 89999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||+.|++|+||+|+||+++.+ .+++  +|||.........  ....+..++..|.|||...+.   .
T Consensus       120 ~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l--~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~  195 (286)
T cd06614         120 YVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKL--ADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGP  195 (286)
T ss_pred             HHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEE--Cccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCC
Confidence            999999999999999999999999999999864 4444  5888765433221  111233456789999987655   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|+++|++  +..||..
T Consensus       196 ~~Dv-~slGvil~~l~~g~~p~~~  218 (286)
T cd06614         196 KVDI-WSLGIMCIEMAEGEPPYLR  218 (286)
T ss_pred             cccc-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6677763

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.89  E-value=2.5e-23  Score=212.65  Aligned_cols=174  Identities=24%  Similarity=0.316  Sum_probs=135.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------   73 (477)
                      +++.||+|+++.... ....+.+.+|+.+|.++. ||||+++++++..++..++||||+++|+|.+++.+.+        
T Consensus        66 ~~~~vavK~l~~~~~-~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~  144 (401)
T cd05107          66 STMKVAVKMLKSTAR-SSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYL  144 (401)
T ss_pred             CceEEEEEecCCCCC-hhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhc
Confidence            456899999976532 333457889999999997 9999999999999999999999999999999996531        


Q ss_pred             --------------------------------------------------------------------------------
Q psy6508          74 --------------------------------------------------------------------------------   73 (477)
Q Consensus        74 --------------------------------------------------------------------------------   73 (477)
                                                                                                      
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (401)
T cd05107         145 DKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERT  224 (401)
T ss_pred             ccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCc
Confidence                                                                                            


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEE
Q psy6508          74 ----------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVI  143 (477)
Q Consensus        74 ----------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~  143 (477)
                                .+++..+..++.|++.||.|||++|++||||||+|||++.+. .+.+.|||++.............+..+
T Consensus       225 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~  303 (401)
T cd05107         225 RRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFL  303 (401)
T ss_pred             chhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCC-EEEEEecCcceecccccccccCCCcCC
Confidence                      256677889999999999999999999999999999997643 344569998764321111111223345


Q ss_pred             eccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         144 CSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       144 ~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +..|+|||...+.   .++|+ |++|++++|+   +..||..
T Consensus       304 ~~~y~aPE~~~~~~~~~~~Dv-wslGvil~e~l~~g~~P~~~  344 (401)
T cd05107         304 PLKWMAPESIFNNLYTTLSDV-WSFGILLWEIFTLGGTPYPE  344 (401)
T ss_pred             CCceeChHHhcCCCCCcHhHH-HHHHHHHHHHHHcCCCCCCC
Confidence            6679999988655   67899 9999999997   3466653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=4.7e-24  Score=207.02  Aligned_cols=172  Identities=22%  Similarity=0.343  Sum_probs=140.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC---CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH---HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+++.||+|.++... .....+++.+|+.++++++   |||++++++++..+...|++|||++|++|.+++.. +.+++.
T Consensus        24 ~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~  101 (277)
T cd06917          24 PTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEK  101 (277)
T ss_pred             CCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHH
Confidence            478899999987543 2334567889999999996   99999999999999999999999999999999876 479999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||+.|++|+||+|+||++++++ ++.+.|||.+.......  .......++..|+|||...+.  
T Consensus       102 ~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~  178 (277)
T cd06917         102 YISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTG-NVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKY  178 (277)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCC-CEEEccCCceeecCCCc--cccccccCCcceeCHHHhccCCc
Confidence            9999999999999999999999999999999998642 34456999876543221  112334567789999987543  


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|+++|++  +..||..
T Consensus       179 ~~~~~Dv-~slG~~l~~ll~g~~p~~~  204 (277)
T cd06917         179 YDTKADI-WSLGITIYEMATGNPPYSD  204 (277)
T ss_pred             cccchhH-HHHHHHHHHHHhCCCCCCC
Confidence              57899 9999999999  6788864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.89  E-value=2.1e-24  Score=207.80  Aligned_cols=171  Identities=23%  Similarity=0.298  Sum_probs=141.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+++.||+|.+..... ....+++.+|+.++++++||||+++++.+..++..++++||+++++|.+++... ..+++..+
T Consensus        24 ~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  102 (265)
T cd06605          24 PTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERIL  102 (265)
T ss_pred             CCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHH
Confidence            4688999999876543 345577899999999999999999999999999999999999999999999876 67999999


Q ss_pred             HHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++.|++.||.|||+ .|++|+||||+||+++++. .+.+.|||.+......    ......++..|+|||...+.   
T Consensus       103 ~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~~~  177 (265)
T cd06605         103 GKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRG-QIKLCDFGVSGQLVNS----LAKTFVGTSSYMAPERIQGNDYS  177 (265)
T ss_pred             HHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCC-CEEEeecccchhhHHH----HhhcccCChhccCHHHHcCCCCC
Confidence            9999999999999999 9999999999999998743 3444599987543221    11124566789999987665   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|++++++  +..||..
T Consensus       178 ~~~Dv-~slG~~l~~l~~g~~p~~~  201 (265)
T cd06605         178 VKSDI-WSLGLSLIELATGRFPYPP  201 (265)
T ss_pred             chhhH-HHHHHHHHHHHhCCCCCCc
Confidence            67899 9999999999  5677764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.89  E-value=3.2e-23  Score=199.52  Aligned_cols=175  Identities=22%  Similarity=0.314  Sum_probs=142.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---~~l~~~   78 (477)
                      .++..||+|++....... ..+.+.+|+.+++.++||||+++++.+...+..|++||+++|++|.+++...   ..+++.
T Consensus        24 ~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~  102 (267)
T cd06610          24 PNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEA  102 (267)
T ss_pred             CCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHH
Confidence            367889999987665444 5677999999999999999999999999999999999999999999999764   358999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc--ccCCeEEEeccccccccCCCC
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--EQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      .+..++.|++.||.|||++|++||||+|+||+++++. .+.++|||.+.........  .......++..|+|||.....
T Consensus       103 ~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~  181 (267)
T cd06610         103 IIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQV  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCC-CEEEcccchHHHhccCccccccccccccCChhhcChHHHccc
Confidence            9999999999999999999999999999999998653 3445599987543322111  122344667789999986543


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ |++|++++++  +..||..
T Consensus       182 ~~~~~~~Dv-~slG~i~~~l~~g~~p~~~  209 (267)
T cd06610         182 HGYDFKADI-WSFGITAIELATGAAPYSK  209 (267)
T ss_pred             cCcCcccch-HhHhHHHHHHHhCCCCccc
Confidence                66899 9999999999  6677754

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.89  E-value=1.3e-23  Score=199.62  Aligned_cols=162  Identities=18%  Similarity=0.307  Sum_probs=131.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.++...       .+.+|...+....||||+++++.+...+..|++|||++|++|.+++.+...+++..+.
T Consensus        16 ~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~   88 (237)
T cd05576          16 RTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK   88 (237)
T ss_pred             cCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHH
Confidence            578999999987643       1234555556667999999999999999999999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++|++||||||+||+++.+ .+++  .|||.+.......     .+...+..|+|||...+.   .
T Consensus        89 ~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l--~df~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~  161 (237)
T cd05576          89 RWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL--TYFSRWSEVEDSC-----DGEAVENMYCAPEVGGISEETE  161 (237)
T ss_pred             HHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEE--ecccchhcccccc-----ccCCcCccccCCcccCCCCCCc
Confidence            999999999999999999999999999999764 4444  5888764433221     223345679999987654   6


Q ss_pred             cccccCcceEEEEEE--eeeccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++|+ |++|+++|++  +..||.
T Consensus       162 ~~Dv-wslG~il~el~~g~~~~~  183 (237)
T cd05576         162 ACDW-WSLGAILFELLTGKTLVE  183 (237)
T ss_pred             hhhH-HHHHHHHHHHHHCcchhh
Confidence            7899 9999999998  656554

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.89  E-value=3.3e-23  Score=198.28  Aligned_cols=171  Identities=24%  Similarity=0.371  Sum_probs=138.7

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC--CCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK--LSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~--l~~~~~~   81 (477)
                      +..||+|.++.... ....+.+.+|+.+++.++||||+++++.+...+..|++|||+++++|.+++.....  +++..+.
T Consensus        28 ~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~  106 (258)
T smart00219       28 EVEVAVKTLKEDAD-EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLL  106 (258)
T ss_pred             CceEEEEEccCCCC-hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHH
Confidence            58899999865532 23567899999999999999999999999999999999999999999999987544  9999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++++. .+.++|||.+............ ...++..|+|||...+.   .+
T Consensus       107 ~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~-~~~~~~~y~~Pe~~~~~~~~~~  184 (258)
T smart00219      107 SFALQIARGMEYLESKNFIHRDLAARNCLVGENL-VVKISDFGLSRDLYDDDYYKKK-GGKLPIRWMAPESLKDGKFTSK  184 (258)
T ss_pred             HHHHHHHHHHHHHhcCCeeecccccceEEEccCC-eEEEcccCCceecccccccccc-cCCCcccccChHHhccCCCCcc
Confidence            9999999999999999999999999999998764 4444599987654432221111 11245679999987544   77


Q ss_pred             ccccCcceEEEEEE---eeeccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      +|+ |++|++++++   +..||.
T Consensus       185 ~Di-~slG~i~~~l~~~g~~p~~  206 (258)
T smart00219      185 SDV-WSFGVLLWEIFTLGESPYP  206 (258)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999988   456665

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.89  E-value=7.1e-24  Score=202.56  Aligned_cols=174  Identities=29%  Similarity=0.408  Sum_probs=145.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----CCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----EKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~l~~   77 (477)
                      ++++.|++|++..........+.+.+|+++++.++|||++++++.+..+...++++||+++++|.+++...    ..+++
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  102 (258)
T cd08215          23 SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE  102 (258)
T ss_pred             CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCH
Confidence            46889999999877665566778999999999999999999999999999999999999999999999764    57999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..+..++.|++.||.|||++|++|+||+|+||+++++. .+.+.|||.+.......  ....+..+++.|+|||...+. 
T Consensus       103 ~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~  179 (258)
T cd08215         103 EQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNG-LVKLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKP  179 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCC-cEEECCccceeecccCc--ceecceeeeecccChhHhccCC
Confidence            99999999999999999999999999999999998642 33445888876543322  223445677889999987655 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|++++++  +..||..
T Consensus       180 ~~~~~Dv-~slG~~~~~l~~g~~p~~~  205 (258)
T cd08215         180 YNYKSDI-WSLGCVLYELCTLKHPFEG  205 (258)
T ss_pred             CCccccH-HHHHHHHHHHHcCCCCCCC
Confidence              67899 9999999998  5566653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.89  E-value=6.1e-24  Score=206.97  Aligned_cols=171  Identities=30%  Similarity=0.435  Sum_probs=136.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+|+.||+|.++...........+.+|+.++++++||||+++++++.+.+..|+++||++ ++|.+++.. .+.+++..+
T Consensus        23 ~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  101 (284)
T cd07839          23 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIV  101 (284)
T ss_pred             CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHH
Confidence            478899999997654444344567889999999999999999999999999999999997 688888765 457999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.||++||.|||++|++||||||+||+++.++ ++.+.|||.+.......  .......++..|+|||...+.    
T Consensus       102 ~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  178 (284)
T cd07839         102 KSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG-ELKLADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYS  178 (284)
T ss_pred             HHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC-cEEECccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccC
Confidence            99999999999999999999999999999997642 33445999875432111  111234567789999987553    


Q ss_pred             CcccccCcceEEEEEE--eeecc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPF  177 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf  177 (477)
                      .++|+ ||+|+++|+|  +..||
T Consensus       179 ~~~Di-wslG~il~~l~tg~~p~  200 (284)
T cd07839         179 TSIDM-WSAGCIFAELANAGRPL  200 (284)
T ss_pred             cHHHH-HHHHHHHHHHHhcCCCC
Confidence            56899 9999999999  44444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.89  E-value=2.9e-23  Score=203.93  Aligned_cols=168  Identities=26%  Similarity=0.348  Sum_probs=131.8

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-----------
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-----------   73 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------   73 (477)
                      .+++|.++.. ......+.+.+|+.+++++ +||||+++++++...+.+|++|||+++++|.+++.+..           
T Consensus        31 ~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  109 (297)
T cd05089          31 NAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKE  109 (297)
T ss_pred             eeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccc
Confidence            4788887632 2334456789999999999 79999999999999999999999999999999997532           


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          74 -----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        74 -----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                           .+++..++.++.|++.||+|||++|++||||||+||+++.+. ...+.|||++........   ......+..|+
T Consensus       110 ~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~  185 (297)
T cd05089         110 HGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENL-ASKIADFGLSRGEEVYVK---KTMGRLPVRWM  185 (297)
T ss_pred             cCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCC-eEEECCcCCCccccceec---cCCCCcCcccc
Confidence                 478899999999999999999999999999999999997653 334459998753321110   01111234699


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |||...+.   .++|+ ||+|+++|||   +..||..
T Consensus       186 aPE~~~~~~~~~~~Dv-wSlG~il~el~t~g~~pf~~  221 (297)
T cd05089         186 AIESLNYSVYTTKSDV-WSFGVLLWEIVSLGGTPYCG  221 (297)
T ss_pred             CchhhccCCCCchhhH-HHHHHHHHHHHcCCCCCCCC
Confidence            99987655   67899 9999999998   4467753

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.89  E-value=6.8e-24  Score=206.74  Aligned_cols=173  Identities=20%  Similarity=0.311  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++++.||+|.+..........+.+.+|+.+++.++||||+++++++..++..|+++||+++++|..+......+++..+.
T Consensus        24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  103 (286)
T cd07846          24 ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVR  103 (286)
T ss_pred             CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHH
Confidence            46889999998765544444567889999999999999999999999999999999999999998887766679999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||.|||++|++||||+|+||+++++. .+.+.|||.+........  ......++..|+|||...+.    .
T Consensus       104 ~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  180 (286)
T cd07846         104 KYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPELLVGDTKYGR  180 (286)
T ss_pred             HHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC-cEEEEeeeeeeeccCCcc--ccCcccceeeccCcHHhccccccCc
Confidence            9999999999999999999999999999997653 344459998765433221  11234567789999987643    5


Q ss_pred             cccccCcceEEEEEE--eeeccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++|+ ||+|++++++  +..||.
T Consensus       181 ~~Dv-~slG~~l~el~~g~~~~~  202 (286)
T cd07846         181 AVDI-WAVGCLVTEMLTGEPLFP  202 (286)
T ss_pred             hHhH-HHHHHHHHHHHcCCCCCC
Confidence            6899 9999999999  545554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=4.6e-24  Score=205.09  Aligned_cols=172  Identities=24%  Similarity=0.335  Sum_probs=137.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      ++++.||||.+......   .+++.+|+.++++++||||+++++++..+...+++|||+++++|.+++....  .+++..
T Consensus        28 ~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~  104 (261)
T cd05034          28 NGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQ  104 (261)
T ss_pred             cCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHH
Confidence            34577999998765433   3568899999999999999999999998899999999999999999997643  689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.|+.|||++|++|+||||+||+++++. .+...|||.+........ ........+..|.|||...+.   
T Consensus       105 ~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~  182 (261)
T cd05034         105 LVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENL-VCKIADFGLARLIEDDEY-TAREGAKFPIKWTAPEAANYGRFT  182 (261)
T ss_pred             HHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCC-CEEECccccceeccchhh-hhhhccCCCccccCHHHhccCCcC
Confidence            999999999999999999999999999999997652 334459998754332111 111122234579999988765   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ |++|++++++   +..||.+
T Consensus       183 ~~~Di-~slG~il~~l~t~g~~p~~~  207 (261)
T cd05034         183 IKSDV-WSFGILLTEIVTYGRVPYPG  207 (261)
T ss_pred             chhHH-HHHHHHHHHHHhCCCCCCCC
Confidence            67899 9999999987   5677754

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.89  E-value=4.3e-24  Score=205.07  Aligned_cols=175  Identities=29%  Similarity=0.454  Sum_probs=142.1

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.|++|.+...... ....+.+.+|+.++++++||||+++++.+..+...|+++||++|++|.+++.+.+.+++..+
T Consensus        16 ~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~   95 (265)
T cd05579          16 STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVA   95 (265)
T ss_pred             CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHH
Confidence            46899999998765432 34557799999999999999999999999999999999999999999999988778999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCccc------ccCCeEEEeccccccccC
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYI------EQGNTKVICSVFEPREIP  153 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~------~~g~t~v~~~~y~ppE~~  153 (477)
                      ..++.|++.||.|||++|++||||+|+||+++++ .+++  .|||.+.........      .......+...|.|||..
T Consensus        96 ~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l--~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~  173 (265)
T cd05579          96 RIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKL--TDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI  173 (265)
T ss_pred             HHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEE--EecccchhcccCcccccccccccccCcccCccccCHHHh
Confidence            9999999999999999999999999999999764 4444  589887543221110      011223455679999987


Q ss_pred             CCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         154 SSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+.   .++|+ |++|++++++  +..||..
T Consensus       174 ~~~~~~~~~Dv-~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         174 LGQGHSKTVDW-WSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             cCCCCCcchhh-HHHHHHHHHHHhCCCCCCC
Confidence            655   57899 9999999999  6677753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.89  E-value=2.5e-23  Score=201.37  Aligned_cols=168  Identities=24%  Similarity=0.336  Sum_probs=132.5

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-----------
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-----------   73 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----------   73 (477)
                      .+++|.++... .....+.+.+|+.+++++ +||||+++++++...+.+|++|||+++++|.+++....           
T Consensus        24 ~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~  102 (270)
T cd05047          24 DAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA  102 (270)
T ss_pred             EEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccc
Confidence            46888876432 334456789999999999 89999999999999999999999999999999997542           


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          74 -----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        74 -----~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                           .+++..++.++.|++.||+|||++|++||||||+||+++.+. ++...|||++......   ........+..|+
T Consensus       103 ~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~-~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~  178 (270)
T cd05047         103 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVY---VKKTMGRLPVRWM  178 (270)
T ss_pred             cCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCC-eEEECCCCCccccchh---hhccCCCCccccC
Confidence                 378899999999999999999999999999999999997643 3445699987532211   1111122244699


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |||.....   .++|+ ||+|++++|+   +..||.+
T Consensus       179 apE~~~~~~~~~~~Di-~slG~il~el~~~g~~pf~~  214 (270)
T cd05047         179 AIESLNYSVYTTNSDV-WSYGVLLWEIVSLGGTPYCG  214 (270)
T ss_pred             ChHHHccCCCCchhhH-HHHHHHHHHHHcCCCCCccc
Confidence            99987655   67899 9999999998   4567753

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.89  E-value=3.8e-23  Score=198.00  Aligned_cols=173  Identities=22%  Similarity=0.328  Sum_probs=142.1

Q ss_pred             CCCcEEEEEEcccCCC---ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKV---SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      ++++.|++|.+.....   .++..+.+.+|+.+++.++||||+++++++.....+|+++||++|++|.+++.+.+.+++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  102 (258)
T cd06632          23 DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEP  102 (258)
T ss_pred             CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHH
Confidence            3788999999866542   2345578999999999999999999999999999999999999999999999887779999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||+.|++|+||+|+||+++.+. .+.+.|||.+.......   ...+..++..|+|||.....  
T Consensus       103 ~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~-~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~  178 (258)
T cd06632         103 VIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNG-VVKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGG  178 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEccCccceeccccc---cccccCCCcceeCHHHhcCCCC
Confidence            9999999999999999999999999999999997643 34445998876543221   12334566779999976543  


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|++++++  +..||..
T Consensus       179 ~~~~~D~-~slG~~l~~l~~g~~pf~~  204 (258)
T cd06632         179 YGLAADI-WSLGCTVLEMATGKPPWSQ  204 (258)
T ss_pred             CCchhhh-HHHHHHHHHHHhCCCCccc
Confidence              56899 9999999999  6677754

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.89  E-value=3.2e-23  Score=198.74  Aligned_cols=167  Identities=22%  Similarity=0.371  Sum_probs=136.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~   80 (477)
                      .|+.||+|.++....   ..+++.+|+.+++.++||||+++++++...+..+++|||+++++|.+++....  .+++..+
T Consensus        28 ~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~  104 (256)
T cd05039          28 RGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQ  104 (256)
T ss_pred             cCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHH
Confidence            478899999875532   45678999999999999999999999998999999999999999999998765  6899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. ++.+.|||.+.......     ........|.|||.....   .
T Consensus       105 ~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~~~-----~~~~~~~~~~ape~~~~~~~~~  178 (256)
T cd05039         105 LGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQGQ-----DSGKLPVKWTAPEALREKKFST  178 (256)
T ss_pred             HHHHHHHHHHHHHHHhCCccchhcccceEEEeCCC-CEEEccccccccccccc-----ccCCCcccccCchhhcCCcCCc
Confidence            99999999999999999999999999999997653 33445999876542211     112223469999987654   5


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|++++++   +..||..
T Consensus       179 ~~Di-~slG~il~~l~~~g~~p~~~  202 (256)
T cd05039         179 KSDV-WSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             HHHH-HHHHHHHHHHHhcCCCCCCC
Confidence            6899 9999999987   5567653

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.89  E-value=3.2e-24  Score=210.88  Aligned_cols=170  Identities=22%  Similarity=0.345  Sum_probs=139.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.+.....  ...+.+.+|+.+++.++||||+++++.+..++..|+++||+++++|.+++.. ..+++..+.
T Consensus        44 ~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~  120 (297)
T cd06659          44 HSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIA  120 (297)
T ss_pred             CCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHH
Confidence            3688999999865432  2345688999999999999999999999999999999999999999998765 568999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.......  .......++..|.|||...+.   .+
T Consensus       121 ~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  197 (297)
T cd06659         121 TVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTE  197 (297)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCC-cEEEeechhHhhccccc--ccccceecCccccCHHHHccCCCCch
Confidence            9999999999999999999999999999997643 34456999875332111  112345677789999988664   67


Q ss_pred             ccccCcceEEEEEE--eeeccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      +|+ |++|++++|+  +..||.
T Consensus       198 ~Dv-~slG~il~el~~g~~p~~  218 (297)
T cd06659         198 VDI-WSLGIMVIEMVDGEPPYF  218 (297)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCC
Confidence            899 9999999999  667775

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=6e-24  Score=205.39  Aligned_cols=171  Identities=24%  Similarity=0.370  Sum_probs=136.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHh---
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRS---   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~---   71 (477)
                      .+++.|++|++.....   ..+.+.+|+.+++++ +||||+++++++....      .+|++|||+++++|.+++..   
T Consensus        29 ~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~  105 (275)
T cd06608          29 KTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRK  105 (275)
T ss_pred             CCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhh
Confidence            4678899999875532   345788999999999 7999999999987644      48999999999999999865   


Q ss_pred             -CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          72 -HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        72 -~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                       ...+++..+..++.|++.||.|||++|++|+||+|+||+++.+. ++.++|||.+.......  .......++..|+||
T Consensus       106 ~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~aP  182 (275)
T cd06608         106 KGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNA-EVKLVDFGVSAQLDSTL--GRRNTFIGTPYWMAP  182 (275)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCC-eEEECCCccceecccch--hhhcCccccccccCH
Confidence             34789999999999999999999999999999999999997642 34445999875443221  122345577789999


Q ss_pred             ccCCCC--------CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK--------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~--------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |.....        .++|+ |++|++++++  +..||..
T Consensus       183 E~~~~~~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         183 EVIACDEQPDASYDARSDV-WSLGITAIELADGKPPLCD  220 (275)
T ss_pred             hHhcccccccCCccccccH-HHhHHHHHHHHhCCCCccc
Confidence            986432        46899 9999999999  6778764

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.89  E-value=4e-23  Score=202.02  Aligned_cols=174  Identities=21%  Similarity=0.339  Sum_probs=141.0

Q ss_pred             CCCcEEEEEEcccCCCC--hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVS--ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      ++|+.||+|+++.....  ....+.+.+|+.+++++ +||||+++++.++.+...|+||||+++++|.+++...+.+++.
T Consensus        26 ~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~  105 (290)
T cd05613          26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ  105 (290)
T ss_pred             CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHH
Confidence            36889999998764322  22346688999999999 6999999999999999999999999999999999887789999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++|++||||+|+||+++.+. ++.+.|||++........ .......++..|+|||...+.  
T Consensus       106 ~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~  183 (290)
T cd05613         106 EVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDG  183 (290)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCC-CEEEeeCccceecccccc-cccccccCCcccCChhhccCCCC
Confidence            9999999999999999999999999999999997643 455569998765432211 111234566789999987642  


Q ss_pred             ---CcccccCcceEEEEEE--eeeccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                         .++|+ |++|+++|++  +..||.
T Consensus       184 ~~~~~~Dv-~slG~~l~~ll~g~~p~~  209 (290)
T cd05613         184 GHDKAVDW-WSMGVLMYELLTGASPFT  209 (290)
T ss_pred             CCCccccH-HHHHHHHHHHhcCCCCCC
Confidence               56899 9999999999  556765

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.89  E-value=3.3e-23  Score=198.63  Aligned_cols=163  Identities=17%  Similarity=0.206  Sum_probs=131.8

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~   84 (477)
                      .|++|.+.....   ....+.+|+.+++.++||||+++++++.. ...++||||+++++|.+++...+ .++...+..++
T Consensus        32 ~v~~k~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  107 (259)
T cd05037          32 SVVLKVLGSDHR---DSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVA  107 (259)
T ss_pred             eeeeeccccchh---hHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHH
Confidence            577887654431   15678899999999999999999999887 77899999999999999998765 68999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCc------ceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNT------LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~------~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .|++.||.|||++||+||||||+||+++.+.      ..+..+|||.+.....      .....+...|.|||...+.  
T Consensus       108 ~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~  181 (259)
T cd05037         108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQA  181 (259)
T ss_pred             HHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCC
Confidence            9999999999999999999999999997644      2355569998754332      2234455679999987543  


Q ss_pred             ---CcccccCcceEEEEEE---eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                         .++|+ ||+|++++++   +..||..
T Consensus       182 ~~~~~~Di-~slG~~~~~l~~~~~~p~~~  209 (259)
T cd05037         182 SLTIAADK-WSFGTTLLEICSNGEEPLST  209 (259)
T ss_pred             CcchhhHH-HHHHHHHHHHHhCCCCCccc
Confidence               56899 9999999998   3466654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=8.6e-23  Score=194.92  Aligned_cols=174  Identities=29%  Similarity=0.375  Sum_probs=145.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.|++|.+......+...+.+.+|+.++++++|||++++++++..++..+++|||+++++|.+++.....+++..+.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~  102 (254)
T cd06627          23 ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA  102 (254)
T ss_pred             CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHH
Confidence            46789999999887665566778999999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||+|+||+++.+. .+.+.|||.+........  ......++..|.|||...+.   .+
T Consensus       103 ~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~  179 (254)
T cd06627         103 VYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDG-VVKLADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTA  179 (254)
T ss_pred             HHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCC-CEEEeccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcc
Confidence            9999999999999999999999999999998642 344459998765443221  12234567789999987655   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|++++++  +..||..
T Consensus       180 ~Dv-~~lG~~l~~l~~g~~p~~~  201 (254)
T cd06627         180 SDI-WSLGCTVIELLTGNPPYYD  201 (254)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999999  5667753

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.89  E-value=2.1e-23  Score=206.65  Aligned_cols=171  Identities=22%  Similarity=0.367  Sum_probs=134.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSH--------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~--------   72 (477)
                      +++.||+|.+......    ..+.+|+.++++++||||+++++++..  +...|++|||++ ++|.+++...        
T Consensus        27 ~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~  101 (317)
T cd07867          27 DEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKK  101 (317)
T ss_pred             ccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCC
Confidence            5678999998655322    346789999999999999999998853  567899999997 6888887532        


Q ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc---CcceeecccccceecccCCcc-cccCCeEEEeccc
Q psy6508          73 -EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVF  147 (477)
Q Consensus        73 -~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~---~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y  147 (477)
                       ..+++..+..++.|++.||.|||++||+||||||+||++..   ...++.++|||.+........ .....+..++..|
T Consensus       102 ~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y  181 (317)
T cd07867         102 PMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY  181 (317)
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccc
Confidence             24889999999999999999999999999999999999942   233455669999865432211 1122345778899


Q ss_pred             cccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         148 EPREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       148 ~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|||...+.    .++|+ ||+|+++||+  +..||..
T Consensus       182 ~aPE~~~~~~~~~~~~Di-wSlG~il~el~tg~~~f~~  218 (317)
T cd07867         182 RAPELLLGARHYTKAIDI-WAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             cCcHHhcCCCccCcHHHH-HhHHHHHHHHHhCCCCccc
Confidence            999987653    56899 9999999999  6678864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.89  E-value=4.8e-23  Score=197.77  Aligned_cols=174  Identities=28%  Similarity=0.386  Sum_probs=143.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHh----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRS----HEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~----~~~l   75 (477)
                      .+|+.||+|.++.........+++.+|+.+++.++||||+++++.+..  ....|++|||+++++|.+++..    ..++
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l  102 (265)
T cd08217          23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI  102 (265)
T ss_pred             CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCC
Confidence            467899999998776666667789999999999999999999998753  4578999999999999999976    3578


Q ss_pred             CHHHHHHHHHHHHHHHHHHH-----hCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          76 SEFQCQQFVRQLVLALKFLR-----ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH-----~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                      ++..++.++.|++.||.|||     +.+++|+||||+||+++++. ++.+.|||.+........  ...+..++..|+||
T Consensus       103 ~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~-~~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~p  179 (265)
T cd08217         103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANN-NVKLGDFGLAKILGHDSS--FAKTYVGTPYYMSP  179 (265)
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCC-CEEEecccccccccCCcc--cccccccCCCccCh
Confidence            99999999999999999999     89999999999999998642 344459998765443221  12345678889999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.   .++|+ |++|++++++  +..||..
T Consensus       180 E~~~~~~~~~~~Dv-~slG~il~~l~~g~~p~~~  212 (265)
T cd08217         180 EQLNHMSYDEKSDI-WSLGCLIYELCALSPPFTA  212 (265)
T ss_pred             hhhcCCCCCchhHH-HHHHHHHHHHHHCCCcccC
Confidence            998765   56899 9999999999  6677764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.89  E-value=1.1e-23  Score=206.43  Aligned_cols=174  Identities=25%  Similarity=0.332  Sum_probs=136.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCe-----EEEEEecCCCCCHHHHHHhC---
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFIRSH---   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~-----~~lv~e~~~g~sL~~~l~~~---   72 (477)
                      .+|+.||+|.++...........+.+|+.+++.+ +||||+++++++...+.     .|++|||++ ++|.+++...   
T Consensus        24 ~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~  102 (295)
T cd07837          24 NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLD-SDLKKFMDSNGRG  102 (295)
T ss_pred             CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccC-cCHHHHHHHhccc
Confidence            4788999999876544333446788999999999 56999999999876655     899999998 5899988653   


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          73 --EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        73 --~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                        ..+++..++.++.|++.||.|||++|++||||||+||+++.+...+.+.|||.+......  .........++.|.||
T Consensus       103 ~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~aP  180 (295)
T cd07837         103 PGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP--VKSYTHEIVTLWYRAP  180 (295)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCC--ccccCCcccccCCCCh
Confidence              357999999999999999999999999999999999999874345555699987543211  1111234567789999


Q ss_pred             ccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.    .++|+ |++|+++|++  +..||.+
T Consensus       181 E~~~~~~~~~~~~Di-~slG~~l~~l~~g~~~~~~  214 (295)
T cd07837         181 EVLLGSTHYSTPVDI-WSVGCIFAEMSRKQPLFPG  214 (295)
T ss_pred             HHhhCCCCCCchHHH-HHHHHHHHHHHcCCCCCCC
Confidence            977543    67899 9999999998  6667753

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.89  E-value=6.3e-24  Score=206.75  Aligned_cols=173  Identities=26%  Similarity=0.357  Sum_probs=140.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      .+|+.||+|++..........+.+.+|+.+++.++|||++++++++..++..|++|||++ ++|.+++....  .+++..
T Consensus        22 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~  100 (283)
T cd07835          22 LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPL  100 (283)
T ss_pred             CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHH
Confidence            478999999987665444444678899999999999999999999999999999999996 79999998765  689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||+|+||+++.+. .+.+.|||.+.......  .......++..|+|||...+.   
T Consensus       101 ~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~  177 (283)
T cd07835         101 IKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG-ALKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQY  177 (283)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-cEEEeecccccccCCCc--cccCccccccCCCCCceeecCccc
Confidence            999999999999999999999999999999997642 44556999875432111  111233557789999987543   


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ |++|+++|++  +..||..
T Consensus       178 ~~~~Di-~slG~~l~~l~~g~~pf~~  202 (283)
T cd07835         178 STPVDI-WSIGCIFAEMVNRRPLFPG  202 (283)
T ss_pred             CcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence             56899 9999999999  6677753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.89  E-value=1.1e-23  Score=205.89  Aligned_cols=171  Identities=22%  Similarity=0.349  Sum_probs=139.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.|++|+++...  ....+.+.+|+.+++.++||||+++++++...+..++++||++|++|.+++.. +++++..+.
T Consensus        42 ~~~~~~~iK~~~~~~--~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~  118 (285)
T cd06648          42 STGRQVAVKKMDLRK--QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIA  118 (285)
T ss_pred             CCCCEEEEEEEeccc--hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHH
Confidence            467889999886442  33345688999999999999999999999999999999999999999999987 579999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||+|+||+++.+. .+.++|||.........  .......++..|+|||...+.   .+
T Consensus       119 ~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~  195 (285)
T cd06648         119 TVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTE  195 (285)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCC-cEEEcccccchhhccCC--cccccccCCccccCHHHhcCCCCCCc
Confidence            9999999999999999999999999999997643 34445888764332211  111234567789999998665   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|++++++  +..||..
T Consensus       196 ~Dv-~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         196 VDI-WSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             ccH-HHHHHHHHHHHhCCCCCcC
Confidence            899 9999999999  6677753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.89  E-value=1.1e-23  Score=203.42  Aligned_cols=171  Identities=22%  Similarity=0.294  Sum_probs=135.5

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i   83 (477)
                      ..||+|.++... .....+.+.+|+.++++++||||+++++++...+..|++|||+++++|.+++... +.+++..+..+
T Consensus        34 ~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~  112 (268)
T cd05063          34 VAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGM  112 (268)
T ss_pred             eEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHH
Confidence            379999986543 3444567899999999999999999999999999999999999999999999764 47899999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCC-eEEEeccccccccCCCC---Ccc
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGN-TKVICSVFEPREIPSSK---TSL  159 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~-t~v~~~~y~ppE~~~~~---~~~  159 (477)
                      +.|++.||.|||++|++||||||+||+++.+. .+...|||.+............. .......|+|||.....   .++
T Consensus       113 ~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  191 (268)
T cd05063         113 LRGIAAGMKYLSDMNYVHRDLAARNILVNSNL-ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS  191 (268)
T ss_pred             HHHHHHHHHHHHHCCeeccccchhhEEEcCCC-cEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHh
Confidence            99999999999999999999999999997643 34455999876543221111110 11122469999987654   678


Q ss_pred             cccCcceEEEEEE---eeeccc
Q psy6508         160 EYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       160 Di~~s~G~il~e~---~~~Pf~  178 (477)
                      |+ ||+|+++||+   +..||.
T Consensus       192 Dv-~slG~il~ell~~g~~p~~  212 (268)
T cd05063         192 DV-WSFGIVMWEVMSFGERPYW  212 (268)
T ss_pred             HH-HHHHHHHHHHHhCCCCCCC
Confidence            99 9999999995   566765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.89  E-value=7.8e-24  Score=212.52  Aligned_cols=174  Identities=20%  Similarity=0.298  Sum_probs=133.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHHhC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD-ERYVYIILEYCDGGDLCSFIRSH--------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~--------   72 (477)
                      +++.||||+++... .......+.+|+.++.++ +||||+++++++.. +..++++|||+++|+|.+++...        
T Consensus        36 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~  114 (343)
T cd05103          36 TCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK  114 (343)
T ss_pred             cceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccc
Confidence            57889999987543 233456788999999999 78999999998764 45789999999999999998642        


Q ss_pred             -----------------------------------------------------------CCCCHHHHHHHHHHHHHHHHH
Q psy6508          73 -----------------------------------------------------------EKLSEFQCQQFVRQLVLALKF   93 (477)
Q Consensus        73 -----------------------------------------------------------~~l~~~~~~~i~~qi~~aL~~   93 (477)
                                                                                 ..+++..+..++.|++.||.|
T Consensus       115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  194 (343)
T cd05103         115 TKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF  194 (343)
T ss_pred             ccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHH
Confidence                                                                       136777888999999999999


Q ss_pred             HHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEE
Q psy6508          94 LRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYV  170 (477)
Q Consensus        94 LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~  170 (477)
                      ||++||+||||||+||+++.+. .+.++|||.+.............+..++..|+|||...+.   .++|+ |++|++++
T Consensus       195 lH~~~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~~l~  272 (343)
T cd05103         195 LASRKCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV-WSFGVLLW  272 (343)
T ss_pred             HHhCCeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhH-HHHHHHHH
Confidence            9999999999999999997542 3444599987653222111111122334569999987655   67899 99999999


Q ss_pred             EE---eeecccc
Q psy6508         171 EF---KFAPFAS  179 (477)
Q Consensus       171 e~---~~~Pf~~  179 (477)
                      ++   +..||..
T Consensus       273 el~~~g~~p~~~  284 (343)
T cd05103         273 EIFSLGASPYPG  284 (343)
T ss_pred             HHHHCCCCCCCC
Confidence            97   5567653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.89  E-value=1.1e-23  Score=202.48  Aligned_cols=171  Identities=21%  Similarity=0.312  Sum_probs=134.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      +++..||+|.+......   .+.+.+|+.++++++|||++++++++. ....|++|||+++++|.+++...  ..+++..
T Consensus        28 ~~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  103 (260)
T cd05070          28 NGNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKDGEGRALKLPN  103 (260)
T ss_pred             cCCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcHHHHHHhcCCCCCCHHH
Confidence            35677999998765433   356889999999999999999999875 45689999999999999999763  3589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||||+||+++++. ++.+.|||.+......... ......+...|+|||...+.   
T Consensus       104 ~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  181 (260)
T cd05070         104 LVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGL-VCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFT  181 (260)
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCc-eEEeCCceeeeeccCcccc-cccCCCCCccccChHHHhcCCCc
Confidence            999999999999999999999999999999998753 4555699988654322211 11112234469999987654   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|++++++   +..||.+
T Consensus       182 ~~~Di-~slG~~l~~l~~~g~~p~~~  206 (260)
T cd05070         182 IKSDV-WSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             chhhh-HHHHHHHHHHHhcCCCCCCC
Confidence            67899 9999999998   4567754

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0983|consensus

Probab=99.89  E-value=5e-24  Score=195.30  Aligned_cols=211  Identities=18%  Similarity=0.256  Sum_probs=158.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+|...|||.+.+.. +.+..+++.+.+.++..- .+|+||+.+|+|..+..+++.||.+. ..+..++++ .+++|+..
T Consensus       115 s~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C~ekLlkrik~piPE~i  192 (391)
T KOG0983|consen  115 STGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TCAEKLLKRIKGPIPERI  192 (391)
T ss_pred             ccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HHHHHHHHHhcCCchHHh
Confidence            468899999997764 455567788888887766 49999999999999999999999985 666666655 35799999


Q ss_pred             HHHHHHHHHHHHHHHHh-CCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          80 CQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      +-++...+++||.||-+ +||+|||+||+|||+|+ +++++  ||||++.+...|.   ......||+.||+||.+... 
T Consensus       193 lGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKl--CDFGIsGrlvdSk---AhtrsAGC~~YMaPERidp~~  267 (391)
T KOG0983|consen  193 LGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKL--CDFGISGRLVDSK---AHTRSAGCAAYMAPERIDPPD  267 (391)
T ss_pred             hhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEe--ecccccceeeccc---ccccccCCccccCccccCCCC
Confidence            99999999999999976 59999999999999986 56665  5999997765543   22346799999999988655 


Q ss_pred             -----CcccccCcceEEEEEE--eeeccccccc------------cCC-C-CCcchHHHHHHHHHHhhhhh-hcccCCCC
Q psy6508         157 -----TSLEYQRSKGELYVEF--KFAPFASQIR------------TGW-L-RDSEEKELGNHLKRALEPAV-CRHEFSNF  214 (477)
Q Consensus       157 -----~~~Di~~s~G~il~e~--~~~Pf~~~~r------------~~~-~-~~~~~~~l~~~i~~~l~~~i-~~~~~Pr~  214 (477)
                           ..+|+ ||+|+.++|+  +..||.+...            ++. + .......+..+++.++.... .+.+|+..
T Consensus       268 ~~kYDiRaDV-WSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~L  346 (391)
T KOG0983|consen  268 KPKYDIRADV-WSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKL  346 (391)
T ss_pred             CCccchhhhh-hhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHH
Confidence                 56899 9999999999  6788876321            111 1 11245566666666665554 24555554


Q ss_pred             cccEEE
Q psy6508         215 QVDLFV  220 (477)
Q Consensus       215 ~i~i~v  220 (477)
                      .-.-++
T Consensus       347 l~h~Fi  352 (391)
T KOG0983|consen  347 LEHPFI  352 (391)
T ss_pred             hcCcce
Confidence            444333

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.89  E-value=7.7e-23  Score=197.82  Aligned_cols=170  Identities=21%  Similarity=0.316  Sum_probs=135.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~   82 (477)
                      ...||||...... .....+.+.+|+.++++++||||+++++++.. +..|++|||+++++|.+++.+.. .+++..+..
T Consensus        34 ~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  111 (270)
T cd05056          34 KIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLIL  111 (270)
T ss_pred             CcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHH
Confidence            3568999876543 24455789999999999999999999998875 45789999999999999998744 589999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      ++.|++.||.|||++|++||||||+||+++.+ .+++  .|||.+....+...... ........|+|||.....   .+
T Consensus       112 ~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l--~d~g~~~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~  188 (270)
T cd05056         112 YSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKL--GDFGLSRYLEDESYYKA-SKGKLPIKWMAPESINFRRFTSA  188 (270)
T ss_pred             HHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEE--ccCceeeecccccceec-CCCCccccccChhhhccCCCCch
Confidence            99999999999999999999999999999764 4444  49998765544322111 112233469999987654   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|++++++   +..||..
T Consensus       189 ~Di-~slG~il~el~~~g~~pf~~  211 (270)
T cd05056         189 SDV-WMFGVCMWEILMLGVKPFQG  211 (270)
T ss_pred             hhh-HHHHHHHHHHHHcCCCCCCC
Confidence            899 9999999995   6678864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.89  E-value=1.3e-23  Score=203.23  Aligned_cols=170  Identities=24%  Similarity=0.374  Sum_probs=136.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSH--   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~--   72 (477)
                      ++++.||+|.+.....   ....+.+|+.+++++ +||||+++++++...      ...|++|||+++++|.+++...  
T Consensus        29 ~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~  105 (272)
T cd06637          29 KTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG  105 (272)
T ss_pred             CCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC
Confidence            4678999999875532   235678999999999 799999999998753      4689999999999999999864  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ..+++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||++......  .....+..++..|.|||.
T Consensus       106 ~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~  182 (272)
T cd06637         106 NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRT--VGRRNTFIGTPYWMAPEV  182 (272)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCC-CEEEccCCCceecccc--cccCCcccccccccCHhH
Confidence            3689999999999999999999999999999999999998653 3445699987644321  122345567788999998


Q ss_pred             CCCC--------CcccccCcceEEEEEE--eeeccc
Q psy6508         153 PSSK--------TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       153 ~~~~--------~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ..+.        .++|+ ||+|++++|+  +..||.
T Consensus       183 ~~~~~~~~~~~~~~~Dv-~slGv~l~el~~g~~p~~  217 (272)
T cd06637         183 IACDENPDATYDFKSDL-WSLGITAIEMAEGAPPLC  217 (272)
T ss_pred             hccccCcCCCCCchhhH-HHHHHHHHHHHhCCCCcc
Confidence            7521        46899 9999999999  666765

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.89  E-value=6.3e-23  Score=197.30  Aligned_cols=173  Identities=19%  Similarity=0.291  Sum_probs=132.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEE-eCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++..||||.+.... .....+.+.+|+.+++.++||||+++++++. .++..+++|||+.+++|.+++.+. ...++..+
T Consensus        22 ~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  100 (262)
T cd05058          22 QKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL  100 (262)
T ss_pred             ceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHH
Confidence            34679999875432 3344567889999999999999999999765 455689999999999999999764 34677888


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccc--cCCeEEEeccccccccCCCC--
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE--QGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~--~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      ..++.|++.||.|||+.|++||||||+||+++++. .+.+.|||.+..........  ......++..|+|||...+.  
T Consensus       101 ~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  179 (262)
T cd05058         101 IGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESF-TVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF  179 (262)
T ss_pred             HHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCccccccccCCcceeecccccCcCCccccChhHhccCcc
Confidence            99999999999999999999999999999997653 34556999876443221111  11122334579999987654  


Q ss_pred             -CcccccCcceEEEEEE---eeeccc
Q psy6508         157 -TSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                       .++|+ ||+|+++||+   +.+||.
T Consensus       180 ~~~~Di-~slG~~l~el~~~~~~~~~  204 (262)
T cd05058         180 TTKSDV-WSFGVLLWELMTRGAPPYP  204 (262)
T ss_pred             chHHHH-HHHHHHHHHHHcCCCCCCC
Confidence             67899 9999999998   345554

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.89  E-value=2.5e-23  Score=202.08  Aligned_cols=172  Identities=22%  Similarity=0.308  Sum_probs=139.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.++.... ....+.+.+|+.++++++||||+++++.+..++..|+||||+++++|.+++.. +.+++..+.
T Consensus        27 ~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~  104 (277)
T cd06642          27 RTKEVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIA  104 (277)
T ss_pred             CCCeEEEEEEeccccc-hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHH
Confidence            4678899999875542 33456789999999999999999999999999999999999999999998865 478999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.|+.|||++|++|+||+|+||+++.+. .+...|||.+........  ......++..|.|||...+.   .+
T Consensus       105 ~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  181 (277)
T cd06642         105 TILREILKGLDYLHSERKIHRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDFK  181 (277)
T ss_pred             HHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC-CEEEccccccccccCcch--hhhcccCcccccCHHHhCcCCCchh
Confidence            9999999999999999999999999999997643 234459998754332211  11223466789999998765   57


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|++++|+  +..||..
T Consensus       182 ~Dv-~slG~il~el~tg~~p~~~  203 (277)
T cd06642         182 ADI-WSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCcc
Confidence            899 9999999999  6677653

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.89  E-value=1.2e-23  Score=206.35  Aligned_cols=171  Identities=19%  Similarity=0.328  Sum_probs=139.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++...  .......+.+|+.+++.++||||+++++.+...+..|++|||+++++|.+++.. +.+++..++
T Consensus        43 ~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~  119 (292)
T cd06657          43 SSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIA  119 (292)
T ss_pred             CCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhc-CCCCHHHHH
Confidence            47889999987543  233456789999999999999999999999999999999999999999998755 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||+|||++|++||||+|+||+++.+. .+...|||........  ........++..|+|||...+.   .+
T Consensus       120 ~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~  196 (292)
T cd06657         120 AVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMAPELISRLPYGPE  196 (292)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEcccccceecccc--cccccccccCccccCHHHhcCCCCCch
Confidence            9999999999999999999999999999998653 3445599876533211  1122334567789999987654   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|+++|++  +..||.+
T Consensus       197 ~Dv-~slGvil~el~tg~~p~~~  218 (292)
T cd06657         197 VDI-WSLGIMVIEMVDGEPPYFN  218 (292)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999999  5577764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0608|consensus

Probab=99.89  E-value=9.5e-24  Score=212.12  Aligned_cols=176  Identities=22%  Similarity=0.373  Sum_probs=146.6

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      ++...||+|.+.+... ..........|..||..-.++-||++|-.|++.+.+|+||+|++||++-.+|.+.+-|++..+
T Consensus       652 DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LA  731 (1034)
T KOG0608|consen  652 DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLA  731 (1034)
T ss_pred             chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHH
Confidence            4566788888876543 233445678899999999999999999999999999999999999999999999899999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-Ccceeecccccceecc---cCCcccccCC-----------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKA---KGSAYIEQGN-----------------  139 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~---~gs~~~~~g~-----------------  139 (477)
                      +.++.++..|+++.|.-|+|||||||+|||||. +.+++.  |||++...   ..+.|+..|+                 
T Consensus       732 RFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLT--DFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~  809 (1034)
T KOG0608|consen  732 RFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLT--DFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADIS  809 (1034)
T ss_pred             HHHHHHHHHHHHHHHhccceecccCccceEEccCCceeee--eccccccceeccccccccCCCccccccCCCchhhcccc
Confidence            999999999999999999999999999999986 456666  99988532   1222222111                 


Q ss_pred             --------------------eEEEeccccccccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         140 --------------------TKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       140 --------------------t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                                          .-+||+.|.+||++...   ...|+ |+.|+|+|||  |..||...
T Consensus       810 ~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdw-ws~gvil~em~~g~~pf~~~  874 (1034)
T KOG0608|consen  810 KCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDW-WSVGVILYEMLVGQPPFLAD  874 (1034)
T ss_pred             ccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchh-hHhhHHHHHHhhCCCCccCC
Confidence                                45889999999998776   67899 9999999999  77888753

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.89  E-value=5.4e-23  Score=201.44  Aligned_cols=172  Identities=23%  Similarity=0.319  Sum_probs=138.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCC-CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHE-KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~-~l~~~   78 (477)
                      .+++.||+|.++...........+.+|+.++++++||||+++++++...  +..|++|||++ ++|.+++.... .+++.
T Consensus        28 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~  106 (293)
T cd07843          28 KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQS  106 (293)
T ss_pred             CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHH
Confidence            4688999999976654444445677899999999999999999998877  89999999998 69999987644 58999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++.++.|++.||+|||++|++||||||+||+++.+. .+.++|||.+.......  .......++..|+|||...+.  
T Consensus       107 ~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~  183 (293)
T cd07843         107 EVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRG-ILKICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKE  183 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-cEEEeecCceeeccCCc--cccccccccccccCchhhcCCcc
Confidence            9999999999999999999999999999999998653 33445999876543321  111234566789999987653  


Q ss_pred             --CcccccCcceEEEEEE--eeeccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                        .++|+ ||+|++++++  +..||.
T Consensus       184 ~~~~~Di-~slG~~l~~l~~g~~~f~  208 (293)
T cd07843         184 YSTAIDM-WSVGCIFAELLTKKPLFP  208 (293)
T ss_pred             ccchhhH-HHHHHHHHHHHhCCCCCC
Confidence              56899 9999999998  556665

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.89  E-value=2e-23  Score=203.31  Aligned_cols=170  Identities=21%  Similarity=0.234  Sum_probs=131.3

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~   84 (477)
                      .|++|.+.... ......++..|+..+++++||||+++++++. ....++++||+++|+|.+++... +.+++..+..|+
T Consensus        38 ~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~  115 (279)
T cd05111          38 PVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWC  115 (279)
T ss_pred             EEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHH
Confidence            57888875332 2344567888999999999999999999875 45678999999999999999764 468999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEY  161 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di  161 (477)
                      .|++.||.|||++|++||||||+||+++.+. .+..+|||.+................++..|+|||...+.   .++|+
T Consensus       116 ~qi~~~l~~lH~~~iiH~dlkp~nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv  194 (279)
T cd05111         116 VQIAKGMYYLEEHRMVHRNLAARNILLKSDS-IVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDV  194 (279)
T ss_pred             HHHHHHHHHHHHCCEeccccCcceEEEcCCC-cEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhH
Confidence            9999999999999999999999999997653 3445699988654322111111222344579999988654   67899


Q ss_pred             cCcceEEEEEE---eeecccc
Q psy6508         162 QRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       162 ~~s~G~il~e~---~~~Pf~~  179 (477)
                       ||+|+++||+   +..||.+
T Consensus       195 -~slG~il~el~t~g~~p~~~  214 (279)
T cd05111         195 -WSYGVTVWEMMSYGAEPYAG  214 (279)
T ss_pred             -HHHHHHHHHHHcCCCCCCCC
Confidence             9999999998   4556653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.89  E-value=3e-23  Score=202.92  Aligned_cols=172  Identities=26%  Similarity=0.352  Sum_probs=137.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+++.||||.+...... .....+.+|+.++++++||||+++++++..++..|+||||++ ++|.+++... ..+++..+
T Consensus        28 ~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~  105 (291)
T cd07844          28 LTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNV  105 (291)
T ss_pred             CCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHH
Confidence            36789999998765322 222346789999999999999999999999999999999998 5999998764 36899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++|++||||||+||+++.+. ++.+.|||.+....-..  ..+....++..|.|||...+.    
T Consensus       106 ~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~  182 (291)
T cd07844         106 RLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERG-ELKLADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYS  182 (291)
T ss_pred             HHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCC-CEEECccccccccCCCC--ccccccccccccCCcHHhhcCcccC
Confidence            99999999999999999999999999999997653 34456999875432111  112233456789999987543    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|++++++  +..||.+
T Consensus       183 ~~~Dv-~slG~il~~l~~g~~~~~~  206 (291)
T cd07844         183 TSLDM-WGVGCIFYEMATGRPLFPG  206 (291)
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            56899 9999999999  6677753

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=1.3e-23  Score=212.03  Aligned_cols=158  Identities=18%  Similarity=0.205  Sum_probs=129.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+++.||+|+.....        ...|+.++++++||||+++++++...+..++|||++. ++|.+++.. ...+++..+
T Consensus        89 ~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~  159 (357)
T PHA03209         89 GQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQA  159 (357)
T ss_pred             CCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHH
Confidence            457789999754331        3469999999999999999999999999999999996 789888865 357999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..|+.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......   ...+..++..|+|||...+.   .
T Consensus       160 ~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~  235 (357)
T PHA03209        160 LIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAP---AFLGLAGTVETNAPEVLARDKYNS  235 (357)
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEecCccccccccCc---ccccccccccccCCeecCCCCCCc
Confidence            99999999999999999999999999999997643 23456999875432211   11234577889999998765   7


Q ss_pred             cccccCcceEEEEEEe
Q psy6508         158 SLEYQRSKGELYVEFK  173 (477)
Q Consensus       158 ~~Di~~s~G~il~e~~  173 (477)
                      ++|+ ||+|+++||+.
T Consensus       236 ~~Di-wSlGvvl~ell  250 (357)
T PHA03209        236 KADI-WSAGIVLFEML  250 (357)
T ss_pred             hhhH-HHHHHHHHHHH
Confidence            7899 99999999983

>KOG1035|consensus

Probab=99.89  E-value=2.9e-24  Score=230.06  Aligned_cols=172  Identities=24%  Similarity=0.405  Sum_probs=139.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--------------------------------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--------------------------------   50 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------------------------------   50 (477)
                      +|+.||||+++... +.....++.+|+.+|.+|+|||||++|..|.+.                                
T Consensus       503 DGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q  581 (1351)
T KOG1035|consen  503 DGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQ  581 (1351)
T ss_pred             cchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccCCCcccceeeec
Confidence            79999999998887 667778899999999999999999999876421                                


Q ss_pred             --------------------------------------------------------------------------------
Q psy6508          51 --------------------------------------------------------------------------------   50 (477)
Q Consensus        51 --------------------------------------------------------------------------------   50 (477)
                                                                                                      
T Consensus       582 ~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~  661 (1351)
T KOG1035|consen  582 PTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEP  661 (1351)
T ss_pred             cCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhhhccccCCcccc
Confidence                                                                                            


Q ss_pred             -------CeEEEEEecCCCCCHHHHHHhCCCC-CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-Ccceeecc
Q psy6508          51 -------RYVYIILEYCDGGDLCSFIRSHEKL-SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL  121 (477)
Q Consensus        51 -------~~~~lv~e~~~g~sL~~~l~~~~~l-~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~  121 (477)
                             ..+||-||||+..+|++++..+... .....+++++||++||.|+|++||+||||||.|||+++ +.+++.  
T Consensus       662 ~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIG--  739 (1351)
T KOG1035|consen  662 MVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIG--  739 (1351)
T ss_pred             ccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeec--
Confidence                   1369999999977777776665333 47888999999999999999999999999999999986 456655  


Q ss_pred             cccceeccc---------CC-------cccccCCeEEEeccccccccCCCC------CcccccCcceEEEEEEeeecccc
Q psy6508         122 KQGVSEKAK---------GS-------AYIEQGNTKVICSVFEPREIPSSK------TSLEYQRSKGELYVEFKFAPFAS  179 (477)
Q Consensus       122 dfG~~~~~~---------gs-------~~~~~g~t~v~~~~y~ppE~~~~~------~~~Di~~s~G~il~e~~~~Pf~~  179 (477)
                      |||++....         ++       +.....++.+||..|.|||++.+.      .++|+ ||+|++++||.++ |.+
T Consensus       740 DFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDm-YSLGIVlFEM~yP-F~T  817 (1351)
T KOG1035|consen  740 DFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDM-YSLGIVLFEMLYP-FGT  817 (1351)
T ss_pred             ccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhh-HHHHHHHHHHhcc-CCc
Confidence            999886511         11       111233468999999999998765      67999 9999999999876 875

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.88  E-value=7.9e-23  Score=197.10  Aligned_cols=169  Identities=22%  Similarity=0.323  Sum_probs=132.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~   80 (477)
                      ++..||+|.++.....   .+.+.+|+.+++.++||||+++++.+. +...|++|||+++++|.+++.+.  ..+++..+
T Consensus        29 ~~~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~  104 (262)
T cd05071          29 GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQL  104 (262)
T ss_pred             CCceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHHHHHhhccccCCCHHHH
Confidence            3456999998765433   356889999999999999999999874 45689999999999999999763  35889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++++. ++.++|||.+......... ......++..|+|||...+.   .
T Consensus       105 ~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~  182 (262)
T cd05071         105 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTI  182 (262)
T ss_pred             HHHHHHHHHHHHHHHHCCccccccCcccEEEcCCC-cEEeccCCceeeccccccc-cccCCcccceecCHhHhccCCCCc
Confidence            99999999999999999999999999999997653 3445699988644322211 11122344579999987654   6


Q ss_pred             cccccCcceEEEEEE---eeeccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      ++|+ |++|+++|++   +..||.
T Consensus       183 ~~Dv-wslG~~l~ellt~g~~p~~  205 (262)
T cd05071         183 KSDV-WSFGILLTELTTKGRVPYP  205 (262)
T ss_pred             hhhH-HHHHHHHHHHHcCCCCCCC
Confidence            7899 9999999998   345665

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.88  E-value=5e-23  Score=197.05  Aligned_cols=169  Identities=22%  Similarity=0.349  Sum_probs=139.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +++.|++|.++...    ..+.+.+|+.++++++||||+++++.+..+...|+++||+++++|.+++... ..+++..+.
T Consensus        27 ~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~  102 (256)
T cd06612          27 TGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIA  102 (256)
T ss_pred             CCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHH
Confidence            57899999986542    2578999999999999999999999999999999999999999999999763 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||+.|++||||+|+||+++++. .+.+.|||.+.......  .......++..|.|||...+.   .+
T Consensus       103 ~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~  179 (256)
T cd06612         103 AILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNK  179 (256)
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCcceEEECCCC-cEEEcccccchhcccCc--cccccccCCccccCHHHHhcCCCCch
Confidence            9999999999999999999999999999997653 24445999876543221  011234456789999987665   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|++++++  +..||..
T Consensus       180 ~Di-~s~G~il~~l~~g~~p~~~  201 (256)
T cd06612         180 ADI-WSLGITAIEMAEGKPPYSD  201 (256)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999999  6677764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.88  E-value=2.1e-23  Score=198.28  Aligned_cols=170  Identities=28%  Similarity=0.453  Sum_probs=141.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++++.|++|+++....  .....+.+|+..+++++|||++++++.+...+..++++||++|++|.+++... ..+++..+
T Consensus        23 ~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~  100 (253)
T cd05122          23 RTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQI  100 (253)
T ss_pred             CCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHH
Confidence            3688999999876543  34567899999999999999999999999999999999999999999999875 57999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++.|++.||.+||++|++||||+|+||+++++ .+++  .|||.+........   .....++..|.|||...+.   
T Consensus       101 ~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l--~d~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~  175 (253)
T cd05122         101 AYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKL--IDFGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYD  175 (253)
T ss_pred             HHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEE--eecccccccccccc---ccceecCCcccCHHHHcCCCCC
Confidence            9999999999999999999999999999999864 4444  58887755433211   2345667789999987655   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|++++++  +..||..
T Consensus       176 ~~~Dv-~slG~il~~l~~g~~p~~~  199 (253)
T cd05122         176 YKADI-WSLGITAIELAEGKPPYSE  199 (253)
T ss_pred             ccccH-HHHHHHHHHHHhCCCCCCC
Confidence            56899 9999999999  5566653

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.88  E-value=1.9e-23  Score=200.51  Aligned_cols=165  Identities=24%  Similarity=0.390  Sum_probs=131.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEE-eCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      .|+.||+|.++...    ..+.+.+|+.++++++|||++++++++. .++..+++|||+++++|.+++...+  .+++..
T Consensus        28 ~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  103 (256)
T cd05082          28 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC  103 (256)
T ss_pred             cCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHH
Confidence            46789999875432    2456889999999999999999999754 5567999999999999999997644  488999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||+|||++|++||||||+||+++++. ++.++|||.+.......     .+...+..|+|||...+.   
T Consensus       104 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~  177 (256)
T cd05082         104 LLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFS  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCC-cEEecCCccceeccccC-----CCCccceeecCHHHHccCCCC
Confidence            999999999999999999999999999999997653 34456999876433211     122233469999987665   


Q ss_pred             CcccccCcceEEEEEE---eeeccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      .++|+ |++|+++|++   +..||.
T Consensus       178 ~~~Dv-~slG~i~~~l~~~g~~p~~  201 (256)
T cd05082         178 TKSDV-WSFGILLWEIYSFGRVPYP  201 (256)
T ss_pred             chhhh-HHHHHHHHHHHhCCCCCCC
Confidence            57899 9999999998   445554

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.88  E-value=1.5e-23  Score=205.26  Aligned_cols=171  Identities=22%  Similarity=0.370  Sum_probs=134.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHh----
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRS----   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~----   71 (477)
                      ++++.||+|++....   .....+.+|+.+++++ +|||++++++++...     +..|+||||++|++|.++++.    
T Consensus        45 ~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~  121 (291)
T cd06639          45 KDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC  121 (291)
T ss_pred             CCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhc
Confidence            468899999986542   2235677899999999 899999999998753     368999999999999998863    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccc
Q psy6508          72 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        72 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE  151 (477)
                      ...+++..++.++.|++.||.|||++|++||||||+||+++.+. ++.+.|||.+........  ......++..|+|||
T Consensus       122 ~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE  198 (291)
T cd06639         122 GQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMAPE  198 (291)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCC-CEEEeecccchhcccccc--cccCccCCccccChh
Confidence            34689999999999999999999999999999999999997643 334459998764332111  112345677899999


Q ss_pred             cCCC--------CCcccccCcceEEEEEE--eeecccc
Q psy6508         152 IPSS--------KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       152 ~~~~--------~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ....        ..++|+ ||+|+++|++  +..||..
T Consensus       199 ~~~~~~~~~~~~~~~~Di-~slGvi~~el~~g~~p~~~  235 (291)
T cd06639         199 VIACEQQYDYSYDARCDV-WSLGITAIELGDGDPPLFD  235 (291)
T ss_pred             hhcCCCCcccccCCccch-HHHHHHHHHHhhCCCCCCC
Confidence            8643        157899 9999999999  6677764

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.88  E-value=2.7e-23  Score=202.57  Aligned_cols=174  Identities=21%  Similarity=0.303  Sum_probs=141.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++++.||+|.++.........+.+.+|+.++++++||||+++++++..++..+++|||++++.+..+..+...+++..+.
T Consensus        24 ~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~  103 (288)
T cd07833          24 ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVR  103 (288)
T ss_pred             CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHH
Confidence            46889999998776555555678999999999999999999999999999999999999987777666665679999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||.|||++|++||||+|+||+++++. .+.+.|||.+........ .......++..|+|||...+.    .
T Consensus       104 ~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~  181 (288)
T cd07833         104 SYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG-VLKLCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGK  181 (288)
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCc
Confidence            9999999999999999999999999999997642 344459998765443321 011234567789999987655    6


Q ss_pred             cccccCcceEEEEEE--eeeccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++|+ |++|++++++  +..||.
T Consensus       182 ~~Dv-~slG~~l~~l~~g~~~~~  203 (288)
T cd07833         182 PVDV-WAIGCIMAELLDGEPLFP  203 (288)
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCC
Confidence            7899 9999999999  556665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>PRK04282 exosome complex RNA-binding protein Rrp42; Provisional

Probab=99.88  E-value=1.4e-21  Score=188.82  Aligned_cols=208  Identities=24%  Similarity=0.311  Sum_probs=175.3

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      ++.|.+.+.+|....++||++++.|+|++.|.++..+.....    +- -.-|.+.+++.+.||+...+....++..+.+
T Consensus        32 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~vl~~V~~~~~~p~~----~~-~~~g~i~~~v~~~~~a~~~~~~~~~~~~~~~  106 (271)
T PRK04282         32 DEYRPIEIETGVIKKAEGSALVKLGNTQVLAGVKLEIGEPFP----DT-PNEGVLIVNAELLPLASPTFEPGPPDENAIE  106 (271)
T ss_pred             ccccCeEEEeCCccCCCcEEEEEECCCEEEEEEEEEEecCCC----CC-CCCCEEEEEEEECCCcCccccCCCCCHHHHH
Confidence            578999999999999999999999999999999854422111    11 3458888999999998765544455667788


Q ss_pred             HHHHHHHHhhhhhhccc--C---C---CCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCC------------------
Q psy6508         194 LGNHLKRALEPAVCRHE--F---S---NFQVDLFVLVLQNDGSALSAAINCANLALVDAAIP------------------  247 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~--~---P---r~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~------------------  247 (477)
                      +++++++.+++....+.  +   |   .|.+.+.+.||++||+.+.++++|+++||.|+|+|                  
T Consensus       107 l~~~l~r~l~~~~~~dl~~L~I~~g~~~w~i~Vdv~VL~~dG~~~daa~~Aa~aAL~~~~iP~~~~~~~~~~~~~~~~~~  186 (271)
T PRK04282        107 LARVVDRGIRESKAIDLEKLVIEPGKKVWVVFIDVYVLDHDGNLLDASMLAAVAALLNTKVPAVEEGEDGVVDKLGEDFP  186 (271)
T ss_pred             HHHHHHHHHhccCCccHHHcEEecCcEEEEEEEEEEEECCCCCHHHHHHHHHHHHHHhCCCCcEEEcCCceeccCCCccc
Confidence            99999999887633222  2   4   45899999999999999999999999999999995                  


Q ss_pred             --CCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE--eeecHHHHHHHHHHHH
Q psy6508         248 --MYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV--GTIQQERLADHIEQLI  323 (477)
Q Consensus       248 --m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~--g~~~~~~~~~~l~~~~  323 (477)
                        |++++.++|++..++.+++||+..|+..          ..+.+++++.++ ++|+.++..  |.++.+++.++++.|.
T Consensus       187 l~~~~~p~~vt~~~~~~~~v~Dpt~~Ee~~----------~~~~l~va~~~~-g~i~~l~~~g~~~~~~~~l~~~i~~A~  255 (271)
T PRK04282        187 LPVNDKPVTVTFAKIGNYLIVDPTLEEESV----------MDARITITTDED-GNIVAIQKSGIGSFTEEEVDKAIDIAL  255 (271)
T ss_pred             CCCCCeeEEEEEEEECCEEEECCCHHHHhh----------cCceEEEEECCC-CcEEEEEcCCCCCCCHHHHHHHHHHHH
Confidence              9999999999999999999999999995          478999998664 589999987  5599999999999999


Q ss_pred             hcccchhhHHHHhHh
Q psy6508         324 GCCESLCTDRVQKLV  338 (477)
Q Consensus       324 ~~~~~i~~~~i~~~l  338 (477)
                      +.|+.+.+. +++.+
T Consensus       256 ~~~~~l~~~-~~~~l  269 (271)
T PRK04282        256 EKAKELREK-LKEAL  269 (271)
T ss_pred             HHHHHHHHH-HHHHh
Confidence            999999999 88776

>KOG1151|consensus

Probab=99.88  E-value=1.6e-22  Score=196.05  Aligned_cols=175  Identities=28%  Similarity=0.439  Sum_probs=142.8

Q ss_pred             CCcEEEEEEcccCCCC-h----hHHHHHHHHHHHHHhcCCCCccceEEEEE-eCCeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVS-E----NRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~-~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      ..+.||+|+-...+.- +    ...+...+|..|.+.|.||.||++|++|. +...+|-|+|||+|.+|.-||+.++-++
T Consensus       487 EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmS  566 (775)
T KOG1151|consen  487 EQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMS  566 (775)
T ss_pred             hhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhh
Confidence            4678999985443321 1    12245779999999999999999999986 5568999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHHHHhC--CcEEccCCCCceeecc----CcceeecccccceecccCCcccc-----cCCeEEEec
Q psy6508          77 EFQCQQFVRQLVLALKFLREN--NVCHFDLKPQNILIKN----NTLKLAGLKQGVSEKAKGSAYIE-----QGNTKVICS  145 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~--givHrDlkp~NIll~~----~~~rl~~~dfG~~~~~~gs~~~~-----~g~t~v~~~  145 (477)
                      +++++.|+.||+.||.||.+.  .|+|-||||.|||+-+    +++++.  |||++...++.+|-.     ......||.
T Consensus       567 EKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKIT--DFGLSKIMdddSy~~vdGmeLTSQgAGTY  644 (775)
T KOG1151|consen  567 EKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKIT--DFGLSKIMDDDSYNSVDGMELTSQGAGTY  644 (775)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEee--ecchhhhccCCccCcccceeeecccCcee
Confidence            999999999999999999875  6999999999999954    466666  999999888777642     222356788


Q ss_pred             cccccccCCCC-------CcccccCcceEEEEEE--eeeccccc
Q psy6508         146 VFEPREIPSSK-------TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       146 ~y~ppE~~~~~-------~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ||.|||.+.-.       .++|+ ||.|+++|..  |..||...
T Consensus       645 WYLPPEcFvVgkePPKIsnKVDV-WSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  645 WYLPPECFVVGKEPPKISNKVDV-WSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             eecCcceeecCCCCCccccceee-EeeehhhhhhhccCCCCCCc
Confidence            99999976422       67899 9999999998  66888643

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.88  E-value=1e-22  Score=201.05  Aligned_cols=169  Identities=20%  Similarity=0.321  Sum_probs=137.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+|+.||+|.+..... ..+..+++.+|+.+++.++||||+++++++..++..|+||||++ |+|.+++.. ...+++..
T Consensus        38 ~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~  116 (307)
T cd06607          38 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVE  116 (307)
T ss_pred             CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHH
Confidence            3688999999865433 34455678999999999999999999999999999999999997 688777754 34689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC---C
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS---K  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~---~  156 (477)
                      +..++.|++.||.|||++|++||||+|+||+++++. .+.+.|||.+.....      ..+..++..|+|||...+   .
T Consensus       117 ~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~  189 (307)
T cd06607         117 IAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPG-TVKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEG  189 (307)
T ss_pred             HHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCC-CEEEeecCcceecCC------CCCccCCccccCceeeeccCCC
Confidence            999999999999999999999999999999997653 334459997754322      123456678999998632   1


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|+++|++  +..||.+
T Consensus       190 ~~~~~sDv-~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         190 QYDGKVDV-WSLGITCIELAERKPPLFN  216 (307)
T ss_pred             CCCcccch-HHHHHHHHHHHcCCCCCCC
Confidence               67899 9999999999  6677764

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.88  E-value=3.8e-23  Score=197.78  Aligned_cols=172  Identities=26%  Similarity=0.331  Sum_probs=143.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~~   77 (477)
                      .+++.|++|.+......+....++.+|+.++++++||||+++++++......|+++||+++++|.+++.+    ...+++
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~  102 (256)
T cd08530          23 SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE  102 (256)
T ss_pred             CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCH
Confidence            4688999999987665566667888999999999999999999999999999999999999999999876    346899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..+..++.|++.||.|||+.|++|+||+|.||+++++. ++...|||.+......    ...+..++..|.|||...+. 
T Consensus       103 ~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~  177 (256)
T cd08530         103 QEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVAND-LVKIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRP  177 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCC-cEEEeeccchhhhccC----CcccccCCccccCHHHHCCCC
Confidence            99999999999999999999999999999999997642 3444599987554332    22334567789999998666 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|++++++  +..||..
T Consensus       178 ~~~~~D~-~slG~~~~~l~~g~~p~~~  203 (256)
T cd08530         178 YSYKSDI-WSLGCLLYEMATFAPPFEA  203 (256)
T ss_pred             CCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence              56899 9999999999  6678764

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.88  E-value=1.1e-22  Score=197.66  Aligned_cols=171  Identities=19%  Similarity=0.257  Sum_probs=133.2

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i   83 (477)
                      ..||+|.++... .......+.+|+.++++++||||+++++++.. ...+++|||+++++|.+++... ..+++..+..+
T Consensus        37 ~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~  114 (279)
T cd05057          37 IPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNW  114 (279)
T ss_pred             eEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHH
Confidence            368999886554 34455678999999999999999999999887 7899999999999999999874 36899999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cccc
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLE  160 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~D  160 (477)
                      +.|++.||.|||++|++||||||+||+++++. .+.+.|||.+.................+..|+|||.....   .++|
T Consensus       115 ~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~D  193 (279)
T cd05057         115 CVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSD  193 (279)
T ss_pred             HHHHHHHHHHHHhCCEEecccCcceEEEcCCC-eEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhh
Confidence            99999999999999999999999999997643 3344599987654322110011111123469999987544   6789


Q ss_pred             ccCcceEEEEEE---eeecccc
Q psy6508         161 YQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       161 i~~s~G~il~e~---~~~Pf~~  179 (477)
                      + |++|++++|+   +..||.+
T Consensus       194 i-~slG~~l~el~~~g~~p~~~  214 (279)
T cd05057         194 V-WSYGVTVWELMTFGAKPYEG  214 (279)
T ss_pred             H-HHHHHHHHHHhcCCCCCCCC
Confidence            9 9999999986   4566653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.88  E-value=2.4e-23  Score=200.27  Aligned_cols=171  Identities=23%  Similarity=0.346  Sum_probs=135.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      ++++.||+|.+......   .+.+.+|+.++++++||||+++++.+. .+..|++|||+++++|.+++...  ..+++..
T Consensus        28 ~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~  103 (260)
T cd05067          28 NGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINK  103 (260)
T ss_pred             CCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHH
Confidence            46788999998765433   356889999999999999999999864 45789999999999999998753  3689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||+.|++||||||+||+++++. .+.+.|||.+........... ....++..|.|||.....   
T Consensus       104 ~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~~~~~~~~-~~~~~~~~y~~pe~~~~~~~~  181 (260)
T cd05067         104 LIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETL-CCKIADFGLARLIEDNEYTAR-EGAKFPIKWTAPEAINYGTFT  181 (260)
T ss_pred             HHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCC-CEEEccCcceeecCCCCcccc-cCCcccccccCHHHhccCCcC
Confidence            999999999999999999999999999999998653 234459998865542221111 112234579999987655   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ |++|++++|+   +..||.+
T Consensus       182 ~~~Di-~slG~~l~el~~~g~~p~~~  206 (260)
T cd05067         182 IKSDV-WSFGILLTEIVTYGRIPYPG  206 (260)
T ss_pred             cccch-HHHHHHHHHHHhCCCCCCCC
Confidence            67899 9999999987   5577764

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.88  E-value=2.7e-23  Score=202.09  Aligned_cols=174  Identities=21%  Similarity=0.273  Sum_probs=136.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHHhC--------C
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-ERYVYIILEYCDGGDLCSFIRSH--------E   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~--------~   73 (477)
                      ++..|++|.+... ......+.+.+|+.++++++||||+++++++.. ....++++||+++++|.+++...        .
T Consensus        34 ~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~  112 (280)
T cd05043          34 KEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ  112 (280)
T ss_pred             ceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhcccccccccc
Confidence            3678999988643 344556778999999999999999999998765 56789999999999999999763        3


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      .+++..+..++.|++.||.|||++|++||||||+||+++++. .+...|||++...........+....++..|+|||..
T Consensus       113 ~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~  191 (280)
T cd05043         113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEEL-QVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL  191 (280)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCC-cEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence            588999999999999999999999999999999999997642 3444599998654332221122223344569999987


Q ss_pred             CCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         154 SSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       154 ~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .+.   .++|+ ||+|+++||+   +..||..
T Consensus       192 ~~~~~~~~~Di-~slG~~l~el~~~g~~p~~~  222 (280)
T cd05043         192 VNKEYSSASDV-WSFGVLLWELMTLGQTPYVE  222 (280)
T ss_pred             hcCCCCchhhH-HHhHHHHHHHhcCCCCCcCc
Confidence            655   67899 9999999997   4566653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PTZ00284 protein kinase; Provisional

Probab=99.88  E-value=3.2e-23  Score=216.73  Aligned_cols=168  Identities=18%  Similarity=0.233  Sum_probs=132.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC------CCccceEEEEEeC-CeEEEEEecCCCCCHHHHHHhCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH------QHIVTMLDFLWDE-RYVYIILEYCDGGDLCSFIRSHEK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~~~~~~~~~-~~~~lv~e~~~g~sL~~~l~~~~~   74 (477)
                      .+++.||||+++...   .....+..|+.+++.++|      ++++++++++..+ .++|+|||++ |++|.+++.+.+.
T Consensus       152 ~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~  227 (467)
T PTZ00284        152 KRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP  227 (467)
T ss_pred             CCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCC
Confidence            367889999986432   223445678888877754      4588888888754 5789999998 6899999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCc---------------ceeecccccceecccCCcccccC
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNT---------------LKLAGLKQGVSEKAKGSAYIEQG  138 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~---------------~rl~~~dfG~~~~~~gs~~~~~g  138 (477)
                      +++..+..++.||+.||.|||+ .||+||||||+|||++.++               .++.++|||.+.....     ..
T Consensus       228 l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~  302 (467)
T PTZ00284        228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-----SR  302 (467)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-----cc
Confidence            9999999999999999999998 5999999999999997542               2456679997643221     12


Q ss_pred             CeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         139 NTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       139 ~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+.+++..|+|||++.+.   .++|+ ||+|+++|||  +..||.+
T Consensus       303 ~~~~gt~~Y~APE~~~~~~~~~~~Di-wSlGvil~elltG~~pf~~  347 (467)
T PTZ00284        303 TAIVSTRHYRSPEVVLGLGWMYSTDM-WSMGCIIYELYTGKLLYDT  347 (467)
T ss_pred             ccccCCccccCcHHhhcCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            345778899999998766   67899 9999999999  6677764

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.88  E-value=5e-23  Score=207.44  Aligned_cols=170  Identities=24%  Similarity=0.366  Sum_probs=138.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||.+.+..........+.+|+.++++++||||+++++++...      ...|+||||+. ++|.+++...  +
T Consensus        39 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l  115 (353)
T cd07850          39 VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--L  115 (353)
T ss_pred             CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--C
Confidence            4788999999876554555556788999999999999999999988643      35799999997 6999988753  8


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +...+..++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+.......   ...+..++..|+|||...+
T Consensus       116 ~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  191 (353)
T cd07850         116 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG  191 (353)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEccCccceeCCCCC---CCCCCcccccccCHHHHhC
Confidence            9999999999999999999999999999999999998653 34445999886544321   1233456778999998866


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ ||+|++++++  +..||..
T Consensus       192 ~~~~~~~Dv-wslG~~l~~l~~g~~pf~~  219 (353)
T cd07850         192 MGYKENVDI-WSVGCIMGEMIRGTVLFPG  219 (353)
T ss_pred             CCCCCchhh-HhHHHHHHHHHHCCCCCCC
Confidence            5   67899 9999999999  6677764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.88  E-value=2.7e-23  Score=199.98  Aligned_cols=170  Identities=21%  Similarity=0.303  Sum_probs=132.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~   80 (477)
                      .+..||+|.+.....   ..+.+.+|+.++++++|||++++++++. .+..+++|||+++++|.+++....  .+++..+
T Consensus        29 ~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~  104 (260)
T cd05069          29 GTTKVAIKTLKPGTM---MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL  104 (260)
T ss_pred             CCceEEEEEcccCCc---cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHH
Confidence            345799998765432   2356889999999999999999999875 456899999999999999997643  4789999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||+.|++||||||+||+++++. ++.+.|||.+........ .......++..|+|||...+.   .
T Consensus       105 ~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~~Pe~~~~~~~~~  182 (260)
T cd05069         105 VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNL-VCKIADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTI  182 (260)
T ss_pred             HHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCC-eEEECCCccceEccCCcc-cccCCCccchhhCCHHHhccCCcCh
Confidence            99999999999999999999999999999997653 344559998764332211 111122345579999987654   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ |++|+++|++   +..||.+
T Consensus       183 ~~Di-~slG~~l~el~t~g~~p~~~  206 (260)
T cd05069         183 KSDV-WSFGILLTELVTKGRVPYPG  206 (260)
T ss_pred             HHHH-HHHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999999   4567754

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.88  E-value=2.5e-23  Score=202.39  Aligned_cols=170  Identities=23%  Similarity=0.287  Sum_probs=132.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHH-HHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKA-LKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----EKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~i-l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~l~   76 (477)
                      .+|+.||||.++....... ..++..|..+ ++.++||||+++++++..++..|++|||++ ++|.+++...    ..++
T Consensus        24 ~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~  101 (283)
T cd06617          24 PTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIP  101 (283)
T ss_pred             CCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCC
Confidence            4789999999876644333 3445566665 566799999999999999999999999997 7898887642    3689


Q ss_pred             HHHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..+..++.|++.||.|||++ +++||||||+||+++.+. .+.+.|||.+.......   ......++..|+|||...+
T Consensus       102 ~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  177 (283)
T cd06617         102 EDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLVDSV---AKTIDAGCKPYMAPERINP  177 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeeccccccccccc---ccccccCCccccChhhcCC
Confidence            999999999999999999997 999999999999997643 33445999876443211   1123456778999998754


Q ss_pred             C-------CcccccCcceEEEEEE--eeeccc
Q psy6508         156 K-------TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       156 ~-------~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      .       .++|+ |++|+++|++  +..||.
T Consensus       178 ~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~  208 (283)
T cd06617         178 ELNQKGYDVKSDV-WSLGITMIELATGRFPYD  208 (283)
T ss_pred             cccccccCccccc-hhhHHHHHHHHhCCCCCC
Confidence            1       56899 9999999999  666775

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.88  E-value=1.5e-23  Score=199.99  Aligned_cols=174  Identities=25%  Similarity=0.402  Sum_probs=143.9

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|.+++.... ......+.+|+.++++++||||+++++.+..++..|++|||+++++|.+++.....+++..+
T Consensus        16 ~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~   95 (250)
T cd05123          16 DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERA   95 (250)
T ss_pred             CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHH
Confidence            35889999998776443 23456789999999999999999999999999999999999999999999988778999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|+++||.|||++|++|+||+|+||+++.+. ++.+.|||.........  .......++..|.|||...+.   .
T Consensus        96 ~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~  172 (250)
T cd05123          96 RFYAAEIVLALEYLHSLGIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGK  172 (250)
T ss_pred             HHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCC-cEEEeecCcceecccCC--CcccCCcCCccccChHHhCCCCCCc
Confidence            99999999999999999999999999999997653 34446999876544321  112234556679999987665   5


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|++++++  +..||..
T Consensus       173 ~~D~-~slG~~~~~l~~g~~p~~~  195 (250)
T cd05123         173 AVDW-WSLGVLLYEMLTGKPPFYA  195 (250)
T ss_pred             hhhH-HHHHHHHHHHHHCCCCCCC
Confidence            6899 9999999999  6677754

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.88  E-value=8.7e-23  Score=200.27  Aligned_cols=172  Identities=25%  Similarity=0.359  Sum_probs=139.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.+....  ....+.+.+|+.+++.++||||+++++.+...+..|+|+||+++++|.+++.+. .+++..+.
T Consensus        42 ~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~  118 (293)
T cd06647          42 ATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIA  118 (293)
T ss_pred             CCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhc-CCCHHHHH
Confidence            367889999986443  233467889999999999999999999999999999999999999999998763 68899999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+........  ......++..|+|||...+.   .+
T Consensus       119 ~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~  195 (293)
T cd06647         119 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK  195 (293)
T ss_pred             HHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCC-CEEEccCcceeccccccc--ccccccCChhhcCchhhccCCCCch
Confidence            9999999999999999999999999999997643 334459997754332221  11234566789999987655   67


Q ss_pred             ccccCcceEEEEEE--eeeccccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      +|+ |++|++++++  +..||...
T Consensus       196 ~Dv-~slG~ll~~ll~g~~pf~~~  218 (293)
T cd06647         196 VDI-WSLGIMAIEMVEGEPPYLNE  218 (293)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCCC
Confidence            899 9999999999  77888653

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.88  E-value=7.2e-23  Score=199.54  Aligned_cols=168  Identities=20%  Similarity=0.311  Sum_probs=132.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhC-CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSH-EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~   78 (477)
                      .+++.||+|.+...  .....+.+.+|+.++++++||||+++++++..  ...+++||||+++++|.+++.+. ..+++.
T Consensus        31 ~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~  108 (284)
T cd05081          31 NTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHR  108 (284)
T ss_pred             CCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHH
Confidence            46789999998654  34456788999999999999999999998653  34689999999999999999764 368999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc-ccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||.|||++|++||||||+||+++.+. ++.+.|||.+....... .............|.|||...+. 
T Consensus       109 ~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  187 (284)
T cd05081         109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESEN-RVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESK  187 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCC-eEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCC
Confidence            9999999999999999999999999999999997653 34456999876543221 11111111122358999987655 


Q ss_pred             --CcccccCcceEEEEEEe
Q psy6508         157 --TSLEYQRSKGELYVEFK  173 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~~  173 (477)
                        .++|+ |++|++++|+.
T Consensus       188 ~~~~~Di-~slG~~l~el~  205 (284)
T cd05081         188 FSVASDV-WSFGVVLYELF  205 (284)
T ss_pred             cChHHHH-HHHHHHHHHHh
Confidence              67899 99999999993

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.88  E-value=2.8e-23  Score=202.49  Aligned_cols=171  Identities=22%  Similarity=0.379  Sum_probs=133.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEE-----eCCeEEEEEecCCCCCHHHHHHh----
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLW-----DERYVYIILEYCDGGDLCSFIRS----   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~-----~~~~~~lv~e~~~g~sL~~~l~~----   71 (477)
                      .+++.||+|++....   ...+.+.+|+.+++.+ +||||+++++++.     .++.++++|||++|++|.+++..    
T Consensus        41 ~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~  117 (286)
T cd06638          41 KNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKR  117 (286)
T ss_pred             CCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhcc
Confidence            467899999875432   2235678899999999 7999999999874     34579999999999999998753    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccc
Q psy6508          72 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        72 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE  151 (477)
                      ...+++..+..++.|++.||.|||+++++||||||+||+++.+. .+.++|||.+.......  ....+..++..|+|||
T Consensus       118 ~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE  194 (286)
T cd06638         118 GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPE  194 (286)
T ss_pred             CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCC-CEEEccCCceeecccCC--CccccccCCCcccChh
Confidence            24688999999999999999999999999999999999997653 23345999875443221  1223456778899999


Q ss_pred             cCCCC--------CcccccCcceEEEEEE--eeecccc
Q psy6508         152 IPSSK--------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       152 ~~~~~--------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+...        .++|+ ||+|++++++  +..||..
T Consensus       195 ~~~~~~~~~~~~~~~~Dv-~slGvi~~el~~g~~p~~~  231 (286)
T cd06638         195 VIACEQQLDSTYDARCDV-WSLGITAIELGDGDPPLAD  231 (286)
T ss_pred             hhchhhhccccccchhhh-hhHHHHHHHHhcCCCCCCC
Confidence            86421        57899 9999999999  5566653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.88  E-value=1.8e-22  Score=193.38  Aligned_cols=171  Identities=20%  Similarity=0.304  Sum_probs=136.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +++.+|+|.+......   ...+.+|+.++++++|||++++++++......+++|||+++++|.+++... +.+++..+.
T Consensus        27 ~~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~  103 (256)
T cd05112          27 EKRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLL  103 (256)
T ss_pred             CCCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHH
Confidence            4678999998755433   246889999999999999999999999999999999999999999999764 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+........ .......++..|+|||...+.   .+
T Consensus       104 ~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~~~aPe~~~~~~~~~~  181 (256)
T cd05112         104 GMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYSSK  181 (256)
T ss_pred             HHHHHHHHHHHHHHHCCccccccccceEEEcCCC-eEEECCCcceeecccCcc-cccCCCccchhhcCHhHhccCCcChH
Confidence            9999999999999999999999999999997643 344569998754322211 111122234579999987655   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ |++|+++||+   +..||..
T Consensus       182 ~Dv-~slG~~l~el~~~g~~p~~~  204 (256)
T cd05112         182 SDV-WSFGVLMWEVFSEGKTPYEN  204 (256)
T ss_pred             HHH-HHHHHHHHHHHcCCCCCCCc
Confidence            899 9999999997   4567753

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.88  E-value=4e-23  Score=197.99  Aligned_cols=165  Identities=22%  Similarity=0.352  Sum_probs=132.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~   80 (477)
                      +++.||+|.++...    ..+.+.+|+.+++.++|||++++++++..+ ..+++|||+++++|.+++....  .+++..+
T Consensus        28 ~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~  102 (254)
T cd05083          28 TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQL  102 (254)
T ss_pred             CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHH
Confidence            57889999986432    235688999999999999999999998654 4799999999999999997643  5889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.......     ........|.|||...+.   .
T Consensus       103 ~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~  176 (254)
T cd05083         103 LQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSS  176 (254)
T ss_pred             HHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCC-cEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCc
Confidence            99999999999999999999999999999997643 34445999876433211     122234579999987654   5


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ |++|++++++   +..||..
T Consensus       177 ~~Dv-~slG~~l~el~~~g~~p~~~  200 (254)
T cd05083         177 KSDV-WSYGVLLWEVFSYGRAPYPK  200 (254)
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCCcc
Confidence            6899 9999999997   5677754

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.88  E-value=6.1e-23  Score=199.95  Aligned_cols=172  Identities=26%  Similarity=0.360  Sum_probs=138.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      .+|+.||||.++...........+.+|+.++++++||||+++++++.+.+..+++|||+. ++|..++...  ..+++..
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~  101 (284)
T cd07860          23 LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPL  101 (284)
T ss_pred             CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHH
Confidence            468899999987665444445678899999999999999999999999999999999996 6899988653  4689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||+|||++|++||||+|+||+++.+. .+...|||.+.......  .......++..|+|||...+.   
T Consensus       102 ~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~  178 (284)
T cd07860         102 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYY  178 (284)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-CEEEeeccchhhcccCc--cccccccccccccCCeEEecCCCC
Confidence            999999999999999999999999999999997653 34445999875432111  111233456789999987553   


Q ss_pred             -CcccccCcceEEEEEE--eeeccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                       .++|+ |++|+++|++  +..||.
T Consensus       179 ~~~~Dv-~slG~il~~l~tg~~p~~  202 (284)
T cd07860         179 STAVDI-WSLGCIFAEMVTRRALFP  202 (284)
T ss_pred             CcHHHH-HHHHHHHHHHHHCCCCCC
Confidence             56899 9999999999  556665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.88  E-value=1.1e-22  Score=198.07  Aligned_cols=172  Identities=27%  Similarity=0.374  Sum_probs=137.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---~l~~~   78 (477)
                      .+|+.||||+++.... ....+.+.+|+.++++++||||+++++++...+..++||||++ ++|.+++...+   .+++.
T Consensus        23 ~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  100 (284)
T cd07836          23 TTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPN  100 (284)
T ss_pred             CCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHH
Confidence            4688999999876543 2234567789999999999999999999999999999999998 58999887543   58999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++|++||||||+||+++++. .+.++|||.+.......  ....+..++..|+|||...+.  
T Consensus       101 ~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~  177 (284)
T cd07836         101 TVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRG-ELKLADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRT  177 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCC-cEEEeecchhhhhcCCc--cccccccccccccChHHhcCCCC
Confidence            9999999999999999999999999999999997642 34445998875432211  122345567789999987543  


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|++++++  +..||.+
T Consensus       178 ~~~~~Dv-~slG~~l~~l~~g~~~~~~  203 (284)
T cd07836         178 YSTSIDI-WSVGCIMAEMITGRPLFPG  203 (284)
T ss_pred             CCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence              56899 9999999999  6677763

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.88  E-value=1.2e-22  Score=200.66  Aligned_cols=172  Identities=24%  Similarity=0.330  Sum_probs=135.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhC-CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSH-EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~-~~l~~~   78 (477)
                      .+|+.||+|.++...........+.+|+.++++++||||+++++++...  +..++||||++ ++|.+++... ..+++.
T Consensus        30 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~  108 (309)
T cd07845          30 TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSES  108 (309)
T ss_pred             CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHH
Confidence            4689999999876543333334567899999999999999999998755  56899999997 6899988763 568999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.......  ........+..|+|||...+.  
T Consensus       109 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~  185 (309)
T cd07845         109 QVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKG-CLKIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTT  185 (309)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECccceeeecCCcc--CCCCcccccccccChhhhcCCCC
Confidence            9999999999999999999999999999999997643 34445999876543211  111233456789999987643  


Q ss_pred             --CcccccCcceEEEEEE--eeeccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                        .++|+ |++|+++|++  +..||.
T Consensus       186 ~~~~~Dv-wslG~il~el~~g~~~f~  210 (309)
T cd07845         186 YTTAIDM-WAVGCILAELLAHKPLLP  210 (309)
T ss_pred             cCchHHH-HHHHHHHHHHHhCCCCCC
Confidence              67899 9999999999  556665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.88  E-value=7e-23  Score=198.58  Aligned_cols=176  Identities=26%  Similarity=0.398  Sum_probs=144.7

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|++.+... .....+.+.+|..++++++ ||||+++++.+...+..+++||++++++|.+++.+.+.+++..
T Consensus        24 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~  103 (280)
T cd05581          24 ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKC  103 (280)
T ss_pred             CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHH
Confidence            4788999999877543 2344567889999999998 9999999999999999999999999999999999887899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc------------------ccCCeE
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI------------------EQGNTK  141 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~------------------~~g~t~  141 (477)
                      +..++.|++.||.|||++|++|+||+|+||+++.++ ++..+|||......+....                  ......
T Consensus       104 ~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~-~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  182 (280)
T cd05581         104 TRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDM-HIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF  182 (280)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC-CEEecCCccccccCCccccccCCCCCccccccccccccccccc
Confidence            999999999999999999999999999999997643 3455699987654433221                  112234


Q ss_pred             EEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         142 VICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       142 v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++..|.|||...+.   .++|+ |++|++++++  +..||..
T Consensus       183 ~~~~~~~~Pe~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~  224 (280)
T cd05581         183 VGTAEYVSPELLNEKPAGKSSDL-WALGCIIYQMLTGKPPFRG  224 (280)
T ss_pred             cCCccccCHHHhCCCCCChhhhH-HHHHHHHHHHHhCCCCCCC
Confidence            556789999987655   56899 9999999998  6677764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG1094|consensus

Probab=99.88  E-value=1.8e-23  Score=208.69  Aligned_cols=173  Identities=23%  Similarity=0.298  Sum_probs=145.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~~   81 (477)
                      +..||+|.++... ....+.+|.+|+++|.+|+||||++++++|..++.+++||||+++|+|.+++..+.  .+......
T Consensus       562 ~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~v  640 (807)
T KOG1094|consen  562 PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGV  640 (807)
T ss_pred             ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhH
Confidence            5789999987553 44556889999999999999999999999999999999999999999999998873  34566677


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      +++.||+.|++||.+.++||||+.+.|+|++.+. .+.++|||.++......|.......+....||++|.+.-.   .+
T Consensus       641 si~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFtta  719 (807)
T KOG1094|consen  641 SICTQIASGMAYLESLNFVHRDLATRNCLVDGEF-TIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTA  719 (807)
T ss_pred             HHHHHHHHHHHHHHhhchhhccccccceeecCcc-cEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccch
Confidence            8999999999999999999999999999998763 3444699999876655555554556677789999976544   78


Q ss_pred             ccccCcceEEEEEEe----eecccc
Q psy6508         159 LEYQRSKGELYVEFK----FAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~~----~~Pf~~  179 (477)
                      +|+ |++|+++||+.    -.||+.
T Consensus       720 SDv-WafgvTlwE~~~~C~e~Py~~  743 (807)
T KOG1094|consen  720 SDV-WAFGVTLWEVFMLCREQPYSQ  743 (807)
T ss_pred             hhh-hhhHHHHHHHHHHHhhCchhh
Confidence            999 99999999993    367764

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.88  E-value=8.1e-23  Score=199.98  Aligned_cols=172  Identities=23%  Similarity=0.366  Sum_probs=135.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+|+.||+|.+..... ......+.+|+.+++.++||||+++++++..+...|+||||+. ++|.+++... ..+++..+
T Consensus        28 ~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  105 (291)
T cd07870          28 INGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNV  105 (291)
T ss_pred             CCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHH
Confidence            3688999999876542 2223456789999999999999999999999999999999996 7887777543 46788999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+......  ........++..|+|||...+.    
T Consensus       106 ~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  182 (291)
T cd07870         106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLG-ELKLADFGLARAKSIP--SQTYSSEVVTLWYRPPDVLLGATDYS  182 (291)
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCC-cEEEeccccccccCCC--CCCCCCccccccccCCceeecCCCCC
Confidence            99999999999999999999999999999997643 3444599987542211  1122344567889999987543    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|++++++  +..||..
T Consensus       183 ~~~Dv-~slG~~l~~l~~g~~~f~~  206 (291)
T cd07870         183 SALDI-WGAGCIFIEMLQGQPAFPG  206 (291)
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            56899 9999999999  6677763

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0695|consensus

Probab=99.88  E-value=1.4e-23  Score=197.00  Aligned_cols=175  Identities=23%  Similarity=0.385  Sum_probs=152.7

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      ++.+.||+|+++++..++ +...-.+.|-.+..+- +||++|.++.+|+.+..+++|.||++||+|--.+++++++|++.
T Consensus       273 ~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeh  352 (593)
T KOG0695|consen  273 KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH  352 (593)
T ss_pred             ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHH
Confidence            577899999999987754 4556678899998887 79999999999999999999999999999999999988999999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      ++.+..+|+.||.|||++||++||||.+|+|++. +.+++.  |+|.++..-+..  ....|..+|+.|.+||.+.+.  
T Consensus       353 arfys~ei~lal~flh~rgiiyrdlkldnvlldaeghiklt--dygmcke~l~~g--d~tstfcgtpnyiapeilrgeey  428 (593)
T KOG0695|consen  353 ARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLT--DYGMCKEGLGPG--DTTSTFCGTPNYIAPEILRGEEY  428 (593)
T ss_pred             hhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeec--ccchhhcCCCCC--cccccccCCCcccchhhhccccc
Confidence            9999999999999999999999999999999986 456665  999886433322  234578899999999999988  


Q ss_pred             -CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                       .++|+ |++|++++||  +..||.-.+
T Consensus       429 gfsvdw-walgvlmfemmagrspfdivg  455 (593)
T KOG0695|consen  429 GFSVDW-WALGVLMFEMMAGRSPFDIVG  455 (593)
T ss_pred             CceehH-HHHHHHHHHHHcCCCCcceec
Confidence             88999 9999999999  889997544

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.88  E-value=7.7e-23  Score=202.26  Aligned_cols=176  Identities=21%  Similarity=0.334  Sum_probs=138.5

Q ss_pred             CCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhC-----CC
Q psy6508           3 QHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSH-----EK   74 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~-----~~   74 (477)
                      +++.||+|.+..... .....+.+.+|+.++++++||||+++++++...  ..+|+||||++ ++|.+++...     ..
T Consensus        26 ~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~  104 (316)
T cd07842          26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVS  104 (316)
T ss_pred             CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcC
Confidence            688999999887432 122345678899999999999999999999988  78999999997 5787777532     26


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc---CcceeecccccceecccCCcc-cccCCeEEEecccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPR  150 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~---~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~pp  150 (477)
                      +++..+..++.|++.||.|||++|++||||||+||+++.   ....+.++|||.+........ ...++...++..|+||
T Consensus       105 ~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  184 (316)
T cd07842         105 IPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAP  184 (316)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCH
Confidence            889999999999999999999999999999999999976   123455569998765432221 1223445677889999


Q ss_pred             ccCCCC----CcccccCcceEEEEEE--eeeccccc
Q psy6508         151 EIPSSK----TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       151 E~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      |...+.    .++|+ ||+|++++++  +..||.+.
T Consensus       185 E~~~~~~~~~~~~Dv-~slG~~l~~l~~~~~~~~~~  219 (316)
T cd07842         185 ELLLGARHYTKAIDI-WAIGCIFAELLTLEPIFKGR  219 (316)
T ss_pred             HHHhCCCCCCcHHHH-HHHHHHHHHHHhcCCCCcCC
Confidence            976543    56899 9999999998  67788754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.88  E-value=1.7e-22  Score=196.41  Aligned_cols=172  Identities=22%  Similarity=0.331  Sum_probs=139.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|.+..... ....+.+.+|+.++++++||||+++++.+..++..|+||||+++++|.+++.. ..+++..+.
T Consensus        27 ~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~  104 (277)
T cd06641          27 RTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIA  104 (277)
T ss_pred             CCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHH
Confidence            4678999999865432 33456789999999999999999999999999999999999999999999875 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.|+.|||++|++|+||+|+||+++.+. .+..+|||.+.......  ....+..++..|+|||...+.   .+
T Consensus       105 ~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~  181 (277)
T cd06641         105 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSK  181 (277)
T ss_pred             HHHHHHHHHHHHHccCCeecCCCCHHhEEECCCC-CEEEeecccceecccch--hhhccccCCccccChhhhccCCCCch
Confidence            9999999999999999999999999999997653 34445999775433211  111234566789999987654   56


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|++++++  +..||..
T Consensus       182 ~Dv-~slG~~l~~l~~g~~p~~~  203 (277)
T cd06641         182 ADI-WSLGITAIELAKGEPPHSE  203 (277)
T ss_pred             hhH-HHHHHHHHHHHcCCCCCCc
Confidence            899 9999999999  6667753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>KOG1006|consensus

Probab=99.88  E-value=2.6e-23  Score=189.96  Aligned_cols=170  Identities=21%  Similarity=0.272  Sum_probs=139.2

Q ss_pred             CCCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-----CCC
Q psy6508           1 NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-----HEK   74 (477)
Q Consensus         1 ~~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-----~~~   74 (477)
                      +++|+..|||+++.... +...+++..|.....+- +.||||++||+...++.-||.||+|+ .||..+.+.     +..
T Consensus        86 k~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~  163 (361)
T KOG1006|consen   86 KPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSR  163 (361)
T ss_pred             CccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhcc
Confidence            47899999999987764 45567888898876555 79999999999999999999999997 888876642     347


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++..+-.|..-.+.||.||-. ..|+|||+||+|||++. +.+++  ||||++....+|--   ..-..||..|+|||.
T Consensus       164 ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKL--CDFGIcGqLv~SiA---kT~daGCrpYmAPER  238 (361)
T KOG1006|consen  164 IPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKL--CDFGICGQLVDSIA---KTVDAGCRPYMAPER  238 (361)
T ss_pred             CcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEee--ecccchHhHHHHHH---hhhccCCccccChhc
Confidence            9999999999999999999975 58999999999999976 56665  59999977666532   234689999999998


Q ss_pred             CCCC-----CcccccCcceEEEEEEee--eccc
Q psy6508         153 PSSK-----TSLEYQRSKGELYVEFKF--APFA  178 (477)
Q Consensus       153 ~~~~-----~~~Di~~s~G~il~e~~~--~Pf~  178 (477)
                      +...     ..+|+ ||+|+++||+..  .|+.
T Consensus       239 i~p~~~gyDiRSDv-WSLGITL~EvAtG~fPyr  270 (361)
T KOG1006|consen  239 IDPSDKGYDIRSDV-WSLGITLYEVATGNFPYR  270 (361)
T ss_pred             cCCccCCcchhhhh-hhhcceEeeeecCCCCcc
Confidence            8765     56899 999999999954  4444

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.87  E-value=4e-23  Score=201.08  Aligned_cols=171  Identities=23%  Similarity=0.368  Sum_probs=135.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe------CCeEEEEEecCCCCCHHHHHHhC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD------ERYVYIILEYCDGGDLCSFIRSH--   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~------~~~~~lv~e~~~g~sL~~~l~~~--   72 (477)
                      ++++.||+|++....   .....+..|+.+++++ +||||+++++++..      ....|++|||+++++|.+++...  
T Consensus        39 ~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~  115 (282)
T cd06636          39 KTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG  115 (282)
T ss_pred             CCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC
Confidence            467899999986542   3345688999999999 79999999998853      45789999999999999999763  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ..+++..+..++.|++.||.|||++|++||||||+||+++++. .+.+.|||.+.......  ....+..++..|+|||.
T Consensus       116 ~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~  192 (282)
T cd06636         116 NALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEV  192 (282)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCcchhhhhccc--cCCCcccccccccCHhh
Confidence            3588889999999999999999999999999999999997653 34456999875433211  12234567788999998


Q ss_pred             CCCC--------CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK--------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~--------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +...        .++|+ |++|+++|++  +..||..
T Consensus       193 l~~~~~~~~~~~~~~Dv-wslG~~l~el~~g~~p~~~  228 (282)
T cd06636         193 IACDENPDATYDYRSDI-WSLGITAIEMAEGAPPLCD  228 (282)
T ss_pred             cCcccCcCcCCCcccch-hHHHHHHHHHHhCCCCccc
Confidence            6521        46899 9999999999  6677754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.87  E-value=4e-23  Score=203.05  Aligned_cols=173  Identities=26%  Similarity=0.374  Sum_probs=135.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC----------eEEEEEecCCCCCHHHHHHh
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER----------YVYIILEYCDGGDLCSFIRS   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----------~~~lv~e~~~g~sL~~~l~~   71 (477)
                      .+|+.||+|.++...........+.+|+.++++++||||+++++++.+..          .+|+++||++ ++|..++..
T Consensus        30 ~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~  108 (302)
T cd07864          30 DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD-HDLMGLLES  108 (302)
T ss_pred             CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccC-ccHHHHHhc
Confidence            46889999998765433334456788999999999999999999887654          7999999998 578887765


Q ss_pred             C-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          72 H-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        72 ~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                      . ..+++..++.++.|++.||.|||+.||+||||||+||+++++. .+.+.|||.+........ ........+..|+||
T Consensus       109 ~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~P  186 (302)
T cd07864         109 GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKG-QIKLADFGLARLYNSEES-RPYTNKVITLWYRPP  186 (302)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-cEEeCcccccccccCCcc-cccccceeccCccCh
Confidence            4 3689999999999999999999999999999999999998653 334459998764432211 111223456789999


Q ss_pred             ccCCCC----CcccccCcceEEEEEE--eeeccc
Q psy6508         151 EIPSSK----TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       151 E~~~~~----~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      |...+.    .++|+ |++|++++++  +..||.
T Consensus       187 E~~~~~~~~~~~~Di-~slG~~~~el~~g~~~~~  219 (302)
T cd07864         187 ELLLGEERYGPAIDV-WSCGCILGELFTKKPIFQ  219 (302)
T ss_pred             HHhcCCCCCCchhHH-HHHHHHHHHHHhCCCCCC
Confidence            977543    67899 9999999999  666665

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.87  E-value=3.1e-22  Score=198.58  Aligned_cols=169  Identities=21%  Similarity=0.341  Sum_probs=137.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .++..||+|.+..... ..+....+.+|+.++++++|||++++++++..++..|+||||+. |+|.+.+.. ..++++..
T Consensus        48 ~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~  126 (317)
T cd06635          48 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE  126 (317)
T ss_pred             CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHH
Confidence            4678999999876533 33455678999999999999999999999999999999999997 588887754 45689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC---C
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS---K  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~---~  156 (477)
                      +..++.|++.||.|||++|++||||+|+||+++.+. .+.+.|||.+....      ...+..++..|.|||....   .
T Consensus       127 ~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~  199 (317)
T cd06635         127 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASIAS------PANSFVGTPYWMAPEVILAMDEG  199 (317)
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCC-CEEEecCCCccccC------CcccccCCccccChhhhhcCCCC
Confidence            999999999999999999999999999999997643 34445999764322      2234456778999998631   1


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|++++++  +..||..
T Consensus       200 ~~~~~~Dv-~slGvil~el~~g~~p~~~  226 (317)
T cd06635         200 QYDGKVDV-WSLGITCIELAERKPPLFN  226 (317)
T ss_pred             CCCccccH-HHHHHHHHHHHhCCCCCCC
Confidence               67899 9999999999  6677764

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG4257|consensus

Probab=99.87  E-value=9.5e-23  Score=204.77  Aligned_cols=172  Identities=19%  Similarity=0.296  Sum_probs=145.2

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i   83 (477)
                      --||||..+.+. ..+..+.|..|..+|+.++||||++++|++.+ .+.|||||.++.|.|+.||+.++ .++......+
T Consensus       419 iaVAvKtCK~d~-t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly  496 (974)
T KOG4257|consen  419 IAVAVKTCKTDC-TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLY  496 (974)
T ss_pred             eeeeeehhccCC-ChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEecccchhHHHHHHhccccchHHHHHHH
Confidence            358999886644 45557899999999999999999999999865 57899999999999999998865 6999999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cccc
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLE  160 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~D  160 (477)
                      ++||+.||.|||++.+|||||...|||+.+.++ +.+.|||+++..+.++|+....++ ..--||+||...-+   .++|
T Consensus       497 ~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~C-VKLaDFGLSR~~ed~~yYkaS~~k-LPIKWmaPESINfRrFTtASD  574 (974)
T KOG4257|consen  497 CYQICTALAYLESKRFVHRDIAARNILVSSPQC-VKLADFGLSRYLEDDAYYKASRGK-LPIKWMAPESINFRRFTTASD  574 (974)
T ss_pred             HHHHHHHHHHHHhhchhhhhhhhhheeecCcce-eeecccchhhhccccchhhccccc-cceeecCccccchhcccchhh
Confidence            999999999999999999999999999987642 334699999998888887655322 22349999987644   7889


Q ss_pred             ccCcceEEEEEE---eeecccccc
Q psy6508         161 YQRSKGELYVEF---KFAPFASQI  181 (477)
Q Consensus       161 i~~s~G~il~e~---~~~Pf~~~~  181 (477)
                      + |.||+.+||+   |..||.+..
T Consensus       575 V-WMFgVCmWEIl~lGvkPfqgvk  597 (974)
T KOG4257|consen  575 V-WMFGVCMWEILSLGVKPFQGVK  597 (974)
T ss_pred             H-HHHHHHHHHHHHhcCCcccccc
Confidence            9 9999999998   889998743

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.87  E-value=3.9e-23  Score=201.90  Aligned_cols=174  Identities=20%  Similarity=0.304  Sum_probs=139.4

Q ss_pred             CCcEEEEEEcccCCCC--hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVS--ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      +++.||||.+++....  ....+.+.+|+.+++++ +||||+++++.+......|+||||+++++|.+++.....+++..
T Consensus        27 ~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  106 (288)
T cd05583          27 AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESE  106 (288)
T ss_pred             CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHH
Confidence            5788999998754332  23345788999999999 69999999999999999999999999999999998777899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|+++||.|||+.|++||||||.||+++.+. ++.++|||++......... ......+...|++||...+.   
T Consensus       107 ~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  184 (288)
T cd05583         107 VRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEG-HVVLTDFGLSKEFLAEEEE-RAYSFCGTIEYMAPEVIRGGSGG  184 (288)
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC-CEEEEECcccccccccccc-ccccccCCccccCHHHhcCCCCC
Confidence            999999999999999999999999999999997653 3445699987543322110 11123456679999987543   


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|++++++  +..||..
T Consensus       185 ~~~~~Dv-~slG~il~el~tg~~p~~~  210 (288)
T cd05583         185 HDKAVDW-WSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             Ccchhhh-HHHHHHHHHHHhCCCCccc
Confidence              57899 9999999999  5677753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.87  E-value=4.3e-22  Score=191.56  Aligned_cols=170  Identities=22%  Similarity=0.325  Sum_probs=133.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~   80 (477)
                      .+..||+|.+....   ...+.+.+|+.++++++||||+++++.+.. ...+++|||+++++|.+++.+.  ..+++..+
T Consensus        29 ~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~  104 (260)
T cd05073          29 KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL  104 (260)
T ss_pred             CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHH
Confidence            45679999876542   234678899999999999999999999877 7789999999999999999763  35788899


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+......... ......++..|+|||.....   .
T Consensus       105 ~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~  182 (260)
T cd05073         105 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTI  182 (260)
T ss_pred             HHHHHHHHHHHHHHHhCCccccccCcceEEEcCCC-cEEECCCcceeeccCCCcc-cccCCcccccccCHhHhccCCcCc
Confidence            99999999999999999999999999999997653 4445699987543322111 11112334569999988655   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ |++|++++++   +..||.+
T Consensus       183 ~~Di-~slG~~l~~l~t~g~~p~~~  206 (260)
T cd05073         183 KSDV-WSFGILLMEIVTYGRIPYPG  206 (260)
T ss_pred             cccc-hHHHHHHHHHHhcCCCCCCC
Confidence            7899 9999999987   4567753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.87  E-value=1.3e-22  Score=199.97  Aligned_cols=174  Identities=21%  Similarity=0.361  Sum_probs=134.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC--------eEEEEEecCCCCCHHHHHHhCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--------YVYIILEYCDGGDLCSFIRSHE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--------~~~lv~e~~~g~sL~~~l~~~~   73 (477)
                      .+++.||||.+............+.+|+.++++++||||+++++++....        ..++||||+. ++|.+++....
T Consensus        35 ~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~  113 (310)
T cd07865          35 KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKN  113 (310)
T ss_pred             CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcc
Confidence            47899999998765433333445678999999999999999999876543        4699999997 68988887643


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc--cccCCeEEEecccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY--IEQGNTKVICSVFEPR  150 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~--~~~g~t~v~~~~y~pp  150 (477)
                       .+++..++.++.|++.||.|||++|++|+||||+||+++.+. .+.+.|||.+........  ........++..|+||
T Consensus       114 ~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aP  192 (310)
T cd07865         114 VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPP  192 (310)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-cEEECcCCCcccccCCcccCCCCccCcccCccccCc
Confidence             689999999999999999999999999999999999997653 344459998764332111  0111234566789999


Q ss_pred             ccCCCC----CcccccCcceEEEEEE--eeeccc
Q psy6508         151 EIPSSK----TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       151 E~~~~~----~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      |...+.    .++|+ ||+|+++|++  +..||.
T Consensus       193 E~~~~~~~~~~~~Di-~slG~~l~el~t~~~~~~  225 (310)
T cd07865         193 ELLLGERDYGPPIDM-WGAGCIMAEMWTRSPIMQ  225 (310)
T ss_pred             HHhcCCcccCchhhh-HHHHHHHHHHHhCCCCCC
Confidence            987553    57899 9999999999  556665

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.87  E-value=1.3e-22  Score=199.90  Aligned_cols=170  Identities=17%  Similarity=0.253  Sum_probs=132.4

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i~   84 (477)
                      .||+|.+.... .......+.+|+.+++.++||||+++++++... ..++++||+++|+|.+++..+. .+++..+..++
T Consensus        38 ~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~  115 (303)
T cd05110          38 PVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWC  115 (303)
T ss_pred             eEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHH
Confidence            57999886543 233345688999999999999999999988654 4679999999999999997754 58999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEY  161 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di  161 (477)
                      .|++.||.|||++|++||||||+||+++.+. .+.++|||.+....+............+..|+|||...+.   .++|+
T Consensus       116 ~qi~~~L~~LH~~~ivH~dikp~Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di  194 (303)
T cd05110         116 VQIAKGMMYLEERRLVHRDLAARNVLVKSPN-HVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDV  194 (303)
T ss_pred             HHHHHHHHHHhhcCeeccccccceeeecCCC-ceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHH
Confidence            9999999999999999999999999997542 3444599988755432211111223344579999987655   67899


Q ss_pred             cCcceEEEEEE---eeecccc
Q psy6508         162 QRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       162 ~~s~G~il~e~---~~~Pf~~  179 (477)
                       ||+|+++||+   +..||.+
T Consensus       195 -wslG~~l~el~t~g~~p~~~  214 (303)
T cd05110         195 -WSYGVTIWELMTFGGKPYDG  214 (303)
T ss_pred             -HHHHHHHHHHHhCCCCCCCC
Confidence             9999999997   3466653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=3.1e-22  Score=195.64  Aligned_cols=172  Identities=24%  Similarity=0.311  Sum_probs=137.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHh----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRS----HEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~----~~~l   75 (477)
                      .+++.||+|.+..... .....++.+|++++++++||||+++++++...  +.+|+||||++|++|.+++..    ...+
T Consensus        24 ~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l  102 (287)
T cd06621          24 NTGMIFALKTITTDPN-PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRI  102 (287)
T ss_pred             CCCeEEEEEEEecCCc-hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCC
Confidence            4688999999875532 34456789999999999999999999988643  478999999999999998753    2458


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||+.|++|+||+|+||+++.+. .+.++|||.+.......    .....++..|+|||...+
T Consensus       103 ~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~  177 (287)
T cd06621         103 GEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKG-QVKLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQG  177 (287)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCC-eEEEeeccccccccccc----cccccCCccccCHHHhcC
Confidence            8999999999999999999999999999999999997643 35556999865432111    112335667999998765


Q ss_pred             C---CcccccCcceEEEEEE--eeeccccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .   .++|+ |++|+++|++  +..||...
T Consensus       178 ~~~~~~~Dv-~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         178 KPYSITSDV-WSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             CCCCchhhH-HHHHHHHHHHHhCCCCCCcc
Confidence            5   57899 9999999999  66777643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0665|consensus

Probab=99.87  E-value=3.1e-23  Score=194.21  Aligned_cols=171  Identities=22%  Similarity=0.348  Sum_probs=142.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+++||+|++.....+....++..+|..++..++|+||++++.+|....      .+|+|||++. .+|.+.+..  .++
T Consensus        40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~--elD  116 (369)
T KOG0665|consen   40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM--ELD  116 (369)
T ss_pred             ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH--hcc
Confidence            4788999998887766666778899999999999999999999987443      5899999997 899999884  588


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      ...+..+++|++.|++|||+.||+||||||+||+++.+. .+...|||.+...+..   -.-...+.+..|.+||+..+.
T Consensus       117 H~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~-~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~  192 (369)
T KOG0665|consen  117 HETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDC-TLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGM  192 (369)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchh-heeeccchhhcccCcc---cccCchhheeeccCchheecc
Confidence            999999999999999999999999999999999998753 3334599999776654   122456788899999999876


Q ss_pred             ---CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                         ..+|+ ||.||++-||  +.--|.+..
T Consensus       193 ~~ke~vdi-wSvGci~gEli~~~Vlf~g~d  221 (369)
T KOG0665|consen  193 GYKENVDI-WSVGCIMGELILGTVLFPGKD  221 (369)
T ss_pred             CCcccchh-hhhhhHHHHHhhceEEecCch
Confidence               78999 9999999999  444454443

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.87  E-value=8.4e-23  Score=204.50  Aligned_cols=173  Identities=29%  Similarity=0.434  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||.+............+.+|+.+++.++||||+++++++...     ...|+++||+. ++|.+++...++++
T Consensus        28 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~  106 (337)
T cd07858          28 ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLS  106 (337)
T ss_pred             CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCCCC
Confidence            4789999999876543344455678999999999999999999987643     35899999996 79999998878899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..+..++.|++.||.|||++|++||||||+||+++.+. .+.+.|||.+.......  ....+..++..|+|||...+.
T Consensus       107 ~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~  183 (337)
T cd07858         107 DDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNC  183 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCC-CEEECcCccccccCCCc--ccccccccccCccChHHHhcC
Confidence            999999999999999999999999999999999997643 34445999876543321  122345667889999976532


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ |++|+++|++  +..||.+
T Consensus       184 ~~~~~~~Di-wslG~il~~l~~g~~pf~~  211 (337)
T cd07858         184 SEYTTAIDV-WSVGCIFAELLGRKPLFPG  211 (337)
T ss_pred             CCCCCcccH-HHHHHHHHHHHcCCCCCCC
Confidence                67899 9999999998  6677764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.87  E-value=7.8e-23  Score=204.41  Aligned_cols=175  Identities=20%  Similarity=0.306  Sum_probs=138.9

Q ss_pred             CCCcEEEEEEcccCCCChh------------HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSEN------------RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFI   69 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l   69 (477)
                      .+++.||||++........            ....+.+|+.++++++||||+++++++..++..|++|||++ ++|.+++
T Consensus        32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l  110 (335)
T PTZ00024         32 LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV  110 (335)
T ss_pred             CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHH
Confidence            4688999999876543221            01247799999999999999999999999999999999997 7999999


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc------------cc
Q psy6508          70 RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI------------EQ  137 (477)
Q Consensus        70 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~------------~~  137 (477)
                      .....+++..+..++.|++.||.|||++|++||||+|+||+++.+. .+.+.|||.+.....+.+.            ..
T Consensus       111 ~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  189 (335)
T PTZ00024        111 DRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETMQRREE  189 (335)
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCC-CEEECCccceeeccccccccccccccccccccc
Confidence            8877899999999999999999999999999999999999997653 3344599987654311110            11


Q ss_pred             CCeEEEeccccccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         138 GNTKVICSVFEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       138 g~t~v~~~~y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .....++..|.|||...+.    .++|+ |++|++++++  +..||.+
T Consensus       190 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv-~slG~~l~el~tg~~p~~~  236 (335)
T PTZ00024        190 MTSKVVTLWYRAPELLMGAEKYHFAVDM-WSVGCIFAELLTGKPLFPG  236 (335)
T ss_pred             ccccccccCCCCChhcccCCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            1223456789999987653    57899 9999999999  6677764

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.87  E-value=3.8e-23  Score=217.54  Aligned_cols=148  Identities=22%  Similarity=0.264  Sum_probs=120.2

Q ss_pred             HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHH
Q psy6508          21 RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-----KLSEFQCQQFVRQLVLALKFLR   95 (477)
Q Consensus        21 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH   95 (477)
                      ....+.+|+.+|++++||||+++++++...+..|++++++. ++|..++....     ......++.++.|++.||.|||
T Consensus       206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH  284 (501)
T PHA03210        206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH  284 (501)
T ss_pred             HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence            34568899999999999999999999999999999999996 78888775431     2346678899999999999999


Q ss_pred             hCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE
Q psy6508          96 ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF  172 (477)
Q Consensus        96 ~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~  172 (477)
                      ++||+||||||+|||++.+. ++.++|||++........ ....+.+++..|+|||.+.+.   .++|+ ||+|+++|||
T Consensus       285 ~~gIiHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wSlGvil~el  361 (501)
T PHA03210        285 DKKLIHRDIKLENIFLNCDG-KIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDI-WSCGLILLDM  361 (501)
T ss_pred             hCCeecCCCCHHHEEECCCC-CEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHH-HHHHHHHHHH
Confidence            99999999999999997643 344569999865432211 112235688899999998766   67899 9999999999

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.87  E-value=1.1e-22  Score=196.43  Aligned_cols=172  Identities=22%  Similarity=0.380  Sum_probs=136.4

Q ss_pred             CCcEEEEEEcccCCC--------ChhHHHHHHHHHHHHHh-cCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh--
Q psy6508           3 QHTEVAIKCIDKTKV--------SENRFDSIVNEIKALKL-LHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS--   71 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~--------~~~~~~~~~~E~~il~~-l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~--   71 (477)
                      +++.+|+|.+.....        ......++.+|+.++.+ ++||||+++++.+...+..+++|||++|++|.+++..  
T Consensus        25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~  104 (269)
T cd08528          25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK  104 (269)
T ss_pred             CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHH
Confidence            468899998864421        22344567889998875 6999999999999999999999999999999998743  


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          72 --HEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        72 --~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                        ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.+. .+.+.|||.+.......   ......++..|.
T Consensus       105 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~  180 (269)
T cd08528         105 EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVTITDFGLAKQKQPES---KLTSVVGTILYS  180 (269)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEEEecccceeeccccc---ccccccCcccCc
Confidence              3468999999999999999999996 7899999999999997643 33445999886543221   112345667899


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |||...+.   .++|+ ||+|+++|++  +..||..
T Consensus       181 ~Pe~~~~~~~~~~~Dv-~slG~ll~~l~~g~~p~~~  215 (269)
T cd08528         181 CPEIVKNEPYGEKADV-WAFGCILYQMCTLQPPFYS  215 (269)
T ss_pred             ChhhhcCCCCchHHHH-HHHHHHHHHHHhCCCcccc
Confidence            99998765   67899 9999999999  5677753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.87  E-value=2.1e-22  Score=195.76  Aligned_cols=170  Identities=24%  Similarity=0.387  Sum_probs=134.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhC-CCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSH-EKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~-~~l~~   77 (477)
                      .+++.||+|+++....+... ....+|+.+++++. |||++++++++.++  +.+++||||++ ++|.+++... ..+++
T Consensus        22 ~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~   99 (282)
T cd07831          22 KTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPE   99 (282)
T ss_pred             CCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCH
Confidence            46889999998765433322 33457999999995 99999999999887  88999999997 6888888763 46899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..+..++.|++.||.|||++|++||||||+||+++.+.+  .+.|||.+........   .....++..|+|||..... 
T Consensus       100 ~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~~~~--kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~  174 (282)
T cd07831         100 KRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDDIL--KLADFGSCRGIYSKPP---YTEYISTRWYRAPECLLTDG  174 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcCCCe--EEEecccccccccCCC---cCCCCCCcccCChhHhhcCC
Confidence            999999999999999999999999999999999988444  4459998865433221   1223456789999975432 


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++||+  +..||.+
T Consensus       175 ~~~~~~Di-~slGv~l~el~~~~~p~~~  201 (282)
T cd07831         175 YYGPKMDI-WAVGCVFFEILSLFPLFPG  201 (282)
T ss_pred             CCCcchhH-HHHHHHHHHHHcCCcCCCC
Confidence               67899 9999999999  5677764

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.87  E-value=9.2e-23  Score=203.92  Aligned_cols=175  Identities=26%  Similarity=0.359  Sum_probs=139.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      ++|+.||+|++............+.+|+.+|++++||||+++++++..    ....|+||||+. ++|.+++...+.+++
T Consensus        28 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~  106 (334)
T cd07855          28 RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTE  106 (334)
T ss_pred             CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCH
Confidence            468999999987654444455678899999999999999999998763    357899999996 799999987778999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc--cccCCeEEEeccccccccCCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY--IEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~--~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ..+..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+........  .....+..++..|.|||...+
T Consensus       107 ~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  185 (334)
T cd07855         107 EHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDC-ELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLS  185 (334)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-cEEecccccceeecccCcCCCcccccccccccccChHHhcC
Confidence            99999999999999999999999999999999997643 344459998754322111  111123467778999998654


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ |++|+++|++  +..||.+
T Consensus       186 ~~~~~~~~Di-~slG~~l~el~~g~~pf~~  214 (334)
T cd07855         186 LPEYTTAIDM-WSVGCIFAEMLGRRQLFPG  214 (334)
T ss_pred             Ccccccccch-HHHHHHHHHHHcCCCccCC
Confidence            2    67899 9999999998  6677764

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0196|consensus

Probab=99.87  E-value=5.3e-22  Score=204.18  Aligned_cols=171  Identities=24%  Similarity=0.317  Sum_probs=140.2

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      -..||||.++.. .+++.+.+|+.|..||-+++||||+++-|+......+.||+|||++|+|..+|+.+ +.++.-++..
T Consensus       657 e~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVg  735 (996)
T KOG0196|consen  657 EITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVG  735 (996)
T ss_pred             ceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHH
Confidence            357999998654 46778889999999999999999999999999999999999999999999999876 4799999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecc-cCC-cccccCCeEEEeccccccccCCCC---C
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKA-KGS-AYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~-~gs-~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +++.|+.|++||-+.|+|||||...|||++.| +..+..|||+++.. +++ ++......+ +.-.|.|||.+.-+   .
T Consensus       736 MLrGIAsGMkYLsdm~YVHRDLAARNILVNsn-LvCKVsDFGLSRvledd~~~~ytt~GGK-IPiRWTAPEAIa~RKFTs  813 (996)
T KOG0196|consen  736 MLRGIASGMKYLSDMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAAYTTLGGK-IPIRWTAPEAIAYRKFTS  813 (996)
T ss_pred             HHHHHHHHhHHHhhcCchhhhhhhhheeeccc-eEEEeccccceeecccCCCccccccCCc-cceeecChhHhhhcccCc
Confidence            99999999999999999999999999999987 34444599999754 222 111111112 12348999987655   7


Q ss_pred             cccccCcceEEEEEE---eeeccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~  178 (477)
                      ++|+ ||+|+++||+   |-.||-
T Consensus       814 ASDV-WSyGIVmWEVmSyGERPYW  836 (996)
T KOG0196|consen  814 ASDV-WSYGIVMWEVMSYGERPYW  836 (996)
T ss_pred             hhhc-cccceEEEEecccCCCccc
Confidence            7899 9999999999   445654

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.87  E-value=1.1e-22  Score=197.84  Aligned_cols=174  Identities=26%  Similarity=0.369  Sum_probs=139.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhC-CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSH-EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~-~~l~~~   78 (477)
                      .+|+.||+|.+..........+.+.+|+.+++.++|||++++++++...  +..++|+||++ ++|.+++... ..+++.
T Consensus        22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~  100 (287)
T cd07840          22 KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTES  100 (287)
T ss_pred             CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHH
Confidence            3578999999987653344456788999999999999999999999887  89999999998 5999988765 479999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++|++|+||+|+||+++++. .+.+.|||.+........ .......++..|+|||...+.  
T Consensus       101 ~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~  178 (287)
T cd07840         101 QIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDG-VLKLADFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATR  178 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCC-CEEEccccceeeccCCCc-ccccccccccccCCceeeEcccc
Confidence            9999999999999999999999999999999998643 334459998865543321 111224556789999976543  


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ |++|++++++  +..||..
T Consensus       179 ~~~~~Dv-~slG~~l~el~t~~~p~~~  204 (287)
T cd07840         179 YGPEVDM-WSVGCILAELFLGKPIFQG  204 (287)
T ss_pred             CChHHHH-HHHHHHHHHHHhCCCCCCC
Confidence              67899 9999999999  6667653

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.87  E-value=2.5e-22  Score=201.00  Aligned_cols=172  Identities=27%  Similarity=0.360  Sum_probs=136.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+|+.||+|++............+.+|+.+++++ +||||+++++++...  ...|+||||++ ++|.+++... .+++.
T Consensus        30 ~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~  107 (337)
T cd07852          30 RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDV  107 (337)
T ss_pred             CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHH
Confidence            3688999999866544444456788999999999 999999999988643  46899999997 6999998775 78899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCccc---ccCCeEEEeccccccccCC
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYI---EQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~---~~g~t~v~~~~y~ppE~~~  154 (477)
                      .+..++.|++.||.|||++||+||||||+||+++.+ .+++  .|||.+.........   ......+++..|+|||...
T Consensus       108 ~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl--~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  185 (337)
T cd07852         108 HKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKL--ADFGLARSLSELEENPENPVLTDYVATRWYRAPEILL  185 (337)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEE--eeccchhccccccccccCcchhcccccccccCceeee
Confidence            999999999999999999999999999999999765 4555  489987643322111   1112345677899999765


Q ss_pred             CC----CcccccCcceEEEEEE--eeeccc
Q psy6508         155 SK----TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       155 ~~----~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      +.    .++|+ ||+|+++|++  +..||.
T Consensus       186 ~~~~~~~~sDi-~slG~~l~el~tg~~pf~  214 (337)
T cd07852         186 GSTRYTKGVDM-WSVGCILGEMLLGKPLFP  214 (337)
T ss_pred             ccccccccchH-HHHHHHHHHHHhCCCCCC
Confidence            43    67899 9999999999  666665

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.87  E-value=2.1e-22  Score=199.48  Aligned_cols=169  Identities=20%  Similarity=0.353  Sum_probs=136.6

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+|+.|++|.+..... .....+.+.+|+.+++.++|||++++++++.+....|++|||+. ++|.+++.. ..++++..
T Consensus        44 ~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~  122 (313)
T cd06633          44 HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVE  122 (313)
T ss_pred             CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHH
Confidence            4688999999876543 33445678899999999999999999999999999999999997 688887765 34689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC---C
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS---K  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~---~  156 (477)
                      +..++.|++.||.|||++|++||||+|+||+++.+. .+.++|||.+....      ..++..++..|+|||....   .
T Consensus       123 ~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~  195 (313)
T cd06633         123 IAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG-QVKLADFGSASKSS------PANSFVGTPYWMAPEVILAMDEG  195 (313)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC-CEEEeecCCCcccC------CCCCccccccccChhhccccCCC
Confidence            999999999999999999999999999999997643 23445888764321      1234566778999998732   1


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|++++++  +..||..
T Consensus       196 ~~~~~sDv-~slGvil~el~~g~~p~~~  222 (313)
T cd06633         196 QYDGKVDV-WSLGITCIELAERKPPLFN  222 (313)
T ss_pred             CCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence               56899 9999999999  6677754

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG1027|consensus

Probab=99.87  E-value=2.3e-22  Score=208.61  Aligned_cols=171  Identities=26%  Similarity=0.326  Sum_probs=141.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-C---CCH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-K---LSE   77 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~---l~~   77 (477)
                      .|+.||||.+-.+     ...-..+|+..|+.- +||||+++|+.-.++...||..|.|. .+|.++++... .   ...
T Consensus       532 e~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~  605 (903)
T KOG1027|consen  532 EGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSD  605 (903)
T ss_pred             CCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhccc
Confidence            4789999987543     334567999999988 69999999999889999999999998 89999998741 1   112


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc----CcceeecccccceecccCC-cccccCCeEEEecccccccc
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLAGLKQGVSEKAKGS-AYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~----~~~rl~~~dfG~~~~~~gs-~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ...+..+.|+++||++||+.+||||||||+||||..    +.+|..+.|||++++..+. .-+..-.+..|+..|.|||+
T Consensus       606 i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~  685 (903)
T KOG1027|consen  606 IDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQ  685 (903)
T ss_pred             ccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHH
Confidence            445788999999999999999999999999999964    5688899999999875543 22333456778889999999


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeeccccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFASQ  180 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~~~  180 (477)
                      +...   .++|+ +++||++|.+   |..||.+.
T Consensus       686 L~~~~~~~avDi-FslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  686 LREDRKTQAVDI-FSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             HhccccCcccch-hhcCceEEEEecCCccCCCch
Confidence            9876   77899 9999999998   67899753

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.87  E-value=2.2e-22  Score=195.53  Aligned_cols=173  Identities=27%  Similarity=0.382  Sum_probs=140.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+|+.+++|.++.....+.....+.+|+.++++++||||+++++++..++..++++||++ ++|.+++... ..+++..+
T Consensus        22 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~  100 (283)
T cd05118          22 LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLI  100 (283)
T ss_pred             CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhcccCCHHHH
Confidence            478899999987766554556788899999999999999999999999999999999998 5888888763 57899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||++|++|+||||+||+++.+. .+.+.|||.+.......  .......++..|.|||...+.    
T Consensus       101 ~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~  177 (283)
T cd05118         101 KSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEG-VLKLADFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYS  177 (283)
T ss_pred             HHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCC-cEEEeeeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCC
Confidence            99999999999999999999999999999998642 33445999876543322  111224566789999987544    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|++++++  +..||..
T Consensus       178 ~~~Di-~slG~~l~~l~tg~~~~~~  201 (283)
T cd05118         178 TPVDI-WSVGCIFAELLSRRPLFPG  201 (283)
T ss_pred             chhHH-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6666653

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>KOG0587|consensus

Probab=99.87  E-value=2.6e-21  Score=201.73  Aligned_cols=171  Identities=25%  Similarity=0.391  Sum_probs=142.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe-----CCeEEEEEecCCCCCHHHHHHhC--C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD-----ERYVYIILEYCDGGDLCSFIRSH--E   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~~--~   73 (477)
                      ++|+.+|+|++....-   ..+++.-|..+|+.+ .|||++.+|++|..     .+.+|||||||.|||..+++++.  .
T Consensus        42 ~~~~~aa~kI~~~~~d---~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~  118 (953)
T KOG0587|consen   42 KTGQLAAIKIMDPTED---EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGN  118 (953)
T ss_pred             ecCceeeeEeecCCcc---ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhccc
Confidence            4678889998765542   335677899999998 79999999999863     45899999999999999999764  4


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ++.|..+..|++.++.||.+||.+.++|||+|-.|||++.+ ++++  +|||++...+...  ..-+|.+||+.||+||+
T Consensus       119 rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKL--vDFGvSaQldsT~--grRnT~iGtP~WMAPEV  194 (953)
T KOG0587|consen  119 RLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKL--VDFGVSAQLDSTV--GRRNTFIGTPYWMAPEV  194 (953)
T ss_pred             chhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEE--eeeeeeeeeeccc--ccccCcCCCccccccee
Confidence            78999999999999999999999999999999999999764 5555  5999997766443  34578999999999999


Q ss_pred             CCCC--------CcccccCcceEEEEEE--eeeccccc
Q psy6508         153 PSSK--------TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       153 ~~~~--------~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ....        ..+|+ ||+|++..||  +-+|+...
T Consensus       195 iac~e~~d~tyd~R~D~-WsLGITaIEladG~PPl~Dm  231 (953)
T KOG0587|consen  195 IACDESPDATYDYRSDL-WSLGITAIEMAEGAPPLCDM  231 (953)
T ss_pred             eecccCCCCCcccccch-hhccceeehhcCCCCCccCc
Confidence            8765        45789 9999999999  55777653

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.86  E-value=1.6e-22  Score=201.63  Aligned_cols=175  Identities=29%  Similarity=0.385  Sum_probs=142.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-----eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-----YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+++.||||++..........+.+.+|+.+++.++||||+++++++....     .+|++|||++ ++|.+++.+...++
T Consensus        23 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~  101 (330)
T cd07834          23 RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLT  101 (330)
T ss_pred             CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCC
Confidence            35889999998765443445577999999999999999999999987765     7899999998 68999998877899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..+..++.|++.||.|||++|++||||||+||+++.+ .++.++|||.+........ ........++..|.|||...+
T Consensus       102 ~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~-~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  180 (330)
T cd07834         102 DDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSN-CDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLS  180 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEcccCceEeecccccccccccccccccCcCCceeeec
Confidence            99999999999999999999999999999999999876 3455569998875443221 011223456778999998765


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ |++|++++++  +..||.+
T Consensus       181 ~~~~~~~sDi-~slG~il~~l~~g~~pf~~  209 (330)
T cd07834         181 SSRYTKAIDI-WSVGCIFAELLTRKPLFPG  209 (330)
T ss_pred             ccCCCcchhH-HHHHHHHHHHHcCCCCcCC
Confidence            4    57899 9999999999  6677764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0603|consensus

Probab=99.86  E-value=8.7e-23  Score=207.16  Aligned_cols=165  Identities=30%  Similarity=0.417  Sum_probs=136.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.+++|++.+...      +..+|+.++... +||||+++.+.+.+..+.|+|||.+.|+-|.+.+...+.+. .++
T Consensus       345 ~t~~~~~vkii~~~~~------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~  417 (612)
T KOG0603|consen  345 PTDQEPAVKIISKRAD------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEA  417 (612)
T ss_pred             ccccchhheecccccc------ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHH
Confidence            4677888999876632      134678776666 79999999999999999999999999998888887754444 788


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeec-c-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIK-N-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~-~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      ..|+.+|+.|+.|||++|++||||||+|||++ + +.+|++  |||..+....+     -.+...|..|.|||+....  
T Consensus       418 ~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrlt--yFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~y  490 (612)
T KOG0603|consen  418 SQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLT--YFGFWSELERS-----CDTPALTLQYVAPEVLAIQEY  490 (612)
T ss_pred             HHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEE--EechhhhCchh-----hcccchhhcccChhhhccCCC
Confidence            88999999999999999999999999999994 3 457776  89987665544     2456778889999998866  


Q ss_pred             -CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                       +++|+ ||+|+++|+|  |+.||....
T Consensus       491 t~acD~-WSLGvlLy~ML~G~tp~~~~P  517 (612)
T KOG0603|consen  491 TEACDW-WSLGVLLYEMLTGRTLFAAHP  517 (612)
T ss_pred             Ccchhh-HHHHHHHHHHHhCCCccccCC
Confidence             88999 9999999999  889998644

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.86  E-value=1.1e-21  Score=193.79  Aligned_cols=169  Identities=20%  Similarity=0.310  Sum_probs=136.3

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+++.||+|.+..... .....+++.+|+.+++.++|||++++++++..+...|+||||+. ++|.+++.. ...+++..
T Consensus        38 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~  116 (308)
T cd06634          38 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE  116 (308)
T ss_pred             CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHH
Confidence            3678899999875432 33445678899999999999999999999999999999999997 688887754 34689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      +..++.|++.||.|||++|++||||+|+||+++.+. ++...|||.+.....      .....++..|+|||...+    
T Consensus       117 ~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~  189 (308)
T cd06634         117 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEG  189 (308)
T ss_pred             HHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCC-cEEECCcccceeecC------cccccCCccccCHHHHhhcccC
Confidence            999999999999999999999999999999997643 344569998754321      223456678999998631    


Q ss_pred             --CCcccccCcceEEEEEE--eeecccc
Q psy6508         156 --KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 --~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        ..++|+ ||+|++++++  +..||..
T Consensus       190 ~~~~~~Di-~slG~il~el~~g~~p~~~  216 (308)
T cd06634         190 QYDGKVDV-WSLGITCIELAERKPPLFN  216 (308)
T ss_pred             CCCcccch-HHHHHHHHHHHcCCCCCcc
Confidence              167899 9999999999  6677753

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG2052|consensus

Probab=99.86  E-value=2.4e-22  Score=195.44  Aligned_cols=162  Identities=17%  Similarity=0.260  Sum_probs=134.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc--CCCCccceEEEEEeC----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDE----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~~~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      -|+.||||++...     ..+.+.+|.+|.+.+  +|+||+.+++.-..+    .++|||++|.+.|||.+||.+ ..++
T Consensus       233 rGe~VAVKiF~sr-----dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~  306 (513)
T KOG2052|consen  233 RGEDVAVKIFSSR-----DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVT  306 (513)
T ss_pred             cCCceEEEEeccc-----chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCC
Confidence            3789999998644     235688999999875  999999999875433    268999999999999999998 5799


Q ss_pred             HHHHHHHHHHHHHHHHHHHhC--------CcEEccCCCCceeeccCcceeecccccceecccCC-ccc-ccCCeEEEecc
Q psy6508          77 EFQCQQFVRQLVLALKFLREN--------NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGS-AYI-EQGNTKVICSV  146 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~--------givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs-~~~-~~g~t~v~~~~  146 (477)
                      .....+++..++.||.+||..        .|.|||||..|||+..|..-. +.|+|++...+.. ... ...+.++||..
T Consensus       307 ~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~-IADLGLAv~h~~~t~~idi~~N~rVGTKR  385 (513)
T KOG2052|consen  307 TEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCC-IADLGLAVRHDSDTDTIDIPPNPRVGTKR  385 (513)
T ss_pred             HHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEE-EeeceeeEEecccCCcccCCCCCccceee
Confidence            999999999999999999962        599999999999998875433 3799998754433 222 34567999999


Q ss_pred             ccccccCCCC---------CcccccCcceEEEEEE
Q psy6508         147 FEPREIPSSK---------TSLEYQRSKGELYVEF  172 (477)
Q Consensus       147 y~ppE~~~~~---------~~~Di~~s~G~il~e~  172 (477)
                      |||||++...         ..+|| |++|.++||+
T Consensus       386 YMAPEvLdetin~~~Fesyk~ADI-YafgLVlWEi  419 (513)
T KOG2052|consen  386 YMAPEVLDETINMKHFESYKRADI-YAFGLVLWEI  419 (513)
T ss_pred             ccChHHhhhhcChhhhhhhhHHHH-HHHHHHHHHH
Confidence            9999998776         45899 9999999998

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.86  E-value=2e-22  Score=202.24  Aligned_cols=173  Identities=26%  Similarity=0.372  Sum_probs=136.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--------------CeEEEEEecCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--------------RYVYIILEYCDGGDLCS   67 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------------~~~~lv~e~~~g~sL~~   67 (477)
                      ++|+.||+|.+.....  ...+.+.+|+.++++++||||+++++.+...              ...|++|||++ ++|.+
T Consensus        28 ~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~  104 (342)
T cd07854          28 DCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLAN  104 (342)
T ss_pred             CCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHH
Confidence            4788999999866543  3456788999999999999999999876543              35899999997 69998


Q ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccc-cCCeEEEecc
Q psy6508          68 FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE-QGNTKVICSV  146 (477)
Q Consensus        68 ~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~-~g~t~v~~~~  146 (477)
                      ++.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++..+...|||.+.......... ......++..
T Consensus       105 ~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~  183 (342)
T cd07854         105 VLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKW  183 (342)
T ss_pred             HHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccccccc
Confidence            8865 4799999999999999999999999999999999999998655455566999876543221100 1122356778


Q ss_pred             ccccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         147 FEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |.|||...+.    .++|+ ||+|+++|++  +..||.+
T Consensus       184 y~aPE~~~~~~~~~~~~Di-wSlGvil~el~~g~~pf~~  221 (342)
T cd07854         184 YRSPRLLLSPNNYTKAIDM-WAAGCIFAEMLTGKPLFAG  221 (342)
T ss_pred             ccCHHHHhCccccCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            9999976442    57899 9999999999  6678864

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.86  E-value=7.4e-22  Score=198.36  Aligned_cols=169  Identities=22%  Similarity=0.359  Sum_probs=135.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||+|++..........+.+.+|+.++++++||||+++++++...      +..|++++++ |++|.+++.. ..+
T Consensus        40 ~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l  117 (345)
T cd07877          40 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKL  117 (345)
T ss_pred             CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCC
Confidence            4788999999876544444456788999999999999999999987643      3478999987 6899988865 469


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||+|||++|++||||||+||+++.+. .+.+.|||.+......     .....++..|+|||...+
T Consensus       118 ~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  191 (345)
T cd07877         118 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN  191 (345)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCC-CEEEeccccccccccc-----ccccccCCCccCHHHHhC
Confidence            9999999999999999999999999999999999997653 3444599987654321     123456778999998654


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ |++|++++++  +..||..
T Consensus       192 ~~~~~~~~Dv-wslG~il~el~~g~~pf~~  220 (345)
T cd07877         192 WMHYNQTVDI-WSVGCIMAELLTGRTLFPG  220 (345)
T ss_pred             ccCCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            2    67899 9999999999  6667753

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0664|consensus

Probab=99.86  E-value=2.9e-24  Score=196.70  Aligned_cols=188  Identities=22%  Similarity=0.319  Sum_probs=148.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-----eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-----YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||+|++..-..+-...+++.+|.++|..++|.|++..+++.+..+     .+|+++|.+. .+|...+-....++
T Consensus        76 RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSPQ~Ls  154 (449)
T KOG0664|consen   76 RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSPQALT  154 (449)
T ss_pred             CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccCCCCC
Confidence            47999999998766555555678999999999999999999999876543     4689999997 89999888878899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      ...++-+++||+.||+|||+.||.||||||.|+|+++|- .+.++|||+++.-+.... ..-...+.|..|.+||.+.|.
T Consensus       155 ~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNC-vLKICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGa  232 (449)
T KOG0664|consen  155 PDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNC-ILKICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGA  232 (449)
T ss_pred             cchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCc-eEEecccccccccchhhh-hhhHHHHHHHHhccHHHhhcc
Confidence            999999999999999999999999999999999999874 566689999875432211 111235777889999999887


Q ss_pred             ----CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHH
Q psy6508         157 ----TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLK  199 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~  199 (477)
                          .++|+ ||.||++-|+.      .+|-.+....+..++..++.
T Consensus       233 RhYs~AvDi-WSVGCIFaELL------gRrILFQAq~PiqQL~lItd  272 (449)
T KOG0664|consen  233 RRYTGAVDI-WSVGCIFAELL------QRKILFQAAGPIEQLQMIID  272 (449)
T ss_pred             hhhcCccce-ehhhHHHHHHH------hhhhhhhccChHHHHHHHHH
Confidence                67899 99999999983      22223334444455544443

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.86  E-value=4.1e-22  Score=200.02  Aligned_cols=169  Identities=24%  Similarity=0.378  Sum_probs=136.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||+|++..........+.+.+|+.++++++||||+++++++....      .+++||||+ |++|.+++.. ..+
T Consensus        38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l  115 (343)
T cd07880          38 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH-EKL  115 (343)
T ss_pred             CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhc-CCC
Confidence            46889999998765444445567889999999999999999999987543      469999998 6899988865 579


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..++.++.|++.||.|||+.||+||||||+||+++.+. ++.+.|||.+.......     ....++..|+|||...+
T Consensus       116 ~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~  189 (343)
T cd07880         116 SEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQTDSEM-----TGYVVTRWYRAPEVILN  189 (343)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccccccccCc-----cccccCCcccCHHHHhC
Confidence            9999999999999999999999999999999999997643 34445999876543221     22345678999998754


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ |++|++++++  +..||.+
T Consensus       190 ~~~~~~~~Di-~slG~ll~~l~~g~~pf~~  218 (343)
T cd07880         190 WMHYTQTVDI-WSVGCIMAEMLTGKPLFKG  218 (343)
T ss_pred             CCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            2    67899 9999999998  6677764

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG3653|consensus

Probab=99.86  E-value=2.1e-22  Score=197.17  Aligned_cols=160  Identities=20%  Similarity=0.313  Sum_probs=133.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc--CCCCccceEEEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDER----YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      +++.||||+++.     ...+.|.+|..|.+..  +|+||++++++-....    .+|||++|.+.|+|.+||+.+ .++
T Consensus       232 ~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tis  305 (534)
T KOG3653|consen  232 DNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TIS  305 (534)
T ss_pred             cCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-ccc
Confidence            468999999864     3456788898888754  8999999999866544    799999999999999999985 799


Q ss_pred             HHHHHHHHHHHHHHHHHHHh---------CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCC--eEEEec
Q psy6508          77 EFQCQQFVRQLVLALKFLRE---------NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGN--TKVICS  145 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~---------~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~--t~v~~~  145 (477)
                      +....+++..++.||+|||+         ..|+|||||.+|||+.+|- ...+.|||++......-  ..|.  ..+||.
T Consensus       306 w~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFGLAl~~~p~~--~~~d~~~qVGT~  382 (534)
T KOG3653|consen  306 WNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFGLALRLEPGK--PQGDTHGQVGTR  382 (534)
T ss_pred             HHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccceeEEecCCC--CCcchhhhhhhh
Confidence            99999999999999999996         3699999999999998764 33447999998765322  2333  389999


Q ss_pred             cccccccCCCC---------CcccccCcceEEEEEE
Q psy6508         146 VFEPREIPSSK---------TSLEYQRSKGELYVEF  172 (477)
Q Consensus       146 ~y~ppE~~~~~---------~~~Di~~s~G~il~e~  172 (477)
                      .|||||++.+.         ...|+ |++|.+++|+
T Consensus       383 RYMAPEvLEgainl~d~~Afkr~Dv-YamgLVLWEi  417 (534)
T KOG3653|consen  383 RYMAPEVLEGAINLQDRDAFKRIDV-YAMGLVLWEI  417 (534)
T ss_pred             hhcCHHHHhhhcccccHHHHHHHHH-HHHHHHHHHH
Confidence            99999998876         45799 9999999999

>KOG0696|consensus

Probab=99.86  E-value=2.5e-23  Score=200.07  Aligned_cols=173  Identities=21%  Similarity=0.310  Sum_probs=144.4

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+.+.||||+++++-+- ++..+--+.|-++|... +-|++++++.+|+.-+.+|+||||+.||+|--.++.-+++.+..
T Consensus       372 gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~  451 (683)
T KOG0696|consen  372 GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPV  451 (683)
T ss_pred             CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCch
Confidence            35678999999987653 33444456788888876 67899999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      +..++.+|+.||-|||++||++||||.+|||++.+ .+++  .|||.+...--.  -....|..+|+-|++||+..-+  
T Consensus       452 AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi--~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPY  527 (683)
T KOG0696|consen  452 AVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKI--ADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPY  527 (683)
T ss_pred             hhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEe--eecccccccccC--CcceeeecCCCcccccceEEeccc
Confidence            99999999999999999999999999999999875 4555  599998632111  1223467888899999998765  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ |++|+++|||  +.+||.+
T Consensus       528 gksvDW-Wa~GVLLyEmlaGQpPFdG  552 (683)
T KOG0696|consen  528 GKSVDW-WAFGVLLYEMLAGQPPFDG  552 (683)
T ss_pred             ccchhH-HHHHHHHHHHHcCCCCCCC
Confidence             77899 9999999999  7788874

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.86  E-value=1.9e-21  Score=189.27  Aligned_cols=170  Identities=25%  Similarity=0.335  Sum_probs=135.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc---CCCCccceEEEEEeCCe-----EEEEEecCCCCCHHHHHHhCC-
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL---HHQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFIRSHE-   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~~~~~~~~~~~-----~~lv~e~~~g~sL~~~l~~~~-   73 (477)
                      +++.||+|.++...........+.+|+.+++++   +|||++++++++.....     .+++|||+. ++|.+++.... 
T Consensus        23 ~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~  101 (287)
T cd07838          23 TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPK  101 (287)
T ss_pred             CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccC
Confidence            588999999976654444445677888887766   59999999999987776     999999997 68999887643 


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                       .+++..++.++.|++.||.|||+.|++|+||+|+||+++.+ .++.+.|||.+.......   ......++..|.|||.
T Consensus       102 ~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~-~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~  177 (287)
T cd07838         102 PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSD-GQVKIADFGLARIYSFEM---ALTSVVVTLWYRAPEV  177 (287)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccC-CCEEEeccCcceeccCCc---ccccccccccccChHH
Confidence             58999999999999999999999999999999999999876 345556999875543211   1122345678999998


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeeccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ..+.   .++|+ |++|++++++  +..||.
T Consensus       178 ~~~~~~~~~~Di-~s~G~~l~~l~~~~~~~~  207 (287)
T cd07838         178 LLQSSYATPVDM-WSVGCIFAELFRRRPLFR  207 (287)
T ss_pred             hccCCCCCcchh-hhHHHHHHHHHhCCCccc
Confidence            8665   67899 9999999998  556665

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.86  E-value=6e-22  Score=197.59  Aligned_cols=169  Identities=27%  Similarity=0.328  Sum_probs=136.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-ERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|.+.+........+.+.+|+.++++++||||+++++++.. .+..|+++||+. ++|.+++.. .++++..+
T Consensus        33 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~  110 (328)
T cd07856          33 LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLG-TDLHRLLTS-RPLEKQFI  110 (328)
T ss_pred             CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehhc-cCHHHHHhc-CCCCHHHH
Confidence            478899999987654444455678899999999999999999998875 567899999985 799988875 46889999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|+++||.|||++|++||||+|+||+++.+. .+.++|||.+......     ..+..++..|+|||...+.    
T Consensus       111 ~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~  184 (328)
T cd07856         111 QYFLYQILRGLKYVHSAGVVHRDLKPSNILINENC-DLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYD  184 (328)
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCC-CEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcC
Confidence            99999999999999999999999999999997642 3444599987543321     1234556789999986542    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|+++|++  +..||.+
T Consensus       185 ~~~Dv-~slG~il~el~tg~~~f~~  208 (328)
T cd07856         185 VEVDI-WSAGCIFAEMLEGKPLFPG  208 (328)
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6677764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.86  E-value=4.8e-22  Score=198.86  Aligned_cols=173  Identities=27%  Similarity=0.375  Sum_probs=134.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||+|+++... .......+.+|+.++++++||||+++++++...     ...|+++||++ ++|.+++.. ..++
T Consensus        28 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~l~  104 (336)
T cd07849          28 PTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIKT-QHLS  104 (336)
T ss_pred             CCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHhc-CCCC
Confidence            478999999986432 223446688999999999999999999986543     35899999997 689888865 5799


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||++........ ........++..|+|||...+
T Consensus       105 ~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  183 (336)
T cd07849         105 NDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNC-DLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLN  183 (336)
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC-CEEECcccceeeccccccccCCcCCcCcCCCccChHHhhC
Confidence            999999999999999999999999999999999997642 334459998764332111 111123456778999997643


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|+++|++  +..||.+
T Consensus       184 ~~~~~~~~Dv-wslGvil~el~~G~~~f~~  212 (336)
T cd07849         184 SKGYTKAIDI-WSVGCILAEMLSNRPLFPG  212 (336)
T ss_pred             CCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            2    67899 9999999999  7777764

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.85  E-value=7.3e-22  Score=197.26  Aligned_cols=173  Identities=25%  Similarity=0.308  Sum_probs=135.4

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      ++.||+|.+..........+.+.+|+.+++++ +||||+++++.+..    ....|++++++. ++|.+++.....+++.
T Consensus        27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~  105 (332)
T cd07857          27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQPLTDA  105 (332)
T ss_pred             CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCCCCHH
Confidence            78899999875443333456788999999999 59999999987542    246899999986 7999999887789999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc--ccCCeEEEeccccccccCCCC
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--EQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      .++.++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.........  .......++..|+|||...+.
T Consensus       106 ~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  184 (332)
T cd07857         106 HFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSF  184 (332)
T ss_pred             HHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCC-CEEeCcCCCceecccccccccccccCcccCccccCcHHHhCC
Confidence            9999999999999999999999999999999997653 3445699988654322111  111234677889999976542


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ ||+|++++++  +..||.+
T Consensus       185 ~~~~~~~Di-~slGv~l~~l~~g~~pf~~  212 (332)
T cd07857         185 QSYTKAIDV-WSVGCILAELLGRKPVFKG  212 (332)
T ss_pred             CCCCcHHHH-HHHHHHHHHHHhCCcCCCC
Confidence                67899 9999999998  5666653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.85  E-value=4.4e-22  Score=196.25  Aligned_cols=175  Identities=26%  Similarity=0.369  Sum_probs=134.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--------CeEEEEEecCCCCCHHHHHHhC-
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--------RYVYIILEYCDGGDLCSFIRSH-   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~lv~e~~~g~sL~~~l~~~-   72 (477)
                      .+++.||+|.+............+.+|+.++++++||||+++++.+...        ..+|+++||+. ++|...+... 
T Consensus        31 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~  109 (311)
T cd07866          31 KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPS  109 (311)
T ss_pred             CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccc
Confidence            4688999999876544333334677899999999999999999987543        35799999997 6788777653 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccc---------cCCeEEE
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE---------QGNTKVI  143 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~---------~g~t~v~  143 (477)
                      ..+++..+..++.|+++||.|||++|++||||||+||+++++. .+.+.|||.+..........         ...+.++
T Consensus       110 ~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (311)
T cd07866         110 VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQG-ILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVV  188 (311)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEECcCccchhccCCCcccccCCccccccccccee
Confidence            4799999999999999999999999999999999999997653 33445999886443221110         0123456


Q ss_pred             eccccccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         144 CSVFEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       144 ~~~y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +..|+|||...+.    .++|+ |++|+++|++  +..||.+
T Consensus       189 ~~~y~aPE~~~~~~~~~~~~Dv-~slG~il~el~~g~~~~~~  229 (311)
T cd07866         189 TRWYRPPELLLGERRYTTAVDI-WGIGCVFAEMFTRRPILQG  229 (311)
T ss_pred             ccCcCChHHhhCCCccCchhHh-HHHHHHHHHHHhCCCCCCC
Confidence            7789999986543    66899 9999999999  6666653

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.85  E-value=1.5e-21  Score=190.64  Aligned_cols=171  Identities=22%  Similarity=0.251  Sum_probs=134.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHH-----hCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIR-----SHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~-----~~~~l   75 (477)
                      .+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++|||+. ++|.++..     ....+
T Consensus        27 ~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l  104 (288)
T cd06616          27 PSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVI  104 (288)
T ss_pred             CCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCC
Confidence            46889999998765433 44567889999999996 9999999999999999999999986 57665432     23579


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ++..+..++.|++.||+|||+. |++||||||+||+++.++ .+.++|||++.....+.   ......++..|.|||.+.
T Consensus       105 ~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  180 (288)
T cd06616         105 PEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERID  180 (288)
T ss_pred             CHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHhccCC---ccccccCccCccCHHHhc
Confidence            9999999999999999999975 999999999999997643 24445999875433221   112334667899999875


Q ss_pred             CC------CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.      .++|+ |++|++++++  +..||..
T Consensus       181 ~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~  212 (288)
T cd06616         181 PSARDGYDVRSDV-WSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             cccccCCcchhhh-hHHHHHHHHHHhCCCCchh
Confidence            32      56899 9999999999  7778764

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>KOG0669|consensus

Probab=99.85  E-value=5.7e-23  Score=186.34  Aligned_cols=168  Identities=20%  Similarity=0.381  Sum_probs=134.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--------CCeEEEEEecCCCCCHHHHHHhC-
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--------ERYVYIILEYCDGGDLCSFIRSH-   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--------~~~~~lv~e~~~g~sL~~~l~~~-   72 (477)
                      ++|+.||+|++-.++..........+|+++|+.|.|+|++.++.+|..        ...+|+|+.+|+ .+|.-+|... 
T Consensus        40 n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~  118 (376)
T KOG0669|consen   40 NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRK  118 (376)
T ss_pred             CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCcc
Confidence            567889998766544333334557899999999999999999887642        245999999998 8999999775 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-c-ccCCeEEEecccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-I-EQGNTKVICSVFEPR  150 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~-~~g~t~v~~~~y~pp  150 (477)
                      -+++..++.+++.+++.||.|+|+..|+|||+||+|+||+.++ .+.+.|||+++...-+.. . ......+.|.||.||
T Consensus       119 vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dg-ilklADFGlar~fs~~~n~~kprytnrvvTLwYrpp  197 (376)
T KOG0669|consen  119 VRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDG-ILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPP  197 (376)
T ss_pred             ccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCc-eEEeeccccccceecccccCCCCcccceeeeecCCH
Confidence            4799999999999999999999999999999999999998754 233459999853221111 0 112457899999999


Q ss_pred             ccCCCC----CcccccCcceEEEEEE
Q psy6508         151 EIPSSK----TSLEYQRSKGELYVEF  172 (477)
Q Consensus       151 E~~~~~----~~~Di~~s~G~il~e~  172 (477)
                      |.+.+.    ++.|+ |..||++.||
T Consensus       198 EllLG~r~yg~~iDi-WgAgCimaeM  222 (376)
T KOG0669|consen  198 ELLLGDREYGPPIDI-WGAGCIMAEM  222 (376)
T ss_pred             HHhhcccccCCcchh-HhHHHHHHHH
Confidence            998876    78999 9999999999

>KOG0671|consensus

Probab=99.85  E-value=4.7e-21  Score=183.50  Aligned_cols=168  Identities=22%  Similarity=0.304  Sum_probs=134.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-C-C----CccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-H-Q----HIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-H-p----nIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--   73 (477)
                      +++..||||+++.-   ...++..+-|+.+|+++. + |    -++++.++|.-.++.|||+|.+ |.|+.++++.++  
T Consensus       112 ~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~  187 (415)
T KOG0671|consen  112 ETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYI  187 (415)
T ss_pred             CCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCcc
Confidence            45788999998643   344566778999999994 2 3    3788888899999999999998 589999998865  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-------------------cceeecccccceecccCCcc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-------------------TLKLAGLKQGVSEKAKGSAY  134 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-------------------~~rl~~~dfG~~~~~~gs~~  134 (477)
                      ++|...++.+++|++++++|||+.+++|-||||+|||+-+.                   ..-+..+|||.+...+    
T Consensus       188 ~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~----  263 (415)
T KOG0671|consen  188 PFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDH----  263 (415)
T ss_pred             ccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceec----
Confidence            69999999999999999999999999999999999999321                   1112345777654322    


Q ss_pred             cccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         135 IEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       135 ~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       +.-.+.|.|..|.|||++.+-   ...|+ ||+|||++|+  |..-|.+
T Consensus       264 -e~hs~iVsTRHYRAPEViLgLGwS~pCDv-WSiGCIL~ElytG~~LFqt  311 (415)
T KOG0671|consen  264 -EHHSTIVSTRHYRAPEVILGLGWSQPCDV-WSIGCILVELYTGETLFQT  311 (415)
T ss_pred             -cCcceeeeccccCCchheeccCcCCccCc-eeeeeEEEEeeccceeccc
Confidence             223567889999999998875   77899 9999999999  6666664

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.85  E-value=9.5e-22  Score=190.97  Aligned_cols=171  Identities=30%  Similarity=0.424  Sum_probs=139.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++++.||+|.+......+...+.+.+|+.++++++|||++++++++......++++||++ ++|.+++.+. ..+++..+
T Consensus        22 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~  100 (282)
T cd07829          22 KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLI  100 (282)
T ss_pred             CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHH
Confidence            468999999998765344445678899999999999999999999999999999999998 6999999876 57999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++.|++.||.|||++|++||||+|+||+++++ .+++  .|||.+.......  ........+..|.|||...+.   
T Consensus       101 ~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l--~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~  176 (282)
T cd07829         101 KSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKL--ADFGLARAFGIPL--RTYTHEVVTLWYRAPEILLGSKHY  176 (282)
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEE--ecCCcccccCCCc--cccCccccCcCcCChHHhcCCcCC
Confidence            9999999999999999999999999999999774 4554  4899875443221  112233455679999987543   


Q ss_pred             -CcccccCcceEEEEEE--eeeccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                       .++|+ |++|++++|+  +..||.
T Consensus       177 ~~~~Dv-~slG~~l~~l~~~~~~~~  200 (282)
T cd07829         177 STAVDI-WSVGCIFAEMITGKPLFP  200 (282)
T ss_pred             CccccH-HHHHHHHHHHHhCCCCCC
Confidence             67899 9999999999  555554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>TIGR03591 polynuc_phos polyribonucleotide nucleotidyltransferase

Probab=99.85  E-value=2.5e-20  Score=199.76  Aligned_cols=202  Identities=18%  Similarity=0.225  Sum_probs=164.9

Q ss_pred             eeecccccce-ecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecccc-----cc-ccCCCCCc
Q psy6508         117 KLAGLKQGVS-EKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFAS-----QI-RTGWLRDS  189 (477)
Q Consensus       117 rl~~~dfG~~-~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~-----~~-r~~~~~~~  189 (477)
                      |.+.+.+|.. +.++||++++.|+|++.+.+++|.|...+.   |    +.-+.+++...+|+.     .. ++...++.
T Consensus         5 R~i~ie~G~la~~AdGSa~v~~G~T~VlatV~~~~~~~~~~---d----f~pL~vey~e~~~A~gkipg~f~kReg~p~~   77 (684)
T TIGR03591         5 RTLTLETGKIARQADGAVVVRYGDTVVLVTVVAAKEAKEGQ---D----FFPLTVNYQEKFYAAGKIPGGFFKREGRPSE   77 (684)
T ss_pred             ccEEEEECCcCCCCCeEEEEEECCeEEEEEEEcCCCCCCCC---c----eEeEEEEEEehhhhccCCCCCcccCCCCCCH
Confidence            4566789976 679999999999999999999998854433   3    345666665544432     22 23345667


Q ss_pred             chHHHHHHHHHHhhhhhhcccCCC---CcccEEEEEEeCCCchH--HHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeE
Q psy6508         190 EEKELGNHLKRALEPAVCRHEFSN---FQVDLFVLVLQNDGSAL--SAAINCANLALVDAAIPMYDLVTSSTLALRGGLT  264 (477)
Q Consensus       190 ~~~~l~~~i~~~l~~~i~~~~~Pr---~~i~i~v~vL~~dg~~~--~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~  264 (477)
                      .+.++++++.+.++|.     ||+   +.+++.+++|+.||+..  .+|+|||++||.|+||||+++|+|++++..+|.+
T Consensus        78 ~eil~srlIdR~lrpl-----fp~~~~~~i~V~~~VLs~Dg~~~~d~aai~aAsaAL~~s~IP~~~~v~av~vg~idg~~  152 (684)
T TIGR03591        78 KETLTSRLIDRPIRPL-----FPKGFRNEVQVVATVLSYDPENDPDILAIIGASAALAISGIPFNGPIAAVRVGYIDGQY  152 (684)
T ss_pred             HHHHHHHHHhhHHHHh-----cCCCCCceEEEEEEEEecCcCCchHHHHHHHHHHHHHhcCCCcCCCeEEEEEEEECCEE
Confidence            7888999999998774     777   88999999999999975  4999999999999999999999999999999999


Q ss_pred             EeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee-ecHHHHHHHHHHHHhcccchhhHHHHhHhhhccc
Q psy6508         265 FIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT-IQQERLADHIEQLIGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       265 ~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~-~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ++|||..|++.          +...++++  ...+.++.++..|+ ++.+++.++++.|.++|+.+... +++.+.....
T Consensus       153 ildPt~~E~~~----------s~~~l~va--~t~~~i~mie~~~~~i~e~~l~~al~~a~~~~~~i~~~-~~~~~~~~~~  219 (684)
T TIGR03591       153 VLNPTVDELEK----------SDLDLVVA--GTKDAVLMVESEAKELSEEVMLGAIEFGHEEIQPVIEA-IEELAEEAGK  219 (684)
T ss_pred             EEcCCHHHHhh----------CCceEEEE--ccCCcEEEEEcCCCCCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHhCC
Confidence            99999999983          35666665  55677888888765 99999999999999999999999 8887765543

Members of this protein family are polyribonucleotide nucleotidyltransferase, also called polynucleotide phosphorylase. Some members have been shown also to have additional functions as guanosine pentaphosphate synthetase and as poly(A) polymerase (see model TIGR02696 for an exception clade, within this family).

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.85  E-value=1.4e-21  Score=196.14  Aligned_cols=168  Identities=24%  Similarity=0.359  Sum_probs=134.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||+|++.+....+.....+.+|+.+++.++||||+++++++...      ..+|+++||+. .+|.++..  ..+
T Consensus        38 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~  114 (342)
T cd07879          38 RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG--HPL  114 (342)
T ss_pred             CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc--CCC
Confidence            4688999999876544444446688999999999999999999998754      34699999997 68877653  368


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++|++||||||+||+++.+. ++.+.|||++......     .....++..|+|||...+
T Consensus       115 ~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  188 (342)
T cd07879         115 SEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDC-ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILN  188 (342)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcC
Confidence            9999999999999999999999999999999999997642 3445599987644321     123466788999998755


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|++++|+  +..||.+
T Consensus       189 ~~~~~~~~Dv-~slGvil~el~~g~~pf~~  217 (342)
T cd07879         189 WMHYNQTVDI-WSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             ccccCchHHH-HHHHHHHHHHHhCCCCCCC
Confidence            3    57899 9999999999  6677764

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.84  E-value=1.9e-21  Score=186.94  Aligned_cols=169  Identities=27%  Similarity=0.366  Sum_probs=132.7

Q ss_pred             cEEEEEEcccC---CCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCCH
Q psy6508           5 TEVAIKCIDKT---KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLSE   77 (477)
Q Consensus         5 ~~vAiK~i~~~---~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~~   77 (477)
                      ..+++|+++..   .........+.+|+.+++.++||||+++++.+......++++||+++++|.+++..    ...+++
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  105 (260)
T cd08222          26 AEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSE  105 (260)
T ss_pred             CcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCH
Confidence            34555555432   22233344677899999999999999999999988899999999999999998864    346899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..++.++.|++.||.|||++|++|+||+|+||+++++.+++.  |||.+....+...  ...+..++..|.|||...+. 
T Consensus       106 ~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~~~~~l~--d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~  181 (260)
T cd08222         106 NQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLLKIG--DFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQG  181 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCccccCCChhheEeecCCEeec--ccCceeecCCCcc--cccCCCCCcCccCHHHHccCC
Confidence            999999999999999999999999999999999988765555  9988765433221  12233456789999987654 


Q ss_pred             --CcccccCcceEEEEEE--eeeccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                        .++|+ |++|++++++  +..||.
T Consensus       182 ~~~~~Dv-~slG~~~~~l~~~~~~~~  206 (260)
T cd08222         182 YDSKSDI-WSLGCILYEMCCLAHAFE  206 (260)
T ss_pred             CCchhhH-HHHHHHHHHHHhCCCCCC
Confidence              56899 9999999998  556665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.84  E-value=1.4e-21  Score=196.16  Aligned_cols=169  Identities=24%  Similarity=0.369  Sum_probs=136.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCe------EEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~------~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+++.||+|++..........+.+.+|+.++++++||||+++++++...+.      .|+|+||+ +++|.+++.. .++
T Consensus        38 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l  115 (343)
T cd07851          38 KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKL  115 (343)
T ss_pred             CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCC
Confidence            367899999987654444455678899999999999999999998765554      89999999 5899999876 479


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||+.|++||||||+||+++++. ++.++|||.+......     .....++..|.|||...+
T Consensus       116 ~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~-~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~  189 (343)
T cd07851         116 SDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDC-ELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLN  189 (343)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC-CEEEcccccccccccc-----ccCCcccccccCHHHHhC
Confidence            9999999999999999999999999999999999997643 3455699988654322     123456678999998644


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|+++|++  +..||.+
T Consensus       190 ~~~~~~~~Dv-wslGv~l~elltg~~pf~~  218 (343)
T cd07851         190 WMHYNQTVDI-WSVGCIMAELLTGKTLFPG  218 (343)
T ss_pred             CCCCCchHhH-HHHHHHHHHHHhCCCCCCC
Confidence            2    67899 9999999999  6677753

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG4278|consensus

Probab=99.84  E-value=4.6e-22  Score=199.60  Aligned_cols=173  Identities=21%  Similarity=0.321  Sum_probs=143.4

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~~   81 (477)
                      .-.||||.++.+.+   ..++|.+|..+|+.++|||+|+++++|..+..+|||+|||.+|+|.+||++..  .++.-...
T Consensus       292 slTvAVKtLKEDtM---eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLl  368 (1157)
T KOG4278|consen  292 SLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLL  368 (1157)
T ss_pred             ceeeehhhhhhcch---hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHH
Confidence            34689998865533   35789999999999999999999999999999999999999999999998754  47777888


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.||..|+.||..++++||||...|+|+..+.+.. ..|||+++...|..|...-..+ ..--|.+||.+.-.   .+
T Consensus       369 yMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVK-vADFGLsRlMtgDTYTAHAGAK-FPIKWTAPEsLAyNtFSiK  446 (1157)
T KOG4278|consen  369 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVK-VADFGLSRLMTGDTYTAHAGAK-FPIKWTAPESLAYNTFSIK  446 (1157)
T ss_pred             HHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEE-eeccchhhhhcCCceecccCcc-CcccccCcccccccccccc
Confidence            9999999999999999999999999999998775433 3699999988877664322221 11238899987654   77


Q ss_pred             ccccCcceEEEEEE---eeeccccccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFASQIR  182 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~~~r  182 (477)
                      +|+ |+||+++||+   ++.||.+.++
T Consensus       447 SDV-WAFGVLLWEIATYGMsPYPGidl  472 (1157)
T KOG4278|consen  447 SDV-WAFGVLLWEIATYGMSPYPGIDL  472 (1157)
T ss_pred             hhh-HHHHHHHHHHHhcCCCCCCCccH
Confidence            899 9999999998   7899987654

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.84  E-value=2.9e-21  Score=187.87  Aligned_cols=170  Identities=22%  Similarity=0.348  Sum_probs=136.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~   78 (477)
                      .+++.|+||.+....... ......+|+..+++++ |||++++++++..++..|+||||+ +++|.+++....  .+++.
T Consensus        22 ~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~   99 (283)
T cd07830          22 ETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSES   99 (283)
T ss_pred             CCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHH
Confidence            357889999987654322 2234567999999998 999999999999999999999999 689999987754  78999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.+|.|||++|++|+||+|+||+++++ .+++  .|||..........   .....++..|+|||...+. 
T Consensus       100 ~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l--~d~~~~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~  174 (283)
T cd07830         100 VIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKI--ADFGLAREIRSRPP---YTDYVSTRWYRAPEILLRST  174 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEE--eecccceeccCCCC---cCCCCCcccccCceeeecCc
Confidence            999999999999999999999999999999999864 4444  49998765443211   1234566789999987433 


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|++++++  +..||..
T Consensus       175 ~~~~~~Di-~s~G~~l~el~~g~~~~~~  201 (283)
T cd07830         175 SYSSPVDI-WALGCIMAELYTLRPLFPG  201 (283)
T ss_pred             CcCCccch-hhHHHHHHHHHhCCCccCC
Confidence               67899 9999999999  5566653

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.84  E-value=1.2e-21  Score=192.24  Aligned_cols=171  Identities=20%  Similarity=0.268  Sum_probs=132.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+++.||||.++..... .....+.+|+.++.+. .||||+++++++......|++|||+. ++|.+++.. ...+++..
T Consensus        38 ~~~~~~avK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~  115 (296)
T cd06618          38 KTGHVMAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQGPIPEDI  115 (296)
T ss_pred             CCCeEEEEEEEeccCCh-HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcCCCCHHH
Confidence            35889999998765432 2345667788777777 49999999999999999999999986 688887765 34789999


Q ss_pred             HHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      +..++.|++.||.|||+ .||+||||+|+||+++.+. .+.+.|||.+........   .....++..|+|||...+.  
T Consensus       116 ~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~  191 (296)
T cd06618         116 LGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISGRLVDSKA---KTRSAGCAAYMAPERIDPPDP  191 (296)
T ss_pred             HHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccchhccCCCc---ccCCCCCccccCHhhcCCCCC
Confidence            99999999999999997 5999999999999997643 445569998754332111   1122355679999987543  


Q ss_pred             -----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                           .++|+ ||+|+++|++  +..||..
T Consensus       192 ~~~~~~~~Di-~slG~il~el~~g~~p~~~  220 (296)
T cd06618         192 NPKYDIRADV-WSLGISLVELATGQFPYKN  220 (296)
T ss_pred             ccccccchhH-HHHHHHHHHHHhCCCCCCc
Confidence                 46899 9999999999  6677753

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.83  E-value=1.7e-21  Score=183.73  Aligned_cols=172  Identities=32%  Similarity=0.518  Sum_probs=141.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++|+.||+|++........ .+.+.+|+..+++++|+|++++++.+......++++|++++++|.+++.....++...+.
T Consensus        12 ~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~   90 (244)
T smart00220       12 KTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEAR   90 (244)
T ss_pred             CCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHH
Confidence            3688999999876643322 578999999999999999999999999989999999999988999999876668999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.+++.++.+||+.|++|+||+|.||+++++. .+..+|||.+.......   ......+...|.|||...+.   .+
T Consensus        91 ~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE~~~~~~~~~~  166 (244)
T smart00220       91 FYARQILSALEYLHSNGIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGG---LLTTFVGTPEYMAPEVLLGKGYGKA  166 (244)
T ss_pred             HHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCC-cEEEccccceeeecccc---ccccccCCcCCCCHHHHccCCCCch
Confidence            9999999999999999999999999999998752 44455998876544321   11234456679999987643   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|++++++  +..||..
T Consensus       167 ~Di-~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      167 VDV-WSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999998  5566653

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PRK11824 polynucleotide phosphorylase/polyadenylase; Provisional

Probab=99.83  E-value=1.1e-19  Score=195.49  Aligned_cols=204  Identities=18%  Similarity=0.205  Sum_probs=165.1

Q ss_pred             eeecccccce-ecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccc------cccCCCCCc
Q psy6508         117 KLAGLKQGVS-EKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ------IRTGWLRDS  189 (477)
Q Consensus       117 rl~~~dfG~~-~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~------~r~~~~~~~  189 (477)
                      |.+.+.+|.. +.++||++++.|+|.+.+.+++|.|...+.   |    +.-+.+++...+|+..      .++...++.
T Consensus        14 r~i~~e~G~ia~qAdGSa~v~~G~T~VlatV~~~~~~~~~~---d----f~pL~v~y~e~~~A~gkiP~~f~kreg~pse   86 (693)
T PRK11824         14 RTLTLETGKLARQANGAVLVRYGDTVVLVTVVASKEPKEGQ---D----FFPLTVDYEEKTYAAGKIPGGFFKREGRPSE   86 (693)
T ss_pred             ccEEEEECCcCCCCCeEEEEEECCeEEEEEEEcCCCCCCCC---C----eeeeEEEEEehhhhccCCCcccccCCCCCCh
Confidence            4566789977 569999999999999999999999853332   3    3456667655555422      223345677


Q ss_pred             chHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchH--HHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeC
Q psy6508         190 EEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSAL--SAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFID  267 (477)
Q Consensus       190 ~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~--~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~D  267 (477)
                      .+..+++++.+.++|..  +..+++.++|.+++|+.||+..  ++|+|||++||.++||||.++|+|+++++.+|.+++|
T Consensus        87 ~eil~srlIdR~lrplf--p~~~~~~i~I~~~VL~~Dg~~~~d~aai~aAsaAL~~s~IP~~~~v~av~vg~i~g~~ivd  164 (693)
T PRK11824         87 KETLTSRLIDRPIRPLF--PKGFRNEVQVVATVLSVDPENDPDILAMIGASAALSISGIPFNGPIAAVRVGYIDGEFVLN  164 (693)
T ss_pred             HHHHHHHHHhhhHHHhC--CCCCCeEEEEEEEEEeCCCCCcHHHHHHHHHHHHHHhcCCCcCCCeEEEEEEEECCEEEEc
Confidence            78889999999999853  3445899999999999999874  4899999999999999999999999999999999999


Q ss_pred             CChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe-eecHHHHHHHHHHHHhcccchhhHHHHhHhhhcc
Q psy6508         268 PVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG-TIQQERLADHIEQLIGCCESLCTDRVQKLVSDHV  342 (477)
Q Consensus       268 p~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g-~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~  342 (477)
                      ||.+|++.          +...++++  .+.+.++.++..| .++.+++.++++.|.++|+.+... +++.+...-
T Consensus       165 Pt~~E~~~----------s~~~l~va--~t~~~i~mie~~~~~l~e~~l~~al~~a~~~~~~i~~~-~~~~~~~~~  227 (693)
T PRK11824        165 PTVEELEE----------SDLDLVVA--GTKDAVLMVESEAKELSEEVMLEAIEFGHEAIQELIDA-QEELAAEAG  227 (693)
T ss_pred             CCHHHHhh----------CcceEEEE--EccCceEEEECCCCCCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHhcC
Confidence            99999983          35556665  4446788888876 499999999999999999999999 888776444

>KOG0670|consensus

Probab=99.83  E-value=1.1e-20  Score=186.51  Aligned_cols=161  Identities=24%  Similarity=0.309  Sum_probs=135.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC------CCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH------QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H------pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---   73 (477)
                      -|..||||++......   .+.=++|+.+|++|+.      -|+++++..|...+++|||+|.+. .+|.+.|++.+   
T Consensus       456 r~~~vAiKIIRnNE~M---~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nv  531 (752)
T KOG0670|consen  456 RGQEVAIKIIRNNEVM---HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNV  531 (752)
T ss_pred             CCCeeEEEEeecchHH---hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHHhCccc
Confidence            3668999999876432   2345689999999952      489999999999999999999997 89999999876   


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      .+....++.++.|+..||..|-..||+|.||||+|||++.+..-+.+||||.+..+.....    ........|.+||++
T Consensus       532 GL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSRFYRaPEIi  607 (752)
T KOG0670|consen  532 GLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSRFYRAPEII  607 (752)
T ss_pred             ceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccccc----cHHHHHHhccCccee
Confidence            4889999999999999999999999999999999999999888888899998865543211    123344579999999


Q ss_pred             CCC---CcccccCcceEEEEEE
Q psy6508         154 SSK---TSLEYQRSKGELYVEF  172 (477)
Q Consensus       154 ~~~---~~~Di~~s~G~il~e~  172 (477)
                      .|.   ...|+ ||.||.+||+
T Consensus       608 LG~~yd~~iD~-WSvgctLYEl  628 (752)
T KOG0670|consen  608 LGLPYDYPIDT-WSVGCTLYEL  628 (752)
T ss_pred             ecCcccCCccc-eeeceeeEEe
Confidence            887   67899 9999999999

>KOG0199|consensus

Probab=99.82  E-value=1.7e-20  Score=190.96  Aligned_cols=171  Identities=18%  Similarity=0.294  Sum_probs=139.4

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS--HEKLSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~--~~~l~~~~~~   81 (477)
                      .-.||||.++....+. ...+|.+|+.+|.+|+|||++++||+..+ ....||||+++.|+|.+.|.+  ...|.-....
T Consensus       138 ~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lc  215 (1039)
T KOG0199|consen  138 HVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLC  215 (1039)
T ss_pred             EEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHH
Confidence            3469999998776554 56789999999999999999999999877 678999999999999999987  2358888999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCC-cccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGS-AYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs-~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.||+.|+.||.++++|||||...|+++.. ..+|  ++|||+.+...+. .++.++...-.-..|+|||.+...   
T Consensus       216 dya~QiA~aM~YLeskrlvHRDLAARNlllasprtVK--I~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS  293 (1039)
T KOG0199|consen  216 DYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVK--ICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFS  293 (1039)
T ss_pred             HHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceee--eecccceeccCCCCcceEecCCCcCcccccCHhHhcccccc
Confidence            99999999999999999999999999999965 3444  4699998754432 233333333344469999998766   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ |++|+++|||   |--||.+
T Consensus       294 haSDv-WmyGVTiWEMFtyGEePW~G  318 (1039)
T KOG0199|consen  294 HASDV-WMYGVTIWEMFTYGEEPWVG  318 (1039)
T ss_pred             ccchh-hhhhhhHHhhhccCCCCCCC
Confidence            67899 9999999999   4466654

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.82  E-value=1.1e-20  Score=214.68  Aligned_cols=159  Identities=21%  Similarity=0.310  Sum_probs=127.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|.++.....      ..+|+..+++++||||+++++++...+..|+||||+++|+|.++++.   +++..+.
T Consensus       713 ~~~~~vavK~~~~~~~~------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---l~~~~~~  783 (968)
T PLN00113        713 KNGMQFVVKEINDVNSI------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRR  783 (968)
T ss_pred             CCCcEEEEEEccCCccc------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc---CCHHHHH
Confidence            46889999998644321      13568899999999999999999999999999999999999999963   8899999


Q ss_pred             HHHHHHHHHHHHHH---hCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          82 QFVRQLVLALKFLR---ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      +++.|++.||+|||   +.+|+||||||+||+++.+....+  .+|......      ...+..++..|+|||...+.  
T Consensus       784 ~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~--~~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~  855 (968)
T PLN00113        784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL--RLSLPGLLC------TDTKCFISSAYVAPETRETKDI  855 (968)
T ss_pred             HHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE--Eeccccccc------cCCCccccccccCcccccCCCC
Confidence            99999999999999   679999999999999986533222  234322111      11234667889999998765  


Q ss_pred             -CcccccCcceEEEEEE--eeeccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                       .++|+ ||+|+++||+  +..||.
T Consensus       856 ~~~sDv-~S~Gvvl~el~tg~~p~~  879 (968)
T PLN00113        856 TEKSDI-YGFGLILIELLTGKSPAD  879 (968)
T ss_pred             Ccccch-hhHHHHHHHHHhCCCCCC
Confidence             77999 9999999999  667774

>KOG0668|consensus

Probab=99.82  E-value=8.5e-21  Score=170.09  Aligned_cols=165  Identities=24%  Similarity=0.386  Sum_probs=131.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+++.++||+++.-     ..+.+.+|+++|+.|. ||||++++++..+.  ..+.+|+||+++.+...+.   +.++..
T Consensus        61 ~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---~tl~d~  132 (338)
T KOG0668|consen   61 TNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---PTLTDY  132 (338)
T ss_pred             CCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---hhhchh
Confidence            35778999998643     3356889999999995 99999999998754  4688999999988877765   358899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++.++.+++.||.|+|+.||.|||+||.|++|+...-++-++|+|++.......   .-+-.+.+..|--||.+..-  
T Consensus       133 dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~---eYnVRVASRyfKGPELLVdy~~  209 (338)
T KOG0668|consen  133 DIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK---EYNVRVASRYFKGPELLVDYQM  209 (338)
T ss_pred             hHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc---eeeeeeehhhcCCchheeechh
Confidence            9999999999999999999999999999999999765555556999985433211   11345666678889987654  


Q ss_pred             --CcccccCcceEEEEEEe--eeccc
Q psy6508         157 --TSLEYQRSKGELYVEFK--FAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~~--~~Pf~  178 (477)
                        -+.|+ ||+||++..|.  .-||.
T Consensus       210 YDYSLD~-WS~GcmlA~miFrkepFF  234 (338)
T KOG0668|consen  210 YDYSLDM-WSLGCMLASMIFRKEPFF  234 (338)
T ss_pred             ccccHHH-HHHHHHHHHHHhccCccc
Confidence              56799 99999999984  35665

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.82  E-value=7.8e-21  Score=186.55  Aligned_cols=150  Identities=15%  Similarity=0.201  Sum_probs=115.4

Q ss_pred             HHHHHHHhcCCCCccceEEEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEc
Q psy6508          27 NEIKALKLLHHQHIVTMLDFLWDER----YVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHF  102 (477)
Q Consensus        27 ~E~~il~~l~HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr  102 (477)
                      .+...+..++|+|++++++++....    ..+++++++. .++.+.+......++..+..++.|++.||.|||++||+||
T Consensus        72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr  150 (294)
T PHA02882         72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG  150 (294)
T ss_pred             HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            3344556678999999999765443    4578899875 6888887765567889999999999999999999999999


Q ss_pred             cCCCCceeeccCcceeecccccceecccCCc--c---cccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--
Q psy6508         103 DLKPQNILIKNNTLKLAGLKQGVSEKAKGSA--Y---IEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--  172 (477)
Q Consensus       103 Dlkp~NIll~~~~~rl~~~dfG~~~~~~gs~--~---~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--  172 (477)
                      ||||+|||++.+. .+.++|||++.......  .   ........+++.|+|||...+.   .++|+ ||+|++++|+  
T Consensus       151 DiKp~Nill~~~~-~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~Di-wSlG~~l~el~~  228 (294)
T PHA02882        151 DIKPENIMVDGNN-RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDL-ESLGYCMLKWAG  228 (294)
T ss_pred             CCCHHHEEEcCCC-cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHH-HHHHHHHHHHHh
Confidence            9999999997642 34456999986532111  0   0112234678899999988766   67899 9999999999  


Q ss_pred             eeecccc
Q psy6508         173 KFAPFAS  179 (477)
Q Consensus       173 ~~~Pf~~  179 (477)
                      +..||.+
T Consensus       229 g~~P~~~  235 (294)
T PHA02882        229 IKLPWKG  235 (294)
T ss_pred             CCCCCCc
Confidence            6688875

>KOG1345|consensus

Probab=99.81  E-value=1.9e-20  Score=171.71  Aligned_cols=167  Identities=20%  Similarity=0.315  Sum_probs=133.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEE-EEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLD-FLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~-~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .++..+++|.+++..   ...++|.+|..---.| .|.||+.-|+ .|+..+.+.+++||++.|+|..-+... .+-+..
T Consensus        47 ~s~t~ivlKavp~p~---tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~-GigE~~  122 (378)
T KOG1345|consen   47 QSKTRIVLKAVPRPQ---TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA-GIGEAN  122 (378)
T ss_pred             CCceEEEeeccCcch---hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc-cccHHH
Confidence            577889999987764   3456799999876667 5899999888 478888999999999999999887663 588999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceee-ccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll-~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++++.|+++|+.|||++++||||||.+|||| +.+..|+.++|||...... +...    ..--+-.|.|||.....  
T Consensus       123 ~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g-~tV~----~~~~~~~y~~pe~~~~~~n  197 (378)
T KOG1345|consen  123 TKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG-TTVK----YLEYVNNYHAPELCDTVVN  197 (378)
T ss_pred             HHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC-ceeh----hhhhhcccCCcHHHhhccc
Confidence            99999999999999999999999999999999 5677799999999874322 2110    01122348888865322  


Q ss_pred             ------CcccccCcceEEEEEE--eeeccc
Q psy6508         157 ------TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 ------~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                            +..|+ |.+|++++.+  |-.||.
T Consensus       198 e~~~~~ps~D~-WqfGIi~f~cltG~~PWQ  226 (378)
T KOG1345|consen  198 EKLVVNPSTDI-WQFGIIFFYCLTGKFPWQ  226 (378)
T ss_pred             cceEecccccc-hheeeeeeeeecCCCcch
Confidence                  77899 9999999988  556765

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.81  E-value=2.4e-19  Score=194.72  Aligned_cols=161  Identities=24%  Similarity=0.324  Sum_probs=129.5

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||||+++.... .....+.+.+|+.+++.++||||+++++.+.....+|+||||+.|++|.+++...+.+++..+
T Consensus        27 ~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~  106 (669)
T cd05610          27 NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA  106 (669)
T ss_pred             CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHH
Confidence            3688999999976543 334456789999999999999999999999999999999999999999999988778999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.||+.||.|||++||+||||||+|||++.+. ++.++|||++........  .....++++.|.+||.....    
T Consensus       107 ~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g-~vkL~DFGls~~~~~~~~--~~~~~~~t~~~~~pe~~~~~~~~~  183 (669)
T cd05610         107 VKYISEVALALDYLHRHGIIHRDLKPDNMLISNEG-HIKLTDFGLSKVTLNREL--NMMDILTTPSMAKPKNDYSRTPGQ  183 (669)
T ss_pred             HHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCC-CEEEEeCCCCccccCCcc--cccccccCccccCccccccCCCCc
Confidence            99999999999999999999999999999997643 344569999875443321  11234667789999865544    


Q ss_pred             CcccccCcce
Q psy6508         157 TSLEYQRSKG  166 (477)
Q Consensus       157 ~~~Di~~s~G  166 (477)
                      ...++ |++|
T Consensus       184 ~~s~~-~s~g  192 (669)
T cd05610         184 VLSLI-SSLG  192 (669)
T ss_pred             eeeee-eecC
Confidence            22344 5555

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0200|consensus

Probab=99.81  E-value=1.4e-19  Score=193.97  Aligned_cols=172  Identities=24%  Similarity=0.384  Sum_probs=143.5

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---------
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---------   73 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---------   73 (477)
                      ...||||.++..... ...+.+..|+.+|+.+ +||||+.+++++..++.+++|+||++.|+|..+++..+         
T Consensus       328 ~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~  406 (609)
T KOG0200|consen  328 YVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSG  406 (609)
T ss_pred             eEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccC
Confidence            567999998766544 6678899999999999 69999999999999999999999999999999998765         


Q ss_pred             -------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccc-cCCeEEEe
Q psy6508          74 -------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIE-QGNTKVIC  144 (477)
Q Consensus        74 -------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~-~g~t~v~~  144 (477)
                             .++......++.||+.|++||++.+++||||-.+|||+..+ .+|+  +|||+++......+.. .+.....-
T Consensus       407 ~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kI--aDFGlar~~~~~~~y~~~~~~~~LP  484 (609)
T KOG0200|consen  407 VFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKI--ADFGLARDHYNKDYYRTKSSAGTLP  484 (609)
T ss_pred             CCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEE--ccccceeccCCCCceEecCCCCccc
Confidence                   38889999999999999999999999999999999999887 3444  5999998655544443 32221133


Q ss_pred             ccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         145 SVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       145 ~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..|+|||.+...   .++|+ ||+|+++||+   |-.||.+
T Consensus       485 ~kWmApEsl~~~~ft~kSDV-WSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  485 VKWMAPESLFDRVFTSKSDV-WSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             eeecCHHHhccCcccccchh-hHHHHHHHHHhhCCCCCCCC
Confidence            349999998876   77899 9999999998   5577775

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.80  E-value=1.3e-19  Score=169.26  Aligned_cols=172  Identities=28%  Similarity=0.443  Sum_probs=140.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~-l~~~~~~   81 (477)
                      +++.+++|.+...... ...+.+.+|+..+++++|+|++++++.+......++++|++++++|.+++..... +++..+.
T Consensus        23 ~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~  101 (225)
T smart00221       23 TGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEAR  101 (225)
T ss_pred             CCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHH
Confidence            5789999998766433 2457889999999999999999999999988999999999998899999988666 8999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC-CC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS-SK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~-~~---~  157 (477)
                      .++.+++.++.+||++|++|+|++|.||+++.+ .++.++|||......... ........+...|++||... ..   .
T Consensus       102 ~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~-~~~~l~d~g~~~~~~~~~-~~~~~~~~~~~~~~~pe~~~~~~~~~~  179 (225)
T smart00221      102 FYLRQILEALEYLHSLGIVHRDLKPENILLGMD-GLVKLADFGLARFIHRDL-AALLKTVKGTPFYLAPEVLLGGKGYGE  179 (225)
T ss_pred             HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC-CCEEEeeCceeeEecCcc-cccccceeccCCcCCHhHhcCCCCCCc
Confidence            999999999999999999999999999999875 355556999876543321 00223455667799999872 22   6


Q ss_pred             cccccCcceEEEEEE--eeeccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++|+ |++|++++++  +..||.
T Consensus       180 ~~Dv-~~lG~~~~~l~~g~~pf~  201 (225)
T smart00221      180 AVDI-WSLGVILYELLWGPEPFS  201 (225)
T ss_pred             hhhH-HHHHHHHHHHHHCCCCcc
Confidence            7899 9999999998  666665

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.80  E-value=4.5e-19  Score=162.90  Aligned_cols=166  Identities=30%  Similarity=0.458  Sum_probs=135.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +++.+++|++....... ..+.+.+|+..++.++|++++++++++......++++|+++|++|.+++... ..++...+.
T Consensus        17 ~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~   95 (215)
T cd00180          17 TGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEIL   95 (215)
T ss_pred             CCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHH
Confidence            48899999987664322 3467899999999999999999999999989999999999999999999875 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.+++.++++||++|++|+||+|.||+++...-++.++|||..........  ..........|.|||.....    .
T Consensus        96 ~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~  173 (215)
T cd00180          96 RILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSE  173 (215)
T ss_pred             HHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccChhHhcccCCCCc
Confidence            99999999999999999999999999999987222444558888764443221  11234456679999987653    6


Q ss_pred             cccccCcceEEEEEE
Q psy6508         158 SLEYQRSKGELYVEF  172 (477)
Q Consensus       158 ~~Di~~s~G~il~e~  172 (477)
                      ..|+ |++|++++++
T Consensus       174 ~~D~-~~lg~~~~~l  187 (215)
T cd00180         174 KSDI-WSLGVILYEL  187 (215)
T ss_pred             hhhh-HHHHHHHHHH
Confidence            7899 9999999988

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025|consensus

Probab=99.78  E-value=5.5e-20  Score=190.12  Aligned_cols=197  Identities=18%  Similarity=0.275  Sum_probs=145.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~   81 (477)
                      -+-+||||++.... +.+...++..|+.+|.+|+|||++++++++..+. +-||++|+++|+|.+|++.++ ++-.....
T Consensus       724 vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lL  801 (1177)
T KOG1025|consen  724 VKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLL  801 (1177)
T ss_pred             ecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHH
Confidence            35689999986544 4455678999999999999999999999998765 889999999999999998764 78999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCc--ccccCCeEEEeccccccccCCCC--
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSA--YIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~--~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .|..||++|++|||.++++||||-.+|+|+.. +.+++.  |||++.......  |...+  .-....|++-|.....  
T Consensus       802 nw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkit--dfgla~ll~~d~~ey~~~~--gK~pikwmale~i~~~~~  877 (1177)
T KOG1025|consen  802 NWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKIT--DFGLAKLLAPDEKEYSAPG--GKVPIKWMALESIRIRKY  877 (1177)
T ss_pred             HHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEE--ecchhhccCcccccccccc--cccCcHHHHHHHhhccCC
Confidence            99999999999999999999999999999975 555555  999886543322  21111  1112236777766544  


Q ss_pred             -CcccccCcceEEEEEE---eeeccccccccCCCCCcchHHHHHHHHHHhhhhhhcccCCCCcccEE
Q psy6508         157 -TSLEYQRSKGELYVEF---KFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLF  219 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~---~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~  219 (477)
                       ..+|+ |++|+++||+   |-.|+.+         ...+++..+++.    --.+.+=|-..+||+
T Consensus       878 thqSDV-WsfGVtiWElmTFGa~Py~g---------i~~~eI~dlle~----geRLsqPpiCtiDVy  930 (1177)
T KOG1025|consen  878 THQSDV-WSFGVTIWELMTFGAKPYDG---------IPAEEIPDLLEK----GERLSQPPICTIDVY  930 (1177)
T ss_pred             Cchhhh-hhhhhhHHHHHhcCCCccCC---------CCHHHhhHHHhc----cccCCCCCCccHHHH
Confidence             67899 9999999998   4455553         233444444443    222444455555553

>KOG1167|consensus

Probab=99.76  E-value=1.6e-18  Score=168.23  Aligned_cols=168  Identities=25%  Similarity=0.371  Sum_probs=137.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .++.||+|.+.....    ..++.+|++.|..+ .+.||+++.+++..++...+|+||++.....+++..   ++-.+++
T Consensus        63 ~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~---l~~~~i~  135 (418)
T KOG1167|consen   63 KRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS---LSLAEIR  135 (418)
T ss_pred             ccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc---CCHHHHH
Confidence            578899999876542    24578999999999 699999999999999999999999998888888754   7789999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc----------------------------
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA----------------------------  133 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~----------------------------  133 (477)
                      .+++.++.||.++|.+||+||||||+|++.+...-|-.++|||++...++..                            
T Consensus       136 ~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~  215 (418)
T KOG1167|consen  136 WYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVAT  215 (418)
T ss_pred             HHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCccccccccc
Confidence            9999999999999999999999999999998876677778999886211100                            


Q ss_pred             ------ccc--------cCCeEEEeccccccccCCCC----CcccccCcceEEEEEE--eeeccc
Q psy6508         134 ------YIE--------QGNTKVICSVFEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       134 ------~~~--------~g~t~v~~~~y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                            +..        ..-...||+.|.|||++.+-    .++|+ ||.|++++.+  ...||.
T Consensus       216 ~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDi-ws~GVI~Lslls~~~PFf  279 (418)
T KOG1167|consen  216 ASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDI-WSAGVILLSLLSRRYPFF  279 (418)
T ss_pred             ccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccce-eeccceeehhhccccccc
Confidence                  000        00135688899999998754    77999 9999999998  556776

>PLN00207 polyribonucleotide nucleotidyltransferase; Provisional

Probab=99.76  E-value=1.5e-17  Score=178.55  Aligned_cols=204  Identities=18%  Similarity=0.232  Sum_probs=161.0

Q ss_pred             eccccc-ceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEE----eeeccccccccCCCCCcchHH
Q psy6508         119 AGLKQG-VSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEF----KFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       119 ~~~dfG-~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~----~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +.+..| ++++++|+.....|.|.+.+.+-...+...+.   |+ +-+-+=+-|-    |.-|=. ..++...+...+..
T Consensus        91 ~~~etG~~a~qA~gav~v~~g~t~vl~t~~~~~~~~~~~---dF-~PLtV~y~Ek~~AaGkipgg-f~kREgrp~d~eiL  165 (891)
T PLN00207         91 ILVETGHIGRQASGSVTVTDGETIVYTSVCLADVPSEPS---DF-FPLSVHYQERFSAAGRTSGG-FFKREGRTKDHEVL  165 (891)
T ss_pred             EEEEhhHHHHhCCCcEEEEECCeEEEEEEEeccCCCCCC---Cc-cceeEeeeeehhhcCccCCc-eeccCCCCChHHHH
Confidence            345555 45679999999999999998877665554444   54 4333333333    222222 12334456667788


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCc--hHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCChH
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGS--ALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEE  271 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~--~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~~  271 (477)
                      .++++.+.++|.+..+.||+.+|.+  ++|+.||+  ..++|+|||++||+++||||+++|+||+|+..+|.+++||+..
T Consensus       166 ~sRlIdR~lRPlfp~~~~~etQI~i--~VLsaDg~~~pd~~AInAASaAL~~SgIP~~gpVaAVrVG~idg~~VlnPt~~  243 (891)
T PLN00207        166 ICRLIDRPLRPTMPKGFYHETQILS--WVLSYDGLHSPDSLAVTAAGIAVALSEVPNLKAIAGVRVGLIGGKFIVNPTTK  243 (891)
T ss_pred             HHHHHCccchhhccccCCCCcEEEE--EEEeeCCCCChhhHHHHHHHHHHHhhCCCccCceEEEEEEEECCEEEECCCHH
Confidence            8999999999999999999999965  99999998  6699999999999999999999999999999999999999999


Q ss_pred             HHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeee-cHHHHHHHHHHHHhcccchhhHHHHhHhhhcc
Q psy6508         272 EVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTI-QQERLADHIEQLIGCCESLCTDRVQKLVSDHV  342 (477)
Q Consensus       272 E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~-~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~  342 (477)
                      |.+.          +...+.++  ...+.|+.++..|+. +.+++.++|+.|.++|+.+... +++.+....
T Consensus       244 E~~~----------s~ldLvva--gt~~~IvMIE~~a~e~see~l~~Al~~a~~aik~i~~~-~~el~~~~g  302 (891)
T PLN00207        244 EMEE----------SELDLIMA--GTDSAILMIEGYCNFLPEEKLLEAVEVGQDAVRAICKE-IEVLVKKCG  302 (891)
T ss_pred             HHhc----------CCeeEEEE--EcCCeEEEEEcCCCCCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHhC
Confidence            9883          34555554  445779999998865 9999999999999999999999 887665444

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.76  E-value=2.6e-19  Score=190.13  Aligned_cols=167  Identities=16%  Similarity=0.203  Sum_probs=111.8

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEE------EEeCCeEEEEEecCCCCCHHHHHHhCCC---
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF------LWDERYVYIILEYCDGGDLCSFIRSHEK---   74 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~------~~~~~~~~lv~e~~~g~sL~~~l~~~~~---   74 (477)
                      +..||+|++......    +.+.+|  .++...+.++..+...      ...+...++|+||+++++|.+++.....   
T Consensus       161 ~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~  234 (566)
T PLN03225        161 EGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYN  234 (566)
T ss_pred             CcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHHHHHHhcCCchh
Confidence            789999987643211    111111  1122222333332222      2345679999999999999999875421   


Q ss_pred             -----------------CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc
Q psy6508          75 -----------------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ  137 (477)
Q Consensus        75 -----------------l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~  137 (477)
                                       .....+..++.|++.||.|||++||+||||||+|||++.+...+.++|||++........ ..
T Consensus       235 v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~-~~  313 (566)
T PLN03225        235 VEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGIN-YI  313 (566)
T ss_pred             HHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccc-cC
Confidence                             123346689999999999999999999999999999986444455569999864432211 12


Q ss_pred             CCeEEEeccccccccCCCC-------------------------CcccccCcceEEEEEEeeeccc
Q psy6508         138 GNTKVICSVFEPREIPSSK-------------------------TSLEYQRSKGELYVEFKFAPFA  178 (477)
Q Consensus       138 g~t~v~~~~y~ppE~~~~~-------------------------~~~Di~~s~G~il~e~~~~Pf~  178 (477)
                      ..+..+++.|+|||.+...                         .++|+ ||+|+++|||.+++|.
T Consensus       314 ~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV-wSlGviL~el~~~~~~  378 (566)
T PLN03225        314 PKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI-YSAGLIFLQMAFPNLR  378 (566)
T ss_pred             CcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc-HHHHHHHHHHHhCcCC
Confidence            2345678899999965322                         23499 9999999999766554

>PHA02713 hypothetical protein; Provisional

Probab=99.75  E-value=4.1e-19  Score=188.22  Aligned_cols=97  Identities=21%  Similarity=0.201  Sum_probs=88.4

Q ss_pred             cccchhhHHhhhcCcceeEEEEec-CccceeeEeeeehhhhcccHHHHHhcCCCccc---cCCcccCCCCHHHHHHHhhh
Q psy6508         342 VTLPERGRYVLNSGLWSDCKFYVG-NDVHCKEFKAHKLILSMSSPVFATMFHGELCE---KGDTKILDITPEAFSTMLDS  417 (477)
Q Consensus       342 ~~l~~r~~~~~~~~~~~D~~~~v~-~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~---~~~~~~~~~~~~~~~~~l~~  417 (477)
                      .++++.++.|++++.+|||+|.|+ +    ++|+|||+||||+|+||++||++++.|   ..+|.|.++++++|+.+|+|
T Consensus        10 ~~~l~~l~~lr~~~~l~DV~L~v~~~----~~f~~Hr~vLaa~S~YF~amF~~~~~e~~~~~~v~l~~v~~~~~~~ll~y   85 (557)
T PHA02713         10 RRVVSNISNLLDDDILCDVIITIGDG----EEIKAHKTILAAGSKYFRTLFTTPMIIRDLVTRVNLQMFDKDAVKNIVQY   85 (557)
T ss_pred             HHHHHHHHHHHhCCCCCCEEEEeCCC----CEEeehHHHHhhcCHHHHHHhcCCchhhccCceEEeccCCHHHHHHHHHH
Confidence            346688999999999999999998 7    899999999999999999999999986   34589999999999999999


Q ss_pred             hhcCceeeCccchhhhhhccccceeec
Q psy6508         418 DHHARVNISSDHHARVSISSDHHTRVS  444 (477)
Q Consensus       418 ~Ytg~~~~~~~~~~~~~~~a~~~~~~~  444 (477)
                      +|||+  ++.+++.+|+.|||+++|.+
T Consensus        86 ~Yt~~--i~~~nv~~ll~aA~~lqi~~  110 (557)
T PHA02713         86 LYNRH--ISSMNVIDVLKCADYLLIDD  110 (557)
T ss_pred             hcCCC--CCHHHHHHHHHHHHHHCHHH
Confidence            99997  68999999999999877754

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.74  E-value=6.4e-18  Score=154.82  Aligned_cols=123  Identities=19%  Similarity=0.212  Sum_probs=93.2

Q ss_pred             CCCcEEEEEEcccCCCChhH------------------------HHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEE
Q psy6508           2 EQHTEVAIKCIDKTKVSENR------------------------FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIIL   57 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~------------------------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~   57 (477)
                      ++|++||||+++....+...                        .....+|+.+++++.++++.........  ..+|||
T Consensus        19 ~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~~--~~~iVm   96 (190)
T cd05147          19 ANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILLK--SHVLVM   96 (190)
T ss_pred             CCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEec--CCEEEE
Confidence            47899999999765322111                        1123459999999988877544333222  238999


Q ss_pred             ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEEccCCCCceeeccCcceeecccccceec
Q psy6508          58 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEK  128 (477)
Q Consensus        58 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~  128 (477)
                      ||++|+++.........++...+..++.|++.+|.++ |+.||+||||||+||+++++.+++  +|||++..
T Consensus        97 E~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~~~~v~L--iDFG~a~~  166 (190)
T cd05147          97 EFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYHDGKLYI--IDVSQSVE  166 (190)
T ss_pred             EEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEECCcEEE--EEcccccc
Confidence            9999887766544446799999999999999999999 799999999999999998765554  59998864

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG4441|consensus

Probab=99.74  E-value=9.4e-19  Score=184.97  Aligned_cols=97  Identities=26%  Similarity=0.427  Sum_probs=92.0

Q ss_pred             cchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhhhcC
Q psy6508         344 LPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTMLDSDHHA  421 (477)
Q Consensus       344 l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~Ytg  421 (477)
                      +++.++.++++++||||++.+++    ++|+|||+||||+|+||++||+++++|  +.+|.|.++++++++.+++|+|||
T Consensus        23 ~l~~l~~lr~~~~lcDv~L~v~~----~~~~aHR~VLAa~S~YFraMFt~~l~e~~~~~i~l~~v~~~~l~~ll~y~Yt~   98 (571)
T KOG4441|consen   23 LLQGLNELREEGLLCDVTLLVGD----REFPAHRVVLAACSPYFRAMFTSGLKESKQKEINLEGVDPETLELLLDYAYTG   98 (571)
T ss_pred             HHHHHHHHHHhCCCceEEEEECC----eeechHHHHHHhccHHHHHHhcCCcccccceEEEEecCCHHHHHHHHHHhhcc
Confidence            67888999999999999999999    999999999999999999999999999  566799999999999999999999


Q ss_pred             ceeeCccchhhhhhccccceeec
Q psy6508         422 RVNISSDHHARVSISSDHHTRVS  444 (477)
Q Consensus       422 ~~~~~~~~~~~~~~~a~~~~~~~  444 (477)
                      ++.++.+++++++.||+.++|.+
T Consensus        99 ~i~i~~~nVq~ll~aA~~lQi~~  121 (571)
T KOG4441|consen   99 KLEISEDNVQELLEAASLLQIPE  121 (571)
T ss_pred             eEEechHhHHHHHHHHHHhhhHH
Confidence            99999999999999999888765

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.73  E-value=4.4e-18  Score=176.82  Aligned_cols=169  Identities=13%  Similarity=0.179  Sum_probs=118.5

Q ss_pred             CCcEEEEEEcccCCCChh------------HHHHHHHHHHHHHhcCCCCc-----cceEEEEEe--------CCeEEEEE
Q psy6508           3 QHTEVAIKCIDKTKVSEN------------RFDSIVNEIKALKLLHHQHI-----VTMLDFLWD--------ERYVYIIL   57 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~------------~~~~~~~E~~il~~l~HpnI-----v~~~~~~~~--------~~~~~lv~   57 (477)
                      .++.||||.++.......            ..+....|+..+.+++|.++     ++++++|..        ++..|+|+
T Consensus       185 ~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~  264 (507)
T PLN03224        185 KKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVW  264 (507)
T ss_pred             cCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEE
Confidence            467899999865432110            11223457777778866544     667776643        35689999


Q ss_pred             ecCCCCCHHHHHHhCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc
Q psy6508          58 EYCDGGDLCSFIRSHE------------------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN  113 (477)
Q Consensus        58 e~~~g~sL~~~l~~~~------------------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~  113 (477)
                      ||+++++|.+++....                        .+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus       265 Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~  344 (507)
T PLN03224        265 KFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV  344 (507)
T ss_pred             EcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECC
Confidence            9999999999986421                        2356778899999999999999999999999999999976


Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-------------------------CcccccCcceEE
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-------------------------TSLEYQRSKGEL  168 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-------------------------~~~Di~~s~G~i  168 (477)
                      +. ++.++|||.+........ .......+++.|+|||.....                         ...|+ ||+|++
T Consensus       345 ~~-~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~Dv-wSlGvi  421 (507)
T PLN03224        345 DG-QVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDS-YTAGVL  421 (507)
T ss_pred             CC-cEEEEeCcCccccccCCc-cCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccch-hhHHHH
Confidence            43 344459998754322111 111123346789999986432                         23699 999999


Q ss_pred             EEEEee
Q psy6508         169 YVEFKF  174 (477)
Q Consensus       169 l~e~~~  174 (477)
                      +++|..
T Consensus       422 l~em~~  427 (507)
T PLN03224        422 LMQMCV  427 (507)
T ss_pred             HHHHHh
Confidence            999944

>PHA02790 Kelch-like protein; Provisional

Probab=99.73  E-value=1.6e-18  Score=180.97  Aligned_cols=99  Identities=13%  Similarity=0.114  Sum_probs=86.2

Q ss_pred             HhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCcccc-CCccc--CCCCHHHHHHHhhhhhcCceeeC
Q psy6508         350 YVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEK-GDTKI--LDITPEAFSTMLDSDHHARVNIS  426 (477)
Q Consensus       350 ~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~-~~~~~--~~~~~~~~~~~l~~~Ytg~~~~~  426 (477)
                      .++.+|.||||++.+|+     +|+|||+|||++|+|||+||++++.|+ .++.+  .++++++|+.+|+|+|||++.++
T Consensus        15 ~~~~~~~~~~~~~~~~~-----~~~~HR~VLAa~S~YFraMF~~~~~Es~~~v~~~~~~v~~~~l~~lldy~YTg~l~it   89 (480)
T PHA02790         15 ALSMTKKFKTIIEAIGG-----NIIVNSTILKKLSPYFRTHLRQKYTKNKDPVTRVCLDLDIHSLTSIVIYSYTGKVYID   89 (480)
T ss_pred             HHHhhhhhceEEEEcCc-----EEeeehhhhhhcCHHHHHHhcCCccccccceEEEecCcCHHHHHHHHHhheeeeEEEe
Confidence            45778999999987765     699999999999999999999999984 34554  39999999999999999999999


Q ss_pred             ccchhhhhhccccceeec------------ccccceeeE
Q psy6508         427 SDHHARVSISSDHHTRVS------------ISSDHRARV  453 (477)
Q Consensus       427 ~~~~~~~~~~a~~~~~~~------------~~~~~~~~~  453 (477)
                      .+|+++++.||++++|.+            |+.+|-+.+
T Consensus        90 ~~nV~~ll~aA~~Lqi~~v~~~C~~fL~~~l~~~NCl~i  128 (480)
T PHA02790         90 SHNVVNLLRASILTSVEFIIYTCINFILRDFRKEYCVEC  128 (480)
T ss_pred             cccHHHHHHHHHHhChHHHHHHHHHHHHhhCCcchHHHH
Confidence            999999999999877654            677777666

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.72  E-value=6.7e-19  Score=195.43  Aligned_cols=144  Identities=16%  Similarity=0.222  Sum_probs=107.0

Q ss_pred             HhcCC-CCccceEEEE-------EeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEcc
Q psy6508          33 KLLHH-QHIVTMLDFL-------WDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFD  103 (477)
Q Consensus        33 ~~l~H-pnIv~~~~~~-------~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrD  103 (477)
                      +.++| +||.+++++|       .....++.++|++. ++|.+++... ..+++..++.+++||+.||.|||++||+|||
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD  105 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN  105 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence            45566 6888888887       23346888899885 7999999753 4699999999999999999999999999999


Q ss_pred             CCCCceeecc-C-----------------cceeecccccceecccCCc--------------ccccCCeEEEeccccccc
Q psy6508         104 LKPQNILIKN-N-----------------TLKLAGLKQGVSEKAKGSA--------------YIEQGNTKVICSVFEPRE  151 (477)
Q Consensus       104 lkp~NIll~~-~-----------------~~rl~~~dfG~~~~~~gs~--------------~~~~g~t~v~~~~y~ppE  151 (477)
                      |||+||||+. +                 ...+...|||.++......              ....+.+.++|++|+|||
T Consensus       106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE  185 (793)
T PLN00181        106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE  185 (793)
T ss_pred             CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence            9999999953 1                 2234445777765322110              000112245788899999


Q ss_pred             cCCCC---CcccccCcceEEEEEEe--eeccc
Q psy6508         152 IPSSK---TSLEYQRSKGELYVEFK--FAPFA  178 (477)
Q Consensus       152 ~~~~~---~~~Di~~s~G~il~e~~--~~Pf~  178 (477)
                      .+.+.   .++|+ ||+||++|||.  +.|+.
T Consensus       186 ~~~~~~~~~~sDV-wSlGviL~ELl~~~~~~~  216 (793)
T PLN00181        186 EDNGSSSNCASDV-YRLGVLLFELFCPVSSRE  216 (793)
T ss_pred             hhccCCCCchhhh-hhHHHHHHHHhhCCCchh
Confidence            98765   78899 99999999993  44443

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=5.7e-17  Score=161.78  Aligned_cols=156  Identities=17%  Similarity=0.121  Sum_probs=109.0

Q ss_pred             CCcEEEEEEcccCCC---ChhHHHHHHHHHHHHHhcCCCCccc-eEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           3 QHTEVAIKCIDKTKV---SENRFDSIVNEIKALKLLHHQHIVT-MLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~-~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      +++.||||++.....   .+...+.+.+|+.+|++++|+|+++ +++.    +..|+||||++|++|.. +..   ..  
T Consensus        43 ~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~~~LVmE~~~G~~L~~-~~~---~~--  112 (365)
T PRK09188         43 PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GKDGLVRGWTEGVPLHL-ARP---HG--  112 (365)
T ss_pred             CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CCcEEEEEccCCCCHHH-hCc---cc--
Confidence            567789998753321   2334567999999999999999985 4432    45799999999999973 211   11  


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccC-CCCceeeccCcceeecccccceecccCCccc-cc---C--CeEEEeccccccc
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDL-KPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-EQ---G--NTKVICSVFEPRE  151 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDl-kp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-~~---g--~t~v~~~~y~ppE  151 (477)
                       ...++.|+++||.|||++||+|||| ||+|||++.+. ++.++|||+++........ ..   +  .+..++.-|++||
T Consensus       113 -~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~-~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe  190 (365)
T PRK09188        113 -DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDG-EAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPD  190 (365)
T ss_pred             -hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCC-CEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcc
Confidence             1568899999999999999999999 99999996542 3445699998754332210 00   0  2445666789999


Q ss_pred             cCCCC---------CcccccC-cceEEEEE
Q psy6508         152 IPSSK---------TSLEYQR-SKGELYVE  171 (477)
Q Consensus       152 ~~~~~---------~~~Di~~-s~G~il~e  171 (477)
                      .+...         ...|- | ..|-+.+.
T Consensus       191 ~~~~~~~~~~~~~~~~~dg-W~~TGDlg~~  219 (365)
T PRK09188        191 ALTPRERKILARKSLPSRI-WLATGKKVYN  219 (365)
T ss_pred             cCChhhhccccccccccCc-EEeCCCEEEE
Confidence            87654         22454 5 56776664

>KOG0576|consensus

Probab=99.71  E-value=6e-19  Score=179.15  Aligned_cols=164  Identities=26%  Similarity=0.373  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++..|+|+++...  ...+.-++.|+-+++..+||||+.+++.+......|++||||.||+|++..+-.+++++.++.
T Consensus        38 ~s~elaavkvVkLep--~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tgplselqia  115 (829)
T KOG0576|consen   38 RSGELAAVKVVKLEP--GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIA  115 (829)
T ss_pred             ccCchhhheeeeccC--CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHH
Confidence            368889999998764  334566778999999999999999999999999999999999999999999888899999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----K  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----~  156 (477)
                      ..++..++||+|||+.|-+|||||-.||++++ +.+++.  |||++....  +.+.....++||+.||+||+..-    .
T Consensus       116 yvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvkla--Dfgvsaqit--ati~KrksfiGtpywmapEvaaverkgg  191 (829)
T KOG0576|consen  116 YVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLA--DFGVSAQIT--ATIAKRKSFIGTPYWMAPEVAAVERKGG  191 (829)
T ss_pred             HHHhhhhccchhhhcCCcccccccccceeecccCceeec--ccCchhhhh--hhhhhhhcccCCccccchhHHHHHhccc
Confidence            99999999999999999999999999999965 566766  999874432  33444567899999999998532    2


Q ss_pred             --CcccccCcceEEEEEE
Q psy6508         157 --TSLEYQRSKGELYVEF  172 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~  172 (477)
                        ...|+ |+.|+.-.|+
T Consensus       192 ynqlcdi-wa~gitAiel  208 (829)
T KOG0576|consen  192 YNQLCDI-WALGITAIEL  208 (829)
T ss_pred             ccccccc-cccccchhhh
Confidence              67899 9999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.68  E-value=2.4e-16  Score=144.60  Aligned_cols=125  Identities=18%  Similarity=0.171  Sum_probs=94.3

Q ss_pred             CCCcEEEEEEcccCCCChh------------------------HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEE
Q psy6508           2 EQHTEVAIKCIDKTKVSEN------------------------RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIIL   57 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~------------------------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~   57 (477)
                      .+|+.||||+++.......                        ....+.+|...+.++.|+++.....+....  .|+||
T Consensus        19 ~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVm   96 (190)
T cd05145          19 GDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVM   96 (190)
T ss_pred             CCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEE
Confidence            3789999999887532110                        012346899999999999885554443332  48999


Q ss_pred             ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceeccc
Q psy6508          58 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAK  130 (477)
Q Consensus        58 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~  130 (477)
                      ||++|+++.........++......++.|++.++.++|+ +||+||||||+||+++++.++  ++|||++...+
T Consensus        97 E~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~~~~~~--liDFG~a~~~~  168 (190)
T cd05145          97 EFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYHDGKPY--IIDVSQAVELD  168 (190)
T ss_pred             EEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEECCCEE--EEEcccceecC
Confidence            999987654443333568889999999999999999999 999999999999999855544  45999886544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG1290|consensus

Probab=99.67  E-value=1.2e-16  Score=157.37  Aligned_cols=107  Identities=25%  Similarity=0.460  Sum_probs=90.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-----C---CCccceEEEEEe----CCeEEEEEecCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-----H---QHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFI   69 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-----H---pnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l   69 (477)
                      .+++.||+|+++..   +...+....|+++|++++     |   ..||++++.|..    +.++|||+|++ |.+|..+|
T Consensus       101 q~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI  176 (590)
T KOG1290|consen  101 QNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLI  176 (590)
T ss_pred             cCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHH
Confidence            35788999998644   334566889999999983     3   379999999874    45899999998 69999999


Q ss_pred             HhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeec
Q psy6508          70 RSH--EKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIK  112 (477)
Q Consensus        70 ~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~  112 (477)
                      +..  +.+|...++.|++|++.||.|||.. ||+|-||||+|||+.
T Consensus       177 ~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  177 KYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             HHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            874  4699999999999999999999975 999999999999993

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.65  E-value=4.6e-16  Score=144.82  Aligned_cols=148  Identities=13%  Similarity=0.155  Sum_probs=107.0

Q ss_pred             CCcEEEEEEcccCCCChh-HHHH------HHHHHHHHHhcCCCCccceEEEEEeC--------CeEEEEEecCCCCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSEN-RFDS------IVNEIKALKLLHHQHIVTMLDFLWDE--------RYVYIILEYCDGGDLCS   67 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~-~~~~------~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~lv~e~~~g~sL~~   67 (477)
                      +++.+|||++........ ..+.      +.+|+..+.+++||+|+.+.+++...        +..+|+|||++|.+|.+
T Consensus        53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~  132 (232)
T PRK10359         53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND  132 (232)
T ss_pred             CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence            466899999976654332 2233      57999999999999999999886633        35899999999999988


Q ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccc
Q psy6508          68 FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF  147 (477)
Q Consensus        68 ~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y  147 (477)
                      +.    .+++    ....+++.++..+|+.|++|||+||+||++++++  +..+|||.........-.   ...+....|
T Consensus       133 ~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g--i~liDfg~~~~~~e~~a~---d~~vler~y  199 (232)
T PRK10359        133 MP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG--LRIIDLSGKRCTAQRKAK---DRIDLERHY  199 (232)
T ss_pred             hh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC--EEEEECCCcccccchhhH---HHHHHHhHh
Confidence            73    2333    2456999999999999999999999999998877  555699977543211110   111111112


Q ss_pred             cccccCCCCCcccccCcceEEEEEE
Q psy6508         148 EPREIPSSKTSLEYQRSKGELYVEF  172 (477)
Q Consensus       148 ~ppE~~~~~~~~Di~~s~G~il~e~  172 (477)
                      .        .++|+ |++|+.+.-+
T Consensus       200 ~--------~~~di-~~lg~~~~~~  215 (232)
T PRK10359        200 G--------IKNEI-KDLGYYLLIY  215 (232)
T ss_pred             c--------ccccc-cceeEeehHH
Confidence            1        35699 9999998765

>PF00651 BTB: BTB/POZ domain; InterPro: IPR013069 The BTB (for BR-C, ttk and bab) [] or POZ (for Pox virus and Zinc finger) [] domain is present near the N terminus of a fraction of zinc finger (IPR007087 from INTERPRO) proteins and in proteins that contain the IPR006652 from INTERPRO motif such as Kelch and a family of pox virus proteins

Probab=99.64  E-value=1.6e-16  Score=132.44  Aligned_cols=94  Identities=28%  Similarity=0.436  Sum_probs=82.4

Q ss_pred             hHHhhhcCcceeEEEEec-CccceeeEeeeehhhhcccHHHHHhcCCC-ccccC--CcccCCCCHHHHHHHhhhhhcCce
Q psy6508         348 GRYVLNSGLWSDCKFYVG-NDVHCKEFKAHKLILSMSSPVFATMFHGE-LCEKG--DTKILDITPEAFSTMLDSDHHARV  423 (477)
Q Consensus       348 ~~~~~~~~~~~D~~~~v~-~~~~~~~~~~hk~vLa~~S~~f~~~f~~~-~~~~~--~~~~~~~~~~~~~~~l~~~Ytg~~  423 (477)
                      ++.+++++.+||++|.++ +    +.|+|||.||+++|+||++||.+. +.+..  ++.++++++++|+.+++|+|+|++
T Consensus         1 ~~~~~~~~~~~D~~i~v~d~----~~~~vhk~iL~~~S~~F~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~l~~~Y~~~~   76 (111)
T PF00651_consen    1 LNDLFNSNEFSDVTIRVGDG----KTFYVHKNILAARSPYFRNLFEGSKFKESTVPEISLPDVSPEAFEAFLEYMYTGEI   76 (111)
T ss_dssp             HHHHHHHTTS--EEEEETTT----EEEEE-HHHHHHHBHHHHHHHTTTTSTTSSEEEEEETTSCHHHHHHHHHHHHHSEE
T ss_pred             ChHHHcCCCCCCEEEEECCC----EEEeechhhhhccchhhhhcccccccccccccccccccccccccccccccccCCcc
Confidence            356889999999999999 7    999999999999999999999998 45533  568899999999999999999999


Q ss_pred             eeC-ccchhhhhhccccceeecc
Q psy6508         424 NIS-SDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       424 ~~~-~~~~~~~~~~a~~~~~~~~  445 (477)
                      .++ .+++.+++.+|+++.+..+
T Consensus        77 ~~~~~~~~~~ll~lA~~~~~~~L   99 (111)
T PF00651_consen   77 EINSDENVEELLELADKLQIPEL   99 (111)
T ss_dssp             EEE-TTTHHHHHHHHHHTTBHHH
T ss_pred             cCCHHHHHHHHHHHHHHhCcHHH
Confidence            998 9999999999999888764

The BTB/POZ domain mediates homomeric dimerisation and in some instances heteromeric dimerisation []. The structure of the dimerised PLZF BTB/POZ domain has been solved and consists of a tightly intertwined homodimer. The central scaffolding of the protein is made up of a cluster of alpha-helices flanked by short beta-sheets at both the top and bottom of the molecule []. POZ domains from several zinc finger proteins have been shown to mediate transcriptional repression and to interact with components of histone deacetylase co-repressor complexes including N-CoR and SMRT [, , ]. The POZ or BTB domain is also known as BR-C/Ttk or ZiN.; GO: 0005515 protein binding; PDB: 3M5B_A 1R28_B 3LBZ_A 3E4U_F 3BIM_B 1R2B_A 1R29_A 2VPK_A 2YY9_B 3GA1_A ....

>PRK10345 hypothetical protein; Provisional

Probab=99.64  E-value=1.8e-15  Score=140.21  Aligned_cols=112  Identities=22%  Similarity=0.250  Sum_probs=88.9

Q ss_pred             EEEEcccCCCChhHHHHHHHHHHHHHhc-----CCCCccceEEEEEeCC---e-EEEEEec--CCCCCHHHHHHhCCCCC
Q psy6508           8 AIKCIDKTKVSENRFDSIVNEIKALKLL-----HHQHIVTMLDFLWDER---Y-VYIILEY--CDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         8 AiK~i~~~~~~~~~~~~~~~E~~il~~l-----~HpnIv~~~~~~~~~~---~-~~lv~e~--~~g~sL~~~l~~~~~l~   76 (477)
                      +||++.....  ...+.+.+|+.+++.+     .||||++++++++++.   . +.+|+||  +.+++|.+++++. .++
T Consensus        28 ~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~  104 (210)
T PRK10345         28 CIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQC-RYE  104 (210)
T ss_pred             EEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcc-ccc
Confidence            6898866432  2346789999999999     5799999999998763   4 4489999  5579999999764 566


Q ss_pred             HHHHHHHHHHHHHHH-HHHHhCCcEEccCCCCceeecc---Ccceeeccccc
Q psy6508          77 EFQCQQFVRQLVLAL-KFLRENNVCHFDLKPQNILIKN---NTLKLAGLKQG  124 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL-~~LH~~givHrDlkp~NIll~~---~~~rl~~~dfG  124 (477)
                      +.  ..++.|++.++ +|||+++|+||||||+|||++.   ++.+++++|++
T Consensus       105 e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        105 ED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             Hh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            65  35678888888 8999999999999999999963   34467777854

>PHA03098 kelch-like protein; Provisional

Probab=99.64  E-value=8.7e-17  Score=171.00  Aligned_cols=87  Identities=20%  Similarity=0.266  Sum_probs=81.2

Q ss_pred             hhcCcceeEEEEe--cCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCceeeCccc
Q psy6508         352 LNSGLWSDCKFYV--GNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDH  429 (477)
Q Consensus       352 ~~~~~~~D~~~~v--~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~~  429 (477)
                      |.+|.||||+|.|  +|    ++|+|||+|||++|+||++||.+++. +.+|.|++ ++++|+.+|+|+|||++.++.++
T Consensus         4 ~~~~~~~Dv~l~~~~~~----~~~~~Hk~vLaa~S~yF~~mf~~~~~-~~~i~l~~-~~~~~~~~l~y~Ytg~~~i~~~~   77 (534)
T PHA03098          4 FELQKFCDESIIIVNGG----GIIKVHKIILSSSSEYFKKMFKNNFK-ENEINLNI-DYDSFNEVIKYIYTGKINITSNN   77 (534)
T ss_pred             cccCCCCCEEEEEEcCC----EEEEeHHHHHHhhhHHHHHHHhCCCC-CceEEecC-CHHHHHHHHHHhcCCceEEcHHH
Confidence            3389999999999  88    99999999999999999999999998 67788999 99999999999999999999999


Q ss_pred             hhhhhhccccceeec
Q psy6508         430 HARVSISSDHHTRVS  444 (477)
Q Consensus       430 ~~~~~~~a~~~~~~~  444 (477)
                      +.+++.+||++++..
T Consensus        78 ~~~ll~~A~~l~~~~   92 (534)
T PHA03098         78 VKDILSIANYLIIDF   92 (534)
T ss_pred             HHHHHHHHHHhCcHH
Confidence            999999999877655

>COG2123 RNase PH-related exoribonuclease [Translation, ribosomal structure and biogenesis]

Probab=99.64  E-value=3.1e-14  Score=131.64  Aligned_cols=208  Identities=25%  Similarity=0.326  Sum_probs=171.7

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEecccccc-ccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR-EIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEK  192 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp-E~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~  192 (477)
                      ++.|.+.+.+|++..++||+.+..|+|++.+.+-.-. |.+.     |- -.-|++....-..|.++....+.+++....
T Consensus        31 ~efR~ieI~~~vi~ka~GSa~VklG~Tqvv~gvK~eig~Pf~-----Dt-P~eG~~~~n~El~Plas~~fE~Gppde~ai  104 (272)
T COG2123          31 DEFRPLEIETGVIPKANGSALVKLGNTQVVVGVKAEIGEPFP-----DT-PNEGVLVVNVELSPLASPSFEPGPPDELAI  104 (272)
T ss_pred             ccccceEEEeCceecCCCcEEEEecCeEEEEEEEcccCCCCC-----CC-CCCceEEeeeeeeccccccccCCCCchhHH
Confidence            4788999999999999999999999999999874322 2222     33 556888877777788877777667777778


Q ss_pred             HHHHHHHHHhhhhh-------hc-ccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCC-----------------
Q psy6508         193 ELGNHLKRALEPAV-------CR-HEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIP-----------------  247 (477)
Q Consensus       193 ~l~~~i~~~l~~~i-------~~-~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~-----------------  247 (477)
                      ++.+.+.+.++..-       |. +.-.-|.+.+.+.+|..||+.+.++.-|+..||.++.+|                 
T Consensus       105 elsrvvdr~lr~s~aiDlekL~I~~g~kvwvv~vDv~vld~DGnl~Da~~lA~~aAL~~t~vP~~~~~~~~~~v~~~~~~  184 (272)
T COG2123         105 ELSRVVDRGLRESKAIDLEKLCIEEGKKVWVVFVDVHVLDYDGNLIDAASLAAVAALLNTRVPKAVEVGDGEIVIEVEEE  184 (272)
T ss_pred             HHHHHHHHHHHhccCcchhheeEecCCEEEEEEEEEEEEcCCCCHHHHHHHHHHHHHHhcCCCceeecCCcceeecccCC
Confidence            89999999887653       22 233457788999999999999999999999999999987                 


Q ss_pred             -----CCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe--eecHHHHHHHHH
Q psy6508         248 -----MYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG--TIQQERLADHIE  320 (477)
Q Consensus       248 -----m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g--~~~~~~~~~~l~  320 (477)
                           +...+.++|.++.++.+++||+.+||..+          .+.+|+.+ ++.++|+.++..|  .++.+.+.++++
T Consensus       185 ~~pl~~~~~pi~vt~a~ig~~lvvDPsleEe~v~----------d~~ltit~-~~~~~Iv~iqK~g~~~~~~~~~~~~~~  253 (272)
T COG2123         185 PVPLPVSNPPISVTFAKIGNVLVVDPSLEEELVA----------DGRLTITV-NEDGEIVAIQKVGGGSITESDLEKALK  253 (272)
T ss_pred             CcccccCCCceEEEEEEECCEEEeCCCcchhhhc----------CceEEEEE-CCCCcEEEEEEcCCCcCCHHHHHHHHH
Confidence                 66778899999999999999999999954          78899985 6678899999884  588999999999


Q ss_pred             HHHhcccchhhHHHHhHhh
Q psy6508         321 QLIGCCESLCTDRVQKLVS  339 (477)
Q Consensus       321 ~~~~~~~~i~~~~i~~~l~  339 (477)
                      .|.+.+.++++. +.+.|.
T Consensus       254 ~A~~~~~kl~~~-~~~~L~  271 (272)
T COG2123         254 TALSKAEKLREA-LKEALK  271 (272)
T ss_pred             HHHHHHHHHHHH-HHHhhc
Confidence            999999999998 777654

>PF01138 RNase_PH: 3' exoribonuclease family, domain 1 This Prosite family only includes Ribonuclease PH; InterPro: IPR001247 The PH (phosphorolytic) domain is responsible for 3'-5' exoribonuclease activity, although in some proteins this domain has lost its catalytic function

Probab=99.63  E-value=1.6e-15  Score=130.66  Aligned_cols=130  Identities=44%  Similarity=0.630  Sum_probs=113.0

Q ss_pred             cceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC-CCCCcchHH
Q psy6508         115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-WLRDSEEKE  193 (477)
Q Consensus       115 ~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-~~~~~~~~~  193 (477)
                      ++|.+.+.+|....++||++++.|+|.+.+.+++|.+....... |  ..-|.+.+++.+.|+.....+. ..++..+.+
T Consensus         1 e~R~i~i~~~~~~~a~GSa~v~~G~T~V~~~V~~~~~~~~~~~~-~--~~~g~~~v~v~~~~~~~~~~~~~~~~~~~~~~   77 (132)
T PF01138_consen    1 ELRPISIETGVLPRADGSARVSLGNTKVICSVKGPIEPPPSNER-D--DAEGRLTVEVEFSPFASPSFRRGGRPDEEERE   77 (132)
T ss_dssp             CBEEEEEEESSSSSSSEEEEEEETTEEEEEEEEEEEEGCSCSTT-S--SSSEEEEEEEEECCCGSTSSSSSSSTHHHHHH
T ss_pred             CCccEEEEeCCCCCCCeEEEEEECCeEEEEEEEecccccchhcc-c--CCCceEEEEEEeccccccccccccccchhHHH
Confidence            46788889999999999999999999999999999998332211 1  2238999999999998655432 456778889


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCC-chHHHHHHHHHHHHhhCCCC
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDG-SALSAAINCANLALVDAAIP  247 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg-~~~~a~inaa~lAL~dagi~  247 (477)
                      ++..+++.+++.+..+.+|+|.|++.+++|++|| +.+++++||+++||.|+|||
T Consensus        78 l~~~l~~~l~~~~~~~~~~~~~i~v~v~vl~~dG~~~~~a~~~A~~~AL~~~~iP  132 (132)
T PF01138_consen   78 LSSLLERALRSSILLEGYPRWQIHVDVQVLSDDGGNLLDAAINAACLALLDAGIP  132 (132)
T ss_dssp             HHHHHHHHHHHTBSTTTTSSEEEEEEEEEEECSSSSHHHHHHHHHHHHHHHHTCS
T ss_pred             HHHHHhhhccccccccccCceEEEEEEEEEecCCCCHHHHHHHHHHHHHHhcCCC
Confidence            9999999999999999999999999999999999 99999999999999999998

An active PH domain uses inorganic phosphate as a nucleophile, adding it across the phosphodiester bond between the end two nucleotides in order to release ribonucleoside 5'-diphosphate (rNDP) from the 3' end of the RNA substrate. PH domains can be found in bacterial/organelle RNases and PNPases (polynucleotide phosphorylases) [], as well as in archaeal and eukaryotic RNA exosomes [, ], the later acting as nano-compartments for the degradation or processing of RNA (including mRNA, rRNA, snRNA and snoRNA). Bacterial/organelle PNPases share a common barrel structure with RNA exosomes, consisting of a hexameric ring of PH domains that act as a degradation chamber, and an S1-domain/KH-domain containing cap that binds the RNA substrate (and sometimes accessory proteins) in order to regulate and restrict entry into the degradation chamber []. Unstructured RNA substrates feed in through the pore made by the S1 domains, are degraded by the PH domain ring, and exit as nucleotides via the PH pore at the opposite end of the barrel [, ]. This entry represents the phosphorolytic (PH) domain 1, which has a core 2-layer alpha/beta structure with a left-handed crossover, similar to that found in ribosomal protein S5. This domain is found in bacterial/organelle PNPases and in archaeal/eukaryotic exosomes []. More information about these proteins can be found at Protein of the Month: RNA Exosomes [].; PDB: 2C38_G 2BR2_O 2C37_M 3L7Z_A 2JEB_A 2C39_A 2JEA_A 2JE6_A 3U1K_A 4AM3_B ....

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.62  E-value=1.1e-15  Score=149.34  Aligned_cols=173  Identities=27%  Similarity=0.427  Sum_probs=139.6

Q ss_pred             cEEEEEEcccCCCChh-HHHHHHHHHHHHHhcCCC-CccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---CCCHHH
Q psy6508           5 TEVAIKCIDKTKVSEN-RFDSIVNEIKALKLLHHQ-HIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---KLSEFQ   79 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~Hp-nIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---~l~~~~   79 (477)
                      +.+++|.+........ ....+.+|..+++.+.|+ +++++++.+......+++++++.++++.+++....   .++...
T Consensus        23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  102 (384)
T COG0515          23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE  102 (384)
T ss_pred             cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHH
Confidence            4688999877765443 567899999999999888 79999999988888999999999999998887764   799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccc----cCCeEEEeccccccccCCC
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE----QGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~----~g~t~v~~~~y~ppE~~~~  155 (477)
                      ...++.|++.++.|+|+.|++|||+||+||+++.........|||.+..........    ...+..++..|.+||...+
T Consensus       103 ~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~  182 (384)
T COG0515         103 ALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG  182 (384)
T ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcC
Confidence            999999999999999999999999999999998765344456999886443332111    2356788899999998865


Q ss_pred             ---C---CcccccCcceEEEEEE--eeeccc
Q psy6508         156 ---K---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       156 ---~---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                         .   ...|+ |++|++++++  +..||.
T Consensus       183 ~~~~~~~~~~D~-~s~g~~~~~~~~~~~p~~  212 (384)
T COG0515         183 LSLAYASSSSDI-WSLGITLYELLTGLPPFE  212 (384)
T ss_pred             CCCCCCCchHhH-HHHHHHHHHHHhCCCCCC
Confidence               2   67899 9999777765  445543

>KOG1163|consensus

Probab=99.59  E-value=1.5e-14  Score=131.19  Aligned_cols=172  Identities=16%  Similarity=0.220  Sum_probs=134.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+|..||||+=......    ..+.-|.++.+.|+ .+.|+.+..++.+..+-.+||+.. |.+|.++..- .+.++.++
T Consensus        38 ~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkT  112 (341)
T KOG1163|consen   38 TSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKT  112 (341)
T ss_pred             cCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHh
Confidence            37899999985443322    34678999999996 478999998988999999999998 6999998864 24799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcc-----cccCCeEEEecccccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAY-----IEQGNTKVICSVFEPREI  152 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~-----~~~g~t~v~~~~y~ppE~  152 (477)
                      +..++-|++.-++|+|.++++||||||+|+|..-+  .-++..+|||+++.......     ...+..-.+|..|.+...
T Consensus       113 vLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinA  192 (341)
T KOG1163|consen  113 VLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINA  192 (341)
T ss_pred             HHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhh
Confidence            99999999999999999999999999999999543  44666779999976543321     123345678888888766


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+.   ...|. -|+|-++..+  +..||.+
T Consensus       193 h~g~eqSRRDDm-eSvgYvLmYfnrG~LPWQg  223 (341)
T KOG1163|consen  193 HLGIEQSRRDDM-ESVGYVLMYFNRGSLPWQG  223 (341)
T ss_pred             hhhhhhhhhhhh-hhhcceeeeeecCCCcccc
Confidence            5443   44588 9999988877  6677764

>KOG4158|consensus

Probab=99.59  E-value=1.7e-15  Score=146.10  Aligned_cols=143  Identities=20%  Similarity=0.270  Sum_probs=111.2

Q ss_pred             CCCCccceEEEEEeC---------------------------CeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHH
Q psy6508          36 HHQHIVTMLDFLWDE---------------------------RYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLV   88 (477)
Q Consensus        36 ~HpnIv~~~~~~~~~---------------------------~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~   88 (477)
                      +||||+++.++|.++                           ..+|+||..++ .+|++|+..+ ..+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-~~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-HRSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-CCchHHHHHHHHHHH
Confidence            599999999988643                           36899999997 8999999874 567788888999999


Q ss_pred             HHHHHHHhCCcEEccCCCCceee--cc-CcceeecccccceecccCC----cccccCCeEEEeccccccccCCCC-----
Q psy6508          89 LALKFLRENNVCHFDLKPQNILI--KN-NTLKLAGLKQGVSEKAKGS----AYIEQGNTKVICSVFEPREIPSSK-----  156 (477)
Q Consensus        89 ~aL~~LH~~givHrDlkp~NIll--~~-~~~rl~~~dfG~~~~~~gs----~~~~~g~t~v~~~~y~ppE~~~~~-----  156 (477)
                      +|+.|||.+||.|||+|.+|||+  ++ +-..++..|||++...+.-    .|....-..-+...-++||+....     
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            99999999999999999999999  33 4556777899998644431    111111223344557888876543     


Q ss_pred             ----CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                          .++|. |+.|.+-||+  ...||.+.+
T Consensus       432 vvny~kAD~-WA~GalaYEIfg~~NPFY~rG  461 (598)
T KOG4158|consen  432 VVNYEKADT-WAAGALAYEIFGRSNPFYKRG  461 (598)
T ss_pred             eeccchhhh-hhhhhhHHHHhccCCcccccc
Confidence                67899 9999999999  668998743

>KOG1164|consensus

Probab=99.55  E-value=5.3e-15  Score=147.12  Aligned_cols=171  Identities=20%  Similarity=0.210  Sum_probs=131.4

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC----CCccceEEEE-EeCCeEEEEEecCCCCCHHHHHHhC--CCCCH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH----QHIVTMLDFL-WDERYVYIILEYCDGGDLCSFIRSH--EKLSE   77 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H----pnIv~~~~~~-~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~   77 (477)
                      +.+|+|..........  ..+..|..++..+..    ++++++++.+ ..+..-|+||+.+ |.+|.++....  +.++.
T Consensus        45 ~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~  121 (322)
T KOG1164|consen   45 KEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSR  121 (322)
T ss_pred             eeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCH
Confidence            5789998765432221  157789999999863    6999999999 4777899999998 69999988654  47999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc----ceeeccccccee--cc---cCCc-c-ccc-CCeEEEec
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT----LKLAGLKQGVSE--KA---KGSA-Y-IEQ-GNTKVICS  145 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~----~rl~~~dfG~~~--~~---~gs~-~-~~~-g~t~v~~~  145 (477)
                      .++..++.|++.+|++||+.|++||||||+|+++....    ..+..+|||+++  ..   .+.. . ... .....+|.
T Consensus       122 ~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~  201 (322)
T KOG1164|consen  122 KTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTL  201 (322)
T ss_pred             hHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCcc
Confidence            99999999999999999999999999999999996532    456677999998  32   2211 1 111 22345888


Q ss_pred             cccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         146 VFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       146 ~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .|.++....+.   +..|+ ||++-+++++  +..||.+
T Consensus       202 ry~S~~~H~~~e~~r~DDl-es~~Y~l~el~~g~LPW~~  239 (322)
T KOG1164|consen  202 RYASINVHLGIEQGRRDDL-ESLFYMLLELLKGSLPWEA  239 (322)
T ss_pred             ccccHHHhCCCccCCchhh-hhHHHHHHHHhcCCCCCcc
Confidence            99999987766   67799 9988888887  4467654

>KOG4350|consensus

Probab=99.55  E-value=3.1e-15  Score=143.38  Aligned_cols=92  Identities=21%  Similarity=0.314  Sum_probs=80.5

Q ss_pred             cchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhhhcC
Q psy6508         344 LPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTMLDSDHHA  421 (477)
Q Consensus       344 l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~Ytg  421 (477)
                      +-+....++.+..++||+|+|++    ..|+|||+|||+||+|||+|++++|.|  +..|.|.+.+.++|+.+|+|||||
T Consensus        31 fS~~~~~l~~~e~y~DVtfvve~----~rfpAHRvILAaRs~yFRAlLYgGm~Es~q~~ipLq~t~~eAF~~lLrYiYtg  106 (620)
T KOG4350|consen   31 FSQSFDELFTSEDYSDVTFVVED----TRFPAHRVILAARSSYFRALLYGGMQESHQQLIPLQETNSEAFRALLRYIYTG  106 (620)
T ss_pred             hhHHHHHHhhcCcccceEEEEec----cccchhhhhHHHHHHHHHHHHhhhhhhhhhcccccccccHHHHHHHHHHHhhc
Confidence            35566678899999999999999    999999999999999999999999999  455788899999999999999999


Q ss_pred             ceeeCc---cchhhhhhcccc
Q psy6508         422 RVNISS---DHHARVSISSDH  439 (477)
Q Consensus       422 ~~~~~~---~~~~~~~~~a~~  439 (477)
                      ++.+..   +..-++|..|..
T Consensus       107 ~~~l~~~~ed~lld~LslAh~  127 (620)
T KOG4350|consen  107 KIDLAGVEEDILLDYLSLAHR  127 (620)
T ss_pred             ceecccchHHHHHHHHHHHHh
Confidence            998865   456677777763

>KOG0590|consensus

Probab=99.54  E-value=2.5e-15  Score=159.54  Aligned_cols=150  Identities=26%  Similarity=0.394  Sum_probs=121.3

Q ss_pred             HHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccC
Q psy6508          25 IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDL  104 (477)
Q Consensus        25 ~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDl  104 (477)
                      +..|+.+-..+.|||++..+..+.+....+-.||||++ +|..++...+.+...++..++.|++.|++|+|+.|+.|||+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl  446 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL  446 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence            67788888889999998887766655555555999997 99999988778999999999999999999999999999999


Q ss_pred             CCCceeeccC-cceeecccccceec--ccCCcccccCCeEEEeccccccccCCCC----CcccccCcceEEEEEE--eee
Q psy6508         105 KPQNILIKNN-TLKLAGLKQGVSEK--AKGSAYIEQGNTKVICSVFEPREIPSSK----TSLEYQRSKGELYVEF--KFA  175 (477)
Q Consensus       105 kp~NIll~~~-~~rl~~~dfG~~~~--~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~  175 (477)
                      ||+|+++..+ .+++  +|||.+..  .............++...|.|||...+.    ...|+ |+.|++++.|  +..
T Consensus       447 K~enll~~~~g~lki--~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDi-wS~~ii~~~m~~~~~  523 (601)
T KOG0590|consen  447 KLENLLVTENGILKI--IDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDV-WSCGIIYICMILGRF  523 (601)
T ss_pred             ccccEEEecCCceEE--eecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhh-hhccceEEEEecCCC
Confidence            9999999876 4554  48887653  2333322233456788899999999877    67899 9999999999  445


Q ss_pred             ccc
Q psy6508         176 PFA  178 (477)
Q Consensus       176 Pf~  178 (477)
                      ||.
T Consensus       524 ~Wk  526 (601)
T KOG0590|consen  524 PWK  526 (601)
T ss_pred             ccc
Confidence            554

>KOG1024|consensus

Probab=99.53  E-value=9.3e-15  Score=140.66  Aligned_cols=183  Identities=20%  Similarity=0.267  Sum_probs=144.4

Q ss_pred             EEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEE-eCCeEEEEEecCCCCCHHHHHHhC--------CCCCH
Q psy6508           7 VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEYCDGGDLCSFIRSH--------EKLSE   77 (477)
Q Consensus         7 vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~--------~~l~~   77 (477)
                      |-+|.++. ..++-+...+..|.-.+..+.|||+.++.+++. +....++++.+..-|+|..++...        +.++.
T Consensus       317 v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt  395 (563)
T KOG1024|consen  317 VLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTT  395 (563)
T ss_pred             HHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhH
Confidence            33444432 223444556788888888999999999999865 445788999999889999999721        24777


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+...++.|++.|+.|||++|++|.||..+|++|++. +++.+.|-.+++......|-..|....-...||++|.+... 
T Consensus       396 ~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~-LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~  474 (563)
T KOG1024|consen  396 IQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQ-LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSH  474 (563)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhh-eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhh
Confidence            8889999999999999999999999999999999875 67777798888887777777777776666679999998776 


Q ss_pred             --CcccccCcceEEEEEE---eeeccccccccCCCCCcchHHHHHHHHHH
Q psy6508         157 --TSLEYQRSKGELYVEF---KFAPFASQIRTGWLRDSEEKELGNHLKRA  201 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~---~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~  201 (477)
                        .++|+ |++|+++||+   |-.|+.         +-++.+++..++..
T Consensus       475 yssasDv-WsfGVllWELmtlg~~Pya---------eIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  475 YSSASDV-WSFGVLLWELMTLGKLPYA---------EIDPFEMEHYLKDG  514 (563)
T ss_pred             hcchhhh-HHHHHHHHHHHhcCCCCcc---------ccCHHHHHHHHhcc
Confidence              77899 9999999998   445555         44556666666643

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.51  E-value=1.4e-13  Score=128.23  Aligned_cols=120  Identities=18%  Similarity=0.242  Sum_probs=97.0

Q ss_pred             CCcEEEEEEcccCCCChh------HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSEN------RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      +|..|++|+.........      ...++.+|+.++..++|++++....++...+..+++|||++|++|.+++....   
T Consensus        18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~---   94 (211)
T PRK14879         18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNG---   94 (211)
T ss_pred             CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhcc---
Confidence            567899998654332111      12468899999999999998887777777788899999999999999987642   


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceec
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEK  128 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~  128 (477)
                      . ....++.+++.+|.++|+.|++|||++|.||+++.+.+++  +|||.+..
T Consensus        95 ~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~~~~~~l--iDf~~a~~  143 (211)
T PRK14879         95 M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIYL--IDFGLAEF  143 (211)
T ss_pred             H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEECCCEEE--EECCcccC
Confidence            2 7889999999999999999999999999999999655554  59998754

>smart00090 RIO RIO-like kinase

Probab=99.51  E-value=6.4e-14  Score=132.77  Aligned_cols=121  Identities=15%  Similarity=0.132  Sum_probs=90.9

Q ss_pred             CCCcEEEEEEcccCCCCh--------------------h--HHHHHHHHHHHHHhcCC--CCccceEEEEEeCCeEEEEE
Q psy6508           2 EQHTEVAIKCIDKTKVSE--------------------N--RFDSIVNEIKALKLLHH--QHIVTMLDFLWDERYVYIIL   57 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~--------------------~--~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~lv~   57 (477)
                      .+|+.||+|+++......                    .  ....+.+|+.+++++.+  ..++++++.   . ..++||
T Consensus        52 ~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~---~-~~~lV~  127 (237)
T smart00090       52 GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW---R-RNVLVM  127 (237)
T ss_pred             CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe---c-CceEEE
Confidence            478999999987643210                    0  11246789999999975  334555543   2 358999


Q ss_pred             ecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC-cEEccCCCCceeeccCcceeecccccceec
Q psy6508          58 EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN-VCHFDLKPQNILIKNNTLKLAGLKQGVSEK  128 (477)
Q Consensus        58 e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g-ivHrDlkp~NIll~~~~~rl~~~dfG~~~~  128 (477)
                      ||++|.+|..+......+....+..++.|++.++.+||++| ++||||||+||+++.+.++  .+|||.+..
T Consensus       128 E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~~~~i~--LiDFg~a~~  197 (237)
T smart00090      128 EFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVHDGKVV--IIDVSQSVE  197 (237)
T ss_pred             EEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEECCCEE--EEEChhhhc
Confidence            99998888776544445667778899999999999999999 9999999999999854444  459998753

>KOG1165|consensus

Probab=99.51  E-value=6e-14  Score=132.72  Aligned_cols=170  Identities=16%  Similarity=0.286  Sum_probs=133.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++++||||.=+....    ..++..|.+..+.| ..++|+..|-+...+-+-.||+|+. |.||.++..-. ++|+.+++
T Consensus        52 nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV  126 (449)
T KOG1165|consen   52 NNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTV  126 (449)
T ss_pred             cCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhH
Confidence            688999998554432    23577899999998 5799999998888888899999998 69999998764 47999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc----CcceeecccccceecccCC------cccccCCeEEEecccccc
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLAGLKQGVSEKAKGS------AYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~----~~~rl~~~dfG~~~~~~gs------~~~~~g~t~v~~~~y~pp  150 (477)
                      ..++.|++.-++|+|++.+|.|||||+|+||..    +.-.+-.+|||+++.....      +|.+ ...-.||..||+.
T Consensus       127 ~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE-~KSLsGTARYMSI  205 (449)
T KOG1165|consen  127 AMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYRE-HKSLSGTARYMSI  205 (449)
T ss_pred             HHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccc-ccccccceeeeEe
Confidence            999999999999999999999999999999942    2333445699999754332      1212 2344678889998


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ....++   ...|. -++|-++..+  |..||.+
T Consensus       206 NTHlGrEQSRRDDL-EaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  206 NTHLGREQSRRDDL-EALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             eccccchhhhhhhH-HHhhhhhhhhccCCCcccc
Confidence            777666   45688 9999988766  7788875

>KOG2075|consensus

Probab=99.49  E-value=9.7e-15  Score=143.40  Aligned_cols=107  Identities=27%  Similarity=0.403  Sum_probs=97.9

Q ss_pred             hhccccchhhHHhhhcCcceeEEEEecCc-cceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHh
Q psy6508         339 SDHVTLPERGRYVLNSGLWSDCKFYVGND-VHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTML  415 (477)
Q Consensus       339 ~~~~~l~~r~~~~~~~~~~~D~~~~v~~~-~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l  415 (477)
                      .++.++.+|...++++..++||.|+|+++ +..+.|||||.|||..|.+|.+||++++.+  +.++.++|+.|.+|..+|
T Consensus        96 ~~~~t~~er~~~l~~n~~~adv~fivg~~~~~~q~~paHk~vla~gS~VFdaMf~g~~a~~~s~ei~lpdvepaaFl~~L  175 (521)
T KOG2075|consen   96 AQKETMRERQAALFNNELLADVHFIVGEEDGGSQRIPAHKLVLADGSDVFDAMFYGGLAEDASLEIRLPDVEPAAFLAFL  175 (521)
T ss_pred             cchhhHHHhhHhhccCcccceeEEEeccCCCcccccchhhhhhhcchHHHHHHhccCcccccCceeecCCcChhHhHHHH
Confidence            34567889999999999999999999853 456889999999999999999999999988  577899999999999999


Q ss_pred             hhhhcCceeeCccchhhhhhccccceeecc
Q psy6508         416 DSDHHARVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       416 ~~~Ytg~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      +|+|++.+++..+++..++-+|+++.+.++
T Consensus       176 ~flYsdev~~~~dtvi~tl~~AkKY~VpaL  205 (521)
T KOG2075|consen  176 RFLYSDEVKLAADTVITTLYAAKKYLVPAL  205 (521)
T ss_pred             HHHhcchhhhhHHHHHHHHHHHHHhhhHHH
Confidence            999999999999999999999999988764

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.49  E-value=2.1e-13  Score=124.66  Aligned_cols=157  Identities=14%  Similarity=0.084  Sum_probs=103.1

Q ss_pred             CCcEEEEEEcccCCCC--hhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVS--ENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+.+++.+.+.....-  .-....+.+|+++|++|+ |+++++++++    +..|++|||+.|.+|.+.+..      . 
T Consensus        24 ~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~------~-   92 (218)
T PRK12274         24 GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR------G-   92 (218)
T ss_pred             CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh------h-
Confidence            3556666655443321  112235889999999995 6889999986    346999999999998764321      1 


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccC-CCCceeeccCcceeecccccceecccCCccc----cc-------CCeEEEeccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDL-KPQNILIKNNTLKLAGLKQGVSEKAKGSAYI----EQ-------GNTKVICSVF  147 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDl-kp~NIll~~~~~rl~~~dfG~~~~~~gs~~~----~~-------g~t~v~~~~y  147 (477)
                      ...++.|++.+|+++|++||+|||| ||+|||++.++ ++.++|||.+......+..    ..       ..-+..|+.|
T Consensus        93 ~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~  171 (218)
T PRK12274         93 DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDG-SPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAA  171 (218)
T ss_pred             hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCC-CEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            2357889999999999999999999 79999997643 3445599998754433210    00       0012245556


Q ss_pred             cccccCCCC-----CcccccCcceEEEEEE
Q psy6508         148 EPREIPSSK-----TSLEYQRSKGELYVEF  172 (477)
Q Consensus       148 ~ppE~~~~~-----~~~Di~~s~G~il~e~  172 (477)
                      ..|+...--     ...++ .+.|.-+|.+
T Consensus       172 l~~~~~~~l~~~~~~~~~w-~~~g~~~~~~  200 (218)
T PRK12274        172 LTPVERRVLKRTSWIRELW-FATGKPVYRF  200 (218)
T ss_pred             CCHHHHhhhccchhHHHHH-HHhcchHHHH
Confidence            655532211     22344 5678877777

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.49  E-value=1.9e-13  Score=126.15  Aligned_cols=117  Identities=21%  Similarity=0.263  Sum_probs=90.9

Q ss_pred             CCcEEEEEEcccCCCC-h-----hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVS-E-----NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~-~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      +|+.|++|+....... +     ....++.+|+.+++.++|+++....-++...+..+++|||++|++|.+++.....  
T Consensus        16 ~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~--   93 (199)
T TIGR03724        16 LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND--   93 (199)
T ss_pred             CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH--
Confidence            5678999986543221 1     1135678999999999988766555555566678999999999999998765321  


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceec
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEK  128 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~  128 (477)
                           .++.|++.+|.++|+.|++|||++|.||+++++.+++  +|||.+..
T Consensus        94 -----~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~~~~~~l--iDfg~a~~  138 (199)
T TIGR03724        94 -----ELLREIGRLVGKLHKAGIVHGDLTTSNIIVRDDKLYL--IDFGLGKY  138 (199)
T ss_pred             -----HHHHHHHHHHHHHHHCCeecCCCCcceEEEECCcEEE--EECCCCcC
Confidence                 7899999999999999999999999999999555554  59997654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>smart00225 BTB Broad-Complex, Tramtrack and Bric a brac

Probab=99.48  E-value=2.9e-14  Score=113.18  Aligned_cols=83  Identities=28%  Similarity=0.503  Sum_probs=76.4

Q ss_pred             eEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhhhcCceeeCccchhhhhhc
Q psy6508         359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTMLDSDHHARVNISSDHHARVSIS  436 (477)
Q Consensus       359 D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~~~~~~~~~  436 (477)
                      |+++.+++    +.|++||.+|+++|+||++||.+++.+  ...+.+++.++++|+.+|+|+|||++.++.+++..++.+
T Consensus         1 dv~i~v~~----~~~~~h~~iL~~~s~~f~~~~~~~~~~~~~~~i~l~~~~~~~f~~~l~~ly~~~~~~~~~~~~~l~~~   76 (90)
T smart00225        1 DVTLVVGG----KKFKAHKAVLAACSPYFKALFSGDFKESKKSEIYLDDVSPEDFRALLEFLYTGKLDLPEENVEELLEL   76 (90)
T ss_pred             CeEEEECC----EEEehHHHHHhhcCHHHHHHHcCCCccCCCCEEEecCCCHHHHHHHHHeecCceeecCHHHHHHHHHH
Confidence            78999999    999999999999999999999998875  455688899999999999999999999999999999999


Q ss_pred             cccceeecc
Q psy6508         437 SDHHTRVSI  445 (477)
Q Consensus       437 a~~~~~~~~  445 (477)
                      |+++.+.++
T Consensus        77 a~~~~~~~l   85 (90)
T smart00225       77 ADYLQIPGL   85 (90)
T ss_pred             HHHHCcHHH
Confidence            999887654

Domain in Broad-Complex, Tramtrack and Bric a brac. Also known as POZ (poxvirus and zinc finger) domain. Known to be a protein-protein interaction motif found at the N-termini of several C2H2-type transcription factors as well as Shaw-type potassium channels. Known structure reveals a tightly intertwined dimer formed via interactions between N-terminal strand and helix structures. However in a subset of BTB/POZ domains, these two secondary structures appear to be missing. Be aware SMART predicts BTB/POZ domains without the beta1- and alpha1-secondary structures.

>KOG0195|consensus

Probab=99.48  E-value=3.7e-15  Score=137.17  Aligned_cols=168  Identities=19%  Similarity=0.292  Sum_probs=135.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~~   80 (477)
                      +|..++.|+++....+....++|..|.-.|+-+.||||+.+++.|....++.++..|++.|+|...+....  ..+..++
T Consensus       212 qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqa  291 (448)
T KOG0195|consen  212 QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQA  291 (448)
T ss_pred             cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchH
Confidence            46678889998888777777889999999999999999999999999999999999999999999998754  3778899


Q ss_pred             HHHHHHHHHHHHHHHhCC-cE-EccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          81 QQFVRQLVLALKFLRENN-VC-HFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~g-iv-HrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+++.+++.|+.|||+.. ++ ---|....++++++ ..|+.-.|.-.+-+..|         +...+.|++||.+.+. 
T Consensus       292 v~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe~g---------r~y~pawmspealqrkp  362 (448)
T KOG0195|consen  292 VRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVG---------RAYSPAWMSPEALQRKP  362 (448)
T ss_pred             HHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeeccc---------cccCcccCCHHHHhcCc
Confidence            999999999999999963 33 34688889999875 44444333333323333         3446789999998776 


Q ss_pred             -----CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 -----TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 -----~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                           .++|+ ||++++++|+  .-.||+.-
T Consensus       363 ed~n~raadm-wsfaillwel~trevpfadl  392 (448)
T KOG0195|consen  363 EDLNIRAADM-WSFAILLWELNTREVPFADL  392 (448)
T ss_pred             hhcchhhhhH-HHHHHHHHHhhccccccccC
Confidence                 67899 9999999999  44788753

>KOG0603|consensus

Probab=99.47  E-value=4.2e-15  Score=151.56  Aligned_cols=169  Identities=22%  Similarity=0.323  Sum_probs=142.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      +.|..+|+|++++.............|..++...+ ||+++++.-.++.+...++++++..||.|...+.+...+.+...
T Consensus        20 da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~   99 (612)
T KOG0603|consen   20 DAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDV   99 (612)
T ss_pred             cccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHH
Confidence            35677899998877654433335667889999996 99999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc-ceeecccccceecccCCcccccCCeEEEeccccccccCCCC-Cc
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-TS  158 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-~~  158 (477)
                      ..+...++-+++++|+.|++|||+|++||+++.++ +++.  |||.++..-.      .....++..|++||+..+. .+
T Consensus       100 ~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~t--dfglske~v~------~~~~cgt~eymApEI~~gh~~a  171 (612)
T KOG0603|consen  100 AFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLT--DFGLSKEAVK------EKIACGTYEYRAPEIINGHLSA  171 (612)
T ss_pred             HHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccC--CchhhhHhHh------hhhcccchhhhhhHhhhccCCc
Confidence            99999999999999999999999999999998865 6666  9998764321      1122567789999999955 88


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|++++|+  +..||.+
T Consensus       172 ~D~-ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  172 ADW-WSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             ccc-hhhhhhHHHHhhCCCCCch
Confidence            899 9999999999  7788876

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.47  E-value=3.3e-14  Score=128.29  Aligned_cols=100  Identities=19%  Similarity=0.152  Sum_probs=80.8

Q ss_pred             CCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeE
Q psy6508          63 GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTK  141 (477)
Q Consensus        63 ~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~  141 (477)
                      |+|.+++..+ ..+++..+..|+.|++.||.|||+++      ||+||+++.+. ++..  ||.+......       ..
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~-~~~~--fG~~~~~~~~-------~~   64 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDG-LLKL--DGSVAFKTPE-------QS   64 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCcc-ceee--ccceEeeccc-------cC
Confidence            6899999874 46999999999999999999999998      99999997754 2222  8877654332       22


Q ss_pred             EEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         142 VICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       142 v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+++.|+|||+..+.   .++|+ ||+|+++||+  +..||..
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~Di-wSlG~il~elltg~~p~~~  106 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADI-YSLGITLYEALDYELPYNE  106 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhH-HHHHHHHHHHHhCCCCccc
Confidence            567899999998766   77999 9999999999  5677753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.41  E-value=1.2e-12  Score=124.18  Aligned_cols=119  Identities=18%  Similarity=0.182  Sum_probs=88.1

Q ss_pred             CcEEEEEEcccCCC-----------ChhHHHHHHHHHHHHHhcCCCCc--cceEEEEEeC-C---eEEEEEecCCC-CCH
Q psy6508           4 HTEVAIKCIDKTKV-----------SENRFDSIVNEIKALKLLHHQHI--VTMLDFLWDE-R---YVYIILEYCDG-GDL   65 (477)
Q Consensus         4 g~~vAiK~i~~~~~-----------~~~~~~~~~~E~~il~~l~HpnI--v~~~~~~~~~-~---~~~lv~e~~~g-~sL   65 (477)
                      +..++||.+.....           +.....++.+|+.++..|+|++|  ++.+++...+ .   ..++|||+++| .+|
T Consensus        55 ~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L  134 (239)
T PRK01723         55 GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDL  134 (239)
T ss_pred             CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCH
Confidence            67789998865321           11223568899999999988775  6777764432 2   23699999997 699


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceec
Q psy6508          66 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEK  128 (477)
Q Consensus        66 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~  128 (477)
                      .+++.. ..+++..    +.|++.+|.+||++||+||||||.|||++.++ ++.++|||.+..
T Consensus       135 ~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~-~v~LIDfg~~~~  191 (239)
T PRK01723        135 VALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDG-KFWLIDFDRGEL  191 (239)
T ss_pred             HHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCC-CEEEEECCCccc
Confidence            998865 3555543    57899999999999999999999999998643 344459987643

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.41  E-value=9.8e-13  Score=139.76  Aligned_cols=98  Identities=20%  Similarity=0.303  Sum_probs=84.9

Q ss_pred             HHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEE
Q psy6508          22 FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCH  101 (477)
Q Consensus        22 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH  101 (477)
                      .+++.+|+.+++.++|++++....++......++||||++|++|.+++.        ....++.|++.+|.+||++|++|
T Consensus       380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH  451 (535)
T PRK09605        380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH  451 (535)
T ss_pred             HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence            3568899999999999999988777777778899999999999999885        35678999999999999999999


Q ss_pred             ccCCCCceeeccCcceeecccccceecc
Q psy6508         102 FDLKPQNILIKNNTLKLAGLKQGVSEKA  129 (477)
Q Consensus       102 rDlkp~NIll~~~~~rl~~~dfG~~~~~  129 (477)
                      ||+||+||+++++.+++  +|||++...
T Consensus       452 rDlkp~NILl~~~~~~l--iDFGla~~~  477 (535)
T PRK09605        452 GDLTTSNFIVRDDRLYL--IDFGLGKYS  477 (535)
T ss_pred             CCCChHHEEEECCcEEE--EeCcccccC
Confidence            99999999996665554  599988643

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.34  E-value=3.2e-12  Score=118.03  Aligned_cols=118  Identities=19%  Similarity=0.170  Sum_probs=86.3

Q ss_pred             CCCcEEEEEEcccCCCChh--------------------HHHHHHHHHHHHHhcCCC--CccceEEEEEeCCeEEEEEec
Q psy6508           2 EQHTEVAIKCIDKTKVSEN--------------------RFDSIVNEIKALKLLHHQ--HIVTMLDFLWDERYVYIILEY   59 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~--------------------~~~~~~~E~~il~~l~Hp--nIv~~~~~~~~~~~~~lv~e~   59 (477)
                      ++|+.||||+++.......                    ....+.+|..++..+.|+  .+++.++    ....+++|||
T Consensus        37 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~  112 (198)
T cd05144          37 PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEY  112 (198)
T ss_pred             CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEE
Confidence            4689999998765431100                    112367899999999877  4555554    2456899999


Q ss_pred             CCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceeccc
Q psy6508          60 CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAK  130 (477)
Q Consensus        60 ~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~  130 (477)
                      ++|++|......      .....++.+++.++.++|+.|++||||||+||+++.+. ++..+|||.+...+
T Consensus       113 ~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~-~~~liDfg~~~~~~  176 (198)
T cd05144         113 IDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE-KIYIIDWPQMVSTD  176 (198)
T ss_pred             eCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC-cEEEEECCccccCC
Confidence            999998775431      34567889999999999999999999999999997532 44445999875433

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1240|consensus

Probab=99.33  E-value=8e-14  Score=149.28  Aligned_cols=237  Identities=19%  Similarity=0.222  Sum_probs=153.9

Q ss_pred             EEEEEEcccCCC--ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHH
Q psy6508           6 EVAIKCIDKTKV--SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQF   83 (477)
Q Consensus         6 ~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i   83 (477)
                      .|+||++-+...  +-+...+-.+|++ ...+++||.+.+..+.+.+...|||-+|.. .+|.+.+..++-+..-+.+.|
T Consensus        48 ~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlSTRPFL~~iEKkWi  125 (1431)
T KOG1240|consen   48 LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLSTRPFLVLIEKKWI  125 (1431)
T ss_pred             eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhccchHHHHHHHHHH
Confidence            499999866542  3234444555666 566699999999888777888899999997 899999988766788888999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeecc-Ccceeecccccceec-----ccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEK-----AKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~-----~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      +.|++.||..+|..||+|||||.+||||+. |.+-+.  ||.-.+.     .+.+.+.-.-.|..--..|.|||.+... 
T Consensus       126 aFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~Lt--DFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~  203 (1431)
T KOG1240|consen  126 AFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLT--DFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSAL  203 (1431)
T ss_pred             HHHHHHHHHHHHHcCccccccccceEEEeeechhhhh--cccccCCccCCCCCcccceEEEecCCceeeecChHhhhccc
Confidence            999999999999999999999999999975 655554  7765432     1122221112233333469999976541 


Q ss_pred             -------------CcccccCcceEEEEEE---eeeccccccccCCC---CCcchHHHHHH----HHHHhhhhhhcccCCC
Q psy6508         157 -------------TSLEYQRSKGELYVEF---KFAPFASQIRTGWL---RDSEEKELGNH----LKRALEPAVCRHEFSN  213 (477)
Q Consensus       157 -------------~~~Di~~s~G~il~e~---~~~Pf~~~~r~~~~---~~~~~~~l~~~----i~~~l~~~i~~~~~Pr  213 (477)
                                   ++-|| +|+||++.|+   |.+||.-..--...   .+..+..++.+    ++..+...|.+++..|
T Consensus       204 ~~~~~~q~~~~L~paMDI-FS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~Ied~~~Rnlil~Mi~rdPs~R  282 (1431)
T KOG1240|consen  204 GKTSVGQDAPLLTPAMDI-FSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKIEDVSLRNLILSMIQRDPSKR  282 (1431)
T ss_pred             cccccCCcccccChhhhh-hhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhCcCccHHHHHHHHHccCchhc
Confidence                         56799 9999999999   67888643221111   23333333333    3334444444444444


Q ss_pred             CcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCC
Q psy6508         214 FQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMY  249 (477)
Q Consensus       214 ~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~  249 (477)
                      ...+-++  -+.-|-..+...-.-.--..+.=.+|.
T Consensus       283 lSAedyL--~~yrG~~FP~yFy~FL~~Y~~~~~~~~  316 (1431)
T KOG1240|consen  283 LSAEDYL--QKYRGLVFPEYFYSFLYDYLDRFVPLT  316 (1431)
T ss_pred             cCHHHHH--HhhhccccHHHHHHHHHHHHHhcCCcc
Confidence            4433221  122566666665554444444444444

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.28  E-value=1.6e-11  Score=112.02  Aligned_cols=122  Identities=16%  Similarity=0.216  Sum_probs=83.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHH----------------------HHHHHHHHHhcCCC--CccceEEEEEeCCeEEEEE
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDS----------------------IVNEIKALKLLHHQ--HIVTMLDFLWDERYVYIIL   57 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~----------------------~~~E~~il~~l~Hp--nIv~~~~~~~~~~~~~lv~   57 (477)
                      ++|+.||||+++...........                      ...|...+.++.+.  .+++.++.    ...+++|
T Consensus        19 ~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~   94 (187)
T cd05119          19 GDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL----NRHVLVM   94 (187)
T ss_pred             CCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec----CCCEEEE
Confidence            36889999998765332211111                      14677777777543  35555553    2358999


Q ss_pred             ecCCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccC
Q psy6508          58 EYCDGGDLCS-FIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKG  131 (477)
Q Consensus        58 e~~~g~sL~~-~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~g  131 (477)
                      ||++|+++.. .+... .. ...+..++.+++.++.++|. +||+||||||+||+++++.++  .+|||.+...++
T Consensus        95 e~~~g~~~~~~~l~~~-~~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~~~~~~--liDfg~a~~~~~  166 (187)
T cd05119          95 EFIGGDGIPAPRLKDV-RL-LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVDDGKVY--IIDVPQAVEIDH  166 (187)
T ss_pred             EEeCCCCccChhhhhh-hh-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEECCcEE--EEECcccccccC
Confidence            9999844322 12111 11 16678999999999999999 999999999999999954544  459998865554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1614|consensus

Probab=99.25  E-value=3.9e-10  Score=101.86  Aligned_cols=209  Identities=18%  Similarity=0.250  Sum_probs=157.9

Q ss_pred             cceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHHH
Q psy6508         115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKEL  194 (477)
Q Consensus       115 ~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l  194 (477)
                      +.|-..+.||-   ..|+.....|+|++++.+-..--.    +..|- .--|.+.......|.++..-.+........++
T Consensus        31 efR~lei~fGk---e~gs~~vt~G~Tkvm~~vt~~ia~----Py~dR-P~eG~~~I~telsPmA~~sfE~Gr~~~~~v~l  102 (291)
T KOG1614|consen   31 EFRDLEIEFGK---EYGSVLVTMGNTKVMARVTAQIAQ----PYIDR-PHEGSFSIFTELSPMASPSFEPGRKGESEVEL  102 (291)
T ss_pred             hhhceEEEecc---ccccEEEEecCeeEEEEeehhhcC----cccCC-CCCCeeeeeeccccccccccCCCCccchHHHH
Confidence            45666667774   468888999999999986432111    11232 34466666555566665444444444667888


Q ss_pred             HHHHHHHhhhh-------hh-cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCC---------------------
Q psy6508         195 GNHLKRALEPA-------VC-RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAA---------------------  245 (477)
Q Consensus       195 ~~~i~~~l~~~-------i~-~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dag---------------------  245 (477)
                      .+++.+.+...       +| .-.-.-|.|.+.+++|..||+...+|..|+..||..-+                     
T Consensus       103 ~Rliek~~R~S~aiD~EsLCI~aG~kvW~IRiDlhiLd~DGnlvDaA~iAviaaL~hFrrPdvTv~g~ev~ihp~eEr~P  182 (291)
T KOG1614|consen  103 SRLIEKALRRSKAIDTESLCIRAGEKVWLIRIDLHILDHDGNLVDAACIAVIAALMHFRRPDVTVGGEEVIIHPVEEREP  182 (291)
T ss_pred             HHHHHHHHHhccccchHHHHhhhCCeEEEEEEEEEEEcCCCCeehhHHHHHHHHHHhcCCCCcccccceeEecChhccCC
Confidence            89998887644       22 33344688999999999999999999999999999988                     


Q ss_pred             --CCCCceEEEEEEEeeC--CeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeee--cHHHHHHHH
Q psy6508         246 --IPMYDLVTSSTLALRG--GLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTI--QQERLADHI  319 (477)
Q Consensus       246 --i~m~~~v~a~s~~~~~--~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~--~~~~~~~~l  319 (477)
                        ..|..+....|.+..+  +.+++|||..|+...          .|.++++ +++.++|+++++.|..  ...++.++.
T Consensus       183 vPL~I~HmPIC~tf~ffnkG~ivviDpt~~Ee~~~----------dGs~vVt-~Nk~rEVc~i~k~G~~~~~~~~i~~C~  251 (291)
T KOG1614|consen  183 VPLSIHHMPICFTFGFFNKGEIVVIDPTEKEEAVM----------DGSMVVT-MNKNREVCAIQKSGGEILDESVIERCY  251 (291)
T ss_pred             cceeeeeccceEEEEEecCceEEEeCCcHHHHhcc----------CceEEEE-EcCCccEEEEecCCCccccHHHHHHHH
Confidence              4488889999999874  567889999999964          7888886 6888999999999874  688899999


Q ss_pred             HHHHhcccchhhHHHHhHhhhccc
Q psy6508         320 EQLIGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       320 ~~~~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ..|...+.++-.. +.+.+.+...
T Consensus       252 k~A~~~a~~vt~i-i~e~l~~d~~  274 (291)
T KOG1614|consen  252 KLAKDRAVEVTGI-ILEALEEDQR  274 (291)
T ss_pred             HHHHHHHHHHHHH-HHHHHHHHHH
Confidence            9999999999998 8888876543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.25  E-value=2.8e-11  Score=105.35  Aligned_cols=112  Identities=22%  Similarity=0.284  Sum_probs=91.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC--CCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH--QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++.+++|.......    ...+.+|+.+++.++|  +++++++.+....+..+++|||++|+++..+       +.....
T Consensus        21 ~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~   89 (155)
T cd05120          21 DEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKE   89 (155)
T ss_pred             CCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHH
Confidence            46899999865532    3568899999999976  5999999988888889999999998777654       556677


Q ss_pred             HHHHHHHHHHHHHHhC---CcEEccCCCCceeecc-Ccceeecccccceec
Q psy6508          82 QFVRQLVLALKFLREN---NVCHFDLKPQNILIKN-NTLKLAGLKQGVSEK  128 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~-~~~rl~~~dfG~~~~  128 (477)
                      .++.+++.++.++|..   +++|+|++|.||++++ +.++  .+|||.+..
T Consensus        90 ~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~--l~Df~~~~~  138 (155)
T cd05120          90 DIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILG--IIDWEYAGY  138 (155)
T ss_pred             HHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEE--EEecccccC
Confidence            8899999999999984   7999999999999987 4444  458887643

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG1166|consensus

Probab=99.17  E-value=7.1e-12  Score=136.54  Aligned_cols=193  Identities=17%  Similarity=0.192  Sum_probs=129.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC---CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH---HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      +|+.||+|+=+....-+     |.-=.+++.+|+   -|-|..+..+....+.-++|+||.+.|+|.+++...+.+++..
T Consensus       721 ~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~l  795 (974)
T KOG1166|consen  721 NGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYL  795 (974)
T ss_pred             CCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchh
Confidence            48999999865543221     111123333443   2455666666666667789999999999999999888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeec------cCcceeecccccceecccCCcccccCC---eEEEecccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIK------NNTLKLAGLKQGVSEKAKGSAYIEQGN---TKVICSVFEPR  150 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~------~~~~rl~~~dfG~~~~~~gs~~~~~g~---t~v~~~~y~pp  150 (477)
                      ++.+..|++..++.||..||||+||||+|+||.      ++..-+.++|||.+....   .+..|.   ....|-.+-.+
T Consensus       796 v~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~---lfp~~~~F~~~~~td~f~C~  872 (974)
T KOG1166|consen  796 VMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK---LFPDGTKFKAVWHTDLFDCI  872 (974)
T ss_pred             hhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeee---EcCCCcEEeeeeccccchhH
Confidence            999999999999999999999999999999994      233444455999764322   222332   24455568889


Q ss_pred             ccCCCC---CcccccCcceEEEEEEeeeccccccccCCCCCcchHHHHHHHHHHhhhhh
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAV  206 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l~~~i~~~l~~~i  206 (477)
                      |+..|+   -.+|+ +.++.+++-|.+.-|-.  ......+.....+.+..++-+|..+
T Consensus       873 EM~~grpWtYq~Dy-fGlAa~~h~mLFG~y~q--~~~g~~~~~~~~~~Ry~~~~~W~~~  928 (974)
T KOG1166|consen  873 EMREGRPWTYQIDY-FGLAATVHVMLFGKYME--VKNGSSWMVKTNFPRYWKRDMWNKF  928 (974)
T ss_pred             HHhcCCCCchhhhh-HHHHHHHHHHHHHHHHH--hcCCcceeccccchhhhhHHHHHHH
Confidence            998888   44687 88888888776554443  1111112222225555555555443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.15  E-value=2.4e-10  Score=104.31  Aligned_cols=95  Identities=17%  Similarity=0.267  Sum_probs=72.9

Q ss_pred             HHHHHHHhcC--CCCccceEEEEEeCCeEEEEEecCCCCCHHH-HHHhCCCCCHHHHHHHHHHHHHHHHHH-HhCCcEEc
Q psy6508          27 NEIKALKLLH--HQHIVTMLDFLWDERYVYIILEYCDGGDLCS-FIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHF  102 (477)
Q Consensus        27 ~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~-~l~~~~~l~~~~~~~i~~qi~~aL~~L-H~~givHr  102 (477)
                      +|+..|+++.  .-++++.+++    ..-+|||||+.+..+.. .++. ..++......+..+++.+|..| |+.|++|+
T Consensus        75 kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG  149 (197)
T cd05146          75 KEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHA  149 (197)
T ss_pred             HHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            8999999994  4677888865    34689999997644422 2322 2456667778899999999998 89999999


Q ss_pred             cCCCCceeeccCcceeecccccceec
Q psy6508         103 DLKPQNILIKNNTLKLAGLKQGVSEK  128 (477)
Q Consensus       103 Dlkp~NIll~~~~~rl~~~dfG~~~~  128 (477)
                      ||+|.||+++++.+.+  +|||.+..
T Consensus       150 DLs~~NIL~~~~~v~i--IDF~qav~  173 (197)
T cd05146         150 DLSEYNMLWHDGKVWF--IDVSQSVE  173 (197)
T ss_pred             CCCHHHEEEECCcEEE--EECCCcee
Confidence            9999999998776555  58887643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1023|consensus

Probab=99.11  E-value=6.7e-12  Score=128.08  Aligned_cols=146  Identities=22%  Similarity=0.309  Sum_probs=115.2

Q ss_pred             HHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHHhCCc-EEccCCCCce
Q psy6508          32 LKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNV-CHFDLKPQNI  109 (477)
Q Consensus        32 l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~gi-vHrDlkp~NI  109 (477)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.+.+... ..+++.....+.++++.||.|+|+..| .|+.+++.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            46789999999999999999999999999999999999873 468888999999999999999998765 9999999999


Q ss_pred             eeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----------CcccccCcceEEEEEE--eeecc
Q psy6508         110 LIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----------TSLEYQRSKGELYVEF--KFAPF  177 (477)
Q Consensus       110 ll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----------~~~Di~~s~G~il~e~--~~~Pf  177 (477)
                      +++... .+.+.|||+.................-...|.|||.+...          .+.|+ ||+|++++|+  ...||
T Consensus        81 lvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi-Ys~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   81 LVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI-YSFGIIMYEILFRSGPF  158 (484)
T ss_pred             eeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCe-ehHHHHHHHHHhccCcc
Confidence            998863 3344588886544322211222222234469999988763          45799 9999999999  44677


Q ss_pred             cc
Q psy6508         178 AS  179 (477)
Q Consensus       178 ~~  179 (477)
                      ..
T Consensus       159 ~~  160 (484)
T KOG1023|consen  159 DL  160 (484)
T ss_pred             cc
Confidence            64

>KOG1067|consensus

Probab=99.11  E-value=5.3e-10  Score=111.84  Aligned_cols=206  Identities=19%  Similarity=0.292  Sum_probs=160.3

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEecc-ccccccCCCC---CcccccCcceEEEEEEeeeccccccccCC-CCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSK---TSLEYQRSKGELYVEFKFAPFASQIRTGW-LRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~-y~ppE~~~~~---~~~Di~~s~G~il~e~~~~Pf~~~~r~~~-~~~  188 (477)
                      +++|.+.+..+..+...||+.+..|.|++.|.+ ++++|....-   ...|   +.+..++.+.|+||+...-... ...
T Consensus       366 delR~I~ce~~m~~~lHGSaLFqRGqTQvlctVtl~s~e~a~klD~l~~~~---~~~~FmLhY~FPPyat~Evgkig~~n  442 (760)
T KOG1067|consen  366 DELRNISCEVDMLKTLHGSALFQRGQTQVLCTVTLDSLESAQKLDSLIGPD---NGINFMLHYEFPPYATNEVGKIGGLN  442 (760)
T ss_pred             hhhcccceecCccccccchhhhhcCceeEEEEEEcCCHHHhhhhhhhccCc---cCceEEEEeccCCccccccccccCCc
Confidence            468889999999999999999999999999987 7888765433   1112   2336677778999997543322 233


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCC------
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGG------  262 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~------  262 (477)
                      +++..-...-++++.|.+. +.|| ..|.+..+||+.+|+.-.|++.+.|+||.|||||.+..|+++++++.-+      
T Consensus       443 RRE~GhgaLAEkaL~~vlP-~dfP-ftIRv~SeVleSnGSsSMASvCGGslALmDaGvPv~a~vAGvaiGlvt~td~e~g  520 (760)
T KOG1067|consen  443 RRELGHGALAEKALLPVLP-EDFP-FTIRVTSEVLESNGSSSMASVCGGSLALMDAGVPVSAHVAGVAIGLVTKTDPEKG  520 (760)
T ss_pred             ccccCchhHhhhhhhccCc-ccCc-eEEEEeeeeeecCCcchHHhhhcchhhhhhcCCccccccceeEEEeEeccCcccC
Confidence            4444445666778887775 5666 7899999999999999999999999999999999999999999998511      


Q ss_pred             -----eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhH
Q psy6508         263 -----LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKL  337 (477)
Q Consensus       263 -----~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~  337 (477)
                           .++.|-..-|..            .|.|.|-+....+.|+.+    .++.+-..+++..|.++-.+|... |.+.
T Consensus       521 ~i~dyriltDIlGiEd~------------~GDMDFKiAGt~dGvTA~----gi~l~Iv~eal~~a~~ar~~Il~~-m~k~  583 (760)
T KOG1067|consen  521 EIEDYRILTDILGIEDY------------NGDMDFKIAGTNDGVTAL----GIPLKIVMEALQKAREARLQILDI-MEKN  583 (760)
T ss_pred             Ccccceeehhhcchhhh------------cCCcceeeccccCcceec----CCcHHHHHHHHHhhhHHHHHHHHH-HHhh
Confidence                 255666666644            577888777888888887    788899999999999999999988 8776


Q ss_pred             hhhc
Q psy6508         338 VSDH  341 (477)
Q Consensus       338 l~~~  341 (477)
                      +...
T Consensus       584 i~~P  587 (760)
T KOG1067|consen  584 INSP  587 (760)
T ss_pred             cCCc
Confidence            6544

>COG1185 Pnp Polyribonucleotide nucleotidyltransferase (polynucleotide phosphorylase) [Translation, ribosomal structure and biogenesis]

Probab=99.06  E-value=5.7e-10  Score=115.42  Aligned_cols=224  Identities=20%  Similarity=0.305  Sum_probs=169.3

Q ss_pred             ccCCCCceeecc---CcceeecccccceecccCCcccccCCeEEEecc-ccccccCCCCCcccccCc--ceEEEEEEeee
Q psy6508         102 FDLKPQNILIKN---NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRS--KGELYVEFKFA  175 (477)
Q Consensus       102 rDlkp~NIll~~---~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~-y~ppE~~~~~~~~Di~~s--~G~il~e~~~~  175 (477)
                      +-|--.++-++.   +++|++.+..|+..+..||+.+..|.|.....+ +++|....--   |..-.  .-..+....++
T Consensus       305 ~~Il~~~vR~DGR~~~~VRpi~~ev~~lpr~HGS~LFtRGeTQal~v~TLG~~~d~Qvi---d~l~~e~~krfm~hYNFP  381 (692)
T COG1185         305 RLILEGKVRIDGRFGDEVRPIGIEVGVLPRTHGSALFTRGETQALVVVTLGTPRDAQVI---DILEGEYKKRFLLHYNFP  381 (692)
T ss_pred             HHHhcCCcccCCCCcceeeeeeEEecCCCCccchhhhccCCCcceEEEEcCCcchhhhh---hhccchhhhheeeeccCC
Confidence            334444555543   589999999999999999999999998765554 6766432211   11011  12344555889


Q ss_pred             cccccccc-CCCCCcchHHHHHHHHHHhhhhhh-cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEE
Q psy6508         176 PFASQIRT-GWLRDSEEKELGNHLKRALEPAVC-RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVT  253 (477)
Q Consensus       176 Pf~~~~r~-~~~~~~~~~~l~~~i~~~l~~~i~-~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~  253 (477)
                      ||+...-. -..+.+++.--...-++++.+.+. .+.|| ..|.+..++++.+|+.-.+.+.+.+|||+|||+|++..|+
T Consensus       382 p~SvGE~g~~g~p~RREiGHG~LA~Ral~~vlp~~e~fp-ytiRvVsEi~eSNGSsSmaSVCg~sLaLmdAGVPIk~pVA  460 (692)
T COG1185         382 PFSVGETGRMGSPGRREIGHGALAERALAPVLPSEEEFP-YTIRVVSEILESNGSSSMASVCGGSLALMDAGVPIKAPVA  460 (692)
T ss_pred             CCCccccCCCCCCCcccccCchhhHHHHhhhCCchhcCC-ceeeeeehhhcccCcccchhhhhhHHHHHhCCCccccccc
Confidence            99954433 334556666667777888888886 45565 7788999999999999999999999999999999999999


Q ss_pred             EEEEEee-CC---eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE---eeecHHHHHHHHHHHHhcc
Q psy6508         254 SSTLALR-GG---LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV---GTIQQERLADHIEQLIGCC  326 (477)
Q Consensus       254 a~s~~~~-~~---~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~---g~~~~~~~~~~l~~~~~~~  326 (477)
                      ++..|++ +|   .++-|-...|.            ..+.|-|-+....+-|+.+|++   ..++.+-+..++..|+.+.
T Consensus       461 GIAMGLI~eg~~~~vLsDI~G~ED------------hlGDMDFKVAGT~~GiTAlQMDiKi~Git~eim~~AL~QAk~aR  528 (692)
T COG1185         461 GIAMGLIKEGDKYAVLSDILGDED------------HLGDMDFKVAGTDDGITALQMDIKIKGITKEIMKKALEQAKGAR  528 (692)
T ss_pred             chhccceecCCceEeecccccccc------------ccCCceeEEecCCCcceeeeeeeeecCCCHHHHHHHHHHHHHHH
Confidence            9999987 22   25556666663            3678888887888889999998   4577999999999999999


Q ss_pred             cchhhHHHHhHhhhcc
Q psy6508         327 ESLCTDRVQKLVSDHV  342 (477)
Q Consensus       327 ~~i~~~~i~~~l~~~~  342 (477)
                      .++... |.+++..+-
T Consensus       529 lhIL~~-M~~ai~~pr  543 (692)
T COG1185         529 LHILIV-MNEAISEPR  543 (692)
T ss_pred             HHHHHH-HHHHHhhhh
Confidence            999999 998886664

>KOG0590|consensus

Probab=99.05  E-value=3.5e-11  Score=128.08  Aligned_cols=172  Identities=26%  Similarity=0.303  Sum_probs=133.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHH-HhCC-CCCHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFI-RSHE-KLSEFQC   80 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l-~~~~-~l~~~~~   80 (477)
                      ...+|.|.+...............|..+-+.+. |+|++++++.....+..++.+++..|+++...+ .... ..+....
T Consensus        46 ~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~  125 (601)
T KOG0590|consen   46 ESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSA  125 (601)
T ss_pred             cceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcch
Confidence            445666766555433444455667888888886 999999999999999999999999999999988 5544 5778888


Q ss_pred             HHHHHHHHHHHHHHH-hCCcEEccCCCCceeeccCcceeecccccceeccc---CCcccccCCeEEE-eccccccccCCC
Q psy6508          81 QQFVRQLVLALKFLR-ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAK---GSAYIEQGNTKVI-CSVFEPREIPSS  155 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~---gs~~~~~g~t~v~-~~~y~ppE~~~~  155 (477)
                      ..++.|+..++.|+| ..++.|||+||+|.+++...-.+...|||++....   |...  .-....+ ++.|++||...+
T Consensus       126 ~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~--~~~~~~g~s~~y~a~E~~~~  203 (601)
T KOG0590|consen  126 SRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAER--SLKDRCGSSPPYGAPEHLSG  203 (601)
T ss_pred             hhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCCcce--eeecccCCCCCCCCcccccc
Confidence            899999999999999 99999999999999997654255556999886432   2221  1123445 788999999988


Q ss_pred             ----CCcccccCcceEEEEEE--eeeccc
Q psy6508         156 ----KTSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       156 ----~~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                          ....|+ |+.|+++.-+  +-.|+.
T Consensus       204 ~~~~~~~~d~-~S~g~~l~~~~~g~~p~~  231 (601)
T KOG0590|consen  204 KAYRGPSVDV-WSLGIVLSAMLTGELPWD  231 (601)
T ss_pred             hhhcCCCccc-ccccccccccccCCCCcc
Confidence                378899 9999999888  334444

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.04  E-value=6.6e-11  Score=113.73  Aligned_cols=171  Identities=19%  Similarity=0.248  Sum_probs=104.6

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCC----------CCccceEEEEE---------eC---C-----eE
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHH----------QHIVTMLDFLW---------DE---R-----YV   53 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~H----------pnIv~~~~~~~---------~~---~-----~~   53 (477)
                      ++|+++|+|+...... ....++++.+|......+.+          -.++.-++...         ..   +     ..
T Consensus        35 ~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~  114 (288)
T PF14531_consen   35 ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNR  114 (288)
T ss_dssp             TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESE
T ss_pred             cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehh
Confidence            5789999998766553 23467788888766655432          12222223221         11   1     24


Q ss_pred             EEEEecCCCCCHHHHHHh---CCC----CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccce
Q psy6508          54 YIILEYCDGGDLCSFIRS---HEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVS  126 (477)
Q Consensus        54 ~lv~e~~~g~sL~~~l~~---~~~----l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~  126 (477)
                      +++|+-+. ++|.+++..   ...    +.......+..|+++.+++||+.|++|+||+|+|++++.++ .+.+.||+..
T Consensus       115 ~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G-~v~Lg~F~~~  192 (288)
T PF14531_consen  115 FLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDG-GVFLGDFSSL  192 (288)
T ss_dssp             EEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS--EEE--GGGE
T ss_pred             hhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCC-CEEEcChHHH
Confidence            78888886 899888642   111    22333356668999999999999999999999999998764 4445688876


Q ss_pred             ecccCCcccccCCeEEEeccccccccCCC------C-----CcccccCcceEEEEEE--eeeccccc
Q psy6508         127 EKAKGSAYIEQGNTKVICSVFEPREIPSS------K-----TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       127 ~~~~gs~~~~~g~t~v~~~~y~ppE~~~~------~-----~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .... ..+..    ...+..|.|||....      .     .+.|. |.+|+++|.+  +..||...
T Consensus       193 ~r~g-~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~Da-W~LG~~ly~lWC~~lPf~~~  253 (288)
T PF14531_consen  193 VRAG-TRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDA-WQLGITLYSLWCGRLPFGLS  253 (288)
T ss_dssp             EETT-EEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHH-HHHHHHHHHHHHSS-STCCC
T ss_pred             eecC-ceeec----cCCCcccCChhhhhhhcccCcccceeeeccCH-HHHHHHHHHHHHccCCCCCC
Confidence            5433 22211    122356999986532      1     55688 9999999999  77888743

>KOG1033|consensus

Probab=99.04  E-value=8.1e-12  Score=125.50  Aligned_cols=117  Identities=19%  Similarity=0.316  Sum_probs=96.5

Q ss_pred             eEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceec
Q psy6508          52 YVYIILEYCDGGDLCSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEK  128 (477)
Q Consensus        52 ~~~lv~e~~~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~  128 (477)
                      ++||.|++|...+|.+|+...+   ..+......|+.|++.|++|   +|.+|||+||.||+...+. .+.+.|||+...
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~-q~kIgDFgl~ts  405 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDD-QLKIGDFGLVTS  405 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccch-hhhhhhhhheee
Confidence            5899999999999999997543   46788899999999999999   9999999999999996654 333459998876


Q ss_pred             ccCCc----ccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEEe
Q psy6508         129 AKGSA----YIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEFK  173 (477)
Q Consensus       129 ~~gs~----~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~~  173 (477)
                      .++..    ....-...+++.+||+||.+.++   .++|| |++|.+++|+.
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdI-yaLGlil~EL~  456 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDI-YALGLILAELL  456 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcch-hhHHHHHHHHH
Confidence            55433    11223467999999999999987   88999 99999999984

>KOG1243|consensus

Probab=99.01  E-value=7.1e-10  Score=114.72  Aligned_cols=160  Identities=19%  Similarity=0.237  Sum_probs=122.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .++.+|.|...+....  ...+...+-++-|+.++||||+++++.++.++..|||+|.+.  .|..++++.   ....+.
T Consensus        35 ~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l---~~~~v~  107 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL---GKEEVC  107 (690)
T ss_pred             ccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---HHHHHH
Confidence            3678899998877653  445567788999999999999999999999999999999985  899999763   477788


Q ss_pred             HHHHHHHHHHHHHH-hCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-Cc
Q psy6508          82 QFVRQLVLALKFLR-ENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-~~  158 (477)
                      ..+.||+.||.||| +.+++|++|.-.-|+++. ++.++.  +|-.+..+.|...  ........-.|..|+..... ..
T Consensus       108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLg--gle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~~s  183 (690)
T KOG1243|consen  108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLG--GLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSEWS  183 (690)
T ss_pred             HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEe--eeEEEeccccCCc--ccccchhhhcccChhhcCccccc
Confidence            88999999999997 578999999999999976 566666  5555555554332  11122222345556543332 45


Q ss_pred             ccccCcceEEEEEEe
Q psy6508         159 LEYQRSKGELYVEFK  173 (477)
Q Consensus       159 ~Di~~s~G~il~e~~  173 (477)
                      .|. |.+|++++|+.
T Consensus       184 ~D~-~~Lg~li~el~  197 (690)
T KOG1243|consen  184 IDS-WGLGCLIEELF  197 (690)
T ss_pred             hhh-hhHHHHHHHHh
Confidence            688 99999999983

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.94  E-value=2e-09  Score=96.36  Aligned_cols=110  Identities=19%  Similarity=0.224  Sum_probs=78.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCC-ccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQH-IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .++.|++|+......   ....+.+|+.+++.+.+.+ +++++...  ....++||||++|.++.+.     .   ....
T Consensus        20 ~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~-----~---~~~~   86 (170)
T cd05151          20 ANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE-----D---FSDP   86 (170)
T ss_pred             CCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc-----c---ccCH
Confidence            367899998754421   1224578999999986544 45666543  3345799999999887653     0   1123


Q ss_pred             HHHHHHHHHHHHHHhCCc-----EEccCCCCceeeccCcceeeccccccee
Q psy6508          82 QFVRQLVLALKFLRENNV-----CHFDLKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~gi-----vHrDlkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      .++.+++.+|..||+.++     +|+|++|.||+++++.++  .+|||.+.
T Consensus        87 ~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~~~~~~--liDf~~a~  135 (170)
T cd05151          87 ENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLDDGRLW--LIDWEYAG  135 (170)
T ss_pred             HHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEECCeEE--EEeccccc
Confidence            456899999999999885     999999999999966555  45888764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.94  E-value=1.4e-08  Score=97.71  Aligned_cols=124  Identities=17%  Similarity=0.139  Sum_probs=90.8

Q ss_pred             CCcEEEEEEcccCCCChhHH----------HHHHHHHHHHHhcCCC--CccceEEEEEe-----CCeEEEEEecCCCC-C
Q psy6508           3 QHTEVAIKCIDKTKVSENRF----------DSIVNEIKALKLLHHQ--HIVTMLDFLWD-----ERYVYIILEYCDGG-D   64 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~----------~~~~~E~~il~~l~Hp--nIv~~~~~~~~-----~~~~~lv~e~~~g~-s   64 (477)
                      +|+.|.||......... ..          ..+.+|...+.+|..-  ..++.+.+++.     ...-++|||++++. +
T Consensus        44 ~g~~~~vKr~~~~~~~~-~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~s  122 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGE-IFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTIS  122 (268)
T ss_pred             CCEEEEEEEecCCcHHH-HhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCcc
Confidence            46789999764332111 11          1377999999988433  34455555543     23578999999875 8


Q ss_pred             HHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc------Ccceeeccccccee
Q psy6508          65 LCSFIRS--HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN------NTLKLAGLKQGVSE  127 (477)
Q Consensus        65 L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~------~~~rl~~~dfG~~~  127 (477)
                      |.+++..  ....+......++.+++..+.-||.+||+|+|++|.|||++.      +..++..+||+.+.
T Consensus       123 L~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        123 LEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            9999864  234566778899999999999999999999999999999974      35677778998763

>KOG0606|consensus

Probab=98.92  E-value=5.3e-11  Score=127.88  Aligned_cols=107  Identities=26%  Similarity=0.394  Sum_probs=78.3

Q ss_pred             CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCC---c----c
Q psy6508          63 GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGS---A----Y  134 (477)
Q Consensus        63 ~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs---~----~  134 (477)
                      |+-...++..+.++-..        +.+++|+|+.||+|||+||+|.+|+. +.+++.  |||+...---+   .    +
T Consensus       136 gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlT--DfgLsk~GLms~atnl~eg~  205 (1205)
T KOG0606|consen  136 GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLT--DFGLSKKGLMSLATNLKEGH  205 (1205)
T ss_pred             chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeeccccccc--chhhhhhhhhhccchhhhcc
Confidence            55566666656666443        77899999999999999999999986 555665  88876421100   0    0


Q ss_pred             -----cccC-CeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         135 -----IEQG-NTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       135 -----~~~g-~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                           .+.. ....+|+.|.|||+...+   ..+|+ |++|+++||+  +..||.+.
T Consensus       206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdw-wamGiIlyeFLVgcvpffGd  261 (1205)
T KOG0606|consen  206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDW-WAMGIILYEFLVGCVPFFGD  261 (1205)
T ss_pred             hHHHHHHhhhccccCCccccChhhhhhhccCCCccH-HHHHHHHHHHheeeeeccCC
Confidence                 0111 234788999999998776   78999 9999999998  66888754

>PF03725 RNase_PH_C: 3' exoribonuclease family, domain 2 This Prosite family only includes Ribonuclease PH; InterPro: IPR015847 The PH (phosphorolytic) domain is responsible for 3'-5' exoribonuclease activity, although in some proteins this domain has lost its catalytic function

Probab=98.91  E-value=1.3e-08  Score=76.71  Aligned_cols=66  Identities=21%  Similarity=0.246  Sum_probs=58.0

Q ss_pred             ceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee--ecHHHHHHHHHHHHhc
Q psy6508         250 DLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT--IQQERLADHIEQLIGC  325 (477)
Q Consensus       250 ~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~--~~~~~~~~~l~~~~~~  325 (477)
                      ++++++|+++.++.+++||+.+||..          +.+.+++++.++.+.+..++..|.  ++++++.++++.|.++
T Consensus         1 ~~~~avt~~~i~~~~v~Dpt~~Ee~~----------~~~~l~~~~~~~~~~~~~~~~~g~~~~~~~~l~~~i~~A~~~   68 (68)
T PF03725_consen    1 DPPVAVTVGIIDGELVVDPTAEEESL----------SDSSLTLAVDGTGNICTLQKSGGGSELSEDQLEEAIELAKKA   68 (68)
T ss_dssp             SEEEEEEEEEETTEEEES--HHHHHH----------SSEEEEEEEETTSSEEEEEEEEESSEEEHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEEEECCEEEECCCHHHHhh----------cCCcEEEEEECCCCEEEEEEcCCCCCCCHHHHHHHHHHHhcC
Confidence            57999999999999999999999985          478999999998888888888887  9999999999999875

An active PH domain uses inorganic phosphate as a nucleophile, adding it across the phosphodiester bond between the end two nucleotides in order to release ribonucleoside 5'-diphosphate (rNDP) from the 3' end of the RNA substrate. PH domains can be found in bacterial/organelle RNases and PNPases (polynucleotide phosphorylases) [], as well as in archaeal and eukaryotic RNA exosomes [, ], the later acting as nano-compartments for the degradation or processing of RNA (including mRNA, rRNA, snRNA and snoRNA). Bacterial/organelle PNPases share a common barrel structure with RNA exosomes, consisting of a hexameric ring of PH domains that act as a degradation chamber, and an S1-domain/KH-domain containing cap that binds the RNA substrate (and sometimes accessory proteins) in order to regulate and restrict entry into the degradation chamber []. Unstructured RNA substrates feed in through the pore made by the S1 domains, are degraded by the PH domain ring, and exit as nucleotides via the PH pore at the opposite end of the barrel [, ]. This entry represents the phosphorolytic (PH) domain 2, which has a core 3-layer alpha/beta/alpha structure. This domain is found in bacterial/organelle PNPases and in archaeal/eukaryotic exosomes []. More information about these proteins can be found at Protein of the Month: RNA Exosomes [].; GO: 0003723 RNA binding, 0006396 RNA processing; PDB: 1E3H_A 1E3P_A 2NN6_E 2WNR_A 3U1K_B 2BA0_H 2BA1_H 3M85_G 3M7N_H 3H1C_K ....

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.89  E-value=1.5e-08  Score=89.83  Aligned_cols=96  Identities=18%  Similarity=0.253  Sum_probs=74.4

Q ss_pred             HHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEc
Q psy6508          23 DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHF  102 (477)
Q Consensus        23 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHr  102 (477)
                      ++-.+|+.++.++.--.|.--+=+..+.....|+|||.+|..|.+++...   .    ..+++.+-.-+.-||..||+|+
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~---~----~~~~r~vG~~vg~lH~~givHG  116 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA---R----PDLLREVGRLVGKLHKAGIVHG  116 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc---c----hHHHHHHHHHHHHHHhcCeecC
Confidence            46788999999986444444443445666778999999999999998774   2    4456667777788999999999


Q ss_pred             cCCCCceeeccCcceeeccccccee
Q psy6508         103 DLKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus       103 Dlkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      ||.++||++.++++  ..+|||+..
T Consensus       117 DLTtsNiIl~~~~i--~~IDfGLg~  139 (204)
T COG3642         117 DLTTSNIILSGGRI--YFIDFGLGE  139 (204)
T ss_pred             CCccceEEEeCCcE--EEEECCccc
Confidence            99999999988764  445999875

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.86  E-value=9.4e-09  Score=106.14  Aligned_cols=100  Identities=18%  Similarity=0.221  Sum_probs=67.9

Q ss_pred             HHHHHHHHHhcC-----CCC--ccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHHHHHHH-HHHHHH
Q psy6508          25 IVNEIKALKLLH-----HQH--IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVL-ALKFLR   95 (477)
Q Consensus        25 ~~~E~~il~~l~-----Hpn--Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~~qi~~-aL~~LH   95 (477)
                      |.+|...+.+++     +|+  +++++.  ...+..+|||||++|++|.++.... ...+   ...++.+++. .+..+|
T Consensus       200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~--~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~  274 (437)
T TIGR01982       200 LRREAANASELGENFKNDPGVYVPEVYW--DRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVL  274 (437)
T ss_pred             HHHHHHHHHHHHHhcCCCCCEEeCCEeh--hhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHH
Confidence            556777666662     232  334332  2234568999999999999876532 1222   3345556655 467889


Q ss_pred             hCCcEEccCCCCceeeccCcceeecccccceeccc
Q psy6508          96 ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAK  130 (477)
Q Consensus        96 ~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~  130 (477)
                      ..|++|+|+||.||++++++ ++..+|||.+...+
T Consensus       275 ~~g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       275 RDGFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             hCCceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            99999999999999997653 45566999986554

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.86  E-value=2.1e-09  Score=112.46  Aligned_cols=99  Identities=17%  Similarity=0.308  Sum_probs=62.9

Q ss_pred             HHHHHHHHHhcC----CCCccceEEEEE-eCCeEEEEEecCCCCCHHHH--HHhCC----CCCHHHHHHHHHHHHHHHHH
Q psy6508          25 IVNEIKALKLLH----HQHIVTMLDFLW-DERYVYIILEYCDGGDLCSF--IRSHE----KLSEFQCQQFVRQLVLALKF   93 (477)
Q Consensus        25 ~~~E~~il~~l~----HpnIv~~~~~~~-~~~~~~lv~e~~~g~sL~~~--l~~~~----~l~~~~~~~i~~qi~~aL~~   93 (477)
                      +.+|...+.+++    +.+.+.+-.++. -.+.-+|||||++|+++.++  +...+    .+.+..+..++.|+      
T Consensus       203 ~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi------  276 (537)
T PRK04750        203 LMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV------  276 (537)
T ss_pred             HHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH------
Confidence            455555555552    333333333322 23456899999999999874  33322    13333444444454      


Q ss_pred             HHhCCcEEccCCCCceeeccCc---ceeecccccceeccc
Q psy6508          94 LRENNVCHFDLKPQNILIKNNT---LKLAGLKQGVSEKAK  130 (477)
Q Consensus        94 LH~~givHrDlkp~NIll~~~~---~rl~~~dfG~~~~~~  130 (477)
                       ...|++|+|+||.||+++.++   .+++.+|||+....+
T Consensus       277 -f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 -FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             -HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence             468999999999999997653   467778999986554

>TIGR02696 pppGpp_PNP guanosine pentaphosphate synthetase I/polynucleotide phosphorylase

Probab=98.85  E-value=1e-07  Score=101.39  Aligned_cols=200  Identities=16%  Similarity=0.107  Sum_probs=140.3

Q ss_pred             eccccc-ceecccCCccccc-CCeEEEeccccccccCCCCCcccccCcceEEEEEE----eeeccccccccCCCCCcchH
Q psy6508         119 AGLKQG-VSEKAKGSAYIEQ-GNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEF----KFAPFASQIRTGWLRDSEEK  192 (477)
Q Consensus       119 ~~~dfG-~~~~~~gs~~~~~-g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~----~~~Pf~~~~r~~~~~~~~~~  192 (477)
                      +.+.+| +++.++|+..... |+|.+.+.+-..-+...+.   |+ +-+-+=+-|-    |.-|=. ..++...+...+.
T Consensus        19 ~~~etG~~A~qA~Gav~v~~~G~t~vl~t~~~~~~~~~~~---dF-~PLtV~y~Ek~yA~GkiPgg-f~kREgrps~~ei   93 (719)
T TIGR02696        19 IRFETGRLARQAAGSVVAYLDDETMLLSATTASKQPKDQF---DF-FPLTVDVEERMYAAGRIPGS-FFRREGRPSTDAI   93 (719)
T ss_pred             EEEEcchhHhhCCceEEEEecCCeEEEEEEEecCCCCCCC---CC-cceeEeeeehhhhcCccCCc-eeccCCCCChhhh
Confidence            345666 4567999999988 9999988776555544443   44 3333332332    222222 1223334555566


Q ss_pred             HHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCc--hHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCCh
Q psy6508         193 ELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGS--ALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVE  270 (477)
Q Consensus       193 ~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~--~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~  270 (477)
                      ..++++.+.++|...  +.-+..++|.+.+|..|+.  .-..|+|||++||.-++||..+.++|+-++..+|..+++||.
T Consensus        94 L~sRliDR~iRPLFp--~~~~~e~qi~~~vls~D~~~~pdvla~~~ASaAl~iSdiPf~gPv~~vrVg~i~g~~viNPt~  171 (719)
T TIGR02696        94 LTCRLIDRPLRPSFV--KGLRNEVQVVVTVLSLNPDHLYDVVAINAASASTQLAGLPFSGPIGGVRVALIDGQWVAFPTH  171 (719)
T ss_pred             HHHHhhCCCCccCCC--CCCCcceEEEEEEEEcCCCCChHHHHHHHHHHHHHhcCCCCCCceEEEEEEEECCEEEECcCH
Confidence            667777777766552  2224557788899999985  445689999999999999999999999999999999999999


Q ss_pred             HHHhhhccCCCCCCCCCceEEEEEccC---CCcEEEEEE------------E-eeecHHHHHHHHHHHHhcccchhhHHH
Q psy6508         271 EEVAYCQSLSSSEDDDSGVITLSYMSV---IQQVTQVTL------------V-GTIQQERLADHIEQLIGCCESLCTDRV  334 (477)
Q Consensus       271 ~E~~~~~~~~~~~~~~~~~~~~a~~~~---~~~i~~~~~------------~-g~~~~~~~~~~l~~~~~~~~~i~~~~i  334 (477)
                      .|.+.          +.-.+++|-...   .+.|+.++.            . ..++.+.+.++|+.+.+.++.+... +
T Consensus       172 ~~~~~----------s~ldLvvagt~~~~~~~~i~MiE~~a~~~~~~~~~~~a~e~~e~~~~~Ai~~a~~~i~~~~~~-~  240 (719)
T TIGR02696       172 EQLEG----------AVFDMVVAGRVLENGDVAIMMVEAEATEKTWDLVKGGAEAPTEEVVAEGLEAAKPFIKVLCRA-Q  240 (719)
T ss_pred             HHHhh----------CeeeEEEEeeecCCCCccEEEEecCCccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHHH-H
Confidence            99873          234455543210   237888886            3 2478999999999999999999888 6


Q ss_pred             Hh
Q psy6508         335 QK  336 (477)
Q Consensus       335 ~~  336 (477)
                      .+
T Consensus       241 ~~  242 (719)
T TIGR02696       241 AD  242 (719)
T ss_pred             HH
Confidence            55

Sohlberg, et al. present characterization of two proteins from Streptomyces coelicolor. The protein in this family was shown to have poly(A) polymerase activity and may be responsible for polyadenylating RNA in this species. Reference 2 showed that a nearly identical plasmid-encoded protein from Streptomyces antibioticus is a bifunctional enzyme that acts also as a guanosine pentaphosphate synthetase.

>KOG1613|consensus

Probab=98.74  E-value=1.7e-07  Score=84.85  Aligned_cols=203  Identities=22%  Similarity=0.317  Sum_probs=142.7

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      ++.|-+.+..|.+..++||+....|+|.+.|..-+-  +..  +..|- -.-|++..++.++|..+..-++.++......
T Consensus        44 gefRdt~in~g~IsTangSal~K~G~ttvi~~Ik~e--i~e--pstda-pdeg~Iv~n~~lpplcs~r~RpG~p~dea~v  118 (298)
T KOG1613|consen   44 GEFRDTAINAGNISTANGSALLKSGKTTVICGIKAE--IAE--PSTDA-PDEGDIVPNYALPPLCSSRFRPGPPTDEAQV  118 (298)
T ss_pred             hHHhhhheecCceeccCcHHHHhcCCcEEEEEeeee--ecc--cccCC-CCCcceeecccCCcccccCCCCCCCchHHHH
Confidence            456777778999999999999999999999986431  111  11233 4568888888899998776666667777777


Q ss_pred             HHHHHHHHhhhhh-------h-cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCC--------------ce
Q psy6508         194 LGNHLKRALEPAV-------C-RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMY--------------DL  251 (477)
Q Consensus       194 l~~~i~~~l~~~i-------~-~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~--------------~~  251 (477)
                      +++.+.+.+...-       | ...---|.....+.+|..||.++.+|.+|+..||-+-.+|.-              ..
T Consensus       119 iSq~LhdtIl~S~ii~~k~Lci~~gKaawvlYadIicLd~dG~~fDa~w~al~aAlknvklP~a~ide~~~~~~~t~e~~  198 (298)
T KOG1613|consen  119 ISQKLHDTILHSRIIPKKALCIKAGKAAWVLYADIICLDYDGPVFDACWNALMAALKNVKLPRAFIDERASDLRMTIEEI  198 (298)
T ss_pred             HHHHHHHHHHhcCCcchhhheeeccceeeEEEEEEEEEcCCCcHHHHHHHHHHHHHhcCCCceeeecccchhhhhhHHHH
Confidence            7777776665431       1 111223556667889999999999999999999988887611              11


Q ss_pred             EEEEEE------------------------EeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE
Q psy6508         252 VTSSTL------------------------ALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV  307 (477)
Q Consensus       252 v~a~s~------------------------~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~  307 (477)
                      .+..+.                        .+.+..++.|||.+||..          ..+.+|+.. .++++++++...
T Consensus       199 ic~~tlt~p~~ln~e~r~~~~~n~~fS~~~vl~~~li~adpT~eEE~l----------~~~~lTIvl-dss~n~v~l~k~  267 (298)
T KOG1613|consen  199 ICDQTLTVPLMLNAENRAFASQNSDFSEEEVLDDVLIAADPTEEEETL----------ITSTLTIVL-DSSGNYVQLTKV  267 (298)
T ss_pred             HHhhhhcchhhhccccccccccCCCccHHHhhcceeEecCCCchhhhh----------hhceEEEEE-cCCCCEEEEEec
Confidence            111111                        111223557999999884          377788865 556777777776


Q ss_pred             ee---ecHHHHHHHHHHHHhcccchhhH
Q psy6508         308 GT---IQQERLADHIEQLIGCCESLCTD  332 (477)
Q Consensus       308 g~---~~~~~~~~~l~~~~~~~~~i~~~  332 (477)
                      |.   .+++.+++++++|...++.+...
T Consensus       268 GG~al~~~~~iK~c~elar~Rakelk~~  295 (298)
T KOG1613|consen  268 GGGALITPEMIKRCLELARVRAKELKTR  295 (298)
T ss_pred             CcccccCHHHHHHHHHHHHHHHHHHHHH
Confidence            54   56799999999999988887765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.73  E-value=3.5e-08  Score=89.67  Aligned_cols=120  Identities=22%  Similarity=0.245  Sum_probs=78.0

Q ss_pred             CCCcEEEEEEcccCCCC----------------------h--hHHHHHHHHHHHHHhcCCC--CccceEEEEEeCCeEEE
Q psy6508           2 EQHTEVAIKCIDKTKVS----------------------E--NRFDSIVNEIKALKLLHHQ--HIVTMLDFLWDERYVYI   55 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~----------------------~--~~~~~~~~E~~il~~l~Hp--nIv~~~~~~~~~~~~~l   55 (477)
                      ++|..+|+|+.+....+                      .  -......+|...|.++..-  ++++.+++.  +  -+|
T Consensus         8 ~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~--~--~~i   83 (188)
T PF01163_consen    8 PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN--R--NVI   83 (188)
T ss_dssp             CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE--T--TEE
T ss_pred             CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe--C--CEE
Confidence            46889999987663111                      0  0123578999999999654  678887653  2  369


Q ss_pred             EEecCC--CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHH-HHhCCcEEccCCCCceeeccCcceeecccccceecc
Q psy6508          56 ILEYCD--GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKF-LRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKA  129 (477)
Q Consensus        56 v~e~~~--g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~-LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~  129 (477)
                      ||||++  |..+..+...  .++......++.+++..+.. +|..|++|+||.+.||+++++  ++..+|||.+...
T Consensus        84 vME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~--~~~iIDf~qav~~  156 (188)
T PF01163_consen   84 VMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG--KVYIIDFGQAVDS  156 (188)
T ss_dssp             EEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT--CEEE--GTTEEET
T ss_pred             EEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc--eEEEEecCcceec
Confidence            999998  7667664432  22245567778888886655 579999999999999999988  5556699977543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG1612|consensus

Probab=98.71  E-value=1.9e-06  Score=78.82  Aligned_cols=207  Identities=24%  Similarity=0.279  Sum_probs=144.4

Q ss_pred             CcceeecccccceecccCCcccccCC-eEEEeccc---cccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCc
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGN-TKVICSVF---EPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDS  189 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~-t~v~~~~y---~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~  189 (477)
                      .+.|++....|+.+..+||+.+..|. |.+...+-   +.|....        ..-|.+.+.+-..|-.+..-...-++.
T Consensus        29 ~~~Rpi~vetdVlp~tNGSaRVk~g~~tdiivgVKaEvg~~~~~~--------p~egk~~~~VD~S~sasp~f~gRggde  100 (288)
T KOG1612|consen   29 HQFRPIEVETDVLPGTNGSARVKLGDGTDIIVGVKAEVGSPDDET--------PVEGKYLFFVDCSPSASPQFQGRGGDE  100 (288)
T ss_pred             cccceEEEEeccccCCCCcEEEEecCCceEEEEEeeeccCccccC--------CCCCeEEEEEEecCCcCccccCCChhh
Confidence            36889999999999999999999988 66666653   3332211        334555555555454433222233455


Q ss_pred             chHHHHHHHHHHhhh--------hhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCC--------------
Q psy6508         190 EEKELGNHLKRALEP--------AVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIP--------------  247 (477)
Q Consensus       190 ~~~~l~~~i~~~l~~--------~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~--------------  247 (477)
                      -..++...+++++..        .+++.+--+|.|.+.+-+++.||+.+.+.--|+-.||-+.-+|              
T Consensus       101 ~~~eltsaLq~~l~~~~sgv~ls~L~lt~~~~W~i~VDvlVi~s~gn~~dAiS~Ai~~AL~~T~lPkv~v~~dd~~~~~i  180 (288)
T KOG1612|consen  101 LVEELTSALQRVLNSLGSGVDLSKLQLTPGYCWKIYVDVLVISSDGNLLDAISIAIYAALNNTRLPKVIVAFDDDGEVEI  180 (288)
T ss_pred             HHHHHHHHHHHHHhCcCcccchhheeccCCeeEEEEEeEEEEecCCCHHHHHHHHHHHHHhcccCCccccccccCCceee
Confidence            566777777777765        1223333568899999999999999999999999999888766              


Q ss_pred             -----CCc--------eEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE--eeecH
Q psy6508         248 -----MYD--------LVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV--GTIQQ  312 (477)
Q Consensus       248 -----m~~--------~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~--g~~~~  312 (477)
                           =+|        +..-++++.++..+++||+.+||..          +...+.+++ ...+-++++...  |...+
T Consensus       181 ~~s~~~Yd~~~~~~~~~P~ivtlskIG~~~lVD~T~eEe~~----------a~s~l~Isv-~a~givs~~r~VG~G~l~~  249 (288)
T KOG1612|consen  181 LLSDEEYDLMVKLVENVPLIVTLSKIGTNMLVDPTAEEESV----------ANSGLLISV-SAGGIVSCTRSVGLGDLDP  249 (288)
T ss_pred             ccCcccchhhhhhcccCCEEEEEEeecceEEccCCccHHHh----------hhcceEEEE-ecCcceEEEEEecCCCCCh
Confidence                 111        2233566777899999999999984          355666665 344556666555  45889


Q ss_pred             HHHHHHHHHHHhcccchhhHHHHhHhhh
Q psy6508         313 ERLADHIEQLIGCCESLCTDRVQKLVSD  340 (477)
Q Consensus       313 ~~~~~~l~~~~~~~~~i~~~~i~~~l~~  340 (477)
                      +....+|+.+++-.+.+... +...|.+
T Consensus       250 s~i~~mle~~~~~~e~l~~~-l~k~L~~  276 (288)
T KOG1612|consen  250 SSIPEMLEQGKAVVETLAPD-LVKSLEN  276 (288)
T ss_pred             hhHHHHHHHHHHHHHhhhHH-HHHHhhh
Confidence            99999999999999988888 6665544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.71  E-value=1.5e-07  Score=87.34  Aligned_cols=105  Identities=21%  Similarity=0.271  Sum_probs=83.5

Q ss_pred             HHHHHHHHHHHhcC--CCCccceEEEEEeC----CeEEEEEecCCC-CCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH
Q psy6508          23 DSIVNEIKALKLLH--HQHIVTMLDFLWDE----RYVYIILEYCDG-GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR   95 (477)
Q Consensus        23 ~~~~~E~~il~~l~--HpnIv~~~~~~~~~----~~~~lv~e~~~g-~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH   95 (477)
                      .+..+|...+..|.  .=.+++.+.+.+..    ...++|||+++| .+|.+++......+......++.+++..+.-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            46788999888884  33456667766543    246899999987 489999987555777788899999999999999


Q ss_pred             hCCcEEccCCCCceeeccCc--ceeeccccccee
Q psy6508          96 ENNVCHFDLKPQNILIKNNT--LKLAGLKQGVSE  127 (477)
Q Consensus        96 ~~givHrDlkp~NIll~~~~--~rl~~~dfG~~~  127 (477)
                      .+||+|+|++|.|||++.++  .++..+||+-+.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            99999999999999997653  566666887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG3087|consensus

Probab=98.68  E-value=1.7e-07  Score=82.91  Aligned_cols=125  Identities=19%  Similarity=0.174  Sum_probs=88.5

Q ss_pred             CCcEEEEEEcccCCC-Ch-----hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCC-CCHHHHHHhCC--
Q psy6508           3 QHTEVAIKCIDKTKV-SE-----NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG-GDLCSFIRSHE--   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~-~~-----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g-~sL~~~l~~~~--   73 (477)
                      .|+...||.=..+.. .+     -..++..+|.+.|.++.--.|.--.=++.+.+.-.|+|||++| .++.+++....  
T Consensus        29 ~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~  108 (229)
T KOG3087|consen   29 SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMED  108 (229)
T ss_pred             CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccC
Confidence            466667774222221 11     1235678899999988644444444455666667899999985 48999987643  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeeccccccee
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSE  127 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~  127 (477)
                      .........++.+|-+.+.-||.++++|+||..+||++.++  ...+..+|||++.
T Consensus       109 ~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen  109 ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            23333347889999999999999999999999999999764  4444788999863

>KOG4591|consensus

Probab=98.68  E-value=8.8e-09  Score=90.48  Aligned_cols=91  Identities=22%  Similarity=0.246  Sum_probs=71.4

Q ss_pred             chhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCcccc-CCcccCCCCHHHHHHHhhhhhcCce
Q psy6508         345 PERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEK-GDTKILDITPEAFSTMLDSDHHARV  423 (477)
Q Consensus       345 ~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~-~~~~~~~~~~~~~~~~l~~~Ytg~~  423 (477)
                      +.....+++..+|+|++|.++|... +.++|||-||||||.+..  |.++..|+ .+..++|+++++|..+++++||+++
T Consensus        54 LaitadL~Ek~qfSDlk~K~~gns~-k~i~AHKfVLAARsD~Wk--faN~~dekse~~~~dDad~Ea~~t~iRWIYTDEi  130 (280)
T KOG4591|consen   54 LAITADLLEKEQFSDLKFKFAGNSD-KHIPAHKFVLAARSDFWK--FANGGDEKSEELDLDDADFEAFHTAIRWIYTDEI  130 (280)
T ss_pred             HHHHHHHhhcccccceeEEecCCcc-ccCchhhhhhhhhcchhh--hccCCCcchhhhcccccCHHHHHHhheeeecccc
Confidence            3344558999999999999985222 789999999999999765  45555554 4457889999999999999999999


Q ss_pred             eeCccc--hhhhhhccc
Q psy6508         424 NISSDH--HARVSISSD  438 (477)
Q Consensus       424 ~~~~~~--~~~~~~~a~  438 (477)
                      ++..++  +-.|+..|.
T Consensus       131 dfk~dD~~L~el~e~An  147 (280)
T KOG4591|consen  131 DFKEDDEFLLELCELAN  147 (280)
T ss_pred             ccccchHHHHHHHHHHH
Confidence            987765  445666665

>KOG0601|consensus

Probab=98.58  E-value=2.3e-08  Score=102.65  Aligned_cols=169  Identities=19%  Similarity=0.177  Sum_probs=130.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC-CCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK-LSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~-l~~~~   79 (477)
                      .++..+|+|.-+.....+....+=.+|+...+.+ .|+|.++.+..|+..+..++-+|+|. .+|..+...... ++...
T Consensus       141 ~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~~~p~~~  219 (524)
T KOG0601|consen  141 ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCNFLPDNL  219 (524)
T ss_pred             cCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccccCCchh
Confidence            4677889988544443333333345677777778 59999999999999999999999996 899999877655 88889


Q ss_pred             HHHHHHHHHH----HHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCC--e-EEEecccccccc
Q psy6508          80 CQQFVRQLVL----ALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGN--T-KVICSVFEPREI  152 (477)
Q Consensus        80 ~~~i~~qi~~----aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~--t-~v~~~~y~ppE~  152 (477)
                      +...+.+..+    ||.++|+.+++|-|+||.||+...+.......|||.+.............  . -.+-..|++||.
T Consensus       220 l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~  299 (524)
T KOG0601|consen  220 LWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKEL  299 (524)
T ss_pred             hhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhh
Confidence            9999999999    99999999999999999999998874455567999887544332111100  1 134457999999


Q ss_pred             CCCC--CcccccCcceEEEEEE
Q psy6508         153 PSSK--TSLEYQRSKGELYVEF  172 (477)
Q Consensus       153 ~~~~--~~~Di~~s~G~il~e~  172 (477)
                      ..+.  ...|+ +++|.++.+.
T Consensus       300 ~~~l~~~~~di-~sl~ev~l~~  320 (524)
T KOG0601|consen  300 LNGLATFASDI-FSLGEVILEA  320 (524)
T ss_pred             hccccchHhhh-cchhhhhHhh
Confidence            9877  77899 9999999887

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.55  E-value=2.4e-07  Score=86.38  Aligned_cols=122  Identities=17%  Similarity=0.190  Sum_probs=86.8

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC--CCccceEEEEEeC---CeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH--QHIVTMLDFLWDE---RYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~---~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      |+.+++|........ .....+.+|+.+++.+++  .++++++.+....   +..+++|||++|.++.+.+.. ..++..
T Consensus        22 g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~   99 (223)
T cd05154          22 GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPE   99 (223)
T ss_pred             CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHH
Confidence            578999987654321 123467899999999965  4568888776553   367899999999888775432 346666


Q ss_pred             HHHHHHHHHHHHHHHHHh--------------------------------------------------------CCcEEc
Q psy6508          79 QCQQFVRQLVLALKFLRE--------------------------------------------------------NNVCHF  102 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~--------------------------------------------------------~givHr  102 (477)
                      ....++.+++.+|..||+                                                        ..++|+
T Consensus       100 ~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~Hg  179 (223)
T cd05154         100 ERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHG  179 (223)
T ss_pred             HHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEEC
Confidence            777777777777777773                                                        236899


Q ss_pred             cCCCCceeeccC-cceeeccccccee
Q psy6508         103 DLKPQNILIKNN-TLKLAGLKQGVSE  127 (477)
Q Consensus       103 Dlkp~NIll~~~-~~rl~~~dfG~~~  127 (477)
                      |++|.||+++++ .-....+||+.+.
T Consensus       180 D~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         180 DYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             CCCcccEEEcCCCCcEEEEEeccccc
Confidence            999999999873 2233456887664

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG1185 Pnp Polyribonucleotide nucleotidyltransferase (polynucleotide phosphorylase) [Translation, ribosomal structure and biogenesis]

Probab=98.46  E-value=4.1e-06  Score=87.34  Aligned_cols=202  Identities=17%  Similarity=0.219  Sum_probs=144.5

Q ss_pred             eeeccccc-ceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEee--ecccc-ccccCCCCCcchH
Q psy6508         117 KLAGLKQG-VSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKF--APFAS-QIRTGWLRDSEEK  192 (477)
Q Consensus       117 rl~~~dfG-~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~--~Pf~~-~~r~~~~~~~~~~  192 (477)
                      |.+.+..| ++++++|+.....|.|.+.+.+-++. ...+.   |+ +-+-+=+-|-.|  .-+++ -.++...+...+.
T Consensus        14 ~~l~~etg~~A~qa~gav~~~~gdt~vl~t~~~~~-~~~~~---dF-~PLtV~y~Ek~yaaGkiPGgf~kREGrpse~e~   88 (692)
T COG1185          14 RTLTLETGKIARQANGAVLVRYGDTVVLATVVASK-PKEGQ---DF-FPLTVNYEEKTYAAGKIPGGFFKREGRPSEKEI   88 (692)
T ss_pred             eeEEEEcchhhhhcCccEEEEECCeEEEEEEeecC-CCCCC---Cc-cceeEeeeeehhccCcCCCcccccCCCCCccch
Confidence            33445666 45678999999999999999988876 44444   55 444333333322  11111 1233335556666


Q ss_pred             HHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCch--HHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCCh
Q psy6508         193 ELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSA--LSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVE  270 (477)
Q Consensus       193 ~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~--~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~  270 (477)
                      ..++++.+.++|..  ..--+..++|...++..|+..  -..+++++++||.-++||....++++.++.++|..+++|+.
T Consensus        89 L~sRLIDRpiRPlF--p~g~~~evqIv~tvls~D~~~~pdi~a~~gaSaAl~is~iPf~gpi~~vrvg~idg~~vlNPt~  166 (692)
T COG1185          89 LTSRLIDRPIRPLF--PKGFRNEVQIVNTVLSVDPENDPDILAMVGASAALSLSGIPFLGPIGAVRVGYIDGIFVLNPTL  166 (692)
T ss_pred             hhhhhccccccccc--chhhccceEEEEEEEEECCCCCHHHHHHHHHHHHHhccCCCccCccceEEEEEECCEEEECCCh
Confidence            67777777766554  222355688899999999864  45689999999999999999999999999999999999999


Q ss_pred             HHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee-ecHHHHHHHHHHHHhcccchhhHHHHhHh
Q psy6508         271 EEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT-IQQERLADHIEQLIGCCESLCTDRVQKLV  338 (477)
Q Consensus       271 ~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~-~~~~~~~~~l~~~~~~~~~i~~~~i~~~l  338 (477)
                      +|.+.            +.+-+.+..+.+.|..++.... ++.+.+.+++..+.+..+.+.+. +.+..
T Consensus       167 ~e~~~------------s~lDlvVAGT~~aV~MVE~~a~~l~E~~ml~Av~fg~~~~~~~~~~-qe~l~  222 (692)
T COG1185         167 EELEE------------SKLDLVVAGTKDAVNMVESEADELDEEVMLEAVEFGHEAIQSVINA-QEELA  222 (692)
T ss_pred             HHhhh------------cceeeEecCChhhhheeecccccCCHHHHHHHHHHHHHHHHHHHHH-HHHHH
Confidence            99873            3444444455557888888754 67889999999999999999888 44433

>KOG0601|consensus

Probab=98.39  E-value=3.1e-07  Score=94.42  Aligned_cols=166  Identities=21%  Similarity=0.153  Sum_probs=118.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .++..|++|.+.+..........-..|+.+...+ .|.++++++..|......|+-.|||+++++.....-...+.+...
T Consensus       289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~  368 (524)
T KOG0601|consen  289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPR  368 (524)
T ss_pred             CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchh
Confidence            4567788888766655444334456788888777 599999999988888888899999999998877755457888999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccc-cccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF-EPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y-~ppE~~~~~---  156 (477)
                      +++..|++.++.++|+..++|+|+||+||++..+..-....+||+....    .+..+....+...| .++......   
T Consensus       369 ~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~----~~~~~~~~~~~r~~p~~~~~~e~~~~~  444 (524)
T KOG0601|consen  369 LRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL----AFSSGVFHHIDRLYPIAEILLEDYPHL  444 (524)
T ss_pred             hhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc----ceecccccccccccccchhhccccccc
Confidence            9999999999999999999999999999999764322223356554321    11222222223334 233333332   


Q ss_pred             CcccccCcceEEEEEE
Q psy6508         157 TSLEYQRSKGELYVEF  172 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~  172 (477)
                      ..+|+ +++|.-+.+.
T Consensus       445 ~~~~~-~sl~~~~~e~  459 (524)
T KOG0601|consen  445 SKADI-FSLGLSVDEA  459 (524)
T ss_pred             ccccc-cccccccccc
Confidence            66788 9999888887

>KOG0783|consensus

Probab=98.36  E-value=8.1e-08  Score=100.34  Aligned_cols=88  Identities=23%  Similarity=0.214  Sum_probs=71.9

Q ss_pred             CcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccC--CCCHHHHHHHhhhhh-cCceeeCc----
Q psy6508         355 GLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL--DITPEAFSTMLDSDH-HARVNISS----  427 (477)
Q Consensus       355 ~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~--~~~~~~~~~~l~~~Y-tg~~~~~~----  427 (477)
                      .+.-|+.+...+|   ++|+|||.+|+||++||..||..-|.|.+.+...  -++.+.++.+|+|+| +.+..+-.    
T Consensus       708 ~e~~d~~i~~KDG---kvl~aHkc~L~aRlEYF~smf~~~w~E~sS~t~~~~p~~~e~m~ivLdylYs~d~~~~~k~~~~  784 (1267)
T KOG0783|consen  708 EETMDTVIKLKDG---KVLKAHKCFLSARLEYFSSMFQFVWMESSSITVNLSPLTVEHMSIVLDYLYSDDKVELFKDLKE  784 (1267)
T ss_pred             ccceeEEEEecCC---cCcccceeEeeeHHHHHHHHHHHHHhhhccceeecCcchHHHHHHHHHHHHccchHHHHhccch
Confidence            5566777777654   8899999999999999999999999997766555  456999999999999 66665533    


Q ss_pred             -cchhhhhhccccceeecc
Q psy6508         428 -DHHARVSISSDHHTRVSI  445 (477)
Q Consensus       428 -~~~~~~~~~a~~~~~~~~  445 (477)
                       +-+..++..||.++|.++
T Consensus       785 ~dF~~~il~iaDqlli~~L  803 (1267)
T KOG0783|consen  785 SDFMFEILSIADQLLILEL  803 (1267)
T ss_pred             hhhhHHHHHHHHHHHHHHH
Confidence             347789999998888765

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.34  E-value=3.6e-06  Score=77.56  Aligned_cols=114  Identities=18%  Similarity=0.238  Sum_probs=73.1

Q ss_pred             CCcEEEEEEcccCCCChh-HHHH------HHHHHHHHHhcCC---CCccceEEEEE-----eCCeEEEEEecCCCCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSEN-RFDS------IVNEIKALKLLHH---QHIVTMLDFLW-----DERYVYIILEYCDGGDLCS   67 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~-~~~~------~~~E~~il~~l~H---pnIv~~~~~~~-----~~~~~~lv~e~~~g~sL~~   67 (477)
                      +|+.+.+|..+.+..-.+ ....      ..+++..+.+++.   -....++-+.+     -....+++|||++|..|.+
T Consensus        53 ~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d  132 (229)
T PF06176_consen   53 DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELND  132 (229)
T ss_pred             CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEEecCeeccc
Confidence            467788887655432211 1111      2344444444432   23333333322     2245679999999988876


Q ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccce
Q psy6508          68 FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVS  126 (477)
Q Consensus        68 ~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~  126 (477)
                      ...    +++    .+...+.+++.-+|+.|+.|+|.+|.|+++++++++++  ||+.-
T Consensus       133 ~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~i~iI--D~~~k  181 (229)
T PF06176_consen  133 IED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNGIRII--DTQGK  181 (229)
T ss_pred             chh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCcEEEE--ECccc
Confidence            532    333    24456778899999999999999999999999998877  77654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG1266|consensus

Probab=98.33  E-value=1.9e-07  Score=89.11  Aligned_cols=140  Identities=20%  Similarity=0.273  Sum_probs=98.7

Q ss_pred             HHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhC--C
Q psy6508          30 KALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHE----KLSEFQCQQFVRQLVLALKFLREN--N   98 (477)
Q Consensus        30 ~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~----~l~~~~~~~i~~qi~~aL~~LH~~--g   98 (477)
                      ..|-++-|.||++++.+|.+.     ....+++||++.|+|.++|++..    .+......+|+.||+.||.|||+.  -
T Consensus       119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp  198 (458)
T KOG1266|consen  119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP  198 (458)
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence            334556799999999998654     35899999999999999998643    588999999999999999999986  6


Q ss_pred             cEEccCCCCceeeccCcceeecccccceecccCCccc-ccCCe--EEEeccccccccCCCC---CcccccCcceEEEEEE
Q psy6508          99 VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-EQGNT--KVICSVFEPREIPSSK---TSLEYQRSKGELYVEF  172 (477)
Q Consensus        99 ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-~~g~t--~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~  172 (477)
                      |+|+++....|++..+++-.+  +.+.-.....+... ....+  ..+.+.|.+||.-...   .++|| |++|...+||
T Consensus       199 iihgnlTc~tifiq~ngLIki--g~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dI-y~fgmcAlem  275 (458)
T KOG1266|consen  199 IIHGNLTCDTIFIQHNGLIKI--GSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDI-YKFGMCALEM  275 (458)
T ss_pred             cccCCcchhheeecCCceEEe--cccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhh-hhhhHHHHHH
Confidence            999999999999987764333  22221111111110 00011  2234457777653322   67899 9999777777

>KOG3741|consensus

Probab=98.29  E-value=2.7e-06  Score=86.18  Aligned_cols=116  Identities=15%  Similarity=0.232  Sum_probs=90.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEE----eCCeEEEEEecCCC-CCHHHHHHh-----
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW----DERYVYIILEYCDG-GDLCSFIRS-----   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~----~~~~~~lv~e~~~g-~sL~~~l~~-----   71 (477)
                      -+|..|++|++.......  ...-..-++.++++.|+|+|++.++|.    .+..+++|++|.++ ++|.++.-.     
T Consensus       299 ~DG~~YvLkRlhg~r~~~--~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t  376 (655)
T KOG3741|consen  299 VDGNAYVLKRLHGDRDQS--TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFT  376 (655)
T ss_pred             cCCceeeeeeeccccccC--cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccc
Confidence            478999999984332211  112235688899999999999999886    34579999999875 677776521     


Q ss_pred             ----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceee
Q psy6508          72 ----------HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA  119 (477)
Q Consensus        72 ----------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~  119 (477)
                                +...++..++.++.|+..||.++|+.|+.-+-|.|.+|+++.+ .+|+.
T Consensus       377 ~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS  435 (655)
T KOG3741|consen  377 KRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRIS  435 (655)
T ss_pred             cccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEe
Confidence                      1247889999999999999999999999999999999999887 44444

>KOG0783|consensus

Probab=98.29  E-value=4.7e-07  Score=94.77  Aligned_cols=65  Identities=28%  Similarity=0.452  Sum_probs=55.0

Q ss_pred             CcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCC------------cccCCCCHHHHHHHhhhhhc
Q psy6508         355 GLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGD------------TKILDITPEAFSTMLDSDHH  420 (477)
Q Consensus       355 ~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~------------~~~~~~~~~~~~~~l~~~Yt  420 (477)
                      ..+.||+|.||+    +-|+|||-||+++|++||.+|......  .+.            +...++.|..|+.+|+|+||
T Consensus       556 ds~hDVtf~vg~----~~F~aHKfIl~~rs~flrkL~l~~~~~s~~~dIY~~~~~~~~~~~~ve~i~p~mfe~lL~~iYt  631 (1267)
T KOG0783|consen  556 DSFHDVTFYVGT----SMFHAHKFILCARSSFLRKLLLQKKKSSVSNDIYIEEITQSHSTIRVEDIPPLMFEILLHYIYT  631 (1267)
T ss_pred             cccceEEEEecC----eecccceEEEEeccHHHHHHHHhhccccccceeeeecccccCceeeeccCCHHHHHHHHHHHhc
Confidence            468899999999    999999999999999999999665432  222            24678999999999999999


Q ss_pred             Cce
Q psy6508         421 ARV  423 (477)
Q Consensus       421 g~~  423 (477)
                      +++
T Consensus       632 dt~  634 (1267)
T KOG0783|consen  632 DTL  634 (1267)
T ss_pred             ccc
Confidence            953

>PRK09902 hypothetical protein; Provisional

Probab=98.18  E-value=2.3e-05  Score=72.02  Aligned_cols=123  Identities=18%  Similarity=0.115  Sum_probs=86.4

Q ss_pred             CcEEEEEEcccCC-CC---hhHHHHHHHHHHHHHhcCC--CCccceEEEEEe----CCeEEEEEecCCC-CCHHHHHHhC
Q psy6508           4 HTEVAIKCIDKTK-VS---ENRFDSIVNEIKALKLLHH--QHIVTMLDFLWD----ERYVYIILEYCDG-GDLCSFIRSH   72 (477)
Q Consensus         4 g~~vAiK~i~~~~-~~---~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~----~~~~~lv~e~~~g-~sL~~~l~~~   72 (477)
                      |+.+=+|.-.... -+   +-....|.+|+..|++|..  -.+++.......    ....+||+|-++| .+|.+++.+.
T Consensus        41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~  120 (216)
T PRK09902         41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQH  120 (216)
T ss_pred             CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcC
Confidence            3456677654111 01   2234679999999999842  235555522221    1247899997654 7899988663


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeec-cCcceeecccccce
Q psy6508          73 --EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQGVS  126 (477)
Q Consensus        73 --~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~-~~~~rl~~~dfG~~  126 (477)
                        .+.+......++.+++..+.-||+.|+.|+|+.|.||+++ .++..+..+||-..
T Consensus       121 ~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        121 AVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             CcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence              2457777889999999999999999999999999999997 45544666687654

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.97  E-value=3.3e-05  Score=72.89  Aligned_cols=92  Identities=16%  Similarity=0.266  Sum_probs=69.7

Q ss_pred             HHHHHHHHHHHhcCCC--CccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcE
Q psy6508          23 DSIVNEIKALKLLHHQ--HIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVC  100 (477)
Q Consensus        23 ~~~~~E~~il~~l~Hp--nIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv  100 (477)
                      ....+|...|++|...  .+++.+++    +...+|||+++|..|...     +++......++..|+.-+.-+-..|+|
T Consensus       154 l~A~rEf~~L~~L~~~G~~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiV  224 (304)
T COG0478         154 LAAEREFEALQRLYPEGVKVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIV  224 (304)
T ss_pred             HHHHHHHHHHHHhhhcCCCCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCcc
Confidence            3467999999999655  78888775    456899999998666543     224555666777777777777789999


Q ss_pred             EccCCCCceeeccC-cceeecccccc
Q psy6508         101 HFDLKPQNILIKNN-TLKLAGLKQGV  125 (477)
Q Consensus       101 HrDlkp~NIll~~~-~~rl~~~dfG~  125 (477)
                      |+|+.+-||+++++ ++.++  ||--
T Consensus       225 HGDlSefNIlV~~dg~~~vI--DwPQ  248 (304)
T COG0478         225 HGDLSEFNILVTEDGDIVVI--DWPQ  248 (304)
T ss_pred             ccCCchheEEEecCCCEEEE--eCcc
Confidence            99999999999876 55554  7753

>KOG4682|consensus

Probab=97.95  E-value=6.5e-06  Score=80.14  Aligned_cols=91  Identities=22%  Similarity=0.153  Sum_probs=79.2

Q ss_pred             HHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCC--c--ccC--CCCHHHHHHHhhhhhcCc
Q psy6508         349 RYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGD--T--KIL--DITPEAFSTMLDSDHHAR  422 (477)
Q Consensus       349 ~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~--~--~~~--~~~~~~~~~~l~~~Ytg~  422 (477)
                      ..+|.+|.-+||.+.+-|    .+++.||.=|+ .|+||.+||.|-++|.+.  |  +|+  .++.++|...+--+|.++
T Consensus        61 q~lf~q~enSDv~l~alg----~eWrlHk~yL~-QS~yf~smf~Gtw~es~~~iIqleI~Dp~Id~~al~~a~gsLY~dE  135 (488)
T KOG4682|consen   61 QNLFLQGENSDVILEALG----FEWRLHKPYLF-QSEYFKSMFSGTWKESSMNIIQLEIPDPNIDVVALQVAFGSLYRDE  135 (488)
T ss_pred             HHHHhcCCCcceehhhcc----ceeeeeeeeee-ccHHHHHHhccccChhhCceEEEEcCCCcccHHHHHHHHhhhhhhh
Confidence            347889999999999999    99999999986 689999999999999433  3  454  689999999999999999


Q ss_pred             eeeCccchhhhhhccccceeec
Q psy6508         423 VNISSDHHARVSISSDHHTRVS  444 (477)
Q Consensus       423 ~~~~~~~~~~~~~~a~~~~~~~  444 (477)
                      +.+..+.+..|+-||-++..-+
T Consensus       136 veI~l~dv~gvlAaA~~lqldg  157 (488)
T KOG4682|consen  136 VEIKLSDVVGVLAAACLLQLDG  157 (488)
T ss_pred             eeccHHHHHHHHHHHHHHHHhh
Confidence            9999999999999997665444

>KOG1067|consensus

Probab=97.89  E-value=6.7e-05  Score=76.07  Aligned_cols=197  Identities=19%  Similarity=0.224  Sum_probs=126.1

Q ss_pred             eeecccccce-ecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEEeeeccccccccCCCCCcchH
Q psy6508         117 KLAGLKQGVS-EKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEK  192 (477)
Q Consensus       117 rl~~~dfG~~-~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~  192 (477)
                      |.+.+..|.. +.++|+.....|.|.+.+.+-.+--.-.++   -.+|++    .=.+-.|..|-..-.| ...+...+.
T Consensus        56 R~i~~etGklaRfAngsvvv~~GeT~Vm~Tv~~a~~PSp~qFlPL~VdYq----eK~aAvGRip~~fmRR-Eg~tkdkEi  130 (760)
T KOG1067|consen   56 REILFETGKLARFANGSVVVQMGETAVMTTVVLADKPSPPQFLPLVVDYQ----EKFAAVGRIPGNFMRR-EGRTKDKEI  130 (760)
T ss_pred             eEEEEecchhhhhcCCcEEEccCCeEEEEEEEecCCCCccccceEEEehh----hhhhhhccCCCccccc-ccCCcchhh
Confidence            5555666654 568899999999999988764332111111   111110    0000012222221112 112223333


Q ss_pred             HHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchH--HHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCCh
Q psy6508         193 ELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSAL--SAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVE  270 (477)
Q Consensus       193 ~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~--~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~  270 (477)
                      ...+++.+.+.|......  ....++...+|..||-..  .-++|+++.||.-.-||....+.++-+++++|+.+++||.
T Consensus       131 L~~rLidrsirplfp~g~--~~etqi~~n~Ls~dG~~~pdvlainaas~Al~lsdvpw~gpig~vRigLi~Ge~vVNPT~  208 (760)
T KOG1067|consen  131 LTGRLIDRPIRPLFPKGF--YHETQILCNVLSSDGVHDPDVLAINAASAALSLSDVPWNGPIGAVRIGLIDGEFVVNPTR  208 (760)
T ss_pred             eeeeccccccccCCcccc--hhHHHHHhhheecccccCchHHHHhHHHHHhhhccCCCCCceeeeEeeeecceEEeCcch
Confidence            334555555544442222  234556678888888543  3479999999999999999999999999999999999999


Q ss_pred             HHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee-ecHHHHHHHHHHHHhcccchhhH
Q psy6508         271 EEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT-IQQERLADHIEQLIGCCESLCTD  332 (477)
Q Consensus       271 ~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~-~~~~~~~~~l~~~~~~~~~i~~~  332 (477)
                      .|.+.            +.+.+.+....++++.++..+. +.++.|..++..+...+.++..-
T Consensus       209 kEmss------------S~Lnlvvagt~~~~vmle~~s~~i~qqdl~~Aikvg~~~~q~~i~~  259 (760)
T KOG1067|consen  209 KEMSS------------SQLNLVVAGTKSQTVMLEGSSNNILQQDLLHAIKVGVKEAQQIIQG  259 (760)
T ss_pred             hhhhh------------ccceeEEEeccceEEEEEcccccccHHHHHHHHHhccHHHHHHHHH
Confidence            99883            3444444455788888888765 67888899999888888877665

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.75  E-value=0.00049  Score=63.16  Aligned_cols=115  Identities=18%  Similarity=0.342  Sum_probs=80.0

Q ss_pred             CCcEEEEEEcccCC--------------CChhHHHHHHHHHHHHHhcC------CCCccceEEEEEeCCeEEEEEecCC-
Q psy6508           3 QHTEVAIKCIDKTK--------------VSENRFDSIVNEIKALKLLH------HQHIVTMLDFLWDERYVYIILEYCD-   61 (477)
Q Consensus         3 ~g~~vAiK~i~~~~--------------~~~~~~~~~~~E~~il~~l~------HpnIv~~~~~~~~~~~~~lv~e~~~-   61 (477)
                      +.....||++....              .......+..+|+.-...+.      +.+|.+++|+.+++--..+|+|.+. 
T Consensus        22 ~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d  101 (199)
T PF10707_consen   22 DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRD  101 (199)
T ss_pred             CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEEC
Confidence            44556788887765              11122455667777666665      7899999999999888899999642 


Q ss_pred             -----CCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc---Ccceeeccc
Q psy6508          62 -----GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLAGLK  122 (477)
Q Consensus        62 -----g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~---~~~rl~~~d  122 (477)
                           ..+|.++++.. .+++ .....+.   +-.+||-+.+|+.+|++|.||++..   +..+++.+|
T Consensus       102 ~dG~~s~TL~~~l~~~-~~~~-~~~~~L~---~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  102 ADGNISPTLEDYLKEG-GLTE-ELRQALD---EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLID  165 (199)
T ss_pred             CCCCcCccHHHHHHcC-CccH-HHHHHHH---HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEe
Confidence                 26788888653 4665 4444333   3356788999999999999999953   233566555

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG0606|consensus

Probab=97.74  E-value=2.7e-06  Score=92.48  Aligned_cols=152  Identities=19%  Similarity=0.195  Sum_probs=107.4

Q ss_pred             HHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCC
Q psy6508          26 VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLK  105 (477)
Q Consensus        26 ~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlk  105 (477)
                      ..+-.++-..++|.+++..-.+......+|+++|..|++|...++.-+..+..-.+.....+.+++++||+..+.|||++
T Consensus       852 r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~  931 (1205)
T KOG0606|consen  852 RSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLK  931 (1205)
T ss_pred             CCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhccccc
Confidence            33333333345566665554455667899999999999999999987778888888889999999999999999999999


Q ss_pred             CCceeeccCcceeecccccc------eecccCC--------cc----------ccc-----CCeEEEeccccccccCCCC
Q psy6508         106 PQNILIKNNTLKLAGLKQGV------SEKAKGS--------AY----------IEQ-----GNTKVICSVFEPREIPSSK  156 (477)
Q Consensus       106 p~NIll~~~~~rl~~~dfG~------~~~~~gs--------~~----------~~~-----g~t~v~~~~y~ppE~~~~~  156 (477)
                      |.|+++..+..+.. .+||.      .....+.        .+          ...     ....++++-|.+||...+.
T Consensus       932 p~~~l~~~~gh~~l-~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~ 1010 (1205)
T KOG0606|consen  932 PDSLLIAYDGHRPL-TDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGR 1010 (1205)
T ss_pred             ccchhhcccCCccc-CccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccc
Confidence            99999965433322 24431      1111111        00          001     1234567779999988776


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         ..+|+ |+.|+.++|.  +..||..
T Consensus      1011 ~hgs~ad~-~~~g~~l~e~l~g~pp~na 1037 (1205)
T KOG0606|consen 1011 RHGSAADW-WSSGVCLFEVLTGIPPFNA 1037 (1205)
T ss_pred             cCCCcchh-hhhhhhhhhhhcCCCCCCC
Confidence               77899 9999999998  5566663

>KOG2838|consensus

Probab=97.74  E-value=3.1e-05  Score=71.72  Aligned_cols=79  Identities=15%  Similarity=0.187  Sum_probs=65.6

Q ss_pred             ccccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCC----cccCCCCHHHHHHHhh
Q psy6508         341 HVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGD----TKILDITPEAFSTMLD  416 (477)
Q Consensus       341 ~~~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~----~~~~~~~~~~~~~~l~  416 (477)
                      .-++++.+...++...-+|+.+....    ..|+|||++||+|+|+|+-+.+++......    ++.-+++.+.|+++|.
T Consensus       114 a~sf~kD~ad~ye~k~c~dldiiFke----TcfpahRA~laaRCpffK~l~nsd~e~~ae~i~dik~ag~dm~~feafLh  189 (401)
T KOG2838|consen  114 ANSFLKDFADGYERKVCGDLDIIFKE----TCFPAHRAFLAARCPFFKILANSDEEPEAEDICDIKFAGFDMDAFEAFLH  189 (401)
T ss_pred             hhHHHHHHhhhhheeeeccceeeeee----ccchHHHHHHHhhCcchhhhccCCCCcchhhhhhhhhhccChHHHHHHHH
Confidence            33466777777777888999999998    889999999999999999998877544333    3556899999999999


Q ss_pred             hhhcCce
Q psy6508         417 SDHHARV  423 (477)
Q Consensus       417 ~~Ytg~~  423 (477)
                      |.|||+-
T Consensus       190 ~l~tgEf  196 (401)
T KOG2838|consen  190 SLITGEF  196 (401)
T ss_pred             HHHhccc
Confidence            9999985

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.72  E-value=0.00015  Score=75.87  Aligned_cols=101  Identities=15%  Similarity=0.227  Sum_probs=64.9

Q ss_pred             HHHHHHHHHhcC-----CCC--ccceEEEEEeCCeEEEEEecCCCCCHHHHH--HhCCCCCHHHHHHHHHHHHHHHHHHH
Q psy6508          25 IVNEIKALKLLH-----HQH--IVTMLDFLWDERYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLR   95 (477)
Q Consensus        25 ~~~E~~il~~l~-----Hpn--Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l--~~~~~l~~~~~~~i~~qi~~aL~~LH   95 (477)
                      +.+|...+.+++     .|+  |+++|  ++-.+.-.|+|||++|-.+.+..  +. ..++.+.+.....++  -+..+-
T Consensus       208 y~~EA~n~~~~~~nf~~~~~v~VP~V~--we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~  282 (517)
T COG0661         208 YRREAANAERFRENFKDDPDVYVPKVY--WEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLL  282 (517)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEeceee--hhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHH
Confidence            556666666652     232  33333  23344568999999999888874  44 345544433322222  123334


Q ss_pred             hCCcEEccCCCCceeeccCcceeecccccceecccC
Q psy6508          96 ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKG  131 (477)
Q Consensus        96 ~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~g  131 (477)
                      ..|+.|.|.+|.||+++.+ .+++.+|||+....+.
T Consensus       283 ~dgffHaDpHpGNi~v~~~-g~i~~lDfGi~g~l~~  317 (517)
T COG0661         283 RDGFFHADPHPGNILVRSD-GRIVLLDFGIVGRLDP  317 (517)
T ss_pred             hcCccccCCCccceEEecC-CcEEEEcCcceecCCH
Confidence            5899999999999999887 3777789999865543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.68  E-value=0.00022  Score=66.65  Aligned_cols=120  Identities=16%  Similarity=0.161  Sum_probs=82.0

Q ss_pred             CCCcEEEEEEcccCCCChhH----------------------HHHHHHHHHHHHhcC--CCCccceEEEEEeCCeEEEEE
Q psy6508           2 EQHTEVAIKCIDKTKVSENR----------------------FDSIVNEIKALKLLH--HQHIVTMLDFLWDERYVYIIL   57 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~----------------------~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv~   57 (477)
                      .++..||+|+.+.....-..                      ..-..+|+..|+++.  +-.+++-+.+..    -.|||
T Consensus        70 ~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~----nVLvM  145 (268)
T COG1718          70 GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN----NVLVM  145 (268)
T ss_pred             CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC----CeEEE
Confidence            35789999998765332111                      112467899999883  566777776643    36999


Q ss_pred             ecCCCC-CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceec
Q psy6508          58 EYCDGG-DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEK  128 (477)
Q Consensus        58 e~~~g~-sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~  128 (477)
                      ||+... .-.-.|+.- .+...+...+..++++.+.-|-. .|+||+||..-|||+.++++.++  |+|-+..
T Consensus       146 EfIg~~g~pAP~LkDv-~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~~~~p~iI--D~~QaV~  215 (268)
T COG1718         146 EFIGDDGLPAPRLKDV-PLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVHDGEPYII--DVSQAVT  215 (268)
T ss_pred             EeccCCCCCCCCcccC-CcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEECCeEEEE--ECccccc
Confidence            998532 111112221 23344788889999999998877 89999999999999997766555  8886643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.66  E-value=0.00054  Score=64.48  Aligned_cols=57  Identities=16%  Similarity=0.102  Sum_probs=41.8

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCC--CccceEEEEEeCCeEEEEEecCCCCC
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQ--HIVTMLDFLWDERYVYIILEYCDGGD   64 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hp--nIv~~~~~~~~~~~~~lv~e~~~g~s   64 (477)
                      |..+++|......    ......+|.++++.+..-  -+++.+++....+..+++||+++|.+
T Consensus        22 ~~~~VlR~~~~~~----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172        22 TGKWMLKLYNPGF----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             CCCEEEEeCCCCC----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            4467788765432    223468899999999533  35788888888888899999999863

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.49  E-value=0.00081  Score=63.93  Aligned_cols=60  Identities=12%  Similarity=0.179  Sum_probs=44.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSF   68 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~   68 (477)
                      +..+.+|......     ...+.+|+.+++.+. +--+++++++....+..++|||+++|.+|.+.
T Consensus        22 ~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          22 NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            3577888765432     234668999998883 45577888887776778999999998887754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=97.41  E-value=7e-06  Score=89.79  Aligned_cols=78  Identities=15%  Similarity=0.215  Sum_probs=53.4

Q ss_pred             EEccCCCC-ceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--e
Q psy6508         100 CHFDLKPQ-NILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--K  173 (477)
Q Consensus       100 vHrDlkp~-NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~  173 (477)
                      -+++.+|. |++++... .....+||...............+.++|+.|++||++.+.   .++|+ |++|+++||+  +
T Consensus       499 ~~~~~~p~~~~~~~p~~-~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~Di-wSlG~il~ElltG  576 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQ-VKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDW-WALGVCLFEFLTG  576 (669)
T ss_pred             CCCCCCCCCceeECCcc-ccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHH-HHHHHHHHHHHHC
Confidence            35666666 44555444 3345678876554332222233457899999999998766   67899 9999999999  6


Q ss_pred             eecccc
Q psy6508         174 FAPFAS  179 (477)
Q Consensus       174 ~~Pf~~  179 (477)
                      ..||.+
T Consensus       577 ~~pf~~  582 (669)
T cd05610         577 IPPFND  582 (669)
T ss_pred             CCCCCC
Confidence            677763

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PLN02876 acyl-CoA dehydrogenase

Probab=97.24  E-value=0.0022  Score=71.99  Aligned_cols=60  Identities=17%  Similarity=0.263  Sum_probs=41.9

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCc--cceEEEEEeC---CeEEEEEecCCCCCH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHI--VTMLDFLWDE---RYVYIILEYCDGGDL   65 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnI--v~~~~~~~~~---~~~~lv~e~~~g~sL   65 (477)
                      ..+++|+.+..... .....+.+|+.+|+.+. |+++  ++++.++.+.   +..|+||||++|..+
T Consensus        66 ~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         66 KRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             eeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence            46778876543221 12346789999999995 6665  8888877654   467899999997643

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.20  E-value=0.0035  Score=58.48  Aligned_cols=59  Identities=19%  Similarity=0.282  Sum_probs=41.0

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC--CCccceEEEEE---eCCeEEEEEecCCCCCHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH--QHIVTMLDFLW---DERYVYIILEYCDGGDLCS   67 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~---~~~~~~lv~e~~~g~sL~~   67 (477)
                      +.+++|.....    .....+.+|..+++.+..  ..+++++....   .....+++|++++|.++..
T Consensus        21 ~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   21 GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            58899986433    345678899999998842  24677776443   3346799999999988877

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	477
3m7n_D	258	Archaeoglobus Fulgidus Exosome With Rna Bound To Th		2e-19
2ba0_F	258	Archaeal Exosome Core Length = 258		2e-19
2pnz_A	249	Crystal Structure Of The P. Abyssi Exosome Rnase Ph		3e-19
2je6_B	250	Structure Of A 9-Subunit Archaeal Exosome Length =		8e-18
3l7z_B	245	Crystal Structure Of The S. Solfataricus Archaeal E		2e-17
2br2_B	248	Rnase Ph Core Of The Archaeal Exosome Length = 248		3e-17
2nn6_B	249	Structure Of The Human Rna Exosome Composed Of Rrp4		3e-17
2nn6_F	272	Structure Of The Human Rna Exosome Composed Of Rrp4		3e-16
2wnr_B	240	The Structure Of Methanothermobacter Thermautotroph		8e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-15
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		7e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-15
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-14
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-14
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-13
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		3e-13
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-13
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		3e-13
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-13
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		3e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-12
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-12
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-11
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-11
4ifd_B	248	Crystal Structure Of An 11-subunit Eukaryotic Exoso		2e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-11
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		3e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-11
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-11
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		4e-11
2wp8_B	246	Yeast Rrp44 Nuclease Length = 246		4e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-10
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-10
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-10
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-10
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		3e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		7e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		8e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-09
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		1e-09
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-09
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-09
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-09
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-09
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-09
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-09
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-09
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-09
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-09
3kk8_A	284	Camkii Substrate Complex A Length = 284		6e-09
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-09
3kk9_A	282	Camkii Substrate Complex B Length = 282		6e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		7e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		7e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		7e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		8e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		8e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		8e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		9e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		9e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-08
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-08
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		2e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-08
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-08
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-08
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-08
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-08
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-08
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-08
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		3e-08
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-08
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-08
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-08
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		4e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		4e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-08
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-08
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-08
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-08
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-08
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-08
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-08
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-08
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-08
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-08
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		5e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		5e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-08
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		5e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		5e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		7e-08
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-08
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-08
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		7e-08
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		8e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		8e-08
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		8e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-07
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-07
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-07
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		1e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-07
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		2e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-07
3soa_A	444	Full-Length Human Camkii Length = 444		2e-07
1udq_A	255	Crystal Structure Of The Trna Processing Enzyme Rna		3e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-07
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-07
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-07
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-07
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		4e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-07
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-07
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-07
3hkm_A	246	Crystal Structure Of Rice(Oryza Sativa) Rrp46 Lengt		4e-07
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		5e-07
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		5e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-07
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-07
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-07
1uds_A	255	Crystal Structure Of The Trna Processing Enzyme Rna		7e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		7e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		7e-07
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-07
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-07
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		8e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-07
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		8e-07
1udn_A	255	Crystal Structure Of The Trna Processing Enzyme Rna		9e-07
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-07
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-07
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-07
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-07
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		9e-07
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		9e-07
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-07
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		9e-07
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-06
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-06
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-06
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-06
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-06
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-06
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		1e-06
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-06
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-06
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-06
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-06
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-06
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-06
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-06
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-06
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-06
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-06
1udo_A	255	Crystal Structure Of The Trna Processing Enzyme Rna		1e-06
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-06
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-06
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		1e-06
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-06
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		1e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-06
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-06
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-06
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-06
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-06
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-06
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-06
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		3e-06
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-06
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-06
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-06
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-06
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-06
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-06
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-06
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-06
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		6e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		6e-06
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-06
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-06
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		7e-06
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-06
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		7e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-06
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		7e-06
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		8e-06
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		8e-06
3a4o_X	286	Lyn Kinase Domain Length = 286		8e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		8e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		8e-06
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-06
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-06
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-06
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-06
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-06
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		9e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		9e-06
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-06
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-06
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-05
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-05
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-05
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-05
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-05
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-05
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-05
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-05
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-05
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-05
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-05
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-05
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-05
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-05
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-05
4ifd_D	245	Crystal Structure Of An 11-subunit Eukaryotic Exoso		1e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-05
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-05
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		1e-05
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		2e-05
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-05
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-05
3hqi_A	312	Structures Of Spop-Substrate Complexes: Insights In		2e-05
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-05
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-05
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-05
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-05
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-05
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-05
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-05
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-05
4eoz_A	145	Crystal Structure Of The Spop Btb Domain Complexed		2e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
3dd6_A	255	Crystal Structure Of Rph, An Exoribonuclease From B		2e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-05
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-05
2vkp_A	109	Crystal Structure Of Btb Domain From Btbd6 Length =		3e-05
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-05
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-05
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		3e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-05
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-05
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-05
3u1k_A	630	Crystal Structure Of Human Pnpase Length = 630		3e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		4e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-05
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		4e-05
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-05
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-05
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-05
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-05
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-05
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-05
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-05
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		4e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-05
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		4e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		4e-05
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-05
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		5e-05
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-05
2nn6_D	237	Structure Of The Human Rna Exosome Composed Of Rrp4		5e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		5e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		5e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-05
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		5e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		5e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		5e-05
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		5e-05
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		6e-05
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-05
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		6e-05
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-05
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-05
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-05
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-05
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		7e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-05
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-05
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-05
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-05
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		8e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-05
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-05
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-05
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		9e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		9e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		9e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-04
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-04
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-04
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-04
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-04
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-04
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-04
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-04
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		1e-04
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-04
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-04
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-04
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-04
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-04
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-04
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-04
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-04
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-04
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-04
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-04
3b4t_A	262	Crystal Structure Of Mycobacterium Tuberculosis Rna		2e-04
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-04
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-04
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-04
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-04
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-04
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-04
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-04
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-04
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-04
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-04
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		2e-04
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-04
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-04
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-04
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-04
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-04
1oyp_A	245	Crystal Structure Of The Phosphorolytic Exoribonucl		2e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-04
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-04
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		3e-04
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		3e-04
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-04
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-04
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-04
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-04
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-04
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-04
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-04
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		3e-04
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		3e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		3e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-04
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-04
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-04
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-04
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-04
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-04
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-04
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		4e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-04
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-04
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		4e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-04
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-04
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		4e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		4e-04
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		4e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		4e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		4e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-04
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		4e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-04
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		4e-04
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-04
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-04
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		5e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		5e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-04
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-04
1r6m_A	239	Crystal Structure Of The Trna Processing Enzyme Rna		5e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		5e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		5e-04
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		6e-04
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		6e-04
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-04
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-04
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-04
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-04
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-04
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		7e-04
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-04
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		8e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		8e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		8e-04
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		8e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		8e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-04
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		8e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-04
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-04
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		9e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		9e-04
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		9e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		9e-04
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-04

>pdb|3M7N|D Chain D, Archaeoglobus Fulgidus Exosome With Rna Bound To The Active Site Length = 258

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 23/194 (11%)
Query: 99  VCHFDLKPQNILI--------KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR 150
           +  F+ KP+ +++        K + L+   ++  V ++A GS Y+E G  KVI +VF PR
Sbjct: 1   MSEFNEKPEKLIVDGLRLDGRKFDELRPIKIEASVLKRADGSCYLEMGKNKVIAAVFGPR 60
Query: 151 EI-P-----SSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEP 204
           E+ P      SK  + Y+         +  APF+ + R     D    E+    K A E 
Sbjct: 61  EVHPEHLQDPSKAIIRYR---------YNMAPFSVEERKRPGPDRRSIEISKVSKEAFEA 111
Query: 205 AVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLT 264
            + +  F    +D+FV VLQ D  + +A +N A++ALVDA +PM  ++TS  +    G  
Sbjct: 112 VIMKELFPRSAIDIFVEVLQADAGSRTACLNAASVALVDAGVPMKGMITSVAVGKADGQL 171
Query: 265 FIDPVEEEVAYCQS 278
            +DP++EE  + ++
Sbjct: 172 VLDPMKEEDNFGEA 185

>pdb|2BA0|F Chain F, Archaeal Exosome Core Length = 258

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 23/194 (11%)
Query: 99  VCHFDLKPQNILI--------KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR 150
           +  F+ KP+ +++        K + L+   ++  V ++A GS Y+E G  KVI +VF PR
Sbjct: 1   MSEFNEKPEKLIVDGLRLDGRKFDELRPIKIEASVLKRADGSCYLEMGKNKVIAAVFGPR 60
Query: 151 EI-P-----SSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEP 204
           E+ P      SK  + Y+         +  APF+ + R     D    E+    K A E 
Sbjct: 61  EVHPRHLQDPSKAIIRYR---------YNMAPFSVEERKRPGPDRRSIEISKVSKEAFEA 111
Query: 205 AVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLT 264
            + +  F    +D+FV VLQ D  + +A +N A++ALVDA +PM  ++TS  +    G  
Sbjct: 112 VIMKELFPRSAIDIFVEVLQADAGSRTACLNAASVALVDAGVPMKGMITSVAVGKADGQL 171
Query: 265 FIDPVEEEVAYCQS 278
            +DP++EE  + ++
Sbjct: 172 VLDPMKEEDNFGEA 185

>pdb|2PNZ|A Chain A, Crystal Structure Of The P. Abyssi Exosome Rnase Ph Ring Complexed With Udp And Gmp Length = 249

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 66/187 (35%), Positives = 92/187 (49%), Gaps = 18/187 (9%)
Query: 105 KPQNI-LIKNNTLKLAGLKQ----------GVSEKAKGSAYIEQGNTKVICSVFEPREI- 152
           KP+ + LI  N  ++ G K+          GV + A GSAYIE G  K+I +V+ PRE+ 
Sbjct: 4   KPEGLKLIDENGRRIDGRKKYELRPIKMEVGVLKNANGSAYIEWGKNKIIAAVYGPRELH 63
Query: 153 PSSKTSLEYQRS-KGELYVEFKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEF 211
           P        QR  +  L V +  APF+ + R     D    E+   +K ALEPA+    F
Sbjct: 64  PKH-----LQRPDRAILRVRYNMAPFSVEERKKPGPDRRSIEISKVIKGALEPALILEMF 118
Query: 212 SNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEE 271
               +D+F+ VLQ D     A I  A+LAL DA IPM DLV +       G   +D  +E
Sbjct: 119 PRTAIDVFIEVLQADAGTRVAGITAASLALADAGIPMRDLVAACAAGKIEGEIVLDLNKE 178
Query: 272 EVAYCQS 278
           E  Y ++
Sbjct: 179 EDNYGEA 185

>pdb|2JE6|B Chain B, Structure Of A 9-Subunit Archaeal Exosome Length = 250

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 13/237 (5%)
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVE 171
           K + L+   ++ GV + A GSA  E GNTK I +V+ P+E+     SL     +  L V 
Sbjct: 26  KPDELRSIKIELGVLKNADGSAIFEMGNTKAIAAVYGPKEMHPRHLSLP---DRAVLRVR 82
Query: 172 FKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALS 231
           +   PF++  R        E EL   ++ ALE AV    F    +D+F  +LQ D  +  
Sbjct: 83  YHMTPFSTDERKNPAPSRREIELSKVIREALESAVLVELFPRTAIDVFTEILQADAGSRL 142
Query: 232 AAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVIT 291
            ++  A+LAL DA IPM DL+    +    G+  +D  E E  + ++           + 
Sbjct: 143 VSLMAASLALADAGIPMRDLIAGVAVGKADGVIILDLNETEAMWGEA----------DMP 192
Query: 292 LSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERG 348
           ++ M  + QVT   L G++  +      +  +     +     + L S +V   E G
Sbjct: 193 IAMMPSLNQVTLFQLNGSMTPDEFRQAFDLAVKGINIIYNLEREALKSKYVEFKEEG 249

>pdb|3L7Z|B Chain B, Crystal Structure Of The S. Solfataricus Archaeal Exosome Length = 245

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 13/237 (5%)
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVE 171
           K + L+   ++ GV + A GSA  E GNTK I +V+ P+E+     SL     +  L V 
Sbjct: 21  KPDELRSIKIELGVLKNADGSAIFEMGNTKAIAAVYGPKEMHPRHLSLP---DRAVLRVR 77
Query: 172 FKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALS 231
           +   PF++  R        E EL   ++ ALE AV    F    +D+F  +LQ D  +  
Sbjct: 78  YHMTPFSTDERKNPAPSRREIELSKVIREALESAVLVELFPRTAIDVFTEILQADAGSRL 137
Query: 232 AAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVIT 291
            ++  A+LAL DA IPM DL+    +    G+  +D  E E  + ++           + 
Sbjct: 138 VSLMAASLALADAGIPMRDLIAGVAVGKADGVIILDLNETEDMWGEA----------DMP 187
Query: 292 LSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERG 348
           ++ M  + QVT   L G++  +      +  +     +     + L S +V   E G
Sbjct: 188 IAMMPSLNQVTLFQLNGSMTPDEFRQAFDLAVKGINIIYNLEREALKSKYVEFKEEG 244

>pdb|2BR2|B Chain B, Rnase Ph Core Of The Archaeal Exosome Length = 248

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 13/237 (5%)
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVE 171
           K + L+   ++ GV + A GSA  E GNTK I +V+ P+E+     SL     +  L V 
Sbjct: 24  KPDELRSIKIELGVLKNADGSAIFEMGNTKAIAAVYGPKEMHPRHLSLP---DRAVLRVR 80
Query: 172 FKFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALS 231
           +   PF++  R        E EL   ++ ALE AV    F    +D+F  +LQ D  +  
Sbjct: 81  YHMTPFSTDERKNPAPSRREIELSKVIREALESAVLVELFPRTAIDVFTEILQADAGSRL 140
Query: 232 AAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVIT 291
            ++  A+LAL DA IPM DL+    +    G+  +D  E E  + ++           + 
Sbjct: 141 VSLMAASLALADAGIPMRDLIAGVAVGKADGVIILDLNETEDMWGEA----------DMP 190
Query: 292 LSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTLPERG 348
           ++ M  + QVT   L G++  +      +  +     +     + L S +V   E G
Sbjct: 191 IAMMPSLNQVTLFQLNGSMTPDEFRQAFDLAVKGINIIYNLEREALKSKYVEFKEEG 247

>pdb|2NN6|B Chain B, Structure Of The Human Rna Exosome Composed Of Rrp41, Rrp45, Rrp46, Rrp43, Mtr3, Rrp42, Csl4, Rrp4, And Rrp40 Length = 249

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/176 (34%), Positives = 87/176 (49%), Gaps = 4/176 (2%)
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQI 181
           + GV  +A GSAYIEQGNTK +  V+ P EI  S+      R+   +  ++  A F++  
Sbjct: 32  RMGVFAQADGSAYIEQGNTKALAVVYGPHEIRGSRARALPDRAL--VNCQYSSATFSTGE 89
Query: 182 RTGWLR-DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
           R      D +  E+G  L++  E A+        Q+D++V VLQ DG   +A +N A LA
Sbjct: 90  RKRRPHGDRKSCEMGLQLRQTFEAAILTQLHPRSQIDIYVQVLQADGGTYAACVNAATLA 149
Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVE-EEVAYCQSLSSSEDDDSGVITLSYM 295
           ++DA IPM D V + +     G    D    EE A    L+ +    SG I L  M
Sbjct: 150 VLDAGIPMRDFVCACSAGFVDGTALADLSHVEEAAGGPQLALALLPASGQIALLEM 205

>pdb|2NN6|F Chain F, Structure Of The Human Rna Exosome Composed Of Rrp41, Rrp45, Rrp46, Rrp43, Mtr3, Rrp42, Csl4, Rrp4, And Rrp40 Length = 272

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 100/192 (52%), Gaps = 21/192 (10%)
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRS--------KGELYVEFK 173
           + G+  +AKGSAY+E G TKV+C+V  PR+    +       +        +G L  +F+
Sbjct: 42  RAGLLSQAKGSAYLEAGGTKVLCAVSGPRQAEGGERGGGPAGAGGEAPAALRGRLLCDFR 101
Query: 174 FAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAA 233
            APFA + R       EE+EL   L+ ALEPAV    +   Q+++  L+L++ GSAL+AA
Sbjct: 102 RAPFAGRRRRAPPGGCEERELALALQEALEPAVRLGRYPRAQLEVSALLLEDGGSALAAA 161
Query: 234 INCANLALVDAAIPMYDLVTSSTLALRGGLT---FIDPVEEEVAYCQSLSSSEDDDSGVI 290
           +  A LAL DA + MYDLV    L+L  G      +DP   E          E+  +  +
Sbjct: 162 LTAAALALADAGVEMYDLVVGCGLSLAPGPAPTWLLDPTRLE----------EERAAAGL 211
Query: 291 TLSYMSVIQQVT 302
           T++ M V+ QV 
Sbjct: 212 TVALMPVLNQVA 223

>pdb|2WNR|B Chain B, The Structure Of Methanothermobacter Thermautotrophicus Exosome Core Assembly Length = 240

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 5/160 (3%)
Query: 114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRS-KGELYVEF 172
           + L+   ++ G+ E+A GS+Y+E G  K++ +V+ PRE    K     QR  +  +   +
Sbjct: 24  DELRPLKIEAGILERADGSSYLEFGGNKILVAVYGPREAQIRK----LQRPDRAVIRCRY 79
Query: 173 KFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSA 232
             APF+ + R     D    E+      AL PA+   +F    +D+F+ VL+ +G    A
Sbjct: 80  NMAPFSVEERKRPGPDRRSVEISKITAEALRPALILEKFPRSVIDVFIEVLEAEGGTRCA 139
Query: 233 AINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEE 272
            I  A++AL DA IPM D+V +      G    +D  EEE
Sbjct: 140 GITAASVALADAGIPMRDMVVACAAGKVGDQVVLDLSEEE 179

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 69/106 (65%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAIK IDKT+++      +  E++ +K+L+H +IV + + +  E+ +Y+I+EY  GG++
Sbjct: 39  EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV 98
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 99  FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL 144

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 69/106 (65%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAIK IDKT+++      +  E++ +K+L+H +IV + + +  E+ +Y+I+EY  GG++
Sbjct: 42  EVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEV 101
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 102 FDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL 147

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 34/115 (29%), Positives = 74/115 (64%), Gaps = 1/115 (0%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA+K IDKT+++      +  E++ +K+L+H +IV + + +  E+ +Y+++EY  GG++
Sbjct: 42  EVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEV 101
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
             ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+  +  +K+A
Sbjct: 102 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIA 156

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 70/106 (66%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA+K IDKT+++ +    +  E++ +K+L+H +IV + + +  E+ +Y+++EY  GG++
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL 146

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 70/106 (66%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA+K IDKT+++ +    +  E++ +K+L+H +IV + + +  E+ +Y+++EY  GG++
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL 146

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 70/106 (66%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA+K IDKT+++ +    +  E++ +K+L+H +IV + + +  E+ +Y+++EY  GG++
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL 146

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 39/110 (35%), Positives = 66/110 (60%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H E AIK I KT VS +    ++ E+  LKLL H +I+ + DF  D+R  Y+++E   GG
Sbjct: 62  HVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           +L   I    K +E      ++Q++  + +L ++N+ H DLKP+N+L+++
Sbjct: 122 ELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLES 171

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 70/106 (66%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA++ IDKT+++ +    +  E++ +K+L+H +IV + + +  E+ +Y+++EY  GG++
Sbjct: 41  EVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL 146

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 70/106 (66%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA++ IDKT+++ +    +  E++ +K+L+H +IV + + +  E+ +Y+++EY  GG++
Sbjct: 41  EVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 100
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 101 FDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL 146

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 39/121 (32%), Positives = 69/121 (57%), Gaps = 11/121 (9%)
Query: 4   HTEVAIKCIDKTKVSENRF-----------DSIVNEIKALKLLHHQHIVTMLDFLWDERY 52
           H+E AIK I K++  + R+           + I NEI  LK L H +I+ + D   D++Y
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120
Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
            Y++ E+ +GG+L   I +  K  E      ++Q++  + +L ++N+ H D+KP+NIL++
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLE 180
Query: 113 N 113
           N
Sbjct: 181 N 181

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 69/106 (65%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA+K IDKT+++ +    +  E++ +K+L+H +IV + + +  E+ +Y+++EY  GG++
Sbjct: 34  EVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEV 93
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H  + E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 94  FDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL 139

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 67/106 (63%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVA+K IDKT+++ +    +  E++  K+L+H +IV + + +  E+ +Y++ EY  GG++
Sbjct: 41  EVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEV 100
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             ++ +H +  E + +   RQ+V A+++  +  + H DLK +N+L+
Sbjct: 101 FDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLL 146

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 68/111 (61%), Gaps = 1/111 (0%)
Query: 6   EVAIKCIDKTKVSENR-FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K I K +V +    +S++ E++ LK L H +I+ + +F  D+ Y Y++ E   GG+
Sbjct: 76  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 135
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           L   I S ++ SE    + +RQ++  + ++ +N + H DLKP+N+L+++ +
Sbjct: 136 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 186

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 68/111 (61%), Gaps = 1/111 (0%)
Query: 6   EVAIKCIDKTKVSENR-FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K I K +V +    +S++ E++ LK L H +I+ + +F  D+ Y Y++ E   GG+
Sbjct: 77  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 136
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           L   I S ++ SE    + +RQ++  + ++ +N + H DLKP+N+L+++ +
Sbjct: 137 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 187

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 68/112 (60%), Gaps = 7/112 (6%)
Query: 6   EVAIKCIDKTKV---SENRFDSIVN---EIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAIK I K K    S    D  +N   EI+ LK L+H  I+ + +F   E Y YI+LE 
Sbjct: 43  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 101
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+
Sbjct: 102 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 153

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 68/112 (60%), Gaps = 7/112 (6%)
Query: 6   EVAIKCIDKTKV---SENRFDSIVN---EIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAIK I K K    S    D  +N   EI+ LK L+H  I+ + +F   E Y YI+LE 
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 95
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+
Sbjct: 96  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 68/112 (60%), Gaps = 7/112 (6%)
Query: 6   EVAIKCIDKTKV---SENRFDSIVN---EIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAIK I K K    S    D  +N   EI+ LK L+H  I+ + +F   E Y YI+LE 
Sbjct: 36  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 94
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+
Sbjct: 95  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 146

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 68/112 (60%), Gaps = 7/112 (6%)
Query: 6   EVAIKCIDKTKV---SENRFDSIVN---EIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAIK I K K    S    D  +N   EI+ LK L+H  I+ + +F   E Y YI+LE 
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 95
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+
Sbjct: 96  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 43/112 (38%), Positives = 68/112 (60%), Gaps = 7/112 (6%)
Query: 6   EVAIKCIDKTKV---SENRFDSIVN---EIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAIK I K K    S    D  +N   EI+ LK L+H  I+ + +F   E Y YI+LE 
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 95
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+
Sbjct: 96  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 68/111 (61%), Gaps = 1/111 (0%)
Query: 6   EVAIKCIDKTKVSENR-FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K I K +V +    +S++ E++ LK L H +I+ + +F  D+ Y Y++ E   GG+
Sbjct: 53  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           L   I S ++ SE    + +RQ++  + ++ +N + H DLKP+N+L+++ +
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 163

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 17/143 (11%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K ++S +R     + I  E+  L+ + H +I+T+ D   ++  V +ILE   
Sbjct: 32  EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVS 91
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL-----IKNNTL 116
           GG+L  F+   E L+E +  QF++Q++  + +L    + HFDLKP+NI+     + N  +
Sbjct: 92  GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151
Query: 117 KLAGLKQGVSEKAKGSAYIEQGN 139
           KL     G++ K      IE GN
Sbjct: 152 KLIDF--GIAHK------IEAGN 166

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 17/143 (11%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K ++S +R     + I  E+  L+ + H +I+T+ D   ++  V +ILE   
Sbjct: 39  EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVS 98
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL-----IKNNTL 116
           GG+L  F+   E L+E +  QF++Q++  + +L    + HFDLKP+NI+     + N  +
Sbjct: 99  GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 158
Query: 117 KLAGLKQGVSEKAKGSAYIEQGN 139
           KL     G++ K      IE GN
Sbjct: 159 KLIDF--GIAHK------IEAGN 173

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 68/111 (61%), Gaps = 1/111 (0%)
Query: 6   EVAIKCIDKTKVSENR-FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K I K +V +    +S++ E++ LK L H +I+ + +F  D+ Y Y++ E   GG+
Sbjct: 59  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 118
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           L   I S ++ SE    + +RQ++  + ++ +N + H DLKP+N+L+++ +
Sbjct: 119 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKS 169

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 35/111 (31%), Positives = 66/111 (59%), Gaps = 1/111 (0%)
Query: 6   EVAIKCIDKTKVSENR-FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K I K +V +    +S++ E++ LK L H +I  + +F  D+ Y Y++ E   GG+
Sbjct: 53  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGE 112
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           L   I S ++ SE    + +RQ++  + +  +N + H DLKP+N+L+++ +
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKS 163

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/112 (37%), Positives = 68/112 (60%), Gaps = 7/112 (6%)
Query: 6   EVAIKCIDKTKV---SENRFDSIVN---EIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAI+ I K K    S    D  +N   EI+ LK L+H  I+ + +F   E Y YI+LE 
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 220
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 272

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 75/143 (52%), Gaps = 17/143 (11%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K ++  +R     + I  E+  L+ + H +I+T+ D   ++  V +ILE   
Sbjct: 53  EYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVS 112
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL-----IKNNTL 116
           GG+L  F+   E L+E +  QF++Q++  + +L    + HFDLKP+NI+     + N  +
Sbjct: 113 GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 172
Query: 117 KLAGLKQGVSEKAKGSAYIEQGN 139
           KL     G++ K      IE GN
Sbjct: 173 KLIDF--GIAHK------IEAGN 187

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 42/112 (37%), Positives = 68/112 (60%), Gaps = 7/112 (6%)
Query: 6   EVAIKCIDKTKV---SENRFDSIVN---EIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAI+ I K K    S    D  +N   EI+ LK L+H  I+ + +F   E Y YI+LE 
Sbjct: 176 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLEL 234
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+
Sbjct: 235 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 286

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 33/108 (30%), Positives = 61/108 (56%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A+K I+K         +I+ E++ LK L H +I+ + + L D    YI+ E   GG+L
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
              I   ++ SE    + ++Q+   + ++ ++N+ H DLKP+NIL+++
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLES 156

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 67/112 (59%), Gaps = 1/112 (0%)
Query: 5   TEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
            E AIK I K+ V+  +   ++++E+  LK L H +I+ + +F  D+R  Y+++E   GG
Sbjct: 47  AERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG 106
Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           +L   I   +K SE      ++Q++    +L ++N+ H DLKP+N+L+++ +
Sbjct: 107 ELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKS 158

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 67/112 (59%), Gaps = 1/112 (0%)
Query: 5   TEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
            E AIK I K+ V+  +   ++++E+  LK L H +I+ + +F  D+R  Y+++E   GG
Sbjct: 30  AERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGG 89
Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           +L   I   +K SE      ++Q++    +L ++N+ H DLKP+N+L+++ +
Sbjct: 90  ELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKS 141

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 37/121 (30%), Positives = 65/121 (53%), Gaps = 4/121 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K +   +R     + I  E+  L+ + H +I+T+ D   +   V +ILE   
Sbjct: 39  EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVS 98
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E LSE +   F++Q++  + +L    + HFDLKP+NI++ +  + +  +
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 122 K 122
           K
Sbjct: 159 K 159

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 4/121 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K +   +R     + I  E+  L+ + H +++T+ D   +   V +ILE   
Sbjct: 39  EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E LSE +   F++Q++  + +L    + HFDLKP+NI++ +  + +  +
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 122 K 122
           K
Sbjct: 159 K 159

>pdb|4IFD|B Chain B, Crystal Structure Of An 11-subunit Eukaryotic Exosome Complex Bound To Rna Length = 248

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/133 (32%), Positives = 69/133 (51%), Gaps = 5/133 (3%)
Query: 129 AKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRD 188
           A GS+Y+EQGN K+I  V  P+E P  K+ ++   SK  L V      F+   R+     
Sbjct: 38  ADGSSYMEQGNNKIITLVKGPKE-PRLKSQMDT--SKALLNVSVNITKFSKFERSKSSHK 94
Query: 189 SEEK--ELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI 246
           +E +  E+   L R  E  V  + +    +D+ + VL+ DG  + + IN   LAL+DA I
Sbjct: 95  NERRVLEIQTSLVRMFEKNVMLNIYPRTVIDIEIHVLEQDGGIMGSLINGITLALIDAGI 154
Query: 247 PMYDLVTSSTLAL 259
            M+D ++  ++ L
Sbjct: 155 SMFDYISGISVGL 167

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 61/109 (55%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A+K I+K         +I+ E++ LK L H +I+ + + L D    YI+ E   GG+L
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
              I   ++ SE    + ++Q+   + ++ ++N+ H DLKP+NIL+++ 
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 4/121 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K +   +R     + I  E+  L+ + H +++T+ D   +   V +ILE   
Sbjct: 39  EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E LSE +   F++Q++  + +L    + HFDLKP+NI++ +  + +  +
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 122 K 122
           K
Sbjct: 159 K 159

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 61/109 (55%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A+K I+K         +I+ E++ LK L H +I+ + + L D    YI+ E   GG+L
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
              I   ++ SE    + ++Q+   + ++ ++N+ H DLKP+NIL+++ 
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 4/121 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K +   +R     + I  E+  L+ + H +++T+ D   +   V +ILE   
Sbjct: 39  EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E LSE +   F++Q++  + +L    + HFDLKP+NI++ +  + +  +
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 122 K 122
           K
Sbjct: 159 K 159

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 63/107 (58%), Gaps = 1/107 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +++ K+ S +    I  EI+ LKL  H HI+ +   +      ++++EY  GG+
Sbjct: 38  KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L  +I  H ++ E + ++  +Q++ A+ +   + V H DLKP+N+L+
Sbjct: 98  LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL 144

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 39/114 (34%), Positives = 65/114 (57%), Gaps = 5/114 (4%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E  IK I+K + S+   + I  EI+ LK L H +I+ + +   D   +YI++E C+GG+L
Sbjct: 49  ERVIKTINKDR-SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL 107
Query: 66  CSFIRSHE----KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
              I S +     LSE    + ++Q++ AL +    +V H DLKP+NIL ++ +
Sbjct: 108 LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTS 161

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 4/121 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K +   +R     + I  E+  L+ + H +++T+ D   +   V +ILE   
Sbjct: 39  EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E LSE +   F++Q++  + +L    + HFDLKP+NI++ +  + +  +
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 122 K 122
           K
Sbjct: 159 K 159

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 63/107 (58%), Gaps = 1/107 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +++ K+ S +    I  EI+ LKL  H HI+ +   +      ++++EY  GG+
Sbjct: 38  KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L  +I  H ++ E + ++  +Q++ A+ +   + V H DLKP+N+L+
Sbjct: 98  LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL 144

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 4/121 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K +   +R     + I  E+  L+ + H +++T+ D   +   V +ILE   
Sbjct: 39  EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E LSE +   F++Q++  + +L    + HFDLKP+NI++ +  + +  +
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158
Query: 122 K 122
           K
Sbjct: 159 K 159

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 2/103 (1%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+KCI K+     R  S+ NEI  LK + H++IVT+ D      + Y++++   GG+L  
Sbjct: 38  ALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFD 95
Query: 68  FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
            I      +E      ++Q++ A+K+L EN + H DLKP+N+L
Sbjct: 96  RILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLL 138

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 76/147 (51%), Gaps = 16/147 (10%)
Query: 1   NEQHTEVAIKCIDKTKVSEN------RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVY 54
            E++ EV +K I K KV E+      +   +  EI  L  + H +I+ +LD   ++ +  
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQ 105
Query: 55  IILE-YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           +++E +  G DL +FI  H +L E       RQLV A+ +LR  ++ H D+K +NI+I  
Sbjct: 106 LVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAE 165
Query: 114 N-TLKLAGLKQGVSEKAKGSAYIEQGN 139
           + T+KL             +AY+E+G 
Sbjct: 166 DFTIKLIDFGS--------AAYLERGK 184

>pdb|2WP8|B Chain B, Yeast Rrp44 Nuclease Length = 246

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 5/141 (3%)
Query: 129 AKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRD 188
           A GS+Y+EQGN K+I  V  P+E P  K+ ++   SK  L V      F+   R+     
Sbjct: 36  ADGSSYMEQGNNKIITLVKGPKE-PRLKSQMDT--SKALLNVSVNINKFSKFERSKSSHK 92
Query: 189 SEEK--ELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI 246
           +E +  E+   L R  E  V  + +    +D+ + VL+ DG  + + IN   LAL+DA I
Sbjct: 93  NERRVLEIQTSLVRMFEKNVMLNIYPRTVIDIEIHVLEQDGGIMGSLINGITLALIDAGI 152
Query: 247 PMYDLVTSSTLALRGGLTFID 267
            M+D ++  ++ L      +D
Sbjct: 153 SMFDYISGISVGLYDTTPLLD 173

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 68/128 (53%), Gaps = 4/128 (3%)
Query: 6   EVAIKCI-DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VAIK I    +  E        E+     L HQ+IV+M+D   ++   Y+++EY +G  
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL--AGL 121
           L  +I SH  LS      F  Q++  +K   +  + H D+KPQNILI +N TLK+   G+
Sbjct: 98  LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGI 157
Query: 122 KQGVSEKA 129
            + +SE +
Sbjct: 158 AKALSETS 165

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 67/107 (62%), Gaps = 2/107 (1%)
Query: 6   EVAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K I+K  ++++     I  EI  L+LL H HI+ + D +  +  + +++EY  G +
Sbjct: 41  KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNE 99
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L  +I   +K+SE + ++F +Q++ A+++   + + H DLKP+N+L+
Sbjct: 100 LFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL 146

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 67/107 (62%), Gaps = 2/107 (1%)
Query: 6   EVAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K I+K  ++++     I  EI  L+LL H HI+ + D +  +  + +++EY  G +
Sbjct: 40  KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNE 98
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L  +I   +K+SE + ++F +Q++ A+++   + + H DLKP+N+L+
Sbjct: 99  LFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL 145

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 67/107 (62%), Gaps = 2/107 (1%)
Query: 6   EVAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K I+K  ++++     I  EI  L+LL H HI+ + D +  +  + +++EY  G +
Sbjct: 35  KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNE 93
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L  +I   +K+SE + ++F +Q++ A+++   + + H DLKP+N+L+
Sbjct: 94  LFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL 140

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 67/107 (62%), Gaps = 2/107 (1%)
Query: 6   EVAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K I+K  ++++     I  EI  L+LL H HI+ + D +  +  + +++EY  G +
Sbjct: 31  KVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNE 89
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L  +I   +K+SE + ++F +Q++ A+++   + + H DLKP+N+L+
Sbjct: 90  LFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL 136

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 66/117 (56%), Gaps = 3/117 (2%)
Query: 6   EVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           EVAIK IDK  + +      + NE+K    L H  I+ + ++  D  YVY++LE C  G+
Sbjct: 38  EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGE 97
Query: 65  LCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           +  ++++  K  SE + + F+ Q++  + +L  + + H DL   N+L+ +N  +K+A
Sbjct: 98  MNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIA 154

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIR-SHEKLSEFQCQ 81
           +++  EI+ + +L H  +V + D   D+  + +I E+  GG+L   +   H K+SE +  
Sbjct: 199 ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 258
Query: 82  QFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKL 118
           +++RQ+   L  + ENN  H DLKP+NI+    ++N LKL
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKL 298

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 58/100 (58%), Gaps = 4/100 (4%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQ 81
           +++  EI+ + +L H  +V + D   D+  + +I E+  GG+L   +   H K+SE +  
Sbjct: 93  ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAV 152
Query: 82  QFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKL 118
           +++RQ+   L  + ENN  H DLKP+NI+    ++N LKL
Sbjct: 153 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKL 192

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 37  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 97  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 146

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 67/110 (60%), Gaps = 2/110 (1%)
Query: 6   EVAIKCIDKTKVSENRFDSIV-NEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K I +  + ++     V  EI  LKLL H HI+ + D +     + +++EY  GG+
Sbjct: 36  KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGE 94
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +I   ++++E + ++F +Q++ A+++   + + H DLKP+N+L+ +N
Sbjct: 95  LFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN 144

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 37  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 96
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 97  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 146

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 63/107 (58%), Gaps = 1/107 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +++ K+ S +    I  EI+ LKL  H HI+ +   +     +++++EY  GG+
Sbjct: 43  KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE 102
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L  +I  + +L E + ++  +Q++  + +   + V H DLKP+N+L+
Sbjct: 103 LFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL 149

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/110 (30%), Positives = 62/110 (56%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 74/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYM 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GGD+ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +K+A
Sbjct: 124 PGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVA 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 38/135 (28%), Positives = 74/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYM 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GGD+ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +K+A
Sbjct: 124 PGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVA 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 33/103 (32%), Positives = 57/103 (55%), Gaps = 1/103 (0%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+KCI K K  + +  SI NEI  L+ + H++IV + D      ++Y++++   GG+L  
Sbjct: 51  AVKCIPK-KALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFD 109
Query: 68  FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
            I      +E      +RQ++ A+ +L    + H DLKP+N+L
Sbjct: 110 RIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDLKPENLL 152

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 77  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 195

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 77  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 195

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 72/148 (48%), Gaps = 9/148 (6%)
Query: 2   EQHTEVAIKCIDKTKVSEN---RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILE 58
           E   + A+K +D  K + +     + +  E     +L H HIV +L+    +  +Y++ E
Sbjct: 47  ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106
Query: 59  YCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--K 112
           + DG DLC  I          SE     ++RQ++ AL++  +NN+ H D+KP+N+L+  K
Sbjct: 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASK 166
Query: 113 NNTLKLAGLKQGVSEKAKGSAYIEQGNT 140
            N+  +     GV+ +   S  +  G  
Sbjct: 167 ENSAPVKLGDFGVAIQLGESGLVAGGRV 194

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 77  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 137 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 195

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 8/153 (5%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A K ID TK  E   D +V EI  L    H +IV +LD  + E  ++I++E+C GG + +
Sbjct: 66  AAKVID-TKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 68  FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQGV 125
            +   E+ L+E Q Q   +Q + AL +L +N + H DLK  NIL   +  +KLA    GV
Sbjct: 124 VMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADF--GV 181
Query: 126 SEKAKGSAYIEQGNTKVICSVFEPREIPSSKTS 158
           S  AK +  I++ ++ +    +   E+   +TS
Sbjct: 182 S--AKNTRXIQRRDSFIGTPYWMAPEVVMCETS 212

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/123 (38%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A K ID TK  E   D +V EI  L    H +IV +LD  + E  ++I++E+C GG + +
Sbjct: 66  AAKVID-TKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 68  FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQGV 125
            +   E+ L+E Q Q   +Q + AL +L +N + H DLK  NIL   +  +KLA    GV
Sbjct: 124 VMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADF--GV 181
Query: 126 SEK 128
           S K
Sbjct: 182 SAK 184

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 1/104 (0%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIKCI K K  E +  S+ NEI  L  + H +IV + D      ++Y+I++   GG+L 
Sbjct: 46  VAIKCIAK-KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             I      +E    + + Q++ A+K+L +  + H DLKP+N+L
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL 148

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 47/123 (38%), Positives = 68/123 (55%), Gaps = 6/123 (4%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A K ID TK  E   D +V EI  L    H +IV +LD  + E  ++I++E+C GG + +
Sbjct: 66  AAKVID-TKSEEELEDYMV-EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDA 123
Query: 68  FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQGV 125
            +   E+ L+E Q Q   +Q + AL +L +N + H DLK  NIL   +  +KLA    GV
Sbjct: 124 VMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADF--GV 181
Query: 126 SEK 128
           S K
Sbjct: 182 SAK 184

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 30  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 90  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 148

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 74/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +K+A
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVA 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 49  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 109 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 167

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 61/110 (55%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +I E   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVA 97
Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIML 147

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 49  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 109 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 167

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 29  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 88
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 89  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 147

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/120 (28%), Positives = 65/120 (54%), Gaps = 3/120 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 33  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 92
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 93  -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 151

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/122 (36%), Positives = 64/122 (52%), Gaps = 3/122 (2%)
Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E H  VA+K +      E    S + EI  LK L H++IV + D L  ++ + ++ E+CD
Sbjct: 25  ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84
Query: 62  GGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             DL  +  S +  L     + F+ QL+  L F    NV H DLKPQN+LI +N  LKLA
Sbjct: 85  Q-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143
Query: 120 GL 121
Sbjct: 144 NF 145

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 64/120 (53%), Gaps = 3/120 (2%)
Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E H  VA+K +      E    S + EI  LK L H++IV + D L  ++ + ++ E+CD
Sbjct: 25  ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD 84
Query: 62  GGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             DL  +  S +  L     + F+ QL+  L F    NV H DLKPQN+LI +N  LKLA
Sbjct: 85  Q-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLA 143

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 53/88 (60%), Gaps = 1/88 (1%)
Query: 24  SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQ 82
           ++ NEI  +  LHH  ++ + D   D+  + +ILE+  GG+L   I + + K+SE +   
Sbjct: 94  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVIN 153
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNIL 110
           ++RQ    LK + E+++ H D+KP+NI+
Sbjct: 154 YMRQACEGLKHMHEHSIVHLDIKPENIM 181

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 26/78 (33%), Positives = 47/78 (60%)
Query: 37  HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE 96
           H HI+T++D      +++++ +    G+L  ++     LSE + +  +R L+ A+ FL  
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHA 218
Query: 97  NNVCHFDLKPQNILIKNN 114
           NN+ H DLKP+NIL+ +N
Sbjct: 219 NNIVHRDLKPENILLDDN 236

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 4/118 (3%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S   F  +  E +  + L H +IV + D + +E + Y++ +   GG+L
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLA 119
              I + E  SE      ++Q++ ++ +   N + H +LKP+N+L+    K   +KLA
Sbjct: 116 FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 173

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 13/151 (8%)
Query: 1   NEQHTEVAIKCIDKTKVSEN---RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIIL 57
            E   + A+K +D  K + +     + +  E     +L H HIV +L+    +  +Y++ 
Sbjct: 48  RETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVF 107
Query: 58  EYCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-- 111
           E+ DG DLC  I          SE     ++RQ++ AL++  +NN+ H D+KP  +L+  
Sbjct: 108 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLAS 167
Query: 112 KNNT--LKLAGLKQGVSEKAKGSAYIEQGNT 140
           K N+  +KL G   GV+ +   S  +  G  
Sbjct: 168 KENSAPVKLGGF--GVAIQLGESGLVAGGRV 196

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 1/104 (0%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIKCI K  + E +  S+ NEI  L  + H +IV + D      ++Y+I++   GG+L 
Sbjct: 46  VAIKCIAKEAL-EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             I      +E    + + Q++ A+K+L +  + H DLKP+N+L
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL 148

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 1/104 (0%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIKCI K  + E +  S+ NEI  L  + H +IV + D      ++Y+I++   GG+L 
Sbjct: 46  VAIKCIAKEAL-EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             I      +E    + + Q++ A+K+L +  + H DLKP+N+L
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL 148

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 73/150 (48%), Gaps = 13/150 (8%)
Query: 2   EQHTEVAIKCIDKTKVSEN---RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILE 58
           E   + A+K +D  K + +     + +  E     +L H HIV +L+    +  +Y++ E
Sbjct: 47  ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFE 106
Query: 59  YCDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--K 112
           + DG DLC  I          SE     ++RQ++ AL++  +NN+ H D+KP  +L+  K
Sbjct: 107 FMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK 166
Query: 113 NNT--LKLAGLKQGVSEKAKGSAYIEQGNT 140
            N+  +KL G   GV+ +   S  +  G  
Sbjct: 167 ENSAPVKLGGF--GVAIQLGESGLVAGGRV 194

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 35/104 (33%), Positives = 58/104 (55%), Gaps = 1/104 (0%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIKCI K  + E +  S+ NEI  L  + H +IV + D      ++Y+I++   GG+L 
Sbjct: 46  VAIKCIAKEAL-EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELF 104
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             I      +E    + + Q++ A+K+L +  + H DLKP+N+L
Sbjct: 105 DRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLL 148

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 37/135 (27%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE +  + ++   +V +     D   +Y++LEY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYA 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +K+A
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVA 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 4/118 (3%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S   F  +  E +  + L H +IV + D + +E + Y++ +   GG+L
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLA 119
              I + E  SE      ++Q++ ++ +   N + H +LKP+N+L+    K   +KLA
Sbjct: 93  FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 4/118 (3%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S   F  +  E +  + L H +IV + D + +E + Y++ +   GG+L
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLA 119
              I + E  SE      ++Q++ ++ +   N + H +LKP+N+L+    K   +KLA
Sbjct: 93  FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 150

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 62/118 (52%), Gaps = 4/118 (3%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S   F  +  E +  + L H +IV + D + +E + Y++ +   GG+L
Sbjct: 32  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 91
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLA 119
              I + E  SE      ++Q++ ++ +   N + H +LKP+N+L+    K   +KLA
Sbjct: 92  FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLA 149

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 4/155 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S      +  E +  +LL H +IV + D + +E + Y++ +   GG+L
Sbjct: 58  EYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL 117
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLAGL 121
              I + E  SE      + Q++ ++  + ++++ H DLKP+N+L+    K   +KLA  
Sbjct: 118 FEDIVAREYYSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADF 177
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK 156
              +  + +  A+     T    S    R+ P  K
Sbjct: 178 GLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGK 212

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N++I +   +K+ 
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVT 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICS 145
               G +++ KG  +   G  + +  
Sbjct: 184 DF--GFAKRVKGRTWXLXGTPEYLAP 207

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +    +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N++I +   +K+ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G++++ KG  +
Sbjct: 184 DF--GLAKRVKGRTW 196

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICS 145
               G +++ KG  +   G  + +  
Sbjct: 184 DF--GFAKRVKGRTWXLAGTPEYLAP 207

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N++I +   +K+ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 35  VAVKIVDMKRAVDCP-ENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 74/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 85  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 144
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 145 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 204
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG+ +
Sbjct: 205 DF--GFAKRVKGATW 217

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 35  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 85  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 144
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 145 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 204
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 205 DF--GFAKRVKGRTW 217

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/121 (27%), Positives = 65/121 (53%), Gaps = 2/121 (1%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K+++ +   +  +  EI+    L H +I+ M ++  D + +Y++LE+   G+L
Sbjct: 42  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQG 124
              ++ H +  E +   F+ +L  AL +  E  V H D+KP+N+L+     LK+A     
Sbjct: 102 YKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS 161
Query: 125 V 125
           V
Sbjct: 162 V 162

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/115 (27%), Positives = 64/115 (55%), Gaps = 2/115 (1%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K+++ +   +  +  EI+    L H +I+ M ++  D + +Y++LE+   G+L
Sbjct: 43  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 102
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 119
              ++ H +  E +   F+ +L  AL +  E  V H D+KP+N+L+     LK+A
Sbjct: 103 YKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIA 157

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 35  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 35  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 35  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 70/130 (53%), Gaps = 5/130 (3%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           N++   +A   + +TK  E   D IV EI+ L    H +IV +L   + +  ++I++E+C
Sbjct: 32  NKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 90
Query: 61  DGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKL 118
            GG + + +   ++ L+E Q Q   RQ++ AL FL    + H DLK  N+L+     ++L
Sbjct: 91  PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRL 150
Query: 119 AGLKQGVSEK 128
           A    GVS K
Sbjct: 151 ADF--GVSAK 158

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/130 (32%), Positives = 70/130 (53%), Gaps = 5/130 (3%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           N++   +A   + +TK  E   D IV EI+ L    H +IV +L   + +  ++I++E+C
Sbjct: 40  NKETGALAAAKVIETKSEEELEDYIV-EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFC 98
Query: 61  DGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKL 118
            GG + + +   ++ L+E Q Q   RQ++ AL FL    + H DLK  N+L+     ++L
Sbjct: 99  PGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRL 158
Query: 119 AGLKQGVSEK 128
           A    GVS K
Sbjct: 159 ADF--GVSAK 166

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 59/113 (52%), Gaps = 11/113 (9%)
Query: 10  KCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCS 67
           K +D   ++E     +V+E+  L+ L H +IV   D + D     +YI++EYC+GGDL S
Sbjct: 37  KELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS 96
Query: 68  FIRSHEKLSEFQCQQFV----RQLVLALKFLRENN-----VCHFDLKPQNILI 111
            I    K  ++  ++FV     QL LALK     +     V H DLKP N+ +
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 57  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 116
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 117 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 176
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 177 DF--GFAKRVKGRTW 189

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 59/113 (52%), Gaps = 11/113 (9%)
Query: 10  KCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCS 67
           K +D   ++E     +V+E+  L+ L H +IV   D + D     +YI++EYC+GGDL S
Sbjct: 37  KELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS 96
Query: 68  FIRSHEKLSEFQCQQFV----RQLVLALKFLRENN-----VCHFDLKPQNILI 111
            I    K  ++  ++FV     QL LALK     +     V H DLKP N+ +
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 50  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 109
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 110 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 169
Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICS 145
               G +++ KG  +   G  + +  
Sbjct: 170 DF--GFAKRVKGRTWTLCGTPEYLAP 193

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 72/155 (46%), Gaps = 4/155 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S      +  E +  +LL H +IV + D + +E + Y+I +   GG+L
Sbjct: 49  EYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 108
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL----IKNNTLKLAGL 121
              I + E  SE      ++Q++ A+    +  V H DLKP+N+L    +K   +KLA  
Sbjct: 109 FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADF 168
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK 156
              +  + +  A+     T    S    R+ P  K
Sbjct: 169 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 203

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 125 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 76/136 (55%), Gaps = 6/136 (4%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEY 59
           E     A+K +DK KV +  + +  +NE + L+ ++    +T L+F + D   +Y+++EY
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP-FLTKLEFSFKDNSNLYMVMEY 123
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N++I +   +K+
Sbjct: 124 APGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKV 183
Query: 119 AGLKQGVSEKAKGSAY 134
                G +++ KG  +
Sbjct: 184 TDF--GFAKRVKGRTW 197

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/113 (34%), Positives = 59/113 (52%), Gaps = 11/113 (9%)
Query: 10  KCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCS 67
           K +D   ++E     +V+E+  L+ L H +IV   D + D     +YI++EYC+GGDL S
Sbjct: 37  KELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLAS 96
Query: 68  FIRSHEKLSEFQCQQFV----RQLVLALKFLRENN-----VCHFDLKPQNILI 111
            I    K  ++  ++FV     QL LALK     +     V H DLKP N+ +
Sbjct: 97  VITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 4/155 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S      +  E +  +LL H +IV + D + +E + Y++ +   GG+L
Sbjct: 31  EYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL 90
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLAGL 121
              I + E  SE      ++Q++ ++     N + H DLKP+N+L+    K   +KLA  
Sbjct: 91  FEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADF 150
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK 156
              +  +    A+     T    S    R+ P  K
Sbjct: 151 GLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGK 185

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 37/136 (27%), Positives = 76/136 (55%), Gaps = 6/136 (4%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEY 59
           E     A+K +DK KV +  + +  +NE + L+ ++    +T L+F + D   +Y+++EY
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP-FLTKLEFSFKDNSNLYMVMEY 123
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N++I +   +K+
Sbjct: 124 APGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKV 183
Query: 119 AGLKQGVSEKAKGSAY 134
                G +++ KG  +
Sbjct: 184 TDF--GFAKRVKGRTW 197

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 4/155 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S      +  E +  +LL H +IV + D + +E + Y++ +   GG+L
Sbjct: 31  EYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGEL 90
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLAGL 121
              I + E  SE      ++Q++ ++     N + H DLKP+N+L+    K   +KLA  
Sbjct: 91  FEDIVAREYYSEADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADF 150
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK 156
              +  +    A+     T    S    R+ P  K
Sbjct: 151 GLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPYGK 185

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 53/107 (49%), Gaps = 5/107 (4%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           + E A+K IDK+K        I+     L+   H +I+T+ D   D +YVY++ E   GG
Sbjct: 47  NXEFAVKIIDKSKRDPTEEIEIL-----LRYGQHPNIITLKDVYDDGKYVYVVTELXKGG 101
Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
           +L   I   +  SE +    +  +   +++L    V H DLKP NIL
Sbjct: 102 ELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNIL 148

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 5/105 (4%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A+K IDK+K        I+     L+   H +I+T+ D   D +YVY++ E   GG+L
Sbjct: 49  EFAVKIIDKSKRDPTEEIEIL-----LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
              I   +  SE +    +  +   +++L    V H DLKP NIL
Sbjct: 104 LDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNIL 148

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 65  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 125 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +    +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N++I +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G++++ KG  +
Sbjct: 184 DF--GLAKRVKGRTW 196

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N++I +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 33  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 91
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 92  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 145

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 51  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 110
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 111 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQGYIQVT 170
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 171 DF--GFAKRVKGRTW 183

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 35  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYA 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N++I +   +K+ 
Sbjct: 124 PGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 35  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 62/114 (54%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 34  VAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 92
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 146

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 87
           EI   + L HQH+V    F  D  +V+++LE C    L    +  + L+E + + ++RQ+
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 130
Query: 88  VLALKFLRENNVCHFDLKPQNILIKNN 114
           VL  ++L  N V H DLK  N+ +  +
Sbjct: 131 VLGCQYLHRNRVIHRDLKLGNLFLNED 157

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/137 (27%), Positives = 71/137 (51%), Gaps = 14/137 (10%)
Query: 24  SIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLSE---- 77
           ++  EI+ L+ L H++++ ++D L++E  + +Y+++EYC    +C      + + E    
Sbjct: 52  NVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYC----VCGMQEMLDSVPEKRFP 107
Query: 78  -FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQGVSEKAKGSAYI 135
             Q   +  QL+  L++L    + H D+KP N+L+    TLK++ L  GV+E     A  
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISAL--GVAEALHPFAAD 165
Query: 136 EQGNTKVICSVFEPREI 152
           +   T      F+P EI
Sbjct: 166 DTCRTSQGSPAFQPPEI 182

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 24/83 (28%), Positives = 49/83 (59%)
Query: 32  LKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLAL 91
           L ++ H  I+ M     D + +++I++Y +GG+L S +R  ++      + +  ++ LAL
Sbjct: 60  LSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 92  KFLRENNVCHFDLKPQNILIKNN 114
           ++L   ++ + DLKP+NIL+  N
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKN 142

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 6/113 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 37  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 92
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ + 
Sbjct: 93  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 62  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 121
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 122 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 171

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 87
           EI   + L HQH+V    F  D  +V+++LE C    L    +  + L+E + + ++RQ+
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 88  VLALKFLRENNVCHFDLKPQNILIKNN 114
           VL  ++L  N V H DLK  N+ +  +
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLFLNED 177

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 87
           EI   + L HQH+V    F  D  +V+++LE C    L    +  + L+E + + ++RQ+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 88  VLALKFLRENNVCHFDLKPQNILIKNN 114
           VL  ++L  N V H DLK  N+ +  +
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNED 153

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 45  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 100
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 101 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 152

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N++I +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 60  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 119
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 120 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 169

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 87
           EI   + L HQH+V    F  D  +V+++LE C    L    +  + L+E + + ++RQ+
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 88  VLALKFLRENNVCHFDLKPQNILIKNN 114
           VL  ++L  N V H DLK  N+ +  +
Sbjct: 149 VLGCQYLHRNRVIHRDLKLGNLFLNED 175

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 87
           EI   + L HQH+V    F  D  +V+++LE C    L    +  + L+E + + ++RQ+
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 126
Query: 88  VLALKFLRENNVCHFDLKPQNILIKNN 114
           VL  ++L  N V H DLK  N+ +  +
Sbjct: 127 VLGCQYLHRNRVIHRDLKLGNLFLNED 153

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 60  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 119
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 120 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 169

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 4/139 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S      +  E +  +LL H +IV + D + +E + Y++ +   GG+L
Sbjct: 31  EYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGEL 90
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLAGL 121
              I + E  SE      ++Q++ A+    +  V H DLKP+N+L+    K   +KLA  
Sbjct: 91  FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADF 150
Query: 122 KQGVSEKAKGSAYIEQGNT 140
              +  +    A+     T
Sbjct: 151 GLAIEVQGDQQAWFGFAGT 169

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 47  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 102
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 103 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 154

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 166

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 36/121 (29%), Positives = 64/121 (52%), Gaps = 3/121 (2%)
Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E   +  IK I+ +++S    +    E+  L  + H +IV   +   +   +YI+++YC+
Sbjct: 47  EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCE 106
Query: 62  GGDLCSFIRSHEKL--SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI-LIKNNTLKL 118
           GGDL   I + + +   E Q   +  Q+ LALK + +  + H D+K QNI L K+ T++L
Sbjct: 107 GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQL 166
Query: 119 A 119
Sbjct: 167 G 167

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/87 (32%), Positives = 47/87 (54%)
Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 87
           EI   + L HQH+V    F  D  +V+++LE C    L    +  + L+E + + ++RQ+
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 88  VLALKFLRENNVCHFDLKPQNILIKNN 114
           VL  ++L  N V H DLK  N+ +  +
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLFLNED 151

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 46  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 101
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 102 SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 153

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 43  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 98
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 99  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 150

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 37  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 92
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 93  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 73/135 (54%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   + +E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 39  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 94
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 95  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 146

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 32  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 87
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 88  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 139

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 38  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 93
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 94  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 145

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 42  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 97
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 98  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 149

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 43  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 98
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 99  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 150

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 37  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 92
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 93  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 37  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 92
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ +
Sbjct: 93  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSD 144

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 57  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 116
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 117 PGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 176
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 177 DF--GFAKRVKGRTW 189

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 61/112 (54%), Gaps = 1/112 (0%)
Query: 1   NEQHTEVAIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           N+     A+K ++K K V  N   ++  E++ ++ L H  +V +     DE  ++++++ 
Sbjct: 37  NDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDL 96
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             GGDL   ++ +    E   + F+ +LV+AL +L+   + H D+KP NIL+
Sbjct: 97  LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL 148

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 124
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 125 PGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 184
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 185 DF--GFAKRVKGRTW 197

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/111 (27%), Positives = 61/111 (54%), Gaps = 1/111 (0%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 85  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 144
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI
Sbjct: 145 AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 195

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 75/136 (55%), Gaps = 6/136 (4%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEY 59
           E     A+K +DK KV +  + +  +NE + L+ ++    +T L+F + D   +Y+++EY
Sbjct: 65  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP-FLTKLEFSFKDNSNLYMVMEY 123
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N++I +   +K+
Sbjct: 124 APGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKV 183
Query: 119 AGLKQGVSEKAKGSAY 134
                G +++ KG  +
Sbjct: 184 TDF--GFAKRVKGRTW 197

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 PGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 68/135 (50%), Gaps = 22/135 (16%)
Query: 6   EVAIKCIDKTKVSENRFDSIVN------EIKALKLLHHQHIVTMLDFL------WDERYV 53
           +VAIK I       N FD + N      E+K LK   H +I+ + D L       + + V
Sbjct: 82  QVAIKKI------PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 135
Query: 54  YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           Y++L+  +  DL   I S + L+    + F+ QL+  LK++    V H DLKP N+L+  
Sbjct: 136 YVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE 194
Query: 114 N-TLKLA--GLKQGV 125
           N  LK+   G+ +G+
Sbjct: 195 NCELKIGDFGMARGL 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 64  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGE 123
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 124 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 173

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 37  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 96
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 97  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 146

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/149 (25%), Positives = 68/149 (45%), Gaps = 6/149 (4%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H +VA+K +     +  +F +  NE+  L+   H +I+  + ++  +  + I+ ++C+G 
Sbjct: 58  HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDN-LAIVTQWCEGS 116
Query: 64  DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA-- 119
            L   +   E K   FQ     RQ    + +L   N+ H D+K  NI +    T+K+   
Sbjct: 117 SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDF 176
Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICSVFE 148
           GL   V  +  GS  +EQ    V+    E
Sbjct: 177 GLAT-VKSRWSGSQQVEQPTGSVLWMAPE 204

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 68/135 (50%), Gaps = 22/135 (16%)
Query: 6   EVAIKCIDKTKVSENRFDSIVN------EIKALKLLHHQHIVTMLDFL------WDERYV 53
           +VAIK I       N FD + N      E+K LK   H +I+ + D L       + + V
Sbjct: 81  QVAIKKI------PNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSV 134
Query: 54  YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           Y++L+  +  DL   I S + L+    + F+ QL+  LK++    V H DLKP N+L+  
Sbjct: 135 YVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNE 193
Query: 114 N-TLKLA--GLKQGV 125
           N  LK+   G+ +G+
Sbjct: 194 NCELKIGDFGMARGL 208

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 36  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 95
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 96  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 145

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 59  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 118
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 119 AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 178
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 179 DF--GFAKRVKGRTW 191

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 72/135 (53%), Gaps = 4/135 (2%)
Query: 2   EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           E     A+K +DK KV +  + +  +NE + L+ ++   +V +     D   +Y+++EY 
Sbjct: 64  ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV 123
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            GG++ S +R   +  E   + +  Q+VL  ++L   ++ + DLKP+N+LI +   +++ 
Sbjct: 124 AGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVT 183
Query: 120 GLKQGVSEKAKGSAY 134
               G +++ KG  +
Sbjct: 184 DF--GFAKRVKGRTW 196

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 34  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 93
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 94  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 143

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 35  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 95  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 144

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 41  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 100
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 101 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 150

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 56  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 115
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 116 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 165

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 53/110 (48%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G+
Sbjct: 56  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 115
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 116 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 165

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/114 (28%), Positives = 61/114 (53%), Gaps = 2/114 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +D  +  +   ++I  EI    +L+H+++V       +    Y+ LEYC GG+L 
Sbjct: 35  VAVKIVDMKRAVDCP-ENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGELF 93
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 94  DRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 10/122 (8%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTM------LDFLWDERYVYIILEY 59
           +VAIK   +    +NR +    EI+ +K L+H ++V+       L  L       + +EY
Sbjct: 42  QVAIKQCRQELSPKNR-ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 100
Query: 60  CDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           C+GGDL  ++   E    L E   +  +  +  AL++L EN + H DLKP+NI+++    
Sbjct: 101 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 160
Query: 117 KL 118
           +L
Sbjct: 161 RL 162

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/122 (30%), Positives = 63/122 (51%), Gaps = 10/122 (8%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTM------LDFLWDERYVYIILEY 59
           +VAIK   +    +NR +    EI+ +K L+H ++V+       L  L       + +EY
Sbjct: 41  QVAIKQCRQELSPKNR-ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEY 99
Query: 60  CDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           C+GGDL  ++   E    L E   +  +  +  AL++L EN + H DLKP+NI+++    
Sbjct: 100 CEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQ 159
Query: 117 KL 118
           +L
Sbjct: 160 RL 161

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 58/112 (51%), Gaps = 6/112 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S    D+ + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 33  HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 88
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            L  F+++    KL+  +      Q+   + F+ E N  H +L+  NIL+ +
Sbjct: 89  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSD 140

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 59/106 (55%), Gaps = 3/106 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K I+K +   +R   +  E++ L +   +++I+ +++F  D+   Y++ E   GG 
Sbjct: 40  EYAVKIIEK-QAGHSR-SRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVFEKLQGGS 97
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
           + + I+  +  +E +  + VR +  AL FL    + H DLKP+NIL
Sbjct: 98  ILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENIL 143

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 53/94 (56%), Gaps = 1/94 (1%)
Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVR 85
           + EI+ LK L H ++V +L+    +R ++++ EYCD   L    R    + E   +    
Sbjct: 50  LREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITW 109
Query: 86  QLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
           Q + A+ F  ++N  H D+KP+NILI K++ +KL
Sbjct: 110 QTLQAVNFCHKHNCIHRDVKPENILITKHSVIKL 143

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/157 (31%), Positives = 79/157 (50%), Gaps = 27/157 (17%)
Query: 7   VAIKCIDKTKVSENRFD--SIVNEIKALKLLHHQHIVTMLDFL-------WDERYVYIIL 57
           VAIK I   +V E+  D   I+ EI  L  L+H H+V +LD +       +DE  +Y++L
Sbjct: 81  VAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE--LYVVL 136
Query: 58  EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           E  D  D     R+   L+E   +  +  L++ +K++    + H DLKP N L+  + ++
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSV 195
Query: 117 KLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE 151
           K+   GL + V        Y E GN+++  S   PRE
Sbjct: 196 KVCDFGLARTVD-------YPENGNSQLPIS---PRE 222

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 56/94 (59%), Gaps = 3/94 (3%)
Query: 28  EIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQ 86
           EI ALKL   H +IV + +   D+ + ++++E  +GG+L   I+  +  SE +    +R+
Sbjct: 55  EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRK 114
Query: 87  LVLALKFLRENNVCHFDLKPQNILI--KNNTLKL 118
           LV A+  + +  V H DLKP+N+L   +N+ L++
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEI 148

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/116 (33%), Positives = 61/116 (52%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+ D  DL 
Sbjct: 34  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVD-QDLK 92
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 93  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 148

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 57/109 (52%), Gaps = 1/109 (0%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
            + H  VA+K + K+++ +   +  +  EI+    LHH +I+ + ++ +D R +Y+ILEY
Sbjct: 45  KKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEY 104
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
              G+L   ++      E +    + +L  AL +     V H D+KP+N
Sbjct: 105 APRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPEN 153

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 61/113 (53%), Gaps = 3/113 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           ++A K I KT+  +++ + + NEI  +  L H +++ + D    +  + +++EY DGG+L
Sbjct: 116 KLAAKII-KTRGMKDK-EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 66  CS-FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
               I     L+E     F++Q+   ++ + +  + H DLKP+NIL  N   K
Sbjct: 174 FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK 226

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/110 (29%), Positives = 52/110 (47%), Gaps = 1/110 (0%)
Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   G 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGC 118
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+  +
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNED 168

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 4/155 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A   I+  K+S      +  E +  +LL H +IV + D + +E + Y+I +   GG+L
Sbjct: 38  EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL----IKNNTLKLAGL 121
              I + E  SE      ++Q++ A+    +  V H +LKP+N+L    +K   +KLA  
Sbjct: 98  FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK 156
              +  + +  A+     T    S    R+ P  K
Sbjct: 158 GLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGK 192

>pdb|1UDQ|A Chain A, Crystal Structure Of The Trna Processing Enzyme Rnase Ph T125a Mutant From Aquifex Aeolicus Length = 255

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/147 (27%), Positives = 72/147 (48%), Gaps = 17/147 (11%)
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYV- 170
           K + L+   +++   E  +GS  I  G TKVIC+      +P+      + + KG+ ++ 
Sbjct: 7   KEDQLRPVSIQRDFLEYPEGSCLISFGKTKVICTASVIENVPN------WLKGKGQGWIT 60
Query: 171 -EFKFAPFASQIRTGWLRDSEEKELGNH-------LKRALEPAVCRHEFSNFQVDLFVLV 222
            E+   P A+Q RT  +R+S +  +G         + RA+  AV   +     + +   V
Sbjct: 61  AEYSMLPRATQQRT--IRESVQGRIGGRTHEIQRMIGRAMRTAVELTKIGERTIWVDCDV 118
Query: 223 LQNDGSALSAAINCANLALVDAAIPMY 249
           +Q DG A +AAI  A +A+ DA I ++
Sbjct: 119 IQADGGARTAAITGAFVAVADAIIKLH 145

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + +  EI   K L + H+V    F  D+ +VY++LE C    L    +  + ++E + + 
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           F+RQ +  +++L  N V H DLK  N+ + ++
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDD 178

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + +  EI   K L + H+V    F  D+ +VY++LE C    L    +  + ++E + + 
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           F+RQ +  +++L  N V H DLK  N+ + ++
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDD 178

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + +  EI   K L + H+V    F  D+ +VY++LE C    L    +  + ++E + + 
Sbjct: 87  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 146
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           F+RQ +  +++L  N V H DLK  N+ + ++
Sbjct: 147 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDD 178

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 5/105 (4%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A+K IDK+K   +    I+     L+   H +I+T+ D   D ++VY++ E   GG+L
Sbjct: 54  EYAVKVIDKSKRDPSEEIEIL-----LRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
              I   +  SE +    +  +   +++L    V H DLKP NIL
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNIL 153

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 5/105 (4%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A+K IDK+K   +    I+     L+   H +I+T+ D   D ++VY++ E   GG+L
Sbjct: 54  EYAVKVIDKSKRDPSEEIEIL-----LRYGQHPNIITLKDVYDDGKHVYLVTELMRGGEL 108
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
              I   +  SE +    +  +   +++L    V H DLKP NIL
Sbjct: 109 LDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVHRDLKPSNIL 153

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 59/109 (54%), Gaps = 3/109 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHH-QHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A K + K +  ++    I++EI  L+L      ++ + +   +   + +ILEY  GG+
Sbjct: 56  EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           + S       E +SE    + ++Q++  + +L +NN+ H DLKPQNIL+
Sbjct: 116 IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILL 164

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K I++  K+ EN    I+N     + L H +IV   + +    ++ I++EY  GG+L
Sbjct: 47  VAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              I +  + SE + + F +QL+  + +     VCH DLK +N L+
Sbjct: 103 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 148

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/142 (26%), Positives = 69/142 (48%), Gaps = 4/142 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KL 118
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N + K+
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKV 188
Query: 119 AGLKQG-VSEKAKGSAYIEQGN 139
           +    G V E    +AY  +G 
Sbjct: 189 SDFGLGRVLEDDPEAAYTTRGG 210

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K I++  K+ EN    I+N     + L H +IV   + +    ++ I++EY  GG+L
Sbjct: 47  VAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              I +  + SE + + F +QL+  + +     VCH DLK +N L+
Sbjct: 103 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 148

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 69/130 (53%), Gaps = 9/130 (6%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERY-----VYIILEY 59
           +VAIK + +   SE        E++ LK + H++++ +LD F  DE        Y+++ +
Sbjct: 52  KVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF 111
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
             G DL   ++ HEKL E + Q  V Q++  L+++    + H DLKP N+ + N   +L 
Sbjct: 112 M-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV-NEDCELK 168
Query: 120 GLKQGVSEKA 129
            L  G++ +A
Sbjct: 169 ILDFGLARQA 178

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K I++  K+ EN    I+N     + L H +IV   + +    ++ I++EY  GG+L
Sbjct: 46  VAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 101
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              I +  + SE + + F +QL+  + +     VCH DLK +N L+
Sbjct: 102 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 147

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 3/121 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           + Q   VA+K I      E    + + EI  LK LHH +IV+++D +  ER + ++ E+ 
Sbjct: 42  DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101
Query: 61  DGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +  DL   +  ++  L + Q + ++ QL+  +    ++ + H DLKPQN+LI ++  LKL
Sbjct: 102 E-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
Query: 119 A 119
           A
Sbjct: 161 A 161

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 26/92 (28%), Positives = 49/92 (53%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + +  EI   K L + H+V    F  D+ +VY++LE C    L    +  + ++E + + 
Sbjct: 71  EKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARY 130
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           F+RQ +  +++L  N V H DLK  N+ + ++
Sbjct: 131 FMRQTIQGVQYLHNNRVIHRDLKLGNLFLNDD 162

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 3/121 (2%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           + Q   VA+K I      E    + + EI  LK LHH +IV+++D +  ER + ++ E+ 
Sbjct: 42  DSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM 101
Query: 61  DGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +  DL   +  ++  L + Q + ++ QL+  +    ++ + H DLKPQN+LI ++  LKL
Sbjct: 102 E-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKL 160
Query: 119 A 119
           A
Sbjct: 161 A 161

>pdb|3HKM|A Chain A, Crystal Structure Of Rice(Oryza Sativa) Rrp46 Length = 246

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/128 (30%), Positives = 60/128 (46%), Gaps = 12/128 (9%)
Query: 127 EKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWL 186
           ++A GSA   QG+T V+ +V+ P+  P ++     +++     +E  + P   QI     
Sbjct: 25  DRAHGSARWAQGDTIVLAAVYGPK--PGTRKGENPEKAS----IEVVWKPMTGQI----- 73
Query: 187 RDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI 246
              +EKE    LKR L+         N    + + V+ NDGS L  AIN    ALV A I
Sbjct: 74  -GKQEKEYEMTLKRTLQSICLLTVHPNTTTSVILQVVGNDGSLLPCAINACCAALVFAGI 132
Query: 247 PMYDLVTS 254
           P+  L  +
Sbjct: 133 PLKHLAVA 140

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/120 (33%), Positives = 59/120 (49%), Gaps = 9/120 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + K    E    + + EI  +K L H++IV + D +  E  + ++ E+ D  DL 
Sbjct: 33  VALKEV-KLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLK 90
Query: 67  SFIRSH------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            ++ S         L     + F  QL+  L F  EN + H DLKPQN+LI K   LKL 
Sbjct: 91  KYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLG 150

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 61/116 (52%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 34  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 92
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
           +F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 93  TFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 148

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/164 (26%), Positives = 75/164 (45%), Gaps = 18/164 (10%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +  T  ++ + +++++E+K +  L  H++IV +L        V +I EYC  GD
Sbjct: 78  KVAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 65  LCSFIR-------------SH---EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           L +F+R             SH   E+LS      F  Q+   + FL   N  H D+  +N
Sbjct: 137 LLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARN 196
Query: 109 ILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +L+ N  +   G      +    S YI +GN ++      P  I
Sbjct: 197 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 240

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + KT++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 40  LALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 96
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
            +  R  +KLS F  Q+   ++ +L  AL +     V H D+KP+N+L+  N  LK+A  
Sbjct: 97  GTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADF 156
Query: 122 KQGV 125
              V
Sbjct: 157 GWSV 160

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + KT++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 40  LALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 96
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
            +  R  +KLS F  Q+   ++ +L  AL +     V H D+KP+N+L+  N  LK+A  
Sbjct: 97  GTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADF 156
Query: 122 KQGV 125
              V
Sbjct: 157 GWSV 160

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 58  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 116
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 117 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 171

>pdb|1UDS|A Chain A, Crystal Structure Of The Trna Processing Enzyme Rnase Ph R126a Mutant From Aquifex Aeolicus Length = 255

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 17/147 (11%)
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYV- 170
           K + L+   +++   E  +GS  I  G TKVIC+      +P+      + + KG+ ++ 
Sbjct: 7   KEDQLRPVSIQRDFLEYPEGSCLISFGKTKVICTASVIENVPN------WLKGKGQGWIT 60
Query: 171 -EFKFAPFASQIRTGWLRDSEEKELGNH-------LKRALEPAVCRHEFSNFQVDLFVLV 222
            E+   P A+Q RT  +R+S +  +G         + RA+  AV   +     + +   V
Sbjct: 61  AEYSMLPRATQQRT--IRESVQGRIGGRTHEIQRMIGRAMRTAVELTKIGERTIWVDCDV 118
Query: 223 LQNDGSALSAAINCANLALVDAAIPMY 249
           +Q DG   +AAI  A +A+ DA I ++
Sbjct: 119 IQADGGTATAAITGAFVAVADAIIKLH 145

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSN 183

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 41  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 99
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 100 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 154

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 33  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLK 91
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 92  DFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 147

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 34  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLK 92
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 93  DFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 148

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 38  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 96
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 97  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 152

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 68  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 126
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 127 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 181

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 65/113 (57%), Gaps = 6/113 (5%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHEKLSEFQC 80
           + +  EI  LK L H ++V +++ L D  E ++Y++ E  + G +   + + + LSE Q 
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQA 139
Query: 81  QQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQGVSEKAKGS 132
           + + + L+  +++L    + H D+KP N+L+ ++  +K+A    GVS + KGS
Sbjct: 140 RFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADF--GVSNEFKGS 190

>pdb|1UDN|A Chain A, Crystal Structure Of The Trna Processing Enzyme Rnase Ph From Aquifex Aeolicus Length = 255

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 17/147 (11%)
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYV- 170
           K + L+   +++   E  +GS  I  G TKVIC+      +P+      + + KG+ ++ 
Sbjct: 7   KEDQLRPVSIQRDFLEYPEGSCLISFGKTKVICTASVIENVPN------WLKGKGQGWIT 60
Query: 171 -EFKFAPFASQIRTGWLRDSEEKELGNH-------LKRALEPAVCRHEFSNFQVDLFVLV 222
            E+   P A+Q RT  +R+S +  +G         + RA+  AV   +     + +   V
Sbjct: 61  AEYSMLPRATQQRT--IRESVQGRIGGRTHEIQRMIGRAMRTAVELTKIGERTIWVDCDV 118
Query: 223 LQNDGSALSAAINCANLALVDAAIPMY 249
           +Q DG   +AAI  A +A+ DA I ++
Sbjct: 119 IQADGGTRTAAITGAFVAVADAIIKLH 145

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 38  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 96
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 97  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 152

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 34  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 92
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 93  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 148

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 35  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 93
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 94  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 149

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 33  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 91
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 92  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 147

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 32  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 90
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 91  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 146

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 32  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 90
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 91  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 146

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 34  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 92
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 93  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 148

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 33  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 91
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 92  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 147

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 32  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 90
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 91  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 146

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 59/123 (47%), Gaps = 11/123 (8%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D    EI+ +K L H +I+ + +   D   +Y+++E C GG+L   +       E    +
Sbjct: 51  DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR 110
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKL------AGLKQGVSEKAK-G 131
            ++ ++ A+ +  + NV H DLKP+N L      ++ LKL      A  K G   + K G
Sbjct: 111 IMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG 170
Query: 132 SAY 134
           + Y
Sbjct: 171 TPY 173

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 35  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 93
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 94  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 149

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 5/106 (4%)
Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K I++  K++ N    I+N     + L H +IV   + +    ++ I++EY  GG+L
Sbjct: 47  VAVKYIERGEKIAANVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              I +  + SE + + F +QL+  + +     VCH DLK +N L+
Sbjct: 103 FERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLL 148

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 66/118 (55%), Gaps = 9/118 (7%)
Query: 1   NEQHT--EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYII 56
            E+HT  +VA+K +D  K  + R + + NE+  ++  HH ++V M     + DE  ++++
Sbjct: 65  TEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDE--LWVV 120
Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           +E+ +GG L   + +H +++E Q       ++ AL +L    V H D+K  +IL+ ++
Sbjct: 121 MEFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD 177

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 61/116 (52%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 30  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVH-QDLK 88
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
           +F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 89  TFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 144

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 65/138 (47%), Gaps = 13/138 (9%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A K I K  V +   D    EI+ +K L H +I+ + +   D   +Y+++E C GG+L  
Sbjct: 55  AAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFE 112
Query: 68  FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKL----- 118
            +       E    + ++ ++ A+ +  + NV H DLKP+N L      ++ LKL     
Sbjct: 113 RVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGL 172
Query: 119 -AGLKQGVSEKAK-GSAY 134
            A  K G   + K G+ Y
Sbjct: 173 AARFKPGKMMRTKVGTPY 190

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 30  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 88
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 89  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 144

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 30  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 88
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 89  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 144

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 54/117 (46%), Gaps = 6/117 (5%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++   VAIK +      + R D  + E   +    H +I+ +   +   + + II EY 
Sbjct: 70  GKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 128
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L  F+R  EK  EF   Q V   R +   +K+L   N  H DL  +NIL+ +N
Sbjct: 129 ENGALDKFLR--EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 30  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 88
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 89  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 144

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 18/117 (15%)
Query: 11  CIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--------------VYII 56
            I K + +E +  +I++E+  L  L+HQ++V      W ER               ++I 
Sbjct: 35  AIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQ 93
Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQ--QFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           +EYC+ G L   I S E L++ + +  +  RQ++ AL ++    + H DLKP NI I
Sbjct: 94  MEYCENGTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI 149

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 30  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 88
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 89  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 144

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 46/72 (63%), Gaps = 2/72 (2%)
Query: 49  DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           D+RY+Y+++EY  GGDL + + +++ + E   + +  ++VLAL  +      H D+KP N
Sbjct: 145 DDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 203
Query: 109 ILI-KNNTLKLA 119
           +L+ K+  LKLA
Sbjct: 204 MLLDKSGHLKLA 215

>pdb|1UDO|A Chain A, Crystal Structure Of The Trna Processing Enzyme Rnase Ph R86a Mutant From Aquifex Aeolicus Length = 255

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 71/147 (48%), Gaps = 17/147 (11%)
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYV- 170
           K + L+   +++   E  +GS  I  G TKVIC+      +P+      + + KG+ ++ 
Sbjct: 7   KEDQLRPVSIQRDFLEYPEGSCLISFGKTKVICTASVIENVPN------WLKGKGQGWIT 60
Query: 171 -EFKFAPFASQIRTGWLRDSEEKELGN-------HLKRALEPAVCRHEFSNFQVDLFVLV 222
            E+   P A+Q RT  +R+S +  +G         + RA+  AV   +     + +   V
Sbjct: 61  AEYSMLPRATQQRT--IRESVQGRIGGATHEIQRMIGRAMRTAVELTKIGERTIWVDCDV 118
Query: 223 LQNDGSALSAAINCANLALVDAAIPMY 249
           +Q DG   +AAI  A +A+ DA I ++
Sbjct: 119 IQADGGTRTAAITGAFVAVADAIIKLH 145

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 46/72 (63%), Gaps = 2/72 (2%)
Query: 49  DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           D+RY+Y+++EY  GGDL + + +++ + E   + +  ++VLAL  +      H D+KP N
Sbjct: 145 DDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 203
Query: 109 ILI-KNNTLKLA 119
           +L+ K+  LKLA
Sbjct: 204 MLLDKSGHLKLA 215

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 26/72 (36%), Positives = 46/72 (63%), Gaps = 2/72 (2%)
Query: 49  DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           D+RY+Y+++EY  GGDL + + +++ + E   + +  ++VLAL  +      H D+KP N
Sbjct: 140 DDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDN 198
Query: 109 ILI-KNNTLKLA 119
           +L+ K+  LKLA
Sbjct: 199 MLLDKSGHLKLA 210

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 11  CIDKTKVSENRFDSIVNEIKALK-------LLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           CI   K S+      V+E  AL+       L  H H+V       ++ ++ I  EYC+GG
Sbjct: 35  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 94
Query: 64  DLCSFIRSHEKL----SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
            L   I  + ++     E + +  + Q+   L+++   ++ H D+KP NI I   ++  A
Sbjct: 95  SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 154
Query: 120 GLKQG 124
             ++G
Sbjct: 155 ASEEG 159

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 11  CIDKTKVSENRFDSIVNEIKALK-------LLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           CI   K S+      V+E  AL+       L  H H+V       ++ ++ I  EYC+GG
Sbjct: 37  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 96
Query: 64  DLCSFIRSHEKL----SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
            L   I  + ++     E + +  + Q+   L+++   ++ H D+KP NI I   ++  A
Sbjct: 97  SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 156
Query: 120 GLKQG 124
             ++G
Sbjct: 157 ASEEG 161

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 11  CIDKTKVSENRFDSIVNEIKALK-------LLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           CI   K S+      V+E  AL+       L  H H+V       ++ ++ I  EYC+GG
Sbjct: 35  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 94
Query: 64  DLCSFIRSHEKL----SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
            L   I  + ++     E + +  + Q+   L+++   ++ H D+KP NI I   ++  A
Sbjct: 95  SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 154
Query: 120 GLKQG 124
             ++G
Sbjct: 155 ASEEG 159

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +  T  ++ + +++++E+K +  L  H++IV +L        V +I EYC  GD
Sbjct: 78  KVAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 65  LCSFIR--------------SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
           L +F+R              ++  LS      F  Q+   + FL   N  H D+  +N+L
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196
Query: 111 IKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
           + N  +   G      +    S YI +GN ++      P  I
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/140 (25%), Positives = 72/140 (51%), Gaps = 10/140 (7%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C+G 
Sbjct: 34  HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGS 92
Query: 64  DLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            L   + + E  ++F+ ++ +   RQ    + +L   ++ H DLK  NI + ++NT+K+ 
Sbjct: 93  SLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIG 150
Query: 120 --GLKQGVSEKAKGSAYIEQ 137
             GL   V  +  GS   EQ
Sbjct: 151 DFGLAT-VKSRWSGSHQFEQ 169

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/125 (25%), Positives = 58/125 (46%), Gaps = 11/125 (8%)
Query: 11  CIDKTKVSENRFDSIVNEIKALK-------LLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           CI   K S+      V+E  AL+       L  H H+V       ++ ++ I  EYC+GG
Sbjct: 33  CIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGG 92
Query: 64  DLCSFIRSHEKL----SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
            L   I  + ++     E + +  + Q+   L+++   ++ H D+KP NI I   ++  A
Sbjct: 93  SLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNA 152
Query: 120 GLKQG 124
             ++G
Sbjct: 153 ASEEG 157

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/117 (29%), Positives = 61/117 (52%), Gaps = 8/117 (6%)
Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K I++  K+ EN    I+N     + L H +IV   + +    ++ I++EY  GG+L
Sbjct: 47  VAVKYIERGEKIDENVKREIINH----RSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT---LKLA 119
              I +  + SE + + F +QL+  + +     V H DLK +N L+  +    LK+A
Sbjct: 103 FERICNAGRFSEDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIA 159

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 34  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLK 92
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKP+N+LI     +KLA
Sbjct: 93  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLA 148

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/109 (29%), Positives = 57/109 (52%), Gaps = 5/109 (4%)
Query: 7   VAIKCIDK-TKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K I++   + EN    I+N     + L H +IV   + +    ++ II+EY  GG+L
Sbjct: 48  VAVKYIERGAAIDENVQREIINH----RSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
              I +  + SE + + F +QL+  + +     +CH DLK +N L+  +
Sbjct: 104 YERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGS 152

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 25/72 (34%), Positives = 47/72 (65%), Gaps = 2/72 (2%)
Query: 49  DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           D++Y+Y+++EY  GGDL + + +++ + E   + +  ++VLAL  +    + H D+KP N
Sbjct: 146 DDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDN 204
Query: 109 ILI-KNNTLKLA 119
           +L+ K+  LKLA
Sbjct: 205 MLLDKHGHLKLA 216

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 32  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLS-MDLK 90
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKP+N+LI     +KLA
Sbjct: 91  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLA 146

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/112 (37%), Positives = 61/112 (54%), Gaps = 10/112 (8%)
Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFIRSHEKLSEFQC 80
           + EIK LK   H++I+T+ +    + +     VYII E     DL   I S + LS+   
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLSDDHI 114
Query: 81  QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GLKQGVSEKA 129
           Q F+ Q + A+K L  +NV H DLKP N+LI +N  LK+   GL + + E A
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/112 (37%), Positives = 61/112 (54%), Gaps = 10/112 (8%)
Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFIRSHEKLSEFQC 80
           + EIK LK   H++I+T+ +    + +     VYII E     DL   I S + LS+   
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLSDDHI 114
Query: 81  QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GLKQGVSEKA 129
           Q F+ Q + A+K L  +NV H DLKP N+LI +N  LK+   GL + + E A
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 57/114 (50%), Gaps = 1/114 (0%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H EVAI+ ID  + +E++  +   E+ A +   H+++V  +       ++ II   C G 
Sbjct: 55  HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114
Query: 64  DLCSFIRSHEKLSEF-QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
            L S +R  + + +  + +Q  +++V  + +L    + H DLK +N+   N  +
Sbjct: 115 TLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKV 168

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 75/142 (52%), Gaps = 14/142 (9%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C+G 
Sbjct: 46  HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWCEGS 104
Query: 64  DLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            L   + + E  ++F+ ++ +   RQ    + +L   ++ H DLK  NI + ++NT+K+ 
Sbjct: 105 SLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIG 162
Query: 120 --GLKQGVSEKAK--GSAYIEQ 137
             GL    +EK++  GS   EQ
Sbjct: 163 DFGL---ATEKSRWSGSHQFEQ 181

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/112 (37%), Positives = 61/112 (54%), Gaps = 10/112 (8%)
Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFIRSHEKLSEFQC 80
           + EIK LK   H++I+T+ +    + +     VYII E     DL   I S + LS+   
Sbjct: 57  LREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQT-DLHRVI-STQMLSDDHI 114
Query: 81  QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GLKQGVSEKA 129
           Q F+ Q + A+K L  +NV H DLKP N+LI +N  LK+   GL + + E A
Sbjct: 115 QYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA 166

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 32  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 90
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKP+N+LI     +KLA
Sbjct: 91  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLA 146

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 33  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 91
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKP+N+LI     +KLA
Sbjct: 92  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLA 147

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 64/157 (40%), Gaps = 43/157 (27%)
Query: 1   NEQHTEVAIKCIDKTKVSE---NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIIL 57
           N+     AIK ++K K+ +      + I  E++ +K LHH +I  + +   DE+Y+ +++
Sbjct: 48  NQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107
Query: 58  EYCDGGDLCS----FIRS--------------------------------HEKLSEFQCQ 81
           E C GG L      FI                                   E L   Q +
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167
Query: 82  QFV----RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + +    RQ+  AL +L    +CH D+KP+N L   N
Sbjct: 168 KLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTN 204

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 24/75 (32%), Positives = 48/75 (64%)
Query: 40  IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNV 99
           +VT+      E  +++IL+Y +GG+L + +   E+ +E + Q +V ++VLAL+ L +  +
Sbjct: 121 LVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180
Query: 100 CHFDLKPQNILIKNN 114
            + D+K +NIL+ +N
Sbjct: 181 IYRDIKLENILLDSN 195

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 16/162 (9%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +  T  ++ + +++++E+K +  L  H++IV +L        V +I EYC  GD
Sbjct: 78  KVAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 65  LCSFIRSHEKLSEFQCQ--------------QFVRQLVLALKFLRENNVCHFDLKPQNIL 110
           L +F+R   ++ E                   F  Q+   + FL   N  H D+  +N+L
Sbjct: 137 LLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVL 196
Query: 111 IKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
           + N  +   G      +    S YI +GN ++      P  I
Sbjct: 197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 238

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 60/116 (51%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKP+N+LI     +KLA
Sbjct: 90  DFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLA 145

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 60/115 (52%), Gaps = 2/115 (1%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY   G++
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV 100
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
              ++   K  E +   ++ +L  AL +     V H D+KP+N+L+ +   LK+A
Sbjct: 101 YKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 155

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 27/84 (32%), Positives = 43/84 (51%)
Query: 27  NEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQ 86
            EI  L  L H +I+ + +       + ++LE   GG+L   I      SE      V+Q
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQ 156
Query: 87  LVLALKFLRENNVCHFDLKPQNIL 110
           ++ A+ +L EN + H DLKP+N+L
Sbjct: 157 ILEAVAYLHENGIVHRDLKPENLL 180

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 60/115 (52%), Gaps = 2/115 (1%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY   G++
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEV 100
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
              ++   K  E +   ++ +L  AL +     V H D+KP+N+L+ +   LK+A
Sbjct: 101 YKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 155

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 74/142 (52%), Gaps = 14/142 (9%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +      + I+ ++C+G 
Sbjct: 46  HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGS 104
Query: 64  DLCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            L   + + E  ++F+ ++ +   RQ    + +L   ++ H DLK  NI + ++NT+K+ 
Sbjct: 105 SLYHHLHASE--TKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIG 162
Query: 120 --GLKQGVSEKAK--GSAYIEQ 137
             GL    +EK++  GS   EQ
Sbjct: 163 DFGL---ATEKSRWSGSHQFEQ 181

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/131 (28%), Positives = 64/131 (48%), Gaps = 7/131 (5%)
Query: 24  SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQCQQ 82
           + + E+  LK L H +IVT+ D +  E+ + ++ EY D  DL  ++      ++    + 
Sbjct: 46  TAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKL 104
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQGVSEKAKGSAYIEQGNTK 141
           F+ QL+  L +     V H DLKPQN+LI +   LKLA      ++      Y    + +
Sbjct: 105 FLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY----DNE 160
Query: 142 VICSVFEPREI 152
           V+   + P +I
Sbjct: 161 VVTLWYRPPDI 171

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 11/131 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +AIK I +    ++R+   ++E  AL K L H++IV  L    +  ++ I +E   GG L
Sbjct: 50  IAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 106
Query: 66  CSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLAG 120
            + +RS     K +E     + +Q++  LK+L +N + H D+K  N+LI   +  LK++ 
Sbjct: 107 SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISD 166
Query: 121 LKQGVSEKAKG 131
              G S++  G
Sbjct: 167 F--GTSKRLAG 175

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G L
Sbjct: 50  DVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106
Query: 66  CSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++R  E    FQ QQ +   + +  A+++L      H DL  +N L+ + 
Sbjct: 107 LNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 156

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/115 (23%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++   VAIK + K   +E +    ++E   +    H +I+ +   +   R   I+ EY 
Sbjct: 74  GQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L +F+R+H+ + +  Q    +R +   +++L +    H DL  +N+L+ +N
Sbjct: 133 ENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN 187

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 27/115 (23%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++   VAIK + K   +E +    ++E   +    H +I+ +   +   R   I+ EY 
Sbjct: 74  GQRDVPVAIKAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L +F+R+H+ + +  Q    +R +   +++L +    H DL  +N+L+ +N
Sbjct: 133 ENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSN 187

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G L
Sbjct: 50  DVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106
Query: 66  CSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++R  E    FQ QQ +   + +  A+++L      H DL  +N L+ + 
Sbjct: 107 LNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 156

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+  I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 31  VALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 89
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 90  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 145

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 59/116 (50%), Gaps = 4/116 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+  I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    DL 
Sbjct: 30  VALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLK 88
Query: 67  SFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            F+ +     +     + ++ QL+  L F   + V H DLKPQN+LI     +KLA
Sbjct: 89  KFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLA 144

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           +HT+VA+K +    +S    ++ + E   +K L H  +V +   +  E  +YII E+   
Sbjct: 211 KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAK 266
Query: 63  GDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           G L  F++S E  K    +   F  Q+   + F+ + N  H DL+  NIL+
Sbjct: 267 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 317

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/117 (26%), Positives = 60/117 (51%), Gaps = 1/117 (0%)
Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVR 85
           + EIK LK L H+++V +L+    ++  Y++ E+ D   L         L     Q+++ 
Sbjct: 72  MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLF 131
Query: 86  QLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQGVSEKAKGSAYIEQGNTK 141
           Q++  + F   +N+ H D+KP+NIL+ ++  +KL       +  A G  Y ++  T+
Sbjct: 132 QIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATR 188

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 56/115 (48%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ E  
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSN 183

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 11/131 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +AIK I +    ++R+   ++E  AL K L H++IV  L    +  ++ I +E   GG L
Sbjct: 36  IAIKEIPE---RDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL 92
Query: 66  CSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLAG 120
            + +RS     K +E     + +Q++  LK+L +N + H D+K  N+LI   +  LK++ 
Sbjct: 93  SALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISD 152
Query: 121 LKQGVSEKAKG 131
              G S++  G
Sbjct: 153 F--GTSKRLAG 161

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G L
Sbjct: 41  DVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 97
Query: 66  CSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++R  E    FQ QQ +   + +  A+++L      H DL  +N L+ + 
Sbjct: 98  LNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 147

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           +HT+VA+K +    +S    ++ + E   +K L H  +V +   +  E  +YII E+   
Sbjct: 205 KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAK 260
Query: 63  GDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           G L  F++S E  K    +   F  Q+   + F+ + N  H DL+  NIL+
Sbjct: 261 GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 311

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAI+ ++  +  + + + I+NEI  ++   + +IV  LD       +++++EY  GG L
Sbjct: 47  EVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              + +   + E Q     R+ + AL+FL  N V H D+K  NIL+
Sbjct: 105 TDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +  T  ++ + +++++E+K +  L  H++IV +L        V +I EYC  GD
Sbjct: 70  KVAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 128
Query: 65  LCSFIRSHEK----------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L +F+R   +          L       F  Q+   + FL   N  H D+  +N+L+ N 
Sbjct: 129 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 188
Query: 115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
            +   G      +    S YI +GN ++      P  I
Sbjct: 189 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 226

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAI+ ++  +  + + + I+NEI  ++   + +IV  LD       +++++EY  GG L
Sbjct: 47  EVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              + +   + E Q     R+ + AL+FL  N V H D+K  NIL+
Sbjct: 105 TDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAI+ ++  +  + + + I+NEI  ++   + +IV  LD       +++++EY  GG L
Sbjct: 47  EVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              + +   + E Q     R+ + AL+FL  N V H D+K  NIL+
Sbjct: 105 TDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/135 (25%), Positives = 60/135 (44%), Gaps = 8/135 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYV----YIILE 58
           H +VA+K +      +  F      E +    L+H  IV + D    E       YI++E
Sbjct: 37  HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLK 117
           Y DG  L   + +   ++  +  + +     AL F  +N + H D+KP NILI   N +K
Sbjct: 97  YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISATNAVK 156
Query: 118 LA--GLKQGVSEKAK 130
           +   G+ + +++   
Sbjct: 157 VVDFGIARAIADSGN 171

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 56/115 (48%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ E  
Sbjct: 41  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXM 99
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 100 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 154

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 292 TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 347
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 348 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 399

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G L
Sbjct: 34  DVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 90
Query: 66  CSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++R  E    FQ QQ +   + +  A+++L      H DL  +N L+ + 
Sbjct: 91  LNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 140

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/115 (26%), Positives = 56/115 (48%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ E  
Sbjct: 70  SKKEISVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXM 128
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSN 183

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G L
Sbjct: 30  DVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86
Query: 66  CSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++R  E    FQ QQ +   + +  A+++L      H DL  +N L+ + 
Sbjct: 87  LNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 136

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAI+ ++  +  + + + I+NEI  ++   + +IV  LD       +++++EY  GG L
Sbjct: 48  EVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 105
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              + +   + E Q     R+ + AL+FL  N V H D+K  NIL+
Sbjct: 106 TDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 150

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G L
Sbjct: 35  DVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 91
Query: 66  CSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++R  E    FQ QQ +   + +  A+++L      H DL  +N L+ + 
Sbjct: 92  LNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 141

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/158 (25%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +  T  ++ + +++++E+K +  L  H++IV +L        V +I EYC  GD
Sbjct: 78  KVAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 136
Query: 65  LCSFIRSHEK----------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L +F+R   +          L       F  Q+   + FL   N  H D+  +N+L+ N 
Sbjct: 137 LLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 196
Query: 115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
            +   G      +    S YI +GN ++      P  I
Sbjct: 197 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 234

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/114 (27%), Positives = 54/114 (47%), Gaps = 5/114 (4%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T+VA+K +    +S   F   + E   +K L H  +V +   +  E  +YII EY   G 
Sbjct: 38  TKVAVKTLKPGTMSVQAF---LEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGS 94
Query: 65  LCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           L  F++S E  K+   +   F  Q+   + ++   N  H DL+  N+L+  + +
Sbjct: 95  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM 148

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 55/111 (49%), Gaps = 6/111 (5%)
Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           +HT+VA+K +    +S    ++ + E   +K L H  +V +   +  E  +YII E+   
Sbjct: 38  KHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAK 93
Query: 63  GDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           G L  F++S E  K    +   F  Q+   + F+ + N  H DL+  NIL+
Sbjct: 94  GSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV 144

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 69/148 (46%), Gaps = 3/148 (2%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK I      E    + + E+  LK L H++I+ +   +     +++I EY +  DL 
Sbjct: 62  VAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLK 120
Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQGV 125
            ++  +  +S    + F+ QL+  + F       H DLKPQN+L+  ++  +   LK G 
Sbjct: 121 KYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180
Query: 126 SEKAKGSAY-IEQGNTKVICSVFEPREI 152
              A+     I Q   ++I   + P EI
Sbjct: 181 FGLARAFGIPIRQFTHEIITLWYRPPEI 208

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)
Query: 36  HHQHIVTMLDFLWDERYVYIILEYCDG---GDLCSFIRSHEKLSEFQCQQFVRQLVLALK 92
           HH+ ++         +Y+ +I+EY        L SFIRS   +       ++ QL  A+ 
Sbjct: 99  HHKSVIVNPS---QNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVG 155
Query: 93  FLRENNVCHFDLKPQNILI--KNNTLKL 118
           F+    +CH D+KPQN+L+  K+NTLKL
Sbjct: 156 FIHSLGICHRDIKPQNLLVNSKDNTLKL 183

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G L
Sbjct: 35  DVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 91
Query: 66  CSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++R  E    FQ QQ +   + +  A+++L      H DL  +N L+ + 
Sbjct: 92  LNYLR--EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQ 141

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 8/118 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 95
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 153

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII+E+   G+L 
Sbjct: 41  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 98  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 155
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 95
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 122 KQGV 125
              V
Sbjct: 156 GWSV 159

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI++EY   G 
Sbjct: 43  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGS 98
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 38  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 94
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 95  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANF 154
Query: 122 KQGV 125
              V
Sbjct: 155 GWSV 158

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI++EY   G 
Sbjct: 43  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVIEYMSKGS 98
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 36/138 (26%), Positives = 71/138 (51%), Gaps = 12/138 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   ++        E+  LK ++H++I+++L+    ++       VY+++E  
Sbjct: 50  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 109
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
           D  +LC  I  H +L   +    + Q++  +K L    + H DLKP NI++K++ TLK+ 
Sbjct: 110 DA-NLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 166
Query: 120 --GLKQGVSEKAKGSAYI 135
             GL +  S     + Y+
Sbjct: 167 DFGLARTASTNFMMTPYV 184

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 95
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANF 155
Query: 122 KQGV 125
              V
Sbjct: 156 GWSV 159

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 48.5 bits (114), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII+E+   G+L 
Sbjct: 41  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 97
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 98  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 155
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 8/118 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 118
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A
Sbjct: 119 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 176

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 8/118 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 40  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 96
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A
Sbjct: 97  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 154

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAP---L 92
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADF 152
Query: 122 KQGV 125
              V
Sbjct: 153 GWSV 156

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 8/118 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 93
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 151

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 48  VAIKKVLQGKAFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 102 PATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 162 LKLCDFGSAKQLVRG-----EPNVSXICSRY 187

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 97
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 98  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157
Query: 122 KQGV 125
              V
Sbjct: 158 GWSV 161

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 92
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 122 KQGV 125
              V
Sbjct: 153 GWSV 156

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 8/118 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 62  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 118
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A
Sbjct: 119 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 176

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 63/118 (53%), Gaps = 8/118 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 97
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA 119
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A
Sbjct: 98  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 155

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 41  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 97
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 98  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 157
Query: 122 KQGV 125
              V
Sbjct: 158 GWSV 161

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 92
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 122 KQGV 125
              V
Sbjct: 153 GWSV 156

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 92
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 122 KQGV 125
              V
Sbjct: 153 GWSV 156

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 92
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 122 KQGV 125
              V
Sbjct: 153 GWSV 156

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 92
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 93  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 122 KQGV 125
              V
Sbjct: 153 GWSV 156

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 6/121 (4%)
Query: 4   HTEVAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYV----YIILE 58
           H +VA+K +      +  F      E +    L+H  IV + D    E       YI++E
Sbjct: 37  HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLK 117
           Y DG  L   + +   ++  +  + +     AL F  +N + H D+KP NI+I   N +K
Sbjct: 97  YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 118 L 118
           +
Sbjct: 157 V 157

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 6/121 (4%)
Query: 4   HTEVAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYV----YIILE 58
           H +VA+K +      +  F      E +    L+H  IV + D    E       YI++E
Sbjct: 37  HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLK 117
           Y DG  L   + +   ++  +  + +     AL F  +N + H D+KP NI+I   N +K
Sbjct: 97  YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 118 L 118
           +
Sbjct: 157 V 157

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 46  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 103
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 104 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 161
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 162 LSRYMEDSTYYKASKGKLPIKWMAPESI 189

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 10/91 (10%)
Query: 39  HIVTMLDFLWD----ERYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALK 92
           HIV +LD   +    +R + II+E  +GG+L S I  R  +  +E +  + +R +  A++
Sbjct: 83  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 142
Query: 93  FLRENNVCHFDLKPQNILI----KNNTLKLA 119
           FL  +N+ H D+KP+N+L     K+  LKL 
Sbjct: 143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 69  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 126
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 127 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 184
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 185 LSRYMEDSTYYKASKGKLPIKWMAPESI 212

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 44  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 101
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 102 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 159
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 160 LSRYMEDSTYYKASKGKLPIKWMAPESI 187

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 35  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 91
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 92  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 151
Query: 122 KQGV 125
              V
Sbjct: 152 GWSV 155

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 93
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 122 KQGV 125
              V
Sbjct: 154 GWSV 157

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 93
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 153
Query: 122 KQGV 125
              V
Sbjct: 154 GWSV 157

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 95
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 122 KQGV 125
              V
Sbjct: 156 GWSV 159

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY   G  
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG-- 93
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 94  -TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 122 KQGV 125
              V
Sbjct: 153 GWSV 156

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 58/114 (50%), Gaps = 3/114 (2%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+K I   K  E    + + EI  LK L H +IV + D +  ++ + ++ E+ D  DL  
Sbjct: 30  ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKK 88
Query: 68  FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            +   E  L     + F+ QL+  + +  +  V H DLKPQN+LI +   LK+A
Sbjct: 89  LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 5/113 (4%)
Query: 26  VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK----LSEFQCQ 81
           + EI  LK L+H +++       ++  + I+LE  D GDL   I+  +K    + E    
Sbjct: 80  IKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVW 139
Query: 82  QFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQGVSEKAKGSA 133
           ++  QL  AL+ +    V H D+KP N+ I     +KL  L  G    +K +A
Sbjct: 140 KYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA 192

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 6/121 (4%)
Query: 4   HTEVAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYV----YIILE 58
           H +VA+K +      +  F      E +    L+H  IV + D    E       YI++E
Sbjct: 37  HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 96
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLK 117
           Y DG  L   + +   ++  +  + +     AL F  +N + H D+KP NI+I   N +K
Sbjct: 97  YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 118 L 118
           +
Sbjct: 157 V 157

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/102 (26%), Positives = 51/102 (50%), Gaps = 10/102 (9%)
Query: 21  RFD-----SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKL 75
           RFD     + + E+K ++ L H +++  +  L+ ++ +  I EY  GG L   I+S +  
Sbjct: 45  RFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD-- 102
Query: 76  SEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           S++   Q   F + +   + +L   N+ H DL   N L++ N
Sbjct: 103 SQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVREN 144

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 38  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 94
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 95  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 154
Query: 122 KQGV 125
              V
Sbjct: 155 GWSV 158

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 53  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 109
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 110 GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 169
Query: 122 KQGV 125
              V
Sbjct: 170 GWSV 173

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 95
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 122 KQGV 125
              V
Sbjct: 156 GWSV 159

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 58/114 (50%), Gaps = 3/114 (2%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+K I   K  E    + + EI  LK L H +IV + D +  ++ + ++ E+ D  DL  
Sbjct: 30  ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKK 88
Query: 68  FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            +   E  L     + F+ QL+  + +  +  V H DLKPQN+LI +   LK+A
Sbjct: 89  LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 10/91 (10%)
Query: 39  HIVTMLDFLWD----ERYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALK 92
           HIV +LD   +    +R + II+E  +GG+L S I  R  +  +E +  + +R +  A++
Sbjct: 64  HIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ 123
Query: 93  FLRENNVCHFDLKPQNILI----KNNTLKLA 119
           FL  +N+ H D+KP+N+L     K+  LKL 
Sbjct: 124 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 154

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 36/114 (31%), Positives = 58/114 (50%), Gaps = 3/114 (2%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+K I   K  E    + + EI  LK L H +IV + D +  ++ + ++ E+ D  DL  
Sbjct: 30  ALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKK 88
Query: 68  FIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            +   E  L     + F+ QL+  + +  +  V H DLKPQN+LI +   LK+A
Sbjct: 89  LLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 43  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 100
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 101 SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 158
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 159 LSRYMEDSTYYKASKGKLPIKWMAPESI 186

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 58/117 (49%), Gaps = 18/117 (15%)
Query: 11  CIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--------------VYII 56
            I K + +E +  +I++E+  L  L+HQ++V      W ER               ++I 
Sbjct: 35  AIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYA-AWLERRNFVKPMTAVKKKSTLFIQ 93
Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQ--QFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           +EYC+   L   I S E L++ + +  +  RQ++ AL ++    + H DLKP NI I
Sbjct: 94  MEYCENRTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI 149

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 33  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 89
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 90  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 149
Query: 122 KQGV 125
              V
Sbjct: 150 GWSV 153

>pdb|4IFD|D Chain D, Crystal Structure Of An 11-subunit Eukaryotic Exosome Complex Bound To Rna Length = 245

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 33/232 (14%)
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           G+ +   GS+     +TKVICSV  P E P ++  L  Q     L +E    P A  + T
Sbjct: 30  GILDHVDGSSEFVSQDTKVICSVTGPIE-PKARQELPTQ-----LALEIIVRP-AKGVAT 82
Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSA-------LSAAINC 236
                + EK L + L+  L P + RH +      +   +L++           LS  IN 
Sbjct: 83  -----TREKVLEDKLRAVLTPLITRHCYPRQLCQITCQILESGEDEAEFSLRELSCCINA 137
Query: 237 ANLALVDAAIPMYDLVTSSTLALRGGLT--FIDPVEEEVAYCQSLSSSEDDDSGVITLSY 294
           A LALVDA I +  +  S  +A+    +   +DP  E++    S+ +        + L +
Sbjct: 138 AFLALVDAGIALNSMCASIPIAIIKDTSDIIVDPTAEQLKISLSVHT--------LALEF 189
Query: 295 MSVIQQVTQVTLV---GTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVT 343
           ++  + V  V L+   G   +++L   +E     C+ L T+ +++++ D+++
Sbjct: 190 VNGGKVVKNVLLLDSNGDFNEDQLFSLLELGEQKCQELVTN-IRRIIQDNIS 240

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 210 TRVAIKTLKPGNMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 265
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 266 LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 317

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 41  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 98
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 99  SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 156
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESI 184

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 38  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 95
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 96  SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 153
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 154 LSRYMEDSTYYKASKGKLPIKWMAPESI 181

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 41  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 98
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 99  SFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 156
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESI 184

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY     L
Sbjct: 39  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---L 95
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 96  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 155
Query: 122 KQGV 125
              V
Sbjct: 156 GWSV 159

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 22/166 (13%)
Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY-VYIILEYCD 61
           +  +VA+KCI     ++    + + E   +  L H ++V +L  + +E+  +YI+ EY  
Sbjct: 43  RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 98
Query: 62  GGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
            G L  ++RS  +  L      +F   +  A+++L  NN  H DL  +N+L+  + +   
Sbjct: 99  KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--- 155
Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSK 165
                    AK S +   G TK   S  +  ++P   T+ E  R K
Sbjct: 156 ---------AKVSDF---GLTKEASSTQDTGKLPVKWTAPEALREK 189

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/124 (28%), Positives = 64/124 (51%), Gaps = 8/124 (6%)
Query: 7   VAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +   +  +  E++    L H +I+ +  +  D   VY+ILEY   G  
Sbjct: 36  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG-- 93
Query: 66  CSFIRSHEKLSEFQCQQ---FVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGL 121
            +  R  +KLS+F  Q+   ++ +L  AL +     V H D+KP+N+L+ +   LK+A  
Sbjct: 94  -TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADF 152
Query: 122 KQGV 125
              V
Sbjct: 153 GWSV 156

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 209 TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 264
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 316

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 46  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 103 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 160
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 209 TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 264
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 316

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/117 (25%), Positives = 59/117 (50%), Gaps = 7/117 (5%)
Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY-VYIILEYCD 61
           +  +VA+KCI     ++    + + E   +  L H ++V +L  + +E+  +YI+ EY  
Sbjct: 34  RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 89
Query: 62  GGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
            G L  ++RS  +  L      +F   +  A+++L  NN  H DL  +N+L+  + +
Sbjct: 90  KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 146

>pdb|3HQI|A Chain A, Structures Of Spop-Substrate Complexes: Insights Into Molecular Architectures Of Btb-Cul3 Ubiquitin Ligases: SpopmathxBTB3-Box-Pucsbc1 Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 28/68 (41%), Positives = 38/68 (55%), Gaps = 9/68 (13%)
Query: 354 SGLWSDCKFYVGND----VHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDIT 407
            GLW + +F    D    V  +EF+AHK IL+  SPVF+ MF  E+ E  K   +I D+ 
Sbjct: 166 GGLWENSRF---TDCCLCVAGQEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVE 222
Query: 408 PEAFSTML 415
           PE F  M+
Sbjct: 223 PEVFKEMM 230

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 60/135 (44%), Gaps = 8/135 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYV----YIILE 58
           H +VA+K +      +  F      E +    L+H  IV + D    E       YI++E
Sbjct: 54  HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 113
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLK 117
           Y DG  L   + +   ++  +  + +     AL F  +N + H D+KP NI+I   N +K
Sbjct: 114 YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 173
Query: 118 LA--GLKQGVSEKAK 130
           +   G+ + +++   
Sbjct: 174 VMDFGIARAIADSGN 188

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 73/140 (52%), Gaps = 18/140 (12%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 117 KLAGLKQGVSEKAKGSAYIE 136
           K+  L  G++  A  S  +E
Sbjct: 166 KI--LDFGLARTAGTSFMME 183

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 46/73 (63%), Gaps = 2/73 (2%)
Query: 49  DERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           DE ++Y++++Y  GGDL + +   E KL E   + ++ ++VLA+  + + +  H D+KP 
Sbjct: 145 DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPD 204
Query: 108 NILIK-NNTLKLA 119
           N+L+  N  ++LA
Sbjct: 205 NVLLDVNGHIRLA 217

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 54/114 (47%), Gaps = 5/114 (4%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T+VA+K +    +S   F   + E   +K L H  +V +   +  E  +YII E+   G 
Sbjct: 37  TKVAVKTLKPGTMSVQAF---LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGS 93
Query: 65  LCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           L  F++S E  K+   +   F  Q+   + ++   N  H DL+  N+L+  + +
Sbjct: 94  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLM 147

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 76/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 45  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 102
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  ++++H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 103 LRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 199

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 24/73 (32%), Positives = 46/73 (63%), Gaps = 2/73 (2%)
Query: 49  DERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           DE ++Y++++Y  GGDL + +   E KL E   + ++ ++VLA+  + + +  H D+KP 
Sbjct: 161 DENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPD 220
Query: 108 NILIK-NNTLKLA 119
           N+L+  N  ++LA
Sbjct: 221 NVLLDVNGHIRLA 233

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 150 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 204 KI--LDFGLARTA-GTSFM 219

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 73/140 (52%), Gaps = 18/140 (12%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 117 KLAGLKQGVSEKAKGSAYIE 136
           K+  L  G++  A  S  +E
Sbjct: 166 KI--LDFGLARTAGTSFMME 183

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 41  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 98  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 155
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 421 VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 478
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 479 SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 536
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESI 564

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/109 (26%), Positives = 56/109 (51%), Gaps = 2/109 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + K+  +E +    ++E   +    H +++ +   +     V II E+ + G L 
Sbjct: 64  VAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 122
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           SF+R ++ + +  Q    +R +   +K+L + N  H DL  +NIL+ +N
Sbjct: 123 SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSN 171

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 43  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 98
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII+E+   G+L 
Sbjct: 46  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 102
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 103 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 160
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 8/113 (7%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY + G 
Sbjct: 40  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGS 95
Query: 65  LCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++  E     +  Q V    Q+   + ++   N  H DL+  NIL+  N
Sbjct: 96  LLDFLKG-ETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGEN 147

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/113 (28%), Positives = 53/113 (46%), Gaps = 8/113 (7%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY + G 
Sbjct: 40  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMNKGS 95
Query: 65  LCSFIRSHEKLSEFQCQQFV---RQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++  E     +  Q V    Q+   + ++   N  H DL+  NIL+  N
Sbjct: 96  LLDFLKG-ETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGEN 147

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 41  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 98  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 155
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 67/130 (51%), Gaps = 9/130 (6%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF------LWDERYVYIILEY 59
           +VA+K + +   S         E++ LK L H++++ +LD       + D   VY++   
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 114
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
             G DL + ++S + LS+   Q  V QL+  LK++    + H DLKP N+ +  ++ +L 
Sbjct: 115 M-GADLNNIVKS-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDS-ELR 171
Query: 120 GLKQGVSEKA 129
            L  G++ +A
Sbjct: 172 ILDFGLARQA 181

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 36  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 91
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 92  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 143

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/115 (26%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           +T+VAIK +    +S    +S + E + +K L H  +V +   +  E  +YI+ EY + G
Sbjct: 33  NTKVAIKTLKPGTMSP---ESFLEEAQIMKKLKHDKLVQLYAVV-SEEPIYIVTEYMNKG 88
Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
            L  F++  E   L          Q+   + ++   N  H DL+  NIL+ N  +
Sbjct: 89  SLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLI 143

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 76/166 (45%), Gaps = 22/166 (13%)
Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY-VYIILEYCD 61
           +  +VA+KCI     ++    + + E   +  L H ++V +L  + +E+  +YI+ EY  
Sbjct: 28  RGNKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83
Query: 62  GGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
            G L  ++RS  +  L      +F   +  A+++L  NN  H DL  +N+L+  + +   
Sbjct: 84  KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV--- 140
Query: 120 GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSK 165
                    AK S +   G TK   S  +  ++P   T+ E  R K
Sbjct: 141 ---------AKVSDF---GLTKEASSTQDTGKLPVKWTAPEALREK 174

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/156 (25%), Positives = 75/156 (48%), Gaps = 29/156 (18%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEY 59
           EVAIK + + K  +NR      E++ ++++ H ++V +  F +      DE ++ ++LEY
Sbjct: 66  EVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119
Query: 60  CDGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KNN 114
                  +   + +  + +     + ++ QL+ +L ++    +CH D+KPQN+L+   + 
Sbjct: 120 VPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG 179
Query: 115 TLKLAGLKQGVSEKAKGSAYI---EQGNTKVICSVF 147
            LKL            GSA I    + N   ICS +
Sbjct: 180 VLKLIDF---------GSAKILIAGEPNVSXICSRY 206

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 32  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 87
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 88  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 139

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/128 (25%), Positives = 68/128 (53%), Gaps = 3/128 (2%)
Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEYCDGGDLC 66
           A+K ++K  + +    S   E + + +   +  +T L F + DE Y+Y+++EY  GGDL 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149
Query: 67  SFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           + + +  E++     + ++ ++V+A+  +      H D+KP NIL+ +   ++LA     
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209
Query: 125 VSEKAKGS 132
           +  +A G+
Sbjct: 210 LKLRADGT 217

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 34  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 89
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 90  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 141

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 149
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 150 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 203
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 204 KI--LDFGLARTA-GTSFM 219

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 49  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 106
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 107 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 166
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 167 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 203

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 114 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 167
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 168 KI--LDFGLARTA-GTSFM 183

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 48  VAIKKVLQGKAFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 162 LKLCDFGSAKQLVRG-----EPNVSYICSRY 187

>pdb|4EOZ|A Chain A, Crystal Structure Of The Spop Btb Domain Complexed With The Cul3 N- Terminal Domain Length = 145

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 32/83 (38%), Positives = 44/83 (53%), Gaps = 9/83 (10%)
Query: 339 SDHVTLPERGRYVLNSGLWSDCKFYVGND----VHCKEFKAHKLILSMSSPVFATMFHGE 394
           S+ V +PE        GLW + +F    D    V  +EF+AHK IL+  SPVF+ MF  E
Sbjct: 2   SNMVKVPECRLADELGGLWENSRF---TDCCLCVAGQEFQAHKAILAARSPVFSAMFEHE 58
Query: 395 LCE--KGDTKILDITPEAFSTML 415
           + E  K   +I D+ PE F  M+
Sbjct: 59  MEESKKNRVEINDVEPEVFKEMM 81

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 71/157 (45%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YI+ EY   G+L 
Sbjct: 60  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLL 116
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQ 123
            ++R  + E+++         Q+  A+++L + N  H DL  +N L+ +N+ +K+A    
Sbjct: 117 DYLRECNREEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADF-- 174
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +  S++
Sbjct: 175 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIK 211

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 48  VAIKKVLQGKAFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 162 LKLCDFGSAKQLVRG-----EPNVSYICSRY 187

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 58/114 (50%), Gaps = 7/114 (6%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY-VYIILEYCDGGD 64
           +VA+KCI     ++    + + E   +  L H ++V +L  + +E+  +YI+ EY   G 
Sbjct: 218 KVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273
Query: 65  LCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           L  ++RS  +  L      +F   +  A+++L  NN  H DL  +N+L+  + +
Sbjct: 274 LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNV 327

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 52/112 (46%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI++EY   G 
Sbjct: 43  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVMEYMSKGC 98
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/169 (24%), Positives = 75/169 (44%), Gaps = 17/169 (10%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           +T VA+K   +T +  +     + E + LK   H +IV ++     ++ +YI++E   GG
Sbjct: 139 NTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 64  DLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
           D  +F+R+   +L      Q V      +++L      H DL  +N L+ + N LK++  
Sbjct: 198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIP---SSKTSLEYQRSKGE 167
             G+S +     Y   G           R++P   ++  +L Y R   E
Sbjct: 258 --GMSREEADGVYAASGGL---------RQVPVKWTAPEALNYGRYSSE 295

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|3DD6|A Chain A, Crystal Structure Of Rph, An Exoribonuclease From Bacillus Anthracis At 1.7 A Resolution Length = 255

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/150 (27%), Positives = 69/150 (46%), Gaps = 28/150 (18%)
Query: 130 KGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYV--EFKFAPFASQIRTGWLR 187
           +GS  IE G+TKVICS      +P       + R +G+ +V  E+   P A++ RT  +R
Sbjct: 35  EGSVLIEVGDTKVICSATIEERVPP------FMRGEGKGWVTAEYAMIPRATEQRT--IR 86
Query: 188 DSEEK-------ELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
           +S +        E+   + RAL   V         V +   V+Q DG   +A+I  A +A
Sbjct: 87  ESSKGKVTGRTMEIQRLIGRALRAVVDLEALGERTVWIDCDVIQADGGTRTASITGAYVA 146
Query: 241 LVDA-----------AIPMYDLVTSSTLAL 259
           +V A            IP+ D + ++++ +
Sbjct: 147 MVLAFEKLLQAEKVSKIPVKDYLAATSVGI 176

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 209 TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVGEYMSKGS 264
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 265 LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 316

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 57/106 (53%), Gaps = 3/106 (2%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           EVAI+ ++  +  + + + I+NEI  ++   + +IV  LD       +++++EY  GG L
Sbjct: 48  EVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 105
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              + +   + E Q     R+ + AL+FL  N V H ++K  NIL+
Sbjct: 106 TDVV-TETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILL 150

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 60  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 117
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 118 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 177
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 73  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 130
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 131 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 190
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 191 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 227

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 117 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 170
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 171 KI--LDFGLARTA-GTSFM 186

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 113 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 167 KI--LDFGLARTA-GTSFM 182

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 45  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 102
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 103 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 199

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 60  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 117
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 118 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 177
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 178 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 214

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 40  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 97
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 98  LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 157
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 158 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 194

>pdb|2VKP|A Chain A, Crystal Structure Of Btb Domain From Btbd6 Length = 109

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Composition-based stats.
 Identities = 25/78 (32%), Positives = 41/78 (52%), Gaps = 1/78 (1%)
Query: 352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE-KGDTKILDITPEA 410
            N+ L +D  F VG     +   AHK +L++ S VF   F+G+L E K +  I D+ P A
Sbjct: 3   FNNELXADVHFVVGPPGATRTVPAHKYVLAVGSSVFYAXFYGDLAEVKSEIHIPDVEPAA 62
Query: 411 FSTMLDSDHHARVNISSD 428
           F  +L   +   +++ +D
Sbjct: 63  FLILLKYXYSDEIDLEAD 80

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 48  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 105
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 106 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 165
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 166 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 202

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 32/131 (24%), Positives = 66/131 (50%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+T+L     +  +Y+I+EY   G+L
Sbjct: 70  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 189 LVTENNVMKIA 199

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 113 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 167 KI--LDFGLARTA-GTSFM 182

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 28/102 (27%), Positives = 56/102 (54%), Gaps = 4/102 (3%)
Query: 27  NEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVR 85
            EI  L +  H++I+ + +       + +I E+  G D+   I +   +L+E +   +V 
Sbjct: 50  KEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVH 109
Query: 86  QLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLAGLKQG 124
           Q+  AL+FL  +N+ HFD++P+NI+    +++T+K+    Q 
Sbjct: 110 QVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 42  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 196

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 43  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVCEYMSKGS 98
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 112
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 113 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 166
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 167 KI--LDFGLARTA-GTSFM 182

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 47  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 104
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 105 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 164
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 165 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 201

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 110
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 111 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 164
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 165 KI--LDFGLARTA-GTSFM 180

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 42  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 160 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 196

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 41  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 98
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 99  LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 158
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 159 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 195

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 106 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 160 KI--LDFGLARTA-GTSFM 175

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 46  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 103
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 104 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 163
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 164 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 200

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 248 VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 304
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H +L  +N L+  N L K+A    
Sbjct: 305 DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADF-- 362
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 363 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

>pdb|3U1K|A Chain A, Crystal Structure Of Human Pnpase Length = 630

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/150 (28%), Positives = 81/150 (54%), Gaps = 14/150 (9%)
Query: 131 GSAYIEQGNTKVICSV-FEPRE--IPSSK--TSLEYQRSKGELYVEFKFAPFASQIRTGW 185
           GSA  ++G T+V+C+V F+  E  I S +  T++   + K    + ++F P+A+    G 
Sbjct: 343 GSALFQRGQTQVLCTVTFDSLESGIKSDQVITAINGIKDK-NFMLHYEFPPYATN-EIGK 400
Query: 186 LRDSEEKELGNHL--KRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
           +     +ELG+    ++AL P + R +F  F + +   VL+++GS+  A+    +LAL+D
Sbjct: 401 VTGLNRRELGHGALAEKALYPVIPR-DFP-FTIRVTSEVLESNGSSSMASACGGSLALMD 458
Query: 244 AAIPMYDLVTSSTLALRGGLTFIDPVEEEV 273
           + +P+   V    + L   +T  DP + E+
Sbjct: 459 SGVPISSAVAGVAIGL---VTKTDPEKGEI 485

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 105 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 159 KI--LDFGLARTA-GTSFM 174

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 83/174 (47%), Gaps = 31/174 (17%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K + K K   +  +++++E+K + +L  H++IV +L        +Y+I EYC  GD
Sbjct: 77  QVAVKML-KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGD 135
Query: 65  LCSFIRS-HEKLS----EFQCQQ------------------FVRQLVLALKFLRENNVCH 101
           L +++RS  EK S    E++ Q+                  F  Q+   ++FL   +  H
Sbjct: 136 LLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVH 195
Query: 102 FDLKPQNILIK-NNTLKLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
            DL  +N+L+     +K+   GL + +      S Y+ +GN ++      P  +
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLARDI---MSDSNYVVRGNARLPVKWMAPESL 246

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 106 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 160 KI--LDFGLARTA-GTSFM 175

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K + H+ +V +   +  E  +YI+ EY   G 
Sbjct: 43  TRVAIKTLKPGTMSPEAF---LQEAQVMKKIRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 98
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/119 (26%), Positives = 64/119 (53%), Gaps = 10/119 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   ++        E+  LK ++H++I+++L+    ++       VY+++E  
Sbjct: 52  VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           D  +LC  I  H +L   +    + Q++  +K L    + H DLKP NI++K++ TLK+
Sbjct: 112 DA-NLCQVI--HMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 167

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 105
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +LC  I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 106 DA-NLCQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 159
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 160 KI--LDFGLARTA-GTSFM 175

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K+++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q+++ +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLSQVIQMELDHERMS-----YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 50/112 (44%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 43  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGS 98
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL   NIL+  N
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGEN 150

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 46  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 103 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 160
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 63/123 (51%), Gaps = 17/123 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 127 VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 180
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-- 115
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 181 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 240
Query: 116 LKL 118
           LKL
Sbjct: 241 LKL 243

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 10/118 (8%)
Query: 6   EVAIKCIDKT--------KVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYII 56
           E A+K ID T        +V E R ++ + E+  L K+  H +I+ + D      + +++
Sbjct: 44  EYAVKIIDVTGGGSFSAEEVQELR-EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +    G+L  ++     LSE + ++ +R L+  +  L + N+ H DLKP+NIL+ ++
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 160

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 63/123 (51%), Gaps = 17/123 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 82  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-- 115
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 136 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
Query: 116 LKL 118
           LKL
Sbjct: 196 LKL 198

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K+++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q+++ +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLSQVIQMELDHERMS-----YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 63/123 (51%), Gaps = 17/123 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 84  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 137
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-- 115
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 138 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 197
Query: 116 LKL 118
           LKL
Sbjct: 198 LKL 200

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 43  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 100 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 157
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 158 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 35/123 (28%), Positives = 63/123 (51%), Gaps = 17/123 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 86  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 139
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-- 115
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 140 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 199
Query: 116 LKL 118
           LKL
Sbjct: 200 LKL 202

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 45  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 101
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 102 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 159
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 160 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 53  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 106
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 107 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 166
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 167 LKLCDFGSAKQLVRG-----EPNVSYICSRY 192

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 10/118 (8%)
Query: 6   EVAIKCIDKT--------KVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYII 56
           E A+K ID T        +V E R ++ + E+  L K+  H +I+ + D      + +++
Sbjct: 44  EYAVKIIDVTGGGSFSAEEVQELR-EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 102
Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +    G+L  ++     LSE + ++ +R L+  +  L + N+ H DLKP+NIL+ ++
Sbjct: 103 FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 160

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 46  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 103 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 160
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 161 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 43  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 100 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 157
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 158 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 82  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 136 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 195
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 196 LKLCDFGSAKQLVRG-----EPNVSXICSRY 221

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 60  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 113
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 114 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 173
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 174 LKLCDFGSAKQLVRG-----EPNVSXICSRY 199

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 76  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 129
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 130 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 189
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 190 LKLCDFGSAKQLVRG-----EPNVSYICSRY 215

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 43  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 99
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 100 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 157
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 158 GLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 194

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 76/139 (54%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K+++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q+++ +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLSQVIQMELDHERMS-----YLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 61  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 114
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 115 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 174
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 175 LKLCDFGSAKQLVRG-----EPNVSYICSRY 200

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 41  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 98  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 155
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

>pdb|2NN6|D Chain D, Structure Of The Human Rna Exosome Composed Of Rrp41, Rrp45, Rrp46, Rrp43, Mtr3, Rrp42, Csl4, Rrp4, And Rrp40 Length = 237

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 13/152 (8%)
Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQI 181
           +Q +  +  GSA   QG+T V+  V+ P E+  SK    + ++  E+ +  K        
Sbjct: 36  EQNLLSRPDGSASFLQGDTSVLAGVYGPAEVKVSKEI--FNKATLEVILRPKIG------ 87
Query: 182 RTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLAL 241
               L    EK     ++   E  V         + + + V+ + GS L+  +N A +AL
Sbjct: 88  ----LPGVAEKSRERLIRNTCEAVVLGTLHPRTSITVVLQVVSDAGSLLACCLNAACMAL 143
Query: 242 VDAAIPMYDLVTSSTLALRG-GLTFIDPVEEE 272
           VDA +PM  L      AL   G   +DP  ++
Sbjct: 144 VDAGVPMRALFCGVACALDSDGTLVLDPTSKQ 175

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 60  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 113
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 114 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 173
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 174 LKLCDFGSAKQLVRG-----EPNVSXICSRY 199

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 48  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 162 LKLCDFGSAKQLVRG-----EPNVSXICSRY 187

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 67  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 120
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 121 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 180
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 181 LKLCDFGSAKQLVRG-----EPNVSXICSRY 206

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 29/107 (27%), Positives = 59/107 (55%), Gaps = 7/107 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILEYCDGGD 64
           VA+K +D  K  + R + + NE+  ++   H+++V M +   + DE  +++++E+ +GG 
Sbjct: 179 VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGA 234
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L   + +H +++E Q       ++ AL  L    V H D+K  +IL+
Sbjct: 235 LTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 280

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 49  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 102
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 103 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 162
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 163 LKLCDFGSAKQLVRG-----EPNVSXICSRY 188

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 48  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 162 LKLCDFGSAKQLVRG-----EPNVSYICSRY 187

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 48  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 101
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 162 LKLCDFGSAKQLVRG-----EPNVSXICSRY 187

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 56  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 109
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 110 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 169
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 170 LKLCDFGSAKQLVRG-----EPNVSXICSRY 195

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 41  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 97
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 98  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 155
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 156 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/115 (25%), Positives = 60/115 (52%), Gaps = 8/115 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
            G DL + ++S +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  ++
Sbjct: 109 MGADLNNIVKS-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDS 162

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 54  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 110
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 111 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 168
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 169 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 205

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 42  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 98
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 99  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 156
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 157 GLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 193

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 39/151 (25%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 52  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 105
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 106 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 165
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 166 LKLCDFGSAKQLVRG-----EPNVSXICSRY 191

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 61/110 (55%), Gaps = 7/110 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILEYCDGGD 64
           VA+K +D  K  + R + + NE+  ++   H+++V M +   + DE  +++++E+ +GG 
Sbjct: 102 VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGA 157
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L   + +H +++E Q       ++ AL  L    V H D+K  +IL+ ++
Sbjct: 158 LTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 206

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 39  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 96  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 153
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  +      K       P  +  +K S++
Sbjct: 154 GLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIK 190

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/118 (27%), Positives = 62/118 (52%), Gaps = 10/118 (8%)
Query: 6   EVAIKCIDKT--------KVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYII 56
           E A+K ID T        +V E R ++ + E+  L K+  H +I+ + D      + +++
Sbjct: 31  EYAVKIIDVTGGGSFSAEEVQELR-EATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV 89
Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +    G+L  ++     LSE + ++ +R L+  +  L + N+ H DLKP+NIL+ ++
Sbjct: 90  FDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDD 147

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G 
Sbjct: 43  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGC 98
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 99  LLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 150

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/123 (27%), Positives = 55/123 (44%), Gaps = 22/123 (17%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVT------------MLDFLWDERYVY 54
            AIK +D T   E      +N +K  K  HH++I T            M D LW      
Sbjct: 52  AAIKVMDVTGDEEEEIKQEINMLK--KYSHHRNIATYYGAFIKKNPPGMDDQLW------ 103
Query: 55  IILEYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
           +++E+C  G +   I++ +   L E       R+++  L  L ++ V H D+K QN+L+ 
Sbjct: 104 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 163
Query: 113 NNT 115
            N 
Sbjct: 164 ENA 166

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/133 (24%), Positives = 67/133 (50%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 61  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 64  DL-------------CSFIRSHEKLSEFQCQQFVR---QLVLALKFLRENNVCHFDLKPQ 107
           +L              SF  SH    +   +  V    Q+   +++L      H DL  +
Sbjct: 120 NLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 179
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 180 NVLVTEDNVMKIA 192

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 41  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 98
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+   + +KL     G
Sbjct: 99  SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDF--G 156
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 157 LSRYMEDSTYYKASKGKLPIKWMAPESI 184

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 56/115 (48%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++   VAIK + K   +E +    + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 47  GKRELPVAIKTL-KVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYM 105
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L +F++ ++ + +  Q    +R +   +K+L +    H DL  +NILI +N
Sbjct: 106 ENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSN 160

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 58/124 (46%), Gaps = 12/124 (9%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLH---HQHIVTMLDFLWDERY-----VYIILE 58
           VA+K +      E    S V E+  L+ L    H ++V ++D     R      V ++ E
Sbjct: 32  VALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE 91
Query: 59  YCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNT 115
           + D  DL +++       L     +  +RQ +  L FL  N + H DLKP+NIL+    T
Sbjct: 92  HVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT 150
Query: 116 LKLA 119
           +KLA
Sbjct: 151 VKLA 154

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 58/124 (46%), Gaps = 12/124 (9%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLH---HQHIVTMLDFLWDERY-----VYIILE 58
           VA+K +      E    S V E+  L+ L    H ++V ++D     R      V ++ E
Sbjct: 32  VALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE 91
Query: 59  YCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNT 115
           + D  DL +++       L     +  +RQ +  L FL  N + H DLKP+NIL+    T
Sbjct: 92  HVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT 150
Query: 116 LKLA 119
           +KLA
Sbjct: 151 VKLA 154

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 61/110 (55%), Gaps = 7/110 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILEYCDGGD 64
           VA+K +D  K  + R + + NE+  ++   H+++V M +   + DE  +++++E+ +GG 
Sbjct: 59  VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGA 114
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L   + +H +++E Q       ++ AL  L    V H D+K  +IL+ ++
Sbjct: 115 LTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 163

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/159 (25%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+EY   G 
Sbjct: 42  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGS 99
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 100 LRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 159
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 160 LTKVLPQDKEFFKVKEPGESPIFW--YAPESLTESKFSV 196

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/133 (22%), Positives = 68/133 (51%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 61  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 120 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 179
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 180 NVLVTEDNVMKIA 192

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 61/110 (55%), Gaps = 7/110 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILEYCDGGD 64
           VA+K +D  K  + R + + NE+  ++   H+++V M +   + DE  +++++E+ +GG 
Sbjct: 57  VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGA 112
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L   + +H +++E Q       ++ AL  L    V H D+K  +IL+ ++
Sbjct: 113 LTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 161

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 71/141 (50%), Gaps = 8/141 (5%)
Query: 7   VAIKCIDKTKVSENRFDSI----VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           VAIK I     SE + D I    + EIK L+ L H +I+ +LD    +  + ++ ++ + 
Sbjct: 38  VAIKKIKLGHRSEAK-DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96
Query: 63  GDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAG 120
            DL   I+ +   L+    + ++   +  L++L ++ + H DLKP N+L+ +N  LKLA 
Sbjct: 97  -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLAD 155
Query: 121 LKQGVSEKAKGSAYIEQGNTK 141
                S  +   AY  Q  T+
Sbjct: 156 FGLAKSFGSPNRAYXHQVVTR 176

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 61/110 (55%), Gaps = 7/110 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILEYCDGGD 64
           VA+K +D  K  + R + + NE+  ++   H+++V M +   + DE  +++++E+ +GG 
Sbjct: 52  VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGA 107
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L   + +H +++E Q       ++ AL  L    V H D+K  +IL+ ++
Sbjct: 108 LTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 156

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/133 (22%), Positives = 68/133 (51%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 53  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 111
Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 112 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 171
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 172 NVLVTEDNVMKIA 184

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/133 (22%), Positives = 68/133 (51%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 61  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 120 NLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 179
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 180 NVLVTEDNVMKIA 192

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/110 (26%), Positives = 61/110 (55%), Gaps = 7/110 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILEYCDGGD 64
           VA+K +D  K  + R + + NE+  ++   H+++V M +   + DE  +++++E+ +GG 
Sbjct: 48  VAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE--LWVVMEFLEGGA 103
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L   + +H +++E Q       ++ AL  L    V H D+K  +IL+ ++
Sbjct: 104 LTDIV-THTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHD 152

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 36/150 (24%), Positives = 71/150 (47%), Gaps = 5/150 (3%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + K   +E +    ++E   +    H +I+ +   + +   V I+ E+ + G L 
Sbjct: 45  VAIKTL-KGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALD 103
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLA--GLK 122
           SF+R ++ + +  Q    +R +   +++L E +  H DL  +NIL+ +N + K++  GL 
Sbjct: 104 SFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLS 163
Query: 123 QGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
           + + E +    Y      K+      P  I
Sbjct: 164 RFLEENSSDPTYTSSLGGKIPIRWTAPEAI 193

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/133 (22%), Positives = 68/133 (51%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 54  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 112
Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 113 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 172
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 173 NVLVTEDNVMKIA 185

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII+E+   G+L 
Sbjct: 39  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 95
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 96  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 153
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G         K       P  +  +K S++
Sbjct: 154 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 37/124 (29%), Positives = 58/124 (46%), Gaps = 12/124 (9%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLH---HQHIVTMLDFLWDERY-----VYIILE 58
           VA+K +      E    S V E+  L+ L    H ++V ++D     R      V ++ E
Sbjct: 32  VALKSVRVPNGEEGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFE 91
Query: 59  YCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNT 115
           + D  DL +++       L     +  +RQ +  L FL  N + H DLKP+NIL+    T
Sbjct: 92  HVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGT 150
Query: 116 LKLA 119
           +KLA
Sbjct: 151 VKLA 154

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 30/133 (22%), Positives = 68/133 (51%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 50  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 108
Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 109 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 168
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 169 NVLVTEDNVMKIA 181

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 6/160 (3%)
Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           +T VA+K   +T +  +     + E + LK   H +IV ++     ++ +YI++E   GG
Sbjct: 139 NTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 197
Query: 64  DLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
           D  +F+R+   +L      Q V      +++L      H DL  +N L+ + N LK++  
Sbjct: 198 DFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDF 257
Query: 122 KQGVS-EKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
             G+S E+A G      G  +V      P  +   + S E
Sbjct: 258 --GMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 51/110 (46%), Gaps = 4/110 (3%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VA+K I +  +SE+ F     E + +  L H  +V        E  +YI+ EY   G L
Sbjct: 34  DVAVKMIKEGSMSEDEF---FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90
Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +++RSH K L   Q  +    +   + FL  +   H DL  +N L+  +
Sbjct: 91  LNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRD 140

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 10/159 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGD 64
           VA+K +  +  +E        EI+ LK L H +IV      +    R + +I+E+   G 
Sbjct: 45  VAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYGS 102
Query: 65  LCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLA--G 120
           L  +++ H E++   +  Q+  Q+   +++L      H DL  +NIL++N N +K+   G
Sbjct: 103 LREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFG 162
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL 159
           L + + +  +     E G + +    + P  +  SK S+
Sbjct: 163 LTKVLPQDKEXXKVKEPGESPIFW--YAPESLTESKFSV 199

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 287 VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 343
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H +L  +N L+  N L K+A    
Sbjct: 344 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADF-- 401
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G  Y      K       P  +  +K S++
Sbjct: 402 GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 438

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 70/140 (50%), Gaps = 21/140 (15%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 116 VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 234
Query: 110 LI-KNNTLKLA--GLKQGVS 126
           L+ +NN +K+A  GL + ++
Sbjct: 235 LVTENNVMKIADFGLARDIN 254

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 421 VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 478
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+   + +KL     G
Sbjct: 479 SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDF--G 536
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S Y +    K+      P  I
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWMAPESI 564

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/115 (23%), Positives = 57/115 (49%), Gaps = 2/115 (1%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++   VAIK + K   +E +    + E   +    H ++V +   +   + V I++E+ 
Sbjct: 68  GKRDVAVAIKTL-KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFM 126
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + G L +F+R H+ + +  Q    +R +   +++L +    H DL  +NIL+ +N
Sbjct: 127 ENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSN 181

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/133 (22%), Positives = 68/133 (51%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 102 TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 160
Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 221 NVLVTEDNVMKIA 233

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 30/133 (22%), Positives = 68/133 (51%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 61  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 119
Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 120 NLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 179
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 180 NVLVTEDNVMKIA 192

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/117 (28%), Positives = 57/117 (48%), Gaps = 18/117 (15%)
Query: 11  CIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--------------VYII 56
            I K + +E +  +I++E+  L  L+HQ++V      W ER               ++I 
Sbjct: 35  AIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYA-AWLERRNFVKPXTAVKKKSTLFIQ 93
Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQ--QFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            EYC+   L   I S E L++ + +  +  RQ++ AL ++    + H +LKP NI I
Sbjct: 94  XEYCENRTLYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFI 149

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 2/109 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK +      + R D  ++E   +    H +I+ +   +   + V II EY + G L 
Sbjct: 60  VAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD 118
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           +F+R ++ + +  Q    +R +   +K+L + +  H DL  +NIL+ +N
Sbjct: 119 AFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSN 167

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/121 (25%), Positives = 53/121 (43%), Gaps = 6/121 (4%)
Query: 4   HTEVAIKCIDKTKVSENRFD-SIVNEIKALKLLHHQHIVTMLDFLWDERYV----YIILE 58
           H +VA+K +      +  F      E +    L+H  IV +      E       YI++E
Sbjct: 37  HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVME 96
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLK 117
           Y DG  L   + +   ++  +  + +     AL F  +N + H D+KP NI+I   N +K
Sbjct: 97  YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 156
Query: 118 L 118
           +
Sbjct: 157 V 157

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 30/133 (22%), Positives = 68/133 (51%), Gaps = 19/133 (14%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY   G
Sbjct: 46  TKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 104
Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 105 NLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164
Query: 108 NILI-KNNTLKLA 119
           N+L+ ++N +K+A
Sbjct: 165 NVLVTEDNVMKIA 177

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 65/131 (49%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 70  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 189 LVTENNVMKIA 199

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 74/171 (43%), Gaps = 25/171 (14%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +  T  ++ + +++++E+K +  L  H++IV +L        V +I EYC  GD
Sbjct: 63  KVAVKMLKSTAHADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGD 121
Query: 65  LCSFIRSHEK------LSEFQCQQ-----------------FVRQLVLALKFLRENNVCH 101
           L +F+R   +      L+  Q  +                 F  Q+   + FL   N  H
Sbjct: 122 LLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIH 181
Query: 102 FDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
            D+  +N+L+ N  +   G      +    S YI +GN ++      P  I
Sbjct: 182 RDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESI 232

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/109 (25%), Positives = 56/109 (51%), Gaps = 2/109 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + K   +E +    ++E   +    H +I+ +   + +   V I+ E+ + G L 
Sbjct: 47  VAIKTL-KGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALD 105
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           SF+R ++ + +  Q    +R +   +++L E +  H DL  +NIL+ +N
Sbjct: 106 SFLRLNDGQFTVIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSN 154

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 65/131 (49%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 70  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 189 LVTENNVMKIA 199

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 65/131 (49%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 70  VAVKML-KDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 189 LVTENNVMKIA 199

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 65/131 (49%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 62  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 180
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 181 LVTENNVMKIA 191

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 65/131 (49%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 70  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 189 LVTENNVMKIA 199

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K+++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLSQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 65/131 (49%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 59  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 117
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 118 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 177
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 178 LVTENNVMKIA 188

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/134 (25%), Positives = 68/134 (50%), Gaps = 11/134 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL- 118
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +  LK+ 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 119 -AGLKQGVSEKAKG 131
            AGL +   ++  G
Sbjct: 168 DAGLARHTDDEMTG 181

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 22/76 (28%), Positives = 41/76 (53%)
Query: 36  HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR 95
           +H  +V +      E  ++ ++EY +GGDL   ++   KL E   + +  ++ LAL +L 
Sbjct: 111 NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 170
Query: 96  ENNVCHFDLKPQNILI 111
           E  + + DLK  N+L+
Sbjct: 171 ERGIIYRDLKLDNVLL 186

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 35/130 (26%), Positives = 66/130 (50%), Gaps = 9/130 (6%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF------LWDERYVYIILEY 59
           +VA+K + +   S         E++ LK L H++++ +LD       + D   VY++   
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 114
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
             G DL + ++  + LS+   Q  V QL+  LK++    + H DLKP N+ +  ++ +L 
Sbjct: 115 M-GADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDS-ELR 171
Query: 120 GLKQGVSEKA 129
            L  G++ +A
Sbjct: 172 ILDFGLARQA 181

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 2/109 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK +      + R D  ++E   +    H +I+ +   +   + V II EY + G L 
Sbjct: 39  VAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD 97
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           +F+R ++ + +  Q    +R +   +K+L + +  H DL  +NIL+ +N
Sbjct: 98  AFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN 146

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK   K   S++  +  + E   ++   H HIV ++  +  E  V+II+E C  G+L 
Sbjct: 41  VAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELR 98
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
           SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL     G
Sbjct: 99  SFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDF--G 156
Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREI 152
           +S   + S   +    K+      P  I
Sbjct: 157 LSRYMEDSTXXKASKGKLPIKWMAPESI 184

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 49/107 (45%), Gaps = 16/107 (14%)
Query: 26  VNEIKALKLLHHQHIVTMLDFLWDE--------------RYVYIILEYCDGGDLCSFIRS 71
           + EIK ++ L H +IV + + L                   VYI+ EY +  DL + +  
Sbjct: 56  LREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMET-DLANVLEQ 114
Query: 72  HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
              L E   + F+ QL+  LK++   NV H DLKP N+ I    L L
Sbjct: 115 GPLLEE-HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 46/77 (59%), Gaps = 4/77 (5%)
Query: 37  HQHIVTMLDFLW--DERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL 94
           H++IV +L+ L   ++R VY++ +Y +  DL + IR++  L     Q  V QL+  +K+L
Sbjct: 68  HENIVNLLNVLRADNDRDVYLVFDYMET-DLHAVIRAN-ILEPVHKQYVVYQLIKVIKYL 125
Query: 95  RENNVCHFDLKPQNILI 111
               + H D+KP NIL+
Sbjct: 126 HSGGLLHRDMKPSNILL 142

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 70/140 (50%), Gaps = 21/140 (15%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 57  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 115
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 116 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNV 175
Query: 110 LI-KNNTLKLA--GLKQGVS 126
           L+ +NN +K+A  GL + ++
Sbjct: 176 LVTENNVMKIADFGLARDIN 195

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/109 (26%), Positives = 55/109 (50%), Gaps = 2/109 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK +      + R D  ++E   +    H +I+ +   +   + V II EY + G L 
Sbjct: 45  VAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLD 103
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           +F+R ++ + +  Q    +R +   +K+L + +  H DL  +NIL+ +N
Sbjct: 104 AFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSN 152

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%)
Query: 35  LHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL 94
           ++H  IV +      E  +Y+IL++  GGDL + +      +E   + ++ +L LAL  L
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 95  RENNVCHFDLKPQNILI 111
               + + DLKP+NIL+
Sbjct: 143 HSLGIIYRDLKPENILL 159

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 65/130 (50%), Gaps = 9/130 (6%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF------LWDERYVYIILEY 59
           +VA+K + +   S         E++ LK L H++++ +LD       + D   VY++   
Sbjct: 47  KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTTL 106
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA 119
             G DL + ++  + LS+   Q  V QL+  LK++    + H DLKP N+ + N   +L 
Sbjct: 107 M-GADLNNIVKC-QALSDEHVQFLVYQLLRGLKYIHSAGIIHRDLKPSNVAV-NEDCELR 163
Query: 120 GLKQGVSEKA 129
            L  G++ +A
Sbjct: 164 ILDFGLARQA 173

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 28/109 (25%), Positives = 55/109 (50%), Gaps = 2/109 (1%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + K+  +E +    ++E   +    H +++ +   +     V II E+ + G L 
Sbjct: 38  VAIKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLD 96
Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           SF+R ++ + +  Q    +R +   +K+L + N  H  L  +NIL+ +N
Sbjct: 97  SFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSN 145

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/76 (28%), Positives = 41/76 (53%)
Query: 36  HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR 95
           +H  +V +      E  ++ ++EY +GGDL   ++   KL E   + +  ++ LAL +L 
Sbjct: 79  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 138
Query: 96  ENNVCHFDLKPQNILI 111
           E  + + DLK  N+L+
Sbjct: 139 ERGIIYRDLKLDNVLL 154

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%)
Query: 35  LHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL 94
           ++H  IV +      E  +Y+IL++  GGDL + +      +E   + ++ +L LAL  L
Sbjct: 84  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 143
Query: 95  RENNVCHFDLKPQNILI 111
               + + DLKP+NIL+
Sbjct: 144 HSLGIIYRDLKPENILL 160

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/113 (26%), Positives = 58/113 (51%), Gaps = 5/113 (4%)
Query: 1   NEQHT--EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILE 58
            E+H+  +VA+K +D  K  + R + + NE+  ++   H ++V M         +++++E
Sbjct: 65  REKHSGRQVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122
Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           +  GG L   + S  +L+E Q       ++ AL +L    V H D+K  +IL+
Sbjct: 123 FLQGGALTDIV-SQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL 174

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/107 (28%), Positives = 57/107 (53%), Gaps = 14/107 (13%)
Query: 39  HIVTMLDFLWDERY-----VYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLAL 91
           HIV ++D +++  Y     + I++E  DGG+L S I  R  +  +E +  + ++ +  A+
Sbjct: 72  HIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 92  KFLRENNVCHFDLKPQNILI----KNNTLKLAGLKQGVSEKAKGSAY 134
           ++L   N+ H D+KP+N+L      N  LKL     G +++  G  Y
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF--GFAKETTGEKY 175

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 24/77 (31%), Positives = 42/77 (54%)
Query: 35  LHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL 94
           ++H  IV +      E  +Y+IL++  GGDL + +      +E   + ++ +L LAL  L
Sbjct: 83  VNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHL 142
Query: 95  RENNVCHFDLKPQNILI 111
               + + DLKP+NIL+
Sbjct: 143 HSLGIIYRDLKPENILL 159

>pdb|3B4T|A Chain A, Crystal Structure Of Mycobacterium Tuberculosis Rnase Ph, The Mycobacterium Tuberculosis Structural Genomics Consortium Target Rv1340 Length = 262

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/130 (27%), Positives = 57/130 (43%), Gaps = 11/130 (8%)
Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           + +G +E   GS  IE G+TKV+C+      +P  + +       G L  E+   P A+ 
Sbjct: 21  ITRGFTENPAGSVLIEFGHTKVLCTASVTEGVPRWRKATGL----GWLTAEYAMLPSATH 76
Query: 181 IRT------GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAI 234
            R+      G L     +E+   + R+L   +         + +   VLQ DG   +AAI
Sbjct: 77  SRSDRESVRGRL-SGRTQEISRLIGRSLRACIDLAALGENTIAIDCDVLQADGGTRTAAI 135
Query: 235 NCANLALVDA 244
             A +AL DA
Sbjct: 136 TGAYVALADA 145

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K +  +     R +++++E+K L  L +H +IV +L          +I EYC  GDL
Sbjct: 56  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 114
Query: 66  CSFIRSHEKLSEFQCQQ--------------------FVRQLVLALKFLRENNVCHFDLK 105
            +F+R   K   F C +                    F  Q+   + FL   N  H DL 
Sbjct: 115 LNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 172
Query: 106 PQNILIKNNTL-KLAGLKQGVSEKAKG-SAYIEQGNTKVICSVFEPREI 152
            +NIL+ +  + K+     G++   K  S Y+ +GN ++      P  I
Sbjct: 173 ARNILLTHGRITKICDF--GLARDIKNDSNYVVKGNARLPVKWMAPESI 219

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/76 (28%), Positives = 41/76 (53%)
Query: 36  HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR 95
           +H  +V +      E  ++ ++EY +GGDL   ++   KL E   + +  ++ LAL +L 
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 96  ENNVCHFDLKPQNILI 111
           E  + + DLK  N+L+
Sbjct: 124 ERGIIYRDLKLDNVLL 139

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 65/126 (51%), Gaps = 9/126 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAG 120
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ + N   +L  
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKI 166
Query: 121 LKQGVS 126
           L +G++
Sbjct: 167 LDRGLA 172

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/122 (25%), Positives = 62/122 (50%), Gaps = 9/122 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +  LK+ 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 120 GL 121
           G 
Sbjct: 168 GF 169

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 32  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 90
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 91  EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 150
Query: 119 A--GLKQGVSEKAKGSAYIEQ 137
              GL   V  +  GS   EQ
Sbjct: 151 GDFGLAT-VKSRWSGSHQFEQ 170

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 50/112 (44%), Gaps = 6/112 (5%)
Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   +  E  + I+ EY   G 
Sbjct: 33  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIXIVTEYMSKGS 88
Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  F++    + L   Q      Q+   + ++   N  H DL+  NIL+  N
Sbjct: 89  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGEN 140

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 38/157 (24%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 39  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 95
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + +++S         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 96  DYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 153
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G         K       P  +  +K S++
Sbjct: 154 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 29  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 87
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 88  EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 147
Query: 119 A--GLKQGVSEKAKGSAYIEQ 137
              GL   V  +  GS   EQ
Sbjct: 148 GDFGLAT-VKSRWSGSHQFEQ 167

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 55  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 113
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 114 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 173
Query: 119 A--GLKQGVSEKAKGSAYIEQ 137
              GL   V  +  GS   EQ
Sbjct: 174 GDFGLAT-VKSRWSGSHQFEQ 193

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 22/76 (28%), Positives = 41/76 (53%)
Query: 36  HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR 95
           +H  +V +      E  ++ ++EY +GGDL   ++   KL E   + +  ++ LAL +L 
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 96  ENNVCHFDLKPQNILI 111
           E  + + DLK  N+L+
Sbjct: 128 ERGIIYRDLKLDNVLL 143

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/114 (25%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + K   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 62  VAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 120
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 173

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 54  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 112
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 113 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 172
Query: 119 A--GLKQGVSEKAKGSAYIEQ 137
              GL   V  +  GS   EQ
Sbjct: 173 GDFGLAT-VKSRWSGSHQFEQ 192

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 32  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 90
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 91  EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 150
Query: 119 A--GLKQGVSEKAKGSAYIEQ 137
              GL   V  +  GS   EQ
Sbjct: 151 GDFGLAT-VKSRWSGSHQFEQ 170

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 6/141 (4%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 27  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 85
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 86  EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 145
Query: 119 A--GLKQGVSEKAKGSAYIEQ 137
              GL   V  +  GS   EQ
Sbjct: 146 GDFGLAT-VKSRWSGSHQFEQ 165

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 70/157 (44%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII+E+   G+L 
Sbjct: 42  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLL 98
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 99  DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 156
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G         K       P  +  +K S++
Sbjct: 157 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 193

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 30/131 (22%), Positives = 65/131 (49%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 70  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +++A
Sbjct: 189 LVTENNVMRIA 199

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLXQVIQMELDHERMS-----YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDE----RYVYIILEYCDGGDLCSFIRSHEK---L 75
           D  + E + LK L+H++IV +  F  +E    R+  +I+E+C  G L + +        L
Sbjct: 52  DVQMREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109
Query: 76  SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
            E +    +R +V  +  LREN + H ++KP NI+
Sbjct: 110 PESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/155 (29%), Positives = 73/155 (47%), Gaps = 23/155 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW-----DERYVY--IILEY 59
           VAIK + +     NR   I+ +   L +LHH +IV +  + +     D R +Y  +++EY
Sbjct: 51  VAIKKVIQDPRFRNRELQIMQD---LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107
Query: 60  C-DGGDLC--SFIRSHEKLSEFQCQQFVRQLVLALK--FLRENNVCHFDLKPQNILIK-- 112
             D    C  ++ R          + F+ QL+ ++    L   NVCH D+KP N+L+   
Sbjct: 108 VPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEA 167
Query: 113 NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF 147
           + TLKL     G ++K   S    + N   ICS +
Sbjct: 168 DGTLKLCDF--GSAKKLSPS----EPNVAYICSRY 196

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K +  +     R +++++E+K L  L +H +IV +L          +I EYC  GDL
Sbjct: 72  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 130
Query: 66  CSFIRSHEKLSEFQCQQ--------------------FVRQLVLALKFLRENNVCHFDLK 105
            +F+R   K   F C +                    F  Q+   + FL   N  H DL 
Sbjct: 131 LNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 188
Query: 106 PQNILIKNNTL-KLAGLKQGVSEKAKG-SAYIEQGNTKVICSVFEPREI 152
            +NIL+ +  + K+     G++   K  S Y+ +GN ++      P  I
Sbjct: 189 ARNILLTHGRITKICDF--GLARDIKNDSNYVVKGNARLPVKWMAPESI 235

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/95 (30%), Positives = 50/95 (52%), Gaps = 9/95 (9%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDE----RYVYIILEYCDGGDLCSFIRSHEK---L 75
           D  + E + LK L+H++IV +  F  +E    R+  +I+E+C  G L + +        L
Sbjct: 52  DVQMREFEVLKKLNHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGL 109
Query: 76  SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
            E +    +R +V  +  LREN + H ++KP NI+
Sbjct: 110 PESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIM 144

>pdb|1OYP|A Chain A, Crystal Structure Of The Phosphorolytic Exoribonuclease Rnase Ph From Bacillus Subtilis Length = 245

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 37/137 (27%), Positives = 63/137 (45%), Gaps = 20/137 (14%)
Query: 130 KGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYV--EFKFAPFASQIRTGWLR 187
           +GS  I  GNTKVIC+      +P       + R  G+ ++  E+   P A+  RT  +R
Sbjct: 25  EGSVLITAGNTKVICNASVEDRVPP------FLRGGGKGWITAEYSMLPRATNQRT--IR 76
Query: 188 DSEEKELGNH-------LKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
           +S + ++          + RAL   V   +     + +   V+Q DG   +A+I  A LA
Sbjct: 77  ESSKGKISGRTMEIQRLIGRALRAVVDLEKLGERTIWIDCDVIQADGGTRTASITGAFLA 136
Query: 241 LVDAAIPMYDLVTSSTL 257
           +   AI +  L+ + T+
Sbjct: 137 M---AIAIGKLIKAGTI 150

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 31/131 (23%), Positives = 65/131 (49%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY   G+L
Sbjct: 70  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 189 LVTENNVMKIA 199

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 64/126 (50%), Gaps = 9/126 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAG 120
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ + N   +L  
Sbjct: 109 MGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDXELKI 166
Query: 121 LKQGVS 126
           L  G++
Sbjct: 167 LDFGLA 172

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K +  +     R +++++E+K L  L +H +IV +L          +I EYC  GDL
Sbjct: 74  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 132
Query: 66  CSFIRSHEKLSEFQCQQ--------------------FVRQLVLALKFLRENNVCHFDLK 105
            +F+R   K   F C +                    F  Q+   + FL   N  H DL 
Sbjct: 133 LNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 190
Query: 106 PQNILIKNNTL-KLAGLKQGVSEKAKG-SAYIEQGNTKVICSVFEPREI 152
            +NIL+ +  + K+     G++   K  S Y+ +GN ++      P  I
Sbjct: 191 ARNILLTHGRITKICDF--GLARDIKNDSNYVVKGNARLPVKWMAPESI 237

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K +  +     R +++++E+K L  L +H +IV +L          +I EYC  GDL
Sbjct: 79  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 137
Query: 66  CSFIRSHEKLSEFQCQQ--------------------FVRQLVLALKFLRENNVCHFDLK 105
            +F+R   K   F C +                    F  Q+   + FL   N  H DL 
Sbjct: 138 LNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 195
Query: 106 PQNILIKNNTL-KLAGLKQGVSEKAKG-SAYIEQGNTKVICSVFEPREI 152
            +NIL+ +  + K+     G++   K  S Y+ +GN ++      P  I
Sbjct: 196 ARNILLTHGRITKICDF--GLARDIKNDSNYVVKGNARLPVKWMAPESI 242

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 59/115 (51%), Gaps = 8/115 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 56  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 114
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  ++
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDS 168

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 474
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 475 LVHQVSMGMKYLEESNFVHRDLAARNVLL 503

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/115 (24%), Positives = 59/115 (51%), Gaps = 8/115 (6%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 52  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 110
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  ++
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDS 164

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 73/169 (43%), Gaps = 28/169 (16%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K +  +     R +++++E+K L  L +H +IV +L          +I EYC  GDL
Sbjct: 79  VAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL 137
Query: 66  CSFIRSHEKLSEFQCQQ--------------------FVRQLVLALKFLRENNVCHFDLK 105
            +F+R   K   F C +                    F  Q+   + FL   N  H DL 
Sbjct: 138 LNFLR--RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLA 195
Query: 106 PQNILIKNNTL-KLAGLKQGVSEKAKG-SAYIEQGNTKVICSVFEPREI 152
            +NIL+ +  + K+     G++   K  S Y+ +GN ++      P  I
Sbjct: 196 ARNILLTHGRITKICDF--GLARHIKNDSNYVVKGNARLPVKWMAPESI 242

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKX-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 3/112 (2%)
Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VAIK +  + K S  ++  I+ E++ L+ L H + +        E   ++++EYC  G  
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSA 140
Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
              +  H+K L E +        +  L +L  +N+ H D+K  NIL+    L
Sbjct: 141 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 192

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 56  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 114
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 62/139 (44%), Gaps = 21/139 (15%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           + AIK + K   S++       E++ L KL HH +I+ +L       Y+Y+ +EY   G+
Sbjct: 44  DAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 102
Query: 65  LCSFIR----------------SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           L  F+R                +   LS  Q   F   +   + +L +    H DL  +N
Sbjct: 103 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 162
Query: 109 ILIKNNTL-KLA--GLKQG 124
           IL+  N + K+A  GL +G
Sbjct: 163 ILVGENYVAKIADFGLSRG 181

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 30/109 (27%), Positives = 50/109 (45%), Gaps = 1/109 (0%)
Query: 7   VAIKCIDKTKVSENRFDSIVN-EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K   +T  S+  F +    E +    L   H+V + DF   +  +Y+     +G DL
Sbjct: 62  VALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLINGVDL 121
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            + +R    L+  +    VRQ+  AL         H D+KP+NIL+  +
Sbjct: 122 AAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSAD 170

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 473
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 474 LVHQVSMGMKYLEESNFVHRDLAARNVLL 502

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 62/139 (44%), Gaps = 21/139 (15%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           + AIK + K   S++       E++ L KL HH +I+ +L       Y+Y+ +EY   G+
Sbjct: 54  DAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 112
Query: 65  LCSFIR----------------SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           L  F+R                +   LS  Q   F   +   + +L +    H DL  +N
Sbjct: 113 LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172
Query: 109 ILIKNNTL-KLA--GLKQG 124
           IL+  N + K+A  GL +G
Sbjct: 173 ILVGENYVAKIADFGLSRG 191

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 74/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLSQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 74/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+ +L+    ++       VYI++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLSQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 70  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 128
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 181

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 67/134 (50%), Gaps = 11/134 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL- 118
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +  LK+ 
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 167
Query: 119 -AGLKQGVSEKAKG 131
             GL +   ++  G
Sbjct: 168 DGGLARHTDDEMTG 181

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 56  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 114
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 18/160 (11%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +   SE+       E + L +L HQHIV       + R + ++ EY   GDL 
Sbjct: 74  VAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 131
Query: 67  SFIRSH---------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            F+RSH                 L   Q      Q+   + +L   +  H DL  +N L+
Sbjct: 132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE 151
               +   G   G+S     + Y   G   ++   + P E
Sbjct: 192 GQGLVVKIG-DFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 230

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 34/114 (29%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIIL 57
           + T VAIK I   +  +      + EI+ L    H++++ + D L        R VYI+ 
Sbjct: 67  RKTRVAIKKISPFE-HQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQ 125
Query: 58  EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           +  +  DL   ++S +  ++  C  F+ Q++  LK++   NV H DLKP N+LI
Sbjct: 126 DLMET-DLYKLLKSQQLSNDHICY-FLYQILRGLKYIHSANVLHRDLKPSNLLI 177

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 69  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 127
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 128 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 180

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 70  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 128
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 181

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 69  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 127
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 128 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 180

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 55  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 113
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 114 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 173
Query: 119 A--GLKQGVSEKAK--GSAYIEQ 137
              GL    +EK++  GS   EQ
Sbjct: 174 GDFGL---ATEKSRWSGSHQFEQ 193

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 104
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 105 DA-NLXQVIQMELDHERMS-----YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 158
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 159 KI--LDFGLARTA-GTSFM 174

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 64/126 (50%), Gaps = 9/126 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAG 120
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ + N   +L  
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDCELKI 166
Query: 121 LKQGVS 126
           L  G++
Sbjct: 167 LDYGLA 172

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLXQVIQMELDHERMS-----YLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 16/158 (10%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K +     S+N       E + L  L H+HIV       +   + ++ EY   GDL 
Sbjct: 46  VAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLN 103
Query: 67  SFIRSH-------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
            F+R+H              +L++ Q     +Q+   + +L   +  H DL  +N L+  
Sbjct: 104 KFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGE 163
Query: 114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE 151
           N L   G   G+S     + Y   G   ++   + P E
Sbjct: 164 NLLVKIG-DFGMSRDVYSTDYYRVGGHTMLPIRWMPPE 200

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 36/139 (25%), Positives = 75/139 (53%), Gaps = 19/139 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VAIK + +   ++        E+  +K ++H++I+++L+    ++       VY+++E  
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM 111
Query: 61  DGGDLCSFIR---SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           D  +L   I+    HE++S       + Q++  +K L    + H DLKP NI++K++ TL
Sbjct: 112 DA-NLXQVIQMELDHERMS-----YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTL 165
Query: 117 KLAGLKQGVSEKAKGSAYI 135
           K+  L  G++  A G++++
Sbjct: 166 KI--LDFGLARTA-GTSFM 181

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 34/141 (24%), Positives = 64/141 (45%), Gaps = 6/141 (4%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +      + I+ ++C
Sbjct: 27  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWC 85
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 86  EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 145
Query: 119 A--GLKQGVSEKAKGSAYIEQ 137
              GL   V  +  GS   EQ
Sbjct: 146 GDFGLAT-VKSRWSGSHQFEQ 165

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 70  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 128
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 129 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 181

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 68/134 (50%), Gaps = 11/134 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 57  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 115
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +  LK+ 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 120 --GLKQGVSEKAKG 131
             GL +  +++  G
Sbjct: 175 DFGLARHTADEMTG 188

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 68/134 (50%), Gaps = 11/134 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 57  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 115
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +  LK+ 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 120 --GLKQGVSEKAKG 131
             GL +  +++  G
Sbjct: 175 DFGLARHTADEMTG 188

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 73  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 131
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 132 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 184

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/134 (24%), Positives = 68/134 (50%), Gaps = 11/134 (8%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 57  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 115
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +  LK+ 
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174
Query: 120 --GLKQGVSEKAKG 131
             GL +  +++  G
Sbjct: 175 DFGLARHTADEMTG 188

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 47  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 105
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 106 EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 165
Query: 119 A--GLKQGVSEKAK--GSAYIEQ 137
              GL    +EK++  GS   EQ
Sbjct: 166 GDFGL---ATEKSRWSGSHQFEQ 185

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 52  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 110
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 163

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 62  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 120
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 173

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--------VYIIL 57
           +VA+K +      E    + + EIK L+LL H+++V +++    +          +Y++ 
Sbjct: 45  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 104
Query: 58  EYC--DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 114
           ++C  D   L S +     LSE +  + ++ L+  L ++  N + H D+K  N+LI ++ 
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIK--RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 162
Query: 115 TLKLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
            LKLA  GL +  S  AK S      N +V+   + P E+
Sbjct: 163 VLKLADFGLARAFS-LAKNSQPNRYXN-RVVTLWYRPPEL 200

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 62  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 120
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 121 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 173

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 38/151 (25%), Positives = 72/151 (47%), Gaps = 21/151 (13%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      D  Y+ ++L+Y 
Sbjct: 48  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYV 101
Query: 61  DGGDLCS---FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLK 117
                     + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T  
Sbjct: 102 PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAV 161
Query: 118 LAGLKQGVSEK-AKGSAYIEQGNTKVICSVF 147
           L     G +++  +G     + N   ICS +
Sbjct: 162 LKLCDFGSAKQLVRG-----EPNVSXICSRY 187

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 64/126 (50%), Gaps = 9/126 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 55  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 113
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAG 120
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ + N   +L  
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDXELKI 171
Query: 121 LKQGVS 126
           L  G++
Sbjct: 172 LDFGLA 177

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/126 (25%), Positives = 64/126 (50%), Gaps = 9/126 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 55  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 113
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAG 120
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ + N   +L  
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV-NEDXELKI 171
Query: 121 LKQGVS 126
           L  G++
Sbjct: 172 LDFGLA 177

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 61  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 119
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 120 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 172

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/157 (23%), Positives = 69/157 (43%), Gaps = 8/157 (5%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+L 
Sbjct: 46  VAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL 102
Query: 67  SFIR--SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLAGLKQ 123
            ++R  + ++++         Q+  A+++L + N  H DL  +N L+  N L K+A    
Sbjct: 103 DYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF-- 160
Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE 160
           G+S    G         K       P  +  +K S++
Sbjct: 161 GLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 197

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 52  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 110
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 163

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 18/160 (11%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +   SE+       E + L +L HQHIV       + R + ++ EY   GDL 
Sbjct: 45  VAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 102
Query: 67  SFIRSH---------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            F+RSH                 L   Q      Q+   + +L   +  H DL  +N L+
Sbjct: 103 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 162
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE 151
               +   G   G+S     + Y   G   ++   + P E
Sbjct: 163 GQGLVVKIG-DFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 201

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I+  K  +   D ++ EI+A+   HH +IV+       +  ++++++   GG +
Sbjct: 37  KVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 95
Query: 66  CSFIR------SHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              I+       H+   L E      +R+++  L++L +N   H D+K  NIL+
Sbjct: 96  LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL 149

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 52  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 110
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 111 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 163

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 55  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 113
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 166

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/143 (24%), Positives = 68/143 (47%), Gaps = 10/143 (6%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +   +  + I+ ++C
Sbjct: 27  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TKPQLAIVTQWC 85
Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKL 118
           +G  L   +   E K    +     RQ    + +L   ++ H DLK  NI +  + T+K+
Sbjct: 86  EGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKI 145
Query: 119 A--GLKQGVSEKAK--GSAYIEQ 137
              GL    +EK++  GS   EQ
Sbjct: 146 GDFGL---ATEKSRWSGSHQFEQ 165

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 56  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 114
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 115 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 167

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 46  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 104
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 62/160 (38%), Gaps = 18/160 (11%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VA+K + +   SE+       E + L +L HQHIV       + R + ++ EY   GDL 
Sbjct: 51  VAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLN 108
Query: 67  SFIRSH---------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            F+RSH                 L   Q      Q+   + +L   +  H DL  +N L+
Sbjct: 109 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 168
Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE 151
               +   G   G+S     + Y   G   ++   + P E
Sbjct: 169 GQGLVVKIG-DFGMSRDIYSTDYYRVGGRTMLPIRWMPPE 207

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 60  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 118
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 119 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 171

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 61  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 119
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 120 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 172

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 46  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 104
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 52/107 (48%), Gaps = 12/107 (11%)
Query: 24  SIVNEIKALKLLH---HQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFI--RSHE 73
           S V E+  L+ L    H ++V ++D     R      V ++ E+ D  DL +++      
Sbjct: 57  STVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPP 115
Query: 74  KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            L     +  +RQ +  L FL  N + H DLKP+NIL+    T+KLA
Sbjct: 116 GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLA 162

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--------VYIIL 57
           +VA+K +      E    + + EIK L+LL H+++V +++    +          +Y++ 
Sbjct: 45  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVF 104
Query: 58  EYC--DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 114
           ++C  D   L S +     LSE +  + ++ L+  L ++  N + H D+K  N+LI ++ 
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIK--RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 162
Query: 115 TLKLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
            LKLA  GL +  S  AK S      N +V+   + P E+
Sbjct: 163 VLKLADFGLARAFS-LAKNSQPNRYXN-RVVTLWYRPPEL 200

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 55  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 113
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 114 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 166

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--------VYIIL 57
           +VA+K +      E    + + EIK L+LL H+++V +++    +          +Y++ 
Sbjct: 44  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103
Query: 58  EYC--DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 114
           ++C  D   L S +     LSE +  + ++ L+  L ++  N + H D+K  N+LI ++ 
Sbjct: 104 DFCEHDLAGLLSNVLVKFTLSEIK--RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 161
Query: 115 TLKLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
            LKLA  GL +  S  AK S      N +V+   + P E+
Sbjct: 162 VLKLADFGLARAFS-LAKNSQPNRYXN-RVVTLWYRPPEL 199

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 49  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 107
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 108 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 160

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 48  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 106
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 107 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 159

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/114 (26%), Positives = 58/114 (50%), Gaps = 9/114 (7%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +VAIK I+  K  +   D ++ EI+A+   HH +IV+       +  ++++++   GG +
Sbjct: 42  KVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSV 100
Query: 66  CSFIR------SHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              I+       H+   L E      +R+++  L++L +N   H D+K  NIL+
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL 154

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 57  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 115
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 116 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 168

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 30/112 (26%), Positives = 53/112 (47%), Gaps = 3/112 (2%)
Query: 7   VAIKCIDKT-KVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VAIK +  + K S  ++  I+ E++ L+ L H + +        E   ++++EYC  G  
Sbjct: 43  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC-LGSA 101
Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
              +  H+K L E +        +  L +L  +N+ H D+K  NIL+    L
Sbjct: 102 SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/77 (28%), Positives = 41/77 (53%)
Query: 35  LHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL 94
           ++H  +V +      E  +Y+IL++  GGDL + +      +E   + ++ +L L L  L
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 95  RENNVCHFDLKPQNILI 111
               + + DLKP+NIL+
Sbjct: 147 HSLGIIYRDLKPENILL 163

>pdb|1R6M|A Chain A, Crystal Structure Of The Trna Processing Enzyme Rnase Ph From Pseudomonas Aeruginosa In Complex With Phosphate Length = 239

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 67/160 (41%), Gaps = 30/160 (18%)
Query: 129 AKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRD 188
           A+GS  +E G+TKVIC+V     +P     L+ Q  +G L  E+   P     R+   R+
Sbjct: 25  AEGSVLVEFGDTKVICTVSAESGVPR---FLKGQ-GQGWLTAEYGMLP-----RSTGERN 75
Query: 189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVL----------VLQNDGSALSAAINCAN 238
             E   G    R LE            +DL  L          V+Q DG   +A+I  A 
Sbjct: 76  QREASRGKQGGRTLEIQRLIGRSLRAALDLSKLGENTLYIDCDVIQADGGTRTASITGAT 135
Query: 239 LALVDA-----------AIPMYDLVTSSTLALRGGLTFID 267
           +AL+DA             P+  +V + ++ +  G+  +D
Sbjct: 136 VALIDALAVLKKRGALKGNPLKQMVAAVSVGIYQGVPVLD 175

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 73  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 131
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 132 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 184

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 1/92 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + I+ E++ L   +  +IV      + +  + I +E+ DGG L   ++   ++ E    +
Sbjct: 111 NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 170
Query: 83  FVRQLVLALKFLREN-NVCHFDLKPQNILIKN 113
               ++  L +LRE   + H D+KP NIL+ +
Sbjct: 171 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 202

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 46  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 104
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 105 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 47  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 105
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 106 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 158

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 47  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 105
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 106 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 158

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 58/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 50  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 108
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 109 MGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 161

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 8   AIKCIDKTKVSENRFDSI-VNEIKALKLLHH---QHIVTMLDFLWDERYVYIILEYCDGG 63
           A+KC+DK ++   + +++ +NE   L L+       IV M         +  IL+  +GG
Sbjct: 217 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 276
Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   +  H   SE   + +  +++L L+ +    V + DLKP NIL+
Sbjct: 277 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 324

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 23/92 (25%), Positives = 47/92 (51%), Gaps = 1/92 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + I+ E++ L   +  +IV      + +  + I +E+ DGG L   ++  +++ E    +
Sbjct: 59  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGK 118
Query: 83  FVRQLVLALKFLREN-NVCHFDLKPQNILIKN 113
               ++  L +LRE   + H D+KP NIL+ +
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNS 150

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 2/106 (1%)
Query: 8   AIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           A+K + K  +  N  D+     E   L+ + H  IV ++        +Y+ILEY  GG+L
Sbjct: 49  AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              +       E     ++ ++ +AL  L +  + + DLKP+NI++
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 17/160 (10%)
Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--------VYIIL 57
           +VA+K +      E    + + EIK L+LL H+++V +++    +          +Y++ 
Sbjct: 45  KVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 104
Query: 58  EYC--DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 114
           ++C  D   L S +     LSE +  + ++ L+  L ++  N + H D+K  N+LI ++ 
Sbjct: 105 DFCEHDLAGLLSNVLVKFTLSEIK--RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG 162
Query: 115 TLKLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
            LKLA  GL +  S  AK S      N +V+   + P E+
Sbjct: 163 VLKLADFGLARAFS-LAKNSQPNRYXN-RVVTLWYRPPEL 200

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/112 (31%), Positives = 57/112 (50%), Gaps = 10/112 (8%)
Query: 7   VAIKCIDKTKVSENRFD--SIVNEIKALKLLHHQHIVTMLDFLWDERYV-----YIILEY 59
           VAIK +++  + E+  D   I+ EI  L  L   +I+ + D +  E  +     YI+LE 
Sbjct: 56  VAIKKVNR--MFEDLIDCKRILREITILNRLKSDYIIRLHDLIIPEDLLKFDELYIVLEI 113
Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            D  DL    ++   L+E   +  +  L+L  KF+ E+ + H DLKP N L+
Sbjct: 114 ADS-DLKKLFKTPIFLTEQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLL 164

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 2/106 (1%)
Query: 8   AIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           A+K + K  +  N  D+     E   L+ + H  IV ++        +Y+ILEY  GG+L
Sbjct: 49  AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108
Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
              +       E     ++ ++ +AL  L +  + + DLKP+NI++
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML 154

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 30/131 (22%), Positives = 64/131 (48%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+ Y   G+L
Sbjct: 70  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 189 LVTENNVMKIA 199

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 8   AIKCIDKTKVSENRFDSI-VNEIKALKLLHH---QHIVTMLDFLWDERYVYIILEYCDGG 63
           A+KC+DK ++   + +++ +NE   L L+       IV M         +  IL+  +GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   +  H   SE   + +  +++L L+ +    V + DLKP NIL+
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 8   AIKCIDKTKVSENRFDSI-VNEIKALKLLHH---QHIVTMLDFLWDERYVYIILEYCDGG 63
           A+KC+DK ++   + +++ +NE   L L+       IV M         +  IL+  +GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   +  H   SE   + +  +++L L+ +    V + DLKP NIL+
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 31/108 (28%), Positives = 54/108 (50%), Gaps = 4/108 (3%)
Query: 8   AIKCIDKTKVSENRFDSI-VNEIKALKLLHH---QHIVTMLDFLWDERYVYIILEYCDGG 63
           A+KC+DK ++   + +++ +NE   L L+       IV M         +  IL+  +GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277
Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   +  H   SE   + +  +++L L+ +    V + DLKP NIL+
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 14/140 (10%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 46  DEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 104
Query: 61  DGGDLCSFIRSHEKLSE----------FQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS     E           +  Q   ++   + +L  N   H DL  +N +
Sbjct: 105 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 164
Query: 111 IKNN-TLKLA--GLKQGVSE 127
           +  + T+K+   G+ + + E
Sbjct: 165 VAEDFTVKIGDFGMTRDIXE 184

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 129
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 130 LVHQVSMGMKYLEESNFVHRDLAARNVLL 158

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLL 160

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 131
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 132 LVHQVSMGMKYLEESNFVHRDLAARNVLL 160

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 30/131 (22%), Positives = 64/131 (48%), Gaps = 19/131 (14%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+ Y   G+L
Sbjct: 70  VAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNL 128
Query: 66  CSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
             ++R+                 E+++         QL   +++L      H DL  +N+
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV 188
Query: 110 LI-KNNTLKLA 119
           L+ +NN +K+A
Sbjct: 189 LVTENNVMKIA 199

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 1/92 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + I+ E++ L   +  +IV      + +  + I +E+ DGG L   ++   ++ E    +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 83  FVRQLVLALKFLREN-NVCHFDLKPQNILIKN 113
               ++  L +LRE   + H D+KP NIL+ +
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 140

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 1/92 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + I+ E++ L   +  +IV      + +  + I +E+ DGG L   ++   ++ E    +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 83  FVRQLVLALKFLREN-NVCHFDLKPQNILIKN 113
               ++  L +LRE   + H D+KP NIL+ +
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 140

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 1/92 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + I+ E++ L   +  +IV      + +  + I +E+ DGG L   ++   ++ E    +
Sbjct: 49  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 108
Query: 83  FVRQLVLALKFLREN-NVCHFDLKPQNILIKN 113
               ++  L +LRE   + H D+KP NIL+ +
Sbjct: 109 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 140

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLL 144

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 42.0 bits (97), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/73 (30%), Positives = 45/73 (61%), Gaps = 2/73 (2%)
Query: 49  DERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           D+  +Y++++Y  GGDL + +   E +L E   + ++ ++V+A+  + + +  H D+KP 
Sbjct: 145 DDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPD 204
Query: 108 NILIK-NNTLKLA 119
           NIL+  N  ++LA
Sbjct: 205 NILMDMNGHIRLA 217

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 115
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 116 LVHQVSMGMKYLEESNFVHRDLAARNVLL 144

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 121
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 122 LVHQVSMGMKYLEESNFVHRDLAARNVLL 150

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 33/140 (23%), Positives = 63/140 (45%), Gaps = 14/140 (10%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 37  DEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 95
Query: 61  DGGDLCSFIRSHEKLSE----------FQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS     E           +  Q   ++   + +L  N   H DL  +N +
Sbjct: 96  TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 155
Query: 111 IKNN-TLKLA--GLKQGVSE 127
           +  + T+K+   G+ + + E
Sbjct: 156 VAEDFTVKIGDFGMTRDIXE 175

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 34/154 (22%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 46  DEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 104
Query: 61  DGGDLCSFIRSHEKLSE----------FQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS     E           +  Q   ++   + +L  N   H DL  +N +
Sbjct: 105 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 164
Query: 111 IKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVI 143
           +  + T+K+     G++     + Y  +G   ++
Sbjct: 165 VAEDFTVKIGDF--GMTRDIYETDYYRKGGKGLL 196

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 109
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 110 LVHQVSMGMKYLEESNFVHRDLAARNVLL 138

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/114 (24%), Positives = 57/114 (50%), Gaps = 8/114 (7%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYC 60
           VA+K + +   S         E++ LK + H++++ +LD     R       VY++  + 
Sbjct: 46  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV-THL 104
Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            G DL + ++   KL++   Q  + Q++  LK++   ++ H DLKP N+ +  +
Sbjct: 105 MGADLNNIVKC-AKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNED 157

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 39  HIVTMLDFLWDERY-----VYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLAL 91
           HIV ++D +++  Y     + I++E  DGG+L S I  R  +  +E +  + ++ +  A+
Sbjct: 86  HIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 144
Query: 92  KFLRENNVCHFDLKPQNILI----KNNTLKLA 119
           ++L   N+ H D+KP+N+L      N  LKL 
Sbjct: 145 QYLHSINIAHRDVKPENLLYTSKRPNAILKLT 176

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 39  HIVTMLDFLWDERY-----VYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLAL 91
           HIV ++D +++  Y     + I++E  DGG+L S I  R  +  +E +  + ++ +  A+
Sbjct: 72  HIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 130
Query: 92  KFLRENNVCHFDLKPQNILI----KNNTLKLA 119
           ++L   N+ H D+KP+N+L      N  LKL 
Sbjct: 131 QYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/89 (23%), Positives = 49/89 (55%), Gaps = 1/89 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           D ++ E   ++ L + +IV M+     E ++ +++E  + G L  +++ +  + +    +
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIE 111
Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI 111
            V Q+ + +K+L E+N  H DL  +N+L+
Sbjct: 112 LVHQVSMGMKYLEESNFVHRDLAARNVLL 140

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 23/92 (25%), Positives = 46/92 (50%), Gaps = 1/92 (1%)
Query: 23  DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQ 82
           + I+ E++ L   +  +IV      + +  + I +E+ DGG L   ++   ++ E    +
Sbjct: 52  NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGK 111
Query: 83  FVRQLVLALKFLREN-NVCHFDLKPQNILIKN 113
               ++  L +LRE   + H D+KP NIL+ +
Sbjct: 112 VSIAVIKGLTYLREKHKIMHRDVKPSNILVNS 143

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 42.0 bits (97), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 40/68 (58%), Gaps = 1/68 (1%)
Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 111
           ++ ++EY +GGDL   I+S  K    +   +  +++L L+FL    + + DLK  NIL+ 
Sbjct: 93  LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 152
Query: 112 KNNTLKLA 119
           K+  +K+A
Sbjct: 153 KDGHIKIA 160

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/154 (22%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 39  DEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 97
Query: 61  DGGDLCSFIRSHEKLSE----------FQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS     E           +  Q   ++   + +L  N   H DL  +N +
Sbjct: 98  TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 157
Query: 111 IKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVI 143
           +  + T+K+     G++     + Y  +G   ++
Sbjct: 158 VAEDFTVKIGDF--GMTRDIYETDYYRKGGKGLL 189

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/154 (22%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 45  DEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 103
Query: 61  DGGDLCSFIRSHEKLSE----------FQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS     E           +  Q   ++   + +L  N   H DL  +N +
Sbjct: 104 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 163
Query: 111 IKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVI 143
           +  + T+K+     G++     + Y  +G   ++
Sbjct: 164 VAEDFTVKIGDF--GMTRDIYETDYYRKGGKGLL 195

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 36/142 (25%), Positives = 65/142 (45%), Gaps = 7/142 (4%)
Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--VYIILEYCDGGD 64
           VA+K +      ++R      EI  L+ L+H+HI+       D     + +++EY   G 
Sbjct: 63  VAVKALKADAGPQHR-SGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-KLA--GL 121
           L  ++  H  +   Q   F +Q+   + +L   +  H DL  +N+L+ N+ L K+   GL
Sbjct: 122 LRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGL 180
Query: 122 KQGVSEKAKGSAYIEQGNTKVI 143
            + V E  +     E G++ V 
Sbjct: 181 AKAVPEGHEXYRVREDGDSPVF 202

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 39  HIVTMLDFLWDERY-----VYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLAL 91
           HIV ++D +++  Y     + I++E  DGG+L S I  R  +  +E +  + ++ +  A+
Sbjct: 122 HIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 180
Query: 92  KFLRENNVCHFDLKPQNILI----KNNTLKLA 119
           ++L   N+ H D+KP+N+L      N  LKL 
Sbjct: 181 QYLHSINIAHRDVKPENLLYTSKRPNAILKLT 212

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 12/92 (13%)
Query: 39  HIVTMLDFLWDERY-----VYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLAL 91
           HIV ++D +++  Y     + I++E  DGG+L S I  R  +  +E +  + ++ +  A+
Sbjct: 116 HIVRIVD-VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAI 174
Query: 92  KFLRENNVCHFDLKPQNILI----KNNTLKLA 119
           ++L   N+ H D+KP+N+L      N  LKL 
Sbjct: 175 QYLHSINIAHRDVKPENLLYTSKRPNAILKLT 206

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/154 (22%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 43  DEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 101
Query: 61  DGGDLCSFIRSHEKLSE----------FQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS     E           +  Q   ++   + +L  N   H DL  +N +
Sbjct: 102 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 161
Query: 111 IKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVI 143
           +  + T+K+     G++     + Y  +G   ++
Sbjct: 162 VAEDFTVKIGDF--GMTRDIYETDYYRKGGKGLL 193

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 22/68 (32%), Positives = 40/68 (58%), Gaps = 1/68 (1%)
Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 111
           ++ ++EY +GGDL   I+S  K    +   +  +++L L+FL    + + DLK  NIL+ 
Sbjct: 94  LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLD 153
Query: 112 KNNTLKLA 119
           K+  +K+A
Sbjct: 154 KDGHIKIA 161

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 34/154 (22%), Positives = 67/154 (43%), Gaps = 14/154 (9%)
Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R +  +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 52  DEPETRVAIKTVNEAASMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 110
Query: 61  DGGDLCSFIRSHEKLSE----------FQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS     E           +  Q   ++   + +L  N   H DL  +N +
Sbjct: 111 TRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170
Query: 111 IKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVI 143
           +  + T+K+     G++     + Y  +G   ++
Sbjct: 171 VAEDFTVKIGDF--GMTRDIYETDYYRKGGKGLL 202

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	477
2nn6_F	272	MTR3, exosome component 6; RNA, exosome, PM/SCL, p	5e-49
2wp8_B	246	Exosome complex component SKI6; nucleus, hydrolase	7e-47
3krn_A	222	Protein C14A4.5, confirmed by transcript evidence;	5e-44
2nn6_D	237	Exosome complex exonuclease RRP46; RNA, exosome, P	2e-43
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-38
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-35
2wnr_B	240	Probable exosome complex exonuclease 1; phosphate	7e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-33
2nn6_B	249	Exosome complex exonuclease RRP41; RNA, exosome, P	2e-32
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-32
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-31
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-30
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-30
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-30
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-30
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-30
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-30
2po1_A	249	Probable exosome complex exonuclease 1; RNAse PH,	4e-30
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	7e-30
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-29
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-29
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-29
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-29
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-29
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-28
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	2e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-28
3hkm_A	246	OS03G0854200 protein; RNAse PH domain, phosphoryla	3e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-28
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	5e-28
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	5e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	5e-28
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-27
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-27
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-27
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-27
3b4t_A	262	Ribonuclease PH; RNAse, tRNA nucleotidyltransferas	5e-27
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	5e-27
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-26
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-26
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-26
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-26
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	4e-26
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	6e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	7e-26
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-26
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-26
1r6l_A	239	Ribonuclease PH; beta-alpha-beta-alpha fold, hexam	8e-26
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-26
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-25
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-25
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-25
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-25
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-24
1udn_A	255	Ribonuclease PH, RNAse PH; transferase, riken stru	2e-24
2je6_B	250	RRP41, exosome complex exonuclease 1; nuclease, hy	2e-24
3m7n_D	258	Probable exosome complex exonuclease 1; exosome, R	2e-24
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-24
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-24
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-24
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-23
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-23
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-23
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-23
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	4e-23
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	4e-23
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-22
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-22
3dd6_A	255	Ribonuclease PH; exoribonuclease, tRNA maturation,	3e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	9e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-22
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-21
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-21
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-21
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	7e-21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-20
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-20
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	7e-20
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-20
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-20
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	9e-20
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-19
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-19
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	3e-19
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	9e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-18
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-18
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	4e-18
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	6e-18
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-18
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	7e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	8e-18
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	9e-18
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-17
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-17
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	4e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-17
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	5e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	5e-17
1oys_A	245	Ribonuclease PH; transferase, tRNA processing; 2.4	6e-17
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-17
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-17
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	9e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-16
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-16
2vkp_A	109	BTB/POZ domain-containing protein 6; protein-bindi	2e-16
2wnr_A	271	Probable exosome complex exonuclease 2; phosphate	2e-16
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-16
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-16
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-16
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-16
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-16
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	6e-16
3m7n_G	259	Probable exosome complex exonuclease 2; exosome, R	8e-16
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	9e-16
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-15
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-15
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-15
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-15
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	3e-15
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-15
2po1_B	277	Probable exosome complex exonuclease 2; RNAse PH,	4e-15
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-14
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-14
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-14
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-14
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-14
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-14
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-14
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-14
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-14
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-14
2je6_A	277	RRP42, exosome complex exonuclease 2; nuclease, hy	5e-14
4eoz_A	145	Speckle-type POZ protein; E3 ubiquitin ligase, nuc	5e-14
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-14
3aln_A	327	Dual specificity mitogen-activated protein kinase;	8e-14
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-14
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	8e-14
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	9e-14
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-13
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-13
3htm_A	172	Speckle-type POZ protein; BTB, SPOP, ubiquitin, li	1e-13
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-13
2nn6_C	278	Exosome complex exonuclease RRP43; RNA, exosome, P	2e-13
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-13
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-13
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-13
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-13
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-13
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-13
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-13
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-13
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-13
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-13
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	7e-13
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	8e-13
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	8e-13
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-13
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-12
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	1e-12
2nn6_E	305	Exosome complex exonuclease RRP42; RNA, exosome, P	2e-12
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-12
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-12
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-12
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-12
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-12
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-12
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-12
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-12
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-12
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-12
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	4e-12
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	4e-12
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	5e-12
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-12
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-12
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	6e-12
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	6e-12
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-12
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	8e-12
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-12
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-11
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-11
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-11
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-11
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-11
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-11
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-11
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-11
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-11
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-11
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	6e-11
3hqi_A	312	Speckle-type POZ protein; SPOP, ubiquitin, puckere	8e-11
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-10
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-10
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-10
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-10
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-10
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-10
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-10
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	6e-10
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	6e-10
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	9e-10
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-09
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-09
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	1e-09
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-09
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-09
1r29_A	127	B-cell lymphoma 6 protein; BTB domain, transcripti	5e-09
2nn6_A	358	Polymyositis/scleroderma autoantigen 1; RNA, exoso	6e-09
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-08
2wp8_A	305	Exosome complex component RRP45; nucleus, hydrolas	2e-08
2vpk_A	116	Myoneurin; transcription regulation, transcription	6e-08
3ohu_A	125	Transcription regulator protein BACH2; BTB/POZ dom	7e-08
2if5_A	120	Zinc finger and BTB domain-containing protein 7A;	7e-08
2z8h_A	138	Transcription regulator protein BACH1; BTB, POZ, d	8e-07
1buo_A	121	POZ domain, protein (promyelocytic leukemia zinc f	1e-06
3ga1_A	129	Nucleus accumbens-associated protein 1; BTB/POZ do	1e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-06
2ihc_A	124	Transcription regulator protein BACH1; BRIC-A-BRAC	2e-06
2ppi_A	144	Gigaxonin; BTB domain, protein degradation, struct	4e-06
3b84_A	119	Zinc finger and BTB domain-containing protein 48;	5e-06
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-06
2yy9_A	135	Zinc finger and BTB domain-containing protein 48;	7e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-06
2q81_A	119	MIZ-1 protein; BTB/POZ domain, transcription; HET:	1e-05
3i3n_A	279	Kelch-like protein 11; structural genomics, BTB, K	2e-05
3fkc_A	116	Transcriptional regulator kaiso; zinc finger and B	3e-05
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-05
3m5b_A	119	Zinc finger and BTB domain-containing protein 32;	4e-05
3hve_A	256	Gigaxonin; ubiquitin, cytoplasm, cytoskeleton, dis	9e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	5e-04
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	7e-04
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-04

>2nn6_F MTR3, exosome component 6; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1 Length = 272

 Score =  168 bits (427), Expect = 5e-49
 Identities = 69/223 (30%), Positives = 105/223 (47%), Gaps = 24/223 (10%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQR--------SKGELYVEF 172
            + G+  +AKGSAY+E G TKV+C+V  PR+    +                +G L  +F
Sbjct: 41  ARAGLLSQAKGSAYLEAGGTKVLCAVSGPRQAEGGERGGGPAGAGGEAPAALRGRLLCDF 100

Query: 173 KFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSA 232
           + APFA + R       EE+EL   L+ ALEPAV    +   Q+++  L+L++ GSAL+A
Sbjct: 101 RRAPFAGRRRRAPPGGCEERELALALQEALEPAVRLGRYPRAQLEVSALLLEDGGSALAA 160

Query: 233 AINCANLALVDAAIPMYDLVTSSTLAL---RGGLTFIDPVEEEVAYCQSLSSSEDDDSGV 289
           A+  A LAL DA + MYDLV    L+L         +DP   E          E+  +  
Sbjct: 161 ALTAAALALADAGVEMYDLVVGCGLSLAPGPAPTWLLDPTRLE----------EERAAAG 210

Query: 290 ITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTD 332
           +T++ M V+ QV  +   G      L +   + +      C  
Sbjct: 211 LTVALMPVLNQVAGLLGSGEGG---LTESWAEAVRLGLEGCQR 250

>2wp8_B Exosome complex component SKI6; nucleus, hydrolase, RNA-binding, exonucle binding, mitochondrion, rRNA processing; 3.00A {Saccharomyces cerevisiae} Length = 246

 Score =  161 bits (410), Expect = 7e-47
 Identities = 49/207 (23%), Positives = 87/207 (42%), Gaps = 16/207 (7%)

Query: 125 VSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG 184
               A GS+Y+EQGN K+I  V  P+E            SK  L V      F+   R+ 
Sbjct: 32  HPHAADGSSYMEQGNNKIITLVKGPKEPRLKSQMDT---SKALLNVSVNINKFSKFERSK 88

Query: 185 WLR--DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALV 242
                +    E+   L R  E  V  + +    +D+ + VL+ DG  + + IN   LAL+
Sbjct: 89  SSHKNERRVLEIQTSLVRMFEKNVMLNIYPRTVIDIEIHVLEQDGGIMGSLINGITLALI 148

Query: 243 DAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVT 302
           DA I M+D ++  ++ L      +D            +S E++    +TL  +   ++++
Sbjct: 149 DAGISMFDYISGISVGLYDTTPLLD-----------TNSLEENAMSTVTLGVVGKSEKLS 197

Query: 303 QVTLVGTIQQERLADHIEQLIGCCESL 329
            + +   I  +RL + +   I     +
Sbjct: 198 LLLVEDKIPLDRLENVLAIGIAGAHRV 224

>3krn_A Protein C14A4.5, confirmed by transcript evidence; RNAse PH domain, homodimer, exosome, cell-death-related DNAS hydrolase; 3.92A {Caenorhabditis elegans} Length = 222

 Score =  153 bits (388), Expect = 5e-44
 Identities = 39/209 (18%), Positives = 71/209 (33%), Gaps = 21/209 (10%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
            +    + A GSA   QG T +  S   P ++ +SK S E       + ++  +      
Sbjct: 10  CELSFLKNADGSACFSQGATCIWASCSGPGDVHASKASDE------AMTLDISYRANCG- 62

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
                  D++   L N +   L  A+    F +  + + V  +Q+DGS  + AIN A  A
Sbjct: 63  -------DNKFNVLNNIIHSTLSNAINLELFPHTTISVTVHGIQDDGSMGAVAINGACFA 115

Query: 241 LVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQ 300
           L+D  +P   +     +        IDP  ++ A                         +
Sbjct: 116 LLDNGMPFETVFCGVLIVRVKDELIIDPTAKQEAASTG-------RVLFSVCKGSDGHPE 168

Query: 301 VTQVTLVGTIQQERLADHIEQLIGCCESL 329
           V  +  +G     +L            ++
Sbjct: 169 VCAMDAIGHWDFIQLEAAWSLAQPSASAI 197

>2nn6_D Exosome complex exonuclease RRP46; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1 Length = 237

 Score =  152 bits (385), Expect = 2e-43
 Identities = 47/224 (20%), Positives = 84/224 (37%), Gaps = 26/224 (11%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
            +Q +  +  GSA   QG+T V+  V+ P E+  SK          E++     A     
Sbjct: 35  CEQNLLSRPDGSASFLQGDTSVLAGVYGPAEVKVSK----------EIF---NKATLEVI 81

Query: 181 IRTG-WLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANL 239
           +R    L    EK     ++   E  V         + + + V+ + GS L+  +N A +
Sbjct: 82  LRPKIGLPGVAEKSRERLIRNTCEAVVLGTLHPRTSITVVLQVVSDAGSLLACCLNAACM 141

Query: 240 ALVDAAIPMYDLVTSSTLALRG-GLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVI 298
           ALVDA +PM  L      AL   G   +DP  ++          E +   V+T +  SV 
Sbjct: 142 ALVDAGVPMRALFCGVACALDSDGTLVLDPTSKQ----------EKEARAVLTFALDSVE 191

Query: 299 QQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHV 342
           +++   +  G      L   +       + +     ++ +    
Sbjct: 192 RKLLMSSTKGLYSDTELQQCLAAAQAASQHVF-RFYRESLQRRY 234

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  141 bits (357), Expect = 3e-38
 Identities = 33/121 (27%), Positives = 64/121 (52%), Gaps = 3/121 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 30  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 89

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
                DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 90  CG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 148

Query: 119 A 119
            
Sbjct: 149 I 149

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  140 bits (354), Expect = 5e-38
 Identities = 34/121 (28%), Positives = 65/121 (53%), Gaps = 3/121 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L  H   I+ + D+   ++Y+Y+++E
Sbjct: 49  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 108

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
            C   DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 109 -CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 167

Query: 119 A 119
            
Sbjct: 168 I 168

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (352), Expect = 4e-37
 Identities = 32/121 (26%), Positives = 63/121 (52%), Gaps = 3/121 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH--QHIVTMLDFLWDERYVYIILE 58
           NE+    AIK ++  +      DS  NEI  L  L      I+ + D+   ++Y+Y+++E
Sbjct: 77  NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
                DL S+++  + +  ++ + + + ++ A+  + ++ + H DLKP N LI +  LKL
Sbjct: 137 CG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL 195

Query: 119 A 119
            
Sbjct: 196 I 196

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  133 bits (336), Expect = 2e-35
 Identities = 32/126 (25%), Positives = 55/126 (43%), Gaps = 11/126 (8%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCD 61
               AIK  +         D  + E + LK L+H++IV +     +   R+  +I+E+C 
Sbjct: 34  GDLFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCP 92

Query: 62  GGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-----KN 113
            G L + +        L E +    +R +V  +  LREN + H ++KP NI+        
Sbjct: 93  CGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQ 152

Query: 114 NTLKLA 119
           +  KL 
Sbjct: 153 SVYKLT 158

>2wnr_B Probable exosome complex exonuclease 1; phosphate binding, 3'-5' exoribonuclease, hydrolase; 2.65A {Methanothermobacter thermautotrophicusorganism_taxid} Length = 240

 Score =  126 bits (319), Expect = 7e-34
 Identities = 51/199 (25%), Positives = 89/199 (44%), Gaps = 15/199 (7%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           G+ E+A GS+Y+E G  K++ +V+ PRE    K        +  +   +  APF+ + R 
Sbjct: 34  GILERADGSSYLEFGGNKILVAVYGPREAQIRKLQRPD---RAVIRCRYNMAPFSVEERK 90

Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
               D    E+      AL PA+   +F    +D+F+ VL+ +G    A I  A++AL D
Sbjct: 91  RPGPDRRSVEISKITAEALRPALILEKFPRSVIDVFIEVLEAEGGTRCAGITAASVALAD 150

Query: 244 AAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGV-ITLSYMSVIQQVT 302
           A IPM D+V +      G    +D           LS  ED +    + ++ +   +++T
Sbjct: 151 AGIPMRDMVVACAAGKVGDQVVLD-----------LSEEEDKEGQADVPVAILPRTREIT 199

Query: 303 QVTLVGTIQQERLADHIEQ 321
            +   G +  E     ++ 
Sbjct: 200 LLQSDGNLTPEEFERALDL 218

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  128 bits (324), Expect = 3e-33
 Identities = 32/124 (25%), Positives = 55/124 (44%), Gaps = 11/124 (8%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGG 63
             AIK  +         D  + E + LK L+H++IV +     +   R+  +I+E+C  G
Sbjct: 36  LFAIKVFNNISFLRPV-DVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG 94

Query: 64  DLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-----KNNT 115
            L + +        L E +    +R +V  +  LREN + H ++KP NI+        + 
Sbjct: 95  SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSV 154

Query: 116 LKLA 119
            KL 
Sbjct: 155 YKLT 158

>2nn6_B Exosome complex exonuclease RRP41; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1 Length = 249

 Score =  122 bits (309), Expect = 2e-32
 Identities = 52/151 (34%), Positives = 74/151 (49%), Gaps = 5/151 (3%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV  +A GSAYIEQGNTK +  V+ P EI  S+      R+   +  ++  A F S    
Sbjct: 34  GVFAQADGSAYIEQGNTKALAVVYGPHEIRGSRARALPDRAL--VNCQYSSATF-STGER 90

Query: 184 GWLR--DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLAL 241
                 D +  E+G  L++  E A+        Q+D++V VLQ DG   +A +N A LA+
Sbjct: 91  KRRPHGDRKSCEMGLQLRQTFEAAILTQLHPRSQIDIYVQVLQADGGTYAACVNAATLAV 150

Query: 242 VDAAIPMYDLVTSSTLALRGGLTFIDPVEEE 272
           +DA IPM D V + +     G    D    E
Sbjct: 151 LDAGIPMRDFVCACSAGFVDGTALADLSHVE 181

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  123 bits (311), Expect = 7e-32
 Identities = 36/116 (31%), Positives = 74/116 (63%), Gaps = 1/116 (0%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
            EVAIK IDKT+++      +  E++ +K+L+H +IV + + +  E+ +Y+I+EY  GG+
Sbjct: 41  REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           +  ++ +H ++ E + +   RQ+V A+++  +  + H DLK +N+L+  +  +K+A
Sbjct: 101 VFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIA 156

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  120 bits (303), Expect = 4e-31
 Identities = 36/119 (30%), Positives = 66/119 (55%), Gaps = 3/119 (2%)

Query: 4   HTEVAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
             EVAIK IDK  + +      + NE+K    L H  I+ + ++  D  YVY++LE C  
Sbjct: 36  GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95

Query: 63  GDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           G++  ++++  K  SE + + F+ Q++  + +L  + + H DL   N+L+ +N  +K+A
Sbjct: 96  GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIA 154

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  119 bits (301), Expect = 6e-31
 Identities = 30/115 (26%), Positives = 57/115 (49%), Gaps = 2/115 (1%)

Query: 7   VAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +A+K + K ++ +      +  E++    L H +I+ +  +  D   VY+ILEY   G +
Sbjct: 37  LALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTV 96

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
              ++   K  E +   ++ +L  AL +     V H D+KP+N+L+     LK+A
Sbjct: 97  YRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 151

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  120 bits (303), Expect = 1e-30
 Identities = 35/123 (28%), Positives = 64/123 (52%), Gaps = 5/123 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
             IK I+ +++S    +    E+  L  + H +IV   +   +   +YI+++YC+GGDL 
Sbjct: 52  YVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLF 111

Query: 67  SFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQ 123
             I + +     E Q   +  Q+ LALK + +  + H D+K QNI + K+ T++L     
Sbjct: 112 KRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDF-- 169

Query: 124 GVS 126
           G++
Sbjct: 170 GIA 172

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  120 bits (303), Expect = 2e-30
 Identities = 35/122 (28%), Positives = 64/122 (52%), Gaps = 6/122 (4%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S   F  +  E +  + L H +IV + D + +E + Y++ +   GG+L
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA-- 119
              I + E  SE      ++Q++ ++ +   N + H +LKP+N+L+ +      +KLA  
Sbjct: 116 FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 175

Query: 120 GL 121
           GL
Sbjct: 176 GL 177

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  124 bits (311), Expect = 2e-30
 Identities = 36/128 (28%), Positives = 63/128 (49%), Gaps = 14/128 (10%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF------LWDERYVYIILE 58
            +VAIK   +    +NR +    EI+ +K L+H ++V+  +       L       + +E
Sbjct: 40  EQVAIKQCRQELSPKNR-ERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98

Query: 59  YCDGGDLCSFIRSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN- 114
           YC+GGDL  ++   E    L E   +  +  +  AL++L EN + H DLKP+NI+++   
Sbjct: 99  YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGP 158

Query: 115 ---TLKLA 119
                K+ 
Sbjct: 159 QRLIHKII 166

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  118 bits (298), Expect = 2e-30
 Identities = 34/120 (28%), Positives = 61/120 (50%), Gaps = 4/120 (3%)

Query: 6   EVAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             A K + K+ + +      +  EI   + L HQH+V    F  D  +V+++LE C    
Sbjct: 42  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 101

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
           L    +  + L+E + + ++RQ+VL  ++L  N V H DLK  N+ + ++  +K+   GL
Sbjct: 102 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 161

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  118 bits (297), Expect = 3e-30
 Identities = 35/145 (24%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 4   HTEVAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
              +A+K + K+++ +      +  EI+    L H +I+ M ++  D + +Y++LE+   
Sbjct: 39  KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA-- 119
           G+L   ++ H +  E +   F+ +L  AL +  E  V H D+KP+N+L+     LK+A  
Sbjct: 99  GELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADF 158

Query: 120 GLKQGVSEKAKGSAYIEQGNTKVIC 144
           G           S +      + +C
Sbjct: 159 GW----------SVHAPSLRRRTMC 173

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  118 bits (297), Expect = 3e-30
 Identities = 35/122 (28%), Positives = 64/122 (52%), Gaps = 6/122 (4%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A K I+  K+S   F  +  E +  + L H +IV + D + +E + Y++ +   GG+L
Sbjct: 33  EFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA-- 119
              I + E  SE      ++Q++ ++ +   N + H +LKP+N+L+ +      +KLA  
Sbjct: 93  FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADF 152

Query: 120 GL 121
           GL
Sbjct: 153 GL 154

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  118 bits (299), Expect = 3e-30
 Identities = 38/145 (26%), Positives = 68/145 (46%), Gaps = 16/145 (11%)

Query: 6   EVAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             A K + K+ + +      +  EI   + L HQH+V    F  D  +V+++LE C    
Sbjct: 68  VFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRS 127

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
           L    +  + L+E + + ++RQ+VL  ++L  N V H DLK  N+ + ++  +K+   GL
Sbjct: 128 LLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGL 187

Query: 122 KQGVSEKAKGSAYIEQGNT--KVIC 144
                     +  +E      KV+C
Sbjct: 188 ----------ATKVEYDGERKKVLC 202

>2po1_A Probable exosome complex exonuclease 1; RNAse PH, hydrolase/hydrolase/RNA complex; 1.94A {Pyrococcus abyssi} PDB: 2po0_A* 2pnz_A 2po2_A* Length = 249

 Score =  116 bits (293), Expect = 4e-30
 Identities = 55/149 (36%), Positives = 74/149 (49%), Gaps = 3/149 (2%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV + A GSAYIE G  K+I +V+ PRE+            +  L V +  APF+ + R 
Sbjct: 34  GVLKNANGSAYIEWGKNKIIAAVYGPRELHPKHLQRPD---RAILRVRYNMAPFSVEERK 90

Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
               D    E+   +K ALEPA+    F    +D+F+ VLQ D     A I  A+LAL D
Sbjct: 91  KPGPDRRSIEISKVIKGALEPALILEMFPRTAIDVFIEVLQADAGTRVAGITAASLALAD 150

Query: 244 AAIPMYDLVTSSTLALRGGLTFIDPVEEE 272
           A IPM DLV +       G   +D  +EE
Sbjct: 151 AGIPMRDLVAACAAGKIEGEIVLDLNKEE 179

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  118 bits (297), Expect = 7e-30
 Identities = 45/145 (31%), Positives = 74/145 (51%), Gaps = 20/145 (13%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVN------EIKALKLLHHQHIVTMLDFLWDERYVYIILE 58
            EV +K I K KV E+ +           EI  L  + H +I+ +LD   ++ +  +++E
Sbjct: 50  KEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVME 109

Query: 59  -YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTL 116
            +  G DL +FI  H +L E       RQLV A+ +LR  ++ H D+K +NI+I ++ T+
Sbjct: 110 KHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTI 169

Query: 117 KLA--GLKQGVSEKAKGSAYIEQGN 139
           KL   G           +AY+E+G 
Sbjct: 170 KLIDFGS----------AAYLERGK 184

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  115 bits (291), Expect = 2e-29
 Identities = 38/121 (31%), Positives = 68/121 (56%), Gaps = 4/121 (3%)

Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K ++S +R     + I  E+  L+ + H +I+T+ D   ++  V +ILE   
Sbjct: 32  EYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVS 91

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E L+E +  QF++Q++  + +L    + HFDLKP+NI++ +  +    +
Sbjct: 92  GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151

Query: 122 K 122
           K
Sbjct: 152 K 152

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  116 bits (293), Expect = 2e-29
 Identities = 34/121 (28%), Positives = 66/121 (54%), Gaps = 4/121 (3%)

Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE   
Sbjct: 38  QYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVA 97

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++ +  +    +
Sbjct: 98  GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 157

Query: 122 K 122
           K
Sbjct: 158 K 158

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  115 bits (291), Expect = 3e-29
 Identities = 36/121 (29%), Positives = 65/121 (53%), Gaps = 4/121 (3%)

Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K +   +R     + I  E+  L+ + H +++T+ D   +   V +ILE   
Sbjct: 39  EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVS 98

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E LSE +   F++Q++  + +L    + HFDLKP+NI++ +  + +  +
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158

Query: 122 K 122
           K
Sbjct: 159 K 159

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  115 bits (290), Expect = 4e-29
 Identities = 35/153 (22%), Positives = 56/153 (36%), Gaps = 23/153 (15%)

Query: 5   TEVAIKCIDKTKVSENRFDS----IVNEIKALKLLH----HQHIVTMLDFLWDERYVYII 56
            +VAIK I + +V      S       E+  L  +     H  ++ +LD+   +    ++
Sbjct: 57  LQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLV 116

Query: 57  LEY-CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KN 113
           LE      DL  +I     L E   + F  Q+V A++      V H D+K +NILI  + 
Sbjct: 117 LERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRR 176

Query: 114 NTLKLA--GLKQGVSEKAKGSAYIEQGNTKVIC 144
              KL   G            A +         
Sbjct: 177 GCAKLIDFGS----------GALLHDEPYTDFD 199

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  115 bits (291), Expect = 7e-29
 Identities = 37/121 (30%), Positives = 65/121 (53%), Gaps = 4/121 (3%)

Query: 6   EVAIKCIDKTKVSENRF----DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           E A K I K +   +R     + I  E+  L+ + H +I+T+ D   +   V +ILE   
Sbjct: 39  EYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVS 98

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGL 121
           GG+L  F+   E LSE +   F++Q++  + +L    + HFDLKP+NI++ +  + +  +
Sbjct: 99  GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158

Query: 122 K 122
           K
Sbjct: 159 K 159

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  117 bits (294), Expect = 1e-28
 Identities = 36/122 (29%), Positives = 62/122 (50%), Gaps = 6/122 (4%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A   I+  K+S      +  E +  +LL H +IV + D + +E + Y+I +   GG+L
Sbjct: 38  EYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 97

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA-- 119
              I + E  SE      ++Q++ A+    +  V H +LKP+N+L+ +      +KLA  
Sbjct: 98  FEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADF 157

Query: 120 GL 121
           GL
Sbjct: 158 GL 159

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  117 bits (294), Expect = 2e-28
 Identities = 39/118 (33%), Positives = 68/118 (57%), Gaps = 4/118 (3%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E AIK I KT VS +    ++ E+  LKLL H +I+ + DF  D+R  Y+++E   GG+L
Sbjct: 64  ERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL 123

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA 119
              I    K +E      ++Q++  + +L ++N+ H DLKP+N+L+++      +K+ 
Sbjct: 124 FDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIV 181

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  116 bits (293), Expect = 2e-28
 Identities = 34/118 (28%), Positives = 64/118 (54%), Gaps = 4/118 (3%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A+K I+K         +I+ E++ LK L H +I+ + + L D    YI+ E   GG+L
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA 119
              I   ++ SE    + ++Q+   + ++ ++N+ H DLKP+NIL+++      +K+ 
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  115 bits (290), Expect = 2e-28
 Identities = 40/128 (31%), Positives = 73/128 (57%), Gaps = 13/128 (10%)

Query: 6   EVAIKCIDKTKVS------ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAI+ I K K +       +   ++  EI+ LK L+H  I+ + +F +D    YI+LE 
Sbjct: 162 KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 220

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----T 115
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+ +      
Sbjct: 221 MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 280

Query: 116 LKLA--GL 121
           +K+   G 
Sbjct: 281 IKITDFGH 288

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  112 bits (283), Expect = 2e-28
 Identities = 34/118 (28%), Positives = 64/118 (54%), Gaps = 4/118 (3%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E A+K I+K         +I+ E++ LK L H +I+ + + L D    YI+ E   GG+L
Sbjct: 49  EYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL 108

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA 119
              I   ++ SE    + ++Q+   + ++ ++N+ H DLKP+NIL+++      +K+ 
Sbjct: 109 FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKII 166

>3hkm_A OS03G0854200 protein; RNAse PH domain, phosphorylase, hydrolase; 1.98A {Oryza sativa japonica group} Length = 246

 Score =  111 bits (279), Expect = 3e-28
 Identities = 48/207 (23%), Positives = 77/207 (37%), Gaps = 19/207 (9%)

Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQI 181
            +   ++A GSA   QG+T V+ +V+ P+       + E    K  + V +K        
Sbjct: 20  TRNPLDRAHGSARWAQGDTIVLAAVYGPKPGTRKGENPE----KASIEVVWKPMTGQIGK 75

Query: 182 RTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLAL 241
           +        EKE    LKR L+         N    + + V+ NDGS L  AIN    AL
Sbjct: 76  Q--------EKEYEMTLKRTLQSICLLTVHPNTTTSVILQVVGNDGSLLPCAINACCAAL 127

Query: 242 VDAAIPMYDLVTSSTLAL-RGGLTFIDPVEEEVAYCQSL------SSSEDDDSGVITLSY 294
           V A IP+  L  +    +   G   +D  + E    +S       +S +   S       
Sbjct: 128 VFAGIPLKHLAVAIGCGVLEDGEVILDTNKAEEQQLKSFAHLVFPNSRKSASSKEPNQKE 187

Query: 295 MSVIQQVTQVTLVGTIQQERLADHIEQ 321
               + +      G + +E     IE+
Sbjct: 188 EDSERGLITSITHGVMSEEDYFSCIER 214

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  112 bits (282), Expect = 3e-28
 Identities = 35/122 (28%), Positives = 58/122 (47%), Gaps = 8/122 (6%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
             A K I K  V +   D    EI+ +K L H +I+ + +   D   +Y+++E C GG+L
Sbjct: 36  RRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL 93

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA-- 119
              +       E    + ++ ++ A+ +  + NV H DLKP+N L   +     LKL   
Sbjct: 94  FERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDF 153

Query: 120 GL 121
           GL
Sbjct: 154 GL 155

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  111 bits (280), Expect = 5e-28
 Identities = 34/116 (29%), Positives = 67/116 (57%), Gaps = 2/116 (1%)

Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +++ K+ S +    I  EI+ LKL  H HI+ +   +      ++++EY  GG+
Sbjct: 38  KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGE 97

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           L  +I  H ++ E + ++  +Q++ A+ +   + V H DLKP+N+L+  +   K+A
Sbjct: 98  LFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 153

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  112 bits (282), Expect = 5e-28
 Identities = 36/133 (27%), Positives = 60/133 (45%), Gaps = 20/133 (15%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-------------Y 52
             AIK I  T+       +I++E+  L  L+HQ++V       + R              
Sbjct: 33  YYAIKKIRHTEEKL---STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKST 89

Query: 53  VYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           ++I +EYC+ G L   I S        +  +  RQ++ AL ++    + H DLKP NI I
Sbjct: 90  LFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI 149

Query: 112 -KNNTLKLA--GL 121
            ++  +K+   GL
Sbjct: 150 DESRNVKIGDFGL 162

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  112 bits (282), Expect = 5e-28
 Identities = 40/145 (27%), Positives = 67/145 (46%), Gaps = 18/145 (12%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
             A+KCI K+    +   S+ NEI  LK + H++IVT+ D      + Y++++   GG+L
Sbjct: 36  LFALKCIKKSPAFRD--SSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA-- 119
              I      +E      ++Q++ A+K+L EN + H DLKP+N+L         + +   
Sbjct: 94  FDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDF 153

Query: 120 GLKQGVSEKAKGSAYIEQGNTKVIC 144
           GL          S   + G     C
Sbjct: 154 GL----------SKMEQNGIMSTAC 168

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  113 bits (284), Expect = 5e-28
 Identities = 34/125 (27%), Positives = 63/125 (50%), Gaps = 11/125 (8%)

Query: 6   EVAIKCIDKTKVSENR---FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           + A+K +D  K + +     + +  E     +L H HIV +L+    +  +Y++ E+ DG
Sbjct: 51  QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDG 110

Query: 63  GDLCSFI----RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---- 114
            DLC  I     +    SE     ++RQ++ AL++  +NN+ H D+KP  +L+ +     
Sbjct: 111 ADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSA 170

Query: 115 TLKLA 119
            +KL 
Sbjct: 171 PVKLG 175

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  112 bits (281), Expect = 9e-28
 Identities = 37/151 (24%), Positives = 59/151 (39%), Gaps = 21/151 (13%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVN----EIKALKLLHHQ--HIVTMLDFLWDERYVYIILE 58
             VAIK ++K ++S+            E+  LK +      ++ +LD+        +ILE
Sbjct: 69  LPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILE 128

Query: 59  YCDG-GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-- 115
             +   DL  FI     L E   + F  Q++ A++      V H D+K +NILI  N   
Sbjct: 129 RPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGE 188

Query: 116 LKLA--GLKQGVSEKAKGSAYIEQGNTKVIC 144
           LKL   G            A ++        
Sbjct: 189 LKLIDFGS----------GALLKDTVYTDFD 209

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 1e-27
 Identities = 40/126 (31%), Positives = 66/126 (52%), Gaps = 11/126 (8%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           E  IK I+K +      + I  EI+ LK L H +I+ + +   D   +YI++E C+GG+L
Sbjct: 49  ERVIKTINKDRSQVPM-EQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGEL 107

Query: 66  ----CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLK 117
                S     + LSE    + ++Q++ AL +    +V H DLKP+NIL ++      +K
Sbjct: 108 LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIK 167

Query: 118 LA--GL 121
           +   GL
Sbjct: 168 IIDFGL 173

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  114 bits (286), Expect = 2e-27
 Identities = 35/119 (29%), Positives = 70/119 (58%), Gaps = 5/119 (4%)

Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K I K +V  +   +S++ E++ LK L H +I+ + +F  D+ Y Y++ E   GG+
Sbjct: 53  ECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGE 112

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA 119
           L   I S ++ SE    + +RQ++  + ++ +N + H DLKP+N+L+++      +++ 
Sbjct: 113 LFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRII 171

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  111 bits (279), Expect = 2e-27
 Identities = 41/128 (32%), Positives = 73/128 (57%), Gaps = 13/128 (10%)

Query: 6   EVAIKCIDKTKVS------ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           +VAIK I K K +       +   ++  EI+ LK L+H  I+ + +F +D    YI+LE 
Sbjct: 37  KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNF-FDAEDYYIVLEL 95

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----T 115
            +GG+L   +  +++L E  C+ +  Q++LA+++L EN + H DLKP+N+L+ +      
Sbjct: 96  MEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCL 155

Query: 116 LKLA--GL 121
           +K+   G 
Sbjct: 156 IKITDFGH 163

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (276), Expect = 2e-27
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 2/115 (1%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L
Sbjct: 34  AVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
              I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  110 bits (278), Expect = 2e-27
 Identities = 37/149 (24%), Positives = 69/149 (46%), Gaps = 20/149 (13%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A K + K +  ++    I++EI  L+L      ++ + +   +   + +ILEY  GG+
Sbjct: 56  EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115

Query: 65  LCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT----LKL 118
           + S       E +SE    + ++Q++  + +L +NN+ H DLKPQNIL+ +      +K+
Sbjct: 116 IFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKI 175

Query: 119 A--GLKQGVSEKAKGSAYIEQGNT-KVIC 144
              G+          S  I      + I 
Sbjct: 176 VDFGM----------SRKIGHACELREIM 194

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  110 bits (278), Expect = 3e-27
 Identities = 33/170 (19%), Positives = 69/170 (40%), Gaps = 37/170 (21%)

Query: 2   EQHTEVAIKCIDKTKV---------------SENRFDSIVNEIKALKLLHHQHIVTMLDF 46
           + +   A+K  +K+ +                ++++D   NE++ +  + +++ +T    
Sbjct: 52  KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGI 111

Query: 47  LWDERYVYIILEYCDGGDLCSFIRSHEKL--------SEFQCQQFVRQLVLALKFL-REN 97
           + +   VYII EY +   +  F      L             +  ++ ++ +  ++  E 
Sbjct: 112 ITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171

Query: 98  NVCHFDLKPQNILI-KNNTLKLA--GLKQGVSEKAKGSAYIEQGNTKVIC 144
           N+CH D+KP NIL+ KN  +KL+  G           S Y+     K   
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFGE----------SEYMVDKKIKGSR 211

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  108 bits (273), Expect = 5e-27
 Identities = 41/125 (32%), Positives = 61/125 (48%), Gaps = 12/125 (9%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGD 64
           +  K +D   ++E     +V+E+  L+ L H +IV   D + D     +YI++EYC+GGD
Sbjct: 34  LVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD 93

Query: 65  LCSFIRSHEK----LSEFQCQQFVRQLVLALKFL-----RENNVCHFDLKPQNILI-KNN 114
           L S I    K    L E    + + QL LALK         + V H DLKP N+ +    
Sbjct: 94  LASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ 153

Query: 115 TLKLA 119
            +KL 
Sbjct: 154 NVKLG 158

>3b4t_A Ribonuclease PH; RNAse, tRNA nucleotidyltransferase, RPHA, STRU genomics, TBSGC; 2.10A {Mycobacterium tuberculosis} Length = 262

 Score =  108 bits (271), Expect = 5e-27
 Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 35/235 (14%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           + +G +E   GS  IE G+TKV+C+      +P  + +       G L  E+   P A+ 
Sbjct: 21  ITRGFTENPAGSVLIEFGHTKVLCTASVTEGVPRWRKATG----LGWLTAEYAMLPSATH 76

Query: 181 IRTG-----WLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAIN 235
            R+             +E+   + R+L   +         + +   VLQ DG   +AAI 
Sbjct: 77  SRSDRESVRGRLSGRTQEISRLIGRSLRACIDLAALGENTIAIDCDVLQADGGTRTAAIT 136

Query: 236 CANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSY- 294
            A +AL DA            L+  G L+   P+   +A     S    D    + L Y 
Sbjct: 137 GAYVALADAVTY---------LSAAGKLSDPRPLSCAIAAV---SVGVVDGRIRVDLPYE 184

Query: 295 --------MSVIQQVT-QVTLV-GTIQQERLA-DHIEQLIGCCESLCTD--RVQK 336
                   M+V+   T  +  + GT +    A   +++L+      C      Q+
Sbjct: 185 EDSRAEVDMNVVATDTGTLVEIQGTGEGATFARSTLDKLLDMALGACDTLFAAQR 239

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  109 bits (275), Expect = 5e-27
 Identities = 32/119 (26%), Positives = 56/119 (47%), Gaps = 6/119 (5%)

Query: 7   VAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K +    + + +     + EI  LK L+H +++       ++  + I+LE  D GDL
Sbjct: 60  VALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDL 119

Query: 66  CSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
              I+  +K    + E    ++  QL  AL+ +    V H D+KP N+ I     +KL 
Sbjct: 120 SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLG 178

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  108 bits (271), Expect = 1e-26
 Identities = 29/133 (21%), Positives = 50/133 (37%), Gaps = 25/133 (18%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--------------- 50
              IK +          +    E+KAL  L H +IV                        
Sbjct: 38  TYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSK 91

Query: 51  -RYVYIILEYCDGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
            + ++I +E+CD G L  +I  R  EKL +    +   Q+   + ++    + + DLKP 
Sbjct: 92  TKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPS 151

Query: 108 NILI-KNNTLKLA 119
           NI +     +K+ 
Sbjct: 152 NIFLVDTKQVKIG 164

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  108 bits (272), Expect = 1e-26
 Identities = 34/115 (29%), Positives = 62/115 (53%), Gaps = 2/115 (1%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+L
Sbjct: 34  AVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
              I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 93  FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 147

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  107 bits (269), Expect = 3e-26
 Identities = 31/127 (24%), Positives = 63/127 (49%), Gaps = 11/127 (8%)

Query: 6   EVAIKCIDKTKVS-------ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIIL 57
           E A+K ID T          +   ++ + E+  L+ +  H +I+ + D      + +++ 
Sbjct: 44  EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVF 103

Query: 58  EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           +    G+L  ++     LSE + ++ +R L+  +  L + N+ H DLKP+NIL+ ++  +
Sbjct: 104 DLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNI 163

Query: 117 KLA--GL 121
           KL   G 
Sbjct: 164 KLTDFGF 170

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  107 bits (269), Expect = 4e-26
 Identities = 29/122 (23%), Positives = 60/122 (49%), Gaps = 9/122 (7%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
               K +      +     +  EI  L +  H++I+ + +       + +I E+  G D+
Sbjct: 32  TYMAKFVKVKGTDQ---VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88

Query: 66  CSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLA-- 119
              I +   +L+E +   +V Q+  AL+FL  +N+ HFD++P+NI+    +++T+K+   
Sbjct: 89  FERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF 148

Query: 120 GL 121
           G 
Sbjct: 149 GQ 150

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  109 bits (275), Expect = 4e-26
 Identities = 33/116 (28%), Positives = 67/116 (57%), Gaps = 2/116 (1%)

Query: 6   EVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K +++ K+ S +    I  EI+ LKL  H HI+ +   +     +++++EY  GG+
Sbjct: 43  KVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGE 102

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           L  +I  + +L E + ++  +Q++  + +   + V H DLKP+N+L+  +   K+A
Sbjct: 103 LFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIA 158

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  106 bits (268), Expect = 4e-26
 Identities = 32/121 (26%), Positives = 67/121 (55%), Gaps = 8/121 (6%)

Query: 6   EVAIKCIDKTKVS--ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCD 61
             A+K + K K+    N   ++  EI+ L+ L H++++ ++D L++E  + +Y+++EYC 
Sbjct: 32  RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCV 91

Query: 62  GG--DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
            G  ++   +   ++    Q   +  QL+  L++L    + H D+KP N+L+    TLK+
Sbjct: 92  CGMQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKI 150

Query: 119 A 119
           +
Sbjct: 151 S 151

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  109 bits (274), Expect = 6e-26
 Identities = 39/129 (30%), Positives = 68/129 (52%), Gaps = 15/129 (11%)

Query: 6   EVAIKCIDKTKVS-----------ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVY 54
           E AIK I K++             E   + I NEI  LK L H +I+ + D   D++Y Y
Sbjct: 63  EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122

Query: 55  IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           ++ E+ +GG+L   I +  K  E      ++Q++  + +L ++N+ H D+KP+NIL++N 
Sbjct: 123 LVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182

Query: 115 ----TLKLA 119
                +K+ 
Sbjct: 183 NSLLNIKIV 191

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  106 bits (267), Expect = 7e-26
 Identities = 26/125 (20%), Positives = 47/125 (37%), Gaps = 11/125 (8%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER----YVYIILEY 59
               A+K I   +  +        E    +L +H +I+ ++ +   ER      +++L +
Sbjct: 54  GHFYALKRILCHEQQDRE--EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPF 111

Query: 60  CDGGDLCSFI----RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 114
              G L + I         L+E Q    +  +   L+ +      H DLKP NIL+    
Sbjct: 112 FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG 171

Query: 115 TLKLA 119
              L 
Sbjct: 172 QPVLM 176

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (265), Expect = 7e-26
 Identities = 28/113 (24%), Positives = 49/113 (43%), Gaps = 5/113 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            AIK   K         + + E+ A   L  H H+V       ++ ++ I  EYC+GG L
Sbjct: 39  YAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSL 98

Query: 66  CSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
              I  + +      E + +  + Q+   L+++   ++ H D+KP NI I   
Sbjct: 99  ADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRT 151

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  107 bits (269), Expect = 8e-26
 Identities = 35/126 (27%), Positives = 66/126 (52%), Gaps = 10/126 (7%)

Query: 6   EVAIKCIDKTKVS------ENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILE 58
           E A+K ++ T         E   ++   E   L+ +  H HI+T++D      +++++ +
Sbjct: 121 EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFD 180

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLK 117
               G+L  ++     LSE + +  +R L+ A+ FL  NN+ H DLKP+NIL+ +N  ++
Sbjct: 181 LMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIR 240

Query: 118 LA--GL 121
           L+  G 
Sbjct: 241 LSDFGF 246

>1r6l_A Ribonuclease PH; beta-alpha-beta-alpha fold, hexamer, phosphate bound, transf; HET: NHE; 1.90A {Pseudomonas aeruginosa} SCOP: d.14.1.4 d.101.1.1 PDB: 1r6m_A Length = 239

 Score =  104 bits (261), Expect = 8e-26
 Identities = 37/168 (22%), Positives = 72/168 (42%), Gaps = 20/168 (11%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           + +  ++ A+GS  +E G+TKVIC+V     +P         + +G L  E+   P ++ 
Sbjct: 17  ITRHYTKHAEGSVLVEFGDTKVICTVSAESGVPRFLKG----QGQGWLTAEYGMLPRSTG 72

Query: 181 IRT-----GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAIN 235
            R         +     E+   + R+L  A+   +     + +   V+Q DG   +A+I 
Sbjct: 73  ERNQREASRGKQGGRTLEIQRLIGRSLRAALDLSKLGENTLYIDCDVIQADGGTRTASIT 132

Query: 236 CANLALVDA-----------AIPMYDLVTSSTLALRGGLTFIDPVEEE 272
            A +AL+DA             P+  +V + ++ +  G+  +D    E
Sbjct: 133 GATVALIDALAVLKKRGALKGNPLKQMVAAVSVGIYQGVPVLDLDYLE 180

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  109 bits (274), Expect = 9e-26
 Identities = 38/122 (31%), Positives = 63/122 (51%), Gaps = 8/122 (6%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
             A K +     S+   +++  EI+ + +L H  +V + D   D+  + +I E+  GG+L
Sbjct: 184 NFAAKFVMTPHESD--KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL 241

Query: 66  CSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLA-- 119
              +   H K+SE +  +++RQ+   L  + ENN  H DLKP+NI+      N LKL   
Sbjct: 242 FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF 301

Query: 120 GL 121
           GL
Sbjct: 302 GL 303

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  106 bits (267), Expect = 9e-26
 Identities = 36/122 (29%), Positives = 57/122 (46%), Gaps = 10/122 (8%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
             A+K + KT   +     +  EI  L  L H +I+ + +       + ++LE   GG+L
Sbjct: 80  PYALKVLKKTVDKK----IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA-- 119
              I      SE      V+Q++ A+ +L EN + H DLKP+N+L         LK+A  
Sbjct: 136 FDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADF 195

Query: 120 GL 121
           GL
Sbjct: 196 GL 197

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  107 bits (268), Expect = 1e-25
 Identities = 33/124 (26%), Positives = 62/124 (50%), Gaps = 12/124 (9%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           ++A K I    + +   + + NEI  +  L H +++ + D    +  + +++EY DGG+L
Sbjct: 116 KLAAKIIKTRGMKDK--EEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173

Query: 66  CSF---IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN---NTLKLA 119
             F   I     L+E     F++Q+   ++ + +  + H DLKP+NIL  N     +K+ 
Sbjct: 174 --FDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKII 231

Query: 120 --GL 121
             GL
Sbjct: 232 DFGL 235

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  107 bits (268), Expect = 1e-25
 Identities = 35/124 (28%), Positives = 63/124 (50%), Gaps = 12/124 (9%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
               K I+     +    ++ NEI  +  LHH  ++ + D   D+  + +ILE+  GG+L
Sbjct: 78  VFVAKFINTPYPLD--KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL 135

Query: 66  CSF---IRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLA 119
             F        K+SE +   ++RQ    LK + E+++ H D+KP+NI+    K +++K+ 
Sbjct: 136 --FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKII 193

Query: 120 --GL 121
             GL
Sbjct: 194 DFGL 197

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  105 bits (265), Expect = 2e-25
 Identities = 34/117 (29%), Positives = 70/117 (59%), Gaps = 3/117 (2%)

Query: 5   TEVAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
            +VA+K I +  + ++     +  EI  LKLL H HI+ + D +     + +++EY  GG
Sbjct: 35  QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GG 93

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           +L  +I   ++++E + ++F +Q++ A+++   + + H DLKP+N+L+  N  +K+A
Sbjct: 94  ELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIA 150

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  104 bits (262), Expect = 2e-25
 Identities = 27/116 (23%), Positives = 42/116 (36%), Gaps = 4/116 (3%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            A+K               + E+ +  K+  H   V +     +   +Y+  E C G  L
Sbjct: 85  YAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSL 143

Query: 66  CSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
                     L E Q   ++R  +LAL  L    + H D+KP NI +      KL 
Sbjct: 144 QQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLG 199

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  103 bits (258), Expect = 7e-25
 Identities = 32/128 (25%), Positives = 54/128 (42%), Gaps = 17/128 (13%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------------YVY 54
            AIK I        R + ++ E+KAL  L H  IV   +   ++             Y+Y
Sbjct: 33  YAIKRIRLPNRELAR-EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLY 91

Query: 55  IILEYCDGGDLCSFIRSHEKLSEF---QCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           I ++ C   +L  ++     + E     C     Q+  A++FL    + H DLKP NI  
Sbjct: 92  IQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF 151

Query: 112 -KNNTLKL 118
             ++ +K+
Sbjct: 152 TMDDVVKV 159

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  103 bits (258), Expect = 7e-25
 Identities = 38/156 (24%), Positives = 74/156 (47%), Gaps = 30/156 (19%)

Query: 4   HTEVAIKCIDKTKV------------------------SENRFDSIVNEIKALKLLHHQH 39
           +T  A+K + K K+                             + +  EI  LK L H +
Sbjct: 38  NTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN 97

Query: 40  IVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN 97
           +V +++ L D  E ++Y++ E  + G +   + + + LSE Q + + + L+  +++L   
Sbjct: 98  VVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQ 156

Query: 98  NVCHFDLKPQNILI-KNNTLKLAGLKQGVSEKAKGS 132
            + H D+KP N+L+ ++  +K+A    GVS + KGS
Sbjct: 157 KIIHRDIKPSNLLVGEDGHIKIADF--GVSNEFKGS 190

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  103 bits (258), Expect = 1e-24
 Identities = 37/124 (29%), Positives = 66/124 (53%), Gaps = 15/124 (12%)

Query: 7   VAIKCIDKTKVSENRFDSIVN-----EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           VAIK     K  E+  D ++      EI+ LK L H ++V +L+    +R ++++ EYCD
Sbjct: 31  VAIK-----KFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85

Query: 62  GGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
              +   +  +++ + E   +    Q + A+ F  ++N  H D+KP+NILI K++ +KL 
Sbjct: 86  H-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLC 144

Query: 120 --GL 121
             G 
Sbjct: 145 DFGF 148

>1udn_A Ribonuclease PH, RNAse PH; transferase, riken structural genomics/proteomics initiative structural genomics; 2.30A {Aquifex aeolicus} SCOP: d.14.1.4 d.101.1.1 PDB: 1udq_A 1uds_A 1udo_A Length = 255

 Score =  100 bits (252), Expect = 2e-24
 Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 9/143 (6%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
              E  +GS  I  G TKVIC+      +P+        + +G +  E+   P A+Q RT
Sbjct: 19  DFLEYPEGSCLISFGKTKVICTASVIENVPNWLK----GKGQGWITAEYSMLPRATQQRT 74

Query: 184 -----GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCAN 238
                         E+   + RA+  AV   +     + +   V+Q DG   +AAI  A 
Sbjct: 75  IRESVQGRIGGRTHEIQRMIGRAMRTAVELTKIGERTIWVDCDVIQADGGTRTAAITGAF 134

Query: 239 LALVDAAIPMYDLVTSSTLALRG 261
           +A+ DA I ++         ++ 
Sbjct: 135 VAVADAIIKLHKEGIIEETPIKD 157

>2je6_B RRP41, exosome complex exonuclease 1; nuclease, hydrolase, exonuclease, phosphorolytic, exoribonuclease, RNA degradation; HET: 1PE; 1.6A {Sulfolobus solfataricus} SCOP: d.14.1.4 d.101.1.1 PDB: 2jea_B* 2jeb_B* 2br2_B 2c37_B* 2c38_B* 2c39_B* 3l7z_B Length = 250

 Score =  100 bits (252), Expect = 2e-24
 Identities = 51/149 (34%), Positives = 73/149 (48%), Gaps = 3/149 (2%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV + A GSA  E GNTK I +V+ P+E+     SL     +  L V +   PF++  R 
Sbjct: 38  GVLKNADGSAIFEMGNTKAIAAVYGPKEMHPRHLSLPD---RAVLRVRYHMTPFSTDERK 94

Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
                  E EL   ++ ALE AV    F    +D+F  +LQ D  +   ++  A+LAL D
Sbjct: 95  NPAPSRREIELSKVIREALESAVLVELFPRTAIDVFTEILQADAGSRLVSLMAASLALAD 154

Query: 244 AAIPMYDLVTSSTLALRGGLTFIDPVEEE 272
           A IPM DL+    +    G+  +D  E E
Sbjct: 155 AGIPMRDLIAGVAVGKADGVIILDLNETE 183

>3m7n_D Probable exosome complex exonuclease 1; exosome, RNA, exonuclease, hydrolase, nuclease, hydrolase-RN; 2.40A {Archaeoglobus fulgidus} PDB: 3m85_D 2ba0_F 2ba1_E Length = 258

 Score =  100 bits (252), Expect = 2e-24
 Identities = 51/151 (33%), Positives = 77/151 (50%), Gaps = 7/151 (4%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFA--SQI 181
            V ++A GS Y+E G  KVI +VF PRE+            K  +   +  APF+   + 
Sbjct: 34  SVLKRADGSCYLEMGKNKVIAAVFGPREVHPEHLQDPS---KAIIRYRYNMAPFSVEERK 90

Query: 182 RTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLAL 241
           R G  R     E+    K A E  + +  F    +D+FV VLQ D  + +A +N A++AL
Sbjct: 91  RPGPDR--RSIEISKVSKEAFEAVIMKELFPRSAIDIFVEVLQADAGSRTACLNAASVAL 148

Query: 242 VDAAIPMYDLVTSSTLALRGGLTFIDPVEEE 272
           VDA +PM  ++TS  +    G   +DP++EE
Sbjct: 149 VDAGVPMKGMITSVAVGKADGQLVLDPMKEE 179

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  102 bits (256), Expect = 2e-24
 Identities = 39/185 (21%), Positives = 67/185 (36%), Gaps = 48/185 (25%)

Query: 6   EVAIKCIDKTKV---SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
             AIK ++K K+   +    + I  E++ +K LHH +I  + +   DE+Y+ +++E C G
Sbjct: 53  IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHG 112

Query: 63  GDLCSFIRSHEK----------------------------------------LSEFQCQQ 82
           G L   +                                               E     
Sbjct: 113 GHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISN 172

Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLAGLKQGVSEKAKGSAYIEQGN 139
            +RQ+  AL +L    +CH D+KP+N L    K+  +KL     G+S++       E   
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF--GLSKEFYKLNNGEYYG 230

Query: 140 TKVIC 144
                
Sbjct: 231 MTTKA 235

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  102 bits (257), Expect = 3e-24
 Identities = 32/118 (27%), Positives = 57/118 (48%), Gaps = 6/118 (5%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             VA+K I++    +     +  EI   + L H +IV   + +    ++ II+EY  GG+
Sbjct: 46  ELVAVKYIERGAAIDEN---VQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGE 102

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLA 119
           L   I +  + SE + + F +QL+  + +     +CH DLK +N L+       LK+ 
Sbjct: 103 LYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKIC 160

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  102 bits (257), Expect = 4e-24
 Identities = 33/126 (26%), Positives = 65/126 (51%), Gaps = 19/126 (15%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEY 59
           EVAIK + + K  +NR      E++ ++++ H ++V +  F +      DE ++ ++LEY
Sbjct: 66  EVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119

Query: 60  CDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KN 113
                +    R + K    +     + ++ QL+ +L ++    +CH D+KPQN+L+   +
Sbjct: 120 VPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPS 178

Query: 114 NTLKLA 119
             LKL 
Sbjct: 179 GVLKLI 184

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  101 bits (255), Expect = 4e-24
 Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 7/118 (5%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K IDK+K           EI+ L +   H +I+T+ D   D +YVY++ E   GG+
Sbjct: 49  EFAVKIIDKSKRDPTE------EIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGE 102

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLK 122
           L   I   +  SE +    +  +   +++L    V H DLKP NIL  + +     ++
Sbjct: 103 LLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIR 160

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  100 bits (250), Expect = 1e-23
 Identities = 31/119 (26%), Positives = 57/119 (47%), Gaps = 7/119 (5%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           E A+K I+K          +  E++ L     H++++ +++F  +E   Y++ E   GG 
Sbjct: 40  EYAVKIIEKQPGHIR--SRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA 119
           + S I      +E +    V+ +  AL FL    + H DLKP+NIL ++      +K+ 
Sbjct: 98  ILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKIC 156

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  101 bits (252), Expect = 3e-23
 Identities = 30/116 (25%), Positives = 49/116 (42%), Gaps = 14/116 (12%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
            VA+K +          D  + EIK L +   H +++        +R++YI LE C   +
Sbjct: 41  PVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLN 94

Query: 65  LCSFIRSH-------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           L   + S        +   E+     +RQ+   +  L    + H DLKPQNIL+  
Sbjct: 95  LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVST 150

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 99.2 bits (248), Expect = 3e-23
 Identities = 35/124 (28%), Positives = 63/124 (50%), Gaps = 15/124 (12%)

Query: 7   VAIKCIDKTKVSENRFDSIVN-----EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           VAIK     K  E+  D +V      EIK LK L H+++V +L+    ++  Y++ E+ D
Sbjct: 53  VAIK-----KFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVD 107

Query: 62  GGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
              +   +      L     Q+++ Q++  + F   +N+ H D+KP+NIL+ ++  +KL 
Sbjct: 108 H-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLC 166

Query: 120 --GL 121
             G 
Sbjct: 167 DFGF 170

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 98.1 bits (245), Expect = 4e-23
 Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 7/118 (5%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           +AIK I +          +  EI   K L H++IV  L    +  ++ I +E   GG L 
Sbjct: 50  IAIKEIPERDSRY--SQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS 107

Query: 67  SFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KNNTLKLA 119
           + +RS     K +E     + +Q++  LK+L +N + H D+K  N+LI   +  LK++
Sbjct: 108 ALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKIS 165

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 98.9 bits (247), Expect = 4e-23
 Identities = 34/119 (28%), Positives = 60/119 (50%), Gaps = 10/119 (8%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             A+K I K         +   EI ALKL   H +IV + +   D+ + ++++E  +GG+
Sbjct: 38  AFAVKIISKRME-----ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----TLKLA 119
           L   I+  +  SE +    +R+LV A+  + +  V H DLKP+N+L  +      +K+ 
Sbjct: 93  LFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKII 151

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  100 bits (250), Expect = 4e-23
 Identities = 27/111 (24%), Positives = 45/111 (40%), Gaps = 8/111 (7%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+K I         F     E++ L+    H +++       D ++ YI +E C    
Sbjct: 50  DVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AAT 103

Query: 65  LCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  ++   +      +    ++Q    L  L   N+ H DLKP NILI   
Sbjct: 104 LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMP 154

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 25/116 (21%), Positives = 48/116 (41%), Gaps = 9/116 (7%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           + A+K +               E+ A   L    IV +   + +  +V I +E  +GG L
Sbjct: 85  QCAVKKVRLEVFRVE-------ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLA 119
              I+    L E +   ++ Q +  L++L    + H D+K  N+L+ ++     L 
Sbjct: 138 GQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALC 193

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 27/122 (22%), Positives = 55/122 (45%), Gaps = 8/122 (6%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVT----MLDFLWDERYVYIILEYCD 61
           EVA   +   K++++       E + LK L H +IV         +  ++ + ++ E   
Sbjct: 53  EVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMT 112

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILI--KNNTLK 117
            G L ++++  + +     + + RQ++  L+FL      + H DLK  NI I     ++K
Sbjct: 113 SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVK 172

Query: 118 LA 119
           + 
Sbjct: 173 IG 174

>3dd6_A Ribonuclease PH; exoribonuclease, tRNA maturation, RNAse PH., transferase; 1.70A {Bacillus anthracis} Length = 255

 Score = 94.7 bits (236), Expect = 3e-22
 Identities = 37/145 (25%), Positives = 56/145 (38%), Gaps = 20/145 (13%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
              +  +GS  IE G+TKVICS      +P           KG +  E+   P A++ RT
Sbjct: 29  NYLKHPEGSVLIEVGDTKVICSATIEERVPPFMR----GEGKGWVTAEYAMIPRATEQRT 84

Query: 184 -----GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCAN 238
                         E+   + RAL   V         V +   V+Q DG   +A+I  A 
Sbjct: 85  IRESSKGKVTGRTMEIQRLIGRALRAVVDLEALGERTVWIDCDVIQADGGTRTASITGAY 144

Query: 239 LALVD-----------AAIPMYDLV 252
           +A+V            + IP+ D +
Sbjct: 145 VAMVLAFEKLLQAEKVSKIPVKDYL 169

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 97.9 bits (244), Expect = 3e-22
 Identities = 35/125 (28%), Positives = 63/125 (50%), Gaps = 19/125 (15%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILEYC 60
           VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+Y 
Sbjct: 82  VAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV 135

Query: 61  DGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT- 115
               +    R + +    L     + ++ QL  +L ++    +CH D+KPQN+L+  +T 
Sbjct: 136 PE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTA 194

Query: 116 -LKLA 119
            LKL 
Sbjct: 195 VLKLC 199

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 94.1 bits (235), Expect = 9e-22
 Identities = 36/120 (30%), Positives = 60/120 (50%), Gaps = 7/120 (5%)

Query: 7   VAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
            A+K I + +  +    S  + EI  LK L H +IV + D +  ++ + ++ E+ D  DL
Sbjct: 29  FALKKI-RLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL 86

Query: 66  CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
              +      L     + F+ QL+  + +  +  V H DLKPQN+LI +   LK+A  GL
Sbjct: 87  KKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGL 146

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 94.5 bits (236), Expect = 9e-22
 Identities = 39/120 (32%), Positives = 66/120 (55%), Gaps = 7/120 (5%)

Query: 7   VAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K I +    +    S  + EI  LK LHH +IV+++D +  ER + ++ E+ +  DL
Sbjct: 48  VALKRI-RLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DL 105

Query: 66  CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
              +  +   L + Q + ++ QL+  +    ++ + H DLKPQN+LI  +  LKLA  GL
Sbjct: 106 KKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGL 165

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 94.1 bits (235), Expect = 1e-21
 Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQCQQFVR 85
           EI  LK L+H +IV +LD +  E  +Y++ E+    DL  F+ +     +     + ++ 
Sbjct: 52  EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLF 110

Query: 86  QLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
           QL+  L F   + V H DLKPQN+LI     +KLA  GL
Sbjct: 111 QLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGL 149

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 42/172 (24%), Positives = 79/172 (45%), Gaps = 14/172 (8%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLWDERY-----V 53
             +   VAIK I   +V E+  D   I+ EI  L  L+H H+V +LD +  +       +
Sbjct: 75  KLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132

Query: 54  YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-K 112
           Y++LE  D  D     R+   L+E   +  +  L++ +K++    + H DLKP N L+ +
Sbjct: 133 YVVLEIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQ 191

Query: 113 NNTLKLA--GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL-EY 161
           + ++K+   GL + V     G++ +     +   ++       + K  L  +
Sbjct: 192 DCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGH 243

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.1 bits (235), Expect = 1e-21
 Identities = 44/120 (36%), Positives = 64/120 (53%), Gaps = 7/120 (5%)

Query: 7   VAIKCIDKTKVSENRFDS-IVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           VA+K + +    +    S  + EI  LK L H++IV + D L  ++ + ++ E+CD  DL
Sbjct: 30  VALKRV-RLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DL 87

Query: 66  CSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
             +  S    L     + F+ QL+  L F    NV H DLKPQN+LI +N  LKLA  GL
Sbjct: 88  KKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGL 147

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 37/123 (30%), Positives = 64/123 (52%), Gaps = 10/123 (8%)

Query: 7   VAIKCIDKTKVSENRFDSI----VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           VAIK I K        D I    + EIK L+ L H +I+ +LD    +  + ++ ++ + 
Sbjct: 38  VAIKKI-KLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96

Query: 63  GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA- 119
            DL   I+ +   L+    + ++   +  L++L ++ + H DLKP N+L+ +N  LKLA 
Sbjct: 97  -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLAD 155

Query: 120 -GL 121
            GL
Sbjct: 156 FGL 158

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 93.4 bits (233), Expect = 3e-21
 Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 5/98 (5%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFVRQ 86
           E+  LK L H +IVT+ D +  E+ + ++ EY D  DL  ++      ++    + F+ Q
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQ 108

Query: 87  LVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
           L+  L +     V H DLKPQN+LI +   LKLA  GL
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGL 146

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 28/102 (27%), Positives = 50/102 (49%), Gaps = 9/102 (8%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQL 87
           E+  LK L H++I+ +   +     +++I EY +  DL  ++  +  +S    + F+ QL
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141

Query: 88  VLALKFLRENNVCHFDLKPQNILI------KNNTLKLA--GL 121
           +  + F       H DLKPQN+L+      +   LK+   GL
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 92.4 bits (230), Expect = 7e-21
 Identities = 36/146 (24%), Positives = 66/146 (45%), Gaps = 24/146 (16%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWD----ERYVYIILEYC 60
           + A+K +  +  +         E+    +     HIV +LD   +    +R + II+E  
Sbjct: 56  KCALKLLYDSPKARQ-------EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108

Query: 61  DGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---- 114
           +GG+L S I  R  +  +E +  + +R +  A++FL  +N+ H D+KP+N+L  +     
Sbjct: 109 EGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDA 168

Query: 115 TLKLA--GL----KQGVSEKAKGSAY 134
            LKL   G      Q   +    + Y
Sbjct: 169 VLKLTDFGFAKETTQNALQTPCYTPY 194

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 23/125 (18%), Positives = 52/125 (41%), Gaps = 5/125 (4%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             V ++ I+    S      +  E+   KL +H +IV        +  ++++  +   G 
Sbjct: 53  EYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGS 112

Query: 65  LCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGL 121
               I +H  + ++E      ++ ++ AL ++      H  +K  +ILI  +  + L+GL
Sbjct: 113 AKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGL 172

Query: 122 KQGVS 126
               +
Sbjct: 173 --RSN 175

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 37/103 (35%), Positives = 52/103 (50%), Gaps = 10/103 (9%)

Query: 28  EIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH------EKLSEFQCQ 81
           EI  +K L H++IV + D +  E  + ++ E+ D  DL  ++ S         L     +
Sbjct: 53  EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111

Query: 82  QFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
            F  QL+  L F  EN + H DLKPQN+LI K   LKL   GL
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGL 154

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 29/125 (23%), Positives = 58/125 (46%), Gaps = 18/125 (14%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDF----LWDERYVYIILEYC 60
           + A+K +     +         E++   +     HIV ++D         + + I++E  
Sbjct: 45  KFALKMLQDCPKARR-------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 97

Query: 61  DGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---- 114
           DGG+L S I  R  +  +E +  + ++ +  A+++L   N+ H D+KP+N+L  +     
Sbjct: 98  DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 157

Query: 115 TLKLA 119
            LKL 
Sbjct: 158 ILKLT 162

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 88.9 bits (221), Expect = 7e-20
 Identities = 41/139 (29%), Positives = 73/139 (52%), Gaps = 10/139 (7%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGDL 65
            A K I+    SE   +  + EI+ L    H +IV +L  +  D + ++I++E+C GG +
Sbjct: 47  AAAKVIETK--SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGK-LWIMIEFCPGGAV 103

Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQ 123
            + +   ++ L+E Q Q   RQ++ AL FL    + H DLK  N+L+     ++LA    
Sbjct: 104 DAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADF-- 161

Query: 124 GVSEKAKGSAYIEQGNTKV 142
           GVS  AK    +++ ++ +
Sbjct: 162 GVS--AKNLKTLQKRDSFI 178

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 90.2 bits (224), Expect = 8e-20
 Identities = 29/125 (23%), Positives = 57/125 (45%), Gaps = 18/125 (14%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDF----LWDERYVYIILEYC 60
           + A+K +     +         E++         HIV ++D         + + I++E  
Sbjct: 89  KFALKMLQDCPKARR-------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECL 141

Query: 61  DGGDLCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---- 114
           DGG+L S I  R  +  +E +  + ++ +  A+++L   N+ H D+KP+N+L  +     
Sbjct: 142 DGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201

Query: 115 TLKLA 119
            LKL 
Sbjct: 202 ILKLT 206

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 90.6 bits (225), Expect = 9e-20
 Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 13/151 (8%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLWDERY-----V 53
                 VAIK +   ++ E+  D   I+ EI  L  L   +I+ + D +  +       +
Sbjct: 48  KNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105

Query: 54  YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           YI+LE  D  DL    ++   L+E   +  +  L+L   F+ E+ + H DLKP N L+  
Sbjct: 106 YIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQ 164

Query: 114 N-TLKLA--GLKQGVSEKAKGSAYIEQGNTK 141
           + ++K+   GL + ++ +   +   +    +
Sbjct: 165 DCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 89.7 bits (223), Expect = 9e-20
 Identities = 39/146 (26%), Positives = 68/146 (46%), Gaps = 21/146 (14%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW-------DERYVYIILEY 59
           VAIK + +     NR    +  ++ L +LHH +IV +  + +        + Y+ +++EY
Sbjct: 51  VAIKKVIQDPRFRNR---ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY 107

Query: 60  CDGGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLREN--NVCHFDLKPQNILI-- 111
                L    R++ +          + F+ QL+ ++  L     NVCH D+KP N+L+  
Sbjct: 108 VPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNE 166

Query: 112 KNNTLKLA--GLKQGVSEKAKGSAYI 135
            + TLKL   G  + +S      AYI
Sbjct: 167 ADGTLKLCDFGSAKKLSPSEPNVAYI 192

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 31/116 (26%), Positives = 61/116 (52%), Gaps = 6/116 (5%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGD 64
           +VA+K +D  K  + R + + NE+  ++   H ++V M   +L  E  +++++E+  GG 
Sbjct: 72  QVAVKMMDLRK--QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGE-ELWVLMEFLQGGA 128

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
           L   +    +L+E Q       ++ AL +L    V H D+K  +IL+  +  +KL+
Sbjct: 129 LTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLS 183

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 31/121 (25%), Positives = 59/121 (48%), Gaps = 3/121 (2%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H EVAI+ ID  + +E++  +   E+ A +   H+++V  +       ++ II   C G 
Sbjct: 55  HGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGR 114

Query: 64  DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA--G 120
            L S +R  +  L   + +Q  +++V  + +L    + H DLK +N+   N  + +   G
Sbjct: 115 TLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVITDFG 174

Query: 121 L 121
           L
Sbjct: 175 L 175

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 35/116 (30%), Positives = 64/116 (55%), Gaps = 6/116 (5%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGD 64
           EVAI+ ++  +  + + + I+NEI  ++   + +IV  LD +L  +  +++++EY  GG 
Sbjct: 47  EVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDE-LWVVMEYLAGGS 103

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
           L   +     + E Q     R+ + AL+FL  N V H D+K  NIL+  + ++KL 
Sbjct: 104 LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLT 158

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 86.6 bits (214), Expect = 9e-19
 Identities = 16/114 (14%), Positives = 40/114 (35%), Gaps = 7/114 (6%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           +  +K        E  F      ++ LK       +        +    ++ E    G L
Sbjct: 97  KFVLKVQKPANPWE--FYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154

Query: 66  CSFIRSH-----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            + I  +     + + +     F  +++  ++ + +  + H D+KP N ++ N 
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNG 208

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 33/115 (28%), Positives = 55/115 (47%), Gaps = 5/115 (4%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGDL 65
           VAIK ID  + +E+  + I  EI  L      ++      +L D + ++II+EY  GG  
Sbjct: 50  VAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTK-LWIIMEYLGGGSA 107

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
              +     L E Q    +R+++  L +L      H D+K  N+L+  +  +KLA
Sbjct: 108 LDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLA 161

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 29/130 (22%), Positives = 53/130 (40%), Gaps = 16/130 (12%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLW-------DERYVYI 55
             E A+K +      E +  +I+ E+  +K L  H +IV                +  ++
Sbjct: 53  GREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFL 110

Query: 56  ILEYCDGGDLCSFI---RSHEKLSEFQCQQFVRQLVLALKFL--RENNVCHFDLKPQNIL 110
           +L     G L  F+    S   LS     +   Q   A++ +  ++  + H DLK +N+L
Sbjct: 111 LLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLL 170

Query: 111 I-KNNTLKLA 119
           +    T+KL 
Sbjct: 171 LSNQGTIKLC 180

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 35/177 (19%), Positives = 66/177 (37%), Gaps = 53/177 (29%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFL----------------- 47
              A+K + +    +NR      E+  +K+L H +I+ ++D+                  
Sbjct: 33  KRFALKKVLQDPRYKNR------ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDH 86

Query: 48  ---------------------WDERYVYIILEYCDGGDLCSFIRSHEK----LSEFQCQQ 82
                                   +Y+ +I+EY     L   ++S  +    +       
Sbjct: 87  NKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISI 145

Query: 83  FVRQLVLALKFLRENNVCHFDLKPQNILIKNNT--LKLA--GLKQGVSEKAKGSAYI 135
           ++ QL  A+ F+    +CH D+KPQN+L+ +    LKL   G  + +       AYI
Sbjct: 146 YIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYI 202

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 84.6 bits (210), Expect = 4e-18
 Identities = 28/106 (26%), Positives = 58/106 (54%), Gaps = 13/106 (12%)

Query: 28  EIKALKLLHHQHIVTMLD--------FLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEF 78
           EIK L+LL H+++V +++        +   +  +Y++ ++C+  DL   + +   K +  
Sbjct: 66  EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124

Query: 79  QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA--GL 121
           + ++ ++ L+  L ++  N + H D+K  N+LI  +  LKLA  GL
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 83.5 bits (207), Expect = 4e-18
 Identities = 31/123 (25%), Positives = 63/123 (51%), Gaps = 12/123 (9%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGDL 65
           VAIK I+  K  +   D ++ EI+A+   HH +IV+    F+  +  ++++++   GG +
Sbjct: 43  VAIKRINLEK-CQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE-LWLVMKLLSGGSV 100

Query: 66  CSFIRSHEK--------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
              I+            L E      +R+++  L++L +N   H D+K  NIL+  + ++
Sbjct: 101 LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSV 160

Query: 117 KLA 119
           ++A
Sbjct: 161 QIA 163

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 83.4 bits (207), Expect = 6e-18
 Identities = 37/131 (28%), Positives = 58/131 (44%), Gaps = 17/131 (12%)

Query: 7   VAIKCI--DKTKVSENRFDS-IVNEIKALKLLH---HQHIVTMLD-----FLWDERYVYI 55
           VA+K +                V E+  L+ L    H ++V ++D         E  V +
Sbjct: 37  VALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTL 96

Query: 56  ILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-K 112
           + E+ D  DL +++       L     +  +RQ +  L FL  N + H DLKP+NIL+  
Sbjct: 97  VFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTS 155

Query: 113 NNTLKLA--GL 121
             T+KLA  GL
Sbjct: 156 GGTVKLADFGL 166

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 83.2 bits (206), Expect = 7e-18
 Identities = 31/116 (26%), Positives = 53/116 (45%), Gaps = 8/116 (6%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGDL 65
           VAIK +      E+    I+ EI  ++     H+V     +  +   ++I++EYC  G +
Sbjct: 57  VAIKQVP----VESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTD-LWIVMEYCGAGSV 111

Query: 66  CSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
              IR   K L+E +    ++  +  L++L      H D+K  NIL+      KLA
Sbjct: 112 SDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLA 167

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 30/122 (24%), Positives = 60/122 (49%), Gaps = 5/122 (4%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +    +   I+ ++C+G 
Sbjct: 46  HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQL-AIVTQWCEGS 104

Query: 64  DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA-- 119
            L   + + E K    +     RQ    + +L   ++ H DLK  NI + ++NT+K+   
Sbjct: 105 SLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDF 164

Query: 120 GL 121
           GL
Sbjct: 165 GL 166

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 36/145 (24%), Positives = 56/145 (38%), Gaps = 19/145 (13%)

Query: 1   NEQHTEVAIKCIDKT---KVSENRFDSIVN------EIKALKLLHHQHIVTMLDFLWDER 51
           + +   VAIK +  T     + N             EI+ L   HH +I+ + D      
Sbjct: 43  DSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFE 102

Query: 52  Y-----VYIILEYCDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLK 105
                 +Y++ E     DL   I      +S    Q F+  ++L L  L E  V H DL 
Sbjct: 103 EPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLH 161

Query: 106 PQNILI-KNNTLKLA--GLKQGVSE 127
           P NIL+  NN + +    L +  + 
Sbjct: 162 PGNILLADNNDITICDFNLAREDTA 186

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 83.0 bits (206), Expect = 9e-18
 Identities = 31/107 (28%), Positives = 52/107 (48%), Gaps = 14/107 (13%)

Query: 28  EIKALKLLH---HQHIVTMLD-----FLWDERYVYIILEYCDGGDLCSFIRSHEK--LSE 77
           E+  L+ L    H ++V + D         E  + ++ E+ D  DL +++    +  +  
Sbjct: 61  EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPT 119

Query: 78  FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
              +  + QL+  L FL  + V H DLKPQNIL+  +  +KLA  GL
Sbjct: 120 ETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 32/134 (23%), Positives = 59/134 (44%), Gaps = 23/134 (17%)

Query: 6   EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGG 63
           + A+K I+          S   EI  L+ L H +++++        +R V+++ +Y +  
Sbjct: 50  DYALKQIEG----TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104

Query: 64  DLCSFIRSH---------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--- 111
           DL   I+ H          +L     +  + Q++  + +L  N V H DLKP NIL+   
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGE 164

Query: 112 --KNNTLKLA--GL 121
             +   +K+A  G 
Sbjct: 165 GPERGRVKIADMGF 178

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 81.2 bits (201), Expect = 3e-17
 Identities = 27/121 (22%), Positives = 53/121 (43%), Gaps = 6/121 (4%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           ++VA+K + +      R +  + E+  +K L H +IV  +  +     + I+ EY   G 
Sbjct: 61  SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120

Query: 65  LCSFIRSHE---KLSEFQCQQFVRQLVLALKFL--RENNVCHFDLKPQNILI-KNNTLKL 118
           L   +       +L E +       +   + +L  R   + H +LK  N+L+ K  T+K+
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKV 180

Query: 119 A 119
            
Sbjct: 181 C 181

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 81.5 bits (202), Expect = 3e-17
 Identities = 29/124 (23%), Positives = 60/124 (48%), Gaps = 15/124 (12%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWD--ERYVYIILEYCD 61
            +V +K +   K  +     I  EIK L+ L    +I+T+ D + D   R   ++ E+ +
Sbjct: 62  EKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVN 116

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KNNTLKLA 119
             D     +    L+++  + ++ +++ AL +     + H D+KP N++I  ++  L+L 
Sbjct: 117 NTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLI 173

Query: 120 --GL 121
             GL
Sbjct: 174 DWGL 177

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 40/129 (31%), Positives = 62/129 (48%), Gaps = 12/129 (9%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDS--IVNEIKALKLLH-HQHIVTMLDFLWDERY--VYI 55
                 VA+K I      +N  D+     EI  L  L  H++IV +L+ L  +    VY+
Sbjct: 31  RRTGEVVAVKKI--FDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL 88

Query: 56  ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN- 114
           + +Y +  DL + IR+   L     Q  V QL+  +K+L    + H D+KP NIL+    
Sbjct: 89  VFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC 146

Query: 115 TLKLA--GL 121
            +K+A  GL
Sbjct: 147 HVKVADFGL 155

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 81.6 bits (202), Expect = 5e-17
 Identities = 32/138 (23%), Positives = 64/138 (46%), Gaps = 15/138 (10%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLW------DERY 52
                +VAIK +   +  ++   +     E++ LK + H++++ +LD         D   
Sbjct: 47  GRTGAKVAIKKL--YRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
            Y+++ +    DL   ++  EKL E + Q  V Q++  L+++    + H DLKP N+ + 
Sbjct: 105 FYLVMPFMGT-DLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVN 162

Query: 113 NN-TLKLA--GLKQGVSE 127
            +  LK+   GL +    
Sbjct: 163 EDCELKILDFGLARQADS 180

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 31/117 (26%), Positives = 56/117 (47%), Gaps = 6/117 (5%)

Query: 7   VAIKCID-KTKVSENRFDSIVNEIKALKLLHHQHIVTMLD-FLWDERYVYIILEYCDGGD 64
           VAIK +    K S  ++  I+ E++ L+ L H + +     +L +    ++++EYC G  
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-AWLVMEYCLGS- 139

Query: 65  LCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
               +  H+K L E +        +  L +L  +N+ H D+K  NIL+     +KL 
Sbjct: 140 ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 196

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 81.2 bits (201), Expect = 5e-17
 Identities = 31/105 (29%), Positives = 60/105 (57%), Gaps = 1/105 (0%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K +DK K V   + +  +NE + L+ ++   +V +     D   +Y+++EY  GG++ 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174

>1oys_A Ribonuclease PH; transferase, tRNA processing; 2.40A {Bacillus subtilis} SCOP: d.14.1.4 d.101.1.1 PDB: 1oyp_A 1oyr_A Length = 245

 Score = 79.3 bits (196), Expect = 6e-17
 Identities = 35/145 (24%), Positives = 55/145 (37%), Gaps = 13/145 (8%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
                 +GS  I  GNTKVIC+      +P           KG +  E+   P A+  +T
Sbjct: 19  DFISHPEGSVLITAGNTKVICNASVEDRVPPFLR----GGGKGWITAEYSMLPQATNQQT 74

Query: 184 GWLRDSE-------EKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINC 236
              ++S          E+   + RAL   V   +     + +   V+Q DG   +A+I  
Sbjct: 75  I--QESSKGKISGRTMEIQRLIGRALRAVVDLEKLGERTIWIDCDVIQADGGTRTASITG 132

Query: 237 ANLALVDAAIPMYDLVTSSTLALRG 261
           A LA+  A   +    T  T  +  
Sbjct: 133 AFLAMAIAIGKLIKAGTIKTNPITD 157

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 81.1 bits (201), Expect = 6e-17
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 15/149 (10%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLWDERY-----V 53
                 VAIK I+     +    +   + EIK LK   H++I+T+ +    + +     V
Sbjct: 33  KPTGEIVAIKKIE---PFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89

Query: 54  YIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           YII E     DL   I + + LS+   Q F+ Q + A+K L  +NV H DLKP N+LI +
Sbjct: 90  YIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINS 147

Query: 114 N-TLKLA--GLKQGVSEKAKGSAYIEQGN 139
           N  LK+   GL + + E A  ++      
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQ 176

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 80.0 bits (198), Expect = 8e-17
 Identities = 45/130 (34%), Positives = 68/130 (52%), Gaps = 12/130 (9%)

Query: 6   EVAIKCIDKTKVSEN-----RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +VAIK I      E      RF+    E+     L HQ+IV+M+D   ++   Y+++EY 
Sbjct: 38  KVAIKAI-FIPPREKEETLKRFE---REVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYI 93

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           +G  L  +I SH  LS      F  Q++  +K   +  + H D+KPQNILI  N TLK+ 
Sbjct: 94  EGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIF 153

Query: 120 --GLKQGVSE 127
             G+ + +SE
Sbjct: 154 DFGIAKALSE 163

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 80.8 bits (200), Expect = 9e-17
 Identities = 38/149 (25%), Positives = 64/149 (42%), Gaps = 23/149 (15%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVN------EIKALKLLHHQHIVTMLDFLWDERY-- 52
           N     VAIK I       + F+          EIK L    H++I+ + D +       
Sbjct: 49  NLNKVRVAIKKI-------SPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101

Query: 53  ---VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
              VYI+ +  +  DL   +++ + LS      F+ Q++  LK++   NV H DLKP N+
Sbjct: 102 MKDVYIVQDLMET-DLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNL 159

Query: 110 LIKNN-TLKLA--GLKQGVSEKAKGSAYI 135
           L+     LK+   GL +        + ++
Sbjct: 160 LLNTTCDLKICDFGLARVADPDHDHTGFL 188

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 33/138 (23%), Positives = 62/138 (44%), Gaps = 16/138 (11%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLD-FLWDERY----- 52
                +VAIK +  ++  ++   +     E+  LK + H++++ +LD F           
Sbjct: 46  KRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103

Query: 53  VYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK 112
            Y+++ +    DL   +    K SE + Q  V Q++  LK++    V H DLKP N+ + 
Sbjct: 104 FYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVN 160

Query: 113 NN-TLKLA--GLKQGVSE 127
            +  LK+   GL +    
Sbjct: 161 EDCELKILDFGLARHADA 178

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 80.3 bits (198), Expect = 1e-16
 Identities = 28/118 (23%), Positives = 53/118 (44%), Gaps = 3/118 (2%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
              +A K I    +     + I+ E++ L   +  +IV      + +  + I +E+ DGG
Sbjct: 58  GLVMARKLIHLE-IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG 116

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILI-KNNTLKLA 119
            L   ++   ++ E    +    ++  L +LRE   + H D+KP NIL+     +KL 
Sbjct: 117 SLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 174

>2vkp_A BTB/POZ domain-containing protein 6; protein-binding; 1.9A {Homo sapiens} Length = 109

 Score = 74.1 bits (183), Expect = 2e-16
 Identities = 24/66 (36%), Positives = 34/66 (51%), Gaps = 1/66 (1%)

Query: 352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDT-KILDITPEA 410
            N+ L +D  F VG     +   AHK +L++ S VF  MF+G+L E      I D+ P A
Sbjct: 3   FNNELMADVHFVVGPPGATRTVPAHKYVLAVGSSVFYAMFYGDLAEVKSEIHIPDVEPAA 62

Query: 411 FSTMLD 416
           F  +L 
Sbjct: 63  FLILLK 68

>2wnr_A Probable exosome complex exonuclease 2; phosphate binding, 3'-5' exoribonuclease, hydrolase; 2.65A {Methanothermobacter thermautotrophicusorganism_taxid} Length = 271

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 39/178 (21%), Positives = 61/178 (34%), Gaps = 35/178 (19%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIR 182
           GV  KA+GS+ ++ GNT++I  V  +  E P   T        G +    +  P AS   
Sbjct: 42  GVISKAEGSSRVKLGNTQIIVGVKPQIGE-PFPDTP-----EMGVILTNSELLPMASPTF 95

Query: 183 TGWLRDSEEKELGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALSAAI 234
                D    EL   + R +  +                + + L + ++  DG+   AA+
Sbjct: 96  EPGPPDERSVELSRVVDRCIRESRMIDLEKLCIIEGSKVWMLFLDLHIIDYDGNLFDAAV 155

Query: 235 NCANLALVDAAIP--------------------MYDLVTSSTLALRGGLTFIDPVEEE 272
                AL+D  IP                    +       T A  G    +DP  EE
Sbjct: 156 LATVAALLDTRIPAAEVEDGEVVINREKMQPLPVNRKALMCTFAKIGNEIVLDPSLEE 213

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 78.0 bits (193), Expect = 4e-16
 Identities = 31/105 (29%), Positives = 51/105 (48%), Gaps = 1/105 (0%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           AIK ++K   + EN+   +  E   +  L H   V +     D+  +Y  L Y   G+L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
            +IR      E   + +  ++V AL++L    + H DLKP+NIL+
Sbjct: 119 KYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 163

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 77.3 bits (191), Expect = 4e-16
 Identities = 19/140 (13%), Positives = 51/140 (36%), Gaps = 15/140 (10%)

Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFL-----WDERYVYIIL 57
           Q  ++ +K +     S  +      E   L++  H +++     L         +  +I 
Sbjct: 32  QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLP---VLGACQSPPAPHPTLIT 88

Query: 58  EYCDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFL--RENNVCHFDLKPQNILI-K 112
            +   G L + +       + + Q  +F   +   + FL   E  +    L  ++++I +
Sbjct: 89  HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDE 148

Query: 113 NNTLKLA--GLKQGVSEKAK 130
           + T +++   +K       +
Sbjct: 149 DMTARISMADVKFSFQSPGR 168

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 29/125 (23%), Positives = 58/125 (46%), Gaps = 6/125 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            E    + +K + +    E    + + E+K ++ L H +++  +  L+ ++ +  I EY 
Sbjct: 32  RETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89

Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
            GG L   I+S + +    Q   F + +   + +L   N+ H DL   N L+ +N  + +
Sbjct: 90  KGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVV 149

Query: 119 A--GL 121
           A  GL
Sbjct: 150 ADFGL 154

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 37/142 (26%), Positives = 73/142 (51%), Gaps = 16/142 (11%)

Query: 5   TEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDF------LWDERYVYII 56
             VAIK +  ++  +N+  +     E+  +K ++H++I+ +L+       L + + VYI+
Sbjct: 51  RNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-T 115
           +E  D  +LC  I+   +L   +    + Q++  +K L    + H DLKP NI++K++ T
Sbjct: 109 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 165

Query: 116 LKLA--GLKQGVSEKAKGSAYI 135
           LK+   GL +        + Y+
Sbjct: 166 LKILDFGLARTAGTSFMMTPYV 187

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 29/134 (21%), Positives = 68/134 (50%), Gaps = 15/134 (11%)

Query: 5   TEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLW------DERYVYII 56
             VA+K +  ++  ++   +     E++ LK + H++++ +LD         +   VY++
Sbjct: 55  LRVAVKKL--SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNT 115
                  DL + ++  +KL++   Q  + Q++  LK++   ++ H DLKP N+ + ++  
Sbjct: 113 THLMGA-DLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE 170

Query: 116 LKLA--GLKQGVSE 127
           LK+   GL +  ++
Sbjct: 171 LKILDFGLARHTAD 184

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 78.1 bits (193), Expect = 6e-16
 Identities = 35/147 (23%), Positives = 66/147 (44%), Gaps = 9/147 (6%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
              +T VA+K   +T   + +    + E + LK   H +IV ++     ++ +YI++E  
Sbjct: 136 RADNTLVAVKSCRETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV 194

Query: 61  DGGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
            GGD  +F+R+   +L      Q V      +++L      H DL  +N L+ + N LK+
Sbjct: 195 QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKI 254

Query: 119 A--GLKQGVSEKAKGSAYIEQGNTKVI 143
           +  G+    S +     Y   G  + +
Sbjct: 255 SDFGM----SREEADGVYAASGGLRQV 277

>3m7n_G Probable exosome complex exonuclease 2; exosome, RNA, exonuclease, hydrolase, nuclease, hydrolase-RN; 2.40A {Archaeoglobus fulgidus} PDB: 2ba1_H 2ba0_I 3m85_G Length = 259

 Score = 76.2 bits (188), Expect = 8e-16
 Identities = 43/174 (24%), Positives = 69/174 (39%), Gaps = 28/174 (16%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKFAPFAS 179
           +   V EKA+GSA ++ G+T+V+  V  +P E P   T       +G + V  +  P AS
Sbjct: 37  IIPNVIEKAEGSALVKLGDTQVVVGVKMQPGE-PYPDTP-----DRGVIIVNAELVPLAS 90

Query: 180 QIRTGWLRDSEEKELGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALS 231
                   D    EL   + R +  +                + V + +  L +DG+ L 
Sbjct: 91  PTFEPGPPDENSIELARVVDRGIRESEAVDLSKLVIEEGEKVWIVFVDIHALDDDGNLLD 150

Query: 232 AAINCANLALVDA-------------AIPMYDLVTSSTLALRGGLTFIDPVEEE 272
           A+   A  AL++               +P+ DL  S T  + G    +DP  EE
Sbjct: 151 ASALAAIAALMNTKVPAERFDLGEDYLLPVRDLPVSVTSLIVGNKYLVDPSREE 204

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 78.7 bits (194), Expect = 9e-16
 Identities = 35/147 (23%), Positives = 64/147 (43%), Gaps = 12/147 (8%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            +    VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+ 
Sbjct: 242 KKYSLTVAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 298

Query: 61  DGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLK 117
             G+L  ++R   +  +S         Q+  A+++L + N  H +L  +N L+ +N+ +K
Sbjct: 299 TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVK 358

Query: 118 LA--GLKQGVSEKAKGSAYIEQGNTKV 142
           +A  GL    S    G  Y      K 
Sbjct: 359 VADFGL----SRLMTGDTYTAHAGAKF 381

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 76.8 bits (190), Expect = 1e-15
 Identities = 28/105 (26%), Positives = 58/105 (55%), Gaps = 1/105 (0%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K + K   V   + +   +E   L ++ H  I+ M     D + +++I++Y +GG+L 
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           S +R  ++      + +  ++ LAL++L   ++ + DLKP+NIL+
Sbjct: 95  SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL 139

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 26/122 (21%), Positives = 50/122 (40%), Gaps = 4/122 (3%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
                 +  +  D    S +  D+   +I+ +     ++ V  L     + Y+YI ++ C
Sbjct: 84  EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLC 143

Query: 61  DGGDLCSFI---RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTL 116
              +L  ++    S E      C     Q+  A++FL    + H DLKP NI    ++ +
Sbjct: 144 RKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVV 203

Query: 117 KL 118
           K+
Sbjct: 204 KV 205

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 77.6 bits (191), Expect = 2e-15
 Identities = 34/135 (25%), Positives = 70/135 (51%), Gaps = 16/135 (11%)

Query: 5   TEVAIKCIDKTKVSENRFDS--IVNEIKALKLLHHQHIVTMLDFLW------DERYVYII 56
             VAIK +  ++  +N+  +     E+  +K ++H++I+++L+         + + VY++
Sbjct: 88  RNVAIKKL--SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-T 115
           +E  D  +LC  I+   +L   +    + Q++  +K L    + H DLKP NI++K++ T
Sbjct: 146 MELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT 202

Query: 116 LKLA--GLKQGVSEK 128
           LK+   GL +     
Sbjct: 203 LKILDFGLARTAGTS 217

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 35/144 (24%), Positives = 64/144 (44%), Gaps = 8/144 (5%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            +    VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+ 
Sbjct: 35  KKYSLTVAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 91

Query: 61  DGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLK 117
             G+L  ++R   +  +S         Q+  A+++L + N  H DL  +N L+ +N+ +K
Sbjct: 92  TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVK 151

Query: 118 LAGLKQGVSEKAKGSAYIEQGNTK 141
           +A    G+S    G  Y      K
Sbjct: 152 VADF--GLSRLMTGDTYTAHAGAK 173

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 75.0 bits (185), Expect = 3e-15
 Identities = 35/142 (24%), Positives = 65/142 (45%), Gaps = 11/142 (7%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
             +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G
Sbjct: 48  QYDVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANG 104

Query: 64  DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA-- 119
            L +++R    +    Q  +  + +  A+++L      H DL  +N L+     +K++  
Sbjct: 105 CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDF 164

Query: 120 GLKQGVSEKAKGSAYIEQGNTK 141
           GL + V +      Y     +K
Sbjct: 165 GLSRYVLD----DEYTSSVGSK 182

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 76.2 bits (188), Expect = 3e-15
 Identities = 32/109 (29%), Positives = 60/109 (55%), Gaps = 9/109 (8%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLW----DERYVYIILEYCDG 62
           A+K ++K K V  N   ++  E++ ++ L H  +V     LW    DE  ++++++   G
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVN----LWYSFQDEEDMFMVVDLLLG 99

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           GDL   ++ +    E   + F+ +LV+AL +L+   + H D+KP NIL+
Sbjct: 100 GDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL 148

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 75.4 bits (186), Expect = 3e-15
 Identities = 41/155 (26%), Positives = 67/155 (43%), Gaps = 28/155 (18%)

Query: 1   NEQHTEVAIKCIDKTKVS-ENRFDS--IVNEIKALKLLHHQHIVTMLD------------ 45
           N+    VAIK     K+   +       + EIK ++ L H +IV + +            
Sbjct: 33  NDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87

Query: 46  --FLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFD 103
              L +   VYI+ EY +  DL + +     L E   + F+ QL+  LK++   NV H D
Sbjct: 88  VGSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRD 145

Query: 104 LKPQNILI--KNNTLKLA--GLKQGVSEKAKGSAY 134
           LKP N+ I  ++  LK+   GL + +        +
Sbjct: 146 LKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 74.5 bits (184), Expect = 3e-15
 Identities = 31/142 (21%), Positives = 62/142 (43%), Gaps = 11/142 (7%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
             +VAIK I +  +SE  F   + E + +  L H  +V +     ++  + ++ E+ + G
Sbjct: 32  KDKVAIKTIREGAMSEEDF---IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHG 88

Query: 64  DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA-- 119
            L  ++R+     +          +   + +L E  V H DL  +N L+ +N  +K++  
Sbjct: 89  CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDF 148

Query: 120 GLKQGVSEKAKGSAYIEQGNTK 141
           G+ + V +      Y     TK
Sbjct: 149 GMTRFVLD----DQYTSSTGTK 166

>2po1_B Probable exosome complex exonuclease 2; RNAse PH, hydrolase/hydrolase/RNA complex; 1.94A {Pyrococcus abyssi} PDB: 2po0_B* 2pnz_B 2po2_B* Length = 277

 Score = 74.3 bits (183), Expect = 4e-15
 Identities = 42/178 (23%), Positives = 65/178 (36%), Gaps = 34/178 (19%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV EKA+GSA ++ G+T+V+  +      P   T      + G +    +  P AS    
Sbjct: 44  GVIEKAEGSALVKLGSTQVLVGIKTSLGEPFPDTP-----NMGVMTTNVELVPLASPTFE 98

Query: 184 GWLRDSEEKELGNHLKRA--------LEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAIN 235
               D    EL   + R         LE  V         V + V VL +DG+ + A   
Sbjct: 99  PGPPDERAIELARVIDRGIRESKALNLEKMVIVPGKIVRVVFIDVHVLDHDGNLMDAIGI 158

Query: 236 CANLALVDAAIP---------------------MYDLVTSSTLALRGGLTFIDPVEEE 272
            A  AL++A +P                     +  +    T A  G +  +DP  +E
Sbjct: 159 AAIAALLNARVPKVRYNEETGEVETLDETEPLPVEKIPVPVTFAKIGNILVVDPSLDE 216

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 73.0 bits (180), Expect = 1e-14
 Identities = 36/142 (25%), Positives = 65/142 (45%), Gaps = 11/142 (7%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
             +VA+K I +  +SE+ F     E + +  L H  +V        E  +YI+ EY   G
Sbjct: 32  QYDVAVKMIKEGSMSEDEF---FQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNG 88

Query: 64  DLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA-- 119
            L +++RSH + L   Q  +    +   + FL  +   H DL  +N L+ ++  +K++  
Sbjct: 89  CLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDF 148

Query: 120 GLKQGVSEKAKGSAYIEQGNTK 141
           G+ + V +      Y+    TK
Sbjct: 149 GMTRYVLD----DQYVSSVGTK 166

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 27/126 (21%), Positives = 53/126 (42%), Gaps = 6/126 (4%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
              +A+K + ++  ++     I+ ++  + K     +IV           V+I +E    
Sbjct: 50  GHVIAVKQMRRS-GNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGT 108

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR-ENNVCHFDLKPQNILI-KNNTLKLAG 120
                  R    + E    +    +V AL +L+ ++ V H D+KP NIL+ +   +KL  
Sbjct: 109 CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCD 168

Query: 121 LKQGVS 126
              G+S
Sbjct: 169 F--GIS 172

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 13/123 (10%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLD-FL-----WDERYVYIILEY 59
            AIK +D   V+ +  + I  EI  LK   HH++I T    F+       +  +++++E+
Sbjct: 52  AAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF 108

Query: 60  CDGGDLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TL 116
           C  G +   I++ +   L E       R+++  L  L ++ V H D+K QN+L+  N  +
Sbjct: 109 CGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEV 168

Query: 117 KLA 119
           KL 
Sbjct: 169 KLV 171

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 28/122 (22%), Positives = 52/122 (42%), Gaps = 7/122 (5%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIK-ALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
              +A+K I  T V+      ++ ++  +++ +     VT    L+ E  V+I +E  D 
Sbjct: 32  GQIMAVKRIRAT-VNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT 90

Query: 63  G---DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILI-KNNTLK 117
                    I   + + E    +    +V AL+ L    +V H D+KP N+LI     +K
Sbjct: 91  SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 150

Query: 118 LA 119
           + 
Sbjct: 151 MC 152

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 30/125 (24%), Positives = 59/125 (47%), Gaps = 5/125 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++   VAIK +        R D  ++E   +    H +I+ +   +   R   I+ EY 
Sbjct: 74  GQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYM 132

Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
           + G L +F+R+H+ + +  Q    +R +   +++L +    H DL  +N+L+  N   K+
Sbjct: 133 ENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKV 192

Query: 119 A--GL 121
           +  GL
Sbjct: 193 SDFGL 197

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 37/142 (26%), Positives = 64/142 (45%), Gaps = 19/142 (13%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
            +VAIK I+    SE+   + + E++ L  ++H +IV +     +   V +++EY +GG 
Sbjct: 32  KDVAIKQIE----SESERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGS 85

Query: 65  LCSFIRSHEKLSEFQCQQFVR---QLVLALKFL---RENNVCHFDLKPQNILI--KNNTL 116
           L + +   E L  +     +    Q    + +L   +   + H DLKP N+L+      L
Sbjct: 86  LYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL 145

Query: 117 KLA--GL---KQGVSEKAKGSA 133
           K+   G     Q      KGSA
Sbjct: 146 KICDFGTACDIQTHMTNNKGSA 167

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 34/125 (27%), Positives = 60/125 (48%), Gaps = 5/125 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +++   VAIK +      + R D  + E   +    H +I+ +   +   + V I+ EY 
Sbjct: 70  SKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYM 128

Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
           + G L SF+R H+ + +  Q    +R +   +K+L +    H DL  +NILI  N   K+
Sbjct: 129 ENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKV 188

Query: 119 A--GL 121
           +  GL
Sbjct: 189 SDFGL 193

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 71.5 bits (176), Expect = 3e-14
 Identities = 28/129 (21%), Positives = 52/129 (40%), Gaps = 15/129 (11%)

Query: 5   TEVAIKCI--DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
            EVA+K    D  +      +++  E K   +L H +I+ +      E  + +++E+  G
Sbjct: 31  DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARG 90

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN---VCHFDLKPQNILI-------- 111
           G L   +    ++       +  Q+   + +L +     + H DLK  NILI        
Sbjct: 91  GPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGD 149

Query: 112 -KNNTLKLA 119
             N  LK+ 
Sbjct: 150 LSNKILKIT 158

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 71.9 bits (177), Expect = 4e-14
 Identities = 38/156 (24%), Positives = 70/156 (44%), Gaps = 28/156 (17%)

Query: 6   EVAIKCIDKTKVSEN-----RFDSIVNEIKALKLLHHQHIVTMLDFLWDE----RYVYII 56
           +VA+K + +  ++ +     RF     E +    L+H  IV + D    E       YI+
Sbjct: 39  DVAVK-VLRADLARDPSFYLRFR---REAQNAAALNHPAIVAVYDTGEAETPAGPLPYIV 94

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNT 115
           +EY DG  L   + +   ++  +  + +     AL F  +N + H D+KP NI+I   N 
Sbjct: 95  MEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNA 154

Query: 116 LKLA--GLKQGVSEKAK---------GSA-YI--EQ 137
           +K+   G+ + +++            G+A Y+  EQ
Sbjct: 155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 30/145 (20%), Positives = 66/145 (45%), Gaps = 6/145 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            +    VA+K +          D ++ E   ++ L + +IV M+     E    +++E  
Sbjct: 41  KKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES-WMLVMEMA 99

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           + G L  +++ +  + +    + V Q+ + +K+L E+N  H DL  +N+L+   +  K++
Sbjct: 100 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKIS 159

Query: 120 --GLKQGVSEKAKGSAYIEQGNTKV 142
             GL + +      + Y  Q + K 
Sbjct: 160 DFGLSKALRADE--NYYKAQTHGKW 182

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 40/143 (27%), Positives = 70/143 (48%), Gaps = 13/143 (9%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S + F   + E   +K L HQ +V +   +  E  +YII EY + G
Sbjct: 37  HTKVAVKSLKQGSMSPDAF---LAEANLMKQLQHQRLVRLYAVVTQEP-IYIITEYMENG 92

Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA- 119
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+    + K+A 
Sbjct: 93  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIAD 152

Query: 120 -GLKQGVSEKAKGSAYIEQGNTK 141
            GL + + +    + Y  +   K
Sbjct: 153 FGLARLIED----NEYTAREGAK 171

>2je6_A RRP42, exosome complex exonuclease 2; nuclease, hydrolase, exonuclease, phosphorolytic, exoribonuclease, RNA degradation; HET: 1PE; 1.6A {Sulfolobus solfataricus} SCOP: d.14.1.4 d.101.1.1 PDB: 2jea_A* 2jeb_A* 2br2_A 2c37_A* 2c38_A* 2c39_A* 3l7z_A Length = 277

 Score = 71.3 bits (175), Expect = 5e-14
 Identities = 37/179 (20%), Positives = 60/179 (33%), Gaps = 36/179 (20%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIR 182
             ++KA GSA ++ G T V+     E  + P   T      ++G L V  +  P A +  
Sbjct: 47  DYAKKADGSALVKLGTTMVLAGTKLEIDK-PYEDTP-----NQGNLIVNVELLPLAYETF 100

Query: 183 TGWLRDSEEKELGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALSAAI 234
                D    EL   + R+L  +              S + V L V VL   G+ L A  
Sbjct: 101 EPGPPDENAIELARVVDRSLRDSKALDLTKLVIEPGKSVWTVWLDVYVLDYGGNVLDACT 160

Query: 235 NCANLALVDAAIPMY---------------------DLVTSSTLALRGGLTFIDPVEEE 272
             +  AL +  +                          V + ++A       +DP  +E
Sbjct: 161 LASVAALYNTKVYKVEQHSNGISVNKNEVVGKLPLNYPVVTISVAKVDKYLVVDPDLDE 219

>4eoz_A Speckle-type POZ protein; E3 ubiquitin ligase, nucleus, protein binding; 2.40A {Homo sapiens} Length = 145

 Score = 68.0 bits (167), Expect = 5e-14
 Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 6/67 (8%)

Query: 352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTK--ILDITPE 409
             +  ++DC   V      +EF+AHK IL+  SPVF+ MF  E+ E    +  I D+ PE
Sbjct: 20  WENSRFTDCCLCVAG----QEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVEPE 75

Query: 410 AFSTMLD 416
            F  M+ 
Sbjct: 76  VFKEMMC 82

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 36/141 (25%), Positives = 63/141 (44%), Gaps = 6/141 (4%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           ++   VAIK +      + R D  + E   +    H +I+ +   +   + + II EY +
Sbjct: 71  KKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME 129

Query: 62  GGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            G L  F+R  + + S  Q    +R +   +K+L   N  H DL  +NIL+  N   K++
Sbjct: 130 NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVS 189

Query: 120 --GLKQGVSEKAKGSAYIEQG 138
             GL + + E    + Y   G
Sbjct: 190 DFGLSRVL-EDDPEATYTTSG 209

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 29/124 (23%), Positives = 52/124 (41%), Gaps = 10/124 (8%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIK-ALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
              +A+K I  T V E     ++ ++   ++     +IV     L+ E   +I +E    
Sbjct: 47  GQIMAVKRIRST-VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST 105

Query: 63  GDLCSFIRS-----HEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILI-KNNT 115
                F +       + + E    +     V AL  L+EN  + H D+KP NIL+ ++  
Sbjct: 106 S-FDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGN 164

Query: 116 LKLA 119
           +KL 
Sbjct: 165 IKLC 168

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 71.2 bits (175), Expect = 8e-14
 Identities = 25/136 (18%), Positives = 56/136 (41%), Gaps = 15/136 (11%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTML------DFLWDERYVY 54
           +    +VA+K +    ++ +  +  + E   +K   H H+  ++                
Sbjct: 48  DGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM 107

Query: 55  IILEYCDGGDLCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQN 108
           +IL +   GDL +F+ +         L      +F+  +   +++L   N  H DL  +N
Sbjct: 108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARN 167

Query: 109 ILI-KNNTLKLA--GL 121
            ++ ++ T+ +A  GL
Sbjct: 168 CMLAEDMTVCVADFGL 183

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 70.8 bits (174), Expect = 8e-14
 Identities = 22/129 (17%), Positives = 50/129 (38%), Gaps = 16/129 (12%)

Query: 5   TEVAIKCIDKTKVSEN-----RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           + VAIK +             +F     E+  +  L+H +IV +   + +     +++E+
Sbjct: 45  SVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP--PRMVMEF 102

Query: 60  CDGGDLCSFIRS-HEKLSEFQCQQFVRQLVLALKFL--RENNVCHFDLKPQNILI----- 111
              GDL   +      +      + +  + L ++++  +   + H DL+  NI +     
Sbjct: 103 VPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162

Query: 112 -KNNTLKLA 119
                 K+A
Sbjct: 163 NAPVCAKVA 171

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 70.3 bits (173), Expect = 9e-14
 Identities = 36/123 (29%), Positives = 64/123 (52%), Gaps = 10/123 (8%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEYCDGG 63
            +VA+KCI K   +   F   + E   +  L H ++V +L  + +E+  +YI+ EY   G
Sbjct: 45  NKVAVKCI-KNDATAQAF---LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 100

Query: 64  DLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA- 119
            L  ++RS  +  L      +F   +  A+++L  NN  H DL  +N+L+ ++N  K++ 
Sbjct: 101 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 160

Query: 120 -GL 121
            GL
Sbjct: 161 FGL 163

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 31/134 (23%), Positives = 56/134 (41%), Gaps = 14/134 (10%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +     S       +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 52  DEPETRVAIKTV-NEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 110

Query: 61  DGGDLCSFIRSHEKLSEFQCQ----------QFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS                    Q   ++   + +L  N   H DL  +N +
Sbjct: 111 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 170

Query: 111 I-KNNTLKLA--GL 121
           + ++ T+K+   G+
Sbjct: 171 VAEDFTVKIGDFGM 184

>3htm_A Speckle-type POZ protein; BTB, SPOP, ubiquitin, ligase, nucleus, UBL conjugation pathway, protein binding; 2.50A {Homo sapiens} Length = 172

 Score = 67.7 bits (166), Expect = 1e-13
 Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 6/67 (8%)

Query: 352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTK--ILDITPE 409
             +  ++DC   V      +EF+AHK IL+  SPVF+ MF  E+ E    +  I D+ PE
Sbjct: 29  WENSRFTDCCLCVAG----QEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVEPE 84

Query: 410 AFSTMLD 416
            F  M+ 
Sbjct: 85  VFKEMMC 91

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 27/120 (22%), Positives = 53/120 (44%), Gaps = 3/120 (2%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
              TEV +K +DK     N  +S       +  L H+H+V             ++ E+  
Sbjct: 38  LHETEVLLKVLDKA--HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVK 95

Query: 62  GGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAG 120
            G L ++++ ++  ++     +  +QL  A+ FL EN + H ++  +NIL+     +  G
Sbjct: 96  FGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155

>2nn6_C Exosome complex exonuclease RRP43; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1 Length = 278

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 28/139 (20%), Positives = 45/139 (32%), Gaps = 13/139 (9%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           +  G    A GSA ++ GNT VIC V      PS+         KG +       P  S 
Sbjct: 39  VNIGSISTADGSALVKLGNTTVICGVKAEFAAPSTDAP-----DKGYVVPNVDLPPLCSS 93

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALSA 232
                    E +     +   +E +                + +   ++ L  DG+ L A
Sbjct: 94  RFRSGPPGEEAQVASQFIADVIENSQIIQKEDLCISPGKLVWVLYCDLICLDYDGNILDA 153

Query: 233 AINCANLALVDAAIPMYDL 251
                  AL +  +P   +
Sbjct: 154 CTFALLAALKNVQLPEVTI 172

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 13/144 (9%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
            T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G
Sbjct: 291 TTRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG 346

Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA- 119
            L  F++      L   Q      Q+   + ++   N  H DL+  NIL+ +N   K+A 
Sbjct: 347 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 406

Query: 120 -GLKQGVSEKAKGSAYIEQGNTKV 142
            GL    +   + + Y  +   K 
Sbjct: 407 FGL----ARLIEDNEYTARQGAKF 426

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 39/143 (27%), Positives = 66/143 (46%), Gaps = 13/143 (9%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K +    +S   F   + E   +K L H  +V +   +  E  +YII E+   G
Sbjct: 212 HTKVAVKTMKPGSMSVEAF---LAEANVMKTLQHDKLVKLHAVVTKEP-IYIITEFMAKG 267

Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA- 119
            L  F++S E  K    +   F  Q+   + F+ + N  H DL+  NIL+  +   K+A 
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIAD 327

Query: 120 -GLKQGVSEKAKGSAYIEQGNTK 141
            GL + + +    + Y  +   K
Sbjct: 328 FGLARVIED----NEYTAREGAK 346

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 37/144 (25%), Positives = 62/144 (43%), Gaps = 13/144 (9%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
            T VAIK +    +S   F   + E + +K L H+ +V +   +  E  +YI+ EY   G
Sbjct: 208 TTRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKG 263

Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA- 119
            L  F++      L   Q      Q+   + ++   N  H DL+  NIL+ +N   K+A 
Sbjct: 264 SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVAD 323

Query: 120 -GLKQGVSEKAKGSAYIEQGNTKV 142
            GL    +   + + Y  +   K 
Sbjct: 324 FGL----ARLIEDNEYTARQGAKF 343

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 6/144 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
                 VAIK   K   S++  +  + E   ++   H HIV ++  + +   V+II+E C
Sbjct: 40  ENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELC 97

Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             G+L SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL
Sbjct: 98  TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 157

Query: 119 AGLKQGVSEKAKGSAYIEQGNTKV 142
                G+S   + S Y +    K+
Sbjct: 158 GDF--GLSRYMEDSTYYKASKGKL 179

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 70.5 bits (173), Expect = 3e-13
 Identities = 36/134 (26%), Positives = 65/134 (48%), Gaps = 10/134 (7%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF-LWDERYVYIILEYCDGG 63
            +VA+KCI K   +   F   + E   +  L H ++V +L   + ++  +YI+ EY   G
Sbjct: 217 NKVAVKCI-KNDATAQAF---LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 272

Query: 64  DLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA- 119
            L  ++RS  +  L      +F   +  A+++L  NN  H DL  +N+L+ ++N  K++ 
Sbjct: 273 SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSD 332

Query: 120 -GLKQGVSEKAKGS 132
            GL +  S      
Sbjct: 333 FGLTKEASSTQDTG 346

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 69.7 bits (171), Expect = 5e-13
 Identities = 26/108 (24%), Positives = 54/108 (50%), Gaps = 2/108 (1%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K + K + +  +       E   +   +   +V +     D+RY+Y+++EY  GGDL 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV 157

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + + ++  + E   + +  ++VLAL  +      H D+KP N+L+  +
Sbjct: 158 NLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKS 204

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 68.8 bits (169), Expect = 5e-13
 Identities = 25/135 (18%), Positives = 57/135 (42%), Gaps = 14/135 (10%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTML-----DFLWDERYVYI 55
           +    +VA+K +     S+   +  ++E   +K   H +++ +L               +
Sbjct: 59  DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV 118

Query: 56  ILEYCDGGDLCSFIRSH------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNI 109
           IL +   GDL +++         + +      +F+  + L +++L   N  H DL  +N 
Sbjct: 119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNC 178

Query: 110 LI-KNNTLKLA--GL 121
           ++  + T+ +A  GL
Sbjct: 179 MLRDDMTVCVADFGL 193

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 28/126 (22%), Positives = 61/126 (48%), Gaps = 6/126 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEY 59
            +   + AIK +        + ++ + E   ++ L+H +++ ++  +       +++L Y
Sbjct: 46  AQNRIQCAIKSL-SRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPY 104

Query: 60  CDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLK 117
              GDL  FIRS ++  +      F  Q+   +++L E    H DL  +N ++ ++ T+K
Sbjct: 105 MCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVK 164

Query: 118 LA--GL 121
           +A  GL
Sbjct: 165 VADFGL 170

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 34/141 (24%), Positives = 54/141 (38%), Gaps = 23/141 (16%)

Query: 1   NEQHTEVAIK-CIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
            +    VA+K   D T  +   F     E + L  L H+HIV       D   + ++ EY
Sbjct: 42  TKDKMLVAVKALKDPTLAARKDF---QREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEY 98

Query: 60  CDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFD 103
              GDL  F+R+H                 +L   Q      Q+   + +L   +  H D
Sbjct: 99  MKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 158

Query: 104 LKPQNILI-KNNTLKLA--GL 121
           L  +N L+  N  +K+   G+
Sbjct: 159 LATRNCLVGANLLVKIGDFGM 179

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 26/130 (20%), Positives = 48/130 (36%), Gaps = 21/130 (16%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIV------TMLDFLWDERYVYIILE 58
             VA+K            ++   E+    +L H++I+              +  +++I  
Sbjct: 32  ENVAVKIFSSRDEKSWFRET---ELYNTVMLRHENILGFIASDMTSRHSSTQ--LWLITH 86

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE--------NNVCHFDLKPQNIL 110
           Y + G L  +++    L    C + V  +   L  L            + H DLK +NIL
Sbjct: 87  YHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL 145

Query: 111 IKNN-TLKLA 119
           +K N    +A
Sbjct: 146 VKKNGQCCIA 155

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 22/159 (13%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEY 59
            +   +VA+K + K+    +  +++++E+K +  L  H++IV +L        V +I EY
Sbjct: 73  EDAVLKVAVKML-KSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEY 131

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALK--------------FLRENNVCHFDLK 105
           C  GDL +F+R   ++ E      +     + +              FL   N  H D+ 
Sbjct: 132 CCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVA 191

Query: 106 PQNILI-KNNTLKLA--GLKQGVSEKAKGSAYIEQGNTK 141
            +N+L+   +  K+   GL + +      S YI +GN +
Sbjct: 192 ARNVLLTNGHVAKIGDFGLARDI---MNDSNYIVKGNAR 227

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 68.8 bits (169), Expect = 6e-13
 Identities = 26/124 (20%), Positives = 53/124 (42%), Gaps = 6/124 (4%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           +    VAIK + +   S      I++E   +  + + H+  +L        V +I +   
Sbjct: 42  KVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99

Query: 62  GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 119
            G L  ++R H + +       +  Q+   + +L +  + H DL  +N+L+K    +K+ 
Sbjct: 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 159

Query: 120 --GL 121
             GL
Sbjct: 160 DFGL 163

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 33/140 (23%), Positives = 57/140 (40%), Gaps = 22/140 (15%)

Query: 1   NEQHTEVAIKCI-DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
            +    VA+K + + ++ +   F     E + L +L HQHIV       + R + ++ EY
Sbjct: 68  EQDKMLVAVKALKEASESARQDF---QREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEY 124

Query: 60  CDGGDLCSFIRSH---------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 104
              GDL  F+RSH                 L   Q      Q+   + +L   +  H DL
Sbjct: 125 MRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL 184

Query: 105 KPQNILI-KNNTLKLA--GL 121
             +N L+ +   +K+   G+
Sbjct: 185 ATRNCLVGQGLVVKIGDFGM 204

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 68.1 bits (167), Expect = 7e-13
 Identities = 29/126 (23%), Positives = 54/126 (42%), Gaps = 6/126 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF-LWDERYVYIILEY 59
           + +    A+K +             + E   +K   H +++++L   L  E    ++L Y
Sbjct: 50  DGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 108

Query: 60  CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLK 117
              GDL +FIR+     +      F  Q+   +K+L      H DL  +N ++ +  T+K
Sbjct: 109 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVK 168

Query: 118 LA--GL 121
           +A  GL
Sbjct: 169 VADFGL 174

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 29/126 (23%), Positives = 54/126 (42%), Gaps = 7/126 (5%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--VYIILE 58
           +     VA+K + K             EI  L+ L+H+HI+       D     + +++E
Sbjct: 57  DGTGEMVAVKAL-KADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME 115

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLK 117
           Y   G L  ++  H  +   Q   F +Q+   + +L   +  H DL  +N+L+  +  +K
Sbjct: 116 YVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVK 174

Query: 118 LA--GL 121
           +   GL
Sbjct: 175 IGDFGL 180

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 25/128 (19%), Positives = 50/128 (39%), Gaps = 17/128 (13%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTML----DFLWDERYVYIILEYC 60
            EVA+K     +      ++   EI    +L H++I+  +            ++++ +Y 
Sbjct: 66  EEVAVKIFSSREERSWFREA---EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN--------NVCHFDLKPQNILIK 112
           + G L  ++  +  ++     +        L  L            + H DLK +NIL+K
Sbjct: 123 EHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 181

Query: 113 NN-TLKLA 119
            N T  +A
Sbjct: 182 KNGTCCIA 189

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 68.2 bits (167), Expect = 8e-13
 Identities = 30/128 (23%), Positives = 54/128 (42%), Gaps = 17/128 (13%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTML----DFLWDERYVYIILEYC 60
            +VA+K    T+ +    ++   EI    L+ H++I+  +            +Y+I +Y 
Sbjct: 61  EKVAVKVFFTTEEASWFRET---EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYH 117

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL--------RENNVCHFDLKPQNILIK 112
           + G L  +++S   L      +     V  L  L         +  + H DLK +NIL+K
Sbjct: 118 ENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVK 176

Query: 113 NN-TLKLA 119
            N T  +A
Sbjct: 177 KNGTCCIA 184

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 28/127 (22%), Positives = 62/127 (48%), Gaps = 7/127 (5%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY--VYIILE 58
           +    +VA+K + K +   N    +  EI+ L+ L+H++IV       ++    + +I+E
Sbjct: 47  DNTGEQVAVKSL-KPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105

Query: 59  YCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTL 116
           +   G L  ++  ++ K++  Q  ++  Q+   + +L      H DL  +N+L+   + +
Sbjct: 106 FLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQV 165

Query: 117 KLA--GL 121
           K+   GL
Sbjct: 166 KIGDFGL 172

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 40/164 (24%), Positives = 67/164 (40%), Gaps = 26/164 (15%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEY 59
           ++    VA+K + K        +++++E+K L  L +H +IV +L          +I EY
Sbjct: 50  SDAAMTVAVKML-KPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108

Query: 60  CDGGDLCSFIRSH------------------EKLSEFQCQQFVRQLVLALKFLRENNVCH 101
           C  GDL +F+R                      L       F  Q+   + FL   N  H
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168

Query: 102 FDLKPQNILI-KNNTLKLA--GLKQGVSEKAKGSAYIEQGNTKV 142
            DL  +NIL+      K+   GL + +      S Y+ +GN ++
Sbjct: 169 RDLAARNILLTHGRITKICDFGLARDI---KNDSNYVVKGNARL 209

>2nn6_E Exosome complex exonuclease RRP42; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1 Length = 305

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 32/193 (16%), Positives = 57/193 (29%), Gaps = 40/193 (20%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           ++  V     GSA ++ G+T ++  V      P  +       ++G L      +  A+ 
Sbjct: 51  VETDVVSNTSGSARVKLGHTDILVGVKAEMGTPKLEKP-----NEGYLEFFVDCSASATP 105

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALSA 232
              G   D    E+ N L R                     + + + VL+L+  G+   A
Sbjct: 106 EFEGRGGDDLGTEIANTLYRIFNNKSSVDLKTLCISPREHCWVLYVDVLLLECGGNLFDA 165

Query: 233 AINCANLALVDAAIPMY---------------------------DLVTSSTLALRGGLTF 265
                  AL +  IP                             ++    TL   G    
Sbjct: 166 ISIAVKAALFNTRIPRVRVLEDEEGSKDIELSDDPYDCIRLSVENVPCIVTLCKIGYRHV 225

Query: 266 IDPVEEEVAYCQS 278
           +D   +E A   +
Sbjct: 226 VDATLQEEACSLA 238

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 31/130 (23%), Positives = 56/130 (43%), Gaps = 12/130 (9%)

Query: 6   EVAIKCIDKTKVSEN-----RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            VA+K +    +S +     R      E +    L   H+V + DF   +  +Y+ +   
Sbjct: 61  IVALKLM-SETLSSDPVFRTRMQ---REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLI 116

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           +G DL + +R    L+  +    VRQ+  AL         H D+KP+NIL+  ++   L 
Sbjct: 117 NGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLV 176

Query: 120 --GLKQGVSE 127
             G+    ++
Sbjct: 177 DFGIASATTD 186

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 28/167 (16%), Positives = 55/167 (32%), Gaps = 21/167 (12%)

Query: 14  KTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY----CD----GGDL 65
           K +         +     +K    + ++ +     D   +     Y     +    G  L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLKQG 124
            S   +H+ L      Q   Q++  L  L    + H  L+P +I++ +   + L G    
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGF--- 250

Query: 125 VSEKAKGSAYIEQGNTKVIC--SVFEPREIPSSKTSLEYQRSKGELY 169
                     +  G   V      FEP E+ + + ++ Y R +  L 
Sbjct: 251 ------EHL-VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLM 290

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 6/126 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF-LWDERYVYIILEY 59
           + +    A+K +             + E   +K   H +++++L   L  E    ++L Y
Sbjct: 114 DGKKIHCAVKSL-NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 172

Query: 60  CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLK 117
              GDL +FIR+     +      F  Q+   +KFL      H DL  +N ++ +  T+K
Sbjct: 173 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK 232

Query: 118 LA--GL 121
           +A  GL
Sbjct: 233 VADFGL 238

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 29/130 (22%), Positives = 53/130 (40%), Gaps = 12/130 (9%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +    +VA+K + +    ++  D  + E   +   +HQ+IV  +         +I+LE  
Sbjct: 98  DPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELM 156

Query: 61  DGGDLCSFIRSH-------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-- 111
            GGDL SF+R           L+        R +    ++L EN+  H D+  +N L+  
Sbjct: 157 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 216

Query: 112 --KNNTLKLA 119
                  K+ 
Sbjct: 217 PGPGRVAKIG 226

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 33/140 (23%), Positives = 69/140 (49%), Gaps = 21/140 (15%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYC 60
           ++   VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY 
Sbjct: 65  KEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 123

Query: 61  DGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 104
             G+L  ++R+                 E+++         QL   +++L      H DL
Sbjct: 124 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 183

Query: 105 KPQNILI-KNNTLKLA--GL 121
             +N+L+ +NN +K+A  GL
Sbjct: 184 AARNVLVTENNVMKIADFGL 203

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 28/130 (21%), Positives = 53/130 (40%), Gaps = 12/130 (9%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +    +VA+K + +    ++  D  + E   +   +HQ+IV  +         +I++E  
Sbjct: 57  DPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELM 115

Query: 61  DGGDLCSFIRSH-------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-- 111
            GGDL SF+R           L+        R +    ++L EN+  H D+  +N L+  
Sbjct: 116 AGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTC 175

Query: 112 --KNNTLKLA 119
                  K+ 
Sbjct: 176 PGPGRVAKIG 185

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 24/126 (19%), Positives = 53/126 (42%), Gaps = 6/126 (4%)

Query: 1   NEQHTEVAIKCI-DKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           + +   VA+KC+           D  + E+ A+  L H++++ +   +     + ++ E 
Sbjct: 43  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL 101

Query: 60  CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLK 117
              G L   +R H+         ++  Q+   + +L      H DL  +N+L+   + +K
Sbjct: 102 APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVK 161

Query: 118 LA--GL 121
           +   GL
Sbjct: 162 IGDFGL 167

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 29/126 (23%), Positives = 57/126 (45%), Gaps = 15/126 (11%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQ------HIVTMLDFLWDERYVYIIL 57
           H  VA+K +   +  +        EI+ L+ L  Q      +++ ML+      ++ +  
Sbjct: 122 HQHVALKMV---RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTF 178

Query: 58  EYCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-- 113
           E     +L   I+ +  +  S    ++F   ++  L  L +N + H DLKP+NIL+K   
Sbjct: 179 ELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQG 237

Query: 114 -NTLKL 118
            + +K+
Sbjct: 238 RSGIKV 243

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 36/141 (25%), Positives = 59/141 (41%), Gaps = 21/141 (14%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEY 59
           +    + AIK + K   S++       E++ L  L HH +I+ +L       Y+Y+ +EY
Sbjct: 49  DGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107

Query: 60  CDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFD 103
              G+L  F+R                    LS  Q   F   +   + +L +    H D
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 167

Query: 104 LKPQNILI-KNNTLKLA--GL 121
           L  +NIL+ +N   K+A  GL
Sbjct: 168 LAARNILVGENYVAKIADFGL 188

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 65.7 bits (161), Expect = 3e-12
 Identities = 33/146 (22%), Positives = 66/146 (45%), Gaps = 10/146 (6%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
             +   VA+K   K   + +  +  ++E   +K L H HIV ++  + +E   +II+E  
Sbjct: 37  KGEKINVAVKTC-KKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELY 94

Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             G+L  ++  ++  L       +  Q+  A+ +L   N  H D+  +NIL+     +KL
Sbjct: 95  PYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKL 154

Query: 119 A--GLKQGVSEKAKGSAYIEQGNTKV 142
              GL + + +      Y +   T++
Sbjct: 155 GDFGLSRYIED----EDYYKASVTRL 176

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 34/160 (21%), Positives = 77/160 (48%), Gaps = 24/160 (15%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYC 60
            + T+VA+K + K+  +E     +++E++ +K++  H++I+ +L     +  +Y+I+EY 
Sbjct: 99  NRVTKVAVKML-KSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 157

Query: 61  DGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 104
             G+L  ++++                 E+LS         Q+   +++L      H DL
Sbjct: 158 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDL 217

Query: 105 KPQNILI-KNNTLKLA--GLKQGVSEKAKGSAYIEQGNTK 141
             +N+L+ ++N +K+A  GL + +        Y +  N +
Sbjct: 218 AARNVLVTEDNVMKIADFGLARDIHH---IDYYKKTTNGR 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 66.1 bits (162), Expect = 4e-12
 Identities = 32/148 (21%), Positives = 61/148 (41%), Gaps = 28/148 (18%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
              +T VA+K + K   S +    +++E   LK ++H H++ +      +  + +I+EY 
Sbjct: 50  RAGYTTVAVKML-KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYA 108

Query: 61  DGGDLCSFIRSH------------------------EKLSEFQCQQFVRQLVLALKFLRE 96
             G L  F+R                            L+      F  Q+   +++L E
Sbjct: 109 KYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE 168

Query: 97  NNVCHFDLKPQNILI-KNNTLKLA--GL 121
             + H DL  +NIL+ +   +K++  GL
Sbjct: 169 MKLVHRDLAARNILVAEGRKMKISDFGL 196

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 29/123 (23%), Positives = 56/123 (45%), Gaps = 6/123 (4%)

Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
               V IK I + K     F ++ + + A+  L H HIV +L        + ++ +Y   
Sbjct: 41  IKIPVCIKVI-EDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPL 98

Query: 63  GDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA- 119
           G L   +R H   L       +  Q+   + +L E+ + H +L  +N+L+K  + +++A 
Sbjct: 99  GSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVAD 158

Query: 120 -GL 121
            G+
Sbjct: 159 FGV 161

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 66.2 bits (162), Expect = 4e-12
 Identities = 26/124 (20%), Positives = 53/124 (42%), Gaps = 6/124 (4%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCD 61
           +    VAIK + +   S      I++E   +  + + H+  +L        V +I +   
Sbjct: 42  KVKIPVAIKEL-REATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP 99

Query: 62  GGDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTLKLA 119
            G L  ++R H + +       +  Q+   + +L +  + H DL  +N+L+K    +K+ 
Sbjct: 100 FGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 159

Query: 120 --GL 121
             GL
Sbjct: 160 DFGL 163

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 67.2 bits (164), Expect = 4e-12
 Identities = 29/121 (23%), Positives = 54/121 (44%), Gaps = 12/121 (9%)

Query: 6   EVAIKCIDKTKVSE--NRFDSIVNEIKALKLLHHQHIVTMLDF-----LWDERYVYIILE 58
            V +K +  +  +E        + E + L  + H  IV + +F        +   YI++E
Sbjct: 108 PVVLKGLVHSGDAEAQAMA---MAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
           Y  G  L       +KL   +   ++ +++ AL +L    + + DLKP+NI++    LKL
Sbjct: 165 YVGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKL 222

Query: 119 A 119
            
Sbjct: 223 I 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 66.7 bits (163), Expect = 5e-12
 Identities = 25/106 (23%), Positives = 49/106 (46%), Gaps = 2/106 (1%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K ++K   +          E   L     + I  +     DE Y+Y+++EY  GGDL 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149

Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           + +     ++     + ++ ++V+A+  +      H D+KP NIL+
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL 195

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 30/152 (19%), Positives = 63/152 (41%), Gaps = 15/152 (9%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-----HHQHIVTMLD-FLWDERYVYI 55
           +     A+K +   +  +    S   E   LK +     ++ +IV     F++ + ++ +
Sbjct: 58  DNKKYYAVKVV---RNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD-HMCL 113

Query: 56  ILEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN 113
           I E   G  L   I  +          + +  +++ AL +LR+ ++ H DLKP+NIL+ +
Sbjct: 114 IFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172

Query: 114 NTLKLAGLKQGVSEKAKGSAYIEQGNT--KVI 143
              + + +        K        +T  K+I
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLI 204

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 67.2 bits (164), Expect = 5e-12
 Identities = 38/144 (26%), Positives = 66/144 (45%), Gaps = 6/144 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
                 VAIK   K   S++  +  + E   ++   H HIV ++  + +   V+II+E C
Sbjct: 415 ENPAMAVAIKTC-KNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENP-VWIIMELC 472

Query: 61  DGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
             G+L SF++  +  L       +  QL  AL +L      H D+  +N+L+  N+ +KL
Sbjct: 473 TLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 532

Query: 119 AGLKQGVSEKAKGSAYIEQGNTKV 142
                G+S   + S Y +    K+
Sbjct: 533 GDF--GLSRYMEDSTYYKASKGKL 554

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 65.8 bits (161), Expect = 6e-12
 Identities = 35/161 (21%), Positives = 77/161 (47%), Gaps = 24/161 (14%)

Query: 2   EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYC 60
           ++   VA+K + K   +E     +V+E++ +K++  H++I+ +L     +  +Y+I+EY 
Sbjct: 111 KEAVTVAVKML-KDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 169

Query: 61  DGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 104
             G+L  ++R+                 E+++         QL   +++L      H DL
Sbjct: 170 SKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDL 229

Query: 105 KPQNILI-KNNTLKLA--GLKQGVSEKAKGSAYIEQGNTKV 142
             +N+L+ +NN +K+A  GL + ++       Y +  N ++
Sbjct: 230 AARNVLVTENNVMKIADFGLARDINN---IDYYKKTTNGRL 267

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 64.9 bits (159), Expect = 6e-12
 Identities = 33/140 (23%), Positives = 57/140 (40%), Gaps = 20/140 (14%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            EQ   VAIK + K K      +   +E      L H ++V +L  +  ++ + +I  YC
Sbjct: 36  GEQTQAVAIKTL-KDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC 94

Query: 61  DGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 104
             GDL  F+                     L        V Q+   +++L  ++V H DL
Sbjct: 95  SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDL 154

Query: 105 KPQNILI-KNNTLKLA--GL 121
             +N+L+     +K++  GL
Sbjct: 155 ATRNVLVYDKLNVKISDLGL 174

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 65.9 bits (161), Expect = 8e-12
 Identities = 27/109 (24%), Positives = 55/109 (50%), Gaps = 2/109 (1%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K ++K + +          E   L     + I T+     D+  +Y++++Y  GGDL 
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162

Query: 67  SFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + +   E +L E   + ++ ++V+A+  + + +  H D+KP NIL+  N
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN 211

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 64.6 bits (158), Expect = 8e-12
 Identities = 28/121 (23%), Positives = 59/121 (48%), Gaps = 6/121 (4%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
            +VAIK + K    +   + ++ E + +  L + +IV ++     E  + +++E   GG 
Sbjct: 38  IDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGP 95

Query: 65  LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--G 120
           L  F+     ++      + + Q+ + +K+L E N  H DL  +N+L+   +  K++  G
Sbjct: 96  LHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFG 155

Query: 121 L 121
           L
Sbjct: 156 L 156

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 64.6 bits (158), Expect = 9e-12
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 8/127 (6%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILE 58
           +     VA+K + +    E+  D    EI+ LK L H +IV      +    R + +I+E
Sbjct: 36  DNTGEVVAVKKL-QHSTEEHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 93

Query: 59  YCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTL 116
           Y   G L  +++ H+ ++   +  Q+  Q+   +++L      H DL  +NIL+   N +
Sbjct: 94  YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 153

Query: 117 KLA--GL 121
           K+   GL
Sbjct: 154 KIGDFGL 160

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 65.1 bits (159), Expect = 1e-11
 Identities = 33/127 (25%), Positives = 60/127 (47%), Gaps = 8/127 (6%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILE 58
           +     VA+K + +    E+  D    EI+ LK L H +IV      +    R + +I+E
Sbjct: 67  DNTGEVVAVKKL-QHSTEEHLRD-FEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIME 124

Query: 59  YCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTL 116
           Y   G L  +++ H+ ++   +  Q+  Q+   +++L      H DL  +NIL+   N +
Sbjct: 125 YLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRV 184

Query: 117 KLA--GL 121
           K+   GL
Sbjct: 185 KIGDFGL 191

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 18/116 (15%), Positives = 39/116 (33%), Gaps = 4/116 (3%)

Query: 6   EVAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           +VA+  +D   V  +      ++    L  +    +  +LD +       ++ E+  GG 
Sbjct: 58  QVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGS 117

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLA 119
           L     +    S     + ++ L  A        V      P  + +  +  + LA
Sbjct: 118 LQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLA 171

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 17/149 (11%), Positives = 32/149 (21%), Gaps = 36/149 (24%)

Query: 6   EVAIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFL----------------- 47
           + A+K        S +  + +     A   L  +      D                   
Sbjct: 89  DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPF 148

Query: 48  ---------WDERYVYIILEYCDGGDLCSFIR-------SHEKLSEFQCQQFVRQLVLAL 91
                    +      +++      DL                           QL+   
Sbjct: 149 AQLSPGQDDYAVANYLLLMPAA-SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLA 207

Query: 92  KFLRENNVCHFDLKPQNILI-KNNTLKLA 119
             L+   + H    P N+ I  +  L L 
Sbjct: 208 ANLQSKGLVHGHFTPDNLFIMPDGRLMLG 236

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 31/129 (24%), Positives = 69/129 (53%), Gaps = 7/129 (5%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTML-DFLWDERYVYIILEYCDGGDL 65
           A+K + K   ++++     V E + L+   H  +  +   F   +R +  ++EY +GG+L
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR-LCFVMEYANGGEL 92

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL- 121
              +      +E + + +  ++V AL++L   +V + D+K +N+++ K+  +K+   GL 
Sbjct: 93  FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152

Query: 122 KQGVSEKAK 130
           K+G+S+ A 
Sbjct: 153 KEGISDGAT 161

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 31/127 (24%), Positives = 58/127 (45%), Gaps = 8/127 (6%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLD--FLWDERYVYIILE 58
           +     VA+K + +    + + D    EI+ LK LH   IV      +    + + +++E
Sbjct: 49  DNTGALVAVKQL-QHSGPDQQRD-FQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVME 106

Query: 59  YCDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK-NNTL 116
           Y   G L  F++ H  +L   +   +  Q+   +++L      H DL  +NIL++    +
Sbjct: 107 YLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHV 166

Query: 117 KLA--GL 121
           K+A  GL
Sbjct: 167 KIADFGL 173

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 35/148 (23%), Positives = 64/148 (43%), Gaps = 28/148 (18%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEY 59
                +VA+K + K K   +  +++++E+K +  L  H++IV +L        +Y+I EY
Sbjct: 72  TGVSIQVAVKML-KEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEY 130

Query: 60  CDGGDLCSFIRSH-----------------------EKLSEFQCQQFVRQLVLALKFLRE 96
           C  GDL +++RS                          L+      F  Q+   ++FL  
Sbjct: 131 CCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF 190

Query: 97  NNVCHFDLKPQNILI-KNNTLKLA--GL 121
            +  H DL  +N+L+     +K+   GL
Sbjct: 191 KSCVHRDLAARNVLVTHGKVVKICDFGL 218

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 33/148 (22%), Positives = 55/148 (37%), Gaps = 28/148 (18%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            E  T VA+K + K + S +       E   +    + +IV +L      + + ++ EY 
Sbjct: 74  YEPFTMVAVKML-KEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 132

Query: 61  DGGDLCSFIRSHEKLSEFQCQ------------------------QFVRQLVLALKFLRE 96
             GDL  F+RS    +                                RQ+   + +L E
Sbjct: 133 AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 192

Query: 97  NNVCHFDLKPQNILI-KNNTLKLA--GL 121
               H DL  +N L+ +N  +K+A  GL
Sbjct: 193 RKFVHRDLATRNCLVGENMVVKIADFGL 220

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 28/123 (22%), Positives = 61/123 (49%), Gaps = 6/123 (4%)

Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
           +  +VAIK + K    +   + ++ E + +  L + +IV ++     E  + +++E   G
Sbjct: 362 KQIDVAIKVL-KQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGG 419

Query: 63  GDLCSFIRSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA- 119
           G L  F+    E++      + + Q+ + +K+L E N  H +L  +N+L+   +  K++ 
Sbjct: 420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISD 479

Query: 120 -GL 121
            GL
Sbjct: 480 FGL 482

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 63.1 bits (154), Expect = 5e-11
 Identities = 29/134 (21%), Positives = 56/134 (41%), Gaps = 12/134 (8%)

Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQ------HIVTMLDFLWDERYVYII 56
               VA+K +   K  +   ++  +EI+ L+ L+          V ML++     ++ I+
Sbjct: 39  GGRHVAVKIV---KNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95

Query: 57  LEYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            E   G     FI+ +          ++   Q+  ++ FL  N + H DLKP+NIL   +
Sbjct: 96  FELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154

Query: 115 TLKLAGLKQGVSEK 128
               A   +   ++
Sbjct: 155 DYTEAYNPKIKRDE 168

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 32/129 (24%), Positives = 65/129 (50%), Gaps = 6/129 (4%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A+K + K   V+++     + E + L+   H  +  +         +  ++EY +GG+L 
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLKPQNILI-KNNTLKLA--GL- 121
             +      SE + + +  ++V AL +L  E NV + DLK +N+++ K+  +K+   GL 
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296

Query: 122 KQGVSEKAK 130
           K+G+ + A 
Sbjct: 297 KEGIKDGAT 305

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 62.7 bits (153), Expect = 6e-11
 Identities = 32/142 (22%), Positives = 64/142 (45%), Gaps = 22/142 (15%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDF-LWDERYVYIILE 58
                 VA+K + K   + +   ++++E+K L  + HH ++V +L         + +I+E
Sbjct: 54  TATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 112

Query: 59  YCDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHF 102
           +C  G+L +++RS                 + L+      +  Q+   ++FL      H 
Sbjct: 113 FCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHR 172

Query: 103 DLKPQNILI-KNNTLKLA--GL 121
           DL  +NIL+ + N +K+   GL
Sbjct: 173 DLAARNILLSEKNVVKICDFGL 194

>3hqi_A Speckle-type POZ protein; SPOP, ubiquitin, puckered, nucleus, UBL conjugation pathway, protein binding, ligase; 2.62A {Homo sapiens} PDB: 3hu6_A Length = 312

 Score = 62.2 bits (151), Expect = 8e-11
 Identities = 24/67 (35%), Positives = 35/67 (52%), Gaps = 6/67 (8%)

Query: 352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDT--KILDITPE 409
             +  ++DC   V      +EF+AHK IL+  SPVF+ MF  E+ E      +I D+ PE
Sbjct: 169 WENSRFTDCCLCVAG----QEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVEPE 224

Query: 410 AFSTMLD 416
            F  M+ 
Sbjct: 225 VFKEMMC 231

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 63.0 bits (153), Expect = 1e-10
 Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 4/108 (3%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKLLH---HQHIVTMLDFLWDERYVYIILEYCDGG 63
           A+KC+DK +   +      +NE   L L+       IV M         +  IL+  +GG
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           DL   +  H   SE   + +  +++L L+ +    V + DLKP NIL+
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 325

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 27/107 (25%), Positives = 58/107 (54%), Gaps = 3/107 (2%)

Query: 8   AIKCIDKTKVSENRFD--SIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEYCDGGD 64
           A+K + K  + +          E + L+ +     +  L + +  E  +++IL+Y +GG+
Sbjct: 86  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           L + +   E+ +E + Q +V ++VLAL+ L +  + + D+K +NIL+
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 192

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 61.0 bits (149), Expect = 2e-10
 Identities = 33/129 (25%), Positives = 59/129 (45%), Gaps = 6/129 (4%)

Query: 8   AIKCIDKTKVSENRFD--SIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           A+K + K  +  N  D      E   L+ + H  IV ++        +Y+ILEY  GG+L
Sbjct: 49  AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL- 121
              +       E     ++ ++ +AL  L +  + + DLKP+NI++     +KL   GL 
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168

Query: 122 KQGVSEKAK 130
           K+ + +   
Sbjct: 169 KESIHDGTV 177

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 26/135 (19%), Positives = 48/135 (35%), Gaps = 25/135 (18%)

Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNE--IKALKLLHHQHIV------TMLDFLWDERYVY 54
               VA+K       S     + +NE  I  + L+ H +I         +       Y  
Sbjct: 35  DERPVAVK-----VFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY-L 88

Query: 55  IILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE---------NNVCHFDLK 105
           +++EY   G L  ++  H         +    +   L +L             + H DL 
Sbjct: 89  LVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLN 147

Query: 106 PQNILIKNN-TLKLA 119
            +N+L+KN+ T  ++
Sbjct: 148 SRNVLVKNDGTCVIS 162

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 35/129 (27%), Positives = 64/129 (49%), Gaps = 6/129 (4%)

Query: 8   AIKCIDKTKV-SENRFDSIVNEIKALKL-LHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           AIK + K  V  ++  +  + E + L L   H  +  M      +  ++ ++EY +GGDL
Sbjct: 46  AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLA--GL- 121
              I+S  K    +   +  +++L L+FL    + + DLK  NIL+  +  +K+A  G+ 
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165

Query: 122 KQGVSEKAK 130
           K+ +   AK
Sbjct: 166 KENMLGDAK 174

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 25/134 (18%), Positives = 57/134 (42%), Gaps = 23/134 (17%)

Query: 3   QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTML------DFLWDERYVYII 56
            +  VA+K          + +    E+ +L  + H++I+  +        +  + +  +I
Sbjct: 46  LNEYVAVKIFPIQDKQSWQNE---YEVYSLPGMKHENILQFIGAEKRGTSVDVDLW--LI 100

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLREN----------NVCHFDLKP 106
             + + G L  F++++  +S  +       +   L +L E+           + H D+K 
Sbjct: 101 TAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159

Query: 107 QNILIKNN-TLKLA 119
           +N+L+KNN T  +A
Sbjct: 160 KNVLLKNNLTACIA 173

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 60.3 bits (147), Expect = 4e-10
 Identities = 34/130 (26%), Positives = 63/130 (48%), Gaps = 8/130 (6%)

Query: 8   AIKCIDKTKV-SENRFDSIVNEIKALKL-LHHQHIVTML-DFLWDERYVYIILEYCDGGD 64
           A+K + K  V  +   D +  E    +   +H  +V +   F  + R ++ ++EY +GGD
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVNGGD 96

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL 121
           L   ++   KL E   + +  ++ LAL +L E  + + DLK  N+L+     +KL   G+
Sbjct: 97  LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 156

Query: 122 -KQGVSEKAK 130
            K+G+     
Sbjct: 157 CKEGLRPGDT 166

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 61.0 bits (148), Expect = 5e-10
 Identities = 23/107 (21%), Positives = 51/107 (47%), Gaps = 3/107 (2%)

Query: 8   AIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           A K ++K ++         +NE + L+ ++ + +V++      +  + ++L   +GGDL 
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272

Query: 67  SFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             I    +    E +   +  ++   L+ L    + + DLKP+NIL+
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL 319

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 60.6 bits (147), Expect = 5e-10
 Identities = 24/109 (22%), Positives = 53/109 (48%), Gaps = 5/109 (4%)

Query: 8   AIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL- 65
           A K ++K ++     +   + E K L  +H + IV++      +  + +++   +GGD+ 
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273

Query: 66  ---CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
               +    +    E +   +  Q+V  L+ L + N+ + DLKP+N+L+
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL 322

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 60.1 bits (146), Expect = 6e-10
 Identities = 33/130 (25%), Positives = 64/130 (49%), Gaps = 8/130 (6%)

Query: 8   AIKCIDKTKV-SENRFDSIVNEIKALKL-LHHQHIVTML-DFLWDERYVYIILEYCDGGD 64
           A++ + K  V  +   D +  E    +   +H  +V +   F  + R ++ ++EY +GGD
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR-LFFVIEYVNGGD 139

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLA--GL 121
           L   ++   KL E   + +  ++ LAL +L E  + + DLK  N+L+ +   +KL   G+
Sbjct: 140 LMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 199

Query: 122 -KQGVSEKAK 130
            K+G+     
Sbjct: 200 CKEGLRPGDT 209

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 31/129 (24%), Positives = 62/129 (48%), Gaps = 6/129 (4%)

Query: 8   AIKCIDKTKVSENR-FDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           A+K + K  + + +    I++E   L K + H  +V +         +Y +L+Y +GG+L
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL- 121
              ++      E + + +  ++  AL +L   N+ + DLKP+NIL+     + L   GL 
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLC 186

Query: 122 KQGVSEKAK 130
           K+ +   + 
Sbjct: 187 KENIEHNST 195

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 59.1 bits (144), Expect = 9e-10
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 4/127 (3%)

Query: 8   AIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS 67
           A+K + K  +          E   L  ++H  IV +      E  +Y+IL++  GGDL +
Sbjct: 56  AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFT 115

Query: 68  FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA--GL-KQ 123
            +      +E   + ++ +L LAL  L    + + DLKP+NIL+ +   +KL   GL K+
Sbjct: 116 RLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE 175

Query: 124 GVSEKAK 130
            +  + K
Sbjct: 176 SIDHEKK 182

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 31/130 (23%), Positives = 66/130 (50%), Gaps = 8/130 (6%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKL-LHHQHIVTML-DFLWDERYVYIILEYCDGGD 64
           A+K + K   + ++  +  + E + L L  +H  +  +   F   +R ++ ++E+ +GGD
Sbjct: 52  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGD 110

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLA--GL 121
           L   I+   +  E + + +  +++ AL FL +  + + DLK  N+L+ +    KLA  G+
Sbjct: 111 LMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGM 170

Query: 122 -KQGVSEKAK 130
            K+G+     
Sbjct: 171 CKEGICNGVT 180

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 31/128 (24%), Positives = 59/128 (46%), Gaps = 17/128 (13%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQ------HIVTMLDFLWDERYVYIIL 57
              VAIK I   K  +   +    E++ L+L++        +IV +        ++ ++ 
Sbjct: 79  QEWVAIKII---KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVF 135

Query: 58  EYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLREN--NVCHFDLKPQNILIKN 113
           E     +L   +R+     +S    ++F +Q+  AL FL     ++ H DLKP+NIL+ N
Sbjct: 136 EML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN 194

Query: 114 ---NTLKL 118
              + +K+
Sbjct: 195 PKRSAIKI 202

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 22/129 (17%), Positives = 47/129 (36%), Gaps = 12/129 (9%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY---- 59
             EV    + +   ++ +    +  I    L+       M+    DER ++++  +    
Sbjct: 126 KEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYP 185

Query: 60  ---CDGGD----LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI- 111
               +       L S   +H+ L      Q   Q++  L  L    + H  L+P +I++ 
Sbjct: 186 RMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLD 245

Query: 112 KNNTLKLAG 120
           +   + L G
Sbjct: 246 QRGGVFLTG 254

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 38/163 (23%), Positives = 65/163 (39%), Gaps = 21/163 (12%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQ------HIVTMLDFLWDERYVYIIL 57
            ++VA+K I   +      ++   EI  LK +  +        V M D+     ++ I  
Sbjct: 45  KSQVALKII---RNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101

Query: 58  EYCDGGDLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           E   G +   F++ +          +    QL  AL+FL EN + H DLKP+NIL  N+ 
Sbjct: 102 ELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160

Query: 116 -LKLAGLKQGVSEKAKGSAYIEQGNTKVI---CSVFEPREIPS 154
              L    +   EK+  +  I     +V     + F+     +
Sbjct: 161 FETLYNEHKSCEEKSVKNTSI-----RVADFGSATFDHEHHTT 198

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 28/127 (22%), Positives = 62/127 (48%), Gaps = 8/127 (6%)

Query: 8   AIKCIDKTK-VSENRFDSIVNEIKALKL-LHHQHIVTML-DFLWDERYVYIILEYCDGGD 64
           A+K + K   + ++  +  + E + L L      +  +   F   +R +Y ++EY +GGD
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR-LYFVMEYVNGGD 107

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLA--GL 121
           L   I+   +  E     +  ++ + L FL+   + + DLK  N+++ +   +K+A  G+
Sbjct: 108 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 167

Query: 122 -KQGVSE 127
            K+ + +
Sbjct: 168 CKENIWD 174

>1r29_A B-cell lymphoma 6 protein; BTB domain, transcriptional repression, transcription; 1.30A {Homo sapiens} SCOP: d.42.1.1 PDB: 1r28_A 1r2b_A 3bim_A 3lbz_A* 3e4u_A Length = 127

 Score = 53.4 bits (129), Expect = 5e-09
 Identities = 20/72 (27%), Positives = 35/72 (48%), Gaps = 6/72 (8%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL--DITPEAFSTMLD 416
           D    V      ++F+AHK +L   S +F ++F  +L        L  +I PE F+ +LD
Sbjct: 31  DVVIVVSR----EQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLD 86

Query: 417 SDHHARVNISSD 428
             + +R+N+   
Sbjct: 87  FMYTSRLNLREG 98

>2nn6_A Polymyositis/scleroderma autoantigen 1; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1 Length = 358

 Score = 56.6 bits (136), Expect = 6e-09
 Identities = 24/132 (18%), Positives = 49/132 (37%), Gaps = 13/132 (9%)

Query: 128 KAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLR 187
              G   +E G T+V+  V      P    +     ++G L+   + +  A+       +
Sbjct: 58  TDYGCCIVELGKTRVLGQVSCELVSPKLNRA-----TEGILFFNLELSQMAAPAFEPGRQ 112

Query: 188 DSEEKELGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALSAAINCANL 239
                +L   ++R L  + C              +Q+ + + +L +DG+ + AA   A +
Sbjct: 113 SDLLVKLNRLMERCLRNSKCIDTESLCVVAGEKVWQIRVDLHLLNHDGNIIDAASIAAIV 172

Query: 240 ALVDAAIPMYDL 251
           AL     P   +
Sbjct: 173 ALCHFRRPDVSV 184

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 27/129 (20%), Positives = 59/129 (45%), Gaps = 6/129 (4%)

Query: 8   AIKCIDKTKV-SENRFDSIVNEIKALKL-LHHQHIVTMLDFLWDERYVYIILEYCDGGDL 65
           A+K + K  V  ++  +  + E + L L      +  +         +Y ++EY +GGDL
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429

Query: 66  CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLA--GL- 121
              I+   +  E     +  ++ + L FL+   + + DLK  N+++ +   +K+A  G+ 
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

Query: 122 KQGVSEKAK 130
           K+ + +   
Sbjct: 490 KENIWDGVT 498

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 31/130 (23%), Positives = 63/130 (48%), Gaps = 22/130 (16%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-----------HQHIVTMLD-FLW--- 48
           +T VA+K +   +  +   ++  +EIK L+ ++             HI+ +LD F     
Sbjct: 44  NTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 100

Query: 49  DERYVYIILEYCDGGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLK 105
           +  +V ++ E   G +L + I+   H  +     +Q  +QL+L L ++ R   + H D+K
Sbjct: 101 NGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIK 159

Query: 106 PQNILIKNNT 115
           P+N+L++   
Sbjct: 160 PENVLMEIVD 169

>2wp8_A Exosome complex component RRP45; nucleus, hydrolase, RNA-binding, exonucle binding, mitochondrion, rRNA processing; 3.00A {Saccharomyces cerevisiae} Length = 305

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 23/133 (17%), Positives = 43/133 (32%), Gaps = 14/133 (10%)

Query: 128 KAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFAS-QIRTGWL 186
           K  G   ++ GNTKV C +      P           +G   +  + +P A  Q   G +
Sbjct: 42  KEFGDVSVKMGNTKVHCRISCQIAQPYEDRP-----FEGLFVISTEISPMAGSQFENGNI 96

Query: 187 RDSEEKELGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALSAAINCAN 238
              +E      +++++  +                + V   V  L  DG  + A+     
Sbjct: 97  TGEDEVLCSRIIEKSVRRSGALDVEGLCIVAGSKCWAVRADVHFLDCDGGFIDASCIAVM 156

Query: 239 LALVDAAIPMYDL 251
             L+    P   +
Sbjct: 157 AGLMHFKKPDITV 169

>2vpk_A Myoneurin; transcription regulation, transcription, metal-binding, alternative splicing, zinc, nucleus, BTB domain, zinc-finger, DNA-binding; 2.00A {Homo sapiens} Length = 116

 Score = 49.9 bits (120), Expect = 6e-08
 Identities = 12/58 (20%), Positives = 23/58 (39%), Gaps = 4/58 (6%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLD 416
           DC   +G      +FKAH+ +L+  S  F  ++              +  + F  +L+
Sbjct: 24  DCTIVIGE----FQFKAHRNVLASFSEYFGAIYRSTSENNVFLDQSQVKADGFQKLLE 77

>3ohu_A Transcription regulator protein BACH2; BTB/POZ domain; 2.10A {Homo sapiens} PDB: 3ohv_A Length = 125

 Score = 49.9 bits (120), Expect = 7e-08
 Identities = 16/71 (22%), Positives = 30/71 (42%), Gaps = 5/71 (7%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL-DITPEAFSTMLDS 417
           D    V      KEF+AH+ +L+  S  F     G+        +  ++T   F  +L  
Sbjct: 34  DVTLIVER----KEFRAHRAVLAACSEYFWQALVGQTKNDLVVSLPEEVTARGFGPLLQF 89

Query: 418 DHHARVNISSD 428
            + A++ +S +
Sbjct: 90  AYTAKLLLSRE 100

>2if5_A Zinc finger and BTB domain-containing protein 7A; POZ domain, POK, proto oncogene, transcription F transcription; 2.00A {Homo sapiens} PDB: 2nn2_A Length = 120

 Score = 49.9 bits (120), Expect = 7e-08
 Identities = 12/60 (20%), Positives = 22/60 (36%), Gaps = 6/60 (10%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL--DITPEAFSTMLD 416
           D    V      +EF  H+ +L+  S  F  +F                ++ EA + ++D
Sbjct: 27  DVVILVEG----REFPTHRSVLAACSQYFKKLFTSGAVVDQQNVYEIDFVSAEALTALMD 82

>2z8h_A Transcription regulator protein BACH1; BTB, POZ, disulfide bond, activator, DNA-binding, nucleus, phosphorylation, repressor; 2.50A {Mus musculus} Length = 138

 Score = 47.3 bits (113), Expect = 8e-07
 Identities = 16/71 (22%), Positives = 32/71 (45%), Gaps = 5/71 (7%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGEL-CEKGDTKILDITPEAFSTMLDS 417
           D    V      + F+AH+ +L+  S  F +   G+   E   T   ++T + F  ++  
Sbjct: 38  DVTVLVEG----QRFRAHRSVLAACSSYFHSRIVGQTDAELTVTLPEEVTVKGFEPLIQF 93

Query: 418 DHHARVNISSD 428
            + A++ +S D
Sbjct: 94  AYTAKLILSKD 104

>1buo_A POZ domain, protein (promyelocytic leukemia zinc finger prote; protein-protein interaction domain, transcriptional represso finger protein; 1.90A {Homo sapiens} SCOP: d.42.1.1 PDB: 1cs3_A Length = 121

 Score = 46.4 bits (111), Expect = 1e-06
 Identities = 15/70 (21%), Positives = 33/70 (47%), Gaps = 7/70 (10%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSD 418
           D    V +    +EF AH+ +L+ +S +F  +FH          +  ++P+ F  +L+  
Sbjct: 30  DVVIMVDS----QEFHAHRTVLACTSKMFEILFHRNSQH---YTLDFLSPKTFQQILEYA 82

Query: 419 HHARVNISSD 428
           + A +   ++
Sbjct: 83  YTATLQAKAE 92

>3ga1_A Nucleus accumbens-associated protein 1; BTB/POZ domain, phosphoprotein, repressor, transcri transcription regulation; 2.10A {Homo sapiens} Length = 129

 Score = 46.5 bits (111), Expect = 1e-06
 Identities = 15/70 (21%), Positives = 30/70 (42%), Gaps = 5/70 (7%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSD 418
           D    V        FKAH+ +L+ SS  F  +F+       +     + P++F  +L   
Sbjct: 35  DVSVVVKG----HAFKAHRAVLAASSSYFRDLFNNSRSAVVELPA-AVQPQSFQQILSFC 89

Query: 419 HHARVNISSD 428
           +  R++++  
Sbjct: 90  YTGRLSMNVG 99

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 48.7 bits (115), Expect = 2e-06
 Identities = 37/161 (22%), Positives = 55/161 (34%), Gaps = 49/161 (30%)

Query: 4   HTEVAIKCI------DKTKVSENRFDSIVNEIKALKL-----------------LHHQHI 40
           HT VAIK I            +  F+ I+ EI   K                  L+  H 
Sbjct: 43  HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHC 102

Query: 41  VT-----MLDFLWD-----------------ERYVYIILEYCDGG-DLCSFIRSHEKLSE 77
           V      +L   WD                 +  ++I+LE+  GG DL       +  S 
Sbjct: 103 VQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSL 160

Query: 78  FQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLK 117
              +  + QL  +L     +    H DL   N+L+K  +LK
Sbjct: 161 ATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLK 201

>2ihc_A Transcription regulator protein BACH1; BRIC-A-BRAC domain,transcription factor, protein-PROT interaction; 2.44A {Homo sapiens} Length = 124

 Score = 45.7 bits (109), Expect = 2e-06
 Identities = 15/71 (21%), Positives = 33/71 (46%), Gaps = 5/71 (7%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGEL-CEKGDTKILDITPEAFSTMLDS 417
           D   +V      + F+AH+ +L+  S  F +   G+   E   T   ++T + F  ++  
Sbjct: 31  DVTIFVEG----QRFRAHRSVLAACSSYFHSRIVGQADGELNITLPEEVTVKGFEPLIQF 86

Query: 418 DHHARVNISSD 428
            + A++ +S +
Sbjct: 87  AYTAKLILSKE 97

>2ppi_A Gigaxonin; BTB domain, protein degradation, structural genomics, struct genomics consortium, SGC, structural protein; 2.40A {Homo sapiens} Length = 144

 Score = 45.8 bits (109), Expect = 4e-06
 Identities = 12/74 (16%), Positives = 26/74 (35%), Gaps = 8/74 (10%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTK----ILDITPEAFSTM 414
           D    +      +E    K IL+ +SP   T  +    +   +     +  I+      +
Sbjct: 49  DAHLVLDG----EEIPVQKNILAAASPYIRTKLNYNPPKDDGSTYKIELEGISVMVMREI 104

Query: 415 LDSDHHARVNISSD 428
           LD     ++ ++ D
Sbjct: 105 LDYIFSGQIRLNED 118

>3b84_A Zinc finger and BTB domain-containing protein 48; krueppel related zinc finger protein 3, HKR3, ZBTB48, Z finger, oncogene; 1.74A {Homo sapiens} Length = 119

 Score = 44.5 bits (106), Expect = 5e-06
 Identities = 15/70 (21%), Positives = 26/70 (37%), Gaps = 6/70 (8%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSD 418
           D    VG       FKAH  +L+  S  F +++           +     E F  +LD  
Sbjct: 26  DATLDVGG----LVFKAHWSVLACCSHFFQSLYGDGSGGS--VVLPAGFAEIFGLLLDFF 79

Query: 419 HHARVNISSD 428
           +   + ++S 
Sbjct: 80  YTGHLALTSG 89

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 47.6 bits (113), Expect = 5e-06
 Identities = 29/129 (22%), Positives = 62/129 (48%), Gaps = 19/129 (14%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH--------HQHIVTMLD-FLWD-- 49
            +    VA+K +   K +E+  ++ ++EI+ LK +          + +V +LD F     
Sbjct: 59  IQGKKFVAMKVV---KSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV 115

Query: 50  -ERYVYIILEYCDGGDLCSFIRS--HEKLSEFQCQQFVRQLVLALKFL-RENNVCHFDLK 105
              ++ ++ E   G  L  +I    ++ L     ++ ++Q++  L +L  +  + H D+K
Sbjct: 116 NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIK 174

Query: 106 PQNILIKNN 114
           P+NIL+  N
Sbjct: 175 PENILLSVN 183

>2yy9_A Zinc finger and BTB domain-containing protein 48; mouse, HKR3, structural genomics, NPPSFA; 2.60A {Mus musculus} Length = 135

 Score = 44.5 bits (106), Expect = 7e-06
 Identities = 15/70 (21%), Positives = 25/70 (35%), Gaps = 6/70 (8%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSD 418
           D    VG       FKAH  +L+  S  F  ++           +     E F  +LD  
Sbjct: 27  DATLDVGG----LVFKAHWSVLACCSHFFQRIYGDGTGGS--VVLPAGFAEIFGLLLDFF 80

Query: 419 HHARVNISSD 428
           +   + ++S 
Sbjct: 81  YTGHLALTSG 90

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 47.5 bits (112), Expect = 7e-06
 Identities = 83/518 (16%), Positives = 147/518 (28%), Gaps = 142/518 (27%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VA+      KV + + D    +I  L L +     T+L+ L       I   +    D
Sbjct: 164 TWVALDVCLSYKV-QCKMD---FKIFWLNLKNCNSPETVLEMLQK-LLYQIDPNWTSRSD 218

Query: 65  LCSFIRSH-----EKLSEFQCQQFVRQLVLALKFLRENNVCH------FDLKPQNILI-- 111
             S I+        +L         +     L  L   NV +      F+L  + IL+  
Sbjct: 219 HSSNIKLRIHSIQAELRRLLKS---KPYENCLLVLL--NVQNAKAWNAFNLSCK-ILLTT 272

Query: 112 --KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVF---EPREIPSS--KTSLEYQRS 164
             K  T  L+            S  +     K +   +    P+++P     T+      
Sbjct: 273 RFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNP----- 327

Query: 165 KGELYVEFKFAPFASQIRTG---W--LRDSEEKELGNHLK---RALEPAVCRHEFSNFQV 216
                   + +  A  IR G   W   +     +L   ++     LEPA  R  F     
Sbjct: 328 -------RRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF----D 376

Query: 217 DLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLA-LRGGLTFIDPVEEEVAY 275
            L V                       A IP      +  L+ +   +   D     V  
Sbjct: 377 RLSVF---PP----------------SAHIP------TILLSLIWFDVIKSDV-MVVVNK 410

Query: 276 CQSLSSSE-DDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRV 334
               S  E       I++     I    +V L     +   A H   ++           
Sbjct: 411 LHKYSLVEKQPKESTISI-PS--IYLELKVKL-----ENEYALH-RSIVDHYNIP----- 456

Query: 335 QKLVSDHVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVF------- 387
           +   SD +  P   +Y  +         ++G+  H K  +  + +      VF       
Sbjct: 457 KTFDSDDLIPPYLDQYFYS---------HIGH--HLKNIEHPERMTLFRM-VFLDFRFLE 504

Query: 388 ATMFHGELCEKGDTKILDITP-----EAFSTMLDSDHHARVNISSD---HHARVSISSDH 439
             + H          IL+        + +    D  +   VN   D         I S +
Sbjct: 505 QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSKY 564

Query: 440 HTRVSISSDHRARVSISSDHHVRVSISSDHHARYIMAY 477
            T +                 +R+++ ++  A +  A+
Sbjct: 565 -TDL-----------------LRIALMAEDEAIFEEAH 584

>2q81_A MIZ-1 protein; BTB/POZ domain, transcription; HET: PG4; 2.10A {Homo sapiens} PDB: 3m52_A Length = 119

 Score = 43.8 bits (104), Expect = 1e-05
 Identities = 17/70 (24%), Positives = 30/70 (42%), Gaps = 7/70 (10%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSD 418
           DC F V        FKAHK +L+  S  F  +F     +K    +          +L+  
Sbjct: 29  DCTFVVDG----VHFKAHKAVLAACSEYFKMLFVD---QKDVVHLDISNAAGLGQVLEFM 81

Query: 419 HHARVNISSD 428
           + A++++S +
Sbjct: 82  YTAKLSLSPE 91

>3i3n_A Kelch-like protein 11; structural genomics, BTB, KLHL11A, SGC, structural genomics consortium, kelch repeat, secreted, protein binding; 2.60A {Homo sapiens} Length = 279

 Score = 45.3 bits (108), Expect = 2e-05
 Identities = 11/73 (15%), Positives = 30/73 (41%), Gaps = 8/73 (10%)

Query: 364 VGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKI--------LDITPEAFSTML 415
                  +EF+AH+ +L+ ++  F  +  G+  E    ++            P+    ++
Sbjct: 38  CFGGAGGREFRAHRSVLAAATEYFTPLLSGQFSESRSGRVEMRKWSSEPGPEPDTVEAVI 97

Query: 416 DSDHHARVNISSD 428
           +  +  R+ +S+ 
Sbjct: 98  EYMYTGRIRVSTG 110

>3fkc_A Transcriptional regulator kaiso; zinc finger and BTB domain containing 33, kaiso transcriptio ZNF-kaiso, ZNF348,wugsc:H_DJ525N14.1; 1.70A {Homo sapiens} PDB: 3m4t_A 3m8v_A Length = 116

 Score = 42.7 bits (101), Expect = 3e-05
 Identities = 19/63 (30%), Positives = 30/63 (47%), Gaps = 7/63 (11%)

Query: 354 SGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFST 413
            GL+ D    V +    ++F+AHK ILS SS  F  +F          ++  I  E F+ 
Sbjct: 28  HGLFCDVTVIVED----RKFRAHKNILSASSTYFHQLFSV---AGQVVELSFIRAEIFAE 80

Query: 414 MLD 416
           +L+
Sbjct: 81  ILN 83

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 44.9 bits (106), Expect = 3e-05
 Identities = 18/74 (24%), Positives = 39/74 (52%), Gaps = 3/74 (4%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTML-DFLWDERYVYIILE 58
                 VA+K + K   + +   ++++E+K L  + HH ++V +L         + +I+E
Sbjct: 49  TATCRTVAVKML-KEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVE 107

Query: 59  YCDGGDLCSFIRSH 72
           +C  G+L +++RS 
Sbjct: 108 FCKFGNLSTYLRSK 121

>3m5b_A Zinc finger and BTB domain-containing protein 32; POZ domain, BTB/POZ domain, ZBTB32, zinc finger domain-containing protein 32; 2.00A {Homo sapiens} Length = 119

 Score = 41.9 bits (99), Expect = 4e-05
 Identities = 17/70 (24%), Positives = 27/70 (38%), Gaps = 11/70 (15%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSD 418
           D    VG+    +EF AH L+L+  S          L E        I+P  F+ +L+  
Sbjct: 32  DTLITVGS----QEFPAHSLVLAGVSQQLGRRGQWALGE-------GISPSTFAQLLNFV 80

Query: 419 HHARVNISSD 428
           +   V +   
Sbjct: 81  YGESVELQPG 90

>3hve_A Gigaxonin; ubiquitin, cytoplasm, cytoskeleton, disease mutation, kelch repeat, neurodegeneration, phosphoprotein, polymorphism, UBL conjugation; 2.80A {Homo sapiens} PDB: 3hve_B Length = 256

 Score = 43.0 bits (102), Expect = 9e-05
 Identities = 13/62 (20%), Positives = 21/62 (33%), Gaps = 8/62 (12%)

Query: 359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMF--HGELCEKGDTKIL--DITPEAFSTM 414
           D    +      +E    K IL+ +SP   T    +    +    KI    I+      +
Sbjct: 33  DAHLVLDG----EEIPVQKNILAAASPYIRTKLNYNPPKDDGSTYKIELEGISVMVMREI 88

Query: 415 LD 416
           LD
Sbjct: 89  LD 90

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 27/110 (24%), Positives = 46/110 (41%), Gaps = 7/110 (6%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH-QHIVTMLDFLWDERYVYIILEYCDG 62
           +  VAIK ++  K   +R   +  E +  K L     I  +  F    +Y  ++LE   G
Sbjct: 34  NEYVAIK-LEPMK---SRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-G 88

Query: 63  GDLCS-FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             L   F       S         QL+  ++++   N+ + D+KP+N LI
Sbjct: 89  PSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI 138

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 41.1 bits (96), Expect = 7e-04
 Identities = 24/117 (20%), Positives = 48/117 (41%), Gaps = 21/117 (17%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDG 62
           + EVAIK  +     + +   ++ E K  ++L     I  +  F  +  Y  ++++   G
Sbjct: 32  NEEVAIKLENV----KTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-G 86

Query: 63  GDLCSFIRSHEKLSEFQCQQF--------VRQLVLALKFLRENNVCHFDLKPQNILI 111
             L       E L  F  ++           Q++  ++F+   +  H D+KP N L+
Sbjct: 87  PSL-------EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLM 136

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 28/111 (25%), Positives = 44/111 (39%), Gaps = 9/111 (8%)

Query: 4   HTEVAIKC-IDKTKVSENRFDSIVNEIKALKLLHH-QHIVTMLDFLWDERYVYIILEYCD 61
             EVAIK    KTK        +  E K  K++     I T+     +  Y  +++E   
Sbjct: 34  GEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL- 87

Query: 62  GGDLCS-FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
           G  L   F     K S         Q++  ++++   N  H D+KP N L+
Sbjct: 88  GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLM 138

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	477
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3m7n_D	258	Probable exosome complex exonuclease 1; exosome, R	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.98
2wnr_B	240	Probable exosome complex exonuclease 1; phosphate	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
2po1_A	249	Probable exosome complex exonuclease 1; RNAse PH,	99.97
2nn6_B	249	Exosome complex exonuclease RRP41; RNA, exosome, P	99.97
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
2je6_B	250	RRP41, exosome complex exonuclease 1; nuclease, hy	99.97
2nn6_D	237	Exosome complex exonuclease RRP46; RNA, exosome, P	99.97
2wp8_B	246	Exosome complex component SKI6; nucleus, hydrolase	99.97
2nn6_F	272	MTR3, exosome component 6; RNA, exosome, PM/SCL, p	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
3krn_A	222	Protein C14A4.5, confirmed by transcript evidence;	99.96
1oys_A	245	Ribonuclease PH; transferase, tRNA processing; 2.4	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.96
3dd6_A	255	Ribonuclease PH; exoribonuclease, tRNA maturation,	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.95
3hkm_A	246	OS03G0854200 protein; RNAse PH domain, phosphoryla	99.95
1udn_A	255	Ribonuclease PH, RNAse PH; transferase, riken stru	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.95
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.95
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.95
1r6l_A	239	Ribonuclease PH; beta-alpha-beta-alpha fold, hexam	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.95
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.95
3b4t_A	262	Ribonuclease PH; RNAse, tRNA nucleotidyltransferas	99.95
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.95
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.95
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.95
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.95
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
3gme_A	549	Polyribonucleotide nucleotidyltransferase; protein	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3niz_A	311	Rhodanese family protein; structural genomics, str	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.94
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.94
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.94
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.94
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.94
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.94
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.94
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.94
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.94
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.94
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.94
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.94
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.94
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.94
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.94
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.94
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.94
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.94
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.94
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.94
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.94
4aid_A	726	Polyribonucleotide nucleotidyltransferase; transfe	99.94
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.94
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.94
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.94
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.94
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.94
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.94
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.94
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.94
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.94
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.94
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.94
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.94
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.94
3bhy_A	283	Death-associated protein kinase 3; death associate	99.94
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.94
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.94
2po1_B	277	Probable exosome complex exonuclease 2; RNAse PH,	99.94
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.94
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.94
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.93
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.93
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.93
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.93
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.93
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.93
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.93
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.93
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.93
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.93
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.93
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.93
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.93
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.93
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.93
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.93
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.93
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.93
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.93
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.93
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.93
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.93
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.93
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.93
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.93
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.93
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.93
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.93
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.93
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.93
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.93
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.93
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.93
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.93
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.93
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.93
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.93
2je6_A	277	RRP42, exosome complex exonuclease 2; nuclease, hy	99.93
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.93
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.93
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.93
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.93
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.93
2wnr_A	271	Probable exosome complex exonuclease 2; phosphate	99.93
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.93
3u1k_A	630	Polyribonucleotide nucleotidyltransferase 1, MITO;	99.93
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.93
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.93
1e3p_A	757	Guanosine pentaphosphate synthetase; polyribonucle	99.93
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.93
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.93
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.93
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.93
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.93
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.93
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.93
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.93
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.93
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.93
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.92
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.92
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.92
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.92
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.92
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.92
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.92
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.92
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.92
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.92
3m7n_G	259	Probable exosome complex exonuclease 2; exosome, R	99.92
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.92
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.92
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.92
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.92
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.92
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.92
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.92
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.92
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.92
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.92
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.92
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.92
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.92
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.92
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.92
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.92
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.92
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.92
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.92
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.92
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.92
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.92
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.92
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.92
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.92
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.92
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.92
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.92
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.92
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.92
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.92
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.92
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.92
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.92
2nn6_C	278	Exosome complex exonuclease RRP43; RNA, exosome, P	99.91
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.91
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.91
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.91
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.91
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.91
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.91
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.91
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.91
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.91
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.91
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.91
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.91
2nn6_A	358	Polymyositis/scleroderma autoantigen 1; RNA, exoso	99.91
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.91
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.91
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.91
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.91
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.91
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.91
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.91
3uqc_A	286	Probable conserved transmembrane protein; structur	99.91
3cdi_A	723	Polynucleotide phosphorylase; mRNA turnover, RNAse	99.91
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.91
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.91
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.91
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.91
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.9
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.9
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.9
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.9
2nn6_E	305	Exosome complex exonuclease RRP42; RNA, exosome, P	99.9
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.9
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.9
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.89
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.89
2wp8_A	305	Exosome complex component RRP45; nucleus, hydrolas	99.89
3u1k_A	630	Polyribonucleotide nucleotidyltransferase 1, MITO;	99.88
3ohu_A	125	Transcription regulator protein BACH2; BTB/POZ dom	99.86
2ihc_A	124	Transcription regulator protein BACH1; BRIC-A-BRAC	99.85
3b84_A	119	Zinc finger and BTB domain-containing protein 48;	99.85
2if5_A	120	Zinc finger and BTB domain-containing protein 7A;	99.85
2z8h_A	138	Transcription regulator protein BACH1; BTB, POZ, d	99.84
1r29_A	127	B-cell lymphoma 6 protein; BTB domain, transcripti	99.84
2yy9_A	135	Zinc finger and BTB domain-containing protein 48;	99.84
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.84
2vkp_A	109	BTB/POZ domain-containing protein 6; protein-bindi	99.84
2vpk_A	116	Myoneurin; transcription regulation, transcription	99.84
2ppi_A	144	Gigaxonin; BTB domain, protein degradation, struct	99.83
1buo_A	121	POZ domain, protein (promyelocytic leukemia zinc f	99.83
3fkc_A	116	Transcriptional regulator kaiso; zinc finger and B	99.83
2q81_A	119	MIZ-1 protein; BTB/POZ domain, transcription; HET:	99.83
3ga1_A	129	Nucleus accumbens-associated protein 1; BTB/POZ do	99.83
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.8
4eoz_A	145	Speckle-type POZ protein; E3 ubiquitin ligase, nuc	99.79
3m5b_A	119	Zinc finger and BTB domain-containing protein 32;	99.78
3htm_A	172	Speckle-type POZ protein; BTB, SPOP, ubiquitin, li	99.78
3hve_A	256	Gigaxonin; ubiquitin, cytoplasm, cytoskeleton, dis	99.76
3i3n_A	279	Kelch-like protein 11; structural genomics, BTB, K	99.74
4aid_A	726	Polyribonucleotide nucleotidyltransferase; transfe	99.74
3gme_A	549	Polyribonucleotide nucleotidyltransferase; protein	99.74
1e3p_A	757	Guanosine pentaphosphate synthetase; polyribonucle	99.73
3hqi_A	312	Speckle-type POZ protein; SPOP, ubiquitin, puckere	99.7
3cdi_A	723	Polynucleotide phosphorylase; mRNA turnover, RNAse	99.67
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.64
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.52
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.35
4ajy_C	97	Transcription elongation factor B polypeptide 1; E	99.2
2ast_A	159	S-phase kinase-associated protein 1A; SCF-substrat	99.13
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.94
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.73
1fs1_B	141	SKP1, cyclin A/CDK2-associated P45; F-BOX, LRR, le	98.69
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.63
2p1m_A	160	SKP1-like protein 1A; F-BOX, leucine rich repeat,	98.53
1hv2_A	99	Elongin C, ELC1; protein-peptide complex, signalin	98.36
2fnj_C	96	Transcription elongation factor B polypeptide 1; b	98.28
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.05
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.04
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.97
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.92
1vcb_B	112	Protein (elongin C); tumor suppressor, cancer, ubi	97.65
3v7d_A	169	Suppressor of kinetochore protein 1; WD 40 domain,	97.64
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.45
3drz_A	107	BTB/POZ domain-containing protein KCTD5; potassium	97.39
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.06
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.06
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.63
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.46
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.46
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.02
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.97
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.33
3kvt_A	115	Potassium channel protein SHAW; tetramerization do	94.57
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.53
3drx_A	202	BTB/POZ domain-containing protein KCTD5; golgi, gr	94.37
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.17
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	93.4
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	93.17
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.96
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	92.82
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.65
1s1g_A	124	Potassium voltage-gated channel subfamily D membe;	92.29
1nn7_A	105	Potassium channel KV4.2; teteramerization domain,	91.06
2nz0_B	140	Potassium voltage-gated channel subfamily D membe;	90.81
1t1d_A	100	Protein (potassium channel KV1.1); potassium chann	89.01
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	86.25

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-39  Score=312.67  Aligned_cols=173  Identities=22%  Similarity=0.299  Sum_probs=150.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+++.||+|++..........++|.+|+.+|++|+|||||+++++|++    ++.+|||||||+||+|.+++.+.+.+++
T Consensus        49 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~  128 (290)
T 3fpq_A           49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI  128 (290)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCH
T ss_pred             CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCH
Confidence            578999999998877777777889999999999999999999999875    3568999999999999999998889999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ..++.|+.||+.||+|||++|  |+||||||+|||++.....+.++|||++....++.    ..+.+||+.|+|||++.+
T Consensus       129 ~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~----~~~~~GTp~YmAPE~~~~  204 (290)
T 3fpq_A          129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE  204 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc----cCCcccCccccCHHHcCC
Confidence            999999999999999999998  99999999999997532244456999986544332    245689999999999877


Q ss_pred             C--CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K--TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~--~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .  .++|+ ||+|+++|||  +..||.+
T Consensus       205 ~y~~~~Di-wSlGvilyelltg~~Pf~~  231 (290)
T 3fpq_A          205 KYDESVDV-YAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             CCCTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             CCCcHHHH-HHHHHHHHHHHHCCCCCCC
Confidence            6  78999 9999999999  7788864

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.1e-39  Score=312.23  Aligned_cols=177  Identities=23%  Similarity=0.376  Sum_probs=152.8

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++.... ....+.+.+|+.+|++++||||++++++|++++.+|||||||+||+|.+++++.+.+++..+
T Consensus        55 ~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~  134 (311)
T 4aw0_A           55 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT  134 (311)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHH
T ss_pred             CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHH
Confidence            57999999999865432 23456799999999999999999999999999999999999999999999998889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.||+.||+|||++||+||||||+|||++.+. .+.++|||++.............+.+||+.|+|||++.+.   .
T Consensus       135 ~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g-~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~  213 (311)
T 4aw0_A          135 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK  213 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCH
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCC-CEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCc
Confidence            99999999999999999999999999999997643 3444599999865543333334567899999999998766   6


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|||  |..||.+.
T Consensus       214 ~~Di-WSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          214 SSDL-WALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHH-HHHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999999  88999753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=7.9e-38  Score=310.52  Aligned_cols=175  Identities=23%  Similarity=0.358  Sum_probs=151.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      .+|+.||||++++........+.+.+|+.+|++|+|||||++++++++++.+|||||||+||+|.+++...+  .+++..
T Consensus        47 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~  126 (350)
T 4b9d_A           47 EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQ  126 (350)
T ss_dssp             TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHH
T ss_pred             CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHH
Confidence            578999999999887777778899999999999999999999999999999999999999999999997643  579999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.|+.||+.||+|||++||+||||||+|||++.++ .+.++|||+++......  ....+.+||+.|+|||++.+.   
T Consensus       127 ~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~l~~~~y~  203 (350)
T 4b9d_A          127 ILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDG-TVQLGDFGIARVLNSTV--ELARACIGTPYYLSPEICENKPYN  203 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTC-CEEECSTTEESCCCHHH--HHHHHHHSCCTTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCC-CEEEcccccceeecCCc--ccccccCCCccccCHHHHCCCCCC
Confidence            999999999999999999999999999999997653 34445999997554321  112356789999999999876   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ ||+||++|||  +..||.+.
T Consensus       204 ~~~Di-wSlGvilyemltG~~PF~~~  228 (350)
T 4b9d_A          204 NKSDI-WALGCVLYELCTLKHAFEAG  228 (350)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCSCCCS
T ss_pred             cHHHH-HHHHHHHHHHHHCCCCCCCc
Confidence            67999 9999999999  77898753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.7e-38  Score=313.82  Aligned_cols=171  Identities=19%  Similarity=0.246  Sum_probs=145.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||+++.+...       .+|+.+|++++|||||++++++.+++.+|||||||+||+|.+++++.+++++..++
T Consensus        81 ~~g~~vAiK~i~~~~~~-------~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~  153 (336)
T 4g3f_A           81 QTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRAL  153 (336)
T ss_dssp             TTCCEEEEEEEETTTCC-------THHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHH
T ss_pred             CCCCEEEEEEECHHHhH-------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHH
Confidence            57899999999866432       36999999999999999999999999999999999999999999988899999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc---cccCCeEEEeccccccccCCCC--
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY---IEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~---~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .|+.||+.||+|||++||+||||||+|||++.++.++.++|||++........   ...+.+.+||+.|+|||++.+.  
T Consensus       154 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y  233 (336)
T 4g3f_A          154 YYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC  233 (336)
T ss_dssp             HHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCC
Confidence            99999999999999999999999999999987654556679999976543221   1223445799999999998876  


Q ss_pred             -CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                       .++|+ ||+|+++|||  +..||.+.
T Consensus       234 ~~~~Di-wSlGvilyemltG~~Pf~~~  259 (336)
T 4g3f_A          234 DAKVDI-WSSCCMMLHMLNGCHPWTQY  259 (336)
T ss_dssp             CTHHHH-HHHHHHHHHHHHSSCSSTTT
T ss_pred             CcHHHH-HHHHHHHHHHHHCcCCCCCC
Confidence             77999 9999999999  78999754

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.1e-38  Score=312.92  Aligned_cols=171  Identities=20%  Similarity=0.322  Sum_probs=147.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++++....  ..+.+.+|+.+|++++|||||+++++|.+++.+|||||||+||+|.+++.+ +++++..++
T Consensus        97 ~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~  173 (346)
T 4fih_A           97 SSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIA  173 (346)
T ss_dssp             TTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHH
T ss_pred             CCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHH
Confidence            57999999999766433  235688999999999999999999999999999999999999999999987 579999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .|+.||+.||+|||++||+||||||+|||++.++ .+.++|||++.......  ....+.+||+.|+|||++.+.   .+
T Consensus       174 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~  250 (346)
T 4fih_A          174 AVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPE  250 (346)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             HHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC-CEEEecCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcH
Confidence            9999999999999999999999999999997643 34445999987654332  122467899999999998776   78


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ ||+|+++|||  |..||.+
T Consensus       251 ~Di-WSlGvilyeml~G~~PF~~  272 (346)
T 4fih_A          251 VDI-WSLGIMVIEMVDGEPPYFN  272 (346)
T ss_dssp             HHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             HHH-HHHHHHHHHHHHCCCCCCC
Confidence            999 9999999999  7888875

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.7e-37  Score=294.35  Aligned_cols=172  Identities=25%  Similarity=0.440  Sum_probs=138.5

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++..... ...+.+.+|+.+|++++||||+++++++++++.+|+||||| +|+|.+++.+++++++..+
T Consensus        36 ~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~  114 (275)
T 3hyh_A           36 TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEA  114 (275)
T ss_dssp             TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHH
T ss_pred             CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHH
Confidence            579999999998776543 34567999999999999999999999999999999999999 5899999999889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.||+.||+|||++||+||||||+|||++.+. ++.++|||++.......   ...+.+||+.|+|||++.+.    
T Consensus       115 ~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~~---~~~~~~GT~~Y~APE~~~~~~y~~  190 (275)
T 3hyh_A          115 RRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHL-NVKIADFGLSNIMTDGN---FLKTSCGSPNYAAPEVISGKLYAG  190 (275)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTC-CEEECCSSCC------------------CTTSCHHHHSSSSCCC
T ss_pred             HHHHHHHHHHHHHHHHCCcccccCChHHeEECCCC-CEEEeecCCCeecCCCC---ccCCeeECcccCChhhhcCCCCCC
Confidence            99999999999999999999999999999997653 34445999986543322   23467899999999998765    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|+|  +..||.+
T Consensus       191 ~~~Di-wSlGvily~lltg~~PF~~  214 (275)
T 3hyh_A          191 PEVDV-WSCGVILYVMLCRRLPFDD  214 (275)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             Chhhh-HHHHHHHHHHHHCCCCCCC
Confidence            57899 9999999999  7788875

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=5.2e-38  Score=306.66  Aligned_cols=174  Identities=24%  Similarity=0.339  Sum_probs=143.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++++.||||++++.........++.+|+.+|++++||||+++++++++++.+|||||||+||+|.+++.+.+.+++..++
T Consensus        50 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~  129 (304)
T 3ubd_A           50 DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVK  129 (304)
T ss_dssp             TTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHH
T ss_pred             CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHH
Confidence            46889999999876554444456889999999999999999999999999999999999999999999988899999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||+|||++||+||||||+|||++.+ .+++  +|||+++......  ....+.+||+.|+|||++.+.   .
T Consensus       130 ~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl--~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~  205 (304)
T 3ubd_A          130 FYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL--TDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQ  205 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEE--ESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCT
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEe--cccccceeccCCC--ccccccccCcccCCHHHhccCCCCC
Confidence            999999999999999999999999999999764 4444  5999997543322  223467899999999998766   7


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|||  +..||.+.
T Consensus       206 ~~Di-wSlGvilyemltG~~PF~~~  229 (304)
T 3ubd_A          206 SADW-WSFGVLMFEMLTGTLPFQGK  229 (304)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcc-cchHHHHHHHHhCCCCCCCc
Confidence            8999 9999999999  78898753

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.2e-37  Score=314.34  Aligned_cols=171  Identities=20%  Similarity=0.322  Sum_probs=148.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||+++.....  ..+.+.+|+.+|++++|||||+++++|.+++.+|||||||+||+|.++++. +++++..++
T Consensus       174 ~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~  250 (423)
T 4fie_A          174 SSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIA  250 (423)
T ss_dssp             TTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHH
T ss_pred             CCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHH
Confidence            57999999999866433  235688999999999999999999999999999999999999999999976 579999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .|+.||+.||+|||++||+||||||+||||+.++ .+.++|||++.......  ....+.+||+.|+|||++.+.   .+
T Consensus       251 ~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~  327 (423)
T 4fie_A          251 AVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPE  327 (423)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC-CEEECCCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTH
T ss_pred             HHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEecCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcH
Confidence            9999999999999999999999999999997643 34455999987654332  123467999999999998876   78


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ ||+||++|||  |..||.+
T Consensus       328 ~Di-WSlGvilyeml~G~~PF~~  349 (423)
T 4fie_A          328 VDI-WSLGIMVIEMVDGEPPYFN  349 (423)
T ss_dssp             HHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             HHH-HHHHHHHHHHHHCCCCCCC
Confidence            999 9999999999  7788875

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-36  Score=296.54  Aligned_cols=174  Identities=24%  Similarity=0.350  Sum_probs=149.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---------   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------   72 (477)
                      .+++.||||+++..  +....++|.+|+.+|++++|||||++++++.+++.+|||||||+||+|.++|++.         
T Consensus        41 ~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~  118 (299)
T 4asz_A           41 QDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAE  118 (299)
T ss_dssp             --CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC--
T ss_pred             CCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccc
Confidence            35788999999754  4556678999999999999999999999999999999999999999999999764         


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          73 ----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        73 ----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                          ..+++..+..|+.|++.||.|||+++|+||||||+|||++.+. .+.++|||+++..........+.+..+|+.|+
T Consensus       119 ~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ym  197 (299)
T 4asz_A          119 GNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM  197 (299)
T ss_dssp             --CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCEEETTTEEECGGGC
T ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCC-cEEECCcccceecCCCCceeecCceecChhhc
Confidence                2699999999999999999999999999999999999998653 34445999997665555555556678999999


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |||.+.+.   .++|+ ||+|+++|||   +..||.+
T Consensus       198 APE~~~~~~~~~k~DV-wS~Gvvl~Ellt~G~~Pf~~  233 (299)
T 4asz_A          198 PPESIMYRKFTTESDV-WSLGVVLWEIFTYGKQPWYQ  233 (299)
T ss_dssp             CHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCTTTT
T ss_pred             CHHHHcCCCCCchhhH-HHHHHHHHHHHcCCCCCCCC
Confidence            99998755   78999 9999999998   4678865

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=294.34  Aligned_cols=174  Identities=25%  Similarity=0.326  Sum_probs=138.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---------   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------   72 (477)
                      .+++.||||+++..  +....++|.+|+.+|++++|||||++++++.+++.+|||||||+||+|.+++++.         
T Consensus        69 ~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~  146 (329)
T 4aoj_A           69 QDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAG  146 (329)
T ss_dssp             --CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC------
T ss_pred             CCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccc
Confidence            36789999999754  4556678999999999999999999999999999999999999999999999764         


Q ss_pred             ------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecc
Q psy6508          73 ------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV  146 (477)
Q Consensus        73 ------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~  146 (477)
                            +++++..+..|+.|++.||.|||+++|+||||||+|||++.+. .+.++|||+++............+..+|+.
T Consensus       147 ~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~  225 (329)
T 4aoj_A          147 GEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIR  225 (329)
T ss_dssp             -----CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC----------------CCCCGG
T ss_pred             cccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCC-cEEEcccccceeccCCCcceecCccccccc
Confidence                  2589999999999999999999999999999999999998753 444569999976655444444455678899


Q ss_pred             ccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         147 FEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |+|||++.+.   .++|+ ||+|+++|||   +..||.+
T Consensus       226 ymAPE~~~~~~~~~~sDv-wS~Gvvl~Ellt~G~~Pf~~  263 (329)
T 4aoj_A          226 WMPPESILYRKFTTESDV-WSFGVVLWEIFTYGKQPWYQ  263 (329)
T ss_dssp             GCCHHHHTTCCCCHHHHH-HHHHHHHHHHHTTSCCTTCS
T ss_pred             ccChhhhcCCCCCccccc-cchHHHHHHHHcCCCCCCCC
Confidence            9999998776   77999 9999999998   4677764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=289.34  Aligned_cols=173  Identities=19%  Similarity=0.333  Sum_probs=141.0

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      +..||||+++....+.+..+.|.+|+.+|++++||||+++++++. ++.+|||||||+||+|.+++... .++++..+..
T Consensus        58 ~~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~  136 (307)
T 3omv_A           58 HGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-KDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLID  136 (307)
T ss_dssp             SSEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHH
T ss_pred             CCcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-CCeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHH
Confidence            346999999877767777789999999999999999999999875 45689999999999999999764 4799999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC------
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK------  156 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~------  156 (477)
                      |+.|++.||.|||++||+||||||+|||++.+. .+.++|||++.............+.+||+.|+|||++.+.      
T Consensus       137 i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~  215 (307)
T 3omv_A          137 IARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFS  215 (307)
T ss_dssp             HHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTE-EEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCC
T ss_pred             HHHHHHHHHHHHHHCCccCCccCHHHEEECCCC-cEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCC
Confidence            999999999999999999999999999998653 4445699998654332222223456789999999987532      


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  +..||.+
T Consensus       216 ~ksDV-wS~Gvvl~Elltg~~Pf~~  239 (307)
T 3omv_A          216 FQSDV-YSYGIVLYELMTGELPYSH  239 (307)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             cHHHh-HhHHHHHHHHHHCCCCCCC
Confidence            57899 9999999999  7788874

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.7e-35  Score=290.21  Aligned_cols=175  Identities=20%  Similarity=0.307  Sum_probs=145.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---------   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------   72 (477)
                      ++++.||||+++... .....++|.+|+.+|++++|||||++++++.+++.+|||||||++|+|.++|...         
T Consensus        54 ~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~  132 (308)
T 4gt4_A           54 EQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGST  132 (308)
T ss_dssp             --CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC--
T ss_pred             CCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCcccccccc
Confidence            367889999997543 3344578999999999999999999999999999999999999999999999653         


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEec
Q psy6508          73 -------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICS  145 (477)
Q Consensus        73 -------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~  145 (477)
                             ..+++..+..|+.||+.||.|||+++|+||||||+|||++++. .+.++|||+++...+........+..+++
T Consensus       133 ~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~  211 (308)
T 4gt4_A          133 DDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKL-NVKISDLGLFREVYAADYYKLLGNSLLPI  211 (308)
T ss_dssp             ---CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred             ccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCC-CEEECCcccceeccCCCceeEecccccCC
Confidence                   2589999999999999999999999999999999999998652 34446999987665544444445567889


Q ss_pred             cccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         146 VFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       146 ~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .|+|||.+.+.   .++|+ ||+|+++|||   +..||.+
T Consensus       212 ~ymAPE~l~~~~~s~ksDV-wSfGvvl~El~t~g~~Pf~~  250 (308)
T 4gt4_A          212 RWMAPEAIMYGKFSIDSDI-WSYGVVLWEVFSYGLQPYCG  250 (308)
T ss_dssp             GGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCTTTT
T ss_pred             cccCHHHHhCCCCCccchh-hhHHHHHHHHHhCCCCCCCC
Confidence            99999987655   77999 9999999998   4578875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=6.4e-35  Score=285.29  Aligned_cols=174  Identities=22%  Similarity=0.339  Sum_probs=136.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------------eEEEEEecCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------------YVYIILEYCDGGDLCSFI   69 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------------~~~lv~e~~~g~sL~~~l   69 (477)
                      .+|+.||||+++... .+...+.+.+|+.+|++|+||||++++++|...+            .+|+|||||+||+|.+++
T Consensus        28 ~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l  106 (299)
T 4g31_A           28 VDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM  106 (299)
T ss_dssp             TTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHH
T ss_pred             CCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHH
Confidence            478999999997654 3445678999999999999999999999987544            479999999999999999


Q ss_pred             HhCCC---CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc----------c
Q psy6508          70 RSHEK---LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI----------E  136 (477)
Q Consensus        70 ~~~~~---l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~----------~  136 (477)
                      .....   .++..++.|+.||++||+|||++||+||||||+|||++.++ .+.++|||++...+.....          .
T Consensus       107 ~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~-~vKl~DFGla~~~~~~~~~~~~~~~~~~~~  185 (299)
T 4g31_A          107 NGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYA  185 (299)
T ss_dssp             HTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCCCC--------------------
T ss_pred             HhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCC-cEEEccCccceecCCCcccccccccccccc
Confidence            87654   45667899999999999999999999999999999997653 3444699998765432211          1


Q ss_pred             cCCeEEEeccccccccCCCC---CcccccCcceEEEEEEeeecccc
Q psy6508         137 QGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEFKFAPFAS  179 (477)
Q Consensus       137 ~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~~~~Pf~~  179 (477)
                      ...+.+||+.|+|||++.+.   .++|+ ||+|+++|||.+ ||.+
T Consensus       186 ~~~~~~GT~~YmAPE~~~~~~y~~~~Di-wSlGvilyell~-Pf~~  229 (299)
T 4g31_A          186 RHTGQVGTKLYMSPEQIHGNSYSHKVDI-FSLGLILFELLY-PFST  229 (299)
T ss_dssp             ------CCCTTSCHHHHTTCCCCTHHHH-HHHHHHHHHHHS-CCSS
T ss_pred             ccCCcccCccccCHHHHcCCCCCCHHHH-HHHHHHHHHHcc-CCCC
Confidence            12346799999999998876   78999 999999999975 7764

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.5e-34  Score=288.66  Aligned_cols=175  Identities=26%  Similarity=0.336  Sum_probs=146.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++++........+.+.+|+.+|+.++||||+++++++...      +.+|||||||+ |+|.+++.+.+.+
T Consensus        77 ~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l  155 (398)
T 4b99_A           77 LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPL  155 (398)
T ss_dssp             TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCC
T ss_pred             CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCC
Confidence            5799999999988776666677899999999999999999999997643      57999999997 7899999988899


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc--cccCCeEEEeccccccccC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY--IEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~--~~~g~t~v~~~~y~ppE~~  153 (477)
                      ++..++.+++||+.||.|||++||+||||||+|||++.+. .+.++|||++.....+..  .....+.+||+.|+|||++
T Consensus       156 ~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~  234 (398)
T 4b99_A          156 TLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM  234 (398)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCC-CEEEeecceeeecccCccccccccccceeChHhcCHHHh
Confidence            9999999999999999999999999999999999997653 344459999875543322  1223467899999999987


Q ss_pred             CCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         154 SSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+.    .++|+ ||+||++|||  |..||.+
T Consensus       235 ~~~~~~~~~~Di-WSlG~il~ell~G~~pF~g  265 (398)
T 4b99_A          235 LSLHEYTQAIDL-WSVGCIFGEMLARRQLFPG  265 (398)
T ss_dssp             TTCSCCCTHHHH-HHHHHHHHHHHHTSCSSCC
T ss_pred             cCCCCCCChhhe-ehhHHHHHHHHHCCCCCCC
Confidence            653    67899 9999999999  6778764

>3m7n_D Probable exosome complex exonuclease 1; exosome, RNA, exonuclease, hydrolase, nuclease, hydrolase-RN; 2.40A {Archaeoglobus fulgidus} PDB: 3m85_D 2ba0_F 2ba1_E

Probab=100.00  E-value=1.5e-31  Score=253.92  Aligned_cols=223  Identities=25%  Similarity=0.421  Sum_probs=201.2

Q ss_pred             Cceeec---cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecccccccc
Q psy6508         107 QNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT  183 (477)
Q Consensus       107 ~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~  183 (477)
                      +++-.|   .+++|.+.+.+|...+++||++++.|+|++.|.+++|.|.....  .+. -..|.+.+++.++||+...+.
T Consensus        14 ~~~R~DGR~~~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~gp~e~~~~~--~~~-~~~g~l~~~~~~~P~s~~~r~   90 (258)
T 3m7n_D           14 DGLRLDGRKFDELRPIKIEASVLKRADGSCYLEMGKNKVIAAVFGPREVHPEH--LQD-PSKAIIRYRYNMAPFSVEERK   90 (258)
T ss_dssp             TTEETTSCCTTCCCCEEEEECCCSSSSEEEEEEETTEEEEEEEEEEEECSSST--TCC-SSSCEEEEEEEECGGGSSSCC
T ss_pred             cCCCCCCCCcCCccCeEEEECCCCCCCceEEEEECCeEEEEEEEcccCCCCcc--ccC-CCceEEEEEEEeCCccccccc
Confidence            444454   36899999999999999999999999999999999887765432  012 456899999999999988777


Q ss_pred             CCCCCcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCe
Q psy6508         184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGL  263 (477)
Q Consensus       184 ~~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~  263 (477)
                      ...++..+.++++.+++++++.+.++.||++.|+|.++||++||+.+.+++||+++||.||||||+++++|+|+++.++.
T Consensus        91 ~~~~~~re~ei~~li~r~l~~~i~~~~~p~~~I~V~~~VL~~DG~~~~Aai~aa~lAL~dagiP~~~~v~avsvg~i~~~  170 (258)
T 3m7n_D           91 RPGPDRRSIEISKVSKEAFEAVIMKELFPRSAIDIFVEVLQADAGSRTACLNAASVALVDAGVPMKGMITSVAVGKADGQ  170 (258)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHTTBCGGGSTTEEEEEEEEEEECCTTHHHHHHHHHHHHHHHTTCCBSSEEEEEEEEEETTE
T ss_pred             CCCCCHHHHHHHHHHHHHHHhhcCHHhCCceEEEEEEEEEEcCCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEEEECCE
Confidence            66778889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEeCCChHHHhhhccCCCCCCCCCceEEEEEccCC---CcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhh
Q psy6508         264 TFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVI---QQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSD  340 (477)
Q Consensus       264 ~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~---~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~  340 (477)
                      +++||+..|+..          +.+.++++++++.   ++|+.++++|.++.+++.++++.|.++|+++.+. +++.+.+
T Consensus       171 ~llDpt~~Ee~~----------~~~d~~va~~~~~~~~~~I~~lq~~g~~~~~~l~~~l~~A~~~~~~i~~~-~~~~l~~  239 (258)
T 3m7n_D          171 LVLDPMKEEDNF----------GEADMPFAFLIRNGKIESIALLQMDGRMTRDEVKQAIELAKKGALQIYEM-QREAILR  239 (258)
T ss_dssp             EEESCCHHHHHH----------SSEEEEEEEEEETTEEEEEEEEEEEEEECHHHHHHHHHHHHHHHHHHHHH-HHHHHHH
T ss_pred             EEECCCHHHHhc----------cCceEEEEEEcCCCCCCCEEEEEecCCcCHHHHHHHHHHHHHHHHHHHHH-HHHHHHH
Confidence            999999999985          4789999998777   8999999999999999999999999999999999 9999987


Q ss_pred             ccc
Q psy6508         341 HVT  343 (477)
Q Consensus       341 ~~~  343 (477)
                      +..
T Consensus       240 ~~~  242 (258)
T 3m7n_D          240 RYI  242 (258)
T ss_dssp             HHH
T ss_pred             Hhh
Confidence            654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.98  E-value=1.4e-34  Score=288.88  Aligned_cols=174  Identities=19%  Similarity=0.280  Sum_probs=143.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC-CCccceEEEEEeC-CeEEEEEecCCCCCHHHHHHhC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH-QHIVTMLDFLWDE-RYVYIILEYCDGGDLCSFIRSH--------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~-~~~~lv~e~~~g~sL~~~l~~~--------   72 (477)
                      +++.||||.++... .....+.|.+|+.+|++++| ||||+++++|... +.+|||||||+||+|.++|++.        
T Consensus        93 ~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~  171 (353)
T 4ase_A           93 TCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK  171 (353)
T ss_dssp             CEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-
T ss_pred             CCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhccccccccc
Confidence            45789999997553 44556789999999999965 9999999998764 5789999999999999999753        


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEe
Q psy6508          73 --------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVIC  144 (477)
Q Consensus        73 --------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~  144 (477)
                              ..+++..+..++.||+.||.|||+++|+||||||+|||++.+. .+.++|||+++............+..+|
T Consensus       172 ~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt  250 (353)
T 4ase_A          172 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLP  250 (353)
T ss_dssp             ------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred             ccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC-CEEECcchhhhhcccCCCceeecccccc
Confidence                    2488999999999999999999999999999999999997653 3444599999765443333333456788


Q ss_pred             ccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         145 SVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       145 ~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +.|+|||++.+.   .++|+ ||+|+++|||   +..||.+
T Consensus       251 ~~ymAPE~l~~~~y~~ksDV-wS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          251 LKWMAPETIFDRVYTIQSDV-WSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             GGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSSTT
T ss_pred             ccccCHHHHhcCCCCCcccE-eehHHHHHHHHhCCCCCCCC
Confidence            999999988765   77899 9999999998   4678864

>2wnr_B Probable exosome complex exonuclease 1; phosphate binding, 3'-5' exoribonuclease, hydrolase; 2.65A {Methanothermobacter thermautotrophicusorganism_taxid}

Probab=99.97  E-value=4.4e-31  Score=249.39  Aligned_cols=215  Identities=25%  Similarity=0.420  Sum_probs=196.2

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.+++|.|.....  .+. -..|.+.+++.++||++..+....++..+.+
T Consensus        24 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~gp~e~~~~~--~~~-~~~g~l~~~~~~~p~a~~~~~~~~~~~~~~~  100 (240)
T 2wnr_B           24 DELRPLKIEAGILERADGSSYLEFGGNKILVAVYGPREAQIRK--LQR-PDRAVIRCRYNMAPFSVEERKRPGPDRRSVE  100 (240)
T ss_dssp             TCCCCEEEEESCCSSSSEEEEEEETTEEEEEEEEEEEECCSSS--SCC-SSSCEEEEEEEECTTSSSSCCCSSCCHHHHH
T ss_pred             CCccCeEEEeCCCCCCCEEEEEEECCeEEEEEEEcCCCCCccc--ccC-CCcEEEEEEEEeCCCCcCCccCCCCChhHHH
Confidence            5899999999999999999999999999999999987754321  122 4579999999999999887766677888999


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCChHHH
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEV  273 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~~E~  273 (477)
                      +++.+++++++.+.++.||++.|++.++||++||+.+.++++|+++||.|||+||+++++++|+++.++.+++||+..|+
T Consensus       101 l~~ll~r~l~~~i~l~~~p~~~I~i~~~VL~~dG~~~~a~i~aa~~AL~da~iP~~~~v~avs~g~~~~~~l~Dp~~~Ee  180 (240)
T 2wnr_B          101 ISKITAEALRPALILEKFPRSVIDVFIEVLEAEGGTRCAGITAASVALADAGIPMRDMVVACAAGKVGDQVVLDLSEEED  180 (240)
T ss_dssp             HHHHHHHHHGGGBCGGGSTTEEEEEEEEEEECCSCHHHHHHHHHHHHHHHTTCCBSSCCEEEEEEESSSSEEESCCSHHH
T ss_pred             HHHHHHHHHHHhcCHHHCCCcEEEEEEEEEeCCCCHHHHHHHHHHHHHHHcCCccccceeeEEEEEECCEEEeCCCHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhcc
Q psy6508         274 AYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHV  342 (477)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~  342 (477)
                      ..          +.+.++++++++.++|+.+++.|+++.+++.++++.|.++|+++.+. +++.+.++.
T Consensus       181 ~~----------~~~~~~v~~~~~~~~i~~lq~~g~~~~~~l~~~l~~A~~~~~~i~~~-~~~~l~~~~  238 (240)
T 2wnr_B          181 KE----------GQADVPVAILPRTREITLLQSDGNLTPEEFERALDLAVEGCLRIHEV-QKEALRKRY  238 (240)
T ss_dssp             HS----------CSEEEEEEEETTTTEEEEEEEEECBCHHHHHHHHHHHHHHHHHHHHH-HHHHHHC--
T ss_pred             cc----------CCceEEEEEECCCCCEEEEEEEcccCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHhh
Confidence            84          58899999989999999999999999999999999999999999999 999988764

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=9.4e-33  Score=292.93  Aligned_cols=173  Identities=21%  Similarity=0.288  Sum_probs=144.3

Q ss_pred             CCCcEEEEEEcccCCCC----hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVS----ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||||++++....    ........+++.+++.++||||++++++|++++.+|||||||+||+|.+++.+.+.+++
T Consensus       212 ~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E  291 (689)
T 3v5w_A          212 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE  291 (689)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCH
T ss_pred             CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCH
Confidence            57999999999765432    11222334446677788999999999999999999999999999999999998889999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC-C
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS-K  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~-~  156 (477)
                      ..++.++.||+.||.|||++||+||||||+||||+.++ .+.++|||++.......    ..+.+||+.|+|||++.+ .
T Consensus       292 ~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G-~vKL~DFGlA~~~~~~~----~~t~~GTp~YmAPEvl~~~~  366 (689)
T 3v5w_A          292 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV  366 (689)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSCC----CCSCCSCGGGCCHHHHSTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCC-CEEecccceeeecCCCC----CCCccCCcCccCHHHHhCCC
Confidence            99999999999999999999999999999999998643 34445999997654322    346789999999999853 2


Q ss_pred             ---CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                         .++|+ ||+||++|||  |..||.+.
T Consensus       367 ~y~~~vDi-WSLGvilYEmLtG~~PF~~~  394 (689)
T 3v5w_A          367 AYDSSADW-FSLGCMLFKLLRGHSPFRQH  394 (689)
T ss_dssp             CCCTHHHH-HHHHHHHHHHHHSSCTTCGG
T ss_pred             CCCcHHHH-HHHHHHHHHHHhCCCCCCCC
Confidence               77999 9999999999  88999753

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=1.4e-32  Score=275.75  Aligned_cols=183  Identities=18%  Similarity=0.268  Sum_probs=146.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||||++.+..    ...++.+|+.+|+.+ +||||++++++|.+++++|+||||++||+|.++++   .+++.++
T Consensus        47 ~~~~~vAiK~i~~~~----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~  119 (361)
T 4f9c_A           47 GPEEKIALKHLIPTS----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEV  119 (361)
T ss_dssp             SCEEEEEEEEECTTS----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHH
T ss_pred             CCCCEEEEEEEcccc----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHH
Confidence            357899999986543    234678999999999 69999999999999999999999999999999984   5999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-------------------------
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-------------------------  135 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-------------------------  135 (477)
                      +.++.|++.||+|||++||+||||||+|||++.+.-++.++|||+++....+...                         
T Consensus       120 ~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (361)
T 4f9c_A          120 REYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSR  199 (361)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------
T ss_pred             HHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999865445556699998754332110                         


Q ss_pred             -ccCCeEEEeccccccccCCCC----CcccccCcceEEEEEE--eeeccccccccCCCCCcchHHHHHHHH
Q psy6508         136 -EQGNTKVICSVFEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFASQIRTGWLRDSEEKELGNHLK  199 (477)
Q Consensus       136 -~~g~t~v~~~~y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~~~r~~~~~~~~~~~l~~~i~  199 (477)
                       ..-.+.+||+.|+|||++.+.    .++|+ ||+||++|||  |..||..       +..+...+..+++
T Consensus       200 ~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di-WSlG~il~ell~G~~Pf~~-------~~~~~~~l~~I~~  262 (361)
T 4f9c_A          200 RQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM-WSAGVIFLSLLSGRYPFYK-------ASDDLTALAQIMT  262 (361)
T ss_dssp             ------CCCCGGGCCHHHHTTCSCCCTHHHH-HHHHHHHHHHHHTCSSSSC-------CSSHHHHHHHHHH
T ss_pred             cccccccccCccccCHHHHcCCCCCCCccch-hhhHHHHHHHHHCCCCCCC-------CCCHHHHHHHHHH
Confidence             111245799999999988654    67899 9999999999  6778863       3444555555544

>2po1_A Probable exosome complex exonuclease 1; RNAse PH, hydrolase/hydrolase/RNA complex; 1.94A {Pyrococcus abyssi} PDB: 2po0_A* 2pnz_A 2po2_A*

Probab=99.97  E-value=9.2e-31  Score=248.47  Aligned_cols=215  Identities=29%  Similarity=0.453  Sum_probs=196.7

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.+++|.|.....  .+. -..|.+.+++.++||++..+....++..+.+
T Consensus        24 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~gp~e~~~~~--~~~-~~~g~l~v~~~~~p~a~~~~~~~~~~~~~~~  100 (249)
T 2po1_A           24 YELRPIKMEVGVLKNANGSAYIEWGKNKIIAAVYGPRELHPKH--LQR-PDRAILRVRYNMAPFSVEERKKPGPDRRSIE  100 (249)
T ss_dssp             TCCCCEEEEECCCSSSSEEEEEEETTEEEEEEEEEEEECSSGG--GCC-SSSCEEEEEEEECGGGSSSCCCSSCCHHHHH
T ss_pred             ccccCEEEEeCCcCCCCEEEEEEECCcEEEEEEEcCcccCccc--ccC-CCceEEEEEEEeCCcccccccCCCCCHHHHH
Confidence            5799999999999999999999999999999999987754311  122 4578999999999999877665567888999


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCChHHH
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEV  273 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~~E~  273 (477)
                      +++.+++.+++++.++.||++.|+|.++||++||+.+.++++|+++||.||||||+++++++|+++.++.+++||+..|+
T Consensus       101 ~s~li~r~l~~~i~l~~~p~~~i~I~~~VL~~dG~~~~aai~aa~~AL~da~iP~~~~v~avs~g~~~~~~l~Dp~~~Ee  180 (249)
T 2po1_A          101 ISKVIKGALEPALILEMFPRTAIDVFIEVLQADAGTRVAGITAASLALADAGIPMRDLVAACAAGKIEGEIVLDLNKEED  180 (249)
T ss_dssp             HHHHHHHHHGGGBCGGGSTTEEEEEEEEEEECCSCHHHHHHHHHHHHHHHTTCCBSSCCEEEEEEEETTEEEESCCHHHH
T ss_pred             HHHHHHHHHHhhccHHHCCCCEEEEEEEEEecCCCHHHHHHHHHHHHHHhcCCCccCceEEEEEEEECCEEEecCcHHHh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhcc
Q psy6508         274 AYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHV  342 (477)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~  342 (477)
                      ..          +.+.++++++++.++|+.++..|.++.+++.++++.|.++|+.+... +++.+.++.
T Consensus       181 ~~----------~~~~l~va~~~~~~~i~~~~~~g~~~~~~l~~~l~~A~~~~~~i~~~-~~~~l~~~~  238 (249)
T 2po1_A          181 NY----------GEADVPVAIMPLKNDITLLQMDGYLTKDEFIEAVKLAIKGAKAVYQK-QREALKEKY  238 (249)
T ss_dssp             HT----------CSEEEEEEEEGGGTEEEEECCEECCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHH
T ss_pred             cc----------CCceEEEEEECCCCCEEEEEEEcccCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHH
Confidence            84          58899999989899999999999999999999999999999999999 999887653

>2nn6_B Exosome complex exonuclease RRP41; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1

Probab=99.97  E-value=1.5e-30  Score=247.02  Aligned_cols=225  Identities=28%  Similarity=0.428  Sum_probs=198.8

Q ss_pred             CCceeecc---CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccc
Q psy6508         106 PQNILIKN---NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIR  182 (477)
Q Consensus       106 p~NIll~~---~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r  182 (477)
                      .+++-.|.   +++|.+.+.+|...+++||++++.|+|++.|.+++|.|..... ..+. -..|.+.+++.++||++..+
T Consensus        13 ~~~~R~DGR~~~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~g~~~~~~~~-~~~~-~~~g~l~~~~~~~p~a~~~~   90 (249)
T 2nn6_B           13 DQGYRVDGRRAGELRKIQARMGVFAQADGSAYIEQGNTKALAVVYGPHEIRGSR-ARAL-PDRALVNCQYSSATFSTGER   90 (249)
T ss_dssp             BTTBCSSSSCTTSCCCEEEEESCSSSSSEEEEEEESSCEEEEEEEEEEECCSSS-CCCC-CSSCCEEEEEEECTTTSSSC
T ss_pred             cCCcCCCCCCcCCcCCeEEEeCCCCCCCeEEEEEECCeEEEEEEEccCCccccc-cccC-CCcEEEEEEEEcCCCccccc
Confidence            34454543   5899999999999999999999999999999999876653320 0012 45689999999999998665


Q ss_pred             c-CCCCCcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeC
Q psy6508         183 T-GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRG  261 (477)
Q Consensus       183 ~-~~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~  261 (477)
                      . ...++..+.++++.+++++++.+.++.||++.|+|.++||++||+.+.++++|+++||.||||||+++++++|+++.+
T Consensus        91 ~~~~~~~~~~~~~~~ll~r~l~~~i~~~~~p~~~I~i~~~VL~~dG~~~~A~i~aa~~AL~da~iPl~~~v~avs~g~~~  170 (249)
T 2nn6_B           91 KRRPHGDRKSCEMGLQLRQTFEAAILTQLHPRSQIDIYVQVLQADGGTYAACVNAATLAVLDAGIPMRDFVCACSAGFVD  170 (249)
T ss_dssp             CCTTTSTHHHHHHHHHHHHHHHHTTCGGGCTTEEEEEEEEEEECCSCHHHHHHHHHHHHHHHTCCCCSSCCEEEEEEEET
T ss_pred             ccCCCCCHhHHHHHHHHHHHHHHhcCHHHCCCcEEEEEEEEEeCCCCHHHHHHHHHHHHHHhcCCcccCCeeeEEEEEEC
Confidence            5 346778899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhc
Q psy6508         262 GLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDH  341 (477)
Q Consensus       262 ~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~  341 (477)
                      +.+++||+..|+..          +.+.++++++++.++|+.+++.|.++.+++.++++.|.++|+++.+. +++.+.++
T Consensus       171 ~~~l~Dp~~~Ee~~----------~~~~~~v~~~~~~~~i~~lq~~g~~~~~~l~~~l~~A~~~~~~i~~~-~~~~l~~~  239 (249)
T 2nn6_B          171 GTALADLSHVEEAA----------GGPQLALALLPASGQIALLEMDARLHEDHLERVLEAAAQAARDVHTL-LDRVVRQH  239 (249)
T ss_dssp             TEEEESCCHHHHTS----------SCCCEEEEEETTTTEEEEEEECSCCBTTSHHHHHHHHHHHHHHHHHH-HHHHHHHH
T ss_pred             CeEEECCChHHhcc----------CCcEEEEEEECCCCCEEEEEEECCcCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHH
Confidence            99999999999984          47889999988889999999999999999999999999999999999 99998776


Q ss_pred             cc
Q psy6508         342 VT  343 (477)
Q Consensus       342 ~~  343 (477)
                      ..
T Consensus       240 ~~  241 (249)
T 2nn6_B          240 VR  241 (249)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.97  E-value=4.6e-32  Score=265.90  Aligned_cols=171  Identities=18%  Similarity=0.224  Sum_probs=132.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER----YVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      +|+.||||+++...   .....+..|+..+.+++||||+++++++..++    .+|||||||+||+|.++++.. ++++.
T Consensus        25 ~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~-~l~~~  100 (303)
T 3hmm_A           25 RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVE  100 (303)
T ss_dssp             TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHH
T ss_pred             CCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC-CCCHH
Confidence            57899999986542   12222345666677899999999999988653    689999999999999999874 69999


Q ss_pred             HHHHHHHHHHHHHHHHHhC--------CcEEccCCCCceeeccCcceeecccccceecccCCcc--cccCCeEEEecccc
Q psy6508          79 QCQQFVRQLVLALKFLREN--------NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY--IEQGNTKVICSVFE  148 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~--------givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~--~~~g~t~v~~~~y~  148 (477)
                      .+.+++.|++.||.|||++        ||+||||||+|||++.+. .+.++|||+++..+....  .....+.++|+.|+
T Consensus       101 ~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ym  179 (303)
T 3hmm_A          101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM  179 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEESCC-----CCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCCCCccccCCCCceeeeccccccccccc
Confidence            9999999999999999987        999999999999998653 344459999876543322  11223568999999


Q ss_pred             ccccCCCC---------CcccccCcceEEEEEE--eeecccc
Q psy6508         149 PREIPSSK---------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |||++.+.         .++|+ ||+|+++|||  +..||..
T Consensus       180 APE~l~~~~~~~~~~~~~k~DV-wS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          180 APEVLDDSINMKHFESFKRADI-YAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             CHHHHTTCSCTTCHHHHHHHHH-HHHHHHHHHHHHTBCBTTB
T ss_pred             CHHHhcccccccCCccChhHhh-hhHHHHHHHHHHCCCCCCc
Confidence            99998653         46899 9999999999  4455543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=5e-32  Score=287.64  Aligned_cols=172  Identities=24%  Similarity=0.398  Sum_probs=148.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+|+.||||++.+..  ....+.+.+|+.+|+.|+||||++++++|.+++.+|||||||+||+|.+++.. .+.+++..+
T Consensus       180 ~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~  257 (573)
T 3uto_A          180 ATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA  257 (573)
T ss_dssp             TTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHH
T ss_pred             CCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHH
Confidence            579999999997653  34456789999999999999999999999999999999999999999999964 357999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.++.||+.||+|||++||+||||||+|||++.+ ...+.++|||++........   ..+.+||+.|+|||++.+.   
T Consensus       258 ~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~---~~~~~GT~~y~APEv~~~~~y~  334 (573)
T 3uto_A          258 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS---VKVTTGTAEFAAPEVAEGKPVG  334 (573)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSE---EEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCc---eeeeEECccccCHHHhCCCCCC
Confidence            9999999999999999999999999999999753 23455569999987654322   2356789999999999877   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  |..||.+
T Consensus       335 ~~~Di-WSlGvilyeml~G~~Pf~~  358 (573)
T 3uto_A          335 YYTDM-WSVGVLSYILLSGLSPFGG  358 (573)
T ss_dssp             HHHHH-HHHHHHHHHHHHSCCSSCC
T ss_pred             cHHHH-HHHHHHHHHHHHCCCCCCC
Confidence            67899 9999999999  7889875

>2je6_B RRP41, exosome complex exonuclease 1; nuclease, hydrolase, exonuclease, phosphorolytic, exoribonuclease, RNA degradation; HET: 1PE; 1.6A {Sulfolobus solfataricus} SCOP: d.14.1.4 d.101.1.1 PDB: 2jea_B* 2jeb_B* 2br2_B 2c37_B* 2c38_B* 2c39_B* 3l7z_B

Probab=99.97  E-value=1.5e-29  Score=240.34  Aligned_cols=216  Identities=26%  Similarity=0.426  Sum_probs=196.7

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|+..+++||++++.|+|++.|.+++|.|.....  .+- -..|.+.+++.+.||+...++...++..+.+
T Consensus        28 ~e~R~i~i~~g~~~~a~GSa~v~~G~T~Vl~~V~g~~e~~~~~--~~~-~~~g~l~v~~~~~p~a~~~~~~g~~~~~e~~  104 (250)
T 2je6_B           28 DELRSIKIELGVLKNADGSAIFEMGNTKAIAAVYGPKEMHPRH--LSL-PDRAVLRVRYHMTPFSTDERKNPAPSRREIE  104 (250)
T ss_dssp             TCCCCEEEEESCCSSSSEEEEEEETTEEEEEEEEEEEECSSGG--GSC-SSSCEEEEEEEECTTSSSSCCCSSCCHHHHH
T ss_pred             cCcCCeEEEeCCCCCCCeEEEEEECCcEEEEEEEccccccccc--ccC-CCcEEEEEEEEeCCCccCCccCCCCChhHHH
Confidence            5799999999999999999999999999999999877754311  122 4578999999999999877665567788999


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCChHHH
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEV  273 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~~E~  273 (477)
                      +++++++.+++.+.++.||++.|+|.++||++||+.+.++++|+++||.||||||+++++++|+++.++.+++||+..|+
T Consensus       105 ~s~li~r~l~~~i~~~~~p~~~i~I~~~VL~~DG~~~~aai~aa~~AL~~a~iP~~~~v~avsvg~~~~~~l~Dpt~~Ee  184 (250)
T 2je6_B          105 LSKVIREALESAVLVELFPRTAIDVFTEILQADAGSRLVSLMAASLALADAGIPMRDLIAGVAVGKADGVIILDLNETEA  184 (250)
T ss_dssp             HHHHHHHHHHTTBCGGGSTTEEEEEEEEEEECSSCHHHHHHHHHHHHHHHTTCCBSSCCEEEEEEEETTEEEESCCHHHH
T ss_pred             HHHHHHHHHHhhcCHhhCCCcEEEEEEEEEeCCCCHHHHHHHHHHHHHHhcCCCccCceEEEEEEEECCEEEeCCCHHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhccc
Q psy6508         274 AYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ..          +.+.++++++++.++|+.++..|.++.+++.++++.|.++|+.+.+. +++.+.+...
T Consensus       185 ~~----------~~~~l~va~~~~~~~i~~v~~~g~~~~~~l~~~l~~A~~~~~~i~~~-~~~~l~~~~~  243 (250)
T 2je6_B          185 MW----------GEADMPIAMMPSLNQVTLFQLNGSMTPDEFRQAFDLAVKGINIIYNL-EREALKSKYV  243 (250)
T ss_dssp             HH----------SSEEEEEEEEGGGTEEEEEEEEECBCHHHHHHHHHHHHHHHHHHHHH-HHHHHHGGGC
T ss_pred             hc----------CCceEEEEEECCCCCEEEEEEEcccCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHh
Confidence            85          47899999988889999999999999999999999999999999999 9999887644

>2nn6_D Exosome complex exonuclease RRP46; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1

Probab=99.97  E-value=1.5e-29  Score=238.41  Aligned_cols=206  Identities=24%  Similarity=0.326  Sum_probs=183.5

Q ss_pred             cceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHHH
Q psy6508         115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKEL  194 (477)
Q Consensus       115 ~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l  194 (477)
                      ++|.+.+.+|...+++||++++.|+|++.|.+|+|.|.....   +. ...|.+.++  +.||.+      .++.++.++
T Consensus        29 e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~g~~~~~~~~---~~-~~~g~l~~~--~~p~~g------~~~~~e~~~   96 (237)
T 2nn6_D           29 SLRHFACEQNLLSRPDGSASFLQGDTSVLAGVYGPAEVKVSK---EI-FNKATLEVI--LRPKIG------LPGVAEKSR   96 (237)
T ss_dssp             CCCCEEEEESCCSSSSEEEEEEETTEEEEEEEEEEEECC----------CCEEEEEE--EECSSS------CCCHHHHHH
T ss_pred             cccceEEEeCCCCCCCEEEEEEECCcEEEEEEeCCCcccccc---cC-CCcEEEEEE--ecCCCC------CCCccHHHH
Confidence            789999999999999999999999999999999998854322   22 345666555  468753      456788999


Q ss_pred             HHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEee-CCeEEeCCChHHH
Q psy6508         195 GNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALR-GGLTFIDPVEEEV  273 (477)
Q Consensus       195 ~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~-~~~~~~Dp~~~E~  273 (477)
                      ++++++.+++.+..+.||++.|+|.++||++||+.+.+++||+++||.||||||+++++|+|+++. ++.+++||+..||
T Consensus        97 ~~li~r~l~~~i~~~~~p~~~I~I~~~VL~~dG~~~~aai~aa~~AL~da~iP~~~~v~avs~g~~~~~~~llDp~~~Ee  176 (237)
T 2nn6_D           97 ERLIRNTCEAVVLGTLHPRTSITVVLQVVSDAGSLLACCLNAACMALVDAGVPMRALFCGVACALDSDGTLVLDPTSKQE  176 (237)
T ss_dssp             HHHHHHHHHHHCGGGCSSSEEEEEEEEEEECSSCHHHHHHHHHHHHHHHTTCCCSSCEEEEEEEECTTCCEEESCCHHHH
T ss_pred             HHHHHHHHHHHhchhcCCceEEEEEEEEEECCCcHHHHHHHHHHHHHHHcCCCcccCeeeEEEEEecCCcEEeCCCHHHH
Confidence            999999999999999999999999999999999999999999999999999999999999999998 7899999999999


Q ss_pred             hhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhccc
Q psy6508         274 AYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ..          ..+.+++++.+..++|+.++..|.++.+++.++++.|.++|+++.+. +++.+.+++.
T Consensus       177 ~~----------~~~~~~v~~~~~~~~i~~lq~~g~~~~~~l~~~l~~A~~~~~~i~~~-~~~~l~~~~~  235 (237)
T 2nn6_D          177 KE----------ARAVLTFALDSVERKLLMSSTKGLYSDTELQQCLAAAQAASQHVFRF-YRESLQRRYS  235 (237)
T ss_dssp             HH----------CSEEEEEEEETTTCCCCEEEEEESCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHTC
T ss_pred             hc----------cCCceEEEEcCCCCCEEEEEEeCCcCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHhcc
Confidence            85          37899999999888999999999999999999999999999999999 9999987653

>2wp8_B Exosome complex component SKI6; nucleus, hydrolase, RNA-binding, exonucle binding, mitochondrion, rRNA processing; 3.00A {Saccharomyces cerevisiae}

Probab=99.97  E-value=2.8e-29  Score=237.91  Aligned_cols=215  Identities=24%  Similarity=0.315  Sum_probs=184.5

Q ss_pred             Ccceeecccccceecc-cCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC--CCCCcc
Q psy6508         114 NTLKLAGLKQGVSEKA-KGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG--WLRDSE  190 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~-~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~--~~~~~~  190 (477)
                      +++|.+.+.+|...++ +||++++.|+|++.|.+++|.+.....  .+. -..|.+.+++.+.||+...+..  .+++..
T Consensus        20 ~e~R~i~i~~g~l~~aa~GSa~v~~G~T~Vl~~V~~~~~~~~~~--~~~-~~~g~l~v~~~~~p~a~~~~~~r~g~~~~~   96 (246)
T 2wp8_B           20 NELRRFESSINTHPHAADGSSYMEQGNNKIITLVKGPKEPRLKS--QMD-TSKALLNVSVNINKFSKFERSKSSHKNERR   96 (246)
T ss_dssp             TCCCCEEEEECSCTTTCSEEEEEEETTEEEEEEEEEEEC--------CC-SSSEEEEEEEEEC--------------CHH
T ss_pred             CCccCeEEEeCCCCCCCCceEEEEECCeEEEEEEEecCCccccc--ccC-CCcEEEEEEEEeCCcccccccccCCCCChh
Confidence            5899999999999998 999999999999999999887743211  022 4679999999999999776543  355688


Q ss_pred             hHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCCh
Q psy6508         191 EKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVE  270 (477)
Q Consensus       191 ~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~  270 (477)
                      +.++++++++.+++.+.++.||++.|++.++||++||+.+.+++||+++||.||||||+++++++++++.++.+++||+.
T Consensus        97 ~~~~s~li~r~l~~~i~~~~~p~~~I~i~~~VL~~dG~~~~aai~aa~~AL~~a~iP~~~~v~avs~g~~~~~~l~Dp~~  176 (246)
T 2wp8_B           97 VLEIQTSLVRMFEKNVMLNIYPRTVIDIEIHVLEQDGGIMGSLINGITLALIDAGISMFDYISGISVGLYDTTPLLDTNS  176 (246)
T ss_dssp             HHHHHHHHHHHHHHHBCTTTSCSEEEEEEEEEEECCSCHHHHHHHHHHHHHHHHTCCBSSCEEEEEEEEETTEEESSCCH
T ss_pred             HHHHHHHHHHHHHHhhhHHHCCCeEEEEEEEEEECCCCHHHHHHHHHHHHHHHcCCcccCceeEEEEEEECCEEEECCCc
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhccc
Q psy6508         271 EEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       271 ~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      .|+ ..          .+.+++++.++.++|+.++..|.++.+++.++++.|.++|+.+... +++.+.+...
T Consensus       177 ~Ee-~~----------~~~l~v~~~~~~~~i~~i~~~g~~~~~~l~~~l~~A~~~~~~i~~~-~~~~l~~~~~  237 (246)
T 2wp8_B          177 LEE-NA----------MSTVTLGVVGKSEKLSLLLVEDKIPLDRLENVLAIGIAGAHRVRDL-MDEELRKHAQ  237 (246)
T ss_dssp             HHH-HH----------SEEEEEEEETTSSCEEEEEECSCEEHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHH
T ss_pred             hhh-cc----------CceEEEEEeCCCCCEEEEEecCCcCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHH
Confidence            999 64          7889999888899999999999999999999999999999999999 9999877643

>2nn6_F MTR3, exosome component 6; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1

Probab=99.96  E-value=6.6e-30  Score=245.75  Aligned_cols=214  Identities=34%  Similarity=0.485  Sum_probs=194.9

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCccc------------ccCcceEEEEEEeeecccccc
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLE------------YQRSKGELYVEFKFAPFASQI  181 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~D------------i~~s~G~il~e~~~~Pf~~~~  181 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.+++|.+.....   |            . -..|.+.+++.+.||++..
T Consensus        34 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~~~~~---~~~~~~~~~~~~~~-~~~g~l~v~~~~~p~a~~~  109 (272)
T 2nn6_F           34 TRLRPVYARAGLLSQAKGSAYLEAGGTKVLCAVSGPRQAEGGE---RGGGPAGAGGEAPA-ALRGRLLCDFRRAPFAGRR  109 (272)
T ss_dssp             SCCCCCCCCCSCCSSSSEEECCCSSSCEEEEEEEEEECC-----------------------CBCEEEEEEEECTTSSSS
T ss_pred             cccCCeEEEeCCCCCCCeEEEEEeCCeEEEEEEECCCcccccc---cccccccccccccC-CCceEEEEEEEecCCCcCC
Confidence            5789999999999999999999999999999999988765432   1            2 3468999999999999888


Q ss_pred             ccCCCCCcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEe--
Q psy6508         182 RTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLAL--  259 (477)
Q Consensus       182 r~~~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~--  259 (477)
                      ++...++..+.++++++++.+++.+.++.||++.|+|.++||+.||+.+.+++||+++||.||||||+++++|+++++  
T Consensus       110 ~~~~~~~~~e~~~s~li~r~l~~~i~~~~~p~~~I~I~~~VL~~DG~~~~aai~aa~~AL~da~iP~~~~v~avsvg~~~  189 (272)
T 2nn6_F          110 RRAPPGGCEERELALALQEALEPAVRLGRYPRAQLEVSALLLEDGGSALAAALTAAALALADAGVEMYDLVVGCGLSLAP  189 (272)
T ss_dssp             CCCSCCHHHHHHHHHHHHHHHTTTBCSTTSBTCEEEEEEEEEECCSSHHHHHHHHHHHHHHHHCCCBSSCCEEEECCCCS
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHhccHHHCCceEEEEEEEEEeCCCCHHHHHHHHHHHHHHHcCCcccCcEEEEEEEEee
Confidence            777778889999999999999999999999999999999999999999999999999999999999999999999999  


Q ss_pred             -eCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecH-HHHHHHHHHHHhcccchhhHHHHhH
Q psy6508         260 -RGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQ-ERLADHIEQLIGCCESLCTDRVQKL  337 (477)
Q Consensus       260 -~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~-~~~~~~l~~~~~~~~~i~~~~i~~~  337 (477)
                       .++.+++||+..|+..          +.+.++++++++.++|+.++..|.++. +++.++++.|.++|+.+... +++.
T Consensus       190 ~~~~~~llDpt~~Ee~~----------~~~~l~va~~~~~~~I~~i~~~g~~~~~~~l~~~l~~A~~~~~~i~~~-~~~~  258 (272)
T 2nn6_F          190 GPAPTWLLDPTRLEEER----------AAAGLTVALMPVLNQVAGLLGSGEGGLTESWAEAVRLGLEGCQRLYPV-LQQS  258 (272)
T ss_dssp             CSSCCCCSSCCTTTGGG----------CSSEEEEEEETTTTEEEEEEEECCSSCTTTTHHHHHHHHHHHHHHHHH-HHHH
T ss_pred             ccCCeEEeCCCHHHhcc----------CCceEEEEEeCCCCCEEEEEEecCCCHHHHHHHHHHHHHHHHHHHHHH-HHHH
Confidence             8899999999999984          478999999999999999999999999 99999999999999999999 9998


Q ss_pred             hhhcc
Q psy6508         338 VSDHV  342 (477)
Q Consensus       338 l~~~~  342 (477)
                      +.+..
T Consensus       259 l~~~~  263 (272)
T 2nn6_F          259 LVRAA  263 (272)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=3.6e-30  Score=255.42  Aligned_cols=173  Identities=24%  Similarity=0.446  Sum_probs=149.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++.+...+....+++.+|+.+|+.++||||+++++++..++..|+||||++|++|.+++...+++++..+.
T Consensus        38 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~  117 (328)
T 3fe3_A           38 LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEAR  117 (328)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHH
T ss_pred             CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHH
Confidence            57899999999887777777788999999999999999999999999999999999999999999999888899999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+........   ..+..+++.|+|||...+.    .
T Consensus       118 ~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~  193 (328)
T 3fe3_A          118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADM-NIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPELFQGKKYDGP  193 (328)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHHHHHTCCCCSH
T ss_pred             HHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCC-CEEEeeccCceecCCCCc---cccccCCcceeCcccccCCCcCCc
Confidence            9999999999999999999999999999997653 344459998865433221   1345678899999988655    4


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||.+
T Consensus       194 ~~Di-wslG~il~ell~g~~pf~~  216 (328)
T 3fe3_A          194 EVDV-WSLGVILYTLVSGSLPFDG  216 (328)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             hhhh-hhhHHHHHHHHhCCCCCCC
Confidence            6899 9999999999  7788875

>3krn_A Protein C14A4.5, confirmed by transcript evidence; RNAse PH domain, homodimer, exosome, cell-death-related DNAS hydrolase; 3.92A {Caenorhabditis elegans}

Probab=99.96  E-value=1.4e-30  Score=242.49  Aligned_cols=205  Identities=20%  Similarity=0.238  Sum_probs=163.0

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|...+++||++++.|+|++.+.+++|.|.....   +. ...|.+  ++.|.||.+.      +...  +
T Consensus         3 ~e~R~i~ie~g~l~~A~GSa~v~~G~T~Vl~~V~~~~e~~~~~---~~-~~~~~l--~v~~~p~~G~------~~~~--e   68 (222)
T 3krn_A            3 GRLREMRCELSFLKNADGSACFSQGATCIWASCSGPGDVHASK---AS-DEAMTL--DISYRANCGD------NKFN--V   68 (222)
T ss_dssp             CCCCCBCCBSCCC----CCCBCCBTTCEEECCCCSSCC-------------------CCCSSCCCC--------CCS--S
T ss_pred             CcccceEEEECCCCCCCeEEEEEECCcEEEEEEECCCCCcccc---cC-CceEEE--EEEEcCCCCC------CCHH--H
Confidence            5789999999999999999999999999999999988765432   11 233444  3455687642      2222  8


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeCCChHHH
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEEV  273 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~Dp~~~E~  273 (477)
                      +++.+++.+++.+.++.||++.|+|.++||+.||+.+.+++||+++||+||||||+++++|+++++.+|.+++||+..|+
T Consensus        69 ~~~li~r~l~~~i~~~~~p~~~I~I~~~VL~~DG~~~~aai~aa~~AL~dagiP~~~~v~avsvg~~~g~~llDpt~~Ee  148 (222)
T 3krn_A           69 LNNIIHSTLSNAINLELFPHTTISVTVHGIQDDGSMGAVAINGACFALLDNGMPFETVFCGVLIVRVKDELIIDPTAKQE  148 (222)
T ss_dssp             CTTHHHHC--CCSCC-----CCCCCCCEEEECCSCHHHHHHHGGGTTTTTTTCCTTSCCCCCCCEECSSSEESSCCTTTT
T ss_pred             HHHHHHHHHHHhccHHhCCCcEEEEEEEEEECCCChHHHHHHHHHHHHHHCCCCccCcEEEEEEEEECCEEEeCCCHHHH
Confidence            89999999999999999999999999999999999999999999999999999999999999999999999999999998


Q ss_pred             hhhccCCCCCCCCCceEEEEE---ccCCCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHhHhhhccc
Q psy6508         274 AYCQSLSSSEDDDSGVITLSY---MSVIQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~a~---~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      .          .+.+.+++++   +++.++|+.++.+|.++.+++.++++.|.++|+.+.+. +++.+.++..
T Consensus       149 ~----------~~~~~l~va~~~~~~~~~~i~~vq~~g~~~~~~l~~~l~~a~~~~~~i~~~-~~~~l~~~~~  210 (222)
T 3krn_A          149 A----------ASTGRVLFSVCKGSDGHPEVCAMDAIGHWDFIQLEAAWSLAQPSASAIFDF-YKTVMKRKLS  210 (222)
T ss_dssp             T----------SCC-CCCCEECCCSSSSCCEEEECCBSSCTTHHHHTHHHHTTHHHHHHHHH-HHHHHHHHHH
T ss_pred             h----------ccCccEEEEEEccCCCCCCEEEEEEeCCcCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHhc
Confidence            7          3578899998   77789999999999999999999999999999999999 9999887654

>1oys_A Ribonuclease PH; transferase, tRNA processing; 2.40A {Bacillus subtilis} SCOP: d.14.1.4 d.101.1.1 PDB: 1oyp_A 1oyr_A

Probab=99.96  E-value=2.6e-28  Score=231.16  Aligned_cols=214  Identities=21%  Similarity=0.232  Sum_probs=173.4

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC-----CCCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-----WLRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-----~~~~  188 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.++++++.....   +- -..|.+.+++.+.||++..+..     ..++
T Consensus         9 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~~---~~-~~~g~l~~~~~~~p~a~~~~~~Re~~~G~~~   84 (245)
T 1oys_A            9 DELRPITFDLDFISHPEGSVLITAGNTKVICNASVEDRVPPFL---RG-GGKGWITAEYSMLPQATNQQTIQESSKGKIS   84 (245)
T ss_dssp             TCCCCEEEECC-----CCCEEEEETTEEEEEEEEEESCCCGGG---TT-SCCCEEEEEEEC-------------------
T ss_pred             CCcCCeEEEeCCCCCCCEEEEEEECCeEEEEEEEeccccCCcc---CC-CCceEEEEEEEeCCCcCcccccccccCCCCc
Confidence            5789999999999999999999999999999999988754211   11 4568999999999999776532     2467


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCC-----------CCCCceEEEEEE
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAA-----------IPMYDLVTSSTL  257 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dag-----------i~m~~~v~a~s~  257 (477)
                      ..+.++++.+++.+++.+.++.+|++.+.|.++||++||+.+.++++|+++||.|||           +||+++++++|+
T Consensus        85 ~~~~eis~li~r~l~~~i~~~~l~~~~i~i~~~VL~~DG~~~~aai~aa~~AL~~a~~~~~~~~~~~~ipl~~~v~avs~  164 (245)
T 1oys_A           85 GRTMEIQRLIGRALRAVVDLEKLGERTIWIDCDVIQADGGTRTASITGAFLAMAIAIGKLIKAGTIKTNPITDFLAAISV  164 (245)
T ss_dssp             CHHHHHHHHHHHHHHHTBCHHHHCSCEEEEEEEEEECSSCHHHHHHHHHHHHHHHHHHHHHHTTSSSSCCBCSCEEEEEE
T ss_pred             hHHHHHHHHHHHHHHHhcCHhHCCCEEEEEEEEEEeCCCCHHHHHHHHHHHHHHhccchhcccCcccccCCCCceeEEEE
Confidence            889999999999999999999999999999999999999999999999999999999           999999999999


Q ss_pred             EeeCCeEE-eCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe---eecHHHHHHHHHHHHhcccchhhHH
Q psy6508         258 ALRGGLTF-IDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG---TIQQERLADHIEQLIGCCESLCTDR  333 (477)
Q Consensus       258 ~~~~~~~~-~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g---~~~~~~~~~~l~~~~~~~~~i~~~~  333 (477)
                      ++.+|.++ +||+..|+...          .+.+++++ ++.++|+.++..|   .++.+++.++++.|.++|+++.+. 
T Consensus       165 g~~~g~~vl~Dp~~~Ee~~~----------~~~~~v~~-~~~g~i~~iq~~g~~~~~~~~~l~~~l~~A~~~~~~i~~~-  232 (245)
T 1oys_A          165 GIDKEQGILLDLNYEEDSSA----------EVDMNVIM-TGSGRFVELQGTGEEATFSREDLNGLLGLAEKGIQELIDK-  232 (245)
T ss_dssp             EEETTTEEEESCCHHHHHHE----------EEEEEEEE-ETTSCEEEEEEEESSCCCCHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             EEECCEEEEecCCHHHHhcC----------CCcEEEEE-cCCCcEEEEEEeCCCCCcCHHHHHHHHHHHHHHHHHHHHH-
Confidence            99998888 99999999853          78899986 6678899999986   699999999999999999999999 


Q ss_pred             HHhHhhhccc
Q psy6508         334 VQKLVSDHVT  343 (477)
Q Consensus       334 i~~~l~~~~~  343 (477)
                      +++.+.++.+
T Consensus       233 ~~~~l~~~~~  242 (245)
T 1oys_A          233 QKEVLGDSLP  242 (245)
T ss_dssp             HHHHC-----
T ss_pred             HHHHHhhhhh
Confidence            9999887654

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=1.7e-29  Score=253.98  Aligned_cols=175  Identities=21%  Similarity=0.352  Sum_probs=151.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|+++.........+.+.+|+.++++++||||+++++++.+++..|+||||++|++|.+++...+.+++..+.
T Consensus        52 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~  131 (362)
T 2bdw_A           52 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS  131 (362)
T ss_dssp             TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHH
T ss_pred             CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHH
Confidence            47899999999887777777788999999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.||.|||++||+||||||+|||++.+  ...+.++|||.+.......   ...+..+++.|+|||+..+.   
T Consensus       132 ~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~  208 (362)
T 2bdw_A          132 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYS  208 (362)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCC
Confidence            999999999999999999999999999999753  3345566999986554322   12245678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ ||+|+++|++  +..||.+.
T Consensus       209 ~~~Di-wslG~il~~ll~g~~Pf~~~  233 (362)
T 2bdw_A          209 KPVDI-WACGVILYILLVGYPPFWDE  233 (362)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             chhhH-HHHHHHHHHHHHCCCCCCCC
Confidence            67899 9999999999  77888753

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=1.8e-29  Score=251.24  Aligned_cols=174  Identities=16%  Similarity=0.283  Sum_probs=147.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++++... .....+.+.+|+.+|+.++||||+++++++...+.+|+||||++||+|.+++.+.+.+++..+
T Consensus        28 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~  107 (337)
T 1o6l_A           28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA  107 (337)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHH
T ss_pred             CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence            4789999999976532 123456788999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.||+.||.|||++||+||||||+|||++.++ .+.++|||++.......  ....+..+++.|+|||+..+.   .
T Consensus       108 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~  184 (337)
T 1o6l_A          108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGR  184 (337)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred             HHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCC-CEEEeeccchhhcccCC--CcccccccChhhCChhhhcCCCCCc
Confidence            99999999999999999999999999999997643 34445999886432211  122456889999999998765   7


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||  +..||.+
T Consensus       185 ~~Di-wslG~il~ell~g~~Pf~~  207 (337)
T 1o6l_A          185 AVDW-WGLGVVMYEMMCGRLPFYN  207 (337)
T ss_dssp             THHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             hhhc-ccchhHHHHHhcCCCCCCC
Confidence            8999 9999999999  7788865

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=1.2e-29  Score=254.89  Aligned_cols=175  Identities=25%  Similarity=0.399  Sum_probs=149.4

Q ss_pred             CCCcEEEEEEcccCCCCh----hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSE----NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||+|++++.....    ...+.+.+|+.+|++++||||+++++++.+.+.+|+||||++|++|.+++...+.+++
T Consensus        35 ~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~  114 (361)
T 2yab_A           35 STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE  114 (361)
T ss_dssp             TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBH
T ss_pred             CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCH
Confidence            478999999998765432    1356789999999999999999999999999999999999999999999988888999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcc---eeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL---KLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~---rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ..+..++.|++.||.|||++||+||||||+|||++.++.   .+.++|||.+.......   ...+..+++.|+|||+..
T Consensus       115 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~  191 (361)
T 2yab_A          115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVN  191 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHc
Confidence            999999999999999999999999999999999976532   45566999987654322   123456889999999987


Q ss_pred             CC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      +.   .++|+ ||+|+++|++  +..||.+.
T Consensus       192 ~~~~~~~~Di-wslGvil~~ll~g~~Pf~~~  221 (361)
T 2yab_A          192 YEPLGLEADM-WSIGVITYILLSGASPFLGD  221 (361)
T ss_dssp             TCCCCTHHHH-HHHHHHHHHHHHSCCSSCCS
T ss_pred             CCCCCccccH-HHHHHHHHHHHhCCCCCCCC
Confidence            65   67899 9999999999  77888753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.96  E-value=1.9e-29  Score=260.25  Aligned_cols=175  Identities=21%  Similarity=0.297  Sum_probs=151.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+++..|+||||++||+|.+++...+.+++..+.
T Consensus        34 ~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~  113 (444)
T 3soa_A           34 LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS  113 (444)
T ss_dssp             TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHH
T ss_pred             CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHH
Confidence            47899999999887766666778999999999999999999999999999999999999999999999988899999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.||+.||.|||++||+||||||+|||++.  +...+.++|||.+....+...  ...+..+++.|+|||++.+.   
T Consensus       114 ~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~  191 (444)
T 3soa_A          114 HCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYLSPEVLRKDPYG  191 (444)
T ss_dssp             HHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccCCHHHhcCCCCC
Confidence            99999999999999999999999999999974  234555669999866544321  12345688999999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       192 ~~~DI-wSlGvilyell~G~~Pf~~  215 (444)
T 3soa_A          192 KPVDL-WACGVILYILLVGYPPFWD  215 (444)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             Ccccc-HHHHHHHHHHHhCCCCCCC
Confidence            77899 9999999999  7788864

>3dd6_A Ribonuclease PH; exoribonuclease, tRNA maturation, RNAse PH., transferase; 1.70A {Bacillus anthracis}

Probab=99.96  E-value=6.7e-28  Score=228.57  Aligned_cols=213  Identities=23%  Similarity=0.255  Sum_probs=189.0

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC-----CCCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-----WLRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-----~~~~  188 (477)
                      +++|.+.+.+|..++++||++++.|+|++.|.++++.+....   .+- -.-|.+.+++.+.||++..+..     ..++
T Consensus        19 ~e~R~i~i~~g~~~~A~GSa~v~~G~T~Vl~~V~~~~~~p~~---~~~-~~~g~l~v~~~~~P~a~~~~~~Re~~~g~~~   94 (255)
T 3dd6_A           19 TELRHIHIHTNYLKHPEGSVLIEVGDTKVICSATIEERVPPF---MRG-EGKGWVTAEYAMIPRATEQRTIRESSKGKVT   94 (255)
T ss_dssp             TCCCCEEEEESCSSSSSEEEEEEETTEEEEEEEEEESCCCGG---GTT-SSCCEEEEEEEECTTSSSSCCCCCCC-CCCC
T ss_pred             CCCCCEEEEECCCCCCCeEEEEEECCeEEEEEEEecCCCCCC---CCC-CCceEEEEEEEECCCcccccccccccCCCCC
Confidence            588999999999999999999999999999999988653211   122 4568999999999999876532     4567


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhC-----------CCCCCceEEEEEE
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDA-----------AIPMYDLVTSSTL  257 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~da-----------gi~m~~~v~a~s~  257 (477)
                      ..+.++++++++.+++.+.++.+|++.|+|.++||++||+.+.++++|+++||.||           ||||+++++|+|+
T Consensus        95 ~~~~eisrli~r~lr~~i~~~~l~~~~I~V~~~VL~~DG~~~~aai~aa~~AL~~a~~p~~~~g~~~~iPl~~~v~avsv  174 (255)
T 3dd6_A           95 GRTMEIQRLIGRALRAVVDLEALGERTVWIDCDVIQADGGTRTASITGAYVAMVLAFEKLLQAEKVSKIPVKDYLAATSV  174 (255)
T ss_dssp             HHHHHHHHHHHHHHHHHBCHHHHCSCEEEEEEEEEECSSCHHHHHHHHHHHHHHHHHHHHHHTTSSSSCCBSSCEEEEEE
T ss_pred             HHHHHHHHHHHHHHHHhcChhhcCCeEEEEEEEEEECCCCHHHHHHHHHHHHHHHhhhhhhhcCcccCCCccCceeEEEE
Confidence            78899999999999999999999999999999999999999999999999999999           9999999999999


Q ss_pred             EeeCCeEE-eCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe---eecHHHHHHHHHHHHhcccchhhHH
Q psy6508         258 ALRGGLTF-IDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG---TIQQERLADHIEQLIGCCESLCTDR  333 (477)
Q Consensus       258 ~~~~~~~~-~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g---~~~~~~~~~~l~~~~~~~~~i~~~~  333 (477)
                      ++.+|.++ +||+..|+..          +.+.++++ +++.++|+.++..|   .++.+++.++++.|.++|+.+.+. 
T Consensus       175 g~i~g~~vllDpt~~Ee~~----------~~~~l~Va-~~~~g~i~~vq~~g~~~~~~~~~l~~~l~~A~~~~~~i~~~-  242 (255)
T 3dd6_A          175 GIVEEQGVVLDLNYAEDSK----------ADVDMNVI-MTGKGQFVEVQGTGEEATFSRAQLNELLDAAEQGIFQLIDI-  242 (255)
T ss_dssp             EEETTTEEEESCCHHHHHT----------EEEEEEEE-EETTSCEEEEEEEESSSCCCHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             EEECCEEEEeCCCHHHHhh----------cCceEEEE-EcCCCcEEEEEecCCCCCcCHHHHHHHHHHHHHHHHHHHHH-
Confidence            99999998 9999999984          46788987 57788899999986   599999999999999999999999 


Q ss_pred             HHhHhhhcc
Q psy6508         334 VQKLVSDHV  342 (477)
Q Consensus       334 i~~~l~~~~  342 (477)
                      +++.+.+..
T Consensus       243 ~~~~l~~~~  251 (255)
T 3dd6_A          243 QKEALGDIV  251 (255)
T ss_dssp             HHHHHGGGG
T ss_pred             HHHHHHHHH
Confidence            998887653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.95  E-value=3.5e-30  Score=251.35  Aligned_cols=175  Identities=27%  Similarity=0.376  Sum_probs=143.1

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++..... .....+.+.+|+.++++++||||+++++++..++.+|+||||++|++|.+++...+++++..+
T Consensus        34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~  113 (294)
T 4eqm_A           34 ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTA  113 (294)
T ss_dssp             TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHH
T ss_pred             CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHH
Confidence            4688999999866544 345567899999999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+........ .......+++.|+|||...+.   .
T Consensus       114 ~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  191 (294)
T 4eqm_A          114 INFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDE  191 (294)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCSSSTTC--------------CCSSCCHHHHHTCCCCT
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-CEEEEeCCCccccccccc-cccCccccCccccCHhHhcCCCCCc
Confidence            99999999999999999999999999999997653 344459998865433221 222345688999999987765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||.+
T Consensus       192 ~~Di-~slG~~l~~ll~g~~pf~~  214 (294)
T 4eqm_A          192 CTDI-YSIGIVLYEMLVGEPPFNG  214 (294)
T ss_dssp             THHH-HHHHHHHHHHHHSSCSSCS
T ss_pred             hHhH-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  7788875

>3hkm_A OS03G0854200 protein; RNAse PH domain, phosphorylase, hydrolase; 1.98A {Oryza sativa japonica group}

Probab=99.95  E-value=8.7e-28  Score=226.40  Aligned_cols=207  Identities=23%  Similarity=0.295  Sum_probs=170.9

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|...+++||++++.|+|++.+.+|+|.+.....   +. ...|.+  ++.+.|+.+      .+...+.+
T Consensus        12 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~g~~~~~~~~---~~-~~~~~~--~~~~~P~~g------~~~~~~~e   79 (246)
T 3hkm_A           12 NQLRPFSCTRNPLDRAHGSARWAQGDTIVLAAVYGPKPGTRKG---EN-PEKASI--EVVWKPMTG------QIGKQEKE   79 (246)
T ss_dssp             TCCCCEEEEECCCSSSSEEEEEEETTEEEEEEECCCEECCCTT---SC-SSSCEE--EEEEECSSS------CCCTTHHH
T ss_pred             CCcCCeEEEECCCCCCCeEEEEEECCeEEEEEEecCcCCCccc---CC-CccEEE--EEEeCCCCC------CCChhHHH
Confidence            5889999999999999999999999999999999875543322   11 233444  445677543      35567889


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEee-CCeEEeCCChHH
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALR-GGLTFIDPVEEE  272 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~-~~~~~~Dp~~~E  272 (477)
                      +++++++.+++.+..+.||++.|++.++||++||+.+.++++|+++||.||||||+++++|+++++. ++.+++||+..|
T Consensus        80 ~~~li~r~l~~l~~~~~~~~~~I~v~~~VL~~dG~~~~aai~aa~~AL~dagiP~~~~v~avs~g~~~~g~~llDpt~~E  159 (246)
T 3hkm_A           80 YEMTLKRTLQSICLLTVHPNTTTSVILQVVGNDGSLLPCAINACCAALVFAGIPLKHLAVAIGCGVLEDGEVILDTNKAE  159 (246)
T ss_dssp             HHHHHHHHHHHHBCTTSSCSEEEEEEEEEEECSSCHHHHHHHHHHHHHHHHTCCBSSCEEEEEEEECTTSCEEESCCHHH
T ss_pred             HHHHHHHHHHHhcCccCCCcEEEEEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEEEEECCEEEECCCHHH
Confidence            9999999999999999999999999999999999999999999999999999999999999999998 899999999999


Q ss_pred             HhhhccCCCCCCCCCceEEEEEccC----------------CCcEEEEEEEeeecHHHHHHHHHHHHhcccchhhHHHHh
Q psy6508         273 VAYCQSLSSSEDDDSGVITLSYMSV----------------IQQVTQVTLVGTIQQERLADHIEQLIGCCESLCTDRVQK  336 (477)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~a~~~~----------------~~~i~~~~~~g~~~~~~~~~~l~~~~~~~~~i~~~~i~~  336 (477)
                      +..          +.+.+++++..+                .++++.++..|.++.+++.++++.|.++|+.+.+. +++
T Consensus       160 e~~----------~~~~~~va~~~~~i~~lq~~g~~~~~~~~~~~i~~~~~g~~~~~~l~~~l~~A~~~~~~i~~~-~~~  228 (246)
T 3hkm_A          160 EQQ----------LKSFAHLVFPNSRKSASSKEPNQKEEDSERGLITSITHGVMSEEDYFSCIERGLAASSRISDF-MRT  228 (246)
T ss_dssp             HTT----------CSEEEEEEEEC--------------------CCCEEEEECEEHHHHHHHHHHHHHHHHHHHHH-HHT
T ss_pred             Hhc----------CCeeEEEEEeCCceEEEeecccccccccccceeeeeccCCcCHHHHHHHHHHHHHHHHHHHHH-HHH
Confidence            984          578888887543                01223333478999999999999999999999999 999


Q ss_pred             Hhhhccc
Q psy6508         337 LVSDHVT  343 (477)
Q Consensus       337 ~l~~~~~  343 (477)
                      .+.++..
T Consensus       229 ~l~~~~~  235 (246)
T 3hkm_A          229 TLQKQAP  235 (246)
T ss_dssp             TTC----
T ss_pred             HHHhhhh
Confidence            8877654

>1udn_A Ribonuclease PH, RNAse PH; transferase, riken structural genomics/proteomics initiative structural genomics; 2.30A {Aquifex aeolicus} SCOP: d.14.1.4 d.101.1.1 PDB: 1udq_A 1uds_A 1udo_A

Probab=99.95  E-value=1.3e-27  Score=227.47  Aligned_cols=211  Identities=22%  Similarity=0.264  Sum_probs=188.4

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecccccccc-----CCCCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT-----GWLRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~-----~~~~~  188 (477)
                      +++|.+.+.+|+..+++||++++.|+|++.|.++++++.....   +- -..|.+.+++.+.||+...+.     ...++
T Consensus         9 ~e~R~i~i~~g~~~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~~---~~-~~~g~l~~~~~~~P~a~~~r~~Re~~~G~~~   84 (255)
T 1udn_A            9 DQLRPVSIQRDFLEYPEGSCLISFGKTKVICTASVIENVPNWL---KG-KGQGWITAEYSMLPRATQQRTIRESVQGRIG   84 (255)
T ss_dssp             TCCCCEEEEECCSSSSSEEEEEEETTEEEEEEEEEESCCCGGG---TT-SSCCEEEEEEEECSCCTTSCCCCSSTTCSCC
T ss_pred             CCccCeEEEECCCCCCCEEEEEEECCEEEEEEEEcCCcCCCCC---CC-CCceEEEEEEEcCCCccccccccccCCCCCC
Confidence            5789999999999999999999999999999999987753111   11 356899999999999977652     23567


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCC-----------CCCCceEEEEEE
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAA-----------IPMYDLVTSSTL  257 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dag-----------i~m~~~v~a~s~  257 (477)
                      ..+.++++.+++.+++.+.++.+|++.|+|.++||++||+.+.++++|+++||.|||           |||+++++++|+
T Consensus        85 ~~~~eisrli~r~lr~~i~~~~l~~~~i~I~~~VL~~DG~~~~aai~aa~~AL~da~~~~~~~~~~~~ipl~~~v~avsv  164 (255)
T 1udn_A           85 GRTHEIQRMIGRAMRTAVELTKIGERTIWVDCDVIQADGGTRTAAITGAFVAVADAIIKLHKEGIIEETPIKDFVAAVSV  164 (255)
T ss_dssp             HHHHHHHHHHHHHHHHHBCGGGGCSCEEEEEEEEEECSSCHHHHHHHHHHHHHHHHHHHHHHTTSSSSCCBCCCEEEEEE
T ss_pred             HHHHHHHHHHHHHHHHhcCHHHcCCeEEEEEEEEEeCCCCHHHHHHHHHHHHHHhhcchhcccCcccCCCccCceeEEEE
Confidence            789999999999999999999999999999999999999999999999999999999           999999999999


Q ss_pred             EeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe---eecHHHHHHHHHHHHhcccchhhHHH
Q psy6508         258 ALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG---TIQQERLADHIEQLIGCCESLCTDRV  334 (477)
Q Consensus       258 ~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g---~~~~~~~~~~l~~~~~~~~~i~~~~i  334 (477)
                      ++.++.+++||+..|+..          +.+.+++++ ++.++++.++.+|   .++.+++.++++.|.++|+.+... +
T Consensus       165 g~~~g~~llDpt~~Ee~~----------~~~~l~va~-~~~g~i~~~q~~g~~~~~~~~~l~~~l~~A~~~~~~i~~~-~  232 (255)
T 1udn_A          165 GIVNDRILLDLNFEEDSA----------AQVDMNVVG-TGSGRLSEVHTMGEEYSFTKDELIKMLDLAQKGINELIEL-Q  232 (255)
T ss_dssp             EEETTEEEESCCHHHHHT----------CSEEEEEEE-ETTSCEEEEEEEESSCCCCHHHHHHHHHHHHHHHHHHHHH-H
T ss_pred             EEECCEEEECCCHHHHhh----------CCCCEEEEE-eCCCCEEEEEEeCCCCCcCHHHHHHHHHHHHHHHHHHHHH-H
Confidence            999999999999999984          578899987 6667899999975   699999999999999999999999 8


Q ss_pred             HhHhhh
Q psy6508         335 QKLVSD  340 (477)
Q Consensus       335 ~~~l~~  340 (477)
                      ++.+.+
T Consensus       233 ~~~l~~  238 (255)
T 1udn_A          233 KKLYVI  238 (255)
T ss_dssp             HTTEEE
T ss_pred             HHHHHh
Confidence            888876

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=3.3e-29  Score=250.70  Aligned_cols=171  Identities=26%  Similarity=0.418  Sum_probs=147.4

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++.... ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++|++|.+++.+.+.+++..+
T Consensus        64 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~  143 (350)
T 1rdq_E           64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA  143 (350)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHH
T ss_pred             CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHH
Confidence            47899999998765321 23456788999999999999999999999999999999999999999999998788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.|++.||.|||++||+||||||+|||++.++ .+.++|||.+....+..     .+..+++.|+|||+..+.   .
T Consensus       144 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~  217 (350)
T 1rdq_E          144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNK  217 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHCCcccccCccceEEECCCC-CEEEcccccceeccCCc-----ccccCCccccCHHHhcCCCCCC
Confidence            99999999999999999999999999999997643 34445999987655432     356789999999998765   7


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||  +..||.+
T Consensus       218 ~~Di-wslG~il~ell~g~~Pf~~  240 (350)
T 1rdq_E          218 AVDW-WALGVLIYEMAAGYPPFFA  240 (350)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             cCCE-ecccHhHhHHhhCCCCCCC
Confidence            7999 9999999999  7788875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.95  E-value=8e-30  Score=249.25  Aligned_cols=172  Identities=24%  Similarity=0.345  Sum_probs=145.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++......  ..+.+.+|+.++++++||||+++++++..++..|+||||++|++|.+++... .+++..+.
T Consensus        43 ~~~~~vaiK~~~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~  119 (297)
T 3fxz_A           43 ATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIA  119 (297)
T ss_dssp             TTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHH
T ss_pred             CCCcEEEEEEeeccccc--HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHH
Confidence            57899999998765433  2456889999999999999999999999999999999999999999999874 69999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++||+||||||+|||++.+. ++.++|||.+........  ...+..+++.|+|||...+.   .+
T Consensus       120 ~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~  196 (297)
T 3fxz_A          120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK  196 (297)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTH
T ss_pred             HHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCC-CEEEeeCCCceecCCccc--ccCCccCCcCccChhhhcCCCCCcH
Confidence            9999999999999999999999999999997643 344559998765443221  22345788899999988665   77


Q ss_pred             ccccCcceEEEEEE--eeeccccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      +|+ ||+|+++|++  +..||.+.
T Consensus       197 ~Di-wslG~il~ell~g~~pf~~~  219 (297)
T 3fxz_A          197 VDI-WSLGIMAIEMIEGEPPYLNE  219 (297)
T ss_dssp             HHH-HHHHHHHHHHHHSSCTTTTS
T ss_pred             HHH-HHHHHHHHHHHhCCCCCCCC
Confidence            899 9999999999  77888653

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.95  E-value=3.4e-29  Score=247.31  Aligned_cols=171  Identities=24%  Similarity=0.415  Sum_probs=146.2

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++++.... ....+.+.+|..+++.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+
T Consensus        29 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~  108 (318)
T 1fot_A           29 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA  108 (318)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHH
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHH
Confidence            47899999999765321 13346788999999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.|++.||.|||++||+||||||+|||++.++ .+.++|||.+.......     .+..+++.|+|||+..+.   .
T Consensus       109 ~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~Dfg~a~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~  182 (318)
T 1fot_A          109 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNK  182 (318)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCChheEEEcCCC-CEEEeecCcceecCCcc-----ccccCCccccCHhHhcCCCCCc
Confidence            99999999999999999999999999999997643 34445999987544322     345678899999998765   7


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||  +..||.+
T Consensus       183 ~~Di-wslG~il~ell~g~~pf~~  205 (318)
T 1fot_A          183 SIDW-WSFGILIYEMLAGYTPFYD  205 (318)
T ss_dssp             THHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             ccch-hhhHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  7788864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.95  E-value=2e-29  Score=252.57  Aligned_cols=175  Identities=19%  Similarity=0.351  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||||++++... .....+.+.+|..+++.+ +||||+++++++.+.+.+|+||||++||+|.+++.+.+.+++..
T Consensus        46 ~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~  125 (353)
T 3txo_A           46 ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEAR  125 (353)
T ss_dssp             TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence            4789999999976532 223456688999999998 79999999999999999999999999999999999888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.||+.||.|||++||+||||||+|||++.++ .+.++|||++.......  ....+..+++.|+|||+..+.   
T Consensus       126 ~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g-~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  202 (353)
T 3txo_A          126 ARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGICNG--VTTATFCGTPDYIAPEILQEMLYG  202 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCT
T ss_pred             HHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCC-CEEEccccceeecccCC--ccccccCCCcCeEChhhcCCCCcC
Confidence            999999999999999999999999999999997643 34455999886432211  123456789999999987654   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ ||+|+++|||  +..||.+.
T Consensus       203 ~~~Di-wslG~il~ell~G~~Pf~~~  227 (353)
T 3txo_A          203 PAVDW-WAMGVLLYEMLCGHAPFEAE  227 (353)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             CccCC-CcchHHHHHHHhCCCCCCCC
Confidence            67899 9999999999  77888753

>1r6l_A Ribonuclease PH; beta-alpha-beta-alpha fold, hexamer, phosphate bound, transf; HET: NHE; 1.90A {Pseudomonas aeruginosa} SCOP: d.14.1.4 d.101.1.1 PDB: 1r6m_A

Probab=99.95  E-value=3.1e-27  Score=223.16  Aligned_cols=210  Identities=20%  Similarity=0.256  Sum_probs=185.9

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC-----CCCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-----WLRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-----~~~~  188 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.++++++.....   .- -..|.+.+++.+.||+...+..     ..++
T Consensus        10 ~e~R~i~i~~g~~~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~~---~~-~~~g~l~v~~~~~p~~~~~r~~Re~~~G~~~   85 (239)
T 1r6l_A           10 DQLRPIRITRHYTKHAEGSVLVEFGDTKVICTVSAESGVPRFL---KG-QGQGWLTAEYGMLPRSTGERNQREASRGKQG   85 (239)
T ss_dssp             TCCCCEEEESSCSSSSSEEEEEEETTEEEEEEEEEEESCSSCC---C----CCEEEEEEEECTTSSSSCCCCHHHHTSCC
T ss_pred             CCcCCeEEEeCCcCCCCeEEEEEECCEEEEEEEEccCccCCcc---CC-CCcEEEEEEEEeCCCccccccccccCCCCCc
Confidence            4789999999999999999999999999999999987753211   11 3468899999999998776522     3567


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCC-----------CCCCceEEEEEE
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAA-----------IPMYDLVTSSTL  257 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dag-----------i~m~~~v~a~s~  257 (477)
                      ..+.++++.+++.+++.+.++.+|++.++|.++||+.||+.+.+++||+++||.|||           |||+++++++|+
T Consensus        86 ~~~~~isrli~r~l~~~i~~~~l~~~~i~I~~~VL~~DG~~~~aai~aa~~AL~da~~~~~~~~~~~~ip~~~~~~avs~  165 (239)
T 1r6l_A           86 GRTLEIQRLIGRSLRAALDLSKLGENTLYIDCDVIQADGGTRTASITGATVALIDALAVLKKRGALKGNPLKQMVAAVSV  165 (239)
T ss_dssp             HHHHHHHHHHHHHHHHTBCGGGTCSEEEEEEEEEEECSSCHHHHHHHHHHHHHHHHHHHHHHTTCCSSCCBCCCEEEEEE
T ss_pred             HHHHHHHHHHHHHHHHhcCHHHcCCeEEEEEEEEEeCCCCHHHHHHHHHHHHHHHhcchhcccCcccccCccCceeEEEE
Confidence            789999999999999999999999999999999999999999999999999999999           999999999999


Q ss_pred             EeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe---eecHHHHHHHHHHHHhcccchhhHHH
Q psy6508         258 ALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG---TIQQERLADHIEQLIGCCESLCTDRV  334 (477)
Q Consensus       258 ~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g---~~~~~~~~~~l~~~~~~~~~i~~~~i  334 (477)
                      ++.++.+++||+..|+..          +.+.+++++ ++.++++.++..|   .++.+++.++++.|.++|+.+... +
T Consensus       166 g~~~~~~l~Dpt~~Ee~~----------~~~~l~va~-~~~g~i~~~~~~g~~~~~~~~~l~~~l~~a~~~~~~i~~~-~  233 (239)
T 1r6l_A          166 GIYQGVPVLDLDYLEDSA----------AETDLNVVM-TDAGGFIEVQGTAEGAPFRPAELNAMLELAQQGMQELFEL-Q  233 (239)
T ss_dssp             EEETTEEEESCCHHHHHH----------CSEEEEEEE-ETTSCEEEEEEEESSSCCCHHHHHHHHHHHHHHHHHHHHH-H
T ss_pred             EEECCEEEECCCHHHHhc----------CCceEEEEE-eCCCCEEEEEEeCCCCCcCHHHHHHHHHHHHHHHHHHHHH-H
Confidence            999999999999999985          478899987 5667899999876   699999999999999999999999 8


Q ss_pred             HhHhh
Q psy6508         335 QKLVS  339 (477)
Q Consensus       335 ~~~l~  339 (477)
                      ++.+.
T Consensus       234 ~~~l~  238 (239)
T 1r6l_A          234 RAALA  238 (239)
T ss_dssp             HHHHT
T ss_pred             HHHHh
Confidence            88764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=9.3e-29  Score=246.99  Aligned_cols=174  Identities=22%  Similarity=0.364  Sum_probs=148.0

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|++++.... ....+.+.+|..+++++ +||||+++++++.+++.+|+||||++||+|.+++.+.+.+++..
T Consensus        32 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~  111 (345)
T 3a8x_A           32 KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH  111 (345)
T ss_dssp             TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence            47899999999876543 34567789999999998 89999999999999999999999999999999998878899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......  ....+..+++.|+|||+..+.   
T Consensus       112 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  188 (345)
T 3a8x_A          112 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYG  188 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEEeccccccccCCC--CcccccCCCccccCccccCCCCCC
Confidence            999999999999999999999999999999997643 34456999986432211  112345788999999998775   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  +..||..
T Consensus       189 ~~~Di-wslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          189 FSVDW-WALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             hHHhH-HHHHHHHHHHHhCCCCcCC
Confidence            67899 9999999999  7789864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.95  E-value=8.5e-29  Score=250.49  Aligned_cols=173  Identities=22%  Similarity=0.358  Sum_probs=146.5

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++++... .....+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+|.+++...+.+++..+
T Consensus        38 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~  117 (384)
T 4fr4_A           38 DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETV  117 (384)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHH
T ss_pred             CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHH
Confidence            5788999999876532 223456788999999999999999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+|||++.++ .+.++|||++.......   ...+..+|+.|+|||++.+.    
T Consensus       118 ~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~---~~~~~~gt~~Y~aPE~~~~~~~~~  193 (384)
T 4fr4_A          118 KLFICELVMALDYLQNQRIIHRDMKPDNILLDEHG-HVHITDFNIAAMLPRET---QITTMAGTKPYMAPEMFSSRKGAG  193 (384)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTC---CBCCCCSCGGGCCGGGTCCCSSCC
T ss_pred             HHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCC-CEEEeccceeeeccCCC---ceeccCCCccccCCeeeccCCCCC
Confidence            99999999999999999999999999999997643 34456999987544322   12356788999999998632    


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+|+++|+|  +..||..
T Consensus       194 ~~~~~Di-wSlG~il~elltG~~Pf~~  219 (384)
T 4fr4_A          194 YSFAVDW-WSLGVTAYELLRGRRPYHI  219 (384)
T ss_dssp             BCTTHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCcccee-echHHHHHHHHhCCCCCCC
Confidence              67899 9999999999  7788864

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.95  E-value=5.8e-29  Score=252.63  Aligned_cols=174  Identities=21%  Similarity=0.363  Sum_probs=146.3

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||+|++++..... ...+.+.+|..+++++ +||||+++++++.+++.+|+||||++||+|..++.+.+.+++..
T Consensus        75 ~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~  154 (396)
T 4dc2_A           75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEH  154 (396)
T ss_dssp             TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHH
T ss_pred             CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHH
Confidence            478899999998765433 3345688999999987 89999999999999999999999999999999999888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..+|+.|+|||++.+.   
T Consensus       155 ~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aPE~l~~~~~~  231 (396)
T 4dc2_A          155 ARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYG  231 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCC-CEEEeecceeeecccCC--CccccccCCcccCCchhhcCCCCC
Confidence            999999999999999999999999999999997653 34456999986422111  122456789999999998876   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  +..||..
T Consensus       232 ~~~Di-wslGvllyell~G~~Pf~~  255 (396)
T 4dc2_A          232 FSVDW-WALGVLMFEMMAGRSPFDI  255 (396)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSTT
T ss_pred             hHHHH-HHHHHHHHHHHhCCCCCcc
Confidence            78999 9999999999  7889964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=7.1e-29  Score=245.81  Aligned_cols=174  Identities=24%  Similarity=0.380  Sum_probs=147.9

Q ss_pred             CCCcEEEEEEcccCCCCh----hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSE----NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||+|+++......    ...+.+.+|+.+|++++||||+++++++...+..|+||||++|++|.+++...+.+++
T Consensus        34 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  113 (326)
T 2y0a_A           34 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE  113 (326)
T ss_dssp             TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBH
T ss_pred             CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCH
Confidence            478999999998765422    1356799999999999999999999999999999999999999999999988788999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc---ceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT---LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~---~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ..+..++.|++.||.|||++||+||||||+||+++.+.   .++.++|||.+.......   ...+..+++.|+|||...
T Consensus       114 ~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~  190 (326)
T 2y0a_A          114 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVN  190 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeec
Confidence            99999999999999999999999999999999997643   255666999987654322   123456788999999987


Q ss_pred             CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.   .++|+ ||+|+++|++  +..||.+
T Consensus       191 ~~~~~~~~Di-wslG~il~~ll~g~~pf~~  219 (326)
T 2y0a_A          191 YEPLGLEADM-WSIGVITYILLSGASPFLG  219 (326)
T ss_dssp             TCCCCTHHHH-HHHHHHHHHHHHSCCSSCC
T ss_pred             CCCCCcHHHH-HHHHHHHHHHHHCcCCCCC
Confidence            65   67899 9999999999  6788864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.95  E-value=1.2e-28  Score=242.27  Aligned_cols=173  Identities=18%  Similarity=0.294  Sum_probs=140.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC---CCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK---LSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~---l~~~~   79 (477)
                      +|+.||+|++..........+.+.+|+.++++++||||+++++++...+..++||||++|++|.+++...+.   +++..
T Consensus        59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  138 (309)
T 3p86_A           59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR  138 (309)
T ss_dssp             TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHH
T ss_pred             CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHH
Confidence            578899999988776677778899999999999999999999999999999999999999999999987553   99999


Q ss_pred             HHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          80 CQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      +..++.|++.||.|||++|  |+||||||+||+++.+. ++.++|||.+.......  ....+..+++.|+|||...+. 
T Consensus       139 ~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~  215 (309)
T 3p86_A          139 RLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKY-TVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEP  215 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTC-CEEECCCC-------------------CCTTSCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCC-cEEECCCCCCccccccc--cccccCCCCccccChhhhcCCC
Confidence            9999999999999999999  99999999999998653 34446999886433221  123456788999999998766 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+|+++|++  +..||.+
T Consensus       216 ~~~~~Di-wslG~il~elltg~~Pf~~  241 (309)
T 3p86_A          216 SNEKSDV-YSFGVILWELATLQQPWGN  241 (309)
T ss_dssp             CCTTHHH-HHHHHHHHHHHHCCCTTTT
T ss_pred             CCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence              77899 9999999999  7788875

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=1.4e-29  Score=254.42  Aligned_cols=171  Identities=23%  Similarity=0.332  Sum_probs=137.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++.......   +.+.+|+.+++.++||||+++++++...+.+|+||||++|++|.+++...+++++..++
T Consensus        43 ~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  119 (361)
T 3uc3_A           43 LTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEAR  119 (361)
T ss_dssp             TTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHH
T ss_pred             CCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHH
Confidence            478999999997654322   45789999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      .++.|++.||.|||++||+||||||+||+++.+ ..++.++|||.+......   ....+..+++.|+|||...+.    
T Consensus       120 ~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~  196 (361)
T 3uc3_A          120 FFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDG  196 (361)
T ss_dssp             HHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSCHHHHHCSSCCH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCC
Confidence            999999999999999999999999999999764 434666799987632221   123456789999999987655    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       197 ~~~Di-wslG~il~ell~g~~Pf~~  220 (361)
T 3uc3_A          197 KIADV-WSCGVTLYVMLVGAYPFED  220 (361)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCSCC-
T ss_pred             Ceeee-ehhHHHHHHHHhCCCCCCC
Confidence            34799 9999999999  6788875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.9e-29  Score=248.14  Aligned_cols=171  Identities=20%  Similarity=0.324  Sum_probs=145.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+++.||+|.+...   ....+.+.+|+.+++.++||||+++++++.+.+.+|+||||++|++|.+++...+ .+++..+
T Consensus        28 ~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~  104 (321)
T 1tki_A           28 SSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI  104 (321)
T ss_dssp             TTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHH
T ss_pred             CCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHH
Confidence            46889999998644   2345678899999999999999999999999999999999999999999997654 6999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++.|++.||.|||++||+||||||+|||++.+ ...+.++|||.+........   .....+++.|+|||...+.   
T Consensus       105 ~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~  181 (321)
T 1tki_A          105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVS  181 (321)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCE---EEEEESCGGGSCHHHHTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCc---cccccCChhhcCcHHhcCCCCC
Confidence            9999999999999999999999999999999752 34556669999876543221   1345678899999998776   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       182 ~~~Di-wslG~il~~ll~g~~pf~~  205 (321)
T 1tki_A          182 TATDM-WSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             chhhH-HHHHHHHHHHHhCCCCCcC
Confidence            67899 9999999999  6678864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.95  E-value=6.2e-29  Score=248.16  Aligned_cols=175  Identities=24%  Similarity=0.365  Sum_probs=146.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||||++++... .....+.+.+|..+++.+ +||||+++++++.+.+.+|+||||++||+|.+++.+.+.+++..
T Consensus        40 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~  119 (345)
T 1xjd_A           40 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR  119 (345)
T ss_dssp             TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHH
T ss_pred             CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHH
Confidence            4789999999976532 122345688999999987 89999999999999999999999999999999999878899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.++ .+.++|||++.......  ....+..+++.|+|||+..+.   
T Consensus       120 ~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  196 (345)
T 1xjd_A          120 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYN  196 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCC-CEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCC
Confidence            999999999999999999999999999999997653 34456999886432111  112356788999999998765   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ ||+|+++|||  +..||.+.
T Consensus       197 ~~~Di-wslG~il~ell~g~~Pf~~~  221 (345)
T 1xjd_A          197 HSVDW-WSFGVLLYEMLIGQSPFHGQ  221 (345)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             Chhhh-HHHHHHHHHHhcCCCCCCCC
Confidence            77899 9999999999  77888753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.95  E-value=1.7e-28  Score=248.88  Aligned_cols=176  Identities=16%  Similarity=0.206  Sum_probs=147.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      .+|+.||||+++.........+.+.+|+.+++.++||||+++++++..++.+|+||||++|++|.+++...  ..+++..
T Consensus        50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  129 (389)
T 3gni_B           50 PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELA  129 (389)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHH
T ss_pred             CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHH
Confidence            47899999999887767777788999999999999999999999999999999999999999999999875  5799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccC--Ccc---cccCCeEEEeccccccccCC
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKG--SAY---IEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~g--s~~---~~~g~t~v~~~~y~ppE~~~  154 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. ++.++|||.+.....  ...   ........++..|+|||...
T Consensus       130 ~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  208 (389)
T 3gni_B          130 IAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG-KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ  208 (389)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHS
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEcccccceeeccccccccccccccccccccccccCHHHHh
Confidence            999999999999999999999999999999997543 444459987653221  111   11122346778899999987


Q ss_pred             CC-----CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.     .++|+ ||+|+++|+|  +..||.+
T Consensus       209 ~~~~~~~~~~Di-wslG~il~el~~g~~pf~~  239 (389)
T 3gni_B          209 QNLQGYDAKSDI-YSVGITACELANGHVPFKD  239 (389)
T ss_dssp             TTSSCBCTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             ccCCCCCcHhHH-HHHHHHHHHHHHCCCCCCC
Confidence            62     67899 9999999999  7788875

>3b4t_A Ribonuclease PH; RNAse, tRNA nucleotidyltransferase, RPHA, STRU genomics, TBSGC; 2.10A {Mycobacterium tuberculosis}

Probab=99.95  E-value=6.5e-27  Score=223.63  Aligned_cols=214  Identities=21%  Similarity=0.309  Sum_probs=188.8

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC-----CCCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-----WLRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-----~~~~  188 (477)
                      +++|.+.+.+|+..+++||++++.|+|++.|.++++.+.....   +- -..|.+.+++.+.||+...+..     ..++
T Consensus        14 ~e~R~i~i~~g~~~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~~---~~-~~~g~l~v~~~~~p~a~~~~~~Re~~~G~~~   89 (262)
T 3b4t_A           14 HELRPVIITRGFTENPAGSVLIEFGHTKVLCTASVTEGVPRWR---KA-TGLGWLTAEYAMLPSATHSRSDRESVRGRLS   89 (262)
T ss_dssp             TCCCCEEEEETSSSSSSEEEEEEETTEEEEEEEEEEESCC-------C-CSCCEEEEEEEECGGGSSSCCCCHHHHTSCC
T ss_pred             cCcCCeEEEeCCcCCCCeEEEEEECCCEEEEEEEecCcCCCcc---CC-CCceEEEEEEEeCCCccccccccccCCCCCC
Confidence            5789999999999999999999999999999999987753211   10 2347789999999998766532     3567


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhC------------CCCCCceEEEEE
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDA------------AIPMYDLVTSST  256 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~da------------gi~m~~~v~a~s  256 (477)
                      ..+.++++++++.+++.+.++.+|+++|.|.++||++||+.+.+++||+++||.||            ||||+++++++|
T Consensus        90 ~~~~~isrli~r~lr~~i~~~~l~~~~I~i~~~VL~~DG~~~~aai~aa~~AL~~a~~~~~~~~~~~~~ip~~~~v~avs  169 (262)
T 3b4t_A           90 GRTQEISRLIGRSLRACIDLAALGENTIAIDCDVLQADGGTRTAAITGAYVALADAVTYLSAAGKLSDPRPLSCAIAAVS  169 (262)
T ss_dssp             HHHHHHHHHHHHHHHTTBCHHHHCSEEEEEEEEEEECSSCHHHHHHHHHHHHHHHHHHHHHHTTCCSSSCCBCSCEEEEE
T ss_pred             HHHHHHHHHHHHHHHHhcCHhHCCCeEEEEEEEEEeCCCCHHHHHHHHHHHHHHHhhhhhccCCccccCCcccCceeEEE
Confidence            88999999999999999999999999999999999999999999999999999999            999999999999


Q ss_pred             EEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe---eecHHHHHHHHHHHHhcccchhhHH
Q psy6508         257 LALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG---TIQQERLADHIEQLIGCCESLCTDR  333 (477)
Q Consensus       257 ~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g---~~~~~~~~~~l~~~~~~~~~i~~~~  333 (477)
                      +++.++.+++||+..|+..          +.+.+++++ ++.++|+.++..|   .++.+++.++++.|.++|+.+... 
T Consensus       170 vg~~~g~~l~Dpt~~Ee~~----------~~~~l~va~-~~~g~i~~i~~~g~~~~~~~~~l~~~l~~A~~~~~~i~~~-  237 (262)
T 3b4t_A          170 VGVVDGRIRVDLPYEEDSR----------AEVDMNVVA-TDTGTLVEIQGTGEGATFARSTLDKLLDMALGACDTLFAA-  237 (262)
T ss_dssp             EEEETTEEEESCCHHHHTT----------CSEEEEEEE-ETTSCEEEEEECSSCCCBCHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             EEEECCEEEECCCHHHHhc----------cCceEEEEE-cCCCCEEEEEeeCCCCCcCHHHHHHHHHHHHHHHHHHHHH-
Confidence            9999999999999999984          478899986 6668899999986   699999999999999999999999 


Q ss_pred             HHhHhhhccc
Q psy6508         334 VQKLVSDHVT  343 (477)
Q Consensus       334 i~~~l~~~~~  343 (477)
                      +++.+.+...
T Consensus       238 ~~~~l~~~~~  247 (262)
T 3b4t_A          238 QRDALALPYP  247 (262)
T ss_dssp             HHHHHTSCCS
T ss_pred             HHHHHhcchh
Confidence            9999876544

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.95  E-value=4.3e-29  Score=247.11  Aligned_cols=175  Identities=22%  Similarity=0.346  Sum_probs=143.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|++...... ...+.+.+|+.+++.++||||+++++++..++..|+||||++|++|.+++.....+++..++
T Consensus        30 ~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  108 (323)
T 3tki_A           30 VTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ  108 (323)
T ss_dssp             TTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHH
T ss_pred             CCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHH
Confidence            47899999998765432 23456889999999999999999999999999999999999999999999887789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||.|||++||+||||||+|||++.+. ++.++|||.+.............+..+++.|+|||...+.    .
T Consensus       109 ~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  187 (323)
T 3tki_A          109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE  187 (323)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHH
T ss_pred             HHHHHHHHHHHHHHHCCccccccchHHEEEeCCC-CEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCC
Confidence            9999999999999999999999999999997643 3444699988654322222222345788899999998655    4


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||..
T Consensus       188 ~~Di-wslG~il~~ll~g~~pf~~  210 (323)
T 3tki_A          188 PVDV-WSCGIVLTAMLAGELPWDQ  210 (323)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSCSS
T ss_pred             cccH-HHHHHHHHHHHhCCCCCCC
Confidence            6899 9999999999  7788865

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.95  E-value=2.8e-28  Score=241.47  Aligned_cols=171  Identities=25%  Similarity=0.403  Sum_probs=129.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++.+.     ....+.+|+.+++.+. ||||+++++++.++...|+||||++|++|.+++...+.+++..+
T Consensus        34 ~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  108 (325)
T 3kn6_A           34 KSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEA  108 (325)
T ss_dssp             TTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHH
T ss_pred             CCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHH
Confidence            47899999998643     3456789999999996 99999999999999999999999999999999999888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+  ..++.++|||.+.......  ....+..+++.|+|||...+.  
T Consensus       109 ~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~  186 (325)
T 3kn6_A          109 SYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGY  186 (325)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------------------------CCC
T ss_pred             HHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC--CcccccCCCcCccCHHHhcCCCC
Confidence            9999999999999999999999999999999753  3456667999986543221  122355678899999998765  


Q ss_pred             -CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                       .++|+ ||+|+++|++  +..||.+.
T Consensus       187 ~~~~Di-wslG~il~~ll~g~~pf~~~  212 (325)
T 3kn6_A          187 DESCDL-WSLGVILYTMLSGQVPFQSH  212 (325)
T ss_dssp             CHHHHH-HHHHHHHHHHHHSSCTTC--
T ss_pred             CCccch-HHHHHHHHHHHhCCCCCCCC
Confidence             67899 9999999999  77899754

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.95  E-value=6e-28  Score=236.98  Aligned_cols=174  Identities=19%  Similarity=0.313  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+++.||+|++...  .....+.+.+|+.++++++||||+++++++.+++..++||||++|++|.+++.. ...+++..+
T Consensus        33 ~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  110 (310)
T 3s95_A           33 ETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQR  110 (310)
T ss_dssp             TTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHH
T ss_pred             CCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHH
Confidence            57899999988543  456667899999999999999999999999999999999999999999999987 457999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc------------CCeEEEecccc
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ------------GNTKVICSVFE  148 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~------------g~t~v~~~~y~  148 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+...........            ..+..+++.|+
T Consensus       111 ~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  189 (310)
T 3s95_A          111 VSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENK-NVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM  189 (310)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTS-CEEECCCTTCEECC--------------------CCCCSCGGGC
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCC-CEEEeecccceecccccccccccccccccccccccccCCCccee
Confidence            99999999999999999999999999999997653 344459999865433221111            01446788899


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |||...+.   .++|+ ||+|+++|++  +..||..
T Consensus       190 aPE~~~~~~~~~~~Di-~slG~~l~el~~g~~~~~~  224 (310)
T 3s95_A          190 APEMINGRSYDEKVDV-FSFGIVLCEIIGRVNADPD  224 (310)
T ss_dssp             CHHHHTTCCCCTHHHH-HHHHHHHHHHHHTCCSSTT
T ss_pred             CHHHhcCCCCCcHHHH-HHHHHHHHHHhcCCCCCcc
Confidence            99998766   67899 9999999999  5566654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=1.4e-28  Score=245.40  Aligned_cols=174  Identities=22%  Similarity=0.410  Sum_probs=143.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC--CCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH--QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H--pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      ++++.||||+++.........+.+.+|+.+|++++|  |||+++++++..++.+|+|||+ .+++|.+++...+.+++..
T Consensus        31 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~  109 (343)
T 3dbq_A           31 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE  109 (343)
T ss_dssp             TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHH
T ss_pred             CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHH
Confidence            568899999998877667777889999999999976  9999999999999999999995 5689999999988999999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      +..++.|++.||.|||++||+||||||+|||++++.+++  +|||.+.............+..+++.|+|||...+    
T Consensus       110 ~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~~~~~kl--~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  187 (343)
T 3dbq_A          110 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL--IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS  187 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEE--CCCSSSCCC------------CCCCSSCCHHHHHHCC--
T ss_pred             HHHHHHHHHHHHHHHHhCCeecCCCCcceEEEECCcEEE--eecccccccCcccccccCCCCcCCcCcCCHHHHhhcccc
Confidence            999999999999999999999999999999998776555  59999865543332223345678999999998742    


Q ss_pred             -------C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 -------K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 -------~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                             .   .++|+ ||+|+++|++  +..||..
T Consensus       188 ~~~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          188 RENGKSKSKISPKSDV-WSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             ---------CCHHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccCCCchhhH-HHHHHHHHHHHhCCCcchh
Confidence                   1   57899 9999999999  7788864

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=1.2e-28  Score=244.33  Aligned_cols=174  Identities=20%  Similarity=0.300  Sum_probs=136.2

Q ss_pred             CCCcEEEEEEcccCCCC--hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS--ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||+|++++....  ......+.+|+.+|+.++||||+++++++...+.+|+||||++|++|.+++...+.+++..
T Consensus        43 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  122 (327)
T 3a62_A           43 NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDT  122 (327)
T ss_dssp             TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHH
T ss_pred             CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHH
Confidence            47899999999876432  2334568899999999999999999999999999999999999999999998878899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......  ....+..+++.|+|||...+.   
T Consensus       123 ~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  199 (327)
T 3a62_A          123 ACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQG-HVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHN  199 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTS-CEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCC
T ss_pred             HHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCC-cEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCC
Confidence            999999999999999999999999999999997643 34445999876432211  112234578899999998665   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       200 ~~~Di-wslG~il~el~~g~~pf~~  223 (327)
T 3a62_A          200 RAVDW-WSLGALMYDMLTGAPPFTG  223 (327)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             Ccccc-hhHHHHHHHHHHCCCCCCC
Confidence            67899 9999999999  6788865

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=4.1e-28  Score=236.08  Aligned_cols=171  Identities=30%  Similarity=0.425  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+|+.||+|+++.........+.+.+|+.++++++||||+++++++.+++..|+||||+++ +|.+++.. .+.+++..+
T Consensus        25 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~  103 (292)
T 3o0g_A           25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIV  103 (292)
T ss_dssp             TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHH
T ss_pred             CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHH
Confidence            4789999999987766666667899999999999999999999999999999999999985 66666554 568999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.......  ....+..+++.|+|||...+.    
T Consensus       104 ~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~  180 (292)
T 3o0g_A          104 KSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYS  180 (292)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCC
T ss_pred             HHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEeecccceecCCcc--ccccCCccccCCcChHHHcCCCCcC
Confidence            99999999999999999999999999999997643 34445999986543221  222345678899999987654    


Q ss_pred             CcccccCcceEEEEEE--eeecc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPF  177 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf  177 (477)
                      .++|+ ||+|+++|++  +..||
T Consensus       181 ~~~Di-wslG~il~~l~~~~~p~  202 (292)
T 3o0g_A          181 TSIDM-WSAGCIFAELANAGRPL  202 (292)
T ss_dssp             THHHH-HHHHHHHHHHTTTSCCS
T ss_pred             chHHH-HHHHHHHHHHHHcCCCC
Confidence            67899 9999999999  34443

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.95  E-value=9.6e-29  Score=247.58  Aligned_cols=174  Identities=20%  Similarity=0.305  Sum_probs=145.7

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||||++++... .....+.+.+|..+++.+ +||||+++++++...+.+|+||||++||+|.+++...+.+++..
T Consensus        43 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~  122 (353)
T 2i0e_A           43 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH  122 (353)
T ss_dssp             TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            4678999999976532 123356788999999988 89999999999999999999999999999999999878899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.++ .+.++|||++.......  ....+..+++.|+|||+..+.   
T Consensus       123 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  199 (353)
T 2i0e_A          123 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYG  199 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBS
T ss_pred             HHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCC-cEEEEeCCcccccccCC--cccccccCCccccChhhhcCCCcC
Confidence            999999999999999999999999999999997653 34456999886532211  122356788999999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  +..||.+
T Consensus       200 ~~~Di-wslG~il~ell~G~~Pf~~  223 (353)
T 2i0e_A          200 KSVDW-WAFGVLLYEMLAGQAPFEG  223 (353)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             Ccccc-cchHHHHHHHHcCCCCCCC
Confidence            77899 9999999999  7788875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=2.3e-28  Score=248.20  Aligned_cols=174  Identities=23%  Similarity=0.425  Sum_probs=145.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC--CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH--HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||||+++.........+.+.+|+.+|++++  ||||+++++++..++.+|+||| +.+++|.+++...+.+++..
T Consensus        78 ~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~~~~~~~  156 (390)
T 2zmd_A           78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWE  156 (390)
T ss_dssp             TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCSSCCHHH
T ss_pred             CCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcCCCCHHH
Confidence            45889999999887766677788999999999996  5999999999999999999999 55799999999888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      +..++.||+.||.|||++||+||||||+|||++++.+++.  |||++.............+.++++.|+|||++.+    
T Consensus       157 ~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~kl~--DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  234 (390)
T 2zmd_A          157 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKLI--DFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS  234 (390)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEESSSCEEEC--CCSSSCCC---------CCSCCCGGGCCHHHHHCC---
T ss_pred             HHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEECCeEEEE--ecCccccccCCCccccCCCCCcCCCccChHHhhhcccc
Confidence            9999999999999999999999999999999987665555  9999865443222222345678999999998753    


Q ss_pred             ----------CCcccccCcceEEEEEE--eeecccc
Q psy6508         156 ----------KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ----------~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                                ..++|+ ||+|+++||+  +..||..
T Consensus       235 ~~~~~~~~~~~~~~Di-wSlGvil~ell~G~~Pf~~  269 (390)
T 2zmd_A          235 RENGKSKSKISPKSDV-WSLGCILYYMTYGKTPFQQ  269 (390)
T ss_dssp             ---------CCHHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             ccccccccCCCChhhH-HHHHHHHHHHHHCCCcchh
Confidence                      157899 9999999999  7788864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.95  E-value=1.4e-28  Score=247.96  Aligned_cols=174  Identities=20%  Similarity=0.361  Sum_probs=143.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------   73 (477)
                      ++..||||+++... .....+.+.+|+.+++++ +||||+++++++...+.+|+||||++||+|.+++...+        
T Consensus       112 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  190 (370)
T 2psq_A          112 EAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY  190 (370)
T ss_dssp             CEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC------
T ss_pred             cceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccc
Confidence            46689999997653 445567899999999999 89999999999999999999999999999999998743        


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEec
Q psy6508          74 --------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICS  145 (477)
Q Consensus        74 --------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~  145 (477)
                              .+++..+..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+................+++
T Consensus       191 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~  269 (370)
T 2psq_A          191 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPV  269 (370)
T ss_dssp             -----CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCG
T ss_pred             cccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCC-CEEEccccCCcccCcccceecccCCCccc
Confidence                    478999999999999999999999999999999999997643 34445999987655433323333344567


Q ss_pred             cccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         146 VFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       146 ~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .|+|||...+.   .++|+ ||+|+++|||   +..||.+
T Consensus       270 ~y~aPE~~~~~~~~~~~Dv-wslG~il~ellt~g~~p~~~  308 (370)
T 2psq_A          270 KWMAPEALFDRVYTHQSDV-WSFGVLMWEIFTLGGSPYPG  308 (370)
T ss_dssp             GGCCHHHHHTCCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             ceECHhHhcCCCCCcHHHH-HHHHHHHHHHHcCCCCCCCC
Confidence            89999987665   67899 9999999998   5577764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.95  E-value=9.8e-29  Score=247.37  Aligned_cols=175  Identities=24%  Similarity=0.383  Sum_probs=144.9

Q ss_pred             CCCcEEEEEEcccCCC---ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----CC
Q psy6508           2 EQHTEVAIKCIDKTKV---SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----EK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~   74 (477)
                      .+|+.||||+++....   .....+.+.+|+.+++.++||||+++++++..++.+|+||||++|++|.+++...    ..
T Consensus        47 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~  126 (351)
T 3c0i_A           47 ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV  126 (351)
T ss_dssp             TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCC
T ss_pred             CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCC
Confidence            4789999999865321   1123567899999999999999999999999999999999999999999888542    25


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++..+..++.|++.||.|||++||+||||||+|||++.+  ...+.++|||.+........  ...+..+++.|+|||+
T Consensus       127 ~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~  204 (351)
T 3c0i_A          127 YSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVGTPHFMAPEV  204 (351)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCCSCGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCcCCcCccCHHH
Confidence            8999999999999999999999999999999999999753  33455669999876544322  1234578899999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++|++  +..||.+
T Consensus       205 ~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          205 VKREPYGKPVDV-WGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             HTTCCBCTHHHH-HHHHHHHHHHHHSSCSSCS
T ss_pred             HcCCCCCchHhh-HHHHHHHHHHHHCCCCCCC
Confidence            8765   77899 9999999999  7788875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.95  E-value=7.8e-29  Score=246.55  Aligned_cols=174  Identities=24%  Similarity=0.445  Sum_probs=145.6

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++.+..... ...+.+.+|+.+++.++||||+++++++...+..|+||||+ +|+|.+++...+++++..+
T Consensus        32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~  110 (336)
T 3h4j_B           32 KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEG  110 (336)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHH
T ss_pred             CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHH
Confidence            578999999987543221 22356889999999999999999999999999999999999 5899999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+........   ..+..+++.|+|||...+.    
T Consensus       111 ~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~  186 (336)
T 3h4j_B          111 RRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNL-NVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPEVINGKLYAG  186 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTC-CEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGGGSCCSGGGC
T ss_pred             HHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCC-CEEEEEeccceeccCCcc---cccccCCcCcCCHHHHcCCCCCC
Confidence            99999999999999999999999999999998653 344459998865443321   2345678899999998876    


Q ss_pred             CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      .++|+ ||+|+++|++  +..||.+..
T Consensus       187 ~~~Di-wslG~il~~ll~g~~Pf~~~~  212 (336)
T 3h4j_B          187 PEVDV-WSCGIVLYVMLVGRLPFDDEF  212 (336)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCSSBCSS
T ss_pred             Cccch-hHHHHHHHHHHhCCCCCCCcc
Confidence            46899 9999999999  788997643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.95  E-value=6.2e-29  Score=241.56  Aligned_cols=173  Identities=22%  Similarity=0.299  Sum_probs=147.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .++..||+|.+.....+....+.+.+|+.++++++||||+++++++..    ...+|+||||+++++|.+++...+.+++
T Consensus        49 ~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  128 (290)
T 1t4h_A           49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI  128 (290)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCH
T ss_pred             CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCH
Confidence            578899999998877777777889999999999999999999999875    4568999999999999999998788999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ..+..++.|++.||.|||++|  ++||||||+||+++.+...+.++|||.+.......    .....+++.|+|||...+
T Consensus       129 ~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~~~~  204 (290)
T 1t4h_A          129 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE  204 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCCcCcCCHHHHhc
Confidence            999999999999999999999  99999999999997443355566999885433322    123456788999998876


Q ss_pred             C--CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K--TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~--~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .  .++|+ ||+|+++|++  +..||..
T Consensus       205 ~~~~~~Di-~slG~~l~~l~~g~~pf~~  231 (290)
T 1t4h_A          205 KYDESVDV-YAFGMCMLEMATSEYPYSE  231 (290)
T ss_dssp             CCCTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             cCCCcchH-HHHHHHHHHHHhCCCCCCC
Confidence            6  78899 9999999999  6678864

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.95  E-value=5.1e-30  Score=252.08  Aligned_cols=176  Identities=22%  Similarity=0.325  Sum_probs=138.4

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER----YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+++.||||+++..... ....+.+.+|+.++++++||||+++++++....    ..|+||||++|++|.+++...+.++
T Consensus        35 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~  114 (311)
T 3ork_A           35 RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT  114 (311)
T ss_dssp             TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCC
T ss_pred             CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCC
Confidence            57889999999876543 345678999999999999999999999987654    3599999999999999998878899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+........ ........+++.|+|||...+
T Consensus       115 ~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  193 (311)
T 3ork_A          115 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATN-AVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG  193 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTS-CEEECCCSCC------------------CCTTCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCC-CEEEeeccCcccccccccccccccccCcCcccCCHHHhcC
Confidence            999999999999999999999999999999999997643 344469998865433221 122234568899999998876


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ ||+|+++|++  +..||.+
T Consensus       194 ~~~~~~~Di-~slG~~l~~ll~g~~pf~~  221 (311)
T 3ork_A          194 DSVDARSDV-YSLGCVLYEVLTGEPPFTG  221 (311)
T ss_dssp             CCCCHHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CCCCchHhH-HHHHHHHHHHHhCCCCCCC
Confidence            5   67899 9999999999  6678864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=2.7e-28  Score=255.38  Aligned_cols=175  Identities=27%  Similarity=0.464  Sum_probs=147.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|++++........+.+.+|+.+++.++||||+++++++...+.+|+|||||+||+|.+++.....+++..+.
T Consensus        60 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~  139 (494)
T 3lij_A           60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAA  139 (494)
T ss_dssp             TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHH
T ss_pred             CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHH
Confidence            47889999999877655545577899999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccCCCC--C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--~  157 (477)
                      .++.|++.||.|||++||+||||||+|||++.+  ...+.++|||++.......   ...+..+++.|+|||++.+.  .
T Consensus       140 ~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~  216 (494)
T 3lij_A          140 VIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK---KMKERLGTAYYIAPEVLRKKYDE  216 (494)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB---CBCCCCSCTTTCCHHHHTTCBCT
T ss_pred             HHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc---cccccCCCcCeeCHHHHcccCCC
Confidence            999999999999999999999999999999653  3345566999886554322   12345688999999998766  7


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|++  +..||.+.
T Consensus       217 ~~Di-wslG~il~~ll~g~~pf~~~  240 (494)
T 3lij_A          217 KCDV-WSIGVILFILLAGYPPFGGQ  240 (494)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             chhH-HHHHHHHHHHHhCCCCCCCC
Confidence            8999 9999999999  77888753

>3gme_A Polyribonucleotide nucleotidyltransferase; protein-RNA complex, cytoplasm, nucleotidyltransferase, RNA- binding, transferase, hydrolase; 2.40A {Escherichia coli E24377A} PDB: 3gll_A 3gcm_A 3h1c_A 3cdj_A

Probab=99.95  E-value=7.1e-27  Score=240.27  Aligned_cols=221  Identities=16%  Similarity=0.213  Sum_probs=181.8

Q ss_pred             CCceeec---cCcceeecccccceecccCCcccccCCeEEEecc-ccccccCCCCCcccccCcceEEEEEEeeecccccc
Q psy6508         106 PQNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQI  181 (477)
Q Consensus       106 p~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~-y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~  181 (477)
                      .+++-+|   .+++|.+.+.+|+..+++||++++.|+|++.|.+ |+|+|.........- -..|.+.+++.++||++..
T Consensus       311 ~~g~R~DGR~~~elRpi~i~~g~l~~a~GSal~~~G~T~Vl~~Vt~gp~~~~~~~~~l~~-~~~g~~~~~y~~~P~st~e  389 (549)
T 3gme_A          311 AGEPRIDGREKDMIRGLDVRTGVLPRTHGSALFTRGETQALVTATLGTARDAQVLDELMG-ERTDTFLFHYNFPPYSVGE  389 (549)
T ss_dssp             HTCCCTTSCCTTCCCCEEEEECCCSSSSEEEEEEETTEEEEEEEEEEC----------------CCEEEEEECCGGGTTC
T ss_pred             cCCCCCCCCCCCCccceEEEECCCCCCCceEEEEECCeEEEEEEEecCcccccCccccCC-CCceEEEEEEEeCCCCcCC
Confidence            3445554   3689999999999999999999999999999998 999775432200000 2458899999999999876


Q ss_pred             ccC-CCCCcchHHHHHHHHHHhhhhhh-cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEe
Q psy6508         182 RTG-WLRDSEEKELGNHLKRALEPAVC-RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLAL  259 (477)
Q Consensus       182 r~~-~~~~~~~~~l~~~i~~~l~~~i~-~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~  259 (477)
                      +.. ..++.++.++.+.+++++++.+. .+.||++ |++.++||++||+.+.+++||+++||+||||||+++|+|+|+++
T Consensus       390 ~~~~g~~~~Reie~~~li~raL~~vI~~~~~~P~t-I~V~~~VLesDGs~~~AsI~aa~lAL~DAGvPm~~~Vaavs~Gl  468 (549)
T 3gme_A          390 TGMVGSPKRREIGHGRLAKRGVLAVMPDMDKFPYT-VRVVSEITESNGSSSMASVCGASLALMDAGVPIKAAVAGIAMGL  468 (549)
T ss_dssp             CCCSSCCCSSHHHHHHHHHHHHTTTCCCTTTCCCE-EEEEEEEEECSSCHHHHHHHHHHHHHHHHTCCCSSCCEEEEEEE
T ss_pred             cccCCCCChhHHHHHHHHHHHHHHhcCccccCCeE-EEEEEEEEECCCCHHHHHHHHHHHHHHhCCCCcccceeEEEEEE
Confidence            543 35778889999999999999998 7899987 99999999999999999999999999999999999999999999


Q ss_pred             eCC----eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee---ecHHHHHHHHHHHHhcccchhhH
Q psy6508         260 RGG----LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT---IQQERLADHIEQLIGCCESLCTD  332 (477)
Q Consensus       260 ~~~----~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~---~~~~~~~~~l~~~~~~~~~i~~~  332 (477)
                      .++    .+++||+..|+...          ...++++  ++.+.+++++++++   |+.+++.++|+.|+++|..+...
T Consensus       469 i~~g~~~~iL~D~~~~Ed~~~----------d~d~~Va--~t~~gitalqmd~ki~G~s~~~l~~~L~~A~~g~~~I~~~  536 (549)
T 3gme_A          469 VKEGDNYVVLSDILGDEDHLG----------DMDFKVA--GSRDGISALQMDIKIEGITKEIMQVALNQAKGARLHILGV  536 (549)
T ss_dssp             EEETTEEEEEESCCHHHHHHS----------SEEEEEE--ECSSCEEEEEEEECCSCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EcCCCceEEEecCChHHHccC----------CceEEEE--ecCCCeEEEEEccccCCcCHHHHHHHHHHHHHHHHHHHHH
Confidence            854    68999999999842          4445554  66777999999876   59999999999999999999999


Q ss_pred             HHHhHhhhc
Q psy6508         333 RVQKLVSDH  341 (477)
Q Consensus       333 ~i~~~l~~~  341 (477)
                       |++++..+
T Consensus       537 -m~~al~~p  544 (549)
T 3gme_A          537 -MEQAINAP  544 (549)
T ss_dssp             -HHHHCCSC
T ss_pred             -HHHHHHhh
Confidence             99988764

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=1.7e-28  Score=256.38  Aligned_cols=175  Identities=23%  Similarity=0.408  Sum_probs=147.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++.+........+.+.+|+.++++++||||+++++++...+.+|+||||++|++|.+++...+.+++..+.
T Consensus        45 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  124 (486)
T 3mwu_A           45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA  124 (486)
T ss_dssp             TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHH
T ss_pred             CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHH
Confidence            47899999998765433344577899999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--~  157 (477)
                      .++.|++.||.|||++||+||||||+|||++.  ....+.++|||++.......   ...+.++++.|+|||++.+.  .
T Consensus       125 ~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~  201 (486)
T 3mwu_A          125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGTYDE  201 (486)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGSCCCH
T ss_pred             HHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC---ccCCCcCCCCCCCHHHhCCCCCc
Confidence            99999999999999999999999999999964  23455666999886544322   12345678899999998876  6


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|++  +..||.+.
T Consensus       202 ~~Di-wslG~il~~ll~g~~pf~~~  225 (486)
T 3mwu_A          202 KCDV-WSAGVILYILLSGTPPFYGK  225 (486)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999999  77888753

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.94  E-value=4.8e-28  Score=238.18  Aligned_cols=173  Identities=25%  Similarity=0.366  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      ++|+.||+|+++.........+.+.+|+.++++++||||+++++++.+++..|+||||++ ++|.+++.... .+++..+
T Consensus        43 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  121 (311)
T 3niz_A           43 SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQI  121 (311)
T ss_dssp             TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHH
T ss_pred             CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHH
Confidence            468999999997765555556788999999999999999999999999999999999998 58888887653 5999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......  .......+++.|+|||...+.    
T Consensus       122 ~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~  198 (311)
T 3niz_A          122 KIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDG-ALKLADFGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYS  198 (311)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCC-CEEEccCcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCC
Confidence            99999999999999999999999999999997653 34456999986543221  112334678899999987653    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       199 ~~~Di-wslG~il~~ll~g~~pf~~  222 (311)
T 3niz_A          199 TSVDI-WSIGCIFAEMITGKPLFPG  222 (311)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             chHHh-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6778864

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=6.5e-28  Score=233.34  Aligned_cols=174  Identities=21%  Similarity=0.347  Sum_probs=150.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|++.....+....+.+.+|+.++++++||||+++++++..++..|++|||++|++|.+++...+.+++..+.
T Consensus        29 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~  108 (284)
T 3kk8_A           29 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS  108 (284)
T ss_dssp             TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHH
T ss_pred             CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHH
Confidence            46899999999887777777788999999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.||.|||++||+||||||+||+++.+  ...+.++|||.+........   .....+++.|+|||...+.   
T Consensus       109 ~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~  185 (284)
T 3kk8_A          109 HCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYS  185 (284)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCC
Confidence            999999999999999999999999999999753  33455669999865443221   1234678899999998766   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|++++++  +..||.+
T Consensus       186 ~~~Di-~slG~~l~~l~~g~~pf~~  209 (284)
T 3kk8_A          186 KPVDI-WACGVILYILLVGYPPFWD  209 (284)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             cccch-HHHHHHHHHHHHCCCCCCC
Confidence            67899 9999999999  6788864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.94  E-value=8.1e-29  Score=244.86  Aligned_cols=171  Identities=22%  Similarity=0.332  Sum_probs=144.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++.....  ...+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++.. ..+++..+.
T Consensus        68 ~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~  144 (321)
T 2c30_A           68 HSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIA  144 (321)
T ss_dssp             TTCCEEEEEEEETTTC--CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHH
T ss_pred             CCCcEEEEEEEeccch--hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHH
Confidence            4789999999876542  3356788999999999999999999999999999999999999999999875 479999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+........  ...+..+++.|+|||...+.   .+
T Consensus       145 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~  221 (321)
T 2c30_A          145 TVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEVISRSLYATE  221 (321)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             HHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCC-cEEEeeeeeeeecccCcc--ccccccCCccccCHhhhcCCCCCch
Confidence            9999999999999999999999999999998643 345569998765443211  12345688899999998765   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ ||+|+++|++  +..||.+
T Consensus       222 ~Dv-~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          222 VDI-WSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             HHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             hhH-HHHHHHHHHHHhCCCCCCC
Confidence            899 9999999999  6778764

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.94  E-value=2.1e-28  Score=246.90  Aligned_cols=174  Identities=20%  Similarity=0.333  Sum_probs=137.7

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHH-HHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKA-LKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~i-l~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||||++++.... ....+.+.+|..+ ++.++||||+++++++.+.+.+|+||||++||+|.+++.+.+.+++..
T Consensus        61 ~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~  140 (373)
T 2r5t_A           61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPR  140 (373)
T ss_dssp             TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHH
Confidence            46889999999876543 2334567778777 567899999999999999999999999999999999999888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.||+.||.|||++||+||||||+|||++.++ ++.++|||++.......  ....+..+++.|+|||++.+.   
T Consensus       141 ~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g-~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  217 (373)
T 2r5t_A          141 ARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEHN--STTSTFCGTPEYLAPEVLHKQPYD  217 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCC-CEEEeeCccccccccCC--CccccccCCccccCHHHhCCCCCC
Confidence            999999999999999999999999999999997643 34456999886432211  123456788999999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  +..||.+
T Consensus       218 ~~~Di-wslG~il~ell~G~~Pf~~  241 (373)
T 2r5t_A          218 RTVDW-WCLGAVLYEMLYGLPPFYS  241 (373)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             chhhh-HHHHHHHHHHHcCCCCCCC
Confidence            67899 9999999999  7788865

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.94  E-value=3.9e-28  Score=244.12  Aligned_cols=173  Identities=14%  Similarity=0.099  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC---CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-----CC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH---HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-----HE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-----~~   73 (477)
                      .+++.||||+++...     ..++.+|..+++.++   ||||+++++++...+..|+||||++||+|.+++..     ..
T Consensus        93 ~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~  167 (365)
T 3e7e_A           93 KNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEK  167 (365)
T ss_dssp             -CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTC
T ss_pred             ccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhccccc
Confidence            368899999986542     345778888888886   99999999999999999999999999999999974     45


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC----------cceeecccccceecccCCcccccCCeEEE
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN----------TLKLAGLKQGVSEKAKGSAYIEQGNTKVI  143 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~----------~~rl~~~dfG~~~~~~gs~~~~~g~t~v~  143 (477)
                      .+++..++.++.|++.||.|||++||+||||||+|||++.+          ...+.++|||++.............+..+
T Consensus       168 ~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~g  247 (365)
T 3e7e_A          168 VMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE  247 (365)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecC
Confidence            79999999999999999999999999999999999999761          34555569999864331111111234567


Q ss_pred             eccccccccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         144 CSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       144 ~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      |+.|+|||+..+.   .++|+ ||+|+++|||  +..||...
T Consensus       248 t~~y~aPE~~~~~~~~~~~Di-wslG~il~elltg~~pf~~~  288 (365)
T 3e7e_A          248 TSGFQCVEMLSNKPWNYQIDY-FGVAATVYCMLFGTYMKVKN  288 (365)
T ss_dssp             TTSCCCHHHHTTCCBSTHHHH-HHHHHHHHHHHHSSCCCEEE
T ss_pred             CCCCCChHHhcCCCCCccccH-HHHHHHHHHHHhCCCccccC
Confidence            8899999998776   77899 9999999999  66787644

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=2e-28  Score=243.58  Aligned_cols=196  Identities=27%  Similarity=0.336  Sum_probs=155.3

Q ss_pred             CCCcEEEEEEcccCCCChh------HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCC-CHHHHHHhCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSEN------RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG-DLCSFIRSHEK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~-sL~~~l~~~~~   74 (477)
                      .+|+.||||+++.......      ..+.+.+|+.++++++||||+++++++...+.+++||||+.+| +|.+++...+.
T Consensus        47 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~  126 (335)
T 3dls_A           47 EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR  126 (335)
T ss_dssp             TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCC
T ss_pred             CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCC
Confidence            4788999999987654321      3345778999999999999999999999999999999998666 99999998888


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      +++..+..++.|++.||.|||++||+||||||+|||++.+. ++.++|||.+.......   ...+..+++.|+|||...
T Consensus       127 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~  202 (335)
T 3dls_A          127 LDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF-TIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLM  202 (335)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCC-cEEEeecccceECCCCC---ceeccCCCccccChhhhc
Confidence            99999999999999999999999999999999999997652 34456999886544322   123566789999999887


Q ss_pred             CC----CcccccCcceEEEEEE--eeeccccccccC----CCCCcchHHHHHHHHHHh
Q psy6508         155 SK----TSLEYQRSKGELYVEF--KFAPFASQIRTG----WLRDSEEKELGNHLKRAL  202 (477)
Q Consensus       155 ~~----~~~Di~~s~G~il~e~--~~~Pf~~~~r~~----~~~~~~~~~l~~~i~~~l  202 (477)
                      +.    .++|+ ||+|+++|++  +..||.......    ..+.....++..++++++
T Consensus       203 ~~~~~~~~~Di-wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~l~~li~~~L  259 (335)
T 3dls_A          203 GNPYRGPELEM-WSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMSLVSGLL  259 (335)
T ss_dssp             TCCBCSHHHHH-HHHHHHHHHHHHSSCSCSSGGGGTTTCCCCSSCCCHHHHHHHHHHT
T ss_pred             CCCCCCCcccc-hhHHHHHHHHHhCCCchhhHHHHHhhccCCCcccCHHHHHHHHHHc
Confidence            65    46799 9999999999  778887543321    122333555666666544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.94  E-value=8.8e-29  Score=249.80  Aligned_cols=172  Identities=22%  Similarity=0.358  Sum_probs=144.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+|+.||+|+++...  ....+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++... ..+++..+
T Consensus       112 ~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~  189 (373)
T 2x4f_A          112 ATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDT  189 (373)
T ss_dssp             TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHH
T ss_pred             CCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHH
Confidence            468999999997653  345578999999999999999999999999999999999999999999988764 36999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++.|++.||.|||++||+||||||+|||+.. +..++.++|||.+........   ..+..+++.|+|||...+.   
T Consensus       190 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~  266 (373)
T 2x4f_A          190 ILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFLAPEVVNYDFVS  266 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCC
T ss_pred             HHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEeChhhccCCCCC
Confidence            999999999999999999999999999999953 334556669999876543321   2344678899999988765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  +..||.+
T Consensus       267 ~~~Di-wslG~il~elltg~~pf~~  290 (373)
T 2x4f_A          267 FPTDM-WSVGVIAYMLLSGLSPFLG  290 (373)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             cHHhH-HHHHHHHHHHHhCCCCCCC
Confidence            57899 9999999999  6677764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.94  E-value=4.3e-28  Score=240.37  Aligned_cols=174  Identities=25%  Similarity=0.337  Sum_probs=137.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||+++.........+.+.+|+.++++++||||+++++++..++.+|+||||++ ++|.+++...+.+++..++
T Consensus        57 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~  135 (329)
T 3gbz_A           57 VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIK  135 (329)
T ss_dssp             TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHH
T ss_pred             CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHH
Confidence            478899999998776555556678899999999999999999999999999999999998 6999999998889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc----CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~----~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .++.|++.||.|||++||+||||||+|||++.    +...+.++|||.+.......  .......++..|+|||...+. 
T Consensus       136 ~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~  213 (329)
T 3gbz_A          136 SFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSR  213 (329)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc--cccCCCcCCccccCHHHhcCCC
Confidence            99999999999999999999999999999953    23345667999886543221  122345678899999987653 


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|++  +..||.+
T Consensus       214 ~~~~~~Di-wslG~il~ell~g~~pf~~  240 (329)
T 3gbz_A          214 HYSTSVDI-WSIACIWAEMLMKTPLFPG  240 (329)
T ss_dssp             CCCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCcHHHH-HHHHHHHHHHHHCCCCcCC
Confidence               67899 9999999999  6677764

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.94  E-value=3.6e-28  Score=245.68  Aligned_cols=175  Identities=22%  Similarity=0.344  Sum_probs=146.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+++.||||+++.. ......+.+.+|+.+|++++||||+++++++..++..|+||||++||+|.+++...+ .+++..+
T Consensus       137 ~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  215 (377)
T 3cbl_A          137 ADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTL  215 (377)
T ss_dssp             TTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHH
T ss_pred             cCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHH
Confidence            46889999998754 344555678999999999999999999999999999999999999999999998654 6999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......+...+....++..|+|||...+.   .
T Consensus       216 ~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~-~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  294 (377)
T 3cbl_A          216 LQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKN-VLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS  294 (377)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEH
T ss_pred             HHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCC-cEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCc
Confidence            99999999999999999999999999999997643 3444599998765554444444455667789999988655   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||.+
T Consensus       295 ~~Dv-wslG~il~el~t~g~~p~~~  318 (377)
T 3cbl_A          295 ESDV-WSFGILLWETFSLGASPYPN  318 (377)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999998   5677764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.94  E-value=1.7e-28  Score=240.97  Aligned_cols=175  Identities=21%  Similarity=0.219  Sum_probs=140.0

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|+++..... ....+.+.+|+.++++++||||+++++++..++..|++|||++|++|.+++...+.+++..+
T Consensus        57 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  136 (309)
T 2h34_A           57 VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRA  136 (309)
T ss_dssp             TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHH
T ss_pred             CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHH
Confidence            46889999999766443 34457899999999999999999999999999999999999999999999998788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+........ .......++..|+|||...+.   .
T Consensus       137 ~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  214 (309)
T 2h34_A          137 VAIVRQIGSALDAAHAAGATHRDVKPENILVSADD-FAYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATY  214 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSCCC-----------------CCGGGCCGGGTCC----C
T ss_pred             HHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCC-CEEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCc
Confidence            99999999999999999999999999999997643 344569998765443221 122345678899999998766   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|+++|++  +..||.+
T Consensus       215 ~~Di-~slG~il~~l~~g~~pf~~  237 (309)
T 2h34_A          215 RADI-YALTCVLYECLTGSPPYQG  237 (309)
T ss_dssp             CCHH-HHHHHHHHHHHHSSCSSCS
T ss_pred             hHhH-HHHHHHHHHHHHCCCCCCC
Confidence            7899 9999999999  6677764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=4.7e-28  Score=254.16  Aligned_cols=175  Identities=27%  Similarity=0.491  Sum_probs=147.5

Q ss_pred             CCCcEEEEEEcccCCCCh-----------hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-----------NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIR   70 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-----------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~   70 (477)
                      .+++.||+|++++.....           ...+.+.+|+.+|++++||||+++++++.+...+|+|||||+||+|.+++.
T Consensus        59 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~  138 (504)
T 3q5i_A           59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII  138 (504)
T ss_dssp             TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred             CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH
Confidence            468899999998764332           235678999999999999999999999999999999999999999999998


Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc--ceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          71 SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT--LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        71 ~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~--~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                      ..+.+++..+..++.|++.||.|||++||+||||||+|||++.++  .++.++|||++.......   ...+..+++.|+
T Consensus       139 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~  215 (504)
T 3q5i_A          139 NRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYI  215 (504)
T ss_dssp             HHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTC
T ss_pred             HcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCC---ccccccCCcCCC
Confidence            878899999999999999999999999999999999999997643  356667999987554322   123456889999


Q ss_pred             ccccCCCC--CcccccCcceEEEEEE--eeeccccc
Q psy6508         149 PREIPSSK--TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       149 ppE~~~~~--~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      |||.+.+.  .++|+ ||+|+++|++  +..||.+.
T Consensus       216 aPE~~~~~~~~~~Di-wslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          216 APEVLKKKYNEKCDV-WSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             CHHHHTTCBCTHHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             CHHHhccCCCchHHH-HHHHHHHHHHHhCCCCCCCC
Confidence            99998766  78899 9999999999  77888753

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.94  E-value=1.7e-27  Score=230.26  Aligned_cols=164  Identities=21%  Similarity=0.266  Sum_probs=141.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----EKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~l~   76 (477)
                      .+++.||+|+++..........++.+|+..+..+ +||||+++++++..++..++||||++|++|.+++...    ..++
T Consensus        34 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  113 (289)
T 1x8b_A           34 LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK  113 (289)
T ss_dssp             TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCC
T ss_pred             CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCC
Confidence            4789999999987766566667899999999999 9999999999999999999999999999999999764    5699


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc------------------CcceeecccccceecccCCcccccC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN------------------NTLKLAGLKQGVSEKAKGSAYIEQG  138 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~------------------~~~rl~~~dfG~~~~~~gs~~~~~g  138 (477)
                      +..+..++.|++.||.|||++||+||||||+||+++.                  +...+.++|||.+......      
T Consensus       114 ~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------  187 (289)
T 1x8b_A          114 EAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------  187 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS------
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc------
Confidence            9999999999999999999999999999999999974                  2335566799988654432      


Q ss_pred             CeEEEeccccccccCCCC----CcccccCcceEEEEEE
Q psy6508         139 NTKVICSVFEPREIPSSK----TSLEYQRSKGELYVEF  172 (477)
Q Consensus       139 ~t~v~~~~y~ppE~~~~~----~~~Di~~s~G~il~e~  172 (477)
                      ....+++.|+|||...+.    .++|+ ||+|++++++
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l  224 (289)
T 1x8b_A          188 QVEEGDSRFLANEVLQENYTHLPKADI-FALALTVVCA  224 (289)
T ss_dssp             CCCCCCGGGCCHHHHTTCCTTHHHHHH-HHHHHHHHHH
T ss_pred             cccCCCccccChhHhcCCCCCCchhhH-HHHHHHHHHH
Confidence            234578899999998765    57899 9999999999

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.94  E-value=3.8e-28  Score=238.29  Aligned_cols=174  Identities=23%  Similarity=0.311  Sum_probs=143.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK--------   74 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~--------   74 (477)
                      +++.||+|+++... .....+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++.....        
T Consensus        52 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  130 (314)
T 2ivs_A           52 GYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGS  130 (314)
T ss_dssp             SEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC--
T ss_pred             CcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccc
Confidence            56889999997543 455667899999999999999999999999999999999999999999999987543        


Q ss_pred             ----------------CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccC
Q psy6508          75 ----------------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQG  138 (477)
Q Consensus        75 ----------------l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g  138 (477)
                                      +++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+............
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~  209 (314)
T 2ivs_A          131 GGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKR  209 (314)
T ss_dssp             --------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECS
T ss_pred             cccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCC-CEEEccccccccccccccceec
Confidence                            88999999999999999999999999999999999998653 3445699988755433222223


Q ss_pred             CeEEEeccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         139 NTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       139 ~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ....++..|+|||...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       210 ~~~~~~~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~  255 (314)
T 2ivs_A          210 SQGRIPVKWMAIESLFDHIYTTQSDV-WSFGVLLWEIVTLGGNPYPG  255 (314)
T ss_dssp             SCCCSCGGGCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             cCCCCcccccChhhhcCCCcCchhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            334556789999987655   67899 9999999998   4577764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=5.6e-28  Score=238.57  Aligned_cols=174  Identities=24%  Similarity=0.404  Sum_probs=147.5

Q ss_pred             CCCcEEEEEEcccCCCCh----hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSE----NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||+|+++......    ...+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++...+.+++
T Consensus        35 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  114 (321)
T 2a2a_A           35 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE  114 (321)
T ss_dssp             TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEH
T ss_pred             CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCH
Confidence            478999999998765432    1356799999999999999999999999999999999999999999999998888999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcc---eeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL---KLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~---rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ..+..++.|++.||.|||++||+||||||+||+++.++.   ++.++|||.+.......   ......+++.|+|||...
T Consensus       115 ~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~  191 (321)
T 2a2a_A          115 EEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVN  191 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc---cccccCCCCCccCccccc
Confidence            999999999999999999999999999999999976542   45566999986544322   113446788999999887


Q ss_pred             CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.   .++|+ ||+|+++|++  +..||.+
T Consensus       192 ~~~~~~~~Di-~slG~il~~l~~g~~pf~~  220 (321)
T 2a2a_A          192 YEPLGLEADM-WSIGVITYILLSGASPFLG  220 (321)
T ss_dssp             TCCCCTHHHH-HHHHHHHHHHHHSCCSSCC
T ss_pred             CCCCCCcccc-HHHHHHHHHHHHCCCCCCC
Confidence            65   67899 9999999999  6678864

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=2.1e-28  Score=251.68  Aligned_cols=175  Identities=21%  Similarity=0.299  Sum_probs=143.4

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+++.||+|++++..... ...+.+.+|..+++.++||||+++++++.+++.+|+||||++||+|.+++.+ .+.+++..
T Consensus        97 ~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~  176 (437)
T 4aw2_A           97 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEM  176 (437)
T ss_dssp             TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHH
T ss_pred             CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHH
Confidence            468899999987532211 1223478999999999999999999999999999999999999999999987 46899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC-----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS-----  154 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~-----  154 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.+. .+.++|||++........ ....+.++|+.|+|||++.     
T Consensus       177 ~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g-~vkL~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~  254 (437)
T 4aw2_A          177 ARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG-HIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGG  254 (437)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTS
T ss_pred             HHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCC-CEEEcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccC
Confidence            999999999999999999999999999999997643 344569998865433221 1123457899999999875     


Q ss_pred             CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..   .++|+ ||+|+++|||  +..||.+
T Consensus       255 ~~~~~~~~Dv-wSlGvil~elltG~~Pf~~  283 (437)
T 4aw2_A          255 KGRYGPECDW-WSLGVCMYEMLYGETPFYA  283 (437)
T ss_dssp             CCEECTHHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             CCCCCCcCee-HHHHHHHHHHHhCCCCCCC
Confidence            22   68999 9999999999  7788864

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.94  E-value=8.9e-29  Score=249.23  Aligned_cols=176  Identities=23%  Similarity=0.311  Sum_probs=144.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-------C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-------K   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------~   74 (477)
                      .+++.||||+++... .......+.+|+.++++++||||+++++++......|+||||++||+|.+++...+       .
T Consensus        99 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  177 (367)
T 3l9p_A           99 PSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSS  177 (367)
T ss_dssp             -CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCC
T ss_pred             CcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCcccc
Confidence            357789999986443 44555679999999999999999999999999999999999999999999997642       4


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++..+..++.|++.||.|||++||+||||||+|||++.+  ...+.++|||.+...........+.+..+++.|+|||.
T Consensus       178 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~  257 (367)
T 3l9p_A          178 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEA  257 (367)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHH
Confidence            8999999999999999999999999999999999999743  33455669999864432222233344566788999998


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++||+   +..||.+
T Consensus       258 ~~~~~~~~~~Dv-wslG~il~ellt~g~~pf~~  289 (367)
T 3l9p_A          258 FMEGIFTSKTDT-WSFGVLLWEIFSLGYMPYPS  289 (367)
T ss_dssp             HHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             hcCCCCCcHHHH-HHHHHHHHHHHhCCCCCCCC
Confidence            7544   67899 9999999998   5678764

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=3.2e-28  Score=254.07  Aligned_cols=175  Identities=25%  Similarity=0.447  Sum_probs=149.0

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++.+.... ....+.+.+|+.++++++||||+++++++...+.+|+||||+.|++|.+++...+.+++..+
T Consensus        49 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  128 (484)
T 3nyv_A           49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDA  128 (484)
T ss_dssp             TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHH
T ss_pred             CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHH
Confidence            47899999999776543 34457799999999999999999999999999999999999999999999998889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      ..++.|++.||.|||++||+||||||+|||++.  ....+.++|||.+........   ..+..+++.|+|||+..+.  
T Consensus       129 ~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~  205 (484)
T 3nyv_A          129 ARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGTAYYIAPEVLHGTYD  205 (484)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCS---HHHHTTGGGTCCHHHHHTCCC
T ss_pred             HHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccc---cccCCCCccccCceeecCCCC
Confidence            999999999999999999999999999999953  234555669998865443321   1234678899999998766  


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ ||+|+++|++  +..||.+.
T Consensus       206 ~~~Di-wslG~il~~ll~g~~pf~~~  230 (484)
T 3nyv_A          206 EKCDV-WSTGVILYILLSGCPPFNGA  230 (484)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             Cccee-HHHHHHHHHHHHCCCCCCCC
Confidence            77899 9999999999  77898754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.94  E-value=1.3e-27  Score=235.55  Aligned_cols=173  Identities=20%  Similarity=0.285  Sum_probs=140.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC--eEEEEEecCCCCCHHHHHHhCC---CCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCSFIRSHE---KLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~lv~e~~~g~sL~~~l~~~~---~l~   76 (477)
                      .+|+.||||+++.... ....+.+.+|+.++++++||||+++++++...+  ..|+||||++|++|.+++....   .++
T Consensus        32 ~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  110 (319)
T 4euu_A           32 KTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP  110 (319)
T ss_dssp             TTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCC
T ss_pred             CCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCC
Confidence            4689999999875432 223567889999999999999999999998765  7899999999999999998643   399


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeec---cCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      +..+..++.|++.||.|||++||+||||||+|||+.   ++...+.++|||.+........   ..+..++..|+|||..
T Consensus       111 ~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~  187 (319)
T 4euu_A          111 ESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMY  187 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecccCCCccCHHHh
Confidence            999999999999999999999999999999999982   2334555679999876543321   1234678899999976


Q ss_pred             C---------CC--CcccccCcceEEEEEE--eeecccc
Q psy6508         154 S---------SK--TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~---------~~--~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .         ..  .++|+ ||+|+++||+  +..||..
T Consensus       188 ~~~~~~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~  225 (319)
T 4euu_A          188 ERAVLRKDHQKKYGATVDL-WSIGVTFYHAATGSLPFRP  225 (319)
T ss_dssp             HHHTSCCCCCCCBCTTHHH-HHHHHHHHHHHHSSCSEEC
T ss_pred             hhccccccccCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            3         12  67899 9999999999  6788863

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=1.8e-28  Score=250.30  Aligned_cols=174  Identities=22%  Similarity=0.342  Sum_probs=143.8

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++++.... ....+.+.+|..+++.++||||+++++++.+++.+|+||||++||+|.+++.. ..+++..+
T Consensus        92 ~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~  170 (410)
T 3v8s_A           92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWA  170 (410)
T ss_dssp             TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHH
T ss_pred             CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHH
Confidence            46889999998753221 11223478999999999999999999999999999999999999999999987 47999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+|||++.++ .+.++|||++........ ....+.++|+.|+|||++.+.    
T Consensus       171 ~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g-~ikL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~  248 (410)
T 3v8s_A          171 RFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSG-HLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG  248 (410)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTC
T ss_pred             HHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCC-CEEEeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCc
Confidence            99999999999999999999999999999997643 344569999876543322 123456789999999987643    


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|||  +..||.+
T Consensus       249 ~~~~~~Di-wSlGvilyell~G~~Pf~~  275 (410)
T 3v8s_A          249 YYGRECDW-WSVGVFLYEMLVGDTPFYA  275 (410)
T ss_dssp             EEETHHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             CCCCcceE-ecchHHHHHHHhCCCCCCC
Confidence               57899 9999999999  7788874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.94  E-value=8.9e-28  Score=243.47  Aligned_cols=172  Identities=24%  Similarity=0.369  Sum_probs=145.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+|+.||+|++....  ......+.+|+.+|++++||||+++++++.+.+..|+||||++|++|.+++...+ .+++..+
T Consensus        74 ~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~  151 (387)
T 1kob_A           74 ATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV  151 (387)
T ss_dssp             TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHH
T ss_pred             CCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHH
Confidence            478999999987653  3344678999999999999999999999999999999999999999999997654 6999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++.|++.||.|||++||+||||||+|||++. +...+.++|||.+........   .....+++.|+|||+..+.   
T Consensus       152 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~  228 (387)
T 1kob_A          152 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIVDREPVG  228 (387)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC---EEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcc---eeeeccCCCccCchhccCCCCC
Confidence            999999999999999999999999999999974 334555669999876543221   1245678899999998766   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|+|  +..||.+
T Consensus       229 ~~~Di-wSlG~il~elltg~~Pf~~  252 (387)
T 1kob_A          229 FYTDM-WAIGVLGYVLLSGLSPFAG  252 (387)
T ss_dssp             HHHHH-HHHHHHHHHHHHSCCSSCC
T ss_pred             CcccE-eeHhHHHHHHHhCCCCCCC
Confidence            67899 9999999999  7788874

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.94  E-value=5.4e-28  Score=240.40  Aligned_cols=175  Identities=23%  Similarity=0.292  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC---------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH---------   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~---------   72 (477)
                      ++++.||||+++... .....+.+.+|+.++++++||||+++++++...+..|+||||+++++|.+++...         
T Consensus        75 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  153 (343)
T 1luf_A           75 EPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS  153 (343)
T ss_dssp             SSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC-------
T ss_pred             CCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccc
Confidence            456899999997553 4455678999999999999999999999999999999999999999999999864         


Q ss_pred             ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc
Q psy6508          73 ---------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ  137 (477)
Q Consensus        73 ---------------~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~  137 (477)
                                     ..+++..++.++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+...........
T Consensus       154 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~  232 (343)
T 1luf_A          154 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKA  232 (343)
T ss_dssp             ---------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC-
T ss_pred             cccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCC-eEEEeecCCCcccccCccccc
Confidence                           4689999999999999999999999999999999999997643 444569998865443333233


Q ss_pred             CCeEEEeccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         138 GNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       138 g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .....++..|+|||...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       233 ~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          233 DGNDAIPIRWMPPESIFYNRYTTESDV-WAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             ---CCBCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCTTTT
T ss_pred             cCCCcccceecChhhhccCCcCccccc-HHHHHHHHHHHhcCCCcCCC
Confidence            3345667889999987544   67899 9999999998   3467764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.94  E-value=2e-27  Score=233.13  Aligned_cols=174  Identities=22%  Similarity=0.331  Sum_probs=142.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|++..........+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++...+.+++..+.
T Consensus        26 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  105 (311)
T 4agu_A           26 DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVK  105 (311)
T ss_dssp             TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHH
T ss_pred             CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHH
Confidence            46899999999777655666678899999999999999999999999999999999999999999998887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+....+...  ...+..++..|+|||...+.    .
T Consensus       106 ~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  182 (311)
T 4agu_A          106 SITWQTLQAVNFCHKHNCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGP  182 (311)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECC--------------GGGCCHHHHHTCSCCCT
T ss_pred             HHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCC-CEEEeeCCCchhccCccc--ccCCCcCCccccChHHHhcCCCCCc
Confidence            9999999999999999999999999999997643 344569999876543321  12345788899999987542    6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|++++++  +..||.+
T Consensus       183 ~~Di-~slG~il~~l~~g~~p~~~  205 (311)
T 4agu_A          183 PVDV-WAIGCVFAELLSGVPLWPG  205 (311)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             chhh-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6677764

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.94  E-value=6.3e-28  Score=241.55  Aligned_cols=175  Identities=19%  Similarity=0.296  Sum_probs=142.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCC-eEEEEEecCCCCCHHHHHHhCCC-----
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDER-YVYIILEYCDGGDLCSFIRSHEK-----   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~~-----   74 (477)
                      .+++.||||+++... .....+.+.+|+.+++++ +||||+++++++...+ .+++||||++||+|.+++.....     
T Consensus        50 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~  128 (359)
T 3vhe_A           50 ATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY  128 (359)
T ss_dssp             TCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSC
T ss_pred             ccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhcccccccc
Confidence            357899999997543 445567899999999999 7999999999988754 58999999999999999986532     


Q ss_pred             -------------------------------------------------------------CCHHHHHHHHHHHHHHHHH
Q psy6508          75 -------------------------------------------------------------LSEFQCQQFVRQLVLALKF   93 (477)
Q Consensus        75 -------------------------------------------------------------l~~~~~~~i~~qi~~aL~~   93 (477)
                                                                                   +++..+..++.|++.||.|
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~  208 (359)
T 3vhe_A          129 KTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEF  208 (359)
T ss_dssp             C------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHH
T ss_pred             ccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHH
Confidence                                                                         8999999999999999999


Q ss_pred             HHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEE
Q psy6508          94 LRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYV  170 (477)
Q Consensus        94 LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~  170 (477)
                      ||++||+||||||+|||++.+. ++.++|||.+.............+..++..|+|||...+.   .++|+ ||+|+++|
T Consensus       209 LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~  286 (359)
T 3vhe_A          209 LASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV-WSFGVLLW  286 (359)
T ss_dssp             HHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHH
T ss_pred             HHHCCcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhh-hhHHHHHH
Confidence            9999999999999999997543 3445699998754333322333456778889999987544   67899 99999999


Q ss_pred             EE---eeecccc
Q psy6508         171 EF---KFAPFAS  179 (477)
Q Consensus       171 e~---~~~Pf~~  179 (477)
                      |+   +..||.+
T Consensus       287 ellt~g~~p~~~  298 (359)
T 3vhe_A          287 EIFSLGASPYPG  298 (359)
T ss_dssp             HHTTTSCCSSTT
T ss_pred             HHHhcCCCCCCc
Confidence            98   5577765

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.94  E-value=1.1e-27  Score=236.60  Aligned_cols=169  Identities=21%  Similarity=0.296  Sum_probs=136.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------------------------------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------------------------------   51 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------------------------------   51 (477)
                      .+|+.||||+++... .....+.+.+|+.+|++++||||+++++++.+..                              
T Consensus        29 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  107 (332)
T 3qd2_B           29 VDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDA  107 (332)
T ss_dssp             TTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC--------------------
T ss_pred             CCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccc
Confidence            478999999997654 3345678999999999999999999999986543                              


Q ss_pred             ---------------------------eEEEEEecCCCCCHHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHHhCCcEE
Q psy6508          52 ---------------------------YVYIILEYCDGGDLCSFIRSHE---KLSEFQCQQFVRQLVLALKFLRENNVCH  101 (477)
Q Consensus        52 ---------------------------~~~lv~e~~~g~sL~~~l~~~~---~l~~~~~~~i~~qi~~aL~~LH~~givH  101 (477)
                                                 ..++||||++|++|.+++....   ..++..+..++.|++.||.|||++||+|
T Consensus       108 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH  187 (332)
T 3qd2_B          108 PSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMH  187 (332)
T ss_dssp             ------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             cccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeee
Confidence                                       3899999999999999998754   3566678999999999999999999999


Q ss_pred             ccCCCCceeeccCcceeecccccceecccCCcc----------cccCCeEEEeccccccccCCCC---CcccccCcceEE
Q psy6508         102 FDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY----------IEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGEL  168 (477)
Q Consensus       102 rDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~----------~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~i  168 (477)
                      |||||+||+++.+. ++.++|||.+........          .....+..+++.|+|||...+.   .++|+ ||+|++
T Consensus       188 ~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~i  265 (332)
T 3qd2_B          188 RDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDI-FSLGLI  265 (332)
T ss_dssp             CCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHH-HHHHHH
T ss_pred             cCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhH-HHHHHH
Confidence            99999999998643 455569999876543321          1122345788999999987665   77899 999999


Q ss_pred             EEEEe
Q psy6508         169 YVEFK  173 (477)
Q Consensus       169 l~e~~  173 (477)
                      +|++.
T Consensus       266 l~el~  270 (332)
T 3qd2_B          266 LFELL  270 (332)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            99994

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=3.1e-28  Score=248.60  Aligned_cols=175  Identities=20%  Similarity=0.301  Sum_probs=144.0

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~   79 (477)
                      .+|+.||||++++.... ....+.+.+|..++..++||||+++++++.+++.+|+||||++||+|.+++.+. ..+++..
T Consensus        84 ~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~  163 (412)
T 2vd5_A           84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEM  163 (412)
T ss_dssp             TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHH
T ss_pred             CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHH
Confidence            47899999999754321 122345889999999999999999999999999999999999999999999875 4799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      ++.++.|++.||.|||++||+||||||+|||++.+. .+.++|||++........ ....+.++|+.|+|||++.+    
T Consensus       164 ~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g-~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~  241 (412)
T 2vd5_A          164 ARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCG-HIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGG  241 (412)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCC-CEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccC
Confidence            999999999999999999999999999999998643 344459999875443221 11234578899999998762    


Q ss_pred             ---C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 ---K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ---~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .   .++|+ ||+|+++|||  +..||.+
T Consensus       242 ~~~~~~~~~~Di-wSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          242 PGTGSYGPECDW-WALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             TTCSEECTHHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             cCCCCCChHHhh-hHHhHHHHHHHhCCCCCCC
Confidence               1   77899 9999999999  7788864

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.94  E-value=6.3e-28  Score=234.38  Aligned_cols=173  Identities=23%  Similarity=0.340  Sum_probs=139.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++|+.||+|++..........+.+.+|+.++++++||||+++++++..++..|+||||++ ++|.+++... +.+++..+
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  102 (288)
T 1ob3_A           24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTA  102 (288)
T ss_dssp             TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTSTTCCCHHHH
T ss_pred             CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcccCCCHHHH
Confidence            468899999997665444445678899999999999999999999999999999999998 5999999764 57999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......  .......+++.|+|||...+.    
T Consensus       103 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~  179 (288)
T 1ob3_A          103 KSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYS  179 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCC
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEeECccccccCccc--cccccccccccccCchheeCCCCCC
Confidence            99999999999999999999999999999997643 34445999886543221  112345678899999987543    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       180 ~~~Di-wslG~il~~l~~g~~pf~~  203 (288)
T 1ob3_A          180 TTIDI-WSVGCIFAEMVNGTPLFPG  203 (288)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6677764

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.94  E-value=8.7e-28  Score=247.26  Aligned_cols=174  Identities=22%  Similarity=0.356  Sum_probs=141.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||+++.........+++.+|+.+|++++||||+++++++...     +.+|+||||++ ++|.+++.....++
T Consensus        49 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~  127 (432)
T 3n9x_A           49 NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLT  127 (432)
T ss_dssp             TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCC
T ss_pred             CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCC
Confidence            4788999999987665666678899999999999999999999998766     57999999997 69999999888899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc--------------------c
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--------------------E  136 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--------------------~  136 (477)
                      +..++.++.||+.||+|||++||+||||||+|||++.+. .+.++|||++.........                    .
T Consensus       128 ~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (432)
T 3n9x_A          128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK  206 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEEC---------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCC-CEEEccCCCcccccccccccccccccccccccccccchhc
Confidence            999999999999999999999999999999999997653 4455699998765432211                    1


Q ss_pred             cCCeEEEeccccccccCCC-C---CcccccCcceEEEEEE--eeeccc
Q psy6508         137 QGNTKVICSVFEPREIPSS-K---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       137 ~g~t~v~~~~y~ppE~~~~-~---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      .-.+.++|++|+|||++.. .   .++|+ ||+|+++|||  +..||.
T Consensus       207 ~~~~~~gt~~Y~APE~~~~~~~~~~~~Di-wSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          207 QLTSHVVTRWYRAPELILLQENYTKSIDI-WSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             ----CCCCCTTCCHHHHTTCSCCCTHHHH-HHHHHHHHHHHTTCTTTC
T ss_pred             cccCCCCCccccCHHHHhcCCCCCccccc-chHHHHHHHHHhcccccc
Confidence            1245678899999997532 2   77899 9999999999  444554

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.94  E-value=1.4e-27  Score=253.32  Aligned_cols=163  Identities=14%  Similarity=0.094  Sum_probs=123.4

Q ss_pred             CCcEEEEEEcccCCCC--------hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC
Q psy6508           3 QHTEVAIKCIDKTKVS--------ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~--------~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~   73 (477)
                      .|+.||+|++.+....        +...++|.+|+.+|+++ .|+||+++++++++++.+||||||++|++|.+++.+.+
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~  337 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE  337 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence            4778999999776321        23456799999999999 79999999999999999999999999999999999988


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      ++++.   +|+.||+.||+|+|++||+||||||+|||++.++ +++++|||+++......  ....+.++|+.|++||+.
T Consensus       338 ~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg-~vKL~DFGlAr~~~~~~--~~~~t~vGTp~YmAPE~l  411 (569)
T 4azs_A          338 EIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQ-HARLIDFGSIVTTPQDC--SWPTNLVQSFFVFVNELF  411 (569)
T ss_dssp             CCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTS-CEEECCCTTEESCC-----CCSHHHHHHHHHHHHHHC
T ss_pred             CCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCC-CEEEeecccCeeCCCCC--ccccCceechhhccHHHh
Confidence            88765   4789999999999999999999999999997653 44556999987654332  123457899999999999


Q ss_pred             CCC--CcccccCcceEEEEEE
Q psy6508         154 SSK--TSLEYQRSKGELYVEF  172 (477)
Q Consensus       154 ~~~--~~~Di~~s~G~il~e~  172 (477)
                      .+.  ..+|+ |+.|++.+++
T Consensus       412 ~g~~~~~~d~-~s~g~~~~~l  431 (569)
T 4azs_A          412 AENKSWNGFW-RSAPVHPFNL  431 (569)
T ss_dssp             ------------------CCC
T ss_pred             CCCCCCcccc-cccccchhhh
Confidence            887  67899 9999999887

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.94  E-value=1.2e-27  Score=252.45  Aligned_cols=174  Identities=18%  Similarity=0.249  Sum_probs=145.9

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~   78 (477)
                      .+|+.||+|++.+.... ....+.+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+|.+++...+  .+++.
T Consensus       207 ~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~  286 (576)
T 2acx_A          207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEA  286 (576)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHH
T ss_pred             CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHH
Confidence            47899999999765321 2234568899999999999999999999999999999999999999999998754  49999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++.++.||+.||.|||++||+||||||+|||++.++ .+.++|||++........   ..+.++++.|+|||++.+.  
T Consensus       287 ~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g-~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~APEvl~~~~~  362 (576)
T 2acx_A          287 RAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHG-HIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERY  362 (576)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCTTCC---EECCCSCGGGCCHHHHTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCC-CeEEEecccceecccCcc---ccccCCCccccCHHHHcCCCC
Confidence            9999999999999999999999999999999997643 344459999875443221   1234788999999998876  


Q ss_pred             -CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                       .++|+ ||+|+++|||  +..||.+.
T Consensus       363 ~~~~Di-wSLGvilyeLltG~~PF~~~  388 (576)
T 2acx_A          363 TFSPDW-WALGCLLYEMIAGQSPFQQR  388 (576)
T ss_dssp             SSHHHH-HHHHHHHHHHHHSSCSSSCS
T ss_pred             CccchH-HHHHHHHHHHHhCCCCCccc
Confidence             77899 9999999999  77888753

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.94  E-value=1e-27  Score=252.25  Aligned_cols=175  Identities=20%  Similarity=0.289  Sum_probs=146.2

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----EKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----~~l~   76 (477)
                      .+|+.||||++++..... ...+.+.+|+.+|++++||||+++++++...+.+|+||||++||+|.+++...    ..++
T Consensus       208 ~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~  287 (543)
T 3c4z_A          208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ  287 (543)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCC
T ss_pred             CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhccccccc
Confidence            478999999997654321 33467889999999999999999999999999999999999999999999764    3699


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..++.++.||+.||.|||++||+||||||+|||++.++ .+.++|||++........  ...+..+|+.|+|||++.+.
T Consensus       288 e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g-~vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~  364 (543)
T 3c4z_A          288 EPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDG-NVRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGE  364 (543)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCC-CEEEeecceeeeccCCCc--ccccccCCccccChhhhcCC
Confidence            999999999999999999999999999999999997653 344459999875443221  11234788999999998776


Q ss_pred             ---CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                         .++|+ ||+|+++|||  +..||.+.
T Consensus       365 ~~~~~~Di-wSlGvilyelltG~~PF~~~  392 (543)
T 3c4z_A          365 EYDFSVDY-FALGVTLYEMIAARGPFRAR  392 (543)
T ss_dssp             CBCTHHHH-HHHHHHHHHHHHSSCSSCCT
T ss_pred             CCChHHhc-CcchHHHHHHHhCCCCCCCC
Confidence               77899 9999999999  77898753

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.94  E-value=5.1e-28  Score=251.32  Aligned_cols=173  Identities=23%  Similarity=0.418  Sum_probs=146.6

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++.... ....+.+.+|+.+++.++||||+++++++...+.+|+||||++|++|.+++.+++.+++..+
T Consensus        39 ~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~  118 (476)
T 2y94_A           39 LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKES  118 (476)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHH
T ss_pred             CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHH
Confidence            47899999999765322 12346789999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......   ...+..+++.|+|||...+.    
T Consensus       119 ~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~-~vkL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~  194 (476)
T 2y94_A          119 RRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAG  194 (476)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTC-CEEECCCSSCEECCTTC---CBCCCCSCSTTCCHHHHTTCCBCS
T ss_pred             HHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCC-CeEEEeccchhhccccc---cccccCCCcCeEChhhccCCCCCC
Confidence            99999999999999999999999999999997653 34445999987544322   12355788999999998765    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       195 ~~~Di-wSlGvil~elltG~~Pf~~  218 (476)
T 2y94_A          195 PEVDI-WSSGVILYALLCGTLPFDD  218 (476)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             Cccee-hhhHHHHHHHhhCCCCCCC
Confidence            56899 9999999999  7788875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.94  E-value=9.1e-28  Score=236.96  Aligned_cols=174  Identities=18%  Similarity=0.213  Sum_probs=144.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC----CCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE----KLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----~l~~   77 (477)
                      ++|+.||||++....  ....+.+.+|+.+++.++||||+++++++...+..|+||||++|++|.+++....    .+++
T Consensus        61 ~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  138 (321)
T 2qkw_B           61 RDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSW  138 (321)
T ss_dssp             TTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCH
T ss_pred             CCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCH
Confidence            468899999987653  3445779999999999999999999999999999999999999999999987643    5899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+................+++.|+|||...+. 
T Consensus       139 ~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  217 (321)
T 2qkw_B          139 EQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENF-VPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGR  217 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTC-CEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCB
T ss_pred             HHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCC-CEEEeecccccccccccccccccccCCCccccCHHHhcCCC
Confidence            99999999999999999999999999999999997653 4445699988654322222223345688999999987544 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+|+++|++  +..||.+
T Consensus       218 ~~~~~Di-~slG~il~ell~g~~p~~~  243 (321)
T 2qkw_B          218 LTEKSDV-YSFGVVLFEVLCARSAIVQ  243 (321)
T ss_dssp             CCTHHHH-HHHHHHHHHHHHCCTTCSC
T ss_pred             CCcccch-HhHHHHHHHHHhCCCcccc
Confidence              77899 9999999999  7778864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.94  E-value=8.2e-28  Score=249.22  Aligned_cols=169  Identities=23%  Similarity=0.365  Sum_probs=135.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||++..........+++.+|+.+|+.++||||+++++++...     ..+|+||||+. ++|.+++.....++
T Consensus        76 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~  154 (458)
T 3rp9_A           76 LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLT  154 (458)
T ss_dssp             C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCCCC
T ss_pred             CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCCCC
Confidence            4789999999977665666678899999999999999999999998543     57999999985 89999999888899


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc----------------------
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY----------------------  134 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~----------------------  134 (477)
                      +..++.++.||+.||+|||++||+||||||+|||++.+. .+.++|||++........                      
T Consensus       155 ~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (458)
T 3rp9_A          155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHT  233 (458)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTC-CEEECCCTTCBCTTSCTTCCCCCC----------------
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCC-CEeecccccchhccCccccccccccCcccccccccccccc
Confidence            999999999999999999999999999999999998753 445569999875432110                      


Q ss_pred             ---cccCCeEEEeccccccccCC-CC---CcccccCcceEEEEEEe
Q psy6508         135 ---IEQGNTKVICSVFEPREIPS-SK---TSLEYQRSKGELYVEFK  173 (477)
Q Consensus       135 ---~~~g~t~v~~~~y~ppE~~~-~~---~~~Di~~s~G~il~e~~  173 (477)
                         .....+.++|+.|+|||++. +.   .++|+ ||+||++|||.
T Consensus       234 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Di-wSlG~il~ell  278 (458)
T 3rp9_A          234 KNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV-WSIGCIFAELL  278 (458)
T ss_dssp             -----------CCCTTCCHHHHTTCCCCCTHHHH-HHHHHHHHHHH
T ss_pred             ccccccccCCcccccccChHHhhCCCCCCcHhHH-HHHHHHHHHHH
Confidence               01123457789999999753 22   77899 99999999993

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=7.8e-28  Score=239.98  Aligned_cols=169  Identities=27%  Similarity=0.384  Sum_probs=141.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++....      ..+|+.++.++ +||||+++++++.+++.+|+||||++||+|.+++...+.+++..+
T Consensus        45 ~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~  118 (342)
T 2qr7_A           45 ATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREA  118 (342)
T ss_dssp             TTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHH
T ss_pred             CCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHH
Confidence            47889999999766432      34688889888 799999999999999999999999999999999998888999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC---cceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN---TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~---~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..++.|++.||.|||++||+||||||+|||+.++   ...+.++|||.+........  ...+..+++.|+|||+..+. 
T Consensus       119 ~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~  196 (342)
T 2qr7_A          119 SAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTANFVAPEVLERQG  196 (342)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSSCCCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCccccCHHHhcCCC
Confidence            9999999999999999999999999999998432   23455669999875433211  12345678899999998765 


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+|+++|+|  +..||.+
T Consensus       197 ~~~~~Di-wslG~il~ell~g~~Pf~~  222 (342)
T 2qr7_A          197 YDAACDI-WSLGVLLYTMLTGYTPFAN  222 (342)
T ss_dssp             HHHHHHH-HHHHHHHHHHHHSSCSSCS
T ss_pred             CCCccCe-eeHhHHHHHHhcCCCCCCC
Confidence              67899 9999999999  7789975

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.94  E-value=7.5e-28  Score=234.95  Aligned_cols=173  Identities=26%  Similarity=0.401  Sum_probs=139.1

Q ss_pred             CCCcEEEEEEcccCCCCh------------------------hHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEE
Q psy6508           2 EQHTEVAIKCIDKTKVSE------------------------NRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYI   55 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~------------------------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~l   55 (477)
                      .+|+.||||++.......                        ...+.+.+|+.++++++||||+++++++..  .+..|+
T Consensus        36 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  115 (298)
T 2zv2_A           36 NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYM  115 (298)
T ss_dssp             TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEE
T ss_pred             CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEE
Confidence            468899999997654321                        123568999999999999999999999986  568999


Q ss_pred             EEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc
Q psy6508          56 ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI  135 (477)
Q Consensus        56 v~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~  135 (477)
                      ||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+....+....
T Consensus       116 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~  193 (298)
T 2zv2_A          116 VFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDAL  193 (298)
T ss_dssp             EEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCE
T ss_pred             EEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCC-CEEEecCCCcccccccccc
Confidence            9999999999886543 5799999999999999999999999999999999999997643 3445699998765443211


Q ss_pred             ccCCeEEEeccccccccCCCC------CcccccCcceEEEEEE--eeecccc
Q psy6508         136 EQGNTKVICSVFEPREIPSSK------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       136 ~~g~t~v~~~~y~ppE~~~~~------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        ..+..+++.|+|||...+.      .++|+ ||+|+++|++  +..||.+
T Consensus       194 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di-~slG~~l~~l~~g~~pf~~  242 (298)
T 2zv2_A          194 --LSNTVGTPAFMAPESLSETRKIFSGKALDV-WAMGVTLYCFVFGQCPFMD  242 (298)
T ss_dssp             --ECCCCSCGGGCCGGGCCTTCCCEESHHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             --ccCCcCCccccChhhhccCCCCCCCchhhh-HhHHHHHHHHHHCCCCCCC
Confidence              1234678899999998754      35799 9999999999  6788865

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.94  E-value=1.4e-27  Score=229.87  Aligned_cols=175  Identities=22%  Similarity=0.344  Sum_probs=145.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|+++.... ....+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++.....+++..+.
T Consensus        30 ~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  108 (276)
T 2yex_A           30 VTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ  108 (276)
T ss_dssp             TTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHH
T ss_pred             CCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHH
Confidence            4689999999876543 234577899999999999999999999999999999999999999999999877789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.............+..++..|+|||...+.    .
T Consensus       109 ~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  187 (276)
T 2yex_A          109 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE  187 (276)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHH
T ss_pred             HHHHHHHHHHHHHHhCCeeccCCChHHEEEccCC-CEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCC
Confidence            9999999999999999999999999999997643 3445599988654322211222345678889999998765    4


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||..
T Consensus       188 ~~Di-~slG~il~~l~~g~~p~~~  210 (276)
T 2yex_A          188 PVDV-WSCGIVLTAMLAGELPWDQ  210 (276)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCCCSC
T ss_pred             cchH-HHHHHHHHHHHhCCCCCCC
Confidence            6899 9999999999  6788865

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.94  E-value=8.5e-28  Score=240.37  Aligned_cols=170  Identities=25%  Similarity=0.311  Sum_probs=130.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||||+++...    ..+.+.+|+.++++++||||+++++++...+..++||||++|++|.+++...+.+++..+.
T Consensus        76 ~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  151 (349)
T 2w4o_A           76 GTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA  151 (349)
T ss_dssp             TTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHH
T ss_pred             CCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHH
Confidence            468899999987543    2356789999999999999999999999999999999999999999999888889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.||.|||++||+||||||+||+++.  +...+.++|||.+.......   ...+..+++.|+|||...+.   
T Consensus       152 ~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~  228 (349)
T 2w4o_A          152 DAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV---LMKTVCGTPGYCAPEILRGCAYG  228 (349)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGSCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc---ccccccCCCCccCHHHhcCCCCC
Confidence            99999999999999999999999999999973  23455566999886544322   12346788999999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||..
T Consensus       229 ~~~Di-wslG~il~ell~g~~pf~~  252 (349)
T 2w4o_A          229 PEVDM-WSVGIITYILLCGFEPFYD  252 (349)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             cccch-HHHHHHHHHHHhCCCCCCC
Confidence            78999 9999999999  6678764

>4aid_A Polyribonucleotide nucleotidyltransferase; transferase-peptide complex; 2.60A {Caulobacter vibrioides} PDB: 4aim_A 4am3_A

Probab=99.94  E-value=1.8e-26  Score=244.23  Aligned_cols=219  Identities=17%  Similarity=0.231  Sum_probs=187.4

Q ss_pred             Cceeec---cCcceeecccccceecccCCcccccCCeEEEecc-ccccccCCCCCcccc--cCcceEEEEEEeeeccccc
Q psy6508         107 QNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEY--QRSKGELYVEFKFAPFASQ  180 (477)
Q Consensus       107 ~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~-y~ppE~~~~~~~~Di--~~s~G~il~e~~~~Pf~~~  180 (477)
                      +++-+|   .+++|.+.+.+|+..+++||++++.|+|++.|.+ |+|.+.....   |.  .-..|.+++++.++||++.
T Consensus       328 ~g~R~DGR~~~elRpI~ie~gvl~~a~GSAl~~~G~TkVl~~Vt~Gp~~~~~~~---d~l~~~~~g~~~~~y~~~P~st~  404 (726)
T 4aid_A          328 TGLRIDGRDVKTVRPILGEVGILPRTHGSALFTRGETQAIVVATLGTGDDEQFI---DALEGTYKESFLLHYNFPPYSVG  404 (726)
T ss_dssp             SSBCTTSCBTTCCCCEEEEECSSTTSSEEEEEEETTEEEEEEEEEECGGGSEEE---EETTEEEEECEEEEEECCGGGGT
T ss_pred             CCCCCCCCCCCCccceEEEECCCCCCCceEEEEeCCeEEEEEEEeCCCCccccc---ccccCCCceEEEEEEEeCCCccc
Confidence            444444   3689999999999999999999999999999998 9988754321   10  0245889999999999987


Q ss_pred             cccCC-CCCcchHHHHHHHHHHhhhhhh-cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEE
Q psy6508         181 IRTGW-LRDSEEKELGNHLKRALEPAVC-RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLA  258 (477)
Q Consensus       181 ~r~~~-~~~~~~~~l~~~i~~~l~~~i~-~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~  258 (477)
                      .+... .++.++.++.+.++++|++.+. .+.||++ |++.++||++||+.+.|++||+++||+||||||+++|+|+|++
T Consensus       405 er~~~g~~~~Reie~~~li~raL~~vI~~~~~~P~t-I~V~~~VLesDGs~~~AsI~aa~lAL~DAGIPm~~~VaavsvG  483 (726)
T 4aid_A          405 ETGRMGSPGRREIGHGKLAWRALRPMLPTKEDFPYT-IRLVSEITESNGSSSMATVCGSSLAMMDAGVPLVRPVSGIAMG  483 (726)
T ss_dssp             CCCCCSSCCHHHHHHHHHHHHHHGGGSCCTTTCCCE-EEEEEEEEECSSCHHHHHHHHHHHHHHHTTCCCSSCCEEEEEE
T ss_pred             ccccCCCcchhhHHHHHHHHHHHHHhcCccccCCeE-EEEEEEEEEcCCcHHHHHHHHHHHHHHhcCCccccCeeEEEEE
Confidence            66543 5778899999999999999998 7899997 9999999999999999999999999999999999999999999


Q ss_pred             eeCC----eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee---ecHHHHHHHHHHHHhcccchhh
Q psy6508         259 LRGG----LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT---IQQERLADHIEQLIGCCESLCT  331 (477)
Q Consensus       259 ~~~~----~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~---~~~~~~~~~l~~~~~~~~~i~~  331 (477)
                      +.++    .+++||+..|+..            +.+.+.+.++.+.|+.+|++|+   |+.+++.++|+.|.++|..+..
T Consensus       484 li~~g~~~~iLlD~~~~Ed~~------------gd~d~~Va~t~~gIt~lQ~d~k~~~~s~e~l~~aL~~A~~g~~~I~~  551 (726)
T 4aid_A          484 LILEQDGFAVLSDILGDEDHL------------GDMDFKVAGTSEGLTSLQMDIKIAGITPAIMEQALAQAKEGRAHILG  551 (726)
T ss_dssp             EEECSSCEEEEESCCTTGGGG------------SSEEEEEEEETTEEEEEEEEECSSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEcCCCceEEEecCChhHHhc------------CCceEEEEecCCceEEEEecCCcCCcCHHHHHHHHHHHHHHHHHHHH
Confidence            9843    4788999999873            4555555567788999999986   4999999999999999999999


Q ss_pred             HHHHhHhhhcc
Q psy6508         332 DRVQKLVSDHV  342 (477)
Q Consensus       332 ~~i~~~l~~~~  342 (477)
                      . |++++..+-
T Consensus       552 ~-m~~al~~~r  561 (726)
T 4aid_A          552 E-MNKAMDAPR  561 (726)
T ss_dssp             H-HHTTCSSCC
T ss_pred             H-HHHHHHhhh
Confidence            9 999997653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.94  E-value=6.9e-28  Score=236.94  Aligned_cols=176  Identities=21%  Similarity=0.342  Sum_probs=140.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||||+++...  ....+.+.+|+.+++++ +||||+++++++..++.+|+||||++|++|.+++...+.+++..+
T Consensus        36 ~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  113 (316)
T 2ac3_A           36 ITSQEYAVKIIEKQP--GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA  113 (316)
T ss_dssp             SSCCEEEEEEEECCS--SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHH
T ss_pred             CCCcEEEEEEEeeCc--chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHH
Confidence            478999999997653  23456789999999995 799999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc--ceeecccccceecccCCcc-----cccCCeEEEeccccccccC
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT--LKLAGLKQGVSEKAKGSAY-----IEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~--~rl~~~dfG~~~~~~gs~~-----~~~g~t~v~~~~y~ppE~~  153 (477)
                      ..++.|++.||.|||++||+||||||+||+++.++  ..+.++|||.+........     .....+..++..|+|||..
T Consensus       114 ~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  193 (316)
T 2ac3_A          114 SVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVV  193 (316)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHh
Confidence            99999999999999999999999999999997643  2345569988754321110     0111234578899999987


Q ss_pred             CC--------CCcccccCcceEEEEEE--eeeccccc
Q psy6508         154 SS--------KTSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       154 ~~--------~~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .+        ..++|+ ||+|+++|++  +..||.+.
T Consensus       194 ~~~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~~  229 (316)
T 2ac3_A          194 EAFSEEASIYDKRCDL-WSLGVILYILLSGYPPFVGR  229 (316)
T ss_dssp             HHTSHHHHHHTTTHHH-HHHHHHHHHHHHSSCSCCCC
T ss_pred             hcccccccCCCccccc-HhHHHHHHHHHHCCCCCccc
Confidence            53        167899 9999999999  77888754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=2.3e-27  Score=240.49  Aligned_cols=174  Identities=25%  Similarity=0.315  Sum_probs=140.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCC--eEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDER--YVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~--~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+|+.||||++..........+++.+|+.+++.+. ||||+++++++..++  .+|+||||++ ++|.+++.. +.+++.
T Consensus        32 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~  109 (388)
T 3oz6_A           32 RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPV  109 (388)
T ss_dssp             TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHH
T ss_pred             CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHH
Confidence            57899999999876666667788999999999997 999999999998554  7999999998 699999987 479999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-------------------cccCC
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-------------------IEQGN  139 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-------------------~~~g~  139 (477)
                      .+..++.|++.||+|||++||+||||||+|||++.+. .+.++|||++........                   .....
T Consensus       110 ~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  188 (388)
T 3oz6_A          110 HKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAEC-HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILT  188 (388)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEESSSCCCCCCCGGGCCC--------------
T ss_pred             HHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCC-CEEecCCccccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999999999999997653 455569999865432100                   01123


Q ss_pred             eEEEeccccccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         140 TKVICSVFEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       140 t~v~~~~y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.++|+.|+|||++.+.    .++|+ ||+|++++||  +..||.+
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~~Di-wSlG~il~ell~g~~pf~~  233 (388)
T 3oz6_A          189 DYVATRWYRAPEILLGSTKYTKGIDM-WSLGCILGEILCGKPIFPG  233 (388)
T ss_dssp             -CCCGGGGCCHHHHTTCCCCCTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CCcccCCcCCHHHhcCCCCCCChhhH-HHHHHHHHHHHhCCCCCCC
Confidence            45788999999988653    67899 9999999999  6677764

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.5e-28  Score=244.79  Aligned_cols=174  Identities=21%  Similarity=0.308  Sum_probs=140.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------   73 (477)
                      +++.||+|+++... .....+.+.+|+.+++++ +||||+++++++...+..|+||||++|++|.+++....        
T Consensus        74 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  152 (344)
T 1rjb_A           74 VSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEI  152 (344)
T ss_dssp             CEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-----
T ss_pred             cceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhcccccccccc
Confidence            56789999997543 333456799999999999 89999999999999999999999999999999998643        


Q ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccC
Q psy6508          74 ---------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQG  138 (477)
Q Consensus        74 ---------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g  138 (477)
                                     .+++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+............
T Consensus       153 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~  231 (344)
T 1rjb_A          153 EYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVR  231 (344)
T ss_dssp             ----------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEE
T ss_pred             chhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCC-cEEeCCCccCcccccCccceec
Confidence                           278999999999999999999999999999999999998653 4445699998654333222223


Q ss_pred             CeEEEeccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         139 NTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       139 ~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .+..+++.|+|||...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       232 ~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          232 GNARLPVKWMAPESLFEGIYTIKSDV-WSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             TTEEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccCccCccCHHHhccCCCChhHhH-HHHHHHHHHHHcCCCCCccc
Confidence            345677889999987544   67899 9999999998   4577764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.94  E-value=1.6e-28  Score=238.27  Aligned_cols=173  Identities=27%  Similarity=0.423  Sum_probs=141.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~~   77 (477)
                      .+++.||+|++..... ....+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++..    ...+++
T Consensus        45 ~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  123 (285)
T 3is5_A           45 SSGLERVIKTINKDRS-QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSE  123 (285)
T ss_dssp             TTCCEEEEEEEEGGGC-CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCH
T ss_pred             cCCceEEEEEeecccc-chhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCH
Confidence            4688999999876542 23456789999999999999999999999999999999999999999999854    357999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ..+..++.|++.||.|||++||+||||||+||+++.+  ..++.++|||.+.......   ......+++.|+|||...+
T Consensus       124 ~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~  200 (285)
T 3is5_A          124 GYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE---HSTNAAGTALYMAPEVFKR  200 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTTGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc---cCcCcccccCcCChHHhcc
Confidence            9999999999999999999999999999999999542  3445566999886433221   1234567788999998876


Q ss_pred             C--CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K--TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~--~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .  .++|+ ||+|++++++  +..||.+
T Consensus       201 ~~~~~~Di-~slG~il~~ll~g~~pf~~  227 (285)
T 3is5_A          201 DVTFKCDI-WSAGVVMYFLLTGCLPFTG  227 (285)
T ss_dssp             CCCHHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCcccCe-ehHHHHHHHHHhCCCCCCC
Confidence            5  67899 9999999999  6788865

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.94  E-value=1.8e-27  Score=229.56  Aligned_cols=172  Identities=23%  Similarity=0.370  Sum_probs=145.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|++......  ..+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++...+.+++..+.
T Consensus        32 ~~~~~~a~k~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  109 (277)
T 3f3z_A           32 GTRIRRAAKKIPKYFVE--DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAA  109 (277)
T ss_dssp             TTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHH
T ss_pred             CCCcEEEEEeehhhccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHH
Confidence            46789999998765432  3467899999999999999999999999999999999999999999999888889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeec--cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~--~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--~  157 (477)
                      .++.|++.||.|||++||+||||||+||++.  ++..++.++|||.+.......   ...+..+++.|+|||...+.  .
T Consensus       110 ~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~  186 (277)
T 3f3z_A          110 RIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEGLYGP  186 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTTCBCT
T ss_pred             HHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc---chhccCCCCCccChHHhcccCCc
Confidence            9999999999999999999999999999993  223355566999886544322   12345678899999998776  7


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|++++++  +..||..
T Consensus       187 ~~Di-~slG~~l~~l~~g~~p~~~  209 (277)
T 3f3z_A          187 ECDE-WSAGVMMYVLLCGYPPFSA  209 (277)
T ss_dssp             THHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             hhhe-hhHHHHHHHHHHCCCCCCC
Confidence            8899 9999999999  6788864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.94  E-value=2e-28  Score=240.14  Aligned_cols=175  Identities=22%  Similarity=0.280  Sum_probs=144.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-------   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------   73 (477)
                      .+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++..++..++||||+++++|.+++....       
T Consensus        51 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  129 (313)
T 1t46_A           51 DAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK  129 (313)
T ss_dssp             TCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC----
T ss_pred             chhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhccccccccc
Confidence            467899999997553 344567899999999999 99999999999999999999999999999999998753       


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEE
Q psy6508          74 -----------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKV  142 (477)
Q Consensus        74 -----------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v  142 (477)
                                 .+++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.............+..
T Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~  208 (313)
T 1t46_A          130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNAR  208 (313)
T ss_dssp             ----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSE
T ss_pred             ccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCC-CEEEccccccccccccccceeccCCC
Confidence                       389999999999999999999999999999999999997653 34456999987655443323334456


Q ss_pred             EeccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         143 ICSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       143 ~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++..|+|||...+.   .++|+ ||+|++++++   +..||.+
T Consensus       209 ~~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~  250 (313)
T 1t46_A          209 LPVKWMAPESIFNCVYTFESDV-WSYGIFLWELFSLGSSPYPG  250 (313)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCSSTT
T ss_pred             CcceeeChHHhcCCCCChHHHH-HHHHHHHHHHHhCCCCCCCc
Confidence            77889999976544   67899 9999999998   5577764

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.94  E-value=7.9e-28  Score=238.18  Aligned_cols=174  Identities=20%  Similarity=0.280  Sum_probs=139.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      .+..||||+++... .....+.+.+|+.++++++||||+++++++..++..|+||||++|++|.+++... +.+++..+.
T Consensus        76 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  154 (325)
T 3kul_A           76 RDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLV  154 (325)
T ss_dssp             CCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHH
T ss_pred             CCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHH
Confidence            35569999997543 4555678999999999999999999999999999999999999999999999764 479999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-ccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-EQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+......... .......++..|+|||...+.   .
T Consensus       155 ~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  233 (325)
T 3kul_A          155 GMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSS  233 (325)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCC-CEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCc
Confidence            9999999999999999999999999999997653 4445699998754432211 111223445679999988755   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++   +..||.+
T Consensus       234 ~~Di-~slG~il~ell~~g~~p~~~  257 (325)
T 3kul_A          234 ASDV-WSFGVVMWEVLAYGERPYWN  257 (325)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             HHHH-HHHHHHHHHHHcCCCCCccc
Confidence            7899 9999999997   5677754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.94  E-value=4.2e-28  Score=250.62  Aligned_cols=174  Identities=17%  Similarity=0.279  Sum_probs=136.4

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++... .......+.+|+.+++.++||||+++++++...+.+|+||||++|++|.+++...+.+++..+
T Consensus       171 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  250 (446)
T 4ejn_A          171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRA  250 (446)
T ss_dssp             TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHH
T ss_pred             CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHH
Confidence            4789999999976532 233446688999999999999999999999999999999999999999999988888999999


Q ss_pred             HHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.++.|++.||.|||+ +||+||||||+|||++.+. .+.++|||++.......  ....+..+++.|+|||++.+.   
T Consensus       251 ~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  327 (446)
T 4ejn_A          251 RFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYG  327 (446)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSS-CEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCC
T ss_pred             HHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCC-CEEEccCCCceeccCCC--cccccccCCccccCHhhcCCCCCC
Confidence            9999999999999998 9999999999999997653 44556999886432221  122345788999999988655   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++||+  +..||.+
T Consensus       328 ~~~Di-wslG~il~ell~g~~Pf~~  351 (446)
T 4ejn_A          328 RAVDW-WGLGVVMYEMMCGRLPFYN  351 (446)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             Cccch-hhhHHHHHHHhhCCCCCCC
Confidence            78899 9999999999  6788864

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.94  E-value=6.2e-28  Score=231.38  Aligned_cols=167  Identities=17%  Similarity=0.258  Sum_probs=144.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCC--CCCHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHE--KLSEF   78 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~--~l~~~   78 (477)
                      +++.||+|+++....+....+.+.+|+.++++++||||+++++++...  +..++||||++|++|.+++....  .+++.
T Consensus        32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  111 (271)
T 3kmu_A           32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQS  111 (271)
T ss_dssp             TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHH
T ss_pred             CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHH
Confidence            478899999988776777778899999999999999999999999876  78899999999999999998765  48999


Q ss_pred             HHHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          79 QCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      .+..++.|++.||.|||++|  ++||||||+||+++.+ ..++.++|||.....         ....+++.|+|||...+
T Consensus       112 ~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~---------~~~~~t~~y~aPE~~~~  182 (271)
T 3kmu_A          112 QAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS---------PGRMYAPAWVAPEALQK  182 (271)
T ss_dssp             HHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC---------TTCBSCGGGSCHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc---------cCccCCccccChhhhcc
Confidence            99999999999999999999  9999999999999864 677887777765222         23456789999999876


Q ss_pred             C---C---cccccCcceEEEEEE--eeecccc
Q psy6508         156 K---T---SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~---~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .   ++|+ ||+|+++|++  +..||.+
T Consensus       183 ~~~~~~~~~~Di-~slG~il~el~~g~~p~~~  213 (271)
T 3kmu_A          183 KPEDTNRRSADM-WSFAVLLWELVTREVPFAD  213 (271)
T ss_dssp             CGGGSCHHHHHH-HHHHHHHHHHHHCSCTTTT
T ss_pred             CCCCCCCchhhH-HHHHHHHHHHHhCCCCccc
Confidence            5   2   5899 9999999999  7788864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.94  E-value=2e-27  Score=240.60  Aligned_cols=174  Identities=19%  Similarity=0.359  Sum_probs=144.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------   73 (477)
                      ++..||+|+++... .....+++.+|+.+++++ +||||+++++++..++..|+||||++|++|.+++....        
T Consensus       100 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~  178 (382)
T 3tt0_A          100 RVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY  178 (382)
T ss_dssp             CEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCC
T ss_pred             cceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhccccccccc
Confidence            44689999987653 455667899999999999 99999999999999999999999999999999998753        


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEec
Q psy6508          74 --------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICS  145 (477)
Q Consensus        74 --------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~  145 (477)
                              .+++..++.++.|++.||.|||++||+||||||+|||++.+. ++.++|||.+................++.
T Consensus       179 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~  257 (382)
T 3tt0_A          179 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPV  257 (382)
T ss_dssp             CCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGG
T ss_pred             ccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCC-cEEEcccCcccccccccccccccCCCCCc
Confidence                    489999999999999999999999999999999999997643 44456999987554433323333445677


Q ss_pred             cccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         146 VFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       146 ~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .|+|||...+.   .++|+ ||+|++++++   +..||.+
T Consensus       258 ~y~aPE~~~~~~~~~~~Di-wslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          258 KWMAPEALFDRIYTHQSDV-WSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             GGSCHHHHHSCCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             ceeCHHHhcCCCCCchhHH-HHHHHHHHHHHhCCCCCCCC
Confidence            89999987665   67899 9999999998   4577764

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.94  E-value=5.8e-28  Score=238.39  Aligned_cols=173  Identities=19%  Similarity=0.327  Sum_probs=129.3

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeE------EEEEecCCCCCHHHHHHhCC-----
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYV------YIILEYCDGGDLCSFIRSHE-----   73 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~------~lv~e~~~g~sL~~~l~~~~-----   73 (477)
                      ..||||+++.........+.+.+|+.++++++||||+++++++......      +++|||+++++|.+++....     
T Consensus        52 ~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~  131 (323)
T 3qup_A           52 VKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENP  131 (323)
T ss_dssp             CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---C
T ss_pred             eeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccc
Confidence            3799999987766666678899999999999999999999999876654      99999999999999996532     


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                       .+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+...........+....++..|+|||.
T Consensus       132 ~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~  210 (323)
T 3qup_A          132 FNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDM-TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALES  210 (323)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------------CCGGGCCHHH
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCC-CEEEeeccccccccccccccccccccCcccccCchh
Confidence             599999999999999999999999999999999999997653 444569999876554443344444556678999998


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++|++   +..||.+
T Consensus       211 ~~~~~~~~~~Di-~slG~il~ell~~g~~p~~~  242 (323)
T 3qup_A          211 LADNLYTVHSDV-WAFGVTMWEIMTRGQTPYAG  242 (323)
T ss_dssp             HHHCCCCHHHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             hcCCCCCCccch-hhHHHHHHHHHhCCCCCccc
Confidence            7654   67899 9999999997   5677765

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.94  E-value=2.9e-27  Score=240.94  Aligned_cols=168  Identities=21%  Similarity=0.346  Sum_probs=133.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCC--C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHE--K   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~--~   74 (477)
                      .+|+.||||+++..       ..+.+|+.++.++ +||||+++++++..    ...+|+||||++||+|.+++...+  .
T Consensus        85 ~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~  157 (400)
T 1nxk_A           85 RTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA  157 (400)
T ss_dssp             TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---C
T ss_pred             CCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCC
Confidence            47899999998632       3467899887554 89999999999875    567999999999999999998753  5


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++..++.++.|++.||.|||++||+||||||+|||++.+  ...+.++|||++.......   ...+..+++.|+|||+
T Consensus       158 l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~  234 (400)
T 1nxk_A          158 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEV  234 (400)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--------------CTTCCGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCCC---ccccCCCCCCccCHhh
Confidence            9999999999999999999999999999999999999752  3455566999987544221   2245678899999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      +.+.   .++|+ ||+|+++|+|  +..||.+.
T Consensus       235 ~~~~~~~~~~Di-wslG~il~ell~g~~pf~~~  266 (400)
T 1nxk_A          235 LGPEKYDKSCDM-WSLGVIMYILLCGYPPFYSN  266 (400)
T ss_dssp             SCCCCSSSHHHH-HHHHHHHHHHHHSSCSCCCC
T ss_pred             cCCCCCCCcccH-HHHHHHHHHHHhCCCCCCCC
Confidence            8765   77899 9999999999  77888753

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.94  E-value=5.7e-27  Score=229.41  Aligned_cols=176  Identities=20%  Similarity=0.228  Sum_probs=145.6

Q ss_pred             CCcEEEEEEcccCCC--ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh---CCCCCH
Q psy6508           3 QHTEVAIKCIDKTKV--SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS---HEKLSE   77 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~--~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~---~~~l~~   77 (477)
                      +++.||+|++.....  .....+.+.+|+.++++++||||+++++++...+..|++|||++|++|.+++..   ...+++
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  132 (307)
T 2nru_A           53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW  132 (307)
T ss_dssp             SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCH
T ss_pred             CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCH
Confidence            578999999876432  234567899999999999999999999999999999999999999999999974   346999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..+..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+................+++.|+|||...+. 
T Consensus       133 ~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~  211 (307)
T 2nru_A          133 HMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAF-TAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEI  211 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTEE
T ss_pred             HHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCC-cEEEeecccccccccccccccccccCCCcCcCChHHhcCCC
Confidence            99999999999999999999999999999999997653 4445699988654432222222345678899999988765 


Q ss_pred             -CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                       .++|+ ||+|+++|++  +..||...
T Consensus       212 ~~~~Dv-~slG~il~~l~~g~~p~~~~  237 (307)
T 2nru_A          212 TPKSDI-YSFGVVLLEIITGLPAVDEH  237 (307)
T ss_dssp             CTHHHH-HHHHHHHHHHHHCCCSBCTT
T ss_pred             Cccchh-HHHHHHHHHHHHCCCCcccC
Confidence             77899 9999999999  77888753

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.94  E-value=1.3e-27  Score=234.87  Aligned_cols=175  Identities=18%  Similarity=0.325  Sum_probs=133.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-----eEEEEEecCCCCCHHHHHHh------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-----YVYIILEYCDGGDLCSFIRS------   71 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~------   71 (477)
                      +++.||+|+++.........+.+.+|+.++++++||||+++++++...+     ..++||||+++++|.+++..      
T Consensus        61 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~  140 (313)
T 3brb_A           61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG  140 (313)
T ss_dssp             CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTS
T ss_pred             ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcC
Confidence            5678999999877766777788999999999999999999999987654     45999999999999999943      


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccc
Q psy6508          72 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        72 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE  151 (477)
                      ...+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+...........+....+++.|+|||
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  219 (313)
T 3brb_A          141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM-TVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE  219 (313)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS-CEEECSCSCC----------------CCGGGSCHH
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEEeecCcceecccccccCcccccCCCccccCch
Confidence            34699999999999999999999999999999999999997653 34456999886554333333344455677899999


Q ss_pred             cCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         152 IPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       152 ~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       220 ~~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~  252 (313)
T 3brb_A          220 SLADRVYTSKSDV-WAFGVTMWEIATRGMTPYPG  252 (313)
T ss_dssp             HHHSSCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             hhcCCCccchhhh-HHHHHHHHHHHhcCCCCCcc
Confidence            87655   67899 9999999998   4467764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.94  E-value=2e-27  Score=229.81  Aligned_cols=174  Identities=26%  Similarity=0.421  Sum_probs=144.6

Q ss_pred             CCCcEEEEEEcccCCCCh----hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSE----NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||+|+++......    ...+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++.....+++
T Consensus        28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  107 (283)
T 3bhy_A           28 GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE  107 (283)
T ss_dssp             TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCH
T ss_pred             CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCH
Confidence            478999999998765432    1357799999999999999999999999999999999999999999999988778999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc---ceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT---LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~---~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ..+..++.|++.||.|||++|++||||||+||+++.+.   .++.++|||.+........   .....+++.|+|||...
T Consensus       108 ~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~  184 (283)
T 3bhy_A          108 DEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVN  184 (283)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCCcCccCcceec
Confidence            99999999999999999999999999999999997643   2555669998865443221   12345788899999887


Q ss_pred             CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.   .++|+ |++|++++++  +..||.+
T Consensus       185 ~~~~~~~~Di-~slG~il~~l~~g~~p~~~  213 (283)
T 3bhy_A          185 YEPLGLEADM-WSIGVITYILLSGASPFLG  213 (283)
T ss_dssp             TCCCCTHHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             CCCCCcchhh-hhHHHHHHHHHHCCCCCCC
Confidence            65   67899 9999999999  6678764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=7e-28  Score=239.90  Aligned_cols=177  Identities=25%  Similarity=0.418  Sum_probs=139.2

Q ss_pred             CCCcEEEEEEcccCCC---ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-------
Q psy6508           2 EQHTEVAIKCIDKTKV---SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-------   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-------   71 (477)
                      .+++.||+|++.+...   .....+.+.+|+.++++++||||+++++++.+.+..|+||||++|++|.+++..       
T Consensus        49 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~  128 (345)
T 3hko_A           49 QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG  128 (345)
T ss_dssp             TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTT
T ss_pred             CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccc
Confidence            5788999999876432   334567899999999999999999999999999999999999999999999852       


Q ss_pred             ---------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cce
Q psy6508          72 ---------------------------------HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLK  117 (477)
Q Consensus        72 ---------------------------------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~r  117 (477)
                                                       ...+++..++.++.|++.||.|||++||+||||||+||+++.+ ..+
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~  208 (345)
T 3hko_A          129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFE  208 (345)
T ss_dssp             EEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCC
T ss_pred             ccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCce
Confidence                                             0124677889999999999999999999999999999999754 335


Q ss_pred             eecccccceecccCC--cccccCCeEEEeccccccccCCCC-----CcccccCcceEEEEEE--eeecccc
Q psy6508         118 LAGLKQGVSEKAKGS--AYIEQGNTKVICSVFEPREIPSSK-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       118 l~~~dfG~~~~~~gs--~~~~~g~t~v~~~~y~ppE~~~~~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.++|||.+......  .......+..+++.|+|||...+.     .++|+ ||+|+++|++  +..||.+
T Consensus       209 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di-wslG~il~el~~g~~pf~~  278 (345)
T 3hko_A          209 IKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA-WSAGVLLHLLLMGAVPFPG  278 (345)
T ss_dssp             EEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             EEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH-HHHHHHHHHHHHCCCCCCC
Confidence            566699988643211  111122356788899999987642     67899 9999999999  6788864

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.94  E-value=5.1e-27  Score=232.70  Aligned_cols=174  Identities=21%  Similarity=0.281  Sum_probs=142.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|++..........+.+.+|+.++++++||||+++++++...+..|+||||+++++|.+++...+.+++..+.
T Consensus        48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  127 (331)
T 4aaa_A           48 DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQ  127 (331)
T ss_dssp             TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHH
T ss_pred             CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHH
Confidence            46899999999777666666677899999999999999999999999999999999999999999988777789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.......  .......++..|+|||...+.    .
T Consensus       128 ~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~  204 (331)
T 4aaa_A          128 KYLFQIINGIGFCHSHNIIHRDIKPENILVSQSG-VVKLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGK  204 (331)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCTTC--------------CCCCCTTCCHHHHTTCTTCCT
T ss_pred             HHHHHHHHHHHHHHHCCEEccCcChheEEEcCCC-cEEEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcch
Confidence            9999999999999999999999999999997653 44456999886443221  112345678889999987653    6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||.+
T Consensus       205 ~~Di-~slG~il~~l~~g~~pf~~  227 (331)
T 4aaa_A          205 AVDV-WAIGCLVTEMFMGEPLFPG  227 (331)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             HHHH-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6677764

>2po1_B Probable exosome complex exonuclease 2; RNAse PH, hydrolase/hydrolase/RNA complex; 1.94A {Pyrococcus abyssi} PDB: 2po0_B* 2pnz_B 2po2_B*

Probab=99.94  E-value=2.4e-25  Score=214.62  Aligned_cols=209  Identities=23%  Similarity=0.269  Sum_probs=183.5

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEecccc-ccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE-PREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEK  192 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~-ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~  192 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.++. +.+....     - -..|.+.+++.+.||+...+....++..+.
T Consensus        34 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~~-----~-~~~g~l~~~~~~~p~a~~~~~~g~~~~~~~  107 (277)
T 2po1_B           34 EDYRPIEIEVGVIEKAEGSALVKLGSTQVLVGIKTSLGEPFPD-----T-PNMGVMTTNVELVPLASPTFEPGPPDERAI  107 (277)
T ss_dssp             TCCCCEEEEECCSTTSSEEEEEEETTEEEEEEEEEEEECCCTT-----C-TTSCEEEEEEEECGGGCTTCCSSSCCHHHH
T ss_pred             CCcCCeEEEeCCcCCCCeEEEEEECCeEEEEEEEecccCCCCC-----C-CCceEEEEEEEeCCCccccccCCCCChHHH
Confidence            57899999999999999999999999999999994 4343222     2 456899999999999987666666788899


Q ss_pred             HHHHHHHHHhhh--hhhcccC---CC---CcccEEEEEEeCCCchHHHHHHHHHHHHhhCC-------------------
Q psy6508         193 ELGNHLKRALEP--AVCRHEF---SN---FQVDLFVLVLQNDGSALSAAINCANLALVDAA-------------------  245 (477)
Q Consensus       193 ~l~~~i~~~l~~--~i~~~~~---Pr---~~i~i~v~vL~~dg~~~~a~inaa~lAL~dag-------------------  245 (477)
                      ++++++++++++  ++.++.+   |+   |.|.+.++||++||+.+.++++|+++||.|||                   
T Consensus       108 ~l~~li~r~l~~s~~idl~~L~i~pg~~~w~i~id~~VL~~dG~~~~a~i~aa~~AL~da~~p~~~~~~~~~~~~~~~~~  187 (277)
T 2po1_B          108 ELARVIDRGIRESKALNLEKMVIVPGKIVRVVFIDVHVLDHDGNLMDAIGIAAIAALLNARVPKVRYNEETGEVETLDET  187 (277)
T ss_dssp             HHHHHHHHHHHTTTSBCGGGGEEETTTEEEEEEEEEEEEECSSCHHHHHHHHHHHHHHHCEEEEEEECTTTCCEEEEEEE
T ss_pred             HHHHHHHHHHhhcccccHHHccccCCcEEEEEEEEEEEECCCCCHHHHHHHHHHHHHHhcCCCcEEEeCCCceeeccccc
Confidence            999999999998  4666655   53   59999999999999999999999999999999                   


Q ss_pred             --CCCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE--eeecHHHHHHHHHH
Q psy6508         246 --IPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV--GTIQQERLADHIEQ  321 (477)
Q Consensus       246 --i~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~--g~~~~~~~~~~l~~  321 (477)
                        +||+++++++|+++.++.+++||+..||..          +.+.+++++. ..++|+.++..  |.++.+++.++++.
T Consensus       188 ~~ipl~~~~~avs~g~~~~~~l~Dp~~~Ee~~----------~~~~~~v~~~-~~g~i~~lq~~g~~~~~~~~l~~~l~~  256 (277)
T 2po1_B          188 EPLPVEKIPVPVTFAKIGNILVVDPSLDEELV----------MDGKITITTD-ETGHISAVQKSEGGAFKLEEVMYAVET  256 (277)
T ss_dssp             EECCBCCCCEEEEEEEETTEEEESCCHHHHHH----------CSEEEEEEEC-TTSCEEEEEEESSCCCCHHHHHHHHHH
T ss_pred             ccccccCceEEEEEEEECCEEEeCCCHHHHhh----------CCCcEEEEEc-CCCCEEEEEccCCCCCCHHHHHHHHHH
Confidence              899999999999999999999999999985          4788999974 45789999998  68999999999999


Q ss_pred             HHhcccchhhHHHHhHhhh
Q psy6508         322 LIGCCESLCTDRVQKLVSD  340 (477)
Q Consensus       322 ~~~~~~~i~~~~i~~~l~~  340 (477)
                      |.++|+++.+. +++.+.+
T Consensus       257 A~~~~~~l~~~-~~~~l~~  274 (277)
T 2po1_B          257 AFKKAEEIRKL-ILEAVEK  274 (277)
T ss_dssp             HHHHHHHHHHH-HHHHHHH
T ss_pred             HHHHHHHHHHH-HHHHHhh
Confidence            99999999999 9988865

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.94  E-value=3.2e-27  Score=229.70  Aligned_cols=175  Identities=18%  Similarity=0.249  Sum_probs=139.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||||+++.........+.+.+|+.+++.++||||+++++++ ..+..|+||||+++++|.+++...+.+++..+.
T Consensus        42 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  120 (291)
T 1xbb_A           42 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNII  120 (291)
T ss_dssp             SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHH
T ss_pred             CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHH
Confidence            3578999999987655555577899999999999999999999998 567789999999999999999988889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+........ ........++..|+|||...+.   .
T Consensus       121 ~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  199 (291)
T 1xbb_A          121 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS  199 (291)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH
T ss_pred             HHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCC-cEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCCh
Confidence            9999999999999999999999999999997653 344569998865433221 1122223445679999988665   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++   +..||.+
T Consensus       200 ~~Di-~slG~il~~l~~~g~~p~~~  223 (291)
T 1xbb_A          200 KSDV-WSFGVLMWEAFSYGQKPYRG  223 (291)
T ss_dssp             HHHH-HHHHHHHHHHHTTTCCSSTT
T ss_pred             hhhH-HHHHHHHHHHHhcCCCCCCC
Confidence            7899 9999999998   4577764

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=2e-27  Score=229.48  Aligned_cols=172  Identities=24%  Similarity=0.364  Sum_probs=141.3

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++....... ...+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++.....+++..+
T Consensus        32 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~  111 (279)
T 3fdn_A           32 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT  111 (279)
T ss_dssp             TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHH
T ss_pred             cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHH
Confidence            467899999986543222 2345788999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......    .....+++.|+|||...+.   .
T Consensus       112 ~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~-~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  186 (279)
T 3fdn_A          112 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAG-ELKIADFGWSVHAPSSR----RTDLCGTLDYLPPEMIEGRMHDE  186 (279)
T ss_dssp             HHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTS-CEEECSCCEESCC------------CCCCTTCCHHHHTTCCCCT
T ss_pred             HHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCC-CEEEEeccccccCCccc----ccccCCCCCccCHhHhccCCCCc
Confidence            99999999999999999999999999999997643 34445999875443322    1345677899999988765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|+++|++  +..||..
T Consensus       187 ~~Di-~slG~il~~l~~g~~p~~~  209 (279)
T 3fdn_A          187 KVDL-WSLGVLCYEFLVGKPPFEA  209 (279)
T ss_dssp             THHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             cchh-HhHHHHHHHHHHCCCCCCC
Confidence            7899 9999999999  6778764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.94  E-value=2.6e-27  Score=228.56  Aligned_cols=175  Identities=25%  Similarity=0.437  Sum_probs=129.1

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~   79 (477)
                      .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++...+..|+||||+++++|.+++... ..+++..
T Consensus        34 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  113 (278)
T 3cok_A           34 HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENE  113 (278)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHH
T ss_pred             cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHH
Confidence            47899999998654321 123467899999999999999999999999999999999999999999999875 5799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.......  ....+..+++.|+|||...+.   
T Consensus       114 ~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~  190 (278)
T 3cok_A          114 ARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHG  190 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTC-CEEECCCTTCEECC-----------------------------
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC-CEEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCC
Confidence            999999999999999999999999999999997643 34455999886543221  112345678899999998765   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ |++|++++++  +..||...
T Consensus       191 ~~~Di-~slG~il~~l~~g~~p~~~~  215 (278)
T 3cok_A          191 LESDV-WSLGCMFYTLLIGRPPFDTD  215 (278)
T ss_dssp             -CTHH-HHHHHHHHHHHHSSCSSCCC
T ss_pred             chhhH-HHHHHHHHHHHhCCCCCCCh
Confidence            67899 9999999999  77888754

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.94  E-value=3.2e-27  Score=232.84  Aligned_cols=172  Identities=26%  Similarity=0.349  Sum_probs=140.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC------CCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH------EKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~------~~l   75 (477)
                      .+|+.||+|+++.... ....+.+.+|+.++++++||||+++++++..++..|+||||++ ++|.+++...      ..+
T Consensus        28 ~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~  105 (317)
T 2pmi_A           28 TTGVYVALKEVKLDSE-EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGL  105 (317)
T ss_dssp             SSCCEEEEEEEECCST-TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCC
T ss_pred             CCCcEEEEEEeecccc-cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCC
Confidence            4789999999976542 2234568899999999999999999999999999999999998 6999998753      358


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......  .......+++.|+|||...+
T Consensus       106 ~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~  182 (317)
T 2pmi_A          106 ELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRG-QLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMG  182 (317)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCC-CEEECcCccceecCCCc--ccCCCCcccccccCchHhhC
Confidence            9999999999999999999999999999999999997643 34445999886543221  12234567889999998765


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|+++|++  +..||.+
T Consensus       183 ~~~~~~~~Di-wslG~il~el~~g~~pf~~  211 (317)
T 2pmi_A          183 SRTYSTSIDI-WSCGCILAEMITGKPLFPG  211 (317)
T ss_dssp             CCCCCTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            3    67899 9999999999  6677763

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.93  E-value=4e-27  Score=230.46  Aligned_cols=171  Identities=27%  Similarity=0.395  Sum_probs=141.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|+++....  ...+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++...+.+++..+.
T Consensus        32 ~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  109 (304)
T 2jam_A           32 LTGKLFALKCIKKSPA--FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS  109 (304)
T ss_dssp             TTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHH
T ss_pred             CCCCEEEEEEEecccc--cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHH
Confidence            4789999999976532  23356889999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeec--cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~--~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.||.|||++||+||||||+||++.  ++..++.++|||.+.......    ..+..+++.|+|||...+.   
T Consensus       110 ~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~  185 (304)
T 2jam_A          110 LVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVLAQKPYS  185 (304)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBT----THHHHSCCCBCCTTTBSSCSCC
T ss_pred             HHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCc----cccccCCCCccChHHhccCCCC
Confidence            9999999999999999999999999999993  233456667999875433221    1234567889999998765   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       186 ~~~Di-~slG~il~~l~~g~~pf~~  209 (304)
T 2jam_A          186 KAVDC-WSIGVITYILLCGYPPFYE  209 (304)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             chhhH-HHHHHHHHHHHHCCCCCCC
Confidence            67899 9999999999  6678764

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.93  E-value=4.8e-27  Score=232.09  Aligned_cols=172  Identities=17%  Similarity=0.240  Sum_probs=140.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER----YVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .++.||||+++...   .....+.+|+.++++++||||+++++++....    .+|+||||+++|+|.++++.. .+++.
T Consensus        46 ~~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~  121 (322)
T 3soc_A           46 LNEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWN  121 (322)
T ss_dssp             TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHH
T ss_pred             CCCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHH
Confidence            46889999986542   33345667999999999999999999998743    479999999999999999874 69999


Q ss_pred             HHHHHHHHHHHHHHHHHhC----------CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          79 QCQQFVRQLVLALKFLREN----------NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~----------givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                      .+..++.|++.||.|||++          ||+||||||+|||++.+. .+.++|||.+................+++.|+
T Consensus       122 ~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~  200 (322)
T 3soc_A          122 ELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACIADFGLALKFEAGKSAGDTHGQVGTRRYM  200 (322)
T ss_dssp             HHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC-CEEECCCTTCEEECTTSCCCCCTTCCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC-eEEEccCCcccccccccCccccccCccCcccc
Confidence            9999999999999999999          999999999999997653 34456999987654433322333467889999


Q ss_pred             ccccCCCC--------CcccccCcceEEEEEE--eeeccccc
Q psy6508         149 PREIPSSK--------TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       149 ppE~~~~~--------~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      |||...+.        .++|+ ||+|+++||+  +..||.+.
T Consensus       201 aPE~~~~~~~~~~~~~~~~Di-wslG~il~el~tg~~pf~~~  241 (322)
T 3soc_A          201 APEVLEGAINFQRDAFLRIDM-YAMGLVLWELASRCTAADGP  241 (322)
T ss_dssp             CHHHHTTCCCCCHHHHHHHHH-HHHHHHHHHHHTTBTTSSSC
T ss_pred             CHhhcccccccCcCCCccchh-HHHHHHHHHHHhCCCCCCCC
Confidence            99998762        46799 9999999999  66788753

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.2e-27  Score=239.89  Aligned_cols=175  Identities=22%  Similarity=0.345  Sum_probs=143.9

Q ss_pred             CCCcEEEEEEcccCCCC--hhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVS--ENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+|+.||||++++....  ....+.+.+|+.+++.+ +||||+++++++..++..|+||||++|++|.+++...+.+++.
T Consensus        80 ~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~  159 (355)
T 1vzo_A           80 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH  159 (355)
T ss_dssp             TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHH
T ss_pred             CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHH
Confidence            47899999998764321  12234567899999999 7999999999999999999999999999999999887889999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++||+||||||+|||++.+. ++.++|||++........ ....+..+++.|+|||...+.  
T Consensus       160 ~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~  237 (355)
T 1vzo_A          160 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADET-ERAYDFCGTIEYMAPDIVRGGDS  237 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECCGGGG-GGGCGGGSCCTTCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC-cEEEeeCCCCeecccCCC-CcccCcccCcCccChhhhcCCCC
Confidence            9999999999999999999999999999999997653 444569999865432211 112234678899999998752  


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|++  +..||..
T Consensus       238 ~~~~~~Dv-wslG~il~ell~g~~pf~~  264 (355)
T 1vzo_A          238 GHDKAVDW-WSLGVLMYELLTGASPFTV  264 (355)
T ss_dssp             --CTHHHH-HHHHHHHHHHHHSSCTTSC
T ss_pred             CCCchhhH-HHHHHHHHHHHHCCCCCcc
Confidence               67899 9999999999  6788864

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.93  E-value=2.9e-27  Score=227.17  Aligned_cols=171  Identities=19%  Similarity=0.301  Sum_probs=141.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +++.||+|++.......   +++.+|+.++++++||||+++++++.+++..|+||||+++++|.+++... +.+++..+.
T Consensus        33 ~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  109 (269)
T 4hcu_A           33 NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLL  109 (269)
T ss_dssp             TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHH
T ss_pred             CCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHH
Confidence            57789999998665433   56889999999999999999999999999999999999999999999764 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+........ .......++..|+|||...+.   .+
T Consensus       110 ~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~  187 (269)
T 4hcu_A          110 GMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSK  187 (269)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCeecCCcchheEEEcCCC-CEEecccccccccccccc-ccccCcccccccCCHHHhcCCCCCch
Confidence            9999999999999999999999999999997653 344569998865433222 222334456779999987644   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|+++|++   +..||.+
T Consensus       188 ~Di-~slG~~l~~ll~~g~~p~~~  210 (269)
T 4hcu_A          188 SDV-WSFGVLMWEVFSEGKIPYEN  210 (269)
T ss_dssp             HHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             hhh-HHHHHHHHHHhcCCCCCCCC
Confidence            899 9999999998   5677764

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.93  E-value=5.5e-27  Score=230.52  Aligned_cols=165  Identities=19%  Similarity=0.218  Sum_probs=135.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~   79 (477)
                      .+|+.||||++...........++..|+..+.++ +||||+++++++..++..|+||||+ +++|.+++... ..+++..
T Consensus        80 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~  158 (311)
T 3p1a_A           80 EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQ  158 (311)
T ss_dssp             TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHH
T ss_pred             CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHH
Confidence            4789999999877665555566677777777666 8999999999999999999999999 57999988764 3699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--C
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--T  157 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--~  157 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......   ......+++.|+|||...+.  .
T Consensus       159 ~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~  234 (311)
T 3p1a_A          159 VWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAG---AGEVQEGDPRYMAPELLQGSYGT  234 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGG-CEEECCCTTCEECC---------CCCCCGGGCCGGGGGTCCST
T ss_pred             HHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC-CEEEccceeeeecccCC---CCcccCCCccccCHhHhcCCCCc
Confidence            999999999999999999999999999999997643 34456999876543221   22345578899999998776  7


Q ss_pred             cccccCcceEEEEEE
Q psy6508         158 SLEYQRSKGELYVEF  172 (477)
Q Consensus       158 ~~Di~~s~G~il~e~  172 (477)
                      ++|+ ||+|++++|+
T Consensus       235 ~~Di-wslG~il~el  248 (311)
T 3p1a_A          235 AADV-FSLGLTILEV  248 (311)
T ss_dssp             HHHH-HHHHHHHHHH
T ss_pred             hhhH-HHHHHHHHHH
Confidence            7899 9999999999

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.93  E-value=3e-27  Score=238.52  Aligned_cols=175  Identities=21%  Similarity=0.295  Sum_probs=133.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      +++..||||+++... .....+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++...+ .+++..+
T Consensus        71 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~  149 (373)
T 2qol_A           71 KKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQL  149 (373)
T ss_dssp             SCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHH
T ss_pred             CCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHH
Confidence            357789999997653 45566789999999999999999999999999999999999999999999998754 6999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc-CCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ-GNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~-g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+........... .....++..|+|||...+.   
T Consensus       150 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  228 (373)
T 2qol_A          150 VGMLRGIASGMKYLSDMGYVHRDLAARNILINSNL-VCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT  228 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC----------------------CTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCC-CEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcC
Confidence            99999999999999999999999999999997653 344569998865443221111 1112335579999987654   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++||+   +..||..
T Consensus       229 ~~~Dv-~SlG~il~ellt~g~~P~~~  253 (373)
T 2qol_A          229 SASDV-WSYGIVLWEVMSYGERPYWE  253 (373)
T ss_dssp             HHHHH-HHHHHHHHHHHTTC-CTTTT
T ss_pred             chhcH-HHHHHHHHHHHhCCCCCCCC
Confidence            67899 9999999996   5677754

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.93  E-value=3.1e-27  Score=226.76  Aligned_cols=172  Identities=22%  Similarity=0.303  Sum_probs=141.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      +++..||+|+++......   +++.+|+.++++++||||+++++++..++..|+||||+++++|.+++...+ .+++..+
T Consensus        30 ~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  106 (268)
T 3sxs_A           30 KGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL  106 (268)
T ss_dssp             TTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHH
T ss_pred             cCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHH
Confidence            356789999997665433   568899999999999999999999999999999999999999999998754 5999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.......... .....++..|+|||...+.   .
T Consensus       107 ~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~  184 (268)
T 3sxs_A          107 LEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQYVS-SVGTKFPVKWSAPEVFHYFKYSS  184 (268)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTC-CEEECCTTCEEECCTTCEEE-CCSCCCCGGGCCHHHHHHSEEET
T ss_pred             HHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCC-CEEEccCccceecchhhhhc-ccCCCcCcccCCHHHHhccCCch
Confidence            99999999999999999999999999999997653 34456999887554433221 1223445679999998765   7


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|++++++   +..||..
T Consensus       185 ~~Di-~slG~il~~l~~~g~~p~~~  208 (268)
T 3sxs_A          185 KSDV-WAFGILMWEVFSLGKMPYDL  208 (268)
T ss_dssp             THHH-HHHHHHHHHHHTTTCCTTTT
T ss_pred             hhhh-HHHHHHHHHHHcCCCCCccc
Confidence            8899 9999999998   4567754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.93  E-value=1.4e-26  Score=225.40  Aligned_cols=175  Identities=23%  Similarity=0.373  Sum_probs=146.7

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++...+.+++..+
T Consensus        38 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  117 (294)
T 2rku_A           38 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA  117 (294)
T ss_dssp             TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHH
T ss_pred             CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHH
Confidence            4688999999876644 345567899999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.......  .......++..|+|||...+.   .
T Consensus       118 ~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  194 (294)
T 2rku_A          118 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSF  194 (294)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCT
T ss_pred             HHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCC-CEEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCc
Confidence            99999999999999999999999999999998652 34445999886543211  111234567889999998765   6


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ |++|++++++  +..||.+.
T Consensus       195 ~~Di-~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          195 EVDV-WSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCTTCCS
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999999  77888653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=4e-27  Score=237.10  Aligned_cols=169  Identities=24%  Similarity=0.377  Sum_probs=142.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++..........+++.+|+.+|+.++||||+++++++...+      .+|+||||+ +++|.++++. +.+
T Consensus        48 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l  125 (367)
T 1cm8_A           48 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKL  125 (367)
T ss_dssp             TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCC
T ss_pred             CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCC
Confidence            57899999999776666666778999999999999999999999987653      469999999 6999999987 579


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+......     ....++++.|+|||...+
T Consensus       126 ~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~  199 (367)
T 1cm8_A          126 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILN  199 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCC-CEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhC
Confidence            9999999999999999999999999999999999998653 3445699998765432     234567889999998755


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|++++|+  +..||.+
T Consensus       200 ~~~~~~~~Di-wslG~il~ell~g~~pf~~  228 (367)
T 1cm8_A          200 WMRYTQTVDI-WSVGCIMAEMITGKTLFKG  228 (367)
T ss_dssp             TTCCCTTHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCChhhhH-HHHHHHHHHHHhCCCCCCC
Confidence            2    77899 9999999999  6677764

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.93  E-value=3e-27  Score=233.00  Aligned_cols=174  Identities=21%  Similarity=0.288  Sum_probs=144.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      +++.||+|.+.... .......+.+|+.++++++||||+++++++...+..++||||++|++|.+++...          
T Consensus        54 ~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  132 (322)
T 1p4o_A           54 PETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL  132 (322)
T ss_dssp             EEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTC
T ss_pred             CceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCC
Confidence            57789999987543 4445567999999999999999999999999999999999999999999999752          


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ..+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+...........+....+++.|+|||.
T Consensus       133 ~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  211 (322)
T 1p4o_A          133 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  211 (322)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC-eEEECcCccccccccccccccccCCCCCCCccChhh
Confidence            3578999999999999999999999999999999999998653 344569999876544443344445677888999998


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++|++   +..||.+
T Consensus       212 ~~~~~~~~~~Di-~slG~il~el~~~g~~p~~~  243 (322)
T 1p4o_A          212 LKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQG  243 (322)
T ss_dssp             HHHCCCCHHHHH-HHHHHHHHHHHHTSCCTTTT
T ss_pred             hccCCCCchhhH-HHHHHHHHHHHhcCCCcccc
Confidence            7544   67899 9999999998   4567754

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.93  E-value=2.6e-27  Score=256.37  Aligned_cols=175  Identities=19%  Similarity=0.307  Sum_probs=146.8

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+++.||||++++... .....+.+.+|..++..+ +||||+++++++.+.+.+|+||||++||+|.+++...+.+++..
T Consensus       364 ~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~  443 (674)
T 3pfq_A          364 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPH  443 (674)
T ss_dssp             SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHH
T ss_pred             CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHH
Confidence            4788999999976432 123346688999999988 79999999999999999999999999999999999888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.......  ....+..+|+.|+|||++.+.   
T Consensus       444 ~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g-~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~  520 (674)
T 3pfq_A          444 AVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEG-HIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYG  520 (674)
T ss_dssp             HHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSS-CEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBS
T ss_pred             HHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCC-cEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCC
Confidence            999999999999999999999999999999997653 34455999987432221  122356788999999998766   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ ||+|+++|||  +..||.+.
T Consensus       521 ~~~Dv-wSlGvilyelltG~~Pf~~~  545 (674)
T 3pfq_A          521 KSVDW-WAFGVLLYEMLAGQAPFEGE  545 (674)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             ccceE-echHHHHHHHHcCCCCCCCC
Confidence            78999 9999999999  77888753

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.93  E-value=2.9e-27  Score=234.22  Aligned_cols=174  Identities=24%  Similarity=0.366  Sum_probs=143.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~   78 (477)
                      .+|+.||+|+++...........+.+|+.+++.+ +||||+++++++...+..|+||||++|++|.+++...  +.+++.
T Consensus        52 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~  131 (327)
T 3lm5_A           52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSEN  131 (327)
T ss_dssp             TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHH
T ss_pred             CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHH
Confidence            4689999999987665555567899999999999 5799999999999999999999999999999998653  579999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      .++.++.|++.||.|||++||+||||||+||+++.  +..++.++|||.+.......   ......+++.|+|||...+.
T Consensus       132 ~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~  208 (327)
T 3lm5_A          132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYD  208 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCC
Confidence            99999999999999999999999999999999976  23345556999987544322   11345678899999998765


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|+++|++  +..||.+
T Consensus       209 ~~~~~~Di-wslG~il~~ll~g~~pf~~  235 (327)
T 3lm5_A          209 PITTATDM-WNIGIIAYMLLTHTSPFVG  235 (327)
T ss_dssp             CCCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence               67899 9999999999  6778764

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.93  E-value=5.6e-27  Score=232.69  Aligned_cols=175  Identities=19%  Similarity=0.361  Sum_probs=142.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-------   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------   73 (477)
                      .+++.||+|+++... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+++++|.+++....       
T Consensus        65 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  143 (334)
T 2pvf_A           65 KEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS  143 (334)
T ss_dssp             ---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSC
T ss_pred             ccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhcccccccc
Confidence            357789999997553 455567899999999999 89999999999999999999999999999999998653       


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEe
Q psy6508          74 ---------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVIC  144 (477)
Q Consensus        74 ---------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~  144 (477)
                               .+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+................++
T Consensus       144 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~  222 (334)
T 2pvf_A          144 YDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLP  222 (334)
T ss_dssp             C--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCC
T ss_pred             ccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCC-CEEEccccccccccccccccccCCCCcc
Confidence                     389999999999999999999999999999999999997643 3445599998765543332333334556


Q ss_pred             ccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         145 SVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       145 ~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..|+|||...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       223 ~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          223 VKWMAPEALFDRVYTHQSDV-WSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             GGGCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             cceeChHHhcCCCcChHHHH-HHHHHHHHHHHhCCCCCcCc
Confidence            789999987655   67899 9999999998   4577764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.93  E-value=8.2e-27  Score=229.19  Aligned_cols=174  Identities=23%  Similarity=0.413  Sum_probs=141.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC--CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH--HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      ++++.||+|++..........+.+.+|+.++++++  ||||+++++++..++..|++||+ .+++|.+++...+.+++..
T Consensus        50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~  128 (313)
T 3cek_A           50 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWE  128 (313)
T ss_dssp             TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHH
T ss_pred             CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHH
Confidence            46889999999877766677788999999999996  59999999999999999999994 5699999999888899999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      +..++.|++.||.|||++||+||||||+||+++++.+++  +|||.+.............+..+++.|+|||...+    
T Consensus       129 ~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~kL--~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  206 (313)
T 3cek_A          129 RKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVDGMLKL--IDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS  206 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTEEEE--CCCSSSCC--------------CCGGGCCHHHHTTCC--
T ss_pred             HHHHHHHHHHHHHHHHHCCceecCCCcccEEEECCeEEE--eeccccccccCccccccccCCCCCCCcCCHHHHhhcccc
Confidence            999999999999999999999999999999998766555  49998865443322222345678899999999764    


Q ss_pred             --------C--CcccccCcceEEEEEE--eeecccc
Q psy6508         156 --------K--TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 --------~--~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                              .  .++|+ ||+|+++|++  +..||..
T Consensus       207 ~~~~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~  241 (313)
T 3cek_A          207 RENGKSKSKISPKSDV-WSLGCILYYMTYGKTPFQQ  241 (313)
T ss_dssp             --------CCCHHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             cccccccccCCchHHH-HHHHHHHHHHHhCCCchhh
Confidence                    1  57899 9999999999  6678864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.93  E-value=4.2e-27  Score=244.25  Aligned_cols=170  Identities=23%  Similarity=0.369  Sum_probs=137.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++.+........+++.+|+.+|+.++||||+++++++...      ..+|+||||++ ++|.+.+..  .+
T Consensus        85 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~-~~l~~~~~~--~l  161 (464)
T 3ttj_A           85 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQM--EL  161 (464)
T ss_dssp             TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS-EEHHHHHTS--CC
T ss_pred             CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCC-CCHHHHHhh--cC
Confidence            4688999999987765666678899999999999999999999998654      46899999998 567777754  59


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..++.++.|++.||+|||++||+||||||+|||++.+. .+.++|||++.......   ...+.++++.|+|||++.+
T Consensus       162 ~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  237 (464)
T 3ttj_A          162 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG  237 (464)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCCCCC-----CC---CC----CCCTTCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCC-CEEEEEEEeeeecCCCc---ccCCCcccccccCHHHHcC
Confidence            9999999999999999999999999999999999998653 34456999986554321   2245688999999999877


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ ||+|+++|||  +..||.+
T Consensus       238 ~~~~~~~Di-wSlG~il~ell~g~~pF~g  265 (464)
T 3ttj_A          238 MGYKENVDI-WSVGCIMGEMVRHKILFPG  265 (464)
T ss_dssp             CCCCTTHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCHHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            6   78999 9999999999  6677764

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.93  E-value=1.1e-26  Score=230.84  Aligned_cols=174  Identities=23%  Similarity=0.362  Sum_probs=146.5

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..|+||||+++++|.+++...+.+++..+
T Consensus        64 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~  143 (335)
T 2owb_A           64 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEA  143 (335)
T ss_dssp             TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHH
T ss_pred             CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHH
Confidence            4688999999876643 345567899999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+........  ......++..|+|||...+.   .
T Consensus       144 ~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~  220 (335)
T 2owb_A          144 RYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSF  220 (335)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCT
T ss_pred             HHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCC-CEEEeeccCceecccCcc--cccccCCCccccCHHHhccCCCCc
Confidence            99999999999999999999999999999997652 344459999865432211  11234577889999987655   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|+++|++  +..||..
T Consensus       221 ~~Di-~slG~il~~l~~g~~pf~~  243 (335)
T 2owb_A          221 EVDV-WSIGCIMYTLLVGKPPFET  243 (335)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             hhhH-HHHHHHHHHHHHCcCCCCC
Confidence            7899 9999999999  6778865

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.93  E-value=4.4e-27  Score=228.24  Aligned_cols=174  Identities=23%  Similarity=0.407  Sum_probs=147.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|++..........+.+.+|+.++++++||||+++++++...+..|+||||+++++|.+++...+.+++..+.
T Consensus        45 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  124 (287)
T 2wei_A           45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA  124 (287)
T ss_dssp             TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHH
T ss_pred             CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHH
Confidence            47899999999776555555678999999999999999999999999999999999999999999999877789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccCCCC--C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--~  157 (477)
                      .++.|++.||.|||++|++||||||+||+++.+  ...+.++|||.+.......   ......+++.|+|||...+.  .
T Consensus       125 ~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  201 (287)
T 2wei_A          125 RIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRGTYDE  201 (287)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTTCCCT
T ss_pred             HHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC---ccccccCcccccChHHhcCCCCC
Confidence            999999999999999999999999999999753  3355666999876543221   11234567889999988766  7


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|++++++  +..||.+
T Consensus       202 ~~Di-~slG~~l~~l~~g~~p~~~  224 (287)
T 2wei_A          202 KCDV-WSAGVILYILLSGTPPFYG  224 (287)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             chhh-HhHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6677764

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.93  E-value=1.2e-26  Score=229.88  Aligned_cols=172  Identities=16%  Similarity=0.157  Sum_probs=143.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~   79 (477)
                      .+|+.||||++......    +.+.+|+.+++++ +||||+++++++..++..|+||||+ +++|.+++... +.+++..
T Consensus        32 ~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~  106 (330)
T 2izr_A           32 YTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKT  106 (330)
T ss_dssp             TTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHH
T ss_pred             CCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHH
Confidence            57899999998765322    3478999999999 9999999999999999999999999 89999999863 5799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcc----eeecccccceecccCCccc-----ccCCeEEEecccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL----KLAGLKQGVSEKAKGSAYI-----EQGNTKVICSVFEPR  150 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~----rl~~~dfG~~~~~~gs~~~-----~~g~t~v~~~~y~pp  150 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+..    .+.++|||.+.........     ....+..+++.|+||
T Consensus       107 ~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  186 (330)
T 2izr_A          107 VLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI  186 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccCh
Confidence            9999999999999999999999999999999976531    2555699998754322111     112456788999999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.   .++|+ ||+|+++||+  +..||.+
T Consensus       187 E~~~~~~~~~~~Di-~slG~il~ell~g~~Pf~~  219 (330)
T 2izr_A          187 NTHLGKEQSRRDDL-EALGHMFMYFLRGSLPWQG  219 (330)
T ss_dssp             HHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             HHHcCCCCCchhHH-HHHHHHHHHHhcCCCCccc
Confidence            998776   67899 9999999999  7788875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.93  E-value=1.4e-27  Score=236.31  Aligned_cols=176  Identities=22%  Similarity=0.309  Sum_probs=141.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-------C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-------K   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------~   74 (477)
                      .+++.||||.+.... ......++.+|+.++++++||||+++++++......|+||||++|++|.+++....       .
T Consensus        58 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  136 (327)
T 2yfx_A           58 PSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSS  136 (327)
T ss_dssp             --CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTS
T ss_pred             CccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhccccccccc
Confidence            467789999996443 44556789999999999999999999999999999999999999999999998753       4


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++..+..++.|++.||.|||++||+||||||+||+++.  +...+.++|||.+...........+....++..|+|||.
T Consensus       137 ~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  216 (327)
T 2yfx_A          137 LAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEA  216 (327)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHH
T ss_pred             ccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhH
Confidence            899999999999999999999999999999999999974  233455669998865444333333444556778999998


Q ss_pred             CCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..+.   .++|+ |++|+++|++   +..||.+
T Consensus       217 ~~~~~~~~~~Di-~slG~il~ellt~g~~p~~~  248 (327)
T 2yfx_A          217 FMEGIFTSKTDT-WSFGVLLWEIFSLGYMPYPS  248 (327)
T ss_dssp             HHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             hcCCCCCchhhH-HHHHHHHHHHHcCCCCCCCC
Confidence            7544   67899 9999999998   4577764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.93  E-value=1.4e-27  Score=231.39  Aligned_cols=170  Identities=16%  Similarity=0.248  Sum_probs=138.4

Q ss_pred             CCCcEEEEEEcccCCCChhH-----HHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENR-----FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l   75 (477)
                      .+++.||+|++.........     .+.+.+|+.++++++||||+++++++.+..  ++||||+++++|.+++... ..+
T Consensus        42 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~  119 (287)
T 4f0f_A           42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPI  119 (287)
T ss_dssp             TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCC
T ss_pred             CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCc
Confidence            47899999998765543221     167899999999999999999999986655  7999999999999988654 369


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccCc----ceeecccccceecccCCcccccCCeEEEeccccc
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNNT----LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEP  149 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~----~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~p  149 (477)
                      ++..+..++.|++.||.|||++|  |+||||||+||+++.+.    ..+.++|||.+......     ..+..+++.|+|
T Consensus       120 ~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~a  194 (287)
T 4f0f_A          120 KWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMA  194 (287)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSC
T ss_pred             cHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----ccccCCCccccC
Confidence            99999999999999999999999  99999999999996532    33556699988643322     123467789999


Q ss_pred             cccCCCC-----CcccccCcceEEEEEE--eeecccc
Q psy6508         150 REIPSSK-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       150 pE~~~~~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ||...+.     .++|+ ||+|+++|++  +..||..
T Consensus       195 PE~~~~~~~~~~~~~Di-~slG~~l~~l~~g~~pf~~  230 (287)
T 4f0f_A          195 PETIGAEEESYTEKADT-YSFAMILYTILTGEGPFDE  230 (287)
T ss_dssp             GGGSSCSSCEECHHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             chhhccCCCCcCchhhH-HHHHHHHHHHHcCCCCCcc
Confidence            9998432     57899 9999999999  6788864

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.93  E-value=4.5e-27  Score=227.65  Aligned_cols=172  Identities=26%  Similarity=0.421  Sum_probs=143.9

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+++.||+|++...... ....+.+.+|+.++++++||||+++++++..++..|+||||+++++|.+++...+.+++..+
T Consensus        37 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  116 (284)
T 2vgo_A           37 QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRS  116 (284)
T ss_dssp             TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHH
T ss_pred             CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHH
Confidence            46789999998654321 12346789999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.......    ..+..+++.|+|||...+.   .
T Consensus       117 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~  191 (284)
T 2vgo_A          117 ATFMEELADALHYCHERKVIHRDIKPENLLMGYKG-ELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDE  191 (284)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTC-CEEECCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCC-CEEEecccccccCcccc----cccccCCCCcCCHHHhccCCCCc
Confidence            99999999999999999999999999999997543 34445999875543321    1345678899999998765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|++++++  +..||..
T Consensus       192 ~~Di-~slG~il~~l~~g~~pf~~  214 (284)
T 2vgo_A          192 KVDL-WCAGVLCYEFLVGMPPFDS  214 (284)
T ss_dssp             THHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             ccch-hhHHHHHHHHHHCCCCCCC
Confidence            7899 9999999999  6778864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.93  E-value=2.5e-27  Score=232.45  Aligned_cols=174  Identities=22%  Similarity=0.291  Sum_probs=136.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCC
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~   76 (477)
                      .+|+.||+|+++.... .....+.+.+|+.++++++||||+++++++...+..++||||+++++|.+++..    ...++
T Consensus        55 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  134 (310)
T 2wqm_A           55 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP  134 (310)
T ss_dssp             TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCC
T ss_pred             CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCC
Confidence            4789999999976543 345667899999999999999999999999999999999999999999999864    35699


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..+..++.|++.||.|||++|++||||||+||+++.++ ++.++|||.+.......  .......++..|+|||...+.
T Consensus       135 ~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~  211 (310)
T 2wqm_A          135 ERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG-VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHEN  211 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEECCC--------------------CCSSCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCC-CEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCC
Confidence            999999999999999999999999999999999998643 34445999876443221  112345678889999987665


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|++++++  +..||.+
T Consensus       212 ~~~~~~Dv-~slG~il~~l~~g~~p~~~  238 (310)
T 2wqm_A          212 GYNFKSDI-WSLGCLLYEMAALQSPFYG  238 (310)
T ss_dssp             CCCHHHHH-HHHHHHHHHHHHSSCTTC-
T ss_pred             CCCchhhH-HHHHHHHHHHHhCCCCCcc
Confidence               67899 9999999999  6678764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.93  E-value=7.9e-27  Score=231.24  Aligned_cols=173  Identities=23%  Similarity=0.303  Sum_probs=142.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      ++.||+|.++... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+++|+|.+++...          
T Consensus        76 ~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  154 (333)
T 2i1m_A           76 VLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF  154 (333)
T ss_dssp             CCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC---
T ss_pred             hhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccc
Confidence            3589999987553 344567899999999999 8999999999999999999999999999999999753          


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          73 ----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        73 ----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                          ..+++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.............+..++..|+
T Consensus       155 ~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~  233 (333)
T 2i1m_A          155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWM  233 (333)
T ss_dssp             ----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGS
T ss_pred             cccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC-eEEECccccccccccccceeecCCCCCCcccc
Confidence                3579999999999999999999999999999999999997653 44556999987543332222333456778899


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      |||...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       234 aPE~~~~~~~~~~~Di-~slG~il~el~t~g~~p~~~  269 (333)
T 2i1m_A          234 APESIFDCVYTVQSDV-WSYGILLWEIFSLGLNPYPG  269 (333)
T ss_dssp             CHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSSTT
T ss_pred             CHHHhccCCCChHHHH-HHHHHHHHHHHcCCCCCCcc
Confidence            99987544   67899 9999999998   4577764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.93  E-value=4.2e-27  Score=241.17  Aligned_cols=174  Identities=26%  Similarity=0.425  Sum_probs=136.7

Q ss_pred             CCCcEEEEEEcccCCCC------hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVS------ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+++.||||++.+....      ......+.+|+.+|++++||||+++++++. .+..|+||||+++++|.+++...+.+
T Consensus       158 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~  236 (419)
T 3i6u_A          158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRL  236 (419)
T ss_dssp             TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEEECCTTCBGGGGTSSSCCC
T ss_pred             CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEEEcCCCCcHHHHHhccCCC
Confidence            57899999999765432      112235889999999999999999999975 45689999999999999999888889


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      ++..+..++.|++.||.|||++||+||||||+|||++.+  ...+.++|||.+.......   ...+..+++.|+|||.+
T Consensus       237 ~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~  313 (419)
T 3i6u_A          237 KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS---LMRTLCGTPTYLAPEVL  313 (419)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecCCCc---cccccCCCCCccCceee
Confidence            999999999999999999999999999999999999743  3456667999986543221   22356788999999998


Q ss_pred             CC---C---CcccccCcceEEEEEE--eeeccccc
Q psy6508         154 SS---K---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       154 ~~---~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .+   .   .++|+ ||+|+++|++  +..||...
T Consensus       314 ~~~~~~~~~~~~Di-wslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          314 VSVGTAGYNRAVDC-WSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             C----CTTHHHHHH-HHHHHHHHHHHHSSCSSCCC
T ss_pred             ecCCCCCCCchhhh-HhHHHHHHHHHHCCCCCCCC
Confidence            53   1   57899 9999999999  77888753

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.93  E-value=6.5e-28  Score=238.30  Aligned_cols=173  Identities=16%  Similarity=0.181  Sum_probs=140.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC----CCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE----KLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----~l~~   77 (477)
                      .+|+.||||++...... .....+.+|+.+++.++||||+++++++...+..++||||+++++|.+++....    .+++
T Consensus        52 ~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  130 (326)
T 3uim_A           52 ADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW  130 (326)
T ss_dssp             SSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCH
T ss_pred             cCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCH
Confidence            46889999999765432 222368899999999999999999999999999999999999999999998643    4999


Q ss_pred             HHHHHHHHHHHHHHHHHHhC---CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          78 FQCQQFVRQLVLALKFLREN---NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ..+..++.|++.||.|||++   ||+||||||+|||++.+. ++.++|||.+........ .......+++.|+|||...
T Consensus       131 ~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~  208 (326)
T 3uim_A          131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLAKLMDYKDT-HVTTAVRGTIGHIAPEYLS  208 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSCEECCSSSS-CEECCCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCccccccCcccc-cccccccCCcCccCHHHhc
Confidence            99999999999999999999   999999999999998752 344469999865432221 1112344788999999876


Q ss_pred             CC---CcccccCcceEEEEEE--eeeccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      +.   .++|+ ||+|+++|++  +..||.
T Consensus       209 ~~~~~~~~Di-~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          209 TGKSSEKTDV-FGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             HSEECHHHHH-HHHHHHHHHHHHCCCSBC
T ss_pred             cCCCCccccc-hhHHHHHHHHHhCCCccc
Confidence            55   67899 9999999999  778885

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.93  E-value=3.9e-27  Score=227.87  Aligned_cols=172  Identities=23%  Similarity=0.343  Sum_probs=130.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~   81 (477)
                      .+..||+|+++... .....+.+.+|+.++++++||||+++++++ .++..|+||||+++++|.+++...+ .+++..+.
T Consensus        42 ~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  119 (281)
T 1mp8_A           42 PALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLI  119 (281)
T ss_dssp             CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHH
T ss_pred             CceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecCCCCCHHHHHHhcCCCCCHHHHH
Confidence            35679999986543 445567899999999999999999999997 4567899999999999999998654 69999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+......... ......+++.|+|||...+.   .+
T Consensus       120 ~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~  197 (281)
T 1mp8_A          120 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSA  197 (281)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC--------------------CCGGGCCHHHHHHCCCSHH
T ss_pred             HHHHHHHHHHHHHHhCCeecccccHHHEEECCCC-CEEECccccccccCccccc-ccccCCCcccccChhhcccCCCCCc
Confidence            9999999999999999999999999999998543 3445699988655433221 12233455679999987644   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|+++|++   +..||.+
T Consensus       198 ~Di-~slG~~l~ell~~g~~pf~~  220 (281)
T 1mp8_A          198 SDV-WMFGVCMWEILMHGVKPFQG  220 (281)
T ss_dssp             HHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             cCc-hHHHHHHHHHHhcCCCCCCc
Confidence            899 9999999997   5578865

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.93  E-value=5.7e-27  Score=230.12  Aligned_cols=175  Identities=19%  Similarity=0.296  Sum_probs=142.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCC-eEEEEEecCCCCCHHHHHHhCCC-----
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDER-YVYIILEYCDGGDLCSFIRSHEK-----   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~~-----   74 (477)
                      .+++.||||+++... .....+.+.+|+.+++++ +||||+++++++...+ .++++|||++|++|.+++.....     
T Consensus        55 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  133 (316)
T 2xir_A           55 ATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY  133 (316)
T ss_dssp             TCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC
T ss_pred             ccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccc
Confidence            367899999997653 444567899999999999 7999999999987654 59999999999999999987543     


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEE
Q psy6508          75 -----------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVI  143 (477)
Q Consensus        75 -----------l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~  143 (477)
                                 +++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+................+
T Consensus       134 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~  212 (316)
T 2xir_A          134 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARL  212 (316)
T ss_dssp             -------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTTCTTSEEETTEEE
T ss_pred             cccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEECCCccccccccCccceeccCCCc
Confidence                       88999999999999999999999999999999999997542 344559998865443322222334567


Q ss_pred             eccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         144 CSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       144 ~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +..|+|||...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       213 t~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          213 PLKWMAPETIFDRVYTIQSDV-WSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             ceeecCchhhccccccchhHH-HHHHHHHHHHHhCCCCCCcc
Confidence            8889999987554   67899 9999999998   5577764

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.93  E-value=7e-28  Score=241.62  Aligned_cols=171  Identities=22%  Similarity=0.269  Sum_probs=144.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||+|++.... .....+.+.+|+.++++++||||+++++++..++..|+||||++|++|.+++...+.+++..+.
T Consensus        56 ~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  134 (360)
T 3eqc_A           56 PSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG  134 (360)
T ss_dssp             TTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHH
T ss_pred             CCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHH
Confidence            478999999987653 4555678999999999999999999999999999999999999999999999987889999999


Q ss_pred             HHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++ ||+||||||+||+++.+. ++.++|||.+......    ......+++.|+|||...+.   .
T Consensus       135 ~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~  209 (360)
T 3eqc_A          135 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSV  209 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH----C----CCCCTTCCHHHHTTCCCSH
T ss_pred             HHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcccccc----cccCCCCCCCeECHHHHcCCCCCc
Confidence            9999999999999996 999999999999997643 3445699987543221    22345678899999998765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++  +..||..
T Consensus       210 ~~Di-~slG~il~~l~~g~~pf~~  232 (360)
T 3eqc_A          210 QSDI-WSMGLSLVEMAVGRYPIPP  232 (360)
T ss_dssp             HHHH-HHHHHHHHHHHHTSCCSSC
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6678864

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.93  E-value=2.9e-27  Score=230.30  Aligned_cols=173  Identities=20%  Similarity=0.302  Sum_probs=135.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhCC-CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHE-KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~   78 (477)
                      .+++.||||++...  .....+.+.+|+.++++++||||+++++++..  ...+++||||+++++|.+++...+ ++++.
T Consensus        37 ~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  114 (295)
T 3ugc_A           37 NTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI  114 (295)
T ss_dssp             SCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHH
T ss_pred             CCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHH
Confidence            47889999998754  45556789999999999999999999999864  356899999999999999998754 59999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+........ ........++..|+|||...+. 
T Consensus       115 ~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  193 (295)
T 3ugc_A          115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK  193 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCSCC-------------CTTCGGGGCCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCC-eEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCC
Confidence            9999999999999999999999999999999997643 344569998865433221 1112223345569999987654 


Q ss_pred             --CcccccCcceEEEEEE--eeeccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                        .++|+ ||+|++++++  +..||.
T Consensus       194 ~~~~~Di-~slG~~l~~l~~g~~~~~  218 (295)
T 3ugc_A          194 FSVASDV-WSFGVVLYELFTYIEKSK  218 (295)
T ss_dssp             CCHHHHH-HHHHHHHHHHHHTTCTTC
T ss_pred             CChHHHH-HHHHHHHHHHHhcccccC
Confidence              67899 9999999999  445554

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.93  E-value=2.3e-27  Score=230.91  Aligned_cols=172  Identities=15%  Similarity=0.187  Sum_probs=142.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~   79 (477)
                      .+|+.||||+++.....    +.+.+|+.+++.+ +|||++++++++......++||||+ +++|.+++...+ ++++..
T Consensus        33 ~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~  107 (298)
T 1csn_A           33 LNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKT  107 (298)
T ss_dssp             TTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHH
T ss_pred             CCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHH
Confidence            57899999998655322    3477899999999 7999999999999999999999999 899999998754 599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc----ceeecccccceecccCCccc-----ccCCeEEEecccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT----LKLAGLKQGVSEKAKGSAYI-----EQGNTKVICSVFEPR  150 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~----~rl~~~dfG~~~~~~gs~~~-----~~g~t~v~~~~y~pp  150 (477)
                      +..++.|++.||.|||++||+||||||+||+++.+.    .++.++|||.+.........     .......+++.|+||
T Consensus       108 ~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  187 (298)
T 1csn_A          108 VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI  187 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCc
Confidence            999999999999999999999999999999997532    23556699998755433211     122345688899999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.   .++|+ ||+|+++|++  +..||.+
T Consensus       188 E~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~  220 (298)
T 1csn_A          188 NTHLGREQSRRDDL-EALGHVFMYFLRGSLPWQG  220 (298)
T ss_dssp             HHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSS
T ss_pred             hhhcCCCCChHHHH-HHHHHHHHHHHcCCCCcch
Confidence            998765   67899 9999999999  6788875

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.93  E-value=1.5e-26  Score=228.08  Aligned_cols=174  Identities=19%  Similarity=0.232  Sum_probs=142.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||||+++... .....+.+.+|+.++++++||||+++++++..  ...+++||||+++++|.+++... .+++..
T Consensus        58 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~  135 (318)
T 3lxp_A           58 GTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQ  135 (318)
T ss_dssp             -CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHH
T ss_pred             CCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHH
Confidence            478899999997653 45556789999999999999999999999987  46899999999999999999874 599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc-ccccCCeEEEeccccccccCCCC--
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      +..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+....... .........++..|+|||...+.  
T Consensus       136 ~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  214 (318)
T 3lxp_A          136 LLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDR-LVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF  214 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCC-CEEECCccccccccccccccccccCCCCCceeeChHHhcCCCC
Confidence            999999999999999999999999999999997653 34445999987654322 11223344566779999998765  


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ ||+|++++++  +..||..
T Consensus       215 ~~~~Di-~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          215 YYASDV-WSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             EHHHHH-HHHHHHHHHHHTTTCGGGS
T ss_pred             CcHHHH-HHHHHHHHHHHhCCCcccc
Confidence             67899 9999999999  5567764

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.93  E-value=9.3e-27  Score=232.76  Aligned_cols=169  Identities=20%  Similarity=0.316  Sum_probs=141.3

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+|+.||||++...... ....+.+.+|+.++++++||||+++++++..++..|+||||++ |+|.+++.. ...+++..
T Consensus        77 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~  155 (348)
T 1u5q_A           77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE  155 (348)
T ss_dssp             TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHH
T ss_pred             cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHH
Confidence            47889999999766443 3445789999999999999999999999999999999999998 688888854 45799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC----C
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS----S  155 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~----~  155 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.....      ..+..+++.|+|||...    +
T Consensus       156 ~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~  228 (348)
T 1u5q_A          156 IAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEG  228 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCC-CEEEeeccCceecCC------CCcccCCcceeCHhhhccccCC
Confidence            999999999999999999999999999999998643 444569998764332      23456788999999863    2


Q ss_pred             C--CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K--TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~--~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .  .++|+ ||+|++++|+  +..||.+
T Consensus       229 ~~~~~~Di-wslG~il~ell~g~~p~~~  255 (348)
T 1u5q_A          229 QYDGKVDV-WSLGITCIELAERKPPLFN  255 (348)
T ss_dssp             CBCTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             CCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            2  67899 9999999999  6678764

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.93  E-value=2.9e-26  Score=229.69  Aligned_cols=168  Identities=19%  Similarity=0.242  Sum_probs=141.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-----CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-----HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--K   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-----HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~   74 (477)
                      .+++.||||+++..   ....+.+.+|+.+++.++     ||||+++++++...+..|+||||+ +++|.+++....  .
T Consensus        58 ~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~  133 (360)
T 3llt_A           58 DNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNG  133 (360)
T ss_dssp             TTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCC
T ss_pred             CCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCC
Confidence            47889999998643   344567788999999996     999999999999999999999999 799999998754  5


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc------------------------Ccceeecccccceeccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN------------------------NTLKLAGLKQGVSEKAK  130 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~------------------------~~~rl~~~dfG~~~~~~  130 (477)
                      +++..++.++.|++.||.|||++||+||||||+|||++.                        ....+.++|||.+....
T Consensus       134 ~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~  213 (360)
T 3llt_A          134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKS  213 (360)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecC
Confidence            999999999999999999999999999999999999974                        23455566999986543


Q ss_pred             CCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         131 GSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       131 gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..     ..+..+++.|+|||+..+.   .++|+ ||+|+++|++  +..||.+
T Consensus       214 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          214 DY-----HGSIINTRQYRAPEVILNLGWDVSSDM-WSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             SC-----CCSCCSCGGGCCHHHHTTCCCCTTHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CC-----CcCccCcccccCcHHHcCCCCCCccch-HHHHHHHHHHHHCCCCCCC
Confidence            22     2345678899999998765   78999 9999999999  6678764

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.93  E-value=9.3e-27  Score=227.26  Aligned_cols=174  Identities=17%  Similarity=0.235  Sum_probs=138.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHh-CCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRS-HEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~-~~~l~~~   78 (477)
                      .+++.||+|+++... .....+.+.+|+.++++++||||+++++++...  +.+++||||+++++|.+++.. ...+++.
T Consensus        48 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  126 (302)
T 4e5w_A           48 NTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLK  126 (302)
T ss_dssp             SCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHH
T ss_pred             ccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHH
Confidence            478999999997654 333457789999999999999999999999876  678999999999999999954 4579999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+........ ........++..|+|||...+. 
T Consensus       127 ~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  205 (302)
T 4e5w_A          127 QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH-QVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK  205 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCC-CEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCC
Confidence            9999999999999999999999999999999997653 445569998865443221 1222334566779999987665 


Q ss_pred             --CcccccCcceEEEEEE--eeeccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                        .++|+ ||+|+++|++  +..|+.
T Consensus       206 ~~~~~Di-~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          206 FYIASDV-WSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             EEHHHHH-HHHHHHHHHHHTTTCGGG
T ss_pred             CCcchhH-HHHHHHHHHHHHccCCCc
Confidence              67899 9999999999  444443

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.93  E-value=1.1e-26  Score=223.86  Aligned_cols=173  Identities=23%  Similarity=0.425  Sum_probs=137.4

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||+++..... ....+.+.+|+.+++.++||||+++++++...+..|+||||+++++|.+++...+.+++..+
T Consensus        34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  113 (276)
T 2h6d_A           34 LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEA  113 (276)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHH
T ss_pred             CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHH
Confidence            47899999998654321 23356789999999999999999999999999999999999999999999988788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.......   ......+++.|+|||...+.    
T Consensus       114 ~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~  189 (276)
T 2h6d_A          114 RRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAG  189 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTS-CEEECCCCGGGCCCC----------------CCTGGGTTSCCCH
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCC-CEEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCC
Confidence            99999999999999999999999999999997643 34455999876544322   12345678889999998765    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ |++|++++++  +..||..
T Consensus       190 ~~~Di-~slG~~l~~l~~g~~p~~~  213 (276)
T 2h6d_A          190 PEVDI-WSCGVILYALLCGTLPFDD  213 (276)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             ccchH-HHHHHHHHHHHhCCCCCCC
Confidence            56899 9999999999  6677764

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.93  E-value=1.5e-26  Score=231.11  Aligned_cols=175  Identities=19%  Similarity=0.350  Sum_probs=140.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--------CCeEEEEEecCCCCCHHHHHHhC-
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--------ERYVYIILEYCDGGDLCSFIRSH-   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--------~~~~~lv~e~~~g~sL~~~l~~~-   72 (477)
                      .+|+.||||++............+.+|+.+++.++||||+++++++..        .+.+|+||||++ ++|.+.+... 
T Consensus        40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~  118 (351)
T 3mi9_A           40 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNVL  118 (351)
T ss_dssp             TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCS-EEHHHHHHCTT
T ss_pred             CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccC-CCHHHHHhhcc
Confidence            578999999997766555445678899999999999999999999886        456899999998 5888877654 


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc--ccccCCeEEEecccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA--YIEQGNTKVICSVFEPR  150 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~--~~~~g~t~v~~~~y~pp  150 (477)
                      ..+++..++.++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.......  ......+..+++.|+||
T Consensus       119 ~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  197 (351)
T 3mi9_A          119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPP  197 (351)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC-CEEEccchhcccccccccccccccCCcccccCccCc
Confidence            5799999999999999999999999999999999999997643 34456999886543211  11122345678899999


Q ss_pred             ccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.    .++|+ ||+|+++|++  +..||.+
T Consensus       198 E~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~  231 (351)
T 3mi9_A          198 ELLLGERDYGPPIDL-WGAGCIMAEMWTRSPIMQG  231 (351)
T ss_dssp             HHHTTCCSCCTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             hhhcCCCCCCcHhHH-HHHHHHHHHHHhCCCCCCC
Confidence            987653    67899 9999999999  6677764

>2je6_A RRP42, exosome complex exonuclease 2; nuclease, hydrolase, exonuclease, phosphorolytic, exoribonuclease, RNA degradation; HET: 1PE; 1.6A {Sulfolobus solfataricus} SCOP: d.14.1.4 d.101.1.1 PDB: 2jea_A* 2jeb_A* 2br2_A 2c37_A* 2c38_A* 2c39_A* 3l7z_A

Probab=99.93  E-value=8e-25  Score=211.17  Aligned_cols=208  Identities=20%  Similarity=0.256  Sum_probs=183.5

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.++..|.....    +- -..|.+.+++.+.||+...++...++..+.+
T Consensus        37 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~----~~-~~~g~l~v~~~~~p~a~~~~~~g~~~~~~~~  111 (277)
T 2je6_A           37 TDYRPLSITLDYAKKADGSALVKLGTTMVLAGTKLEIDKPYE----DT-PNQGNLIVNVELLPLAYETFEPGPPDENAIE  111 (277)
T ss_dssp             TCCCCEEEEETCSTTSSEEEEEEETTEEEEEEEEEEEECCCT----TC-TTCCEEEEEEEECTTSCTTCCCSSCCHHHHH
T ss_pred             CcccCeEEEeCCcCCCCeEEEEEECCeEEEEEEEeeeeCCCC----CC-CCccEEEEEEEeCCccCcccccCCCChHHHH
Confidence            578999999999999999999999999999999965532222    11 4578999999999999877666677888999


Q ss_pred             HHHHHHHHhhhh--hhcccC------CCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCC--------------------
Q psy6508         194 LGNHLKRALEPA--VCRHEF------SNFQVDLFVLVLQNDGSALSAAINCANLALVDAA--------------------  245 (477)
Q Consensus       194 l~~~i~~~l~~~--i~~~~~------Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dag--------------------  245 (477)
                      +++.+++.+++.  +.++.+      ++|.+.+.++||++||+.+.++++|+++||.|+|                    
T Consensus       112 is~li~r~lr~~~~i~~~~l~i~~g~~~~~i~i~~~VL~~DG~~~~aai~aa~~AL~~a~~p~v~~~~~~~~~~~~~~~~  191 (277)
T 2je6_A          112 LARVVDRSLRDSKALDLTKLVIEPGKSVWTVWLDVYVLDYGGNVLDACTLASVAALYNTKVYKVEQHSNGISVNKNEVVG  191 (277)
T ss_dssp             HHHHHHHHHHHTTCSCGGGGEEETTTEEEEEEEEEEEEECCSCHHHHHHHHHHHHHHTCEEEEEECC---CEEEEEEEEE
T ss_pred             HHHHHHHHHhccCCcCHHHceeecCceEEEEEEEEEEECCCCCHHHHHHHHHHHHHHhcCCCeEEecCCcceEeccCccc
Confidence            999999999994  667776      4789999999999999999999999999999999                    


Q ss_pred             -CCCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE--eeecHHHHHHHHHHH
Q psy6508         246 -IPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV--GTIQQERLADHIEQL  322 (477)
Q Consensus       246 -i~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~--g~~~~~~~~~~l~~~  322 (477)
                       +||+++++++|+++.++.+++||+..|+..          +.+.+++++.. .++|+.++..  |.++.+++.++++.|
T Consensus       192 ~ip~~~~~~avsvg~~~~~~l~Dpt~~Ee~~----------~~~~l~va~~~-~g~i~~v~~~g~~~~~~~~l~~~l~~A  260 (277)
T 2je6_A          192 KLPLNYPVVTISVAKVDKYLVVDPDLDEESI----------MDAKISFSYTP-DLKIVGIQKSGKGSMSLQDIDQAENTA  260 (277)
T ss_dssp             ECCCSCCCEEEEEEEETTEEEESCCHHHHHH----------CSEEEEEEECT-TCCEEEEEEESSSCEEHHHHHHHHHHH
T ss_pred             cccccCCeEEEEEEEECCEEecCCCHHHHhc----------CCCcEEEEEeC-CCCEEEEECCCCCCCCHHHHHHHHHHH
Confidence             999999999999999999999999999985          47889999744 5789999999  579999999999999


Q ss_pred             HhcccchhhHHHHhHh
Q psy6508         323 IGCCESLCTDRVQKLV  338 (477)
Q Consensus       323 ~~~~~~i~~~~i~~~l  338 (477)
                      .++|+.+.+. +++.+
T Consensus       261 ~~~~~~i~~~-~~~~l  275 (277)
T 2je6_A          261 RSTAVKLLEE-LKKHL  275 (277)
T ss_dssp             HHHHHHHHHH-HHHHH
T ss_pred             HHHHHHHHHH-HHHHh
Confidence            9999999999 88765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.93  E-value=5.9e-27  Score=238.27  Aligned_cols=173  Identities=20%  Similarity=0.284  Sum_probs=141.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC--eEEEEEecCCCCCHHHHHHhCC---CCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCSFIRSHE---KLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~lv~e~~~g~sL~~~l~~~~---~l~   76 (477)
                      .+|+.||||+++.... ....+.+.+|+.++++++||||+++++++...+  ..|+||||++|++|.+++....   .++
T Consensus        32 ~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~  110 (396)
T 4eut_A           32 KTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP  110 (396)
T ss_dssp             TTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCC
T ss_pred             CCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCC
Confidence            4689999999875432 223467889999999999999999999998765  7899999999999999997643   399


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeec---cCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      +..++.++.|++.||.|||++||+||||||+|||+.   ++...+.++|||.+........   ..+..++..|+|||..
T Consensus       111 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~  187 (396)
T 4eut_A          111 ESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLYGTEEYLHPDMY  187 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSSSCCTTCCHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---cccccCCccccCHHHh
Confidence            999999999999999999999999999999999982   3344555679999876543321   2245678899999987


Q ss_pred             CC--------C---CcccccCcceEEEEEE--eeecccc
Q psy6508         154 SS--------K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~~--------~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .+        .   .++|+ ||+|+++||+  +..||..
T Consensus       188 ~~~~~~~~~~~~~~~~~Di-wSlG~il~el~tg~~Pf~~  225 (396)
T 4eut_A          188 ERAVLRKDHQKKYGATVDL-WSIGVTFYHAATGSLPFRP  225 (396)
T ss_dssp             HHHCC--CHHHHHHHHHHH-HHHHHHHHHHHHSSCSEEC
T ss_pred             hccccccccccCCCcHHHH-HHHHHHHHHHHHCCCCCCC
Confidence            53        1   57899 9999999999  7788863

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.93  E-value=1.5e-26  Score=228.88  Aligned_cols=175  Identities=19%  Similarity=0.266  Sum_probs=143.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEE--eCCeEEEEEecCCCCCHHHHHHhC-CCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW--DERYVYIILEYCDGGDLCSFIRSH-EKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~   78 (477)
                      .+++.||+|++...  .....+.+.+|+.++++++||||+++++++.  ..+..|+||||++|++|.+++... ..+++.
T Consensus        50 ~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  127 (327)
T 3lxl_A           50 NTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDAS  127 (327)
T ss_dssp             SCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHH
T ss_pred             CcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHH
Confidence            47889999998755  3455677999999999999999999999887  456799999999999999999863 469999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc-ccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+....... .........++..|+|||...+. 
T Consensus       128 ~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  206 (327)
T 3lxl_A          128 RLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEA-HVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI  206 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCC-CEEEcccccceecccCCccceeeccCCccccccCHHHhccCC
Confidence            9999999999999999999999999999999997643 34456999987544322 12223345567779999988765 


Q ss_pred             --CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                        .++|+ ||+|+++|++  +..||...
T Consensus       207 ~~~~~Di-~slG~il~~ll~g~~p~~~~  233 (327)
T 3lxl_A          207 FSRQSDV-WSFGVVLYELFTYCDKSCSP  233 (327)
T ss_dssp             EEHHHHH-HHHHHHHHHHHTTTCGGGSH
T ss_pred             CChHHhH-HHHHHHHHHHHhCCCCCccc
Confidence              67899 9999999999  55777543

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.93  E-value=7.3e-27  Score=251.23  Aligned_cols=175  Identities=18%  Similarity=0.253  Sum_probs=141.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++++.||||+++.........+.+.+|+.+|++++||||+++++++.. +..++||||+++|+|.+++...+.+++..+.
T Consensus       394 ~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~  472 (635)
T 4fl3_A          394 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNII  472 (635)
T ss_dssp             SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHH
T ss_pred             CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHH
Confidence            357889999998766555667889999999999999999999999864 4589999999999999999988889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc-ccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.||+.||.|||++||+||||||+|||++.+. .+.++|||++....... .........++..|+|||...+.   .
T Consensus       473 ~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~  551 (635)
T 4fl3_A          473 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS  551 (635)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCC-CEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCc
Confidence            9999999999999999999999999999997653 34456999986543221 12222334456779999988654   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||.+
T Consensus       552 ~sDv-wSlGv~l~ellt~G~~Pf~~  575 (635)
T 4fl3_A          552 KSDV-WSFGVLMWEAFSYGQKPYRG  575 (635)
T ss_dssp             HHHH-HHHHHHHHHHHTTTCCSSTT
T ss_pred             HHHH-HHHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999997   5677765

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.93  E-value=2.9e-26  Score=224.07  Aligned_cols=172  Identities=22%  Similarity=0.335  Sum_probs=144.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+++.||||+++.... ....+.+.+|+.++++++||||+++++++..++..|+||||++|++|.+++.. +.+++..+.
T Consensus        45 ~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~  122 (303)
T 3a7i_A           45 RTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIA  122 (303)
T ss_dssp             TTCCEEEEEEEETTTC-STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHH
T ss_pred             CCCcEEEEEEeccccc-HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHH
Confidence            4789999999976643 33457899999999999999999999999999999999999999999999876 579999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+........  ...+..+++.|+|||...+.   .+
T Consensus       123 ~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~  199 (303)
T 3a7i_A          123 TILREILKGLDYLHSEKKIHRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSK  199 (303)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTH
T ss_pred             HHHHHHHHHHHHHHHCCCccCCCChheEEECCCC-CEEEeecccceecCcccc--ccCccCCCcCccCHHHHhcCCCCch
Confidence            9999999999999999999999999999997643 344569998865443221  12345678889999998765   67


Q ss_pred             ccccCcceEEEEEE--eeecccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +|+ |++|++++++  +..||..
T Consensus       200 ~Di-~slG~il~~l~~g~~p~~~  221 (303)
T 3a7i_A          200 ADI-WSLGITAIELARGEPPHSE  221 (303)
T ss_dssp             HHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             hhh-HHHHHHHHHHccCCCCCCC
Confidence            899 9999999999  6677764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.93  E-value=1.4e-26  Score=225.01  Aligned_cols=173  Identities=17%  Similarity=0.296  Sum_probs=133.0

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      +..||+|+++.........+.+.+|+.++++++||||++++++. ..+..++||||++|++|.+++... ..+++..+..
T Consensus        46 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  124 (289)
T 3og7_A           46 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLID  124 (289)
T ss_dssp             SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHH
T ss_pred             cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHH
Confidence            45699999988776777778899999999999999999999964 566789999999999999999653 4699999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC---C---
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS---K---  156 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~---~---  156 (477)
                      ++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+................+++.|+|||....   .   
T Consensus       125 i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  203 (289)
T 3og7_A          125 IARQTARGMDYLHAKSIIHRDLKSNNIFLHEDN-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS  203 (289)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTT-EEEECCCC------------------CCCTTCCHHHHC----CCSC
T ss_pred             HHHHHHHHHHHHHhCCcccccCccceEEECCCC-CEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCC
Confidence            999999999999999999999999999997653 445569998864332111122234567889999998752   2   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|++++++  +..||.+
T Consensus       204 ~~~Di-~slG~il~el~~g~~p~~~  227 (289)
T 3og7_A          204 FQSDV-YAFGIVLYELMTGQLPYSN  227 (289)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCTTSS
T ss_pred             cccch-HHHHHHHHHHHHCCCCccc
Confidence            47899 9999999999  6678864

>2wnr_A Probable exosome complex exonuclease 2; phosphate binding, 3'-5' exoribonuclease, hydrolase; 2.65A {Methanothermobacter thermautotrophicusorganism_taxid}

Probab=99.93  E-value=1.5e-24  Score=208.57  Aligned_cols=208  Identities=19%  Similarity=0.244  Sum_probs=182.4

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEecccccc-ccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR-EIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEK  192 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp-E~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~  192 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.++..| +.....      -..|.+.+++.+.||+...++...++..+.
T Consensus        32 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~~~------~~~g~l~v~~~~~p~a~~~~~~g~~~~~~~  105 (271)
T 2wnr_A           32 HEFRDISIETGVISKAEGSSRVKLGNTQIIVGVKPQIGEPFPDT------PEMGVILTNSELLPMASPTFEPGPPDERSV  105 (271)
T ss_dssp             TCCCCEEEEESCSTTSSEEEEEEETTEEEEEEEEEEEECCCTTC------TTCCEEEEEEEECGGGCTTCCCSSCCHHHH
T ss_pred             ccccCeEEEeCccCCCCeEEEEEECCeEEEEEEEeeeecCCCCC------CCceEEEEEEEeCCcccccccCCCCchHHH
Confidence            5789999999999999999999999999999999544 432222      456899999999999987776667788899


Q ss_pred             HHHHHHHHHhhh--hhhcccC---C---CCcccEEEEEEeCCCchHHHHHHHHHHHHhhCC-------------------
Q psy6508         193 ELGNHLKRALEP--AVCRHEF---S---NFQVDLFVLVLQNDGSALSAAINCANLALVDAA-------------------  245 (477)
Q Consensus       193 ~l~~~i~~~l~~--~i~~~~~---P---r~~i~i~v~vL~~dg~~~~a~inaa~lAL~dag-------------------  245 (477)
                      ++++.+++.+++  .+.++.+   |   .|.+.+.++||++||+.+.++++|+++||.|+|                   
T Consensus       106 ~~s~li~r~lr~s~~i~l~~l~i~pg~~~~~i~i~~~VL~~DG~~~~aai~aa~~AL~~a~~p~~~~~~~~~~~~~~~~~  185 (271)
T 2wnr_A          106 ELSRVVDRCIRESRMIDLEKLCIIEGSKVWMLFLDLHIIDYDGNLFDAAVLATVAALLDTRIPAAEVEDGEVVINREKMQ  185 (271)
T ss_dssp             HHHHHHHHHHHHTTCBCGGGGEEETTTEEEEEEEEEEEEECSSCHHHHHHHHHHHHHHHCEEEEEEEETTEEEEEEEEEE
T ss_pred             HHHHHHHHHHhccCCccHHHccccCCcEEEEEEEEEEEECCCCCHHHHHHHHHHHHHHhcCCCeEEecCCceeeccCccc
Confidence            999999999999  4655665   4   469999999999999999999999999999999                   


Q ss_pred             -CCCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE--eeecHHHHHHHHHHH
Q psy6508         246 -IPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV--GTIQQERLADHIEQL  322 (477)
Q Consensus       246 -i~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~--g~~~~~~~~~~l~~~  322 (477)
                       +||+++++++|+++.++.+++||+..|+..          +.+.+++++. ..++|+.++..  |.++.+++.++++.|
T Consensus       186 ~ip~~~~~~avt~g~~~~~~l~Dpt~~Ee~~----------~~~~l~va~~-~~~~i~~i~~~g~~~~~~~~l~~~l~~a  254 (271)
T 2wnr_A          186 PLPVNRKALMCTFAKIGNEIVLDPSLEEEDI----------LTARISIGVT-EEGSICAMQKGGEGPLTRDDVLKAVSIA  254 (271)
T ss_dssp             ECCBCCCEEEEEEEEETTEEEESCCHHHHTT----------CSEEEEEEEE-TTSCEEEEEEESSSCBCHHHHHHHHHHH
T ss_pred             ccCccCCeEEEEEEEECCEEEeCCCHHHHhc----------CCCcEEEEEe-CCCCEEEEECCCCCCCCHHHHHHHHHHH
Confidence             999999999999999999999999999984          4788999974 45889999998  479999999999999


Q ss_pred             HhcccchhhHHHHhHhh
Q psy6508         323 IGCCESLCTDRVQKLVS  339 (477)
Q Consensus       323 ~~~~~~i~~~~i~~~l~  339 (477)
                      .++|+.+.+. +++.+.
T Consensus       255 ~~~~~~i~~~-~~~~l~  270 (271)
T 2wnr_A          255 VEKVPQLIEY-LDKSMT  270 (271)
T ss_dssp             HHHHHHHHHH-HHHHC-
T ss_pred             HHHHHHHHHH-HHHHhC
Confidence            9999999999 887653

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.93  E-value=2.6e-27  Score=229.71  Aligned_cols=160  Identities=21%  Similarity=0.232  Sum_probs=134.3

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC-CCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK-LSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~-l~~~~~~~i   83 (477)
                      +.||+|++....  ....+.+.+|+.++++++||||+++++++..++..|+||||++|++|.+++...+. +++..+..+
T Consensus        41 ~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i  118 (289)
T 4fvq_A           41 TEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEV  118 (289)
T ss_dssp             EEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHH
T ss_pred             hhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHH
Confidence            579999986543  34557799999999999999999999999999999999999999999999987654 999999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcc-------eeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTL-------KLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~-------rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +.|++.||.|||++||+||||||+|||++.+..       .+.++|||.+.......      ...++..|+|||...+.
T Consensus       119 ~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~y~aPE~~~~~  192 (289)
T 4fvq_A          119 AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------ILQERIPWVPPECIENP  192 (289)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH------HHHHTTTTSCHHHHHCG
T ss_pred             HHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCcc------ccCCcCcccCHHHhCCC
Confidence            999999999999999999999999999976532       14556999875443221      23356679999988752


Q ss_pred             ----CcccccCcceEEEEEEe
Q psy6508         157 ----TSLEYQRSKGELYVEFK  173 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~~  173 (477)
                          .++|+ ||+|+++|++.
T Consensus       193 ~~~~~~~Di-wslG~il~el~  212 (289)
T 4fvq_A          193 KNLNLATDK-WSFGTTLWEIC  212 (289)
T ss_dssp             GGCCHHHHH-HHHHHHHHHHH
T ss_pred             CCCCchhHH-HHHHHHHHHHH
Confidence                67899 99999999993

>3u1k_A Polyribonucleotide nucleotidyltransferase 1, MITO; RNAse PH, KH domain, exoribonuclease; HET: CIT; 2.13A {Homo sapiens}

Probab=99.93  E-value=5.6e-25  Score=230.95  Aligned_cols=213  Identities=19%  Similarity=0.230  Sum_probs=179.9

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCC-cc----cccCcceEEEEEEeeeccccccccC-CCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKT-SL----EYQRSKGELYVEFKFAPFASQIRTG-WLR  187 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~-~~----Di~~s~G~il~e~~~~Pf~~~~r~~-~~~  187 (477)
                      +++|.+.+.+|+..+++||++++.|+|++.|.++++|....... ..    .- -..|.+++++.++||++..+.. ..+
T Consensus       326 ~elRpi~i~~g~l~~a~GSal~~~G~T~Vl~~Vt~~~~~~~~~~d~~~~~l~~-~~~g~~~~~y~~~P~st~e~~~~g~~  404 (630)
T 3u1k_A          326 TSLRNVSCEVDMFKTLHGSALFQRGQTQVLCTVTFDSLESGIKSDQVITAING-IKDKNFMLHYEFPPYATNEIGKVTGL  404 (630)
T ss_dssp             TCCCCEEEEECCSTTSSEEEEEEETTEEEEEEEEEECGGGGSCSSHHHHHHHC-CCGGGEEEEEECCGGGGTCCCCCSSC
T ss_pred             ccccceEEEECCCCCCCceEEEEECCeEEEEEEEcCCCCchhcccccccccCC-CCceEEEEEEEecCCcccccccCCCC
Confidence            68999999999999999999999999999999998654322110 00    01 2457899999999999876543 356


Q ss_pred             CcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEeeC------
Q psy6508         188 DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALRG------  261 (477)
Q Consensus       188 ~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~------  261 (477)
                      +.++.++.+++++++++.+. ..||++ |++.++||++||+.+.++++|+++||+||||||+++|+|+|+++.+      
T Consensus       405 ~rREi~~~~Li~raLr~vi~-~~~p~t-I~V~~~VLesDGs~~~AsI~aa~lAL~dAGIPl~~~Vaavs~gli~~~~~~~  482 (630)
T 3u1k_A          405 NRRELGHGALAEKALYPVIP-RDFPFT-IRVTSEVLESNGSSSMASACGGSLALMDSGVPISSAVAGVAIGLVTKTDPEK  482 (630)
T ss_dssp             CHHHHHHHHHHHHHHGGGSC-TTCSSE-EEEEEEEEECSSCHHHHHHHHHHHHHHHTTCCCSSCCEEEEEEEEEEECSSS
T ss_pred             ChHHHHHHHHHHHHHHhhCc-ccCCeE-EEEEEEEEEcCCCHHHHHHHHHHHHHHhCCCCcccceEEEEEEEecCCCccc
Confidence            77888899999999999886 679986 9999999999999999999999999999999999999999999986      


Q ss_pred             C-----eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee---ecHHHHHHHHHHHHhcccchhhHH
Q psy6508         262 G-----LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT---IQQERLADHIEQLIGCCESLCTDR  333 (477)
Q Consensus       262 ~-----~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~---~~~~~~~~~l~~~~~~~~~i~~~~  333 (477)
                      +     .+++||+..|+..          +...+.++  ...+.|+.++++|+   |+.+++.++|+.|.++|..+... 
T Consensus       483 g~~~~~~iLlD~~~~Ed~~----------~d~d~~Va--~t~~gIt~lQ~~~k~~~~s~~~l~~aL~~A~~g~~~I~~~-  549 (630)
T 3u1k_A          483 GEIEDYRLLTDILGIEDYN----------GDMDFKIA--GTNKGITALQADIKLPGIPIKIVMEAIQQASVAKKEILQI-  549 (630)
T ss_dssp             SCEEEEEEEESCCHHHHHT----------SSEEEEEE--ECSSCEEEEEEEECSSCBCHHHHHHHHHHHHHHHHHHHHH-
T ss_pred             ccccCceEEecCCHHHHhh----------CcceEEEE--ecCCceEEEEecCCCCCCCHHHHHHHHHHHHHHHHHHHHH-
Confidence            3     6999999999883          24445554  55566999999984   69999999999999999999999 


Q ss_pred             HHhHhhhcc
Q psy6508         334 VQKLVSDHV  342 (477)
Q Consensus       334 i~~~l~~~~  342 (477)
                      |++++.+.-
T Consensus       550 m~~al~~~~  558 (630)
T 3u1k_A          550 MNKTISKPR  558 (630)
T ss_dssp             HHHHCSSCC
T ss_pred             HHHHHHHHH
Confidence            999997763

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.93  E-value=8.1e-27  Score=224.04  Aligned_cols=172  Identities=19%  Similarity=0.300  Sum_probs=131.9

Q ss_pred             CCcEEEEEEcccCCCCh--hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSE--NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~--~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      +|+.||+|+++......  ...+.+.+|+.+++.++||||+++++++..++..|+||||++|++|.+++.. +++++..+
T Consensus        29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~  107 (271)
T 3dtc_A           29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDIL  107 (271)
T ss_dssp             TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTS-SCCCHHHH
T ss_pred             cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhc-CCCCHHHH
Confidence            47889999987654322  3356789999999999999999999999999999999999999999999864 57999999


Q ss_pred             HHHHHHHHHHHHHHHhCC---cEEccCCCCceeecc-------CcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          81 QQFVRQLVLALKFLRENN---VCHFDLKPQNILIKN-------NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~-------~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                      ..++.|++.||.|||++|   |+||||||+||+++.       ....+.++|||.+.......    .....+++.|+||
T Consensus       108 ~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aP  183 (271)
T 3dtc_A          108 VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT----KMSAAGAYAWMAP  183 (271)
T ss_dssp             HHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-----------------CCGGGSCH
T ss_pred             HHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc----ccCCCCccceeCH
Confidence            999999999999999999   899999999999974       13445566999886543322    1245678899999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      |...+.   .++|+ ||+|++++++  +..||.+.
T Consensus       184 E~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~~  217 (271)
T 3dtc_A          184 EVIRASMFSKGSDV-WSYGVLLWELLTGEVPFRGI  217 (271)
T ss_dssp             HHHHHCCCSHHHHH-HHHHHHHHHHHHCCCTTTTS
T ss_pred             HHhccCCCCchhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            987654   67899 9999999999  77888753

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=7.1e-27  Score=253.89  Aligned_cols=167  Identities=20%  Similarity=0.286  Sum_probs=138.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCe-----EEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY-----VYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~-----~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      +|+.||||++.... .....+.+.+|+.++++++||||+++++++...+.     .|+||||++|++|.+++..  .+++
T Consensus       105 ~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~  181 (681)
T 2pzi_A          105 NGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPV  181 (681)
T ss_dssp             TTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCH
T ss_pred             CCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCH
Confidence            58899999986543 34556778999999999999999999999987654     7999999999999998765  7999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..++.++.|++.||.|||++||+||||||+|||++.+.+++  +|||.+......      .+..+++.|+|||+..+. 
T Consensus       182 ~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~~~kl--~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~  253 (681)
T 2pzi_A          182 AEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQLKL--IDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP  253 (681)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSCEEE--CCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCCcEEE--EecccchhcccC------CccCCCccccCHHHHcCCC
Confidence            99999999999999999999999999999999999875554  599998755432      345688999999987655 


Q ss_pred             -CcccccCcceEEEEEE--eeecccccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                       .++|+ ||+|++++++  ++.||.+..
T Consensus       254 ~~~sDi-~slG~~l~~l~~g~~~~~~~~  280 (681)
T 2pzi_A          254 TVATDI-YTVGRTLAALTLDLPTRNGRY  280 (681)
T ss_dssp             CHHHHH-HHHHHHHHHHHSCCCEETTEE
T ss_pred             CCceeh-hhhHHHHHHHHhCCCCCcccc
Confidence             67899 9999999998  667777543

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.93  E-value=4.7e-27  Score=227.30  Aligned_cols=172  Identities=22%  Similarity=0.352  Sum_probs=140.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+++.||+|+++......   +++.+|+.++++++||||+++++++...+..|+||||+++++|.+++.. ...+++..+
T Consensus        46 ~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  122 (283)
T 3gen_A           46 RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL  122 (283)
T ss_dssp             TTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHH
T ss_pred             cCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHH
Confidence            356789999998665443   5688999999999999999999999999999999999999999999976 457999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+........ .......++..|+|||...+.   .
T Consensus       123 ~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  200 (283)
T 3gen_A          123 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS  200 (283)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTS-CEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCHHHHHHCCCSH
T ss_pred             HHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCC-CEEEcccccccccccccc-ccccCCccCcccCCHHHhccCCCCc
Confidence            99999999999999999999999999999997653 344559998865443221 112233446679999987644   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++   +..||..
T Consensus       201 ~~Dv-~slG~~l~~l~t~g~~p~~~  224 (283)
T 3gen_A          201 KSDI-WAFGVLMWEIYSLGKMPYER  224 (283)
T ss_dssp             HHHH-HHHHHHHHHHHTTTCCTTTT
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCccc
Confidence            7899 9999999998   4567764

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.93  E-value=4.3e-26  Score=229.40  Aligned_cols=173  Identities=23%  Similarity=0.356  Sum_probs=144.2

Q ss_pred             CCCcEEEEEEcccCCC--Ch----hHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCC
Q psy6508           2 EQHTEVAIKCIDKTKV--SE----NRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~--~~----~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~   74 (477)
                      .+|+.||||+++....  ..    ...+.+.+|+.+++++ +||||+++++++...+..|+||||++|++|.+++.....
T Consensus       117 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~  196 (365)
T 2y7j_A          117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVA  196 (365)
T ss_dssp             TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSS
T ss_pred             CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCC
Confidence            4789999999876542  21    2245688999999999 799999999999999999999999999999999988778


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      +++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+........   ..+..+++.|+|||...
T Consensus       197 l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~-~ikl~DfG~~~~~~~~~~---~~~~~gt~~y~aPE~~~  272 (365)
T 2y7j_A          197 LSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILK  272 (365)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCC-CEEEEecCcccccCCCcc---cccCCCCCCccChhhcc
Confidence            99999999999999999999999999999999999997653 444569998866543221   13456788999999864


Q ss_pred             C---------CCcccccCcceEEEEEE--eeecccc
Q psy6508         155 S---------KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~---------~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +         ..++|+ ||+|+++|++  +..||.+
T Consensus       273 ~~~~~~~~~~~~~~Di-~slG~il~ell~g~~pf~~  307 (365)
T 2y7j_A          273 CSMDETHPGYGKEVDL-WACGVILFTLLAGSPPFWH  307 (365)
T ss_dssp             HTTCTTSCCBCTTHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccCcCCCchhhH-HhHHHHHHHHHHCCCCCCC
Confidence            2         157899 9999999999  6778864

>1e3p_A Guanosine pentaphosphate synthetase; polyribonucleotide transferase, ATP-GTP diphosphotransferase RNA processing, RNA degradation; 2.5A {Streptomyces antibioticus} SCOP: a.4.9.1 b.40.4.5 d.14.1.4 d.14.1.4 d.52.3.1 d.101.1.1 d.101.1.1 PDB: 1e3h_A

Probab=99.93  E-value=4.3e-25  Score=235.89  Aligned_cols=213  Identities=16%  Similarity=0.248  Sum_probs=186.0

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEecc-ccccccCCCCCcccccCcceEEEEEEeeeccccccccC-CCCCcch
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-WLRDSEE  191 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~-y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-~~~~~~~  191 (477)
                      +++|.+.+.+|+..+++||++++.|+|++.|.+ ++|++.......... -..|.+++++.++||++..+.. ..++.++
T Consensus       363 ~elRpI~ie~gvl~~a~GSAl~~~G~TqVL~~Vt~Gp~~~~~~~d~l~~-~~~g~~~~~y~f~P~st~e~~~~g~~~~re  441 (757)
T 1e3p_A          363 TDIRTLAAEVEAIPRVHGSALFERGETQILGVTTLNMLRMEQQLDTLSP-VTRKRYMHNYNFPPYSVGETGRVGSPKRRE  441 (757)
T ss_dssp             TCCCCEEEEECCSSSSSEEEEEEETTEEEEEEEEEEEGGGSEECCSSSS-CCEESEEEEEECCGGGGTCCCCCSSCCHHH
T ss_pred             ccccceeEEeCCCCCCCEEEEEEECCcEEEEEEEecCCCccccccccCC-CCceEEEEEEEeCCcccccccCCCCCchhH
Confidence            589999999999999999999999999999999 888775432200001 2458899999999999866543 3677889


Q ss_pred             HHHHHHHHHHhhhhhh-cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEEEEEee----CC----
Q psy6508         192 KELGNHLKRALEPAVC-RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSSTLALR----GG----  262 (477)
Q Consensus       192 ~~l~~~i~~~l~~~i~-~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~s~~~~----~~----  262 (477)
                      .++.+++++++++.+. .+.||++ |++.++||++||+.+.|+++|+++||+||||||+++|+|+|+++.    ++    
T Consensus       442 ie~~~li~raL~~vI~~~~~~P~t-I~V~~~VLesDGs~~~Asi~aa~lAL~dAgIP~k~~Vaavs~gli~eg~dg~~~~  520 (757)
T 1e3p_A          442 IGHGALAERAIVPVLPTREEFPYA-IRQVSEALGSNGSTSMGSVCASTMSLLNAGVPLKAPVAGIAMGLISQEINGETHY  520 (757)
T ss_dssp             HHHHHHHHHHHGGGCCCTTTSCEE-EEEEEEEEECSSCHHHHHHHHHHHHHHHHTCCCSSCCEEEEEEEEEEESSSCEEE
T ss_pred             HHHHHHHHHHHHHhccccccCCEE-EEEEEEEEECCCCHHHHHHHHHHHHHHHcCCCcccceEEEEEEEEecCCCCccce
Confidence            9999999999999998 7899987 999999999999999999999999999999999999999999998    44    


Q ss_pred             eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeee---cHHHHHHHHHHHHhcccchhhHHHHhHhh
Q psy6508         263 LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTI---QQERLADHIEQLIGCCESLCTDRVQKLVS  339 (477)
Q Consensus       263 ~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~---~~~~~~~~l~~~~~~~~~i~~~~i~~~l~  339 (477)
                      .+++||+..|+..          +...++++  ++.++|+.+|++|++   +.+++.++++.|.++|..+... |++++.
T Consensus       521 ~iLlDp~~~Ed~~----------gd~d~~Va--~t~~~It~lQ~~gk~~gi~~e~l~~aL~~A~~~~~~I~~~-m~~al~  587 (757)
T 1e3p_A          521 VALTDILGAEDAF----------GDMDFKVA--GTKEFVTALQLDTKLDGIPASVLAAALKQARDARLHILDV-MMEAID  587 (757)
T ss_dssp             EEEESCCHHHHHH----------CSEEEEEE--ECSSSEEEEEEEECSSCCCHHHHHHHHHHHHHHHHHHHHH-HHHHCS
T ss_pred             eEEeCCCHHHHhc----------cCceEEEE--ecCCeEEEEEEcCCccccCHHHHHHHHHHHHHHHHHHHHH-HHHHhc
Confidence            7999999999984          36777776  556889999999886   9999999999999999999999 999998


Q ss_pred             hc
Q psy6508         340 DH  341 (477)
Q Consensus       340 ~~  341 (477)
                      ++
T Consensus       588 ~~  589 (757)
T 1e3p_A          588 TP  589 (757)
T ss_dssp             SC
T ss_pred             cc
Confidence            76

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.93  E-value=1.1e-26  Score=243.06  Aligned_cols=171  Identities=20%  Similarity=0.327  Sum_probs=142.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~   80 (477)
                      ++..||||+++....   ..+.|.+|+.+|++++||||+++++++...+.+|+||||+++|+|.+++...  ..+++..+
T Consensus       244 ~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~  320 (495)
T 1opk_A          244 YSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVL  320 (495)
T ss_dssp             GTEEEEEEECCSSSS---CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHH
T ss_pred             CCeEEEEEEecCccc---chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHH
Confidence            578999999976543   3467999999999999999999999999999999999999999999999864  35899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++....+..+... ....++..|+|||...+.   .
T Consensus       321 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~  398 (495)
T 1opk_A          321 LYMATQISSAMEYLEKKNFIHRNLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFSI  398 (495)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEECCTTCCEECC-TTCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCC-cEEEeecccceeccCCceeec-CCCcCCcceeCHhHHhcCCCCc
Confidence            99999999999999999999999999999997643 344569999876654433221 223345679999988655   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||.+
T Consensus       399 ~sDv-wSlG~~l~el~t~g~~p~~~  422 (495)
T 1opk_A          399 KSDV-WAFGVLLWEIATYGMSPYPG  422 (495)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             HHhH-HhHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999998   4577764

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.93  E-value=8.7e-27  Score=225.88  Aligned_cols=172  Identities=21%  Similarity=0.319  Sum_probs=142.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      .+++.||+|++....   ...+.+.+|+.++++++||||+++++++..++..|+||||++|++|.+++....  .+++..
T Consensus        36 ~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~  112 (288)
T 3kfa_A           36 KYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV  112 (288)
T ss_dssp             GGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHH
T ss_pred             CCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhH
Confidence            357899999987543   345678999999999999999999999999999999999999999999998743  599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+....+... .......++..|+|||...+.   
T Consensus       113 ~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~  190 (288)
T 3kfa_A          113 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFS  190 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGG-CEEECCCCGGGTSCSSSS-EEETTEEECGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCC-CEEEccCccceeccCCcc-ccccCCccccCcCChhhhccCCCC
Confidence            999999999999999999999999999999997653 344569998865554332 122335567789999987644   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++   +..||.+
T Consensus       191 ~~~Di-~slG~il~~ll~~g~~p~~~  215 (288)
T 3kfa_A          191 IKSDV-WAFGVLLWEIATYGMSPYPG  215 (288)
T ss_dssp             HHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             chhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            67899 9999999998   4577764

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=1.6e-26  Score=224.32  Aligned_cols=174  Identities=19%  Similarity=0.306  Sum_probs=140.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++++.||+|+++... .....+.+.+|+.++++++||||+++++++ ..+..++||||+++++|.+++... ..+++..+
T Consensus        35 ~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  112 (287)
T 1u59_A           35 KKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNV  112 (287)
T ss_dssp             -CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHH
T ss_pred             CCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHH
Confidence            367889999997653 445667899999999999999999999998 556799999999999999999654 46999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc-ccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+....... .........++..|+|||...+.   
T Consensus       113 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  191 (287)
T 1u59_A          113 AELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS  191 (287)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCC-CEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCC
Confidence            99999999999999999999999999999997643 44456999887543221 11222233456789999988654   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++   +..||..
T Consensus       192 ~~~Di-~slG~il~ellt~g~~p~~~  216 (287)
T 1u59_A          192 SRSDV-WSYGVTMWEALSYGQKPYKK  216 (287)
T ss_dssp             HHHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             chhhH-HHHHHHHHHHHcCCCCCccc
Confidence            67899 9999999997   4677764

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.93  E-value=5.7e-26  Score=223.04  Aligned_cols=170  Identities=22%  Similarity=0.341  Sum_probs=142.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHH-hCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIR-SHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~-~~~~l~~~~~   80 (477)
                      .+|+.||+|.++...    ..+.+.+|+.++++++||||+++++++...+..|+||||+++++|.+++. ....+++..+
T Consensus        52 ~~~~~vaiK~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  127 (314)
T 3com_A           52 ETGQIVAIKQVPVES----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI  127 (314)
T ss_dssp             TTCCEEEEEEEETTS----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHH
T ss_pred             CCCCEEEEEecCchH----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHH
Confidence            468999999987653    23568899999999999999999999999999999999999999999997 3467999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.......  .......++..|.|||...+.   .
T Consensus       128 ~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~  204 (314)
T 3com_A          128 ATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNC  204 (314)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred             HHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCC-CEEEeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCc
Confidence            99999999999999999999999999999997643 34456999886544321  112345678899999987765   6


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ |++|+++|++  +..||..
T Consensus       205 ~~Di-~slG~il~~l~~g~~p~~~  227 (314)
T 3com_A          205 VADI-WSLGITAIEMAEGKPPYAD  227 (314)
T ss_dssp             THHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             cccH-HHHHHHHHHHHhCCCCCCC
Confidence            7899 9999999999  6678764

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=4.4e-27  Score=238.11  Aligned_cols=167  Identities=22%  Similarity=0.386  Sum_probs=134.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--------------------------------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--------------------------------   49 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--------------------------------   49 (477)
                      .+|+.||||++......      ..+|+.+++.++||||+++++++..                                
T Consensus        30 ~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  103 (383)
T 3eb0_A           30 ESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSV  103 (383)
T ss_dssp             TTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------
T ss_pred             CCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccc
Confidence            57899999998655322      2379999999999999999999843                                


Q ss_pred             ------CCeEEEEEecCCCCCHHHHHH----hCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceee
Q psy6508          50 ------ERYVYIILEYCDGGDLCSFIR----SHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLA  119 (477)
Q Consensus        50 ------~~~~~lv~e~~~g~sL~~~l~----~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~  119 (477)
                            ...+++||||++ ++|.+.+.    ....+++..++.++.|++.||.|||++||+||||||+||+++....++.
T Consensus       104 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~k  182 (383)
T 3eb0_A          104 IVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLK  182 (383)
T ss_dssp             ------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEE
T ss_pred             cccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEE
Confidence                  335899999998 68777765    3467999999999999999999999999999999999999975444566


Q ss_pred             cccccceecccCCcccccCCeEEEeccccccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         120 GLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       120 ~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|||.+.......   ...+..+++.|+|||...+.    .++|+ ||+|+++|++  +..||.+
T Consensus       183 l~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Di-wslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          183 LCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDL-WSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             ECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             EEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhh-hhHHHHHHHHHhCCCCCCC
Confidence            67999987543322   22345678889999987653    67899 9999999999  6677763

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.93  E-value=4.1e-28  Score=243.93  Aligned_cols=175  Identities=12%  Similarity=0.151  Sum_probs=136.4

Q ss_pred             CCcEEEEEEcccCCCChhH---------HHHHHHHHHHHHhcCCCCccceEEEEEeC----CeEEEEEecCCCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENR---------FDSIVNEIKALKLLHHQHIVTMLDFLWDE----RYVYIILEYCDGGDLCSFI   69 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~----~~~~lv~e~~~g~sL~~~l   69 (477)
                      .++.||||++.........         ...+..|+..++.++||||+++++++...    ...|+||||+ |++|.+++
T Consensus        64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~  142 (364)
T 3op5_A           64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY  142 (364)
T ss_dssp             TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHH
T ss_pred             cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHH
Confidence            3688999998765321100         01244566677788899999999998764    5689999999 89999999


Q ss_pred             HhC-CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCccc-----ccCCeEE
Q psy6508          70 RSH-EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYI-----EQGNTKV  142 (477)
Q Consensus        70 ~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~-----~~g~t~v  142 (477)
                      ... +.+++..+..++.|++.||.|||++||+||||||+|||++. +..++.++|||++.........     ....+..
T Consensus       143 ~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~  222 (364)
T 3op5_A          143 EANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHD  222 (364)
T ss_dssp             HHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCC
T ss_pred             HhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccC
Confidence            876 57999999999999999999999999999999999999972 2335556799998654322111     1113445


Q ss_pred             EeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         143 ICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       143 ~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +++.|+|||...+.   .++|+ ||+|+++||+  +..||.+
T Consensus       223 gt~~y~aPE~~~~~~~~~~~Di-~slG~~l~el~~g~~Pf~~  263 (364)
T 3op5_A          223 GTIEFTSIDAHNGVAPSRRGDL-EILGYCMIQWLTGHLPWED  263 (364)
T ss_dssp             CCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSCCTTGG
T ss_pred             CCCCccCHHHhCCCCCCchhhH-HHHHHHHHHHHhCCCCccc
Confidence            88899999998776   67899 9999999999  7788874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.93  E-value=1.1e-26  Score=233.82  Aligned_cols=169  Identities=22%  Similarity=0.357  Sum_probs=129.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++.....+....+++.+|+.+++.++||||+++++++...      ...|+++|++ +++|.+++.. +.+
T Consensus        52 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l  129 (367)
T 2fst_X           52 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKL  129 (367)
T ss_dssp             TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCC
T ss_pred             CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCC
Confidence            5789999999987665666677899999999999999999999998754      5689999999 5899999876 579


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+......     ....+++..|+|||...+
T Consensus       130 ~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~-~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~  203 (367)
T 2fst_X          130 TDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTADE-----MTGYVATRWYRAPEIMLN  203 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECC--------------------CCCTTCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCC-CEEEeecccccccccc-----CCCcCcCcCccChHHHcC
Confidence            9999999999999999999999999999999999997653 4445699998654322     234578899999998765


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|++++||  +..||.+
T Consensus       204 ~~~~~~~~Di-wslG~il~ell~g~~pf~~  232 (367)
T 2fst_X          204 WMHYNQTVDI-WSVGCIMAELLTGRTLFPG  232 (367)
T ss_dssp             CCSCCTTHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CcCCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            2    67899 9999999999  6677764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.93  E-value=9.4e-27  Score=230.20  Aligned_cols=172  Identities=24%  Similarity=0.360  Sum_probs=133.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+++.||+|+++..... .....+.+|+.++++++||||+++++++..++..|+||||++ ++|.+++...+ .+++..+
T Consensus        25 ~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~  102 (324)
T 3mtl_A           25 LTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNV  102 (324)
T ss_dssp             TTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHH
T ss_pred             CCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHH
Confidence            47899999998755321 112245679999999999999999999999999999999998 69999988754 5999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......  .......+++.|+|||...+.    
T Consensus       103 ~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~  179 (324)
T 3mtl_A          103 KLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERG-ELKLADFGLARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYS  179 (324)
T ss_dssp             HHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTC-CEEECSSSEEECC--------------CGGGCCHHHHTTCCCCC
T ss_pred             HHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCC-CEEEccCcccccccCCc--cccccccCcccccChhhhcCCCCCC
Confidence            99999999999999999999999999999997653 34456999886433221  122345778999999987653    


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++  +..||.+
T Consensus       180 ~~~Di-wslG~il~~l~~g~~pf~~  203 (324)
T 3mtl_A          180 TQIDM-WGVGCIFYEMATGRPLFPG  203 (324)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            67899 9999999999  6677764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.93  E-value=2.5e-26  Score=237.61  Aligned_cols=166  Identities=25%  Similarity=0.405  Sum_probs=135.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-eEEEEEecCCCCCHHHHHHhCCC--CCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEYCDGGDLCSFIRSHEK--LSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~lv~e~~~g~sL~~~l~~~~~--l~~~~   79 (477)
                      +|+.||||+++...    ..+.|.+|+.+|++++||||+++++++.... ..|+||||+++|+|.+++...+.  +++..
T Consensus       215 ~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~  290 (450)
T 1k9a_A          215 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC  290 (450)
T ss_dssp             TTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHH
T ss_pred             cCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHH
Confidence            46789999997653    3457899999999999999999999987665 79999999999999999987543  79999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++......     ..+..++..|+|||...+.   
T Consensus       291 ~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~  364 (450)
T 1k9a_A          291 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFS  364 (450)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTS-CEEECCCTTCEECC-----------CCCTTTSCHHHHHSSCCC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCC-CEEEeeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCC
Confidence            999999999999999999999999999999997643 3444599998643321     1223456779999988655   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++||+   +..||.+
T Consensus       365 ~~sDv-wslG~~l~el~t~g~~P~~~  389 (450)
T 1k9a_A          365 TKSDV-WSFGILLWEIYSFGRVPYPR  389 (450)
T ss_dssp             HHHHH-HHHHHHHHHHHTTTCCSSTT
T ss_pred             cHHHH-HHHHHHHHHHHhCCCCCCCC
Confidence            67899 9999999998   5677764

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.93  E-value=1.9e-26  Score=228.27  Aligned_cols=170  Identities=17%  Similarity=0.240  Sum_probs=131.5

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~   84 (477)
                      .||+|.++... .....+.+.+|+.++++++||||+++++++..+. .++++||+++|+|.+++... +.+++..+..|+
T Consensus        46 ~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~  123 (327)
T 3poz_A           46 PVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC  123 (327)
T ss_dssp             EEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHH
T ss_pred             EEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence            46888876443 3344578999999999999999999999998765 78999999999999999874 479999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEY  161 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di  161 (477)
                      .|++.||.|||++||+||||||+|||++.+. ++.++|||.+................++..|+|||...+.   .++|+
T Consensus       124 ~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  202 (327)
T 3poz_A          124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV  202 (327)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHhhCCeeCCCCChheEEECCCC-CEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhh
Confidence            9999999999999999999999999997643 3455699998654433222222233456689999987655   67899


Q ss_pred             cCcceEEEEEE---eeecccc
Q psy6508         162 QRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       162 ~~s~G~il~e~---~~~Pf~~  179 (477)
                       ||+|+++||+   +..||.+
T Consensus       203 -~slG~il~ellt~g~~p~~~  222 (327)
T 3poz_A          203 -WSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             -HHHHHHHHHHHTTSCCTTTT
T ss_pred             -hhhHHHHHHHHhcCCCCccC
Confidence             9999999997   5677764

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.93  E-value=2.8e-26  Score=224.78  Aligned_cols=172  Identities=23%  Similarity=0.324  Sum_probs=136.2

Q ss_pred             CCCcEEEEEEcccCCCC---hhHHHHHHHHHHHHHhc---CCCCccceEEEEEeCC-----eEEEEEecCCCCCHHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS---ENRFDSIVNEIKALKLL---HHQHIVTMLDFLWDER-----YVYIILEYCDGGDLCSFIR   70 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~---~~~~~~~~~E~~il~~l---~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~   70 (477)
                      .+|+.||||+++.....   ......+.+|+.+++++   +||||+++++++....     ..+++|||+. ++|.+++.
T Consensus        32 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~  110 (308)
T 3g33_A           32 HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLD  110 (308)
T ss_dssp             TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHH
T ss_pred             CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHh
Confidence            57899999998754422   11224566788887776   4999999999998755     5899999997 69999998


Q ss_pred             hCCC--CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          71 SHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        71 ~~~~--l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                      ....  +++..++.++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......   ...+..+++.|+
T Consensus       111 ~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~  186 (308)
T 3g33_A          111 KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG-TVKLADFGLARIYSYQM---ALTPVVVTLWYR  186 (308)
T ss_dssp             TCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTS-CEEECSCSCTTTSTTCC---CSGGGGCCCSSC
T ss_pred             hccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC-CEEEeeCccccccCCCc---ccCCcccccccc
Confidence            7654  99999999999999999999999999999999999997643 34445999886443221   123456788999


Q ss_pred             ccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |||...+.   .++|+ ||+|+++|++  +..||.+
T Consensus       187 aPE~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~  221 (308)
T 3g33_A          187 APEVLLQSTYATPVDM-WSVGCIFAEMFRRKPLFCG  221 (308)
T ss_dssp             CHHHHHTSCCCSTHHH-HHHHHHHHHTTTSSCSCCC
T ss_pred             CchHHcCCCCCchHHH-HHHHHHHHHHHhCCCCCCC
Confidence            99987554   77899 9999999999  6677753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.93  E-value=1.7e-27  Score=235.09  Aligned_cols=173  Identities=27%  Similarity=0.438  Sum_probs=138.1

Q ss_pred             CCCcEEEEEEcccCCCC------hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVS------ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+++.||||++......      ......+.+|+.++++++||||+++++++..++ .|+||||+++++|.+++...+.+
T Consensus        33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~  111 (322)
T 2ycf_A           33 KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRL  111 (322)
T ss_dssp             TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCC
T ss_pred             CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCC
Confidence            46889999999765431      122345889999999999999999999987665 89999999999999999888889


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      ++..+..++.|++.||.|||++||+||||||+||+++.+  ...+.++|||.+........   ..+..+++.|+|||..
T Consensus       112 ~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~  188 (322)
T 2ycf_A          112 KEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGTPTYLAPEVL  188 (322)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCCcCccCchhh
Confidence            999999999999999999999999999999999999753  33455669999865443221   1234567889999985


Q ss_pred             C---CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         154 S---SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~---~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   ..   .++|+ ||+|+++|++  +..||..
T Consensus       189 ~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~  221 (322)
T 2ycf_A          189 VSVGTAGYNRAVDC-WSLGVILFICLSGYPPFSE  221 (322)
T ss_dssp             HHTTTTTCTTHHHH-HHHHHHHHHHHHSSCSSCS
T ss_pred             ccCCCCCCCchhhH-HHHHHHHHHHHhCCCCCcc
Confidence            2   11   67899 9999999999  7788864

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.92  E-value=2.6e-26  Score=231.44  Aligned_cols=170  Identities=24%  Similarity=0.361  Sum_probs=134.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+      ..|+||||++ ++|.+++..  .+
T Consensus        48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~  124 (371)
T 2xrw_A           48 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--EL  124 (371)
T ss_dssp             TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHHS--CC
T ss_pred             CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHhh--cc
Confidence            46889999999876666666778999999999999999999999987654      7899999998 689998864  58


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+|||++.+. ++.++|||.+.......   ...+..+++.|+|||...+
T Consensus       125 ~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~  200 (371)
T 2xrw_A          125 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSF---MMTPYVVTRYYRAPEVILG  200 (371)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCC-------------------CTTCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC-CEEEEEeeccccccccc---ccCCceecCCccCHHHhcC
Confidence            9999999999999999999999999999999999998653 34455999986544321   1234678889999999876


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ ||+|+++|++  +..||.+
T Consensus       201 ~~~~~~~Di-wslG~il~el~~g~~pf~~  228 (371)
T 2xrw_A          201 MGYKENVDI-WSVGCIMGEMIKGGVLFPG  228 (371)
T ss_dssp             CCCCTTHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCchHhH-HHHHHHHHHHHhCCCCCCC
Confidence            5   77899 9999999999  6677764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.92  E-value=1.6e-26  Score=221.34  Aligned_cols=172  Identities=19%  Similarity=0.273  Sum_probs=140.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+++.||+|+++.....   .+.+.+|+.++++++||||+++++++..++..|++|||++|++|.+++... +.+++..+
T Consensus        30 ~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  106 (267)
T 3t9t_A           30 LNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETL  106 (267)
T ss_dssp             TTTEEEEEEEECTTTBC---HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHH
T ss_pred             cCCCeEEEEEccccCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHH
Confidence            35778999999766543   356889999999999999999999999999999999999999999999875 46899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+........ .......++..|+|||...+.   .
T Consensus       107 ~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~  184 (267)
T 3t9t_A          107 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSS  184 (267)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGG-CEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHhCCcccCCCchheEEECCCC-CEEEcccccccccccccc-cccccccccccccChhhhcCCCccc
Confidence            99999999999999999999999999999997643 344569998865443221 112233456779999987644   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|++   +..||..
T Consensus       185 ~~Di-~slG~il~~l~~~g~~p~~~  208 (267)
T 3t9t_A          185 KSDV-WSFGVLMWEVFSEGKIPYEN  208 (267)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             hhch-hhhHHHHHHHhccCCCCCCC
Confidence            7899 9999999998   4677764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.92  E-value=1.1e-27  Score=242.13  Aligned_cols=171  Identities=16%  Similarity=0.156  Sum_probs=131.8

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHH---HHHhcCCCCccceE-------EEEEeCC-----------------eE
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIK---ALKLLHHQHIVTML-------DFLWDER-----------------YV   53 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~---il~~l~HpnIv~~~-------~~~~~~~-----------------~~   53 (477)
                      .+|+.||||+++.... .....+.+.+|+.   ++++++||||++++       +++...+                 ..
T Consensus        96 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  175 (377)
T 3byv_A           96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR  175 (377)
T ss_dssp             CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESE
T ss_pred             CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEE
Confidence            4689999999986543 3445678999995   55556899999998       7766553                 38


Q ss_pred             EEEEecCCCCCHHHHHHhCCCCCH-------HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccce
Q psy6508          54 YIILEYCDGGDLCSFIRSHEKLSE-------FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVS  126 (477)
Q Consensus        54 ~lv~e~~~g~sL~~~l~~~~~l~~-------~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~  126 (477)
                      |++|||+ +|+|.+++...+.+++       ..+..++.|++.||.|||++||+||||||+|||++.+. ++.++|||++
T Consensus       176 ~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a  253 (377)
T 3byv_A          176 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHL  253 (377)
T ss_dssp             EEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGC
T ss_pred             EEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC-CEEEEechhh
Confidence            9999999 5899999987554554       78888999999999999999999999999999998653 4555699998


Q ss_pred             ecccCCcccccCCeEEEeccccccccCCCC--------------CcccccCcceEEEEEE--eeecccccc
Q psy6508         127 EKAKGSAYIEQGNTKVICSVFEPREIPSSK--------------TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       127 ~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--------------~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      .......     .+..+ +.|+|||...+.              .++|+ ||+|+++||+  +..||.+..
T Consensus       254 ~~~~~~~-----~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv-wSlG~il~elltg~~Pf~~~~  317 (377)
T 3byv_A          254 VRDGARV-----VSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA-WALGLVIYWIWCADLPITKDA  317 (377)
T ss_dssp             EETTCEE-----ECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH-HHHHHHHHHHHHSSCCC----
T ss_pred             eecCCcc-----cCCCC-cCccChhhhcccccccccccccccCChhhhH-HHHHHHHHHHHHCCCCCcccc
Confidence            7533211     23345 889999986532              67899 9999999999  778887543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.92  E-value=2.1e-26  Score=223.77  Aligned_cols=173  Identities=25%  Similarity=0.328  Sum_probs=140.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---~l~~~   78 (477)
                      .+++.||||.++...  ....+.+.+|+.+++.++||||+++++++...+..++||||+++++|.+++....   .+++.
T Consensus        45 ~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  122 (295)
T 2clq_A           45 SNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ  122 (295)
T ss_dssp             TTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHH
T ss_pred             CCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHH
Confidence            468899999987653  3345678999999999999999999999999999999999999999999998752   46789


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .+..++.|++.||.|||++|++||||||+||+++....++.++|||.+....+..  ....+..++..|+|||...+.  
T Consensus       123 ~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~  200 (295)
T 2clq_A          123 TIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPR  200 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGG
T ss_pred             HHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC--CcccccCCCccccChhhhcCCCC
Confidence            9999999999999999999999999999999998633355566999886554322  112345678899999987542  


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ |++|+++|++  +..||..
T Consensus       201 ~~~~~~Di-~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          201 GYGKAADI-WSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             GCSHHHHH-HHHHHHHHHHHHTSCTTGG
T ss_pred             CCCcHHHH-HHHHHHHHHHHHCCCCccC
Confidence               57899 9999999999  6778864

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.3e-26  Score=228.40  Aligned_cols=173  Identities=22%  Similarity=0.274  Sum_probs=135.4

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      +..||+|+++... .......+.+|+.++++++||||+++++++...+..++||||+++++|.+++... +.+++..+..
T Consensus        73 ~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  151 (333)
T 1mqb_A           73 EVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVG  151 (333)
T ss_dssp             EEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHH
T ss_pred             cccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHH
Confidence            4569999987543 4455678999999999999999999999999999999999999999999999865 5799999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccc-cCCeEEEeccccccccCCCC---Cc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE-QGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~-~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      ++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......... ......++..|+|||...+.   .+
T Consensus       152 i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  230 (333)
T 1mqb_A          152 MLRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA  230 (333)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHH
T ss_pred             HHHHHHHHHHHHHhCCeeCCCCChheEEECCCC-cEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCch
Confidence            999999999999999999999999999997653 44556999886544322111 11122345679999987654   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|+++|++   +..||.+
T Consensus       231 ~Di-~slG~il~ellt~g~~pf~~  253 (333)
T 1mqb_A          231 SDV-WSFGIVMWEVMTYGERPYWE  253 (333)
T ss_dssp             HHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             hhh-HHHHHHHHHHHcCCCCCccc
Confidence            899 9999999997   5677754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.92  E-value=1.2e-26  Score=223.85  Aligned_cols=174  Identities=28%  Similarity=0.377  Sum_probs=141.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhC----CCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSH----EKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~----~~l   75 (477)
                      .+|+.||+|.+.....+....+.+.+|+.++++++||||+++++++..  .+..|+||||++|++|.+++...    ..+
T Consensus        29 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  108 (279)
T 2w5a_A           29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL  108 (279)
T ss_dssp             TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCC
T ss_pred             CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCC
Confidence            478999999998877677777889999999999999999999998754  56899999999999999999753    249


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCC-----cEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENN-----VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                      ++..+..++.|++.||.|||++|     ++||||||+||+++.+. ++.++|||.+........  ...+..++..|+||
T Consensus       109 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~-~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP  185 (279)
T 2w5a_A          109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDTS--FAKTFVGTPYYMSP  185 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSS-CEEECCCCHHHHC---CH--HHHHHHSCCTTCCH
T ss_pred             CHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCC-CEEEecCchheeeccccc--cccccCCCccccCh
Confidence            99999999999999999999999     99999999999998643 344459998754432211  11233567789999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.   .++|+ ||+|+++|++  +..||..
T Consensus       186 E~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~  218 (279)
T 2w5a_A          186 EQMNRMSYNEKSDI-WSLGCLLYELCALMPPFTA  218 (279)
T ss_dssp             HHHHCC-CCHHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             HHhccCCCCchhhH-HHHHHHHHHHHHCCCCCcc
Confidence            987665   67899 9999999999  6678764

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.92  E-value=5.6e-26  Score=221.46  Aligned_cols=162  Identities=21%  Similarity=0.300  Sum_probs=130.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHh--cCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKL--LHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      +|+.||||++...     ....+.+|.+++..  ++||||+++++++..    ....|+||||+++|+|.++++. ..++
T Consensus        30 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~  103 (301)
T 3q4u_A           30 QGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-TTLD  103 (301)
T ss_dssp             TTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTT-CCBC
T ss_pred             CCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhh-cccC
Confidence            5789999998643     23456677777776  799999999998654    2468999999999999999965 5799


Q ss_pred             HHHHHHHHHHHHHHHHHHH--------hCCcEEccCCCCceeeccCcceeecccccceecccCCccc--ccCCeEEEecc
Q psy6508          77 EFQCQQFVRQLVLALKFLR--------ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--EQGNTKVICSV  146 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH--------~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--~~g~t~v~~~~  146 (477)
                      +..+..++.|++.||.|||        ++||+||||||+|||++.+. ++.++|||.+.........  ....+..+++.
T Consensus       104 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  182 (301)
T 3q4u_A          104 TVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNG-QCCIADLGLAVMHSQSTNQLDVGNNPRVGTKR  182 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEEECCCCCCCCCGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCC-CEEEeeCCCeeecccccccccccccccccccc
Confidence            9999999999999999999        99999999999999997643 3445699988654332211  11234578899


Q ss_pred             ccccccCCCC---------CcccccCcceEEEEEE
Q psy6508         147 FEPREIPSSK---------TSLEYQRSKGELYVEF  172 (477)
Q Consensus       147 y~ppE~~~~~---------~~~Di~~s~G~il~e~  172 (477)
                      |+|||...+.         .++|+ ||+|+++||+
T Consensus       183 y~aPE~~~~~~~~~~~~~~~~~Dv-wslG~il~el  216 (301)
T 3q4u_A          183 YMAPEVLDETIQVDCFDSYKRVDI-WAFGLVLWEV  216 (301)
T ss_dssp             GCCHHHHTTCCCTTCHHHHHHHHH-HHHHHHHHHH
T ss_pred             eeChhhhcCcCCCCcccCCchhhH-HHHHHHHHHH
Confidence            9999998765         47899 9999999999

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.92  E-value=8e-26  Score=220.18  Aligned_cols=173  Identities=21%  Similarity=0.327  Sum_probs=142.6

Q ss_pred             CCCcEEEEEEcccCCC---C----hhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC
Q psy6508           2 EQHTEVAIKCIDKTKV---S----ENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~---~----~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~   73 (477)
                      .+|+.||||+++....   .    ....+.+.+|+.+++++. ||||+++++++...+..++||||+++++|.+++....
T Consensus        40 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  119 (298)
T 1phk_A           40 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV  119 (298)
T ss_dssp             TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred             CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC
Confidence            4788999999976542   1    123467889999999995 9999999999999999999999999999999998877


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccC
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIP  153 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~  153 (477)
                      .+++..+..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+........   .....+++.|+|||..
T Consensus       120 ~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~  195 (298)
T 1phk_A          120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM-NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEII  195 (298)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCC-cEEEecccchhhcCCCcc---cccccCCccccCHHHh
Confidence            899999999999999999999999999999999999997653 344459998865443221   1234577899999986


Q ss_pred             C------C---CCcccccCcceEEEEEE--eeecccc
Q psy6508         154 S------S---KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       154 ~------~---~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .      .   ..++|+ |++|++++++  +..||..
T Consensus       196 ~~~~~~~~~~~~~~~Di-~slG~~l~~l~~g~~p~~~  231 (298)
T 1phk_A          196 ECSMNDNHPGYGKEVDM-WSTGVIMYTLLAGSPPFWH  231 (298)
T ss_dssp             HHHHCTTSCCBCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             ccccccccccCCccccc-HhHHHHHHHHHHCCCCCcC
Confidence            3      1   167899 9999999999  6677754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.9e-26  Score=223.13  Aligned_cols=166  Identities=19%  Similarity=0.283  Sum_probs=135.9

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeE-EEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYV-YIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~-~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +..||+|.++... .....+.+.+|+.++++++||||+++++++...+.. +++|||+.+++|.+++... ..+++..+.
T Consensus        49 ~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~  127 (298)
T 3pls_A           49 RIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI  127 (298)
T ss_dssp             EEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHH
T ss_pred             eeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHH
Confidence            4479999987543 445567899999999999999999999999766554 9999999999999999873 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc--ccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--EQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+.........  .......++..|.|||...+.   
T Consensus       128 ~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  206 (298)
T 3pls_A          128 SFGLQVARGMEYLAEQKFVHRDLAARNCMLDESF-TVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFT  206 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC-cEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCC
Confidence            9999999999999999999999999999997653 3445699998654433221  122234566789999998765   


Q ss_pred             CcccccCcceEEEEEE
Q psy6508         157 TSLEYQRSKGELYVEF  172 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~  172 (477)
                      .++|+ ||+|+++|++
T Consensus       207 ~~~Di-~slG~il~~l  221 (298)
T 3pls_A          207 TKSDV-WSFGVLLWEL  221 (298)
T ss_dssp             HHHHH-HHHHHHHHHH
T ss_pred             hhhch-hhHHHHHHHH
Confidence            67899 9999999999

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.92  E-value=2.9e-27  Score=230.87  Aligned_cols=172  Identities=24%  Similarity=0.368  Sum_probs=135.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++..++..|+||||+++++|.+++.. ...+++..+
T Consensus        42 ~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~  119 (302)
T 2j7t_A           42 ETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI  119 (302)
T ss_dssp             TTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHH
T ss_pred             CCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHH
Confidence            468899999987553  33457789999999999999999999999999999999999999999999875 457999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC-----C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS-----S  155 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~-----~  155 (477)
                      ..++.|++.||.|||++|++||||||+||+++.+. .+.++|||.+......  .....+..++..|+|||...     +
T Consensus       120 ~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (302)
T 2j7t_A          120 QVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKD  196 (302)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTS-CEEECCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTS
T ss_pred             HHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCC-CEEEEECCCCcccccc--ccccccccCChhhcCCeeeccccCCC
Confidence            99999999999999999999999999999997543 3444599976432111  11223456788999999862     2


Q ss_pred             C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .   .++|+ |++|+++|++  +..||..
T Consensus       197 ~~~~~~~Di-~slG~il~~l~~g~~p~~~  224 (302)
T 2j7t_A          197 TPYDYKADI-WSLGITLIEMAQIEPPHHE  224 (302)
T ss_dssp             TTTTTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             CCCchhhhH-HHHHHHHHHHhcCCCCCcc
Confidence            2   67899 9999999999  6677764

>3m7n_G Probable exosome complex exonuclease 2; exosome, RNA, exonuclease, hydrolase, nuclease, hydrolase-RN; 2.40A {Archaeoglobus fulgidus} PDB: 2ba1_H 2ba0_I 3m85_G

Probab=99.92  E-value=1.8e-24  Score=206.38  Aligned_cols=206  Identities=23%  Similarity=0.322  Sum_probs=179.5

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      ++.|.+.+.+|...+++||++++.|+|++.|.+++.++....    +- -..|.+.+++.+.||++..++...++..+.+
T Consensus        30 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~----~~-~~~g~l~v~~~~~p~a~~~~~~g~~~~~~~~  104 (259)
T 3m7n_G           30 DEFRKVEIIPNVIEKAEGSALVKLGDTQVVVGVKMQPGEPYP----DT-PDRGVIIVNAELVPLASPTFEPGPPDENSIE  104 (259)
T ss_dssp             TCCCCEEEEETSSTTSSEEEEEEETTEEEEEEEEEEEECCCS----SC-TTSCEEEEEEECCTTSCTTCCSSSSCHHHHH
T ss_pred             ccccCeEEEeCCcCCCCceEEEEECCcEEEEEEEecccCCCC----CC-CCceEEEEEEEeCCcccccccCCCCChHHHH
Confidence            588999999999999999999999999999999976653321    11 3457889999999999876655667788899


Q ss_pred             HHHHHHHHhhh--hhhcccC---CC---CcccEEEEEEeCCCchHHHHHHHHHHHHhhCCC-------------CCCceE
Q psy6508         194 LGNHLKRALEP--AVCRHEF---SN---FQVDLFVLVLQNDGSALSAAINCANLALVDAAI-------------PMYDLV  252 (477)
Q Consensus       194 l~~~i~~~l~~--~i~~~~~---Pr---~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi-------------~m~~~v  252 (477)
                      +++.+++.+++  .+.++.+   |+   +.+.+.++||+.||+.+.++++|+++||.|+||             ||++++
T Consensus       105 ~srli~r~lr~s~~i~l~~L~i~pg~~~~~i~i~~~VL~~DG~~~~aai~aa~~AL~~a~iP~~~~~~~~~~~lp~~~~~  184 (259)
T 3m7n_G          105 LARVVDRGIRESEAVDLSKLVIEEGEKVWIVFVDIHALDDDGNLLDASALAAIAALMNTKVPAERFDLGEDYLLPVRDLP  184 (259)
T ss_dssp             HHHHHHHHHHHTTCBCGGGGEEETTTEEEEEEEEEEEEECSSCHHHHHHHHHHHHHHTCEECTGGGTSSSCEECCBCCCC
T ss_pred             HHHHHHHHHhhcCCccHHHhcccCCcEEEEEEEEEEEEcCCCCHHHHHHHHHHHHHHhCCCCeEEecCCceecccccCce
Confidence            99999999999  6766665   73   899999999999999999999999999999999             799999


Q ss_pred             EEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE--eeecHHHHHHHHHHHHhcccchh
Q psy6508         253 TSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV--GTIQQERLADHIEQLIGCCESLC  330 (477)
Q Consensus       253 ~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~--g~~~~~~~~~~l~~~~~~~~~i~  330 (477)
                      +++|+++.++.+++||+..|+..          +.+.+++++.+ .++++.++..  |.++.+++.++++.|.++|+.+.
T Consensus       185 ~avtvg~~~~~~l~Dpt~~Ee~~----------~~~~l~va~~~-~g~i~~i~~~g~~~~~~~~l~~~l~~a~~~~~~l~  253 (259)
T 3m7n_G          185 VSVTSLIVGNKYLVDPSREEMSV----------GDTTLTITTDK-DDNVVAMQKSGGYLLDEKLFDELLDVSINCARKLR  253 (259)
T ss_dssp             EEEEEEEETTEEEESCCTTGGGG----------CSCEEEEEECT-TSCEEEEEEESSCCBCHHHHHHHHHHHHHHHHHHH
T ss_pred             eEEEEEEECCEEEECCCHHHHhh----------CCCcEEEEEeC-CCcEEEEECCCCCCcCHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999884          47899999755 5789999998  58999999999999999999999


Q ss_pred             hHHHHh
Q psy6508         331 TDRVQK  336 (477)
Q Consensus       331 ~~~i~~  336 (477)
                      +. |++
T Consensus       254 ~~-~~~  258 (259)
T 3m7n_G          254 EK-FKE  258 (259)
T ss_dssp             HT-TC-
T ss_pred             HH-Hhh
Confidence            88 543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.92  E-value=5e-28  Score=241.48  Aligned_cols=175  Identities=13%  Similarity=0.103  Sum_probs=140.5

Q ss_pred             CCcEEEEEEcccCCCChh---------HHHHHHHHHHHHHhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSEN---------RFDSIVNEIKALKLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFI   69 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~---------~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l   69 (477)
                      ++..||+|++........         ....+.+|+..++.++||||+++++++..    ....|+||||+ |++|.+++
T Consensus        64 ~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l  142 (345)
T 2v62_A           64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS  142 (345)
T ss_dssp             GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHC
T ss_pred             ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHH
Confidence            678899999876542110         11246788999999999999999999987    77899999999 89999999


Q ss_pred             HhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc-ceeecccccceecccCCccc-----ccCCeEEE
Q psy6508          70 RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLAGLKQGVSEKAKGSAYI-----EQGNTKVI  143 (477)
Q Consensus        70 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~rl~~~dfG~~~~~~gs~~~-----~~g~t~v~  143 (477)
                      ...+.+++..++.++.|++.||.|||++||+||||||+|||++.+. .++.++|||.+.........     ....+..+
T Consensus       143 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~g  222 (345)
T 2v62_A          143 GQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNG  222 (345)
T ss_dssp             BGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCS
T ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCC
Confidence            8777899999999999999999999999999999999999997542 24555699998654322110     01134567


Q ss_pred             eccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         144 CSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       144 ~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +..|+|||...+.   .++|+ ||+|+++||+  +..||.+
T Consensus       223 t~~y~aPE~~~~~~~~~~~Di-~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          223 TIEFTSLDAHKGVALSRRSDV-EILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             CTTTCCHHHHHTCCCCHHHHH-HHHHHHHHHHHHSSCTTGG
T ss_pred             CccccCHHHhcCCCCCchhhH-HHHHHHHHHHHhCCCCccc
Confidence            8899999998765   67899 9999999999  7788864

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.92  E-value=4.6e-26  Score=221.83  Aligned_cols=171  Identities=24%  Similarity=0.421  Sum_probs=133.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-------------CCeEEEEEecCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-------------ERYVYIILEYCDGGDLCSF   68 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-------------~~~~~lv~e~~~g~sL~~~   68 (477)
                      .+|+.||||+++..   ....+.+.+|+.++++++||||+++++++..             .+..|+||||++|++|.++
T Consensus        29 ~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  105 (303)
T 1zy4_A           29 LDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDL  105 (303)
T ss_dssp             TTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHH
T ss_pred             CCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHh
Confidence            47899999998643   3456789999999999999999999998865             4578999999999999999


Q ss_pred             HHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc------------c
Q psy6508          69 IRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY------------I  135 (477)
Q Consensus        69 l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~------------~  135 (477)
                      +...+ .+++..+..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+........            .
T Consensus       106 l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~  184 (303)
T 1zy4_A          106 IHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESR-NVKIGDFGLAKNVHRSLDILKLDSQNLPGSS  184 (303)
T ss_dssp             HHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCCCCCSCTTC----------------
T ss_pred             hhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCC-CEEEeeCcchhhcccccchhccccccccccc
Confidence            98654 588899999999999999999999999999999999997643 344569998865432210            1


Q ss_pred             ccCCeEEEeccccccccCCCC----CcccccCcceEEEEEEeeeccc
Q psy6508         136 EQGNTKVICSVFEPREIPSSK----TSLEYQRSKGELYVEFKFAPFA  178 (477)
Q Consensus       136 ~~g~t~v~~~~y~ppE~~~~~----~~~Di~~s~G~il~e~~~~Pf~  178 (477)
                      ....+..+++.|+|||...+.    .++|+ |++|+++|++.+ ||.
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di-~slG~il~~l~~-p~~  229 (303)
T 1zy4_A          185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDM-YSLGIIFFEMIY-PFS  229 (303)
T ss_dssp             ---------CTTSCHHHHTSCSCCCTHHHH-HHHHHHHHHHHS-CCS
T ss_pred             cccccCCCcccccCcccccCCCCCcchhhH-HHHHHHHHHHHh-ccC
Confidence            112345678899999987643    67899 999999999965 554

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.92  E-value=4.5e-26  Score=234.34  Aligned_cols=171  Identities=21%  Similarity=0.271  Sum_probs=135.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~   79 (477)
                      .+|+.||||++......     .+.+|+.+|+.+ +||||+++++++.+.+..|+||||++ |+|.+++.... .+++..
T Consensus        46 ~~~~~vAvK~~~~~~~~-----~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~  119 (432)
T 3p23_A           46 FDNRDVAVKRILPECFS-----FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLE  119 (432)
T ss_dssp             SSSSEEEEEEECTTTEE-----ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSC
T ss_pred             eCCeEEEEEEECHHHHH-----HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchh
Confidence            36899999998654322     245899999999 79999999999999999999999997 69999998754 456667


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeec----cCcceeecccccceecccCCc-ccccCCeEEEeccccccccCC
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIK----NNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~----~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      +..++.|++.||.|||++||+||||||+|||++    .+..++.++|||++....... ......+..+++.|+|||++.
T Consensus       120 ~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~  199 (432)
T 3p23_A          120 PITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS  199 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTS
T ss_pred             HHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhh
Confidence            789999999999999999999999999999995    345676778999987654221 112223456889999999987


Q ss_pred             CC------CcccccCcceEEEEEE---eeecccc
Q psy6508         155 SK------TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       155 ~~------~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +.      .++|+ ||+|++++|+   +..||..
T Consensus       200 ~~~~~~~t~~~Di-wSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          200 EDCKENPTYTVDI-FSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             CC---CCCTHHHH-HHHHHHHHHHHTTSCBTTBS
T ss_pred             cccccCCCcHHHH-HHHHHHHHHHHcCCCCCcch
Confidence            42      47899 9999999998   5677754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.92  E-value=5.2e-26  Score=224.93  Aligned_cols=173  Identities=20%  Similarity=0.307  Sum_probs=139.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC--eEEEEEecCCCCCHHHHHHhCC-CCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER--YVYIILEYCDGGDLCSFIRSHE-KLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~--~~~lv~e~~~g~sL~~~l~~~~-~l~~~   78 (477)
                      .+|+.||+|++...  .....+.+.+|+.++++++||||+++++++...+  ..++||||+++++|.+++...+ .+++.
T Consensus        68 ~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  145 (326)
T 2w1i_A           68 NTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHI  145 (326)
T ss_dssp             SCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHH
T ss_pred             CCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHH
Confidence            47889999998764  3455678999999999999999999999886543  7899999999999999998753 69999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc-ccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+....... .........++..|+|||...+. 
T Consensus       146 ~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  224 (326)
T 2w1i_A          146 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENEN-RVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK  224 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCC-cEEEecCcchhhccccccccccccCCCCceeEECchhhcCCC
Confidence            9999999999999999999999999999999997643 44556999887544322 11222334456679999987665 


Q ss_pred             --CcccccCcceEEEEEE--eeeccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                        .++|+ ||+|++++++  +..||.
T Consensus       225 ~~~~~Di-~slG~il~el~tg~~~~~  249 (326)
T 2w1i_A          225 FSVASDV-WSFGVVLYELFTYIEKSK  249 (326)
T ss_dssp             EEHHHHH-HHHHHHHHHHHHTTCGGG
T ss_pred             CCchhhH-HHHHHHHHHHHhcCCCCC
Confidence              67899 9999999999  445554

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.92  E-value=8.7e-26  Score=223.31  Aligned_cols=165  Identities=24%  Similarity=0.377  Sum_probs=138.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+++.||||+++...     .+.+.+|+.++++++ ||||+++++++..  ....++||||+++++|.++++   .+++.
T Consensus        59 ~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~  130 (330)
T 3nsz_A           59 TNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDY  130 (330)
T ss_dssp             TTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHH
T ss_pred             CCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHH
Confidence            478999999986432     356889999999996 9999999999987  668999999999999999885   48999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++.++.|++.||.|||++||+||||||+|||++.+..++.++|||.+.......   ...+..++..|+|||...+.  
T Consensus       131 ~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~  207 (330)
T 3nsz_A          131 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQM  207 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC---ccccccccccccChhhhcCCCc
Confidence            9999999999999999999999999999999998765566667999986544322   12345677889999987652  


Q ss_pred             --CcccccCcceEEEEEE--eeeccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                        .++|+ ||+|+++|++  +..||.
T Consensus       208 ~~~~~Di-wslG~il~~ll~g~~p~~  232 (330)
T 3nsz_A          208 YDYSLDM-WSLGCMLASMIFRKEPFF  232 (330)
T ss_dssp             CCTHHHH-HHHHHHHHHHHHTCSSSS
T ss_pred             CCchhhH-HHHHHHHHHHHhCCCCcc
Confidence              67899 9999999998  667774

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.92  E-value=3.1e-26  Score=223.88  Aligned_cols=175  Identities=25%  Similarity=0.444  Sum_probs=137.9

Q ss_pred             CCCcEEEEEEcccCCCC--hhHHHHHHHHHHHHHhcCCCCccceEEEEE--eCCeEEEEEecCCCCCHHHHHHh--CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVS--ENRFDSIVNEIKALKLLHHQHIVTMLDFLW--DERYVYIILEYCDGGDLCSFIRS--HEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--~~~~~~lv~e~~~g~sL~~~l~~--~~~l   75 (477)
                      .+++.||+|+++.....  ....+.+.+|+.++++++||||+++++++.  ..+..|+||||++++ |.+++..  ...+
T Consensus        28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~  106 (305)
T 2wtk_C           28 ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRF  106 (305)
T ss_dssp             TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSC
T ss_pred             CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCccccc
Confidence            47889999998765321  234567999999999999999999999984  455899999999855 8888765  3469


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.............+..++..|+|||...+
T Consensus       107 ~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  185 (305)
T 2wtk_C          107 PVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGG-TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANG  185 (305)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTC-CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCC-cEEeeccccccccCccccccccccCCCCCCCcChhhccC
Confidence            9999999999999999999999999999999999997643 344459998865443222222234567889999998875


Q ss_pred             C-----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K-----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~-----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .     .++|+ ||+|+++|++  +..||.+
T Consensus       186 ~~~~~~~~~Di-~slG~il~~l~~g~~p~~~  215 (305)
T 2wtk_C          186 LDTFSGFKVDI-WSAGVTLYNITTGLYPFEG  215 (305)
T ss_dssp             CSCEESHHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             cccCCcchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            3     46899 9999999999  6677764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.92  E-value=6.3e-27  Score=226.95  Aligned_cols=172  Identities=22%  Similarity=0.261  Sum_probs=128.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh----CCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS----HEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~----~~~l~~   77 (477)
                      .+|+.||+|+++.........+.+..+...++.++||||+++++++..++..|+||||++ ++|.+++..    ...+++
T Consensus        30 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~  108 (290)
T 3fme_A           30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPE  108 (290)
T ss_dssp             TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCH
T ss_pred             CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCH
Confidence            478999999997665444444445566666888899999999999999999999999998 688887754    457999


Q ss_pred             HHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC--
Q psy6508          78 FQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS--  154 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~--  154 (477)
                      ..+..++.|++.||.|||++ ||+||||||+||+++.+. ++.++|||.+.......   ......+++.|+|||...  
T Consensus       109 ~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~  184 (290)
T 3fme_A          109 DILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISGYLVDDV---AKDIDAGCKPYMAPERINPE  184 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC------------------CCCCCCSCHHHHSCC
T ss_pred             HHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcccccccc---cccccCCCccccChhhcChh
Confidence            99999999999999999998 999999999999998643 44556999886543321   123346788899999952  


Q ss_pred             --CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 --SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 --~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        +.   .++|+ ||+|++++++  +..||..
T Consensus       185 ~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          185 LNQKGYSVKSDI-WSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             TTC--CCHHHHH-HHHHHHHHHHHHTSCSSCC
T ss_pred             hcCcCCCcHHHH-HHHHHHHHHHHHCCCCccc
Confidence              22   57899 9999999999  6678864

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.92  E-value=2.9e-26  Score=226.80  Aligned_cols=171  Identities=23%  Similarity=0.324  Sum_probs=134.9

Q ss_pred             CCcE--EEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC------
Q psy6508           3 QHTE--VAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE------   73 (477)
Q Consensus         3 ~g~~--vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~------   73 (477)
                      +|..  ||+|.++... .....+.+.+|+.+++++ +||||+++++++...+..|+||||+++++|.+++...+      
T Consensus        49 ~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  127 (327)
T 1fvr_A           49 DGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDP  127 (327)
T ss_dssp             TTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCH
T ss_pred             CCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccc
Confidence            4454  4999986532 334456789999999999 89999999999999999999999999999999998754      


Q ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEE
Q psy6508          74 ----------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVI  143 (477)
Q Consensus        74 ----------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~  143 (477)
                                .+++..++.++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.....   ........+
T Consensus       128 ~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~-~~kL~Dfg~~~~~~~---~~~~~~~~~  203 (327)
T 1fvr_A          128 AFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEV---YVKKTMGRL  203 (327)
T ss_dssp             HHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEESSCE---ECCC----C
T ss_pred             cccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC-eEEEcccCcCccccc---cccccCCCC
Confidence                      699999999999999999999999999999999999997653 344559998763221   112233455


Q ss_pred             eccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         144 CSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       144 ~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +..|+|||...+.   .++|+ ||+|+++|++   +..||.+
T Consensus       204 ~~~y~aPE~~~~~~~~~~~Di-~slG~il~ellt~g~~pf~~  244 (327)
T 1fvr_A          204 PVRWMAIESLNYSVYTTNSDV-WSYGVLLWEIVSLGGTPYCG  244 (327)
T ss_dssp             CTTTCCHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             CccccChhhhccccCCchhcc-hHHHHHHHHHHcCCCCCCCC
Confidence            6789999987655   67899 9999999998   4577764

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=3.4e-26  Score=228.30  Aligned_cols=173  Identities=21%  Similarity=0.325  Sum_probs=136.6

Q ss_pred             CCCcEEEEEEcccCCCCh---hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSE---NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~   77 (477)
                      .+|+.||||+++......   ...+.+.+|+.++++++||||+++++++...+..++||||++ ++|.+++.... .+++
T Consensus        33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~  111 (346)
T 1ua2_A           33 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTP  111 (346)
T ss_dssp             SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS-EEHHHHHTTCCSSCCS
T ss_pred             CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCC-CCHHHHHHhcCcCCCH
Confidence            468999999997654322   122468899999999999999999999999999999999998 59999987653 6899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.......  ....+..+++.|+|||...+. 
T Consensus       112 ~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~  188 (346)
T 1ua2_A          112 SHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENG-VLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGAR  188 (346)
T ss_dssp             SHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCC-CEEEEecccceeccCCc--ccCCcccccccccCchHhhCCC
Confidence            99999999999999999999999999999999997653 34456999986543221  122345678899999987543 


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|++  +..||.+
T Consensus       189 ~~~~~~Di-wslG~il~ell~g~~~~~~  215 (346)
T 1ua2_A          189 MYGVGVDM-WAVGCILAELLLRVPFLPG  215 (346)
T ss_dssp             CCCHHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCchhhh-HhHHHHHHHHHHCCCCCCC
Confidence               56899 9999999999  5566653

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.92  E-value=4.7e-26  Score=219.98  Aligned_cols=166  Identities=20%  Similarity=0.302  Sum_probs=135.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe----------------CCeEEEEEecCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD----------------ERYVYIILEYCDGGDL   65 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----------------~~~~~lv~e~~~g~sL   65 (477)
                      .+|+.||+|+++...      +.+.+|+.++++++||||+++++++..                ...+|+||||+++++|
T Consensus        34 ~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L  107 (284)
T 2a19_B           34 IDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL  107 (284)
T ss_dssp             TTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBH
T ss_pred             CCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCH
Confidence            478999999987553      246789999999999999999998864                4468999999999999


Q ss_pred             HHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEE
Q psy6508          66 CSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVI  143 (477)
Q Consensus        66 ~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~  143 (477)
                      .+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......   ......+
T Consensus       108 ~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~~  183 (284)
T 2a19_B          108 EQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTK-QVKIGDFGLVTSLKNDG---KRTRSKG  183 (284)
T ss_dssp             HHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEESSCCS---CCCCCCS
T ss_pred             HHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCC-CEEECcchhheeccccc---cccccCC
Confidence            9999754  5799999999999999999999999999999999999997643 34556999886544322   1223457


Q ss_pred             eccccccccCCCC---CcccccCcceEEEEEE--eeeccc
Q psy6508         144 CSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       144 ~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++.|+|||...+.   .++|+ ||+|+++|++  +..||.
T Consensus       184 ~~~y~aPE~~~~~~~~~~~Di-~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          184 TLRYMSPEQISSQDYGKEVDL-YALGLILAELLHVCDTAF  222 (284)
T ss_dssp             CCTTSCHHHHHCSCCCTHHHH-HHHHHHHHHHHSCCSSHH
T ss_pred             cccccChhhhccCCCcchhhh-HHHHHHHHHHHhcCCcch
Confidence            7899999987655   67899 9999999999  444443

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.92  E-value=4.6e-26  Score=220.18  Aligned_cols=172  Identities=20%  Similarity=0.257  Sum_probs=135.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      ++..||+|.++... .....+.+.+|+.++++++||||+++++++.. +..|+||||+++++|.+++... ..+++..+.
T Consensus        39 ~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~  116 (281)
T 3cc6_A           39 EKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLV  116 (281)
T ss_dssp             CEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHH
T ss_pred             CcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCCCCCHHHHHHhccccCCHHHHH
Confidence            34579999987653 44556789999999999999999999999765 4568999999999999999764 359999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+......... ......++..|+|||...+.   .+
T Consensus       117 ~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~  194 (281)
T 3cc6_A          117 LYSLQICKAMAYLESINCVHRDIAVRNILVASPE-CVKLGDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTA  194 (281)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETT-EEEECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHHHHCCcccCCCccceEEECCCC-cEEeCccCCCccccccccc-ccccCCCCcceeCchhhccCCCCch
Confidence            9999999999999999999999999999997653 4445699988654432211 11223446679999987544   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|+++|++   +..||..
T Consensus       195 ~Di-~slG~il~~llt~g~~p~~~  217 (281)
T 3cc6_A          195 SDV-WMFAVCMWEILSFGKQPFFW  217 (281)
T ss_dssp             HHH-HHHHHHHHHHHTTTCCTTTT
T ss_pred             hcc-HHHHHHHHHHHhCCCCCccc
Confidence            899 9999999998   4577753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.92  E-value=2.7e-26  Score=225.23  Aligned_cols=165  Identities=21%  Similarity=0.311  Sum_probs=132.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC---CCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE---KLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~---~l~~~~   79 (477)
                      .++.||+|++...    ...+.+.+|+.++++++||||+++++++.  +..|+||||++|++|.+++....   .++...
T Consensus        30 ~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  103 (307)
T 2eva_A           30 RAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAH  103 (307)
T ss_dssp             TTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHHHHHCSSSEECCCHHH
T ss_pred             CCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHHHHhccCCCCccCHHH
Confidence            4678999998643    34567899999999999999999999876  34799999999999999998754   378999


Q ss_pred             HHHHHHHHHHHHHHHHh---CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          80 CQQFVRQLVLALKFLRE---NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..++.|+++||.|||+   +||+||||||+||+++.++..+.++|||.+......     .....+++.|+|||...+.
T Consensus       104 ~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~  178 (307)
T 2eva_A          104 AMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGS  178 (307)
T ss_dssp             HHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSCHHHHTCC
T ss_pred             HHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEChhhhCCC
Confidence            99999999999999999   899999999999999876544555699988543321     1234678899999998765


Q ss_pred             ---CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                         .++|+ ||+|+++|++  +..||..
T Consensus       179 ~~~~~~Di-~slG~il~el~~g~~p~~~  205 (307)
T 2eva_A          179 NYSEKCDV-FSWGIILWEVITRRKPFDE  205 (307)
T ss_dssp             CCCTHHHH-HHHHHHHHHHHHTCCTTTT
T ss_pred             CCCcHHHH-HHHHHHHHHHHHCCCCchh
Confidence               67899 9999999999  6678864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.92  E-value=4.7e-26  Score=221.91  Aligned_cols=173  Identities=18%  Similarity=0.283  Sum_probs=137.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEE-eCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +..||+|.++... .....+.+.+|+.++++++||||+++++++. .++..+++|||+++++|.+++... ..+++..+.
T Consensus        53 ~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~  131 (298)
T 3f66_A           53 KIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI  131 (298)
T ss_dssp             CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHH
T ss_pred             eeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHH
Confidence            3468999987543 4455678999999999999999999999854 556889999999999999999764 468999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccc--cCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE--QGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~--~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+..........  ......+++.|+|||...+.   
T Consensus       132 ~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  210 (298)
T 3f66_A          132 GFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFT  210 (298)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHhCCccCCCCchheEEECCCC-CEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCC
Confidence            9999999999999999999999999999997653 44456999987554332211  12234556789999987654   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++|++   +.+||.+
T Consensus       211 ~~~Di-~slG~il~~l~~~~~~~~~~  235 (298)
T 3f66_A          211 TKSDV-WSFGVLLWELMTRGAPPYPD  235 (298)
T ss_dssp             HHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             hHHHH-HHHHHHHHHHHhCCCCCCcc
Confidence            67899 9999999998   4456654

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.92  E-value=6.6e-26  Score=222.90  Aligned_cols=174  Identities=17%  Similarity=0.204  Sum_probs=139.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHh----CC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRS----HE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~----~~   73 (477)
                      .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++..    ....|+||||+++++|.+++..    ..
T Consensus        52 ~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  129 (317)
T 2buj_A           52 HDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGN  129 (317)
T ss_dssp             TTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTC
T ss_pred             CCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCC
Confidence            57899999998654  34556789999999999999999999999873    3478999999999999999976    35


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-------ccCCeEEEecc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-------EQGNTKVICSV  146 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-------~~g~t~v~~~~  146 (477)
                      .+++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+.........       .......+++.
T Consensus       130 ~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  208 (317)
T 2buj_A          130 FLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEG-QPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS  208 (317)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGG
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCC-CEEEEecCcchhcccccccccccccccccccccCCcc
Confidence            799999999999999999999999999999999999997642 3444599976543211000       00012345788


Q ss_pred             ccccccCCCC------CcccccCcceEEEEEE--eeecccc
Q psy6508         147 FEPREIPSSK------TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~------~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |+|||...+.      .++|+ |++|+++|++  +..||..
T Consensus       209 y~aPE~~~~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          209 YRAPELFSVQSHCVIDERTDV-WSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             GCCGGGSSCCSEEEECTHHHH-HHHHHHHHHHHHSSCTTHH
T ss_pred             cCCHhHhccCCCcCCCchhhH-HHHHHHHHHHHhCCCChhh
Confidence            9999998653      57899 9999999999  6788854

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.92  E-value=6.5e-26  Score=232.41  Aligned_cols=179  Identities=22%  Similarity=0.352  Sum_probs=139.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHHHHh----
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSFIRS----   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~l~~----   71 (477)
                      .+|+.||||++.....      .+.+|+.+|+.++||||+++++++...      ..+++||||++ ++|.+.+..    
T Consensus        77 ~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~  149 (420)
T 1j1b_A           77 DSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP-ETVYRVARHYSRA  149 (420)
T ss_dssp             TTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCC-EEHHHHHHHHHHT
T ss_pred             CCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhccc-ccHHHHHHHHhhc
Confidence            4789999999865432      134799999999999999999988542      24789999998 577766642    


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccc
Q psy6508          72 HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        72 ~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE  151 (477)
                      ...+++..++.++.||+.||.|||++||+||||||+|||++.+...+.++|||.+.......   ...+.++++.|+|||
T Consensus       150 ~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE  226 (420)
T 1j1b_A          150 KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPE  226 (420)
T ss_dssp             TCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC---CceeeeeCCCcCCHH
Confidence            45799999999999999999999999999999999999998665455567999987543221   123456788999999


Q ss_pred             cCCCC----CcccccCcceEEEEEE--eeeccccccccCCCCCcchHHHHHHHH
Q psy6508         152 IPSSK----TSLEYQRSKGELYVEF--KFAPFASQIRTGWLRDSEEKELGNHLK  199 (477)
Q Consensus       152 ~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~~~r~~~~~~~~~~~l~~~i~  199 (477)
                      ++.+.    .++|+ ||+|+++|||  +..||.+        ......+..+++
T Consensus       227 ~~~~~~~~~~~~Di-wSlG~il~ell~G~~pf~~--------~~~~~~l~~i~~  271 (420)
T 1j1b_A          227 LIFGATDYTSSIDV-WSAGCVLAELLLGQPIFPG--------DSGVDQLVEIIK  271 (420)
T ss_dssp             HHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSSCC--------SSHHHHHHHHHH
T ss_pred             HHcCCCCCCchhhh-HHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHH
Confidence            87543    67899 9999999999  6677763        344455555554

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.92  E-value=4.7e-26  Score=225.56  Aligned_cols=170  Identities=17%  Similarity=0.240  Sum_probs=129.6

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~   84 (477)
                      .||+|.+.... .....+.+.+|+.++++++||||+++++++..+. .+++++++.+++|.+++... +.+++..+..++
T Consensus        46 kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~  123 (327)
T 3lzb_A           46 PVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC  123 (327)
T ss_dssp             EEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHH
T ss_pred             EEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHH
Confidence            35777775433 3345577999999999999999999999998765 78999999999999999874 469999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEY  161 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di  161 (477)
                      .|++.||.|||++||+||||||+|||++.+. ++.++|||.+................++..|+|||...+.   .++|+
T Consensus       124 ~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  202 (327)
T 3lzb_A          124 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV  202 (327)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHhhCCCcCCCCCHHHEEEcCCC-CEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHH
Confidence            9999999999999999999999999997643 3455699998654332222222233456679999987654   67899


Q ss_pred             cCcceEEEEEE---eeecccc
Q psy6508         162 QRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       162 ~~s~G~il~e~---~~~Pf~~  179 (477)
                       ||+|+++|++   +..||.+
T Consensus       203 -~slG~il~ell~~g~~p~~~  222 (327)
T 3lzb_A          203 -WSYGVTVWELMTFGSKPYDG  222 (327)
T ss_dssp             -HHHHHHHHHHHTTSCCTTTT
T ss_pred             -HHHHHHHHHHHHCCCCCCCC
Confidence             9999999997   5677765

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.92  E-value=3e-26  Score=237.24  Aligned_cols=170  Identities=22%  Similarity=0.334  Sum_probs=137.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~   80 (477)
                      ++..||||+++....   ..+.+.+|+.+|++++||||+++++++. .+..|+||||+++|+|.+++...  ..+++..+
T Consensus       211 ~~~~vavK~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  286 (454)
T 1qcf_A          211 KHTKVAVKTMKPGSM---SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKL  286 (454)
T ss_dssp             TTEEEEEEEECTTSB---CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHH
T ss_pred             CccEEEEEEecCCCc---cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHH
Confidence            467899999976543   3567999999999999999999999986 66789999999999999999754  26899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......+.. .....++..|+|||.....   .
T Consensus       287 ~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~  364 (454)
T 1qcf_A          287 IDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASL-VCKIADFGLARVIEDNEYTA-REGAKFPIKWTAPEAINFGSFTI  364 (454)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTC-CEEECSTTGGGGBCCHHHHT-TCSSSSCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCC-cEEEeeCCCceEcCCCceec-cCCCcccccccCHHHhccCCCCc
Confidence            99999999999999999999999999999998653 34456999987654433221 1222345679999987644   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||.+
T Consensus       365 ~~Dv-wslG~~l~el~t~g~~P~~~  388 (454)
T 1qcf_A          365 KSDV-WSFGILLMEIVTYGRIPYPG  388 (454)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             HHHH-HhHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999998   4567764

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.92  E-value=1.2e-25  Score=225.97  Aligned_cols=173  Identities=25%  Similarity=0.339  Sum_probs=140.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+++.||||++.... .....+.+.+|+.++++++||||+++++++...     ...|+||||++ ++|.++++. +.++
T Consensus        50 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~  126 (364)
T 3qyz_A           50 LNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLS  126 (364)
T ss_dssp             TTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCC
T ss_pred             CCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCC
Confidence            468899999987543 345557899999999999999999999998755     36899999998 699999977 4799


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-ccCCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-EQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..++.++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+......... ....+..+++.|+|||...+
T Consensus       127 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  205 (364)
T 3qyz_A          127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN  205 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCC-CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcC
Confidence            999999999999999999999999999999999997652 3444599998754432211 11234578899999997533


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|+++|++  +..||.+
T Consensus       206 ~~~~~~~~Di-wslG~il~ell~g~~pf~~  234 (364)
T 3qyz_A          206 SKGYTKSIDI-WSVGCILAEMLSNRPIFPG  234 (364)
T ss_dssp             BCSCSTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCcchhH-HHHHHHHHHHHHCCCCCCC
Confidence            2    67899 9999999999  6677764

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.92  E-value=5.2e-26  Score=243.81  Aligned_cols=173  Identities=18%  Similarity=0.296  Sum_probs=135.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      ++..||||+++... .....+.+.+|+.+|++++||||+++++++.. +..|+||||++||+|.+++... ..+++..+.
T Consensus       362 ~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~  439 (613)
T 2ozo_A          362 KQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVA  439 (613)
T ss_dssp             CEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHH
T ss_pred             CcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHH
Confidence            56679999997653 33456789999999999999999999999876 5699999999999999999754 469999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCC-cccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGS-AYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs-~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++||+||||||+|||++.+. .+.++|||++...... ..........++..|+|||...+.   .
T Consensus       440 ~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~  518 (613)
T 2ozo_A          440 ELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS  518 (613)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCC-cEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCc
Confidence            9999999999999999999999999999997653 3445699998654321 111111223345679999987644   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||   +..||.+
T Consensus       519 ~sDv-wSlGv~l~ellt~G~~Pf~~  542 (613)
T 2ozo_A          519 RSDV-WSYGVTMWEALSYGQKPYKK  542 (613)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             HHHH-HHHHHHHHHHHHCCCCCCCC
Confidence            7899 9999999997   5677764

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.92  E-value=6e-27  Score=231.23  Aligned_cols=196  Identities=24%  Similarity=0.299  Sum_probs=153.0

Q ss_pred             CCCcEEEEEEcccCCCCh----hHHHHHHHHHHHHHhcC--CCCccceEEEEEeCCeEEEEEecCCC-CCHHHHHHhCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSE----NRFDSIVNEIKALKLLH--HQHIVTMLDFLWDERYVYIILEYCDG-GDLCSFIRSHEK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv~e~~~g-~sL~~~l~~~~~   74 (477)
                      .+|+.||||+++......    ...+.+.+|+.++++++  ||||+++++++..++..+++||++.+ ++|.+++...+.
T Consensus        66 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~  145 (320)
T 3a99_A           66 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA  145 (320)
T ss_dssp             TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS
T ss_pred             CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCC
Confidence            478899999997764332    12245678999999996  59999999999999999999999976 899999988788


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      +++..+..++.|++.||.|||++||+||||||+||+++.+..++.++|||.+........    ....+++.|+|||...
T Consensus       146 l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~----~~~~gt~~y~aPE~~~  221 (320)
T 3a99_A          146 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY----TDFDGTRVYSPPEWIR  221 (320)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCB----CCCCSCGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccc----cCCCCCccCCChHHhc
Confidence            999999999999999999999999999999999999984444555669998876543322    2345788999999875


Q ss_pred             CC----CcccccCcceEEEEEE--eeeccccccc----cCCCCCcchHHHHHHHHHHh
Q psy6508         155 SK----TSLEYQRSKGELYVEF--KFAPFASQIR----TGWLRDSEEKELGNHLKRAL  202 (477)
Q Consensus       155 ~~----~~~Di~~s~G~il~e~--~~~Pf~~~~r----~~~~~~~~~~~l~~~i~~~l  202 (477)
                      +.    .++|+ |++|+++||+  +..||.....    ....+.....++..++++++
T Consensus       222 ~~~~~~~~~Di-~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~li~~~l  278 (320)
T 3a99_A          222 YHRYHGRSAAV-WSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL  278 (320)
T ss_dssp             HSCBCHHHHHH-HHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHHT
T ss_pred             cCCCCCccchH-HhHHHHHHHHHHCCCCCCChhhhhcccccccccCCHHHHHHHHHHc
Confidence            43    56799 9999999999  6788865322    11223334455666665544

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.92  E-value=6.1e-27  Score=232.61  Aligned_cols=168  Identities=21%  Similarity=0.276  Sum_probs=133.5

Q ss_pred             CCcEEEEEEcccCCC------ChhHHHHHHHHHHHHHhcC---------CCCccceEEEEE-----------------e-
Q psy6508           3 QHTEVAIKCIDKTKV------SENRFDSIVNEIKALKLLH---------HQHIVTMLDFLW-----------------D-   49 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~------~~~~~~~~~~E~~il~~l~---------HpnIv~~~~~~~-----------------~-   49 (477)
                      +|+.||||+++....      .....+.+.+|+.+++.++         ||||+++++++.                 . 
T Consensus        42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~  121 (336)
T 2vuw_A           42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST  121 (336)
T ss_dssp             TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence            578999999987643      2234567889999999886         777777766543                 2 


Q ss_pred             ------------CCeEEEEEecCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEEccCCCCceeeccCc-
Q psy6508          50 ------------ERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR-ENNVCHFDLKPQNILIKNNT-  115 (477)
Q Consensus        50 ------------~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~-  115 (477)
                                  ++.+|+||||+++|++.+.+.+ +.+++..++.++.||+.||.||| ++||+||||||+|||++.++ 
T Consensus       122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~  200 (336)
T 2vuw_A          122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL  200 (336)
T ss_dssp             TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSC
T ss_pred             ccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCC
Confidence                        6789999999999976666654 57899999999999999999999 99999999999999997653 


Q ss_pred             ------------------ceeecccccceecccCCcccccCCeEEEeccccccccCCCC--CcccccCcceEE-EEEE--
Q psy6508         116 ------------------LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--TSLEYQRSKGEL-YVEF--  172 (477)
Q Consensus       116 ------------------~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--~~~Di~~s~G~i-l~e~--  172 (477)
                                        .++.++|||++.....       .+.++|+.|+|||++.+.  .++|+ ||++.+ .+++  
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE~~~g~~~~~~Di-wsl~~~~~~~~~~  272 (336)
T 2vuw_A          201 KKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDEDLFTGDGDYQFDI-YRLMKKENNNRWG  272 (336)
T ss_dssp             SEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSGGGCCCSSHHHHH-HHHHHHHHTTCTT
T ss_pred             cceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChhhhcCCCccceeh-hhhhCCCCccccc
Confidence                              3666779999865442       356889999999999876  67899 998555 4445  


Q ss_pred             eeecccc
Q psy6508         173 KFAPFAS  179 (477)
Q Consensus       173 ~~~Pf~~  179 (477)
                      ++.||..
T Consensus       273 g~~p~~~  279 (336)
T 2vuw_A          273 EYHPYSN  279 (336)
T ss_dssp             SCCTHHH
T ss_pred             ccCCCcc
Confidence            6677764

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.92  E-value=2.6e-26  Score=231.65  Aligned_cols=173  Identities=18%  Similarity=0.274  Sum_probs=130.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEE-eCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW-DERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~   81 (477)
                      +..||+|.++... .....+.+.+|+.++++++||||+++++++. .++..|+||||+++++|.+++...+ .+++..+.
T Consensus       117 ~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  195 (373)
T 3c1x_A          117 KIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI  195 (373)
T ss_dssp             EEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHH
T ss_pred             EEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHH
Confidence            3468999986543 3455678999999999999999999999865 4568899999999999999998653 58899999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccc--cCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE--QGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~--~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.|++.||.|||++||+||||||+|||++.+. .+.++|||++..........  ......++..|+|||...+.   
T Consensus       196 ~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  274 (373)
T 3c1x_A          196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFT  274 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC---------------------CCGGGSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHCCEecCccchheEEECCCC-CEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCC
Confidence            9999999999999999999999999999997653 44456999986543322111  11234456679999987654   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++||+   +..||.+
T Consensus       275 ~~~Dv-wSlG~il~ellt~~~~p~~~  299 (373)
T 3c1x_A          275 TKSDV-WSFGVLLWELMTRGAPPYPD  299 (373)
T ss_dssp             HHHHH-HHHHHHHHHHHTTSCCSCTT
T ss_pred             cHHHH-HHHHHHHHHHHhCcCCCCCC
Confidence            67899 9999999998   4567764

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.92  E-value=4.3e-27  Score=235.29  Aligned_cols=168  Identities=20%  Similarity=0.231  Sum_probs=136.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccc---------------eEEEEEe-CCeEEEEEecCCCCCHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVT---------------MLDFLWD-ERYVYIILEYCDGGDLC   66 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~---------------~~~~~~~-~~~~~lv~e~~~g~sL~   66 (477)
                      +++.||+|++...       +.+.+|+.++++++||||++               +++++.. ++..|+||||+ +++|.
T Consensus        74 ~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~  145 (352)
T 2jii_A           74 QKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQ  145 (352)
T ss_dssp             ---CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHH
T ss_pred             cCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHH
Confidence            4889999998754       24779999999999999988               6777766 77899999999 89999


Q ss_pred             HHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc-ceeecccccceecccCCccc-----ccC
Q psy6508          67 SFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLAGLKQGVSEKAKGSAYI-----EQG  138 (477)
Q Consensus        67 ~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~rl~~~dfG~~~~~~gs~~~-----~~g  138 (477)
                      +++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.+. .++.++|||.+.........     ...
T Consensus       146 ~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~  225 (352)
T 2jii_A          146 SALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSR  225 (352)
T ss_dssp             HHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSS
T ss_pred             HHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccccc
Confidence            999876  6799999999999999999999999999999999999998764 35666799998654322110     111


Q ss_pred             CeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         139 NTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       139 ~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ....+++.|+|||...+.   .++|+ ||+|+++|++  +..||..
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          226 SPHEGDLEFISMDLHKGCGPSRRSDL-QSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             CTTCSCTTTCCHHHHTTCCCCHHHHH-HHHHHHHHHHHHSCCTTGG
T ss_pred             ccccCCccccCHHHHccCCCCchhhH-HHHHHHHHHHHhCCCCccc
Confidence            234678899999998775   67899 9999999998  6678875

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.92  E-value=2.5e-26  Score=226.75  Aligned_cols=171  Identities=24%  Similarity=0.368  Sum_probs=134.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe------CCeEEEEEecCCCCCHHHHHHhC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD------ERYVYIILEYCDGGDLCSFIRSH--   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~------~~~~~lv~e~~~g~sL~~~l~~~--   72 (477)
                      .+|+.||||++.....   ..+.+.+|+.+++++ +||||+++++++..      .+..|+||||+++++|.+++...  
T Consensus        47 ~~~~~vaiK~~~~~~~---~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  123 (326)
T 2x7f_A           47 KTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG  123 (326)
T ss_dssp             TTCCEEEEEEEECCSS---TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGG
T ss_pred             CCCCeEEEEEEecCcc---cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhccc
Confidence            4789999999876532   235688999999999 89999999999986      46899999999999999999864  


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ..+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......  ....+..++..|+|||.
T Consensus       124 ~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~  200 (326)
T 2x7f_A          124 NTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEV  200 (326)
T ss_dssp             GCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCTTTC---------------CCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCC-CEEEeeCcCceecCcCc--cccccccCCccccChhh
Confidence            4699999999999999999999999999999999999997643 34455999876543221  12234567889999998


Q ss_pred             CCC-----C---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSS-----K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~-----~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ...     .   .++|+ |++|+++|++  +..||..
T Consensus       201 ~~~~~~~~~~~~~~~Di-~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          201 IACDENPDATYDFKSDL-WSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             HC--------CCTTHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             hccccccCcCCCccchH-HHHHHHHHHHHhCCCCCCC
Confidence            752     1   67899 9999999999  6677764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.92  E-value=9.3e-28  Score=236.21  Aligned_cols=172  Identities=20%  Similarity=0.300  Sum_probs=137.2

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~i   83 (477)
                      ..||+|+++.........+.+.+|+.++++++||||+++++++...+..+++|||++|++|.+++...+ .+++..+..+
T Consensus        56 ~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i  135 (319)
T 2y4i_B           56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQI  135 (319)
T ss_dssp             SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHH
T ss_pred             CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHH
Confidence            358999998765544445567899999999999999999999999999999999999999999998754 6999999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc---ccccCCeEEEeccccccccCCC-----
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA---YIEQGNTKVICSVFEPREIPSS-----  155 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~---~~~~g~t~v~~~~y~ppE~~~~-----  155 (477)
                      +.|++.||.|||++|++||||||+||+++++.+++  +|||.+.......   .........++..|+|||...+     
T Consensus       136 ~~qi~~al~~lH~~~i~H~dlkp~NIl~~~~~~~l--~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~  213 (319)
T 2y4i_B          136 AQEIVKGMGYLHAKGILHKDLKSKNVFYDNGKVVI--TDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT  213 (319)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCCCSTTEEEC--CCEE--CCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC-
T ss_pred             HHHHHHHHHHHHhCCccccCCChhhEEEeCCCEEE--eecCCccccccccccccccccccCCCcccccChHHhhhccccc
Confidence            99999999999999999999999999999776555  4999865332111   1111223456788999998764     


Q ss_pred             -------CCcccccCcceEEEEEE--eeecccc
Q psy6508         156 -------KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 -------~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                             ..++|+ ||+|+++|++  +..||.+
T Consensus       214 ~~~~~~~~~~~Di-~slG~il~el~~g~~p~~~  245 (319)
T 2y4i_B          214 EEDKLPFSKHSDV-FALGTIWYELHAREWPFKT  245 (319)
T ss_dssp             -CCCSCCCHHHHH-HHHHHHHHHHHHSSCSSSS
T ss_pred             cccccCCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence                   256899 9999999999  6677764

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.92  E-value=7.8e-26  Score=230.61  Aligned_cols=174  Identities=21%  Similarity=0.355  Sum_probs=133.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHhC-------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRSH-------   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~~-------   72 (477)
                      .+++.||||++......    ..+.+|+.+|++++||||+++++++..  ...+|+||||++ ++|.+++...       
T Consensus        46 ~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~  120 (405)
T 3rgf_A           46 KDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANK  120 (405)
T ss_dssp             SCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC---
T ss_pred             CCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccc
Confidence            36789999999765433    357799999999999999999999965  678999999997 6898888632       


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeec---cCcceeecccccceecccCCcc-cccCCeEEEecc
Q psy6508          73 --EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIK---NNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSV  146 (477)
Q Consensus        73 --~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~---~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~  146 (477)
                        ..+++..++.++.||+.||.|||++||+||||||+|||+.   .+..++.++|||.+........ .....+.++++.
T Consensus       121 ~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  200 (405)
T 3rgf_A          121 KPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  200 (405)
T ss_dssp             ----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCT
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCc
Confidence              1499999999999999999999999999999999999993   2334556679999865443211 122245678899


Q ss_pred             ccccccCCCC----CcccccCcceEEEEEE--eeecccccc
Q psy6508         147 FEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       147 y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      |+|||++.+.    .++|+ ||+|+++|+|  +..||.+..
T Consensus       201 y~aPE~~~~~~~~~~~~Di-wSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          201 YRAPELLLGARHYTKAIDI-WAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TCCHHHHTTCCSCCHHHHH-HHHHHHHHHHHHSSCTTCCCC
T ss_pred             ccCchhhcCCCcccchhhh-HHHHHHHHHHHhCCCCCCCcc
Confidence            9999988663    67899 9999999999  778887543

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.92  E-value=2.9e-26  Score=222.98  Aligned_cols=172  Identities=16%  Similarity=0.192  Sum_probs=138.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEE-EEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF-LWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+|+.||||++......    +.+.+|+.+++.++|++++..+.. +...+..++||||+ +++|.+++.. .+.+++..
T Consensus        32 ~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~  106 (296)
T 3uzp_A           32 AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKT  106 (296)
T ss_dssp             TTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHH
T ss_pred             CCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHH
Confidence            57899999998765432    347899999999998876666554 46778899999999 7999999974 45799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeec--cCcceeecccccceecccCCccc-----ccCCeEEEecccccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLAGLKQGVSEKAKGSAYI-----EQGNTKVICSVFEPREI  152 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~--~~~~rl~~~dfG~~~~~~gs~~~-----~~g~t~v~~~~y~ppE~  152 (477)
                      +..++.|++.||.|||++||+||||||+||+++  ++...+.++|||.+.........     .......+++.|+|||.
T Consensus       107 ~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 3uzp_A          107 VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhh
Confidence            999999999999999999999999999999994  23334556699998754433211     11234567889999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++|++  +..||.+
T Consensus       187 ~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~  217 (296)
T 3uzp_A          187 HLGIEQSRRDDL-ESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             HTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSS
T ss_pred             hcCCCCCcchhh-HHHHHHHHHHHhCCCCCCC
Confidence            8775   67899 9999999999  7788875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.92  E-value=6.3e-26  Score=218.89  Aligned_cols=171  Identities=24%  Similarity=0.368  Sum_probs=137.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      ++++.||+|+++.....   .+.+.+|+.++++++||||+++++++. .+..++||||++|++|.+++....  .+++..
T Consensus        35 ~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~  110 (279)
T 1qpc_A           35 NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK  110 (279)
T ss_dssp             TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHH
T ss_pred             cCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHHHHhcCCCCCCCHHH
Confidence            35678999998765433   457889999999999999999999876 456899999999999999997543  699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+......... ......++..|+|||...+.   
T Consensus       111 ~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  188 (279)
T 1qpc_A          111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFT  188 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCC-CEEECCCcccccccCcccc-cccCCCCccCccChhhhccCCCC
Confidence            999999999999999999999999999999997642 3445599998765443321 12233456679999987654   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|++++++   +..||.+
T Consensus       189 ~~~Di-~slG~il~el~~~g~~p~~~  213 (279)
T 1qpc_A          189 IKSDV-WSFGILLTEIVTHGRIPYPG  213 (279)
T ss_dssp             HHHHH-HHHHHHHHHHHTTTCCSSTT
T ss_pred             chhhh-HHHHHHHHHHHhCCCCCCcc
Confidence            67899 9999999998   4567754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.92  E-value=8.1e-27  Score=228.98  Aligned_cols=174  Identities=24%  Similarity=0.268  Sum_probs=137.9

Q ss_pred             CCCcEEEEEEcccCCCCh----hHHHHHHHHHHHHHhc----CCCCccceEEEEEeCCeEEEEEec-CCCCCHHHHHHhC
Q psy6508           2 EQHTEVAIKCIDKTKVSE----NRFDSIVNEIKALKLL----HHQHIVTMLDFLWDERYVYIILEY-CDGGDLCSFIRSH   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----~~~~~~~~E~~il~~l----~HpnIv~~~~~~~~~~~~~lv~e~-~~g~sL~~~l~~~   72 (477)
                      .+|+.||||+++......    .....+.+|+.+++++    +||||+++++++...+..++|||+ +.+++|.+++...
T Consensus        54 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~  133 (312)
T 2iwi_A           54 TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK  133 (312)
T ss_dssp             TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH
T ss_pred             cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc
Confidence            478899999997664322    1223466899999999    899999999999999999999999 7899999999887


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +.+++..+..++.|++.||.|||++||+||||||+||+++.+..++.++|||.+........    ....++..|+|||.
T Consensus       134 ~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~y~aPE~  209 (312)
T 2iwi_A          134 GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY----TDFDGTRVYSPPEW  209 (312)
T ss_dssp             CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCB----CCCCSCTTTSCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcc----cccCCcccccCcee
Confidence            78999999999999999999999999999999999999984333555669998876544322    23457788999998


Q ss_pred             CCCC----CcccccCcceEEEEEE--eeeccccc
Q psy6508         153 PSSK----TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       153 ~~~~----~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ..+.    .++|+ |++|+++|++  +..||...
T Consensus       210 ~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~  242 (312)
T 2iwi_A          210 ISRHQYHALPATV-WSLGILLYDMVCGDIPFERD  242 (312)
T ss_dssp             HHHSCBCHHHHHH-HHHHHHHHHHHHSSCSCCSH
T ss_pred             eecCCCCCccchH-HHHHHHHHHHHHCCCCCCCh
Confidence            7544    36899 9999999999  77888653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.92  E-value=2.7e-26  Score=228.68  Aligned_cols=172  Identities=20%  Similarity=0.322  Sum_probs=142.9

Q ss_pred             CCcEEEEEEcccCCCChh---------------HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSEN---------------RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCS   67 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~---------------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~   67 (477)
                      +|+.||||++........               ..+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  132 (348)
T 2pml_X           53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK  132 (348)
T ss_dssp             TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSE
T ss_pred             CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHH
Confidence            688999999876532211               12679999999999999999999999999999999999999999999


Q ss_pred             H------HHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccC
Q psy6508          68 F------IRS--HEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQG  138 (477)
Q Consensus        68 ~------l~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g  138 (477)
                      +      +..  ...+++..+..++.|++.||.|||+ +|++||||||+||+++.+. ++.++|||.+.......    .
T Consensus       133 ~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~----~  207 (348)
T 2pml_X          133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKK----I  207 (348)
T ss_dssp             ESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECTTS-CEEECCCTTCEECBTTE----E
T ss_pred             HHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcCCC-cEEEecccccccccccc----c
Confidence            8      665  4579999999999999999999999 9999999999999997653 44556999886544321    1


Q ss_pred             CeEEEeccccccccCCCC----C-cccccCcceEEEEEE--eeeccccc
Q psy6508         139 NTKVICSVFEPREIPSSK----T-SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       139 ~t~v~~~~y~ppE~~~~~----~-~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ....++..|+|||...+.    . ++|+ ||+|++++++  +..||.+.
T Consensus       208 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~  255 (348)
T 2pml_X          208 KGSRGTYEFMPPEFFSNESSYNGAKVDI-WSLGICLYVMFYNVVPFSLK  255 (348)
T ss_dssp             CSSCSCGGGCCGGGGSSCCCEEHHHHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCCCCcCccCchhhcCCCCCCcchhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            334577889999998766    2 7899 9999999999  67888653

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.92  E-value=9.8e-26  Score=221.40  Aligned_cols=173  Identities=26%  Similarity=0.374  Sum_probs=138.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEE--------------eCCeEEEEEecCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW--------------DERYVYIILEYCDGGDLCS   67 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~--------------~~~~~~lv~e~~~g~sL~~   67 (477)
                      .+|+.||+|++...  +....+.+.+|+.++++++||||+++++++.              ..+..|+||||++ ++|.+
T Consensus        34 ~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~  110 (320)
T 2i6l_A           34 DCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLAN  110 (320)
T ss_dssp             TTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHH
T ss_pred             CCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHH
Confidence            46899999998754  3455678999999999999999999999873              3468999999998 69999


Q ss_pred             HHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEecc
Q psy6508          68 FIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSV  146 (477)
Q Consensus        68 ~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~  146 (477)
                      ++.. +++++..++.++.|++.||.|||++||+||||||+||+++.++.++.++|||.+........ ........++..
T Consensus       111 ~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  189 (320)
T 2i6l_A          111 VLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKW  189 (320)
T ss_dssp             HHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCT
T ss_pred             Hhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccccccc
Confidence            9875 57999999999999999999999999999999999999986555566679998865432211 111123445778


Q ss_pred             ccccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         147 FEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |+|||...+.    .++|+ ||+|+++|++  +..||.+
T Consensus       190 y~aPE~~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~  227 (320)
T 2i6l_A          190 YRSPRLLLSPNNYTKAIDM-WAAGCIFAEMLTGKTLFAG  227 (320)
T ss_dssp             TCCHHHHHCTTCCCHHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             ccCcHHhcCcccCCchhhh-HhHHHHHHHHHhCCCCCCC
Confidence            9999976442    67899 9999999999  6677764

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.92  E-value=1.5e-26  Score=228.88  Aligned_cols=170  Identities=20%  Similarity=0.255  Sum_probs=132.6

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~   84 (477)
                      .||+|.+.... .....+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++... +.+++..+..++
T Consensus        44 kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  121 (325)
T 3kex_A           44 PVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG  121 (325)
T ss_dssp             EEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHH
T ss_pred             EEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHH
Confidence            37888875443 2222345778999999999999999999886 45689999999999999999874 479999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEY  161 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di  161 (477)
                      .|++.||.|||++||+||||||+|||++.+. ++.++|||.+................++..|+|||...+.   .++|+
T Consensus       122 ~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  200 (325)
T 3kex_A          122 VQIAKGMYYLEEHGMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDV  200 (325)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCSSTTEEESSSS-CEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCccchheEEECCCC-eEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHh
Confidence            9999999999999999999999999997643 3445699998765433322222344556689999987644   67899


Q ss_pred             cCcceEEEEEE---eeecccc
Q psy6508         162 QRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       162 ~~s~G~il~e~---~~~Pf~~  179 (477)
                       ||+|+++|++   +..||.+
T Consensus       201 -~slG~~l~el~~~g~~p~~~  220 (325)
T 3kex_A          201 -WSYGVTVWELMTFGAEPYAG  220 (325)
T ss_dssp             -HHHHHHHHHHHTTSCCTTTT
T ss_pred             -HHhHHHHHHHHhCCCCCccc
Confidence             9999999997   4567764

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.92  E-value=7.1e-26  Score=228.17  Aligned_cols=171  Identities=15%  Similarity=0.125  Sum_probs=123.8

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhc--CCCCccceE-------EEEEeC-----------------CeEE
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLL--HHQHIVTML-------DFLWDE-----------------RYVY   54 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l--~HpnIv~~~-------~~~~~~-----------------~~~~   54 (477)
                      .+|+.||||++...... ....+.+.+|+.+++.|  +||||++++       +++...                 ..+|
T Consensus        85 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (371)
T 3q60_A           85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL  164 (371)
T ss_dssp             TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEE
T ss_pred             CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEE
Confidence            47899999999887653 34456788886555555  699988755       555433                 3489


Q ss_pred             EEEecCCCCCHHHHHHhCC-CCCHHHH------HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeeccccccee
Q psy6508          55 IILEYCDGGDLCSFIRSHE-KLSEFQC------QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus        55 lv~e~~~g~sL~~~l~~~~-~l~~~~~------~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      +||||++ ++|.+++...+ .+++...      ..++.|++.||.|||++||+||||||+|||++.+. .+.++|||.+.
T Consensus       165 lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~-~~kL~DFG~a~  242 (371)
T 3q60_A          165 LLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDG-RLMLGDVSALW  242 (371)
T ss_dssp             EEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTS-CEEECCGGGEE
T ss_pred             EEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCC-CEEEEecceee
Confidence            9999998 89999998632 3444444      57779999999999999999999999999998653 34456999987


Q ss_pred             cccCCcccccCCeEEEeccccccccCCC--C---CcccccCcceEEEEEE--eeeccccc
Q psy6508         128 KAKGSAYIEQGNTKVICSVFEPREIPSS--K---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       128 ~~~gs~~~~~g~t~v~~~~y~ppE~~~~--~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .......     ...+++.|+|||...+  .   .++|+ ||+|+++|||  +..||.+.
T Consensus       243 ~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~Di-wSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          243 KVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNA-WQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             ETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHH-HHHHHHHHHHHHSSCSTTBC
T ss_pred             ecCCCcc-----CccCCcCCcChhhccCCCCCcCccccH-HHHHHHHHHHHhCCCCCCCc
Confidence            5543221     2334588999999876  2   67899 9999999999  77899865

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.92  E-value=2.7e-25  Score=219.84  Aligned_cols=168  Identities=21%  Similarity=0.341  Sum_probs=140.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCC------CccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQ------HIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hp------nIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--   73 (477)
                      .+|+.||+|+++..   ....+.+.+|+.+++.++|+      +++++++++...+..|+||||+ +++|.+++...+  
T Consensus        38 ~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~  113 (339)
T 1z57_A           38 AGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFL  113 (339)
T ss_dssp             TTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTC
T ss_pred             CCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCC
Confidence            36889999998643   34456788999999998765      4999999999999999999999 799999998765  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC------------------cceeecccccceecccCCccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN------------------TLKLAGLKQGVSEKAKGSAYI  135 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~------------------~~rl~~~dfG~~~~~~gs~~~  135 (477)
                      .+++..+..++.|++.||.|||++||+||||||+||+++.+                  ..++.++|||.+......   
T Consensus       114 ~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---  190 (339)
T 1z57_A          114 PFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH---  190 (339)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC---
T ss_pred             CCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc---
Confidence            68999999999999999999999999999999999999753                  234556699988654322   


Q ss_pred             ccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         136 EQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       136 ~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        ..+..+++.|+|||...+.   .++|+ ||+|+++||+  +..||.+
T Consensus       191 --~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~  236 (339)
T 1z57_A          191 --HSTLVSTRHYRAPEVILALGWSQPCDV-WSIGCILIEYYLGFTVFPT  236 (339)
T ss_dssp             --CCSSCSCGGGCCHHHHTTSCCCTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             --cccccCCccccChHHhhCCCCCcchhh-HHHHHHHHHHHhCCCCCCC
Confidence              2345678899999998765   77899 9999999999  6678864

>2nn6_C Exosome complex exonuclease RRP43; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1

Probab=99.91  E-value=1.6e-24  Score=209.20  Aligned_cols=210  Identities=18%  Similarity=0.257  Sum_probs=182.3

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.++++.+....    +- -..|.+.+++.+.||++..++...++..+.+
T Consensus        32 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~p~~----~~-~~~g~l~v~~~~~p~a~~~~~~g~~~~~~~~  106 (278)
T 2nn6_C           32 GEFRTTTVNIGSISTADGSALVKLGNTTVICGVKAEFAAPST----DA-PDKGYVVPNVDLPPLCSSRFRSGPPGEEAQV  106 (278)
T ss_dssp             CCCCSCCEEETCCSSSSEEEEEEETTEEEEEEEEEEECCCCS----SS-TTCCCCEEEEECCSSSCTTSCSSSCCHHHHH
T ss_pred             ccccCeEEEeCCccCCCceEEEEeCCeEEEEEEEEEeecCCC----CC-CCccEEEEEEEeCCccCccccCCCCcHHHHH
Confidence            578999999999999999999999999999999997663221    11 3568899999999999877665667788899


Q ss_pred             HHHHHHHHhhh--hhhccc------CCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCC-------------------
Q psy6508         194 LGNHLKRALEP--AVCRHE------FSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI-------------------  246 (477)
Q Consensus       194 l~~~i~~~l~~--~i~~~~------~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi-------------------  246 (477)
                      +++.+++.+++  .+.++.      .++|.+.+.++||+.||+.+.++++|+++||.|+||                   
T Consensus       107 ~s~li~r~l~~s~~i~l~~L~i~pg~~~~~i~i~~~VL~~DG~~~~aai~aa~~AL~~a~iP~v~~~~~~~~~~~~~~~~  186 (278)
T 2nn6_C          107 ASQFIADVIENSQIIQKEDLCISPGKLVWVLYCDLICLDYDGNILDACTFALLAALKNVQLPEVTINEETALAEVNLKKK  186 (278)
T ss_dssp             HHHHHHHHHHHHCCSCHHHHCSSBTTBCEEEEEEEEESSCCSCTTHHHHHHHHHHHHTCCCCCCCBCSSSBCCCTTSCCC
T ss_pred             HHHHHHHHHhccCCCCHHHCEEeCCcEEEEEEEEEEEECCCCCHHHHHHHHHHHHHHhCCCCeEEEeCCCcceecCcccc
Confidence            99999999996  454443      357899999999999999999999999999999996                   


Q ss_pred             ---CCCceEEEEEEEeeCC-eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe--eecHHHHHHHHH
Q psy6508         247 ---PMYDLVTSSTLALRGG-LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG--TIQQERLADHIE  320 (477)
Q Consensus       247 ---~m~~~v~a~s~~~~~~-~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g--~~~~~~~~~~l~  320 (477)
                         ||+++++++|+++.++ .+++||+..|+..          +.+.+++++. ..++|+.++..|  .++.+++.++++
T Consensus       187 ~~lp~~~~~~avs~g~~~~~~~l~Dpt~~Ee~~----------~~~~l~va~~-~~g~i~~v~~~g~~~~~~~~l~~~l~  255 (278)
T 2nn6_C          187 SYLNIRTHPVATSFAVFDDTLLIVDPTGEEEHL----------ATGTLTIVMD-EEGKLCCLHKPGGSGLTGAKLQDCMS  255 (278)
T ss_dssp             SCSCCSCCCEEEEEEECTTTCCEESCCTTTTTS----------CSEEEEEEEC-TTCCEEEEEESCCSCCCHHHHHHHHH
T ss_pred             cccccCCceEEEEEEEECCceEEECCCHHHHhh----------cCceEEEEEc-CCCcEEEEEccCCCCCCHHHHHHHHH
Confidence               7999999999999988 9999999999883          4788999874 456899999998  899999999999


Q ss_pred             HHHhcccchhhHHHHhHhhh
Q psy6508         321 QLIGCCESLCTDRVQKLVSD  340 (477)
Q Consensus       321 ~~~~~~~~i~~~~i~~~l~~  340 (477)
                      .|.++|+.+... +++.+.+
T Consensus       256 ~a~~~~~~i~~~-~~~~l~~  274 (278)
T 2nn6_C          256 RAVTRHKEVKKL-MDEVIKS  274 (278)
T ss_dssp             HHHHHHHHHHHH-HHTTTTT
T ss_pred             HHHHHHHHHHHH-HHHHHHh
Confidence            999999999999 8887765

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.91  E-value=1.1e-25  Score=226.92  Aligned_cols=168  Identities=24%  Similarity=0.354  Sum_probs=137.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeE------EEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYV------YIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~------~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+..      |+||||++ ++|.+++..  .+
T Consensus        65 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~  141 (371)
T 4exu_A           65 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGM--EF  141 (371)
T ss_dssp             TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTS--CC
T ss_pred             CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhc--CC
Confidence            4789999999987766666678899999999999999999999999876654      99999998 789888743  59


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......     ....+++.|+|||...+
T Consensus       142 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~  215 (371)
T 4exu_A          142 SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAEM-----TGYVVTRWYRAPEVILS  215 (371)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECSTTCC-------------CTTCCCTTSCHHHHSC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCC-CEEEEecCcccccccCc-----CCcccCccccCHHHhcC
Confidence            9999999999999999999999999999999999998653 34455999886544321     23456888999998765


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|++++++  +..||.+
T Consensus       216 ~~~~~~~~Di-wslG~il~el~~g~~pf~~  244 (371)
T 4exu_A          216 WMHYNQTVDI-WSVGCIMAEMLTGKTLFKG  244 (371)
T ss_dssp             CSCCCTTHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CCCCCcHHhH-HHHHHHHHHHHhCCCCCCC
Confidence            2    77899 9999999999  6678764

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.91  E-value=9.5e-26  Score=233.37  Aligned_cols=170  Identities=22%  Similarity=0.320  Sum_probs=132.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~   80 (477)
                      .+..||||+++.....   .+.|.+|+.+|++++||||+++++++.. +..|+||||+++|+|.+++...  ..+++..+
T Consensus       207 ~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~  282 (452)
T 1fmk_A          207 GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL  282 (452)
T ss_dssp             TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHH
T ss_pred             CCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHH
Confidence            3567999999765433   3578999999999999999999999865 6789999999999999999753  46999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++.......+. ......++..|+|||...+.   .
T Consensus       283 ~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  360 (452)
T 1fmk_A          283 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTI  360 (452)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC---------------CCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCC-CEEECCCccceecCCCcee-cccCCcccccccCHhHHhcCCCCc
Confidence            99999999999999999999999999999997642 4445699998654432221 11223445679999987544   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||.+
T Consensus       361 ~sDv-wslG~~l~el~t~g~~P~~~  384 (452)
T 1fmk_A          361 KSDV-WSFGILLTELTTKGRVPYPG  384 (452)
T ss_dssp             HHHH-HHHHHHHHHHHTTTCCSSTT
T ss_pred             cccH-HhHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999999   4567754

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.91  E-value=8.5e-26  Score=219.09  Aligned_cols=172  Identities=16%  Similarity=0.246  Sum_probs=132.9

Q ss_pred             cEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           5 TEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         5 ~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      ..||+|+++..... ....+.+.+|+.++++++||||+++++++..++ .++||||+++++|.+++... +.+++..+..
T Consensus        47 ~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~  125 (291)
T 1u46_A           47 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSR  125 (291)
T ss_dssp             EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHH
T ss_pred             eEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHH
Confidence            36999998766443 345678999999999999999999999987665 89999999999999999764 4699999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC---Cc
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      ++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+........ ........++..|+|||...+.   .+
T Consensus       126 ~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  204 (291)
T 1u46_A          126 YAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA  204 (291)
T ss_dssp             HHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHH
T ss_pred             HHHHHHHHHHHHHhCCcccCCCchheEEEcCCC-CEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCch
Confidence            999999999999999999999999999997643 344569998865443221 1122234556679999988665   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|++++++   +..||.+
T Consensus       205 ~Di-~slG~il~~l~~~g~~p~~~  227 (291)
T 1u46_A          205 SDT-WMFGVTLWEMFTYGQEPWIG  227 (291)
T ss_dssp             HHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             hhH-HHHHHHHHHHHhCCCCCccc
Confidence            899 9999999998   4577764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.91  E-value=2.5e-25  Score=228.64  Aligned_cols=168  Identities=20%  Similarity=0.312  Sum_probs=139.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc------CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL------HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l------~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--   73 (477)
                      .+++.||||+++..   ....+.+.+|+.+++.+      +||||+++++.+...+.+|+||||+. ++|.+++....  
T Consensus       120 ~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~  195 (429)
T 3kvw_A          120 KVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQ  195 (429)
T ss_dssp             TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTC
T ss_pred             CCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCC
Confidence            46889999998653   34456788899998887      57799999999999999999999997 79999998754  


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc-ceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      .+++..++.++.|++.||.|||++||+||||||+|||++.+. ..+.++|||.+......     ..+.++++.|+|||+
T Consensus       196 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~  270 (429)
T 3kvw_A          196 GFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEV  270 (429)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----ccccCCCCCccChHH
Confidence            499999999999999999999999999999999999998754 23555699998654332     234567889999998


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.+.   .++|+ ||+|+++||+  +..||.+
T Consensus       271 ~~~~~~~~~~Di-wSlG~il~elltG~~pf~~  301 (429)
T 3kvw_A          271 ILGARYGMPIDM-WSLGCILAELLTGYPLLPG  301 (429)
T ss_dssp             HHTBCCCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             HhCCCCCchHHH-HhHHHHHHHHHhCCCCCCC
Confidence            7665   77899 9999999999  6667653

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.91  E-value=4.4e-26  Score=231.75  Aligned_cols=166  Identities=20%  Similarity=0.364  Sum_probs=129.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHH----hC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIR----SH   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~----~~   72 (477)
                      .+..||+|++......      ..+|+.+++.++||||+++++++...+      .+|+||||+++ ++.+.+.    ..
T Consensus        63 ~~~~~aikk~~~~~~~------~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~  135 (394)
T 4e7w_A           63 ESDEVAIKKVLQDKRF------KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLK  135 (394)
T ss_dssp             TTEEEEEEEEECCTTS------CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTT
T ss_pred             CCCeEEEEEEecCcch------HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhc
Confidence            3455899987654321      236999999999999999999986543      38999999985 5544443    24


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ..+++..++.++.|++.||.|||++||+||||||+|||++.....+.++|||.+.......   ...+.++++.|+|||.
T Consensus       136 ~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~  212 (394)
T 4e7w_A          136 QTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE---PNVSYICSRYYRAPEL  212 (394)
T ss_dssp             SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC---CCcccccCcCccCHHH
Confidence            5799999999999999999999999999999999999998444456667999987543221   1234567889999998


Q ss_pred             CCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+.    .++|+ ||+|+++|||  +..||.+
T Consensus       213 ~~~~~~~~~~~Di-wSlG~il~ell~g~~pf~~  244 (394)
T 4e7w_A          213 IFGATNYTTNIDI-WSTGCVMAELMQGQPLFPG  244 (394)
T ss_dssp             HTTCSSCCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             HcCCCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            7553    67899 9999999999  6677764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.91  E-value=2.3e-25  Score=225.63  Aligned_cols=168  Identities=20%  Similarity=0.284  Sum_probs=138.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC--------CCCccceEEEEE----eCCeEEEEEecCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH--------HQHIVTMLDFLW----DERYVYIILEYCDGGDLCSFI   69 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--------HpnIv~~~~~~~----~~~~~~lv~e~~~g~sL~~~l   69 (477)
                      .+++.||||+++..   ....+.+.+|+.+++.++        ||||+++++++.    ....+|+||||+. ++|.+++
T Consensus        60 ~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~  135 (397)
T 1wak_A           60 QGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG-HHLLKWI  135 (397)
T ss_dssp             TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC-CBHHHHH
T ss_pred             CCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC-ccHHHHH
Confidence            46889999998643   345577899999999995        788999999987    4568999999995 6777777


Q ss_pred             HhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCc-------------------------------
Q psy6508          70 RSH--EKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNT-------------------------------  115 (477)
Q Consensus        70 ~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~-------------------------------  115 (477)
                      ...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++                               
T Consensus       136 ~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  215 (397)
T 1wak_A          136 IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA  215 (397)
T ss_dssp             HHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC--------------------
T ss_pred             HhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCc
Confidence            654  4699999999999999999999998 999999999999997553                               


Q ss_pred             -----------------ceeecccccceecccCCcccccCCeEEEeccccccccCCCC---CcccccCcceEEEEEE--e
Q psy6508         116 -----------------LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--K  173 (477)
Q Consensus       116 -----------------~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~  173 (477)
                                       .++.++|||.+......     .....+++.|+|||++.+.   .++|+ ||+|+++|+|  +
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~il~elltg  289 (397)
T 1wak_A          216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADI-WSTACMAFELATG  289 (397)
T ss_dssp             -CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHH-HHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHH-HHHHHHHHHHhhC
Confidence                             35667799998654422     2345678899999988665   77899 9999999999  7


Q ss_pred             eecccc
Q psy6508         174 FAPFAS  179 (477)
Q Consensus       174 ~~Pf~~  179 (477)
                      ..||.+
T Consensus       290 ~~pf~~  295 (397)
T 1wak_A          290 DYLFEP  295 (397)
T ss_dssp             SCSCCC
T ss_pred             CCCCCC
Confidence            788874

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.91  E-value=1.2e-25  Score=222.45  Aligned_cols=174  Identities=20%  Similarity=0.275  Sum_probs=124.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEE--------eCCeEEEEEecCCCCCHHHHHHh-
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLW--------DERYVYIILEYCDGGDLCSFIRS-   71 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~--------~~~~~~lv~e~~~g~sL~~~l~~-   71 (477)
                      .+|+.||||++...  .....+.+.+|+.+++++. ||||+++++++.        ....++++|||++ |+|.+++.. 
T Consensus        51 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~  127 (337)
T 3ll6_A           51 GSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKM  127 (337)
T ss_dssp             TTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHH
T ss_pred             CCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHh
Confidence            47899999998654  3445677899999999995 999999999984        3346899999997 799998865 


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccCcceeecccccceecccCCccc----------cc
Q psy6508          72 --HEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI----------EQ  137 (477)
Q Consensus        72 --~~~l~~~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~----------~~  137 (477)
                        .+.+++..+..++.|++.||.|||++|  |+||||||+|||++.+. ++.++|||.+.........          ..
T Consensus       128 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  206 (337)
T 3ll6_A          128 ESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQG-TIKLCDFGSATTISHYPDYSWSAQRRALVEE  206 (337)
T ss_dssp             HTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTS-CEEBCCCTTCBCCSSCC--------------
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCC-CEEEecCccceeccccCcccccccccccchh
Confidence              457999999999999999999999999  99999999999998653 4455699998654432211          11


Q ss_pred             CCeEEEeccccccccCC---CC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         138 GNTKVICSVFEPREIPS---SK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       138 g~t~v~~~~y~ppE~~~---~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ..+..+++.|+|||...   +.   .++|+ ||+|+++|++  +..||...
T Consensus       207 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv-~slG~il~el~~g~~p~~~~  256 (337)
T 3ll6_A          207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDI-WALGCILYLLCFRQHPFEDG  256 (337)
T ss_dssp             -----------------CCTTSCSSHHHHH-HHHHHHHHHHHHSSCCC---
T ss_pred             hccccCCCCcCChhhhhccccCCCChHHhH-HHHHHHHHHHHhCCCCCcch
Confidence            22456888999999873   22   57899 9999999999  67888653

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.91  E-value=3.7e-25  Score=227.75  Aligned_cols=171  Identities=25%  Similarity=0.316  Sum_probs=130.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCC-----
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKL-----   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l-----   75 (477)
                      .+|+.||||++...     ..+.+.+|+.+++++ +||||+++++++..++..|+||||++ |+|.+++......     
T Consensus        37 ~~g~~vAvK~~~~~-----~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~  110 (434)
T 2rio_A           37 FQGRPVAVKRMLID-----FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLK  110 (434)
T ss_dssp             SSSSEEEEEEEEGG-----GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC--------
T ss_pred             ECCeEEEEEEEcHH-----HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhh
Confidence            46899999998653     234678999999987 89999999999999999999999997 6999999875432     


Q ss_pred             --CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC------------cceeecccccceecccCCcc--cccCC
Q psy6508          76 --SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN------------TLKLAGLKQGVSEKAKGSAY--IEQGN  139 (477)
Q Consensus        76 --~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~------------~~rl~~~dfG~~~~~~gs~~--~~~g~  139 (477)
                        ++..+..++.|++.||.|||++||+||||||+|||++.+            ..++.++|||++........  .....
T Consensus       111 ~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~  190 (434)
T 2rio_A          111 LQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLN  190 (434)
T ss_dssp             ----CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC----------
T ss_pred             hccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeec
Confidence              233457899999999999999999999999999999643            34666779999876543221  11223


Q ss_pred             eEEEeccccccccCCC-------C---CcccccCcceEEEEEE---eeecccc
Q psy6508         140 TKVICSVFEPREIPSS-------K---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       140 t~v~~~~y~ppE~~~~-------~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +..+++.|+|||+..+       .   .++|+ ||+|+++||+   +..||..
T Consensus       191 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di-wSlG~il~ellt~g~~Pf~~  242 (434)
T 2rio_A          191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDI-FSMGCVFYYILSKGKHPFGD  242 (434)
T ss_dssp             ----CCTTSCHHHHSCCCTTSCCCCCCTHHHH-HHHHHHHHHHHTTSCCTTCS
T ss_pred             CCCCCCCccCHHHhccccccccccCcchhhhh-HhHHHHHHHHHhCCCCCCCC
Confidence            4678899999998754       1   67999 9999999998   5678864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.91  E-value=3.6e-25  Score=219.87  Aligned_cols=163  Identities=18%  Similarity=0.262  Sum_probs=134.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHh--cCCCCccceEEEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKL--LHHQHIVTMLDFLWDER----YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~--l~HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      +|+.||||+++..     ..+.+.+|..+++.  ++||||+++++++....    ..|+||||+++++|.+++.+ ..++
T Consensus        64 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~  137 (342)
T 1b6c_B           64 RGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVT  137 (342)
T ss_dssp             TTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBC
T ss_pred             cCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCcc
Confidence            5789999998643     23567889999988  68999999999998775    89999999999999999987 4799


Q ss_pred             HHHHHHHHHHHHHHHHHHH--------hCCcEEccCCCCceeeccCcceeecccccceecccCCccc--ccCCeEEEecc
Q psy6508          77 EFQCQQFVRQLVLALKFLR--------ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--EQGNTKVICSV  146 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH--------~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--~~g~t~v~~~~  146 (477)
                      +..+..++.|++.||.|||        ++||+||||||+||+++.+. ++.++|||.+.........  .......+++.
T Consensus       138 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~  216 (342)
T 1b6c_B          138 VEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKR  216 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTS-CEEECCCTTCEEEETTTTEEEECCCSCCCCGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCC-CEEEEECCCceeccccccccccccccCCcCcc
Confidence            9999999999999999999        89999999999999997653 4445699988654432211  12234578889


Q ss_pred             ccccccCCCC---------CcccccCcceEEEEEEe
Q psy6508         147 FEPREIPSSK---------TSLEYQRSKGELYVEFK  173 (477)
Q Consensus       147 y~ppE~~~~~---------~~~Di~~s~G~il~e~~  173 (477)
                      |+|||...+.         .++|+ ||+|+++||+.
T Consensus       217 y~aPE~~~~~~~~~~~~~~~~~Di-~slG~il~el~  251 (342)
T 1b6c_B          217 YMAPEVLDDSINMKHFESFKRADI-YAMGLVFWEIA  251 (342)
T ss_dssp             GCCHHHHTSCCCTTCHHHHHHHHH-HHHHHHHHHHH
T ss_pred             cCCHhhhcccccccccccCCcccH-HHHHHHHHHHH
Confidence            9999998765         46899 99999999993

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.91  E-value=1.2e-25  Score=225.32  Aligned_cols=172  Identities=24%  Similarity=0.339  Sum_probs=131.7

Q ss_pred             CCCcEEEEEEcccCCCC---------hhHHHHHHHHHHHHHhcCCCCccceEEEEEe-----CCeEEEEEecCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS---------ENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-----ERYVYIILEYCDGGDLCS   67 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~---------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~sL~~   67 (477)
                      .+|+.||||++......         ....+.+.+|+.++++++||||+++++++..     ...+|+||||++ ++|.+
T Consensus        44 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~  122 (362)
T 3pg1_A           44 SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQ  122 (362)
T ss_dssp             TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHH
T ss_pred             CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHH
Confidence            46899999998664332         2234789999999999999999999999854     236899999998 68888


Q ss_pred             HHHhCC-CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecc
Q psy6508          68 FIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV  146 (477)
Q Consensus        68 ~l~~~~-~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~  146 (477)
                      ++...+ .+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......   ......+++.
T Consensus       123 ~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~~t~~  198 (362)
T 3pg1_A          123 VIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNN-DITICDFNLAREDTADA---NKTHYVTHRW  198 (362)
T ss_dssp             HHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCTTC------------------CGG
T ss_pred             HHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCC-CEEEEecCccccccccc---ccceecccce
Confidence            887643 699999999999999999999999999999999999997543 34456999886433221   2234567889


Q ss_pred             ccccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         147 FEPREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       147 y~ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |+|||...+.    .++|+ ||+|+++|++  +..||.+
T Consensus       199 y~aPE~~~~~~~~~~~~Di-wslG~il~~l~~g~~pf~~  236 (362)
T 3pg1_A          199 YRAPELVMQFKGFTKLVDM-WSAGCVMAEMFNRKALFRG  236 (362)
T ss_dssp             GCCHHHHTTCTTCCTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             ecCcHHhcCCCCCCcHhHH-HhHHHHHHHHHhCCCCCCC
Confidence            9999987652    67899 9999999999  6677764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.91  E-value=4.1e-26  Score=220.21  Aligned_cols=166  Identities=25%  Similarity=0.399  Sum_probs=129.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-CeEEEEEecCCCCCHHHHHHhCCC--CCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-RYVYIILEYCDGGDLCSFIRSHEK--LSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e~~~g~sL~~~l~~~~~--l~~~~   79 (477)
                      +|+.||+|+++...    ..+.+.+|+.++++++||||+++++++... +..|+||||+++++|.+++...+.  +++..
T Consensus        43 ~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  118 (278)
T 1byg_A           43 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC  118 (278)
T ss_dssp             TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHH
T ss_pred             cCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHH
Confidence            57899999987543    346789999999999999999999987544 478999999999999999976543  89999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+.......     .+..++..|+|||...+.   
T Consensus       119 ~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~  192 (278)
T 1byg_A          119 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFS  192 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------------CCTTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCC-cEEEeeccccccccccc-----cCCCccccccCHHHhCCCCCC
Confidence            999999999999999999999999999999997643 34456999876443221     233456789999987544   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|++++++   +..||..
T Consensus       193 ~~~Di-~slG~il~~l~t~g~~p~~~  217 (278)
T 1byg_A          193 TKSDV-WSFGILLWEIYSFGRVPYPR  217 (278)
T ss_dssp             HHHHH-HHHHHHHHHHHTTSCCSCTT
T ss_pred             chhcH-HHHHHHHHHHHhCCCCCCCC
Confidence            67899 9999999998   5577764

>2nn6_A Polymyositis/scleroderma autoantigen 1; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1

Probab=99.91  E-value=1e-23  Score=208.54  Aligned_cols=209  Identities=17%  Similarity=0.234  Sum_probs=181.6

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|   .++||++++.|+|++.|.++++.+....    +- -..|.+.+++.+.||+...++...++..+.+
T Consensus        47 ~e~R~i~ie~g---~A~GSa~v~~G~T~VL~tV~~e~~~p~~----~~-~~~g~l~~~v~~~p~a~~~~~~g~~s~~e~e  118 (358)
T 2nn6_A           47 YDYRNIRISFG---TDYGCCIVELGKTRVLGQVSCELVSPKL----NR-ATEGILFFNLELSQMAAPAFEPGRQSDLLVK  118 (358)
T ss_dssp             TCCCCCEEEEC---SSTTEEEEESSSCEEEEEECCEEECCCS----TT-TTSCCEEEEEEECTTTCSSCCSSSTHHHHTH
T ss_pred             cccCCeEEEEe---cCCcEEEEEECCcEEEEEEEecccCCcc----cC-CCCcEEEEEEEecCCccccccCCCCCHHHHH
Confidence            57899988999   8999999999999999999987654322    11 3458899999999999877665567778889


Q ss_pred             HHHHHHHHhhhhhhcccC--------CCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCC------------------
Q psy6508         194 LGNHLKRALEPAVCRHEF--------SNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIP------------------  247 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~--------Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~------------------  247 (477)
                      +++.+.+.+++..+.+.+        |++.|.|.++||+.||+.+.++++|+++||.|||+|                  
T Consensus       119 isrli~r~Lr~s~~idl~~LcI~pg~~~w~I~Vdv~VL~~DGn~~dAai~Aa~aAL~da~iP~v~~~~~~v~i~~~~~~~  198 (358)
T 2nn6_A          119 LNRLMERCLRNSKCIDTESLCVVAGEKVWQIRVDLHLLNHDGNIIDAASIAAIVALCHFRRPDVSVQGDEVTLYTPEERD  198 (358)
T ss_dssp             HHHHHHHHHHHHTCBCSSSSCSBTTTBEEEEEEEEEECSCCSCCHHHHHHHHHHHHHHCCCCCCBCCTTCCBCCHHHHTS
T ss_pred             HHHHHHHHhhhccccchHhhcccCCCccEEEEEEEEEEeCCCCHHHHHHHHHHHHHHHhCcCcEEeeCCeeEeccccccc
Confidence            999999999997554443        889999999999999999999999999999999999                  


Q ss_pred             -----CCceEEEEEEEee--CCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee--ecHHHHHHH
Q psy6508         248 -----MYDLVTSSTLALR--GGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT--IQQERLADH  318 (477)
Q Consensus       248 -----m~~~v~a~s~~~~--~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~--~~~~~~~~~  318 (477)
                           |+++++++|+++.  ++.+++||+..|+..          +.+.++++ +++.++|+.++..|.  ++.+++.++
T Consensus       199 ~~~l~i~~~p~avsvgl~~~~~~illDPt~~Ee~~----------~~~~l~Va-~t~~g~I~~lqk~G~~~ls~~~l~~~  267 (358)
T 2nn6_A          199 PVPLSIHHMPICVSFAFFQQGTYLLVDPNEREERV----------MDGLLVIA-MNKHREICTIQSSGGIMLLKDQVLRC  267 (358)
T ss_dssp             CCCCCBCCCEEEEEEEECTTTSSEEESCCHHHHHH----------CSCEEEEE-EETTTEEEEEEEESCCCCCHHHHHHH
T ss_pred             ccccCccCCEEEEEEEEEeeCCEEEECCCHHHHhh----------cCccEEEE-EcCCCeEEEEEeCCCCCCCHHHHHHH
Confidence                 9999999999976  789999999999985          47889998 577788999998875  699999999


Q ss_pred             HHHHHhcccchhhHHHHhHhhhcc
Q psy6508         319 IEQLIGCCESLCTDRVQKLVSDHV  342 (477)
Q Consensus       319 l~~~~~~~~~i~~~~i~~~l~~~~  342 (477)
                      ++.|.++++.+... +++.+.+..
T Consensus       268 l~~A~~~~~~i~~~-~~~~l~~~~  290 (358)
T 2nn6_A          268 SKIAGVKVAEITEL-ILKALENDQ  290 (358)
T ss_dssp             HHHHHHHHHHHHHH-HHHHHHHHH
T ss_pred             HHHHHHHHHHHHHH-HHHHHHhHH
Confidence            99999999999999 999887653

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.91  E-value=2.5e-25  Score=221.19  Aligned_cols=167  Identities=25%  Similarity=0.383  Sum_probs=117.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHH-HHHHhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCC--C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEI-KALKLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHE--K   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~-~il~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~--~   74 (477)
                      .+|+.||||++...   ..    ..+|+ ..++.++||||+++++++..    ...+++||||++|++|.+++...+  .
T Consensus        52 ~~~~~vavK~~~~~---~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~  124 (336)
T 3fhr_A           52 RTGQKCALKLLYDS---PK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQA  124 (336)
T ss_dssp             TTCCEEEEEEEESS---HH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCC
T ss_pred             CCCCEEEEEEecCc---HH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCC
Confidence            47899999998643   22    22333 33566799999999999876    456899999999999999998754  6


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++..++.++.|++.||.|||++||+||||||+||+++.+  ...+.++|||.+.......    ..+..+++.|+|||.
T Consensus       125 l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t~~y~aPE~  200 (336)
T 3fhr_A          125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPCYTPYYVAPEV  200 (336)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCCCCcCccChhh
Confidence            9999999999999999999999999999999999999753  3345566999886544321    235567889999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ..+.   .++|+ ||+|+++|++  +..||.+.
T Consensus       201 ~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          201 LGPEKYDKSCDM-WSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             ---CHHHHHHHH-HHHHHHHHHHHHSSCCC---
T ss_pred             hCCCCCCchhhH-HHHHHHHHHHHHCCCCCCCc
Confidence            8766   67899 9999999999  77888643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.91  E-value=2.8e-25  Score=215.81  Aligned_cols=172  Identities=16%  Similarity=0.192  Sum_probs=136.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEE-EEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF-LWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~-~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+++.||||++......    +.+.+|+.+++.++|++++..+.. +...+..+++|||+ +++|.+++.. .+.+++..
T Consensus        32 ~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~  106 (296)
T 4hgt_A           32 AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKT  106 (296)
T ss_dssp             TTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHH
T ss_pred             CCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHH
Confidence            57889999987655332    347789999999988877766665 46778899999999 7999999985 35799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeec--cCcceeecccccceecccCCccc-----ccCCeEEEecccccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLAGLKQGVSEKAKGSAYI-----EQGNTKVICSVFEPREI  152 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~--~~~~rl~~~dfG~~~~~~gs~~~-----~~g~t~v~~~~y~ppE~  152 (477)
                      +..++.|++.||.|||++||+||||||+|||++  ++..++.++|||.+.........     .......+++.|+|||.
T Consensus       107 ~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  186 (296)
T 4hgt_A          107 VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT  186 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHH
Confidence            999999999999999999999999999999993  22334556699998754432211     12234577889999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++|++  +..||.+
T Consensus       187 ~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~  217 (296)
T 4hgt_A          187 HLGIEQSRRDDL-ESLGYVLMYFNLGSLPWQG  217 (296)
T ss_dssp             HTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSS
T ss_pred             hcCCCCCchhHH-HHHHHHHHHHhcCCCCCcc
Confidence            8775   67899 9999999999  7788875

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.91  E-value=2.7e-26  Score=223.78  Aligned_cols=175  Identities=23%  Similarity=0.322  Sum_probs=126.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh--------CC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS--------HE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~--------~~   73 (477)
                      .+++.||||++..... ....+.+.+|+.++++++||||+++++++...+..|+||||++|++|.+++..        .+
T Consensus        38 ~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  116 (303)
T 2vwi_A           38 PKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSG  116 (303)
T ss_dssp             ---CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTC
T ss_pred             CCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccC
Confidence            3688999999876532 23456788999999999999999999999999999999999999999999974        34


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc---cccCCeEEEecccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY---IEQGNTKVICSVFEPR  150 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~---~~~g~t~v~~~~y~pp  150 (477)
                      .+++..+..++.|++.||.|||++|++||||||+||+++.+. ++.++|||.+........   .....+..+++.|+||
T Consensus       117 ~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  195 (303)
T 2vwi_A          117 VLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDG-SVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP  195 (303)
T ss_dssp             SSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTC-CEEECCCHHHHHCC---------------CCCTTCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCC-CEEEEeccchheeccCCCccchhhhcccCCCccccCH
Confidence            699999999999999999999999999999999999997642 344459998754332111   1112345678889999


Q ss_pred             ccCCC----CCcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSS----KTSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~----~~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+    ..++|+ |++|+++|++  +..||..
T Consensus       196 E~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~  229 (303)
T 2vwi_A          196 EVMEQVRGYDFKADI-WSFGITAIELATGAAPYHK  229 (303)
T ss_dssp             HHHHHHHCCCTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             HHhccccCCCchhhH-HHHHHHHHHHHhCCCCCcc
Confidence            98643    277899 9999999999  6678764

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.91  E-value=1.1e-25  Score=225.11  Aligned_cols=168  Identities=24%  Similarity=0.348  Sum_probs=137.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCe------EEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERY------VYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~------~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++..........+.+.+|+.+++.++||||+++++++...+.      +|++|||++ ++|.+++..  .+
T Consensus        47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~  123 (353)
T 3coi_A           47 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL--KF  123 (353)
T ss_dssp             TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS--CC
T ss_pred             CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC--CC
Confidence            478999999998776666667789999999999999999999999986653      599999998 699888753  59


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+......     .....+++.|+|||...+
T Consensus       124 ~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~  197 (353)
T 3coi_A          124 SEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDC-ELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILS  197 (353)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTC-CEEECSTTCTTC-------------CCSBCCSCHHHHSC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCC-cEEEeecccccCCCCC-----ccccccCcCcCCHHHHhC
Confidence            9999999999999999999999999999999999998653 3444599987654322     234567889999998765


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|++++++  +..||.+
T Consensus       198 ~~~~~~~~Di-~slG~il~el~~g~~pf~~  226 (353)
T 3coi_A          198 WMHYNQTVDI-WSVGCIMAEMLTGKTLFKG  226 (353)
T ss_dssp             CSCCCTTHHH-HHHHHHHHHHHHSSCSSBS
T ss_pred             cCCCCchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            2    77899 9999999999  6678864

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.91  E-value=6.4e-25  Score=217.45  Aligned_cols=162  Identities=23%  Similarity=0.289  Sum_probs=128.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc--CCCCccceEEEEEeC----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL--HHQHIVTMLDFLWDE----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l--~HpnIv~~~~~~~~~----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      +|+.||||++...     ....+.+|..++..+  +||||+++++++...    ...|+||||+++++|.++++.. .++
T Consensus        59 ~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~  132 (337)
T 3mdy_A           59 RGEKVAVKVFFTT-----EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLD  132 (337)
T ss_dssp             TTEEEEEEEEEGG-----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-CBC
T ss_pred             CCceEEEEEEecc-----ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-CCC
Confidence            4789999998543     223455666666655  899999999999877    7899999999999999999774 799


Q ss_pred             HHHHHHHHHHHHHHHHHHHhC--------CcEEccCCCCceeeccCcceeecccccceecccCCccc--ccCCeEEEecc
Q psy6508          77 EFQCQQFVRQLVLALKFLREN--------NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--EQGNTKVICSV  146 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~--------givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--~~g~t~v~~~~  146 (477)
                      +..+..++.|++.||.|||++        ||+||||||+|||++.+. ++.++|||.+.........  ....+..+++.
T Consensus       133 ~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  211 (337)
T 3mdy_A          133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVKFISDTNEVDIPPNTRVGTKR  211 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCTTCEECC---------CCSSCSCGG
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeCCCceeeccccccccCCCCCCccCcc
Confidence            999999999999999999999        999999999999997643 4445699988654322211  11224568889


Q ss_pred             ccccccCCCC---C------cccccCcceEEEEEE
Q psy6508         147 FEPREIPSSK---T------SLEYQRSKGELYVEF  172 (477)
Q Consensus       147 y~ppE~~~~~---~------~~Di~~s~G~il~e~  172 (477)
                      |+|||...+.   .      ++|+ ||+|+++|||
T Consensus       212 y~aPE~~~~~~~~~~~~~~~~~Di-wslG~il~el  245 (337)
T 3mdy_A          212 YMPPEVLDESLNRNHFQSYIMADM-YSFGLILWEV  245 (337)
T ss_dssp             GCCHHHHTTCCCTTCTHHHHHHHH-HHHHHHHHHH
T ss_pred             eeChhhcccccCCccccCccccch-HHHHHHHHHH
Confidence            9999998765   2      2799 9999999999

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.91  E-value=2.4e-25  Score=219.56  Aligned_cols=172  Identities=23%  Similarity=0.310  Sum_probs=136.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc---CCCCccceEEEEE-----eCCeEEEEEecCCCCCHHHHHHhCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL---HHQHIVTMLDFLW-----DERYVYIILEYCDGGDLCSFIRSHE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~~~~~~~-----~~~~~~lv~e~~~g~sL~~~l~~~~   73 (477)
                      .+|+.||+|+++...........+.+|+.+++.+   +||||+++++++.     .....++||||++ ++|.+++....
T Consensus        35 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~  113 (326)
T 1blx_A           35 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP  113 (326)
T ss_dssp             TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC
T ss_pred             CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcc
Confidence            4678999999876544333233566788887776   8999999999987     4567999999998 79999998754


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccc
Q psy6508          74 --KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        74 --~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE  151 (477)
                        .+++..+..++.|++.||.|||++||+||||||+||+++.+. ++.++|||.+.......   ......++..|+|||
T Consensus       114 ~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE  189 (326)
T 1blx_A          114 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSG-QIKLADFGLARIYSFQM---ALTSVVVTLWYRAPE  189 (326)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECSCCSCCCCCGGG---GGCCCCCCCTTCCHH
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCC-CEEEecCcccccccCCC---CccccccccceeCHH
Confidence              499999999999999999999999999999999999997643 34455999876443221   123456788899999


Q ss_pred             cCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         152 IPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       152 ~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ...+.   .++|+ ||+|+++|++  +..||.+
T Consensus       190 ~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~  221 (326)
T 1blx_A          190 VLLQSSYATPVDL-WSVGCIFAEMFRRKPLFRG  221 (326)
T ss_dssp             HHTTCCCCTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             HHhcCCCCcchhH-HHHHHHHHHHHcCCCCCCC
Confidence            88665   77899 9999999999  6677763

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.91  E-value=2.1e-25  Score=222.65  Aligned_cols=173  Identities=29%  Similarity=0.328  Sum_probs=137.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||+++... .......+.+|+.++++++||||+++++++...     ...|++|||++ ++|.+++.. +.++
T Consensus        34 ~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~  110 (353)
T 2b9h_A           34 PTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLS  110 (353)
T ss_dssp             TTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCC
T ss_pred             CCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCC
Confidence            478999999986443 344556788999999999999999999987654     67999999997 799999987 5799


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc--------CCeEEEecccc
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ--------GNTKVICSVFE  148 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~--------g~t~v~~~~y~  148 (477)
                      +..+..++.|++.||.|||++||+||||||+||+++.+. .+.++|||.+...........        .....+++.|+
T Consensus       111 ~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~  189 (353)
T 2b9h_A          111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYR  189 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECC----------------CCCCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCC-cEEEEecccccccccccccccCccccccchhhcccccccc
Confidence            999999999999999999999999999999999997653 344459998875443221110        11246788899


Q ss_pred             ccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         149 PREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |||...+.    .++|+ ||+|+++|++  +..||.+
T Consensus       190 aPE~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~  225 (353)
T 2b9h_A          190 APEVMLTSAKYSRAMDV-WSCGCILAELFLRRPIFPG  225 (353)
T ss_dssp             CHHHHHSCCCCCHHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CCeeeccCCCccchhhH-HHHHHHHHHHHhCCCCCCC
Confidence            99975432    67899 9999999999  6677764

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.91  E-value=1e-24  Score=211.98  Aligned_cols=149  Identities=15%  Similarity=0.183  Sum_probs=124.5

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++...... ....+.+.+|+.++++++||||+++++++..++..|+||||++|++|.++++..  ....++
T Consensus        54 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~  131 (286)
T 3uqc_A           54 ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS--PSPVGA  131 (286)
T ss_dssp             TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC--CCHHHH
T ss_pred             CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC--CChHHH
Confidence            46899999999876553 455678999999999999999999999999999999999999999999999653  466678


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc-ceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcc
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT-LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSL  159 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~-~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~  159 (477)
                      ..++.|++.||.|||++||+||||||+|||++.++ +++.                        ++.|++|    ...++
T Consensus       132 ~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~------------------------~~~~~~~----~~~~~  183 (286)
T 3uqc_A          132 IRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLA------------------------YPATMPD----ANPQD  183 (286)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEEC------------------------SCCCCTT----CCHHH
T ss_pred             HHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEE------------------------eccccCC----CCchh
Confidence            99999999999999999999999999999997653 3332                        1223333    23567


Q ss_pred             cccCcceEEEEEE--eeecccccc
Q psy6508         160 EYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       160 Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      |+ ||+|+++|++  +..||.+..
T Consensus       184 Di-~slG~il~elltg~~Pf~~~~  206 (286)
T 3uqc_A          184 DI-RGIGASLYALLVNRWPLPEAG  206 (286)
T ss_dssp             HH-HHHHHHHHHHHHSEECSCCCS
T ss_pred             HH-HHHHHHHHHHHHCCCCCCcCC
Confidence            99 9999999999  889998644

>3cdi_A Polynucleotide phosphorylase; mRNA turnover, RNAse, RNA degradation, kinase, transferase; 2.60A {Escherichia coli} PDB: 1sro_A

Probab=99.91  E-value=9.4e-24  Score=224.88  Aligned_cols=227  Identities=16%  Similarity=0.213  Sum_probs=179.6

Q ss_pred             ccCCCCceeecc---CcceeecccccceecccCCcccccCCeEEEecc-ccccccCCCCCcccccCcceEEEEEEeeecc
Q psy6508         102 FDLKPQNILIKN---NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSV-FEPREIPSSKTSLEYQRSKGELYVEFKFAPF  177 (477)
Q Consensus       102 rDlkp~NIll~~---~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~-y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf  177 (477)
                      .-+..+++-+|.   +++|.+.+.+|+..+++||++++.|+|++.|.+ ++|.|.........- -..|.+++++.++||
T Consensus       313 ~~i~~~g~R~DGR~~~elRpI~ie~gvl~~a~GSAl~~~G~TqVL~~Vt~gp~e~~~~~d~l~~-~~~g~~~~~y~~~P~  391 (723)
T 3cdi_A          313 SRVLAGEPRIDGREKDMIRGLDVRTGVLPRTHGSALFTRGETQALVTATLGTARDAQVLDELMG-ERTDTFLFHYNFPPY  391 (723)
T ss_dssp             HHHHTTCCCTTSCCTTCCCCEEEEESCSTTSSEEEEEEETTEEEEEEEEECC--------------CTTSEEEEEECCGG
T ss_pred             HHHhccCcCCCCCCccccccceEEeCCCCCCCeEEEEEECCcEEEEEEEecCcccccCCcccCC-CCceEEEEEEecCCC
Confidence            334556666653   589999999999999999999999999999999 899764321100001 245788999999999


Q ss_pred             cccccc-CCCCCcchHHHHHHHHHHhhhhhhc-ccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCceEEEE
Q psy6508         178 ASQIRT-GWLRDSEEKELGNHLKRALEPAVCR-HEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDLVTSS  255 (477)
Q Consensus       178 ~~~~r~-~~~~~~~~~~l~~~i~~~l~~~i~~-~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~v~a~  255 (477)
                      ++..+. ...+..++..+...+++++++++.+ +.||++ |++.++||++||+.+.|+++|+++||+||||||+++|+|+
T Consensus       392 st~e~~r~g~p~~REi~~~~li~raL~~vI~~~~~~p~t-I~Vd~~VLesdGs~~~Asi~aa~lAL~dAgVPl~~~vaav  470 (723)
T 3cdi_A          392 SVGETGMVGSPKRREIGHGRLAKRGVLAVMPDMDKFPYT-VRVVSEITESNGSSSMASVCGASLALMDAGVPIKAAVAGI  470 (723)
T ss_dssp             GGTCCCCC-----CTTHHHHHHHHHHHTTSCCSSSSCSC-EEEEEEEEECSSCHHHHHHHHHHHHHHHTTCCCSSCCEEE
T ss_pred             CccccccCCCCCHHHHHHHHHHHHHHHHhcCcccCCCEE-EEEEEEEEeCCCCHHHHHHHHHHHHHhcCCCCcccceeeE
Confidence            976653 2245677788899999999999974 789987 9999999999999999999999999999999999999999


Q ss_pred             EEEeeC-C---eEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee---ecHHHHHHHHHHHHhcccc
Q psy6508         256 TLALRG-G---LTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT---IQQERLADHIEQLIGCCES  328 (477)
Q Consensus       256 s~~~~~-~---~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~---~~~~~~~~~l~~~~~~~~~  328 (477)
                      |+++.+ |   .+++||+..|+..          +...++++  .+.+.|+.+|++|+   ++.+++.++++.|.++|..
T Consensus       471 s~gli~~g~~~~iL~Dp~~~Ed~~----------~d~d~~Va--~t~~gI~~lq~~gk~~~is~e~l~~~l~~A~~~~~~  538 (723)
T 3cdi_A          471 AMGLVKEGDNYVVLSDILGDEDHL----------GDMDFKVA--GSRDGISALQMDIKIEGITKEIMQVALNQAKGARLH  538 (723)
T ss_dssp             EEEEEEETTEEEEESSCCGGGGGG----------CSEEEEEE--ECSSCEEEEEEEECSSCCCHHHHHHHHHHHHHHHHH
T ss_pred             EEEEEcCCCceEEEECCChHHhhh----------ccceeeec--ccCCceEEEEeCCccCCcCHHHHHHHHHHHHHHHHH
Confidence            999985 4   3999999999984          36778887  33344999999954   7999999999999999999


Q ss_pred             hhhHHHHhHhhhccc
Q psy6508         329 LCTDRVQKLVSDHVT  343 (477)
Q Consensus       329 i~~~~i~~~l~~~~~  343 (477)
                      +... |++++.++..
T Consensus       539 I~~~-m~~al~~~~~  552 (723)
T 3cdi_A          539 ILGV-MEQAINAPRG  552 (723)
T ss_dssp             HHHH-HHHHCC----
T ss_pred             HHHH-HHHHhhhcch
Confidence            9999 9999977643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.91  E-value=6.4e-25  Score=236.98  Aligned_cols=172  Identities=23%  Similarity=0.337  Sum_probs=136.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~   81 (477)
                      .+..||||.++... .....+.+.+|+.++++++||||+++++++. ++..|+||||+++|+|.+++...+ .+++..+.
T Consensus       417 ~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~  494 (656)
T 2j0j_A          417 PAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLI  494 (656)
T ss_dssp             CCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHH
T ss_pred             ccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHH
Confidence            35679999986543 4455678999999999999999999999984 567899999999999999998654 69999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.|++.||.|||++||+||||||+|||++.+. .+.++|||++......... ......++..|+|||...+.   .+
T Consensus       495 ~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~-~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~  572 (656)
T 2j0j_A          495 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSA  572 (656)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHHHhCCccccccchHhEEEeCCC-CEEEEecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCch
Confidence            9999999999999999999999999999997643 3445699998765443321 11233455689999987544   67


Q ss_pred             ccccCcceEEEEEE---eeecccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +|+ ||+|+++||+   +..||.+
T Consensus       573 ~Di-wSlG~il~ellt~g~~Pf~~  595 (656)
T 2j0j_A          573 SDV-WMFGVCMWEILMHGVKPFQG  595 (656)
T ss_dssp             HHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             hhH-HHHHHHHHHHHHcCCCCCCC
Confidence            899 9999999997   5678864

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.91  E-value=1.7e-25  Score=232.82  Aligned_cols=172  Identities=17%  Similarity=0.241  Sum_probs=138.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC-CCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH-QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+++.||||+++.....    ..+.+|+.+++.++| ++++.+..++...+..++||||+ +++|.+++.. .+.+++..
T Consensus        30 ~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~  104 (483)
T 3sv0_A           30 QTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKT  104 (483)
T ss_dssp             TTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHH
T ss_pred             CCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHH
Confidence            46899999998765433    247789999999976 56666677778888999999999 7999999985 45799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeec--cCcceeecccccceecccCCcc-----cccCCeEEEecccccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIK--NNTLKLAGLKQGVSEKAKGSAY-----IEQGNTKVICSVFEPREI  152 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~--~~~~rl~~~dfG~~~~~~gs~~-----~~~g~t~v~~~~y~ppE~  152 (477)
                      ++.|+.||+.||.|||++||+||||||+|||++  ++...+.++|||++........     ........++..|+|||.
T Consensus       105 ~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~  184 (483)
T 3sv0_A          105 VLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNT  184 (483)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHH
Confidence            999999999999999999999999999999994  2333455569999875443321     112235678889999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+.   .++|+ |++|+++|||  +..||.+
T Consensus       185 ~~~~~~s~~sDv-wSlGvil~elltG~~Pf~~  215 (483)
T 3sv0_A          185 HLGIEQSRRDDL-ESLGYVLMYFLRGSLPWQG  215 (483)
T ss_dssp             HTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSS
T ss_pred             hcCCCCChHHHH-HHHHHHHHHHHhCCCCCcc
Confidence            8776   67899 9999999999  6788875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.91  E-value=7.2e-25  Score=216.64  Aligned_cols=171  Identities=20%  Similarity=0.267  Sum_probs=123.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHH-HHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIK-ALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-----HEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~-il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-----~~~l   75 (477)
                      .+|+.||||+++... ......++.+|.. +++.++||||+++++++..++..|+||||++ ++|.+++..     ...+
T Consensus        45 ~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~  122 (327)
T 3aln_A           45 PSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVI  122 (327)
T ss_dssp             TTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCC
T ss_pred             CCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccC
Confidence            478999999997654 3334455666666 6777899999999999999999999999998 588888863     4579


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ++..+..++.|++.||.|||++ ||+||||||+||+++.+. .+.++|||.+.......   ......++..|+|||...
T Consensus       123 ~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~  198 (327)
T 3aln_A          123 PEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERID  198 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSSCC--------------------------
T ss_pred             cHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCceeccccc---ccccCCCCccccCceeec
Confidence            9999999999999999999999 999999999999997643 44556999886543321   112346788999999983


Q ss_pred             ----CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 ----SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ----~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          +.   .++|+ ||+|+++|++  +..||.+
T Consensus       199 ~~~~~~~~~~~~Di-~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          199 PSASRQGYDVRSDV-WSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             -------CCSHHHH-HHHHHHHHHHHHSCCCSSC
T ss_pred             cccCcCCCCchhhH-HHHHHHHHHHHHCCCCCCC
Confidence                22   67899 9999999999  6788875

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.91  E-value=5.6e-25  Score=234.82  Aligned_cols=173  Identities=27%  Similarity=0.413  Sum_probs=144.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe------CCeEEEEEecCCCCCHHHHHHhCC--
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD------ERYVYIILEYCDGGDLCSFIRSHE--   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~------~~~~~lv~e~~~g~sL~~~l~~~~--   73 (477)
                      .+|+.||||+++.. ......+.+.+|+.++++++||||+++++++..      .+..|+||||++|++|.+++....  
T Consensus        37 ~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~  115 (676)
T 3qa8_A           37 DTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENC  115 (676)
T ss_dssp             TTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCT
T ss_pred             CCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccC
Confidence            46889999998764 355566789999999999999999999998754      667899999999999999998754  


Q ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          74 -KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        74 -~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                       .+++..++.++.|++.||.|||++||+||||||+||+++.+  ...+.++|||.+.......   ......++..|+||
T Consensus       116 ~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~AP  192 (676)
T 3qa8_A          116 CGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAP  192 (676)
T ss_dssp             TCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSS
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc---ccccccCCcccCCh
Confidence             58999999999999999999999999999999999999754  3345567999987544322   12345678899999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.   .++|+ ||+|+++|++  +..||..
T Consensus       193 E~l~~~~~s~ksDI-wSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          193 ELLEQKKYTVTVDY-WSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             CSSCCSCCSTTHHH-HHHHHHHHHHHSSCSSCCS
T ss_pred             HHhccCCCCchhHH-HHHHHHHHHHHHCCCCCCc
Confidence            998765   77899 9999999999  7788854

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.90  E-value=5.8e-25  Score=221.02  Aligned_cols=169  Identities=21%  Similarity=0.310  Sum_probs=138.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-----------CCCccceEEEEEeCC----eEEEEEecCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-----------HQHIVTMLDFLWDER----YVYIILEYCDGGDLC   66 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~   66 (477)
                      .+|+.||||++...   ....+.+.+|+.++++++           ||||+++++++...+    .++++||++ +++|.
T Consensus        42 ~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~  117 (373)
T 1q8y_A           42 VNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLL  117 (373)
T ss_dssp             TTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHH
T ss_pred             CCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHH
Confidence            47889999998643   334567889999999886           899999999988654    799999999 79999


Q ss_pred             HHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC-CcEEccCCCCceeecc-----CcceeecccccceecccCCcccccC
Q psy6508          67 SFIRSH--EKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKPQNILIKN-----NTLKLAGLKQGVSEKAKGSAYIEQG  138 (477)
Q Consensus        67 ~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~-----~~~rl~~~dfG~~~~~~gs~~~~~g  138 (477)
                      +++...  ..+++..+..++.|++.||.|||++ ||+||||||+|||++.     +..++.++|||.+......     .
T Consensus       118 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~  192 (373)
T 1q8y_A          118 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-----Y  192 (373)
T ss_dssp             HHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-----C
T ss_pred             HHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-----C
Confidence            999874  3599999999999999999999998 9999999999999952     3345667799998654432     2


Q ss_pred             CeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         139 NTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       139 ~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ....+++.|+|||...+.   .++|+ ||+|+++||+  +..||.+.
T Consensus       193 ~~~~~t~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~~  238 (373)
T 1q8y_A          193 TNSIQTREYRSPEVLLGAPWGCGADI-WSTACLIFELITGDFLFEPD  238 (373)
T ss_dssp             CSCCSCGGGCCHHHHHTCCCCTHHHH-HHHHHHHHHHHHSSCCC---
T ss_pred             CCCCCCccccCcHHHhCCCCCchHhH-HHHHHHHHHHHhCCCCCCCC
Confidence            344678899999988665   67899 9999999999  77888753

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.90  E-value=2.6e-25  Score=234.90  Aligned_cols=170  Identities=22%  Similarity=0.320  Sum_probs=136.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~~   80 (477)
                      .+..||||+++.....   .+.|.+|+.+|++++||||+++++++.. +..|+||||+++|+|.+++...  ..+++..+
T Consensus       290 ~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~  365 (535)
T 2h8h_A          290 GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL  365 (535)
T ss_dssp             TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHH
T ss_pred             CCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHH
Confidence            3567999999765433   3578999999999999999999999865 6789999999999999999753  46999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.......+. ......++..|+|||.....   .
T Consensus       366 ~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~  443 (535)
T 2h8h_A          366 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTI  443 (535)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCTTSTTTCCCHHHH-TTCSTTSCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCC-cEEEcccccceecCCCcee-cccCCcCcccccCHHHhccCCCCc
Confidence            99999999999999999999999999999997643 4445699998654432221 11222345679999987544   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||.+
T Consensus       444 ~sDv-wSlGv~l~el~t~g~~P~~~  467 (535)
T 2h8h_A          444 KSDV-WSFGILLTELTTKGRVPYPG  467 (535)
T ss_dssp             HHHH-HHHHHHHHHHTTTTCCSSTT
T ss_pred             hhhH-HHHHHHHHHHHhCCCCCCCC
Confidence            7899 9999999999   4567754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.90  E-value=9.8e-25  Score=218.38  Aligned_cols=170  Identities=22%  Similarity=0.342  Sum_probs=133.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-------eEEEEEecCCCCCHHHHHH----
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-------YVYIILEYCDGGDLCSFIR----   70 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-------~~~lv~e~~~g~sL~~~l~----   70 (477)
                      .+|+.||||++......   ...+.+|+..++.++||||+++++++...+       .+++||||++ ++|.+.+.    
T Consensus        46 ~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~  121 (360)
T 3e3p_A           46 STGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-DTLHRCCRNYYR  121 (360)
T ss_dssp             TTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCS-CBHHHHHHHHHT
T ss_pred             CCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeeccc-ccHHHHHHHHhh
Confidence            46899999998654322   234567888889999999999999987543       3899999998 46655443    


Q ss_pred             hCCCCCHHHHHHHHHHHHHHHHHHH--hCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          71 SHEKLSEFQCQQFVRQLVLALKFLR--ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        71 ~~~~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                      ....+++..+..++.|++.||.|||  ++||+||||||+|||++....++.++|||.+.......   ...+..+++.|+
T Consensus       122 ~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~  198 (360)
T 3e3p_A          122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYR  198 (360)
T ss_dssp             TTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGC
T ss_pred             cccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCccee
Confidence            4457999999999999999999999  99999999999999998643456667999986544322   122345688899


Q ss_pred             ccccCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         149 PREIPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       149 ppE~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |||...+.    .++|+ ||+|+++|++  +..||.+
T Consensus       199 aPE~~~~~~~~~~~~Di-~slG~il~ell~g~~pf~~  234 (360)
T 3e3p_A          199 APELIFGNQHYTTAVDI-WSVGCIFAEMMLGEPIFRG  234 (360)
T ss_dssp             CHHHHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CHHHHcCCCCCCcHHHH-HHHHHHHHHHHhCCCCcCC
Confidence            99987543    67899 9999999999  6677764

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.90  E-value=1.2e-25  Score=220.86  Aligned_cols=172  Identities=20%  Similarity=0.247  Sum_probs=130.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+|+.||||++..........+.+..+..+++.++||||+++++++..++..|+||||+ ++.+..+... ...+++..+
T Consensus        48 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~  126 (318)
T 2dyl_A           48 KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERIL  126 (318)
T ss_dssp             TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHH
T ss_pred             cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHH
Confidence            47899999999776544344444555666788889999999999999999999999999 4677666654 457999999


Q ss_pred             HHHHHHHHHHHHHHHhC-CcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC----
Q psy6508          81 QQFVRQLVLALKFLREN-NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS----  155 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~----  155 (477)
                      ..++.|++.||.|||++ |++||||||+||+++.+. .+.++|||.+.......   ......+++.|+|||...+    
T Consensus       127 ~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~  202 (318)
T 2dyl_A          127 GKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPT  202 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC-----------------CCTTCCHHHHC-----
T ss_pred             HHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCchhccCCc---cccccCCCccccChhhccccccc
Confidence            99999999999999995 999999999999997643 34445999875443221   1234567889999999742    


Q ss_pred             -C---CcccccCcceEEEEEE--eeecccc
Q psy6508         156 -K---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 -~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .   .++|+ |++|+++|++  +..||..
T Consensus       203 ~~~~~~~~Di-~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          203 KPDYDIRADV-WSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             ---CCTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             ccCCccccch-hhHHHHHHHHHhCCCCCCC
Confidence             1   57899 9999999999  6678764

>2nn6_E Exosome complex exonuclease RRP42; RNA, exosome, PM/SCL, phosphorolytic, hydrolase/transferase complex; 3.35A {Homo sapiens} SCOP: d.14.1.4 d.101.1.1

Probab=99.90  E-value=1.4e-23  Score=204.76  Aligned_cols=214  Identities=21%  Similarity=0.203  Sum_probs=180.6

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|...+++||++++.|+|++.|.++++.+....    +- -..|.+.+++.+.||+...++...++..+.+
T Consensus        44 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~e~~~p~~----~~-~~~g~l~~~v~~~p~a~~~~~~r~~~~~~~~  118 (305)
T 2nn6_E           44 EDYRCVEVETDVVSNTSGSARVKLGHTDILVGVKAEMGTPKL----EK-PNEGYLEFFVDCSASATPEFEGRGGDDLGTE  118 (305)
T ss_dssp             SCCCCCEEEECCCTTSSSEEEEEETTEEEEEECCCCCSCCCS----SS-CSSCCEEEECCCCTTTCSSCCTTSTHHHHHH
T ss_pred             cCccCeEEEeCcccCCCcEEEEEECCeEEEEEEEEEeeCCCc----CC-CCceEEEEEEEeCCCcCccccCCCCchHHHH
Confidence            578999999999999999999999999999999986543211    11 3457888899999998766544445567888


Q ss_pred             HHHHHHHHhhh--hhhcc---cCCCC---cccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCce--------------
Q psy6508         194 LGNHLKRALEP--AVCRH---EFSNF---QVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDL--------------  251 (477)
Q Consensus       194 l~~~i~~~l~~--~i~~~---~~Pr~---~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~--------------  251 (477)
                      +++.+.+.+++  ++.++   .+|+.   .+.+.++||+.||+.+.++++|+++||.|+|+||.++              
T Consensus       119 isrli~r~lr~s~~idl~~L~i~p~~~~w~i~idv~VL~~DG~~~daai~aa~~AL~~a~iP~~~~~~~~~~~~~i~~~~  198 (305)
T 2nn6_E          119 IANTLYRIFNNKSSVDLKTLCISPREHCWVLYVDVLLLECGGNLFDAISIAVKAALFNTRIPRVRVLEDEEGSKDIELSD  198 (305)
T ss_dssp             HHHHHHHHHHHSCCSCSSSSCSSTTTCCCCEEEEEEECCCCSSHHHHHHHHHHHTTTTCCCCEEEEECC------EEEEE
T ss_pred             HHHHHHHHHhhcCcccHHHheeccCcEEEEEEEEEEEECCCCCHHHHHHHHHHHHHHhcCCCeEEEecCCCCceeeeccC
Confidence            99999999998  55555   67754   5999999999999999999999999999999998876              


Q ss_pred             -------------EEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe--eecHHHHH
Q psy6508         252 -------------VTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG--TIQQERLA  316 (477)
Q Consensus       252 -------------v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g--~~~~~~~~  316 (477)
                                   ++++|+++.++.+++||+..|+..          +.+.+++++.+ .++|+.++..|  .++.+++.
T Consensus       199 d~~~~~~l~l~~~p~avt~g~i~~~~l~Dpt~~Ee~~----------~~~~l~Va~~~-~g~i~~i~~~g~~~l~~~~l~  267 (305)
T 2nn6_E          199 DPYDCIRLSVENVPCIVTLCKIGYRHVVDATLQEEAC----------SLASLLVSVTS-KGVVTCMRKVGKGSLDPESIF  267 (305)
T ss_dssp             SSCCCSCCCCTTCCCCEEEEESSSSEESSCCHHHHTS----------CSEEEEECCCS-SSCCCEEEEEESSCBCHHHHH
T ss_pred             cccccccccccCceEEEEEEEECCEEEECCCHHHHhh----------cCCcEEEEEcC-CCCEEEEEccCCCCCCHHHHH
Confidence                         358999999999999999999984          47889998655 47899999998  89999999


Q ss_pred             HHHHHHHhcccchhhHHHHhHhhhcccc
Q psy6508         317 DHIEQLIGCCESLCTDRVQKLVSDHVTL  344 (477)
Q Consensus       317 ~~l~~~~~~~~~i~~~~i~~~l~~~~~l  344 (477)
                      ++++.|.++++.+.+. +++.+.+....
T Consensus       268 ~~l~~A~~~~~~i~~~-~~~~l~~~~~~  294 (305)
T 2nn6_E          268 EMMETGKRVGKVLHAS-LQSVVHKEESL  294 (305)
T ss_dssp             HHHHHHHHHHHHHHHH-HHHHHHHHHC-
T ss_pred             HHHHHHHHHHHHHHHH-HHHHHHHHHhh
Confidence            9999999999999999 99998765553

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.90  E-value=9.9e-25  Score=216.24  Aligned_cols=162  Identities=19%  Similarity=0.302  Sum_probs=126.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHH--HHhcCCCCccceEEEEEe-----CCeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKA--LKLLHHQHIVTMLDFLWD-----ERYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~i--l~~l~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      +++.||||+++...     ...+..|..+  +..++||||+++++.+..     ...+|+||||+++|+|.+++... ..
T Consensus        35 ~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~  108 (336)
T 3g2f_A           35 DERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TS  108 (336)
T ss_dssp             TTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CB
T ss_pred             CCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-cc
Confidence            57899999986442     2334445444  445899999999986542     23679999999999999999875 56


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhC---------CcEEccCCCCceeeccCcceeecccccceecccCCcccc------cCCe
Q psy6508          76 SEFQCQQFVRQLVLALKFLREN---------NVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE------QGNT  140 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~---------givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~------~g~t  140 (477)
                      ++..+..++.|++.||.|||++         ||+||||||+|||++.+. ++.++|||.+..........      ...+
T Consensus       109 ~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~  187 (336)
T 3g2f_A          109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVISDFGLSMRLTGNRLVRPGEEDNAAIS  187 (336)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEECCCTTCEECSSSSCC---------CC
T ss_pred             chhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEEeeccceeecccccccCcccccccccc
Confidence            8999999999999999999999         999999999999998643 44456999987654432211      1123


Q ss_pred             EEEeccccccccCCCC----------CcccccCcceEEEEEE
Q psy6508         141 KVICSVFEPREIPSSK----------TSLEYQRSKGELYVEF  172 (477)
Q Consensus       141 ~v~~~~y~ppE~~~~~----------~~~Di~~s~G~il~e~  172 (477)
                      ..++..|+|||...+.          .++|+ ||+|+++||+
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di-wslG~il~el  228 (336)
T 3g2f_A          188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDM-YALGLIYWEI  228 (336)
T ss_dssp             TTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH-HHHHHHHHHH
T ss_pred             CCCccceeCchhhcCCcccccccccccccch-HHHHHHHHHH
Confidence            4578899999998762          56899 9999999999

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.90  E-value=3.6e-24  Score=213.35  Aligned_cols=166  Identities=25%  Similarity=0.333  Sum_probs=136.5

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCC------ccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CC
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQH------IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KL   75 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn------Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l   75 (477)
                      ++.||+|+++..   ....+.+.+|+.++++++|++      ++.+++++...+..|+||||+. ++|.+++....  .+
T Consensus        45 ~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~  120 (355)
T 2eu9_A           45 KSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLG-KNTFEFLKENNFQPY  120 (355)
T ss_dssp             TEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCC
T ss_pred             ceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccC-CChHHHHHhccCCCC
Confidence            368999998643   344567889999999997665      9999999999999999999995 78888876653  69


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc------------------CcceeecccccceecccCCccccc
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN------------------NTLKLAGLKQGVSEKAKGSAYIEQ  137 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~------------------~~~rl~~~dfG~~~~~~gs~~~~~  137 (477)
                      ++..++.++.|++.||.|||++||+||||||+|||++.                  ...++.++|||.+......     
T Consensus       121 ~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----  195 (355)
T 2eu9_A          121 PLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----  195 (355)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc-----
Confidence            99999999999999999999999999999999999942                  2345566699988653322     


Q ss_pred             CCeEEEeccccccccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         138 GNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       138 g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+..+++.|+|||+..+.   .++|+ ||+|+++||+  +..||.+
T Consensus       196 ~~~~~gt~~y~aPE~~~~~~~~~~~Di-~slG~il~el~~g~~pf~~  241 (355)
T 2eu9_A          196 HTTIVATRHYRPPEVILELGWAQPCDV-WSIGCILFEYYRGFTLFQT  241 (355)
T ss_dssp             CCSSCSCGGGCCHHHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             ccCCcCCCcccCCeeeecCCCCCccch-HHHHHHHHHHHhCCCCCCC
Confidence            2345678899999998765   77899 9999999999  6778864

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.89  E-value=7.4e-24  Score=214.27  Aligned_cols=168  Identities=23%  Similarity=0.304  Sum_probs=137.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CC-----CccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQ-----HIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--E   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-Hp-----nIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~   73 (477)
                      .+++.||||+++..   ......+.+|+.+++.++ |+     +|+++++++...+..|+||||++ ++|.+++...  +
T Consensus        77 ~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~  152 (382)
T 2vx3_A           77 VEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFR  152 (382)
T ss_dssp             TTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTS
T ss_pred             CCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcC
Confidence            46889999998743   344567888999999884 55     49999999999999999999997 6999999875  3


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHH--hCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLR--ENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH--~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                      .+++..++.++.|++.||.|||  +.||+||||||+|||++. +...+.++|||.+......     ..+..+++.|+||
T Consensus       153 ~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aP  227 (382)
T 2vx3_A          153 GVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSP  227 (382)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCH
T ss_pred             CCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccccCCccccCh
Confidence            5999999999999999999999  579999999999999963 3344556699998655432     2345678899999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |+..+.   .++|+ ||+|+++||+  +..||.+
T Consensus       228 E~~~~~~~~~~~Di-wSlG~il~elltg~~pf~~  260 (382)
T 2vx3_A          228 EVLLGMPYDLAIDM-WSLGCILVEMHTGEPLFSG  260 (382)
T ss_dssp             HHHTTCCCCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             HHHcCCCCCcHHHH-HHHHHHHHHHHhCCCCCCC
Confidence            998775   78999 9999999999  6677763

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.89  E-value=1.3e-23  Score=205.11  Aligned_cols=150  Identities=23%  Similarity=0.416  Sum_probs=123.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHH-HhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCC--C
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHE--K   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il-~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~--~   74 (477)
                      .+++.||+|+++..       ..+.+|+.++ +.++||||+++++++..    ...+|+||||++|++|.+++....  .
T Consensus        41 ~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~  113 (299)
T 3m2w_A           41 RTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA  113 (299)
T ss_dssp             TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCC
T ss_pred             CCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCC
Confidence            47899999998642       3467899988 55599999999999887    678999999999999999998754  6


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC--cceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN--TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~--~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++..+..++.|++.||.|||++||+||||||+||+++.+  ...+.++|||.+....+..             |     
T Consensus       114 ~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-------------~-----  175 (299)
T 3m2w_A          114 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEK-------------Y-----  175 (299)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTTCG-------------G-----
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccccc-------------C-----
Confidence            9999999999999999999999999999999999999762  3455666999875443211             1     


Q ss_pred             CCCCCcccccCcceEEEEEE--eeeccccc
Q psy6508         153 PSSKTSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       153 ~~~~~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                         ..++|+ ||+|+++|++  +..||.+.
T Consensus       176 ---~~~~Di-wslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          176 ---DKSCDM-WSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             ---GGHHHH-HHHHHHHHHHHHSSCSCCC-
T ss_pred             ---CchhhH-HHHHHHHHHHHHCCCCCCCC
Confidence               145799 9999999999  77888653

>2wp8_A Exosome complex component RRP45; nucleus, hydrolase, RNA-binding, exonucle binding, mitochondrion, rRNA processing; 3.00A {Saccharomyces cerevisiae}

Probab=99.89  E-value=2.3e-22  Score=196.47  Aligned_cols=211  Identities=18%  Similarity=0.239  Sum_probs=159.6

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCC-cchH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRD-SEEK  192 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~-~~~~  192 (477)
                      +++|.+.+.+|   .++||++++.|+|++.|.++++.+....    +. -..|.+.+.+.+.||+....+...+. ..+.
T Consensus        31 ~e~R~i~i~~g---~a~GSa~v~~G~T~Vl~~V~~~~~~p~~----~~-~~~g~~~~~ve~~~~~~~~~~~g~~~~~~~~  102 (305)
T 2wp8_A           31 DQFRDVEITFG---KEFGDVSVKMGNTKVHCRISCQIAQPYE----DR-PFEGLFVISTEISPMAGSQFENGNITGEDEV  102 (305)
T ss_dssp             TCCCCEEEEEC---SSTTEEEEEETTEEEEEEEEEEEC-CCS----SC-TTCCEEEEEECCC------------------
T ss_pred             cccCCeEEEEc---CCCcEEEEEECCeEEEEEEeccccCCcc----cC-CCCcEEEEEEEECCCCCccccCCCCChhHHH
Confidence            57899989999   7999999999999999999987543221    11 34577777777888876544333444 7788


Q ss_pred             HHHHHHHHHhh--hhhhcccC---CC---CcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCC-----------------
Q psy6508         193 ELGNHLKRALE--PAVCRHEF---SN---FQVDLFVLVLQNDGSALSAAINCANLALVDAAIP-----------------  247 (477)
Q Consensus       193 ~l~~~i~~~l~--~~i~~~~~---Pr---~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~-----------------  247 (477)
                      ++++.+.+.++  +++.++.+   |.   |.|.+.++||++||+.+.++++|+++||.|||+|                 
T Consensus       103 ~is~li~r~l~~s~~idl~~L~i~pg~~~w~I~id~~VL~~DG~~~dAai~aa~~AL~~a~iP~~~~~~~~~~i~~~~~~  182 (305)
T 2wp8_A          103 LCSRIIEKSVRRSGALDVEGLCIVAGSKCWAVRADVHFLDCDGGFIDASCIAVMAGLMHFKKPDITVHGEQIIVHPVNER  182 (305)
T ss_dssp             ----CHHHHHHHTTSBCGGGGEEETTTEEEEEEEEEEEEECSSCHHHHHHHHHHHHHHHCEECCCBCTTSSCCBCCSSSS
T ss_pred             HHHHHHHHHHhhccCcCHHHccccCCcEEEEEEEEEEEEcCCCCHHHHHHHHHHHHHHHhCCCeEEecCCceEecccccc
Confidence            99999999999  45555433   43   6799999999999999999999999999999999                 


Q ss_pred             ------CCceEEEEEEEeeC--------------CeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE
Q psy6508         248 ------MYDLVTSSTLALRG--------------GLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV  307 (477)
Q Consensus       248 ------m~~~v~a~s~~~~~--------------~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~  307 (477)
                            |++.++++|+++.+              +.+++||+..|+..          +.+.+++++. ..++|+.++..
T Consensus       183 ~~~~l~~~~~pvavs~g~i~~~~~~~~~~~~~~~~~~l~Dpt~~Ee~~----------~~~~l~Va~~-~~g~i~~l~~~  251 (305)
T 2wp8_A          183 EPVPLGILHIPICVTFSFFNPQDTEENIKGETNSEISIIDATLKEELL----------RDGVLTVTLN-KNREVVQVSKA  251 (305)
T ss_dssp             CCEECCBSCCCEEEEEEECC---------------CEEESCCHHHHHH----------CSEEEEEEEC-TTSEEEEEEEE
T ss_pred             cccccccccCeEEEEEEEEccccccccccccccCCeEEeCCCHHHHhc----------cCCcEEEEEc-CCCcEEEEEec
Confidence                  77889999999996              78999999999985          4788999864 46789999999


Q ss_pred             e--eecHHHHHHHHHHHHhcccchhhHHHHhHhhhcccc
Q psy6508         308 G--TIQQERLADHIEQLIGCCESLCTDRVQKLVSDHVTL  344 (477)
Q Consensus       308 g--~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~~~l  344 (477)
                      |  .++.+++.++++.|.++++++... +++.+.+...-
T Consensus       252 g~~~~~~~~l~~~l~~A~~~~~~i~~~-~~~~l~~~~~~  289 (305)
T 2wp8_A          252 GGLPMDALTLMKCCHEAYSIIEKITDQ-ILQLLKEDSEK  289 (305)
T ss_dssp             EEEEECHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHHHHH
Confidence            8  699999999999999999999999 99998765543

>3u1k_A Polyribonucleotide nucleotidyltransferase 1, MITO; RNAse PH, KH domain, exoribonuclease; HET: CIT; 2.13A {Homo sapiens}

Probab=99.88  E-value=1.6e-21  Score=204.83  Aligned_cols=202  Identities=20%  Similarity=0.250  Sum_probs=169.6

Q ss_pred             eeeccccccee-cccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccc------cccCCCCCc
Q psy6508         117 KLAGLKQGVSE-KAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ------IRTGWLRDS  189 (477)
Q Consensus       117 rl~~~dfG~~~-~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~------~r~~~~~~~  189 (477)
                      |.+.+..|... +++||++++.|+|++.|.+++|.+...+    |  |.  -+.+++...||+..      .++...+..
T Consensus        15 R~i~ietG~~a~qA~GSa~v~~G~T~VL~tv~~~~~~~~~----d--f~--pL~v~y~~~~~a~g~iPg~f~kRegrps~   86 (630)
T 3u1k_A           15 RKLEISSGKLARFADGSAVVQSGDTAVMVTAVSKTKPSPS----Q--FM--PLVVDYRQKAAAAGRIPTNYLRREVGTSD   86 (630)
T ss_dssp             SEEEEEESSSCTTSSEEEEEEETTEEEEEEEEECSSCCSS----S--SC--CEEEEEECSEETTTTEECTTC-----CCH
T ss_pred             EEEEEEeCCccccCCeeEEEEECCeEEEEEEEecCCCCCC----C--ee--EEEEEEEecccccCCCCccccccCCCCCH
Confidence            66778999665 4999999999999999999999886533    3  32  36666666666642      222234666


Q ss_pred             chHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCch--HHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEeC
Q psy6508         190 EEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSA--LSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFID  267 (477)
Q Consensus       190 ~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~--~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~D  267 (477)
                      .+.+++++|.+.++|.+....+|+.+  |.++||+.||+.  ..+|+|||++||.++||||+++|+|+++++.+|.+++|
T Consensus        87 ~e~lisRlIdR~lRp~~~~~~~~~~q--I~~~VLs~Dg~~~~~~aai~aAs~AL~~s~iP~~~~vaav~vg~i~g~~vld  164 (630)
T 3u1k_A           87 KEILTSRIIDRSIRPLFPAGYFYDTQ--VLCNLLAVDGVNEPDVLAINGASVALSLSDIPWNGPVGAVRIGIIDGEYVVN  164 (630)
T ss_dssp             HHHHHHHHHHHHHGGGSCTTCCCCEE--EEEEEEECCSSSCHHHHHHHHHHHHHHHSSSCCCCCCEEEEEEEETTEEEES
T ss_pred             HHHHHHHHHhHHhhhcccccCCCceE--EEEEEEECCCCCCHHHHHHHHHHHHHhccCCCcCCCeEEEEEEEECCEEEEC
Confidence            78889999999999999988888876  689999999998  89999999999999999999999999999999999999


Q ss_pred             CChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee-ecHHHHHHHHHHHHhcccchhhHHHHhHhhh
Q psy6508         268 PVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT-IQQERLADHIEQLIGCCESLCTDRVQKLVSD  340 (477)
Q Consensus       268 p~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~-~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~  340 (477)
                      |+..|++.          +...++++.. ..++|+.++..|. ++.+++.++++.|.++|+.+... +++.+..
T Consensus       165 Pt~~E~~~----------s~~dl~Va~t-~~~~i~mve~~~~~~se~~~~~al~~a~~~~~~l~~~-~~~~~~~  226 (630)
T 3u1k_A          165 PTRKEMSS----------STLNLVVAGA-PKSQIVMLEASAENILQQDFCHAIKVGVKYTQQIIQG-IQQLVKE  226 (630)
T ss_dssp             CCHHHHHT----------EEEEEEEEEE-TTTEEEEEEEEEEEECHHHHHHHHHHHHHHHHHHHHH-HHHHHHH
T ss_pred             CCHHHHhh----------CCceEEEEEc-cCCcEEEEECCCccCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHH
Confidence            99999984          4788999876 4568999999988 99999999999999999999998 7776654

>3ohu_A Transcription regulator protein BACH2; BTB/POZ domain; 2.10A {Homo sapiens} SCOP: d.42.1.0 PDB: 3ohv_A

Probab=99.86  E-value=2.1e-22  Score=170.67  Aligned_cols=99  Identities=17%  Similarity=0.221  Sum_probs=93.1

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCC-CCHHHHHHHhhhhhcC
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILD-ITPEAFSTMLDSDHHA  421 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~-~~~~~~~~~l~~~Ytg  421 (477)
                      .+.+.++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.+++.+...+.+++ +++++|+.+|+|||||
T Consensus        18 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~f~aHk~vLaa~S~yF~~~f~~~~~e~~~i~l~~~~~~~~f~~~l~~iYtg   93 (125)
T 3ohu_A           18 NILLGLNDQRKKDILCDVTLIVER----KEFRAHRAVLAACSEYFWQALVGQTKNDLVVSLPEEVTARGFGPLLQFAYTA   93 (125)
T ss_dssp             HHHHHHHHHHHHTCSCCEEEEETT----EEEEECHHHHHHHBHHHHHHHTTCCCSSCEEECCTTCCHHHHHHHHHHHTTS
T ss_pred             HHHHHHHHHHhcCCccceEEEECC----EEEechHHHHHHcCHHHHHHhcCCCCCCcEEEeCCCCCHHHHHHHHHhHcCC
Confidence            356778889999999999999999    99999999999999999999999998877889998 9999999999999999


Q ss_pred             ceeeCccchhhhhhccccceeecc
Q psy6508         422 RVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       422 ~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      ++.++.+++.+++.+|+++.+..+
T Consensus        94 ~~~~~~~~v~~ll~~A~~l~i~~L  117 (125)
T 3ohu_A           94 KLLLSRENIREVIRCAEFLRMHNL  117 (125)
T ss_dssp             EEEECTTTHHHHHHHHHHHTBSSC
T ss_pred             ceEECHHHHHHHHHHHHHhCCHHH
Confidence            999999999999999999988765

>2ihc_A Transcription regulator protein BACH1; BRIC-A-BRAC domain,transcription factor, protein-PROT interaction; 2.44A {Homo sapiens}

Probab=99.85  E-value=1.7e-22  Score=170.93  Aligned_cols=99  Identities=15%  Similarity=0.239  Sum_probs=90.2

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccC-CCCHHHHHHHhhhhhcC
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL-DITPEAFSTMLDSDHHA  421 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~-~~~~~~~~~~l~~~Ytg  421 (477)
                      ++.+.++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.+++.+...+.++ ++++++|+.+|+|+|||
T Consensus        15 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~~~aHk~vLaa~S~yF~~mf~~~~~e~~~i~l~~~v~~~~f~~lL~~iYtg   90 (124)
T 2ihc_A           15 NVLLSLNDQRKKDVLCDVTIFVEG----QRFRAHRSVLAACSSYFHSRIVGQADGELNITLPEEVTVKGFEPLIQFAYTA   90 (124)
T ss_dssp             HHHHHHHHHHHHTCSCCEEEEETT----EEEEECHHHHHHHBHHHHHHHTTC---CEEEECCTTSCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHhcCCCcCEEEEECC----EEEecHHHHHHHcCHHHHHHHcCCCCCCceEeecCCcCHHHHHHHHHHhcCC
Confidence            356788889999999999999999    9999999999999999999999999887788884 99999999999999999


Q ss_pred             ceeeCccchhhhhhccccceeecc
Q psy6508         422 RVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       422 ~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      ++.++.+++.+++.+|+++.+..+
T Consensus        91 ~~~i~~~~v~~ll~~A~~~~~~~L  114 (124)
T 2ihc_A           91 KLILSKENVDEVCKCVEFLSVHNI  114 (124)
T ss_dssp             EEEEETTTHHHHHHHHHHHTBSSC
T ss_pred             CcccCHHHHHHHHHHHHHHCCHHH
Confidence            999999999999999999988765

>3b84_A Zinc finger and BTB domain-containing protein 48; krueppel related zinc finger protein 3, HKR3, ZBTB48, Z finger, oncogene; 1.74A {Homo sapiens}

Probab=99.85  E-value=2e-22  Score=169.34  Aligned_cols=97  Identities=19%  Similarity=0.232  Sum_probs=90.8

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHAR  422 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~  422 (477)
                      .+.+.++.++++|.+|||+|.|+|    ++|+|||.|||++|+||++||.+++  ...+.++++++++|+.+|+|||||+
T Consensus        10 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~f~aHk~vLaa~S~yF~~~f~~~~--~~~i~l~~~~~~~f~~ll~~iYtg~   83 (119)
T 3b84_A           10 RVLQELNKQREKGQYCDATLDVGG----LVFKAHWSVLACCSHFFQSLYGDGS--GGSVVLPAGFAEIFGLLLDFFYTGH   83 (119)
T ss_dssp             HHHHHHHHHHHHTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHTTTT--CCCEEECGGGHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHhcCCCcceEEEECC----EEEEeeHHHHhhcCHHHHHHHCCCC--CCeEEeCCCCHHHHHHHHHHHcCCC
Confidence            466788899999999999999999    9999999999999999999999977  6778999999999999999999999


Q ss_pred             eeeCccchhhhhhccccceeecc
Q psy6508         423 VNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 ~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      +.++.+++.+++.+||++.+..+
T Consensus        84 ~~~~~~~v~~ll~~A~~~~i~~L  106 (119)
T 3b84_A           84 LALTSGNRDQVLLAARELRVPEA  106 (119)
T ss_dssp             CCCCTTTHHHHHHHHHHTTCHHH
T ss_pred             CccCHHHHHHHHHHHHHhCcHHH
Confidence            99999999999999999988664

>2if5_A Zinc finger and BTB domain-containing protein 7A; POZ domain, POK, proto oncogene, transcription F transcription; 2.00A {Homo sapiens} PDB: 2nn2_A

Probab=99.85  E-value=2.9e-22  Score=168.55  Aligned_cols=99  Identities=17%  Similarity=0.234  Sum_probs=88.3

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhhhc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTMLDSDHH  420 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~Yt  420 (477)
                      ++.+.++.+++++.+|||+|.|++    +.|+|||.|||++|+||++||.+++.|  ...+.++++++++|+.+|+|+||
T Consensus        11 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~~~aHk~vLaa~S~~F~~~f~~~~~e~~~~~i~l~~~~~~~f~~ll~~~Yt   86 (120)
T 2if5_A           11 DILSGLNEQRTQGLLCDVVILVEG----REFPTHRSVLAACSQYFKKLFTSGAVVDQQNVYEIDFVSAEALTALMDFAYT   86 (120)
T ss_dssp             HHHHHHHHHHHTTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHHC-----CCSEEECCSSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCeEEEECC----EEEeHHHHHHHHhCHHHHHHhcCCccccCCceEEeCCCCHHHHHHHHHHHcC
Confidence            356778889999999999999999    999999999999999999999999987  45578999999999999999999


Q ss_pred             CceeeCccchhhhhhccccceeecc
Q psy6508         421 ARVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       421 g~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      |++.++.+++.+++.+||++.+..+
T Consensus        87 ~~~~~~~~~~~~ll~~A~~~~i~~L  111 (120)
T 2if5_A           87 ATLTVSTANVGDILSAARLLEIPAV  111 (120)
T ss_dssp             SCCCCCGGGHHHHHHHHHHTTCHHH
T ss_pred             CCCccCHHHHHHHHHHHHHhCCHHH
Confidence            9999999999999999999988664

>2z8h_A Transcription regulator protein BACH1; BTB, POZ, disulfide bond, activator, DNA-binding, nucleus, phosphorylation, repressor; 2.50A {Mus musculus}

Probab=99.84  E-value=4.5e-22  Score=171.67  Aligned_cols=99  Identities=16%  Similarity=0.222  Sum_probs=92.0

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccC-CCCHHHHHHHhhhhhcC
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL-DITPEAFSTMLDSDHHA  421 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~-~~~~~~~~~~l~~~Ytg  421 (477)
                      .+.+.++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.+++.+...+.++ ++++++|+.+|+|||||
T Consensus        22 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~f~aHk~vLaa~S~yF~~~f~~~~~e~~~i~l~~~v~~~~~~~lL~~~Ytg   97 (138)
T 2z8h_A           22 NVLLSLNDQRKKDVLCDVTVLVEG----QRFRAHRSVLAACSSYFHSRIVGQTDAELTVTLPEEVTVKGFEPLIQFAYTA   97 (138)
T ss_dssp             HHHHHHHHHHHHTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHTTCCCTTEEEECCTTSCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHHHHhhCCCcCeEEEECC----EEEechHHHHHHcCHHHHHHHhcCCCCCceEEeCCCCCHHHHHHHHHHhcCC
Confidence            356788889999999999999999    9999999999999999999999999887788885 99999999999999999


Q ss_pred             ceeeCccchhhhhhccccceeecc
Q psy6508         422 RVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       422 ~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      ++.++.+++.+++.+|+++.+..+
T Consensus        98 ~~~i~~~~v~~ll~~A~~~~i~~L  121 (138)
T 2z8h_A           98 KLILSKDNVDEVCRCVEFLSVHNI  121 (138)
T ss_dssp             CCCCCTTTHHHHHHHHHHHTCGGG
T ss_pred             CcccCHHHHHHHHHHHHHhCCHHH
Confidence            999999999999999998877654

>1r29_A B-cell lymphoma 6 protein; BTB domain, transcriptional repression, transcription; 1.30A {Homo sapiens} SCOP: d.42.1.1 PDB: 1r28_A 1r2b_A 3bim_A 3lbz_A* 3e4u_A

Probab=99.84  E-value=5e-22  Score=168.88  Aligned_cols=99  Identities=20%  Similarity=0.287  Sum_probs=92.2

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc-cCCccc-CCCCHHHHHHHhhhhhc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE-KGDTKI-LDITPEAFSTMLDSDHH  420 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~-~~~~~~-~~~~~~~~~~~l~~~Yt  420 (477)
                      .+.+.++.+++++.+|||+|.|++    +.|+|||.|||++|+||++||.+++.| ...+.| +++++++|+.+|+||||
T Consensus        15 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~~~aHk~iLaa~S~~F~~~f~~~~~e~~~~i~l~~~~~~~~f~~ll~~~Yt   90 (127)
T 1r29_A           15 DVLLNLNRLRSRDILTDVVIVVSR----EQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYT   90 (127)
T ss_dssp             HHHHHHHHHHHTTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHTSTTTTTCSEEECCTTSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEEEEECC----EEEehHHHHHHHhCHHHHHHhcCCccCCCCEEEeCCCCCHHHHHHHHHHHcC
Confidence            356788889999999999999999    999999999999999999999999987 566799 89999999999999999


Q ss_pred             CceeeCccchhhhhhccccceeecc
Q psy6508         421 ARVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       421 g~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      |++.++.+++.+++.+|+++.+..+
T Consensus        91 g~~~~~~~~~~~ll~~A~~~~i~~L  115 (127)
T 1r29_A           91 SRLNLREGNIMAVMATAMYLQMEHV  115 (127)
T ss_dssp             SCCCCCTTTHHHHHHHHHHTTCHHH
T ss_pred             CCcCcCHHHHHHHHHHHHHhCCHHH
Confidence            9999999999999999999988664

>2yy9_A Zinc finger and BTB domain-containing protein 48; mouse, HKR3, structural genomics, NPPSFA; 2.60A {Mus musculus}

Probab=99.84  E-value=4.4e-22  Score=170.97  Aligned_cols=97  Identities=19%  Similarity=0.231  Sum_probs=87.5

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHAR  422 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~  422 (477)
                      .+.+.++.+++++.+|||+|.|++    +.|+|||.|||++|+||++||.+++  ...|.|+++++++|+.+|+|||||+
T Consensus        11 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~f~aHk~vLaa~S~yF~~mf~~~~--~~~i~l~~~~~~~f~~lL~fiYtg~   84 (135)
T 2yy9_A           11 RVLQELNKQREKGQYCDATLDVGG----LVFKAHWSVLACCSHFFQRIYGDGT--GGSVVLPAGFAEIFGLLLDFFYTGH   84 (135)
T ss_dssp             HHHHHHHHHHHTTTTCCEEEEETT----EEEEECHHHHHHHCHHHHHTCC------CCEEECGGGHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHhcCCCcceEEEECC----EEEehHHHHHHHhCHHHHHHHcCCC--CCeEEeCCCCHHHHHHHHHHHhCCC
Confidence            356788889999999999999999    9999999999999999999999887  6678999999999999999999999


Q ss_pred             eeeCccchhhhhhccccceeecc
Q psy6508         423 VNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 ~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      +.++.+++.+++.+||++.+..+
T Consensus        85 ~~i~~~~v~~ll~~A~~l~i~~L  107 (135)
T 2yy9_A           85 LALTSGNRDQVLLAAKELRVPEA  107 (135)
T ss_dssp             CCCCTTTHHHHHHHHHHTTCHHH
T ss_pred             CCCCHHHHHHHHHHHHHhCcHHH
Confidence            99999999999999998887664

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.84  E-value=8.9e-23  Score=208.60  Aligned_cols=171  Identities=16%  Similarity=0.153  Sum_probs=123.3

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCC-CCc---------------------cceEEEEEe-----CCeE
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHH-QHI---------------------VTMLDFLWD-----ERYV   53 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~H-pnI---------------------v~~~~~~~~-----~~~~   53 (477)
                      .+|+.||||+++.... .....+.+.+|+.+++.++| +|.                     ..+..++..     ...+
T Consensus       101 ~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (413)
T 3dzo_A          101 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR  180 (413)
T ss_dssp             TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSE
T ss_pred             CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccce
Confidence            4789999999874433 22345779999999999976 221                     111111111     2246


Q ss_pred             EEEEecCCCCCHHHHHHh-------CCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccce
Q psy6508          54 YIILEYCDGGDLCSFIRS-------HEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVS  126 (477)
Q Consensus        54 ~lv~e~~~g~sL~~~l~~-------~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~  126 (477)
                      +++|+++. ++|.++++.       .+.+++..+..++.|++.||.|||++||+||||||+|||++.+. .+.++|||++
T Consensus       181 ~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~-~~kL~DFG~a  258 (413)
T 3dzo_A          181 FFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRG-GVFLTGFEHL  258 (413)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCGGGC
T ss_pred             EEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCC-eEEEEeccce
Confidence            88888775 899999852       22477888999999999999999999999999999999998753 2445699997


Q ss_pred             ecccCCcccccCCeEEEeccccccccC----------CCC---CcccccCcceEEEEEE--eeecccccc
Q psy6508         127 EKAKGSAYIEQGNTKVICSVFEPREIP----------SSK---TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       127 ~~~~gs~~~~~g~t~v~~~~y~ppE~~----------~~~---~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      ......     ..+..+ +.|+|||.+          .+.   .++|+ ||+|+++||+  +..||....
T Consensus       259 ~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv-wSlGvil~elltg~~Pf~~~~  321 (413)
T 3dzo_A          259 VRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT-WTLGLAIYWIWCADLPNTDDA  321 (413)
T ss_dssp             EETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH-HHHHHHHHHHHHSSCCCCTTG
T ss_pred             eecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhH-HHHHHHHHHHHHCCCCCCCcc
Confidence            654322     233455 889999988          332   57899 9999999999  778997643

>2vkp_A BTB/POZ domain-containing protein 6; protein-binding; 1.9A {Homo sapiens}

Probab=99.84  E-value=7.5e-22  Score=163.08  Aligned_cols=95  Identities=26%  Similarity=0.427  Sum_probs=82.4

Q ss_pred             hhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCcccc-CCcccCCCCHHHHHHHhhhhhcCceeeCccc
Q psy6508         351 VLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEK-GDTKILDITPEAFSTMLDSDHHARVNISSDH  429 (477)
Q Consensus       351 ~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~-~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~~  429 (477)
                      +++++.+|||+|.|+++++.+.|+|||.|||++|+||++||.+++.|. ..+.++++++++|+.+|+|+|||++.++.++
T Consensus         2 l~~~~~~~Dv~l~v~~~~~~~~~~~Hk~iLa~~S~~F~~~f~~~~~e~~~~i~l~~~~~~~f~~~l~~iYt~~~~~~~~~   81 (109)
T 2vkp_A            2 MFNNELMADVHFVVGPPGATRTVPAHKYVLAVGSSVFYAMFYGDLAEVKSEIHIPDVEPAAFLILLKYMYSDEIDLEADT   81 (109)
T ss_dssp             CTTCCTTCCEEEEESSTTSCEEEEECHHHHHHHCHHHHHHHC------CCEEEETTSCHHHHHHHHHHHHHCCCCCCTTT
T ss_pred             cccCCCcccEEEEECCCCCcEEEEeeHHHHHHcCHHHHHHhcCCcccCCCeEEeCCCCHHHHHHHHHHHcCCCccCCHHH
Confidence            578999999999999855557899999999999999999999999884 5679999999999999999999999999999


Q ss_pred             hhhhhhccccceeecc
Q psy6508         430 HARVSISSDHHTRVSI  445 (477)
Q Consensus       430 ~~~~~~~a~~~~~~~~  445 (477)
                      +.+++.+||++.+..+
T Consensus        82 ~~~ll~~A~~~~~~~L   97 (109)
T 2vkp_A           82 VLATLYAAKKYIVPAL   97 (109)
T ss_dssp             HHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHhCcHHH
Confidence            9999999999887654

>2vpk_A Myoneurin; transcription regulation, transcription, metal-binding, alternative splicing, zinc, nucleus, BTB domain, zinc-finger, DNA-binding; 2.00A {Homo sapiens}

Probab=99.84  E-value=9.8e-22  Score=164.30  Aligned_cols=97  Identities=20%  Similarity=0.338  Sum_probs=89.0

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccC--CCCHHHHHHHhhhhhc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL--DITPEAFSTMLDSDHH  420 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~--~~~~~~~~~~l~~~Yt  420 (477)
                      .+.+.++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.++  ....+.|+  ++++++|+.+|+|+||
T Consensus         8 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~~~aHk~vLaa~S~yF~~~f~~~--~~~~i~l~~~~~~~~~f~~ll~~~Yt   81 (116)
T 2vpk_A            8 HLLERLNKQREAGFLCDCTIVIGE----FQFKAHRNVLASFSEYFGAIYRST--SENNVFLDQSQVKADGFQKLLEFIYT   81 (116)
T ss_dssp             HHHHHHHHHHHHTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHTTC--CCSCEECCTTTCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCcEEEEECC----EEEeccHHHHhhcCHHHHHHHcCC--CCCeEEeecCCCCHHHHHHHHHHHcC
Confidence            356788899999999999999999    999999999999999999999987  35566677  9999999999999999


Q ss_pred             CceeeCccchhhhhhccccceeecc
Q psy6508         421 ARVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       421 g~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      |++.++.+++.+++.+|+++.+..+
T Consensus        82 ~~~~~~~~~v~~ll~~A~~~~i~~L  106 (116)
T 2vpk_A           82 GTLNLDSWNVKEIHQAADYLKVEEV  106 (116)
T ss_dssp             SCCCCCTTTHHHHHHHHHHTTCHHH
T ss_pred             CCcccCHHHHHHHHHHHHHhCCHHH
Confidence            9999999999999999999988654

>2ppi_A Gigaxonin; BTB domain, protein degradation, structural genomics, struct genomics consortium, SGC, structural protein; 2.40A {Homo sapiens}

Probab=99.83  E-value=8.2e-22  Score=171.17  Aligned_cols=98  Identities=15%  Similarity=0.163  Sum_probs=87.4

Q ss_pred             cchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc----cCCcccCCCCHHHHHHHhhhhh
Q psy6508         344 LPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE----KGDTKILDITPEAFSTMLDSDH  419 (477)
Q Consensus       344 l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~----~~~~~~~~~~~~~~~~~l~~~Y  419 (477)
                      +.+.++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.+++.+    ...+.++++++++|+.+|+|+|
T Consensus        34 l~~~l~~l~~~~~~~Dv~l~v~~----~~f~aHk~vLaa~S~yF~~mf~~~~~e~e~~~~~I~l~~v~~~~f~~lL~fiY  109 (144)
T 2ppi_A           34 LLRALSSFREESRFCDAHLVLDG----EEIPVQKNILAAASPYIRTKLNYNPPKDDGSTYKIELEGISVMVMREILDYIF  109 (144)
T ss_dssp             HHHHHHHTTC--CCCCEEEEETT----EEEEECHHHHHHHCHHHHHHHHHCC-----CCCEEECCSSCHHHHHHHHHHHT
T ss_pred             HHHHHHHHHhcCCCcceEEEECC----EEEehHHHHHHHcCHHHHHHHcCCCccccCCCcEEEeCCCCHHHHHHHHHHHh
Confidence            56778889999999999999999    999999999999999999999998864    4457899999999999999999


Q ss_pred             cCceeeCccchhhhhhccccceeecc
Q psy6508         420 HARVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       420 tg~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      ||++.++.+++.+++.+||++.+..+
T Consensus       110 tg~~~i~~~~v~~ll~~A~~l~i~~L  135 (144)
T 2ppi_A          110 SGQIRLNEDTIQDVVQAADLLLLTDL  135 (144)
T ss_dssp             TSCCCCCTTTHHHHHHHHHHTTCHHH
T ss_pred             CCCCCCCHHHHHHHHHHHHHhCcHHH
Confidence            99999999999999999999988664

>1buo_A POZ domain, protein (promyelocytic leukemia zinc finger prote; protein-protein interaction domain, transcriptional represso finger protein; 1.90A {Homo sapiens} SCOP: d.42.1.1 PDB: 1cs3_A

Probab=99.83  E-value=1.6e-21  Score=164.33  Aligned_cols=96  Identities=18%  Similarity=0.299  Sum_probs=88.8

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHAR  422 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~  422 (477)
                      .+.+.++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.++   ...+.++++++++|+.+|+|+|||+
T Consensus        14 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~f~aHk~vLaa~S~yF~~~f~~~---~~~i~l~~~~~~~f~~ll~~~Ytg~   86 (121)
T 1buo_A           14 GLLCKANQMRLAGTLCDVVIMVDS----QEFHAHRTVLACTSKMFEILFHRN---SQHYTLDFLSPKTFQQILEYAYTAT   86 (121)
T ss_dssp             HHHHHHHHHHHHTTTCCEEEEESS----CEEEECHHHHHHHCHHHHHHTTSC---CSEEEECSSCHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHhcCCCCCEEEEECC----EEEehhHHHHhhcCHHHHHHHcCC---CcEEEeCCCCHHHHHHHHHhhcCCC
Confidence            356788889999999999999999    999999999999999999999875   5568899999999999999999999


Q ss_pred             eeeCccchhhhhhccccceeecc
Q psy6508         423 VNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 ~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      +.++.+++.+++.+||++.+..+
T Consensus        87 ~~~~~~~~~~ll~~A~~~~i~~L  109 (121)
T 1buo_A           87 LQAKAEDLDDLLYAAEILEIEYL  109 (121)
T ss_dssp             CCCCGGGHHHHHHHHHHHTCHHH
T ss_pred             cCCCHHHHHHHHHHHHHHCCHHH
Confidence            99999999999999999887654

>3fkc_A Transcriptional regulator kaiso; zinc finger and BTB domain containing 33, kaiso transcriptio ZNF-kaiso, ZNF348,wugsc:H_DJ525N14.1; 1.70A {Homo sapiens} PDB: 3m4t_A 3m8v_A

Probab=99.83  E-value=1.7e-21  Score=162.79  Aligned_cols=96  Identities=25%  Similarity=0.278  Sum_probs=88.8

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHAR  422 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~  422 (477)
                      ++.+.++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.++   ...+.++++++++|+.+|+|+|||+
T Consensus        17 ~l~~~l~~~~~~~~~~Dv~l~v~~----~~f~aHk~vLaa~S~~F~~~f~~~---~~~i~l~~~~~~~f~~~l~~~Ytg~   89 (116)
T 3fkc_A           17 SLLNSLNEQRGHGLFCDVTVIVED----RKFRAHKNILSASSTYFHQLFSVA---GQVVELSFIRAEIFAEILNYIYSSK   89 (116)
T ss_dssp             HHHHHHHHHHHHTTTCCEEEEETT----EEEEECHHHHHHHCHHHHHHTTSC---CSEEEECSSCHHHHHHHHHHHTTSC
T ss_pred             HHHHHHHHHHhcCCceeEEEEECC----EEEehhHHHHHHcCHHHHHHHcCC---CCEEEeCCCCHHHHHHHHHhhcCCC
Confidence            366778889999999999999999    999999999999999999999886   5568899999999999999999999


Q ss_pred             e-eeCccchhhhhhccccceeecc
Q psy6508         423 V-NISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 ~-~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      + .++.+++.+++.+||++.+..+
T Consensus        90 ~~~~~~~~~~~ll~~A~~l~i~~L  113 (116)
T 3fkc_A           90 IVRVRSDLLDELIKSGQLLGVKFI  113 (116)
T ss_dssp             CCSCCHHHHHHHHHHHHHHTCHHH
T ss_pred             cCCCCHHHHHHHHHHHHHhCcccc
Confidence            9 7999999999999999988654

>2q81_A MIZ-1 protein; BTB/POZ domain, transcription; HET: PG4; 2.10A {Homo sapiens} PDB: 3m52_A

Probab=99.83  E-value=1.5e-21  Score=163.96  Aligned_cols=96  Identities=23%  Similarity=0.296  Sum_probs=88.7

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHAR  422 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~  422 (477)
                      .+.++++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.++   ...+.++++++++|+.+|+|+|||+
T Consensus        13 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~~~aHk~vLaa~S~yF~~~f~~~---~~~i~l~~~~~~~f~~ll~~~Ytg~   85 (119)
T 2q81_A           13 HVLEQLNQQRQLGLLCDCTFVVDG----VHFKAHKAVLAACSEYFKMLFVDQ---KDVVHLDISNAAGLGQVLEFMYTAK   85 (119)
T ss_dssp             HHHHHHHHHHHHTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHHHC---CSGGGGGGCCHHHHHHHHHHHHHSC
T ss_pred             HHHHHHHHHHhcCCCcceEEEECC----EEEehhHHHHHHcCHHHHHHHcCC---CCEEEeCCCCHHHHHHHHHHHcCCC
Confidence            467888999999999999999999    999999999999999999999873   4567889999999999999999999


Q ss_pred             eeeCccchhhhhhccccceeecc
Q psy6508         423 VNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 ~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      +.++.+++.+++.+||++.+..+
T Consensus        86 ~~i~~~~~~~ll~~A~~l~i~~L  108 (119)
T 2q81_A           86 LSLSPENVDDVLAVATFLQMQDI  108 (119)
T ss_dssp             CCCCTTTHHHHHHHHHHTTCHHH
T ss_pred             CccCHHHHHHHHHHHHHhCCHHH
Confidence            99999999999999999988654

>3ga1_A Nucleus accumbens-associated protein 1; BTB/POZ domain, phosphoprotein, repressor, transcri transcription regulation; 2.10A {Homo sapiens}

Probab=99.83  E-value=2.4e-21  Score=165.08  Aligned_cols=96  Identities=20%  Similarity=0.309  Sum_probs=89.7

Q ss_pred             cchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccC-CCCHHHHHHHhhhhhcCc
Q psy6508         344 LPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKIL-DITPEAFSTMLDSDHHAR  422 (477)
Q Consensus       344 l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~-~~~~~~~~~~l~~~Ytg~  422 (477)
                      +.++++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.++  ....+.++ ++++++|+.+|+|||||+
T Consensus        20 l~~~l~~l~~~~~~~Dv~l~v~~----~~~~~Hk~vLaa~S~~F~~~f~~~--~~~~i~l~~~~~~~~f~~ll~~iYtg~   93 (129)
T 3ga1_A           20 ILECLNEQRLQGLYCDVSVVVKG----HAFKAHRAVLAASSSYFRDLFNNS--RSAVVELPAAVQPQSFQQILSFCYTGR   93 (129)
T ss_dssp             HHHHHHHHHHTTCSCCEEEEETT----EEEEECHHHHHHHBHHHHHHHHHC--CCSEEECCTTCCHHHHHHHHHHHHHSE
T ss_pred             HHHHHHHHHhcCCCcceEEEECC----EEEEehHHHHHHcCHHHHHHHcCC--CCCEEEECCCCCHHHHHHHHHHHhCCc
Confidence            66778889999999999999999    999999999999999999999887  56678996 999999999999999999


Q ss_pred             eeeCccchhhhhhccccceeecc
Q psy6508         423 VNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 ~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      +.++.+++.+++.+|+++.+..+
T Consensus        94 ~~i~~~~~~~ll~~A~~~~i~~l  116 (129)
T 3ga1_A           94 LSMNVGDQDLLMYTAGFLQIQEI  116 (129)
T ss_dssp             EECCTTTHHHHHHHHHHTTBTTS
T ss_pred             cccCHHHHHHHHHHHHHhCCHHH
Confidence            99999999999999999988765

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.80  E-value=4.2e-21  Score=202.45  Aligned_cols=142  Identities=18%  Similarity=0.114  Sum_probs=112.6

Q ss_pred             CCcEEEEEEcccCCCChh------HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSEN------RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~------~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .++.+++|+.........      ..+++.+|+.++++++||||+++..++..++..|+||||++|++|.+++..     
T Consensus       358 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----  432 (540)
T 3en9_A          358 LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----  432 (540)
T ss_dssp             SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----
T ss_pred             CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----
Confidence            577899998655443221      235689999999999999999665555577778999999999999999875     


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccc-----cCCeEEEeccccccc
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIE-----QGNTKVICSVFEPRE  151 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~-----~g~t~v~~~~y~ppE  151 (477)
                         +..++.|++.||+|||++||+||||||+|||++.   ++.++|||++..........     ...+..+|+.|+|||
T Consensus       433 ---~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~---~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APE  506 (540)
T 3en9_A          433 ---NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK---DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDE  506 (540)
T ss_dssp             ---CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS---SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHH
T ss_pred             ---HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC---eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHH
Confidence               5689999999999999999999999999999998   45556999997655432111     123557889999999


Q ss_pred             cCCC
Q psy6508         152 IPSS  155 (477)
Q Consensus       152 ~~~~  155 (477)
                      ++..
T Consensus       507 v~~~  510 (540)
T 3en9_A          507 IWER  510 (540)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9876

>4eoz_A Speckle-type POZ protein; E3 ubiquitin ligase, nucleus, protein binding; 2.40A {Homo sapiens}

Probab=99.79  E-value=1.9e-20  Score=162.79  Aligned_cols=100  Identities=27%  Similarity=0.393  Sum_probs=92.1

Q ss_pred             ccccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhh
Q psy6508         341 HVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTMLDSD  418 (477)
Q Consensus       341 ~~~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~  418 (477)
                      ..++.+.++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.+++.|  ...+.++++++++|+.+|+|+
T Consensus         9 ~~~l~~~l~~l~~~~~~~Dv~l~v~~----~~~~~Hk~iL~~~S~~F~~~f~~~~~e~~~~~i~l~~~~~~~~~~~l~~~   84 (145)
T 4eoz_A            9 ECRLADELGGLWENSRFTDCCLCVAG----QEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVEPEVFKEMMCFI   84 (145)
T ss_dssp             CCCHHHHHHHHHHHTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHHSSSHHHHHTEEEECSSCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhCCCCcceEEEECC----EEEEeehHHHHHcCHHHHHHHcCCCcCCCCceEEecCCCHHHHHHHHHhh
Confidence            34577888999999999999999999    999999999999999999999999887  467899999999999999999


Q ss_pred             hcCceeeCccchhhhhhccccceeec
Q psy6508         419 HHARVNISSDHHARVSISSDHHTRVS  444 (477)
Q Consensus       419 Ytg~~~~~~~~~~~~~~~a~~~~~~~  444 (477)
                      |||++.++.+++.+++.+||++.+..
T Consensus        85 Y~~~~~~~~~~~~~ll~~A~~~~~~~  110 (145)
T 4eoz_A           85 YTGKAPNLDKMADDLLAAADKYALER  110 (145)
T ss_dssp             HHSCCTTGGGTHHHHHHHHHHTTCHH
T ss_pred             ccCccCCcHHHHHHHHHHHHHhCHHH
Confidence            99999999999999999999766654

>3m5b_A Zinc finger and BTB domain-containing protein 32; POZ domain, BTB/POZ domain, ZBTB32, zinc finger domain-containing protein 32; 2.00A {Homo sapiens} SCOP: d.42.1.0

Probab=99.78  E-value=5.5e-20  Score=154.04  Aligned_cols=83  Identities=19%  Similarity=0.176  Sum_probs=76.8

Q ss_pred             hhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCceeeCccchh
Q psy6508         352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARVNISSDHHA  431 (477)
Q Consensus       352 ~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~~~~  431 (477)
                      +.+|.||||+|.|+|    +.|+|||.|||++|+||++       ....+.++++++++|+.+|+|+|||++.++.+++.
T Consensus        25 r~~~~~~Dv~l~v~~----~~f~aHk~vLaa~S~yF~~-------~~~~i~l~~v~~~~f~~ll~fiYtg~~~i~~~~v~   93 (119)
T 3m5b_A           25 RLRPALCDTLITVGS----QEFPAHSLVLAGVSQQLGR-------RGQWALGEGISPSTFAQLLNFVYGESVELQPGELR   93 (119)
T ss_dssp             HHTTTTCCEEEEETT----EEEEECHHHHHTTCGGGCC-------CEEEECCSSCCHHHHHHHHHHHTTCCEEECGGGHH
T ss_pred             HhcCCCcceEEEECC----EEEeeEHHHHHHcCHHHhc-------CCCEEEeCCCCHHHHHHHHHHHcCCCcCcCHHHHH
Confidence            567999999999999    9999999999999999986       24567899999999999999999999999999999


Q ss_pred             hhhhccccceeecc
Q psy6508         432 RVSISSDHHTRVSI  445 (477)
Q Consensus       432 ~~~~~a~~~~~~~~  445 (477)
                      +++.+||++.+..+
T Consensus        94 ~ll~aA~~l~i~~l  107 (119)
T 3m5b_A           94 PLQEAARALGVQSL  107 (119)
T ss_dssp             HHHHHHHHTTCHHH
T ss_pred             HHHHHHHHhCCHHH
Confidence            99999999988764

>3htm_A Speckle-type POZ protein; BTB, SPOP, ubiquitin, ligase, nucleus, UBL conjugation pathway, protein binding; 2.50A {Homo sapiens}

Probab=99.78  E-value=5.5e-20  Score=164.62  Aligned_cols=100  Identities=27%  Similarity=0.393  Sum_probs=92.2

Q ss_pred             ccccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhh
Q psy6508         341 HVTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTMLDSD  418 (477)
Q Consensus       341 ~~~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~  418 (477)
                      ..++.+.+..+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.+++.|  ...+.++++++++|+.+|+|+
T Consensus        18 ~~~l~~~l~~l~~~~~~~Dv~l~v~~----~~~~~Hk~iL~~~S~~F~~~f~~~~~e~~~~~i~l~~~~~~~f~~~l~~~   93 (172)
T 3htm_A           18 ECRLADELGGLWENSRFTDCCLCVAG----QEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVEPEVFKEMMCFI   93 (172)
T ss_dssp             CCCHHHHHHHHHHHTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHHSCCCGGGTTEEEECSSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcceEEEECC----EEEEeeHHHHHHcCHHHHHHHccCccccCCCeEEecCCCHHHHHHHHHHH
Confidence            34567888899999999999999999    999999999999999999999999988  366799999999999999999


Q ss_pred             hcCceeeCccchhhhhhccccceeec
Q psy6508         419 HHARVNISSDHHARVSISSDHHTRVS  444 (477)
Q Consensus       419 Ytg~~~~~~~~~~~~~~~a~~~~~~~  444 (477)
                      |||++.++.+++.+++.+||++.+..
T Consensus        94 Yt~~~~~~~~~~~~ll~~A~~~~~~~  119 (172)
T 3htm_A           94 YTGKAPNLDKMADDLLAAADKYALER  119 (172)
T ss_dssp             HHSCCTTGGGTHHHHHHHHHHTTCHH
T ss_pred             hCCCCCCcHHHHHHHHHHHHHhCcHH
Confidence            99999999999999999999877654

>3hve_A Gigaxonin; ubiquitin, cytoplasm, cytoskeleton, disease mutation, kelch repeat, neurodegeneration, phosphoprotein, polymorphism, UBL conjugation; 2.80A {Homo sapiens} PDB: 3hve_B

Probab=99.76  E-value=1.7e-19  Score=172.09  Aligned_cols=98  Identities=15%  Similarity=0.157  Sum_probs=81.8

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCcc--c--cCCcccCCCCHHHHHHHhhhh
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELC--E--KGDTKILDITPEAFSTMLDSD  418 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~--~--~~~~~~~~~~~~~~~~~l~~~  418 (477)
                      ++.++++.+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.+++.  |  ...+.++++++++|+.+|+|+
T Consensus        17 ~l~~~l~~l~~~~~~~Dv~l~v~~----~~f~~Hr~vLaa~S~yF~~mf~~~~~~~e~~~~~i~l~~v~~~~f~~ll~~~   92 (256)
T 3hve_A           17 RLLRALSSFREESRFCDAHLVLDG----EEIPVQKNILAAASPYIRTKLNYNPPKDDGSTYKIELEGISVMVMREILDYI   92 (256)
T ss_dssp             HHHHHHHTCCC--CCCCEEEEETT----EEEEECHHHHHTTCHHHHHTC-----------CEEECSSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCcceEEEECC----EEEechHHHHHHcCHHHHHHhCCCCCcccCCCCeEEeCCCCHHHHHHHHhhc
Confidence            366788889999999999999999    99999999999999999999999886  3  456799999999999999999


Q ss_pred             hcCceeeCccchhhhhhccccceeec
Q psy6508         419 HHARVNISSDHHARVSISSDHHTRVS  444 (477)
Q Consensus       419 Ytg~~~~~~~~~~~~~~~a~~~~~~~  444 (477)
                      |||++.++.+++.+++.+|+++.+..
T Consensus        93 Yt~~~~i~~~~v~~ll~~A~~l~i~~  118 (256)
T 3hve_A           93 FSGQIRLNEDTIQDVVQAADLLLLTD  118 (256)
T ss_dssp             HHSCCCCC-CCHHHHHHHHHHHTCHH
T ss_pred             cCCCCcccHhHHHHHHHHHHHHChHH
Confidence            99999999999999999999776654

>3i3n_A Kelch-like protein 11; structural genomics, BTB, KLHL11A, SGC, structural genomics consortium, kelch repeat, secreted, protein binding; 2.60A {Homo sapiens} PDB: 4ap2_A* 4apf_A

Probab=99.74  E-value=2.3e-19  Score=173.47  Aligned_cols=98  Identities=20%  Similarity=0.397  Sum_probs=84.9

Q ss_pred             ccchhhHHhhhcCcceeEEEEec---CccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccC------CCCHHHH
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVG---NDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKIL------DITPEAF  411 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~---~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~------~~~~~~~  411 (477)
                      .++++++.++++|.+|||+|.|+   |    +.|+|||.|||++|+||++||.+++.|  ...+.++      ++++++|
T Consensus        18 ~ll~~l~~l~~~~~~~Dv~l~v~~~~~----~~f~~Hr~vLaa~S~yF~~mf~~~~~e~~~~~i~l~~~~~~~~v~~~~f   93 (279)
T 3i3n_A           18 ELSWRQNEQRRQGLFCDITLCFGGAGG----REFRAHRSVLAAATEYFTPLLSGQFSESRSGRVEMRKWSSEPGPEPDTV   93 (279)
T ss_dssp             HHHHHHHHHHHHTTTCCEEEECC--------CEEEECHHHHHHHCTTSGGGCCC--------EEECCCCSSTTCSCHHHH
T ss_pred             HHHHHHHHHHhcCCCCCeEEEEcCCCC----eEEehHHHHHHHcCHHHHHHhcCCCccccCCeEEeccccccCCCCHHHH
Confidence            36678889999999999999998   6    899999999999999999999999988  4567887      8999999


Q ss_pred             HHHhhhhhcCceeeCccchhhhhhccccceeec
Q psy6508         412 STMLDSDHHARVNISSDHHARVSISSDHHTRVS  444 (477)
Q Consensus       412 ~~~l~~~Ytg~~~~~~~~~~~~~~~a~~~~~~~  444 (477)
                      +.+|+|+|||++.++.+++.+++.+|+++.+..
T Consensus        94 ~~ll~~~Ytg~~~i~~~~v~~ll~~A~~l~i~~  126 (279)
T 3i3n_A           94 EAVIEYMYTGRIRVSTGSVHEVLELADRFLLIR  126 (279)
T ss_dssp             HHHHHHHHHSEEEEETTTHHHHHHHHHHTTCHH
T ss_pred             HHHHHhhCcCCcccCHHHHHHHHHHHHHHCcHH
Confidence            999999999999999999999999999877654

>4aid_A Polyribonucleotide nucleotidyltransferase; transferase-peptide complex; 2.60A {Caulobacter vibrioides} PDB: 4aim_A 4am3_A

Probab=99.74  E-value=7.3e-17  Score=171.08  Aligned_cols=202  Identities=15%  Similarity=0.193  Sum_probs=163.5

Q ss_pred             ceeeccccc-ceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEE-------eeeccccccccCCCC
Q psy6508         116 LKLAGLKQG-VSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEF-------KFAPFASQIRTGWLR  187 (477)
Q Consensus       116 ~rl~~~dfG-~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~-------~~~Pf~~~~r~~~~~  187 (477)
                      -|.+.+..| +.++++||.+.+.|+|.+.|.+.++.+...+.   |+.|    +.+++       +..|-.. .++..++
T Consensus        27 ~R~i~ietg~~ak~A~GSvlv~~GdT~VL~tv~~~~~~~~g~---df~p----ltveY~ek~~a~G~iPg~~-~~REGrp   98 (726)
T 4aid_A           27 GKTLVLETGRIARQADGAVLATMGETVVLATAVFAKSQKPGQ---DFFP----LTVNYQEKTFAAGKIPGGF-FKREGRP   98 (726)
T ss_dssp             TEEEEEEESSSCTTSSEEEEEEETTEEEEEEEEECSSCCTTC---CSCC----EEEEEEECGGGGTCCCCST-TCSCCSC
T ss_pred             CeeEEEEECCccCCCCeeEEEEECCeEEEEEEEecCCCCCCC---CCcC----ceeeeeeehhhcccCCCcc-cCCCCCC
Confidence            466778999 55679999999999999999999988766554   4312    44444       2344322 2333567


Q ss_pred             CcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCch--HHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEE
Q psy6508         188 DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSA--LSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTF  265 (477)
Q Consensus       188 ~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~--~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~  265 (477)
                      ...+.+++++|.+.++|.+....  +..+.|.++||+.||+.  ..+|+|||++||.+++||+++.|+|++|++.+|.++
T Consensus        99 s~~~~li~RlIdR~lRplf~~~~--~~evqI~~~Vls~Dg~~~~d~~ai~gAs~AL~~s~iP~~~~vaaV~Vg~i~g~~v  176 (726)
T 4aid_A           99 SEKETLVSRLIDRPIRPLFVKGF--KNEVQVVVTVLQHDLENDPDILGMVAASAALCLSGAPFMGPIGAARVGWVDGAYV  176 (726)
T ss_dssp             CHHHHHHHHHHHHHHGGGBCTTC--CSCEEEEEEEEECCSSSCHHHHHHHHHHHHHHHHTCSBCCCCEEEEEEEETTEEE
T ss_pred             CchhhhHHHHhCCccccccccCC--ccceEEEEEEEecCCCCChhHHHHHHHHHHHHhcCCCcCCCeEEEEEEEECCEEE
Confidence            77788999999999999875443  45688889999999976  588999999999999999999999999999999999


Q ss_pred             eCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe-eecHHHHHHHHHHHHhcccchhhHHHHhHhhh
Q psy6508         266 IDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG-TIQQERLADHIEQLIGCCESLCTDRVQKLVSD  340 (477)
Q Consensus       266 ~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g-~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~  340 (477)
                      +||+.+|.+          .+...++++...  +.|+.++..| .|+.+++.++|+.|.++++.+... +++.+..
T Consensus       177 ldPt~~E~~----------~s~~dl~va~t~--~~i~mve~~~~~~se~~~~~al~~a~~~i~~l~~~-q~~~~~~  239 (726)
T 4aid_A          177 LNPTLDEMK----------ESKMDLVVAGTA--DAVMMVESEIQELSEEIVLGGVNFAHQQMQAVIDA-IIDLAEH  239 (726)
T ss_dssp             ESCCHHHHH----------TCSEEEEEEECS--SCEEEEEEEESSBCHHHHHHHHHHHHHHTHHHHHH-HHHHHHH
T ss_pred             ECCCHHHHh----------hCceeEEEEEeC--CeEEEEEccCCCCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHH
Confidence            999999998          357788888433  3489999886 599999999999999999999988 7776654

>3gme_A Polyribonucleotide nucleotidyltransferase; protein-RNA complex, cytoplasm, nucleotidyltransferase, RNA- binding, transferase, hydrolase; 2.40A {Escherichia coli E24377A} PDB: 3gll_A 3gcm_A 3h1c_A 3cdj_A

Probab=99.74  E-value=7.1e-17  Score=166.13  Aligned_cols=202  Identities=13%  Similarity=0.166  Sum_probs=160.6

Q ss_pred             eeeccccc-ceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEE-------eeeccccccccCCCCC
Q psy6508         117 KLAGLKQG-VSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEF-------KFAPFASQIRTGWLRD  188 (477)
Q Consensus       117 rl~~~dfG-~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~-------~~~Pf~~~~r~~~~~~  188 (477)
                      |.+.+..| +.++++||.+.+.|+|.+.|.+.++.+...+.   |  |--  +.+++       |..|-. ..++...+.
T Consensus        14 R~i~ietg~~ak~A~GSvlv~~GdT~Vl~tv~~~~~~~~g~---d--f~P--ltv~Y~e~~~a~G~iPg~-~~~REGrps   85 (549)
T 3gme_A           14 HTVTLETGMMARQATAAVMVSMDDTAVFVTVVGQKKAKPGQ---D--FFP--LTVNYQERTYAAGRIPGS-FFRREGRPS   85 (549)
T ss_dssp             EEEEEEESSSCTTSSEEEEEEETTEEEEEEEEECSSCCTTC---C--SCC--EEEEEEECGGGTTCCCSC-C-----CCC
T ss_pred             EEEEEEECCccCCCCeEEEEEECCEEEEEEEEecCCCCCCC---C--Ccc--ceeeeeeehhhcccCCCc-CcCcCCCCC
Confidence            66678899 45679999999999999999999988765554   4  332  33443       233322 122335667


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchH--HHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEe
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSAL--SAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFI  266 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~--~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~  266 (477)
                      ..+.+++++|.+.++|.+....  +..++|.++||+.||+..  .+|+|||++||.+++||+.+.|+|++|++.+|.+++
T Consensus        86 ~~~~l~~RlIdR~lRplfp~~~--~~evqI~~~Vls~D~~~~pd~~ai~gAs~AL~~s~iP~~gpvaaV~Vg~i~g~~vl  163 (549)
T 3gme_A           86 EGETLIARLIDRPIRPLFPEGF--VNEVQVIATVVSVNPQVNPDIVAMIGASAALSLSGIPFNGPIGAARVGYINDQYVL  163 (549)
T ss_dssp             HHHHHHHHHHHHHHGGGSCTTC--CSCEEEEEEEEECCSSSCHHHHHHHHHHHHHHHHCSCCCCCCEEEEEEEETTEEEE
T ss_pred             hhhhHHHHHhCCccccccccCC--cccEEEEEEEEecCCCCcHHHHHHHHHHHHHhccCCCcCCCeeEEEEEEECCEEEE
Confidence            7788999999999998764433  345888899999999774  889999999999999999999999999999999999


Q ss_pred             CCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe-eecHHHHHHHHHHHHhcccchhhHHHHhHhhhc
Q psy6508         267 DPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG-TIQQERLADHIEQLIGCCESLCTDRVQKLVSDH  341 (477)
Q Consensus       267 Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g-~~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~  341 (477)
                      ||+.+|.+          .+...++++..  .+.|+.++..| .|+.+++.++|+.|.++++.+... +++.+...
T Consensus       164 nPt~~e~~----------~s~~dl~va~t--~~~i~mve~e~~~~se~~~~~al~~a~~~i~~l~~~-q~~~~~~~  226 (549)
T 3gme_A          164 NPTQDELK----------ESKLDLVVAGT--EAAVLMVESEAELLSEDQMLGAVVFGHEQQQVVIQN-INELVKEA  226 (549)
T ss_dssp             SCCTTTTT----------TCSBCEEEEEC--SSCEEEEEEEEEEECHHHHHHHHHHHHHHTHHHHHH-HHHHHHHH
T ss_pred             CCCHHHHh----------hCceEEEEEec--CCeEEEEEccCCCCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHh
Confidence            99999988          45778888843  33589999886 699999999999999999999999 87777543

>1e3p_A Guanosine pentaphosphate synthetase; polyribonucleotide transferase, ATP-GTP diphosphotransferase RNA processing, RNA degradation; 2.5A {Streptomyces antibioticus} SCOP: a.4.9.1 b.40.4.5 d.14.1.4 d.14.1.4 d.52.3.1 d.101.1.1 d.101.1.1 PDB: 1e3h_A

Probab=99.73  E-value=7.6e-17  Score=172.42  Aligned_cols=204  Identities=15%  Similarity=0.135  Sum_probs=163.9

Q ss_pred             ceeecccccc-eecccCCccccc-CCeEEEeccccccccCCCCCcccccCcceEEEEEE-------eeeccccccccCCC
Q psy6508         116 LKLAGLKQGV-SEKAKGSAYIEQ-GNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEF-------KFAPFASQIRTGWL  186 (477)
Q Consensus       116 ~rl~~~dfG~-~~~~~gs~~~~~-g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~-------~~~Pf~~~~r~~~~  186 (477)
                      -|.+.+..|. +++++||.+.+. |+|.+.|.++++.+...+.   |+ .-   +.+++       +..|=... ++...
T Consensus        36 ~r~i~~etg~la~qA~GSv~v~~~G~T~Vl~tv~~~~~~~~~~---df-~p---Ltv~y~ek~~a~g~iPg~f~-~REGr  107 (757)
T 1e3p_A           36 TRTIRFETGRLARQAAGSAVAYLDDDTMVLSATTASKNPKDQL---DF-FP---LTVDVEERMYAAGKIPGSFF-RREGR  107 (757)
T ss_dssp             EEEEEEEESSSCTTSSEEEEEEETTTEEEEEEEEEEEEECTTC---SS-CC---EEEEEEECGGGGTCCCCSTT-SSCCS
T ss_pred             CEeEEEEECccccCCCeEEEEEECCCeEEEEEEEecCCCCCCC---CC-cc---EEEEEEecccccccCCCccc-ccCcC
Confidence            3677789996 678999999999 9999999999998875543   43 22   55555       23343322 33345


Q ss_pred             CCcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCch--HHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeE
Q psy6508         187 RDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSA--LSAAINCANLALVDAAIPMYDLVTSSTLALRGGLT  264 (477)
Q Consensus       187 ~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~--~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~  264 (477)
                      +...+.+.+++|.+.|+|.+...  -+..+.|.++||+.||+.  ..+|+|||++||.++||||++.|+|++|++.+|.+
T Consensus       108 ps~~e~l~~RlIdR~LRplfp~~--~~~evqv~~~Vls~D~~~~~~~~ai~gAs~AL~~s~iP~~~~vaav~vg~~~g~~  185 (757)
T 1e3p_A          108 PSEDAILTCRLIDRPLRPSFKKG--LRNEIQVVATIMALNPDHLYDVVAINAASASTQLAGLPFSGPIGGVRVALIRGQW  185 (757)
T ss_dssp             CCHHHHHHHHHHHHHHGGGBCTT--BCEEEEEEEEEEECCTTSCCHHHHHHHHHHHHHHTTSSBCCCCEEEEEEEETTEE
T ss_pred             CChHHHHHHHHHCCcchhccccC--CCCceEEEEEEEEECCCCCHHHHHHHHHHHHHhccCCCCCCceEEEEEEEECCEE
Confidence            66678999999999999965322  245699999999999977  99999999999999999999999999999999999


Q ss_pred             EeCCChHHHhhhccCCCCCCCCCceEEEEEccC---CCcEEEEEE-------------EeeecHHHHHHHHHHHHhcccc
Q psy6508         265 FIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSV---IQQVTQVTL-------------VGTIQQERLADHIEQLIGCCES  328 (477)
Q Consensus       265 ~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~---~~~i~~~~~-------------~g~~~~~~~~~~l~~~~~~~~~  328 (477)
                      ++||+..|.+.          +...++++....   .+.|..++.             .+.++.+++.++|+.|.++++.
T Consensus       186 vlnPt~~e~~~----------s~~dl~va~t~~~~~~~~i~mvE~q~t~~~~~~~~~~~~~~se~~l~~al~~a~~~i~~  255 (757)
T 1e3p_A          186 VAFPTHTELED----------AVFDMVVAGRVLEDGDVAIMMVEAEATEKTIQLVKDGAEAPTEEVVAAGLDAAKPFIKV  255 (757)
T ss_dssp             EESCCHHHHTT----------EEEEEEEEEEECTTSCEEEEEEEEEECSSHHHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             EECCCHHHHhc----------CceeEEEEeccccCCCCcEEEEEEecccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence            99999999883          467788875421   456788887             4679999999999999999999


Q ss_pred             hhhHHHHhHhhh
Q psy6508         329 LCTDRVQKLVSD  340 (477)
Q Consensus       329 i~~~~i~~~l~~  340 (477)
                      +... +++.+..
T Consensus       256 l~~~-q~~~~~~  266 (757)
T 1e3p_A          256 LCKA-QADLAAK  266 (757)
T ss_dssp             HHHH-HHHHHHH
T ss_pred             HHHH-HHHHHHh
Confidence            9999 7776643

>3hqi_A Speckle-type POZ protein; SPOP, ubiquitin, puckered, nucleus, UBL conjugation pathway, protein binding, ligase; 2.62A {Homo sapiens} PDB: 3hu6_A

Probab=99.70  E-value=3.3e-18  Score=168.05  Aligned_cols=99  Identities=27%  Similarity=0.396  Sum_probs=87.2

Q ss_pred             cccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhhh
Q psy6508         342 VTLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTMLDSDH  419 (477)
Q Consensus       342 ~~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~Y  419 (477)
                      .++.+.+..+++++.+|||+|.|+|    +.|+|||.|||++|+||++||.+++.|  ...+.|+++++++|+.+|+|+|
T Consensus       159 ~~l~~~l~~l~~~~~~~Dv~l~v~~----~~f~~Hk~vLaa~S~~F~~~f~~~~~e~~~~~i~l~~~~~~~f~~~L~~iY  234 (312)
T 3hqi_A          159 CRLADELGGLWENSRFTDCCLCVAG----QEFQAHKAILAARSPVFSAMFEHEMEESKKNRVEINDVEPEVFKEMMCFIY  234 (312)
T ss_dssp             CCHHHHHHHHHHTTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHTTC-----CCSEEEECSSCHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHhCCCCCceEEEECC----EEEeHHHHHHHHcCHHHHHHhccCccccCCceEEecCCCHHHHHHHHHhhc
Confidence            3456778889999999999999999    999999999999999999999999988  4567999999999999999999


Q ss_pred             cCceeeCccchhhhhhccccceeec
Q psy6508         420 HARVNISSDHHARVSISSDHHTRVS  444 (477)
Q Consensus       420 tg~~~~~~~~~~~~~~~a~~~~~~~  444 (477)
                      ||++.++.+++.+++.+||++.+..
T Consensus       235 t~~~~~~~~~~~~ll~~A~~~~~~~  259 (312)
T 3hqi_A          235 TGKAPNLDKMADDLLAAADKYALER  259 (312)
T ss_dssp             HSCCTTHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCCCChHHHHHHHHHHHHHhCHHH
Confidence            9999999999999999999776654

>3cdi_A Polynucleotide phosphorylase; mRNA turnover, RNAse, RNA degradation, kinase, transferase; 2.60A {Escherichia coli} PDB: 1sro_A

Probab=99.67  E-value=1.4e-15  Score=162.25  Aligned_cols=202  Identities=13%  Similarity=0.187  Sum_probs=159.3

Q ss_pred             eeecccccc-eecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEe-------eeccccccccCCCCC
Q psy6508         117 KLAGLKQGV-SEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFK-------FAPFASQIRTGWLRD  188 (477)
Q Consensus       117 rl~~~dfG~-~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~-------~~Pf~~~~r~~~~~~  188 (477)
                      |.+.+..|. +++++||+.+..|+|.+.|.+.++.+...+.   |+ .-   +.+++.       ..|-. ..++..++.
T Consensus        20 r~i~ietg~ia~qA~GSv~v~~G~T~Vl~tv~~~~~~~~~~---~f-~p---ltv~y~ek~~a~g~ipg~-f~kReGrps   91 (723)
T 3cdi_A           20 HTVTLETGMMARQATAAVMVSMDDTAVFVTVVGQKKAKPGQ---DF-FP---LTVNYQERTYAAGRIPGS-FFRREGRPS   91 (723)
T ss_dssp             EEEEEEESSSCTTSSEEEEEEETTEEEEEEEEECSSCCSSC---CS-CC---EEEEEEECGGGGTCCCC--------CCC
T ss_pred             EEEEEEeCccccCCCeeEEEEECCEEEEEEEEecCCCCCCC---Ce-ee---EEEEEeEeccccccCCCc-cccCCCCCC
Confidence            566678995 5789999999999999999999887754443   43 22   233332       11211 112345677


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCch--HHHHHHHHHHHHhhCCCCCCceEEEEEEEeeCCeEEe
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSA--LSAAINCANLALVDAAIPMYDLVTSSTLALRGGLTFI  266 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~--~~a~inaa~lAL~dagi~m~~~v~a~s~~~~~~~~~~  266 (477)
                      ..+..++++|.+.++|.+...  -++.+.|.++||+.||+.  ..+|+|||++||..++||+.+.++|+++++.+|.+++
T Consensus        92 e~e~l~sRlIdR~lRplfp~~--~~~~vqv~~~vls~Dg~~~~d~~ai~aAsaAL~~s~iP~~~pv~av~vg~i~g~~v~  169 (723)
T 3cdi_A           92 EGETLIARLIDRPIRPLFPEG--FVNEVQVIATVVSVNPQVNPDIVAMIGASAALSLSGIPFNGPIGAARVGYINDQYVL  169 (723)
T ss_dssp             HHHHHHHHHHHHHHGGGSCTT--CCSCEEEEEEEEECCTTSCHHHHHHHHHHHHHHHHTSSCCCCCCCEEEEEETTEEEE
T ss_pred             hHHhHHHHHhCccchhccccc--CcceEEEEEEEEEcCCCCCHHHHHHHHHHHHHHhcCCCCCCCeEEEEEEEECCEEEE
Confidence            888999999999999976432  257799999999999986  7799999999999999999999999999999999999


Q ss_pred             CCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee-ecHHHHHHHHHHHHhcccchhhHHHHhHhhhc
Q psy6508         267 DPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT-IQQERLADHIEQLIGCCESLCTDRVQKLVSDH  341 (477)
Q Consensus       267 Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~-~~~~~~~~~l~~~~~~~~~i~~~~i~~~l~~~  341 (477)
                      |||.+|++.          +...++++  .+.+.++.++..|. ++.+++.++++.|.++++.+... +++.+...
T Consensus       170 nPt~~e~~~----------s~~~lvva--gt~~~i~mve~~~~~~se~~~~~al~~a~~~~~~l~~~-~~~~~~~~  232 (723)
T 3cdi_A          170 NPTQDELKE----------SKLDLVVA--GTEAAVLMVESEAQLLSEDQMLGAVVFGHEQQQVVIQN-INELVKEA  232 (723)
T ss_dssp             SCCTTGGGG----------CSEEEEEE--ECSSCEEEEEEEEEEECHHHHHHHHHHHHHHTHHHHHH-HHHHHHHT
T ss_pred             CcCHHHHHh----------CCceEEEE--ccCCEEEEEeCCCCCCCHHHHHHHHHHHHHHHHHHHHH-HHHHHHHh
Confidence            999999884          36777777  33455888888765 99999999999999999999999 77776543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.64  E-value=2e-16  Score=152.98  Aligned_cols=113  Identities=18%  Similarity=0.163  Sum_probs=86.5

Q ss_pred             CCCcEEEEEEcccCCCCh----------------hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSE----------------NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL   65 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----------------~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL   65 (477)
                      .+|+.||||+++....+.                .....+.+|+.++++++  | +++++++.. +..|+||||++|++|
T Consensus       112 ~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L  187 (282)
T 1zar_A          112 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKEL  187 (282)
T ss_dssp             TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEG
T ss_pred             CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcH
Confidence            468899999987543211                13467899999999999  4 555555433 456999999999999


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeeccccccee
Q psy6508          66 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus        66 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      .+ +..      .....++.|++.||.|||++||+||||||+|||++++  ++.++|||.+.
T Consensus       188 ~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~~~--~vkl~DFG~a~  240 (282)
T 1zar_A          188 YR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE--GIWIIDFPQSV  240 (282)
T ss_dssp             GG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT--EEEECCCTTCE
T ss_pred             HH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEECC--cEEEEECCCCe
Confidence            98 422      2345799999999999999999999999999999933  45556999874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.52  E-value=8.6e-15  Score=139.60  Aligned_cols=118  Identities=18%  Similarity=0.196  Sum_probs=86.9

Q ss_pred             CCCcE--EEEEEcccCCCCh----------------------hHHHHHHHHHHHHHhcCCCCc--cceEEEEEeCCeEEE
Q psy6508           2 EQHTE--VAIKCIDKTKVSE----------------------NRFDSIVNEIKALKLLHHQHI--VTMLDFLWDERYVYI   55 (477)
Q Consensus         2 ~~g~~--vAiK~i~~~~~~~----------------------~~~~~~~~E~~il~~l~HpnI--v~~~~~~~~~~~~~l   55 (477)
                      .+|+.  ||||+++......                      .....+.+|+.+|++++|+++  +++++.    +..+|
T Consensus        70 ~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~l  145 (258)
T 1zth_A           70 FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVL  145 (258)
T ss_dssp             ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEE
T ss_pred             CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEE
Confidence            36778  9999876542110                      112368899999999988754  455543    24689


Q ss_pred             EEecCCC-C----CHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHH-hCCcEEccCCCCceeeccCcceeecccccceecc
Q psy6508          56 ILEYCDG-G----DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLR-ENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKA  129 (477)
Q Consensus        56 v~e~~~g-~----sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH-~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~  129 (477)
                      ||||+.+ |    +|.++...   .++..+..++.|++.||.||| ++||+||||||+|||++.   ++.++|||.+...
T Consensus       146 VmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          146 LMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             EEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            9999942 3    77776432   235567899999999999999 999999999999999988   4555699988543

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.35  E-value=9.4e-13  Score=131.50  Aligned_cols=118  Identities=14%  Similarity=0.142  Sum_probs=81.2

Q ss_pred             CCCCcEEEEEEcccCCCC------------hhHHH--------HHHHHHHHHHhcCCCCcc--ceEEEEEeCCeEEEEEe
Q psy6508           1 NEQHTEVAIKCIDKTKVS------------ENRFD--------SIVNEIKALKLLHHQHIV--TMLDFLWDERYVYIILE   58 (477)
Q Consensus         1 ~~~g~~vAiK~i~~~~~~------------~~~~~--------~~~~E~~il~~l~HpnIv--~~~~~~~~~~~~~lv~e   58 (477)
                      +++|+.||||+++....+            .....        ...+|...|.++.++++.  +.++.  ..  .+||||
T Consensus       116 d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~--~~--~~LVME  191 (397)
T 4gyi_A          116 DEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQ--SR--HTIVMS  191 (397)
T ss_dssp             CTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEE--ET--TEEEEE
T ss_pred             CCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeec--cC--ceEEEE
Confidence            357999999987643211            00001        134677788888554443  33322  22  379999


Q ss_pred             cCCCCCHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc---------ceeecccccceec
Q psy6508          59 YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT---------LKLAGLKQGVSEK  128 (477)
Q Consensus        59 ~~~g~sL~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~---------~rl~~~dfG~~~~  128 (477)
                      |++|++|.++..    .  .....++.|++.+|.+||++|||||||||.|||+++++         .++..+||+-+..
T Consensus       192 ~i~G~~L~~l~~----~--~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          192 LVDALPMRQVSS----V--PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             CCSCEEGGGCCC----C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             ecCCccHhhhcc----c--HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            999988876432    1  23467889999999999999999999999999997543         2466779986644

>4ajy_C Transcription elongation factor B polypeptide 1; E3 ubiquitin ligase, transcription factor, hypoxic signaling transcription; 1.73A {Homo sapiens} PDB: 2izv_C 3dcg_B 3zrc_B* 3zrf_B 3ztc_B* 3ztd_B* 3zun_B* 2c9w_C 4awj_B* 4b95_B* 4b9k_B* 2fnj_C 1lqb_B 1lm8_C 2jz3_C 2xai_B 4b9k_E*

Probab=99.20  E-value=1.1e-11  Score=99.20  Aligned_cols=78  Identities=13%  Similarity=0.252  Sum_probs=64.5

Q ss_pred             EEEEecCccceeeEeeeehhhhcccHHHHHhcCC--Cccc--cCCcccCCCCHHHHHHHhhhhh-----c---Ccee---
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHG--ELCE--KGDTKILDITPEAFSTMLDSDH-----H---ARVN---  424 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~--~~~~--~~~~~~~~~~~~~~~~~l~~~Y-----t---g~~~---  424 (477)
                      |++.-.+|   ++|++||.| |++|+||++||.+  ++.|  ...|.|+++++.+++.+++|+|     +   +.+.   
T Consensus         4 v~L~SsDg---~~F~v~r~v-A~~S~~ik~m~~~~~~~~E~~~~~I~l~~V~~~iL~kViey~~~h~~~~~~~~~i~~~~   79 (97)
T 4ajy_C            4 VKLISSDG---HEFIVKREH-ALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFP   79 (97)
T ss_dssp             EEEECTTC---CEEEEEHHH-HTTSHHHHHHHCCC--------CEEECTTSCHHHHHHHHHHHHHHHHHTTCCSCCCCCC
T ss_pred             EEEEecCC---cEEEecHHH-HHHhHHHHHHHHhCCCccccCCCceECCCCCHHHHHHHHHHHHHhcccCCCcCCCCcCc
Confidence            55665443   899999999 9999999999987  5555  5568999999999999999999     5   7787   


Q ss_pred             eCccchhhhhhccccce
Q psy6508         425 ISSDHHARVSISSDHHT  441 (477)
Q Consensus       425 ~~~~~~~~~~~~a~~~~  441 (477)
                      ++.+++.+|+.|||++.
T Consensus        80 i~~~~l~eLl~AAnyL~   96 (97)
T 4ajy_C           80 IAPEIALELLMAANFLD   96 (97)
T ss_dssp             CCGGGHHHHHHHHHHHT
T ss_pred             CCHHHHHHHHHHHhhhC
Confidence            99999999999999864

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.94  E-value=2e-09  Score=102.04  Aligned_cols=116  Identities=15%  Similarity=0.199  Sum_probs=89.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .++.+++|..+......  ...+.+|+.+++.+. +..++++++++...+..|+|||+++|.+|.+.+.     +.....
T Consensus        36 ~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~  108 (263)
T 3tm0_A           36 ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPE  108 (263)
T ss_dssp             SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHH
T ss_pred             CCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHH
Confidence            36789999986532111  234789999999994 7789999999999999999999999999987631     122334


Q ss_pred             HHHHHHHHHHHHHHh-----------------------------------------------------------CCcEEc
Q psy6508          82 QFVRQLVLALKFLRE-----------------------------------------------------------NNVCHF  102 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~-----------------------------------------------------------~givHr  102 (477)
                      .++.++..+|..||+                                                           .+++|+
T Consensus       109 ~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~Hg  188 (263)
T 3tm0_A          109 KIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHG  188 (263)
T ss_dssp             HHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECS
T ss_pred             HHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECC
Confidence            678899999999998                                                           458999


Q ss_pred             cCCCCceeeccCcceeecccccce
Q psy6508         103 DLKPQNILIKNNTLKLAGLKQGVS  126 (477)
Q Consensus       103 Dlkp~NIll~~~~~rl~~~dfG~~  126 (477)
                      |++|.||++++++.. ..+||+.+
T Consensus       189 Dl~~~Nil~~~~~~~-~lIDwe~a  211 (263)
T 3tm0_A          189 DLGDSNIFVKDGKVS-GFIDLGRS  211 (263)
T ss_dssp             SCCTTSEEEETTEEE-EECCCTTC
T ss_pred             CCCcCcEEEECCcEE-EEEEchhc
Confidence            999999999875432 24688765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.73  E-value=2.2e-08  Score=94.31  Aligned_cols=111  Identities=19%  Similarity=0.203  Sum_probs=81.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCC--ccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQH--IVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn--Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      +|+.+++|+.....     ...+.+|+.+++.+.+.+  +++++.+...++..|+||||++|.+|.  ..   ..+.   
T Consensus        43 ~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~~---  109 (264)
T 1nd4_A           43 GRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLAP---  109 (264)
T ss_dssp             TSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCCH---
T ss_pred             CCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCCH---
Confidence            46779999875431     134678999999995433  677999888888899999999998884  21   1222   


Q ss_pred             HHHHHHHHHHHHHHHhCC----------------------------------------------------------cEEc
Q psy6508          81 QQFVRQLVLALKFLRENN----------------------------------------------------------VCHF  102 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~g----------------------------------------------------------ivHr  102 (477)
                      ..++.+++..|..||+..                                                          ++|+
T Consensus       110 ~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~Hg  189 (264)
T 1nd4_A          110 AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHG  189 (264)
T ss_dssp             HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECS
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECC
Confidence            256677777788887643                                                          9999


Q ss_pred             cCCCCceeeccCcceeeccccccee
Q psy6508         103 DLKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus       103 Dlkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      |++|.||+++++.+. ..+||+.+.
T Consensus       190 Dl~~~Nil~~~~~~~-~liD~~~a~  213 (264)
T 1nd4_A          190 DACLPNIMVENGRFS-GFIDCGRLG  213 (264)
T ss_dssp             SCCGGGEEEETTEEE-EECCCTTCE
T ss_pred             CCCCCcEEEECCcEE-EEEcchhcc
Confidence            999999999876432 256888753

>1fs1_B SKP1, cyclin A/CDK2-associated P45; F-BOX, LRR, leucine-rich repeat, SCF, ubiquitin, ubiquitin protein ligase; 1.80A {Homo sapiens} SCOP: a.157.1.1 d.42.1.1 PDB: 1fs2_B 1ldk_D

Probab=98.69  E-value=5.6e-09  Score=89.36  Aligned_cols=80  Identities=9%  Similarity=0.128  Sum_probs=69.7

Q ss_pred             EEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCc-----------------
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHAR-----------------  422 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~-----------------  422 (477)
                      |+|...+|   ++|.+||.+ |.+|++|++||.+..  .+.|.++++++.+++.+++|+|+.+                 
T Consensus         4 v~L~SsDg---~~f~v~~~v-A~~S~~ik~ml~~~~--~~~Ipl~~V~~~iL~kVieyc~~h~~~~~~~~~~~~~~~~~~   77 (141)
T 1fs1_B            4 IKLQSSDG---EIFEVDVEI-AKQSVTIKTMLEDLG--MDPVPLPNVNAAILKKVIQWCTHHKDDPPPPEDDENKEKRTD   77 (141)
T ss_dssp             EEEECTTS---CEEEEEGGG-GGTCHHHHHHHHHTC--CSSEECTTCCHHHHHHHHHHHHHHTTCC--------------
T ss_pred             EEEEeCCC---CEEEecHHH-HHHhHHHHHHHHhcC--CCceecCCcCHHHHHHHHHHHHHhccCCCccccccccccchh
Confidence            66777443   999999998 999999999997642  5578999999999999999999977                 


Q ss_pred             ---------eeeCccchhhhhhccccceeecc
Q psy6508         423 ---------VNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 ---------~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                               ++++.+.+.+++.||+|+.|.++
T Consensus        78 ~i~~wD~~F~~vd~~~l~eLi~AAnyL~I~~L  109 (141)
T 1fs1_B           78 DIPVWDQEFLKVDQGTLFELILAANYLDIKGL  109 (141)
T ss_dssp             ---HHHHHHTCSCHHHHHHHHHHHHHHTCHHH
T ss_pred             hhhHHHHHHHhCCHHHHHHHHHHHHHHhhhHH
Confidence                     77889999999999999988764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.63  E-value=7.3e-08  Score=95.79  Aligned_cols=121  Identities=16%  Similarity=0.216  Sum_probs=88.5

Q ss_pred             CcEEEEEEcc--cCCCChhHHHHHHHHHHHHHhcC--CCCccceEEEEEeC---CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           4 HTEVAIKCID--KTKVSENRFDSIVNEIKALKLLH--HQHIVTMLDFLWDE---RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         4 g~~vAiK~i~--~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~---~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      +..+++|+..  ..... .....+.+|+.+++.|.  +..+++++.++.+.   +..|+||||++|.++.+..  ...++
T Consensus        61 ~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~--~~~l~  137 (359)
T 3dxp_A           61 GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQS--LPGMS  137 (359)
T ss_dssp             SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTT--CTTCC
T ss_pred             CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCc--cccCC
Confidence            4678888765  32211 12346789999999996  45688999988766   4589999999988875421  13477


Q ss_pred             HHHHHHHHHHHHHHHHHHHh----------------------------------------------------------CC
Q psy6508          77 EFQCQQFVRQLVLALKFLRE----------------------------------------------------------NN   98 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~----------------------------------------------------------~g   98 (477)
                      ......++.+++..|..||+                                                          .+
T Consensus       138 ~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  217 (359)
T 3dxp_A          138 PAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTS  217 (359)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCE
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCce
Confidence            88888999999999999997                                                          36


Q ss_pred             cEEccCCCCceeeccCccee-eccccccee
Q psy6508          99 VCHFDLKPQNILIKNNTLKL-AGLKQGVSE  127 (477)
Q Consensus        99 ivHrDlkp~NIll~~~~~rl-~~~dfG~~~  127 (477)
                      ++|+|++|.||++++++.++ ..+||+.+.
T Consensus       218 lvHgD~~~~Nil~~~~~~~v~~viDwe~a~  247 (359)
T 3dxp_A          218 IVHGDYRLDNLMFHPTEPRVLAVLDWELST  247 (359)
T ss_dssp             EECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred             EEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence            89999999999998764332 456888764

>2p1m_A SKP1-like protein 1A; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_A* 2p1o_A* 2p1p_A* 2p1q_A* 3c6n_A* 3c6o_A* 3c6p_A* 3ogk_A* 3ogl_A* 3ogm_A*

Probab=98.53  E-value=7e-09  Score=90.77  Aligned_cols=80  Identities=8%  Similarity=0.178  Sum_probs=39.7

Q ss_pred             EEEEe-cCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCc----------------
Q psy6508         360 CKFYV-GNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHAR----------------  422 (477)
Q Consensus       360 ~~~~v-~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~----------------  422 (477)
                      |+|.. +|    +.|.+||.+ |.+|++|++||.+.. ..+.|.|+++++.+|+.+++|+|+.+                
T Consensus         6 v~L~SsDg----~~f~v~~~v-A~~S~~ik~ml~~~~-~~~~Ipl~~V~~~iL~kVieyc~~h~~~~~~~~~~~~~~~~~   79 (160)
T 2p1m_A            6 IVLKSSDG----ESFEVEEAV-ALESQTIAHMVEDDC-VDNGVPLPNVTSKILAKVIEYCKRHVEAAASKAEAVEGAATS   79 (160)
T ss_dssp             --CCC-------------CHH-HHTCTTTC-------------CCTTSCHHHHHHHHHC---------------------
T ss_pred             EEEEcCCC----CEEEECHHH-HHHhHHHHHHHHccC-CCCceeCCcCcHHHHHHHHHHHHHcccCCCcccccccccccc
Confidence            55665 45    999999999 899999999998753 34578999999999999999999987                


Q ss_pred             -----------eeeCccchhhhhhccccceeecc
Q psy6508         423 -----------VNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 -----------~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                                 ++++.+.+.+|+.||+|+.|.++
T Consensus        80 ~~~i~~wD~~Fl~vd~~~l~eLi~AAnyL~I~~L  113 (160)
T 2p1m_A           80 DDDLKAWDADFMKIDQATLFELILAANYLNIKNL  113 (160)
T ss_dssp             ---------------------CHHHHHHTTCHHH
T ss_pred             cchhhHHHHHHHcCCHHHHHHHHHHHHHHhHHHH
Confidence                       57888999999999999988764

>1hv2_A Elongin C, ELC1; protein-peptide complex, signaling protein; NMR {Saccharomyces cerevisiae} SCOP: d.42.1.1

Probab=98.36  E-value=2.4e-07  Score=73.97  Aligned_cols=78  Identities=15%  Similarity=0.295  Sum_probs=65.8

Q ss_pred             EEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhhhcCc--------------e
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE--KGDTKILDITPEAFSTMLDSDHHAR--------------V  423 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~Ytg~--------------~  423 (477)
                      |++.-.+|   ++|.++|.+ |.+|.++++||.+++ +  .+.+.|+++++.+++.+++|+|.-+              -
T Consensus         6 v~L~SsDg---~~f~V~~~v-A~~S~~ik~ml~~~~-e~~~~~Iplp~V~~~iL~kVieyc~~h~~~~~~~~~~~~i~~w   80 (99)
T 1hv2_A            6 VTLVSKDD---KEYEISRSA-AMISPTLKAMIEGPF-RESKGRIELKQFDSHILEKAVEYLNYNLKYSGVSEDDDEIPEF   80 (99)
T ss_dssp             EEEEETTT---EEEEEEHHH-HTTCHHHHHHHHSST-TTCTTEEEETTSCHHHHHHHHHHHHHHHHHHHHCSSCSSCCCC
T ss_pred             EEEEecCC---CEEEECHHH-HHHhHHHHHHHhccc-ccCCCceecCCcCHHHHHHHHHHHHHhcccCCCccccccCCCc
Confidence            66777443   999999997 999999999998865 4  3678999999999999999999855              2


Q ss_pred             eeCccchhhhhhcccccee
Q psy6508         424 NISSDHHARVSISSDHHTR  442 (477)
Q Consensus       424 ~~~~~~~~~~~~~a~~~~~  442 (477)
                      +++.+.+.+++.||+|+.|
T Consensus        81 ~vd~~~lfeLi~AAnyLdI   99 (99)
T 1hv2_A           81 EIPTEMSLELLLAADYLSI   99 (99)
T ss_dssp             CCCHHHHHHHHHHHHHHCC
T ss_pred             cCCHHHHHHHHHHHHHhCc
Confidence            5677889999999998765

>2fnj_C Transcription elongation factor B polypeptide 1; beta-sandwich, lectin-like, SPRY, protein transport/signaling protein complex; 1.80A {Mus musculus} SCOP: d.42.1.1 PDB: 1lqb_B 1lm8_C 2jz3_C 2xai_B 2c9w_C 2izv_C 3dcg_B 3zrc_B* 3zrf_B

Probab=98.28  E-value=3.9e-07  Score=72.30  Aligned_cols=79  Identities=13%  Similarity=0.180  Sum_probs=63.4

Q ss_pred             EEEEecCccceeeEeeeehhhhcccHHHHHhcCCC-c-cc--cCCcccCCCCHHHHHHHhhhhhcCc-----------ee
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGE-L-CE--KGDTKILDITPEAFSTMLDSDHHAR-----------VN  424 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~-~-~~--~~~~~~~~~~~~~~~~~l~~~Ytg~-----------~~  424 (477)
                      |++.-.+|   ++|.++|.+ |.+|+++++||.+. . .|  .+.+.|+++++.+++.+++|+|.-+           -+
T Consensus         3 v~L~SsDg---~~f~V~~~~-A~~S~~ik~ml~~~~~~~e~~~~~Ipl~~V~~~iL~kVieyc~~h~~~~~~~~~i~~w~   78 (96)
T 2fnj_C            3 VKLISSDG---HEFIVKREH-ALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFP   78 (96)
T ss_dssp             EEEECTTS---CEEEEEHHH-HTTSHHHHHHHHCC--------CEEECSSCCHHHHHHHHHHHHHHHHHHSCCSCCCCCC
T ss_pred             EEEEecCC---CEEEeCHHH-HHHhHHHHHHHHccCCcccccCCceeCCCCCHHHHHHHHHHHHHccccCCCcccCCCcc
Confidence            55666333   999999997 99999999999863 2 34  3578999999999999999998754           26


Q ss_pred             eCccchhhhhhcccccee
Q psy6508         425 ISSDHHARVSISSDHHTR  442 (477)
Q Consensus       425 ~~~~~~~~~~~~a~~~~~  442 (477)
                      ++.+.+.+++.||+|+.|
T Consensus        79 vd~~~l~eLi~AAnyLdI   96 (96)
T 2fnj_C           79 IAPEIALELLMAANFLDC   96 (96)
T ss_dssp             CCTTTHHHHHHHHHHHTC
T ss_pred             cCHHHHHHHHHHHHHhCc
Confidence            788899999999998765

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.04  E-value=1e-05  Score=78.20  Aligned_cols=118  Identities=15%  Similarity=0.143  Sum_probs=83.2

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCC--ccceEEEEEeCC---eEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQH--IVTMLDFLWDER---YVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~Hpn--Iv~~~~~~~~~~---~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      +.+++|+...    ......+.+|..+|+.+ .+..  +++++......+   ..|+||++++|.+|......  .++..
T Consensus        41 ~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~--~l~~~  114 (304)
T 3sg8_A           41 RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN--NLPKQ  114 (304)
T ss_dssp             TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH--TSCHH
T ss_pred             CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc--cCCHH
Confidence            3577887532    23456789999999988 3333  455555543333   35899999999888764432  47778


Q ss_pred             HHHHHHHHHHHHHHHHHh----------------------------------------------------------CCcE
Q psy6508          79 QCQQFVRQLVLALKFLRE----------------------------------------------------------NNVC  100 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~----------------------------------------------------------~giv  100 (477)
                      +...++.|++..|..||+                                                          ..++
T Consensus       115 ~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~  194 (304)
T 3sg8_A          115 SQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLI  194 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEE
T ss_pred             HHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeE
Confidence            888888888888888886                                                          1369


Q ss_pred             EccCCCCceeeccC-cceeecccccceec
Q psy6508         101 HFDLKPQNILIKNN-TLKLAGLKQGVSEK  128 (477)
Q Consensus       101 HrDlkp~NIll~~~-~~rl~~~dfG~~~~  128 (477)
                      |+|++|.||+++++ .-....+||+.+..
T Consensus       195 HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          195 HNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             CSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             eCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence            99999999999874 22344568887643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.97  E-value=5.4e-05  Score=73.28  Aligned_cols=86  Identities=16%  Similarity=0.068  Sum_probs=55.9

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCC---CccceEEEEE-eCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQ---HIVTMLDFLW-DERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hp---nIv~~~~~~~-~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      +.+++|+..    .......+.+|..+|+.|.+.   .+++.+.+.. ..+..|++||+++|.+|....-  ..++....
T Consensus        40 ~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~~--~~l~~~~~  113 (306)
T 3tdw_A           40 GDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDGM--AVLPDDAK  113 (306)
T ss_dssp             TTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHHH--TTSCHHHH
T ss_pred             CEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhhh--hhCCHHHH
Confidence            457788742    233456789999999999642   3677777764 3456789999999988876322  12444555


Q ss_pred             HHHHHHHHHHHHHHHh
Q psy6508          81 QQFVRQLVLALKFLRE   96 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~   96 (477)
                      ..+..++...|..||+
T Consensus       114 ~~~~~~lg~~La~LH~  129 (306)
T 3tdw_A          114 DRLALQLAEFMNELSA  129 (306)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhc
Confidence            5555555555555553

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.92  E-value=9.4e-05  Score=69.82  Aligned_cols=115  Identities=16%  Similarity=0.213  Sum_probs=82.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+..+.+|+-+.     .....+.+|...|+.+. +--+++++.++.+.+..|+|||+++|.++.+.....    .....
T Consensus        49 ~~~~~~lk~~~~-----~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~  119 (272)
T 4gkh_A           49 NAPELFLKHGKG-----SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGE  119 (272)
T ss_dssp             TCCCEEEEEEET-----HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHH
T ss_pred             CCeEEEEEECCC-----CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHH
Confidence            345688887542     23456889999999884 434788999999999999999999998888765432    12234


Q ss_pred             HHHHHHHHHHHHHHhC----------------------------------------------------------CcEEcc
Q psy6508          82 QFVRQLVLALKFLREN----------------------------------------------------------NVCHFD  103 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~----------------------------------------------------------givHrD  103 (477)
                      .+..++...|.-||+.                                                          .++|+|
T Consensus       120 ~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGD  199 (272)
T 4gkh_A          120 NIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD  199 (272)
T ss_dssp             HHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSC
T ss_pred             HHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCC
Confidence            4566666666666641                                                          158999


Q ss_pred             CCCCceeeccCcceeeccccccee
Q psy6508         104 LKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus       104 lkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      ++|.||+++++++ ..++||+.+.
T Consensus       200 l~~~Nil~~~~~~-~~viDwe~a~  222 (272)
T 4gkh_A          200 FSLDNLIFDEGKL-IGCIDVGRVG  222 (272)
T ss_dssp             CCTTSEEEETTEE-EEECCCTTCE
T ss_pred             CCCCeEEEECCeE-EEEEECcccc
Confidence            9999999987653 3356887653

>1vcb_B Protein (elongin C); tumor suppressor, cancer, ubiquitin, beta sandwich, transcription, transcriptional elongation; 2.70A {Homo sapiens} SCOP: d.42.1.1

Probab=97.65  E-value=2.7e-05  Score=63.36  Aligned_cols=80  Identities=13%  Similarity=0.156  Sum_probs=63.1

Q ss_pred             eEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCc--cc--cCCcccCCCCHHHHHHHhhhhhcCc-----------e
Q psy6508         359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGEL--CE--KGDTKILDITPEAFSTMLDSDHHAR-----------V  423 (477)
Q Consensus       359 D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~--~~--~~~~~~~~~~~~~~~~~l~~~Ytg~-----------~  423 (477)
                      -|+|.-.+|   ++|.+.|. .|.+|..++.|+.+..  .|  .+.|.|++++..+|+.+++|+|.-+           -
T Consensus        18 ~v~L~SsDG---~~F~V~~~-~A~~S~tIk~ml~~~~~~~e~~~~~IplpnV~s~iL~kVieyc~~h~~~~~~~~~i~~w   93 (112)
T 1vcb_B           18 YVKLISSDG---HEFIVKRE-HALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEF   93 (112)
T ss_dssp             EEEEECTTS---CEEEEEHH-HHHTSHHHHHHSSCC--------CEEECSSCCHHHHHHHHHHHHHHHHHSSCSSCCCCC
T ss_pred             EEEEEcCCC---CEEEECHH-HHHHhHHHHHHHHhcCCcccccCCceeCCCCCHHHHHHHHHHHHHhhhccCCcCCCCCc
Confidence            366665443   99999999 5889999999998532  23  3568999999999999999998754           2


Q ss_pred             eeCccchhhhhhcccccee
Q psy6508         424 NISSDHHARVSISSDHHTR  442 (477)
Q Consensus       424 ~~~~~~~~~~~~~a~~~~~  442 (477)
                      ++..+.+.+|+.||+|+.|
T Consensus        94 ~vd~~~lfeLi~AAnyLdI  112 (112)
T 1vcb_B           94 PIAPEIALELLMAANFLDC  112 (112)
T ss_dssp             CCCHHHHHHHHHHHHHHTC
T ss_pred             ccCHHHHHHHHHHHHHhCc
Confidence            5777889999999998765

>3v7d_A Suppressor of kinetochore protein 1; WD 40 domain, phospho-peptide complex, E3 ubiquitin ligase, cell cycle, phospho binding protein, phosphorylation; HET: SEP; 2.31A {Saccharomyces cerevisiae} PDB: 1nex_A* 3mks_A*

Probab=97.64  E-value=2.3e-05  Score=68.76  Aligned_cols=83  Identities=8%  Similarity=0.181  Sum_probs=66.1

Q ss_pred             eEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCcc----c--cCCcccCCCCHHHHHHHhhhhhcCc----------
Q psy6508         359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELC----E--KGDTKILDITPEAFSTMLDSDHHAR----------  422 (477)
Q Consensus       359 D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~----~--~~~~~~~~~~~~~~~~~l~~~Ytg~----------  422 (477)
                      -|+|.-.+|   +.|.+++.+ |.+|.+++.|+.....    +  ...|.|++++..+|+.+++|++.-+          
T Consensus         8 ~i~L~SsDG---~~F~V~~~v-A~~S~tIk~ml~~~~~~~~~~~~~~~IplpnV~s~iL~kVieyc~~h~~~~~~~~~~~   83 (169)
T 3v7d_A            8 NVVLVSGEG---ERFTVDKKI-AERSLLLKNYLNDMGDDDDEDDDEIVMPVPNVRSSVLQKVIEWAEHHRDSNFPDEDDD   83 (169)
T ss_dssp             EEEEECTTC---CEEEEEHHH-HTTSHHHHHHHHC-----------CEEECTTCCHHHHHHHHHHHHHTTTCCCCC----
T ss_pred             eEEEEeCCC---CEEEecHHH-HHHhHHHHHHHHhcCcccccccCCCceeeCCCCHHHHHHHHHHHHHcccCCCcccccc
Confidence            466766554   899999998 8899999999976433    1  2568999999999999999998754          


Q ss_pred             ---------------eeeCccchhhhhhccccceeecc
Q psy6508         423 ---------------VNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       423 ---------------~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                                     ++++.+.+.+|+.||+|+.|.++
T Consensus        84 ~~~~~~~i~~wD~~Fl~vd~~~LfeLi~AAnyLdIk~L  121 (169)
T 3v7d_A           84 DSRKSAPVDSWDREFLKVDQEMLYEIILAANYLNIKPL  121 (169)
T ss_dssp             ----CCCCCHHHHHHTCSCHHHHHHHHHHHHHTTCHHH
T ss_pred             cccccccccHHHHHHHcCCHHHHHHHHHHHHHhCcHHH
Confidence                           35667889999999999998774

>3drz_A BTB/POZ domain-containing protein KCTD5; potassium channel domain T1, pentamer, unkno function; 1.90A {Homo sapiens}

Probab=97.39  E-value=0.00014  Score=58.70  Aligned_cols=82  Identities=18%  Similarity=0.272  Sum_probs=65.1

Q ss_pred             eEEEEecCccceeeEeeeehhhhccc-HHHHHhcCCCcc------ccCCcccCCCCHHHHHHHhhhhhcCceeeCccc-h
Q psy6508         359 DCKFYVGNDVHCKEFKAHKLILSMSS-PVFATMFHGELC------EKGDTKILDITPEAFSTMLDSDHHARVNISSDH-H  430 (477)
Q Consensus       359 D~~~~v~~~~~~~~~~~hk~vLa~~S-~~f~~~f~~~~~------~~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~~-~  430 (477)
                      =|+|.|||    +.|...+..|+... .+|.+||.++..      +.+++ .-|-+|..|+.+|+|+.||++.++.+- .
T Consensus         7 ~v~LNVGG----~~f~t~~~TL~~~p~s~L~~~~~~~~~~~~~~d~~~~~-fiDRdp~~F~~IL~~lr~g~l~~p~~~~~   81 (107)
T 3drz_A            7 WVRLNVGG----TYFLTTRQTLCRDPKSFLYRLCQADPDLDSDKDETGAY-LIDRDPTYFGPVLNYLRHGKLVINKDLAE   81 (107)
T ss_dssp             EEEEEETT----EEEEEEHHHHTSSTTSHHHHHHTTCGGGGGGBCTTSCE-EECSCHHHHHHHHHHHHHSCCCCCTTSCH
T ss_pred             EEEEEECC----EEEEECHHHHhcCCCcchhHHHhcCCCCCcCCCCCceE-EecCChHHHHHHHHHhCCCeeCCCCCCCH
Confidence            37899999    99999999999886 578999986531      12333 348899999999999999999886543 4


Q ss_pred             hhhhhccccceeecc
Q psy6508         431 ARVSISSDHHTRVSI  445 (477)
Q Consensus       431 ~~~~~~a~~~~~~~~  445 (477)
                      ..++.-|+++.|.++
T Consensus        82 ~~l~~Ea~fy~l~~L   96 (107)
T 3drz_A           82 EGVLEEAEFYNITSL   96 (107)
T ss_dssp             HHHHHHHHHHTCHHH
T ss_pred             HHHHHHHHHCCCHHH
Confidence            678888888887764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.06  E-value=0.0005  Score=67.69  Aligned_cols=63  Identities=5%  Similarity=0.042  Sum_probs=41.6

Q ss_pred             CcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcC-C--CCccceEEEEEeC---CeEEEEEecCCCCCHH
Q psy6508           4 HTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLH-H--QHIVTMLDFLWDE---RYVYIILEYCDGGDLC   66 (477)
Q Consensus         4 g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~-H--pnIv~~~~~~~~~---~~~~lv~e~~~g~sL~   66 (477)
                      ++.+++|....... .......+.+|+.+++.|. +  -.+++++.+..+.   +..|+|||+++|.++.
T Consensus        52 ~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A           52 QQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             EEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred             CceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence            66789998654320 0000134678999999884 3  3678888877654   3568999999986654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.63  E-value=0.0036  Score=62.50  Aligned_cols=59  Identities=15%  Similarity=0.009  Sum_probs=35.6

Q ss_pred             CCcEEEEEEcccCCC--Ch---hHHHHHHHHHHHHHhcCC--C-CccceEEEEEeCCeEEEEEecCCCC
Q psy6508           3 QHTEVAIKCIDKTKV--SE---NRFDSIVNEIKALKLLHH--Q-HIVTMLDFLWDERYVYIILEYCDGG   63 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~--~~---~~~~~~~~E~~il~~l~H--p-nIv~~~~~~~~~~~~~lv~e~~~g~   63 (477)
                      +++.|++|.......  .+   ...+++..|..+|+.+..  | .+++++.+  +....++|||+++|.
T Consensus        54 ~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvmE~l~g~  120 (397)
T 2olc_A           54 HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHL  120 (397)
T ss_dssp             --CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTS
T ss_pred             CCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEEEeCCCc
Confidence            467899998653211  11   112456789999988732  3 45566654  344568999999863

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.46  E-value=0.013  Score=56.57  Aligned_cols=58  Identities=14%  Similarity=0.129  Sum_probs=45.9

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC---CCCccceEEEEEeCCeEEEEEecCCCCCH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH---HQHIVTMLDFLWDERYVYIILEYCDGGDL   65 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~~~~~~~~~lv~e~~~g~sL   65 (477)
                      +++.+++|+....     ....+..|...|+.|.   ...+++++......+..|+||||++|.++
T Consensus        58 ~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           58 EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            4567889986532     2456889999999883   36789999988888899999999998764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.46  E-value=0.023  Score=54.83  Aligned_cols=29  Identities=24%  Similarity=0.392  Sum_probs=21.8

Q ss_pred             CCcEEccCCCCceeeccCcceeecccccce
Q psy6508          97 NNVCHFDLKPQNILIKNNTLKLAGLKQGVS  126 (477)
Q Consensus        97 ~givHrDlkp~NIll~~~~~rl~~~dfG~~  126 (477)
                      .+++|+|++|.||+++.++ ....+||+.+
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a  250 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTV  250 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTC
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhc
Confidence            5799999999999996543 2344588765

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.02  E-value=0.02  Score=55.45  Aligned_cols=59  Identities=5%  Similarity=-0.037  Sum_probs=36.4

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-C-CCccceEEEEEeCCeEEEEEecCCCCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-H-QHIVTMLDFLWDERYVYIILEYCDGGDLCSFI   69 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-H-pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l   69 (477)
                      |+.+++|.......     +.+..|+.+++.+. + -.+++++.+....+  +++||++.+.++.+++
T Consensus        43 ~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~~~l  103 (333)
T 3csv_A           43 GAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFTEVI  103 (333)
T ss_dssp             CCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHHHHH
T ss_pred             CCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchHHHh
Confidence            66788886543321     22446778877773 2 24667777633333  7899999877776544

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.97  E-value=0.027  Score=56.60  Aligned_cols=31  Identities=16%  Similarity=0.347  Sum_probs=24.2

Q ss_pred             HhCCcEEccCCCCceeeccCcceeeccccccee
Q psy6508          95 RENNVCHFDLKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus        95 H~~givHrDlkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      +...++|+|++|.|||++++++.+  +||+.+.
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~~~l--ID~e~a~  260 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDSTQV--IDPEFSF  260 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSCEEE--CCCTTCE
T ss_pred             CCCeEEecCCCCCcEEEeCCCCEE--EeCcccc
Confidence            356899999999999998876544  4877653

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.33  E-value=0.051  Score=52.30  Aligned_cols=59  Identities=14%  Similarity=0.234  Sum_probs=36.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-C-CCccceEEE-----EEeCCeEEEEEecCCCCC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-H-QHIVTMLDF-----LWDERYVYIILEYCDGGD   64 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-H-pnIv~~~~~-----~~~~~~~~lv~e~~~g~s   64 (477)
                      +|+.+++|..+....+   .+.+..|..+++.|. + -.+++++..     ....+..+++|++++|.+
T Consensus        48 ~g~~~vlK~~~~~~~~---~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~~  113 (328)
T 1zyl_A           48 DRRRFVVKFYRPERWT---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  113 (328)
T ss_dssp             TCCCEEEEEECTTTSC---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             CCCEEEEEEcCCCCCC---HHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCCC
Confidence            4667999998643222   245667888888773 2 124444432     233567789999998744

>3kvt_A Potassium channel protein SHAW; tetramerization domain, molecular recogni zinc-binding; 2.00A {Aplysia californica} SCOP: d.42.1.2

Probab=94.57  E-value=0.016  Score=46.95  Aligned_cols=83  Identities=13%  Similarity=0.126  Sum_probs=62.9

Q ss_pred             EEEEecCccceeeEeeeehhhhccc-HHHHHhcCCCc--cccCCcccCCCCHHHHHHHhhhhhcCceeeCcc-chhhhhh
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSS-PVFATMFHGEL--CEKGDTKILDITPEAFSTMLDSDHHARVNISSD-HHARVSI  435 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S-~~f~~~f~~~~--~~~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~-~~~~~~~  435 (477)
                      |+|.|||    ..|...+..|.... ..+.+||.+..  ........-|=+|..|+.+|+|+-||++.++.+ .+..++.
T Consensus         7 V~LNVGG----~~f~T~~~TL~~~P~s~L~~l~~~~~~~~~~~g~~FiDRdp~~F~~ILnylR~G~l~~p~~~~~~~~~~   82 (115)
T 3kvt_A            7 VIINVGG----IRHETYKATLKKIPATRLSRLTEGMLNYDPVLNEYFFDRHPGVFAQIINYYRSGKLHYPTDVCGPLFEE   82 (115)
T ss_dssp             EEEEETT----EEEEEEHHHHTTSCSSTTTTCCTTSTTEETTTTEEEECSCTTTHHHHHHHHHHSCBCCCSSSCHHHHHH
T ss_pred             EEEEECC----EEEEecHHHHhcCCCccHHHHhcCCCCCCCCCCcEEEecChHHHHHHHHHhcCCCCCCCCcccHHHHHH
Confidence            7899999    99999999999774 34566776432  112222344789999999999999999988764 4677888


Q ss_pred             ccccceeeccc
Q psy6508         436 SSDHHTRVSIS  446 (477)
Q Consensus       436 ~a~~~~~~~~~  446 (477)
                      -|+++.|.+..
T Consensus        83 Ea~fy~i~~~~   93 (115)
T 3kvt_A           83 ELEFWGLDSNQ   93 (115)
T ss_dssp             HHHHHTCCGGG
T ss_pred             HHHHhCCChHH
Confidence            89988887743

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.53  E-value=0.052  Score=53.82  Aligned_cols=117  Identities=17%  Similarity=0.158  Sum_probs=68.3

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHH--------------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCS--------------   67 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~--------------   67 (477)
                      +++.|.+|+.....   .......+|..+++.|. +.-.+++++.+.+    .+||||++|.+|..              
T Consensus        81 ~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~  153 (379)
T 3feg_A           81 EPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT  153 (379)
T ss_dssp             CCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred             CCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence            35789999853321   12345668999999883 4445777776543    29999999855431              


Q ss_pred             HH---HhC----C-CC--CHHHHHHHHHHHHH-------------------HHHHHH----h----CCcEEccCCCCcee
Q psy6508          68 FI---RSH----E-KL--SEFQCQQFVRQLVL-------------------ALKFLR----E----NNVCHFDLKPQNIL  110 (477)
Q Consensus        68 ~l---~~~----~-~l--~~~~~~~i~~qi~~-------------------aL~~LH----~----~givHrDlkp~NIl  110 (477)
                      .|   +..    + ..  .+..+.+|..++-.                   .+..|.    .    ..++|+|+.+.||+
T Consensus       154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil  233 (379)
T 3feg_A          154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL  233 (379)
T ss_dssp             HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred             HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence            11   111    0 11  23456666655432                   233332    2    25899999999999


Q ss_pred             eccC---cceeecccccce
Q psy6508         111 IKNN---TLKLAGLKQGVS  126 (477)
Q Consensus       111 l~~~---~~rl~~~dfG~~  126 (477)
                      ++.+   .-++..+||..+
T Consensus       234 ~~~~~~~~~~~~~IDwE~a  252 (379)
T 3feg_A          234 LLSEPENADSLMLVDFEYS  252 (379)
T ss_dssp             EESCC---CCEEECCCTTC
T ss_pred             EcCCCCccCcEEEEecccC
Confidence            9765   123444577654

>3drx_A BTB/POZ domain-containing protein KCTD5; golgi, grAsp55, potassium channel domain T1, pentameric assembly, HOST-virus interaction, nucleus; 3.11A {Homo sapiens} PDB: 3dry_A

Probab=94.37  E-value=0.02  Score=50.95  Aligned_cols=82  Identities=18%  Similarity=0.272  Sum_probs=63.2

Q ss_pred             eEEEEecCccceeeEeeeehhhhccc-HHHHHhcCCCc--c----ccCCcccCCCCHHHHHHHhhhhhcCceeeCccc-h
Q psy6508         359 DCKFYVGNDVHCKEFKAHKLILSMSS-PVFATMFHGEL--C----EKGDTKILDITPEAFSTMLDSDHHARVNISSDH-H  430 (477)
Q Consensus       359 D~~~~v~~~~~~~~~~~hk~vLa~~S-~~f~~~f~~~~--~----~~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~~-~  430 (477)
                      =|+|.|||    ..|...+..|.... .+|.+||.+..  .    +.++ .+-|-+|..|+.+|+|+-||++.+..+- .
T Consensus        13 ~V~LNVGG----~~F~Tt~sTL~r~PdS~L~~lfs~~~~~~~~~De~ge-yFIDRDP~~F~~ILnyLRtG~L~lP~~~~~   87 (202)
T 3drx_A           13 WVRLNVGG----TYFLTTRQTLCRDPKSFLYRLCQADPDLDSDKDETGA-YLIDRDPTYFGPVLNYLRHGKLVINKDLAE   87 (202)
T ss_dssp             EEEEEETT----EEEEEETTGGGSCTTSSTHHHHSCCCC----BCTTCC-EEECSCSTTHHHHHHHHHHSCCCCCTTSCH
T ss_pred             EEEEEECC----EEEEEeHHHHhCCCcchHHHHhcCccccCcccCCCcc-EEecCChHHHHHHHHHhcCCccCCCCCCCH
Confidence            37889999    99999999999875 48899987652  1    1233 3347899999999999999999886543 3


Q ss_pred             hhhhhccccceeecc
Q psy6508         431 ARVSISSDHHTRVSI  445 (477)
Q Consensus       431 ~~~~~~a~~~~~~~~  445 (477)
                      ..++.-|+++.|..+
T Consensus        88 ~~l~eEA~FygL~~L  102 (202)
T 3drx_A           88 EGVLEEAEFYNITSL  102 (202)
T ss_dssp             HHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHCCcHHH
Confidence            568888888777663

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.17  E-value=0.052  Score=52.09  Aligned_cols=29  Identities=21%  Similarity=0.213  Sum_probs=22.1

Q ss_pred             CCcEEccCCCCceeeccCcceeecccccce
Q psy6508          97 NNVCHFDLKPQNILIKNNTLKLAGLKQGVS  126 (477)
Q Consensus        97 ~givHrDlkp~NIll~~~~~rl~~~dfG~~  126 (477)
                      .+++|+|++|.||++++++. ...+||+.+
T Consensus       187 ~~liHgDl~~~Nil~~~~~~-~~lIDf~~a  215 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDEL-SGLIDFYFA  215 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEE-EEECCCTTC
T ss_pred             cccCCCCCCccCEEEeCCce-EEEecchhc
Confidence            36999999999999987643 234588755

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=93.40  E-value=0.12  Score=49.19  Aligned_cols=27  Identities=22%  Similarity=0.203  Sum_probs=20.5

Q ss_pred             CcEEccCCCCceeeccCcceeecccccce
Q psy6508          98 NVCHFDLKPQNILIKNNTLKLAGLKQGVS  126 (477)
Q Consensus        98 givHrDlkp~NIll~~~~~rl~~~dfG~~  126 (477)
                      .++|+|+.|.||+.+++.+.  .+||..+
T Consensus       174 ~l~HgDl~~~Nil~~~~~~~--lID~e~a  200 (301)
T 3dxq_A          174 AACHCDPLCENFLDTGERMW--IVDWEYS  200 (301)
T ss_dssp             EEECSCCCGGGEEECSSCEE--ECCCTTC
T ss_pred             eeeccCCCcCCEEECCCCEE--EEecccc
Confidence            48999999999996666554  4577655

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=93.17  E-value=0.49  Score=44.46  Aligned_cols=58  Identities=14%  Similarity=0.158  Sum_probs=38.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-C--CCccceEEEEEeCCeEEEEEecCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-H--QHIVTMLDFLWDERYVYIILEYCDGGDL   65 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-H--pnIv~~~~~~~~~~~~~lv~e~~~g~sL   65 (477)
                      .+|+.|.+|+-+.....  ....|..|+..|+.|. .  --+++++..  ..  -+++|||.+++..
T Consensus        37 ~DG~~~~vK~~~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~l~~~~~   97 (288)
T 3f7w_A           37 ADGTPLFVKALPDDAPA--LDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEWVDERPP   97 (288)
T ss_dssp             TTSCEEEEEECCTTCCC--CTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEECCCCCCC
T ss_pred             CCCCEEEEEEeCCCCcc--hhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEeecccCC
Confidence            46899999986544322  1234778999999884 2  235666654  22  3789999886543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.96  E-value=0.11  Score=51.13  Aligned_cols=55  Identities=18%  Similarity=0.225  Sum_probs=34.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDL   65 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL   65 (477)
                      ++.+++|+.....   ........|..+++.+. +.-.+++++.+  .+  ++||||++|.++
T Consensus        66 ~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~e~i~G~~l  121 (369)
T 3c5i_A           66 RTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIEEWLYGDPL  121 (369)
T ss_dssp             CCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEEECCCSEEC
T ss_pred             CceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEEEEecCCcC
Confidence            3688888864321   11112357888888884 32356777654  22  689999997543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=92.82  E-value=0.13  Score=51.77  Aligned_cols=54  Identities=15%  Similarity=0.122  Sum_probs=35.4

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDL   65 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL   65 (477)
                      ++.|.+|+..... .   .+.+.+|..+++.|. +.-.+++++.+.  +  .+|+||++|.+|
T Consensus       105 ~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l~G~~l  159 (429)
T 1nw1_A          105 PNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYIPSRPL  159 (429)
T ss_dssp             CSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCCCEEEC
T ss_pred             CceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEeCCccc
Confidence            5789999874321 1   134568999999884 333477777653  2  389999987443

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.65  E-value=0.53  Score=45.55  Aligned_cols=52  Identities=13%  Similarity=0.087  Sum_probs=33.3

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcC---CCCccceEEE------EEeCCeEEEEEecCCCCCH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLH---HQHIVTMLDF------LWDERYVYIILEYCDGGDL   65 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~---HpnIv~~~~~------~~~~~~~~lv~e~~~g~sL   65 (477)
                      .+++|+.+....        ..|..+++.|.   -|++++.+..      ....+..+++|+|++|..+
T Consensus        48 ~~vLK~~~~~~~--------~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~~  108 (339)
T 3i1a_A           48 SYFIKLKYGYHD--------EINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPNG  108 (339)
T ss_dssp             EEEEEEEECSSC--------CHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCBT
T ss_pred             CEEEEEecCccc--------hHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCcC
Confidence            899998765432        25666666662   2335555432      2345778999999998765

>1s1g_A Potassium voltage-gated channel subfamily D membe; K+ channels, tetramerization domain, T1 domain, transport PR; 2.60A {Homo sapiens} SCOP: d.42.1.2

Probab=92.29  E-value=0.11  Score=42.61  Aligned_cols=81  Identities=12%  Similarity=0.097  Sum_probs=59.8

Q ss_pred             eEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCcc-----ccCCcccCCCCHHHHHHHhhhhhcCceeeCcc-chhh
Q psy6508         359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELC-----EKGDTKILDITPEAFSTMLDSDHHARVNISSD-HHAR  432 (477)
Q Consensus       359 D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~-----~~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~-~~~~  432 (477)
                      =|+|.|||    +.|..-+..|.....   .||.....     .......-|=+|..|+.+|+|+-||++.+..+ .+..
T Consensus        14 ~V~LNVGG----~~F~t~~~TL~~~p~---S~L~~~~~~~~~~~~~g~~FiDRdp~~F~~ILnflR~G~l~~p~~~~~~~   86 (124)
T 1s1g_A           14 LIVLNVSG----RRFQTWRTTLERYPD---TLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECISA   86 (124)
T ss_dssp             EEEEEETT----EEEEEEHHHHTTSTT---SSTTSSGGGGTBCSSSCSEEECSCHHHHHHHHHHHHHSCBCCCTTSCHHH
T ss_pred             EEEEEeCC----EEEEEeHHHHhcCCC---ceecccCCcccccCCCCcEEEcCChHHHHHHHHHHhcCCCCCCCCcCHHH
Confidence            48899999    999999999986532   33433111     11112334679999999999999999987654 4677


Q ss_pred             hhhccccceeeccc
Q psy6508         433 VSISSDHHTRVSIS  446 (477)
Q Consensus       433 ~~~~a~~~~~~~~~  446 (477)
                      ++.-|+++.|..+.
T Consensus        87 l~~Ea~fy~i~~l~  100 (124)
T 1s1g_A           87 YDDELAFYGILPEI  100 (124)
T ss_dssp             HHHHHHHTTCCGGG
T ss_pred             HHHHHHHcCCChHH
Confidence            88999999998764

>1nn7_A Potassium channel KV4.2; teteramerization domain, voltage gated potassium channel SHAL, membrane protein; 2.10A {Rattus norvegicus} SCOP: d.42.1.2

Probab=91.06  E-value=0.12  Score=41.11  Aligned_cols=79  Identities=10%  Similarity=0.132  Sum_probs=58.1

Q ss_pred             EEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc-----cCCcccCCCCHHHHHHHhhhhhcCceeeCcc-chhhh
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE-----KGDTKILDITPEAFSTMLDSDHHARVNISSD-HHARV  433 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~-----~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~-~~~~~  433 (477)
                      |+|.|||    +.|...+..|.....   .||......     ......-|=+|..|+.+|+|+-||++.+..+ .+..+
T Consensus         2 V~LNVGG----~~f~t~~~TL~~~p~---s~L~~~~~~~~~~~~~~~~FiDRdp~~F~~ILnflR~g~l~~p~~~~~~~l   74 (105)
T 1nn7_A            2 IVLNVSG----TRFQTWQDTLERYPD---TLLGSSERDFFYHPETQQYFFDRDPDIFRHILNFYRTGKLHYPRHECISAY   74 (105)
T ss_dssp             EEEEETT----EEEEECHHHHHTSCS---SSTTSGGGGGGEEGGGTEEEECSCTTTHHHHHHHHHHSCBCCCTTSCHHHH
T ss_pred             EEEEECC----EEEEEeHHHHhcCCC---ccccccCCcccccCCCCcEEEeCCcHHHHHHHHHHhcCCCCCCCCcCHHHH
Confidence            6899999    999999999986532   244331110     1122334679999999999999999987654 36778


Q ss_pred             hhccccceeecc
Q psy6508         434 SISSDHHTRVSI  445 (477)
Q Consensus       434 ~~~a~~~~~~~~  445 (477)
                      +.-|+++.|..+
T Consensus        75 ~~Ea~fy~i~~l   86 (105)
T 1nn7_A           75 DEELAFFGLIPE   86 (105)
T ss_dssp             HHHHHHHTCCSC
T ss_pred             HHHHHHcCCCHH
Confidence            889999888775

>2nz0_B Potassium voltage-gated channel subfamily D membe; KV4.3, kchip1, membrane protein; 3.20A {Homo sapiens} PDB: 2i2r_A

Probab=90.81  E-value=0.17  Score=42.45  Aligned_cols=83  Identities=12%  Similarity=0.075  Sum_probs=60.8

Q ss_pred             ceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc-----cCCcccCCCCHHHHHHHhhhhhcCceeeCcc-ch
Q psy6508         357 WSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE-----KGDTKILDITPEAFSTMLDSDHHARVNISSD-HH  430 (477)
Q Consensus       357 ~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~-----~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~-~~  430 (477)
                      -.=|+|.|||    +.|...+..|.....   .||......     ......-|=+|..|+.+|+|+-||++.+..+ .+
T Consensus        34 ~~~V~LNVGG----~~F~T~~~TL~~~P~---S~L~~~~~~~~~~~~~g~yFiDRdp~~F~~ILnflR~G~l~~p~~~~~  106 (140)
T 2nz0_B           34 DELIVLNVSG----RRFQTWRTTLERYPD---TLLGSTEKEFFFNEDTKEYFFDRDPEVFRCVLNFYRTGKLHYPRYECI  106 (140)
T ss_dssp             CCEEEEEETT----EEEEEEHHHHHTCTT---STTTSGGGGGSEETTTTEEEECSCHHHHHHHHHHHHHSSBCCCTTSCH
T ss_pred             CCEEEEEECC----EEEEeeHHHHhcCCC---eeecccCCcccccCCCCeEEEeCCcHHHHHHHHHHhcCCcCCCCCcCH
Confidence            3458899999    999999999986532   344331111     1122344779999999999999999987654 47


Q ss_pred             hhhhhccccceeeccc
Q psy6508         431 ARVSISSDHHTRVSIS  446 (477)
Q Consensus       431 ~~~~~~a~~~~~~~~~  446 (477)
                      ..++.-|+++.|..+.
T Consensus       107 ~~l~eEa~fy~i~~l~  122 (140)
T 2nz0_B          107 SAYDDELAFYGILPEI  122 (140)
T ss_dssp             HHHHHHHHHHTCCGGG
T ss_pred             HHHHHHHHHcCCChHH
Confidence            7788899999888754

>1t1d_A Protein (potassium channel KV1.1); potassium channels, tetramerization domain, aplysia KV1.1, proton transport, membrane protein; 1.51A {Aplysia californica} SCOP: d.42.1.2 PDB: 1eod_A 1eof_A 1eoe_A 1a68_A 1qdv_A 1exb_E* 1qdw_A 1dsx_A

Probab=89.01  E-value=0.12  Score=40.73  Aligned_cols=81  Identities=10%  Similarity=0.028  Sum_probs=56.7

Q ss_pred             EEEEecCccceeeEeeeehhhhcccH-HHHHhcCCC--cc-ccCCcccCCCCHHHHHHHhhhhhc-CceeeCcc-chhhh
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSP-VFATMFHGE--LC-EKGDTKILDITPEAFSTMLDSDHH-ARVNISSD-HHARV  433 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~-~f~~~f~~~--~~-~~~~~~~~~~~~~~~~~~l~~~Yt-g~~~~~~~-~~~~~  433 (477)
                      |+|.|||    +.|...+..|+..-. .+.+|+...  .. +.++ ..-|=+|..|+.+|+|+-| |++.+..+ .+..+
T Consensus         3 v~LNVGG----~~f~t~~~TL~~~p~s~L~~~~~~~~~~~~~~~e-yFiDRdp~~F~~ILnflR~~G~l~~p~~~~~~~~   77 (100)
T 1t1d_A            3 VVINVSG----LRFETQLKTLNQFPDTLLGNPQKRNRYYDPLRNE-YFFDRNRPSFDAILYFYQSGGRLRRPVNVPLDVF   77 (100)
T ss_dssp             EEEEETT----EEEEEEHHHHHTSTTSTTTCHHHHGGGEETTTTE-EEECSCSTTHHHHHHHHHTTSCCCCCTTSCHHHH
T ss_pred             EEEEECC----EEEEeeHHHHhcCCCccccchhccccccCCCcee-EEEcCChHHHHHHHHHHhcCCcccCCCCCCHHHH
Confidence            6899999    999999999975421 222333211  01 1223 3347799999999999999 99987654 35678


Q ss_pred             hhccccceeecc
Q psy6508         434 SISSDHHTRVSI  445 (477)
Q Consensus       434 ~~~a~~~~~~~~  445 (477)
                      +.-|+++.|...
T Consensus        78 ~~Ea~fy~i~~~   89 (100)
T 1t1d_A           78 SEEIKFYELGEN   89 (100)
T ss_dssp             HHHHHHTTCCHH
T ss_pred             HHHHHHcCCCHH
Confidence            888888888653

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	477
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	5e-28
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	6e-28
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-27
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-27
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-27
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-27
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-26
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-26
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-26
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-25
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-25
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-24
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-24
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-24
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-24
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-24
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	9e-24
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-23
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-23
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	4e-23
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-23
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	9e-23
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	9e-23
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-22
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-22
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-22
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	8e-22
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	9e-22
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-21
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-21
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-21
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-21
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-21
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	6e-21
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-20
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-20
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-20
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	4e-20
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	5e-20
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-20
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-20
d2nn6f1	147	d.14.1.4 (F:29-175) Exosome complex exonuclease MT	1e-19
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-19
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-19
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-19
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-19
d1e3ha3	137	d.14.1.4 (A:346-482) Polynucleotide phosphorylase/	2e-19
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-19
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-18
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-18
d2je6b1	148	d.14.1.4 (B:8-155) Exosome complex exonuclease 1,	1e-18
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-18
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-18
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-18
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	8e-18
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-17
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-17
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-17
d2ba0d1	144	d.14.1.4 (D:10-153) Exosome complex exonuclease 1,	4e-17
d2nn6d1	122	d.14.1.4 (D:25-146) Exosome complex exonuclease RR	5e-17
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-16
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-16
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	7e-16
d2ba0g1	176	d.14.1.4 (G:3-178) Exosome complex exonuclease 2,E	2e-15
d2nn6b1	145	d.14.1.4 (B:6-150) Exosome complex exonuclease RRP	4e-15
d1r6la1	151	d.14.1.4 (A:1-151) Ribonuclease PH, domain 1 {Pseu	1e-14
d2nn6c1	181	d.14.1.4 (C:7-187) Exosome complex exonuclease RRP	4e-14
d2nn6e1	187	d.14.1.4 (E:5-191) Exosome complex exonuclease RRP	7e-14
d1oysa1	151	d.14.1.4 (A:1-151) Ribonuclease PH, domain 1 {Baci	1e-13
d2nn6a1	184	d.14.1.4 (A:1-184) Exosome complex exonuclease RRP	1e-12
d1udsa1	149	d.14.1.4 (A:2-150) Ribonuclease PH, domain 1 {Aqui	2e-12
d2je6a1	191	d.14.1.4 (A:1-191) Exosome complex exonuclease 2,E	4e-12
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	8e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-09
d1e3ha2	149	d.14.1.4 (A:3-151) Polynucleotide phosphorylase/gu	3e-08
d1r29a_	122	d.42.1.1 (A:) B-cell lymphoma 6 (Bcl6) protein BTB	6e-06
d1buoa_	121	d.42.1.1 (A:) Promyelocytic leukaemia zinc finger	0.002

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 8e-29
 Identities = 28/118 (23%), Positives = 52/118 (44%), Gaps = 2/118 (1%)

Query: 4   HTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
              VAIK +  +   S  ++  I+ E++ L+ L H + +        E   ++++EYC G
Sbjct: 40  SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 99

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
                     + L E +        +  L +L  +N+ H D+K  NIL+ +   +KL 
Sbjct: 100 SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLG 157

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 5e-28
 Identities = 47/151 (31%), Positives = 77/151 (50%), Gaps = 8/151 (5%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
               A K ID    SE   +  + EI  L    H +IV +LD  + E  ++I++E+C GG
Sbjct: 37  SVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGG 94

Query: 64  DLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
            + + +   E+ L+E Q Q   +Q + AL +L +N + H DLK  NIL   +  +KLA  
Sbjct: 95  AVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADF 154

Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
             GVS  AK +  I++ ++ +    +   E+
Sbjct: 155 --GVS--AKNTRTIQRRDSFIGTPYWMAPEV 181

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 6e-28
 Identities = 27/118 (22%), Positives = 56/118 (47%), Gaps = 3/118 (2%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H +VA+K ++ T  +  +  +  NE+  L+   H +I+  + +      + I+ ++C+G 
Sbjct: 30  HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY-STAPQLAIVTQWCEGS 88

Query: 64  DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            L   +   E K    +     RQ    + +L   ++ H DLK  NI + ++ T+K+ 
Sbjct: 89  SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIG 146

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (271), Expect = 2e-27
 Identities = 34/116 (29%), Positives = 62/116 (53%), Gaps = 2/116 (1%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             VA+K +D  +  +   ++I  EI   K+L+H+++V       +    Y+ LEYC GG+
Sbjct: 31  EAVAVKIVDMKRAVDCP-ENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 89

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           L   I     + E   Q+F  QL+  + +L    + H D+KP+N+L+ + + LK++
Sbjct: 90  LFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKIS 145

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 3e-27
 Identities = 30/117 (25%), Positives = 57/117 (48%), Gaps = 2/117 (1%)

Query: 5   TEVAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
             +A+K + K ++ +      +  E++    L H +I+ +  +  D   VY+ILEY   G
Sbjct: 32  FILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLG 91

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
            +   ++   K  E +   ++ +L  AL +     V H D+KP+N+L+     LK+A
Sbjct: 92  TVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIA 148

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  109 bits (273), Expect = 5e-27
 Identities = 36/119 (30%), Positives = 63/119 (52%), Gaps = 6/119 (5%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
              A K +     S+   +++  EI+ + +L H  +V + D   D+  + +I E+  GG+
Sbjct: 52  NNFAAKFVMTPHESDK--ETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE 109

Query: 65  LCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLA 119
           L   +   H K+SE +  +++RQ+   L  + ENN  H DLKP+NI+    ++N LKL 
Sbjct: 110 LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLI 168

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (268), Expect = 8e-27
 Identities = 36/151 (23%), Positives = 69/151 (45%), Gaps = 4/151 (2%)

Query: 4   HTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
             E AIK ++K  +  EN+   +  E   +  L H   V +     D+  +Y  L Y   
Sbjct: 33  SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN 92

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
           G+L  +IR      E   + +  ++V AL++L    + H DLKP+NIL+ ++  +++   
Sbjct: 93  GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 152

Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
             G ++     +   + N+ V  + +   E+
Sbjct: 153 --GTAKVLSPESKQARANSFVGTAQYVSPEL 181

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (266), Expect = 2e-26
 Identities = 36/120 (30%), Positives = 64/120 (53%), Gaps = 5/120 (4%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
              VAIKCI K K  E +  S+ NEI  L  + H +IV + D      ++Y+I++   GG
Sbjct: 34  QKLVAIKCIAK-KALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGG 92

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI----KNNTLKLA 119
           +L   I      +E    + + Q++ A+K+L +  + H DLKP+N+L     +++ + ++
Sbjct: 93  ELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMIS 152

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 3e-26
 Identities = 29/117 (24%), Positives = 54/117 (46%), Gaps = 3/117 (2%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             +A K I        R + I+ E++ L   +  +IV      + +  + I +E+ DGG 
Sbjct: 32  LVMARKLIHLEIKPAIR-NQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS 90

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILI-KNNTLKLA 119
           L   ++   ++ E    +    ++  L +LRE + + H D+KP NIL+     +KL 
Sbjct: 91  LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLC 147

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  104 bits (261), Expect = 6e-26
 Identities = 30/125 (24%), Positives = 61/125 (48%), Gaps = 9/125 (7%)

Query: 4   HTEVAIKCIDKTKVS-------ENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYI 55
             E A+K ID T          +   ++ + E+  L+ +  H +I+ + D      + ++
Sbjct: 28  CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 87

Query: 56  ILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNN 114
           + +    G+L  ++     LSE + ++ +R L+  +  L + N+ H DLKP+NIL+  + 
Sbjct: 88  VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDM 147

Query: 115 TLKLA 119
            +KL 
Sbjct: 148 NIKLT 152

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  104 bits (261), Expect = 2e-25
 Identities = 33/121 (27%), Positives = 63/121 (52%), Gaps = 6/121 (4%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
                K I+     +    ++ NEI  +  LHH  ++ + D   D+  + +ILE+  GG+
Sbjct: 55  RVFVAKFINTPYPLDKY--TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE 112

Query: 65  LCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLAG 120
           L   I + + K+SE +   ++RQ    LK + E+++ H D+KP+NI+    K +++K+  
Sbjct: 113 LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIID 172

Query: 121 L 121
            
Sbjct: 173 F 173

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 7e-25
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 6/113 (5%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           HT+VA+K + +  +S + F   + E   +K L HQ +V +      +  +YII EY + G
Sbjct: 37  HTKVAVKSLKQGSMSPDAF---LAEANLMKQLQHQRLVRLYAV-VTQEPIYIITEYMENG 92

Query: 64  DLCSFIRSHE--KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            L  F+++    KL+  +      Q+   + F+ E N  H DL+  NIL+ + 
Sbjct: 93  SLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDT 145

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  100 bits (251), Expect = 1e-24
 Identities = 33/154 (21%), Positives = 57/154 (37%), Gaps = 5/154 (3%)

Query: 4   HTEVAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDE----RYVYIILE 58
           H +VA+K +      +  F      E +    L+H  IV + D    E       YI++E
Sbjct: 32  HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME 91

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKL 118
           Y DG  L   + +   ++  +  + +     AL F  +N + H D+KP NI+I       
Sbjct: 92  YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVK 151

Query: 119 AGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
                     A     + Q    +  + +   E 
Sbjct: 152 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 2e-24
 Identities = 29/127 (22%), Positives = 56/127 (44%), Gaps = 8/127 (6%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD----ERYVYII 56
            E   EVA   +   K++++       E + LK L H +IV   D        ++ + ++
Sbjct: 31  TETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV 90

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILI--K 112
            E    G L ++++  + +     + + RQ++  L+FL      + H DLK  NI I   
Sbjct: 91  TELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGP 150

Query: 113 NNTLKLA 119
             ++K+ 
Sbjct: 151 TGSVKIG 157

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 3e-24
 Identities = 28/122 (22%), Positives = 58/122 (47%), Gaps = 7/122 (5%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
                 K +      +        EI  L +  H++I+ + +       + +I E+  G 
Sbjct: 30  KKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNILHLHESFESMEELVMIFEFISGL 86

Query: 64  DLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI---KNNTLKLA 119
           D+   I +   +L+E +   +V Q+  AL+FL  +N+ HFD++P+NI+    +++T+K+ 
Sbjct: 87  DIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKII 146

Query: 120 GL 121
             
Sbjct: 147 EF 148

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.7 bits (248), Expect = 3e-24
 Identities = 41/128 (32%), Positives = 61/128 (47%), Gaps = 12/128 (9%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE--RYVYIILEYCD 61
              +  K +D   ++E     +V+E+  L+ L H +IV   D + D     +YI++EYC+
Sbjct: 29  GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 88

Query: 62  GGDLCSFIRSHEK----LSEFQCQQFVRQLVLALKFLRE-----NNVCHFDLKPQNILI- 111
           GGDL S I    K    L E    + + QL LALK         + V H DLKP N+ + 
Sbjct: 89  GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 148

Query: 112 KNNTLKLA 119
               +KL 
Sbjct: 149 GKQNVKLG 156

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  100 bits (250), Expect = 7e-24
 Identities = 28/121 (23%), Positives = 54/121 (44%), Gaps = 5/121 (4%)

Query: 4   HTEVAIKCIDKTKVS----ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
               A+KC+DK ++     E    +    +  +       IV M         +  IL+ 
Sbjct: 29  GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 88

Query: 60  CDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
            +GGDL   +  H   SE   + +  +++L L+ +    V + DLKP NIL+ ++  +++
Sbjct: 89  MNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRI 148

Query: 119 A 119
           +
Sbjct: 149 S 149

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.2 bits (244), Expect = 9e-24
 Identities = 32/117 (27%), Positives = 60/117 (51%), Gaps = 8/117 (6%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-YVYIILEYCDGG 63
            +VA+KCI     ++    + + E   +  L H ++V +L  + +E+  +YI+ EY   G
Sbjct: 31  NKVAVKCIKNDATAQ----AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86

Query: 64  DLCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLK 117
            L  ++RS  +  L      +F   +  A+++L  NN  H DL  +N+L+ ++N  K
Sbjct: 87  SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAK 143

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.1 bits (241), Expect = 2e-23
 Identities = 29/117 (24%), Positives = 56/117 (47%), Gaps = 5/117 (4%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
            +VAIK I +  +SE+ F   + E K +  L H+ +V +      +R ++II EY   G 
Sbjct: 29  YDVAIKMIKEGSMSEDEF---IEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGC 85

Query: 65  LCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           L +++     +    Q  +  + +  A+++L      H DL  +N L+     +K++
Sbjct: 86  LLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVS 142

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.4 bits (242), Expect = 2e-23
 Identities = 32/111 (28%), Positives = 57/111 (51%), Gaps = 3/111 (2%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
             EVAI+ ++  +  + + + I+NEI  ++   + +IV  LD       +++++EY  GG
Sbjct: 45  GQEVAIRQMNLQQ--QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGG 102

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            L   +     + E Q     R+ + AL+FL  N V H D+K  NIL+  +
Sbjct: 103 SLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.7 bits (240), Expect = 3e-23
 Identities = 24/110 (21%), Positives = 53/110 (48%), Gaps = 1/110 (0%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             VA+K +          D ++ E   ++ L + +IV M+     E +  +++E  + G 
Sbjct: 35  KTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGP 93

Query: 65  LCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           L  +++ +  + +    + V Q+ + +K+L E+N  H DL  +N+L+   
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQ 143

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.5 bits (242), Expect = 4e-23
 Identities = 29/113 (25%), Positives = 54/113 (47%), Gaps = 2/113 (1%)

Query: 4   HTEVAIKCIDKTKV-SENRFDSIVNEIKALKL-LHHQHIVTMLDFLWDERYVYIILEYCD 61
           +   AIK + K  V  ++  +  + E + L L   H  +  M      +  ++ ++EY +
Sbjct: 27  NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN 86

Query: 62  GGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           GGDL   I+S  K    +   +  +++L L+FL    + + DLK  NIL+  +
Sbjct: 87  GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 139

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.3 bits (239), Expect = 4e-23
 Identities = 37/144 (25%), Positives = 63/144 (43%), Gaps = 7/144 (4%)

Query: 4   HTEVAIKCIDKTKVSENRFDS----IVNEIKALKLLHHQH--IVTMLDFLWDERYVYIIL 57
           +  VAIK ++K ++S+         +  E+  LK +      ++ +LD+        +IL
Sbjct: 29  NLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL 88

Query: 58  EYCDGG-DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTL 116
           E  +   DL  FI     L E   + F  Q++ A++      V H D+K +NILI  N  
Sbjct: 89  ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRG 148

Query: 117 KLAGLKQGVSEKAKGSAYIEQGNT 140
           +L  +  G     K + Y +   T
Sbjct: 149 ELKLIDFGSGALLKDTVYTDFDGT 172

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.7 bits (240), Expect = 9e-23
 Identities = 25/118 (21%), Positives = 55/118 (46%), Gaps = 14/118 (11%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWD----ERYVYIILE 58
             + A+K +               E++   +     HIV ++D   +     + + I++E
Sbjct: 37  QEKFALKMLQDCP-------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVME 89

Query: 59  YCDGGDLCSFIRSH--EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
             DGG+L S I+    +  +E +  + ++ +  A+++L   N+ H D+KP+N+L  + 
Sbjct: 90  CLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK 147

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.1 bits (236), Expect = 9e-23
 Identities = 27/117 (23%), Positives = 55/117 (47%), Gaps = 5/117 (4%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
            +VAIK I +  +SE  F   + E + +  L H  +V +     ++  + ++ E+ + G 
Sbjct: 30  DKVAIKTIREGAMSEEDF---IEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGC 86

Query: 65  LCSFIRSHEKL-SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           L  ++R+   L +          +   + +L E  V H DL  +N L+ +N  +K++
Sbjct: 87  LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVS 143

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 95.3 bits (236), Expect = 1e-22
 Identities = 34/120 (28%), Positives = 55/120 (45%), Gaps = 1/120 (0%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           N      A+K I   K  E    + + EI  LK L H +IV + D +  ++ + ++ E+ 
Sbjct: 23  NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHL 82

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           D             L     + F+ QL+  + +  +  V H DLKPQN+LI +   LK+A
Sbjct: 83  DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIA 142

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.4 bits (234), Expect = 3e-22
 Identities = 24/115 (20%), Positives = 55/115 (47%), Gaps = 3/115 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++  +VAIK + +    +   + ++ E + +  L + +IV ++        + +++E  
Sbjct: 33  RKKQIDVAIKVLKQ-GTEKADTEEMMREAQIMHQLDNPYIVRLIGV-CQAEALMLVMEMA 90

Query: 61  DGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            GG L  F+    + +      + + Q+ + +K+L E N  H DL  +N+L+ N 
Sbjct: 91  GGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNR 145

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 94.0 bits (233), Expect = 4e-22
 Identities = 37/157 (23%), Positives = 69/157 (43%), Gaps = 8/157 (5%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
             VA+K + +  +    F   + E   +K + H ++V +L     E   YII E+   G+
Sbjct: 43  LTVAVKTLKEDTMEVEEF---LKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99

Query: 65  LCSFI--RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
           L  ++   + +++S         Q+  A+++L + N  H DL  +N L+ +N+ +K+A  
Sbjct: 100 LLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 159

Query: 122 KQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTS 158
             G+S    G  Y      K       P  +  +K S
Sbjct: 160 --GLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.8 bits (232), Expect = 5e-22
 Identities = 31/120 (25%), Positives = 60/120 (50%), Gaps = 4/120 (3%)

Query: 4   HTEVAIKCIDKTKVSENR---FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +  VAIK I     SE +     + + EIK L+ L H +I+ +LD    +  + ++ ++ 
Sbjct: 23  NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           +         +   L+    + ++   +  L++L ++ + H DLKP N+L+ +N  LKLA
Sbjct: 83  ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLA 142

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 8e-22
 Identities = 23/120 (19%), Positives = 57/120 (47%), Gaps = 2/120 (1%)

Query: 4   HTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
               A+K + K  + +++     V E + L+   H  +  +         +  ++EY +G
Sbjct: 30  GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG 89

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGL 121
           G+L   +      +E + + +  ++V AL++L   +V + D+K +N+++ K+  +K+   
Sbjct: 90  GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 93.3 bits (231), Expect = 9e-22
 Identities = 29/121 (23%), Positives = 57/121 (47%), Gaps = 3/121 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++   VAIK +     +E +    ++E   +    H +++ +   +     V II E+ 
Sbjct: 51  GKREIFVAIKTLKS-GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFM 109

Query: 61  DGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
           + G L SF+R ++   +  Q    +R +   +K+L + N  H DL  +NIL+  N   K+
Sbjct: 110 ENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKV 169

Query: 119 A 119
           +
Sbjct: 170 S 170

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.9 bits (230), Expect = 1e-21
 Identities = 33/133 (24%), Positives = 55/133 (41%), Gaps = 20/133 (15%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEY 59
           ++    VA+K +  +     R +++++E+K L  L +H +IV +L          +I EY
Sbjct: 50  SDAAMTVAVKMLKPSAHLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEY 108

Query: 60  CDGGDLCSFIRSHE------------------KLSEFQCQQFVRQLVLALKFLRENNVCH 101
           C  GDL +F+R                      L       F  Q+   + FL   N  H
Sbjct: 109 CCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIH 168

Query: 102 FDLKPQNILIKNN 114
            DL  +NIL+ + 
Sbjct: 169 RDLAARNILLTHG 181

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 92.8 bits (230), Expect = 2e-21
 Identities = 31/118 (26%), Positives = 63/118 (53%), Gaps = 2/118 (1%)

Query: 5   TEVAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
              A+K + K  V   +  +   +E   L ++ H  I+ M     D + +++I++Y +GG
Sbjct: 30  RYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG 89

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAG 120
           +L S +R  ++      + +  ++ LAL++L   ++ + DLKP+NIL+ KN  +K+  
Sbjct: 90  ELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITD 147

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 3e-21
 Identities = 28/124 (22%), Positives = 61/124 (49%), Gaps = 9/124 (7%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--------ERYVYII 56
            +VA+K +      E    + + EIK L+LL H+++V +++            +  +Y++
Sbjct: 36  QKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV 95

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNT 115
            ++C+            K +  + ++ ++ L+  L ++  N + H D+K  N+LI ++  
Sbjct: 96  FDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGV 155

Query: 116 LKLA 119
           LKLA
Sbjct: 156 LKLA 159

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 3e-21
 Identities = 31/130 (23%), Positives = 58/130 (44%), Gaps = 12/130 (9%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
           +E  T VAIK +++      R    +NE   +K  +  H+V +L  +   +   +I+E  
Sbjct: 47  DEPETRVAIKTVNEAASMRER-IEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELM 105

Query: 61  DGGDLCSFIRSHEK----------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
             GDL S++RS              S  +  Q   ++   + +L  N   H DL  +N +
Sbjct: 106 TRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM 165

Query: 111 I-KNNTLKLA 119
           + ++ T+K+ 
Sbjct: 166 VAEDFTVKIG 175

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.7 bits (227), Expect = 3e-21
 Identities = 34/122 (27%), Positives = 66/122 (54%), Gaps = 4/122 (3%)

Query: 5   TEVAIKCIDKTKVSENR----FDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            + A K I K +   +R     + I  E+  LK + H +++T+ +   ++  V +ILE  
Sbjct: 36  LQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELV 95

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAG 120
            GG+L  F+   E L+E +  +F++Q++  + +L    + HFDLKP+NI++ +  +    
Sbjct: 96  AGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPR 155

Query: 121 LK 122
           +K
Sbjct: 156 IK 157

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.4 bits (226), Expect = 6e-21
 Identities = 32/134 (23%), Positives = 62/134 (46%), Gaps = 25/134 (18%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
            +VA+K + +   S  R +++++E+K + +L  H++IV +L        +Y+I EYC  G
Sbjct: 68  IQVAVKMLKEKADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYG 126

Query: 64  DLCSFIRSHEK-----------------------LSEFQCQQFVRQLVLALKFLRENNVC 100
           DL +++RS  +                       L+      F  Q+   ++FL   +  
Sbjct: 127 DLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCV 186

Query: 101 HFDLKPQNILIKNN 114
           H DL  +N+L+ + 
Sbjct: 187 HRDLAARNVLVTHG 200

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.8 bits (222), Expect = 1e-20
 Identities = 22/116 (18%), Positives = 50/116 (43%), Gaps = 3/116 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEY 59
           + +   VA+KC+    +S+    D  + E+ A+  L H++++ +   +     + ++ E 
Sbjct: 33  SGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PMKMVTEL 91

Query: 60  CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
              G L   +R H+         ++  Q+   + +L      H DL  +N+L+   
Sbjct: 92  APLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATR 147

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 91.0 bits (225), Expect = 1e-20
 Identities = 31/112 (27%), Positives = 61/112 (54%), Gaps = 1/112 (0%)

Query: 4   HTEVAIKCIDKTKVSENRF-DSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDG 62
               A+K +DK KV + +  +  +NE + L+ ++   +V +     D   +Y+++EY  G
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           G++ S +R   + SE   + +  Q+VL  ++L   ++ + DLKP+N+LI   
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.5 bits (218), Expect = 3e-20
 Identities = 44/138 (31%), Positives = 64/138 (46%), Gaps = 1/138 (0%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           H  VA+K +      E    S + EI  LK L H++IV + D L  ++ + ++ E+CD  
Sbjct: 27  HEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQD 86

Query: 64  DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLAGLK 122
               F   +  L     + F+ QL+  L F    NV H DLKPQN+LI +N  LKLA   
Sbjct: 87  LKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFG 146

Query: 123 QGVSEKAKGSAYIEQGNT 140
              +       Y  +  T
Sbjct: 147 LARAFGIPVRCYSAEVVT 164

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.8 bits (217), Expect = 4e-20
 Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 7/118 (5%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGD 64
           T VAIK +    +S   F   + E + +K L H+ +V +   + +E   YI+ EY   G 
Sbjct: 42  TRVAIKTLKPGTMSPEAF---LQEAQVMKKLRHEKLVQLYAVVSEEPI-YIVTEYMSKGS 97

Query: 65  LCSFIRSHEK--LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKLA 119
           L  F++      L   Q      Q+   + ++   N  H DL+  NIL+ +N   K+A
Sbjct: 98  LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVA 155

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.7 bits (219), Expect = 5e-20
 Identities = 29/117 (24%), Positives = 63/117 (53%), Gaps = 3/117 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENR--FDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIIL 57
           ++     A+K + K  + +     +    E + L+ +     +VT+      E  +++IL
Sbjct: 49  HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL 108

Query: 58  EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           +Y +GG+L + +   E+ +E + Q +V ++VLAL+ L +  + + D+K +NIL+ +N
Sbjct: 109 DYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSN 165

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 9e-20
 Identities = 31/121 (25%), Positives = 54/121 (44%), Gaps = 3/121 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            ++   VAIK +      + R D  + E   +    H +I+ +   +   + + II EY 
Sbjct: 33  GKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYM 91

Query: 61  DGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
           + G L  F+R  +   S  Q    +R +   +K+L   N  H DL  +NIL+  N   K+
Sbjct: 92  ENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKV 151

Query: 119 A 119
           +
Sbjct: 152 S 152

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 9e-20
 Identities = 34/137 (24%), Positives = 58/137 (42%), Gaps = 19/137 (13%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKAL-KLLHHQHIVTMLDFLWDERYVYIILEY 59
           +    + AIK + +   S++       E++ L KL HH +I+ +L       Y+Y+ +EY
Sbjct: 34  DGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 92

Query: 60  CDGGDLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFD 103
              G+L  F+R                    LS  Q   F   +   + +L +    H D
Sbjct: 93  APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRD 152

Query: 104 LKPQNILI-KNNTLKLA 119
           L  +NIL+ +N   K+A
Sbjct: 153 LAARNILVGENYVAKIA 169

>d2nn6f1 d.14.1.4 (F:29-175) Exosome complex exonuclease MTR3 {Human (Homo sapiens) [TaxId: 9606]} Length = 147

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease MTR3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 83.4 bits (205), Expect = 1e-19
 Identities = 50/134 (37%), Positives = 74/134 (55%), Gaps = 8/134 (5%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPRE-IPSSKTSLEYQR-------SKGELYVEF 172
            + G+  +AKGSAY+E G TKV+C+V  PR+     +               +G L  +F
Sbjct: 13  ARAGLLSQAKGSAYLEAGGTKVLCAVSGPRQAEGGERGGGPAGAGGEAPAALRGRLLCDF 72

Query: 173 KFAPFASQIRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSA 232
           + APFA + R       EE+EL   L+ ALEPAV    +   Q+++  L+L++ GSAL+A
Sbjct: 73  RRAPFAGRRRRAPPGGCEERELALALQEALEPAVRLGRYPRAQLEVSALLLEDGGSALAA 132

Query: 233 AINCANLALVDAAI 246
           A+  A LAL DA +
Sbjct: 133 ALTAAALALADAGV 146

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.6 bits (216), Expect = 1e-19
 Identities = 31/117 (26%), Positives = 57/117 (48%), Gaps = 8/117 (6%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF------LWDERYVYIIL 57
             +VAIK + +   SE        E++ LK + H++++ +LD       L D    Y+++
Sbjct: 43  GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVM 102

Query: 58  EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
            +   G     +  HEKL E + Q  V Q++  L+++    + H DLKP N+ +  +
Sbjct: 103 PFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 157

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.4 bits (213), Expect = 1e-19
 Identities = 30/112 (26%), Positives = 46/112 (41%), Gaps = 3/112 (2%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
                 VAIK          R +  + E   ++   H HIV ++     E  V+II+E C
Sbjct: 32  ENPALAVAIKTCKNCTSDSVR-EKFLQEALTMRQFDHPHIVKLIGV-ITENPVWIIMELC 89

Query: 61  DGGDLCSFI-RSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI 111
             G+L SF+      L       +  QL  AL +L      H D+  +N+L+
Sbjct: 90  TLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV 141

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.2 bits (215), Expect = 2e-19
 Identities = 32/120 (26%), Positives = 60/120 (50%), Gaps = 15/120 (12%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLW------DERYVYIILE 58
             VAIK + + K  +NR      E++ ++ L H +IV +  F +      DE Y+ ++L+
Sbjct: 46  ELVAIKKVLQDKRFKNR------ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD 99

Query: 59  YCDGG---DLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT 115
           Y           + R+ + L     + ++ QL  +L ++    +CH D+KPQN+L+  +T
Sbjct: 100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDT 159

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 86.4 bits (213), Expect = 2e-19
 Identities = 37/177 (20%), Positives = 65/177 (36%), Gaps = 28/177 (15%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYC 60
            E  T VA+K + +   ++ +      E   +    + +IV +L      + + ++ EY 
Sbjct: 40  YEPFTMVAVKMLKEEASADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYM 98

Query: 61  DGGDLCSFIRSHEK------------------------LSEFQCQQFVRQLVLALKFLRE 96
             GDL  F+RS                           LS  +     RQ+   + +L E
Sbjct: 99  AYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE 158

Query: 97  NNVCHFDLKPQNILI-KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI 152
               H DL  +N L+ +N  +K+A    G+S     + Y +      I   + P E 
Sbjct: 159 RKFVHRDLATRNCLVGENMVVKIADF--GLSRNIYSADYYKADGNDAIPIRWMPPES 213

>d1e3ha3 d.14.1.4 (A:346-482) Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 1 and 4 {Streptomyces antibioticus [TaxId: 1890]} Length = 137

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 1 and 4
species: Streptomyces antibioticus [TaxId: 1890]

 Score = 82.2 bits (202), Expect = 2e-19
 Identities = 20/126 (15%), Positives = 47/126 (37%), Gaps = 1/126 (0%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
               +  GSA  E+G T+++            +       ++      + F P++     
Sbjct: 11  EAIPRVHGSALFERGETQILGVTTLNMLRMEQQLDTLSPVTRKRYMHNYNFPPYSVGETG 70

Query: 184 GWLR-DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALV 242
                   E   G   +RA+ P +   E   + +      L ++GS    ++  + ++L+
Sbjct: 71  RVGSPKRREIGHGALAERAIVPVLPTREEFPYAIRQVSEALGSNGSTSMGSVCASTMSLL 130

Query: 243 DAAIPM 248
           +A +P+
Sbjct: 131 NAGVPL 136

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 6e-19
 Identities = 33/112 (29%), Positives = 52/112 (46%), Gaps = 1/112 (0%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
              VA+K I     +E    + + EI  LK L+H +IV +LD +  E  +Y++ E+    
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86

Query: 64  DLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
                  S    +     + ++ QL+  L F   + V H DLKPQN+LI   
Sbjct: 87  LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 138

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 1e-18
 Identities = 33/124 (26%), Positives = 55/124 (44%), Gaps = 7/124 (5%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYV----YII 56
           N     VAIK I   +  +      + EIK L    H++I+ + D +            +
Sbjct: 30  NVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYL 88

Query: 57  LEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNT 115
           + +  G DL   +++   LS      F+ Q++  LK++   NV H DLKP N+L+     
Sbjct: 89  VTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCD 147

Query: 116 LKLA 119
           LK+ 
Sbjct: 148 LKIC 151

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.1 bits (207), Expect = 1e-18
 Identities = 26/127 (20%), Positives = 59/127 (46%), Gaps = 18/127 (14%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGG 63
           T+VA+K +     +E     +++E++ +K +  H++I+ +L     +  +Y+I+EY   G
Sbjct: 46  TKVAVKMLKS-DATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKG 104

Query: 64  DLCSFIRSH----------------EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L  ++++                 E+LS         Q+   +++L      H DL  +
Sbjct: 105 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164

Query: 108 NILIKNN 114
           N+L+  +
Sbjct: 165 NVLVTED 171

>d2je6b1 d.14.1.4 (B:8-155) Exosome complex exonuclease 1, ECX1 {Sulfolobus solfataricus [TaxId: 2287]} Length = 148

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease 1, ECX1
species: Sulfolobus solfataricus [TaxId: 2287]

 Score = 80.2 bits (197), Expect = 1e-18
 Identities = 43/123 (34%), Positives = 61/123 (49%), Gaps = 3/123 (2%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV + A GSA  E GNTK I +V+ P+E+     SL  +     L V +   PF++  R 
Sbjct: 29  GVLKNADGSAIFEMGNTKAIAAVYGPKEMHPRHLSLPDR---AVLRVRYHMTPFSTDERK 85

Query: 184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
                  E EL   ++ ALE AV    F    +D+F  +LQ D  +   ++  A+LAL D
Sbjct: 86  NPAPSRREIELSKVIREALESAVLVELFPRTAIDVFTEILQADAGSRLVSLMAASLALAD 145

Query: 244 AAI 246
           A I
Sbjct: 146 AGI 148

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 83.7 bits (206), Expect = 2e-18
 Identities = 27/121 (22%), Positives = 59/121 (48%), Gaps = 13/121 (10%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALK-LLHHQHIVTMLDFLWD--ERYVYIILEYC 60
           + +V +K +   K  +     I  EIK L+ L    +I+T+ D + D   R   ++ E+ 
Sbjct: 60  NEKVVVKILKPVKKKK-----IKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHV 114

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI--KNNTLKL 118
           +  D     +    L+++  + ++ +++ AL +     + H D+KP N++I  ++  L+L
Sbjct: 115 NNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRL 171

Query: 119 A 119
            
Sbjct: 172 I 172

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 83.0 bits (204), Expect = 3e-18
 Identities = 23/112 (20%), Positives = 41/112 (36%), Gaps = 5/112 (4%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDG 62
             EVAIK        + +   +  E K  K++     I T+     +  Y  +++E    
Sbjct: 32  GEEVAIKLECV----KTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGP 87

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
                F     K S         Q++  ++++   N  H D+KP N L+   
Sbjct: 88  SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 139

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (201), Expect = 7e-18
 Identities = 30/120 (25%), Positives = 51/120 (42%), Gaps = 9/120 (7%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL---HHQHIVTMLDFLWDER-----YVYI 55
              VA+K +      E    S + E+  L+ L    H ++V + D     R      + +
Sbjct: 33  GRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 92

Query: 56  ILEYCDGGDLCSFIRSHEK-LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           + E+ D        +  E  +     +  + QL+  L FL  + V H DLKPQNIL+ ++
Sbjct: 93  VFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSS 152

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.8 bits (201), Expect = 8e-18
 Identities = 20/113 (17%), Positives = 42/113 (37%), Gaps = 2/113 (1%)

Query: 7   VAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLC 66
           VAIK + +   S      I++E   +  + + H+  +L          I      G  L 
Sbjct: 41  VAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLD 99

Query: 67  SFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLKL 118
                 + +       +  Q+   + +L +  + H DL  +N+L+     +K+
Sbjct: 100 YVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKI 152

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.5 bits (200), Expect = 1e-17
 Identities = 26/112 (23%), Positives = 53/112 (47%), Gaps = 6/112 (5%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYV-----YIILE 58
              VA+K + +   S         E++ LK + H++++ +LD     R +       ++ 
Sbjct: 43  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT 102

Query: 59  YCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNIL 110
           +  G D  + I   +KL++   Q  + Q++  LK++   ++ H DLKP N+ 
Sbjct: 103 HLMGAD-LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 153

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.3 bits (197), Expect = 2e-17
 Identities = 31/173 (17%), Positives = 65/173 (37%), Gaps = 17/173 (9%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER----YVYIILEYC 60
            EVA+K     +      +    EI    +L H++I+  +     +      ++++ +Y 
Sbjct: 27  EEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83

Query: 61  DGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFL--------RENNVCHFDLKPQNILI- 111
           + G L  ++  +  ++     +        L  L         +  + H DLK +NIL+ 
Sbjct: 84  EHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK 142

Query: 112 KNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRS 164
           KN T  +A L   V   +         N +V    +   E+     ++++  S
Sbjct: 143 KNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFES 195

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.2 bits (197), Expect = 2e-17
 Identities = 28/122 (22%), Positives = 54/122 (44%), Gaps = 4/122 (3%)

Query: 1   NEQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF-LWDERYVYIILEY 59
           + +    A+K +++           + E   +K   H +++++L   L  E    ++L Y
Sbjct: 52  DGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPY 110

Query: 60  CDGGDLCSFIRSHE-KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILI-KNNTLK 117
              GDL +FIR+     +      F  Q+   +KFL      H DL  +N ++ +  T+K
Sbjct: 111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK 170

Query: 118 LA 119
           +A
Sbjct: 171 VA 172

>d2ba0d1 d.14.1.4 (D:10-153) Exosome complex exonuclease 1, ECX1 {Archaeoglobus fulgidus [TaxId: 2234]} Length = 144

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease 1, ECX1
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 76.0 bits (186), Expect = 4e-17
 Identities = 40/126 (31%), Positives = 63/126 (50%), Gaps = 3/126 (2%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           ++  V ++A GS Y+E G  KVI +VF PRE+         +     +   +  APF+ +
Sbjct: 22  IEASVLKRADGSCYLEMGKNKVIAAVFGPREVHPRHLQDPSK---AIIRYRYNMAPFSVE 78

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLA 240
            R     D    E+    K A E  + +  F    +D+FV VLQ D  + +A +N A++A
Sbjct: 79  ERKRPGPDRRSIEISKVSKEAFEAVIMKELFPRSAIDIFVEVLQADAGSRTACLNAASVA 138

Query: 241 LVDAAI 246
           LVDA +
Sbjct: 139 LVDAGV 144

>d2nn6d1 d.14.1.4 (D:25-146) Exosome complex exonuclease RRP46 {Human (Homo sapiens) [TaxId: 9606]} Length = 122

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP46
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 75.1 bits (184), Expect = 5e-17
 Identities = 26/127 (20%), Positives = 46/127 (36%), Gaps = 14/127 (11%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
            +Q +  +  GSA   QG+T V+  V                +   E++     A     
Sbjct: 9   CEQNLLSRPDGSASFLQGDTSVLAGV----------YGPAEVKVSKEIF---NKATLEVI 55

Query: 181 IRTGWLRDSEE-KELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANL 239
           +R          K     ++   E  V         + + + V+ + GS L+  +N A +
Sbjct: 56  LRPKIGLPGVAEKSRERLIRNTCEAVVLGTLHPRTSITVVLQVVSDAGSLLACCLNAACM 115

Query: 240 ALVDAAI 246
           ALVDA +
Sbjct: 116 ALVDAGV 122

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.8 bits (193), Expect = 1e-16
 Identities = 25/117 (21%), Positives = 54/117 (46%), Gaps = 9/117 (7%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDF------LWDERYVYIIL 57
              VAIK + +   ++        E+  +K ++H++I+++L+       L + + VY+++
Sbjct: 42  DRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 101

Query: 58  EYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN 114
           E  D                 +    + Q++  +K L    + H DLKP NI++K++
Sbjct: 102 ELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD 155

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 77.2 bits (189), Expect = 2e-16
 Identities = 22/118 (18%), Positives = 46/118 (38%), Gaps = 5/118 (4%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDG 62
           + +VAIK   +   +      + +E +  KLL     I  +  F  +  +  ++++    
Sbjct: 30  NQQVAIKFEPRRSDAPQ----LRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGP 85

Query: 63  GDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAG 120
                      K S        +Q++  ++ + E ++ + D+KP N LI     K A 
Sbjct: 86  SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNAN 143

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.1 bits (186), Expect = 7e-16
 Identities = 26/133 (19%), Positives = 53/133 (39%), Gaps = 18/133 (13%)

Query: 5   TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-RYVYIILEYCDGG 63
             VA+K + +          +      + + HH ++V +L         + +I+E+C  G
Sbjct: 44  RTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 103

Query: 64  DLCSFIRSHEK----------------LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQ 107
           +L +++RS                   L+      +  Q+   ++FL      H DL  +
Sbjct: 104 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163

Query: 108 NILI-KNNTLKLA 119
           NIL+ + N +K+ 
Sbjct: 164 NILLSEKNVVKIC 176

>d2ba0g1 d.14.1.4 (G:3-178) Exosome complex exonuclease 2,ECX2 {Archaeoglobus fulgidus [TaxId: 2234]} Length = 176

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease 2,ECX2
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 72.0 bits (176), Expect = 2e-15
 Identities = 34/140 (24%), Positives = 54/140 (38%), Gaps = 13/140 (9%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           +   V EKA+GSA ++ G+T+V+  V      P   T       +G + V  +  P AS 
Sbjct: 35  IIPNVIEKAEGSALVKLGDTQVVVGVKMQPGEPYPDTP-----DRGVIIVNAELVPLASP 89

Query: 181 IRTGWLRDSEEKELGNHLKRA--------LEPAVCRHEFSNFQVDLFVLVLQNDGSALSA 232
                  D    EL   + R         L   V       + V + +  L +DG+ L A
Sbjct: 90  TFEPGPPDENSIELARVVDRGIRESEAVDLSKLVIEEGEKVWIVFVDIHALDDDGNLLDA 149

Query: 233 AINCANLALVDAAIPMYDLV 252
           +   A  AL++  +P     
Sbjct: 150 SALAAIAALMNTKVPAERFD 169

>d2nn6b1 d.14.1.4 (B:6-150) Exosome complex exonuclease RRP41 {Human (Homo sapiens) [TaxId: 9606]} Length = 145

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP41
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.3 bits (171), Expect = 4e-15
 Identities = 44/124 (35%), Positives = 66/124 (53%), Gaps = 3/124 (2%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
           GV  +A GSAYIEQGNTK +  V+ P EI  S+        +  +  ++  A F++  R 
Sbjct: 24  GVFAQADGSAYIEQGNTKALAVVYGPHEIRGSR--ARALPDRALVNCQYSSATFSTGERK 81

Query: 184 GWLR-DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALV 242
                D +  E+G  L++  E A+        Q+D++V VLQ DG   +A +N A LA++
Sbjct: 82  RRPHGDRKSCEMGLQLRQTFEAAILTQLHPRSQIDIYVQVLQADGGTYAACVNAATLAVL 141

Query: 243 DAAI 246
           DA I
Sbjct: 142 DAGI 145

>d1r6la1 d.14.1.4 (A:1-151) Ribonuclease PH, domain 1 {Pseudomonas aeruginosa [TaxId: 287]} Length = 151

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Ribonuclease PH, domain 1
species: Pseudomonas aeruginosa [TaxId: 287]

 Score = 69.1 bits (168), Expect = 1e-14
 Identities = 30/130 (23%), Positives = 53/130 (40%), Gaps = 9/130 (6%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
             ++ A+GS  +E G+TKVIC+V     +P                 E+   P ++  R 
Sbjct: 20  HYTKHAEGSVLVEFGDTKVICTVSAESGVPRFLKGQGQGWL----TAEYGMLPRSTGERN 75

Query: 184 GWLR-----DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCAN 238
                         E+   + R+L  A+   +     + +   V+Q DG   +A+I  A 
Sbjct: 76  QREASRGKQGGRTLEIQRLIGRSLRAALDLSKLGENTLYIDCDVIQADGGTRTASITGAT 135

Query: 239 LALVDAAIPM 248
           +AL+DA   +
Sbjct: 136 VALIDALAVL 145

>d2nn6c1 d.14.1.4 (C:7-187) Exosome complex exonuclease RRP43 {Human (Homo sapiens) [TaxId: 9606]} Length = 181

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP43
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 68.3 bits (166), Expect = 4e-14
 Identities = 28/139 (20%), Positives = 43/139 (30%), Gaps = 13/139 (9%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           +  G    A GSA ++ GNT VIC V      PS+         KG +       P  S 
Sbjct: 31  VNIGSISTADGSALVKLGNTTVICGVKAEFAAPST-----DAPDKGYVVPNVDLPPLCSS 85

Query: 181 IRTGWLRDSEEKELGNHLKR--------ALEPAVCRHEFSNFQVDLFVLVLQNDGSALSA 232
                    E +     +            E          + +   ++ L  DG+ L A
Sbjct: 86  RFRSGPPGEEAQVASQFIADVIENSQIIQKEDLCISPGKLVWVLYCDLICLDYDGNILDA 145

Query: 233 AINCANLALVDAAIPMYDL 251
                  AL +  +P   +
Sbjct: 146 CTFALLAALKNVQLPEVTI 164

>d2nn6e1 d.14.1.4 (E:5-191) Exosome complex exonuclease RRP42 {Human (Homo sapiens) [TaxId: 9606]} Length = 187

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP42
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 67.8 bits (165), Expect = 7e-14
 Identities = 26/140 (18%), Positives = 48/140 (34%), Gaps = 13/140 (9%)

Query: 121 LKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQ 180
           ++  V     GSA ++ G+T ++  V      P  +       ++G L      +  A+ 
Sbjct: 33  VETDVVSNTSGSARVKLGHTDILVGVKAEMGTPKLEKP-----NEGYLEFFVDCSASATP 87

Query: 181 IRTGWLRDSEEKELGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALSA 232
              G   D    E+ N L R                     + + + VL+L+  G+   A
Sbjct: 88  EFEGRGGDDLGTEIANTLYRIFNNKSSVDLKTLCISPREHCWVLYVDVLLLECGGNLFDA 147

Query: 233 AINCANLALVDAAIPMYDLV 252
                  AL +  IP   ++
Sbjct: 148 ISIAVKAALFNTRIPRVRVL 167

>d1oysa1 d.14.1.4 (A:1-151) Ribonuclease PH, domain 1 {Bacillus subtilis [TaxId: 1423]} Length = 151

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Ribonuclease PH, domain 1
species: Bacillus subtilis [TaxId: 1423]

 Score = 66.4 bits (161), Expect = 1e-13
 Identities = 30/130 (23%), Positives = 46/130 (35%), Gaps = 9/130 (6%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
                 +GS  I  GNTKVIC+      +P                 E+   P A+  +T
Sbjct: 19  DFISHPEGSVLITAGNTKVICNASVEDRVPPFLRGGGKGWI----TAEYSMLPQATNQQT 74

Query: 184 GWLR-----DSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCAN 238
                         E+   + RAL   V   +     + +   V+Q DG   +A+I  A 
Sbjct: 75  IQESSKGKISGRTMEIQRLIGRALRAVVDLEKLGERTIWIDCDVIQADGGTRTASITGAF 134

Query: 239 LALVDAAIPM 248
           LA+  A   +
Sbjct: 135 LAMAIAIGKL 144

>d2nn6a1 d.14.1.4 (A:1-184) Exosome complex exonuclease RRP45 {Human (Homo sapiens) [TaxId: 9606]} Length = 184

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP45
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 64.0 bits (155), Expect = 1e-12
 Identities = 26/153 (16%), Positives = 52/153 (33%), Gaps = 20/153 (13%)

Query: 128 KAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLR 187
              G   +E G T+V+  V      P    +     ++G L+   + +  A+       +
Sbjct: 41  TDYGCCIVELGKTRVLGQVSCELVSPKLNRA-----TEGILFFNLELSQMAAPAFEPGRQ 95

Query: 188 DSEEKELGNHLKRA--------LEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANL 239
                +L   ++R          E          +Q+ + + +L +DG+ + AA   A +
Sbjct: 96  SDLLVKLNRLMERCLRNSKCIDTESLCVVAGEKVWQIRVDLHLLNHDGNIIDAASIAAIV 155

Query: 240 ALVDAAIPMYDLVTSSTLALRGGLTFIDPVEEE 272
           AL     P   +           +T   P E +
Sbjct: 156 ALCHFRRPDVSVQG-------DEVTLYTPEERD 181

>d1udsa1 d.14.1.4 (A:2-150) Ribonuclease PH, domain 1 {Aquifex aeolicus [TaxId: 63363]} Length = 149

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Ribonuclease PH, domain 1
species: Aquifex aeolicus [TaxId: 63363]

 Score = 62.6 bits (151), Expect = 2e-12
 Identities = 29/126 (23%), Positives = 46/126 (36%), Gaps = 1/126 (0%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGEL-YVEFKFAPFASQIR 182
              E  +GS  I  G TKVIC+      +P+            E   +         +  
Sbjct: 18  DFLEYPEGSCLISFGKTKVICTASVIENVPNWLKGKGQGWITAEYSMLPRATQQRTIRES 77

Query: 183 TGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALV 242
                     E+   + RA+  AV   +     + +   V+Q DG   +AAI  A +A+ 
Sbjct: 78  VQGRIGGRTHEIQRMIGRAMRTAVELTKIGERTIWVDCDVIQADGGTATAAITGAFVAVA 137

Query: 243 DAAIPM 248
           DA I +
Sbjct: 138 DAIIKL 143

>d2je6a1 d.14.1.4 (A:1-191) Exosome complex exonuclease 2,ECX2 {Sulfolobus solfataricus [TaxId: 2287]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease 2,ECX2
species: Sulfolobus solfataricus [TaxId: 2287]

 Score = 62.5 bits (151), Expect = 4e-12
 Identities = 31/135 (22%), Positives = 50/135 (37%), Gaps = 13/135 (9%)

Query: 124 GVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT 183
             ++KA GSA ++ G T V+       + P   T      ++G L V  +  P A +   
Sbjct: 45  DYAKKADGSALVKLGTTMVLAGTKLEIDKPYEDTP-----NQGNLIVNVELLPLAYETFE 99

Query: 184 GWLRDSEEKELGNHLKRALEPAVCR--------HEFSNFQVDLFVLVLQNDGSALSAAIN 235
               D    EL   + R+L  +              S + V L V VL   G+ L A   
Sbjct: 100 PGPPDENAIELARVVDRSLRDSKALDLTKLVIEPGKSVWTVWLDVYVLDYGGNVLDACTL 159

Query: 236 CANLALVDAAIPMYD 250
            +  AL +  +   +
Sbjct: 160 ASVAALYNTKVYKVE 174

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 58.1 bits (139), Expect = 8e-10
 Identities = 28/128 (21%), Positives = 57/128 (44%), Gaps = 20/128 (15%)

Query: 4   HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH-----------QHIVTMLDFL--WDE 50
           +T VA+K +   KV     +   +EIK L+ ++             HI+ +LD       
Sbjct: 38  NTHVAMKIVRGDKVYTEAAE---DEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP 94

Query: 51  RYVYIILEYCDGGDLCSFI---RSHEKLSEFQCQQFVRQLVLALKFLREN-NVCHFDLKP 106
             V++++ +   G+    +     H  +     +Q  +QL+L L ++     + H D+KP
Sbjct: 95  NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP 154

Query: 107 QNILIKNN 114
           +N+L++  
Sbjct: 155 ENVLMEIV 162

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 54.0 bits (129), Expect = 4e-09
 Identities = 22/164 (13%), Positives = 52/164 (31%), Gaps = 27/164 (16%)

Query: 1   NEQHTEVAIKCIDKTKVS-----------ENRFDSIVNE-----IKALKLLHHQHIVTML 44
           +E+  E  +K       S           +  F  +         +AL+ L    +  + 
Sbjct: 21  SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80

Query: 45  DFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDL 104
            +  +     +++E  D  +L                + +  ++  +       + H DL
Sbjct: 81  AWEGN----AVLMELIDAKELYRVR-------VENPDEVLDMILEEVAKFYHRGIVHGDL 129

Query: 105 KPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE 148
              N+L+    + +    Q V    +G   I + + + I + F 
Sbjct: 130 SQYNVLVSEEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS 173

>d1e3ha2 d.14.1.4 (A:3-151) Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 1 and 4 {Streptomyces antibioticus [TaxId: 1890]} Length = 149

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 1 and 4
species: Streptomyces antibioticus [TaxId: 1890]

 Score = 50.5 bits (120), Expect = 3e-08
 Identities = 21/124 (16%), Positives = 39/124 (31%), Gaps = 10/124 (8%)

Query: 129 AKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGW--- 185
           A GSA     +  ++ S     + P  +                +    A +I   +   
Sbjct: 31  AAGSAVAYLDDDTMVLSATTASKNPKDQ-----LDFFPLTVDVEERMYAAGKIPGSFFRR 85

Query: 186 --LRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVD 243
                 +       + R L P+  +   +  QV   ++ L  D      AIN A+ +   
Sbjct: 86  EGRPSEDAILTCRLIDRPLRPSFKKGLRNEIQVVATIMALNPDHLYDVVAINAASASTQL 145

Query: 244 AAIP 247
           A +P
Sbjct: 146 AGLP 149

>d1r29a_ d.42.1.1 (A:) B-cell lymphoma 6 (Bcl6) protein BTB domain {Human (Homo sapiens) [TaxId: 9606]} Length = 122

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: BTB/POZ domain
domain: B-cell lymphoma 6 (Bcl6) protein BTB domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.2 bits (101), Expect = 6e-06
 Identities = 22/90 (24%), Positives = 43/90 (47%), Gaps = 6/90 (6%)

Query: 352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILD--ITPE 409
            +  + +D    V      ++F+AHK +L   S +F ++F  +L        LD  I PE
Sbjct: 20  RSRDILTDVVIVVSR----EQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPE 75

Query: 410 AFSTMLDSDHHARVNISSDHHARVSISSDH 439
            F+ +LD  + +R+N+   +   V  ++ +
Sbjct: 76  GFNILLDFMYTSRLNLREGNIMAVMATAMY 105

>d1buoa_ d.42.1.1 (A:) Promyelocytic leukaemia zinc finger (PLZF) protein BTB domain {Human (Homo sapiens) [TaxId: 9606]} Length = 121

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: BTB/POZ domain
domain: Promyelocytic leukaemia zinc finger (PLZF) protein BTB domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.2 bits (83), Expect = 0.002
 Identities = 16/78 (20%), Positives = 35/78 (44%), Gaps = 7/78 (8%)

Query: 352 LNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAF 411
             +G   D    V +    +EF AH+ +L+ +S +F  +FH          +  ++P+ F
Sbjct: 23  RLAGTLCDVVIMVDS----QEFHAHRTVLACTSKMFEILFHRNSQ---HYTLDFLSPKTF 75

Query: 412 STMLDSDHHARVNISSDH 429
             +L+  + A +   ++ 
Sbjct: 76  QQILEYAYTATLQAKAED 93

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	477
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.98
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.98
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.97
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.97
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.96
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.96
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.96
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.96
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.96
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.96
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.96
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.96
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.96
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.95
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.95
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.95
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.95
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.95
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.95
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.95
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.95
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.95
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.94
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.94
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.94
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.93
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.85
d1buoa_	121	Promyelocytic leukaemia zinc finger (PLZF) protein	99.85
d1r29a_	122	B-cell lymphoma 6 (Bcl6) protein BTB domain {Human	99.84
d1e3ha3	137	Polynucleotide phosphorylase/guanosine pentaphosph	99.83
d2je6b1	148	Exosome complex exonuclease 1, ECX1 {Sulfolobus so	99.76
d2ba0d1	144	Exosome complex exonuclease 1, ECX1 {Archaeoglobus	99.76
d2nn6b1	145	Exosome complex exonuclease RRP41 {Human (Homo sap	99.74
d2nn6d1	122	Exosome complex exonuclease RRP46 {Human (Homo sap	99.74
d1udsa1	149	Ribonuclease PH, domain 1 {Aquifex aeolicus [TaxId	99.71
d2nn6f1	147	Exosome complex exonuclease MTR3 {Human (Homo sapi	99.7
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.67
d1r6la1	151	Ribonuclease PH, domain 1 {Pseudomonas aeruginosa	99.65
d1oysa1	151	Ribonuclease PH, domain 1 {Bacillus subtilis [TaxI	99.62
d2je6b2	86	Exosome complex exonuclease 1, ECX1 {Sulfolobus so	99.61
d2nn6b2	90	Exosome complex exonuclease RRP41 {Human (Homo sap	99.6
d2nn6d2	89	Exosome complex exonuclease RRP46 {Human (Homo sap	99.58
d2nn6f2	95	Exosome complex exonuclease MTR3 {Human (Homo sapi	99.48
d2ba0g1	176	Exosome complex exonuclease 2,ECX2 {Archaeoglobus	99.45
d2ba0d2	99	Exosome complex exonuclease 1, ECX1 {Archaeoglobus	99.36
d1e3ha2	149	Polynucleotide phosphorylase/guanosine pentaphosph	99.34
d2nn6c1	181	Exosome complex exonuclease RRP43 {Human (Homo sap	99.34
d2je6a1	191	Exosome complex exonuclease 2,ECX2 {Sulfolobus sol	99.34
d2nn6e1	187	Exosome complex exonuclease RRP42 {Human (Homo sap	99.33
d1r6la2	88	Ribonuclease PH, domain 2 {Pseudomonas aeruginosa	99.28
d2nn6a1	184	Exosome complex exonuclease RRP45 {Human (Homo sap	99.15
d2je6a2	84	Exosome complex exonuclease 2, ECX2 {Sulfolobus so	99.12
d1oysa2	86	Ribonuclease PH, domain 2 {Bacillus subtilis [TaxI	99.06
d1udsa2	105	Ribonuclease PH, domain 2 {Aquifex aeolicus [TaxId	99.06
d2ba0g2	79	Exosome complex exonuclease 2, ECX2 {Archaeoglobus	98.94
d2nn6c2	89	Exosome complex exonuclease RRP43 {Human (Homo sap	98.85
d2nn6e2	94	Exosome complex exonuclease RRP42 {Human (Homo sap	98.77
d2nn6a2	118	Exosome complex exonuclease RRP45 {Human (Homo sap	98.59
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.65
d1hv2a_	99	Elongin C {Baker's yeast (Saccharomyces cerevisiae	97.42
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.22
d2c9wc1	96	Elongin C {Human (Homo sapiens) [TaxId: 9606]}	97.22
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	96.35
d3kvta_	103	akv3.1 voltage-gated potassium channel {California	95.95
d1e3ha5	111	Polynucleotide phosphorylase/guanosine pentaphosph	95.71
d1e3ha6	96	Polynucleotide phosphorylase/guanosine pentaphosph	95.47
d1nn7a_	105	Potassium channel kv4.2 {Rat (Rattus norvegicus) [	95.47
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.08
d1fs1b2	61	Cyclin A/CDK2-associated p45, Skp1 {Human (Homo sa	94.11
d1t1da_	100	Shaker potassium channel {California sea hare (Apl	94.1
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	91.8
d1nexa2	72	Centromere DNA-binding protein complex Cbf3 subuni	91.58
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	83.26

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-37  Score=295.30  Aligned_cols=176  Identities=22%  Similarity=0.343  Sum_probs=147.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++++.... +..+++.+|+.+|++++||||+++++++.+++.+|||||||+||+|.+++.+++.+++..++
T Consensus        28 ~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~  106 (271)
T d1nvra_          28 VTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQ  106 (271)
T ss_dssp             TTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHH
T ss_pred             CCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHH
Confidence            57899999999766432 33467899999999999999999999999999999999999999999999887889999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||+|||++||+||||||+|||++.+. ++.++|||++.............+.+||+.|+|||++.+.    .
T Consensus       107 ~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~  185 (271)
T d1nvra_         107 RFFHQLMAGVVYLHGIGITHRDIKPENLLLDERD-NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE  185 (271)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTC-CEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHH
T ss_pred             HHHHHHHHHHHHHHHcCCccCcccHHHEEECCCC-CEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCC
Confidence            9999999999999999999999999999997643 3445599998765433333334567899999999988665    5


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|||  +..||.+.
T Consensus       186 ~~Di-wSlGvilyeml~G~~pf~~~  209 (271)
T d1nvra_         186 PVDV-WSCGIVLTAMLAGELPWDQP  209 (271)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSCSSS
T ss_pred             ceee-eHhHHHHHHHHhCCCCCCCC
Confidence            6899 9999999999  67888653

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-37  Score=295.79  Aligned_cols=173  Identities=22%  Similarity=0.299  Sum_probs=149.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+++.||+|++..........+.+.+|+++|++++||||+++++++++    +..+|+||||++||+|.+++.+.+.+++
T Consensus        32 ~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~  111 (270)
T d1t4ha_          32 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI  111 (270)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCH
T ss_pred             CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccH
Confidence            478899999998877777777889999999999999999999999875    3568999999999999999998888999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCC--cEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENN--VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~g--ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ..++.|+.||+.||+|||++|  |+||||||+|||+++....+.++|||++....++.    ..+.+||+.|+|||++.+
T Consensus       112 ~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~----~~~~~GT~~Y~aPE~~~~  187 (270)
T d1t4ha_         112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEMYEE  187 (270)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSSCCCCCGGGGGT
T ss_pred             HHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc----cCCcccCccccCHHHhCC
Confidence            999999999999999999998  99999999999997533345556999986544332    235578999999999877


Q ss_pred             C--CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K--TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~--~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .  .++|+ ||+|+++|||  +..||.+
T Consensus       188 ~~~~~~DI-wSlGvilyel~~g~~Pf~~  214 (270)
T d1t4ha_         188 KYDESVDV-YAFGMCMLEMATSEYPYSE  214 (270)
T ss_dssp             CCCTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             CCCCcCch-hhHHHHHHHHHHCCCCCCC
Confidence            6  78999 9999999999  7788864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-36  Score=286.82  Aligned_cols=172  Identities=25%  Similarity=0.389  Sum_probs=149.2

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||+|++.+.... ....+.+.+|+.++++++||||+++++++.+++.+|+|||||+||+|.+++.+.+.+++..+
T Consensus        29 ~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~  108 (263)
T d2j4za1          29 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRT  108 (263)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHH
T ss_pred             CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHH
Confidence            57899999998765432 23356789999999999999999999999999999999999999999999998889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.++.||+.||+|||++||+||||||+|||++.+ .+++  +|||++....+..    ..+..||+.|+|||++.+.   
T Consensus       109 ~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl--~DFG~a~~~~~~~----~~~~~Gt~~Y~APE~~~~~~~~  182 (263)
T d2j4za1         109 ATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKI--ADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHD  182 (263)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEE--CCCCSCSCCCCCC----CEETTEEGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEee--cccceeeecCCCc----ccccCCCCcccCHHHHcCCCCC
Confidence            9999999999999999999999999999999764 4444  5999987655432    2345789999999999876   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ ||+|+++|||  |..||.+.
T Consensus       183 ~~~Di-wSlGvilyell~G~~Pf~~~  207 (263)
T d2j4za1         183 EKVDL-WSLGVLCYEFLVGKPPFEAN  207 (263)
T ss_dssp             TTHHH-HHHHHHHHHHHHSSCTTCCS
T ss_pred             chhhh-hhHhHHHHHHhcCCCCCCCC
Confidence            78999 9999999999  77888753

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-35  Score=285.97  Aligned_cols=172  Identities=24%  Similarity=0.346  Sum_probs=147.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||+++.....  ..+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|.+++.+ +.+++..++
T Consensus        43 ~~~~~vAvK~~~~~~~~--~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~  119 (293)
T d1yhwa1          43 ATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIA  119 (293)
T ss_dssp             TTCCEEEEEEEEGGGCS--CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHH
T ss_pred             CCCCEEEEEEEecccCh--HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHH
Confidence            57999999999765433  346789999999999999999999999999999999999999999998876 479999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.||+.||+|||++||+||||||+|||++.++ ++.++|||++........  ...+.++|+.|+|||++.+.   .+
T Consensus       120 ~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~~~~~~~~~~  196 (293)
T d1yhwa1         120 AVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG-SVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPK  196 (293)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHHHSSSCBCTH
T ss_pred             HHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC-cEeeccchhheeeccccc--cccccccCCCccChhhhcCCCCCch
Confidence            9999999999999999999999999999997642 344559999876543321  22456789999999998876   78


Q ss_pred             ccccCcceEEEEEE--eeeccccc
Q psy6508         159 LEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       159 ~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      +|+ ||+|+++|+|  |..||.+.
T Consensus       197 ~Di-wSlGvilyemltG~~Pf~~~  219 (293)
T d1yhwa1         197 VDI-WSLGIMAIEMIEGEPPYLNE  219 (293)
T ss_dssp             HHH-HHHHHHHHHHHHSSCTTTTS
T ss_pred             hce-ehHhHHHHHHhhCCCCCCCC
Confidence            999 9999999999  78898753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-36  Score=289.55  Aligned_cols=177  Identities=23%  Similarity=0.380  Sum_probs=147.1

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++... .....+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|.+++...+.+++..+
T Consensus        31 ~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~  110 (288)
T d1uu3a_          31 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCT  110 (288)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHH
T ss_pred             CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHH
Confidence            4789999999976543 223456799999999999999999999999999999999999999999999998889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.|++.||+|||++||+||||||+|||++.++ .+.++|||++.............+.+||+.|+|||++.+.   .
T Consensus       111 ~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~  189 (288)
T d1uu3a_         111 RFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDM-HIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK  189 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCH
T ss_pred             HHHHHHHHHHHHhhccccEEcCcCCccccccCCCc-eEEecccccceecccCCcccccccccCCccccCceeeccCCCCc
Confidence            99999999999999999999999999999997653 3444599998765433322333456789999999998766   6


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|||  +..||.+.
T Consensus       190 ~~Di-wSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         190 SSDL-WALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             ccce-ehhhHHHHHHhhCCCCCCCc
Confidence            7899 9999999999  78898753

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-35  Score=285.47  Aligned_cols=173  Identities=25%  Similarity=0.370  Sum_probs=133.6

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||||++++..... ..+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|.+++...+.+++..+.
T Consensus        32 ~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~  110 (307)
T d1a06a_          32 RTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS  110 (307)
T ss_dssp             TTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHH
T ss_pred             CCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHH
Confidence            478999999998765432 3456889999999999999999999999999999999999999999999988899999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      .++.||+.||.|||++||+||||||+|||+..  +..++.++|||++...+...   ...+.+||+.|+|||++.+.   
T Consensus       111 ~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~  187 (307)
T d1a06a_         111 RLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYS  187 (307)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTSCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC---eeeeeeeCccccCcHHHcCCCCC
Confidence            99999999999999999999999999999953  33455567999986544322   22457899999999998776   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  |..||.+
T Consensus       188 ~~~Di-wSlGvilyell~g~~Pf~~  211 (307)
T d1a06a_         188 KAVDC-WSIGVIAYILLCGYPPFYD  211 (307)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             cHHHh-hhhhHHHHHHHhCCCCCCC
Confidence            78999 9999999999  7788875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-34  Score=286.02  Aligned_cols=175  Identities=17%  Similarity=0.286  Sum_probs=151.0

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++... .....+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|.+++.+.+.+++..+
T Consensus        28 ~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~  107 (337)
T d1o6la_          28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERA  107 (337)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHH
T ss_pred             CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHH
Confidence            5799999999986543 223456789999999999999999999999999999999999999999999999889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.|++.||+|||++||+||||||+|||++.++ ++.++|||++.......  ....+.+||+.|+|||+..+.   .
T Consensus       108 ~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g-~vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~  184 (337)
T d1o6la_         108 RFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGR  184 (337)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCT
T ss_pred             HHHHHHHhhhhhhhhhcCccccccCHHHeEecCCC-CEEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCCh
Confidence            99999999999999999999999999999998653 34456999987544322  123457899999999999876   7


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|||  |..||.+.
T Consensus       185 ~~Di-wSlGvilyeml~G~~pf~~~  208 (337)
T d1o6la_         185 AVDW-WGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             THHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             hhcc-cchhhHHHHHHHCCCCCCCc
Confidence            8999 9999999999  77888754

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-35  Score=290.16  Aligned_cols=172  Identities=22%  Similarity=0.268  Sum_probs=147.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      .+|+.||+|++++.. .+...+++.+|+.+|++++||||++++++|.+++.+|+||||++||+|.+++.+.+.+++..++
T Consensus        29 ~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~  107 (322)
T d1s9ja_          29 PSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG  107 (322)
T ss_dssp             TTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHH
T ss_pred             CCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHH
Confidence            578999999997654 3444578999999999999999999999999999999999999999999999988899999999


Q ss_pred             HHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||+ +||+||||||+|||++.+. ++.++|||++.....+    ...+.+||+.|+|||++.+.   .
T Consensus       108 ~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~  182 (322)
T d1s9ja_         108 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSV  182 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCT
T ss_pred             HHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccccCCC----ccccccCCccccCchHHcCCCCCc
Confidence            999999999999997 5999999999999997653 3445699998754322    23467899999999998776   7


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+||++|||  +..||.+.
T Consensus       183 ~~Di-WSlGvil~ell~G~~Pf~~~  206 (322)
T d1s9ja_         183 QSDI-WSMGLSLVEMAVGRYPIPPP  206 (322)
T ss_dssp             THHH-HHHHHHHHHHHHSSCCSSCC
T ss_pred             HHHH-HHHHHHHHHHHHCCCCCCCC
Confidence            8999 9999999999  77899753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.6e-35  Score=283.47  Aligned_cols=170  Identities=19%  Similarity=0.282  Sum_probs=146.6

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||+++..... ....+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|..++..++++++..+
T Consensus        38 ~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~  117 (309)
T d1u5ra_          38 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI  117 (309)
T ss_dssp             TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHH
T ss_pred             CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHH
Confidence            57899999999877654 34557899999999999999999999999999999999999999999888887788999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.....      ..+..||+.|+|||++.+.    
T Consensus       118 ~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~  190 (309)
T d1u5ra_         118 AAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPG-LVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQ  190 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTT-EEEECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCC
T ss_pred             HHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCC-CEEEeecccccccCC------CCccccCccccCHHHHhccCCCC
Confidence            99999999999999999999999999999997653 344469999865432      2456789999999987532    


Q ss_pred             --CcccccCcceEEEEEE--eeecccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                        .++|+ ||+|+++|||  +..||.+
T Consensus       191 y~~~~Di-wSlGvilyel~~g~~Pf~~  216 (309)
T d1u5ra_         191 YDGKVDV-WSLGITCIELAERKPPLFN  216 (309)
T ss_dssp             BCTHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             cCchhhh-hhHHHHHHHHHHCCCCCCC
Confidence              57899 9999999999  7788864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.1e-35  Score=277.90  Aligned_cols=174  Identities=27%  Similarity=0.381  Sum_probs=137.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--CCeEEEEEecCCCCCHHHHHHh----CCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--ERYVYIILEYCDGGDLCSFIRS----HEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--~~~~~lv~e~~~g~sL~~~l~~----~~~l   75 (477)
                      .+|+.||||+++....++...+.+.+|+.+|++++||||+++++++.+  ++.+|+|||||+||+|.+++.+    ++.+
T Consensus        27 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l  106 (269)
T d2java1          27 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL  106 (269)
T ss_dssp             TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCC
T ss_pred             CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCC
Confidence            578999999998887777777889999999999999999999999864  4578999999999999999864    3579


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCC-----cEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccc
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENN-----VCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPR  150 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~g-----ivHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~pp  150 (477)
                      ++..++.++.|++.||+|||++|     |+||||||+|||++.+. .+.++|||++.......  ....+..+|+.|+||
T Consensus       107 ~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~-~vkl~DFG~a~~~~~~~--~~~~~~~gt~~Y~AP  183 (269)
T d2java1         107 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQ-NVKLGDFGLARILNHDT--SFAKAFVGTPYYMSP  183 (269)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTS-CEEECCHHHHHHC-------------CCCSCCCH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCC-cEEEeeccceeecccCC--CccccCCCCcccCCH
Confidence            99999999999999999999976     99999999999998653 34456999987544322  122356788999999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |++.+.   .++|+ ||+|+++|||  +..||.+
T Consensus       184 E~l~~~~~~~~~DI-wSlGvilyel~tg~~Pf~~  216 (269)
T d2java1         184 EQMNRMSYNEKSDI-WSLGCLLYELCALMPPFTA  216 (269)
T ss_dssp             HHHTTCCCCHHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             HHHcCCCCChHHHH-HhhCHHHHHHhhCCCCCCC
Confidence            998765   77899 9999999999  7788875

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-35  Score=280.94  Aligned_cols=173  Identities=26%  Similarity=0.377  Sum_probs=144.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+|+.||||+++...  ....+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|.+++.+ .+.+++..+
T Consensus        35 ~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~  112 (288)
T d2jfla1          35 ETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQI  112 (288)
T ss_dssp             TTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHH
T ss_pred             CCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHH
Confidence            578999999997653  34456789999999999999999999999999999999999999999999765 457999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----  156 (477)
                      +.++.||+.||+|||++||+||||||+|||++.+. .+.++|||++.......  ....+..+|+.|+|||++...    
T Consensus       113 ~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~~~~--~~~~~~~Gt~~y~APE~l~~~~~~~  189 (288)
T d2jfla1         113 QVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKD  189 (288)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECHHHH--HHHTCCCSCCTTCCHHHHTTCSTTT
T ss_pred             HHHHHHHHHHHHHHHHCCEEEeecChhheeECCCC-CEEEEechhhhccCCCc--ccccccccccccCCHHHHhhcccCC
Confidence            99999999999999999999999999999998653 34446999986433221  122356789999999987422    


Q ss_pred             ----CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                          .++|+ ||+|+++|||  +..||.+.
T Consensus       190 ~~y~~k~Di-wSlGvilyemltg~~Pf~~~  218 (288)
T d2jfla1         190 RPYDYKADV-WSLGITLIEMAEIEPPHHEL  218 (288)
T ss_dssp             SSTTTHHHH-HHHHHHHHHHHHSSCTTTTS
T ss_pred             CCCChhhhH-HHHHHHHHHHhhCCCCCCCC
Confidence                57899 9999999999  77888753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-34  Score=279.02  Aligned_cols=174  Identities=24%  Similarity=0.380  Sum_probs=150.3

Q ss_pred             CCCcEEEEEEcccCCCCh----hHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSE----NRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||||++++.....    ...+.+.+|+.+|++++||||+++++++.+++.+|||||||+||+|.+++...+.+++
T Consensus        33 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~  112 (293)
T d1jksa_          33 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE  112 (293)
T ss_dssp             TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCH
T ss_pred             CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccch
Confidence            578999999998765432    2357899999999999999999999999999999999999999999999988889999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCc---ceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNT---LKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~---~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ..++.++.|++.||+|||++||+||||||+|||++.++   .++.++|||++...+...   ...+..+++.|+|||++.
T Consensus       113 ~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~---~~~~~~~t~~y~APE~~~  189 (293)
T d1jksa_         113 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVN  189 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC---BCSCCCCCGGGCCHHHHT
T ss_pred             hHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc---cccccCCCCcccCHHHHc
Confidence            99999999999999999999999999999999997543   346667999987654322   224567788999999987


Q ss_pred             CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.   .++|+ ||+|+++|||  +..||.+
T Consensus       190 ~~~~~~~~Di-wSlGvilyell~g~~Pf~~  218 (293)
T d1jksa_         190 YEPLGLEADM-WSIGVITYILLSGASPFLG  218 (293)
T ss_dssp             TCCBCTHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCCcccc-hhhhHHHHHHHcCCCCCCC
Confidence            76   78999 9999999999  6788864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-35  Score=282.38  Aligned_cols=173  Identities=17%  Similarity=0.281  Sum_probs=139.7

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQ   82 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~   82 (477)
                      +..||||+++....+....+.|.+|+.+|++++||||+++++++. ++.+|+|||||+||+|.+++... .++++..+..
T Consensus        30 ~~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~  108 (276)
T d1uwha_          30 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLID  108 (276)
T ss_dssp             SSEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHH
T ss_pred             CCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCCHHHHHhhccCCCCHHHHHH
Confidence            456999999877767777889999999999999999999999864 45689999999999999999764 4699999999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC------
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK------  156 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~------  156 (477)
                      ++.|+++||+|||++||+||||||+|||++.+. .+.++|||++.............+..+|+.|+|||++.+.      
T Consensus       109 i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~  187 (276)
T d1uwha_         109 IARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS  187 (276)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTS-SEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCC
T ss_pred             HHHHHHHHHHHHhcCCEeccccCHHHEEEcCCC-CEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCC
Confidence            999999999999999999999999999997652 3344699998654433222233455788999999987542      


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||  +..||.+
T Consensus       188 ~~sDi-wS~Gv~l~el~tg~~Pf~~  211 (276)
T d1uwha_         188 FQSDV-YAFGIVLYELMTGQLPYSN  211 (276)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCTTTT
T ss_pred             chhhh-hhhHHHHHHHHHCCCCCCC
Confidence            56899 9999999999  6788864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-34  Score=275.81  Aligned_cols=175  Identities=18%  Similarity=0.235  Sum_probs=141.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++++.||||+++....++...++|.+|+.+|++++||||+++++++.. +..||||||++||+|.+++.+...+++..+.
T Consensus        32 ~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~  110 (277)
T d1xbba_          32 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNII  110 (277)
T ss_dssp             SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHH
T ss_pred             CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccCCCHHHHH
Confidence            356789999998766555666789999999999999999999999865 4578999999999999999998899999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .|+.||+.||+|||++||+||||||+|||++.+. ....+|||+++....... ........+++.|+|||.+.+.   .
T Consensus       111 ~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~  189 (277)
T d1xbba_         111 ELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQH-YAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSS  189 (277)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETT-EEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEH
T ss_pred             HHHHHHHHHHhhHHhCCcccCCCcchhhcccccC-cccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCc
Confidence            9999999999999999999999999999997643 334459999875443322 2223345677889999988766   7


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||.+
T Consensus       190 ~sDi-wS~Gv~l~ellt~g~~Pf~~  213 (277)
T d1xbba_         190 KSDV-WSFGVLMWEAFSYGQKPYRG  213 (277)
T ss_dssp             HHHH-HHHHHHHHHHHTTTCCSSTT
T ss_pred             hhhh-ccchhhhhHHhhCCCCCCCC
Confidence            8999 9999999997   4678864

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-34  Score=279.53  Aligned_cols=172  Identities=24%  Similarity=0.413  Sum_probs=149.6

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++.... ....+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|..++.....+++..+
T Consensus        27 ~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~  106 (316)
T d1fota_          27 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVA  106 (316)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHH
T ss_pred             CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHH
Confidence            57899999999765432 23456789999999999999999999999999999999999999999999999889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.||+.||.|||++||+||||||+|||++.++ ++.++|||++.......     .+..||+.|+|||++.+.   .
T Consensus       107 ~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g-~vkL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~l~~~~y~~  180 (316)
T d1fota_         107 KFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNG-HIKITDFGFAKYVPDVT-----YTLCGTPDYIAPEVVSTKPYNK  180 (316)
T ss_dssp             HHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTS-CEEECCCSSCEECSSCB-----CCCCSCTTTCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHhhhhhccCcEEccccCchheeEcCCC-CEEEecCccceEecccc-----ccccCcccccCHHHHcCCCCCc
Confidence            99999999999999999999999999999997643 34455999987655332     356788999999998876   7


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|||  |..||.+.
T Consensus       181 ~~Di-wSlGvilyemltG~~Pf~~~  204 (316)
T d1fota_         181 SIDW-WSFGILIYEMLAGYTPFYDS  204 (316)
T ss_dssp             THHH-HHHHHHHHHHHHSSCTTCCS
T ss_pred             hhhc-cccchhHHHHHhCCCCCCCc
Confidence            8999 9999999999  78999754

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=6.6e-34  Score=281.82  Aligned_cols=172  Identities=24%  Similarity=0.402  Sum_probs=147.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~~   80 (477)
                      .+|+.||||++.+..  ....+.+.+|+.+|++++||||+++++++.+++.+|+|||||+||+|.+++.+ .+++++..+
T Consensus        49 ~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~  126 (350)
T d1koaa2          49 ATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEA  126 (350)
T ss_dssp             TTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHH
T ss_pred             CCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHH
Confidence            478999999997653  34457799999999999999999999999999999999999999999999954 457999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.++.||+.||+|||++||+||||||+|||++.+ ...+.++|||++.......   ...+..+|+.|+|||++.+.   
T Consensus       127 ~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~  203 (350)
T d1koaa2         127 VEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVG  203 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS---CEEEECSCTTTCCHHHHHTCCBC
T ss_pred             HHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc---ccceecCcccccCHHHHcCCCCC
Confidence            9999999999999999999999999999999642 3355566999987654332   22356788999999998776   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|+|  |..||.+
T Consensus       204 ~~~Di-wSlGvilyell~G~~Pf~~  227 (350)
T d1koaa2         204 YYTDM-WSVGVLSYILLSGLSPFGG  227 (350)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             hhHhh-hhhhHHHHHHHhCCCCCCC
Confidence            67999 9999999999  7788864

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.5e-35  Score=279.56  Aligned_cols=175  Identities=22%  Similarity=0.338  Sum_probs=139.8

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER----YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||++++.... ....+.+.+|+.+|++++||||+++++++...+    .+|+||||++|++|.+++...++++
T Consensus        30 ~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~  109 (277)
T d1o6ya_          30 RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT  109 (277)
T ss_dssp             TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCC
T ss_pred             CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCC
Confidence            57899999999876553 455678999999999999999999999987653    4899999999999999998888999


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCc-ccccCCeEEEeccccccccCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSA-YIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~-~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      +.+++.++.||+.||.|||++||+||||||+|||++.+ ..++  .|||.......+. ......+.++|+.|+|||+..
T Consensus       110 ~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l--~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~  187 (277)
T d1o6ya_         110 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKV--MDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR  187 (277)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEE--CCCTTCEECC----------------TTCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCcccccee--ehhhhhhhhccccccccccccccCcccccCHHHHc
Confidence            99999999999999999999999999999999999764 4444  5888775433222 122334568899999999987


Q ss_pred             CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.   .++|+ ||+|+++|||  +..||.+
T Consensus       188 ~~~~~~~~Di-wSlGvilyelltG~~Pf~~  216 (277)
T d1o6ya_         188 GDSVDARSDV-YSLGCVLYEVLTGEPPFTG  216 (277)
T ss_dssp             TCCCCHHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CCCCCcceec-ccchHHHHHHHhCCCCCCC
Confidence            76   67999 9999999999  7788874

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.98  E-value=9.4e-34  Score=280.93  Aligned_cols=172  Identities=24%  Similarity=0.367  Sum_probs=147.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+|+.||||++++..  ....+.+.+|+.+|++++||||++++++|.+++.+|||||||+||+|.+++...+ ++++.++
T Consensus        52 ~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~  129 (352)
T d1koba_          52 ATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV  129 (352)
T ss_dssp             TTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHH
T ss_pred             CCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHH
Confidence            579999999997654  3345678899999999999999999999999999999999999999999876644 6999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.|+.||+.||+|||++||+||||||+|||++. +..++.++|||++.......   ...+..+++.|+|||+..+.   
T Consensus       130 ~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~  206 (352)
T d1koba_         130 INYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVG  206 (352)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC---ceeeccCcccccCHHHHcCCCCC
Confidence            999999999999999999999999999999973 33455667999987655332   22356778899999998876   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|+|  |..||.+
T Consensus       207 ~~~Di-wSlGvilyelltG~~Pf~~  230 (352)
T d1koba_         207 FYTDM-WAIGVLGYVLLSGLSPFAG  230 (352)
T ss_dssp             HHHHH-HHHHHHHHHHHHSCCSSCC
T ss_pred             Cccch-HHHHHHHHHHHhCCCCCCC
Confidence            77899 9999999999  7788874

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.98  E-value=8.7e-34  Score=281.10  Aligned_cols=172  Identities=26%  Similarity=0.418  Sum_probs=150.6

Q ss_pred             CCCcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~   80 (477)
                      .+|+.||||++++.... ....+.+.+|+.+|+.++||||+++++++...+..|+||||+.||+|.+++.+.+.+++..+
T Consensus        64 ~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~  143 (350)
T d1rdqe_          64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHA  143 (350)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHH
T ss_pred             CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHH
Confidence            57999999999765332 23456789999999999999999999999999999999999999999999998889999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.++.||+.||.|||++||+||||||+|||++.++ .+.++|||++....+..     .+..||+.|+|||++.+.   .
T Consensus       144 ~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g-~ikL~DFG~a~~~~~~~-----~~~~Gt~~Y~APE~~~~~~~~~  217 (350)
T d1rdqe_         144 RFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQG-YIQVTDFGFAKRVKGRT-----WTLCGTPEALAPEIILSKGYNK  217 (350)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTS-CEEECCCTTCEECSSCB-----CCCEECGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCC-CEEeeeceeeeeccccc-----ccccCccccCCHHHHcCCCCCc
Confidence            99999999999999999999999999999997653 34456999998766432     356899999999998876   7


Q ss_pred             cccccCcceEEEEEE--eeeccccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ++|+ ||+|+++|||  |..||.+.
T Consensus       218 ~~Di-wSlGvilyemltG~~Pf~~~  241 (350)
T d1rdqe_         218 AVDW-WALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             cccc-cchhHHHHHHHhCCCCCCCc
Confidence            7899 9999999999  78899754

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-33  Score=274.08  Aligned_cols=171  Identities=20%  Similarity=0.327  Sum_probs=147.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~   80 (477)
                      .+|+.||||++++..   .....+.+|+.+|+.++||||+++++++++++.+|+|||||+||+|.+++...+ .+++.++
T Consensus        28 ~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~  104 (321)
T d1tkia_          28 SSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREI  104 (321)
T ss_dssp             TTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHH
T ss_pred             CCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHH
Confidence            478999999997653   233568899999999999999999999999999999999999999999998765 7999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +.|+.||+.||+|||++||+||||||+|||++. +..++.++|||.+.......   ...+..+++.|+|||...+.   
T Consensus       105 ~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~---~~~~~~~t~~y~ape~~~~~~~~  181 (321)
T d1tkia_         105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVHQHDVVS  181 (321)
T ss_dssp             HHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC---EEEEEESCGGGSCHHHHTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC---cccccccccccccchhccCCCCC
Confidence            999999999999999999999999999999975 34566677999987654322   22356778899999998776   


Q ss_pred             CcccccCcceEEEEEE--eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .++|+ ||+|+++|+|  |..||.+
T Consensus       182 ~~~Di-WSlGvily~ll~G~~Pf~~  205 (321)
T d1tkia_         182 TATDM-WSLGTLVYVLLSGINPFLA  205 (321)
T ss_dssp             HHHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             chhhc-ccHHHHHHHHHhCCCCCCC
Confidence            77899 9999999999  7788864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=3.1e-34  Score=276.89  Aligned_cols=165  Identities=21%  Similarity=0.315  Sum_probs=139.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC--CCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH--EKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~--~~l~~~~   79 (477)
                      .+|+.||||+++.....   .++|.+|+.+|++++||||+++++++.+++.+|+|||||++|+|.+++...  ..+++..
T Consensus        40 ~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~  116 (287)
T d1opja_          40 KYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVV  116 (287)
T ss_dssp             GGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHH
T ss_pred             CCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHH
Confidence            46889999999765433   457899999999999999999999999999999999999999999999764  4689999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.|++.||+|||++||+||||||+|||++.+. .+.++|||++....+...... ....++..|+|||.+.+.   
T Consensus       117 ~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~~~~~~~~-~~~~g~~~y~aPE~~~~~~~~  194 (287)
T d1opja_         117 LLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENH-LVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFS  194 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCCTTTCCSSSSEEE-TTEEECGGGCCHHHHHHCCCS
T ss_pred             HHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCC-cEEEccccceeecCCCCceee-ccccccccccChHHHcCCCCC
Confidence            999999999999999999999999999999997653 445569999876554433222 234678889999987655   


Q ss_pred             CcccccCcceEEEEEE
Q psy6508         157 TSLEYQRSKGELYVEF  172 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~  172 (477)
                      .++|+ ||+|+++|||
T Consensus       195 ~k~Di-wS~Gv~l~el  209 (287)
T d1opja_         195 IKSDV-WAFGVLLWEI  209 (287)
T ss_dssp             HHHHH-HHHHHHHHHH
T ss_pred             chhhh-hhHHHHHHHH
Confidence            67999 9999999998

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.7e-34  Score=281.32  Aligned_cols=172  Identities=22%  Similarity=0.314  Sum_probs=140.3

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC----------
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE----------   73 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~----------   73 (477)
                      ..||+|.+.... .......+.+|+.+|+++ +||||+++++++.+.+.+|+|||||+||+|.++++...          
T Consensus        68 ~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~  146 (325)
T d1rjba_          68 IQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEY  146 (325)
T ss_dssp             EEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC-------
T ss_pred             eEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhh
Confidence            479999986553 233446789999999998 89999999999999999999999999999999997642          


Q ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCe
Q psy6508          74 -------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNT  140 (477)
Q Consensus        74 -------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t  140 (477)
                                   .+++..++.++.|++.||+|||++||+||||||+|||++.+. .+.++|||+++............+
T Consensus       147 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~  225 (325)
T d1rjba_         147 ENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGN  225 (325)
T ss_dssp             --------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETT
T ss_pred             ccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCC-eEEEeeccccccccCCCceeeecc
Confidence                         488999999999999999999999999999999999997653 444569999876544433333346


Q ss_pred             EEEeccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         141 KVICSVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       141 ~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ..+|+.|+|||.+.+.   .++|+ ||+|+++|||   +..||.+
T Consensus       226 ~~gt~~y~aPE~l~~~~~~~~~Di-wS~Gvil~emlt~g~~Pf~~  269 (325)
T d1rjba_         226 ARLPVKWMAPESLFEGIYTIKSDV-WSYGILLWEIFSLGVNPYPG  269 (325)
T ss_dssp             EEECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHTTTSCCSSTT
T ss_pred             ccCCCccCChHHHcCCCCCcceec-cchhHHHHHHHhCCCCCCCC
Confidence            6788999999987655   67899 9999999998   4678875

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=5e-33  Score=266.79  Aligned_cols=173  Identities=22%  Similarity=0.357  Sum_probs=146.3

Q ss_pred             CCCcEEEEEEcccCCCCh-------hHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC
Q psy6508           2 EQHTEVAIKCIDKTKVSE-------NRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-------~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~   73 (477)
                      .+|+.||||++++.....       ...+.+.+|+.++++++ ||||+++++++.+++.+||||||++||+|.++++.++
T Consensus        26 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~  105 (277)
T d1phka_          26 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV  105 (277)
T ss_dssp             TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred             CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC
Confidence            478999999998765432       23356889999999996 9999999999999999999999999999999999888


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      .+++..++.++.||++||+|||++||+||||||+|||++.+ .+++  +|||.+.......   .....++++.|.|||.
T Consensus       106 ~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl--~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~  180 (277)
T d1phka_         106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKL--TDFGFSCQLDPGE---KLREVCGTPSYLAPEI  180 (277)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEE--CCCTTCEECCTTC---CBCCCCSCGGGCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEE--ccchheeEccCCC---ceeeeeccCCCCCHHH
Confidence            99999999999999999999999999999999999999765 4444  5999987654322   1234568899999998


Q ss_pred             CCCC---------CcccccCcceEEEEEE--eeeccccc
Q psy6508         153 PSSK---------TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       153 ~~~~---------~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      ..+.         .++|+ ||+|+++|+|  +..||.+.
T Consensus       181 ~~~~~~~~~~~~~~~~Di-wslGvilyeml~g~~Pf~~~  218 (277)
T d1phka_         181 IECSMNDNHPGYGKEVDM-WSTGVIMYTLLAGSPPFWHR  218 (277)
T ss_dssp             HHHHHCTTSCCBCTHHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             hhccccccCCCCCchheE-cccchhhhhhccCCCCCCCC
Confidence            6531         56899 9999999999  77888753

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.4e-33  Score=267.12  Aligned_cols=173  Identities=18%  Similarity=0.280  Sum_probs=142.6

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      ++..||||+++... .....++|.+|+.+|++++||||+++++++.. +.+|+|||||+||+|.+++... +.+++..+.
T Consensus        35 ~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~  112 (285)
T d1u59a_          35 KQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVA  112 (285)
T ss_dssp             CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHH
T ss_pred             CcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHH
Confidence            45689999997553 45566789999999999999999999999865 4689999999999999998654 579999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||+|||++||+||||||+|||++.+. .+.++|||++........ .....+..+++.|+|||.+.+.   .
T Consensus       113 ~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  191 (285)
T d1u59a_         113 ELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRH-YAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS  191 (285)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETT-EEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHhCCeecCcCchhheeeccCC-ceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCc
Confidence            9999999999999999999999999999997653 445569999876543322 2222344577889999988655   7


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++||+   +..||.+
T Consensus       192 ksDV-wS~Gv~l~E~lt~G~~Pf~~  215 (285)
T d1u59a_         192 RSDV-WSYGVTMWEALSYGQKPYKK  215 (285)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             cchh-hcchHHHHHHHhCCCCCCCC
Confidence            7899 9999999997   5788874

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1e-33  Score=269.80  Aligned_cols=165  Identities=19%  Similarity=0.275  Sum_probs=130.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      .+++.||||+++.....   .++|.+|+.++++++||||+++++++..++.+|+||||+++|+|.+++... ..+++..+
T Consensus        27 ~~~~~vAvK~i~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~  103 (263)
T d1sm2a_          27 LNKDKVAIKTIREGAMS---EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETL  103 (263)
T ss_dssp             TTTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHH
T ss_pred             CCCCEEEEEEECCCcCc---HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHH
Confidence            35778999999765433   357899999999999999999999999999999999999999999998765 46899999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.|++.||+|||++||+||||||+|||++.+. .+.++|||++........ .......++..|+|||.+.+.   .
T Consensus       104 ~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~  181 (263)
T d1sm2a_         104 LGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSS  181 (263)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGG-CEEECSCC-------------------CTTSCCHHHHTTCCCCH
T ss_pred             HHHHHHHHHHHHhhhccceeecccchhheeecCCC-CeEecccchheeccCCCc-eeecceecCcccCChHHhcCCCCCc
Confidence            99999999999999999999999999999998653 334459999865443322 122345678889999998776   6


Q ss_pred             cccccCcceEEEEEE
Q psy6508         158 SLEYQRSKGELYVEF  172 (477)
Q Consensus       158 ~~Di~~s~G~il~e~  172 (477)
                      ++|+ ||+|+++||+
T Consensus       182 k~DV-wS~Gvil~el  195 (263)
T d1sm2a_         182 KSDV-WSFGVLMWEV  195 (263)
T ss_dssp             HHHH-HHHHHHHHHH
T ss_pred             hhhh-cchHHHHHHH
Confidence            7899 9999999998

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=1.6e-32  Score=273.45  Aligned_cols=173  Identities=20%  Similarity=0.284  Sum_probs=142.3

Q ss_pred             CCCcEEEEEEcccCCCCh-hHHHHH---HHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVSE-NRFDSI---VNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSE   77 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~-~~~~~~---~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~   77 (477)
                      .+|+.||||++.+..... .....+   .+|+.+++.++||||+++++++.+++.+|+|||||+||+|.+++.++..+++
T Consensus        27 ~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e  106 (364)
T d1omwa3          27 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE  106 (364)
T ss_dssp             TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCH
T ss_pred             CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccH
Confidence            479999999987653321 112233   3456777778899999999999999999999999999999999998889999


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          78 FQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        78 ~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      ..++.++.||+.||.|||++||+||||||+|||++.++ .+.++|||++.......    ..+..||+.|+|||++... 
T Consensus       107 ~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g-~iKl~DFGla~~~~~~~----~~~~~GT~~y~APE~~~~~~  181 (364)
T d1omwa3         107 ADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHG-HVRISDLGLACDFSKKK----PHASVGTHGYMAPEVLQKGV  181 (364)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSS-CEEECCCTTCEECSSSC----CCSCCSCGGGCCHHHHSTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCC-cEEEeeeceeeecCCCc----ccccccccccchhHHhhcCC
Confidence            99999999999999999999999999999999997643 33445999987544322    2346789999999987543 


Q ss_pred             ---CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                         .++|+ ||+|+++|||  |..||.+.
T Consensus       182 ~~~~~~Di-wSlGvilyemltG~~Pf~~~  209 (364)
T d1omwa3         182 AYDSSADW-FSLGCMLFKLLRGHSPFRQH  209 (364)
T ss_dssp             CCCTHHHH-HHHHHHHHHHHHSSCSSCSS
T ss_pred             CCCcccch-hHHHHHHHHHHhCCCCCCCC
Confidence               67899 9999999999  78999753

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.97  E-value=6.3e-33  Score=269.20  Aligned_cols=172  Identities=21%  Similarity=0.263  Sum_probs=132.8

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i   83 (477)
                      ..||||.+.... .....++|.+|+.+|++++||||+++++++..++.+|+|||||+||+|.+++... +.+++..+..+
T Consensus        55 ~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i  133 (299)
T d1jpaa_          55 IFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGM  133 (299)
T ss_dssp             EEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHH
T ss_pred             EEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHH
Confidence            368999886543 4556678999999999999999999999999999999999999999999988874 46999999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc---CCeEEEeccccccccCCCC---C
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ---GNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~---g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      +.||+.||.|||++||+||||||+|||++.+. .+.++|||+++...+......   .....+++.|+|||...+.   .
T Consensus       134 ~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~  212 (299)
T d1jpaa_         134 LRGIAAGMKYLADMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTS  212 (299)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCC-----------------------CGGGSCHHHHHSCCCCH
T ss_pred             HHHHHHHHHHHhhCCCccCccccceEEECCCC-cEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCc
Confidence            99999999999999999999999999998653 344459999875543322111   1123567789999987655   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||   +..||.+
T Consensus       213 ~sDv-wS~Gvvl~el~t~g~~Pf~~  236 (299)
T d1jpaa_         213 ASDV-WSYGIVMWEVMSYGERPYWD  236 (299)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             cccc-ccchHHHHHHHhCCCCCCCC
Confidence            7899 9999999998   4577764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.8e-33  Score=270.23  Aligned_cols=175  Identities=23%  Similarity=0.357  Sum_probs=146.5

Q ss_pred             CCCcEEEEEEcccCCC-ChhHHHHHHHHHHHHH-hcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKV-SENRFDSIVNEIKALK-LLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~-~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~   79 (477)
                      .+|+.||||++++... .....+.+.+|..++. .++||||+++++++.+++.+||||||++||+|.+++...+.+++..
T Consensus        25 ~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~  104 (320)
T d1xjda_          25 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSR  104 (320)
T ss_dssp             TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHH
T ss_pred             CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHH
Confidence            4789999999976432 1233456777877765 6899999999999999999999999999999999999888999999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.||+.||+|||++||+||||||+|||++.++ ++.++|||.+.......  ....+..+|+.|+|||++.+.   
T Consensus       105 ~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~-~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~  181 (320)
T d1xjda_         105 ATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG-HIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYN  181 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTS-CEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCC-ceeccccchhhhccccc--ccccccCCCCCcCCHHHHcCCCCC
Confidence            999999999999999999999999999999998643 33445999986543322  223456789999999999876   


Q ss_pred             CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      .++|+ ||+|+++|||  |..||.+.
T Consensus       182 ~~~Di-wSlGvilyemltG~~PF~~~  206 (320)
T d1xjda_         182 HSVDW-WSFGVLLYEMLIGQSPFHGQ  206 (320)
T ss_dssp             THHHH-HHHHHHHHHHHHSSCSSCCS
T ss_pred             chhhh-hhhhHHHHHHHhCCCCCCCC
Confidence            78999 9999999999  78898753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-32  Score=270.64  Aligned_cols=169  Identities=21%  Similarity=0.341  Sum_probs=141.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEe----CCeEEEEEecCCCCCHHHHHHhC--CC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWD----ERYVYIILEYCDGGDLCSFIRSH--EK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~----~~~~~lv~e~~~g~sL~~~l~~~--~~   74 (477)
                      .+|+.||||+++..       ..+.+|+.++.++ +||||++++++|++    ++.+|+|||||+||+|.+++.+.  .+
T Consensus        35 ~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~  107 (335)
T d2ozaa1          35 RTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA  107 (335)
T ss_dssp             TTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCC
T ss_pred             CCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCC
Confidence            57899999998643       3467899987655 89999999999875    46799999999999999999874  36


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      +++..++.|+.||+.||+|||++||+||||||+|||++.  +...+.++|||++.......   ...+..+++.|+|||+
T Consensus       108 l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~  184 (335)
T d2ozaa1         108 FTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEV  184 (335)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCC
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeeccCCC---ccccccCCcccCCcHH
Confidence            999999999999999999999999999999999999975  23345667999987544322   2345678999999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFASQI  181 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~~  181 (477)
                      +.+.   .++|+ ||+|+++|+|  +..||.+..
T Consensus       185 ~~~~~y~~~~Di-wSlGvily~lltg~~Pf~~~~  217 (335)
T d2ozaa1         185 LGPEKYDKSCDM-WSLGVIMYILLCGYPPFYSNH  217 (335)
T ss_dssp             CCGGGGSHHHHH-HHHHHHHHHHTTSSCSCEETT
T ss_pred             HcCCCCCHHHHH-HhhchhHHHHhhCCCCCCCCC
Confidence            8876   77899 9999999999  789997643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.4e-33  Score=270.30  Aligned_cols=196  Identities=24%  Similarity=0.279  Sum_probs=155.7

Q ss_pred             CCCcEEEEEEcccCCCCh----hHHHHHHHHHHHHHhcC--CCCccceEEEEEeCCeEEEEEecCCC-CCHHHHHHhCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSE----NRFDSIVNEIKALKLLH--HQHIVTMLDFLWDERYVYIILEYCDG-GDLCSFIRSHEK   74 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~----~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv~e~~~g-~sL~~~l~~~~~   74 (477)
                      .+|+.||||++++.....    ....++.+|+.+|++++  ||||+++++++.+++..|+||||+.+ +++.+++..+..
T Consensus        27 ~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~  106 (273)
T d1xwsa_          27 SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA  106 (273)
T ss_dssp             TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCS
T ss_pred             CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCC
Confidence            478999999998764432    11234678999999996  89999999999999999999999975 688899888789


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          75 LSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        75 l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      +++..++.++.|++.||+|||++||+||||||+|||++.+..++.++|||++.......    ..+..||+.|+|||++.
T Consensus       107 l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT~~y~aPE~~~  182 (273)
T d1xwsa_         107 LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGTRVYSPPEWIR  182 (273)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSCGGGSCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccccc----ccccccCCCcCCHHHHc
Confidence            99999999999999999999999999999999999998665566667999987554332    23567899999999876


Q ss_pred             CC----CcccccCcceEEEEEE--eeeccccccc----cCCCCCcchHHHHHHHHHHh
Q psy6508         155 SK----TSLEYQRSKGELYVEF--KFAPFASQIR----TGWLRDSEEKELGNHLKRAL  202 (477)
Q Consensus       155 ~~----~~~Di~~s~G~il~e~--~~~Pf~~~~r----~~~~~~~~~~~l~~~i~~~l  202 (477)
                      +.    .++|+ ||+|+++|||  +..||.+...    ....+..-..++..++++++
T Consensus       183 ~~~~~~~~~Di-wSlGvilyell~g~~Pf~~~~~i~~~~~~~~~~~s~~~~~li~~~L  239 (273)
T d1xwsa_         183 YHRYHGRSAAV-WSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCL  239 (273)
T ss_dssp             HSCBCHHHHHH-HHHHHHHHHHHHSSCSCCSHHHHHHCCCCCSSCCCHHHHHHHHHHT
T ss_pred             CCCCCCccccc-ccceeeehhHhhCCCCCCCchHHhhcccCCCCCCCHHHHHHHHHHc
Confidence            44    56899 9999999999  7889976432    11223334455555555544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.3e-33  Score=268.17  Aligned_cols=172  Identities=20%  Similarity=0.303  Sum_probs=138.5

Q ss_pred             CCCcEEEEEEcccCCCChh---HHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSEN---RFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+|+.||||+++.......   ..+.+.+|+.+|++++||||+++++++..++.+|+||||+.|+++..+......+++.
T Consensus        21 ~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~  100 (299)
T d1ua2a_          21 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPS  100 (299)
T ss_dssp             SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSS
T ss_pred             CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHH
Confidence            5789999999977654321   2356889999999999999999999999999999999999988777776666689999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCCCC-
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK-  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~-  156 (477)
                      .++.+++||+.||+|||++||+||||||+|||++.+ .+++  +|||.+.......  ....+.++|+.|+|||...+. 
T Consensus       101 ~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL--~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~  176 (299)
T d1ua2a_         101 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKL--ADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGAR  176 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE--CCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCcccc--ccCccccccCCCc--ccccceecChhhccHHHHccCC
Confidence            999999999999999999999999999999999764 4444  5999986544322  223456789999999987543 


Q ss_pred             ---CcccccCcceEEEEEE--eeeccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                         .++|+ ||+|+++|||  +..||.
T Consensus       177 ~~~~~~Di-wSlGvil~el~~g~~pf~  202 (299)
T d1ua2a_         177 MYGVGVDM-WAVGCILAELLLRVPFLP  202 (299)
T ss_dssp             CCCHHHHH-HHHHHHHHHHHHSSCSSC
T ss_pred             CCChhhhh-hhcchHHHHHHhCcCCCC
Confidence               67899 9999999999  556665

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.7e-33  Score=267.26  Aligned_cols=164  Identities=24%  Similarity=0.368  Sum_probs=135.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      ++++.||||+++.....   .+.|.+|+.+|++++||||+++++++. ++..|+||||+++|+|.+++....  ++++..
T Consensus        35 ~~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~  110 (272)
T d1qpca_          35 NGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINK  110 (272)
T ss_dssp             TTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHTTSHHHHTCCHHH
T ss_pred             CCCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHHHHhhcCCCCCCHHH
Confidence            35778999999765433   356899999999999999999999875 456799999999999999875432  599999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      +..++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.....+.. .......++..|+|||.+.+.   
T Consensus       111 ~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~  188 (272)
T d1qpca_         111 LLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTL-SCKIADFGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFT  188 (272)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTS-CEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHHhCCcccCccchhheeeeccc-ceeeccccceEEccCCcc-ccccccCCcccccChHHHhCCCCC
Confidence            999999999999999999999999999999998652 344459999976554332 222345677889999988755   


Q ss_pred             CcccccCcceEEEEEE
Q psy6508         157 TSLEYQRSKGELYVEF  172 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~  172 (477)
                      .++|+ ||+|+++|||
T Consensus       189 ~~sDv-wS~Gvvl~el  203 (272)
T d1qpca_         189 IKSDV-WSFGILLTEI  203 (272)
T ss_dssp             HHHHH-HHHHHHHHHH
T ss_pred             chhhh-hhhHHHHHHH
Confidence            67899 9999999999

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.8e-32  Score=261.10  Aligned_cols=173  Identities=26%  Similarity=0.355  Sum_probs=139.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh--CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS--HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~--~~~l~~~~   79 (477)
                      ++|+.||||+++.....+...+.+.+|+.+|++++||||+++++++.+++.+|+||||+.+ ++.+++..  ...+++..
T Consensus        25 ~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~  103 (298)
T d1gz8a_          25 LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPL  103 (298)
T ss_dssp             TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHH
T ss_pred             CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHH
Confidence            5789999999977655544567899999999999999999999999999999999999974 55555543  34699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.|++.||+|||++||+||||||+|||++.+. ...++|||.+.....+.  ....+.++++.|+|||.....   
T Consensus       104 ~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~apE~~~~~~~~  180 (298)
T d1gz8a_         104 IKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEG-AIKLADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYY  180 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECSTTHHHHHCCCS--BCTTCCBCCCTTCCHHHHTTCSSC
T ss_pred             HHHHHHHHHHHHHHhhcCCEEccccCchheeecccC-cceeccCCcceeccCCc--ccceeecccceeeehhhhccccCC
Confidence            999999999999999999999999999999997653 34456999987654332  234456889999999976554   


Q ss_pred             -CcccccCcceEEEEEE--eeecccc
Q psy6508         157 -TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 -~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                       .++|+ ||+|+++|+|  |..||.+
T Consensus       181 ~~~~Di-wSlGvily~m~~G~~Pf~~  205 (298)
T d1gz8a_         181 STAVDI-WSLGCIFAEMVTRRALFPG  205 (298)
T ss_dssp             CTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             Cccccc-cccchhhhHHhhCCCCCCC
Confidence             67999 9999999999  6777763

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.4e-32  Score=263.13  Aligned_cols=165  Identities=22%  Similarity=0.274  Sum_probs=131.7

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQF   83 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i   83 (477)
                      ..||||+++... .+....+|.+|+.+|++++||||+++++++.+.+..++||||+.+++|.+++... +.+++..+..+
T Consensus        37 ~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i  115 (283)
T d1mqba_          37 VPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGM  115 (283)
T ss_dssp             EEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHH
T ss_pred             EEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHH
Confidence            479999986543 4555668999999999999999999999999999999999999999999988765 57999999999


Q ss_pred             HHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccc-ccCCeEEEeccccccccCCCC---Ccc
Q psy6508          84 VRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI-EQGNTKVICSVFEPREIPSSK---TSL  159 (477)
Q Consensus        84 ~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~-~~g~t~v~~~~y~ppE~~~~~---~~~  159 (477)
                      +.|++.||+|||++||+||||||+|||++.+. .+.++|||+++........ .......++..|+|||.+.+.   .++
T Consensus       116 ~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~s  194 (283)
T d1mqba_         116 LRGIAAGMKYLANMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSAS  194 (283)
T ss_dssp             HHHHHHHHHHHHHTTCCCSCCCGGGEEECTTC-CEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHH
T ss_pred             HHHHHHhhhhccccccccCccccceEEECCCC-eEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcc
Confidence            99999999999999999999999999998753 4445699998764433211 111223467789999987665   678


Q ss_pred             cccCcceEEEEEE
Q psy6508         160 EYQRSKGELYVEF  172 (477)
Q Consensus       160 Di~~s~G~il~e~  172 (477)
                      |+ ||+|+++|||
T Consensus       195 DI-~S~Gvil~el  206 (283)
T d1mqba_         195 DV-WSFGIVMWEV  206 (283)
T ss_dssp             HH-HHHHHHHHHH
T ss_pred             cc-cccHHHHHHH
Confidence            99 9999999998

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-31  Score=254.46  Aligned_cols=172  Identities=22%  Similarity=0.347  Sum_probs=142.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQC   80 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~   80 (477)
                      ++++.||||++++.....   ++|.+|+.++++++||||+++++++.+++.+++||||+++|+|.+++... ..+++..+
T Consensus        26 ~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~  102 (258)
T d1k2pa_          26 RGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQL  102 (258)
T ss_dssp             TTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHH
T ss_pred             CCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHH
Confidence            367799999998765443   57899999999999999999999999999999999999999999997653 47999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .+++.|+++||+|||++||+||||||+||+++.+. .+.++|||++......... ......++..|+|||...+.   .
T Consensus       103 ~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~  180 (258)
T d1k2pa_         103 LEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSS  180 (258)
T ss_dssp             HHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhhcCcccccccceeEEEcCCC-cEEECcchhheeccCCCce-eecccCCCCCcCCcHHhcCCCCCc
Confidence            99999999999999999999999999999998753 3445699998654433221 11234577789999998655   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||   +..||.+
T Consensus       181 ksDi-wS~G~~l~el~t~g~~Pf~~  204 (258)
T d1k2pa_         181 KSDI-WAFGVLMWEIYSLGKMPYER  204 (258)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             ceee-cccchhhHhHHhcCCCCCCC
Confidence            8999 9999999998   4577764

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.7e-31  Score=254.40  Aligned_cols=173  Identities=23%  Similarity=0.320  Sum_probs=131.1

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      .+..||||.++... .+...+.+.+|+.+|++++||||+++++++. ++.+|+||||+++|+|.+++... ..+++..++
T Consensus        34 ~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~  111 (273)
T d1mp8a_          34 PALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLI  111 (273)
T ss_dssp             CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHH
T ss_pred             eeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHH
Confidence            34679999986543 4555678999999999999999999999985 56789999999999999987654 469999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Cc
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TS  158 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~  158 (477)
                      .++.||+.||.|||++||+||||||+||+++.+. .+.++|||++........ .......+++.|+|||.+.+.   .+
T Consensus       112 ~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~-~~Kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~  189 (273)
T d1mp8a_         112 LYAYQLSTALAYLESKRFVHRDIAARNVLVSSND-CVKLGDFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSA  189 (273)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETT-EEEECC--------------------CCGGGCCHHHHHHCCCSHH
T ss_pred             HHHHHHHHHhhhhcccCeeccccchhheeecCCC-cEEEccchhheeccCCcc-eeccceecCcccchhhHhccCCCCCc
Confidence            9999999999999999999999999999997643 344459999875443322 122345567889999998654   67


Q ss_pred             ccccCcceEEEEEE---eeeccccc
Q psy6508         159 LEYQRSKGELYVEF---KFAPFASQ  180 (477)
Q Consensus       159 ~Di~~s~G~il~e~---~~~Pf~~~  180 (477)
                      +|+ ||+|+++|||   +..||.+.
T Consensus       190 ~Di-wSlGvil~e~lt~g~~P~~~~  213 (273)
T d1mp8a_         190 SDV-WMFGVCMWEILMHGVKPFQGV  213 (273)
T ss_dssp             HHH-HHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccc-ccchHHHHHHHhcCCCCCCCC
Confidence            899 9999999997   56788753

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.7e-32  Score=263.88  Aligned_cols=174  Identities=20%  Similarity=0.290  Sum_probs=133.2

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeC-CeEEEEEecCCCCCHHHHHHhCC-------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDE-RYVYIILEYCDGGDLCSFIRSHE-------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~-~~~~lv~e~~~g~sL~~~l~~~~-------   73 (477)
                      +++.||||+++... .....+.+.+|..++.++ +||||+++++++... +.+++|||||+||+|.+++...+       
T Consensus        42 ~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~  120 (299)
T d1ywna1          42 TCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK  120 (299)
T ss_dssp             CEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC--
T ss_pred             CCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccc
Confidence            56789999987543 344556788899888887 689999999987654 56899999999999999997532       


Q ss_pred             ---------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEe
Q psy6508          74 ---------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVIC  144 (477)
Q Consensus        74 ---------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~  144 (477)
                               .+++..+..++.||+.||.|||++||+||||||+|||++.+. .+.++|||+++............+..+|
T Consensus       121 ~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt  199 (299)
T d1ywna1         121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGDARLP  199 (299)
T ss_dssp             ---------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG-CEEECC------CCSCTTSCCTTSCCCG
T ss_pred             cchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC-cEEEccCcchhhccccccccccCceeeC
Confidence                     488999999999999999999999999999999999997643 3445699998765444333334456789


Q ss_pred             ccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         145 SVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       145 ~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +.|+|||.+.+.   .++|+ ||+|+++|||   +..||.+
T Consensus       200 ~~y~APE~l~~~~~~~~sDi-wS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         200 LKWMAPETIFDRVYTIQSDV-WSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             GGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             ccccchhHhhcCCCCcccce-eehHHHHHHHHhCCCCCCCC
Confidence            999999988665   67899 9999999998   2356653

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=3.4e-31  Score=257.28  Aligned_cols=175  Identities=23%  Similarity=0.289  Sum_probs=143.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--------   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------   73 (477)
                      .+++.||||+++... ..+..++|.+|+.+|++++||||+++++++...+..+++|||+++|+|.+++....        
T Consensus        41 ~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~  119 (301)
T d1lufa_          41 EPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS  119 (301)
T ss_dssp             SSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC-------
T ss_pred             CCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCcccccccc
Confidence            356889999987543 45556789999999999999999999999999999999999999999999996532        


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCccccc
Q psy6508          74 ----------------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQ  137 (477)
Q Consensus        74 ----------------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~  137 (477)
                                      .+++..+..++.|++.||+|||++|++||||||+|||++.+. .+.++|||++...........
T Consensus       120 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~  198 (301)
T d1lufa_         120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM-VVKIADFGLSRNIYSADYYKA  198 (301)
T ss_dssp             ---------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC-
T ss_pred             ccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCC-cEEEccchhheeccCCccccc
Confidence                            388999999999999999999999999999999999998753 345569999875544333333


Q ss_pred             CCeEEEeccccccccCCCC---CcccccCcceEEEEEEe---eecccc
Q psy6508         138 GNTKVICSVFEPREIPSSK---TSLEYQRSKGELYVEFK---FAPFAS  179 (477)
Q Consensus       138 g~t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~~---~~Pf~~  179 (477)
                      ..+..+++.|+|||...+.   .++|+ ||+|+++|||.   .+||.+
T Consensus       199 ~~~~~~~~~y~aPE~~~~~~~t~ksDV-wS~Gvvl~ell~~~~~p~~~  245 (301)
T d1lufa_         199 DGNDAIPIRWMPPESIFYNRYTTESDV-WAYGVVLWEIFSYGLQPYYG  245 (301)
T ss_dssp             ---CCBCGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTTCCTTTT
T ss_pred             cCCCCcCcCcCCHHHHccCCCChhhhh-ccchhhHHHHHccCCCCCCC
Confidence            4456677889999988765   67899 99999999982   356664

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.9e-32  Score=262.30  Aligned_cols=168  Identities=23%  Similarity=0.271  Sum_probs=143.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-------
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-------   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-------   73 (477)
                      .+++.||||+++... .......+.+|+.+++++ +||||+++++++.+.+..|++||||+||+|.+++.+..       
T Consensus        51 ~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~  129 (311)
T d1t46a_          51 DAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK  129 (311)
T ss_dssp             TCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC----
T ss_pred             CCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccc
Confidence            467899999997654 344556799999999999 79999999999999999999999999999999997643       


Q ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEE
Q psy6508          74 -----------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKV  142 (477)
Q Consensus        74 -----------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v  142 (477)
                                 .+++..+..++.||+.||+|||++|++||||||+||+++.+. ....+|||.+................
T Consensus       130 ~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~  208 (311)
T d1t46a_         130 TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGR-ITKICDFGLARDIKNDSNYVVKGNAR  208 (311)
T ss_dssp             ----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSE
T ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccC-cccccccchheeccCCCcceEeeecc
Confidence                       588999999999999999999999999999999999997653 34446999997665544444445568


Q ss_pred             EeccccccccCCCC---CcccccCcceEEEEEE
Q psy6508         143 ICSVFEPREIPSSK---TSLEYQRSKGELYVEF  172 (477)
Q Consensus       143 ~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~  172 (477)
                      +++.|+|||...+.   .++|+ ||+|+++|||
T Consensus       209 gt~~y~aPE~~~~~~~~~~~DI-wS~G~~l~el  240 (311)
T d1t46a_         209 LPVKWMAPESIFNCVYTFESDV-WSYGIFLWEL  240 (311)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHH-HHHHHHHHHH
T ss_pred             cChHHcCHHHhcCCCCCCcccc-cchHHHHHHH
Confidence            88999999988754   77899 9999999998

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=2.9e-31  Score=255.89  Aligned_cols=174  Identities=21%  Similarity=0.291  Sum_probs=142.5

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++|+.||||+++.....+...+++.+|+.+|++++||||+++++++..++..|++||++.++.+..+....+.+++..++
T Consensus        24 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~  103 (286)
T d1ob3a_          24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAK  103 (286)
T ss_dssp             TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHH
T ss_pred             CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhH
Confidence            57899999999877655555678999999999999999999999999999999999999977777777767789999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.||+.||+|||++||+||||||+|||++.+. .+..+|||.+.....+..  ...+.++++.|+|||...+.    .
T Consensus       104 ~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~  180 (286)
T d1ob3a_         104 SFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREG-ELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYST  180 (286)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTS-CEEECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCT
T ss_pred             HHHHHHHHHHHHhccCcEEecCCCCceeeEcCCC-CEEecccccceecccCcc--ccceecccchhhhHHHHhCCCCCCc
Confidence            9999999999999999999999999999997653 334459999865443221  22345678889999987654    7


Q ss_pred             cccccCcceEEEEEE--eeecccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ++|+ ||+|++++||  |..||.+
T Consensus       181 ~~Di-wslGv~l~el~~G~~pf~~  203 (286)
T d1ob3a_         181 TIDI-WSVGCIFAEMVNGTPLFPG  203 (286)
T ss_dssp             HHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             ceee-hhcCcHHHHHHHCCCCCCC
Confidence            7899 9999999999  6677763

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.1e-32  Score=259.66  Aligned_cols=163  Identities=23%  Similarity=0.314  Sum_probs=129.4

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHh--CCCCCHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRS--HEKLSEFQC   80 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~--~~~l~~~~~   80 (477)
                      +++.||||+++.....   .+.|.+|+.++++++||||+++++++. ++..|+||||+++|+|..++..  .+.+++..+
T Consensus        40 ~~~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~  115 (285)
T d1fmka3          40 GTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL  115 (285)
T ss_dssp             TTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHSHHHHTTCCHHHH
T ss_pred             CCCEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhhhhhhcccccchHHHH
Confidence            4568999999766543   357899999999999999999999985 4568999999999999999864  346999999


Q ss_pred             HHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---C
Q psy6508          81 QQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        81 ~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ..++.||+.||+|||++||+||||||+|||++.+. .+.++|||+++....+.. ....+..+++.|+|||.....   .
T Consensus       116 ~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~  193 (285)
T d1fmka3         116 VDMAAQIASGMAYVERMNYVHRDLRAANILVGENL-VCKVADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTI  193 (285)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG-CEEECCCCTTC---------------CCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhhhheecccccceEEEECCCC-cEEEcccchhhhccCCCc-eeeccccccccccChHHHhCCCCCc
Confidence            99999999999999999999999999999998653 344459999865433322 222345678899999988654   7


Q ss_pred             cccccCcceEEEEEE
Q psy6508         158 SLEYQRSKGELYVEF  172 (477)
Q Consensus       158 ~~Di~~s~G~il~e~  172 (477)
                      ++|+ ||+|+++|||
T Consensus       194 ksDI-~S~Giil~el  207 (285)
T d1fmka3         194 KSDV-WSFGILLTEL  207 (285)
T ss_dssp             HHHH-HHHHHHHHHH
T ss_pred             HHhh-hcchHHHHHH
Confidence            7899 9999999998

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=5.4e-31  Score=252.09  Aligned_cols=173  Identities=16%  Similarity=0.229  Sum_probs=134.9

Q ss_pred             CcEEEEEEcccCCCC-hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHH
Q psy6508           4 HTEVAIKCIDKTKVS-ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQ   81 (477)
Q Consensus         4 g~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~   81 (477)
                      +..||||++++.... ++..++|.+|+.+|++++||||+++++++.+ +..++||||+++|+|.+++..+ +.+++..++
T Consensus        36 ~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~  114 (273)
T d1u46a_          36 TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLS  114 (273)
T ss_dssp             EEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHH
T ss_pred             EEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHH
Confidence            347999999876543 3456789999999999999999999999965 4678999999999999987653 469999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccC-CeEEEeccccccccCCCC---C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQG-NTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g-~t~v~~~~y~ppE~~~~~---~  157 (477)
                      .++.|++.||.|||++||+||||||+||+++.+. .+..+|||++.....+...... ....++..|+|||...+.   .
T Consensus       115 ~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~-~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  193 (273)
T d1u46a_         115 RYAVQVAEGMGYLESKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH  193 (273)
T ss_dssp             HHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETT-EEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEH
T ss_pred             HHHHHHHHHHHHhhhCCEeeeeecHHHhcccccc-ceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCc
Confidence            9999999999999999999999999999997653 3445699998876544322222 234456679999998776   6


Q ss_pred             cccccCcceEEEEEE---eeecccc
Q psy6508         158 SLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       158 ~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      ++|+ ||+|+++|||   |..||.+
T Consensus       194 ~~Di-~S~Gvil~emlt~G~~Pf~~  217 (273)
T d1u46a_         194 ASDT-WMFGVTLWEMFTYGQEPWIG  217 (273)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             chhh-hhhHHHHHHHHhCCCCCCCC
Confidence            7899 9999999998   4678864

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=9.9e-31  Score=253.71  Aligned_cols=173  Identities=20%  Similarity=0.384  Sum_probs=145.5

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC--------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE--------   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~--------   73 (477)
                      ++..||||++++.. ......++.+|...+.++ +||||+++++++.+++..|+||||+++|+|.+++....        
T Consensus        44 ~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~  122 (299)
T d1fgka_          44 RVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSY  122 (299)
T ss_dssp             CEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------
T ss_pred             CceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCcccccc
Confidence            34689999997654 445567899999999998 89999999999999999999999999999999997542        


Q ss_pred             --------CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEe
Q psy6508          74 --------KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVIC  144 (477)
Q Consensus        74 --------~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~  144 (477)
                              ++++..+..++.|++.||+|||++||+||||||+|||++.+ ..++  .|||.+...........+....++
T Consensus       123 ~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl--~dfg~~~~~~~~~~~~~~~~~~~~  200 (299)
T d1fgka_         123 NPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKI--ADFGLARDIHHIDYYKKTTNGRLP  200 (299)
T ss_dssp             ------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEE--CSTTCCCCGGGCCTTCCCTTSCCG
T ss_pred             ccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEe--ccchhhccccccccccccccCCCC
Confidence                    48999999999999999999999999999999999999765 4554  599988766554444445556788


Q ss_pred             ccccccccCCCC---CcccccCcceEEEEEE---eeecccc
Q psy6508         145 SVFEPREIPSSK---TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       145 ~~y~ppE~~~~~---~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      +.|+|||.+.+.   .++|+ ||+|+++|||   +.+||.+
T Consensus       201 ~~y~aPE~l~~~~y~~k~Di-wS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         201 VKWMAPEALFDRIYTHQSDV-WSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             GGGSCHHHHHHCCCCHHHHH-HHHHHHHHHHHTTSCCSSTT
T ss_pred             hhhhhhhHhcCCCCCchhhh-HHhHHHHHHhccCCCCCCCC
Confidence            899999988655   77899 9999999998   4677764

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.5e-30  Score=256.15  Aligned_cols=169  Identities=24%  Similarity=0.383  Sum_probs=143.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC------eEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER------YVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~------~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++++...++...+.+.+|+.+|++++||||++++++|...+      .+|+||||+ |.+|..+.+. +++
T Consensus        41 ~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~-~~l  118 (346)
T d1cm8a_          41 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKL  118 (346)
T ss_dssp             TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCC
T ss_pred             CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHh-ccc
Confidence            57999999999877667777788999999999999999999999997654      579999999 5788887765 579


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      ++..++.++.||+.||.|||++||+||||||+|||++.+. .+..+|||.+...+...     .+.++++.|+|||.+.+
T Consensus       119 ~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~~~~~~~-----~~~~~t~~y~aPE~~~~  192 (346)
T d1cm8a_         119 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDC-ELKILDFGLARQADSEM-----TGYVVTRWYRAPEVILN  192 (346)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCSSC-----CSSCSCGGGCCTHHHHT
T ss_pred             cHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhccccc-ccccccccceeccCCcc-----ccccccccccCHHHHcC
Confidence            9999999999999999999999999999999999998653 34456999987655432     35678889999998754


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|+++|+|  +..||.+
T Consensus       193 ~~~~~~~~Di-wSlGvil~ell~g~~pf~~  221 (346)
T d1cm8a_         193 WMRYTQTVDI-WSVGCIMAEMITGKTLFKG  221 (346)
T ss_dssp             TTCCCTTHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCccchh-hcchHHHHHHHHCcCCCCC
Confidence            3    78999 9999999999  6678764

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.4e-30  Score=251.99  Aligned_cols=170  Identities=17%  Similarity=0.236  Sum_probs=133.1

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC-CCCCHHHHHHHH
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH-EKLSEFQCQQFV   84 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~-~~l~~~~~~~i~   84 (477)
                      .||+|.++... +.+..++|.+|+.+|++++||||+++++++.++ ..++++|++.+++|.+++... ..+++..++.++
T Consensus        40 ~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~  117 (317)
T d1xkka_          40 PVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC  117 (317)
T ss_dssp             EEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHH
T ss_pred             EEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHH
Confidence            68999886543 334567899999999999999999999999765 567888999999999988764 479999999999


Q ss_pred             HHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---Ccccc
Q psy6508          85 RQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---TSLEY  161 (477)
Q Consensus        85 ~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---~~~Di  161 (477)
                      .||+.||.|||++||+||||||+|||++.+. .+.++|||++................++..|+|||.+.+.   .++|+
T Consensus       118 ~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~-~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDv  196 (317)
T d1xkka_         118 VQIAKGMNYLEDRRLVHRDLAARNVLVKTPQ-HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDV  196 (317)
T ss_dssp             HHHHHHHHHHHHTTCCCSCCCGGGEEEEETT-EEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHH
T ss_pred             HHHHHHHHHHHHcCcccCcchhhcceeCCCC-CeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhh
Confidence            9999999999999999999999999998653 3444699998765433322222345678899999987655   67899


Q ss_pred             cCcceEEEEEE---eeecccc
Q psy6508         162 QRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       162 ~~s~G~il~e~---~~~Pf~~  179 (477)
                       ||+|+++|||   +..||.+
T Consensus       197 -wS~Gvil~el~t~g~~p~~~  216 (317)
T d1xkka_         197 -WSYGVTVWELMTFGSKPYDG  216 (317)
T ss_dssp             -HHHHHHHHHHHTTSCCTTTT
T ss_pred             -hhHHHHHHHHHHCCCCCCCC
Confidence             9999999999   4566654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.5e-31  Score=249.45  Aligned_cols=166  Identities=24%  Similarity=0.384  Sum_probs=129.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHHhCC--CCCHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-ERYVYIILEYCDGGDLCSFIRSHE--KLSEFQ   79 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~~--~l~~~~   79 (477)
                      +|+.||||+++.+.    ..+.+.+|+.++++++||||+++++++.+ .+.+|+||||+++|+|.+++.+.+  .+++..
T Consensus        29 ~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~  104 (262)
T d1byga_          29 RGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDC  104 (262)
T ss_dssp             TTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHH
T ss_pred             CCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHH
Confidence            47889999997543    34678999999999999999999998854 456899999999999999997643  589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC---
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK---  156 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~---  156 (477)
                      ++.++.||+.||.|||+++|+||||||+|||++.+. ....+|||.+......     ..+..++..|+|||...+.   
T Consensus       105 ~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t  178 (262)
T d1byga_         105 LLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFS  178 (262)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTS-CEEECCCCC-----------------CCTTTSCHHHHHHCCCC
T ss_pred             HHHHHHHHHhhccccccCceeccccchHhheecCCC-CEeecccccceecCCC-----CccccccccCCChHHHhCCCCC
Confidence            999999999999999999999999999999998654 2334699988654432     2344567789999987654   


Q ss_pred             CcccccCcceEEEEEE---eeecccc
Q psy6508         157 TSLEYQRSKGELYVEF---KFAPFAS  179 (477)
Q Consensus       157 ~~~Di~~s~G~il~e~---~~~Pf~~  179 (477)
                      .++|+ ||+|+++|||   +..||..
T Consensus       179 ~~sDI-wSfG~il~el~t~~~~p~~~  203 (262)
T d1byga_         179 TKSDV-WSFGILLWEIYSFGRVPYPR  203 (262)
T ss_dssp             HHHHH-HHHHHHHHHHHTTSCCSCTT
T ss_pred             hHHHH-HhHHHHHHHHHHCCCCCCCC
Confidence            78999 9999999998   3566654

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.6e-30  Score=253.17  Aligned_cols=176  Identities=22%  Similarity=0.349  Sum_probs=147.0

Q ss_pred             CCCcEEEEEEcccCCCC--hhHHHHHHHHHHHHHhcCC-CCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVS--ENRFDSIVNEIKALKLLHH-QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~--~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+|+.||||++++....  ....+.+.+|+.+|++++| |||+++++++.+...++++|||+.||+|.+++...+.+++.
T Consensus        50 ~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~  129 (322)
T d1vzoa_          50 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEH  129 (322)
T ss_dssp             TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHH
T ss_pred             CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHH
Confidence            46899999999765432  2234568899999999965 89999999999999999999999999999999988889999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++.++.|++.||+|||++||+||||||+||+++.++ ++.++|||++....... .....+..+++.|++||...+.  
T Consensus       130 ~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~-~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~  207 (322)
T d1vzoa_         130 EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNG-HVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDS  207 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTS-CEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCC-CEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCc
Confidence            9999999999999999999999999999999998653 34556999986543322 2223456788899999987653  


Q ss_pred             ---CcccccCcceEEEEEE--eeeccccc
Q psy6508         157 ---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       157 ---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                         .++|+ ||+|+++|+|  |..||.+.
T Consensus       208 ~~~~ksDI-WSlG~iLyelltG~~PF~~~  235 (322)
T d1vzoa_         208 GHDKAVDW-WSLGVLMYELLTGASPFTVD  235 (322)
T ss_dssp             --CTHHHH-HHHHHHHHHHHHSSCTTSCT
T ss_pred             CCCchhhh-HHHHHHHHHHHhCCCCCCCC
Confidence               57899 9999999999  77899764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=5.2e-30  Score=249.58  Aligned_cols=174  Identities=21%  Similarity=0.285  Sum_probs=145.7

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC----------
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH----------   72 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~----------   72 (477)
                      +++.||||+++... .......|.+|+.++++++||||+++++++..++..++||||+++|+|.+++...          
T Consensus        49 ~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~  127 (308)
T d1p4oa_          49 PETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL  127 (308)
T ss_dssp             EEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTC
T ss_pred             CCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhccccccccccc
Confidence            45789999997543 4555677999999999999999999999999999999999999999999998643          


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ..+++..+..++.|++.||.|||+++|+||||||+|||++.+. .+.++|||++...........+.+..+++.|+|||.
T Consensus       128 ~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~  206 (308)
T d1p4oa_         128 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF-TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  206 (308)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC-CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc-eEEEeecccceeccCCcceeeccceecccccCCHHH
Confidence            2478899999999999999999999999999999999998653 444569999876655544455556688999999998


Q ss_pred             CCCC---CcccccCcceEEEEEE--e-eecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--K-FAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~-~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++|||  + ..||.+
T Consensus       207 l~~~~~~~~~Dv-~S~G~il~El~t~~~~p~~~  238 (308)
T d1p4oa_         207 LKDGVFTTYSDV-WSFGVVLWEIATLAEQPYQG  238 (308)
T ss_dssp             HHHCCCCHHHHH-HHHHHHHHHHHHTSCCTTTT
T ss_pred             HccCCCCccccc-ccHHHHHHHHHhCCCCCCCC
Confidence            7655   67899 9999999998  2 356653

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.6e-29  Score=250.70  Aligned_cols=167  Identities=22%  Similarity=0.332  Sum_probs=133.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC------CeEEEEEecCCCCCHHHH---HHhC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE------RYVYIILEYCDGGDLCSF---IRSH   72 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~------~~~~lv~e~~~g~sL~~~---l~~~   72 (477)
                      ++|+.||||++++....      ..+|+.+|++++||||++++++|...      .++|||||||+++.+..+   ....
T Consensus        43 ~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~  116 (350)
T d1q5ka_          43 DSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK  116 (350)
T ss_dssp             TTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTT
T ss_pred             CCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhcc
Confidence            57999999999765432      23799999999999999999998543      358999999985533332   2344


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          73 EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        73 ~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      ..+++..++.|+.||+.||+|||++||+||||||+|||++.+...+.++|||++.......   ...+.+++..|+|||.
T Consensus       117 ~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~  193 (350)
T d1q5ka_         117 QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPEL  193 (350)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS---CCCSCCSCTTSCCHHH
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc---ccccccccccccChHH
Confidence            5799999999999999999999999999999999999998765556667999986543322   2345678899999997


Q ss_pred             CCCC----CcccccCcceEEEEEE--eeeccc
Q psy6508         153 PSSK----TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       153 ~~~~----~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ..+.    .++|+ ||+|+++|||  +..||.
T Consensus       194 ~~~~~~~~~~~DI-wSlG~il~el~~g~~pf~  224 (350)
T d1q5ka_         194 IFGATDYTSSIDV-WSAGCVLAELLLGQPIFP  224 (350)
T ss_dssp             HTTCSSCCTHHHH-HHHHHHHHHHHHTSCSSC
T ss_pred             hhcccCCCcceee-cccceEEEehhhCCCCCC
Confidence            6543    78999 9999999999  667775

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.7e-30  Score=248.95  Aligned_cols=168  Identities=24%  Similarity=0.338  Sum_probs=133.4

Q ss_pred             EEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhC------------
Q psy6508           6 EVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSH------------   72 (477)
Q Consensus         6 ~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~------------   72 (477)
                      .||||.++... ..+..+.|.+|+.+|+++ +||||+++++++.+++.+|+||||++||+|.++++.+            
T Consensus        39 ~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~  117 (309)
T d1fvra_          39 DAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIA  117 (309)
T ss_dssp             EEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHH
T ss_pred             EEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhcc
Confidence            57888875433 334456799999999999 7999999999999999999999999999999999754            


Q ss_pred             ----CCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEecccc
Q psy6508          73 ----EKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFE  148 (477)
Q Consensus        73 ----~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~  148 (477)
                          ..+++..+..++.||+.||.|||++||+||||||+|||++.+. .+.++|||++.......   ......++..|+
T Consensus       118 ~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~-~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~  193 (309)
T d1fvra_         118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY-VAKIADFGLSRGQEVYV---KKTMGRLPVRWM  193 (309)
T ss_dssp             TTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG-CEEECCTTCEESSCEEC---CC----CCTTTC
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC-ceEEccccccccccccc---cccceecCCccc
Confidence                4699999999999999999999999999999999999997653 34456999986433211   223456778899


Q ss_pred             ccccCCCC---CcccccCcceEEEEEEe---eecccc
Q psy6508         149 PREIPSSK---TSLEYQRSKGELYVEFK---FAPFAS  179 (477)
Q Consensus       149 ppE~~~~~---~~~Di~~s~G~il~e~~---~~Pf~~  179 (477)
                      |||.+.+.   .++|+ ||+|+++|||.   ..||.+
T Consensus       194 aPE~l~~~~~~~~sDv-wSfGvil~ell~~~~~p~~~  229 (309)
T d1fvra_         194 AIESLNYSVYTTNSDV-WSYGVLLWEIVSLGGTPYCG  229 (309)
T ss_dssp             CHHHHHHCEECHHHHH-HHHHHHHHHHHTTSCCTTTT
T ss_pred             chHHhccCCCCcccee-ehhHHHHHHHHhcCCCCCCC
Confidence            99998766   67899 99999999982   345654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-29  Score=248.79  Aligned_cols=173  Identities=25%  Similarity=0.335  Sum_probs=139.9

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC-----eEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER-----YVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-----~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||++++.. .....+++.+|+.+|++++||||+++++++....     .+|++++ +.||+|.+++..+ +++
T Consensus        31 ~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~-~~~g~L~~~l~~~-~l~  107 (345)
T d1pmea_          31 VNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKTQ-HLS  107 (345)
T ss_dssp             TTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE-CCCEEHHHHHHHC-CCC
T ss_pred             CCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe-ecCCchhhhhhcC-CCC
Confidence            579999999997654 3455678999999999999999999999987543     3556555 5589999999874 799


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc-cccCCeEEEeccccccccCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY-IEQGNTKVICSVFEPREIPSS  155 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~-~~~g~t~v~~~~y~ppE~~~~  155 (477)
                      +..++.++.|++.||+|||++||+||||||+|||++.+. .+.++|||++........ .....+.++++.|+|||.+..
T Consensus       108 ~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~  186 (345)
T d1pmea_         108 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTC-DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLN  186 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTC-CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTT
T ss_pred             HHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCC-CEEEcccCceeeccCCCccceeeccccccceechHHHhhc
Confidence            999999999999999999999999999999999997643 344459999865433221 122355778999999998754


Q ss_pred             C----CcccccCcceEEEEEE--eeecccc
Q psy6508         156 K----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       156 ~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      .    .++|+ ||+|+++|+|  +..||.+
T Consensus       187 ~~~~~~~~Di-wSlG~il~eml~g~~pf~~  215 (345)
T d1pmea_         187 SKGYTKSIDI-WSVGCILAEMLSNRPIFPG  215 (345)
T ss_dssp             BCSCSTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             CCCCCchhhh-hccCceehHHhhCCCCCCC
Confidence            4    67899 9999999999  6788864

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.5e-29  Score=247.42  Aligned_cols=176  Identities=18%  Similarity=0.301  Sum_probs=138.4

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe--------CCeEEEEEecCCCCCHHHHHHhCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD--------ERYVYIILEYCDGGDLCSFIRSHE   73 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~--------~~~~~lv~e~~~g~sL~~~l~~~~   73 (477)
                      ++|+.||||++......+...+++.+|+.+|++++||||+++++++..        ++.+|++|||++++.+..+.....
T Consensus        33 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~  112 (318)
T d3blha1          33 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV  112 (318)
T ss_dssp             TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC
T ss_pred             CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccc
Confidence            578999999998776655556778999999999999999999998754        346899999999776666555556


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCc--ccccCCeEEEeccccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSA--YIEQGNTKVICSVFEPRE  151 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~--~~~~g~t~v~~~~y~ppE  151 (477)
                      .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+...|||++.......  ......+.++|+.|+|||
T Consensus       113 ~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE  191 (318)
T d3blha1         113 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDG-VLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE  191 (318)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTS-CEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHH
T ss_pred             ccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCC-cEEeeecceeeecccccccccccccceecCHHHhhHH
Confidence            899999999999999999999999999999999999997653 34446999886443222  122334567899999999


Q ss_pred             cCCCC----CcccccCcceEEEEEE--eeecccc
Q psy6508         152 IPSSK----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       152 ~~~~~----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ...+.    .++|+ ||+|+++|||  +..||.+
T Consensus       192 ~~~~~~~~~~k~Di-wSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         192 LLLGERDYGPPIDL-WGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             HHTTCSSCCTHHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             HHcCCCCCCcHHHc-ccCCceeeeHhhCCCCCCC
Confidence            87543    78899 9999999999  6677753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4e-29  Score=241.18  Aligned_cols=173  Identities=28%  Similarity=0.370  Sum_probs=146.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      ++|+.||||+++.....+...+++.+|+.+|+.++||||+++++++......+++++++.|++|..++...+.+++..++
T Consensus        25 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~  104 (292)
T d1unla_          25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVK  104 (292)
T ss_dssp             TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHH
T ss_pred             CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHH
Confidence            57899999999877666667788999999999999999999999999999999999999999999998888899999999


Q ss_pred             HHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC----C
Q psy6508          82 QFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK----T  157 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~----~  157 (477)
                      .++.|++.||+|||++||+||||||+|||++.+. ...++|||.+........  ......++..|.|||...+.    .
T Consensus       105 ~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~  181 (292)
T d1unla_         105 SFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNG-ELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYST  181 (292)
T ss_dssp             HHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC-CEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCT
T ss_pred             HHHHHHHHHHHHhhcCCEeeecccCcccccccCC-ceeeeecchhhcccCCCc--cceeeccccchhhhhHhccCCCCCc
Confidence            9999999999999999999999999999997643 334459999876543221  22334566789999987654    6


Q ss_pred             cccccCcceEEEEEE--eeeccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++|+ ||+|+++|||  +..||.
T Consensus       182 ~~Di-wSlG~il~ell~g~~p~~  203 (292)
T d1unla_         182 SIDM-WSAGCIFAELANAGRPLF  203 (292)
T ss_dssp             HHHH-HHHHHHHHHHTTTSCCSC
T ss_pred             hhhc-cccchHHHHHhhCCCCCC
Confidence            7899 9999999999  455553

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.4e-29  Score=245.10  Aligned_cols=171  Identities=19%  Similarity=0.271  Sum_probs=138.7

Q ss_pred             cEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe-CCeEEEEEecCCCCCHHHHHHhCC-CCCHHHHHH
Q psy6508           5 TEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD-ERYVYIILEYCDGGDLCSFIRSHE-KLSEFQCQQ   82 (477)
Q Consensus         5 ~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~~~~   82 (477)
                      ..||||++++. .+....++|.+|+.+|++++||||+++++++.. ++..++|||||++++|.+++.... .+++..+..
T Consensus        56 ~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~  134 (311)
T d1r0pa_          56 IHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIG  134 (311)
T ss_dssp             EEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHH
T ss_pred             EEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHH
Confidence            36999998653 355667889999999999999999999999765 568999999999999999988643 578889999


Q ss_pred             HHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcc--cccCCeEEEeccccccccCCCC---C
Q psy6508          83 FVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAY--IEQGNTKVICSVFEPREIPSSK---T  157 (477)
Q Consensus        83 i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~--~~~g~t~v~~~~y~ppE~~~~~---~  157 (477)
                      ++.|++.||.|+|++||+||||||+|||++.+. .+.++|||++........  ........++..|+|||.....   .
T Consensus       135 i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  213 (311)
T d1r0pa_         135 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKF-TVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTT  213 (311)
T ss_dssp             HHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTC-CEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHhhhhhcccCcccCCccHHhEeECCCC-CEEEecccchhhccccccccceecccccccccccChHHHhcCCCCC
Confidence            999999999999999999999999999998653 344569999876443322  1222335678889999987654   6


Q ss_pred             cccccCcceEEEEEE--eeeccc
Q psy6508         158 SLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       158 ~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      ++|+ ||+|+++||+  +..||.
T Consensus       214 ksDI-~SfGivl~El~t~~~p~~  235 (311)
T d1r0pa_         214 KSDV-WSFGVLLWELMTRGAPPY  235 (311)
T ss_dssp             HHHH-HHHHHHHHHHHTTSCCSC
T ss_pred             hhHh-hhhHHHHHHHHHCCCCCC
Confidence            7899 9999999999  344544

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-29  Score=246.64  Aligned_cols=184  Identities=23%  Similarity=0.291  Sum_probs=141.0

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhc---CCCCccceEEEEEe-----CCeEEEEEecCCCCCHHHHHHh-CC
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLL---HHQHIVTMLDFLWD-----ERYVYIILEYCDGGDLCSFIRS-HE   73 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l---~HpnIv~~~~~~~~-----~~~~~lv~e~~~g~sL~~~l~~-~~   73 (477)
                      +++.||||+++.....+.....+.+|+.+|+.|   +||||++++++|..     ...+|++||+++++.+...... ..
T Consensus        32 ~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~  111 (305)
T d1blxa_          32 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEP  111 (305)
T ss_dssp             TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTT
T ss_pred             CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCC
Confidence            366799999977654443334566788887766   79999999999863     3478999999997666544443 34


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc-CcceeecccccceecccCCcccccCCeEEEecccccccc
Q psy6508          74 KLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN-NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREI  152 (477)
Q Consensus        74 ~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~-~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~  152 (477)
                      .+++..++.++.|++.||+|||++||+||||||+|||++. +..++  .|||.+......   ....+..+|+.|+|||+
T Consensus       112 ~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl--~dfg~~~~~~~~---~~~~~~~gT~~Y~APE~  186 (305)
T d1blxa_         112 GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKL--ADFGLARIYSFQ---MALTSVVVTLWYRAPEV  186 (305)
T ss_dssp             CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE--CSCCSCCCCCGG---GGGCCCCCCCTTCCHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeee--cchhhhhhhccc---ccCCCcccChhhcCcch
Confidence            6999999999999999999999999999999999999976 45555  488887543322   23356788999999998


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeeccccccccCCCCCcchHHHHHHHHH
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFASQIRTGWLRDSEEKELGNHLKR  200 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~~r~~~~~~~~~~~l~~~i~~  200 (477)
                      +.+.   .++|+ ||+|+++|||  +..||.+        ......+..+++.
T Consensus       187 ~~~~~y~~~~Di-wSlG~il~ell~g~~pf~~--------~~~~~~~~~i~~~  230 (305)
T d1blxa_         187 LLQSSYATPVDL-WSVGCIFAEMFRRKPLFRG--------SSDVDQLGKILDV  230 (305)
T ss_dssp             HTTCCCCTHHHH-HHHHHHHHHHHHSSCSCCC--------SSHHHHHHHHHHH
T ss_pred             hcCCCCChhehh-hchHHHHHHHHHCCCCCCC--------CCHHHHHHHHHHh
Confidence            8766   78999 9999999999  6777763        3344455555443

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.95  E-value=1.2e-28  Score=242.06  Aligned_cols=165  Identities=24%  Similarity=0.376  Sum_probs=137.8

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeC--CeEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDE--RYVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~--~~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      .+|+.||||+++...     .+++.+|+.+|+.++ ||||+++++++...  ..+++|||||++++|..+.   +.+++.
T Consensus        58 ~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~  129 (328)
T d3bqca1          58 TNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDY  129 (328)
T ss_dssp             TTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHH
T ss_pred             CCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHH
Confidence            578999999986542     356889999999995 99999999999844  5699999999999998764   469999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC--
Q psy6508          79 QCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK--  156 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~--  156 (477)
                      .++.++.||+.||+|||++||+||||||+|||++.++..+.++|||.+.......   ...+.++|+.|+|||...+.  
T Consensus       130 ~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~  206 (328)
T d3bqca1         130 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQM  206 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC---cccccccCccccCcccccCCCC
Confidence            9999999999999999999999999999999998755456667999987554322   23456778899999987654  


Q ss_pred             --CcccccCcceEEEEEE--eeeccc
Q psy6508         157 --TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       157 --~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                        .++|+ ||+|++++++  +..||.
T Consensus       207 ~~~~~Di-wslG~~l~e~~~g~~pf~  231 (328)
T d3bqca1         207 YDYSLDM-WSLGCMLASMIFRKEPFF  231 (328)
T ss_dssp             CCTHHHH-HHHHHHHHHHHHTCSSSS
T ss_pred             CCcccch-hhhhhhhHHhccCCCCCC
Confidence              67899 9999999999  556666

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.1e-28  Score=239.67  Aligned_cols=170  Identities=18%  Similarity=0.231  Sum_probs=130.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeCC----eEEEEEecCCCCCHHHHHHhCCCCCHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDER----YVYIILEYCDGGDLCSFIRSHEKLSEF   78 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~----~~~lv~e~~~g~sL~~~l~~~~~l~~~   78 (477)
                      +|+.||||+++.+.   ........|+..+.+++||||+++++++..++    .+|+||||+++|+|.+++++. .+++.
T Consensus        25 ~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~  100 (303)
T d1vjya_          25 RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVE  100 (303)
T ss_dssp             TTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHH
T ss_pred             CCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHH
Confidence            57899999986442   11122334555566789999999999987653    689999999999999999874 69999


Q ss_pred             HHHHHHHHHHHHHHHHHh--------CCcEEccCCCCceeeccCcceeecccccceecccCCccc--ccCCeEEEecccc
Q psy6508          79 QCQQFVRQLVLALKFLRE--------NNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYI--EQGNTKVICSVFE  148 (477)
Q Consensus        79 ~~~~i~~qi~~aL~~LH~--------~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~--~~g~t~v~~~~y~  148 (477)
                      .+..++.|++.||.|+|+        +||+||||||+|||++.+. .+.++|||++.........  ....+.++|+.|+
T Consensus       101 ~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~  179 (303)
T d1vjya_         101 GMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM  179 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCTTCEEEETTTTEECC----CCSCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecCccccccCCCcceeccccceecccCcC
Confidence            999999999999999996        5999999999999997652 4445699988765432211  1223467889999


Q ss_pred             ccccCCCC---------CcccccCcceEEEEEE--eeeccc
Q psy6508         149 PREIPSSK---------TSLEYQRSKGELYVEF--KFAPFA  178 (477)
Q Consensus       149 ppE~~~~~---------~~~Di~~s~G~il~e~--~~~Pf~  178 (477)
                      |||.+.+.         .++|+ ||+|+++|||  +..||.
T Consensus       180 aPE~~~~~~~~~~~~~~~k~Di-~S~Gvvl~el~tg~~~~~  219 (303)
T d1vjya_         180 APEVLDDSINMKHFESFKRADI-YAMGLVFWEIARRCSIGG  219 (303)
T ss_dssp             CHHHHTTCSCTTCHHHHHHHHH-HHHHHHHHHHHHTBCBTT
T ss_pred             ChhhccccccccCCCcCcchhh-hhhHHHHHHHhhCCCCCC
Confidence            99987653         46899 9999999999  445553

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.9e-29  Score=246.23  Aligned_cols=170  Identities=21%  Similarity=0.312  Sum_probs=137.1

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEeC-----CeEEEEEecCCCCCHHHHHHhCCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWDE-----RYVYIILEYCDGGDLCSFIRSHEKLS   76 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-----~~~~lv~e~~~g~sL~~~l~~~~~l~   76 (477)
                      .+|+.||||++++...+....+++.+|+.+|++++||||+++++++...     ...+++++++.||+|.+++.. ++++
T Consensus        41 ~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~  119 (348)
T d2gfsa1          41 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLT  119 (348)
T ss_dssp             TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCC
T ss_pred             CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-cccc
Confidence            5799999999988776666677899999999999999999999998643     234556667778999999865 5799


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecccCCcccccCCeEEEeccccccccCCCC
Q psy6508          77 EFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSK  156 (477)
Q Consensus        77 ~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~  156 (477)
                      +..++.++.||+.||+|||++||+||||||+|||++.+. ....+|||.+.....     ...+..++..|+|||...+.
T Consensus       120 e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~-~~kl~dfg~a~~~~~-----~~~~~~g~~~y~apE~~~~~  193 (348)
T d2gfsa1         120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC-ELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNW  193 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTC-CEEECCC----CCTG-----GGSSSCHHHHTSCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccc-cccccccchhcccCc-----ccccccccccccCchhhcCC
Confidence            999999999999999999999999999999999997653 333458888755432     22456788899999986553


Q ss_pred             ----CcccccCcceEEEEEE--eeecccc
Q psy6508         157 ----TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       157 ----~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                          .++|+ ||+|+++|+|  +..||.+
T Consensus       194 ~~~~~~~Di-wSlGv~l~~ll~g~~pF~~  221 (348)
T d2gfsa1         194 MHYNQTVDI-WSVGCIMAELLTGRTLFPG  221 (348)
T ss_dssp             SCCCTTHHH-HHHHHHHHHHHHSSCSCCC
T ss_pred             ccCCcccch-hhhhHHHHHHHhCCCCCCC
Confidence                67899 9999999999  6677764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.4e-28  Score=242.52  Aligned_cols=169  Identities=24%  Similarity=0.383  Sum_probs=133.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCccceEEEEEe------CCeEEEEEecCCCCCHHHHHHhCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHIVTMLDFLWD------ERYVYIILEYCDGGDLCSFIRSHEKL   75 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~------~~~~~lv~e~~~g~sL~~~l~~~~~l   75 (477)
                      .+|+.||||++++...+.....++.+|+.+|++++||||++++++|..      .+.+|+|||||.| ++.+.+.  ..+
T Consensus        40 ~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~--~~~  116 (355)
T d2b1pa1          40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MEL  116 (355)
T ss_dssp             TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCC
T ss_pred             CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccch-HHHHhhh--cCC
Confidence            479999999998887777777789999999999999999999999863      3689999999975 5555553  469


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccC-cceeecccccceecccCCcccccCCeEEEeccccccccCC
Q psy6508          76 SEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNN-TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPS  154 (477)
Q Consensus        76 ~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~-~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~  154 (477)
                      ++..++.++.|++.||.|||++||+||||||+|||++.+ ..++  .|||........   .......+|+.|+|||++.
T Consensus       117 ~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl--~df~~~~~~~~~---~~~~~~~~t~~y~aPE~l~  191 (355)
T d2b1pa1         117 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI--LDFGLARTAGTS---FMMTPYVVTRYYRAPEVIL  191 (355)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEE--CCCCC------------------CCTTCCHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceee--echhhhhccccc---cccccccccccccChhhhc
Confidence            999999999999999999999999999999999999865 4444  588876544322   2234567889999999987


Q ss_pred             CC---CcccccCcceEEEEEE--eeecccc
Q psy6508         155 SK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       155 ~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      +.   .++|+ ||+|++++++  +..||.+
T Consensus       192 ~~~~~~~~Di-wSlG~~l~ell~g~~pF~~  220 (355)
T d2b1pa1         192 GMGYKENVDI-WSVGCIMGEMVRHKILFPG  220 (355)
T ss_dssp             TCCCCTTHHH-HHHHHHHHHHHHSSCSSCC
T ss_pred             CCCCCCCccc-ccccchHHHHhhCCCCCCC
Confidence            76   78999 9999999999  6777763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.94  E-value=1.6e-27  Score=230.22  Aligned_cols=172  Identities=16%  Similarity=0.200  Sum_probs=141.3

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCC-CCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCC-CCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHH-QHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHE-KLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~H-pnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~-~l~~~~   79 (477)
                      .+|+.||||+++.....    +.+.+|+++++.++| ||++.+++++..+...|+||||+ |++|.+++...+ .+++..
T Consensus        28 ~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~  102 (293)
T d1csna_          28 LNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKT  102 (293)
T ss_dssp             TTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHH
T ss_pred             CCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHH
Confidence            47899999998665322    246789999999965 99999999999999999999999 589999997754 699999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc----CcceeecccccceecccCCcc-----cccCCeEEEecccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN----NTLKLAGLKQGVSEKAKGSAY-----IEQGNTKVICSVFEPR  150 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~----~~~rl~~~dfG~~~~~~gs~~-----~~~g~t~v~~~~y~pp  150 (477)
                      +..++.|++.||+|||++||+||||||+|||++.    ....+.++|||++.....+..     .....+.+||+.|+||
T Consensus       103 ~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aP  182 (293)
T d1csna_         103 VAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI  182 (293)
T ss_dssp             HHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCH
T ss_pred             HHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCH
Confidence            9999999999999999999999999999999963    233455669999876432211     1123356789999999


Q ss_pred             ccCCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         151 EIPSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       151 E~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      |...+.   .++|+ ||+|+++|||  +..||.+
T Consensus       183 E~~~~~~~~~~~Di-wSlG~~l~elltg~~Pf~~  215 (293)
T d1csna_         183 NTHLGREQSRRDDL-EALGHVFMYFLRGSLPWQG  215 (293)
T ss_dssp             HHHTTCCCCHHHHH-HHHHHHHHHHHHSSCTTSS
T ss_pred             HHhcCCCCChHHHH-HHhhHHHHHHHhCCCcCCC
Confidence            998876   67899 9999999999  6788864

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.93  E-value=2.1e-27  Score=230.12  Aligned_cols=172  Identities=17%  Similarity=0.165  Sum_probs=137.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCC-ccceEEEEEeCCeEEEEEecCCCCCHHHHHHh-CCCCCHHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQH-IVTMLDFLWDERYVYIILEYCDGGDLCSFIRS-HEKLSEFQ   79 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~Hpn-Iv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~-~~~l~~~~   79 (477)
                      .+|+.||||++......    +++.+|+.+++.++|+| |+.+..++..++..++||||+. ++|.+.+.. .+.+++..
T Consensus        30 ~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~~~~~~~~  104 (299)
T d1ckia_          30 AAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCSRKFSLKT  104 (299)
T ss_dssp             TTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTCCCHHH
T ss_pred             CCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-CchhhhhhhccCCCcHHH
Confidence            57899999998765432    34778999999997666 5555666778889999999996 677666654 45799999


Q ss_pred             HHHHHHHHHHHHHHHHhCCcEEccCCCCceeecc--CcceeecccccceecccCCcc-----cccCCeEEEecccccccc
Q psy6508          80 CQQFVRQLVLALKFLRENNVCHFDLKPQNILIKN--NTLKLAGLKQGVSEKAKGSAY-----IEQGNTKVICSVFEPREI  152 (477)
Q Consensus        80 ~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~rl~~~dfG~~~~~~gs~~-----~~~g~t~v~~~~y~ppE~  152 (477)
                      +..++.|++.||+|||++||+||||||+|||++.  +...+.++|||++........     .....+..+|+.|+|||.
T Consensus       105 ~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  184 (299)
T d1ckia_         105 VLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT  184 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHH
Confidence            9999999999999999999999999999999853  344566679999876443221     123345678999999999


Q ss_pred             CCCC---CcccccCcceEEEEEE--eeecccc
Q psy6508         153 PSSK---TSLEYQRSKGELYVEF--KFAPFAS  179 (477)
Q Consensus       153 ~~~~---~~~Di~~s~G~il~e~--~~~Pf~~  179 (477)
                      ..+.   .++|+ ||+|+++||+  +..||..
T Consensus       185 ~~~~~~~~~~Di-wSlG~~l~el~tg~~P~~~  215 (299)
T d1ckia_         185 HLGIEQSRRDDL-ESLGYVLMYFNLGSLPWQG  215 (299)
T ss_dssp             HTTBCCCHHHHH-HHHHHHHHHHHHSSCTTCC
T ss_pred             HhCCCCCChhhE-EecCHHHHHHHhCCCcccc
Confidence            8876   77899 9999999999  6688864

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.85  E-value=1.6e-22  Score=200.51  Aligned_cols=170  Identities=21%  Similarity=0.301  Sum_probs=129.0

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-----------CCCccceEEEEEe--CCeEEEEEecCCCCC-HHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-----------HQHIVTMLDFLWD--ERYVYIILEYCDGGD-LCS   67 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-----------HpnIv~~~~~~~~--~~~~~lv~e~~~g~s-L~~   67 (477)
                      .+|+.||||+++++.   ...+.+.+|+.+++.++           ||||+++++++..  ....+++++++.++. ...
T Consensus        36 ~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (362)
T d1q8ya_          36 VNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLA  112 (362)
T ss_dssp             TTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHH
T ss_pred             CCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeeccccccccc
Confidence            578999999997542   33456788999998875           5789999998764  356667776655433 333


Q ss_pred             HHHh--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcEEccCCCCceeeccCc-----ceeecccccceecccCCcccccCC
Q psy6508          68 FIRS--HEKLSEFQCQQFVRQLVLALKFLRE-NNVCHFDLKPQNILIKNNT-----LKLAGLKQGVSEKAKGSAYIEQGN  139 (477)
Q Consensus        68 ~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~-~givHrDlkp~NIll~~~~-----~rl~~~dfG~~~~~~gs~~~~~g~  139 (477)
                      ....  ...+++..++.++.|++.||.|||+ .||+||||||+|||++.++     .++.++|||.+.....     ...
T Consensus       113 ~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~  187 (362)
T d1q8ya_         113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-----HYT  187 (362)
T ss_dssp             HHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-----CCC
T ss_pred             ccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-----ccc
Confidence            3322  3478999999999999999999998 8999999999999996532     3566779998765432     234


Q ss_pred             eEEEeccccccccCCCC---CcccccCcceEEEEEE--eeeccccc
Q psy6508         140 TKVICSVFEPREIPSSK---TSLEYQRSKGELYVEF--KFAPFASQ  180 (477)
Q Consensus       140 t~v~~~~y~ppE~~~~~---~~~Di~~s~G~il~e~--~~~Pf~~~  180 (477)
                      +.++++.|+|||+..+.   .++|+ ||+|+++++|  +..||...
T Consensus       188 ~~~gt~~y~aPE~~~~~~~~~~~Di-wSlG~il~el~~g~~pF~~~  232 (362)
T d1q8ya_         188 NSIQTREYRSPEVLLGAPWGCGADI-WSTACLIFELITGDFLFEPD  232 (362)
T ss_dssp             SCCSCGGGCCHHHHHTCCCCTHHHH-HHHHHHHHHHHHSSCCC---
T ss_pred             cccccccccChhhccccCCCccccc-cchHHHHHHHHHCCCCCCCC
Confidence            56788899999987765   77999 9999999999  67888643

>d1buoa_ d.42.1.1 (A:) Promyelocytic leukaemia zinc finger (PLZF) protein BTB domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: BTB/POZ domain
domain: Promyelocytic leukaemia zinc finger (PLZF) protein BTB domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.85  E-value=1.5e-22  Score=168.04  Aligned_cols=95  Identities=18%  Similarity=0.299  Sum_probs=88.3

Q ss_pred             cchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhcCce
Q psy6508         344 LPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHHARV  423 (477)
Q Consensus       344 l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Ytg~~  423 (477)
                      ++++++.++.+|.|||++|.|+|    ++|+|||.|||++|+||++||.+++   .++.+++++|++|+.+|+|+|||++
T Consensus        15 ll~~l~~l~~~~~~~Dv~l~v~~----~~~~aHk~vLaa~S~~F~~lf~~~~---~~i~~~~v~~~~f~~ll~~~Ytg~i   87 (121)
T d1buoa_          15 LLCKANQMRLAGTLCDVVIMVDS----QEFHAHRTVLACTSKMFEILFHRNS---QHYTLDFLSPKTFQQILEYAYTATL   87 (121)
T ss_dssp             HHHHHHHHHHHTTTCCEEEEESS----CEEEECHHHHHHHCHHHHHHTTSCC---SEEEECSSCHHHHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHhcCCcEeEEEEECC----EEEEEEHHHhcccChhhhhhccCcc---ceeecCCCCHHHHHHHHHheEcccc
Confidence            66788999999999999999999    9999999999999999999998764   4578999999999999999999999


Q ss_pred             eeCccchhhhhhccccceeecc
Q psy6508         424 NISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       424 ~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      .++.+++.+++.+|+++.+.++
T Consensus        88 ~l~~~~v~~ll~~A~~l~~~~L  109 (121)
T d1buoa_          88 QAKAEDLDDLLYAAEILEIEYL  109 (121)
T ss_dssp             CCCGGGHHHHHHHHHHHTCHHH
T ss_pred             CCcHHHHHHHHHHHHHhCCHHH
Confidence            9999999999999999888664

>d1r29a_ d.42.1.1 (A:) B-cell lymphoma 6 (Bcl6) protein BTB domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: BTB/POZ domain
domain: B-cell lymphoma 6 (Bcl6) protein BTB domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.84  E-value=2.5e-22  Score=167.31  Aligned_cols=99  Identities=20%  Similarity=0.264  Sum_probs=90.4

Q ss_pred             ccchhhHHhhhcCcceeEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCC--cccCCCCHHHHHHHhhhhhc
Q psy6508         343 TLPERGRYVLNSGLWSDCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGD--TKILDITPEAFSTMLDSDHH  420 (477)
Q Consensus       343 ~l~~r~~~~~~~~~~~D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~--~~~~~~~~~~~~~~l~~~Yt  420 (477)
                      .+++.++.++++|.||||+|.|+|    ++|+|||.|||++|+||++||.+++.+...  +.+++++|+.|+.+|+|+||
T Consensus        11 ~ll~~l~~l~~~~~~~Dv~l~v~~----~~~~~Hk~vLa~~S~~F~~~f~~~~~e~~~~~~~~~~v~~~~f~~ll~~~Yt   86 (122)
T d1r29a_          11 DVLLNLNRLRSRDILTDVVIVVSR----EQFRAHKTVLMACSGLFYSIFTDQLKRNLSVINLDPEINPEGFNILLDFMYT   86 (122)
T ss_dssp             HHHHHHHHHHHTTCSCCEEEEETT----EEEEECHHHHHHHCHHHHHHHTSTTTTTCSEEECCTTSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCeEEEEEECC----EEEEEehHHhhhCCHHHHHHhccchhhhcceeeeecccCHHHHHHHHhhhcC
Confidence            367788999999999999999999    999999999999999999999999988443  35579999999999999999


Q ss_pred             CceeeCccchhhhhhccccceeecc
Q psy6508         421 ARVNISSDHHARVSISSDHHTRVSI  445 (477)
Q Consensus       421 g~~~~~~~~~~~~~~~a~~~~~~~~  445 (477)
                      |++.++.+++.+++.+|+++.+.++
T Consensus        87 g~~~i~~~~v~~ll~~A~~l~i~~L  111 (122)
T d1r29a_          87 SRLNLREGNIMAVMATAMYLQMEHV  111 (122)
T ss_dssp             SCCCCCTTTHHHHHHHHHHTTCHHH
T ss_pred             CeecCchhhHHHHHHHHHHHCcHHH
Confidence            9999999999999999999988653

>d1e3ha3 d.14.1.4 (A:346-482) Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 1 and 4 {Streptomyces antibioticus [TaxId: 1890]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 1 and 4
species: Streptomyces antibioticus [TaxId: 1890]

Probab=99.83  E-value=6.6e-21  Score=161.85  Aligned_cols=135  Identities=15%  Similarity=0.218  Sum_probs=114.6

Q ss_pred             cceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccC-CCCCcchHH
Q psy6508         115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTG-WLRDSEEKE  193 (477)
Q Consensus       115 ~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~-~~~~~~~~~  193 (477)
                      ++|.+.+..|+..+++||++++.|+|++.+.+++|++..............+...+++.+.||.+..++. ..++..+.+
T Consensus         2 E~R~i~~~~gv~~~adGSa~~~~G~T~Vl~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   81 (137)
T d1e3ha3           2 DIRTLAAEVEAIPRVHGSALFERGETQILGVTTLNMLRMEQQLDTLSPVTRKRYMHNYNFPPYSVGETGRVGSPKRREIG   81 (137)
T ss_dssp             CCCCEEEEECCSSSSSEEEEEEETTEEEEEEEEEEEGGGSEECCSSSSCCEESEEEEEECCGGGGTCCCCCSSCCHHHHH
T ss_pred             CcceEEEEeCCCCCCCeeEEEEECCeEEEEEEccCccCccccccccCcceeeeeeeeccccccccccccccccccccccc
Confidence            4688889999999999999999999999999998876543321001113456677888889998765543 456788999


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCC
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMY  249 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~  249 (477)
                      +...+++.+++.++++.||+++|++.+++|++||+.+++++||+++||+||||||+
T Consensus        82 ~~~~i~~~l~~~i~~~~~~~~~I~v~v~vl~~DG~~~~aainAa~lAL~dAGIpmk  137 (137)
T d1e3ha3          82 HGALAERAIVPVLPTREEFPYAIRQVSEALGSNGSTSMGSVCASTMSLLNAGVPLK  137 (137)
T ss_dssp             HHHHHHHHHGGGCCCTTTSCEEEEEEEEEEECSSCHHHHHHHHHHHHHHHHTCCCS
T ss_pred             cchHHHHHHHhccchhhcCcEEEEEEEEEecCCCCHHHHHHHHHHHHHHHcCCccC
Confidence            99999999999999999999999999999999999999999999999999999997

>d2je6b1 d.14.1.4 (B:8-155) Exosome complex exonuclease 1, ECX1 {Sulfolobus solfataricus [TaxId: 2287]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease 1, ECX1
species: Sulfolobus solfataricus [TaxId: 2287]

Probab=99.76  E-value=9.2e-19  Score=150.47  Aligned_cols=138  Identities=31%  Similarity=0.466  Sum_probs=121.5

Q ss_pred             CCceeecc---CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccc
Q psy6508         106 PQNILIKN---NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIR  182 (477)
Q Consensus       106 p~NIll~~---~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r  182 (477)
                      -+|+-.|.   +++|.+.+.+|...+++||++++.|+|++.|.+++|.|.....  .+. ...|.+.+++.+.||++..+
T Consensus         8 ~~g~R~DGR~~~e~R~i~i~~g~l~~adGSa~v~~G~T~Vl~~V~gp~e~~~~~--~~~-~~~~~~~v~~~~~~~~~~~~   84 (148)
T d2je6b1           8 DDGKRTDGRKPDELRSIKIELGVLKNADGSAIFEMGNTKAIAAVYGPKEMHPRH--LSL-PDRAVLRVRYHMTPFSTDER   84 (148)
T ss_dssp             TTSCBTTSCCTTCCCCEEEEESCCSSSSEEEEEEETTEEEEEEEEEEEECSSGG--GSC-SSSCEEEEEEEECTTSSSSC
T ss_pred             CCCccCCCCCCCCccCeEEEECCCCCCCEEEEEEcCCccEEeecccCccccchh--hcC-CcceEEEEEEEecccccccc
Confidence            35555543   5799999999999999999999999999999999987765432  122 45688999999999998777


Q ss_pred             cCCCCCcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCC
Q psy6508         183 TGWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI  246 (477)
Q Consensus       183 ~~~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi  246 (477)
                      ....+...+.++...+++++++.++++.||+..+++.++||++||+.+++++||+++||+||||
T Consensus        85 ~~~~~~~~~~el~~~l~~~l~~~i~~~~~p~~~i~v~v~VL~~DG~~~~a~i~aa~~AL~daGI  148 (148)
T d2je6b1          85 KNPAPSRREIELSKVIREALESAVLVELFPRTAIDVFTEILQADAGSRLVSLMAASLALADAGI  148 (148)
T ss_dssp             CCSSCCHHHHHHHHHHHHHHHTTBCGGGSTTEEEEEEEEEEECSSCHHHHHHHHHHHHHHHTTC
T ss_pred             ccccccchhHHHHHHHHHHhhccccHHHcCCEEEEEEEEEEEcCCCHHHHHHHHHHHHHHHcCC
Confidence            7777788899999999999999999999999999999999999999999999999999999997

>d2ba0d1 d.14.1.4 (D:10-153) Exosome complex exonuclease 1, ECX1 {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease 1, ECX1
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.76  E-value=9.3e-19  Score=149.81  Aligned_cols=130  Identities=34%  Similarity=0.528  Sum_probs=117.2

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      +++|.+.+.+|....++||++++.|+|++.+.+++|.|.....  .+- -..|.+.+++...||+...+....+...+.+
T Consensus        15 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~gp~~~~~~~--~~~-~~~~~~~~~~~~~~~s~~~~~~~~~~~~~~~   91 (144)
T d2ba0d1          15 DELRPIKIEASVLKRADGSCYLEMGKNKVIAAVFGPREVHPRH--LQD-PSKAIIRYRYNMAPFSVEERKRPGPDRRSIE   91 (144)
T ss_dssp             TCCCCEEEEECCCSSSSEEEEEEETTEEEEEEEEEEEECCSGG--GCC-SSSCEEEEEEEECTTSSSSCCCSSCCHHHHH
T ss_pred             CCccCeEEEECCCCCCCceEEEEEcccceEEEEeccchhhhhh--ccc-ccceEEEEEEecCCcccccccccCCCchhhh
Confidence            5789999999999999999999999999999999998865432  111 4578899999999999888777777788889


Q ss_pred             HHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCC
Q psy6508         194 LGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI  246 (477)
Q Consensus       194 l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi  246 (477)
                      ++.++++++++.+.++.||++.|++.++||++||+.+++|+||+++||+||||
T Consensus        92 l~~~l~~~l~~~i~~~~~~~~~i~v~v~VL~~DG~~~~a~i~aa~lAL~daGI  144 (144)
T d2ba0d1          92 ISKVSKEAFEAVIMKELFPRSAIDIFVEVLQADAGSRTACLNAASVALVDAGV  144 (144)
T ss_dssp             HHHHHHHHHHTTBCGGGCTTEEEEEEEEEEECCTTHHHHHHHHHHHHHHHHTC
T ss_pred             hhhhhhhhhccccchhhcCCeEEEEEEEEEccCCCHHHHHHHHHHHHHHHcCC
Confidence            99999999999999999999999999999999999999999999999999997

>d2nn6b1 d.14.1.4 (B:6-150) Exosome complex exonuclease RRP41 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP41
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=4.1e-18  Score=145.86  Aligned_cols=138  Identities=33%  Similarity=0.520  Sum_probs=116.5

Q ss_pred             Cceeecc---CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecccccccc
Q psy6508         107 QNILIKN---NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT  183 (477)
Q Consensus       107 ~NIll~~---~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~  183 (477)
                      +++-+|.   +++|.+.+.+|+..+++||++++.|+|++.+.+|+|.+....... .- ...|.+.+++.+.||+...+.
T Consensus         4 ~g~R~DGR~~~e~R~i~i~~g~~~~a~GSa~v~~G~T~Vi~~V~gp~~~~~~~~~-~~-~~~~~v~v~~~~~~~~~~~~~   81 (145)
T d2nn6b1           4 QGYRVDGRRAGELRKIQARMGVFAQADGSAYIEQGNTKALAVVYGPHEIRGSRAR-AL-PDRALVNCQYSSATFSTGERK   81 (145)
T ss_dssp             TTBCSSSSCTTSCCCEEEEESCSSSSSEEEEEEESSCEEEEEEEEEEECCSSSCC-CC-CSSCCEEEEEEECTTTSSSCC
T ss_pred             CCccCCCCCCCCccCeEEEECCCCCCCceEEEEeCCceEEEEEEeccccccchhh-cc-ccceeEEEEeeecCccccccc
Confidence            3444542   578999999999999999999999999999999999876543211 00 345788899999999876654


Q ss_pred             CC-CCCcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCC
Q psy6508         184 GW-LRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI  246 (477)
Q Consensus       184 ~~-~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi  246 (477)
                      .. ..+....+++.++++++++.++++.||++.|+|.++||++||+++++++||+++||+||||
T Consensus        82 ~~~~~~~~~~~l~~~l~~~l~~~i~~~~~~~~~I~v~v~VL~~DG~l~~a~i~aa~lAL~daGI  145 (145)
T d2nn6b1          82 RRPHGDRKSCEMGLQLRQTFEAAILTQLHPRSQIDIYVQVLQADGGTYAACVNAATLAVLDAGI  145 (145)
T ss_dssp             CTTTSTHHHHHHHHHHHHHHHHTTCGGGCTTEEEEEEEEEEECCSCHHHHHHHHHHHHHHHTCC
T ss_pred             ccCCCCchhhhHHHHHHHhhhcccchHhhCceeeEEEEEEEeCCCCHHHHHHHHHHHHHHHcCC
Confidence            43 4566788999999999999999999999999999999999999999999999999999997

>d2nn6d1 d.14.1.4 (D:25-146) Exosome complex exonuclease RRP46 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP46
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.74  E-value=2.9e-18  Score=142.22  Aligned_cols=120  Identities=29%  Similarity=0.409  Sum_probs=99.9

Q ss_pred             cceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHHH
Q psy6508         115 TLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKEL  194 (477)
Q Consensus       115 ~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~l  194 (477)
                      ++|.+.+.+|+..+++||++++.|+|++.+.+|+|.|.....   +. ...+.+  ++.+.|..+      .+...++++
T Consensus         3 elR~i~~~~gvl~~adGSa~~~~G~T~Vi~~V~gP~e~~~~~---~~-~~~~~~--~v~~~~~~~------~~~~~~~~~   70 (122)
T d2nn6d1           3 SLRHFACEQNLLSRPDGSASFLQGDTSVLAGVYGPAEVKVSK---EI-FNKATL--EVILRPKIG------LPGVAEKSR   70 (122)
T ss_dssp             CCCCEEEEESCCSSSSEEEEEEETTEEEEEEEEEEEECC----------CCEEE--EEEEECSSS------CCCHHHHHH
T ss_pred             ccceEEEEECCCCCCCeEEEEEECCcEEEEEEEecccccchh---hC-cCCCce--EEEeeeecC------CCCchhhHH
Confidence            678888999999999999999999999999999998865544   22 334444  343334332      456678899


Q ss_pred             HHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCC
Q psy6508         195 GNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAI  246 (477)
Q Consensus       195 ~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi  246 (477)
                      ++++++++++.+.++.||++.|++.+++|++||+.+++++||+++||+||||
T Consensus        71 ~~~l~~~l~~~i~~~~~p~~~i~i~v~Vl~~DG~~~~a~ina~~lAL~dagI  122 (122)
T d2nn6d1          71 ERLIRNTCEAVVLGTLHPRTSITVVLQVVSDAGSLLACCLNAACMALVDAGV  122 (122)
T ss_dssp             HHHHHHHHHHHCGGGCSSSEEEEEEEEEEECSSCHHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHhhhhcccchhhcCCeEEEEEEEEEcCCCChhHHHHHHHHHHHHHcCC
Confidence            9999999999999999999999999999999999999999999999999997

>d1udsa1 d.14.1.4 (A:2-150) Ribonuclease PH, domain 1 {Aquifex aeolicus [TaxId: 63363]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Ribonuclease PH, domain 1
species: Aquifex aeolicus [TaxId: 63363]

Probab=99.71  E-value=7e-18  Score=145.12  Aligned_cols=133  Identities=27%  Similarity=0.335  Sum_probs=113.9

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCC-----CCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGW-----LRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~-----~~~  188 (477)
                      +++|.+.+.+|....++||++++.|+|++.|.+++|.+.....   +- ...|.+.+++.+.|+........     ...
T Consensus         8 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~V~~~V~~~~~~~~~~---~~-~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~   83 (149)
T d1udsa1           8 DQLRPVSIQRDFLEYPEGSCLISFGKTKVICTASVIENVPNWL---KG-KGQGWITAEYSMLPRATQQRTIRESVQGRIG   83 (149)
T ss_dssp             TCCCCEEEEECCSSSSSEEEEEEETTEEEEEEEEEESCCCGGG---TT-SSCCEEEEEEEECSEETTEECCCSSSSCCCC
T ss_pred             CCccCeEEEeCCCCCCCEEEEEEECCCEEEEEEEeeccccccc---cC-CCceeEEeeecchhhcccccccccccccccc
Confidence            5789999999999999999999999999999999987665332   22 46789999999999986554322     234


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCc
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYD  250 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~  250 (477)
                      .....++..+.+.+++.++++.+|++.+.+.++||++||+++++++||+++||+||||||+.
T Consensus        84 ~~~~~~~~~l~~~l~~~i~l~~~~~~~i~v~v~VL~~DG~l~da~~~A~~~AL~dagipm~~  145 (149)
T d1udsa1          84 GRTHEIQRMIGRAMRTAVELTKIGERTIWVDCDVIQADGGTATAAITGAFVAVADAIIKLHK  145 (149)
T ss_dssp             HHHHHHHHHHHHHHHHHBCGGGSCSCEEEEEEEEEECSSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHhhhhheehhhhcCCceEEEEEEEEccCCCHHHHHHHHHHHHHHHhChHHHH
Confidence            45677888999999999999999999999999999999999999999999999999999983

>d2nn6f1 d.14.1.4 (F:29-175) Exosome complex exonuclease MTR3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease MTR3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=2.2e-17  Score=141.73  Aligned_cols=134  Identities=38%  Similarity=0.567  Sum_probs=114.6

Q ss_pred             cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCCC---------cccccCcceEEEEEEeeecccccccc
Q psy6508         113 NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKT---------SLEYQRSKGELYVEFKFAPFASQIRT  183 (477)
Q Consensus       113 ~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~---------~~Di~~s~G~il~e~~~~Pf~~~~r~  183 (477)
                      .+++|.+.+.+|+..+++||++++.|+|++.+.+++|.|......         .... ...|.+.++..+.||.+..+.
T Consensus         5 ~~e~R~i~i~~gvi~~a~GSa~v~~G~T~V~~~V~gp~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~   83 (147)
T d2nn6f1           5 PTRLRPVYARAGLLSQAKGSAYLEAGGTKVLCAVSGPRQAEGGERGGGPAGAGGEAPA-ALRGRLLCDFRRAPFAGRRRR   83 (147)
T ss_dssp             SSCCCCCCCCCSCCSSSSEEECCCSSSCEEEEEEEEEECC--------------------CBCEEEEEEEECTTSSSSCC
T ss_pred             CCCccceEEEeCCCCCCCEEEEEEECCeEEEEEEeccccccccccCCccccccccccc-cccceeEEEEEecCCcccccc
Confidence            357899999999999999999999999999999999988765441         1111 235778888899999987777


Q ss_pred             CCCCCcchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCC
Q psy6508         184 GWLRDSEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIP  247 (477)
Q Consensus       184 ~~~~~~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~  247 (477)
                      .........+++..+...+.+.+.++.+|++.+.+.++||++||+++++++||+++||+||||+
T Consensus        84 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~i~v~v~Vl~~DG~l~~a~i~A~~~AL~daGIe  147 (147)
T d2nn6f1          84 APPGGCEERELALALQEALEPAVRLGRYPRAQLEVSALLLEDGGSALAAALTAAALALADAGVE  147 (147)
T ss_dssp             CSCCHHHHHHHHHHHHHHHTTTBCSTTSBTCEEEEEEEEEECCSSHHHHHHHHHHHHHHHHCCC
T ss_pred             ccCCccchhhhhhhhhhcccccccccccCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHhCCC
Confidence            7677778899999999999999999999999999999999999999999999999999999996

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.67  E-value=6.3e-17  Score=145.04  Aligned_cols=115  Identities=17%  Similarity=0.190  Sum_probs=88.1

Q ss_pred             CCCcEEEEEEcccCCCC----------------hhHHHHHHHHHHHHHhcCCCCccceEEEEEeCCeEEEEEecCCCCCH
Q psy6508           2 EQHTEVAIKCIDKTKVS----------------ENRFDSIVNEIKALKLLHHQHIVTMLDFLWDERYVYIILEYCDGGDL   65 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~----------------~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL   65 (477)
                      ++|+.||||+++....+                ........+|...+.++.|+++++.+++.  .  .+++|||+++..+
T Consensus        22 ~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~--~--~~lvme~~~~~~~   97 (191)
T d1zara2          22 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE--G--NAVLMELIDAKEL   97 (191)
T ss_dssp             TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE--T--TEEEEECCCCEEG
T ss_pred             CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec--C--CEEEEEeeccccc
Confidence            57899999987643211                01123456789999999999999988753  2  2799999997654


Q ss_pred             HHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCcEEccCCCCceeeccCcceeecccccceecc
Q psy6508          66 CSFIRSHEKLSEFQCQQFVRQLVLALKFLRENNVCHFDLKPQNILIKNNTLKLAGLKQGVSEKA  129 (477)
Q Consensus        66 ~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~rl~~~dfG~~~~~  129 (477)
                      .+       ++......++.|++.+|.|||++||+||||||+|||+++++++++  |||.+...
T Consensus        98 ~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~~~li--DFG~a~~~  152 (191)
T d1zara2          98 YR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGIWII--DFPQSVEV  152 (191)
T ss_dssp             GG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTEEEEC--CCTTCEET
T ss_pred             cc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCCEEEE--ECCCcccC
Confidence            33       455566789999999999999999999999999999998876654  99987543

>d1r6la1 d.14.1.4 (A:1-151) Ribonuclease PH, domain 1 {Pseudomonas aeruginosa [TaxId: 287]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Ribonuclease PH, domain 1
species: Pseudomonas aeruginosa [TaxId: 287]

Probab=99.65  E-value=9.4e-17  Score=138.29  Aligned_cols=133  Identities=25%  Similarity=0.346  Sum_probs=112.0

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCC-----CCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGW-----LRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~-----~~~  188 (477)
                      ++.|.+.+.+|...+++||++++.|+|++.+.+++|.+.....   +- -..|.+.+++.+.||........     ...
T Consensus        10 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~~~~~---~~-~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~   85 (151)
T d1r6la1          10 DQLRPIRITRHYTKHAEGSVLVEFGDTKVICTVSAESGVPRFL---KG-QGQGWLTAEYGMLPRSTGERNQREASRGKQG   85 (151)
T ss_dssp             TCCCCEEEESSCSSSSSEEEEEEETTEEEEEEEEEEESCSSCC---C----CCEEEEEEEECTTSSSSCCCCHHHHTSCC
T ss_pred             CCccCeEEEeCCCCCCCEEEEEEeCCCEEEEEEEecccccccc---cC-CCceeEEEEEEecCccccccccccCCCcccc
Confidence            5789999999999999999999999999999999987665433   22 45789999999889986554322     233


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCc
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYD  250 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~  250 (477)
                      ....++...+.+.+.+.+.++.+|++.+.+.++||++||+.++++++|+++||+||||||+.
T Consensus        86 ~~~~~~~~~l~~~~~~~~~l~~~~~~~i~v~v~VL~~DG~~~da~~~Aa~~AL~dagip~~~  147 (151)
T d1r6la1          86 GRTLEIQRLIGRSLRAALDLSKLGENTLYIDCDVIQADGGTRTASITGATVALIDALAVLKK  147 (151)
T ss_dssp             HHHHHHHHHHHHHHHHTBCGGGTCSEEEEEEEEEEECSSCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             ccchhHHHHHHhhhhhccchhhhCceEEEEEEEEEeCCCCHHHHHHHHHHHHHHHhcHHHHH
Confidence            45567788999999999999999999999999999999999999999999999999999974

>d1oysa1 d.14.1.4 (A:1-151) Ribonuclease PH, domain 1 {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Ribonuclease PH, domain 1
species: Bacillus subtilis [TaxId: 1423]

Probab=99.62  E-value=2.2e-16  Score=135.96  Aligned_cols=130  Identities=25%  Similarity=0.268  Sum_probs=97.7

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCC-----CCC
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGW-----LRD  188 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~-----~~~  188 (477)
                      ++.|.+.+.+|+..+++||++++.|+|++.+.++++.+.....   +. ...|.+.+++.+.||....+...     ...
T Consensus         9 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~Vl~~V~~~~~~~~~~---~~-~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~   84 (151)
T d1oysa1           9 DELRPITFDLDFISHPEGSVLITAGNTKVICNASVEDRVPPFL---RG-GGKGWITAEYSMLPQATNQQTIQESSKGKIS   84 (151)
T ss_dssp             TCCCCEEEECC-----CCCEEEEETTEEEEEEEEEESCCCGGG---TT-SCCCEEEEEEEC-------------------
T ss_pred             CCccCeEEEeCCCCCCCEEEEEEEcCCEEEEEEEecccccccc---cc-cccceeeeeeeeccccccccccccccCCccc
Confidence            5789999999999999999999999999999998765554333   22 56789999998888886654322     345


Q ss_pred             cchHHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCC
Q psy6508         189 SEEKELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIP  247 (477)
Q Consensus       189 ~~~~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~  247 (477)
                      ....+++..+++.+++.+.++.||++.|++.++||++||+++++++||+++||+||.++
T Consensus        85 ~~~~~~~~~l~~~l~~~i~l~~~~~~~i~v~v~VL~~DG~l~~a~i~Aa~~AL~dA~~~  143 (151)
T d1oysa1          85 GRTMEIQRLIGRALRAVVDLEKLGERTIWIDCDVIQADGGTRTASITGAFLAMAIAIGK  143 (151)
T ss_dssp             CHHHHHHHHHHHHHHHTBCHHHHCSCEEEEEEEEEECSSCHHHHHHHHHHHHHHHHHHH
T ss_pred             chhhHHhHHHHHHhhhhhhhhhhccceEEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHH
Confidence            56788899999999999999999999999999999999999999999999999999553

>d2je6b2 d.101.1.1 (B:156-241) Exosome complex exonuclease 1, ECX1 {Sulfolobus solfataricus [TaxId: 2287]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease 1, ECX1
species: Sulfolobus solfataricus [TaxId: 2287]

Probab=99.61  E-value=1.3e-15  Score=117.62  Aligned_cols=85  Identities=16%  Similarity=0.312  Sum_probs=80.7

Q ss_pred             CCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcc
Q psy6508         247 PMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCC  326 (477)
Q Consensus       247 ~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~  326 (477)
                      ||+|+|+||++|+.+|.+++|||..|++.          +.+.+++|++++.++|+.++.+|+++.+++.++++.|.++|
T Consensus         1 Pm~d~V~avsvg~~d~~~llDp~~~E~~~----------~~~~l~va~~~~~~~i~~~~~~g~~~~~~~~~~l~~a~~~~   70 (86)
T d2je6b2           1 PMRDLIAGVAVGKADGVIILDLNETEAMW----------GEADMPIAMMPSLNQVTLFQLNGSMTPDEFRQAFDLAVKGI   70 (86)
T ss_dssp             CBSSCCEEEEEEEETTEEEESCCHHHHHH----------SSEEEEEEEEGGGTEEEEEEEEECBCHHHHHHHHHHHHHHH
T ss_pred             CCCCCeEEEEEEEECCEEEEecchhhhhc----------CceeEEEEEeCCCCeEEEEeecCCCCHHHHHHHHHHHHHHH
Confidence            89999999999999999999999999984          47899999999999999999999999999999999999999


Q ss_pred             cchhhHHHHhHhhhcc
Q psy6508         327 ESLCTDRVQKLVSDHV  342 (477)
Q Consensus       327 ~~i~~~~i~~~l~~~~  342 (477)
                      +.++.. +++++++++
T Consensus        71 ~~I~~~-~~e~l~~ry   85 (86)
T d2je6b2          71 NIIYNL-EREALKSKY   85 (86)
T ss_dssp             HHHHHH-HHHHHHGGG
T ss_pred             HHHHHH-HHHHHHhhc
Confidence            999999 999998753

>d2nn6b2 d.101.1.1 (B:151-240) Exosome complex exonuclease RRP41 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease RRP41
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.60  E-value=8.3e-16  Score=119.89  Aligned_cols=85  Identities=19%  Similarity=0.312  Sum_probs=81.0

Q ss_pred             CCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhcc
Q psy6508         247 PMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGCC  326 (477)
Q Consensus       247 ~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~~  326 (477)
                      ||+|+|+|||+++.+|.+++||+..|++.          +.+.+++|++++.++|+.++.+|+++++++.++++.|.++|
T Consensus         1 Pm~d~V~avs~g~~~~~~llDp~~~E~~~----------~~~~l~va~~~~~~~I~~~~~~g~~~~~~~~~~l~~a~~~~   70 (90)
T d2nn6b2           1 PMRDFVCACSAGFVDGTALADLSHVEEAA----------GGPQLALALLPASGQIALLEMDARLHEDHLERVLEAAAQAA   70 (90)
T ss_dssp             CCSSCCEEEEEEEETTEEEESCCHHHHTS----------SCCCEEEEEETTTTEEEEEEECSCCBTTSHHHHHHHHHHHH
T ss_pred             CCCCCeEEEEEEEECCEEeeCCccccccc----------cccceEEEEEecCCCEEEEEEecccCHHHHHHHHHHHHHHH
Confidence            89999999999999999999999999983          57899999999999999999999999999999999999999


Q ss_pred             cchhhHHHHhHhhhcc
Q psy6508         327 ESLCTDRVQKLVSDHV  342 (477)
Q Consensus       327 ~~i~~~~i~~~l~~~~  342 (477)
                      +.++.. +++.++++.
T Consensus        71 ~~i~~~-~~~~l~~~~   85 (90)
T d2nn6b2          71 RDVHTL-LDRVVRQHV   85 (90)
T ss_dssp             HHHHHH-HHHHHHHHH
T ss_pred             HHHHHH-HHHHHHhhh
Confidence            999999 999998764

>d2nn6d2 d.101.1.1 (D:147-235) Exosome complex exonuclease RRP46 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease RRP46
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.58  E-value=3e-15  Score=116.46  Aligned_cols=86  Identities=16%  Similarity=0.223  Sum_probs=80.7

Q ss_pred             CCCceEEEEEEEee-CCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeeecHHHHHHHHHHHHhc
Q psy6508         247 PMYDLVTSSTLALR-GGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTIQQERLADHIEQLIGC  325 (477)
Q Consensus       247 ~m~~~v~a~s~~~~-~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~~~~~~~~~l~~~~~~  325 (477)
                      ||+++|+|+++++. +|.+++|||..|++.          +.+.++++++++.++|+.++..|+++.+++.++++.|.++
T Consensus         1 Pm~~~v~av~~~~~~dg~~vlDpt~~Ee~~----------~~~~~~~a~~~~~~~i~~~~~~g~~s~~~~~~~l~~a~~~   70 (89)
T d2nn6d2           1 PMRALFCGVACALDSDGTLVLDPTSKQEKE----------ARAVLTFALDSVERKLLMSSTKGLYSDTELQQCLAAAQAA   70 (89)
T ss_dssp             CCSSCEEEEEEEECTTCCEEESCCHHHHHH----------CSEEEEEEEETTTCCCCEEEEEESCCHHHHHHHHHHHHHH
T ss_pred             CCCCCEeEEEEEEEcCCceeeCCCHHHHhh----------cceEEEEEEEcCCCeEEEEeecCCcCHHHHHHHHHHHHHH
Confidence            89999999999987 789999999999984          4789999999999999999999999999999999999999


Q ss_pred             ccchhhHHHHhHhhhccc
Q psy6508         326 CESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       326 ~~~i~~~~i~~~l~~~~~  343 (477)
                      |+++++. ++++++++..
T Consensus        71 ~~~I~~~-~r~~l~k~~~   87 (89)
T d2nn6d2          71 SQHVFRF-YRESLQRRYS   87 (89)
T ss_dssp             HHHHHHH-HHHHHHHHTC
T ss_pred             HHHHHHH-HHHHHHHHhc
Confidence            9999999 9999987653

>d2nn6f2 d.101.1.1 (F:176-270) Exosome complex exonuclease MTR3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease MTR3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.48  E-value=7.8e-15  Score=115.29  Aligned_cols=85  Identities=25%  Similarity=0.313  Sum_probs=77.7

Q ss_pred             CCceEEEEEEEeeC---CeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEeee-cHHHHHHHHHHHH
Q psy6508         248 MYDLVTSSTLALRG---GLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGTI-QQERLADHIEQLI  323 (477)
Q Consensus       248 m~~~v~a~s~~~~~---~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~~-~~~~~~~~l~~~~  323 (477)
                      |+|+|+|||+++.+   +.+++|||..|+..          +.+.+++|++|+.++|+.++.+|+. +.+++.++++.|+
T Consensus         1 M~D~V~acs~~~~~~~~~~~llD~~~~Ee~~----------~~~~~~va~~p~~~~i~~~~~~G~~~~~d~l~~~lela~   70 (95)
T d2nn6f2           1 MYDLVVGCGLSLAPGPAPTWLLDPTRLEEER----------AAAGLTVALMPVLNQVAGLLGSGEGGLTESWAEAVRLGL   70 (95)
T ss_dssp             BSSCCEEEECCCCSCSSCCCCSSCCTTTGGG----------CSSEEEEEEETTTTEEEEEEEECCSSCTTTTHHHHHHHH
T ss_pred             CCcEEEEEEEEeecCCCCcEEECCCHHHhcC----------CCCcEEEEEcCCCceeEEEEEecccchHHHHHHHHHHHH
Confidence            89999999999964   57999999999984          4789999999999999999999996 6789999999999


Q ss_pred             hcccchhhHHHHhHhhhccc
Q psy6508         324 GCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       324 ~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ++|+.+++. ++++|.++..
T Consensus        71 ~g~~~I~~i-~~~aL~~~~~   89 (95)
T d2nn6f2          71 EGCQRLYPV-LQQSLVRAAR   89 (95)
T ss_dssp             HHHHHHHHH-HHHHHHHHHH
T ss_pred             HHHHHHHHH-HHHHHHHHHH
Confidence            999999999 9999987643

>d2ba0g1 d.14.1.4 (G:3-178) Exosome complex exonuclease 2,ECX2 {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease 2,ECX2
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.45  E-value=9.1e-14  Score=122.32  Aligned_cols=140  Identities=24%  Similarity=0.294  Sum_probs=112.6

Q ss_pred             Cceeec---cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecccccccc
Q psy6508         107 QNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT  183 (477)
Q Consensus       107 ~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~  183 (477)
                      +|+-.|   .++.|.+.+.+|....++||++++.|+|++.|.+++++......    . -..|.+.+++.+.|+......
T Consensus        18 ~~~R~DGR~~~e~R~i~i~~g~l~~a~GSa~v~~G~T~V~~~V~~~~~~p~~~----~-~~~g~~~~~v~~~~~~~~~~~   92 (176)
T d2ba0g1          18 DNERIDGRGFDEFRKVEIIPNVIEKAEGSALVKLGDTQVVVGVKMQPGEPYPD----T-PDRGVIIVNAELVPLASPTFE   92 (176)
T ss_dssp             TTCCTTCCCTTCCCCEEEEECCCTTSSEEEEEEETTEEEEEEEEEEEECCCTT----C-TTCCEEEEEEECCTTTCTTSC
T ss_pred             hCCCCCCCCCCCccCeEEEeCccCCCCeEEEEEeCCcEEEEEEeccccccccc----c-CCCceeeeeeEeccccCcccc
Confidence            445554   36899999999999999999999999999999998765543322    1 456889999999999887776


Q ss_pred             CCCCCcchHHHHHHHHHHhhhh-------hh-cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCce
Q psy6508         184 GWLRDSEEKELGNHLKRALEPA-------VC-RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDL  251 (477)
Q Consensus       184 ~~~~~~~~~~l~~~i~~~l~~~-------i~-~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~  251 (477)
                      ....+.....+.+.+++++.+.       ++ .+..+.|.+.+.++||++||+.++++++|+++||.|+|||+..+
T Consensus        93 ~~~~~~~~~~~~~~l~~~~~~~~~i~~e~L~i~~~~~~~~i~i~v~VL~~DG~l~dA~~~A~~~AL~da~iP~~~~  168 (176)
T d2ba0g1          93 PGPPDENSIELARVVDRGIRESEAVDLSKLVIEEGEKVWIVFVDIHALDDDGNLLDASALAAIAALMNTKVPAERF  168 (176)
T ss_dssp             SSSCCHHHHHHHHHHHHHHHHTTCBCGGGGEEETTTEEEEEEEEEEEEECSSCHHHHHHHHHHHHHTTCEECTGGG
T ss_pred             CCCCCchhHHHHHHHHHhhccccccchhhccCCCCCceEEEEEEEEEEeCCCCHHHHHHHHHHHHHHHcCCCcEEe
Confidence            6666677788888888887553       22 22344589999999999999999999999999999999999875

>d2ba0d2 d.101.1.1 (D:154-252) Exosome complex exonuclease 1, ECX1 {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease 1, ECX1
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.36  E-value=1.7e-12  Score=102.66  Aligned_cols=85  Identities=14%  Similarity=0.283  Sum_probs=77.2

Q ss_pred             CCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCc---EEEEEEEeeecHHHHHHHHHHHH
Q psy6508         247 PMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQ---VTQVTLVGTIQQERLADHIEQLI  323 (477)
Q Consensus       247 ~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~---i~~~~~~g~~~~~~~~~~l~~~~  323 (477)
                      ||+++|+||++|+.+|.+++||+..|+..          +...++++++++.+.   +..++.+|+++.+++.++++.|.
T Consensus         1 Pm~~~V~avsvG~~d~~~llDp~~~E~~~----------~~~~l~va~~~~~~~~~ei~~~~~~~~~~~~~~~~~l~~a~   70 (99)
T d2ba0d2           1 PMKGMITSVAVGKADGQLVLDPMKEEDNF----------GEADMPFAFLIRNGKIESIALLQMDGRMTRDEVKQAIELAK   70 (99)
T ss_dssp             CBSSEEEEEEEEEETTEEEESCCHHHHHH----------SSEEEEEEEEEETTEEEEEEEEEEEEEECHHHHHHHHHHHH
T ss_pred             CCCCcEEEEEEEEECCEEEEcCCcchhhc----------ccCceEEEEecCcceEEEEEEEeccccchHHHHHHHHHHHH
Confidence            89999999999999999999999999985          478999999888765   66677789999999999999999


Q ss_pred             hcccchhhHHHHhHhhhcc
Q psy6508         324 GCCESLCTDRVQKLVSDHV  342 (477)
Q Consensus       324 ~~~~~i~~~~i~~~l~~~~  342 (477)
                      ++|+.++.. ++++++++.
T Consensus        71 ~~~~~I~~~-~~~alk~~~   88 (99)
T d2ba0d2          71 KGALQIYEM-QREAILRRY   88 (99)
T ss_dssp             HHHHHHHHH-HHHHHHHHH
T ss_pred             HHHHHHHHH-HHHHHhhhh
Confidence            999999999 999988753

>d1e3ha2 d.14.1.4 (A:3-151) Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 1 and 4 {Streptomyces antibioticus [TaxId: 1890]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 1 and 4
species: Streptomyces antibioticus [TaxId: 1890]

Probab=99.34  E-value=1.6e-12  Score=110.46  Aligned_cols=127  Identities=18%  Similarity=0.134  Sum_probs=102.1

Q ss_pred             eeecccccce-ecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecc---cc-ccccCCCCCcch
Q psy6508         117 KLAGLKQGVS-EKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPF---AS-QIRTGWLRDSEE  191 (477)
Q Consensus       117 rl~~~dfG~~-~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf---~~-~~r~~~~~~~~~  191 (477)
                      |.+.+..|.. ++++||++++.|+|++.+.++.+++.....    .....+.+.|+..+.++   .+ ..++...+...+
T Consensus        18 R~i~ie~G~lakqA~GSalv~~G~T~vl~ta~~~~~~~~~~----~~~~~~~v~~~~~~~~~~~~~~~~~rre~~~~~re   93 (149)
T d1e3ha2          18 RTIRFETGRLARQAAGSAVAYLDDDTMVLSATTASKNPKDQ----LDFFPLTVDVEERMYAAGKIPGSFFRREGRPSEDA   93 (149)
T ss_dssp             EEEEEEESSSCTTSSEEEEEEETTTEEEEEEEEECSSCCTT----CSSCCEEEEEEECGGGGTCCCCSTTSSCCSCCHHH
T ss_pred             cEEEEEeCcccccCCceEEEEECCcEEEEEeeecccccccc----cccCCceeEEEEeccccccccccccccccccchHH
Confidence            7888899966 579999999999999999888776654432    11445666666644332   32 233444667888


Q ss_pred             HHHHHHHHHHhhhhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCC
Q psy6508         192 KELGNHLKRALEPAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIP  247 (477)
Q Consensus       192 ~~l~~~i~~~l~~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~  247 (477)
                      ....+++.+.++|.+..+.+++.+|.+.+.+++.||+...+++|||++||+|||||
T Consensus        94 il~~rlidR~Lrpl~p~~~~~~~qI~~~vl~~d~d~~~~~aai~aAs~AL~~agIP  149 (149)
T d1e3ha2          94 ILTCRLIDRPLRPSFKKGLRNEIQVVATIMALNPDHLYDVVAINAASASTQLAGLP  149 (149)
T ss_dssp             HHHHHHHHHHHHHHBCTTBCSCEEEEEEEEECCTTSCCHHHHHHHHHHHHHHTTCS
T ss_pred             HHHHHHHHHHHHhhccccCCCceEEEEEEEEeCCCCChHHHHHHHHHHHHHhcCCC
Confidence            99999999999999998889999999999999999999999999999999999998

>d2nn6c1 d.14.1.4 (C:7-187) Exosome complex exonuclease RRP43 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP43
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.34  E-value=5.5e-13  Score=117.79  Aligned_cols=131  Identities=21%  Similarity=0.252  Sum_probs=106.2

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      ++.|.+.+.+|....++||+++..|+|++.+.++++.+.....    . -..|.+.++....|+................
T Consensus        24 ~e~R~~~i~~g~l~~a~GSa~v~~G~T~v~~~v~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (181)
T d2nn6c1          24 GEFRTTTVNIGSISTADGSALVKLGNTTVICGVKAEFAAPSTD----A-PDKGYVVPNVDLPPLCSSRFRSGPPGEEAQV   98 (181)
T ss_dssp             CCCCSCCEEETCCSSSSEEEEEEETTEEEEEEEEEEECCCCSS----S-TTCCCCEEEEECCSSSCTTSCSSSCCHHHHH
T ss_pred             CCccCeEEEeCCcCCCCeEEEEEeCCcEEEEEEeccccccccc----c-CCCceeeeeeeeeccccccccccCCCchhhh
Confidence            5789999999999999999999999999999999876654432    1 3456777777777777655555555566667


Q ss_pred             HHHHHHHHhh--------hhhhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCC
Q psy6508         194 LGNHLKRALE--------PAVCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMY  249 (477)
Q Consensus       194 l~~~i~~~l~--------~~i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~  249 (477)
                      +.+.+.+.+.        ..+..+.+|.|.|.+.++||++||+.+.++++|+++||.|+++|+-
T Consensus        99 ~~~~~~~~~~~~~~~~~~~l~i~~~~~~~~i~i~v~vl~~DG~l~da~~~A~~~AL~d~~iP~v  162 (181)
T d2nn6c1          99 ASQFIADVIENSQIIQKEDLCISPGKLVWVLYCDLICLDYDGNILDACTFALLAALKNVQLPEV  162 (181)
T ss_dssp             HHHHHHHHHHHHCCSCHHHHCSSBTTBCEEEEEEEEESSCCSCTTHHHHHHHHHHHHTCCCCCC
T ss_pred             hHHHHHHHHHhhhhhhhhhccccCCcceEEEEEEEEEecCCCCHHHHHHHHHHHHHHhcCCCeE
Confidence            7777776654        3345778999999999999999999999999999999999999984

>d2je6a1 d.14.1.4 (A:1-191) Exosome complex exonuclease 2,ECX2 {Sulfolobus solfataricus [TaxId: 2287]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease 2,ECX2
species: Sulfolobus solfataricus [TaxId: 2287]

Probab=99.34  E-value=9.7e-13  Score=117.21  Aligned_cols=140  Identities=23%  Similarity=0.238  Sum_probs=111.9

Q ss_pred             Cceeec---cCcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeecccccccc
Q psy6508         107 QNILIK---NNTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRT  183 (477)
Q Consensus       107 ~NIll~---~~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~  183 (477)
                      +||..|   .++.|.+.+.+|....++||++++.|+|++.|.++++.+.....    - ...|.+.+.+...|+....+.
T Consensus        25 ~giR~DGR~~~e~R~i~i~~g~l~~a~GSa~v~~G~T~V~a~V~~~~~~~~~~----~-~~~~~~~~~~~~~~~~~~~~~   99 (191)
T d2je6a1          25 KGIRQDGRKLTDYRPLSITLDYAKKADGSALVKLGTTMVLAGTKLEIDKPYED----T-PNQGNLIVNVELLPLAYETFE   99 (191)
T ss_dssp             GTBCTTSCBTTCCCCEEEEETCSTTSSEEEEEEETTEEEEEEEEEEEECCCTT----C-TTCCEEEEEEEECTTSCTTCC
T ss_pred             cCCCCCCcCCCCccCeEEEECCccCcCceEEEEcCCceEEEEEEecccCchhc----c-CccCccccccccccccccccc
Confidence            344444   35889999999999999999999999999999999876544332    1 556788888888888866666


Q ss_pred             CCCCCcchHHHHHHHHHHhhhh--------hhcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCce
Q psy6508         184 GWLRDSEEKELGNHLKRALEPA--------VCRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDL  251 (477)
Q Consensus       184 ~~~~~~~~~~l~~~i~~~l~~~--------i~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~  251 (477)
                      ..........+.+.+.+.+...        +.....+.|.|++.++||++||+.+.++++|+++||.|+|||+..+
T Consensus       100 ~~~~~~~~~~l~~~l~~~~~~~~~id~~~l~i~~~~~~w~I~v~v~VL~~DG~l~dA~~~A~~~AL~da~iP~v~~  175 (191)
T d2je6a1         100 PGPPDENAIELARVVDRSLRDSKALDLTKLVIEPGKSVWTVWLDVYVLDYGGNVLDACTLASVAALYNTKVYKVEQ  175 (191)
T ss_dssp             CSSCCHHHHHHHHHHHHHHHHTTCSCGGGGEEETTTEEEEEEEEEEEEECCSCHHHHHHHHHHHHHHTCEEEEEEC
T ss_pred             cccCCcchhHHHHHHHHhhcchhhcccccccccCccccEEEEEEEEEEcCCCCHHHHHHHHHHHHHHHcCCCeEEe
Confidence            6566677778888888776543        2345567889999999999999999999999999999999997554

>d2nn6e1 d.14.1.4 (E:5-191) Exosome complex exonuclease RRP42 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP42
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.33  E-value=1.5e-12  Score=115.58  Aligned_cols=130  Identities=20%  Similarity=0.221  Sum_probs=108.1

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      ++.|.+.+.+|....++||++++.|+|++.|.++++.......    - ...|.+.+.+.+.|+.+.......+.....+
T Consensus        26 ~e~R~i~i~~g~l~~a~GSa~v~~G~T~V~~~V~~~~~~~~~~----~-~~~g~~~~~v~~~~~~~~~~~~~~~~~~~~~  100 (187)
T d2nn6e1          26 EDYRCVEVETDVVSNTSGSARVKLGHTDILVGVKAEMGTPKLE----K-PNEGYLEFFVDCSASATPEFEGRGGDDLGTE  100 (187)
T ss_dssp             SCCCCCEEEECCCTTSSSEEEEEETTEEEEEECCCCCSCCCSS----S-CSSCCEEEECCCCTTTCSSCCTTSTHHHHHH
T ss_pred             CCccCeEEEeCccCCCCceEEEEeCCceEEEEEEecccccccc----c-cccceeeeeeeeccccccCcCCCCcchHHHH
Confidence            6889999999999999999999999999999998875544322    1 4557888888888888766665555666778


Q ss_pred             HHHHHHHHhhhhhh--------cccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCC
Q psy6508         194 LGNHLKRALEPAVC--------RHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPM  248 (477)
Q Consensus       194 l~~~i~~~l~~~i~--------~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m  248 (477)
                      +++.+++.+.+...        .+.++.|.+.+.+++|++||+.+.++++|+++||.|+++|.
T Consensus       101 ls~~l~~~l~~~~~~d~~~L~i~~~~~~w~i~v~v~vL~~DG~~~da~~~A~~~AL~d~~iP~  163 (187)
T d2nn6e1         101 IANTLYRIFNNKSSVDLKTLCISPREHCWVLYVDVLLLECGGNLFDAISIAVKAALFNTRIPR  163 (187)
T ss_dssp             HHHHHHHHHHHSCCSCSSSSCSSTTTCCCCEEEEEEECCCCSSHHHHHHHHHHHTTTTCCCCE
T ss_pred             HHHHHHHHhccccccchhhheecCCCccEEEEEEEEEeCCCCCHHHHHHHHHHHHHHhcCCCE
Confidence            88888888876532        44578899999999999999999999999999999999995

>d1r6la2 d.101.1.1 (A:152-239) Ribonuclease PH, domain 2 {Pseudomonas aeruginosa [TaxId: 287]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Ribonuclease PH, domain 2
species: Pseudomonas aeruginosa [TaxId: 287]

Probab=99.28  E-value=8.5e-12  Score=95.83  Aligned_cols=83  Identities=12%  Similarity=0.115  Sum_probs=75.2

Q ss_pred             CCCCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee---ecHHHHHHHHHH
Q psy6508         245 AIPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT---IQQERLADHIEQ  321 (477)
Q Consensus       245 gi~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~---~~~~~~~~~l~~  321 (477)
                      |+||+++|+||++|+.+|.+++||+..|+..          +...++++ ++..++++.++.+|.   ++.+++.++++.
T Consensus         2 g~P~~~~VaavsvG~idg~~vld~~~~E~~~----------~~~Dl~va-~t~~g~i~~iq~~ge~~~~sed~~~~al~~   70 (88)
T d1r6la2           2 GNPLKQMVAAVSVGIYQGVPVLDLDYLEDSA----------AETDLNVV-MTDAGGFIEVQGTAEGAPFRPAELNAMLEL   70 (88)
T ss_dssp             SCCBCCCEEEEEEEEETTEEEESCCHHHHHH----------CSEEEEEE-EETTSCEEEEEEEESSSCCCHHHHHHHHHH
T ss_pred             CCCcCCCccEEEEEEECCEEEecCcHHhhcc----------CceeEEEE-EeCCCCEEeehhhcccCCCCHHHHHHHHHH
Confidence            8999999999999999999999999999984          47889997 567788999998874   899999999999


Q ss_pred             HHhcccchhhHHHHhHhh
Q psy6508         322 LIGCCESLCTDRVQKLVS  339 (477)
Q Consensus       322 ~~~~~~~i~~~~i~~~l~  339 (477)
                      |.++++.++.. +++++.
T Consensus        71 A~~~i~~i~~~-Qkeal~   87 (88)
T d1r6la2          71 AQQGMQELFEL-QRAALA   87 (88)
T ss_dssp             HHHHHHHHHHH-HHHHHT
T ss_pred             HHHHHHHHHHH-HHHHhc
Confidence            99999999999 888765

>d2nn6a1 d.14.1.4 (A:1-184) Exosome complex exonuclease RRP45 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribosomal protein S5 domain 2-like
superfamily: Ribosomal protein S5 domain 2-like
family: Ribonuclease PH domain 1-like
domain: Exosome complex exonuclease RRP45
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.15  E-value=4.8e-11  Score=105.30  Aligned_cols=130  Identities=18%  Similarity=0.208  Sum_probs=103.3

Q ss_pred             CcceeecccccceecccCCcccccCCeEEEeccccccccCCCCCcccccCcceEEEEEEeeeccccccccCCCCCcchHH
Q psy6508         114 NTLKLAGLKQGVSEKAKGSAYIEQGNTKVICSVFEPREIPSSKTSLEYQRSKGELYVEFKFAPFASQIRTGWLRDSEEKE  193 (477)
Q Consensus       114 ~~~rl~~~dfG~~~~~~gs~~~~~g~t~v~~~~y~ppE~~~~~~~~Di~~s~G~il~e~~~~Pf~~~~r~~~~~~~~~~~  193 (477)
                      ++.|.+.+.+|   .++||+++..|+|++.|.+.++.+.....    - -..|.+.+++.+.|+.+.......+......
T Consensus        30 ~e~R~~~i~~g---~a~GSa~v~~G~T~V~~~V~~~~~~p~~~----~-~~~g~~~~~v~~~~~~~~~~~~~~~~~~~~~  101 (184)
T d2nn6a1          30 YDYRNIRISFG---TDYGCCIVELGKTRVLGQVSCELVSPKLN----R-ATEGILFFNLELSQMAAPAFEPGRQSDLLVK  101 (184)
T ss_dssp             TCCCCCEEEEC---SSTTEEEEESSSCEEEEEECCEEECCCST----T-TTSCCEEEEEEECTTTCSSCCSSSTHHHHTH
T ss_pred             CCcCCeEEEec---CCCCEEEEEeCCCEEEEEEEecccccccc----C-CCccceeEEEEeccccCcccccCCCCchhHH
Confidence            57888888888   37999999999999999998876543322    2 4568888999989998766655555556677


Q ss_pred             HHHHHHHHhhhhh--------hcccCCCCcccEEEEEEeCCCchHHHHHHHHHHHHhhCCCCCCce
Q psy6508         194 LGNHLKRALEPAV--------CRHEFSNFQVDLFVLVLQNDGSALSAAINCANLALVDAAIPMYDL  251 (477)
Q Consensus       194 l~~~i~~~l~~~i--------~~~~~Pr~~i~i~v~vL~~dg~~~~a~inaa~lAL~dagi~m~~~  251 (477)
                      +.+.++..+....        ..+.++.|.|.+.+.||++||+.+.++++|+++||.|+++|+..+
T Consensus       102 l~~~l~~~~~~~~~~d~~~L~i~~~~~~w~i~i~v~VL~~DG~~~da~~~a~~~AL~~~~iP~v~v  167 (184)
T d2nn6a1         102 LNRLMERCLRNSKCIDTESLCVVAGEKVWQIRVDLHLLNHDGNIIDAASIAAIVALCHFRRPDVSV  167 (184)
T ss_dssp             HHHHHHHHHHHHTCBCSSSSCSBTTTBEEEEEEEEEECSCCSCCHHHHHHHHHHHHHHCCCCCCBC
T ss_pred             HHHHHHhhhhhhhhhhhhhhccccccCcEEEEEEEEEECCCCCHHHHHHHHHHHHHHhhCCCeEEE
Confidence            7888887765442        245566789999999999999999999999999999999997664

>d2je6a2 d.101.1.1 (A:192-275) Exosome complex exonuclease 2, ECX2 {Sulfolobus solfataricus [TaxId: 2287]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease 2, ECX2
species: Sulfolobus solfataricus [TaxId: 2287]

Probab=99.12  E-value=1.6e-10  Score=87.96  Aligned_cols=80  Identities=15%  Similarity=0.219  Sum_probs=72.4

Q ss_pred             CCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee--ecHHHHHHHHHHHHh
Q psy6508         247 PMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT--IQQERLADHIEQLIG  324 (477)
Q Consensus       247 ~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~--~~~~~~~~~l~~~~~  324 (477)
                      |+++.++++|+++.++.+++|||.+||...          ++.+++++.++ ++++.++..|.  ++.+++.++++.|.+
T Consensus         1 P~~~~~~~vt~~~i~~~~lvDpt~~EE~~~----------~~~l~v~~~~~-g~i~~~~k~g~~~~~~~~i~~~i~~A~~   69 (84)
T d2je6a2           1 PLNYPVVTISVAKVDKYLVVDPDLDEESIM----------DAKISFSYTPD-LKIVGIQKSGKGSMSLQDIDQAENTARS   69 (84)
T ss_dssp             CCSCCCEEEEEEEETTEEEESCCHHHHHHC----------SEEEEEEECTT-CCEEEEEEESSSCEEHHHHHHHHHHHHH
T ss_pred             CCCCCeEEEEEEEECCEEEecCCHHHHHhc----------CCceeeeecCC-CceeeEEeccCCcCCHHHHHHHHHHHHH
Confidence            789999999999999999999999999954          89999998764 88999888764  999999999999999


Q ss_pred             cccchhhHHHHhHh
Q psy6508         325 CCESLCTDRVQKLV  338 (477)
Q Consensus       325 ~~~~i~~~~i~~~l  338 (477)
                      .++.+++. +++.+
T Consensus        70 ~~~~l~~~-l~~~l   82 (84)
T d2je6a2          70 TAVKLLEE-LKKHL   82 (84)
T ss_dssp             HHHHHHHH-HHHHH
T ss_pred             HHHHHHHH-HHHHh
Confidence            99999999 88765

>d1oysa2 d.101.1.1 (A:152-237) Ribonuclease PH, domain 2 {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Ribonuclease PH, domain 2
species: Bacillus subtilis [TaxId: 1423]

Probab=99.06  E-value=3e-10  Score=86.48  Aligned_cols=81  Identities=11%  Similarity=0.131  Sum_probs=70.2

Q ss_pred             CCCCceEEEEEEEeeCCe-EEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEee---ecHHHHHHHHHH
Q psy6508         246 IPMYDLVTSSTLALRGGL-TFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVGT---IQQERLADHIEQ  321 (477)
Q Consensus       246 i~m~~~v~a~s~~~~~~~-~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g~---~~~~~~~~~l~~  321 (477)
                      .||++.|+||++|+.+|. +++||+++|+..          ++..++++. +..++++.++.+|.   ++.+++.++++.
T Consensus         2 ~P~~~~VaavsvG~i~~~~vlldl~~~Ed~~----------~~~D~~va~-t~~g~i~~iq~~ge~~~~s~d~~~~al~l   70 (86)
T d1oysa2           2 NPITDFLAAISVGIDKEQGILLDLNYEEDSS----------AEVDMNVIM-TGSGRFVELQGTGEEATFSREDLNGLLGL   70 (86)
T ss_dssp             CCBCSCEEEEEEEEETTTEEEESCCHHHHHH----------EEEEEEEEE-ETTSCEEEEEEEESSCCCCHHHHHHHHHH
T ss_pred             CCccCcccEEEEEEEcCCcEECCCHHHHhcC----------CCcceEEEE-eCCCCEEEEEEeeccCcccHHHHHHHHHH
Confidence            599999999999999776 578999999884          378899975 55688888888875   999999999999


Q ss_pred             HHhcccchhhHHHHhHh
Q psy6508         322 LIGCCESLCTDRVQKLV  338 (477)
Q Consensus       322 ~~~~~~~i~~~~i~~~l  338 (477)
                      |.++|+.++.. ++++|
T Consensus        71 A~~gi~~I~~~-Qkeal   86 (86)
T d1oysa2          71 AEKGIQELIDK-QKEVL   86 (86)
T ss_dssp             HHHHHHHHHHH-HHHHC
T ss_pred             HHHHHHHHHHH-HHHhC
Confidence            99999999999 77764

>d1udsa2 d.101.1.1 (A:151-255) Ribonuclease PH, domain 2 {Aquifex aeolicus [TaxId: 63363]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Ribonuclease PH, domain 2
species: Aquifex aeolicus [TaxId: 63363]

Probab=99.06  E-value=1.9e-10  Score=90.96  Aligned_cols=88  Identities=13%  Similarity=0.070  Sum_probs=73.4

Q ss_pred             CCCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEE---EeeecHHHHHHHHHHH
Q psy6508         246 IPMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTL---VGTIQQERLADHIEQL  322 (477)
Q Consensus       246 i~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~---~g~~~~~~~~~~l~~~  322 (477)
                      .||++.|+||++|+.+|.+++||+..|..          .+...++++..++ +.+..++.   .|.++.+++.++++.|
T Consensus         3 ~P~~~~VaAVsvG~idg~~vldp~~~Ed~----------~~~~dl~va~t~~-g~~~ei~~~~e~~~~see~~~eal~~a   71 (105)
T d1udsa2           3 TPIKDFVAAVSVGIVNDRILLDLNFEEDS----------AAQVDMNVVGTGS-GRLSEVHTMGEEYSFTKDELIKMLDLA   71 (105)
T ss_dssp             CCBCCCEEEEEEEEETTEEEESCCHHHHH----------TCSEEEEEEEETT-SCEEEEEEEESSCCCCHHHHHHHHHHH
T ss_pred             CCccCCceEEEEEEECCEEeecCCHHHHh----------cCccceeEEEecC-CcchhhhhhhccccccHHHHHHHHHHH
Confidence            69999999999999999999999999988          4578899998765 44444444   4679999999999999


Q ss_pred             HhcccchhhHHHHhHhhhccccc
Q psy6508         323 IGCCESLCTDRVQKLVSDHVTLP  345 (477)
Q Consensus       323 ~~~~~~i~~~~i~~~l~~~~~l~  345 (477)
                      .++|+.+... ++++|.......
T Consensus        72 ~~~i~~i~~~-Qke~l~~~~~~~   93 (105)
T d1udsa2          72 QKGINELIEL-QKKLYVIQDGKW   93 (105)
T ss_dssp             HHHHHHHHHH-HHTTEEEETTEE
T ss_pred             HHHHHHHHHH-HHHHHhcccCcc
Confidence            9999999999 888776554433

>d2ba0g2 d.101.1.1 (G:179-257) Exosome complex exonuclease 2, ECX2 {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease 2, ECX2
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=98.94  E-value=1.3e-09  Score=81.63  Aligned_cols=75  Identities=21%  Similarity=0.362  Sum_probs=67.7

Q ss_pred             CCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe--eecHHHHHHHHHHHHh
Q psy6508         247 PMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG--TIQQERLADHIEQLIG  324 (477)
Q Consensus       247 ~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g--~~~~~~~~~~l~~~~~  324 (477)
                      |+++++.++|+++.++.+++|||.+||..          +.+.+++++.. .++|+.++..|  .++.+++.++++.|.+
T Consensus         1 Pv~~~Pv~vT~~~~~~~~lvDpt~eEE~~----------~~~~iti~~~~-~g~i~~~~k~G~~~~~~~~i~~~i~~A~~   69 (79)
T d2ba0g2           1 PVRDLPVSVTSLIVGNKYLVDPSREEMSV----------GDTTLTITTDK-DDNVVAMQKSGGYLLDEKLFDELLDVSIN   69 (79)
T ss_dssp             CBCCCCEEEEEEEETTEEEESCCTTGGGG----------CSCEEEEEECT-TSCEEEEEEESSCCBCHHHHHHHHHHHHH
T ss_pred             CCCCceEEEEEEEECCEEEECCCHHHHhc----------CCceEEEEEcC-CCCEEEEEccCCCCcCHHHHHHHHHHHHH
Confidence            78999999999999999999999999995          47899999755 57899999987  4889999999999999


Q ss_pred             cccchhhH
Q psy6508         325 CCESLCTD  332 (477)
Q Consensus       325 ~~~~i~~~  332 (477)
                      .++++++.
T Consensus        70 ~~~~l~e~   77 (79)
T d2ba0g2          70 CARKLREK   77 (79)
T ss_dssp             HHHHHTTT
T ss_pred             HHHHHHHH
Confidence            99998876

>d2nn6c2 d.101.1.1 (C:188-276) Exosome complex exonuclease RRP43 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease RRP43
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.85  E-value=2.5e-09  Score=82.10  Aligned_cols=81  Identities=12%  Similarity=0.217  Sum_probs=70.9

Q ss_pred             CCceEEEEEEEeeCCe-EEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe--eecHHHHHHHHHHHHh
Q psy6508         248 MYDLVTSSTLALRGGL-TFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG--TIQQERLADHIEQLIG  324 (477)
Q Consensus       248 m~~~v~a~s~~~~~~~-~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g--~~~~~~~~~~l~~~~~  324 (477)
                      +++++.++|+++.++. +++|||..||..          +.+.+++++.+ .++++.++..|  .++++++.++++.|..
T Consensus         2 i~~~Pi~vT~~~~~~~~~lvDpt~~EE~~----------~~~~lti~~~~-~g~i~~l~k~G~~~l~~~~l~~~~~~A~~   70 (89)
T d2nn6c2           2 IRTHPVATSFAVFDDTLLIVDPTGEEEHL----------ATGTLTIVMDE-EGKLCCLHKPGGSGLTGAKLQDCMSRAVT   70 (89)
T ss_dssp             CSCCCEEEEEEECTTTCCEESCCTTTTTS----------CSEEEEEEECT-TCCEEEEEESCCSCCCHHHHHHHHHHHHH
T ss_pred             ccCCEEEEEEEEECCEEEEEcCCHHHHhc----------CCceEEEEEcC-CCCEEEEEecCCcccCHHHHHHHHHHHHH
Confidence            6788899999999665 788999999984          58999998654 58999999987  5899999999999999


Q ss_pred             cccchhhHHHHhHhhh
Q psy6508         325 CCESLCTDRVQKLVSD  340 (477)
Q Consensus       325 ~~~~i~~~~i~~~l~~  340 (477)
                      .++++++. +++++++
T Consensus        71 ~~~~l~~~-l~~al~~   85 (89)
T d2nn6c2          71 RHKEVKKL-MDEVIKS   85 (89)
T ss_dssp             HHHHHHHH-HHTTTTT
T ss_pred             HHHHHHHH-HHHHHHh
Confidence            99999999 8888765

>d2nn6e2 d.101.1.1 (E:192-285) Exosome complex exonuclease RRP42 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease RRP42
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.77  E-value=5.2e-09  Score=81.04  Aligned_cols=86  Identities=20%  Similarity=0.186  Sum_probs=74.7

Q ss_pred             CCCceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe--eecHHHHHHHHHHHHh
Q psy6508         247 PMYDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG--TIQQERLADHIEQLIG  324 (477)
Q Consensus       247 ~m~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g--~~~~~~~~~~l~~~~~  324 (477)
                      ++..++.++|+++.++.+++|||..||..          +.+.+++++ +..++|+.++..|  .++++++.++++.|.+
T Consensus         2 ~i~~~Pv~vT~~~i~~~~lvDpt~~EE~~----------~~~~l~v~~-~~~g~i~~l~k~G~~~l~~~~i~~~i~~A~~   70 (94)
T d2nn6e2           2 SVENVPCIVTLCKIGYRHVVDATLQEEAC----------SLASLLVSV-TSKGVVTCMRKVGKGSLDPESIFEMMETGKR   70 (94)
T ss_dssp             CCTTCCCCEEEEESSSSEESSCCHHHHTS----------CSEEEEECC-CSSSCCCEEEEEESSCBCHHHHHHHHHHHHH
T ss_pred             CcCceEEEEEEEEECCEEEECCCHHHHhc----------cCceEEEEE-cCCCcEEEEEecCCCccCHHHHHHHHHHHHH
Confidence            45667788999999999999999999985          489999986 4568999999997  4889999999999999


Q ss_pred             cccchhhHHHHhHhhhcccc
Q psy6508         325 CCESLCTDRVQKLVSDHVTL  344 (477)
Q Consensus       325 ~~~~i~~~~i~~~l~~~~~l  344 (477)
                      .++.+++. +.++|.+.-++
T Consensus        71 ~~~el~~~-l~~~L~~~e~~   89 (94)
T d2nn6e2          71 VGKVLHAS-LQSVVHKEESL   89 (94)
T ss_dssp             HHHHHHHH-HHHHHHHHHC-
T ss_pred             HHHHHHHH-HHHHHHHHhhc
Confidence            99999999 99999776544

>d2nn6a2 d.101.1.1 (A:185-302) Exosome complex exonuclease RRP45 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Exosome complex exonuclease RRP45
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.59  E-value=1.2e-07  Score=76.36  Aligned_cols=85  Identities=11%  Similarity=0.188  Sum_probs=73.9

Q ss_pred             CCCceEEEEEEEee--CCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEEe--eecHHHHHHHHHHH
Q psy6508         247 PMYDLVTSSTLALR--GGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLVG--TIQQERLADHIEQL  322 (477)
Q Consensus       247 ~m~~~v~a~s~~~~--~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~g--~~~~~~~~~~l~~~  322 (477)
                      +++.++.++|+++.  ++.+++||+..||..+          .+.+++++.+ .++|++++..|  .++.+++.++++.|
T Consensus         2 ~i~h~Pi~vT~~~~~~g~~~lvDPt~~EE~~~----------~~~ltv~~n~-~gei~~l~k~Gg~~l~~~~l~~~~~~A   70 (118)
T d2nn6a2           2 SIHHMPICVSFAFFQQGTYLLVDPNEREERVM----------DGLLVIAMNK-HREICTIQSSGGIMLLKDQVLRCSKIA   70 (118)
T ss_dssp             CBCCCEEEEEEEECTTTSSEEESCCHHHHHHC----------SCEEEEEEET-TTEEEEEEEESCCCCCHHHHHHHHHHH
T ss_pred             CcCceEEEEEEEEEecCCeEEECCCHHHHhCC----------CCcEEEEEeC-CCcEEEEEecCCcccCHHHHHHHHHHH
Confidence            57788999999986  3579999999999964          7899999854 57999999887  58999999999999


Q ss_pred             HhcccchhhHHHHhHhhhccc
Q psy6508         323 IGCCESLCTDRVQKLVSDHVT  343 (477)
Q Consensus       323 ~~~~~~i~~~~i~~~l~~~~~  343 (477)
                      ...++++.+. +++.|++...
T Consensus        71 ~~~~~el~~~-i~~aLk~~~~   90 (118)
T d2nn6a2          71 GVKVAEITEL-ILKALENDQK   90 (118)
T ss_dssp             HHHHHHHHHH-HHHHHHHHHH
T ss_pred             HHHHHHHHHH-HHHHHHHHHH
Confidence            9999999999 9999876544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.65  E-value=6.1e-05  Score=68.48  Aligned_cols=117  Identities=14%  Similarity=0.186  Sum_probs=76.8

Q ss_pred             CCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC-CCCccceEEEEEeCCeEEEEEecCCCCCHHHHHHhCCCCCHHHHH
Q psy6508           3 QHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH-HQHIVTMLDFLWDERYVYIILEYCDGGDLCSFIRSHEKLSEFQCQ   81 (477)
Q Consensus         3 ~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~~~l~~~~~l~~~~~~   81 (477)
                      +++.+.+|+.......  ....+.+|...++.+. +--+++++.+...++..|+||++.+|.++.+.....     ....
T Consensus        36 ~~~~~vlk~~~~~~~~--~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~-----~~~~  108 (263)
T d1j7la_          36 ENENLYLKMTDSRYKG--TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE-----QSPE  108 (263)
T ss_dssp             SSCEEEEEEECGGGTT--STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC-----SCHH
T ss_pred             CCCeEEEEEcCCCccc--chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc-----ccHH
Confidence            4667888887544221  1234678999988884 444788898888889999999999988876543211     1122


Q ss_pred             HHHHHHHHHHHHHHhC-----------------------------------------------------------CcEEc
Q psy6508          82 QFVRQLVLALKFLREN-----------------------------------------------------------NVCHF  102 (477)
Q Consensus        82 ~i~~qi~~aL~~LH~~-----------------------------------------------------------givHr  102 (477)
                      .+..++...+..||+.                                                           .++|+
T Consensus       109 ~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~Hg  188 (263)
T d1j7la_         109 KIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHG  188 (263)
T ss_dssp             HHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECS
T ss_pred             HHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEe
Confidence            2344444444555421                                                           16899


Q ss_pred             cCCCCceeeccCcceeeccccccee
Q psy6508         103 DLKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus       103 Dlkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      |+.|.||++++++.. ..+||+.+.
T Consensus       189 D~~~~Nil~~~~~~~-~lIDwe~a~  212 (263)
T d1j7la_         189 DLGDSNIFVKDGKVS-GFIDLGRSG  212 (263)
T ss_dssp             CCCTTSEEEETTEEE-EECCCTTCE
T ss_pred             eccCcceeecCCceE-EEeechhcc
Confidence            999999999877543 245887653

>d1hv2a_ d.42.1.1 (A:) Elongin C {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: BTB/POZ domain
domain: Elongin C
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.42  E-value=7.5e-05  Score=57.44  Aligned_cols=79  Identities=16%  Similarity=0.309  Sum_probs=62.7

Q ss_pred             EEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc-cCCcccCCCCHHHHHHHhhhhhc--------------Ccee
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE-KGDTKILDITPEAFSTMLDSDHH--------------ARVN  424 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~-~~~~~~~~~~~~~~~~~l~~~Yt--------------g~~~  424 (477)
                      |++.-.+|   ..|.+.+.+ |..|+.++.|+.+.+.+ ...+.+++++..+|+.+++|++-              ..-+
T Consensus         6 v~L~SsDg---~~f~V~~~~-A~~S~tI~~ml~~~~~e~~~~Ipl~~V~s~iL~kViey~~~h~~~~~~~~~~~~~~efd   81 (99)
T d1hv2a_           6 VTLVSKDD---KEYEISRSA-AMISPTLKAMIEGPFRESKGRIELKQFDSHILEKAVEYLNYNLKYSGVSEDDDEIPEFE   81 (99)
T ss_dssp             EEEEETTT---EEEEEEHHH-HTTCHHHHHHHHSSTTTCTTEEEETTSCHHHHHHHHHHHHHHHHHHHHCSSCSSCCCCC
T ss_pred             EEEEcCCC---CEEEeeHHH-HHHhHHHHHHHHccCCCCcCccccCCCChHHHHHHHHHHHHhhhCcCcccccccCCCCC
Confidence            56666554   899999998 88999999999887666 55689999999999999999962              1234


Q ss_pred             eCccchhhhhhcccccee
Q psy6508         425 ISSDHHARVSISSDHHTR  442 (477)
Q Consensus       425 ~~~~~~~~~~~~a~~~~~  442 (477)
                      +..+.+.+|+.||||+.|
T Consensus        82 vd~~~l~eLi~AAnyLdI   99 (99)
T d1hv2a_          82 IPTEMSLELLLAADYLSI   99 (99)
T ss_dssp             CCHHHHHHHHHHHHHHCC
T ss_pred             CCHHHHHHHHHHHhhhCC
Confidence            455668889999988764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.22  E-value=0.0004  Score=62.45  Aligned_cols=60  Identities=17%  Similarity=0.198  Sum_probs=43.2

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcC--CCCccceEEEEEeCCeEEEEEecCCCCCHH
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLH--HQHIVTMLDFLWDERYVYIILEYCDGGDLC   66 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~--HpnIv~~~~~~~~~~~~~lv~e~~~g~sL~   66 (477)
                      +.+..+.+|.......     ..+..|...++.+.  .--+++++.+..+++..+++|++++|.++.
T Consensus        33 ~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          33 QGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             TTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             CCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            3466688887654422     23667888888773  334788888888888999999999986653

>d2c9wc1 d.42.1.1 (C:17-112) Elongin C {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: BTB/POZ domain
domain: Elongin C
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.22  E-value=0.00012  Score=55.79  Aligned_cols=77  Identities=13%  Similarity=0.201  Sum_probs=54.8

Q ss_pred             EEEEecCccceeeEeeeehhhhcccHHHHHhcCCCc--cc--cCCcccCCCCHHHHHHHhhhhh-----cC------cee
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGEL--CE--KGDTKILDITPEAFSTMLDSDH-----HA------RVN  424 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~--~~--~~~~~~~~~~~~~~~~~l~~~Y-----tg------~~~  424 (477)
                      |+|.-.+|   ..|.+.+.+ |..|+.++.||.+..  .+  .+.+.|++++...|+.+++|++     ++      ..+
T Consensus         3 i~L~SsDg---~~f~V~~~~-A~~S~tI~~ml~~~~~~~e~~~~~IpL~nV~s~iL~kViey~~~h~~~~~~~~~~~~fd   78 (96)
T d2c9wc1           3 VKLISSDG---HEFIVKREH-ALTSGTIKAMLSGPGQFAENETNEVNFREIPSHVLSKVCMYFTYKVRYTNSSTEIPEFP   78 (96)
T ss_dssp             EEEECTTC---CEEEEEHHH-HTTSHHHHHC------------CEEECTTCCHHHHHHHHHHHHHHHHTC----CCCCCC
T ss_pred             EEEEcCCC---CEEEeeHHH-HHHhHHHHHHHhccCccccCCCCeeECCCCCHHHHHHHHHHHHhhccCcCCcCCCCCCc
Confidence            34555443   889999998 999999999996543  22  4557999999999999999995     22      223


Q ss_pred             eCccchhhhhhccccc
Q psy6508         425 ISSDHHARVSISSDHH  440 (477)
Q Consensus       425 ~~~~~~~~~~~~a~~~  440 (477)
                      +..+.+.+|+.||||+
T Consensus        79 i~~~~l~eLi~AAnyL   94 (96)
T d2c9wc1          79 IAPEIALELLMAANFL   94 (96)
T ss_dssp             CCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhhh
Confidence            5667788899999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=96.35  E-value=0.0027  Score=61.16  Aligned_cols=60  Identities=18%  Similarity=0.076  Sum_probs=35.2

Q ss_pred             CCcEEEEEEcccC-CC-C---hhHHHHHHHHHHHHHhcC-C--CCccceEEEEEeCCeEEEEEecCCCCC
Q psy6508           3 QHTEVAIKCIDKT-KV-S---ENRFDSIVNEIKALKLLH-H--QHIVTMLDFLWDERYVYIILEYCDGGD   64 (477)
Q Consensus         3 ~g~~vAiK~i~~~-~~-~---~~~~~~~~~E~~il~~l~-H--pnIv~~~~~~~~~~~~~lv~e~~~g~s   64 (477)
                      +++.|++|.-... .. .   +....+...|...|+.+. +  ..+++++.+  ++...++|||++++..
T Consensus        50 ~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~lvmE~L~~~~  117 (392)
T d2pula1          50 HDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVMEDLSHLK  117 (392)
T ss_dssp             --CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEECCCTTSE
T ss_pred             CCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEEEEeccCCcc
Confidence            4678999964321 00 0   111234557888888772 2  456777754  4555679999998644

>d3kvta_ d.42.1.2 (A:) akv3.1 voltage-gated potassium channel {California sea hare (Aplysia californica) [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: Tetramerization domain of potassium channels
domain: akv3.1 voltage-gated potassium channel
species: California sea hare (Aplysia californica) [TaxId: 6500]

Probab=95.95  E-value=0.0015  Score=50.11  Aligned_cols=81  Identities=14%  Similarity=0.134  Sum_probs=60.8

Q ss_pred             EEEEecCccceeeEeeeehhhhcccH-HHHHhcCCCccc--cCCcccCCCCHHHHHHHhhhhhcCceeeCccc-hhhhhh
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSP-VFATMFHGELCE--KGDTKILDITPEAFSTMLDSDHHARVNISSDH-HARVSI  435 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~-~f~~~f~~~~~~--~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~~-~~~~~~  435 (477)
                      |+|-|||    +.|.+.+..|..... +|..++......  ......-|=+|+.|+.+|+|+-+|++.+..+. ...++.
T Consensus         4 I~LNVGG----~~F~t~~~tL~~~~~s~l~~~~~~~~~~~~~~~~~fiDRdp~~F~~IL~ylR~g~l~~p~~~~~~~l~~   79 (103)
T d3kvta_           4 VIINVGG----IRHETYKATLKKIPATRLSRLTEGMLNYDPVLNEYFFDRHPGVFAQIINYYRSGKLHYPTDVCGPLFEE   79 (103)
T ss_dssp             EEEEETT----EEEEEEHHHHTTSCSSTTTTCCTTSTTEETTTTEEEECSCTTTHHHHHHHHHHSCBCCCSSSCHHHHHH
T ss_pred             EEEEECC----EEEEEeHHHHhhCccchhHHHHcCCCccCCCCCcEEecCCHHHHHHHHHHHccCCcccccccCHHHHHH
Confidence            7899999    999999999997654 555565544322  22233448999999999999999999887653 566777


Q ss_pred             ccccceeec
Q psy6508         436 SSDHHTRVS  444 (477)
Q Consensus       436 ~a~~~~~~~  444 (477)
                      -|+++.|..
T Consensus        80 Ea~yygi~~   88 (103)
T d3kvta_          80 ELEFWGLDS   88 (103)
T ss_dssp             HHHHHTCCG
T ss_pred             HHHHcCCCH
Confidence            788887753

>d1e3ha5 d.101.1.1 (A:152-262) Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 2 and 5 {Streptomyces antibioticus [TaxId: 1890]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 2 and 5
species: Streptomyces antibioticus [TaxId: 1890]

Probab=95.71  E-value=0.031  Score=43.02  Aligned_cols=79  Identities=15%  Similarity=0.088  Sum_probs=56.7

Q ss_pred             CceEEEEEEEeeCCeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCC---CcEEEEEEEee-------------ecH
Q psy6508         249 YDLVTSSTLALRGGLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVI---QQVTQVTLVGT-------------IQQ  312 (477)
Q Consensus       249 ~~~v~a~s~~~~~~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~---~~i~~~~~~g~-------------~~~  312 (477)
                      .+.++|+-+|..+|+++++||.+|.+.          +.-.+.+|-....   ..+..+...|.             ++.
T Consensus         2 ~GPvgaVRVg~idge~viNPt~~el~~----------S~ldLvVaGt~~~~~~~~v~mie~~~~e~~~~mie~~a~e~~E   71 (111)
T d1e3ha5           2 SGPIGGVRVALIRGQWVAFPTHTELED----------AVFDMVVAGRVLEDGDVAIMMVEAEATEKTIQLVKDGAEAPTE   71 (111)
T ss_dssp             CCCCEEEEEEEETTEEEESCCHHHHTT----------EEEEEEEEEEECTTSCEEEEEEEEEECTTHHHHHHTTCCCCCH
T ss_pred             CCCEEEEEEEEECCEEEECCCHHHHhc----------CceEEEEeecccccchHHHHHHHhcchhHHHHHHHhccccccH
Confidence            467899999999999999999999883          2344444432221   23555555553             567


Q ss_pred             HHHHHHHHHHHhcccchhhHHHHhHh
Q psy6508         313 ERLADHIEQLIGCCESLCTDRVQKLV  338 (477)
Q Consensus       313 ~~~~~~l~~~~~~~~~i~~~~i~~~l  338 (477)
                      +.+.++++.|.+..+.+... +.+..
T Consensus        72 ~~~~~ai~~a~~~i~~~i~~-q~el~   96 (111)
T d1e3ha5          72 EVVAAGLDAAKPFIKVLCKA-QADLA   96 (111)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH-HHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHH-HHHHH
Confidence            88999999999999998877 44433

>d1e3ha6 d.101.1.1 (A:483-578) Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 2 and 5 {Streptomyces antibioticus [TaxId: 1890]}

class: Alpha and beta proteins (a+b)
fold: Ribonuclease PH domain 2-like
superfamily: Ribonuclease PH domain 2-like
family: Ribonuclease PH domain 2-like
domain: Polynucleotide phosphorylase/guanosine pentaphosphate synthase (PNPase/GPSI), domains 2 and 5
species: Streptomyces antibioticus [TaxId: 1890]

Probab=95.47  E-value=0.023  Score=41.77  Aligned_cols=78  Identities=17%  Similarity=0.155  Sum_probs=65.3

Q ss_pred             eEEEEEEEeeC--------CeEEeCCChHHHhhhccCCCCCCCCCceEEEEEccCCCcEEEEEEE---eeecHHHHHHHH
Q psy6508         251 LVTSSTLALRG--------GLTFIDPVEEEVAYCQSLSSSEDDDSGVITLSYMSVIQQVTQVTLV---GTIQQERLADHI  319 (477)
Q Consensus       251 ~v~a~s~~~~~--------~~~~~Dp~~~E~~~~~~~~~~~~~~~~~~~~a~~~~~~~i~~~~~~---g~~~~~~~~~~l  319 (477)
                      .|+++++++..        ..++.|-...|...            |.+-|-+....+-|+.+|++   ..++.+-+.+++
T Consensus         2 PVAGIamGLi~~~~~~~~~~~iLtDI~G~ED~~------------GDMDFKVAGT~~GITa~QmDiKi~Gi~~~il~~Al   69 (96)
T d1e3ha6           2 PVAGIAMGLISQEINGETHYVALTDILGAEDAF------------GDMDFKVAGTKEFVTALQLDTKLDGIPASVLAAAL   69 (96)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEESSCCSHHHHH------------CSEEEEEEECSSCEEEEEEEECCSCCCHHHHHHHH
T ss_pred             CcceeeeeeeeccCCCCccEEEEeeccCchhhc------------cCcccccccCcccceeeeeeecccCCCHHHHHHHH
Confidence            46778888762        14688999999874            67888777888889999999   778999999999


Q ss_pred             HHHHhcccchhhHHHHhHhhhc
Q psy6508         320 EQLIGCCESLCTDRVQKLVSDH  341 (477)
Q Consensus       320 ~~~~~~~~~i~~~~i~~~l~~~  341 (477)
                      +.|+++...+-.. |.+++..+
T Consensus        70 ~qAk~gR~~IL~~-M~~~i~~p   90 (96)
T d1e3ha6          70 KQARDARLHILDV-MMEAIDTP   90 (96)
T ss_dssp             HHHHHHHHHHHHH-HHHHCSSC
T ss_pred             HHHHHHHHHHHHH-HHHHhccc
Confidence            9999999999999 99888654

>d1nn7a_ d.42.1.2 (A:) Potassium channel kv4.2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: Tetramerization domain of potassium channels
domain: Potassium channel kv4.2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=95.47  E-value=0.002  Score=49.55  Aligned_cols=81  Identities=9%  Similarity=0.126  Sum_probs=58.9

Q ss_pred             EEEEecCccceeeEeeeehhhhcccH-HHHHhcCCCccc-cCCcccCCCCHHHHHHHhhhhhcCceeeCccc-hhhhhhc
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSP-VFATMFHGELCE-KGDTKILDITPEAFSTMLDSDHHARVNISSDH-HARVSIS  436 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~-~f~~~f~~~~~~-~~~~~~~~~~~~~~~~~l~~~Ytg~~~~~~~~-~~~~~~~  436 (477)
                      |+|.|||    +.|...+..|+.... ++..++...... ......-|=+|..|+.+|+|+-+|++.+..+. ...++.-
T Consensus         2 I~LNVGG----~~f~t~~~TL~~~p~s~l~~~~~~~~~~~~~~~~FiDRdp~~F~~IL~ylR~G~l~~p~~~~~~~l~~E   77 (105)
T d1nn7a_           2 IVLNVSG----TRFQTWQDTLERYPDTLLGSSERDFFYHPETQQYFFDRDPDIFRHILNFYRTGKLHYPRHECISAYDEE   77 (105)
T ss_dssp             EEEEETT----EEEEECHHHHHTSCSSSTTSGGGGGGEEGGGTEEEECSCTTTHHHHHHHHHHSCBCCCTTSCHHHHHHH
T ss_pred             EEEEECC----EEEEEeHHHHhcCCCCCccccccccCcCCCCCcEEEeCCHHHHHHHHHHHhcCccccCCCccHHHHHHH
Confidence            6899999    999999999987654 333333333222 22234557899999999999999999886654 5667777


Q ss_pred             cccceeec
Q psy6508         437 SDHHTRVS  444 (477)
Q Consensus       437 a~~~~~~~  444 (477)
                      |+++.|..
T Consensus        78 a~fygi~~   85 (105)
T d1nn7a_          78 LAFFGLIP   85 (105)
T ss_dssp             HHHHTCCS
T ss_pred             HHHcCCCH
Confidence            88887754

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.08  E-value=0.024  Score=52.57  Aligned_cols=59  Identities=15%  Similarity=0.284  Sum_probs=37.7

Q ss_pred             CCCcEEEEEEcccCCCChhHHHHHHHHHHHHHhcCCCCc-----cce--EEEEEeCCeEEEEEecCCCC
Q psy6508           2 EQHTEVAIKCIDKTKVSENRFDSIVNEIKALKLLHHQHI-----VTM--LDFLWDERYVYIILEYCDGG   63 (477)
Q Consensus         2 ~~g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnI-----v~~--~~~~~~~~~~~lv~e~~~g~   63 (477)
                      ++|+.|++|+.+....+.   +++..|...+..|....+     +..  -..+...+..+.++++.+|.
T Consensus        44 ~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~  109 (325)
T d1zyla1          44 EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  109 (325)
T ss_dssp             TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence            578889999976544333   456778888887742111     111  11234567789999998863

>d1fs1b2 d.42.1.1 (B:2-68) Cyclin A/CDK2-associated p45, Skp1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: BTB/POZ domain
domain: Cyclin A/CDK2-associated p45, Skp1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.11  E-value=0.042  Score=37.23  Aligned_cols=55  Identities=11%  Similarity=0.138  Sum_probs=44.2

Q ss_pred             EEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccccCCcccCCCCHHHHHHHhhhhhc
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCEKGDTKILDITPEAFSTMLDSDHH  420 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~~~~~~~~~~~~~~~~~~l~~~Yt  420 (477)
                      |+|.-.+|   ..|.+-+. .|..|...+.|+.+..  ...+.+++++...|+.+++|++-
T Consensus         3 I~L~SsDg---~~f~v~~~-~a~~S~tI~~ml~~~~--~~~Ipl~~V~s~iL~kVieyc~~   57 (61)
T d1fs1b2           3 IKLQSSDG---EIFEVDVE-IAKQSVTIKTMLEDLG--MDPVPLPNVNAAILKKVIQWCTH   57 (61)
T ss_dssp             EEEECTTS---CEEEEEGG-GGGTCHHHHHHHHHTC--CSSEECTTCCHHHHHHHHHHHHH
T ss_pred             EEEEecCC---CEEEecHH-HHHHhHHHHHHHhcCC--CCCcccCCcCHHHHHHHHHHHHH
Confidence            45555444   88999888 6889999999996533  45688999999999999999873

>d1t1da_ d.42.1.2 (A:) Shaker potassium channel {California sea hare (Aplysia californica) [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: Tetramerization domain of potassium channels
domain: Shaker potassium channel
species: California sea hare (Aplysia californica) [TaxId: 6500]

Probab=94.10  E-value=0.0071  Score=45.89  Aligned_cols=79  Identities=10%  Similarity=0.043  Sum_probs=57.8

Q ss_pred             EEEEecCccceeeEeeeehhhhcc-cHHHHHhcCCCccc---cCCcccCCCCHHHHHHHhhhhhc-CceeeCccc-hhhh
Q psy6508         360 CKFYVGNDVHCKEFKAHKLILSMS-SPVFATMFHGELCE---KGDTKILDITPEAFSTMLDSDHH-ARVNISSDH-HARV  433 (477)
Q Consensus       360 ~~~~v~~~~~~~~~~~hk~vLa~~-S~~f~~~f~~~~~~---~~~~~~~~~~~~~~~~~l~~~Yt-g~~~~~~~~-~~~~  433 (477)
                      |+|-|||    +.|.+-|..|... +.++.+|+......   ++++ .-|=+|+.|+.+|+|+-| |.+....+. ...+
T Consensus         3 I~LNVGG----~~f~t~~~tL~~~p~s~l~~l~~~~~~~~~~~g~~-FiDRdp~~F~~IL~flR~~~~l~~~~~~~~~~l   77 (100)
T d1t1da_           3 VVINVSG----LRFETQLKTLNQFPDTLLGNPQKRNRYYDPLRNEY-FFDRNRPSFDAILYFYQSGGRLRRPVNVPLDVF   77 (100)
T ss_dssp             EEEEETT----EEEEEEHHHHHTSTTSTTTCHHHHGGGEETTTTEE-EECSCSTTHHHHHHHHHTTSCCCCCTTSCHHHH
T ss_pred             EEEEECC----EEEEEeHHHHhhCCCchhHHHHhCCCcCCCCCCeE-EEecCHHHHHHHHHHHhcCCCcCCCCcccHHHH
Confidence            6899999    9999999999985 56777777544322   3333 337799999999999988 465554433 5667


Q ss_pred             hhccccceee
Q psy6508         434 SISSDHHTRV  443 (477)
Q Consensus       434 ~~~a~~~~~~  443 (477)
                      +.-|+++.|-
T Consensus        78 ~~Ea~y~gi~   87 (100)
T d1t1da_          78 SEEIKFYELG   87 (100)
T ss_dssp             HHHHHHTTCC
T ss_pred             HHHHHHcCCC
Confidence            7778887653

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=91.80  E-value=0.11  Score=49.11  Aligned_cols=54  Identities=15%  Similarity=0.113  Sum_probs=35.1

Q ss_pred             CcEEEEEEcccCCCChhHHHHHHHHHHHHHhc-CCCCccceEEEEEeCCeEEEEEecCCCCCH
Q psy6508           4 HTEVAIKCIDKTKVSENRFDSIVNEIKALKLL-HHQHIVTMLDFLWDERYVYIILEYCDGGDL   65 (477)
Q Consensus         4 g~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l-~HpnIv~~~~~~~~~~~~~lv~e~~~g~sL   65 (477)
                      ++.|.+++.... ..   .....+|..+++.+ .+.-.+++++++.+    .+|+||++|.+|
T Consensus        74 ~~~vllRi~g~~-~~---~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          74 PNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             CSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             CCcEEEEecCCc-ch---hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            355667765421 11   22345899999988 45556788887643    589999987544

>d1nexa2 d.42.1.1 (A:4-103) Centromere DNA-binding protein complex Cbf3 subunit D, CBF3D {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: POZ domain
superfamily: POZ domain
family: BTB/POZ domain
domain: Centromere DNA-binding protein complex Cbf3 subunit D, CBF3D
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=91.58  E-value=0.16  Score=35.51  Aligned_cols=58  Identities=9%  Similarity=0.182  Sum_probs=42.8

Q ss_pred             eEEEEecCccceeeEeeeehhhhcccHHHHHhcCCCccc------cCCcccCCCCHHHHHHHhhhhhc
Q psy6508         359 DCKFYVGNDVHCKEFKAHKLILSMSSPVFATMFHGELCE------KGDTKILDITPEAFSTMLDSDHH  420 (477)
Q Consensus       359 D~~~~v~~~~~~~~~~~hk~vLa~~S~~f~~~f~~~~~~------~~~~~~~~~~~~~~~~~l~~~Yt  420 (477)
                      -|+|.-.+|   ++|.+-+. .|..|..-+.|+.....+      ...|.+++++..+|+.+++|++-
T Consensus         2 ~I~L~SsDg---~~F~v~~~-~a~~S~tIk~ml~~~~~~~~~~~~~~~Ipl~~V~s~iL~kVieyc~~   65 (72)
T d1nexa2           2 NVVLVSGEG---ERFTVDKK-IAERSLLLKNYLNDMGDDDDEDDDEIVMPVPNVRSSVLQKVIEWAEH   65 (72)
T ss_dssp             EEEEECTTS---CEEEEEHH-HHTTSHHHHHTC-------------CEEECTTCCHHHHHHHHHHHHH
T ss_pred             eeEEEeCCC---CEEEecHH-HHHHHHHHHHHHHhcCccccccCCCCcccCCCcCHHHHHHHHHHHHH
Confidence            366666554   88999887 688999999999643222      23478999999999999999864

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=83.26  E-value=0.16  Score=46.12  Aligned_cols=30  Identities=20%  Similarity=0.197  Sum_probs=24.0

Q ss_pred             CCcEEccCCCCceeeccCcceeeccccccee
Q psy6508          97 NNVCHFDLKPQNILIKNNTLKLAGLKQGVSE  127 (477)
Q Consensus        97 ~givHrDlkp~NIll~~~~~rl~~~dfG~~~  127 (477)
                      .|++|+|+.+.|++++++++. ..+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~-gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELS-GLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEE-EECCCTTCE
T ss_pred             cccccCCcchhhhhcccccce-eEecccccc
Confidence            479999999999999987643 457888763